text,title,id,project_number,terms,administration,organization,mechanism,year,funding,score
"ADOLESCENT DRUG USE IN RURAL AMERICA DESCRIPTION:  (Applicant's Abstract)                                                                                                                              This project will provide detailed data on alcohol and drug use and              associated risk factors among rural youth.  Surveys will be administered to      7th-12th grade students in a national sample of rural schools stratified by      region and rurality (county population and distance from a metropolitan          center) with a comparison sample of non-rural schools.  Schools that are         African-American and Mexican-American will be oversampled.  (Comparable data     on drug use of American Indian youth, the other major rural ethnic minority      group, will be available from another project.) The study will also obtain       data on violence, victimization, high risk drug use behaviors, and               delinquency and their relationship to drug use.  The study will use              structural equation modeling to examine how individual risk factors relate       to drug use and delinquency of rural youth and determine whether there are       differences in those relationships by age, gender, ethnicity, and rurality.      Individual risk factors include socialization characteristics such as family     relationships, parental monitoring, school adjustment and peer influences,       personal characteristics such as excitement/risk seeking, anger, emotional       distress, tolerance of deviance and social alienation, and cultural              identification.  The study will use hierarchical linear modeling to              determine how differences in drug use rates across schools are related to        different levels of personal and social risk factors among students in those     schools and to community and school characteristics including school             structure, school normlessness, poverty, ethnic heterogeneity, ascriptive        inequality, community industrial structure, age structure, population            mobility, and family disorganization, and whether these relationships differ     by rurality.                                                                      ",ADOLESCENT DRUG USE IN RURAL AMERICA,2458430,R01DA009349,"['behavioral /social science research tag ', ' clinical research ', ' age difference ', ' violence ', ' rural area ', ' residential mobility ', ' low socioeconomic status ', ' socializations ', ' crime victims ', ' racial /ethnic difference ', ' gender difference ', ' social adjustment ', ' peer group ', ' high risk behavior /lifestyle ', ' mathematical model ', ' mental health epidemiology ', ' human subject ', ' parent offspring interaction ', ' family structure /dynamics ', ' secondary schools ', ' marijuana abuse ', ' adolescence (12-20) ', ' juvenile delinquency ', ' alcoholism /alcohol abuse ', ' ']",NIDA,COLORADO STATE UNIVERSITY,R01,1997,388307,0.16748361737736484
"ADOLESCENT DRUG USE IN RURAL AMERICA DESCRIPTION:  (Applicant's Abstract)                                                                                                                              This project will provide detailed data on alcohol and drug use and              associated risk factors among rural youth.  Surveys will be administered to      7th-12th grade students in a national sample of rural schools stratified by      region and rurality (county population and distance from a metropolitan          center) with a comparison sample of non-rural schools.  Schools that are         African-American and Mexican-American will be oversampled.  (Comparable data     on drug use of American Indian youth, the other major rural ethnic minority      group, will be available from another project.) The study will also obtain       data on violence, victimization, high risk drug use behaviors, and               delinquency and their relationship to drug use.  The study will use              structural equation modeling to examine how individual risk factors relate       to drug use and delinquency of rural youth and determine whether there are       differences in those relationships by age, gender, ethnicity, and rurality.      Individual risk factors include socialization characteristics such as family     relationships, parental monitoring, school adjustment and peer influences,       personal characteristics such as excitement/risk seeking, anger, emotional       distress, tolerance of deviance and social alienation, and cultural              identification.  The study will use hierarchical linear modeling to              determine how differences in drug use rates across schools are related to        different levels of personal and social risk factors among students in those     schools and to community and school characteristics including school             structure, school normlessness, poverty, ethnic heterogeneity, ascriptive        inequality, community industrial structure, age structure, population            mobility, and family disorganization, and whether these relationships differ     by rurality.                                                                      ",ADOLESCENT DRUG USE IN RURAL AMERICA,2770104,R01DA009349,"['substance abuse epidemiology ', ' behavioral /social science research tag ', ' clinical research ', ' age difference ', ' violence ', ' rural area ', ' residential mobility ', ' low socioeconomic status ', ' socializations ', ' crime victims ', ' racial /ethnic difference ', ' gender difference ', ' social adjustment ', ' peer group ', ' high risk behavior /lifestyle ', ' mathematical model ', ' human subject ', ' parent offspring interaction ', ' family structure /dynamics ', ' secondary schools ', ' marijuana abuse ', ' adolescence (12-20) ', ' juvenile delinquency ', ' alcoholism /alcohol abuse ', ' ']",NIDA,COLORADO STATE UNIVERSITY,R01,1998,691699,0.16748361737736484
"ADOLESCENT DRUG USE IN RURAL AMERICA DESCRIPTION:  (Applicant's Abstract)                                                                                                                              This project will provide detailed data on alcohol and drug use and              associated risk factors among rural youth.  Surveys will be administered to      7th-12th grade students in a national sample of rural schools stratified by      region and rurality (county population and distance from a metropolitan          center) with a comparison sample of non-rural schools.  Schools that are         African-American and Mexican-American will be oversampled.  (Comparable data     on drug use of American Indian youth, the other major rural ethnic minority      group, will be available from another project.) The study will also obtain       data on violence, victimization, high risk drug use behaviors, and               delinquency and their relationship to drug use.  The study will use              structural equation modeling to examine how individual risk factors relate       to drug use and delinquency of rural youth and determine whether there are       differences in those relationships by age, gender, ethnicity, and rurality.      Individual risk factors include socialization characteristics such as family     relationships, parental monitoring, school adjustment and peer influences,       personal characteristics such as excitement/risk seeking, anger, emotional       distress, tolerance of deviance and social alienation, and cultural              identification.  The study will use hierarchical linear modeling to              determine how differences in drug use rates across schools are related to        different levels of personal and social risk factors among students in those     schools and to community and school characteristics including school             structure, school normlessness, poverty, ethnic heterogeneity, ascriptive        inequality, community industrial structure, age structure, population            mobility, and family disorganization, and whether these relationships differ     by rurality.                                                                      ",ADOLESCENT DRUG USE IN RURAL AMERICA,2897943,R01DA009349,"['alcoholism /alcohol abuse ', ' juvenile delinquency ', ' adolescence (12-18) ', ' marijuana abuse ', ' secondary school ', ' family structure /dynamics ', ' parent offspring interaction ', ' human subject ', ' mathematical model ', ' high risk life style ', ' peer group ', ' social adjustment ', ' racial /ethnic difference ', ' crime victim ', ' socialization ', ' low income ', ' residential mobility ', ' rural area ', ' violence ', ' age difference ', ' clinical research ', ' behavioral /social science research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' sex difference ', ' ']",NIDA,COLORADO STATE UNIVERSITY,R01,1999,492764,0.16748361737736484
"ADOLESCENT DRUG USE IN RURAL AMERICA DESCRIPTION:  (Applicant's Abstract)                                                                                                                              This project will provide detailed data on alcohol and drug use and              associated risk factors among rural youth.  Surveys will be administered to      7th-12th grade students in a national sample of rural schools stratified by      region and rurality (county population and distance from a metropolitan          center) with a comparison sample of non-rural schools.  Schools that are         African-American and Mexican-American will be oversampled.  (Comparable data     on drug use of American Indian youth, the other major rural ethnic minority      group, will be available from another project.) The study will also obtain       data on violence, victimization, high risk drug use behaviors, and               delinquency and their relationship to drug use.  The study will use              structural equation modeling to examine how individual risk factors relate       to drug use and delinquency of rural youth and determine whether there are       differences in those relationships by age, gender, ethnicity, and rurality.      Individual risk factors include socialization characteristics such as family     relationships, parental monitoring, school adjustment and peer influences,       personal characteristics such as excitement/risk seeking, anger, emotional       distress, tolerance of deviance and social alienation, and cultural              identification.  The study will use hierarchical linear modeling to              determine how differences in drug use rates across schools are related to        different levels of personal and social risk factors among students in those     schools and to community and school characteristics including school             structure, school normlessness, poverty, ethnic heterogeneity, ascriptive        inequality, community industrial structure, age structure, population            mobility, and family disorganization, and whether these relationships differ     by rurality.                                                                      ",ADOLESCENT DRUG USE IN RURAL AMERICA,6175547,R01DA009349,"['substance abuse related behavior ', ' substance abuse epidemiology ', ' behavioral /social science research tag ', ' clinical research ', ' age difference ', ' violence ', ' rural area ', ' residential mobility ', ' low socioeconomic status ', ' socializations ', ' crime victims ', ' racial /ethnic difference ', ' gender difference ', ' social adjustment ', ' peer group ', ' high risk behavior /lifestyle ', ' mathematical model ', ' human subject ', ' parent offspring interaction ', ' family structure /dynamics ', ' secondary schools ', ' marijuana abuse ', ' adolescence (12-20) ', ' juvenile delinquency ', ' alcoholism /alcohol abuse ', ' ']",NIDA,COLORADO STATE UNIVERSITY,R01,2000,453552,0.16748361737736484
"Homeless Women--Drugs, Race/Ethicity, And Health Care   DESCRIPTION: (provided by applicant)                                                 Research has shown that drug use and physical health problems are quite common       among the homeless and that their general health-care needs often go unmet.          However, much of this research is based on samples composed largely of homeless      men. To date, there has been little research on the relationship between drug        use and utilization of general health care among homeless women. Moreover,           possible racial/ethnic differences in this relationship have not been                extensively examined. This study will employ secondary data from two                 complementary funded studies to analyze the association between drug use and         use of general health care (inpatient, ambulatory, and preventive). The first        dataset screened for lifetime drug dependence in a community-based probability       sample of 861 homeless women in Los Angeles County, and the second dataset           assessed current heavy drug use and lifetime injection drug use in a purposive       sample of 1,330 homeless women in Los Angeles. We will test hypotheses               regarding a wide range of predisposing and enabling factors (such as case            management, health insurance, and access to public benefits) potentially             associated with access to general health services by African American, Latina,       and White homeless women with drug problems. The proposed study directly             addresses policy questions prominent in NIDA's strategic plan on reducing            health disparities. By documenting the nature and extent of health problems          affecting drug-using homeless women, their use of general health services, the       extent to which their need for care goes unmet, and possible racial/ethnic           differences in these patterns, this study will inform drug treatment providers       on the value and content of screening/assessment procedures they might employ        and the types of general health services for which more effective linkage is         needed.                                                                                                                                                                   ","Homeless Women--Drugs, Race/Ethicity, And Health Care",6447366,R01DA014835,"['drug abuse ', ' health care service utilization ', ' female ', ' homeless ', ' racial /ethnic difference ', ' human data ', "" women's health "", ' behavioral /social science research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2001,314346,0.18627626917048123
"IDU Access to HIV/HCV Prevention   DESCRIPTION: (provided by applicant)                                                                                      A recent health promotion campaign in Rhode Island (RI) to prevent HIV and           Hepatitis C prompted the deregulation of syringes, allowing their sale in            pharmacies without a prescription. Included in this law is that pharmacies may       sell syringes: if so, pharmacists are required to provide syringe disposal           information and may provide drug treatment referral information. This proposal       is to investigate racial/ethnic and gender disparities in access to                  pharmacy-based prevention services associated with this law change. We propose       to evaluate racial/ethnic and gender disparities by geographic barriers              (Specific Aim 1), barriers related to drug users (the consumer of these              services) (Specific Aim 2), and barriers related to pharmacists (the providers       of these services) (Specific Aim 3). We limit our evaluation to the two largest      non-white groups in RI, African Americans/Blacks, and Latino/ Hispanics in           comparison to whites. Geocoding methods will be used for Specific Aim 1. Census      2000 data will be used to identify racially diverse block groups. Socioeconomic      conditions will be quantified to adjust for class in analyses of race. Both          pharmacy and drug user locations will be overlaid to determine geographic            barriers to access. For drug user studies, qualitative and quantitative methods      will determine both perceived and real barriers to accessing pharmacy                prevention services. The qualitative study will use a targeted street                recruitment of injection drug users, while the quantitative study will include       participants in existing drug user cohorts. For pharmacy-related studies, all        pharmacies in the state will be included. We propose a purchaser experience          trial where non-drug using purchasers of different racial/ethnic groups attempt      to purchase a syringe, as well as a pharmacist telephone survey, evaluating          attitudes regarding the law change, their perception regarding drug users and        racial/ethnic groups in general. Analyses will evaluate access (or barriers to       access) and its relation to race, across and between racially and                    socioeconomically diverse neighborhoods. These analyses will provide important       data regarding the implementation of a policy change and the need for targeted       solutions in response to racial disparities.                                                                                                                              ",IDU Access to HIV/HCV Prevention,6447495,R01DA014853,"['communicable disease control ', ' communicable disease transmission ', ' disease /disorder proneness /risk ', ' pharmacy administration ', ' intravenous drug abuse ', ' health care service availability ', ' human subject ', ' interview ', ' questionnaire ', ' statistics /biometry ', ' high risk life style ', ' gender difference ', ' African American ', ' Hispanic American ', ' racial /ethnic difference ', ' socioenvironment ', ' virus infection mechanism ', ' human immunodeficiency virus ', ' needle sharing ', ' hepatitis C ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' medically underserved population ', ' ']",NIDA,BROWN UNIVERSITY,R01,2001,392500,0.13849189066326564
"Drug use and health disparities in 2 Indian populations                                     DESCRIPTION: (provided by applicant)                                                                                                American Indian (AI) youth consistently report higher use of drugs than other        populations in the United States. Further, AI youth are as likely, if not more       so, to experience serious consequences from drug use. However much remains           unknown: The extant literature is largely restricted to AI youth and,                generally, little attention is paid to cultural differences. A more                  comprehensive description of the negative consequences of drug use is needed.        Finally, incorporation of availability, access, and acceptability of health          services into the understanding of health disparities is warranted. This             proposal responds to RFA DA-01-008 with a plan to make significant progress in       depicting and understanding these disparities. Data from the recently completed      American Indian Service Utilization, Psychiatric Epidemiology, and                   Risk/Protective Factors Project (AI-SUPERPFP) provide an opportunity to better       understand the drug-related health disparities between 2 of the largest tribal       populations. The specific aims are 1) To develop models of the biopsychosocial       factors important to understanding health disparities in drug use and its            adverse consequences. 2) To depict the disparities in the use of drugs               (including tobacco) between 2 AI populations and, further, to investigate the        degree to which ethnic differences in biopsychosocial factors may account for        these disparities. 3) To depict the disparities in the behavioral, social,           medical, and mental health consequences of drug use and to investigate the           degree to which differences in biopsychosocial factors and drug use explain          these disparities. 4) To describe the disparities in utilization of health           services and to investigate the relationships of health services,                    biopsychosocial factors, drug use, and adverse consequences. 5) To place these       findings in a national context with the use of judicious comparisons to the          National Comorbidity Survey (NCS) 14-19 and the National Household Survey of         Drug Abuse (NHSDA).                                                                                                                                                       The proposed analyses of AI-SUPERPFP--the first large-scale, community-based         alcohol, drug and mental health (ADM) epidemiologic study of AIs promises to         provide insights drug-related health disparities in a manner never before            possible: first with a thorough investigation of such disparities across two of      the largest, but culturally distinct, tribal groups; and later with targeted         comparisons of these findings with national data from two comparable efforts         with national samples. Furthermore, the Division of American Indian and Alaska       Native Programs (DAIANP) provides a unique multidisciplinary environment             (including staff from psychology, psychiatry, internal medicine, demography,         anthropology, and public health) in which to conduct this work, thus promising       to inform disparities research more generally.                                                                                                                            ",Drug use and health disparities in 2 Indian populations,6447253,R01DA014817,"['human middle age (35-64) ', ' adolescence (12-18) ', ' family structure /dynamics ', ' health care service utilization ', ' health care service availability ', ' human subject ', ' interview ', ' social psychology ', ' Native American ', ' racial /ethnic difference ', ' socioeconomics ', ' socioenvironment ', ' community ', ' age difference ', ' comorbidity ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' medically underserved population ', ' ']",NIDA,UNIVERSITY OF COLORADO DENVER,R01,2001,339750,0.1468674144593566
"Measuring Sexual Minority Status Among Women Drug Users   DESCRIPTION (provided by investigator): An estimated 20-30 percent of women          drug users are lesbian, bisexual or other women who have sex with women (WSWs).      Contrary to theories that WSW drug users' same-sex behavior is a function of         sex work or incarceration, recent ethnographic work on WSW injectors suggests        that a majority of WSW drug users can be considered ""sexual minorities,"" which       we define as women for whom same-sex orientation is an important aspect of           their social lives. Sexual minority status appears to affect health,                 health-related behaviors, and the health and drug treatment service experiences      of women drug users in important ways. Additional research is needed to              determine precisely how sexual minority status may complicate the health             consequences of illicit drug use among women, and especially to design and           evaluate interventions to reduce disparities in health between sexual minority       and other drug-using women. Research of this sort, however, will first require       the development of measures of sexual minority status that are valid and             reliable for women drug users. This will be accomplished by: 1) increasing our       understanding of the components of sexual minority status via secondary              analysis of a recently-concluded ethnographic study of women lDUs in New York        and Boston (which collected 260 in-depth interviews with 78 WSW subjects); 2)        using these analyses to develop empirically-grounded measures of sexual              minority status; and 3) preliminary validation of these measures via a pilot         survey of 120 women drug users (including an estimated 24-36 sexual minorities)      in New York City. The proposed study directly addresses recent recommendations       by the Institute of Medicine's Committee on Lesbian Health Research Priorities       that improved, multi-dimensional measures of sexual orientation be developed         and applied to low-income and ethnic minority women, with specific attention to      illicit drug use and its sequelae among lesbians. Towards this end, this             proposed R03 study will develop measures of sexual minority status to be used        in future epidemiological and health services research among women drug users.                                                                                            ",Measuring Sexual Minority Status Among Women Drug Users,6364835,R03DA014399,"['human subject ', ' homosexual ', ' female ', ' ethnic group ', ' low income ', ' substance abuse ', "" women's health "", ' clinical research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R03,2001,70413,0.06758977031811379
"Ethnic Differences in Competence and Adolescent Drug Use   DESCRIPTION: (provided by applicant)                                                                                              School-based drug abuse prevention programs that combine social and personal         competence enhancement with refusal skills training have been shown to reduce        adolescent substance use. Etiology research is needed to clarify how the             components of effective prevention programs work. Little is known about the          mediating mechanisms and moderating factors that explain how and when                competence skills are protective and whether these mechanisms change over the        course of adolescence. For example, in addition to being better equipped to          resist peer influences, socially competent youth may perceive fewer social           benefits to engaging in drug use compared to youth with poor interpersonal           negotiation skills. Youth with good cognitive and behavioral self-management         strategies (i.e., personal competence) may succeed in developmental tasks and        experience a sense of mastery and psychological well-being that is protective        in terms of drug involvement. Because rates of substance use differ among            ethnic and gender subgroups of youth, it is important to determine if                competence-based etiological models apply to different subgroups of                  adolescents, in particular inner-city minority youth in high-nisk settings. A        primary aim of the proposed research is to develop, test, and refine several         etiologic models that focus on social and personal competence skills and             adolescent substance use over the course of adolescence, and to examine these        models among two distinct samples from 7th grade through the 12th grade: a           predominantly white, suburban sample (N=3,549), and a largely minority,              inner-city sample (N=2,229). This will be accomplished through secondary data        analysis of control group participants from two school-based drug abuse              prevention trials. The proposed research aims to elucidate how competence            skills influence the initiation, escalation, and maintenance of drug use during      adolescence by examining mediational and moderational models and                     cross-validating them across ethnic and gender subgroups. By improving our           understanding of how drug use develops over the course of adolescence among          youth of different racial/ethnic backgrounds, a long-term goal of the proposed       research is to inform the development of effective prevention programs for           ethnically diverse populations, and ultimately, to reduce rates of substance         abuse and addiction that contribute to health disparities among racial/ethnic        populations.                                                                                                                                                              ",Ethnic Differences in Competence and Adolescent Drug Use,6447580,R03DA014964,"['adolescence (12-18) ', ' disease /disorder proneness /risk ', ' statistics /biometry ', ' model design /development ', ' disease /disorder model ', ' longitudinal human study ', ' attitude ', ' high risk life style ', ' cognition ', ' emotional dependency ', ' performance ', ' developmental psychology ', ' peer group ', ' interpersonal relations ', ' gender difference ', ' African American ', ' Hispanic American ', ' caucasian American ', ' racial /ethnic difference ', ' urban area ', ' human data ', ' clinical research ', ' behavioral /social science research tag ', ' disease /disorder etiology ', ' substance abuse related behavior ', ' ']",NIDA,WEILL MEDICAL COLL OF CORNELL UNIV,R03,2001,84750,0.04332742954940789
"Club Drugs/Resource Inequity/Health Risk in Urban Youth   DESCRIPTION (provided by the applicant): This five year study entitled ""Club         Drugs, Resource Inequities and Health Risks among Urban Youth"" will identify         the contextual, socio-cultural and psychological factors that influence urban        youth and young adults to incorporate club drugs into their drug repertoires,        changes in drug use patterns over time, and the psychosocial, economic and           health consequences of club drug use and concurrent polydrug mixing. The study       responds to NIDA's RFA DA-0 1 -0 10 entitled ""Responding to Club Drugs And           Other Emerging And Current Drug Abuse Trends."" Study aims are to: 1) describe        the marketing and diffusion of club and designer drugs into urban youth and          young adult drug markets through clubs, after-hours, and other social                activities, and describe the meaning of these drugs in relation to traditional       street drugs (regular and high THC marijuana, leaves with formaldehyde,              alcohol, dust, cocaine, crack and heroin), 2) conduct a panel study with two         time points eight months apart with 500 youth ages 16 - 30 to deter-mine             changes in patterns of MDMA and other dance and prescription drugs, and              predictors and consequences of use, 3) utilize the information to develop            strategies for dance and prescription drug risk prevention in street and party       settings. Component 1 (Months I - 50) of the study will continue established         patterns of ethnographic research in settings where urban youth and young            adults buy, sell, learn about and experiment with new drugs and drug mixing.         Component 2 (Months 8 - 58) will involve administering an                            epidemiologic/network survey to the study cohort of 500 youth and young adults       between the ages of 16 - 30. In Component 3 (Months 42-60) we will use ongoing       study results in partnership with a team of youth consultants to develop and         pilot test for acceptability a strategy for preventing risks associated with         MDMA and other club drug use and drug mixing to be utilized in drug use sites,       with distributors and in networks of users. Throughout, we will review and           integrate emerging literature linking findings to the primary theoretical            concepts guiding the study. The significance of the study lies in its                description of the ways in which new potentially dangerous drugs are diffused        into a high risk urban environment, its incorporation of the psychosocial,           economic and contextual factors in understanding drug selling, its focus on          understudied polydrug use among urban youth, its examination of neighborhood         factors in drug selection and use, and its partnership with youth and                youth-serving clubs and site gatekeepers to engage in risk reduction. The study      promises to produce new analytic and theoretical insights into the diffusion of      new drugs into already saturated urban youth drug markets and the consequences       of their use.                                                                                                                                                             ",Club Drugs/Resource Inequity/Health Risk in Urban Youth,6447534,R01DA014863,"['young adult human (19-34) ', ' adolescence (12-18) ', ' disease /disorder proneness /risk ', ' drug abuse ', ' drug abuse prevention ', ' human subject ', ' 3,4 methylenedioxymethamphetamine ', ' social psychology ', ' psychotropic drug ', ' racial /ethnic difference ', ' socioeconomics ', ' urban area ', ' clinical research ', ' behavioral /social science research tag ', ' outcomes research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,INSTITUTE FOR COMMUNITY RESEARCH,R01,2001,583639,0.20819357873312505
"Drug Attitudes and Behavior on the US/Mexico Border   DESCRIPTION: (provided by applicant)                                                 The objective of this study is to improve knowledge and understanding of             disparities in drug use and related attitudes, perceptions, and behaviors            concerning drug use and drug treatment utilization among Hispanic and non            Hispanic populations living in proximity to the U.S./Mexico border. This is a        geographic area in which the mainstream culture is heavily bicultural, a             pattern which is expected to typify an increasingly large segment of the West        and Southwest regions of the United States during the next decade. Knowledge         gained in this study is expected to benefit service planners who would               anticipate need for current and future service strategies to better respond to       the problems and needs of Hispanic and bicultural populations. Specific aims         are 1) to describe the prevalence of substance use, abuse, and dependence, and       the demographic and social correlates of use among households living on the          border, and to measure the changes in prevalence that have occurred during the       past six years since a similar study was done; 2) to investigate the role of         acculturation in explaining differences in substance use within the Hispanic         border community; and 3) to determine border residents' attitudes and behaviors      related to the utilization of treatment services and the correlates of these         attitudes and behaviors. These questions will be addressed through an in-person      survey of 1200 adults living in households: 400 from the El Paso metropolitan        area, 400 from the Rio Grande Valley metropolitan area, and 400 from colonias        (rural, unincorporated communities often characterized by lack of basic public       services).                                                                                                                                                                ",Drug Attitudes and Behavior on the US/Mexico Border,6447139,R01DA014794,"['alcoholism /alcohol abuse ', ' drug abuse prevention ', ' inhalation drug abuse ', ' tobacco abuse ', ' household ', ' Mexico ', ' United States ', ' health care service evaluation ', ' health care service utilization ', ' human subject ', ' interview ', ' data collection methodology /evaluation ', ' longitudinal human study ', ' health survey ', ' health behavior ', ' attitude ', ' gender difference ', ' Hispanic American ', ' racial /ethnic difference ', ' social integration ', ' socioenvironment ', ' international cooperation ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,"UNIVERSITY OF TEXAS, AUSTIN",R01,2001,306475,0.04269354879991353
"Homeless Women: Drugs, Race/Ethicity, And Health Care   DESCRIPTION: (provided by applicant)                                                 Research has shown that drug use and physical health problems are quite common       among the homeless and that their general health-care needs often go unmet.          However, much of this research is based on samples composed largely of homeless      men. To date, there has been little research on the relationship between drug        use and utilization of general health care among homeless women. Moreover,           possible racial/ethnic differences in this relationship have not been                extensively examined. This study will employ secondary data from two                 complementary funded studies to analyze the association between drug use and         use of general health care (inpatient, ambulatory, and preventive). The first        dataset screened for lifetime drug dependence in a community-based probability       sample of 861 homeless women in Los Angeles County, and the second dataset           assessed current heavy drug use and lifetime injection drug use in a purposive       sample of 1,330 homeless women in Los Angeles. We will test hypotheses               regarding a wide range of predisposing and enabling factors (such as case            management, health insurance, and access to public benefits) potentially             associated with access to general health services by African American, Latina,       and White homeless women with drug problems. The proposed study directly             addresses policy questions prominent in NIDA's strategic plan on reducing            health disparities. By documenting the nature and extent of health problems          affecting drug-using homeless women, their use of general health services, the       extent to which their need for care goes unmet, and possible racial/ethnic           differences in these patterns, this study will inform drug treatment providers       on the value and content of screening/assessment procedures they might employ        and the types of general health services for which more effective linkage is         needed.                                                                                                                                                                   ","Homeless Women: Drugs, Race/Ethicity, And Health Care",6523600,R01DA014835,"['drug abuse ', ' health care service utilization ', ' female ', ' homeless ', ' racial /ethnic difference ', ' human data ', "" women's health "", ' behavioral /social science research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2002,314346,0.18627626917048123
"COLLABORATIVE RESEARCH ON DRUG ABUSE DESCRIPTION: (provided by applicant) This P01 aims to develop and apply state-of-the-art methods to analyze existing but under-utilized drug abuse databases in collaboration with their owners. We address contemporary, theoretical, and applied issues in drug abuse research to understand intersections between substance abuse and AIDS risk behaviors as well as minority and gender-based health disparities. We work together with dozens of investigators from education, epidemiology, medicine, psychiatry, psychology, public health, social work, and sociology who own exciting substance abuse data to develop models that test current theories, especially on epidemiology, prevention, intervention, and treatment of drug abuse, using modern multivariate psychometric and statistical methods to control for measurement errors, biases, and other confounds. The Models and Methods Project develops analytic techniques (e.g., improved structural equation methods for small samples, missing and nonnormal data, outliers, dependent and hierarchical data, functional imaging) that hold special promise for improving the quality of drug abuse and AIDS research. The At-Risk Project studies substance abuse related data sets on vulnerable populations (substance abusers, homeless people, individuals who are HIV positive or who have AIDS, victims of domestic abuse, runaways, gang members, and others at high risk for AIDS or drug abuse) with methods to control the sampling, measurement, distributional and other biases that may exist. The Community Project studies drug abuse etiology, adult consequences, HIV risk, intergenerational processes, general deviance, and related issues in large community-based samples, and develops and tests explanatory theories using models that permit separation of common from specific effects, control for artifacts, etc. The Latino Project uses datasets from varied Latino groups to study within- and between-Latino population drug abuse etiology, test and extend an ecological theory of Latino drug use, and study HIV risk and acculturative phenomena related to drug use. The Core Project oversees and integrates all components, hosts visiting scholars, provides computer facilities, and sponsors a mentoring program for disadvantaged students.  ",COLLABORATIVE RESEARCH ON DRUG ABUSE,6417522,P01DA001070,"['drug abuse ', ' clinical research ', ' behavioral /social science research tag ', ' disease /disorder etiology ', ' ']",NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,P01,2002,1269618,0.11190653016281335
"Ethnic Differences in Competence and Adolescent Drug Use   DESCRIPTION: (provided by applicant)                                                                                              School-based drug abuse prevention programs that combine social and personal         competence enhancement with refusal skills training have been shown to reduce        adolescent substance use. Etiology research is needed to clarify how the             components of effective prevention programs work. Little is known about the          mediating mechanisms and moderating factors that explain how and when                competence skills are protective and whether these mechanisms change over the        course of adolescence. For example, in addition to being better equipped to          resist peer influences, socially competent youth may perceive fewer social           benefits to engaging in drug use compared to youth with poor interpersonal           negotiation skills. Youth with good cognitive and behavioral self-management         strategies (i.e., personal competence) may succeed in developmental tasks and        experience a sense of mastery and psychological well-being that is protective        in terms of drug involvement. Because rates of substance use differ among            ethnic and gender subgroups of youth, it is important to determine if                competence-based etiological models apply to different subgroups of                  adolescents, in particular inner-city minority youth in high-nisk settings. A        primary aim of the proposed research is to develop, test, and refine several         etiologic models that focus on social and personal competence skills and             adolescent substance use over the course of adolescence, and to examine these        models among two distinct samples from 7th grade through the 12th grade: a           predominantly white, suburban sample (N=3,549), and a largely minority,              inner-city sample (N=2,229). This will be accomplished through secondary data        analysis of control group participants from two school-based drug abuse              prevention trials. The proposed research aims to elucidate how competence            skills influence the initiation, escalation, and maintenance of drug use during      adolescence by examining mediational and moderational models and                     cross-validating them across ethnic and gender subgroups. By improving our           understanding of how drug use develops over the course of adolescence among          youth of different racial/ethnic backgrounds, a long-term goal of the proposed       research is to inform the development of effective prevention programs for           ethnically diverse populations, and ultimately, to reduce rates of substance         abuse and addiction that contribute to health disparities among racial/ethnic        populations.                                                                                                                                                              ",Ethnic Differences in Competence and Adolescent Drug Use,6523555,R03DA014964,"['adolescence (12-20) ', ' disease /disorder proneness /risk ', ' statistics /biometry ', ' model design /development ', ' disease /disorder model ', ' longitudinal human study ', ' attitude ', ' high risk life style ', ' cognition ', ' emotional dependency ', ' performance ', ' developmental psychology ', ' peer group ', ' interpersonal relations ', ' gender difference ', ' African American ', ' Hispanic American ', ' caucasian American ', ' racial /ethnic difference ', ' urban area ', ' human data ', ' clinical research ', ' behavioral /social science research tag ', ' disease /disorder etiology ', ' substance abuse related behavior ', ' ']",NIDA,WEILL MEDICAL COLL OF CORNELL UNIV,R03,2002,84750,0.04332742954940789
"Club Drugs/Resource Inequity/Health Risk in Urban Youth   DESCRIPTION (provided by the applicant): This five year study entitled ""Club         Drugs, Resource Inequities and Health Risks among Urban Youth"" will identify         the contextual, socio-cultural and psychological factors that influence urban        youth and young adults to incorporate club drugs into their drug repertoires,        changes in drug use patterns over time, and the psychosocial, economic and           health consequences of club drug use and concurrent polydrug mixing. The study       responds to NIDA's RFA DA-0 1 -0 10 entitled ""Responding to Club Drugs And           Other Emerging And Current Drug Abuse Trends."" Study aims are to: 1) describe        the marketing and diffusion of club and designer drugs into urban youth and          young adult drug markets through clubs, after-hours, and other social                activities, and describe the meaning of these drugs in relation to traditional       street drugs (regular and high THC marijuana, leaves with formaldehyde,              alcohol, dust, cocaine, crack and heroin), 2) conduct a panel study with two         time points eight months apart with 500 youth ages 16 - 30 to deter-mine             changes in patterns of MDMA and other dance and prescription drugs, and              predictors and consequences of use, 3) utilize the information to develop            strategies for dance and prescription drug risk prevention in street and party       settings. Component 1 (Months I - 50) of the study will continue established         patterns of ethnographic research in settings where urban youth and young            adults buy, sell, learn about and experiment with new drugs and drug mixing.         Component 2 (Months 8 - 58) will involve administering an                            epidemiologic/network survey to the study cohort of 500 youth and young adults       between the ages of 16 - 30. In Component 3 (Months 42-60) we will use ongoing       study results in partnership with a team of youth consultants to develop and         pilot test for acceptability a strategy for preventing risks associated with         MDMA and other club drug use and drug mixing to be utilized in drug use sites,       with distributors and in networks of users. Throughout, we will review and           integrate emerging literature linking findings to the primary theoretical            concepts guiding the study. The significance of the study lies in its                description of the ways in which new potentially dangerous drugs are diffused        into a high risk urban environment, its incorporation of the psychosocial,           economic and contextual factors in understanding drug selling, its focus on          understudied polydrug use among urban youth, its examination of neighborhood         factors in drug selection and use, and its partnership with youth and                youth-serving clubs and site gatekeepers to engage in risk reduction. The study      promises to produce new analytic and theoretical insights into the diffusion of      new drugs into already saturated urban youth drug markets and the consequences       of their use.                                                                                                                                                             ",Club Drugs/Resource Inequity/Health Risk in Urban Youth,6515958,R01DA014863,"['young adult human (21-34) ', ' adolescence (12-20) ', ' disease /disorder proneness /risk ', ' drug abuse ', ' drug abuse prevention ', ' human subject ', ' 3,4 methylenedioxymethamphetamine ', ' social psychology ', ' psychotropic drug ', ' racial /ethnic difference ', ' socioeconomics ', ' urban area ', ' clinical research ', ' behavioral /social science research tag ', ' outcomes research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,INSTITUTE FOR COMMUNITY RESEARCH,R01,2002,599774,0.20819357873312505
"IDU Access to HIV/HCV Prevention   DESCRIPTION: (provided by applicant)                                                                                      A recent health promotion campaign in Rhode Island (RI) to prevent HIV and           Hepatitis C prompted the deregulation of syringes, allowing their sale in            pharmacies without a prescription. Included in this law is that pharmacies may       sell syringes: if so, pharmacists are required to provide syringe disposal           information and may provide drug treatment referral information. This proposal       is to investigate racial/ethnic and gender disparities in access to                  pharmacy-based prevention services associated with this law change. We propose       to evaluate racial/ethnic and gender disparities by geographic barriers              (Specific Aim 1), barriers related to drug users (the consumer of these              services) (Specific Aim 2), and barriers related to pharmacists (the providers       of these services) (Specific Aim 3). We limit our evaluation to the two largest      non-white groups in RI, African Americans/Blacks, and Latino/ Hispanics in           comparison to whites. Geocoding methods will be used for Specific Aim 1. Census      2000 data will be used to identify racially diverse block groups. Socioeconomic      conditions will be quantified to adjust for class in analyses of race. Both          pharmacy and drug user locations will be overlaid to determine geographic            barriers to access. For drug user studies, qualitative and quantitative methods      will determine both perceived and real barriers to accessing pharmacy                prevention services. The qualitative study will use a targeted street                recruitment of injection drug users, while the quantitative study will include       participants in existing drug user cohorts. For pharmacy-related studies, all        pharmacies in the state will be included. We propose a purchaser experience          trial where non-drug using purchasers of different racial/ethnic groups attempt      to purchase a syringe, as well as a pharmacist telephone survey, evaluating          attitudes regarding the law change, their perception regarding drug users and        racial/ethnic groups in general. Analyses will evaluate access (or barriers to       access) and its relation to race, across and between racially and                    socioeconomically diverse neighborhoods. These analyses will provide important       data regarding the implementation of a policy change and the need for targeted       solutions in response to racial disparities.                                                                                                                              ",IDU Access to HIV/HCV Prevention,6523603,R01DA014853,"['communicable disease control ', ' communicable disease transmission ', ' disease /disorder proneness /risk ', ' pharmacy administration ', ' intravenous drug abuse ', ' health care service availability ', ' human subject ', ' interview ', ' questionnaire ', ' statistics /biometry ', ' high risk life style ', ' gender difference ', ' African American ', ' Hispanic American ', ' racial /ethnic difference ', ' socioenvironment ', ' virus infection mechanism ', ' human immunodeficiency virus ', ' needle sharing ', ' hepatitis C ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' medically underserved population ', ' ']",NIDA,BROWN UNIVERSITY,R01,2002,392500,0.13849189066326564
"Drug use and health disparities in 2 Indian populations                                     DESCRIPTION: (provided by applicant)                                                                                                American Indian (AI) youth consistently report higher use of drugs than other        populations in the United States. Further, AI youth are as likely, if not more       so, to experience serious consequences from drug use. However much remains           unknown: The extant literature is largely restricted to AI youth and,                generally, little attention is paid to cultural differences. A more                  comprehensive description of the negative consequences of drug use is needed.        Finally, incorporation of availability, access, and acceptability of health          services into the understanding of health disparities is warranted. This             proposal responds to RFA DA-01-008 with a plan to make significant progress in       depicting and understanding these disparities. Data from the recently completed      American Indian Service Utilization, Psychiatric Epidemiology, and                   Risk/Protective Factors Project (AI-SUPERPFP) provide an opportunity to better       understand the drug-related health disparities between 2 of the largest tribal       populations. The specific aims are 1) To develop models of the biopsychosocial       factors important to understanding health disparities in drug use and its            adverse consequences. 2) To depict the disparities in the use of drugs               (including tobacco) between 2 AI populations and, further, to investigate the        degree to which ethnic differences in biopsychosocial factors may account for        these disparities. 3) To depict the disparities in the behavioral, social,           medical, and mental health consequences of drug use and to investigate the           degree to which differences in biopsychosocial factors and drug use explain          these disparities. 4) To describe the disparities in utilization of health           services and to investigate the relationships of health services,                    biopsychosocial factors, drug use, and adverse consequences. 5) To place these       findings in a national context with the use of judicious comparisons to the          National Comorbidity Survey (NCS) 14-19 and the National Household Survey of         Drug Abuse (NHSDA).                                                                                                                                                       The proposed analyses of AI-SUPERPFP--the first large-scale, community-based         alcohol, drug and mental health (ADM) epidemiologic study of AIs promises to         provide insights drug-related health disparities in a manner never before            possible: first with a thorough investigation of such disparities across two of      the largest, but culturally distinct, tribal groups; and later with targeted         comparisons of these findings with national data from two comparable efforts         with national samples. Furthermore, the Division of American Indian and Alaska       Native Programs (DAIANP) provides a unique multidisciplinary environment             (including staff from psychology, psychiatry, internal medicine, demography,         anthropology, and public health) in which to conduct this work, thus promising       to inform disparities research more generally.                                                                                                                            ",Drug use and health disparities in 2 Indian populations,6523592,R01DA014817,"['human middle age (35-64) ', ' adolescence (12-20) ', ' family structure /dynamics ', ' health care service utilization ', ' health care service availability ', ' human subject ', ' interview ', ' social psychology ', ' Native American ', ' racial /ethnic difference ', ' socioeconomics ', ' socioenvironment ', ' community ', ' age difference ', ' comorbidity ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' medically underserved population ', ' ']",NIDA,UNIVERSITY OF COLORADO DENVER,R01,2002,339750,0.1468674144593566
"Drug Attitudes and Behavior on the US/Mexico Border   DESCRIPTION: (provided by applicant)                                                 The objective of this study is to improve knowledge and understanding of             disparities in drug use and related attitudes, perceptions, and behaviors            concerning drug use and drug treatment utilization among Hispanic and non            Hispanic populations living in proximity to the U.S./Mexico border. This is a        geographic area in which the mainstream culture is heavily bicultural, a             pattern which is expected to typify an increasingly large segment of the West        and Southwest regions of the United States during the next decade. Knowledge         gained in this study is expected to benefit service planners who would               anticipate need for current and future service strategies to better respond to       the problems and needs of Hispanic and bicultural populations. Specific aims         are 1) to describe the prevalence of substance use, abuse, and dependence, and       the demographic and social correlates of use among households living on the          border, and to measure the changes in prevalence that have occurred during the       past six years since a similar study was done; 2) to investigate the role of         acculturation in explaining differences in substance use within the Hispanic         border community; and 3) to determine border residents' attitudes and behaviors      related to the utilization of treatment services and the correlates of these         attitudes and behaviors. These questions will be addressed through an in-person      survey of 1200 adults living in households: 400 from the El Paso metropolitan        area, 400 from the Rio Grande Valley metropolitan area, and 400 from colonias        (rural, unincorporated communities often characterized by lack of basic public       services).                                                                                                                                                                ",Drug Attitudes and Behavior on the US/Mexico Border,6523516,R01DA014794,"['alcoholism /alcohol abuse ', ' drug abuse prevention ', ' inhalation drug abuse ', ' tobacco abuse ', ' household ', ' Mexico ', ' United States ', ' health care service evaluation ', ' health care service utilization ', ' human subject ', ' interview ', ' data collection methodology /evaluation ', ' longitudinal human study ', ' health survey ', ' health behavior ', ' attitude ', ' gender difference ', ' Hispanic American ', ' racial /ethnic difference ', ' social integration ', ' socioenvironment ', ' international cooperation ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,"UNIVERSITY OF TEXAS, AUSTIN",R01,2002,295877,0.04269354879991353
"Measuring Sexual Minority Status Among Women Drug Users   DESCRIPTION (provided by investigator): An estimated 20-30 percent of women          drug users are lesbian, bisexual or other women who have sex with women (WSWs).      Contrary to theories that WSW drug users' same-sex behavior is a function of         sex work or incarceration, recent ethnographic work on WSW injectors suggests        that a majority of WSW drug users can be considered ""sexual minorities,"" which       we define as women for whom same-sex orientation is an important aspect of           their social lives. Sexual minority status appears to affect health,                 health-related behaviors, and the health and drug treatment service experiences      of women drug users in important ways. Additional research is needed to              determine precisely how sexual minority status may complicate the health             consequences of illicit drug use among women, and especially to design and           evaluate interventions to reduce disparities in health between sexual minority       and other drug-using women. Research of this sort, however, will first require       the development of measures of sexual minority status that are valid and             reliable for women drug users. This will be accomplished by: 1) increasing our       understanding of the components of sexual minority status via secondary              analysis of a recently-concluded ethnographic study of women lDUs in New York        and Boston (which collected 260 in-depth interviews with 78 WSW subjects); 2)        using these analyses to develop empirically-grounded measures of sexual              minority status; and 3) preliminary validation of these measures via a pilot         survey of 120 women drug users (including an estimated 24-36 sexual minorities)      in New York City. The proposed study directly addresses recent recommendations       by the Institute of Medicine's Committee on Lesbian Health Research Priorities       that improved, multi-dimensional measures of sexual orientation be developed         and applied to low-income and ethnic minority women, with specific attention to      illicit drug use and its sequelae among lesbians. Towards this end, this             proposed R03 study will develop measures of sexual minority status to be used        in future epidemiological and health services research among women drug users.                                                                                            ",Measuring Sexual Minority Status Among Women Drug Users,6523347,R03DA014399,"['human subject ', ' homosexual ', ' female ', ' ethnic group ', ' low income ', ' substance abuse ', "" women's health "", ' clinical research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R03,2002,70500,0.06758977031811379
"Measuring Sexual Minority Status Among Women Drug Users   DESCRIPTION (provided by investigator): An estimated 20-30 percent of women          drug users are lesbian, bisexual or other women who have sex with women (WSWs).      Contrary to theories that WSW drug users' same-sex behavior is a function of         sex work or incarceration, recent ethnographic work on WSW injectors suggests        that a majority of WSW drug users can be considered ""sexual minorities,"" which       we define as women for whom same-sex orientation is an important aspect of           their social lives. Sexual minority status appears to affect health,                 health-related behaviors, and the health and drug treatment service experiences      of women drug users in important ways. Additional research is needed to              determine precisely how sexual minority status may complicate the health             consequences of illicit drug use among women, and especially to design and           evaluate interventions to reduce disparities in health between sexual minority       and other drug-using women. Research of this sort, however, will first require       the development of measures of sexual minority status that are valid and             reliable for women drug users. This will be accomplished by: 1) increasing our       understanding of the components of sexual minority status via secondary              analysis of a recently-concluded ethnographic study of women lDUs in New York        and Boston (which collected 260 in-depth interviews with 78 WSW subjects); 2)        using these analyses to develop empirically-grounded measures of sexual              minority status; and 3) preliminary validation of these measures via a pilot         survey of 120 women drug users (including an estimated 24-36 sexual minorities)      in New York City. The proposed study directly addresses recent recommendations       by the Institute of Medicine's Committee on Lesbian Health Research Priorities       that improved, multi-dimensional measures of sexual orientation be developed         and applied to low-income and ethnic minority women, with specific attention to      illicit drug use and its sequelae among lesbians. Towards this end, this             proposed R03 study will develop measures of sexual minority status to be used        in future epidemiological and health services research among women drug users.                                                                                            ",Measuring Sexual Minority Status Among Women Drug Users,6587159,R03DA014399,"['human subject ', ' homosexual ', ' female ', ' ethnic group ', ' low income ', ' substance abuse ', "" women's health "", ' clinical research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R03,2002,49976,0.06758977031811379
"Girls in Drug Abuse Science DESCRIPTION (provided by applicant):    Developing scientists is a priority of the National Institutes of Health, the National Institute on Drug Abuse, and this continuation project. The overall aim of this competing continuation application for a Science Education Drug Abuse Partnership Award Project (SEDAPA) is to extend the development and implementation of a curriculum and manual for high school young women to middle school girls in sixth to eighth grade who live in rural Appalachian Kentucky. The specific aims for the project are: (1) To increase the scientific, technological and interpersonal knowledge as well as skills of participating middle-school girls ages 11 to 15 from rural Appalachian Kentucky; (2) To increase the knowledge of parents and middle schoolteachers on gender equity strategies, and teaching techniques to increase the science participation of middle school girls in rural Appalachian Kentucky; (3) To develop and disseminate a model curriculum to enhance science as well as drug abuse research in rural Appalachian Kentucky; and (4) To develop and disseminate a guide for ""Promoting Gender Equity in the Classroom"" to enhance science education in rural and Appalachian areas. This competing continuation application focuses on 120 rural Appalachian Kentucky girls entering the sixth grade from 21 rural counties; 120 to 240 parents of these girls; and at least 30 rural middle school teachers from the same 21 rural counties. Project Summer Institutes, Saturday Sessions, and scientific as well as community mentoring opportunities will continue for participating girls. For this competing continuation application, younger girls (middle school) will be targeted; workshops for parents and teachers will be added; 21 rather than 14 rural counties will be included; current project participants will be involved as mentors; Chris in Drug Abuse Science Clubs will be added; the Kentucky Department of Education along with project staff will work to promote Gender Equity in all middle schools in Kentucky; and the replication manual will be expanded for girls in grades 6 to 8 to produce a complete and comprehensive manual across grades 6 to 12 for replication in other rural and Appalachian areas. ",Girls in Drug Abuse Science,6574723,R25DA011388,"['adolescence (12-20) ', ' curriculum ', ' drug abuse education ', ' secondary school ', ' teaching ', ' education evaluation /planning ', ' parent ', ' human subject ', ' questionnaire ', ' handbook ', ' female ', ' gender difference ', ' community ', ' rural area ', ' teacher ', ' clinical research ', ' educational resource design /development ', ' medically underserved population ', ' health disparity ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R25,2003,270000,0.07264206386789569
"Drug use and health disparities in 2 Indian populations                                     DESCRIPTION: (provided by applicant)                                                                                                American Indian (AI) youth consistently report higher use of drugs than other        populations in the United States. Further, AI youth are as likely, if not more       so, to experience serious consequences from drug use. However much remains           unknown: The extant literature is largely restricted to AI youth and,                generally, little attention is paid to cultural differences. A more                  comprehensive description of the negative consequences of drug use is needed.        Finally, incorporation of availability, access, and acceptability of health          services into the understanding of health disparities is warranted. This             proposal responds to RFA DA-01-008 with a plan to make significant progress in       depicting and understanding these disparities. Data from the recently completed      American Indian Service Utilization, Psychiatric Epidemiology, and                   Risk/Protective Factors Project (AI-SUPERPFP) provide an opportunity to better       understand the drug-related health disparities between 2 of the largest tribal       populations. The specific aims are 1) To develop models of the biopsychosocial       factors important to understanding health disparities in drug use and its            adverse consequences. 2) To depict the disparities in the use of drugs               (including tobacco) between 2 AI populations and, further, to investigate the        degree to which ethnic differences in biopsychosocial factors may account for        these disparities. 3) To depict the disparities in the behavioral, social,           medical, and mental health consequences of drug use and to investigate the           degree to which differences in biopsychosocial factors and drug use explain          these disparities. 4) To describe the disparities in utilization of health           services and to investigate the relationships of health services,                    biopsychosocial factors, drug use, and adverse consequences. 5) To place these       findings in a national context with the use of judicious comparisons to the          National Comorbidity Survey (NCS) 14-19 and the National Household Survey of         Drug Abuse (NHSDA).                                                                                                                                                       The proposed analyses of AI-SUPERPFP--the first large-scale, community-based         alcohol, drug and mental health (ADM) epidemiologic study of AIs promises to         provide insights drug-related health disparities in a manner never before            possible: first with a thorough investigation of such disparities across two of      the largest, but culturally distinct, tribal groups; and later with targeted         comparisons of these findings with national data from two comparable efforts         with national samples. Furthermore, the Division of American Indian and Alaska       Native Programs (DAIANP) provides a unique multidisciplinary environment             (including staff from psychology, psychiatry, internal medicine, demography,         anthropology, and public health) in which to conduct this work, thus promising       to inform disparities research more generally.                                                                                                                            ",Drug use and health disparities in 2 Indian populations,6650834,R01DA014817,"['human middle age (35-64) ', ' adolescence (12-20) ', ' family structure /dynamics ', ' health care service utilization ', ' health care service availability ', ' human subject ', ' interview ', ' social psychology ', ' Native American ', ' racial /ethnic difference ', ' socioeconomics ', ' socioenvironment ', ' community ', ' age difference ', ' comorbidity ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' medically underserved population ', ' ']",NIDA,UNIVERSITY OF COLORADO DENVER,R01,2003,339750,0.1468674144593566
"Drug Attitudes and Behavior on the US/Mexico Border   DESCRIPTION: (provided by applicant)                                                 The objective of this study is to improve knowledge and understanding of             disparities in drug use and related attitudes, perceptions, and behaviors            concerning drug use and drug treatment utilization among Hispanic and non            Hispanic populations living in proximity to the U.S./Mexico border. This is a        geographic area in which the mainstream culture is heavily bicultural, a             pattern which is expected to typify an increasingly large segment of the West        and Southwest regions of the United States during the next decade. Knowledge         gained in this study is expected to benefit service planners who would               anticipate need for current and future service strategies to better respond to       the problems and needs of Hispanic and bicultural populations. Specific aims         are 1) to describe the prevalence of substance use, abuse, and dependence, and       the demographic and social correlates of use among households living on the          border, and to measure the changes in prevalence that have occurred during the       past six years since a similar study was done; 2) to investigate the role of         acculturation in explaining differences in substance use within the Hispanic         border community; and 3) to determine border residents' attitudes and behaviors      related to the utilization of treatment services and the correlates of these         attitudes and behaviors. These questions will be addressed through an in-person      survey of 1200 adults living in households: 400 from the El Paso metropolitan        area, 400 from the Rio Grande Valley metropolitan area, and 400 from colonias        (rural, unincorporated communities often characterized by lack of basic public       services).                                                                                                                                                                ",Drug Attitudes and Behavior on the US/Mexico Border,6650832,R01DA014794,"['alcoholism /alcohol abuse ', ' drug abuse prevention ', ' inhalation drug abuse ', ' tobacco abuse ', ' household ', ' Mexico ', ' United States ', ' health care service evaluation ', ' health care service utilization ', ' human subject ', ' interview ', ' data collection methodology /evaluation ', ' longitudinal human study ', ' health survey ', ' health behavior ', ' attitude ', ' gender difference ', ' Hispanic American ', ' racial /ethnic difference ', ' social integration ', ' socioenvironment ', ' international cooperation ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,"UNIVERSITY OF TEXAS, AUSTIN",R01,2003,254926,0.04269354879991353
"Club Drugs/Resource Inequity/Health Risk in Urban Youth   DESCRIPTION (provided by the applicant): This five year study entitled ""Club         Drugs, Resource Inequities and Health Risks among Urban Youth"" will identify         the contextual, socio-cultural and psychological factors that influence urban        youth and young adults to incorporate club drugs into their drug repertoires,        changes in drug use patterns over time, and the psychosocial, economic and           health consequences of club drug use and concurrent polydrug mixing. The study       responds to NIDA's RFA DA-0 1 -0 10 entitled ""Responding to Club Drugs And           Other Emerging And Current Drug Abuse Trends."" Study aims are to: 1) describe        the marketing and diffusion of club and designer drugs into urban youth and          young adult drug markets through clubs, after-hours, and other social                activities, and describe the meaning of these drugs in relation to traditional       street drugs (regular and high THC marijuana, leaves with formaldehyde,              alcohol, dust, cocaine, crack and heroin), 2) conduct a panel study with two         time points eight months apart with 500 youth ages 16 - 30 to deter-mine             changes in patterns of MDMA and other dance and prescription drugs, and              predictors and consequences of use, 3) utilize the information to develop            strategies for dance and prescription drug risk prevention in street and party       settings. Component 1 (Months I - 50) of the study will continue established         patterns of ethnographic research in settings where urban youth and young            adults buy, sell, learn about and experiment with new drugs and drug mixing.         Component 2 (Months 8 - 58) will involve administering an                            epidemiologic/network survey to the study cohort of 500 youth and young adults       between the ages of 16 - 30. In Component 3 (Months 42-60) we will use ongoing       study results in partnership with a team of youth consultants to develop and         pilot test for acceptability a strategy for preventing risks associated with         MDMA and other club drug use and drug mixing to be utilized in drug use sites,       with distributors and in networks of users. Throughout, we will review and           integrate emerging literature linking findings to the primary theoretical            concepts guiding the study. The significance of the study lies in its                description of the ways in which new potentially dangerous drugs are diffused        into a high risk urban environment, its incorporation of the psychosocial,           economic and contextual factors in understanding drug selling, its focus on          understudied polydrug use among urban youth, its examination of neighborhood         factors in drug selection and use, and its partnership with youth and                youth-serving clubs and site gatekeepers to engage in risk reduction. The study      promises to produce new analytic and theoretical insights into the diffusion of      new drugs into already saturated urban youth drug markets and the consequences       of their use.                                                                                                                                                             ",Club Drugs/Resource Inequity/Health Risk in Urban Youth,6609738,R01DA014863,"['young adult human (21-34) ', ' adolescence (12-20) ', ' disease /disorder proneness /risk ', ' drug abuse ', ' drug abuse prevention ', ' human subject ', ' 3,4 methylenedioxymethamphetamine ', ' social psychology ', ' psychotropic drug ', ' racial /ethnic difference ', ' socioeconomics ', ' urban area ', ' clinical research ', ' behavioral /social science research tag ', ' outcomes research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,INSTITUTE FOR COMMUNITY RESEARCH,R01,2003,599026,0.20819357873312505
"COLLABORATIVE RESEARCH ON DRUG ABUSE DESCRIPTION: (provided by applicant) This P01 aims to develop and apply state-of-the-art methods to analyze existing but under-utilized drug abuse databases in collaboration with their owners. We address contemporary, theoretical, and applied issues in drug abuse research to understand intersections between substance abuse and AIDS risk behaviors as well as minority and gender-based health disparities. We work together with dozens of investigators from education, epidemiology, medicine, psychiatry, psychology, public health, social work, and sociology who own exciting substance abuse data to develop models that test current theories, especially on epidemiology, prevention, intervention, and treatment of drug abuse, using modern multivariate psychometric and statistical methods to control for measurement errors, biases, and other confounds. The Models and Methods Project develops analytic techniques (e.g., improved structural equation methods for small samples, missing and nonnormal data, outliers, dependent and hierarchical data, functional imaging) that hold special promise for improving the quality of drug abuse and AIDS research. The At-Risk Project studies substance abuse related data sets on vulnerable populations (substance abusers, homeless people, individuals who are HIV positive or who have AIDS, victims of domestic abuse, runaways, gang members, and others at high risk for AIDS or drug abuse) with methods to control the sampling, measurement, distributional and other biases that may exist. The Community Project studies drug abuse etiology, adult consequences, HIV risk, intergenerational processes, general deviance, and related issues in large community-based samples, and develops and tests explanatory theories using models that permit separation of common from specific effects, control for artifacts, etc. The Latino Project uses datasets from varied Latino groups to study within- and between-Latino population drug abuse etiology, test and extend an ecological theory of Latino drug use, and study HIV risk and acculturative phenomena related to drug use. The Core Project oversees and integrates all components, hosts visiting scholars, provides computer facilities, and sponsors a mentoring program for disadvantaged students.  ",COLLABORATIVE RESEARCH ON DRUG ABUSE,6620441,P01DA001070,"['drug abuse ', ' clinical research ', ' behavioral /social science research tag ', ' disease /disorder etiology ', ' ']",NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,P01,2003,1294179,0.11190653016281335
"IDU Access to HIV/HCV Prevention   DESCRIPTION: (provided by applicant)                                                                                      A recent health promotion campaign in Rhode Island (RI) to prevent HIV and           Hepatitis C prompted the deregulation of syringes, allowing their sale in            pharmacies without a prescription. Included in this law is that pharmacies may       sell syringes: if so, pharmacists are required to provide syringe disposal           information and may provide drug treatment referral information. This proposal       is to investigate racial/ethnic and gender disparities in access to                  pharmacy-based prevention services associated with this law change. We propose       to evaluate racial/ethnic and gender disparities by geographic barriers              (Specific Aim 1), barriers related to drug users (the consumer of these              services) (Specific Aim 2), and barriers related to pharmacists (the providers       of these services) (Specific Aim 3). We limit our evaluation to the two largest      non-white groups in RI, African Americans/Blacks, and Latino/ Hispanics in           comparison to whites. Geocoding methods will be used for Specific Aim 1. Census      2000 data will be used to identify racially diverse block groups. Socioeconomic      conditions will be quantified to adjust for class in analyses of race. Both          pharmacy and drug user locations will be overlaid to determine geographic            barriers to access. For drug user studies, qualitative and quantitative methods      will determine both perceived and real barriers to accessing pharmacy                prevention services. The qualitative study will use a targeted street                recruitment of injection drug users, while the quantitative study will include       participants in existing drug user cohorts. For pharmacy-related studies, all        pharmacies in the state will be included. We propose a purchaser experience          trial where non-drug using purchasers of different racial/ethnic groups attempt      to purchase a syringe, as well as a pharmacist telephone survey, evaluating          attitudes regarding the law change, their perception regarding drug users and        racial/ethnic groups in general. Analyses will evaluate access (or barriers to       access) and its relation to race, across and between racially and                    socioeconomically diverse neighborhoods. These analyses will provide important       data regarding the implementation of a policy change and the need for targeted       solutions in response to racial disparities.                                                                                                                              ",IDU Access to HIV/HCV Prevention,6762925,R01DA014853,"['communicable disease control ', ' communicable disease transmission ', ' disease /disorder proneness /risk ', ' pharmacy administration ', ' intravenous drug abuse ', ' health care service availability ', ' human subject ', ' interview ', ' questionnaire ', ' statistics /biometry ', ' high risk behavior /lifestyle ', ' gender difference ', ' African American ', ' Hispanic American ', ' racial /ethnic difference ', ' socioenvironment ', ' virus infection mechanism ', ' human immunodeficiency virus ', ' needle sharing ', ' hepatitis C ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' medically underserved population ', ' ']",NIDA,BROWN UNIVERSITY,R01,2003,10152,0.13849189066326564
"Club Drugs/Resource Inequity/Health Risk in Urban Youth   DESCRIPTION (provided by the applicant): This five year study entitled ""Club         Drugs, Resource Inequities and Health Risks among Urban Youth"" will identify         the contextual, socio-cultural and psychological factors that influence urban        youth and young adults to incorporate club drugs into their drug repertoires,        changes in drug use patterns over time, and the psychosocial, economic and           health consequences of club drug use and concurrent polydrug mixing. The study       responds to NIDA's RFA DA-0 1 -0 10 entitled ""Responding to Club Drugs And           Other Emerging And Current Drug Abuse Trends."" Study aims are to: 1) describe        the marketing and diffusion of club and designer drugs into urban youth and          young adult drug markets through clubs, after-hours, and other social                activities, and describe the meaning of these drugs in relation to traditional       street drugs (regular and high THC marijuana, leaves with formaldehyde,              alcohol, dust, cocaine, crack and heroin), 2) conduct a panel study with two         time points eight months apart with 500 youth ages 16 - 30 to deter-mine             changes in patterns of MDMA and other dance and prescription drugs, and              predictors and consequences of use, 3) utilize the information to develop            strategies for dance and prescription drug risk prevention in street and party       settings. Component 1 (Months I - 50) of the study will continue established         patterns of ethnographic research in settings where urban youth and young            adults buy, sell, learn about and experiment with new drugs and drug mixing.         Component 2 (Months 8 - 58) will involve administering an                            epidemiologic/network survey to the study cohort of 500 youth and young adults       between the ages of 16 - 30. In Component 3 (Months 42-60) we will use ongoing       study results in partnership with a team of youth consultants to develop and         pilot test for acceptability a strategy for preventing risks associated with         MDMA and other club drug use and drug mixing to be utilized in drug use sites,       with distributors and in networks of users. Throughout, we will review and           integrate emerging literature linking findings to the primary theoretical            concepts guiding the study. The significance of the study lies in its                description of the ways in which new potentially dangerous drugs are diffused        into a high risk urban environment, its incorporation of the psychosocial,           economic and contextual factors in understanding drug selling, its focus on          understudied polydrug use among urban youth, its examination of neighborhood         factors in drug selection and use, and its partnership with youth and                youth-serving clubs and site gatekeepers to engage in risk reduction. The study      promises to produce new analytic and theoretical insights into the diffusion of      new drugs into already saturated urban youth drug markets and the consequences       of their use.                                                                                                                                                             ",Club Drugs/Resource Inequity/Health Risk in Urban Youth,6806933,R01DA014863,"['young adult human (21-34) ', ' adolescence (12-20) ', ' disease /disorder proneness /risk ', ' drug abuse ', ' drug abuse prevention ', ' human subject ', ' 3,4 methylenedioxymethamphetamine ', ' social psychology ', ' psychotropic drug ', ' racial /ethnic difference ', ' socioeconomics ', ' urban area ', ' clinical research ', ' behavioral /social science research tag ', ' outcomes research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,INSTITUTE FOR COMMUNITY RESEARCH,R01,2003,28527,0.20819357873312505
"IDU Access to HIV/HCV Prevention   DESCRIPTION: (provided by applicant)                                                                                      A recent health promotion campaign in Rhode Island (RI) to prevent HIV and           Hepatitis C prompted the deregulation of syringes, allowing their sale in            pharmacies without a prescription. Included in this law is that pharmacies may       sell syringes: if so, pharmacists are required to provide syringe disposal           information and may provide drug treatment referral information. This proposal       is to investigate racial/ethnic and gender disparities in access to                  pharmacy-based prevention services associated with this law change. We propose       to evaluate racial/ethnic and gender disparities by geographic barriers              (Specific Aim 1), barriers related to drug users (the consumer of these              services) (Specific Aim 2), and barriers related to pharmacists (the providers       of these services) (Specific Aim 3). We limit our evaluation to the two largest      non-white groups in RI, African Americans/Blacks, and Latino/ Hispanics in           comparison to whites. Geocoding methods will be used for Specific Aim 1. Census      2000 data will be used to identify racially diverse block groups. Socioeconomic      conditions will be quantified to adjust for class in analyses of race. Both          pharmacy and drug user locations will be overlaid to determine geographic            barriers to access. For drug user studies, qualitative and quantitative methods      will determine both perceived and real barriers to accessing pharmacy                prevention services. The qualitative study will use a targeted street                recruitment of injection drug users, while the quantitative study will include       participants in existing drug user cohorts. For pharmacy-related studies, all        pharmacies in the state will be included. We propose a purchaser experience          trial where non-drug using purchasers of different racial/ethnic groups attempt      to purchase a syringe, as well as a pharmacist telephone survey, evaluating          attitudes regarding the law change, their perception regarding drug users and        racial/ethnic groups in general. Analyses will evaluate access (or barriers to       access) and its relation to race, across and between racially and                    socioeconomically diverse neighborhoods. These analyses will provide important       data regarding the implementation of a policy change and the need for targeted       solutions in response to racial disparities.                                                                                                                              ",IDU Access to HIV/HCV Prevention,6660272,R01DA014853,"['communicable disease control ', ' communicable disease transmission ', ' disease /disorder proneness /risk ', ' pharmacy administration ', ' intravenous drug abuse ', ' health care service availability ', ' human subject ', ' interview ', ' questionnaire ', ' statistics /biometry ', ' high risk behavior /lifestyle ', ' gender difference ', ' African American ', ' Hispanic American ', ' racial /ethnic difference ', ' socioenvironment ', ' virus infection mechanism ', ' human immunodeficiency virus ', ' needle sharing ', ' hepatitis C ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' medically underserved population ', ' ']",NIDA,BROWN UNIVERSITY,R01,2003,433468,0.13849189066326564
"Club Drugs/Resource Inequity/Health Risk in Urban Youth   DESCRIPTION (provided by the applicant): This five year study entitled ""Club         Drugs, Resource Inequities and Health Risks among Urban Youth"" will identify         the contextual, socio-cultural and psychological factors that influence urban        youth and young adults to incorporate club drugs into their drug repertoires,        changes in drug use patterns over time, and the psychosocial, economic and           health consequences of club drug use and concurrent polydrug mixing. The study       responds to NIDA's RFA DA-0 1 -0 10 entitled ""Responding to Club Drugs And           Other Emerging And Current Drug Abuse Trends."" Study aims are to: 1) describe        the marketing and diffusion of club and designer drugs into urban youth and          young adult drug markets through clubs, after-hours, and other social                activities, and describe the meaning of these drugs in relation to traditional       street drugs (regular and high THC marijuana, leaves with formaldehyde,              alcohol, dust, cocaine, crack and heroin), 2) conduct a panel study with two         time points eight months apart with 500 youth ages 16 - 30 to deter-mine             changes in patterns of MDMA and other dance and prescription drugs, and              predictors and consequences of use, 3) utilize the information to develop            strategies for dance and prescription drug risk prevention in street and party       settings. Component 1 (Months I - 50) of the study will continue established         patterns of ethnographic research in settings where urban youth and young            adults buy, sell, learn about and experiment with new drugs and drug mixing.         Component 2 (Months 8 - 58) will involve administering an                            epidemiologic/network survey to the study cohort of 500 youth and young adults       between the ages of 16 - 30. In Component 3 (Months 42-60) we will use ongoing       study results in partnership with a team of youth consultants to develop and         pilot test for acceptability a strategy for preventing risks associated with         MDMA and other club drug use and drug mixing to be utilized in drug use sites,       with distributors and in networks of users. Throughout, we will review and           integrate emerging literature linking findings to the primary theoretical            concepts guiding the study. The significance of the study lies in its                description of the ways in which new potentially dangerous drugs are diffused        into a high risk urban environment, its incorporation of the psychosocial,           economic and contextual factors in understanding drug selling, its focus on          understudied polydrug use among urban youth, its examination of neighborhood         factors in drug selection and use, and its partnership with youth and                youth-serving clubs and site gatekeepers to engage in risk reduction. The study      promises to produce new analytic and theoretical insights into the diffusion of      new drugs into already saturated urban youth drug markets and the consequences       of their use.                                                                                                                                                             ",Club Drugs/Resource Inequity/Health Risk in Urban Youth,6797612,R01DA014863,"['young adult human (21-34) ', ' adolescence (12-20) ', ' disease /disorder proneness /risk ', ' drug abuse ', ' drug abuse prevention ', ' human subject ', ' 3,4 methylenedioxymethamphetamine ', ' social psychology ', ' psychotropic drug ', ' racial /ethnic difference ', ' socioeconomics ', ' urban area ', ' clinical research ', ' behavioral /social science research tag ', ' outcomes research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,INSTITUTE FOR COMMUNITY RESEARCH,R01,2003,123732,0.20819357873312505
"Homeless Women: Drugs, Race/Ethicity, And Health Care   DESCRIPTION: (provided by applicant)                                                 Research has shown that drug use and physical health problems are quite common       among the homeless and that their general health-care needs often go unmet.          However, much of this research is based on samples composed largely of homeless      men. To date, there has been little research on the relationship between drug        use and utilization of general health care among homeless women. Moreover,           possible racial/ethnic differences in this relationship have not been                extensively examined. This study will employ secondary data from two                 complementary funded studies to analyze the association between drug use and         use of general health care (inpatient, ambulatory, and preventive). The first        dataset screened for lifetime drug dependence in a community-based probability       sample of 861 homeless women in Los Angeles County, and the second dataset           assessed current heavy drug use and lifetime injection drug use in a purposive       sample of 1,330 homeless women in Los Angeles. We will test hypotheses               regarding a wide range of predisposing and enabling factors (such as case            management, health insurance, and access to public benefits) potentially             associated with access to general health services by African American, Latina,       and White homeless women with drug problems. The proposed study directly             addresses policy questions prominent in NIDA's strategic plan on reducing            health disparities. By documenting the nature and extent of health problems          affecting drug-using homeless women, their use of general health services, the       extent to which their need for care goes unmet, and possible racial/ethnic           differences in these patterns, this study will inform drug treatment providers       on the value and content of screening/assessment procedures they might employ        and the types of general health services for which more effective linkage is         needed.                                                                                                                                                                   ","Homeless Women: Drugs, Race/Ethicity, And Health Care",6669168,R01DA014835,"['drug abuse ', ' health care service utilization ', ' female ', ' homeless ', ' racial /ethnic difference ', ' human data ', "" women's health "", ' behavioral /social science research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2003,314346,0.18627626917048123
"Neurocognitive Function in Russian Heroin Addicts DESCRIPTION (provided by applicant): Research on the neurocognitive consequences of chronic heroin use is sparse, despite the global existence of millions of addicts and young initiates. Most U.S. studies include polydrug abusers and are unable to precisely distinguish between neurocognitive consequences of specific drugs. This deficit is particularly true for heroin addiction, which is often also preceded by several years of extensive use of other drugs, confounding the ability to assess single drug effects. Thus, it is important to determine whether there are neurocognitive impairments associated specifically with heroin addiction that may differ from those associated with alcoholism or whether the same deficits are common to multiple drug users. To elucidate differential neurocognitive consequences of heroin use, it is necessary to identify a population with a dependency on only one drug. Most studies of drug effects on brain function also do not measure prefrontally modulated executive cognitive function (ECF) and focus largely on general neuropsychological function. Recent research using state-of-the-art cognitive instruments provides support for a relationship between specific dimensions of ECF and drug abuse propensity and persistence. ECF may predict relapse propensity, and intact function may be a prerequisite for favorable responses to treatment programs that require a certain level of cognitive processing. There is also insufficient research on gender disparities in the cognitive consequences of drug use, despite differences in historical patterns of use, neurologic drug effects, and involvement of contextual factors. ECF assessment of male and female heroin addicts entering treatment is useful for the evaluation of aspects of cognitive functioning that may be relevant for optimal therapeutic management and treatment planning.      To evaluate differential relationships between ECF in heroin addicts versus alcoholics among these groups, the proposed study will focus on single drug users without extensive prior use of other drugs from an inpatient treatment facility in St. Petersburg, Russia. Two control groups will be included: polydrug abusers from the facility and a group of nondrug abusers from the community. Neurocognitive tests will be administered after detoxification. Mediating effects of personality traits on cognitive outcomes will further be assessed. This innovative design and unique sample population will generate findings critical to understanding differences in ECF among heroin addicts, alcoholics, and polydrug abusers, as well as differential gender effects. Because the nature and degree of recovery from drug abuse are likely a function of the type or pattern of neurocognitive impairment, differential drug effects must be considered. This study will significantly contribute to NIDA's goal to support international collaborative research to increase understanding of consequences of drug abuse. ",Neurocognitive Function in Russian Heroin Addicts,6609542,R01DA015528,"['alcoholism /alcohol abuse ', ' heroin ', ' drug addiction ', ' Commonwealth of Independent States ', ' human subject ', ' impulsive behavior ', ' cognition ', ' depression ', ' neuropsychological test ', ' personality disorder ', ' gender difference ', ' substance abuse ', ' clinical research ', ' health disparity ', ' ']",NIDA,RESEARCH TRIANGLE INSTITUTE,R01,2003,325161,0.1718022058074085
"The neighborhood environment and drug use in NYC DESCRIPTION (provided by applicant): Proposed is a study is to assess the relations between neighborhood characteristics (e.g., neighborhood disadvantage, collective efficacy, residential segregation) and drug use behavior among residents of New York City while controlling for relevant individual-level factors. A secondary purpose of this study is to determine the relation between key neighborhood characteristics and the medical consequences of drug use, particularly fatal drug overdose. Recent work has shown that neighborhood characteristics are associated with the likelihood of drug use, abuse, and dependence and that research focusing exclusively on individual patterns of drug use is insufficient to fully explain inter-individual drug use behavior. Here we propose a systematic collection of data to characterize neighborhoods in a large metropolitan area and to test key hypotheses that may explain inter-individual variability in drug use behavior and its consequences.   Understanding how neighborhood factors affect drug use risk behavior can guide interventions that aim to mitigate drug use and its consequences, to create a social environment that better facilitates users to seek treatment, and to improve overall population health. In order to achieve the aims of this study we will use data from three sources: (i) We will collect data on individual drug use behavior (focusing on cigarette, alcohol, and marijuana use) through a random digit-dial phone survey of 5,000 New York City residents, geo-coding and mapping each respondent to their neighborhood of residence; (ii) we will compile a contextual database characterizing New York City neighborhoods using information collected in the survey and using archival data (collected from the New York City Department of Health and Mental Hygiene, Department of City Planning, Police Department, US Census and other sources); and (iii) we will combine this data with data from a NIDA funded study of drug overdose over time (DA 06534; principal investigator: Tardiff, a consultant on this project). We will test key hypotheses about the relations between neighborhood characteristics and drug use, abuse, and dependence using multi-level hierarchical models. We have recently completed several studies of New York City neighborhoods that serve as preliminary exploration of the key hypotheses of this study. This, coupled with our studies involving telephone interviews with 6,000+ New Yorkers is assurance that the aims of this study can be achieved. ",The neighborhood environment and drug use in NYC,6754044,R01DA017642,"['alcoholic beverage consumption ', ' drug abuse ', ' overdose ', ' tobacco abuse ', ' marijuana abuse ', ' medical record ', ' human subject ', ' interview ', ' human mortality ', ' population survey ', ' high risk behavior /lifestyle ', ' social integration ', ' socioeconomics ', ' socioenvironment ', ' community ', ' housing ', ' urban poverty area ', ' environmental stressor ', ' human data ', ' smoking ', ' clinical research ', ' behavioral /social science research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' medically underserved population ', ' geographic difference ', ' health disparity ', ' ']",NIDA,NEW YORK ACADEMY OF MEDICINE,R01,2004,365607,0.07685429698994137
"Homeless Women: Drugs, Race/Ethicity, And Health Care   DESCRIPTION: (provided by applicant)                                                 Research has shown that drug use and physical health problems are quite common       among the homeless and that their general health-care needs often go unmet.          However, much of this research is based on samples composed largely of homeless      men. To date, there has been little research on the relationship between drug        use and utilization of general health care among homeless women. Moreover,           possible racial/ethnic differences in this relationship have not been                extensively examined. This study will employ secondary data from two                 complementary funded studies to analyze the association between drug use and         use of general health care (inpatient, ambulatory, and preventive). The first        dataset screened for lifetime drug dependence in a community-based probability       sample of 861 homeless women in Los Angeles County, and the second dataset           assessed current heavy drug use and lifetime injection drug use in a purposive       sample of 1,330 homeless women in Los Angeles. We will test hypotheses               regarding a wide range of predisposing and enabling factors (such as case            management, health insurance, and access to public benefits) potentially             associated with access to general health services by African American, Latina,       and White homeless women with drug problems. The proposed study directly             addresses policy questions prominent in NIDA's strategic plan on reducing            health disparities. By documenting the nature and extent of health problems          affecting drug-using homeless women, their use of general health services, the       extent to which their need for care goes unmet, and possible racial/ethnic           differences in these patterns, this study will inform drug treatment providers       on the value and content of screening/assessment procedures they might employ        and the types of general health services for which more effective linkage is         needed.                                                                                                                                                                   ","Homeless Women: Drugs, Race/Ethicity, And Health Care",6867192,R01DA014835,"['drug abuse ', ' health care service utilization ', ' female ', ' homeless ', ' racial /ethnic difference ', ' human data ', "" women's health "", ' behavioral /social science research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2004,48494,0.18627626917048123
"Drug Attitudes and Behavior on the US/Mexico Border   DESCRIPTION: (provided by applicant)                                                 The objective of this study is to improve knowledge and understanding of             disparities in drug use and related attitudes, perceptions, and behaviors            concerning drug use and drug treatment utilization among Hispanic and non            Hispanic populations living in proximity to the U.S./Mexico border. This is a        geographic area in which the mainstream culture is heavily bicultural, a             pattern which is expected to typify an increasingly large segment of the West        and Southwest regions of the United States during the next decade. Knowledge         gained in this study is expected to benefit service planners who would               anticipate need for current and future service strategies to better respond to       the problems and needs of Hispanic and bicultural populations. Specific aims         are 1) to describe the prevalence of substance use, abuse, and dependence, and       the demographic and social correlates of use among households living on the          border, and to measure the changes in prevalence that have occurred during the       past six years since a similar study was done; 2) to investigate the role of         acculturation in explaining differences in substance use within the Hispanic         border community; and 3) to determine border residents' attitudes and behaviors      related to the utilization of treatment services and the correlates of these         attitudes and behaviors. These questions will be addressed through an in-person      survey of 1200 adults living in households: 400 from the El Paso metropolitan        area, 400 from the Rio Grande Valley metropolitan area, and 400 from colonias        (rural, unincorporated communities often characterized by lack of basic public       services).                                                                                                                                                                ",Drug Attitudes and Behavior on the US/Mexico Border,6796002,R01DA014794,"['alcoholism /alcohol abuse ', ' drug abuse prevention ', ' inhalation drug abuse ', ' tobacco abuse ', ' household ', ' Mexico ', ' United States ', ' health care service evaluation ', ' health care service utilization ', ' human subject ', ' interview ', ' data collection methodology /evaluation ', ' longitudinal human study ', ' health survey ', ' health behavior ', ' attitude ', ' gender difference ', ' Hispanic American ', ' racial /ethnic difference ', ' social integration ', ' socioenvironment ', ' international cooperation ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,"UNIVERSITY OF TEXAS, AUSTIN",R01,2004,254926,0.04269354879991353
"Neurocognitive Function in Russian Heroin Addicts DESCRIPTION (provided by applicant): Research on the neurocognitive consequences of chronic heroin use is sparse, despite the global existence of millions of addicts and young initiates. Most U.S. studies include polydrug abusers and are unable to precisely distinguish between neurocognitive consequences of specific drugs. This deficit is particularly true for heroin addiction, which is often also preceded by several years of extensive use of other drugs, confounding the ability to assess single drug effects. Thus, it is important to determine whether there are neurocognitive impairments associated specifically with heroin addiction that may differ from those associated with alcoholism or whether the same deficits are common to multiple drug users. To elucidate differential neurocognitive consequences of heroin use, it is necessary to identify a population with a dependency on only one drug. Most studies of drug effects on brain function also do not measure prefrontally modulated executive cognitive function (ECF) and focus largely on general neuropsychological function. Recent research using state-of-the-art cognitive instruments provides support for a relationship between specific dimensions of ECF and drug abuse propensity and persistence. ECF may predict relapse propensity, and intact function may be a prerequisite for favorable responses to treatment programs that require a certain level of cognitive processing. There is also insufficient research on gender disparities in the cognitive consequences of drug use, despite differences in historical patterns of use, neurologic drug effects, and involvement of contextual factors. ECF assessment of male and female heroin addicts entering treatment is useful for the evaluation of aspects of cognitive functioning that may be relevant for optimal therapeutic management and treatment planning.      To evaluate differential relationships between ECF in heroin addicts versus alcoholics among these groups, the proposed study will focus on single drug users without extensive prior use of other drugs from an inpatient treatment facility in St. Petersburg, Russia. Two control groups will be included: polydrug abusers from the facility and a group of nondrug abusers from the community. Neurocognitive tests will be administered after detoxification. Mediating effects of personality traits on cognitive outcomes will further be assessed. This innovative design and unique sample population will generate findings critical to understanding differences in ECF among heroin addicts, alcoholics, and polydrug abusers, as well as differential gender effects. Because the nature and degree of recovery from drug abuse are likely a function of the type or pattern of neurocognitive impairment, differential drug effects must be considered. This study will significantly contribute to NIDA's goal to support international collaborative research to increase understanding of consequences of drug abuse. ",Neurocognitive Function in Russian Heroin Addicts,6800375,R01DA015528,"['alcoholism /alcohol abuse ', ' heroin ', ' drug addiction ', ' Commonwealth of Independent States ', ' human subject ', ' impulsive behavior ', ' cognition ', ' depression ', ' neuropsychological test ', ' personality disorder ', ' gender difference ', ' substance abuse ', ' clinical research ', ' health disparity ', ' ']",NIDA,RESEARCH TRIANGLE INSTITUTE,R01,2004,237515,0.1718022058074085
"Community Vulnerability and Responses to IDU-Related HIV  DESCRIPTION (provided by applicant): In this competing continuation, we will conduct a longitudinal study (1993-2007) of 96 large metropolitan areas to study trends and predictors of changes in the population prevalence of drug injectors, HIV) prevalence among injectors, and related prevention programs. In stage one of this project, we developed ways to estimate the population density of injection drug use and HIV prevalence rates in metropolitan areas. We showed that per capita injection drug use increased during the 1990s in many localities, including Baltimore and Salt Lake City. HIV prevalence rates among drug injectors increased in Baltimore and some other areas. In many metropolitan areas, drug injection and HIV rates among injectors declined. The extent to which local HIV prevention programs reached drug injectors also varied widely: 3 metropolitan areas provided treatment to 20% or more of their injectors, while 13 areas reached less than 5%. HIV counseling and testing rates also varied widely. In cross-sectional analyses, we showed that local government budgetary decisions, social and economic factors, and drug abuse interventions were related to injection drug users per capita, HIV revalence among drug injectors, and the presence and size of various programs to prevent HIV among drug injectors. We will build upon our existing data and construct a database for these 96 metropolitan areas containing annual estimates from 1993 - 2007 of drug injectors per capita; HIV prevalence, incident AIDS cases and AIDS mortality among drug injectors; program availability and size; socioeconomic conditions, and government budgetary allocations. We will (1) describe patterns of change over time in prevention programs and epidemiology. We will use longitudinal analysis methods to study (2) how changing socioeconomic conditions, epidemiologic need, budgetary constraints and choices, and policy choices are related to subsequent HIV prevention programming; and (3) how all these variables are related to later changes in (a) drug injectors per capita, (b) HIV prevalence and AIDS among drug injectors, (c) drug abuse treatment and other programs for drug injectors, and (d) racial/ethnic disparities in appropriate indicators. We will use these analyses to develop a well-theorized scientific understanding of forces that shape metropolitan area HIV/AIDS epidemics, rates of drug injectors per capita, and prevention programs. The resulting scientific knowledge base can help develop programs and policies so as to avoid epidemics and, if needed, control them.         ",Community Vulnerability and Responses to IDU-Related HIV,6842162,R01DA013336,"['communicable disease control ', ' communicable disease transmission ', ' disease /disorder proneness /risk ', ' drug abuse therapy ', ' intravenous drug abuse ', ' AIDS education /prevention ', ' health system agency ', ' health care service evaluation ', ' health care service availability ', ' health care cost /financing ', ' HIV infection ', ' longitudinal human study ', ' high risk behavior /lifestyle ', ' racial /ethnic difference ', ' socioeconomics ', ' community ', ' urban area ', ' human data ', ' health care policy ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' outcomes research ', ' substance abuse related behavior ', ' health disparity ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R01,2004,413941,0.22464773436225408
"Club Drugs/Resource Inequity/Health Risk in Urban Youth   DESCRIPTION (provided by the applicant): This five year study entitled ""Club         Drugs, Resource Inequities and Health Risks among Urban Youth"" will identify         the contextual, socio-cultural and psychological factors that influence urban        youth and young adults to incorporate club drugs into their drug repertoires,        changes in drug use patterns over time, and the psychosocial, economic and           health consequences of club drug use and concurrent polydrug mixing. The study       responds to NIDA's RFA DA-0 1 -0 10 entitled ""Responding to Club Drugs And           Other Emerging And Current Drug Abuse Trends."" Study aims are to: 1) describe        the marketing and diffusion of club and designer drugs into urban youth and          young adult drug markets through clubs, after-hours, and other social                activities, and describe the meaning of these drugs in relation to traditional       street drugs (regular and high THC marijuana, leaves with formaldehyde,              alcohol, dust, cocaine, crack and heroin), 2) conduct a panel study with two         time points eight months apart with 500 youth ages 16 - 30 to deter-mine             changes in patterns of MDMA and other dance and prescription drugs, and              predictors and consequences of use, 3) utilize the information to develop            strategies for dance and prescription drug risk prevention in street and party       settings. Component 1 (Months I - 50) of the study will continue established         patterns of ethnographic research in settings where urban youth and young            adults buy, sell, learn about and experiment with new drugs and drug mixing.         Component 2 (Months 8 - 58) will involve administering an                            epidemiologic/network survey to the study cohort of 500 youth and young adults       between the ages of 16 - 30. In Component 3 (Months 42-60) we will use ongoing       study results in partnership with a team of youth consultants to develop and         pilot test for acceptability a strategy for preventing risks associated with         MDMA and other club drug use and drug mixing to be utilized in drug use sites,       with distributors and in networks of users. Throughout, we will review and           integrate emerging literature linking findings to the primary theoretical            concepts guiding the study. The significance of the study lies in its                description of the ways in which new potentially dangerous drugs are diffused        into a high risk urban environment, its incorporation of the psychosocial,           economic and contextual factors in understanding drug selling, its focus on          understudied polydrug use among urban youth, its examination of neighborhood         factors in drug selection and use, and its partnership with youth and                youth-serving clubs and site gatekeepers to engage in risk reduction. The study      promises to produce new analytic and theoretical insights into the diffusion of      new drugs into already saturated urban youth drug markets and the consequences       of their use.                                                                                                                                                             ",Club Drugs/Resource Inequity/Health Risk in Urban Youth,6936692,R01DA014863,"['young adult human (21-34) ', ' adolescence (12-20) ', ' disease /disorder proneness /risk ', ' drug abuse ', ' drug abuse prevention ', ' human subject ', ' 3,4 methylenedioxymethamphetamine ', ' social psychology ', ' psychotropic drug ', ' racial /ethnic difference ', ' socioeconomics ', ' urban area ', ' clinical research ', ' behavioral /social science research tag ', ' outcomes research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,INSTITUTE FOR COMMUNITY RESEARCH,R01,2004,28527,0.20819357873312505
"Girls in Drug Abuse Science DESCRIPTION (provided by applicant):    Developing scientists is a priority of the National Institutes of Health, the National Institute on Drug Abuse, and this continuation project. The overall aim of this competing continuation application for a Science Education Drug Abuse Partnership Award Project (SEDAPA) is to extend the development and implementation of a curriculum and manual for high school young women to middle school girls in sixth to eighth grade who live in rural Appalachian Kentucky. The specific aims for the project are: (1) To increase the scientific, technological and interpersonal knowledge as well as skills of participating middle-school girls ages 11 to 15 from rural Appalachian Kentucky; (2) To increase the knowledge of parents and middle schoolteachers on gender equity strategies, and teaching techniques to increase the science participation of middle school girls in rural Appalachian Kentucky; (3) To develop and disseminate a model curriculum to enhance science as well as drug abuse research in rural Appalachian Kentucky; and (4) To develop and disseminate a guide for ""Promoting Gender Equity in the Classroom"" to enhance science education in rural and Appalachian areas. This competing continuation application focuses on 120 rural Appalachian Kentucky girls entering the sixth grade from 21 rural counties; 120 to 240 parents of these girls; and at least 30 rural middle school teachers from the same 21 rural counties. Project Summer Institutes, Saturday Sessions, and scientific as well as community mentoring opportunities will continue for participating girls. For this competing continuation application, younger girls (middle school) will be targeted; workshops for parents and teachers will be added; 21 rather than 14 rural counties will be included; current project participants will be involved as mentors; Chris in Drug Abuse Science Clubs will be added; the Kentucky Department of Education along with project staff will work to promote Gender Equity in all middle schools in Kentucky; and the replication manual will be expanded for girls in grades 6 to 8 to produce a complete and comprehensive manual across grades 6 to 12 for replication in other rural and Appalachian areas. ",Girls in Drug Abuse Science,6805948,R25DA011388,"['adolescence (12-20) ', ' curriculum ', ' drug abuse education ', ' secondary school ', ' teaching ', ' education evaluation /planning ', ' parent ', ' human subject ', ' questionnaire ', ' handbook ', ' female ', ' gender difference ', ' community ', ' rural area ', ' teacher ', ' clinical research ', ' educational resource design /development ', ' medically underserved population ', ' health disparity ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R25,2004,270000,0.07264206386789569
"MINORITY PREDOCTORIAL FELLOWSHIP PROGRAM DESCRIPTION (provided by applicant): The applicant's proposed research is an exploration of the barriers that influence adherence to antiretroviral therapy (ART) by HIV-positive individuals who use illicit drugs. Twenty years of research suggest that patient characteristics, provider factors, treatment regimen factors, and social/environmental factors play a role in chronic disease treatment compliance. However, few studies have explicitly linked these factors to non-adherence among HIV-positive individuals who use illicit drugs. The proposed study aims to study the impact of these potential barriers through a mixed method design: secondary analysis of the HIV Cost and Services Utilization Study (HCSUS) and content analysis of the Participating and Communicating Together Study (PACT). This information can be used to strengthen medication adherence interventions for HIV positive drug using populations. Moreover, because drug-related HIV/AIDS disproportionately affects African Americans and other communities of color, research that leads to improvements in HIV treatment outcomes for drug-using populations may also help reduce racial/ethnic health disparities. ",MINORITY PREDOCTORIAL FELLOWSHIP PROGRAM,6746693,F31AI058913,"['drug abuse ', ' health care quality ', ' health care service availability ', ' AIDS therapy ', ' HIV infection ', ' longitudinal human study ', ' coping ', ' lifestyle ', ' social support network ', ' socioenvironment ', ' therapy compliance ', ' human data ', ' behavioral /social science research tag ', ' substance abuse related behavior ', ' predoctoral investigator ', ' ']",NIAID,UNIV OF NORTH CAROLINA CHAPEL HILL,F31,2004,36862,0.06647796427007553
"COLLABORATIVE RESEARCH ON DRUG ABUSE DESCRIPTION: (provided by applicant) This P01 aims to develop and apply state-of-the-art methods to analyze existing but under-utilized drug abuse databases in collaboration with their owners. We address contemporary, theoretical, and applied issues in drug abuse research to understand intersections between substance abuse and AIDS risk behaviors as well as minority and gender-based health disparities. We work together with dozens of investigators from education, epidemiology, medicine, psychiatry, psychology, public health, social work, and sociology who own exciting substance abuse data to develop models that test current theories, especially on epidemiology, prevention, intervention, and treatment of drug abuse, using modern multivariate psychometric and statistical methods to control for measurement errors, biases, and other confounds. The Models and Methods Project develops analytic techniques (e.g., improved structural equation methods for small samples, missing and nonnormal data, outliers, dependent and hierarchical data, functional imaging) that hold special promise for improving the quality of drug abuse and AIDS research. The At-Risk Project studies substance abuse related data sets on vulnerable populations (substance abusers, homeless people, individuals who are HIV positive or who have AIDS, victims of domestic abuse, runaways, gang members, and others at high risk for AIDS or drug abuse) with methods to control the sampling, measurement, distributional and other biases that may exist. The Community Project studies drug abuse etiology, adult consequences, HIV risk, intergenerational processes, general deviance, and related issues in large community-based samples, and develops and tests explanatory theories using models that permit separation of common from specific effects, control for artifacts, etc. The Latino Project uses datasets from varied Latino groups to study within- and between-Latino population drug abuse etiology, test and extend an ecological theory of Latino drug use, and study HIV risk and acculturative phenomena related to drug use. The Core Project oversees and integrates all components, hosts visiting scholars, provides computer facilities, and sponsors a mentoring program for disadvantaged students.  ",COLLABORATIVE RESEARCH ON DRUG ABUSE,6765225,P01DA001070,"['drug abuse ', ' clinical research ', ' behavioral /social science research tag ', ' disease /disorder etiology ', ' ']",NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,P01,2004,1522990,0.11190653016281335
"Club Drugs/Resource Inequity/Health Risk in Urban Youth   DESCRIPTION (provided by the applicant): This five year study entitled ""Club         Drugs, Resource Inequities and Health Risks among Urban Youth"" will identify         the contextual, socio-cultural and psychological factors that influence urban        youth and young adults to incorporate club drugs into their drug repertoires,        changes in drug use patterns over time, and the psychosocial, economic and           health consequences of club drug use and concurrent polydrug mixing. The study       responds to NIDA's RFA DA-0 1 -0 10 entitled ""Responding to Club Drugs And           Other Emerging And Current Drug Abuse Trends."" Study aims are to: 1) describe        the marketing and diffusion of club and designer drugs into urban youth and          young adult drug markets through clubs, after-hours, and other social                activities, and describe the meaning of these drugs in relation to traditional       street drugs (regular and high THC marijuana, leaves with formaldehyde,              alcohol, dust, cocaine, crack and heroin), 2) conduct a panel study with two         time points eight months apart with 500 youth ages 16 - 30 to deter-mine             changes in patterns of MDMA and other dance and prescription drugs, and              predictors and consequences of use, 3) utilize the information to develop            strategies for dance and prescription drug risk prevention in street and party       settings. Component 1 (Months I - 50) of the study will continue established         patterns of ethnographic research in settings where urban youth and young            adults buy, sell, learn about and experiment with new drugs and drug mixing.         Component 2 (Months 8 - 58) will involve administering an                            epidemiologic/network survey to the study cohort of 500 youth and young adults       between the ages of 16 - 30. In Component 3 (Months 42-60) we will use ongoing       study results in partnership with a team of youth consultants to develop and         pilot test for acceptability a strategy for preventing risks associated with         MDMA and other club drug use and drug mixing to be utilized in drug use sites,       with distributors and in networks of users. Throughout, we will review and           integrate emerging literature linking findings to the primary theoretical            concepts guiding the study. The significance of the study lies in its                description of the ways in which new potentially dangerous drugs are diffused        into a high risk urban environment, its incorporation of the psychosocial,           economic and contextual factors in understanding drug selling, its focus on          understudied polydrug use among urban youth, its examination of neighborhood         factors in drug selection and use, and its partnership with youth and                youth-serving clubs and site gatekeepers to engage in risk reduction. The study      promises to produce new analytic and theoretical insights into the diffusion of      new drugs into already saturated urban youth drug markets and the consequences       of their use.                                                                                                                                                             ",Club Drugs/Resource Inequity/Health Risk in Urban Youth,6767859,R01DA014863,"['young adult human (21-34) ', ' adolescence (12-20) ', ' disease /disorder proneness /risk ', ' drug abuse ', ' drug abuse prevention ', ' human subject ', ' 3,4 methylenedioxymethamphetamine ', ' social psychology ', ' psychotropic drug ', ' racial /ethnic difference ', ' socioeconomics ', ' urban area ', ' clinical research ', ' behavioral /social science research tag ', ' outcomes research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,INSTITUTE FOR COMMUNITY RESEARCH,R01,2004,604782,0.20819357873312505
"Criminal Justice, Race, and HIV Risk in CT Drug Users DESCRIPTION (provided by applicant): This exploratory pilot project is being submitted in response to RFA-DA-04-015, ""HIV/AIDS and Other Infections among Drug Users in the Criminal Justice System"" for support under the R21 mechanism. It will examine how involvement in the criminal justice (CJ) system subsequently shapes the HIV related risks and behaviors of individuals with a history of drug use, and how this varies by race and gender. It will focus in particular on understanding how the criminal justice system operates as a structural determinant of both drug- and sexual-related HIV risk in drug users (DUs), and with this understanding, on identifying potential structural interventions-modifications in the CJ system-for promoting HIV prevention among DUs. The project will examine these issues from the perspective of the individual, in order to better understand the HIV prevention needs of DUs involved with the CJ system, and from the perspective of the CJ system, in order to understand where there may be opportunities for reforms or for utilizing CJ personnel to promote HIV prevention (potential structural interventions). With regard to the individual, it will examine three specific mechanisms through which the CJ system is hypothesized to impact on risk among DUs, including, through its effects on: social support networks and family relationships, socio-economic vulnerability, and access to risk reduction programs. With regard to the CJ system, it will focus on the systems of probation and parole (PIP), including laws and regulations relating to P/P, as well as the responsibilities and authority invested in key actors in these systems (e.g. probation and parole officers, attorneys, and judges) and how they exercise this authority. ","Criminal Justice, Race, and HIV Risk in CT Drug Users",6878355,R21DA019186,"['communicable disease transmission ', ' disease /disorder proneness /risk ', ' drug abuse ', ' AIDS education /prevention ', ' family structure /dynamics ', ' health care service availability ', ' human subject ', ' HIV infection ', ' interview ', ' high risk behavior /lifestyle ', ' gender difference ', ' correctional institution ', ' African American ', ' racial /ethnic difference ', ' social support network ', ' socioeconomics ', ' clinical research ', ' behavioral /social science research tag ', ' health disparity ', ' ']",NIDA,YALE UNIVERSITY,R21,2004,193639,0.08356097600842709
"Ecodevelopmental Classes of Youth Drug Use/Risky Sex DESCRIPTION (provided by applicant):     The goal of the proposed study is to answer the question: ""For which subgroups of Hispanic adolescents are specific drug use and HIV preventive interventions efficacious and for whom are they not?"" This application proposes to answer this question by conducting secondary data analysis with this highly vulnerable population.  The proposed study will be accomplished through two aims.  AIM 1 is to identify classes of risk for this population.  Classes of risk will be identified at baseline based on individual level variables (i.e., attitudes, beliefs, and intentions regarding drug use and sexual behavior) and ecodevelopmental variables (i.e., family functioning, parental monitoring of adolescent's peers, and the adolescent's orientation toward the American culture).  AIM 1 will be tested by hierarchical cluster analyses and discrete latent mixtures.  AIM 2 is to estimate the efficacy of the preventive interventions with respect to preventing drug use and unsafe sexual behavior across the classes of risk identified in Aim 1.  Hierarchical Linear Modeling will be used to test AIM 2.  Planned post-hoc analyses will be conducted to (a) explore the efficacy of the interventions within the classes identified and (b) the mechanisms that may mediate the effects of the intervention within each of the classes.  Findings that intervention efficacy varies as a function of individual's class membership and that intervention efficacy is mediated by different variables within class will have implications for the development of a new generation of drug use and HIV preventive interventions for Hispanic adolescents.  Specifically, the results of this study will help determine what specific ecodevelopmental and individual factors need to be targeted within different subgroups of Hispanic adolescents to maximize intervention efficacy/effectiveness in preventing drug use and HIV.  This study has the potential to help reduce health disparities in Hispanic populations. ",Ecodevelopmental Classes of Youth Drug Use/Risky Sex,6876224,R03DA019101,"['adolescence (12-20) ', ' disease /disorder classification ', ' disease /disorder proneness /risk ', ' drug abuse ', ' drug abuse prevention ', ' AIDS education /prevention ', ' family structure /dynamics ', ' caregiver ', ' HIV infection ', ' attitude ', ' high risk behavior /lifestyle ', ' sex behavior ', ' peer group ', ' Hispanic American ', ' socioenvironment ', ' culture ', ' human therapy evaluation ', ' human data ', ' clinical research ', ' outcomes research ', ' substance abuse related behavior ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R03,2004,75750,0.06166115526044428
"IDU Access to HIV/HCV Prevention   DESCRIPTION: (provided by applicant)                                                                                      A recent health promotion campaign in Rhode Island (RI) to prevent HIV and           Hepatitis C prompted the deregulation of syringes, allowing their sale in            pharmacies without a prescription. Included in this law is that pharmacies may       sell syringes: if so, pharmacists are required to provide syringe disposal           information and may provide drug treatment referral information. This proposal       is to investigate racial/ethnic and gender disparities in access to                  pharmacy-based prevention services associated with this law change. We propose       to evaluate racial/ethnic and gender disparities by geographic barriers              (Specific Aim 1), barriers related to drug users (the consumer of these              services) (Specific Aim 2), and barriers related to pharmacists (the providers       of these services) (Specific Aim 3). We limit our evaluation to the two largest      non-white groups in RI, African Americans/Blacks, and Latino/ Hispanics in           comparison to whites. Geocoding methods will be used for Specific Aim 1. Census      2000 data will be used to identify racially diverse block groups. Socioeconomic      conditions will be quantified to adjust for class in analyses of race. Both          pharmacy and drug user locations will be overlaid to determine geographic            barriers to access. For drug user studies, qualitative and quantitative methods      will determine both perceived and real barriers to accessing pharmacy                prevention services. The qualitative study will use a targeted street                recruitment of injection drug users, while the quantitative study will include       participants in existing drug user cohorts. For pharmacy-related studies, all        pharmacies in the state will be included. We propose a purchaser experience          trial where non-drug using purchasers of different racial/ethnic groups attempt      to purchase a syringe, as well as a pharmacist telephone survey, evaluating          attitudes regarding the law change, their perception regarding drug users and        racial/ethnic groups in general. Analyses will evaluate access (or barriers to       access) and its relation to race, across and between racially and                    socioeconomically diverse neighborhoods. These analyses will provide important       data regarding the implementation of a policy change and the need for targeted       solutions in response to racial disparities.                                                                                                                              ",IDU Access to HIV/HCV Prevention,6948424,R01DA014853,"['communicable disease control ', ' communicable disease transmission ', ' disease /disorder proneness /risk ', ' pharmacy administration ', ' intravenous drug abuse ', ' health care service availability ', ' human subject ', ' interview ', ' questionnaire ', ' statistics /biometry ', ' high risk behavior /lifestyle ', ' gender difference ', ' African American ', ' Hispanic American ', ' racial /ethnic difference ', ' socioenvironment ', ' virus infection mechanism ', ' human immunodeficiency virus ', ' needle sharing ', ' hepatitis C ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' medically underserved population ', ' ']",NIDA,BROWN UNIVERSITY,R01,2004,13535,0.13849189066326564
"Drug Use & Latent Structure of Adolescent Mental Health With cross-classification used to probe for possible male-female and child-adolescent variation, recently published evidence on the mental and behavioral disturbances of young people seems to confirm dimensional models of anxiety and depression (Wadsworth et al., 2001) as well as attention problems (Hudziak et al., 1999). In this new R01 project, the main goal is to investigate youth drug use as it relates to latent structure of mental and behavioral disturbances across age strata in adolescence (12-13,14-15,16-17 years), with due consideration for different drug types (inhalants; club drugs like ecstasy; marijuana; tobacco; alcohol) and levels of drug involvement. Once the underlying latent class structures have been elucidated, and class memberships have been assigned based on the best-supported class structures, the applicant will turn to regression models to probe research questions pertinent to (a) the co-occurrence of adolescent drug involvement and disturbances of the mental life, behavior, and social adaptation, (b) probing for variation in the latent structure across subgroups defined by race-ethnicity to perhaps aid in understanding health disparities that affect minority subgroups, and (c) the clustering of the class members within local areas of residence within the United States, with a specific focus upon analyses that will probe how drug use might sustain delinquent peer groups. The data are from 13,831 youths (age 12-17) recruited after nationally representative sampling for the National Household Survey on Drug Abuse (NHSDA) in 1994-1996. For the NHSDA, the youths completed standardized modules on drug involvement, as well as a survey adaptation of Achenbach's Youth Self Report (YSR). The YSR is perhaps, the most. widely used instrument for measuring youth disturbances in the mental life, behavior, and socxal adaptation. In sum, the  plan of research is one that exploits an untapped research opportunity to learn more about adolescent drug taking as it relates to disturbances of the mental life, behavior, and social adaptation. The plan involves the use of two relatively recent biostatistical developments in the form of latent class regression and alternating logistic regression models, which are innovative approaches to the study of research questions that previously have not been asked in large-sample epidemiological studies of national scope. ",Drug Use & Latent Structure of Adolescent Mental Health,6728839,R01DA016323,"['child behavior disorder ', ' juvenile delinquency ', ' adolescence (12-20) ', ' drug abuse ', ' data collection methodology /evaluation ', ' health survey ', ' aggression ', ' peer group ', ' social adjustment ', ' gender difference ', ' racial /ethnic difference ', ' age difference ', ' human data ', ' clinical research ', ' behavioral /social science research tag ', ' substance abuse epidemiology ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R01,2004,245250,0.12544998213400896
"Club Drugs/Resource Inequity/Health Risk in Urban Youth   DESCRIPTION (provided by the applicant): This five year study entitled ""Club         Drugs, Resource Inequities and Health Risks among Urban Youth"" will identify         the contextual, socio-cultural and psychological factors that influence urban        youth and young adults to incorporate club drugs into their drug repertoires,        changes in drug use patterns over time, and the psychosocial, economic and           health consequences of club drug use and concurrent polydrug mixing. The study       responds to NIDA's RFA DA-0 1 -0 10 entitled ""Responding to Club Drugs And           Other Emerging And Current Drug Abuse Trends."" Study aims are to: 1) describe        the marketing and diffusion of club and designer drugs into urban youth and          young adult drug markets through clubs, after-hours, and other social                activities, and describe the meaning of these drugs in relation to traditional       street drugs (regular and high THC marijuana, leaves with formaldehyde,              alcohol, dust, cocaine, crack and heroin), 2) conduct a panel study with two         time points eight months apart with 500 youth ages 16 - 30 to deter-mine             changes in patterns of MDMA and other dance and prescription drugs, and              predictors and consequences of use, 3) utilize the information to develop            strategies for dance and prescription drug risk prevention in street and party       settings. Component 1 (Months I - 50) of the study will continue established         patterns of ethnographic research in settings where urban youth and young            adults buy, sell, learn about and experiment with new drugs and drug mixing.         Component 2 (Months 8 - 58) will involve administering an                            epidemiologic/network survey to the study cohort of 500 youth and young adults       between the ages of 16 - 30. In Component 3 (Months 42-60) we will use ongoing       study results in partnership with a team of youth consultants to develop and         pilot test for acceptability a strategy for preventing risks associated with         MDMA and other club drug use and drug mixing to be utilized in drug use sites,       with distributors and in networks of users. Throughout, we will review and           integrate emerging literature linking findings to the primary theoretical            concepts guiding the study. The significance of the study lies in its                description of the ways in which new potentially dangerous drugs are diffused        into a high risk urban environment, its incorporation of the psychosocial,           economic and contextual factors in understanding drug selling, its focus on          understudied polydrug use among urban youth, its examination of neighborhood         factors in drug selection and use, and its partnership with youth and                youth-serving clubs and site gatekeepers to engage in risk reduction. The study      promises to produce new analytic and theoretical insights into the diffusion of      new drugs into already saturated urban youth drug markets and the consequences       of their use.                                                                                                                                                             ",Club Drugs/Resource Inequity/Health Risk in Urban Youth,7082734,R01DA014863,"['young adult human (21-34) ', ' adolescence (12-20) ', ' disease /disorder proneness /risk ', ' drug abuse ', ' drug abuse prevention ', ' human subject ', ' 3,4 methylenedioxymethamphetamine ', ' social psychology ', ' psychotropic drug ', ' racial /ethnic difference ', ' socioeconomics ', ' urban area ', ' clinical research ', ' behavioral /social science research tag ', ' outcomes research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,INSTITUTE FOR COMMUNITY RESEARCH,R01,2005,85635,0.20819357873312505
"Neurocognitive Function in Russian Heroin Addicts DESCRIPTION (provided by applicant): Research on the neurocognitive consequences of chronic heroin use is sparse, despite the global existence of millions of addicts and young initiates. Most U.S. studies include polydrug abusers and are unable to precisely distinguish between neurocognitive consequences of specific drugs. This deficit is particularly true for heroin addiction, which is often also preceded by several years of extensive use of other drugs, confounding the ability to assess single drug effects. Thus, it is important to determine whether there are neurocognitive impairments associated specifically with heroin addiction that may differ from those associated with alcoholism or whether the same deficits are common to multiple drug users. To elucidate differential neurocognitive consequences of heroin use, it is necessary to identify a population with a dependency on only one drug. Most studies of drug effects on brain function also do not measure prefrontally modulated executive cognitive function (ECF) and focus largely on general neuropsychological function. Recent research using state-of-the-art cognitive instruments provides support for a relationship between specific dimensions of ECF and drug abuse propensity and persistence. ECF may predict relapse propensity, and intact function may be a prerequisite for favorable responses to treatment programs that require a certain level of cognitive processing. There is also insufficient research on gender disparities in the cognitive consequences of drug use, despite differences in historical patterns of use, neurologic drug effects, and involvement of contextual factors. ECF assessment of male and female heroin addicts entering treatment is useful for the evaluation of aspects of cognitive functioning that may be relevant for optimal therapeutic management and treatment planning.      To evaluate differential relationships between ECF in heroin addicts versus alcoholics among these groups, the proposed study will focus on single drug users without extensive prior use of other drugs from an inpatient treatment facility in St. Petersburg, Russia. Two control groups will be included: polydrug abusers from the facility and a group of nondrug abusers from the community. Neurocognitive tests will be administered after detoxification. Mediating effects of personality traits on cognitive outcomes will further be assessed. This innovative design and unique sample population will generate findings critical to understanding differences in ECF among heroin addicts, alcoholics, and polydrug abusers, as well as differential gender effects. Because the nature and degree of recovery from drug abuse are likely a function of the type or pattern of neurocognitive impairment, differential drug effects must be considered. This study will significantly contribute to NIDA's goal to support international collaborative research to increase understanding of consequences of drug abuse. ",Neurocognitive Function in Russian Heroin Addicts,6894062,R01DA015528,"['alcoholism /alcohol abuse ', ' heroin ', ' drug addiction ', ' Commonwealth of Independent States ', ' human subject ', ' impulsive behavior ', ' cognition ', ' depression ', ' neuropsychological test ', ' personality disorder ', ' gender difference ', ' substance abuse related disorder ', ' clinical research ', ' health disparity ', ' ']",NIDA,RESEARCH TRIANGLE INSTITUTE,R01,2005,236087,0.1718022058074085
"Club Drugs/Resource Inequity/Health Risk in Urban Youth   DESCRIPTION (provided by the applicant): This five year study entitled ""Club         Drugs, Resource Inequities and Health Risks among Urban Youth"" will identify         the contextual, socio-cultural and psychological factors that influence urban        youth and young adults to incorporate club drugs into their drug repertoires,        changes in drug use patterns over time, and the psychosocial, economic and           health consequences of club drug use and concurrent polydrug mixing. The study       responds to NIDA's RFA DA-0 1 -0 10 entitled ""Responding to Club Drugs And           Other Emerging And Current Drug Abuse Trends."" Study aims are to: 1) describe        the marketing and diffusion of club and designer drugs into urban youth and          young adult drug markets through clubs, after-hours, and other social                activities, and describe the meaning of these drugs in relation to traditional       street drugs (regular and high THC marijuana, leaves with formaldehyde,              alcohol, dust, cocaine, crack and heroin), 2) conduct a panel study with two         time points eight months apart with 500 youth ages 16 - 30 to deter-mine             changes in patterns of MDMA and other dance and prescription drugs, and              predictors and consequences of use, 3) utilize the information to develop            strategies for dance and prescription drug risk prevention in street and party       settings. Component 1 (Months I - 50) of the study will continue established         patterns of ethnographic research in settings where urban youth and young            adults buy, sell, learn about and experiment with new drugs and drug mixing.         Component 2 (Months 8 - 58) will involve administering an                            epidemiologic/network survey to the study cohort of 500 youth and young adults       between the ages of 16 - 30. In Component 3 (Months 42-60) we will use ongoing       study results in partnership with a team of youth consultants to develop and         pilot test for acceptability a strategy for preventing risks associated with         MDMA and other club drug use and drug mixing to be utilized in drug use sites,       with distributors and in networks of users. Throughout, we will review and           integrate emerging literature linking findings to the primary theoretical            concepts guiding the study. The significance of the study lies in its                description of the ways in which new potentially dangerous drugs are diffused        into a high risk urban environment, its incorporation of the psychosocial,           economic and contextual factors in understanding drug selling, its focus on          understudied polydrug use among urban youth, its examination of neighborhood         factors in drug selection and use, and its partnership with youth and                youth-serving clubs and site gatekeepers to engage in risk reduction. The study      promises to produce new analytic and theoretical insights into the diffusion of      new drugs into already saturated urban youth drug markets and the consequences       of their use.                                                                                                                                                             ",Club Drugs/Resource Inequity/Health Risk in Urban Youth,7121692,R01DA014863,"['young adult human (21-34) ', ' adolescence (12-20) ', ' disease /disorder proneness /risk ', ' drug abuse ', ' drug abuse prevention ', ' human subject ', ' 3,4 methylenedioxymethamphetamine ', ' social psychology ', ' psychotropic drug ', ' racial /ethnic difference ', ' socioeconomics ', ' urban area ', ' clinical research ', ' behavioral /social science research tag ', ' outcomes research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,INSTITUTE FOR COMMUNITY RESEARCH,R01,2005,34020,0.20819357873312505
"The Center for the Study and Prevention of Drug Use    DESCRIPTION (provided by applicant):     This proposal for the Center for Study and Prevention of Drug Use is submitted by Morgan State University and seeks funding under the PAR-02-016 mechanism in response to the PA entitled ""Minority Institutions' Drug Abuse Research Development Program"" (MIDARP). The proposed Center will be an inter-institutional collaborative effort involving Morgan State University, a minority institution, and research intensive universities and programmatic initiatives that focus on and specialize in research on drug use and disparities associated with drug use. The Center seeks to build on the collaborative relationships established through the Center to increase the capacity of Morgan State, its faculty and its students to conduct rigorous drug use research with and emphasis on drug use epidemiology, public health, and health disparities related to drug use. In order to actualize the mission of the Center, four components were developed which address the necessary aspects of creating a drug use research center. 1) The Faculty Development Plan, which seeks to advance Morgan faculty by allowing them to engage in off-site collaborative research with individuals specializing in drug research. 2) A second aspect is the Student Development Plan, which seeks to expose, educate and, train minority students in the area of drug use research. 3) The research arm of the project includes a primary and four developmental pilot project, allowing researchers at Morgan to begin using their present expertise and investigating topics in the area of drug use and disparities related to drug use. 4) Overseeing, each of the areas is the proposed plan for the Administrative Units and Center Organization. Through this component collaborative relationships, research projects, and faculty and student development will be monitored and enhanced. As a result of the Center faculty at Morgan State will be further enhanced regarding their ability to conduct rigorous research independently, specifically submitting R01's. Further, Morgan will be sufficiently capable of training students for careers in drug use research by developing a structured program in drug research, and the administrative staff will have the skills necessary to support the research staff in all endeavors related to research projects. In sum, the Center will be; self-sustaining and capable of producing future research focused on drug use research.               ",The Center for the Study and Prevention of Drug Use,6944580,R24DA019805,"['biomedical facility ', ' adolescence (12-20) ', ' drug abuse prevention ', ' training ', ' university ', ' public health ', ' minority institution research support ', ' health science research potential ', ' human subject ', ' clinical research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' health disparity ', ' ']",NIDA,MORGAN STATE UNIVERSITY,R24,2005,404053,0.2289119318721305
"Ecodevelopmental Classes of Youth Drug Use/Risky Sex DESCRIPTION (provided by applicant):     The goal of the proposed study is to answer the question: ""For which subgroups of Hispanic adolescents are specific drug use and HIV preventive interventions efficacious and for whom are they not?"" This application proposes to answer this question by conducting secondary data analysis with this highly vulnerable population.  The proposed study will be accomplished through two aims.  AIM 1 is to identify classes of risk for this population.  Classes of risk will be identified at baseline based on individual level variables (i.e., attitudes, beliefs, and intentions regarding drug use and sexual behavior) and ecodevelopmental variables (i.e., family functioning, parental monitoring of adolescent's peers, and the adolescent's orientation toward the American culture).  AIM 1 will be tested by hierarchical cluster analyses and discrete latent mixtures.  AIM 2 is to estimate the efficacy of the preventive interventions with respect to preventing drug use and unsafe sexual behavior across the classes of risk identified in Aim 1.  Hierarchical Linear Modeling will be used to test AIM 2.  Planned post-hoc analyses will be conducted to (a) explore the efficacy of the interventions within the classes identified and (b) the mechanisms that may mediate the effects of the intervention within each of the classes.  Findings that intervention efficacy varies as a function of individual's class membership and that intervention efficacy is mediated by different variables within class will have implications for the development of a new generation of drug use and HIV preventive interventions for Hispanic adolescents.  Specifically, the results of this study will help determine what specific ecodevelopmental and individual factors need to be targeted within different subgroups of Hispanic adolescents to maximize intervention efficacy/effectiveness in preventing drug use and HIV.  This study has the potential to help reduce health disparities in Hispanic populations. ",Ecodevelopmental Classes of Youth Drug Use/Risky Sex,6953121,R03DA019101,"['adolescence (12-20) ', ' disease /disorder classification ', ' disease /disorder proneness /risk ', ' drug abuse ', ' drug abuse prevention ', ' AIDS education /prevention ', ' family structure /dynamics ', ' caregiver ', ' HIV infection ', ' attitude ', ' high risk behavior /lifestyle ', ' sex behavior ', ' peer group ', ' Hispanic American ', ' socioenvironment ', ' culture ', ' human therapy evaluation ', ' human data ', ' clinical research ', ' outcomes research ', ' substance abuse related behavior ', ' ']",NIDA,FLORIDA INTERNATIONAL UNIVERSITY,R03,2005,70000,0.06166115526044428
"Criminal Justice, Race, and HIV Risk in CT Drug Users DESCRIPTION (provided by applicant): This exploratory pilot project is being submitted in response to RFA-DA-04-015, ""HIV/AIDS and Other Infections among Drug Users in the Criminal Justice System"" for support under the R21 mechanism. It will examine how involvement in the criminal justice (CJ) system subsequently shapes the HIV related risks and behaviors of individuals with a history of drug use, and how this varies by race and gender. It will focus in particular on understanding how the criminal justice system operates as a structural determinant of both drug- and sexual-related HIV risk in drug users (DUs), and with this understanding, on identifying potential structural interventions-modifications in the CJ system-for promoting HIV prevention among DUs. The project will examine these issues from the perspective of the individual, in order to better understand the HIV prevention needs of DUs involved with the CJ system, and from the perspective of the CJ system, in order to understand where there may be opportunities for reforms or for utilizing CJ personnel to promote HIV prevention (potential structural interventions). With regard to the individual, it will examine three specific mechanisms through which the CJ system is hypothesized to impact on risk among DUs, including, through its effects on: social support networks and family relationships, socio-economic vulnerability, and access to risk reduction programs. With regard to the CJ system, it will focus on the systems of probation and parole (PIP), including laws and regulations relating to P/P, as well as the responsibilities and authority invested in key actors in these systems (e.g. probation and parole officers, attorneys, and judges) and how they exercise this authority. ","Criminal Justice, Race, and HIV Risk in CT Drug Users",6952441,R21DA019186,"['communicable disease transmission ', ' disease /disorder proneness /risk ', ' drug abuse ', ' AIDS education /prevention ', ' family structure /dynamics ', ' health care service availability ', ' human subject ', ' HIV infection ', ' interview ', ' high risk behavior /lifestyle ', ' gender difference ', ' correctional institution ', ' African American ', ' racial /ethnic difference ', ' social support network ', ' socioeconomics ', ' clinical research ', ' behavioral /social science research tag ', ' health disparity ', ' ']",NIDA,YALE UNIVERSITY,R21,2005,162620,0.08356097600842709
"The neighborhood environment and drug use in NYC DESCRIPTION (provided by applicant): Proposed is a study is to assess the relations between neighborhood characteristics (e.g., neighborhood disadvantage, collective efficacy, residential segregation) and drug use behavior among residents of New York City while controlling for relevant individual-level factors. A secondary purpose of this study is to determine the relation between key neighborhood characteristics and the medical consequences of drug use, particularly fatal drug overdose. Recent work has shown that neighborhood characteristics are associated with the likelihood of drug use, abuse, and dependence and that research focusing exclusively on individual patterns of drug use is insufficient to fully explain inter-individual drug use behavior. Here we propose a systematic collection of data to characterize neighborhoods in a large metropolitan area and to test key hypotheses that may explain inter-individual variability in drug use behavior and its consequences.   Understanding how neighborhood factors affect drug use risk behavior can guide interventions that aim to mitigate drug use and its consequences, to create a social environment that better facilitates users to seek treatment, and to improve overall population health. In order to achieve the aims of this study we will use data from three sources: (i) We will collect data on individual drug use behavior (focusing on cigarette, alcohol, and marijuana use) through a random digit-dial phone survey of 5,000 New York City residents, geo-coding and mapping each respondent to their neighborhood of residence; (ii) we will compile a contextual database characterizing New York City neighborhoods using information collected in the survey and using archival data (collected from the New York City Department of Health and Mental Hygiene, Department of City Planning, Police Department, US Census and other sources); and (iii) we will combine this data with data from a NIDA funded study of drug overdose over time (DA 06534; principal investigator: Tardiff, a consultant on this project). We will test key hypotheses about the relations between neighborhood characteristics and drug use, abuse, and dependence using multi-level hierarchical models. We have recently completed several studies of New York City neighborhoods that serve as preliminary exploration of the key hypotheses of this study. This, coupled with our studies involving telephone interviews with 6,000+ New Yorkers is assurance that the aims of this study can be achieved. ",The neighborhood environment and drug use in NYC,7118486,R01DA017642,"['alcoholic beverage consumption ', ' drug abuse ', ' overdose ', ' tobacco abuse ', ' marijuana abuse ', ' medical record ', ' human subject ', ' interview ', ' human mortality ', ' population survey ', ' high risk behavior /lifestyle ', ' social integration ', ' socioeconomics ', ' socioenvironment ', ' community ', ' housing ', ' urban poverty area ', ' environmental stressor ', ' human data ', ' smoking ', ' clinical research ', ' behavioral /social science research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' medically underserved population ', ' geographic difference ', ' health disparity ', ' ']",NIDA,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2005,295675,0.07685429698994137
"Understanding Self-Reports of Drug Use in Pregnant Women    DESCRIPTION (provided by applicant): Assessing the accuracy of self-reports (SR) of tobacco, alcohol, and illicit drug use among pregnant and post-partum women is crucial to both their treatment and to the health of their children. The public health and drug treatment policy implications of not obtaining accurate self-reports cannot be overestimated. For example, if African-American women are less likely to report drug use than white women, they are less likely to receive treatment. This is a health care disparity issue. Self-report/other alternate measure (drug tests, for example) agreement rates from pregnant women are highly variable according to ethnicity, drug type, and other factors, and no systematic meta-analytic review has attempted to explain this variability. This project builds upon a previous SBIR which has constructed a meta-analytic database containing 325 studies of self-reports of substance use compared to biological indicators (e.g., urinalysis) or collateral reports (e.g., spousal report), and 2083 individual comparisons. A subset of these studies (98) addressing use among pregnant and/or post-partum women have been acquired and are codable. 54 studies have been coded. The present project will summarize the relationship between SR and alternate measures of substance use among pregnant women, the key goals being to provide average estimates of SR agreement, identify distinct subgroups, and search for moderator variables which might influence the relationship between SR and biological indicators in this unique population. The focus will include careful consideration of factors that might be changed to improve self-report accuracy.         ",Understanding Self-Reports of Drug Use in Pregnant Women,6966777,R21DA017800,"['alcoholism /alcohol abuse ', ' biomarker ', ' drug abuse ', ' tobacco abuse ', ' data collection methodology /evaluation ', ' epidemiology ', ' pregnancy ', ' postpartum ', ' female ', ' racial /ethnic difference ', ' age difference ', ' human data ', ' clinical research ', ' substance abuse related behavior ', ' health disparity ', ' data quality /integrity ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R21,2005,216600,0.07307006989190389
"Girls in Drug Abuse Science DESCRIPTION (provided by applicant):    Developing scientists is a priority of the National Institutes of Health, the National Institute on Drug Abuse, and this continuation project. The overall aim of this competing continuation application for a Science Education Drug Abuse Partnership Award Project (SEDAPA) is to extend the development and implementation of a curriculum and manual for high school young women to middle school girls in sixth to eighth grade who live in rural Appalachian Kentucky. The specific aims for the project are: (1) To increase the scientific, technological and interpersonal knowledge as well as skills of participating middle-school girls ages 11 to 15 from rural Appalachian Kentucky; (2) To increase the knowledge of parents and middle schoolteachers on gender equity strategies, and teaching techniques to increase the science participation of middle school girls in rural Appalachian Kentucky; (3) To develop and disseminate a model curriculum to enhance science as well as drug abuse research in rural Appalachian Kentucky; and (4) To develop and disseminate a guide for ""Promoting Gender Equity in the Classroom"" to enhance science education in rural and Appalachian areas. This competing continuation application focuses on 120 rural Appalachian Kentucky girls entering the sixth grade from 21 rural counties; 120 to 240 parents of these girls; and at least 30 rural middle school teachers from the same 21 rural counties. Project Summer Institutes, Saturday Sessions, and scientific as well as community mentoring opportunities will continue for participating girls. For this competing continuation application, younger girls (middle school) will be targeted; workshops for parents and teachers will be added; 21 rather than 14 rural counties will be included; current project participants will be involved as mentors; Chris in Drug Abuse Science Clubs will be added; the Kentucky Department of Education along with project staff will work to promote Gender Equity in all middle schools in Kentucky; and the replication manual will be expanded for girls in grades 6 to 8 to produce a complete and comprehensive manual across grades 6 to 12 for replication in other rural and Appalachian areas. ",Girls in Drug Abuse Science,6922865,R25DA011388,"['adolescence (12-20) ', ' curriculum ', ' drug abuse education ', ' secondary school ', ' teaching ', ' education evaluation /planning ', ' parent ', ' human subject ', ' questionnaire ', ' handbook ', ' female ', ' gender difference ', ' community ', ' rural area ', ' teacher ', ' clinical research ', ' educational resource design /development ', ' medically underserved population ', ' health disparity ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R25,2005,270000,0.07264206386789569
"Community Vulnerability and Responses to IDU-Related HIV  DESCRIPTION (provided by applicant): In this competing continuation, we will conduct a longitudinal study (1993-2007) of 96 large metropolitan areas to study trends and predictors of changes in the population prevalence of drug injectors, HIV) prevalence among injectors, and related prevention programs. In stage one of this project, we developed ways to estimate the population density of injection drug use and HIV prevalence rates in metropolitan areas. We showed that per capita injection drug use increased during the 1990s in many localities, including Baltimore and Salt Lake City. HIV prevalence rates among drug injectors increased in Baltimore and some other areas. In many metropolitan areas, drug injection and HIV rates among injectors declined. The extent to which local HIV prevention programs reached drug injectors also varied widely: 3 metropolitan areas provided treatment to 20% or more of their injectors, while 13 areas reached less than 5%. HIV counseling and testing rates also varied widely. In cross-sectional analyses, we showed that local government budgetary decisions, social and economic factors, and drug abuse interventions were related to injection drug users per capita, HIV revalence among drug injectors, and the presence and size of various programs to prevent HIV among drug injectors. We will build upon our existing data and construct a database for these 96 metropolitan areas containing annual estimates from 1993 - 2007 of drug injectors per capita; HIV prevalence, incident AIDS cases and AIDS mortality among drug injectors; program availability and size; socioeconomic conditions, and government budgetary allocations. We will (1) describe patterns of change over time in prevention programs and epidemiology. We will use longitudinal analysis methods to study (2) how changing socioeconomic conditions, epidemiologic need, budgetary constraints and choices, and policy choices are related to subsequent HIV prevention programming; and (3) how all these variables are related to later changes in (a) drug injectors per capita, (b) HIV prevalence and AIDS among drug injectors, (c) drug abuse treatment and other programs for drug injectors, and (d) racial/ethnic disparities in appropriate indicators. We will use these analyses to develop a well-theorized scientific understanding of forces that shape metropolitan area HIV/AIDS epidemics, rates of drug injectors per capita, and prevention programs. The resulting scientific knowledge base can help develop programs and policies so as to avoid epidemics and, if needed, control them.         ",Community Vulnerability and Responses to IDU-Related HIV,6930368,R01DA013336,"['communicable disease control ', ' communicable disease transmission ', ' disease /disorder proneness /risk ', ' drug abuse therapy ', ' intravenous drug abuse ', ' AIDS education /prevention ', ' health system agency ', ' health care service evaluation ', ' health care service availability ', ' health care cost /financing ', ' HIV infection ', ' longitudinal human study ', ' high risk behavior /lifestyle ', ' racial /ethnic difference ', ' socioeconomics ', ' community ', ' urban area ', ' human data ', ' health care policy ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' outcomes research ', ' substance abuse related behavior ', ' health disparity ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R01,2005,653147,0.22464773436225408
"Drug Use & Latent Structure of Adolescent Mental Health With cross-classification used to probe for possible male-female and child-adolescent variation, recently published evidence on the mental and behavioral disturbances of young people seems to confirm dimensional models of anxiety and depression (Wadsworth et al., 2001) as well as attention problems (Hudziak et al., 1999). In this new R01 project, the main goal is to investigate youth drug use as it relates to latent structure of mental and behavioral disturbances across age strata in adolescence (12-13,14-15,16-17 years), with due consideration for different drug types (inhalants; club drugs like ecstasy; marijuana; tobacco; alcohol) and levels of drug involvement. Once the underlying latent class structures have been elucidated, and class memberships have been assigned based on the best-supported class structures, the applicant will turn to regression models to probe research questions pertinent to (a) the co-occurrence of adolescent drug involvement and disturbances of the mental life, behavior, and social adaptation, (b) probing for variation in the latent structure across subgroups defined by race-ethnicity to perhaps aid in understanding health disparities that affect minority subgroups, and (c) the clustering of the class members within local areas of residence within the United States, with a specific focus upon analyses that will probe how drug use might sustain delinquent peer groups. The data are from 13,831 youths (age 12-17) recruited after nationally representative sampling for the National Household Survey on Drug Abuse (NHSDA) in 1994-1996. For the NHSDA, the youths completed standardized modules on drug involvement, as well as a survey adaptation of Achenbach's Youth Self Report (YSR). The YSR is perhaps, the most. widely used instrument for measuring youth disturbances in the mental life, behavior, and socxal adaptation. In sum, the  plan of research is one that exploits an untapped research opportunity to learn more about adolescent drug taking as it relates to disturbances of the mental life, behavior, and social adaptation. The plan involves the use of two relatively recent biostatistical developments in the form of latent class regression and alternating logistic regression models, which are innovative approaches to the study of research questions that previously have not been asked in large-sample epidemiological studies of national scope. ",Drug Use & Latent Structure of Adolescent Mental Health,6876550,R01DA016323,"['child behavior disorder ', ' juvenile delinquency ', ' adolescence (12-20) ', ' drug abuse ', ' data collection methodology /evaluation ', ' health survey ', ' aggression ', ' peer group ', ' social adjustment ', ' gender difference ', ' racial /ethnic difference ', ' age difference ', ' human data ', ' clinical research ', ' behavioral /social science research tag ', ' substance abuse epidemiology ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R01,2005,245250,0.12544998213400896
"MINORITY PREDOCTORIAL FELLOWSHIP PROGRAM DESCRIPTION (provided by applicant): The applicant's proposed research is an exploration of the barriers that influence adherence to antiretroviral therapy (ART) by HIV-positive individuals who use illicit drugs. Twenty years of research suggest that patient characteristics, provider factors, treatment regimen factors, and social/environmental factors play a role in chronic disease treatment compliance. However, few studies have explicitly linked these factors to non-adherence among HIV-positive individuals who use illicit drugs. The proposed study aims to study the impact of these potential barriers through a mixed method design: secondary analysis of the HIV Cost and Services Utilization Study (HCSUS) and content analysis of the Participating and Communicating Together Study (PACT). This information can be used to strengthen medication adherence interventions for HIV positive drug using populations. Moreover, because drug-related HIV/AIDS disproportionately affects African Americans and other communities of color, research that leads to improvements in HIV treatment outcomes for drug-using populations may also help reduce racial/ethnic health disparities. ",MINORITY PREDOCTORIAL FELLOWSHIP PROGRAM,6901065,F31AI058913,"['drug abuse ', ' health care quality ', ' health care service availability ', ' AIDS therapy ', ' HIV infection ', ' longitudinal human study ', ' coping ', ' lifestyle ', ' social support network ', ' socioenvironment ', ' therapy compliance ', ' human data ', ' behavioral /social science research tag ', ' substance abuse related behavior ', ' predoctoral investigator ', ' ']",NIAID,UNIV OF NORTH CAROLINA CHAPEL HILL,F31,2005,36862,0.06647796427007553
"Homeless Women: Drugs, Race/Ethicity, And Health Care   DESCRIPTION: (provided by applicant)                                                 Research has shown that drug use and physical health problems are quite common       among the homeless and that their general health-care needs often go unmet.          However, much of this research is based on samples composed largely of homeless      men. To date, there has been little research on the relationship between drug        use and utilization of general health care among homeless women. Moreover,           possible racial/ethnic differences in this relationship have not been                extensively examined. This study will employ secondary data from two                 complementary funded studies to analyze the association between drug use and         use of general health care (inpatient, ambulatory, and preventive). The first        dataset screened for lifetime drug dependence in a community-based probability       sample of 861 homeless women in Los Angeles County, and the second dataset           assessed current heavy drug use and lifetime injection drug use in a purposive       sample of 1,330 homeless women in Los Angeles. We will test hypotheses               regarding a wide range of predisposing and enabling factors (such as case            management, health insurance, and access to public benefits) potentially             associated with access to general health services by African American, Latina,       and White homeless women with drug problems. The proposed study directly             addresses policy questions prominent in NIDA's strategic plan on reducing            health disparities. By documenting the nature and extent of health problems          affecting drug-using homeless women, their use of general health services, the       extent to which their need for care goes unmet, and possible racial/ethnic           differences in these patterns, this study will inform drug treatment providers       on the value and content of screening/assessment procedures they might employ        and the types of general health services for which more effective linkage is         needed.                                                                                                                                                                   ","Homeless Women: Drugs, Race/Ethicity, And Health Care",7122156,R01DA014835,"['drug abuse ', ' health care service utilization ', ' female ', ' homeless ', ' racial /ethnic difference ', ' human data ', "" women's health "", ' behavioral /social science research tag ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2005,11880,0.18627626917048123
"Participant Perspectives on Drug Use/HIV Research Ethics    DESCRIPTION (provided by applicant):  Investigators studying illicit drug use and related HIV risk face unique ethical challenges. Intoxication, long term drug use, or advanced stages of HIV/AIDS can impair consent capacity. Involvement in criminal activities to purchase drugs and diagnosis of HIV/AIDS make participants especially vulnerable to breaches in confidentiality that may result in criminal prosecution, social stigmatization, or loss of employment. The need for money to purchase drugs or ethnic and economic health disparities may heighten susceptibility to coercion from cash or treatment compensation for research participation. Participants in RCT designs may suffer withdrawal symptoms during detoxification or side effects when experimental treatments interact with street drugs. Dissemination of research results may further stigmatize or sustain societal prejudices against historically oppressed groups. Through focus groups, in-depth interviews, and structured interview surveys, this research aims to explore the hopes, values, and fears that multiply vulnerable illicit drug users bring to research ethics practices. This collaborative project uniting the strengths of the Fordham University Center for Ethics Education and the community based substance abuse and HIV/AIDS experience of the Hispanic Health Council, will examine in both depth and breath the attitudes of street drug users towards research risks and benefits, informed consent, confidentiality, and use of incentives in research on the epidemiology, social correlates, and treatments for drug abuse and HIV related risks. How gender and ethnicity influence these attitudes will also be examined. Long-term goals of this project are to identify ethical concerns among economically disadvantaged, ethnically diverse illicit street drug users that will inform and enhance drug use and HIV risk research in ways that reflect the values and merit the trust of participants.            ",Participant Perspectives on Drug Use/HIV Research Ethics,6892549,R01DA015649,"['communicable disease transmission ', ' ethics ', ' health science research analysis /evaluation ', ' informed consent ', ' human subject ', ' AIDS ', ' HIV infection ', ' interview ', ' data collection methodology /evaluation ', ' longitudinal human study ', ' attitude ', ' high risk behavior /lifestyle ', ' gender difference ', ' African American ', ' Hispanic American ', ' caucasian American ', ' racial /ethnic difference ', ' low socioeconomic status ', ' substance abuse related disorder ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' experimental design ', ' confidentiality ', ' focus group ', ' ']",NIDA,FORDHAM UNIVERSITY,R01,2005,492573,0.20086343638152432
"COLLABORATIVE RESEARCH ON DRUG ABUSE DESCRIPTION: (provided by applicant) This P01 aims to develop and apply state-of-the-art methods to analyze existing but under-utilized drug abuse databases in collaboration with their owners. We address contemporary, theoretical, and applied issues in drug abuse research to understand intersections between substance abuse and AIDS risk behaviors as well as minority and gender-based health disparities. We work together with dozens of investigators from education, epidemiology, medicine, psychiatry, psychology, public health, social work, and sociology who own exciting substance abuse data to develop models that test current theories, especially on epidemiology, prevention, intervention, and treatment of drug abuse, using modern multivariate psychometric and statistical methods to control for measurement errors, biases, and other confounds. The Models and Methods Project develops analytic techniques (e.g., improved structural equation methods for small samples, missing and nonnormal data, outliers, dependent and hierarchical data, functional imaging) that hold special promise for improving the quality of drug abuse and AIDS research. The At-Risk Project studies substance abuse related data sets on vulnerable populations (substance abusers, homeless people, individuals who are HIV positive or who have AIDS, victims of domestic abuse, runaways, gang members, and others at high risk for AIDS or drug abuse) with methods to control the sampling, measurement, distributional and other biases that may exist. The Community Project studies drug abuse etiology, adult consequences, HIV risk, intergenerational processes, general deviance, and related issues in large community-based samples, and develops and tests explanatory theories using models that permit separation of common from specific effects, control for artifacts, etc. The Latino Project uses datasets from varied Latino groups to study within- and between-Latino population drug abuse etiology, test and extend an ecological theory of Latino drug use, and study HIV risk and acculturative phenomena related to drug use. The Core Project oversees and integrates all components, hosts visiting scholars, provides computer facilities, and sponsors a mentoring program for disadvantaged students.  ",COLLABORATIVE RESEARCH ON DRUG ABUSE,6894275,P01DA001070,"['drug abuse ', ' clinical research ', ' behavioral /social science research tag ', ' disease /disorder etiology ', ' ']",NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,P01,2005,1385290,0.11190653016281335
"Club Drugs/Resource Inequity/Health Risk in Urban Youth   DESCRIPTION (provided by the applicant): This five year study entitled ""Club         Drugs, Resource Inequities and Health Risks among Urban Youth"" will identify         the contextual, socio-cultural and psychological factors that influence urban        youth and young adults to incorporate club drugs into their drug repertoires,        changes in drug use patterns over time, and the psychosocial, economic and           health consequences of club drug use and concurrent polydrug mixing. The study       responds to NIDA's RFA DA-0 1 -0 10 entitled ""Responding to Club Drugs And           Other Emerging And Current Drug Abuse Trends."" Study aims are to: 1) describe        the marketing and diffusion of club and designer drugs into urban youth and          young adult drug markets through clubs, after-hours, and other social                activities, and describe the meaning of these drugs in relation to traditional       street drugs (regular and high THC marijuana, leaves with formaldehyde,              alcohol, dust, cocaine, crack and heroin), 2) conduct a panel study with two         time points eight months apart with 500 youth ages 16 - 30 to deter-mine             changes in patterns of MDMA and other dance and prescription drugs, and              predictors and consequences of use, 3) utilize the information to develop            strategies for dance and prescription drug risk prevention in street and party       settings. Component 1 (Months I - 50) of the study will continue established         patterns of ethnographic research in settings where urban youth and young            adults buy, sell, learn about and experiment with new drugs and drug mixing.         Component 2 (Months 8 - 58) will involve administering an                            epidemiologic/network survey to the study cohort of 500 youth and young adults       between the ages of 16 - 30. In Component 3 (Months 42-60) we will use ongoing       study results in partnership with a team of youth consultants to develop and         pilot test for acceptability a strategy for preventing risks associated with         MDMA and other club drug use and drug mixing to be utilized in drug use sites,       with distributors and in networks of users. Throughout, we will review and           integrate emerging literature linking findings to the primary theoretical            concepts guiding the study. The significance of the study lies in its                description of the ways in which new potentially dangerous drugs are diffused        into a high risk urban environment, its incorporation of the psychosocial,           economic and contextual factors in understanding drug selling, its focus on          understudied polydrug use among urban youth, its examination of neighborhood         factors in drug selection and use, and its partnership with youth and                youth-serving clubs and site gatekeepers to engage in risk reduction. The study      promises to produce new analytic and theoretical insights into the diffusion of      new drugs into already saturated urban youth drug markets and the consequences       of their use.                                                                                                                                                             ",Club Drugs/Resource Inequity/Health Risk in Urban Youth,6925414,R01DA014863,"['young adult human (21-34) ', ' adolescence (12-20) ', ' disease /disorder proneness /risk ', ' drug abuse ', ' drug abuse prevention ', ' human subject ', ' 3,4 methylenedioxymethamphetamine ', ' social psychology ', ' psychotropic drug ', ' racial /ethnic difference ', ' socioeconomics ', ' urban area ', ' clinical research ', ' behavioral /social science research tag ', ' outcomes research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' ']",NIDA,INSTITUTE FOR COMMUNITY RESEARCH,R01,2005,606573,0.20819357873312505
"The Center for the Study and Prevention of Drug Use    DESCRIPTION (provided by applicant):     This proposal for the Center for Study and Prevention of Drug Use is submitted by Morgan State University and seeks funding under the PAR-02-016 mechanism in response to the PA entitled ""Minority Institutions' Drug Abuse Research Development Program"" (MIDARP). The proposed Center will be an inter-institutional collaborative effort involving Morgan State University, a minority institution, and research intensive universities and programmatic initiatives that focus on and specialize in research on drug use and disparities associated with drug use. The Center seeks to build on the collaborative relationships established through the Center to increase the capacity of Morgan State, its faculty and its students to conduct rigorous drug use research with and emphasis on drug use epidemiology, public health, and health disparities related to drug use. In order to actualize the mission of the Center, four components were developed which address the necessary aspects of creating a drug use research center. 1) The Faculty Development Plan, which seeks to advance Morgan faculty by allowing them to engage in off-site collaborative research with individuals specializing in drug research. 2) A second aspect is the Student Development Plan, which seeks to expose, educate and, train minority students in the area of drug use research. 3) The research arm of the project includes a primary and four developmental pilot project, allowing researchers at Morgan to begin using their present expertise and investigating topics in the area of drug use and disparities related to drug use. 4) Overseeing, each of the areas is the proposed plan for the Administrative Units and Center Organization. Through this component collaborative relationships, research projects, and faculty and student development will be monitored and enhanced. As a result of the Center faculty at Morgan State will be further enhanced regarding their ability to conduct rigorous research independently, specifically submitting R01's. Further, Morgan will be sufficiently capable of training students for careers in drug use research by developing a structured program in drug research, and the administrative staff will have the skills necessary to support the research staff in all endeavors related to research projects. In sum, the Center will be; self-sustaining and capable of producing future research focused on drug use research.               ",The Center for the Study and Prevention of Drug Use,7127195,R24DA019805,"['biomedical facility ', ' adolescence (12-20) ', ' drug abuse prevention ', ' training ', ' university ', ' public health ', ' minority institution research support ', ' health science research potential ', ' human subject ', ' clinical research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' health disparity ', ' ']",NIDA,MORGAN STATE UNIVERSITY,R24,2006,396840,0.2289119318721305
"MINORITY PREDOCTORIAL FELLOWSHIP PROGRAM DESCRIPTION (provided by applicant): The applicant's proposed research is an exploration of the barriers that influence adherence to antiretroviral therapy (ART) by HIV-positive individuals who use illicit drugs. Twenty years of research suggest that patient characteristics, provider factors, treatment regimen factors, and social/environmental factors play a role in chronic disease treatment compliance. However, few studies have explicitly linked these factors to non-adherence among HIV-positive individuals who use illicit drugs. The proposed study aims to study the impact of these potential barriers through a mixed method design: secondary analysis of the HIV Cost and Services Utilization Study (HCSUS) and content analysis of the Participating and Communicating Together Study (PACT). This information can be used to strengthen medication adherence interventions for HIV positive drug using populations. Moreover, because drug-related HIV/AIDS disproportionately affects African Americans and other communities of color, research that leads to improvements in HIV treatment outcomes for drug-using populations may also help reduce racial/ethnic health disparities. ",MINORITY PREDOCTORIAL FELLOWSHIP PROGRAM,7074075,F31AI058913,"['predoctoral investigator ', ' substance abuse related behavior ', ' behavioral /social science research tag ', ' human data ', ' therapy compliance ', ' socioenvironment ', ' social support network ', ' lifestyle ', ' coping ', ' longitudinal human study ', ' HIV infections ', ' AIDS therapy ', ' health care service availability ', ' health care quality ', ' drug abuse ', ' ']",NIAID,UNIV OF NORTH CAROLINA CHAPEL HILL,F31,2006,14966,0.06647796427007553
"Understanding Self-Reports of Drug Use in Pregnant Women    DESCRIPTION (provided by applicant): Assessing the accuracy of self-reports (SR) of tobacco, alcohol, and illicit drug use among pregnant and post-partum women is crucial to both their treatment and to the health of their children. The public health and drug treatment policy implications of not obtaining accurate self-reports cannot be overestimated. For example, if African-American women are less likely to report drug use than white women, they are less likely to receive treatment. This is a health care disparity issue. Self-report/other alternate measure (drug tests, for example) agreement rates from pregnant women are highly variable according to ethnicity, drug type, and other factors, and no systematic meta-analytic review has attempted to explain this variability. This project builds upon a previous SBIR which has constructed a meta-analytic database containing 325 studies of self-reports of substance use compared to biological indicators (e.g., urinalysis) or collateral reports (e.g., spousal report), and 2083 individual comparisons. A subset of these studies (98) addressing use among pregnant and/or post-partum women have been acquired and are codable. 54 studies have been coded. The present project will summarize the relationship between SR and alternate measures of substance use among pregnant women, the key goals being to provide average estimates of SR agreement, identify distinct subgroups, and search for moderator variables which might influence the relationship between SR and biological indicators in this unique population. The focus will include careful consideration of factors that might be changed to improve self-report accuracy.         ",Understanding Self-Reports of Drug Use in Pregnant Women,7140430,R21DA017800,"['alcoholism /alcohol abuse ', ' biomarker ', ' drug abuse ', ' tobacco abuse ', ' data collection methodology /evaluation ', ' epidemiology ', ' pregnancy ', ' postpartum ', ' female ', ' racial /ethnic difference ', ' age difference ', ' human data ', ' clinical research ', ' substance abuse related behavior ', ' health disparity ', ' data quality /integrity ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R21,2006,176259,0.07307006989190389
"The Center for the Study and Prevention of Drug Use    DESCRIPTION (provided by applicant):     This proposal for the Center for Study and Prevention of Drug Use is submitted by Morgan State University and seeks funding under the PAR-02-016 mechanism in response to the PA entitled ""Minority Institutions' Drug Abuse Research Development Program"" (MIDARP). The proposed Center will be an inter-institutional collaborative effort involving Morgan State University, a minority institution, and research intensive universities and programmatic initiatives that focus on and specialize in research on drug use and disparities associated with drug use. The Center seeks to build on the collaborative relationships established through the Center to increase the capacity of Morgan State, its faculty and its students to conduct rigorous drug use research with and emphasis on drug use epidemiology, public health, and health disparities related to drug use. In order to actualize the mission of the Center, four components were developed which address the necessary aspects of creating a drug use research center. 1) The Faculty Development Plan, which seeks to advance Morgan faculty by allowing them to engage in off-site collaborative research with individuals specializing in drug research. 2) A second aspect is the Student Development Plan, which seeks to expose, educate and, train minority students in the area of drug use research. 3) The research arm of the project includes a primary and four developmental pilot project, allowing researchers at Morgan to begin using their present expertise and investigating topics in the area of drug use and disparities related to drug use. 4) Overseeing, each of the areas is the proposed plan for the Administrative Units and Center Organization. Through this component collaborative relationships, research projects, and faculty and student development will be monitored and enhanced. As a result of the Center faculty at Morgan State will be further enhanced regarding their ability to conduct rigorous research independently, specifically submitting R01's. Further, Morgan will be sufficiently capable of training students for careers in drug use research by developing a structured program in drug research, and the administrative staff will have the skills necessary to support the research staff in all endeavors related to research projects. In sum, the Center will be; self-sustaining and capable of producing future research focused on drug use research.               ",The Center for the Study and Prevention of Drug Use,7285542,R24DA019805,"['biomedical facility ', ' adolescence (12-20) ', ' drug abuse prevention ', ' training ', ' university ', ' public health ', ' minority institution research support ', ' health science research potential ', ' human subject ', ' clinical research ', ' substance abuse epidemiology ', ' substance abuse related behavior ', ' health disparity ', ' ']",NIDA,MORGAN STATE UNIVERSITY,R24,2006,34299,0.2289119318721305
"Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study    DESCRIPTION (provided by applicant): We propose to extend the Northwestern Juvenile Project to examine the developmental patterns of drug use and disorder and risk for HIV/AIDS and other sexually transmitted infections (STIs) as juvenile justice youth age from adolescence to emerging adulthood and young adulthood. This study responds to NIDA's new initiatives in health disparities in HIV/AIDS in minority populations, specifically the nexus of drug abuse, criminal justice involvement, and HIV/AIDS among African Americans.  African Americans comprise 12% of the US population but 40% of incarcerated populations and 50% of new cases of HIV/AIDS. At year-end 2004, nearly 100,000 juveniles and nearly 2.1 million adults were incarcerated. We will continue to study a racially/ethnically diverse sample (n=758; 330 females, 428 males; 412 African Americans, 137 non-Hispanic whites, 207 Hispanics, 2 other race/ethnicity) of persons who were arrested and detained in Cook County (Chicago) Illinois, aged 10-18 years at recruitment (1997-1998). Since recruitment, data have been collected on the development of substance use and disorders, risk and protective factors, and HIV/AIDS risk behaviors. Participants are re-interviewed whether they are (re)incarcerated or back in the community. We propose to conduct annual interviews 10, 11, 12, and 13 years post-baseline, collect records, and test for HIV infection and selected STIs. Focusing on racial/ethnic disparities, gender and age differences, and effects of incarceration, we will: (1) describe patterns of drug use and disorder - onset, persistence, desistence, and recurrence -- as juvenile justice youth age from adolescence to emerging adulthood and young adulthood; (2) describe patterns of HIV/AIDS risk behaviors during this same period; (3) describe the prevalence and incidence of HIV infection and other STIs; and (4) examine the relationship between drug use and disorder and HIV/AIDS risk behaviors. Extending the Northwestern Juvenile Project allows us to leverage the data already collected to examine health disparities and the role of disproportionate minority confinement in the development of drug use and disorder and HIV/AIDS risk; to identify risk and protective factors that are potentially malleable; to identify points of intervention at key developmental periods; and to extend theoretical models - developed in general population adolescents - to correctional populations.           ","Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study",7230882,R01DA022953,"['aging ', ' drug abuse ', ' AIDS ', ' HIV infection ', ' high risk behavior /lifestyle ', ' sex ', ' correctional institution ', ' clinical research ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2006,1061942,0.10348631909936978
"Community Vulnerability and Responses to IDU-Related HIV  DESCRIPTION (provided by applicant): In this competing continuation, we will conduct a longitudinal study (1993-2007) of 96 large metropolitan areas to study trends and predictors of changes in the population prevalence of drug injectors, HIV) prevalence among injectors, and related prevention programs. In stage one of this project, we developed ways to estimate the population density of injection drug use and HIV prevalence rates in metropolitan areas. We showed that per capita injection drug use increased during the 1990s in many localities, including Baltimore and Salt Lake City. HIV prevalence rates among drug injectors increased in Baltimore and some other areas. In many metropolitan areas, drug injection and HIV rates among injectors declined. The extent to which local HIV prevention programs reached drug injectors also varied widely: 3 metropolitan areas provided treatment to 20% or more of their injectors, while 13 areas reached less than 5%. HIV counseling and testing rates also varied widely. In cross-sectional analyses, we showed that local government budgetary decisions, social and economic factors, and drug abuse interventions were related to injection drug users per capita, HIV revalence among drug injectors, and the presence and size of various programs to prevent HIV among drug injectors. We will build upon our existing data and construct a database for these 96 metropolitan areas containing annual estimates from 1993 - 2007 of drug injectors per capita; HIV prevalence, incident AIDS cases and AIDS mortality among drug injectors; program availability and size; socioeconomic conditions, and government budgetary allocations. We will (1) describe patterns of change over time in prevention programs and epidemiology. We will use longitudinal analysis methods to study (2) how changing socioeconomic conditions, epidemiologic need, budgetary constraints and choices, and policy choices are related to subsequent HIV prevention programming; and (3) how all these variables are related to later changes in (a) drug injectors per capita, (b) HIV prevalence and AIDS among drug injectors, (c) drug abuse treatment and other programs for drug injectors, and (d) racial/ethnic disparities in appropriate indicators. We will use these analyses to develop a well-theorized scientific understanding of forces that shape metropolitan area HIV/AIDS epidemics, rates of drug injectors per capita, and prevention programs. The resulting scientific knowledge base can help develop programs and policies so as to avoid epidemics and, if needed, control them.         ",Community Vulnerability and Responses to IDU-Related HIV,7107141,R01DA013336,"['communicable disease control ', ' communicable disease transmission ', ' disease /disorder proneness /risk ', ' drug abuse therapy ', ' intravenous drug abuse ', ' AIDS education /prevention ', ' health system agency ', ' health care service evaluation ', ' health care service availability ', ' health care cost /financing ', ' HIV infection ', ' longitudinal human study ', ' high risk behavior /lifestyle ', ' racial /ethnic difference ', ' socioeconomics ', ' community ', ' urban area ', ' human data ', ' health care policy ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' outcomes research ', ' substance abuse related behavior ', ' health disparity ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R01,2006,636254,0.22464773436225408
"Drug Use & Latent Structure of Adolescent Mental Health With cross-classification used to probe for possible male-female and child-adolescent variation, recently published evidence on the mental and behavioral disturbances of young people seems to confirm dimensional models of anxiety and depression (Wadsworth et al., 2001) as well as attention problems (Hudziak et al., 1999). In this new R01 project, the main goal is to investigate youth drug use as it relates to latent structure of mental and behavioral disturbances across age strata in adolescence (12-13,14-15,16-17 years), with due consideration for different drug types (inhalants; club drugs like ecstasy; marijuana; tobacco; alcohol) and levels of drug involvement. Once the underlying latent class structures have been elucidated, and class memberships have been assigned based on the best-supported class structures, the applicant will turn to regression models to probe research questions pertinent to (a) the co-occurrence of adolescent drug involvement and disturbances of the mental life, behavior, and social adaptation, (b) probing for variation in the latent structure across subgroups defined by race-ethnicity to perhaps aid in understanding health disparities that affect minority subgroups, and (c) the clustering of the class members within local areas of residence within the United States, with a specific focus upon analyses that will probe how drug use might sustain delinquent peer groups. The data are from 13,831 youths (age 12-17) recruited after nationally representative sampling for the National Household Survey on Drug Abuse (NHSDA) in 1994-1996. For the NHSDA, the youths completed standardized modules on drug involvement, as well as a survey adaptation of Achenbach's Youth Self Report (YSR). The YSR is perhaps, the most. widely used instrument for measuring youth disturbances in the mental life, behavior, and socxal adaptation. In sum, the  plan of research is one that exploits an untapped research opportunity to learn more about adolescent drug taking as it relates to disturbances of the mental life, behavior, and social adaptation. The plan involves the use of two relatively recent biostatistical developments in the form of latent class regression and alternating logistic regression models, which are innovative approaches to the study of research questions that previously have not been asked in large-sample epidemiological studies of national scope. ",Drug Use & Latent Structure of Adolescent Mental Health,7064856,R01DA016323,"['substance abuse epidemiology ', ' behavioral /social science research tag ', ' clinical research ', ' human data ', ' age difference ', ' racial /ethnic difference ', ' gender difference ', ' social adjustment ', ' peer group ', ' aggression ', ' health surveys ', ' data collection methodology /evaluation ', ' drug abuse ', ' adolescence (12-20) ', ' juvenile delinquency ', ' child behavior disorders ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R01,2006,239487,0.12544998213400896
"HIV/AIDS & Womens of Color: Roles of Drug Use, Violence & Insurance in HAART Use    DESCRIPTION (provided by applicant): HIV/AIDS among women is an epidemic that disproportionately affects women of color. It reflects a convergence of politically sensitive issues (i.e., race, drug use, and sexual behavior) that are difficult to disentangle and address. Since the introduction of highly active antiretroviral therapy (HAART) as the standard of care in 1996, mortality rates from AIDS and its complications have declined, but at a much slower rate among women than men. Previous research indicates that HIV positive African American women are less likely than white women to receive HAART. Several national studies indicate that African American women fare worse than white men on a number of standards of HIV care. The proposed study uses data from the Women's Interagency HIV Study (WIHS) confidential data set to 1) assess whether the roles of race and drug use on HAART are moderated by the effects of health insurance coverage and 2) examine longitudinal differences in HAART use among HIV positive female drug users and investigate the extent to which individual latent states (as defined by clusters of psycho-social or behavioral risk factors such as an individual's drug use, drug using partners, depression, and physical or sexual abuse) influence racial/ethnic disparities after controlling for other confounders. Many studies have assessed the independent effects of race, gender, drug use, insurance coverage, and physical or sexual abuse on use of medical care by people with HIV, but little is known about how these risk factors operate in combination or clusters. Several methodological refinements are employed, including use of analytic methods appropriate for longitudinal data and Hidden Markov Models to examine behavioral risk clusters. Study results will improve understanding of the roles of drug use, physical or sexual abuse, and insurance coverage in observed racial disparities of HAART use among HIV positive women and ultimately, improve interventions aimed at reducing racial and other disparities in HIV/AIDS medical care among women. Findings will also inform development of systems for monitoring quality of care among HIV positive women.              ","HIV/AIDS & Womens of Color: Roles of Drug Use, Violence & Insurance in HAART Use",7231107,R21DA022971,"['disease outbreak ', ' health insurance ', ' AIDS ', ' emotion ', ' role ', ' female ', ' violence ', ' sex abuse ', ' ']",NIDA,GEORGE WASHINGTON UNIVERSITY,R21,2006,263646,0.14345262070792456
"The neighborhood environment and drug use in NYC DESCRIPTION (provided by applicant): Proposed is a study is to assess the relations between neighborhood characteristics (e.g., neighborhood disadvantage, collective efficacy, residential segregation) and drug use behavior among residents of New York City while controlling for relevant individual-level factors. A secondary purpose of this study is to determine the relation between key neighborhood characteristics and the medical consequences of drug use, particularly fatal drug overdose. Recent work has shown that neighborhood characteristics are associated with the likelihood of drug use, abuse, and dependence and that research focusing exclusively on individual patterns of drug use is insufficient to fully explain inter-individual drug use behavior. Here we propose a systematic collection of data to characterize neighborhoods in a large metropolitan area and to test key hypotheses that may explain inter-individual variability in drug use behavior and its consequences.   Understanding how neighborhood factors affect drug use risk behavior can guide interventions that aim to mitigate drug use and its consequences, to create a social environment that better facilitates users to seek treatment, and to improve overall population health. In order to achieve the aims of this study we will use data from three sources: (i) We will collect data on individual drug use behavior (focusing on cigarette, alcohol, and marijuana use) through a random digit-dial phone survey of 5,000 New York City residents, geo-coding and mapping each respondent to their neighborhood of residence; (ii) we will compile a contextual database characterizing New York City neighborhoods using information collected in the survey and using archival data (collected from the New York City Department of Health and Mental Hygiene, Department of City Planning, Police Department, US Census and other sources); and (iii) we will combine this data with data from a NIDA funded study of drug overdose over time (DA 06534; principal investigator: Tardiff, a consultant on this project). We will test key hypotheses about the relations between neighborhood characteristics and drug use, abuse, and dependence using multi-level hierarchical models. We have recently completed several studies of New York City neighborhoods that serve as preliminary exploration of the key hypotheses of this study. This, coupled with our studies involving telephone interviews with 6,000+ New Yorkers is assurance that the aims of this study can be achieved. ",The neighborhood environment and drug use in NYC,7093468,R01DA017642,"['health disparity ', ' geographic difference ', ' medically underserved population ', ' substance abuse related behavior ', ' substance abuse epidemiology ', ' behavioral /social science research tag ', ' clinical research ', ' smoking ', ' human data ', ' environmental stressor ', ' urban poverty area ', ' housing ', ' community ', ' socioenvironment ', ' socioeconomics ', ' social integration ', ' high risk behavior /lifestyle ', ' population survey ', ' human mortality ', ' interview ', ' human subject ', ' medical records ', ' marijuana abuse ', ' tobacco abuse ', ' overdose ', ' drug abuse ', ' alcoholic beverage consumption ', ' ']",NIDA,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2006,476676,0.07685429698994137
"Girls in Drug Abuse Science DESCRIPTION (provided by applicant):    Developing scientists is a priority of the National Institutes of Health, the National Institute on Drug Abuse, and this continuation project. The overall aim of this competing continuation application for a Science Education Drug Abuse Partnership Award Project (SEDAPA) is to extend the development and implementation of a curriculum and manual for high school young women to middle school girls in sixth to eighth grade who live in rural Appalachian Kentucky. The specific aims for the project are: (1) To increase the scientific, technological and interpersonal knowledge as well as skills of participating middle-school girls ages 11 to 15 from rural Appalachian Kentucky; (2) To increase the knowledge of parents and middle schoolteachers on gender equity strategies, and teaching techniques to increase the science participation of middle school girls in rural Appalachian Kentucky; (3) To develop and disseminate a model curriculum to enhance science as well as drug abuse research in rural Appalachian Kentucky; and (4) To develop and disseminate a guide for ""Promoting Gender Equity in the Classroom"" to enhance science education in rural and Appalachian areas. This competing continuation application focuses on 120 rural Appalachian Kentucky girls entering the sixth grade from 21 rural counties; 120 to 240 parents of these girls; and at least 30 rural middle school teachers from the same 21 rural counties. Project Summer Institutes, Saturday Sessions, and scientific as well as community mentoring opportunities will continue for participating girls. For this competing continuation application, younger girls (middle school) will be targeted; workshops for parents and teachers will be added; 21 rather than 14 rural counties will be included; current project participants will be involved as mentors; Chris in Drug Abuse Science Clubs will be added; the Kentucky Department of Education along with project staff will work to promote Gender Equity in all middle schools in Kentucky; and the replication manual will be expanded for girls in grades 6 to 8 to produce a complete and comprehensive manual across grades 6 to 12 for replication in other rural and Appalachian areas. ",Girls in Drug Abuse Science,7092252,R25DA011388,"['health disparity ', ' medically underserved population ', ' educational resource design /development ', ' clinical research ', ' teacher ', ' rural area ', ' community ', ' gender difference ', ' female ', ' handbook ', ' questionnaires ', ' human subject ', ' parents ', ' education evaluation /planning ', ' teaching ', ' secondary schools ', ' drug abuse education ', ' curriculum ', ' adolescence (12-20) ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R25,2006,731550,0.07264206386789569
"Participant Perspectives on Drug Use/HIV Research Ethics    DESCRIPTION (provided by applicant):  Investigators studying illicit drug use and related HIV risk face unique ethical challenges. Intoxication, long term drug use, or advanced stages of HIV/AIDS can impair consent capacity. Involvement in criminal activities to purchase drugs and diagnosis of HIV/AIDS make participants especially vulnerable to breaches in confidentiality that may result in criminal prosecution, social stigmatization, or loss of employment. The need for money to purchase drugs or ethnic and economic health disparities may heighten susceptibility to coercion from cash or treatment compensation for research participation. Participants in RCT designs may suffer withdrawal symptoms during detoxification or side effects when experimental treatments interact with street drugs. Dissemination of research results may further stigmatize or sustain societal prejudices against historically oppressed groups. Through focus groups, in-depth interviews, and structured interview surveys, this research aims to explore the hopes, values, and fears that multiply vulnerable illicit drug users bring to research ethics practices. This collaborative project uniting the strengths of the Fordham University Center for Ethics Education and the community based substance abuse and HIV/AIDS experience of the Hispanic Health Council, will examine in both depth and breath the attitudes of street drug users towards research risks and benefits, informed consent, confidentiality, and use of incentives in research on the epidemiology, social correlates, and treatments for drug abuse and HIV related risks. How gender and ethnicity influence these attitudes will also be examined. Long-term goals of this project are to identify ethical concerns among economically disadvantaged, ethnically diverse illicit street drug users that will inform and enhance drug use and HIV risk research in ways that reflect the values and merit the trust of participants.            ",Participant Perspectives on Drug Use/HIV Research Ethics,7123954,R01DA015649,"['communicable disease transmission ', ' ethics ', ' health science research analysis /evaluation ', ' informed consent ', ' human subject ', ' AIDS ', ' HIV infection ', ' interview ', ' data collection methodology /evaluation ', ' longitudinal human study ', ' attitude ', ' high risk behavior /lifestyle ', ' gender difference ', ' African American ', ' Hispanic American ', ' caucasian American ', ' racial /ethnic difference ', ' low socioeconomic status ', ' substance abuse related disorder ', ' clinical research ', ' behavioral /social science research tag ', ' health services research tag ', ' substance abuse epidemiology ', ' experimental design ', ' confidentiality ', ' focus group ', ' ']",NIDA,FORDHAM UNIVERSITY,R01,2006,490431,0.20086343638152432
"The neighborhood environment and drug use in NYC DESCRIPTION (provided by applicant): Proposed is a study is to assess the relations between neighborhood characteristics (e.g., neighborhood disadvantage, collective efficacy, residential segregation) and drug use behavior among residents of New York City while controlling for relevant individual-level factors. A secondary purpose of this study is to determine the relation between key neighborhood characteristics and the medical consequences of drug use, particularly fatal drug overdose. Recent work has shown that neighborhood characteristics are associated with the likelihood of drug use, abuse, and dependence and that research focusing exclusively on individual patterns of drug use is insufficient to fully explain inter-individual drug use behavior. Here we propose a systematic collection of data to characterize neighborhoods in a large metropolitan area and to test key hypotheses that may explain inter-individual variability in drug use behavior and its consequences.   Understanding how neighborhood factors affect drug use risk behavior can guide interventions that aim to mitigate drug use and its consequences, to create a social environment that better facilitates users to seek treatment, and to improve overall population health. In order to achieve the aims of this study we will use data from three sources: (i) We will collect data on individual drug use behavior (focusing on cigarette, alcohol, and marijuana use) through a random digit-dial phone survey of 5,000 New York City residents, geo-coding and mapping each respondent to their neighborhood of residence; (ii) we will compile a contextual database characterizing New York City neighborhoods using information collected in the survey and using archival data (collected from the New York City Department of Health and Mental Hygiene, Department of City Planning, Police Department, US Census and other sources); and (iii) we will combine this data with data from a NIDA funded study of drug overdose over time (DA 06534; principal investigator: Tardiff, a consultant on this project). We will test key hypotheses about the relations between neighborhood characteristics and drug use, abuse, and dependence using multi-level hierarchical models. We have recently completed several studies of New York City neighborhoods that serve as preliminary exploration of the key hypotheses of this study. This, coupled with our studies involving telephone interviews with 6,000+ New Yorkers is assurance that the aims of this study can be achieved. ",The neighborhood environment and drug use in NYC,7242966,R01DA017642,"['health disparity ', ' geographic difference ', ' medically underserved population ', ' substance abuse related behavior ', ' substance abuse epidemiology ', ' behavioral /social science research tag ', ' clinical research ', ' smoking ', ' human data ', ' environmental stressor ', ' urban poverty area ', ' housing ', ' community ', ' socioenvironment ', ' socioeconomics ', ' social integration ', ' high risk behavior /lifestyle ', ' population survey ', ' human mortality ', ' interview ', ' human subject ', ' medical records ', ' marijuana abuse ', ' tobacco abuse ', ' overdose ', ' drug abuse ', ' alcoholic beverage consumption ', ' ']",NIDA,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2006,163780,0.07685429698994137
"Drew MIDARP (Infrastructure in Drug Abuse Research) Drug addiction is now viewed as a brain disease. Understanding the biological basis of substance is needed to develop specific treatment paradigms. The consequences of drug addiction are especially noted in inner city neighborhoods, like the Watts/Willowbrook section of Los Angeles -the catchment area for King/Drew Medical Center. Since addiction is such a complex and devastating illness, a committed public health approach, including education, prevention, treatment and research is needed. Drew University is committed to improvement of the infrastructure needed for substance abuse research, education and treatment. Drew University is well funded for non-substance abuse research and there is a high investigator interest in substance abuse research, yet NIH applications related to drug abuse are deficient. Similar, education on the importance of substance abuse and substance abuse research is lacking on campus. The MIDARP program will provide support to develop the infrastructure needed for substance abuse research at Drew. Thus, the goals of this MIDARP application are to: (1) develop the drug abuse research at Drew; (2) provide research development support and experiences to faculty and staff to facilitate independent drug abuse research  careers, (3) foster interest in drug abuse research for students and residents and provide them research  experiences, and 4) provide for continued drug abuse research funded by NIDA or other agencies. We will  specifically encourage the development of minority faculty and students. The theme of the training and incorporate expertise at Drew The goals of the two research science level and to understand in the reinforcing and addictive projects are to understand the mechanisms of the mechanisms of how the endogenous opioid properties of cocaine. ",Drew MIDARP (Infrastructure in Drug Abuse Research),7494900,R24DA017298,"['Knockout Mice ', ' Null Mouse ', ' Knock-out Mice ', ' Pertussis Toxin ', ' Pertussigen ', ' Lymphocytosis-Promoting Factor ', ' Islet-Activating Protein ', ' IAP Pertussis Toxin ', ' Histamine-Sensitizing Factor ', ' Ice ', ' multicatalytic endopeptidase complex ', ' Proteosome ', ' Proteasome Endopeptidase Complex ', ' Proteasome ', ' Prosome ', ' Multicatalytic Proteinase ', ' Macroxyproteinase ', ' Macropain ', ' 20S Proteosome ', ' 20S Proteasome ', ' 20S Core Proteasome ', ' 20S Catalytic Proteasome ', ' Immunohistochemistry ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' In Vitro ', ' Incubators ', ' Injection of therapeutic agent ', ' Injections ', ' Inpatients ', ' Internal Medicine ', ' Ensure ', ' Equipment and supply inventories ', ' Inventory ', ' Ions ', ' Anabolism ', ' biosynthesis ', ' Chemicals ', ' Financial compensation ', ' Compensation ', ' Evaluation ', ' Training ', ' Italy ', ' Keloid ', ' keloid skin disorder ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Kidney Diseases ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Chronic Kidney Failure ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Oral cavity ', ' Mouth ', ' Cavitas Oris ', ' Buccal Cavity Head and Neck ', ' Buccal Cavity ', ' Kinetics ', ' Laboratories ', ' Laboratory Research ', ' Serum ', ' Blood Serum ', ' Laws ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' insight ', ' Nociception ', ' nociceptive ', ' Slow-Wave Sleep ', ' Delta Wave sleep ', ' Delta Wave ', ' Visual ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Numbers ', ' Lipodystrophy ', ' Trust ', ' Withdrawal ', ' African ', ' Bilateral ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Los Angeles ', ' Hypoxia ', ' Oxygen Deficiency ', ' Hypoxic ', ' Biliary calculi ', ' Compassion ', ' Fostering ', ' immunocytochemistry ', ' Opioid ', ' satisfaction ', ' Policies ', ' Research Activity ', ' Development Plans ', ' Drug usage ', ' drug use ', ' Progress Reports ', ' Gays ', ' Fee-for-Service Plans ', ' Fees for Service ', ' Veterinarians ', ' Needle-Exchange Programs ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Funding ', ' uptake ', ' Americas ', ' male ', ' American Heart Association ', ' Medical Staff ', ' Medicine ', ' men ', "" men's "", ' Mental Health Services ', ' Mental Hygiene Services ', ' Mentors ', ' Mentorship ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Methods ', ' Transgenic Mice ', ' Michigan ', ' Endocrinologist ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Mission ', ' Molecular Biology ', ' DNA Molecular Biology ', ' Morphine ', ' Statex SR ', ' Roxanol ', ' Oramorph SR ', ' Oramorph ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)- ', ' Morphia ', ' MSir ', ' MS Contin ', ' Kadian ', ' Infumorph ', ' Mucous Membrane ', ' Mucosal Tissue ', ' Mucosa ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Naloxone ', ' Narcanti ', ' Narcan ', ' Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)- ', ' Naltrexone ', ' ReVia ', ' Nemexin ', ' Nalorex ', ' Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5alpha)- ', ' Persons ', ' Names ', ' Narcotic Antagonists ', ' Opioid Antagonists ', ' Opiate Antagonist ', ' Narcotics ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' National Research Council (U.S.) ', ' National Research Council ', ' Necrosis ', ' Necrotic ', ' Needles ', ' Neighborhoods ', ' Analgesics ', ' painkiller ', ' pain reliever ', ' pain medication ', ' pain killer ', ' Antinociceptive Drugs ', ' Antinociceptive Agents ', ' Anodynes ', ' Analgesic Preparation ', ' Analgesic Drugs ', ' Analgesic Agents ', ' Nerve Degeneration ', ' neuronal degeneration ', ' neurodegenerative ', ' neurodegeneration ', ' neural degeneration ', ' Neuron Degeneration ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Neuroblastoma ', ' Neuroblastoma (Schwannian Stroma-Poor) ', ' neurochemistry ', ' neurochemical ', ' Neurons ', ' neuronal ', ' Neurocyte ', ' Neural Cell ', ' Nerve Unit ', ' Nerve Cells ', ' Neuropeptides ', ' Chemosensitization ', ' Potentiation ', ' Chemosensitization/Potentiation ', ' Neurosciences ', ' Neurosecretion ', ' Neurosecretory Systems ', ' Neuroendocrine System ', ' Neuroendocrine ', ' New York ', ' Nicotine ', ' Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)- ', ' Nitrogen ', ' N2 element ', ' N element ', ' Internet ', ' world wide web ', ' web ', ' Railroads ', ' rapid eye movement ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Drug Receptors ', ' Opioid Receptor ', ' Opiate Receptors ', ' Epidermal Growth Factor Receptor ', ' proto-oncogene protein c-erbB-1 ', ' erbBl ', ' erbB-1 Proto-Oncogene Protein ', ' erbB-1 ', ' c-erbB-1 Protein ', ' c-erbB-1 ', ' Urogastrone Receptor ', ' Transforming Growth Factor alpha Receptor ', ' TGF-alpha Receptor ', ' HER1 ', ' Epidermal Growth Factor-Urogastrone Receptors ', ' Epidermal Growth Factor Receptor Protein-Tyrosine Kinase ', ' Epidermal Growth Factor Receptor Kinase ', ' ERBB Protein ', ' EGFR ', ' EGF Receptor ', ' Condition ', ' Thyroid Hormone Receptor ', ' Recommendation ', ' Recruitment Activity ', ' recruit ', ' Nature ', ' Rehabilitation Centers ', ' Renin ', ' Angiotensinogenase ', ' Angiotensin-Forming Enzyme ', ' Request for Proposals ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Research Institute ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Research Support ', ' Residencies ', ' Resources ', ' Research Resources ', ' Rewards ', ' Rhode Island ', ' Risk ', ' Risk Factors ', ' Messenger RNA ', ' mRNA ', ' Rodent ', ' Rodents Mammals ', ' Rodentia ', ' Role ', ' social role ', ' Rotation ', ' Safety ', ' Wages ', ' Salaries ', ' San Francisco ', ' Appendix ', ' Appointment ', ' Schools ', ' medical schools ', ' school of medicine ', ' medical college ', ' WWW ', ' Collaborations ', ' Published Comment ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' Letters ', ' Multicenter Studies ', ' Monograph ', ' Mosses ', ' Bryophyte ', ' Bryophyta ', ' Androgens ', ' Therapeutic Androgen ', ' Androgenic Compounds ', ' Androgenic Agents ', ' Nucleic Acids ', ' Nucleus Accumbens ', ' Nurses ', ' Discipline of Nursing ', ' Nursing Profession ', ' Nursing Field ', ' Nursing ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Occupational Exposure ', ' Ohio ', ' Ovary ', ' Overdose ', ' Leptin ', ' ob/ob mouse ', ' Obese Protein ', ' Obese Gene Product ', ' Ob Protein ', ' Ob Gene Product ', ' Oxytocin ', ' Recombinant Oxytocin ', ' Ocytocin ', ' prohormone ', ' Pain ', ' Painful ', ' Pamphlets ', ' Brochures ', ' Booklets ', ' Pancreas ', ' Pancreatic ', ' Liquid substance ', ' liquid ', ' fluid ', ' Paper ', ' Sinus ', ' Paranasal Sinuses ', ' Nasal cavity/Paranasal sinuses ', ' Nasal cavity/Paranasal ', ' Nasal Sinuses ', ' Accessory Sinuses ', ' Animals ', ' Laboratory Animals ', ' Patient Discharge ', ' Discharge from Healthcare Facility ', ' Patients ', ' Pediatrics ', ' Peer Review ', ' Peptide Hydrolases ', ' Proteolytic Enzymes ', ' Proteinases ', ' Proteases ', ' Peptidases ', ' Esteroproteases ', ' Endopeptidases ', ' Peptide Peptidohydrolases ', ' Peptides ', ' Central obesity ', ' waist-predominant obesity ', ' visceral obesity ', ' trunk obesity ', ' male-type obesity ', ' excess adiposity in midsection ', ' Truncal obesity ', ' Obesity of face and trunk, sparing limbs ', ' Obese face+trunk sparing limbs ', ' Fat body with thin limbs ', ' Centripetal obesity ', ' Android fat distribution ', ' Abdominal obesity ', ' Metabolic ', ' Personal Satisfaction ', ' well-being ', ' Spottings ', ' Pharmacology ', ' inhibitor/antagonist ', ' inhibitor ', ' Genetic ', ' Physicians ', ' Physician Assistants ', "" Physicians' Extenders "", "" Doctor's Assistants "", ' Physiology ', ' Pilot Projects ', ' pilot study ', ' Pituitary Gland ', ' Pituitary Nervous System ', ' Pituitary ', ' Hypophysis Cerebri ', ' Hypophysis ', ' Placebos ', ' sham therapy ', ' Sham Treatment ', ' Play ', ' Polymerase Chain Reaction ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Power Sources ', ' Power Supplies ', ' Pro-Opiomelanocortin ', ' Proopiomelanocortin ', ' Proopiocortin ', ' Pro-Opiocortin ', ' Pro-Opio-Melanocortin ', ' Pro-ACTH-Endorphin ', ' Endorphin-ACTH Precursor ', ' Corticotropin-beta-Lipotropin Precursor ', ' ACTH-beta-Lipotropin Precursor ', ' Antigens ', ' immunogen ', ' ATGN ', ' Exposure to ', ' Attenuated ', ' Daily ', ' Staging ', ' Disruption ', ' Contracts ', ' Contracting Opportunities ', ' Production ', ' Productivity ', ' Vesicle ', ' Program Evaluation ', ' Protease Inhibitor ', ' Proteinase Inhibitors ', ' Protease Antagonists ', ' Peptide Peptidohydrolase Inhibitors ', ' Peptide Hydrolase Inhibitors ', ' Peptidase Inhibitors ', ' Endopeptidase Inhibitors ', ' Antiproteases ', ' Protein Kinase C ', ' Phospholipid-Sensitive Calcium-Dependent Protein Kinase ', ' Calcium-Activated Phospholipid-Dependent Kinase ', ' Calcium Phospholipid-Dependent Protein Kinase ', ' tool ', ' Proteins ', ' gene product ', ' Drug user ', ' Drug abuser ', ' Problem drug user ', ' Misuses drugs ', ' Psychiatry ', ' Psychopharmacology ', ' Psychopharmacology / Toxicology ', ' Pharmacology-Psychopharmacology ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Publishing ', ' pyridostigmine ', ' pyroglutamyl-peptidase II ', ' thyrotropin-releasing hormone-degrading serum enzyme ', ' thyrotropin-releasing hormone-degrading ectoenzyme ', ' thyroliberinase ', ' thyroliberin degrading enzyme ', ' thyroliberin deamidating enzyme ', ' thyroliberin deamidase ', ' serum TRH-degrading enzyme ', ' pyroglutamyl-arylamidase ', ' pyroglutamyl aminopeptidase II ', ' TRH-degrading ectoenzyme ', ' TRH pyroglutamyl peptidase II ', ' Questionnaires ', ' Absence of pain sensation ', ' analgesia ', ' No sensitivity to pain ', ' Feels no pain ', ' Absence of sensibility to pain ', ' Radioimmunoassay ', ' Radioimmunoassay Immunologic ', ' Radiology Specialty ', ' Radiology ', ' General Radiology ', ' Science ', ' Scintillation Counter ', ' seal ', ' Seeds ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Serine Protease ', ' Serine Proteinases ', ' Serine Protein Hydrolases ', ' Serine Endopeptidases ', ' Serotonin ', ' Hippophaine ', ' Enteramine ', ' 5HT ', ' 5-Hydroxytryptamine ', ' 5-HT ', ' 3-(2-Aminoethyl)-1H-indol-5-ol ', ' Gonadal Steroid Hormones ', ' sex steroid ', ' gonadal steroids ', ' Sex Steroid Hormones ', ' Sex Hormones ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Sleep ', ' REM Sleep ', ' rapid eye movement sleep ', ' dreaming sleep ', ' Rhombencephalic Sleep ', ' Paradoxical Sleep ', ' Fast-Wave Sleep ', ' Social Behavior ', ' sociobehavioral ', ' sociobehavior ', ' Informal Social Control ', ' Self Regulation ', ' Societies ', ' Opiates ', ' Photocopying ', ' Knowledge ', ' Life ', ' posters ', ' lectures ', ' programs ', ' Argipressin ', ' Vasopressin-Neurophysin II-Copeptin ', ' Arginine Vasopressin ', ' 8-L-arginine-vasopressin ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Staff Development ', ' nociceptin ', ' orphanin FQ ', ' Arts ', ' Angiotensin Type 1a Receptor ', ' Angiotensin II Type 1a Receptor ', ' Angiotensin AT1a Receptor ', ' Stress ', ' Students ', ' Medical Students ', ' Substance P ', ' neurokinin 1 ', ' SP(1-11) ', ' Euler-Gaddum Substance P ', ' Supervision ', ' Surveys ', ' Survey Instrument ', ' Switzerland ', ' Syndrome ', ' Syringes ', ' Systems Analysis ', ' Systems Analyses ', ' CD4 Positive T Lymphocytes ', ' helper T cell ', ' T4 Lymphocytes ', ' T4 Cells ', ' CD4-Positive Lymphocytes ', ' CD4+ T-Lymphocyte ', ' CD4+ T cell ', ' CD4 lymphocyte ', ' CD4 T cells ', ' CD4 Cells ', ' Tablets ', ' tablet (pharmacologic) ', ' Taurine ', ' Tauphon ', ' 2-amino-ethanesulfonic acid ', ' Educational process of instructing ', ' Teaching ', ' Technology ', ' Teleconferences ', ' Testing ', ' Testosterone ', ' Trans-Testosterone ', ' Therapeutic Testosterone ', ' Therapeutic community technique ', ' Therapeutic Community ', ' Thyroid Gland ', ' Thyroid Head and Neck ', ' Thyroid ', ' Thyroid Hormones ', ' Thyroid Gland Hormone ', ' Thyrotropin-Releasing Hormone ', ' Thyroid-Releasing Hormone ', ' Pyr-His-ProNH2 ', ' Protyreline ', ' Protirelin ', ' 5-Oxo-L-prolyl-L-histidyl-L-prolinamide ', ' Scientist ', ' Time ', ' tissue culture ', ' Tissues ', ' Body Tissues ', ' Tort ', ' Training Programs ', ' Translations ', ' Travel ', ' Treatment Protocols ', ' Treatment Schedule ', ' Treatment Regimen ', ' United States Health Resources and Services Administration ', ' Health Resources and Services Administration ', ' HRSA ', ' Universities ', ' Up-Regulation (Physiology) ', ' Upregulation ', ' Up-Regulation ', ' Vasopressins ', ' beta-Hypophamine ', ' Antidiuretic Hormones ', ' Antidiuretic Hormone ', ' War ', ' Water ', ' Hydrogen Oxide ', ' Weight ', ' Woman ', ' Wood material ', ' Wood ', ' Work ', ' Writing ', ' X-Ray Film ', ' Xray Film ', ' Radiographic Film ', ' Yeasts ', ' Autistic Disorder ', "" Kanner's Syndrome "", ' Infantile Autism ', ' Early Infantile Autism ', ' Autism ', ' Hour ', ' day ', ' Week ', ' Inherited ', ' Hereditary ', ' Complex ', ' Dependence ', ' Oral ', ' Visceral ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Autoimmune Process ', ' Autoimmune ', ' Award ', ' Awareness ', ' Source ', ' Pattern ', ' Score ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' Country ', ' Class ', ' Particulate ', ' Hormonal ', ' meter ', ' bean ', ' Beds ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Overweight ', ' Over weight ', ' Berlin ', ' Am 80 ', ' Benzoic acid, 4-(((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)amino)carbonyl)- ', ' Am80 ', ' Physical Function ', ' Spinal ', ' Endocrine ', ' Metabolic Syndrome X ', ' Reaven Syndrome X ', ' Metabolic Cardiovascular Syndrome ', ' Insulin Resistance Syndrome X ', ' Dysmetabolic Syndrome X ', ' Opiate Addiction ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' Marshal ', ' sildenafil ', ' Mono-S ', ' MonoS ', ' psychosocial ', ' Inferior ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' interest ', ' Visit ', ' Binding Sites ', ' Reactive Site ', ' Combining Site ', ' carboxypeptidase H ', ' Enkephalin-Synthesizing Carboxypeptidase ', ' Enkephalin-Forming Carboxypeptidase ', ' Enkephalin Convertase ', ' Carboxypeptidase E ', ' Biochemistry ', ' Biological Chemistry ', ' spine bone structure ', ' Vertebral ', ' Vertebrae ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Sciences ', ' Life Sciences ', ' Biologic Sciences ', ' Biology ', ' Biomedical Research ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Injecting drug user ', ' Injection Drug User ', ' Gray unit of radiation dose ', ' Gray ', ' Postdoctoral Fellow ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' college ', ' collegiate ', ' inner city ', ' Services ', ' Needs Assessment ', ' Medical center ', ' Blood ', ' Blood Reticuloendothelial System ', ' Training and Education ', ' Blood Vessels ', ' vascular ', ' Blood - brain barrier anatomy ', ' Hemato-Encephalic Barrier ', ' Blood-Brain Barrier ', ' Western Blotting ', ' protein blotting ', ' Western Immunoblotting ', ' Body Composition ', ' Body Temperature ', ' Bone Marrow ', ' Bone Marrow Reticuloendothelial System ', ' American ', ' cytotoxicity ', ' Lytotoxicity ', ' data management ', ' experience ', ' Membrane ', ' membrane structure ', ' molecular oncology ', ' muscle metabolism ', ' mutant ', ' peptide hormone ', ' receptor ', ' Receptor Protein ', ' success ', ' hypothalamic-pituitary-adrenal axis ', ' hypothalmus-pituitary-adrenal axis ', ' hypothalamic-pituitary-adrenal (HPA) axis ', ' functional status ', ' biomedical scientist ', ' lipid metabolism ', ' fat metabolism ', ' Meditation ', ' Caring ', ' Drug Rehabilitation Centers ', ' Drug Treatment Centers ', ' Drug Abuse Treatment Centers ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Evidence based practice ', ' Affinity ', ' U-Series Cooperative Agreements ', ' Cooperative Agreements ', ' Core Facility ', ' cytotoxic ', ' Data ', ' Direct Costs ', ' Doctor of Medicine ', ' M.D. ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Economic Burden ', ' Applications Grants ', ' Grant Proposals ', ' High Prevalence ', ' Infrastructure Activities ', ' International ', ' Intramural Research Training Award ', ' Master of Business Administration ', ' M.B.A. ', ' Master of Public Health ', ' M.P.H. ', ' Molecular Medicine ', ' Molecular Virology ', ' Motor ', ' Multi-Institutional Clinical Trial ', ' multi site clinical trial ', ' multi site clinical study ', ' multi center clinical trial ', ' multi center clinical study ', ' Multi-site clinical trial ', ' Multi-site clinical study ', ' Multi-center clinical trial ', ' Multi-center clinical study ', ' Mutate ', ' National Center for Research Resources ', ' NCRR ', ' National Institute of Child Health and Human Development ', ' NICHD ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' NIDDK ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Range ', ' Receptor Signaling ', ' Recombinants ', ' Research Infrastructure ', ' Infrastructure ', ' Study Section ', ' in vivo ', ' Cancer Center Support Grant ', ' Core Grant ', ' CCSG ', ' Catchment Area ', ' Centers of Research Excellence ', ' Center of Biomedical Research Excellence ', ' COBRE ', ' Chemical Agents ', ' Clinical Endocrinology ', ' Enrollment ', ' enroll ', ' Facilities and Administrative Costs ', ' Indirect Costs ', ' Fellowship Program ', ' Funding Mechanisms ', ' Opioid Receptor Binding ', ' Pain Research ', ' Sexual Transmission ', ' Title ', ' Training and Infrastructure ', ' Transgenic Mouse Facility ', ' Translational Research ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Wild Type Mouse ', ' Monitor ', ' trend ', ' Preparation ', ' Rate ', ' Principal Investigator ', ' Characteristics ', ' Molecular ', ' Knock-out ', ' Knockout ', ' Process ', ' sex ', ' Modification ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' sample fixation ', ' Fixation ', ' Community Health ', ' Chairperson ', ' Chairwoman ', ' Chairman ', ' Exercise ', ' Physical Exercise ', ' Development ', ' developmental ', ' Facility Construction Funding Category ', ' malignant mouth neoplasm ', ' malignant mouth tumor ', ' Oral Cancer ', ' Mouth Cancer ', ' Malignant Oral Neoplasm ', ' Malignant Oral Cavity Tumor ', ' Malignant Oral Cavity Neoplasm ', ' Face ', ' facial ', ' faces ', ' Faculty ', ' Nursing Faculty ', ' Nursing Staff Development Specialist ', ' Nursing Staff Developer ', ' Nurse Educator ', ' Clinical Nurse Educator ', ' Clinical Faculty ', ' Family ', ' Fatigue ', ' Lack of Energy ', ' Chronic Fatigue Syndrome ', ' Royal Free Disease ', ' Postviral Fatigue Syndrome ', ' Myalgic Encephalomyelitis ', ' Chronic Infectious Mononucleosis-Like Syndrome ', ' Chronic Fatigue-Fibromyalgia Syndrome ', ' Chronic Fatigue and Immune Dysfunction Syndrome ', ' Chronic Fatigue Disorder ', ' Fatty acid glycerol esters ', ' Fats ', ' Support of Research ', ' Federal Government ', ' National Government ', ' Fees ', ' Fellowship ', ' Female ', ' Adrenal Gland Hyperfunction ', ' hypercortisolism ', ' Hypercorticism ', ' Hyperadrenocorticism ', ' Hyperadrenalism ', ' Adrenocortical Hyperfunction ', ' Journals ', ' Magazine ', ' Advisory Committees ', ' Task Forces ', ' Floor ', ' Transcriptional Activation ', ' Transcription Activation ', ' Adrenal Glands ', ' suprarenal gland ', ' Adrenals ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Friction ', ' In Situ Hybridization ', ' in situ Hybridization Staining Method ', ' in situ Hybridization Genetics ', ' Prevention education ', ' foot ', ' Corticotropin ', ' Corticotropin (1-39) ', ' Adrenocorticotropin ', ' Adrenocorticotropic Hormone ', ' ACTH (1-39) ', ' ACTH ', ' Formalin Tests ', ' Foundations ', ' PPAR gamma ', ' Thiazolidinedione Receptor ', ' Peroxisome Proliferator-Activated Receptor gamma ', ' Peroxisome Proliferative Activated Receptor Gamma ', ' PPARgamma ', ' Fringe Benefit ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' Image ', ' imaging ', ' Pathway interactions ', ' pathway ', ' serotonin transporter ', ' sodium-dependent serotonin transporter ', ' 5HTT protein ', ' 5HT transporter ', ' Affect ', ' Gel ', ' Gene Deletion ', ' gene deletion mutation ', ' Gene Expression ', ' gene therapy ', ' genetic therapy ', ' gene-based therapy ', ' Genetic Intervention ', ' Gene-Tx ', ' Gene Transfer Procedure ', ' Gene Transfer Clinical ', ' Gene Therapy Molecular Biology ', ' DNA Therapy ', ' Patient Care ', ' Patient Care Delivery ', ' Genes ', ' Genetic Markers ', ' Genotype ', ' USA Georgia ', ' Western Asia Georgia ', ' Georgian SSR ', ' Georgian S.S.R. ', ' Georgia SSR ', ' Georgia (Republic) ', ' Gills ', ' Standards of Weights and Measures ', ' autistic Children ', ' Glucocorticoids ', ' Therapeutic Glucocorticoid ', ' animal care ', ' base ', ' Bisexual ', ' brush border membrane ', ' career ', ' germ free condition ', ' specific pathogen free ', ' human subject ', ' species difference ', ' Glycine ', ' Aminoacetic Acid ', ' Goals ', ' Golgi Apparatus ', ' Golgi Complex ', ' Golgi ', ' Label ', ' Grant ', ' Microscope ', ' Microtome - medical device ', ' microtome ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth Factor ', ' Proteins Growth Factors ', ' Growth Substances ', ' Growth Agents ', ' GFAC ', ' improved ', ' Air ', ' Hazardous Substances ', ' Hazardous Materials ', ' Head ', ' Health ', ' Hearing ', ' sound perception ', ' hearing perception ', ' Congestive Heart Failure ', ' Heart Decompensation ', ' Cardiac Failure Congestive ', ' Hemodialysis ', ' Hemodialyses ', ' Hepatitis ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hispanic Americans ', ' Spanish Americans ', ' Histology ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Seroprevalence ', ' HIV-1 ', ' human T lymphotropic virus III ', ' human T cell leukemia virus III ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' Alcohols ', ' Alcohol Chemical Class ', ' Homeostasis ', ' Physiological Homeostasis ', ' Autoregulation ', ' Hormones ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Chemotherapy-Hormones/Steroids ', ' Hospitals ', ' University Hospitals ', ' sample collection ', ' specimen collection ', ' House Staffs ', ' Housing ', ' Aldosterone ', ' Pregn-4-en-18-al, 11,21-dihydroxy-3,20-dioxo-, (11beta)- ', ' DNA analysis ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Hydrolase ', ' Hyperaldosteronism ', ' Aldosteronism ', ' Drug rehabilitation procedure ', ' drug rehabilitation ', ' Hyperplasia ', ' Hyperplastic ', ' Depth ', ' Site ', ' Area ', ' Acute ', ' Chronic ', ' Clinical ', ' Specific qualifier value ', ' Specified ', ' Hypertension ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Phase ', ' Biological ', ' Physiological ', ' Physiologic ', ' Biochemical ', ' Medical ', ' Series ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Endogenous Opiates ', ' endogenous opioid ', ' Opioid Peptide ', ' Opiate Peptides ', ' Petrosal Sinus Sampling ', ' Inferior Petrosal Sinus Sampling ', ' Bilateral Synchronous Inferior Petrosal Sinus Sampling ', ' BSIPSS ', ' Hypopituitarism ', ' Anterior Pituitary Hyposecretion Syndrome ', ' Adenohypophyseal Hyposecretion ', ' Orthostatic Hypotension ', ' Postural Hypotension ', ' Hypothalamic structure ', ' hypothalamic ', ' Hypothalamus ', ' Book Chapters ', ' receptor density ', ' high school ', ' professor ', ' placebo controlled study ', ' placebo controlled trial ', ' cohort ', ' Employee ', ' Municipalities ', ' Cocaine Dependences ', ' Cocaine Addiction ', ' Manuscripts ', ' Toxic effect ', ' Toxicities ', ' Boron ', ' B element ', ' Boxing ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Brain Diseases ', ' Intracranial Central Nervous System Disorders ', ' Intracranial CNS Disorders ', ' Encephalon Diseases ', ' Brain Disorders ', ' glucagon-like peptide 1 ', ' proglucagon (78-107)amide ', ' proglucagon (78-107) ', ' proglucagon (72-108) ', ' GLP-1 ', ' Breast ', ' Breeding ', ' Budgets ', ' link protein ', ' cartilage link protein ', ' Abbott brand of sildenafil citrate ', ' Viagra ', ' Calcium ', ' Factor IV ', ' Coagulation Factor IV ', ' Ca++ element ', ' Blood Coagulation Factor IV ', ' California ', ' N-benzyloxycarbonylprolylprolinal ', ' Speed (motion) ', ' Speed ', ' Structure ', ' Pharmacology and Toxicology ', ' Chemical Exposure ', ' skills ', ' novel ', ' Participant ', ' disorder prevention ', ' disease prevention ', ' Harm Reduction ', ' Harm Minimization ', ' treatment program ', ' member ', ' Agreement ', ' social movement ', ' NIH Program Announcements ', ' Program Announcement ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Basic Science ', ' Basic Research ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Categories ', ' disorder risk ', ' disease risk ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Registered nurse ', ' R.N. ', ' Prevention ', ' Gly-Lys-Arg-oxytocin ', ' pro-oxytocin ', ' precursor-oxytocin ', ' glycyl-lysyl-arginine-oxytocin ', ' OT-GKR ', ' ranpirnase ', ' P30 Protein ', ' P30 ', ' P-30 Protein ', ' Colon Carcinoma ', ' Colonic Carcinoma ', ' Colon Cancer ', ' Human Resources ', ' personnel ', ' Manpower ', ' Reporting ', ' Sorting - Cell Movement ', ' sorting ', ' Carbohydrates ', ' Carbon Dioxide ', ' Carbonic Anhydride ', ' CO2 ', ' Paroxetine ', ' Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S-trans)- ', ' pro-thyrotropin releasing hormone ', ' thyrotropin releasing hormone precursor ', ' pyroglutamyl-histidyl-prolyl-glycyl-lysine ', ' pro-TRH ', ' pGlu-His-Pro-Gly-Lys ', ' TRH-Gly-Lys ', ' proenkephalin ', ' pro-enkephalin ', ' prolyl oligopeptidase ', ' prolyl endopeptidase I ', ' prolyl endopeptidase (thiol-dependent) ', ' prolyl endopeptidase ', ' proline specific endopeptidase ', ' proline endopeptidase ', ' post-proline endopeptidase ', ' post-proline cleaving enzyme ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular system (all sites) ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' social ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Positioning Attribute ', ' Position ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Serine carboxypeptidase ', ' Cattle ', ' cow ', ' bovine ', ' bovid ', ' Bovine Species ', ' reproductive ', ' Gene Proteins ', ' Protein Gene Products ', ' Cell Death ', ' necrocytosis ', ' Cell Line ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell physiology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cells ', ' Cellulitis ', ' Cerebral cortex ', ' Cerebrovascular Circulation ', ' cerebrocirculation ', ' cerebral circulation ', ' cerebral blood flow ', ' Aspartic Endopeptidases ', ' aspartic protease ', ' aspartate protease ', ' Carboxylic Proteinases ', ' Carboxyl (Acid) Proteinases ', ' Aspartyl Proteinases ', ' Aspartyl Proteases ', ' Aspartic Proteinases ', ' County ', ' cytokine ', ' Friends ', ' Generations ', ' Lobe ', ' Measures ', ' Chemistry ', ' Price ', ' pricing ', ' Prize ', ' N-Methyl-D-Aspartate Receptors ', ' NMDA Receptors ', ' NMDA Receptor-Ionophore Complex ', ' N-Methylaspartate Receptors ', ' Relative (related person) ', ' Relative ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' neural circuit ', ' synaptic circuitry ', ' synaptic circuit ', ' neural circuitry ', ' Abscess ', ' Cholelithiasis ', ' cholelith ', ' Gallstones ', ' Gallbladder Stone ', ' Gallbladder Calculus ', ' Proprotein Convertase 2 ', ' Proinsulin Convertase 2 ', ' Prohormone Convertase 2 ', ' PC2 Protein ', ' PC2 Prohormone Convertase ', ' PC2 Endoprotease ', ' PC2 ', ' Neuroendocrine Convertase PC2 ', ' Endopeptidase PC2 ', ' cardiovascular risk factor ', ' cardiovascular risk ', ' Regulation ', ' Crack Cocaine ', ' free base cocaine ', ' Paraffin Embedding ', ' PC12 Cells ', ' pheochromocytoma 12 cell line ', ' Pheochromocytoma Cell Line ', ' PC-12 ', ' Chromatography ', ' Chromatography / Separation Science ', ' Placental Choriocarcinoma ', ' Placenta Choriocarcinoma ', ' High Pressure Liquid Chromatography ', ' High Speed Liquid Chromatography ', ' High Performance Liquid Chromatography ', ' HPLC ', ' abstracting ', ' Administrator ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Factor Analysis ', ' Factor Analyses ', ' Case Study ', ' case report ', ' symposium ', ' conference ', ' Illicit Drugs ', ' Morphine Receptors ', ' Molecular Genetics ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Laboratory Assistant ', ' Latino ', ' Mediating ', ' Promotor (Genetics) ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Research Ethics Committees ', ' Research Methodology ', ' Research Methods ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Schedule ', ' Modeling ', ' Sampling ', ' Property ', ' LOINC Axis 2 Property ', ' response ', ' Youth ', ' Youth 10-21 ', ' sarcopenia ', ' Proteomics ', ' repository ', ' behavior influence ', ' behavioral influence ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Circadian Rhythms ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Cities ', ' Secretory Vesicles ', ' Secretory Granules ', ' Client ', ' Clinical Research ', ' Clinical Study ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' lecturer ', ' alcohol abuse therapy ', ' alcohol treatment ', ' alcohol abuse treatment ', ' insulin sensitivity ', ' AIDS education/prevention ', ' AIDS education ', ' Cognitive Therapy ', ' cognitive behavioral treatment ', ' cognitive behavioral therapy ', ' cognitive behavioral modification ', ' cognitive behavioral intervention ', ' cognitive behavior therapy ', ' cognitive behavior modification ', ' cognitive behavior intervention ', ' Cognitive Psychotherapy ', ' Cognition Therapy ', ' Cohort Studies ', ' Concurrent Studies ', ' Annual Reports ', ' Color ', ' Communicable Diseases ', ' Infectious Disorder ', ' Infectious Diseases and Manifestations ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communication ', ' Communities ', ' Community Health Education ', ' Community HealthTutoring ', ' Community Health Taining ', ' Community Education ', ' Community Participation ', ' Community Surveys ', ' Comorbidity ', ' co-morbidity ', ' Receptor Up-Regulation ', ' Complement ', ' Complement Proteins ', ' tobacco control ', ' Instruction ', ' cost ', ' Behavioral Assay ', ' biobehavior ', ' biobehavioral ', ' performance site ', ' dissemination research ', ' digital ', ' Information Technology ', ' design ', ' designing ', ' Minority ', ' alcohol and other drug ', ' Outcome ', ' Population ', ' Prevalence ', ' diabetic rat ', ' diabetic rat model ', ' Rat model of diabetes ', ' Alcohol dependence ', ' alcohol-dependent ', ' alcohol dependency ', ' alcohol addiction ', ' Alcoholism ', ' National Institute on Alcohol Abuse and Alcoholism ', ' NIAAA ', ' substance abuser ', ' post-doctoral training ', ' postdoctoral training ', ' older men ', ' clinically relevant ', ' clinical relevance ', ' fundamental research ', ' drug of abuse ', ' drugs of abuse ', ' drugs abused ', ' abused drugs ', ' alcohol research ', ' ethanol research ', ' alcohol related research ', ' comparative ', ' stem ', ' brain research ', ' reconstitution ', ' reconstitute ', ' addiction ', ' addictive disorder ', ' racial and ethnic disparities ', ' Computer Systems ', ' computing system ', ' Computers ', ' Consultations ', ' Corticosterone ', ' Pregn-4-ene-3,20-dione, 11,21-dihydroxy-, (11beta)- ', ' Corticotropin-Releasing Hormone ', ' corticotropin releasing hormone ', ' Corticotropin-Releasing Hormone-41 ', ' Corticotropin-Releasing Factor-41 ', ' Corticotropin-Releasing Factor ', ' Corticoliberin ', ' CRF-41 ', ' ACTH-Releasing Factor ', ' Living Costs ', ' Acetylcholinesterase ', ' choline esterase I ', ' acetylcholine acetylhydrolase ', ' Acetylcholine Hydrolase ', ' Educational Curriculum ', ' Curriculum ', ' Cushing Syndrome ', ' pituitary basophilism ', "" Cushing's basophilism "", ' Achievement ', ' Achievement Attainment ', ' Delta Sleep-Inducing Peptide ', ' Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu ', ' Delta-Sleep Peptide ', ' DSIP ', ' Committee Members ', ' IACUC ', ' Institutional Animal Care and Use Committee ', ' Protein Microchips ', ' Protein Microarray ', ' Protein Chips ', ' Protein Biochips ', ' Risk Reduction ', ' Provider ', ' Bos taurus ', ' Domestic Cow ', ' Mismatch Repair ', ' Post-Replication Mismatch Repair ', ' Mental Depression ', ' depression ', ' Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' health disparity ', ' health disparities ', ' Commit ', ' Detergents ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Dextroamphetamine ', ' dextro-Amphetamine ', ' d-Amphetamine ', ' Dexedrine ', ' Dexamfetamine ', ' Benzeneethanamine, alpha-methyl-, (S)- ', ' Diabetes Insipidus ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Vascular Endothelial Growth Factors ', ' Vegf ', ' VEGFs ', ' Prohormone Convertase ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' End stage renal failure ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Institution ', ' Brain region ', ' Disulfiram ', ' Thioperoxydicarbonic diamide (((H2N)C(S))2S2), tetraethyl- ', ' Tetraethylthiuram Disulfide ', ' Tetraethylthioperoxydicarbonic Diamide, ((H2N)C(S))2S2 ', ' Bis(diethylthiocarbamoyl) Disulfide ', ' Antabuse ', ' Effectiveness ', ' DNA ', ' Deoxyribonucleic Acid ', ' Purpose ', ' Tissue Sample ', ' Dopamine ', ' Hydroxytyramine ', ' 4-(2-Aminoethyl)-1,2-benzenediol ', ' 3,4-Dihydroxyphenethylamine ', ' ward ', ' Double-Blind Method ', ' Double-Masked Study ', ' Double-Masked Method ', ' Double-Blinded ', ' Double-Blind Study ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Readiness ', ' Preparedness ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Induction of Apoptosis ', ' Dynorphins ', ' Economics ', ' Proprotein Convertase 1 ', ' Proprotein Convertase SPC3 ', ' Proinsulin Convertase 1 ', ' Prohormone Convertase 3 ', ' Prohormone Convertase 1 ', ' PC3 Prohormone Convertase ', ' PC3 Endoprotease ', ' PC1 Prohormone Convertase ', ' PC1 Endoprotease ', ' PC1 ', ' Neuroendocrine Convertase PC1 ', ' Educational aspects ', ' Education ', ' Medical Education ', ' Professional Education ', ' Educational Activities ', ' CRH gene ', ' CRH ', ' TNFRSF5 gene ', ' p50 ', ' Tumor Necrosis Factor Receptor Superfamily Member 5 Gene ', ' TNFRSF5 ', ' MGC9013 ', ' CDW40 ', ' CD40 ', ' Bp50 ', ' HPSE gene ', ' HSE1 ', ' HPSE1 ', ' HPR1 ', ' Electronics ', ' prodynorphin ', ' pro-vasopressin ', ' propressophysin ', ' pro-pressophysin ', ' Elements ', ' Employment ', ' Receptors, Opioid, delta ', ' delta Receptors ', ' Endocrine System Diseases ', ' endocrine disorder ', ' Endocrine Diseases and Manifestations ', ' Endocrine Diseases ', ' Endocrine system ', ' endocrine gland/system ', ' Metabolic/Endocrine Body System ', ' Hormonal System ', ' Endocrine/Metabolic Organ System ', ' Endocrine system (all sites) ', ' Endocrinology ', ' Metabolism and Endocrinology ', ' Endometrium ', ' Endorphins ', ' Methionine Enkephalin ', ' Met-Enkephalin ', ' Met(5)-Enkephalin ', ' Adrenorphin (human), 6-de-L-arginine-7-de-L-arginine-8-de-L-valinamide- ', ' 5-Methionine Enkephalin ', ' Enkephalins ', ' Environment ', ' Address ', ' Enzymes ', ' Dose ', ' Epidemiologic Methods ', ' Methods Epidemiology ', ' Epidemiological Techniques ', ' Epidemiological Methods ', ' Cyclic AMP ', ' cAMP ', "" adenosine 3'5' monophosphate "", "" Adenosine, cyclic 3',5'-(hydrogen phosphate) "", ' Adenosine Cyclic Monophosphate ', "" Adenosine Cyclic 3',5'-Monophosphate "", "" 3'5'-cyclic ester of AMP "", ' human prostaglandin D2 receptor ', ' human prostaglandin D2 receptor  proten ', ' human PTGDR protein ', ' human DP protein ', ' Equilibrium ', ' balance function ', ' balance ', ' Equipment ', ' Orthostasis ', ' Bathing ', ' Baths ', ' ']",NIDA,CHARLES R. DREW UNIVERSITY OF MED & SCI,R24,2007,61553,0.0371268321939589
"Collaborative Research on Drug Abuse    DESCRIPTION (provided by applicant): This P01 develops and applies state-of-the-art methods to analyze existing but under-utilized drug abuse databases in collaboration with their owners. We address contemporary, theoretical, and applied issues in drug abuse research to understand intersections between substance abuse and AIDS risk behaviors as well as minority and gender-based health disparities. We work with dozens of investigators from drug & social policy, epidemiology, health sciences, medicine, nursing, psychiatry, psychology, public health, and social work who own exciting substance abuse data to develop models that test current theories, especially on epidemiology, prevention, intervention, and treatment of drug abuse, using modern multivariate methods to control for measurement errors, biases, and other confounds. The Models and Methods Project develops psychometric and statistical analytic techniques that hold special promise for improving the quality of drug abuse and AIDS research. The At-Risk Project studies substance abuse related data sets on vulnerable populations (substance abusers, homeless people, individuals who are HIV positive or who have AIDS, victims of domestic abuse, runaways, gang members, and others at high risk for AIDS or drug abuse) with methods to control sampling, measurement, distributional and other biases. The Community Project studies drug abuse etiology, adult consequences, HIV risk, intergenerational processes, general deviance, and related issues in large community-based samples, and develops and tests explanatory theories using models that permit separation of common from specific effects, control for artifacts, etc. The Core Project oversees and integrates all components, hosts visiting scholars, provides computer facilities, and sponsors a mentoring program for disadvantaged students. The substantive part of the Models Project and the At-Risk and Community Projects will be developing and testing integrative theories that can be applied across different populations. The findings from their studies will lead to greater understanding of precursors and concomitants of substance abuse and HIV/AIDS risk and transmission. In turn, these findings will guide development of effective interventions to reduce negative health outcomes and treatment disparities in community, ethnic, and vulnerable populations, and provide guidance on how these may be alleviated.      PROGRAM CHARACTERISTICS          ",Collaborative Research on Drug Abuse,7298116,P01DA001070,[''],NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,P01,2007,954356,0.06373110537308126
"The Growing Disparity in Illegal Drug Use Across Socioeconomic Strata    DESCRIPTION (provided by applicant): A disparity in illegal drug use that disadvantages individuals in the lower socioeconomic strata has significantly increased in the last two decades. New evidence indicates that this increase results in large part from a changing influence of socioeconomic status (SES) on drug use, and not from a negative influence of drug use on SES that has accumulated over time. However, the SES-related influences responsible for this growing disparity remain largely unknown. . The aims of this study are threefold. First, it will address limitations in current evidence on the growing disparity of illegal drug use across socioeconomic strata. Using the most current, available data the project will (a) update analyses of socioeconomic trends in cocaine past 1998 (b) examine socioeconomic trends up to the present in illegal drugs that have not yet been examined, such as marijuana, methamphetamine, ecstasy, and 'blunts,1 (c) examine whether the growing disparity sterns from differential incidence and/or differential duration of drug use across socioeconomic strata, and (d) examine SES indicators other than education. These analyses will use the National Survey on Drug Use and Health, a nationally- representative, cross-sectional survey of drug use administered yearly, although between 1979 and 1988 it was administered only every third year. Second, the study will predict both changes in the prevalence of illegal drugs over time and also changes in the characteristics of illegal drug users over time. We use a ""Diffusion of Innovation"" framework, which predicts that users of an innovation such as illegal drugs fall into distinct categories such as ""innovators,"" ""early adopters,"" and ""late adopters."" People in each of these categories are theorized to differ from each other in terms of sociodemographic, psychological, and environmental characteristics. Furthermore, the profiles of drug users at one point in time are expected to predict the prevalence of drug use in the future. The third aim of the project is to trace the extent to which the key predictors of illegal drug use, as highlighted by the Diffusion framework, have their roots in the early life course. Using a longitudinal survey that has followed 838 children from 1st grade to age 30, the analysis will examine how far back in the life course current predictors of illegal drug use extend. We expect that many early predictors have not yet been linked to later drug use because the current profile of illegal drug users, which includes factors such as low socioeconomic status, did not emerge until recently. Results from this project will inform policy and intervention programs aimed at reducing the prevalence of illegal drug use across all socioeconomic strata.              ",The Growing Disparity in Illegal Drug Use Across Socioeconomic Strata,7262683,R01DA020575,"['Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' ecstasy ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' Diffusion ', ' Diffusion of Innovation ', ' Disadvantaged ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' Educational aspects ', ' Education ', ' Address ', ' Data Set ', ' Dataset ', ' Data ', ' Mentored Research Scientist Development Award ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' Policy Research ', ' Update ', ' trend ', ' Principal Investigator ', ' Characteristics ', ' Process ', ' sex ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' Age ', ' Goals ', ' Health ', ' Health Status ', ' Level of Health ', ' psychologic ', ' psychological ', ' Link ', ' Incidence ', ' Childhood ', ' pediatric ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Fostering ', ' Policies ', ' Drug usage ', ' drug use ', ' Plant Roots ', ' root ', ' Funding ', ' Marihuana ', ' marijuana ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Drug user ', ' Publishing ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Schools ', ' Social Mobility ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Adopted ', ' Woman ', ' Work ', ' Back ', ' Dorsum ', ' directed attention ', ' directs attention ', ' age group ', ' experience ', ' cohort ', ' intervention program ', ' Categories ', ' Prevention ', ' social ', ' Relative (related person) ', ' Relative ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' falls ', ' Causations ', ' Longitudinal Surveys ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Uncertainty ', ' doubt ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Accounting ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' racial and ethnic ', ' racial/ethnic ', ' stem ', ' ']",NIDA,UNIVERSITY OF COLORADO DENVER/HSC DENVER,R01,2007,249364,0.22637589368278796
"Participant Perspectives on Drug Use/HIV Research Ethics    DESCRIPTION (provided by applicant):  Investigators studying illicit drug use and related HIV risk face unique ethical challenges. Intoxication, long term drug use, or advanced stages of HIV/AIDS can impair consent capacity. Involvement in criminal activities to purchase drugs and diagnosis of HIV/AIDS make participants especially vulnerable to breaches in confidentiality that may result in criminal prosecution, social stigmatization, or loss of employment. The need for money to purchase drugs or ethnic and economic health disparities may heighten susceptibility to coercion from cash or treatment compensation for research participation. Participants in RCT designs may suffer withdrawal symptoms during detoxification or side effects when experimental treatments interact with street drugs. Dissemination of research results may further stigmatize or sustain societal prejudices against historically oppressed groups. Through focus groups, in-depth interviews, and structured interview surveys, this research aims to explore the hopes, values, and fears that multiply vulnerable illicit drug users bring to research ethics practices. This collaborative project uniting the strengths of the Fordham University Center for Ethics Education and the community based substance abuse and HIV/AIDS experience of the Hispanic Health Council, will examine in both depth and breath the attitudes of street drug users towards research risks and benefits, informed consent, confidentiality, and use of incentives in research on the epidemiology, social correlates, and treatments for drug abuse and HIV related risks. How gender and ethnicity influence these attitudes will also be examined. Long-term goals of this project are to identify ethical concerns among economically disadvantaged, ethnically diverse illicit street drug users that will inform and enhance drug use and HIV risk research in ways that reflect the values and merit the trust of participants.            ",Participant Perspectives on Drug Use/HIV Research Ethics,7254760,R01DA015649,"['Benefits and Risks ', ' social ', ' Intoxication ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Gender ', ' Legal Liability ', ' Organizational Policy ', ' Research Ethics ', ' Regulation ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Research Ethics Committees ', ' Withdrawal Symptom ', ' theories ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Coercion ', ' Communities ', ' Community Health Education ', ' Community HealthTutoring ', ' Community Health Taining ', ' Community Education ', ' dissemination research ', ' design ', ' designing ', ' Treatment Efficacy ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Population ', ' prospective ', ' racial and ethnic ', ' racial/ethnic ', ' addiction ', ' addictive disorder ', ' Confidentiality ', ' information privacy ', ' Decision Making ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Disadvantaged ', ' Discrimination (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Employment ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Ethics ', ' ethical ', ' Ethnic group ', ' Consent ', ' Data ', ' Population Research ', ' Face ', ' facial ', ' faces ', ' Fright ', ' Fear ', ' Guidelines ', ' Focus Groups ', ' Standards of Weights and Measures ', ' base ', ' Goals ', ' Habits ', ' Procedures ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Depth ', ' Sex Orientation ', ' Sexual Orientation ', ' Incentives ', ' inducement ', ' Informed Consent ', ' Ensure ', ' Interview ', ' Financial compensation ', ' Compensation ', ' Predisposition ', ' Susceptibility ', ' Individual ', ' Trust ', ' Policies ', ' Drug usage ', ' drug use ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Drug Metabolic Detoxication ', ' detoxification ', ' Metabolism of Toxic Agents ', ' Metabolic Drug Detoxications ', ' Drug Metabolic Detoxification ', ' Methods ', ' Morals ', ' Therapeutic Human Experimentation ', ' Therapeutic Research ', ' Prejudice ', ' Staging ', ' Drug user ', ' Public Opinion ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Rights ', ' Risk ', ' Social Welfare ', ' welfare ', ' Knowledge ', ' Life ', ' programs ', ' Stigmatization ', ' Street Drugs ', ' Surveys ', ' Survey Instrument ', ' Syringes ', ' Universities ', ' Attention ', ' Attitude ', ' Voice ', ' Complex ', ' Dependence ', ' Reaction ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Marshal ', ' psychosocial ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Services ', ' AIDS/HIV diagnosis ', ' experience ', ' resource guides ', ' Structure ', ' Participant ', ' member ', ' ethnic difference ', ' ']",NIDA,FORDHAM UNIVERSITY,R01,2007,490744,0.20086343638152432
"Homeless Women: Drugs, Race/Ethicity, And Health Care Research has shown that drug use and physical health problems are quite common among the homeless and that their general health-care needs often go unmet. However, much of this research is based on samples composed largely of homeless men. To date, there has been little research on the relationship between drug use and utilization of general health care among homeless women. Moreover, possible racial/ethnic differences in this relationship have not been extensively examined. This study will employ secondary data from two complementary funded studies to analyze the association between drug use and use of general health care (inpatient, ambulatory, and preventive). The first dataset screened for lifetime drug dependence in a community-based probability sample of 861 homeless women in Los Angeles County, and the second dataset assessed current heavy drug use and lifetime injection drug use in a purposive sample of 1,330 homeless women in Los Angeles. We will test hypotheses regarding a wide range of predisposing and enabling factors (such as case management, health insurance, and access to public benefits) potentially associated with access to general health services by African American, Latina, and White homeless women with drug problems. The proposed study directly addresses policy questions prominent in NIDA's strategic plan on reducing health disparities. By documenting the nature and extent of health problems affecting drug-using homeless women, their use of general health services, the extent to which their need for care goes unmet, and possible racial/ethnic differences in these patterns, this study will inform drug treatment providers on the value and content of screening/assessment procedures they might employ and the types of general health services for which more effective linkage is needed. ","Homeless Women: Drugs, Race/Ethicity, And Health Care",7370963,R01DA014835,"['Pattern ', ' Visit ', ' Services ', ' experience ', ' care seeking ', ' member ', ' sobriety ', ' sober ', ' outreach ', ' General Population ', ' General Public ', ' Prevention ', ' social ', ' reproductive ', ' Asians ', ' oriental ', ' Pap smear ', ' cervical/vaginal smear ', ' Vaginal Smears ', ' Papanicolaou Test ', ' Papanicolaou Smear ', ' Pap Test ', ' Cervical Smears ', ' County ', ' Measures ', ' United States Agency for Healthcare Research and Quality ', ' United States Agency for Health Care Policy and Research ', ' Agency for Healthcare Research and Quality ', ' Agency for Health Care Policy and Research ', ' AHRQ ', ' AHCPR ', "" Women's Health "", ' Female Health ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Case Management ', ' Healthcare ', ' health care ', ' Sampling ', ' Accounting ', ' Acculturation ', ' Cultural Assimilation ', ' Communities ', ' Latina ', ' Latinas ', ' Complement ', ' Complement Proteins ', ' birth control ', ' design ', ' designing ', ' Minority ', ' Outcome ', ' Population ', ' ethnic minority population ', ' ethnic minority ', ' racial and ethnic ', ' racial/ethnic ', ' racial and ethnic disparities ', ' Data Analyses ', ' Data Analysis ', ' Decision Making ', ' health care delivery ', ' health services delivery ', ' Healthcare Delivery ', ' Health Sciences, Allied and Health Services Delivery ', ' Reproductive Health Services ', ' health disparity ', ' health disparities ', ' Purpose ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Enabling Factors ', ' Address ', ' Preventive ', ' Symptoms ', ' Data Set ', ' Dataset ', ' Ethnic group ', ' Caring ', ' Shelter facility ', ' shelter-housing ', ' shelter ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Range ', ' Strategic Planning ', ' Characteristics ', ' N.I.H. Research Support ', ' Face ', ' facial ', ' faces ', ' Family ', ' Affect ', ' Age ', ' base ', ' racial/ethnic difference ', ' improved ', ' Procedures ', ' Health ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Services ', ' health care service ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Health Status ', ' Level of Health ', ' Hospitalization ', ' Hospitals ', ' Site ', ' Acute ', ' Medical ', ' Injection of therapeutic agent ', ' Injections ', ' Inpatients ', ' Health Insurance ', ' Homelessness ', ' unhoused ', ' homeless ', ' Numbers ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' Los Angeles ', ' Policies ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' men ', "" men's "", ' Methodology ', ' Method LOINC Axis 6 ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Native Americans ', ' Parents ', ' Preventive Health Services ', ' Probability ', ' Probability Samples ', ' Staging ', ' Drug user ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Diagnostic ', ' Nature ', ' Research ', ' Resources ', ' Research Resources ', ' Hypersensitivity skin testing ', ' immunologic skin test ', ' hypersensitivity test ', ' Skin Tests ', ' Life ', ' programs ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Translating ', ' Tuberculosis ', ' tuberculous spondyloarthropathy ', ' infection due to Mycobacterium tuberculosis ', ' disseminated tuberculosis ', ' disseminated TB ', ' Mycobacterium tuberculosis infection ', ' Mycobacterium tuberculosis (MTB) infection ', ' Mtb infection [{C0041296}] ', ' MTB infection ', ' M.tuberculosis infection ', ' M. tuberculosis infection ', ' Woman ', ' Dependence ', ' Home environment ', ' Home ', ' Source ', ' ']",NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2007,24030,0.18627626917048123
"Club Drugs, Dance Events, and Asian-American Youth DESCRIPTION (provided by applicant): The focus of this proposed 48 months qualitative continuation project is to expand our existing and on-going research on the overall culture of club drugs use in the San Francisco Bay Area. The prominence of Asian Americans and their drug using practices leads us to propose a change in focus from the scene in its entirety to a detailed examination of the involvement of Asian Americans within the techno dance scene. We will focus on the following four research issues: 1) What are the social, gender and ethnic characteristics of Asian American users of club drugs? 2) What are the patterns, variations and combinations of club drugs used by different Asian ethnic youth subgroups and how do they compare with the larger sample in the parent project? 3) What are the various social settings in which Asian American youth and young adults use club drugs? 4) What are the social processes of club drug use among different Asian ethnic youth? Using primarily qualitative and ethnographic research methods, we will locate and interview 360 young Asian American youth and young adults, between the ages of 16-25, who have used one or more club drugs three or more times in the previous six months. The sample will be sub-divided into equal numbers of male and female and proportionate numbers of immigrants and U.S. born youth. After an initial mapping of Asian participation in the scene, the sampling frame will be expanded to accommodate representative numbers of different Asian ethnic groups.  This project is important for two reasons. First, it will provide much needed empirical data on a growing but understudied population, and possible intra-ethnic variations. While our on-going research seeks to understand the overall social context of club drug use, the proposed research seeks not only to document the extent to which club drugs are used by Asian American youth but to uncover the connections between drug use, involvement in the dance scene and ethnic identity. Second, given the reported increase in problems of club drug use among Asian American youth, data from this project will provide important information on their use of club drugs, their patterns of use and the health and social consequences of their use. This information will assist in designing more effective and culturally appropriate public health initiatives and prevention messages to alert young Asian American adults about the dangers of these drugs. ","Club Drugs, Dance Events, and Asian-American Youth",7234459,R01DA014317,"['Dancing ', ' ecstasy ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' health disparity ', ' health disparities ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Electronics ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Ethnic group ', ' Data ', ' Range ', ' Subgroup ', ' Monitor ', ' Characteristics ', ' Process ', ' Development ', ' developmental ', ' Female ', ' Ethnography ', ' ethnographic ', ' Law Enforcement ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' Age ', ' Health ', ' Household ', ' Area ', ' Variant ', ' Variation ', ' Interview ', ' Psyche structure ', ' mental ', ' Learning ', ' Ritual compulsion ', ' Rituals ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Numbers ', ' young adult ', ' young adulthood ', ' adult youth ', ' Drug usage ', ' drug use ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Maps ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Motivation ', ' Amphetamines ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Benzeneethanamine, alpha-methyl-, (+-)- ', ' Music ', ' Respondent ', ' Immigrant ', ' public health medicine (field) ', ' Public Health ', ' Publishing ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Role ', ' social role ', ' San Francisco ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Life ', ' Employee Strikes ', ' Strikes ', ' Surveys ', ' Survey Instrument ', ' Asian Americans ', ' Scientist ', ' Time ', ' United States ', ' Attention ', ' Work ', ' Event ', ' Pattern ', ' Techniques ', ' Behavior ', ' interest ', ' Services ', ' American ', ' Participant ', ' Prevention program ', ' gang ', ' Prevention ', ' social group ', ' Reporting ', ' social ', ' Asians ', ' oriental ', ' Gender ', ' Illicit Drugs ', ' Promotor (Genetics) ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Research Methodology ', ' Research Methods ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' Communities ', ' design ', ' designing ', ' Outcome ', ' Prevention intervention ', ' Population ', ' Prevalence ', ' Consumption ', ' racial and ethnic ', ' racial/ethnic ', ' club drug ', ' parent grant ', ' parent project ', ' ']",NIDA,SCIENTIFIC ANALYSIS CORPORATION,R01,2007,474824,0.11045806602316477
"HIV/AIDS & Womens of Color: Roles of Drug Use, Violence & Insurance in HAART Use    DESCRIPTION (provided by applicant): HIV/AIDS among women is an epidemic that disproportionately affects women of color. It reflects a convergence of politically sensitive issues (i.e., race, drug use, and sexual behavior) that are difficult to disentangle and address. Since the introduction of highly active antiretroviral therapy (HAART) as the standard of care in 1996, mortality rates from AIDS and its complications have declined, but at a much slower rate among women than men. Previous research indicates that HIV positive African American women are less likely than white women to receive HAART. Several national studies indicate that African American women fare worse than white men on a number of standards of HIV care. The proposed study uses data from the Women's Interagency HIV Study (WIHS) confidential data set to 1) assess whether the roles of race and drug use on HAART are moderated by the effects of health insurance coverage and 2) examine longitudinal differences in HAART use among HIV positive female drug users and investigate the extent to which individual latent states (as defined by clusters of psycho-social or behavioral risk factors such as an individual's drug use, drug using partners, depression, and physical or sexual abuse) influence racial/ethnic disparities after controlling for other confounders. Many studies have assessed the independent effects of race, gender, drug use, insurance coverage, and physical or sexual abuse on use of medical care by people with HIV, but little is known about how these risk factors operate in combination or clusters. Several methodological refinements are employed, including use of analytic methods appropriate for longitudinal data and Hidden Markov Models to examine behavioral risk clusters. Study results will improve understanding of the roles of drug use, physical or sexual abuse, and insurance coverage in observed racial disparities of HAART use among HIV positive women and ultimately, improve interventions aimed at reducing racial and other disparities in HIV/AIDS medical care among women. Findings will also inform development of systems for monitoring quality of care among HIV positive women.              ","HIV/AIDS & Womens of Color: Roles of Drug Use, Violence & Insurance in HAART Use",7295814,R21DA022971,"['Cessation of life ', ' Death ', ' Mental Depression ', ' depression ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' Epidemic ', ' Data Set ', ' Dataset ', ' Caring ', ' Data ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Monitor ', ' Rate ', ' Behavioral ', ' Family ', ' Female ', ' Foundations ', ' Affect ', ' Standards of Weights and Measures ', ' base ', ' improved ', ' Health ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' Site ', ' Variant ', ' Variation ', ' Medical ', ' Insurance ', ' Health Insurance ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Individual ', ' Numbers ', ' Drug usage ', ' drug use ', ' men ', "" men's "", ' Methods ', ' Mortality Vital Statistics ', ' Mortality ', ' Names ', ' Sexual abuse ', ' sex abuse ', ' Tigers ', ' Panthera tigris ', ' cooking ', ' Drug user ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Social Policies ', ' Knowledge ', ' Insurance Coverage ', ' Insurance Status ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' System ', ' LOINC Axis 4 System ', ' Services ', ' AIDS/HIV diagnosis ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Gender ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Drug Insurance ', ' Quality of Care ', ' QOC ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Highly Active Antiretroviral Therapy ', ' highly active anti-retroviral therapy ', ' HAART ', ' Accounting ', ' Color ', ' antiretroviral therapy ', ' markov model ', ' racial and ethnic disparities ', ' Computer Systems Development ', ' ']",NIDA,GEORGE WASHINGTON UNIVERSITY,R21,2007,133484,0.14345262070792456
"Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study    DESCRIPTION (provided by applicant): We propose to extend the Northwestern Juvenile Project to examine the developmental patterns of drug use and disorder and risk for HIV/AIDS and other sexually transmitted infections (STIs) as juvenile justice youth age from adolescence to emerging adulthood and young adulthood. This study responds to NIDA's new initiatives in health disparities in HIV/AIDS in minority populations, specifically the nexus of drug abuse, criminal justice involvement, and HIV/AIDS among African Americans.  African Americans comprise 12% of the US population but 40% of incarcerated populations and 50% of new cases of HIV/AIDS. At year-end 2004, nearly 100,000 juveniles and nearly 2.1 million adults were incarcerated. We will continue to study a racially/ethnically diverse sample (n=758; 330 females, 428 males; 412 African Americans, 137 non-Hispanic whites, 207 Hispanics, 2 other race/ethnicity) of persons who were arrested and detained in Cook County (Chicago) Illinois, aged 10-18 years at recruitment (1997-1998). Since recruitment, data have been collected on the development of substance use and disorders, risk and protective factors, and HIV/AIDS risk behaviors. Participants are re-interviewed whether they are (re)incarcerated or back in the community. We propose to conduct annual interviews 10, 11, 12, and 13 years post-baseline, collect records, and test for HIV infection and selected STIs. Focusing on racial/ethnic disparities, gender and age differences, and effects of incarceration, we will: (1) describe patterns of drug use and disorder - onset, persistence, desistence, and recurrence -- as juvenile justice youth age from adolescence to emerging adulthood and young adulthood; (2) describe patterns of HIV/AIDS risk behaviors during this same period; (3) describe the prevalence and incidence of HIV infection and other STIs; and (4) examine the relationship between drug use and disorder and HIV/AIDS risk behaviors. Extending the Northwestern Juvenile Project allows us to leverage the data already collected to examine health disparities and the role of disproportionate minority confinement in the development of drug use and disorder and HIV/AIDS risk; to identify risk and protective factors that are potentially malleable; to identify points of intervention at key developmental periods; and to extend theoretical models - developed in general population adolescents - to correctional populations.           ","Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study",7291663,R01DA022953,"['Crime ', ' Data Reporting ', ' Decision Making ', ' Healthy People 2010 ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Diagnosis ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' violence prevention ', ' prevent violence ', ' Ethnic group ', ' Social Network ', ' Jail ', ' Age-Years ', ' Data ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Request for Applications ', ' NIH RFA ', ' Child Abuse and Neglect ', ' child maltreatment ', ' Childhood maltreatment ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' transmission process ', ' Transmission ', ' Characteristics ', ' Process ', ' sex ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Authorization documentation ', ' Permission ', ' Authorization ', ' Development ', ' developmental ', ' Heterosexuals ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Foundations ', ' Freedom ', ' Liberty ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Standards of Weights and Measures ', ' Injury ', ' Age ', ' racial/ethnic difference ', ' Goals ', ' Gonorrhea ', ' Gonococcal Infection ', ' improved ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Health Services ', ' health care service ', ' Herpes Simplex Infections ', ' Herpesvirus hominis disease ', ' Herpes simplex disease ', ' Herpes Simplex ', ' alcohol use disorder ', ' ethanol use disorder ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV-1 ', ' human T lymphotropic virus III ', ' human T cell leukemia virus III ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Phase ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Illinois ', ' Incidence ', ' Infant ', ' Infection ', ' Human Papillomavirus ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Injection of therapeutic agent ', ' Injections ', ' Interview ', ' Screening procedure ', ' screenings ', ' screening ', ' Judgment ', ' Justice ', ' Kinetics ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Life Style ', ' Lifestyle ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Numbers ', ' Longitudinal Studies ', ' long-term study ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Marihuana ', ' marijuana ', ' men ', "" men's "", ' Methods ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Theoretical model ', ' Theoretic Models ', ' Persons ', ' Needles ', ' Neighborhoods ', ' Neisseria gonorrhoeae ', ' N.gonorrhoeae ', ' N. gonorrhoeae ', ' Gonococcus ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' Liquid substance ', ' liquid ', ' fluid ', ' Antibodies ', ' Prisons ', ' Staging ', ' cooking ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Anus ', ' Anal ', ' Recommendation ', ' Records ', ' Recurrence ', ' Recurrent ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Saliva ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Specimen ', ' Research Specimen ', ' Social support ', ' social support network ', ' Life ', ' Anti-HIV Agents ', ' antiAIDS agent ', ' Anti-Human Immunodeficiency Virus Agents ', ' Anti-HIV Drugs ', ' Anti-AIDS Drugs ', ' Anti-AIDS Agents ', ' AIDS Drugs ', ' statistics ', ' Substance Use Disorder ', ' Surveys ', ' Survey Instrument ', ' Syphilis ', ' great pox ', ' Tattooing ', ' Tattooings ', ' Technology ', ' Testing ', ' Time ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Trichomonas Infections ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Ulcer ', ' Ulceration ', ' Urine ', ' Urine Urinary System ', ' Vagina ', ' Vaginal ', ' Viral hepatitis ', ' Woman ', ' Work ', ' day ', ' Week ', ' Frequencies (time pattern) ', ' Frequency ', ' Dependence ', ' Event ', ' Oral ', ' Route ', ' Pattern ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' Back ', ' Dorsum ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' interest ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Injecting drug user ', ' Injection Drug User ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Services ', ' Genital system ', ' urogenital system (genital part) ', ' Genital ', ' Surgeon ', ' American ', ' high school ', ' Self Efficacy ', ' Budgets ', ' Cigarette ', ' Participant ', ' health record ', ' NIH Program Announcements ', ' Program Announcement ', ' Patient Self-Report ', ' Self-Report ', ' high risk behavior ', ' deviant ', ' deviancy ', ' disorder risk ', ' disease risk ', ' General Population ', ' General Public ', ' offender ', ' criminal offender ', ' intravenous drug use ', ' age difference ', ' Reporting ', ' emotional abuse ', ' mental abuse ', ' Psychological abuse ', ' Medical Surveillance ', ' Epidemiology / Surveillance ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Cause of Death ', ' Cervical dysplasia ', ' Cervix Dysplasia ', ' County ', ' Gender ', ' Chicago ', ' Admission activity ', ' Admission ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia trachomatis ', ' Rickettsia trachomae ', ' Needle Sharing ', ' Syringe Sharing ', ' Needlesharing ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Cohort Studies ', ' Concurrent Studies ', ' Accounting ', ' Communities ', ' sex risk ', ' sexual risk behavior ', ' violent offender ', ' men who have sex with men ', ' men who have sex with other men ', ' Minority ', ' Outcome ', ' Adolescent Risk Behavior ', ' Youth Risk Behavior ', ' Population ', ' Prevalence ', ' aged ', ' prospective ', ' racial and ethnic ', ' racial/ethnic ', ' racial and ethnic disparities ', ' Nexus (resin cement) ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2007,1136478,0.10348631909936978
"Long-Term Consequences of Exposure to Family Violence    DESCRIPTION (provided by applicant): The objective of the proposed research is to identify the extent to which, and the mechanisms through which, exposure to violence in the family might disrupt individual development in adolescence, with consequences that cascade over the life course and affect a subsequent generation. Exposure to family violence is conceptualized broadly to include domestic violence, child abuse, family conflict and exposure to multiple forms of violence. Key outcomes include public health targets of drug use, HIV/AIDS risk and violence. Guided by a developmental life-span model the study will employ prospective data from three generations of subjects in the Rochester Youth Development Study (RYDS). Generation 2, or G2 are the original RYDS cohort of 1000 urban adolescents followed from early adolescence to their early thirties. Their parents, G1 were also interviewed during the first 10 years of the study. Their children (G3) are followed from early childhood into adolescence. Measurement is multi-agent and multimethod, including self-report, observational and official measurement. Specific aims are (1) To describe the incidence and prevalence of types of family violence exposure in two consecutive generations of an urban, community-based sample with a substantial number of high-risk and minority males and females (2) To examine the adolescent impact of different types of violence exposure (and of multiple  exposure) on drug use, risk for HIV/AIDS and other problem behaviors, as well as pro-social competencies. (3) To examine if G2 exposure to family violence leads to drug use and other problems in emerging adulthood, either directly or indirectly via its consequences on adolescent development. (4) To examine long-term consequences of family violence exposure on consolidation of adult roles by the early 30's, especially stable work and family formation and avoidance of drug use and criminal involvement. (5) To examine intergenerational continuity and discontinuity in exposure to family violence. To examine these aims, several statistical strategies including growth curve modeling and full and limited information SEM will be used.         ",Long-Term Consequences of Exposure to Family Violence,7241528,R01DA020344,"['Achievement ', ' Achievement Attainment ', ' Healthy People 2010 ', ' Mental Depression ', ' depression ', ' health disparity ', ' health disparities ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Disadvantaged ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Environment ', ' Address ', ' Symptoms ', ' Ethnic group ', ' Social Network ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Range ', ' Child Abuse and Neglect ', ' child maltreatment ', ' Childhood maltreatment ', ' transmission process ', ' Transmission ', ' Rate ', ' Process ', ' sex ', ' Development ', ' developmental ', ' Family ', ' Family Relationship ', ' Family Relations ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Pathway interactions ', ' pathway ', ' Affect ', ' Age ', ' base ', ' Aggressive behavior ', ' Aggression ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Area ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Family Violence ', ' Domestic Violence ', ' Link ', ' Incidence ', ' Infection ', ' Institutes ', ' Interview ', ' Ireland ', ' Irish Free State ', ' Eire ', ' Childhood ', ' pediatric ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Discipline ', ' Individual ', ' Numbers ', ' young adult ', ' young adulthood ', ' adult youth ', ' Longevity ', ' lifespan ', ' life span ', ' Length of Life ', ' Measurement ', ' Drug usage ', ' drug use ', ' male ', ' Marriage ', ' Problem behavior ', ' behavioral problem ', ' Study models ', ' Sexual abuse ', ' sex abuse ', ' Parents ', ' Exposure to ', ' Disruption ', ' Prospective Studies ', ' public health medicine (field) ', ' Public Health ', ' Nature ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Schools ', ' self esteem ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Life ', ' Victimization ', ' Traumatic Stress Disorders ', ' Stress Disorders ', ' Time ', ' Videotape ', ' Violence ', ' violent behavior ', ' violent ', ' Work ', ' Dimensions ', ' Severities ', ' Home environment ', ' Home ', ' Source ', ' Pattern ', ' Behavior ', ' experience ', ' intergenerational ', ' early childhood ', ' NIH Program Announcements ', ' Program Announcement ', ' Patient Self-Report ', ' Self-Report ', ' social skills ', ' social competency ', ' social competence ', ' interpersonal competency ', ' interpersonal competence ', ' Prevention ', ' emotional abuse ', ' mental abuse ', ' Psychological abuse ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' anti social ', ' antisocial ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Generations ', ' Measures ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child Abuse ', ' Childhood Abuse ', ' Child Development ', ' Infant and Child Development ', ' Parenting behavior ', ' Parenting ', ' Caregivers ', ' Care Givers ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Latino ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Sampling ', ' Adolescent Development ', ' Youth ', ' Youth 10-21 ', ' theories ', ' Cohort Studies ', ' Concurrent Studies ', ' Communities ', ' neglect ', ' design ', ' designing ', ' next generation ', ' Minority ', ' maltreatment ', ' mistreatment ', ' resilience ', ' Outcome ', ' Prevalence ', ' prospective ', ' Impairment ', ' Conflict (Psychology) ', ' Conflict ', ' ']",NIDA,STATE UNIVERSITY OF NEW YORK AT ALBANY,R01,2007,234104,0.017946967746105106
"Spatial Variations in IDU HIV Risk: Relationship to Structural Interventions    DESCRIPTION (provided by applicant): The likelihood that illicit drug users will engage in drug-related HIV risk behaviors or suffer adverse drug-related health outcomes varies considerably across neighborhoods. While an emerging line of research has investigated whether particular neighborhood-level characteristics (e.g., presence of dilapidated housing and social disorder) determines neighborhood-level variation in these drug-related behaviors and health outcomes, no research has yet studied whether syringe access (SA) programs or drug-related criminal justice (D-RCJ) activities contribute to neighborhood-level variations in drug-related behaviors and health outcomes among illicit drug users, including injection drug users (IDUs). This absence is striking: (1) SA programs and D-RCJ activities affect patterns of drug-related health behaviors, outcomes, and service use; (2) SA programs and D- RCJ activities are place-based, structural interventions: they are unevenly distributed across neighborhoods and shape the local context in which IDUs use drugs; and (3) D-RCJ activities (and possibly SA programs) exert different impacts on drug-related HIV risk behaviors and health service use among IDUs of different racial/ethnic groups. Explaining racial/ethnic variations in drug-related HIV risk and health service use is a NIDA priority. Current measures of SA programs and D-RCJ activities, however, preclude studying whether these interventions shape geographic variation in drug-related HIV risk behaviors, health outcomes and service use among IDUs. The proposed exploratory study will achieve 3 aims by analyzing existing data: to (1a) Construct new measures of SA programs and D-RCJ activities as place-based, structural, and multidimensional interventions; and (1b) Apply these measures to describe variations in SA programs and D- RCJ activities over time (1995-2006) across NYC's 42 health districts. By applying spatial analysis methods we will calculate, for each NYC health district and year, spatial access to syringes and to SA programs (overall and by program type); and intensity of drug-related arrest, incarceration, and police surveillance. (2) Use multilevel methods to explore whether variations in these measures across health districts and time are related to variations among IDUs in drug-related HIV risk behaviors and health service use across districts and time. (3) Explore if variations in these district-level measures create variations in drug-related HIV risk behaviors and service use, both within and between racial/ethnic groups of IDUs. The proposed project will lay the foundations for future investigations of the ways that SA programs and D-RCJ activities shape neighborhood- level variations in a wide range of health behaviors (e.g., HIV sexual risk), outcomes (e.g., HIV transmission), and service use (e.g., drug treatment entry) among IDU populations in multiple cities. Research based on these measures may provide important insight into how to modify SA programs and D-RCJ activities so as to reduce morbidity and mortality among drug users, their sex partners, and neighbors. Public Health Relevance Statement Rates of drug-related HIV risk behaviors and adverse drug-related health outcomes vary across neighborhoods in a city. No research has yet explored whether syringe access (SA) programs or drug-related criminal justice (D-RCJ) activities affect this neighborhood-level variation. The proposed project will construct measures of SA programs and D-RCJ activities that will allow us to explore whether these programs and activities create neighborhood-level variation in key drug-related health behaviors, outcomes, and service use in a city, and will empirically test whether changes in SA programs and D-RCJ activities in one US city (NYC) are associated with (1) neighborhood-level variation in drug injectors' drug-related HIV risk behaviors and health service use and (2) racial/ethnic variations in these outcomes. Project-created measures of SA programs and D-RCJ activities can be applied to other cities, and can be used to analyze neighborhood-level variations in a wide range of health behaviors, outcomes, and service use among injectors (e.g., sexual risk behaviors, HIV or HCV transmission, drug treatment entry). Research based on these measures may provide important insight into how to modify SA programs and D-RCJ activities so as to reduce morbidity and mortality among drug users, their sex partners, and neighbors. Given concerns that SA programs adversely affect local quality of life, project measures can also be used to empirically test the relationship between SA program presence in a neighborhood and local crime rates and other adverse social outcomes.          ",Spatial Variations in IDU HIV Risk: Relationship to Structural Interventions,7283879,R21DA023391,"['Crime ', ' Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' geographic difference ', ' geographic variation ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Legal ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Ethnic group ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Range ', ' transmission process ', ' Transmission ', ' Rate ', ' Characteristics ', ' Foundations ', ' Future ', ' Affect ', ' base ', ' Health ', ' Health behavior ', ' Health Services ', ' health care service ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Housing ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Variant ', ' Variation ', ' Income ', ' Economical Income ', ' Economic Income ', ' insight ', ' Linear Models ', ' Individual ', ' Numbers ', ' Legal Status ', ' Inequality ', ' Drug usage ', ' drug use ', ' Needle-Exchange Programs ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Funding ', ' Drug Metabolic Detoxication ', ' detoxification ', ' Metabolism of Toxic Agents ', ' Metabolic Drug Detoxications ', ' Drug Metabolic Detoxification ', ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' National Research Council (U.S.) ', ' National Research Council ', ' Neighborhoods ', ' Pharmacy facility ', ' Pharmacies ', ' Drug Prescriptions ', ' Drug Prescribing ', ' Shapes ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Quality of life ', ' QOL ', ' Condition ', ' Nature ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Rosa ', ' Rose ', ' Sales ', ' Sexual Partners ', ' sex partner ', ' Knowledge ', ' Life ', ' programs ', ' statistics ', ' Employee Strikes ', ' Strikes ', ' Syringes ', ' Testing ', ' Time ', ' Investigation ', ' Source ', ' Pattern ', ' Location ', ' Behavior ', ' Health behavior outcomes ', ' Injecting drug user ', ' Injection Drug User ', ' Services ', ' Participant ', ' Modality ', ' social ', ' Medical Surveillance ', ' Epidemiology / Surveillance ', ' Measures ', ' Needle Sharing ', ' Syringe Sharing ', ' Needlesharing ', ' Police ', ' Criminal Justice ', ' Illicit Drugs ', ' Latino ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' Hepatitis C Transmission ', ' hepatitis C virus transmission ', ' HCV Transmission ', ' Outcome ', ' drug distribution ', ' Population ', ' administrative database ', ' administrative data base ', ' racial and ethnic ', ' racial/ethnic ', ' ']",NIDA,EMORY UNIVERSITY,R21,2007,229763,0.05989522887805168
"PS07-003, Minority HIV/AIDS Research Initiative (MARI)    DESCRIPTION (provided by applicant):   The proposed study's overarching goal is to reduce the ethnic disparities in HIV infection between Hispanic and non-Hispanic youth living in Miami-Dade County, an HIV epicenter. This goal will be accomplished by two aims: AIM 1 is to develop and manualize a one-and-a-half- month streamlined version of an efficacious HIV preventive intervention entitled Familias Unidas; and AIM II is to evaluate the efficacy of the streamlined version of Familias Unidas plus an HIV Prevention School CurriculumTreatment as Usual, relative to the HIV Prevention School Curriculum Treatment as Usual only, in preventing drug use and unprotected sexual behavior, two risk factors for HIV infection. Familias Unidas aims to prevent drug use and unprotected sexual behavior by (a) increasing family functioning, (b) increasing parental monitoring of peer activities, and (c) influencing adolescent social cognitive mechanisms regarding drug use and unsafe sexual behavior. A sample of 240 Hispanic 9th grade adolescents and their primary caregivers will be randomized to one of two conditions: Familias Unidas plus the HIV School Curriculum Treatment as Usual (hereafter refererred to as Familias Unidas) or the HIV Prevention School Curriculum Treatment as Usual only. Two studies have demonstrated the efficacy of an intensive, 9 to 12 month version of Familias Unidas. In the first study, Familias Unidas was shown to be efficacious relative to a no- intervention control condition in increasing family functioning. In the second study, Familias Unidas was found to be efficacious in preventing drug use and unsafe sexual behavior relative to two attention control conditions. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more efficacious than the HIV Prevention School Curriculum Treatment as Usual in preventing adolescent drug use over time and (H2) Familias Unidas will be more efficacious than the HIV Prevention School Curriculum Treatment as Usual in preventing adolescent unprotected sexual behavior over time. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on drug use will be partially mediated by (1) family functioning; (2) parental monitoring of peers; and (3) social cognitive mechanisms regarding drug use; and (H2a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by (1) family functioning; (2) parental monitoring of peers; (3) social cognitive mechanisms regarding unprotected sex; and (4) drug use. The objective of the proposed study is to reduce HIV contraction health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of interventions to reduce drug use, unprotected sexual behavior, and HIV in Hispanic adolescents.           ","PS07-003, Minority HIV/AIDS Research Initiative (MARI)",7392512,U01PS000671,[''],NCHHSTP,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,U01,2007,220035,0.10409011619734354
"Barriers to Treatment-based HIV Prevention for IDU Couples    DESCRIPTION (provided by applicant): Despite recent advances in HIV prevention, injecting drug users (IDUs) in the U.S. still account for 1/3 of new infections. Racial/ethnic disparities in injection drug use also continue to cause a disproportionate share of new HIV cases among minorities and women. This proposal targets a vulnerable and understudied population of IDUs - minority, heterosexual, IDU couples (i.e. partnered IDUs). While research on partnered IDUs is scarce, existing literature indicates that partnered IDUs are at high risk for HIV from both drug- related and sexual risk behaviors. Partnered IDUs, especially partnered women IDUs, also have limited success in reducing drug use, accessing or completing drug abuse treatment, and maintaining treatment outcomes (reduced drug use, safer drug-use practices, safer sex). This profile of partnered IDUs has important implications for treatment-based HIV prevention. Drug abuse treatment is an effective method for reducing drug-and sex-related HIV risk among IDUs. A recent NIDA publication concludes that ""drug abuse treatment is HIV prevention."" However, the median proportion of IDUs who access treatment in the U.S. is extremely low - less than 9%. Clearly, the full efficacy of HIV prevention cannot be realized unless more IDUs enter treatment. Since a substantial number of IDUs are sexually partnered with other IDUs (more than 40%, according to out own NYC data), understanding and overcoming barriers to successful treatment and treatment-based HIV prevention among partnered IDUs will have a substantial impact on reducing drug use and HIV risk, especially among minority women. This qualitative study of IDU couples and treatment providers focuses on two sets of barriers to drug treatment and treatment-based HIV risk reduction among African American and Latino heterosexual IDU couples in NYC: (1) relationship dynamics among partnered IDUs that deter treatment entry, retention or the maintenance of outcomes; and (2) couples-specific structural barriers in the treatment system that further inhibit treatment entry, retention, and the maintenance of outcomes. We are also interested in (3) how these two kinds of barriers interact. Findings from the proposed research will inform subsequent work to quantify these barriers and develop and evaluate programs to overcome them. This study is proposed by a new investigator and utilizes the R-21 mechanism. PUBLIC HEALTH STATEMENT HIV transmission among injection drug users (IDUs) continues to be an important public health issue. Despite recent advances in HIV prevention, injection drug users in the U.S. still account for 1/3 of all new infections. Racial/ethnic disparities in injection drug use also continue to cause a disproportionate share of infections. The proposed study primarily targets African American and Latino IDUs who are partnered in intimate relationships. While research on partnered IDUs is scarce, existing literature indicates that they are at high risk for HIV from both drug-related and sexual risk behaviors. In addition, they have limited success in reducing drug use, accessing or completing drug abuse treatment and maintaining treatment outcomes (reduced drug use, safer drug use practices, safer sex). The proposed study will contribute to an understanding of interpersonal and structural barriers to drug treatment and treatment-mediated HIV prevention and lead to recommendations for needed improvements.          ",Barriers to Treatment-based HIV Prevention for IDU Couples,7338999,R21DA022960,"['Injecting drug user ', ' Injection Drug User ', ' Blood ', ' Blood Reticuloendothelial System ', ' experience ', ' success ', ' metropolitan ', ' condoms ', ' novel ', ' treatment program ', ' Reporting ', ' Needle Sharing ', ' Syringe Sharing ', ' Needlesharing ', ' Treatment outcome ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Health Benefit ', ' Latino ', ' Mediating ', ' Personal Communication ', ' Interpersonal Communication ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Sampling ', ' response ', ' Classification ', ' Systematics ', ' Accounting ', ' intimate partner violence ', ' Minority ', ' protective behavior ', ' Outcome ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' safer sex ', ' therapy design ', ' treatment design ', ' intervention design ', ' racial and ethnic disparities ', ' Couples ', ' Data Reporting ', ' Risk Reduction ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Prohibit ', ' Address ', ' Preventive ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Exploratory/Developmental Grant for Diagnostic Cancer Imaging ', ' R21 Award ', ' Funding Mechanisms ', ' transmission process ', ' Transmission ', ' Rate ', ' sex ', ' Development ', ' developmental ', ' Heterosexuals ', ' Ethnography ', ' ethnographic ', ' base ', ' improved ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Left ', ' Site ', ' Area ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' Interview ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Numbers ', ' Trust ', ' Literature ', ' Love ', ' Policies ', ' Drug usage ', ' drug use ', ' Risk Reduction Behavior ', ' Lifestyle Risk Reduction ', ' Maintenance ', ' men ', "" men's "", ' Mentorship ', ' Methods ', ' Neighborhoods ', ' New York City ', ' Pilot Projects ', ' pilot study ', ' Staging ', ' Shapes ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Recommendation ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Knowledge ', ' programs ', ' Target Populations ', ' Testing ', ' Translating ', ' Attitude ', ' Woman ', ' Work ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Behavior Therapy ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' interest ', ' Visit ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R21,2007,219150,0.2080351955797551
"The Center for the Study and Prevention of Drug Use    DESCRIPTION (provided by applicant):     This proposal for the Center for Study and Prevention of Drug Use is submitted by Morgan State University and seeks funding under the PAR-02-016 mechanism in response to the PA entitled ""Minority Institutions' Drug Abuse Research Development Program"" (MIDARP). The proposed Center will be an inter-institutional collaborative effort involving Morgan State University, a minority institution, and research intensive universities and programmatic initiatives that focus on and specialize in research on drug use and disparities associated with drug use. The Center seeks to build on the collaborative relationships established through the Center to increase the capacity of Morgan State, its faculty and its students to conduct rigorous drug use research with and emphasis on drug use epidemiology, public health, and health disparities related to drug use. In order to actualize the mission of the Center, four components were developed which address the necessary aspects of creating a drug use research center. 1) The Faculty Development Plan, which seeks to advance Morgan faculty by allowing them to engage in off-site collaborative research with individuals specializing in drug research. 2) A second aspect is the Student Development Plan, which seeks to expose, educate and, train minority students in the area of drug use research. 3) The research arm of the project includes a primary and four developmental pilot project, allowing researchers at Morgan to begin using their present expertise and investigating topics in the area of drug use and disparities related to drug use. 4) Overseeing, each of the areas is the proposed plan for the Administrative Units and Center Organization. Through this component collaborative relationships, research projects, and faculty and student development will be monitored and enhanced. As a result of the Center faculty at Morgan State will be further enhanced regarding their ability to conduct rigorous research independently, specifically submitting R01's. Further, Morgan will be sufficiently capable of training students for careers in drug use research by developing a structured program in drug research, and the administrative staff will have the skills necessary to support the research staff in all endeavors related to research projects. In sum, the Center will be; self-sustaining and capable of producing future research focused on drug use research.               ",The Center for the Study and Prevention of Drug Use,7235614,R24DA019805,"['drug abuse prevention ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' health disparities ', ' Commit ', ' Institution ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Elements ', ' Eligibility Determination ', ' Protocol Screening ', ' Eligibility ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Research Infrastructure ', ' Infrastructure ', ' Research Training ', ' Sum ', ' Enrollment ', ' enroll ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' Monitor ', ' Preparation ', ' Principal Investigator ', ' Development ', ' developmental ', ' Faculty ', ' Support of Research ', ' Future ', ' Affect ', ' career ', ' Grant ', ' Recording of previous events ', ' History ', ' Site ', ' Area ', ' Link ', ' Internships ', ' Ensure ', ' Training ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Individual ', ' Numbers ', ' Development Plans ', ' Drug usage ', ' drug use ', ' Funding ', ' Maryland ', ' Mentors ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Mission ', ' New Jersey ', ' New York ', ' Collaborations ', ' Pennsylvania ', ' Pilot Projects ', ' pilot study ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Rest ', ' Knowledge ', ' programs ', ' Students ', ' Scientist ', ' Universities ', ' Washington ', ' Writing ', ' Award ', ' Upper arm ', ' Country ', ' Baltimore ', ' Behavior ', ' interest ', ' experience ', ' high school ', ' Structure ', ' skills ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' falls ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' forging ', ' Minority ', ' Historically Black Colleges and Universities ', ' Historically Black University ', ' Historically Black Institution ', ' Historically Black Colleges ', ' HBCUs ', ' ']",NIDA,MORGAN STATE UNIVERSITY,R24,2007,681501,0.2289119318721305
"Trajectories of Drugs Abuse in High Risk Youth    DESCRIPTION (provided by applicant): We propose to extend the Northwestern Juvenile Project to examine the dynamic relationships among patterns of drug use and disorder, risk and protective factors for drug use and disorder, and adult social role performance as juvenile justice youth age from adolescence to emerging adulthood and young adulthood. This study responds to NIDA's new initiatives on drug abuse, health disparities, and disproportionate minority confinement of African Americans. At year-end 2004, nearly 100,000 juveniles and nearly 2.1 million adults were incarcerated. African Americans comprise 12% of the US population but 40% of incarcerated populations. We are studying a racially/ethnically diverse sample (n=1709; 624 females, 1085 males) in Cook County (Chicago) Illinois, aged 10-18 years at recruitment (1995-1998). Youth are reinterviewed whether they are (re)incarcerated or back in the community. Our goal is to focus on gender differences, racial/ethnic disparities, and the effect of incarceration as we: (1) describe patterns of drug use and disorder --onset, persistence, desistence, and recurrence - as juvenile justice youth age from adolescence to emerging and young adulthood; (2) examine how risk and protective factors (e.g., comorbid mental disorders, adverse life events, availability of illicit drugs) predict, moderate, and mediate patterns of drug use and disorders; and (3) examine the dynamic relationships between patterns of drug use and disorder and adult social role performance (e.g., residential independence [including avoiding incarceration], employment, marriage, parenting, desistance from crime and violence). To analyze the longitudinal data, we will use summary statistics (e.g., prevalence rates, odds ratios), generalized linear mixed-effects models, survival analyses, and Muthen's recently developed extensions of growth mixture models. Extending the Northwestern Juvenile Project allows us to leverage the data already collected to examine the role of incarceration in the development of drug use and disorder, especially among African Americans; to identify risk and protective factors that are potentially malleable; to identify points of intervention at key developmental periods; and to extend theoretical models - developed in general population adolescents -- to correctional populations.           ",Trajectories of Drugs Abuse in High Risk Youth,7212925,R01DA019380,"['Odds Ratio ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Parents ', ' cooking ', ' public health medicine (field) ', ' Public Health ', ' Public Policy ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Anxiety ', ' Recommendation ', ' Records ', ' Recurrence ', ' Recurrent ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Schools ', ' Crime ', ' Data Reporting ', ' Healthy People 2010 ', ' health disparity ', ' health disparities ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Educational Status ', ' training status ', ' training level ', ' training achievement ', ' educational level ', ' Educational Achievement ', ' Employment ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Health system ', ' violence prevention ', ' prevent violence ', ' Ethnic group ', ' Jail ', ' Age-Years ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Request for Applications ', ' NIH RFA ', ' Child Abuse and Neglect ', ' child maltreatment ', ' Childhood maltreatment ', ' Cognitive ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' Rate ', ' Characteristics ', ' Process ', ' Development ', ' developmental ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Foundations ', ' Freedom ', ' Liberty ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Pathway interactions ', ' pathway ', ' Affect ', ' Injury ', ' Age ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' improved ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Phase ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Domestic Violence ', ' Illinois ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' Justice ', ' juvenile delinquent ', ' Young offender ', ' Juvenile Offender ', ' Psyche structure ', ' mental ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Life Style ', ' Lifestyle ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' African ', ' Longitudinal Studies ', ' long-term study ', ' satisfaction ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Marihuana ', ' marijuana ', ' Marriage ', ' Medical Records ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Theoretical model ', ' Theoretic Models ', ' Neighborhoods ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' aged ', ' prospective ', ' Trauma ', ' Affective ', ' racial and ethnic ', ' racial/ethnic ', ' racial and ethnic disparities ', ' Conflict (Psychology) ', ' Conflict ', ' Drops ', ' self esteem ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Social support ', ' social support network ', ' Life ', ' Victimization ', ' sound ', ' statistics ', ' Substance Use Disorder ', ' Survival Analysis ', ' Survival Analyses ', ' Time ', ' Violence ', ' violent behavior ', ' violent ', ' Attitude ', ' Woman ', ' day ', ' Week ', ' Event ', ' Pattern ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' size ', ' Back ', ' Dorsum ', ' Behavior ', ' Behavior Disorders ', ' behavioral disorder ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Belief ', ' interest ', ' Services ', ' Surgeon ', ' Performance ', ' Self Efficacy ', ' Budgets ', ' Cigarette ', ' Structure ', ' Participant ', ' peer ', ' NIH Program Announcements ', ' Program Announcement ', ' Population Study ', ' Patient Self-Report ', ' Self-Report ', ' deviant ', ' deviancy ', ' disorder risk ', ' disease risk ', ' General Population ', ' General Public ', ' Reporting ', ' emotional abuse ', ' mental abuse ', ' Psychological abuse ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' County ', ' Gender ', ' Chicago ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Parenting behavior ', ' Parenting ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Modeling ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' theories ', ' functional disability ', ' Functional impairment ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' correctional system ', ' Accounting ', ' Communities ', ' Minority ', ' Outcome ', ' coping ', ' Population ', ' Prevalence ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2007,632815,0.15806252262844014
"Tailored Youth Drug Intervention in Primary Care DESCRIPTION (provided by applicant):     Preventing the initiation, and reducing the escalation of marijuana use among adolescents can have a major impact on the development of problem behaviors and health consequences in adulthood. The varying factors associated with initiation and escalation of marijuana use among adolescents (age 12-18) speaks to the importance of tailoring preventive approaches based on individual risk factors. Brief motivational interventions (BMI) have been demonstrated to be effective in reducing drug use (i.e., marijuana, alcohol, and tobacco) among adolescents and young adults. Typically, BMIs are delivered by a clinician; however, more recently, computers have been used successfully to deliver BMI in an interactive, graphically engaging format. The primary care setting represents an underutilized venue for prevention interventions addressing drug use/abuse among youth. This study will take place in three HRSA-funded Bureau of Primary Health Care community health clinics located in Flint, Michigan, a city with a diverse and medically under-served population. The purpose of this five-year study is to: (1) develop and refine promising, empirically-derived, BMI prevention/intervention modules delivered by a clinician or a computer to target marijuana use, and (2) test the effectiveness of BMI in preventing initiation/escalation of marijuana use among youth in community health clinics. The proposed BMI prevention/interventions are innovative because: a) they incorporate tailoring technology based on assessment of the adolescents' behaviors; and b) they incorporate prevention messages for those who have not initiated use, and intervention messages for those who are current users. This randomized controlled trial will screen 1,710 adolescents in primary care clinics over 30 months. A random sample of the approximately 70% who screen negative for past year marijuana use will be selected to participate in the study (n=450); all subjects who screen positive for past year use will be enrolled in the study (n=450). These 900 subjects will be stratified by gender, age, and past year marijuana use and randomized to one of three conditions: 1) computer-delivered brief motivational approach (BMI-C) (n=300; 150 non-users: prevention, 150 users: intervention); 2) therapist-delivered brief motivational approach (BMI-T) (n=300; 150 non-users, 150 users); or 3) a NIDA drug education booklet (DPB) (n=300; 150 non-users, 150 users). Primary outcomes will be evaluated at 3-, 6- and 12-months and include marijuana, alcohol, tobacco and other drug use. Key moderators of effectiveness will be examined, including behavioral intentions, self-efficacy, stage of change, school involvement, susceptibility to peer pressure, and potential health consequences (e.g., STD/HIV risk behaviors). This project will provide the critical first step toward the implementation of tailored marijuana prevention and intervention in primary care clinics. ",Tailored Youth Drug Intervention in Primary Care,7254170,R01DA020075,"['Crime ', ' Mental Depression ', ' depression ', ' health disparity ', ' health disparities ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Effectiveness ', ' Purpose ', ' prevent ', ' preventing ', ' Legal ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Low income ', ' Educational aspects ', ' Education ', ' Elements ', ' Pyrococcus kodakaraensis TIP protein ', ' Pyrococcus kodakaraensis TBP-interacting protein ', ' Pyrococcus kodakaraensis Pk-TIP protein ', ' Address ', ' Preventive ', ' Caring ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Qualifying ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Range ', ' Enrollment ', ' enroll ', ' Rate ', ' Principal Investigator ', ' Teenagers ', ' teen years ', ' Teen ', ' Process ', ' Community Health ', ' Development ', ' developmental ', ' Behavioral ', ' Family ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescent Behavior ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' General Practitioners ', ' Generalists ', ' suicidal behavior ', ' suicide behavior ', ' Age ', ' base ', ' Goals ', ' Aggressive behavior ', ' Aggression ', ' improved ', ' Happiness ', ' positive attitude ', ' Health ', ' Health Maintenance Organizations ', ' Prepaid Group Health Organizations ', ' Health Services ', ' health care service ', ' Recording of previous events ', ' History ', ' Alcohols ', ' Alcohol Chemical Class ', ' Left ', ' Depth ', ' Medical ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Institute of Medicine (U.S.) ', ' NAS/IOM ', ' Institute of Medicine ', ' Insurance ', ' Intervention Studies ', ' interventions research ', ' intervention research ', ' Predisposition ', ' Susceptibility ', ' Screening procedure ', ' screenings ', ' screening ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Rural ', ' Family history of ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Drug usage ', ' drug use ', ' Funding ', ' Manuals ', ' Marihuana ', ' marijuana ', ' Mentors ', ' Methods ', ' Michigan ', ' Problem behavior ', ' behavioral problem ', ' Neighborhoods ', ' Collaborations ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Pamphlets ', ' Brochures ', ' Booklets ', ' Parents ', ' Physicians ', "" Physicians' Offices "", ' pressure ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Staging ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Condition ', ' Nature ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Schools ', ' Social Problems ', ' social disturbance ', ' Life ', ' programs ', ' Arts ', ' Technology ', ' Testing ', ' Time ', ' Tobacco ', ' Attention Deficit Disorder ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' United States Health Resources and Services Administration ', ' Health Resources and Services Administration ', ' HRSA ', ' day ', ' Dependence ', ' Clinic ', ' Nodal ', ' Techniques ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' behavior change ', ' contextual factors ', ' Application Context ', ' interest ', ' skills training ', ' Peer Pressure ', ' age group ', ' American ', ' experience ', ' success ', ' high school ', ' care seeking ', ' Self Efficacy ', ' Prevention program ', ' prevention service ', ' peer ', ' Patient Self-Report ', ' Self-Report ', ' social skills ', ' social competency ', ' social competence ', ' interpersonal competency ', ' interpersonal competence ', ' deviant ', ' deviancy ', ' motivational enhancement therapy ', ' motivational interview ', ' Prevention ', ' Modality ', ' Reporting ', ' Gender ', ' Privacy ', ' universal prevention ', ' universal preventive measure ', ' universal preventive interventions ', ' universal interventions ', ' selective prevention ', ' selective preventive measure ', ' selective preventive intervention ', ' selected prevention ', ' Generic Drugs ', ' generic ', ' Nonproprietary Drugs ', ' Health Care Costs ', ' Healthcare Costs ', ' Health Costs ', ' Alcohol abuse ', ' problem drinking ', ' problem alcohol use ', ' hazardous alcohol use ', ' ethanol abuse ', ' alcohol problem ', ' Community Healthcare ', ' Community Health Care ', ' depressive symptoms ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' Illicit Drugs ', ' Healthcare ', ' health care ', ' Population Heterogeneity ', ' heterogeneous population ', ' diverse populations ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Modeling ', ' Sampling ', ' Uninsured ', ' Youth ', ' Youth 10-21 ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cannabis ', ' Hemp Plant ', ' Communities ', ' early /brief intervention /therapy ', ' cost ', ' adolescent drug use ', ' youth drug use ', ' adolescent substance use ', ' youth substance use ', ' computerized ', ' Underserved Population ', ' underserved people ', ' under served population ', ' design ', ' designing ', ' Outcome ', ' alcohol misuse ', ' unhealthy alcohol use ', ' ethanol misuse ', ' Prevention intervention ', ' Population ', ' aged ', ' Consumption ', ' Individual Differences ', ' innovation ', ' innovative ', ' innovate ', ' family influence ', ' medically underserved ', ' trial comparing ', ' compare effectiveness ', ' motivational intervention ', ' addiction ', ' addictive disorder ', ' Computers ', ' Conflict (Psychology) ', ' Conflict ', ' Drops ', ' ']",NIDA,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2007,590822,0.0221674919206028
"Service Use, ATI Program Outcomes, and Pro-Social Change    DESCRIPTION (provided by applicant):        This application details a proposal for a prospective longitudinal panel study with a random sample of 360 individuals attending alternative to incarceration (ATI) programs in New York City (NYC) that serve drug-involved offenders. The proposed study focuses on (1) the impact of utilization of formal healthcare and psychosocial services on outcomes of ATI program completion, recidivism, technical violations (i.e., lawbreaking behaviors not resulting in re-incarceration), and pro-social change (e.g., fulfilling child- and elder-caretaking roles); and (2) factors affecting service utilization among ATI program participants. The study fulfills several recommendations from the Blue Ribbon Task Force on Health Service Research at NIDA, including broadening both (a) the venues of drug abuse services research to include programs in ""nontraditional"" settings, especially the criminal justice system, and (b) the range of needs and characteristics of subgroups that are studied in order to address a fuller ""continuum of care and patient groups."" The Task Force's recommendations echoed other calls regarding the need to elucidate mediators of success of treatment, especially those in nontraditional settings such as criminal justice programs for drug-involved offenders. Also consistent with the Task Force report, the proposed research will employ new data analysis methods for causal inference using observational data. The significance and feasibility of the proposed study are substantiated by findings from a pilot study successfully completed by the investigators. For the proposed study, we will recruit individuals at the start of their participation in ATI programs designed for adult, drug-involved offenders in NYC, conducting structured interviews every 3 months over the course of 18 months for each participant. Aims, hypotheses, and measurements are guided by the Network Episode Model, an innovative model that conceptualizes access and attendance of formal services as a time-varying behavior driven by level of need and shaped by dynamic processes involving individual/social context factors and service system experiences. The proposed study is designed to achieve the following primary aims: (1) To examine the causal relationship between service utilization and (a) ATI program completion, (b) recidivism, (c) technical violations, and (d) pro-social change; and (2) To identify and estimate the causal impact of factors that influence access and utilization of formal services among ATI participants. Findings will generate substantive and practical implications for researchers and professionals in the areas of drug abuse, services research, criminal justice, and public health in developing and testing future interventions and programs for drug-involved offenders. The proposed study will be conducted by Dr. Elwin Wu and Dr. Nabila EI-Bassel of the Social Intervention Group at the Columbia University School of Social Work.             ","Service Use, ATI Program Outcomes, and Pro-Social Change",7227203,R01DA019496,"['Data Analyses ', ' Data Analysis ', ' Provider ', ' health disparity ', ' health disparities ', ' Dropout ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Employment ', ' Address ', ' Social Network ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Range ', ' Subgroup ', ' Rate ', ' Principal Investigator ', ' Characteristics ', ' Process ', ' Face ', ' facial ', ' faces ', ' Advisory Committees ', ' Task Forces ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' Affect ', ' Age ', ' criminal behavior ', ' Elderly ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Goals ', ' improved ', ' Health ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Site ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Medical ', ' Randomized Clinical Trials ', ' Interview ', ' Laws ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Individual ', ' Trust ', ' Literature ', ' satisfaction ', ' Measurement ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' men ', "" men's "", ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Mentors ', ' Mentorship ', ' Methods ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Motivation ', ' New York City ', ' Collaborations ', ' Therapeutic ', ' Patients ', ' Perception ', ' Pilot Projects ', ' pilot study ', ' Poverty ', ' Shapes ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Condition ', ' Recommendation ', ' Recruitment Activity ', ' recruit ', ' Relapse ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Schools ', ' Social Change ', ' Social transformation ', ' Social modification ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Problems ', ' social disturbance ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Psychiatric Social Work ', ' psychosocial service ', ' Psychiatric Social Service ', ' sociologist ', ' Consensus ', ' Life ', ' programs ', ' Target Populations ', ' Testing ', ' Time ', ' Universities ', ' Attitude ', ' Woman ', ' Work ', ' Severities ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Behavioral Research ', ' psychosocial ', ' Services ', ' drug abuse education ', ' drug use education ', ' experience ', ' success ', ' professor ', ' knowledge base ', ' knowledgebase ', ' intervention program ', ' California ', ' Structure ', ' Participant ', ' Prevention Research ', ' recidivism ', ' Diversion Program ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' offender ', ' criminal offender ', ' Reporting ', ' social ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Gender ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Drug Courts ', ' Criminal Justice ', ' Illicit Drugs ', ' Healthcare ', ' health care ', ' Outcome Measure ', ' Modeling ', ' Sampling ', ' driving behavior ', ' response ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' cost ', ' design ', ' designing ', ' Outcome ', ' Population ', ' prospective ', ' Trauma ', ' innovation ', ' innovative ', ' innovate ', ' service utilization ', ' addiction ', ' addictive disorder ', ' Consultations ', ' Continuity of Patient Care ', ' Continuum of Care ', ' Continuity of Care ', ' ']",NIDA,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2007,351745,0.05534369581301683
"Child Welfare, Drug Abuse and Intergenerational Risk    DESCRIPTION (provided by applicant):        We seek to establish a program of research on Child Welfare, Drug Abuse and Intergenerational Risk (CWDAIR) based in the School of Social Welfare (SSW) at the University at Albany. The goal is to advance research on the development and delivery of coordinated, evidence-based and theoretically-oriented services for parents in the child welfare system with addiction and co-occurring problems including HIV/AIDS. The focus on substance abuse in conjunction with HIV/AIDS within child welfare families is timely, appropriate, and significant since children in these families face significant barriers to healthy development. Improved and more integrated services for parents will reduce the risk of drug abuse and other negative outcomes in the next generation. The CWDAIR Program has two specific aims: first, to build an infrastructure for conducting interdisciplinary research on drug abuse and HIV/AIDS in child welfare families, including the development and support of interdisciplinary research teams based in SSW; and second, to develop collaborative partnerships with state agency leaders and professionals from child welfare, HIV/AlDS, and substance abuse services to improve the design of services to address substance abuse and co-occurring problems among high risk parents. The research program will support high impact collaborative research leading to R01, R03 and K awards, better services for high-risk families, and reduced intergenerational transfer of risk.       In order to achieve Program aims, a capacity-building infrastructure development is planned. Specifically the CWDAIR Program will: (1) launch an intensive faculty development program of seminars and training focused upon crosscutting child welfare, HIV/AIDS and substance abuse interventions; critical collaboration issues; improved services to racially and ethnically diverse families; and state of the art methodologies (2) provide methodological and computer support, training, and pilot project supports to foster the development of fundable research projects, especially involving junior faculty and doctoral students (3) support two initial pilot projects designed with interdisciplinary and community consultation, (4) seed a mini-grants program designed to further develop collaborative research projects among community practitioners, faculty from other disciplines within and beyond the University at Albany and SSW faculty, (5) design and implement an infrastructure evaluation system that identifies key lessons learned, informs subsequent stages of infrastructure and blended research development and (6) advance dissemination and communication through web-pages, listservs, research briefs, presentations and publications.         ","Child Welfare, Drug Abuse and Intergenerational Risk",7244321,R01DA015376,"['Achievement ', ' Achievement Attainment ', ' Cessation of life ', ' Death ', ' Healthy People 2010 ', ' Healthy People 2000 ', ' Commit ', ' prevent ', ' preventing ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Graduate Education ', ' Address ', ' Epidemic ', ' Caring ', ' Policy Research ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Research Infrastructure ', ' Infrastructure ', ' Child Abuse and Neglect ', ' child maltreatment ', ' Childhood maltreatment ', ' Rate ', ' Development ', ' developmental ', ' Face ', ' facial ', ' faces ', ' Faculty ', ' Family ', ' Adoption ', ' Age ', ' base ', ' urban area ', ' Goals ', ' Government ', ' Grant ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' improved ', ' Health ', ' Health Priorities ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Recording of previous events ', ' History ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' Infection ', ' Ensure ', ' Investments ', ' Evaluation ', ' Training ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Discipline ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Numbers ', ' Literature ', ' Fostering ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Methodology ', ' Method LOINC Axis 6 ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Mothers ', ' National Center for Health Statistics (U.S.) ', ' United States National Center for Health Statistics ', ' National Center for Health Statistics ', ' NCHS ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Collaborations ', ' Parents ', ' Pilot Projects ', ' pilot study ', ' Probability ', ' Staging ', ' Program Development ', ' grandparent ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Quality of life ', ' QOL ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Nature ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Rights ', ' Risk ', ' Safety ', ' Schools ', ' Seeds ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Social Policies ', ' Social Welfare ', ' welfare ', ' Knowledge ', ' Anti-HIV Agents ', ' antiAIDS agent ', ' Anti-Human Immunodeficiency Virus Agents ', ' Anti-HIV Drugs ', ' Anti-AIDS Drugs ', ' Anti-AIDS Agents ', ' AIDS Drugs ', ' programs ', ' statistics ', ' Arts ', ' Students ', ' Training Support ', ' Universities ', ' foster care ', ' Adopted ', ' Woman ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' Services ', ' behavioral/social science ', ' intergenerational ', ' knowledge base ', ' knowledgebase ', ' Secure ', ' social inequality ', ' high risk behavior ', ' Capital ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Gender ', ' Generations ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child Welfare ', ' adolescent welfare ', ' Competence ', ' Research Methodology ', ' Research Methods ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Color ', ' Communication ', ' Communities ', ' Intergenerational transfer ', ' design ', ' designing ', ' next generation ', ' Minority ', ' maltreatment ', ' mistreatment ', ' high risk parents ', ' Outcome ', ' Prevention intervention ', ' Population ', ' Mind ', ' Practice based research ', ' addiction ', ' addictive disorder ', ' interdisciplinary approach ', ' multidisciplinary approach ', ' Computers ', ' Consultations ', ' ']",NIDA,STATE UNIVERSITY OF NEW YORK AT ALBANY,R01,2007,428350,0.006746769419971814
"Community Vulnerability and Responses to IDU-Related HIV  DESCRIPTION (provided by applicant): In this competing continuation, we will conduct a longitudinal study (1993-2007) of 96 large metropolitan areas to study trends and predictors of changes in the population prevalence of drug injectors, HIV) prevalence among injectors, and related prevention programs. In stage one of this project, we developed ways to estimate the population density of injection drug use and HIV prevalence rates in metropolitan areas. We showed that per capita injection drug use increased during the 1990s in many localities, including Baltimore and Salt Lake City. HIV prevalence rates among drug injectors increased in Baltimore and some other areas. In many metropolitan areas, drug injection and HIV rates among injectors declined. The extent to which local HIV prevention programs reached drug injectors also varied widely: 3 metropolitan areas provided treatment to 20% or more of their injectors, while 13 areas reached less than 5%. HIV counseling and testing rates also varied widely. In cross-sectional analyses, we showed that local government budgetary decisions, social and economic factors, and drug abuse interventions were related to injection drug users per capita, HIV revalence among drug injectors, and the presence and size of various programs to prevent HIV among drug injectors. We will build upon our existing data and construct a database for these 96 metropolitan areas containing annual estimates from 1993 - 2007 of drug injectors per capita; HIV prevalence, incident AIDS cases and AIDS mortality among drug injectors; program availability and size; socioeconomic conditions, and government budgetary allocations. We will (1) describe patterns of change over time in prevention programs and epidemiology. We will use longitudinal analysis methods to study (2) how changing socioeconomic conditions, epidemiologic need, budgetary constraints and choices, and policy choices are related to subsequent HIV prevention programming; and (3) how all these variables are related to later changes in (a) drug injectors per capita, (b) HIV prevalence and AIDS among drug injectors, (c) drug abuse treatment and other programs for drug injectors, and (d) racial/ethnic disparities in appropriate indicators. We will use these analyses to develop a well-theorized scientific understanding of forces that shape metropolitan area HIV/AIDS epidemics, rates of drug injectors per capita, and prevention programs. The resulting scientific knowledge base can help develop programs and policies so as to avoid epidemics and, if needed, control them.         ",Community Vulnerability and Responses to IDU-Related HIV,7268711,R01DA013336,"['Event ', ' Distant ', ' Pattern ', ' size ', ' Baltimore ', ' contextual factors ', ' Application Context ', ' interest ', ' Injecting drug user ', ' Injection Drug User ', ' metropolitan ', ' knowledge base ', ' knowledgebase ', ' Budgets ', ' Burn injury ', ' Burns ', ' Prevention Research ', ' Prevention program ', ' treatment program ', ' Religion and Spirituality ', ' religious ', ' deviant ', ' deviancy ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Police ', ' falls ', ' outreach program ', ' response ', ' theories ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Communities ', ' comparison group ', ' Outcome ', ' Population ', ' Prevalence ', ' Natural experiment ', ' racial and ethnic disparities ', ' Drug usage ', ' drug use ', ' Needle-Exchange Programs ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Methods ', ' Mortality Vital Statistics ', ' Mortality ', ' Movement ', ' body movement ', ' Local Government ', ' Neighborhoods ', ' New York ', ' Multicenter Studies ', ' Population Density ', ' human population density ', ' Staging ', ' Shapes ', ' public health medicine (field) ', ' Public Health ', ' Condition ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Risk ', ' Science ', ' Sodium Chloride ', ' salt ', ' Sodium chloride (NaCl) ', ' Counseling ', ' Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Heroin ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Disease Outbreaks ', ' Outbreaks ', ' prevent ', ' preventing ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Advocate ', ' Data ', ' trend ', ' Rate ', ' Process ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Government ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Area ', ' Phase ', ' Variant ', ' Variation ', ' Economic Factors ', ' Economical Factors ', ' Incidence ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Individual ', ' Longitudinal Studies ', ' long-term study ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Policies ', ' Knowledge ', ' programs ', ' Employee Strikes ', ' Strikes ', ' Syringes ', ' Testing ', ' Southeastern Asia ', ' Southeast Asia ', ' Time ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R01,2007,622337,0.22464773436225408
"The neighborhood environment and drug use in NYC DESCRIPTION (provided by applicant): Proposed is a study is to assess the relations between neighborhood characteristics (e.g., neighborhood disadvantage, collective efficacy, residential segregation) and drug use behavior among residents of New York City while controlling for relevant individual-level factors. A secondary purpose of this study is to determine the relation between key neighborhood characteristics and the medical consequences of drug use, particularly fatal drug overdose. Recent work has shown that neighborhood characteristics are associated with the likelihood of drug use, abuse, and dependence and that research focusing exclusively on individual patterns of drug use is insufficient to fully explain inter-individual drug use behavior. Here we propose a systematic collection of data to characterize neighborhoods in a large metropolitan area and to test key hypotheses that may explain inter-individual variability in drug use behavior and its consequences.   Understanding how neighborhood factors affect drug use risk behavior can guide interventions that aim to mitigate drug use and its consequences, to create a social environment that better facilitates users to seek treatment, and to improve overall population health. In order to achieve the aims of this study we will use data from three sources: (i) We will collect data on individual drug use behavior (focusing on cigarette, alcohol, and marijuana use) through a random digit-dial phone survey of 5,000 New York City residents, geo-coding and mapping each respondent to their neighborhood of residence; (ii) we will compile a contextual database characterizing New York City neighborhoods using information collected in the survey and using archival data (collected from the New York City Department of Health and Mental Hygiene, Department of City Planning, Police Department, US Census and other sources); and (iii) we will combine this data with data from a NIDA funded study of drug overdose over time (DA 06534; principal investigator: Tardiff, a consultant on this project). We will test key hypotheses about the relations between neighborhood characteristics and drug use, abuse, and dependence using multi-level hierarchical models. We have recently completed several studies of New York City neighborhoods that serve as preliminary exploration of the key hypotheses of this study. This, coupled with our studies involving telephone interviews with 6,000+ New Yorkers is assurance that the aims of this study can be achieved. ",The neighborhood environment and drug use in NYC,7245078,R01DA017642,"['Data Collection ', ' Disadvantaged ', ' Purpose ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Environment ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Principal Investigator ', ' Characteristics ', ' Affect ', ' improved ', ' Health ', ' Health Status ', ' Level of Health ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Medical ', ' Income ', ' Economical Income ', ' Economic Income ', ' Income Distributions ', ' Telephone Interviews ', ' Psyche structure ', ' mental ', ' residence ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Inequality ', ' Drug usage ', ' drug use ', ' Funding ', ' Maps ', ' Marihuana ', ' marijuana ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Mortality Vital Statistics ', ' Mortality ', ' Neighborhoods ', ' New York City ', ' Respondent ', ' Overdose ', ' Condition ', ' Research ', ' Risk ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Social support ', ' social support network ', ' Life ', ' Psychological Stress ', ' Surveys ', ' Survey Instrument ', ' Telephone ', ' Phone ', ' Testing ', ' Time ', ' Work ', ' Dependence ', ' Event ', ' Source ', ' Pattern ', ' Behavior ', ' Digit structure ', ' Digit ', ' metropolitan ', ' Cigarette ', ' Participant ', ' Patient Self-Report ', ' Self-Report ', ' cigarette smoking ', ' smoke cigarette ', ' social ', ' Censuses ', ' segregation ', ' Racial Segregation ', ' Code ', ' Coding System ', ' Police ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Modeling ', ' deprivation ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' City Planning ', ' Classification ', ' Systematics ', ' Accounting ', ' Communities ', ' Population ', ' Coupled ', ' ']",NIDA,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2007,520869,0.07685429698994137
"Gender Differences in Healthcare and Drug Treatment Utilization among Drug Users    DESCRIPTION (provided by applicant): Over the course of the HIV/AIDS epidemic, women (particularly African-American and Hispanic women) have been increasingly affected. Women now account for 1 in every 3 newly reported cases of HIV infection in the U.S., with two major modes of transmission: heterosexual contact and injection drug use. Research has documented a gender disparity in health care and drug treatment utilization. For example, compared with men, drug-using women receive less medical and psychiatric services, although they have poorer physical and mental health. Drug-using women also have lower retention and treatment completion rates than men in substance abuse treatment. In addition, drug-using women with HIV are less likely than men to receive HIV medication and to adhere to HAART. The factors contributing to these gender differences in minority communities are not fully understood and deserve elucidation through research. The proposed study, using existing dual-site longitudinal data, will examine factors related to gender differences in health care and drug use treatment utilization among Puerto Rican IDUs and crack smokers, a group at high risk for HIV. The two sites studied (New York and Puerto Rico) will provide a comparison of gender disparities in health care, for the same ethnic group in two communities with different resource contexts. The specific aims of the proposed study are: 1) To examine, by gender, factors associated with health care utilization among Puerto Rican drug users in NY and PR; 2) to identify (a) factors mediating the relationship between gender and health care utilization, and (b) interaction effects with gender in the relationships with health care utilization; 3) to examine, by gender, factors associated with drug treatment utilization; 4) to identify (a) factors mediating the relationship between gender and drug treatment utilization, and (b) interaction effects with gender in the relationships with drug treatment utilization; and 5) to assess how the relationships above (#1 - #4) vary between two different health resource environments. In addition, the study will assess whether predictors of HIV medication use differ between women and men over time. The major statistical analyses used will be: multiple logistic regression and hierarchical linear modeling (for longitudinal analysis). Findings will be useful in developing gender-specific interventions to improve health care and drug treatment utilization in women. Gender disparities in health care (including drug treatment) utilization are important public health issues. In particular, among minority drug-using populations, women, as compared to men, receive less medical and psychiatric services, although they experience poorer physical and mental health. However, the factors contributing to these gender differences in minority communities remain under-studied. The proposed study will contribute to an understanding of gender-differentiated healthcare behaviors, and further lead to recommendations to narrow the gender gap.             ",Gender Differences in Healthcare and Drug Treatment Utilization among Drug Users,7336643,R03DA022918,"['Counseling ', ' Risk Reduction ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Environment ', ' Address ', ' Length ', ' Epidemic ', ' Symptoms ', ' Data Set ', ' Dataset ', ' Ethnic group ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Adherence (attribute) ', ' Adherence ', ' Data ', ' Range ', ' Enrollment ', ' enroll ', ' transmission process ', ' Transmission ', ' trend ', ' Rate ', ' Characteristics ', ' Heterosexuals ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Affect ', ' base ', ' improved ', ' Health Resources ', ' Health Services ', ' health care service ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seroprevalence ', ' Site ', ' Medical ', ' Logistic Regressions ', ' Injection of therapeutic agent ', ' Injections ', ' Childhood ', ' pediatric ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Linear Models ', ' Individual ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' Literature ', ' Policies ', ' Living Arrangement ', ' Drug usage ', ' drug use ', ' Needle-Exchange Programs ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Marital Status ', ' men ', "" men's "", ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health Services ', ' Mental Hygiene Services ', ' Methadone ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl- ', ' Mortality Vital Statistics ', ' Mortality ', ' New York ', ' New York City ', ' Smoker ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Puerto Rican ', ' Puerto Rico ', ' Condition ', ' Recommendation ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sexual Partners ', ' sex partner ', ' Social support ', ' social support network ', ' Knowledge ', ' Life ', ' Testing ', ' Time ', ' Treatment Protocols ', ' Treatment Schedule ', ' Treatment Regimen ', ' Woman ', ' Hour ', ' Severities ', ' Behavior ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Injecting drug user ', ' Injection Drug User ', ' Services ', ' AIDS/HIV diagnosis ', ' experience ', ' Self Efficacy ', ' Prevention program ', ' Reporting ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Gender ', ' Measures ', ' Admission activity ', ' Admission ', ' Crack Cocaine ', ' free base cocaine ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Case Study ', ' case report ', ' Healthcare ', ' health care ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Highly Active Antiretroviral Therapy ', ' highly active anti-retroviral therapy ', ' HAART ', ' Accounting ', ' Acculturation ', ' Cultural Assimilation ', ' Communities ', ' Community Services ', ' pediatric trauma ', ' childhood trauma ', ' adolescent trauma ', ' Minority ', ' Population ', ' ethnic minority population ', ' ethnic minority ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R03,2007,73050,0.08708573955510976
"STI/HIV Risk, Services, and Drug Use For Young Arrestees DESCRIPTION (provided by applicant):  Large numbers of drug-involved adolescents enter the juvenile justice system at risk for the sexually transmitted infections (STIs) chlamydia and gonorrhea, treatable and often asymptomatic bacterial infections that increase HIV risk. However, current STI surveillance for juvenile offenders is symptom-based and typically limited to correctional facilities (although most juvenile offenders are not incarcerated), resulting in many undetected cases that increase public health risk. Designing and expanding more effective STI health interventions require data on how STI infection among all delinquents (not just those incarcerated) is related to drug use and risk behaviors. Moreover, few STI/HIV risk reduction interventions have been implemented for adolescent offenders in the community. Thus, there is a need to further our understanding of drug use and sex risk behaviors among youth at the ""front end"" of the juvenile justice system, to develop new screening methods that identify infections early in the juvenile justice process, and to provide more effective prevention and treatment services to a broader segment of this population. This grant proposes to implement an STI assessment and urine screening (for chlamydia and gonorrhea) protocol in the Hillsborough County (FL) Juvenile Assessment Center (JAC); analyze relations among drug use, sex risk behaviors and STI infection rates; and identify STI-related service needs and impediments to expanding STI testing and services for this underserved high-risk population. Future planned research will further explore the STI-related service needs of delinquent youth, and develop, pilot, and implement an STI risk reduction program in a controlled clinical trial. Data from an Intake Assessment and STI urine tests will be collected from a sample of 900 eligible delinquent youth consecutively admitted to the JAC (stratified to yield 450 females (an important but understudied subpopulation). Organizational data will be drawn from juvenile justice and service provider records, geocoded data on infections and health service locations, and 40 staff interviews.  Follow-up data on STI treatment and retesting will be collected from the Hillsborough County Health Department for STI-positive participants. JAC and State/County health officials are committed to collaborating with the research team on this and future projects. There are four study aims: AIM 1: To assess STI/HIV risk profiles in high-risk juvenile offenders (i.e. active drug users and those at risk for drug use) and compare them to low-risk offenders. AIM 2: To identify STI and HIV prevention service needs among juvenile offenders and the organizational and individual barriers to delivering these services. AIM 3: To determine STI (chlamydia and gonorrhea) and self-reported HIV prevalence rates among juvenile offenders entering the juvenile justice system. AIM 4: To determine the percentage of STI-positive youth who return for medical treatment, and analyze the factors associated with provision and receipt of treatment. ","STI/HIV Risk, Services, and Drug Use For Young Arrestees",7258899,R01DA020346,"['Knowledge ', ' programs ', ' Supervision ', ' Testing ', ' Time ', ' Urine ', ' Urine Urinary System ', ' Attention ', ' Work ', ' Serous ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' Back ', ' Dorsum ', ' Bacterial Infections ', ' bacterial disease ', ' Behavior ', ' Infection prevention ', ' Prevent infection ', ' Services ', ' experience ', ' Participant ', ' Prevention program ', ' prevention service ', ' Patient Self-Report ', ' Self-Report ', ' organizational structure ', ' Organization Charts ', ' Prevention ', ' offender ', ' criminal offender ', ' social ', ' Medical Surveillance ', ' Epidemiology / Surveillance ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' County ', ' Gender ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia trachomatis ', ' Rickettsia trachomae ', ' Factor Analysis ', ' Factor Analyses ', ' Healthcare ', ' health care ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' sex risk ', ' sexual risk behavior ', ' adolescent drug use ', ' youth drug use ', ' design ', ' designing ', ' Minority ', ' social disparities ', ' juvenile justice system ', ' Population ', ' Prevalence ', ' Controlled Clinical Trials ', ' Individual ', ' Numbers ', ' Literature ', ' Policies ', ' Drug usage ', ' drug use ', ' Sample Size ', ' male ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Neisseria ', ' Collaborations ', ' Nonprofit Organizations ', ' Non-Profit Organizations ', ' Exposure to ', ' Staging ', ' Contracts ', ' Contracting Opportunities ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Recommendation ', ' Records ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' school health ', "" schools' health "", ' health in school ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Risk Reduction ', ' Provider ', ' Commit ', ' Effectiveness ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Eligibility Determination ', ' Protocol Screening ', ' Eligibility ', ' Address ', ' Epidemiologic Monitoring ', ' Epidemiological Monitoring ', ' Symptoms ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Data ', ' Improve Access ', ' Intake ', ' Monitor ', ' transmission process ', ' Transmission ', ' Rate ', ' Characteristics ', ' Process ', ' sex ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Family ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Female Adolescents ', ' adolescent girl ', ' Advisory Committees ', ' Task Forces ', ' Future ', ' Affect ', ' Age ', ' base ', ' Gonorrhea ', ' Gonococcal Infection ', ' Grant ', ' improved ', ' Health ', ' Health Services ', ' health care service ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Medical ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Infection ', ' Interview ', ' Screening procedure ', ' screenings ', ' screening ', ' Justice ', ' juvenile delinquent ', ' Young offender ', ' Juvenile Offender ', ' ']",NIDA,TEMPLE UNIV OF THE COMMONWEALTH,R01,2007,270143,0.11743924131011123
"The Growing Disparity in Illegal Drug Use Across Socioeconomic Strata    DESCRIPTION (provided by applicant): A disparity in illegal drug use that disadvantages individuals in the lower socioeconomic strata has significantly increased in the last two decades. New evidence indicates that this increase results in large part from a changing influence of socioeconomic status (SES) on drug use, and not from a negative influence of drug use on SES that has accumulated over time. However, the SES-related influences responsible for this growing disparity remain largely unknown. . The aims of this study are threefold. First, it will address limitations in current evidence on the growing disparity of illegal drug use across socioeconomic strata. Using the most current, available data the project will (a) update analyses of socioeconomic trends in cocaine past 1998 (b) examine socioeconomic trends up to the present in illegal drugs that have not yet been examined, such as marijuana, methamphetamine, ecstasy, and 'blunts,1 (c) examine whether the growing disparity sterns from differential incidence and/or differential duration of drug use across socioeconomic strata, and (d) examine SES indicators other than education. These analyses will use the National Survey on Drug Use and Health, a nationally- representative, cross-sectional survey of drug use administered yearly, although between 1979 and 1988 it was administered only every third year. Second, the study will predict both changes in the prevalence of illegal drugs over time and also changes in the characteristics of illegal drug users over time. We use a ""Diffusion of Innovation"" framework, which predicts that users of an innovation such as illegal drugs fall into distinct categories such as ""innovators,"" ""early adopters,"" and ""late adopters."" People in each of these categories are theorized to differ from each other in terms of sociodemographic, psychological, and environmental characteristics. Furthermore, the profiles of drug users at one point in time are expected to predict the prevalence of drug use in the future. The third aim of the project is to trace the extent to which the key predictors of illegal drug use, as highlighted by the Diffusion framework, have their roots in the early life course. Using a longitudinal survey that has followed 838 children from 1st grade to age 30, the analysis will examine how far back in the life course current predictors of illegal drug use extend. We expect that many early predictors have not yet been linked to later drug use because the current profile of illegal drug users, which includes factors such as low socioeconomic status, did not emerge until recently. Results from this project will inform policy and intervention programs aimed at reducing the prevalence of illegal drug use across all socioeconomic strata.              ",The Growing Disparity in Illegal Drug Use Across Socioeconomic Strata,7658447,R01DA020575,"['Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Adopted ', ' Woman ', ' Work ', ' Back ', ' Dorsum ', ' directed attention ', ' directs attention ', ' age group ', ' experience ', ' cohort ', ' intervention program ', ' Categories ', ' Prevention ', ' social ', ' Relative (related person) ', ' Relative ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' falls ', ' Causations ', ' Longitudinal Surveys ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Uncertainty ', ' doubt ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Accounting ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' racial and ethnic ', ' racial/ethnic ', ' stem ', ' Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' ecstasy ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' Diffusion ', ' Diffusion of Innovation ', ' Disadvantaged ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' Educational aspects ', ' Education ', ' Address ', ' Data Set ', ' Dataset ', ' Data ', ' Mentored Research Scientist Development Award ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' Policy Research ', ' Update ', ' trend ', ' Principal Investigator ', ' Characteristics ', ' Process ', ' sex ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' Age ', ' Goals ', ' Health ', ' Health Status ', ' Level of Health ', ' psychologic ', ' psychological ', ' Link ', ' Incidence ', ' Childhood ', ' pediatric ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Fostering ', ' Policies ', ' Drug usage ', ' drug use ', ' Plant Roots ', ' root ', ' Funding ', ' Marihuana ', ' marijuana ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Drug user ', ' Publishing ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Schools ', ' Social Mobility ', ' ']",NIDA,UNIVERSITY OF COLORADO DENVER,R01,2008,39291,0.22637589368278796
"African American Female Drug Users: HIV, Health Disparities, & Criminality    DESCRIPTION (provided by applicant): The overall goal of this study is to understand how drug use and criminality are related to health disparities, particularly HIV, and service utilization among African American drug using and non-drug using women across criminal justice status. While drug use is similar across racial groups in the US, African Americans are disproportionately more likely to experience severe health consequences and criminal involvement as a result of drug misuse. Adequate health care may not be received by African American female offenders because they experience the burden of their race, class, gender, and criminal offender status. There is limited scientific data to help understand the linkages between health disparities such as HIV, untreated drug abuse, barriers to service utilization, and status as a criminal offender among African American females. This study is significant because of its potential to identify differences in health disparities and service utilization among African American drug using and non-drug using women in selected levels of criminal justice status (intensive correctional supervision-prison (n=200), moderate correctional supervision-jail (n=200), community supervision-probation (n=200), and no criminal justice involvement (n=200)). All 800 African American females will be followed longitudinally for three 6-month intervals to examine health status and the use of health services across time. The specific aims are: (1) To describe the prevalence of health problems among African American women across criminal justice status and drug use status; (2) To determine the cultural, predisposing, historical health, and potential enabling factors that are predictors of health problems among African American drug using and non-drug using women across criminal justice status over 18 months; (3) To describe the prevalence of untreated health problems, the patterns of health services utilization, and the cultural barriers to service utilization among African American women across criminal justice status and drug use status; and (4) To examine the factors that predict the likelihood of using health services among African American drug using and non-drug using women across criminal justice status over 18 months. The significance of this study includes the potential to provide criminal justice systems-level data for health planning and health policy for prevention, intervention, and treatment of African American female drug users.       This study is significant to the public health field because of its potential to understand the severity of health disparities among African American women across criminal justice status and drug use status and to predict health status and the use of health services over time. This knowledge of African American females can be used as a foundation for future criminal justice systems-level interventions to increase the use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism.          ","African American Female Drug Users: HIV, Health Disparities, & Criminality",7419083,R01DA022967,"[""Women's Health "", ' Female Health ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Healthcare ', ' health care ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' time use ', ' design ', ' designing ', ' criminal offending ', ' Prevention intervention ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' alcohol research ', ' ethanol research ', ' alcohol related research ', ' service utilization ', ' Data Reporting ', ' health disparity ', ' health disparities ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Enabling Factors ', ' Jail ', ' Data ', ' Applications Grants ', ' Grant Proposals ', ' Rate ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Development ', ' developmental ', ' Fright ', ' Fear ', ' Female ', ' Foundations ', ' Future ', ' base ', ' Goals ', ' Gonorrhea ', ' Gonococcal Infection ', ' Health ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Planning ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Health Services ', ' health care service ', ' Health Status ', ' Level of Health ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Alcohols ', ' Alcohol Chemical Class ', ' Hospitalization ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Medical ', ' Series ', ' racism ', ' Incidence ', ' Inpatients ', ' Interview ', ' Hepatitis C virus ', ' Hepatitus C ', ' HCV ', ' Kentucky ', ' Individual ', ' Numbers ', ' Trust ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' Literature ', ' Drug usage ', ' drug use ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Physicians ', ' Prisoner ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisons ', ' Drug user ', ' Drug abuser ', ' Problem drug user ', ' Misuses drugs ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Knowledge ', ' Life ', ' Supervision ', ' Surveys ', ' Survey Instrument ', ' Time ', ' Universities ', ' Woman ', ' Work ', ' Severities ', ' Dependence ', ' Event ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' Class ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Services ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' experience ', ' Seroprevalences ', ' Structure ', ' Participant ', ' recidivism ', ' NIH Program Announcements ', ' Program Announcement ', ' Patient Self-Report ', ' Self-Report ', ' General Population ', ' General Public ', ' probation ', ' offender ', ' criminal offender ', ' Reporting ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Gender ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2008,574039,0.17326562535537318
"Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study    DESCRIPTION (provided by applicant): We propose to extend the Northwestern Juvenile Project to examine the developmental patterns of drug use and disorder and risk for HIV/AIDS and other sexually transmitted infections (STIs) as juvenile justice youth age from adolescence to emerging adulthood and young adulthood. This study responds to NIDA's new initiatives in health disparities in HIV/AIDS in minority populations, specifically the nexus of drug abuse, criminal justice involvement, and HIV/AIDS among African Americans.  African Americans comprise 12% of the US population but 40% of incarcerated populations and 50% of new cases of HIV/AIDS. At year-end 2004, nearly 100,000 juveniles and nearly 2.1 million adults were incarcerated. We will continue to study a racially/ethnically diverse sample (n=758; 330 females, 428 males; 412 African Americans, 137 non-Hispanic whites, 207 Hispanics, 2 other race/ethnicity) of persons who were arrested and detained in Cook County (Chicago) Illinois, aged 10-18 years at recruitment (1997-1998). Since recruitment, data have been collected on the development of substance use and disorders, risk and protective factors, and HIV/AIDS risk behaviors. Participants are re-interviewed whether they are (re)incarcerated or back in the community. We propose to conduct annual interviews 10, 11, 12, and 13 years post-baseline, collect records, and test for HIV infection and selected STIs. Focusing on racial/ethnic disparities, gender and age differences, and effects of incarceration, we will: (1) describe patterns of drug use and disorder - onset, persistence, desistence, and recurrence -- as juvenile justice youth age from adolescence to emerging adulthood and young adulthood; (2) describe patterns of HIV/AIDS risk behaviors during this same period; (3) describe the prevalence and incidence of HIV infection and other STIs; and (4) examine the relationship between drug use and disorder and HIV/AIDS risk behaviors. Extending the Northwestern Juvenile Project allows us to leverage the data already collected to examine health disparities and the role of disproportionate minority confinement in the development of drug use and disorder and HIV/AIDS risk; to identify risk and protective factors that are potentially malleable; to identify points of intervention at key developmental periods; and to extend theoretical models - developed in general population adolescents - to correctional populations.           ","Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study",7416695,R01DA022953,"['Crime ', ' Data Reporting ', ' Decision Making ', ' Healthy People 2010 ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Diagnosis ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' violence prevention ', ' prevent violence ', ' Ethnic group ', ' Social Network ', ' Jail ', ' Age-Years ', ' Data ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Request for Applications ', ' NIH RFA ', ' Child Abuse and Neglect ', ' child maltreatment ', ' Childhood maltreatment ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' transmission process ', ' Transmission ', ' Characteristics ', ' Process ', ' sex ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Authorization documentation ', ' Permission ', ' Authorization ', ' Development ', ' developmental ', ' Heterosexuals ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Foundations ', ' Freedom ', ' Liberty ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Standards of Weights and Measures ', ' Injury ', ' Age ', ' racial/ethnic difference ', ' Goals ', ' Gonorrhea ', ' Gonococcal Infection ', ' improved ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Health Services ', ' health care service ', ' Herpes Simplex Infections ', ' Herpesvirus hominis disease ', ' Herpes simplex disease ', ' Herpes Simplex ', ' alcohol use disorder ', ' ethanol use disorder ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV-1 ', ' human T lymphotropic virus III ', ' human T cell leukemia virus III ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Phase ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Illinois ', ' Incidence ', ' Infant ', ' Infection ', ' Human Papillomavirus ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Injection of therapeutic agent ', ' Injections ', ' Interview ', ' Screening procedure ', ' screenings ', ' screening ', ' Judgment ', ' Justice ', ' Kinetics ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Life Style ', ' Lifestyle ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Numbers ', ' Longitudinal Studies ', ' long-term study ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Marihuana ', ' marijuana ', ' men ', "" men's "", ' Methods ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Theoretical model ', ' Theoretic Models ', ' Persons ', ' Needles ', ' Neighborhoods ', ' Neisseria gonorrhoeae ', ' N.gonorrhoeae ', ' N. gonorrhoeae ', ' Gonococcus ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' Liquid substance ', ' liquid ', ' fluid ', ' Antibodies ', ' Prisons ', ' Staging ', ' cooking ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Anus ', ' Anal ', ' Recommendation ', ' Records ', ' Recurrence ', ' Recurrent ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Saliva ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Specimen ', ' Research Specimen ', ' Social support ', ' social support network ', ' Life ', ' Anti-HIV Agents ', ' antiAIDS agent ', ' Anti-Human Immunodeficiency Virus Agents ', ' Anti-HIV Drugs ', ' Anti-AIDS Drugs ', ' Anti-AIDS Agents ', ' AIDS Drugs ', ' statistics ', ' Substance Use Disorder ', ' Surveys ', ' Survey Instrument ', ' Syphilis ', ' great pox ', ' Tattooing ', ' Tattooings ', ' Technology ', ' Testing ', ' Time ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Trichomonas Infections ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Ulcer ', ' Ulceration ', ' Urine ', ' Urine Urinary System ', ' Vagina ', ' Vaginal ', ' Viral hepatitis ', ' Woman ', ' Work ', ' day ', ' Week ', ' Frequencies (time pattern) ', ' Frequency ', ' Dependence ', ' Event ', ' Oral ', ' Route ', ' Pattern ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' Back ', ' Dorsum ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' interest ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Injecting drug user ', ' Injection Drug User ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Services ', ' Genital system ', ' urogenital system (genital part) ', ' Genital ', ' Surgeon ', ' American ', ' high school ', ' Self Efficacy ', ' Budgets ', ' Cigarette ', ' Participant ', ' health record ', ' NIH Program Announcements ', ' Program Announcement ', ' Patient Self-Report ', ' Self-Report ', ' high risk behavior ', ' deviant ', ' deviancy ', ' disorder risk ', ' disease risk ', ' General Population ', ' General Public ', ' offender ', ' criminal offender ', ' intravenous drug use ', ' age difference ', ' Reporting ', ' emotional abuse ', ' mental abuse ', ' Psychological abuse ', ' Medical Surveillance ', ' Epidemiology / Surveillance ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Cause of Death ', ' Cervical dysplasia ', ' Cervix Dysplasia ', ' County ', ' Gender ', ' Chicago ', ' Admission activity ', ' Admission ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia trachomatis ', ' Rickettsia trachomae ', ' Needle Sharing ', ' Syringe Sharing ', ' Needlesharing ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Cohort Studies ', ' Concurrent Studies ', ' Accounting ', ' Communities ', ' sex risk ', ' sexual risk behavior ', ' violent offender ', ' men who have sex with men ', ' men who have sex with other men ', ' Minority ', ' Outcome ', ' Adolescent Risk Behavior ', ' Youth Risk Behavior ', ' Population ', ' Prevalence ', ' aged ', ' prospective ', ' racial and ethnic ', ' racial/ethnic ', ' racial and ethnic disparities ', ' Nexus (resin cement) ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2008,1132219,0.10348631909936978
"Drug Abuse and Crime Across the Life Course in an African American Population    DESCRIPTION (provided by applicant): African Americans are disproportionately represented in national crime statistics for arrests and incarceration as well as victimization, particularly for drug-related and violent offenses. Their involvement in crime often represents only one component of a well-recognized cluster of negative experiences and circumstances including drug use problems, socioeconomic disadvantage and poor physical and mental health, sometimes evident in childhood. The cost to individuals, families, and society is enormous, yet we know little about the development of these patterns across the life course. Despite these evident disparities, few studies have examined the development of drug use and criminal behaviors over time within African American community populations, especially into mid adulthood. We intend to study the timing and sources of risk over the life span to better understand the disparities in health and social consequences related to criminal justice issues among African Americans. To that end, we request support to analyze existing crime and drug data covering 35 years in the lives of a cohort of first grade, African American children from inner city Chicago. This prospective developmental study (the Woodlawn project) began in 1966-67, with the most recent follow up in 2002-3 at ages 42-43, and interim assessments in adolescence and early adulthood (age 32-33). The study population had high levels of drug use and criminal activity in adulthood. In the proposed project, we will focus on interrelationships of drug abuse and crime, examining predictors and consequences of drug abuse, criminal activity, and involvement with the criminal justice system. Using data from cohort members, mothers, interviewers, and official criminal records, we will identify 1) patterns of drug use and criminal behaviors over the life course; 2) individual and contextual predictors of later drug use, criminal activity/behaviors, and involvement with the criminal justice system; 3) social, economic, and health consequences of drug use, criminal behaviors, and involvement in the criminal justice system. Of particular interest is how drug use in adolescence and early adulthood relates to the risk of being arrested and incarcerated and, conversely, how early arrests and incarceration influence later drug use and criminal behaviors. This information will further our understanding of the etiology and consequences of crime and drug use into mid adulthood, and inform the design of interventions at various stages along the life course.             ",Drug Abuse and Crime Across the Life Course in an African American Population,7462657,R01DA022366,"['Crime ', ' Disadvantaged ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' Address ', ' Data ', ' Request for Applications ', ' NIH RFA ', ' Rate ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Development ', ' developmental ', ' Behavioral ', ' Family ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Pathway interactions ', ' pathway ', ' Affect ', ' Age ', ' base ', ' criminal behavior ', ' Health ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Interviewer ', ' racial discrimination ', ' race discrimination ', ' Childhood ', ' pediatric ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Individual ', ' Longevity ', ' lifespan ', ' life span ', ' Length of Life ', ' Drug usage ', ' drug use ', ' male ', ' men ', "" men's "", ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Mortality Vital Statistics ', ' Mortality ', ' Mothers ', ' Neighborhoods ', ' Personal Satisfaction ', ' well-being ', ' Staging ', ' Condition ', ' Records ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Societies ', ' Life ', ' Victimization ', ' statistics ', ' Time ', ' Time Study ', ' Unemployment ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' Complex ', ' Source ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' interest ', ' inner city ', ' experience ', ' social integration ', ' cohort ', ' intervention program ', ' member ', ' Population Study ', ' social ', ' Gender ', ' Chicago ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Mediating ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Sampling ', ' Communities ', ' cost ', ' health economics ', ' Social Functioning ', ' design ', ' designing ', ' Outcome ', ' Prevention intervention ', ' Population ', ' prospective ', ' therapy design ', ' treatment design ', ' intervention design ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R01,2008,469166,0.19747166288874865
"PRESCRIBING PSYCHOTROPIC DRUGS TO YOUTH: CULTURAL FACTORS IN PARENTAL ATTITUDES    DESCRIPTION (provided by applicant): This project proposes the first study to examine whether culturally related constructs explain ethnic and racial differences in parents' willingness to prescribe psychotropic drugs to youth. Despite 20 years of increasing prescriptions to minors, Black and Latino children remain half as likely as White children to receive medication. Socio-demographic and clinical variables do not account for the difference, which parallels findings of greater Black and Latino skepticism toward psychotropic medication. ""Cultural factors"" are said to explain the difference, but they have rarely been theorized or measured directly in large non-clinical and clinical samples of parents. Familism, traditionalism, fatalism, religiosity, beliefs about causes of youth disorders, perceived psychiatric medication treatment of youth stigma, acceptability of corporal punishment, and acceptability of psychotropic medication may be such factors. If so, then they should mediate the relationship between ethnicity/race and willingness to prescribe. The study will test this assumption using attitudinal and socio-demographic data collected during telephone interviews in English and Spanish with 1224 Black, Latino, and White parents or guardians of 5-17-year-old children, drawn by random-digit dialing from one ethnically diverse South Florida county. The sample will be stratified by ethnicity and race, with each of three equal-sized strata (n=408) further equally stratified by presence (n=204) or absence (n=204) in household of children with emotional or behavior problems, enabling adequate group comparisons to test - both in a general population sample of parents and in a sample of parents whose children might be referred for mental health treatment evaluation - the mediating role of culturally related constructs within a structural equation model. Potentially moderating influences of gender and SES on the model will also be tested. By increasing our ability to interpret ethnic and racial group differences more accurately, we may improve the cultural competence and fit of preventive and clinical interventions aimed at culturally diverse families. Moreover, given an uncertain benefit-to-risk ratio of psychotropic prescriptions to youth, it remains undetermined whether at a population level ethnic and racial differences should be understood as a health disparity favoring the majority because of White youths' greater exposure to drugs' benefits, or, conversely, as a public health advantage for minority youths because of their lesser exposure to drugs' risks. This study takes a logical first step toward exploring culturally embedded reasons for the majority's enthusiasm as well as for minorities' skepticism. PUBLIC HEALTH RELEVANCE: This is the first research to date that directly addresses various potential cultural factors that may mediate, in parents, the decision to have psychotropic drugs prescribed to their children. Authors have often suggested that cultural factors play a role in producing observed differences in prescription rates among ethnic and racial groups, but no model so far has specified these possible factors and their relationships. If cultural factors impact psychotropic drug prescription practices with youth, this study will be help to understand these factors more accurately, which could lead to improved outreach, educational, and clinical interventions for families and youths with mental health problems.          ",PRESCRIBING PSYCHOTROPIC DRUGS TO YOUTH: CULTURAL FACTORS IN PARENTAL ATTITUDES,7459222,R21MH084832,"['Data Analyses ', ' Data Analysis ', ' health disparity ', ' health disparities ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Preventive ', ' Ethnic group ', ' Data ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Rate ', ' prescription document ', ' Family ', ' Female ', ' Florida ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' racial/ethnic difference ', ' improved ', ' Household ', ' Clinical ', ' Specific qualifier value ', ' Specified ', ' Medical ', ' Telephone Interviews ', ' Evaluation ', ' Distress ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Problem behavior ', ' behavioral problem ', ' Minor ', ' Respondent ', ' Odds Ratio ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Parents ', ' Play ', ' prescription procedure ', ' Drug Prescriptions ', ' Drug Prescribing ', ' Exposure to ', ' Psychotropic Drugs ', ' Psychopharmaceuticals ', ' Psychoactive Drugs ', ' Psychoactive Compound ', ' Psychoactive Agents ', ' public health medicine (field) ', ' Public Health ', ' Punishment ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Risk ', ' Role ', ' social role ', ' Stigmata ', ' Knowledge ', ' Testing ', ' Attitude ', ' Dimensions ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' Country ', ' size ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Belief ', ' Equation ', ' Digit structure ', ' Digit ', ' Proxy ', ' parental role ', ' parent role ', ' Agreement ', ' outreach ', ' General Population ', ' General Public ', ' County ', ' Gender ', ' Measures ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Emotional ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Competence ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Latino ', ' Mediating ', ' Modeling ', ' Sampling ', ' social stigma ', ' stigma ', ' Youth ', ' Youth 10-21 ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Accounting ', ' comparison group ', ' design ', ' designing ', ' Minority ', ' willingness ', ' Outcome ', ' Population ', ' 17 year old ', ' seventeen year old ', ' age 17 years ', ' 18 year old ', ' eighteen year old ', ' age 18 years ', ' racial and ethnic ', ' racial/ethnic ', ' ']",NIMH,FLORIDA INTERNATIONAL UNIVERSITY,R21,2008,223650,0.03896925970284357
"Trajectories of Drugs Abuse in High Risk Youth    DESCRIPTION (provided by applicant): We propose to extend the Northwestern Juvenile Project to examine the dynamic relationships among patterns of drug use and disorder, risk and protective factors for drug use and disorder, and adult social role performance as juvenile justice youth age from adolescence to emerging adulthood and young adulthood. This study responds to NIDA's new initiatives on drug abuse, health disparities, and disproportionate minority confinement of African Americans. At year-end 2004, nearly 100,000 juveniles and nearly 2.1 million adults were incarcerated. African Americans comprise 12% of the US population but 40% of incarcerated populations. We are studying a racially/ethnically diverse sample (n=1709; 624 females, 1085 males) in Cook County (Chicago) Illinois, aged 10-18 years at recruitment (1995-1998). Youth are reinterviewed whether they are (re)incarcerated or back in the community. Our goal is to focus on gender differences, racial/ethnic disparities, and the effect of incarceration as we: (1) describe patterns of drug use and disorder --onset, persistence, desistence, and recurrence - as juvenile justice youth age from adolescence to emerging and young adulthood; (2) examine how risk and protective factors (e.g., comorbid mental disorders, adverse life events, availability of illicit drugs) predict, moderate, and mediate patterns of drug use and disorders; and (3) examine the dynamic relationships between patterns of drug use and disorder and adult social role performance (e.g., residential independence [including avoiding incarceration], employment, marriage, parenting, desistance from crime and violence). To analyze the longitudinal data, we will use summary statistics (e.g., prevalence rates, odds ratios), generalized linear mixed-effects models, survival analyses, and Muthen's recently developed extensions of growth mixture models. Extending the Northwestern Juvenile Project allows us to leverage the data already collected to examine the role of incarceration in the development of drug use and disorder, especially among African Americans; to identify risk and protective factors that are potentially malleable; to identify points of intervention at key developmental periods; and to extend theoretical models - developed in general population adolescents -- to correctional populations.           ",Trajectories of Drugs Abuse in High Risk Youth,7502018,R01DA019380,"['Crime ', ' Data Reporting ', ' Healthy People 2010 ', ' health disparity ', ' health disparities ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Educational Status ', ' training status ', ' training level ', ' training achievement ', ' educational level ', ' Educational Achievement ', ' Employment ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Health system ', ' violence prevention ', ' prevent violence ', ' Ethnic group ', ' Jail ', ' Age-Years ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Request for Applications ', ' NIH RFA ', ' Child Abuse and Neglect ', ' child maltreatment ', ' Childhood maltreatment ', ' Cognitive ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' Rate ', ' Characteristics ', ' Process ', ' Development ', ' developmental ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Foundations ', ' Freedom ', ' Liberty ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Pathway interactions ', ' pathway ', ' Affect ', ' Injury ', ' Age ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' improved ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Phase ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Domestic Violence ', ' Illinois ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' Justice ', ' juvenile delinquent ', ' Young offender ', ' Juvenile Offender ', ' Psyche structure ', ' mental ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Life Style ', ' Lifestyle ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' African ', ' Longitudinal Studies ', ' long-term study ', ' satisfaction ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Marihuana ', ' marijuana ', ' Marriage ', ' Medical Records ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Theoretical model ', ' Theoretic Models ', ' Neighborhoods ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' Odds Ratio ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Parents ', ' cooking ', ' public health medicine (field) ', ' Public Health ', ' Public Policy ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Anxiety ', ' Recommendation ', ' Records ', ' Recurrence ', ' Recurrent ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Schools ', ' self esteem ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Social support ', ' social support network ', ' Life ', ' Victimization ', ' sound ', ' statistics ', ' Substance Use Disorder ', ' Survival Analysis ', ' Survival Analyses ', ' Time ', ' Violence ', ' violent behavior ', ' violent ', ' Attitude ', ' Woman ', ' day ', ' Week ', ' Event ', ' Pattern ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' size ', ' Back ', ' Dorsum ', ' Behavior ', ' Behavior Disorders ', ' behavioral disorder ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Belief ', ' interest ', ' Services ', ' Surgeon ', ' Performance ', ' Self Efficacy ', ' Budgets ', ' Cigarette ', ' Structure ', ' Participant ', ' peer ', ' NIH Program Announcements ', ' Program Announcement ', ' Population Study ', ' Patient Self-Report ', ' Self-Report ', ' deviant ', ' deviancy ', ' disorder risk ', ' disease risk ', ' General Population ', ' General Public ', ' Reporting ', ' emotional abuse ', ' mental abuse ', ' Psychological abuse ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' County ', ' Gender ', ' Chicago ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Parenting behavior ', ' Parenting ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Modeling ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' theories ', ' functional disability ', ' Functional impairment ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' correctional system ', ' Accounting ', ' Communities ', ' Minority ', ' Outcome ', ' coping ', ' Population ', ' Prevalence ', ' aged ', ' prospective ', ' Trauma ', ' Affective ', ' racial and ethnic ', ' racial/ethnic ', ' racial and ethnic disparities ', ' Conflict (Psychology) ', ' Conflict ', ' Drops ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2008,550030,0.15806252262844014
"HIV - Emergence of Drug Resistance    DESCRIPTION (provided by applicant): This application is to renew a project focused on using mathematical models to understand and predict the emergence of drug resistance to antiretrovirals (ARVs) for the treatment of Human Immunodeficiency Virus (HIV). As the usage rate of ARVs in resource-poor regions is increasing, high levels of drug resistance potentially could emerge and have a devastating impact on public health worldwide, derailing global plans to provide this treatment to many millions of HIV-infected individuals. Our proposed projects will extend the work of the current award, which showed the value of using mathematical models to understand the temporal dynamics of drug-resistant strains of HIV in the United States (US), and for predicting the magnitude of resistance in this setting. In the renewal our work will be extended by combining mathematical modeling with statistical analysis of datasets collected by collaborating groups in the US, Europe and Africa. We will have access to data on drug resistance and important related variables from large scale epidemiological and treatment studies conducted in these three continents. In resource-poor settings, such as Africa, drugs will be limited and thus demand will often greatly exceed supply. We will investigate the problems of allocating ARVs in Africa by using operation research (OR) techniques. We have three Specific Aims. Aim 1: to understand the emergence, explain the present, and predict the evolution of, complex epidemics of drug-resistant strains of HIV in the US and Europe. Aim 2: to predict the evolution of epidemics of drug-resistant strains, as a result of first- line regimens and prophylactic use of ARVs, in Africa. Aim 3: to evaluate the consequences of allocation of scarce HIV healthcare resources in Africa. To achieve this aim we will use models to evaluate the epidemiological and ethical consequences of gender-inequities in access to treatment, assess the epidemiological and ethical impact of treatment priority criteria, and determine healthcare resource allocation strategies that ensure sustainability. Our studies in the renewal will link transmission modeling, OR techniques and statistical analyses; our analyses will take advantage of the extraordinary data sets provided by our collaborators in the US, Europe and Africa.       PUBLIC HEALTH RELEVANCE: The emergence and control of drug-resistant strains of HIV is now a global problem. The epidemiology of this problem is complex, and the future of the HIV epidemic is unknown. Our projects focus on using mathematical models to understand, explain, and predict, the evolution of complex epidemics composed of drug-resistant strains of HIV in the US, Europe and Africa. The rollout of antiretrovirals in Africa is just beginning; however demand for drugs greatly exceeds supply. We will, by using mathematical models, evaluate the epidemiological and ethical consequences of allocation of the scarce supply of antiretrovirals in Africa. Our studies are based upon both mathematical modeling and data analyses. Our analyses will take advantage of the extraordinary data sets provided by our collaborators in the US, Europe and Africa. Our results will have direct relevance for health policy makers.          ",HIV - Emergence of Drug Resistance,7495955,R01AI041935,"['Data Analyses ', ' Data Analysis ', ' microbicide ', ' microbicidal ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' prevent ', ' preventing ', ' Drug resistance ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Nevirapine ', ' Viramune ', ' PTPN6 gene ', ' SHP-1L ', ' SHP-1 ', ' SH-PTP1 ', ' PTPN6 ', ' PTP-1C ', ' HPTP1C ', ' HCPH ', ' HCP ', ' non-nucleoside reverse transcriptase inhibitors ', ' nonnucleoside reverse transcriptase inhibitors ', ' non-nucleoside RT inhibitors ', ' NNRTI ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data Set ', ' Dataset ', ' Data ', ' Interruption ', ' Europe ', ' transmission process ', ' Transmission ', ' Rate ', ' Evolution ', ' sex ', ' Female ', ' Stavudine ', ' zerit ', ' Didehydrodeoxythymidine ', ' D4T ', "" 3'-Deoxy-2'-thymidinene "", "" 2'3' didehydrodeoxythymidine "", "" 2',3'-didehydro-3'-deoxy-thymidine "", "" 2',3'-Didehydro-3'-deoxythymidine "", "" 2',3'-Didehydro-2',3'-dideoxythmidine "", ' 1-(2,3-Dideoxy-beta-glycero-pent-2-enofuranosyl)thymine ', ' Future ', ' Africa ', ' base ', ' Grant ', ' Health care facility ', ' Healthcare Facility ', ' Health Facilities ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Prophylactic treatment ', ' Prophylaxis ', ' Prevention Measures ', ' Simplexvirus ', ' human herpesvirus 1 group ', ' Herpesvirus hominis ', ' Herpes labialis Virus ', ' Herpes Simplex Virus ', ' HSV ', ' Link ', ' Lamivudine ', ' 3TC ', ' 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)- ', "" 2',3'-Dideoxy-3'-thiacytidine "", ' Ensure ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Linear Models ', ' Individual ', ' Policy Maker ', ' Multi-Drug Resistance ', ' multidrug resistant ', ' multi-drug resistant ', ' Resistant to multidrug ', ' Resistant to multi-drug ', ' Resistant to Multiple Drug ', ' Resistance to Multiple Drug ', ' Resistance to Multidrug ', ' Resistance to Multi-drug ', ' Multiple Drug Resistant ', ' Multiple Drug Resistance ', ' Multidrug Resistance ', ' Vertical Disease Transmission ', ' mother to child transmission ', ' Vertical Transmission ', ' Mothers ', ' Reverse Transcriptase Inhibitors ', ' Nucleosides ', ' Operations Research ', ' Paper ', ' Protease Inhibitor ', ' Proteinase Inhibitors ', ' Protease Antagonists ', ' Peptide Peptidohydrolase Inhibitors ', ' Peptide Hydrolase Inhibitors ', ' Peptidase Inhibitors ', ' Endopeptidase Inhibitors ', ' Antiproteases ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Publishing ', ' Research ', ' Resources ', ' Research Resources ', ' San Francisco ', ' South Africa ', ' Tenofovir ', ' 9-PMPA ', ' 9-(2-phosphonylmethoxypropyl)adenine ', ' 9-(2-phosphonomethoxypropyl)adenine ', ' Treatment Protocols ', ' Treatment Schedule ', ' Treatment Regimen ', ' Trees ', ' Tuberculosis ', ' tuberculous spondyloarthropathy ', ' infection due to Mycobacterium tuberculosis ', ' disseminated tuberculosis ', ' disseminated TB ', ' Mycobacterium tuberculosis infection ', ' Mycobacterium tuberculosis (MTB) infection ', ' Mtb infection [{C0041296}] ', ' MTB infection ', ' M.tuberculosis infection ', ' M. tuberculosis infection ', ' United States ', ' Virus Diseases ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Work ', ' World Health Organization ', ' Zidovudine ', ' azidodeoxythymidine ', ' ZDV ', ' Azidothymidine ', ' AZT (Antiviral) ', ' AZT ', "" 3'-azido-3'-deoxy-thymidine "", "" 3'-Azido-3'-deoxythymidine "", "" 3'-Azido-2',3'-Dideoxythymidine "", ' Complex ', ' Award ', ' prophylactic ', ' Techniques ', ' Equation ', ' Anti-Retroviral Agents ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' efavirenz ', ' 6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one ', ' Structure ', ' Disease regression ', ' Abbreviations ', ' Gender ', ' Measures ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Healthcare ', ' health care ', ' Research Methodology ', ' Research Methods ', ' Resource Allocation ', ' Modeling ', ' Sampling ', ' mathematical model ', ' mathematical modeling ', ' Math Models ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Classification ', ' Systematics ', ' men who have sex with men ', ' men who have sex with other men ', ' design ', ' designing ', ' Population ', ' Resistance ', ' resistant ', ' ']",NIAID,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2008,736294,0.08382042801068632
"HIV Disparities among Drug Users: Neighborhoods, Neurocognition and Sex Behavior    DESCRIPTION (provided by applicant): This R03 application proposes to conduct secondary data analysis to develop statistical models that explain disparities in HIV/AIDS found among African American and white substance users. In the proposed study, we will employ advance statistical analyses (latent variable mixture models) to consider the separate and synergistic influence of neighborhood factors (drug arrest rates and poverty), substance use patterns and neurocognitive functioning on sexual risk partnerships and, in turn, HIV/AIDS. First, we will evaluate the possible specificity in relationships between distinct neighborhood level factors (segregation, drug markets, poverty) and sexual partnerships and HIV/AIDS. Aim 2 of the study is to model the influence of neighborhood characteristics, substance use patterns, incarceration and neurocognitve functioning on sexual risk partnerships and estimate prevalence and incidence over an18-month period. The third aim is to estimate the magnitude of the association between sexual partnerships and being HIV-infected. The possibility of effect modification is considered with a focus on race and gender. If successful, this project should improve prevention science by: (1) increasing understanding of sexual risk partnerships among drug users and how they vary across race and gender; (2) providing support for considering factors beyond traditional SES indicators when attempting to understand racial disparities in HIV by highlighting the importance of contextual influences of drugs (e.g., rate of drug arrests) on sexual partnerships; and (3) specifying potential neurocognitive processes that might mediate/moderate the relationship between neighborhood, substance use and sexual risk partnerships. This study is the first in a series of innovative studies designed to explain racial disparities and prevent HIV/AIDS among African Americans.       PUBLIC HEALTH RELEVANCE: The intersection between substance use and HIV is a major concern as core and peripheral members of drug networks represent a significant portion of HIV/AIDS cases. Although all persons involved in drug networks are at increased risk for HIV, African Americans tend to be disproportionately affected. Because interventions focused solely on the individual have had limited success in slowing the spread of HIV among African Americans, it is important to elucidate the influence and model the pathways through which social and interpersonal factors influence HIV acquisition.          ","HIV Disparities among Drug Users: Neighborhoods, Neurocognition and Sex Behavior",7494882,R03DA024981,"['Crime ', ' Data Analyses ', ' Data Analysis ', ' Cessation of life ', ' Death ', ' Decision Making ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Disease ', ' disease/disorder ', ' Disorder ', ' prevent ', ' preventing ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Address ', ' Data Set ', ' Dataset ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Data ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Rate ', ' To specify ', ' Characteristics ', ' Process ', ' Modification ', ' Fellowship ', ' Female ', ' Pathway interactions ', ' pathway ', ' Affect ', ' base ', ' improved ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Peripheral ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Specific qualifier value ', ' Specified ', ' Series ', ' Economic Factors ', ' Economical Factors ', ' Incidence ', ' Injection of therapeutic agent ', ' Injections ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Literature ', ' Drug usage ', ' drug use ', ' Funding ', ' Study models ', ' Statistical Models ', ' Probabilistic Models ', ' Multiple Partners ', ' Persons ', ' Neighborhoods ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Paper ', ' Parents ', ' Poverty ', ' Problem Solving ', ' Contracts ', ' Contracting Opportunities ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Publishing ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Risk ', ' Risk-Taking ', ' Sampling Studies ', ' Science ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Knowledge ', ' sound ', ' Specificity ', ' Time ', ' Investigation ', ' Woman ', ' Work ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' Award ', ' Pattern ', ' Class ', ' Behavior ', ' Neurocognitive ', ' Injecting drug user ', ' Injection Drug User ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Postdoctoral Fellow ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' AIDS/HIV diagnosis ', ' success ', ' member ', ' drug market ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Gender ', ' Measures ', ' segregation ', ' Racial Segregation ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' symposium ', ' conference ', ' Mediating ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Modeling ', ' Sampling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' executive function ', ' executive control ', ' Accounting ', ' Communicable Diseases ', ' Infectious Disorder ', ' Infectious Diseases and Manifestations ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Sex Functioning ', ' sexual functioning ', ' design ', ' designing ', ' Minority ', ' Outcome ', ' Prevention intervention ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' Neurocognition ', ' person centered ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R03,2008,123000,0.004599709383627865
"HIV Infection in Ethnic Minority IDUs: An International Systematic Review    DESCRIPTION (provided by applicant): Racial/ethnic group disparities in HIV/AIDS are a critical public health issue in the US. These disparities are particularly dramatic with respect to injecting drug use. African-Americans constitute 13% of the US population and 52% of recent US injecting drug use AIDS cases; Hispanics constitute 14% of the US population and 24% of the injecting drug use AIDS cases. These disparities are not the result of more injecting drug users among African-Americans and Hispanics, but of higher rates of HIV infection among African- American and Hispanic IDUs in many areas of the country. Similar disparities-higher rates of HIV infection among ethnic minority IDUs-have also been observed in many foreign countries. Indeed the situation of ethnic minority IDUs in some developing countries can be considered a crisis, with extremely high incidence, prevalence and HIV-related mortality. Disparities have also been observed among non-injecting drug users, with ethnic minority group members having higher rates of HIV infection. The logical next step for addressing these disparities and this epidemiological conundrum is not another individual study, but a systematic review of the large number of relevant studies that have been conducted to date. Our proposed systematic review will use state-of-the-art methods and include the US and the international data on ethnic group differences in HIV infection among drug users. The specific aims include: Developing procedures for combining qualitative and quantitative data from multiple research studies of IDUs in a single geographic area into a ""history of the HIV epidemic among IDUs"" in that area. Determining the frequency of HIV epidemics in which substantial differences in HIV infection have and have not arisen in ethnic minority IDUs vs. ethnic majority IDUs in the US and internationally. Identifying potential causal factors that may generate substantial differences in HIV prevalence among racial/ethnic minority vs. ethnic majority IDUs. Identifying potential causal factors that may perpetuate or reduce differences in HIV infection among racial/ethnic differences over time. Identifying epidemiologic situations in which differences in HIV risk behaviors do or do not statistically ""explain"" differences in HIV infection among racial/ethnic groups of IDUs. The research will also create an extremely rich dataset on HIV infection among ethnic drug uses that will be made available for use by other researchers and HIV prevention service providers. The research addresses one of the most important aspects of HIV/AIDS-the frequent large disparities in HIV infection among ethnic groups in the US and in many other countries. The research will be an innovative application of state of the art methods for systematic review, including extensive searching for published and unpublished studies, quantitative coding of research reports, and applying meta-regression/hierarchical modeling to these problems.       PUBLIC HEALTH RELEVANCE: Higher rates of HIV infection among African-American and Hispanic IDUs are a major health disparity in the US. African-Americans comprise 13% of the US population and 52% of injection drug use AIDS cases, Hispanics 14% of the populations and 24% of cases. Similar disparities, higher rates of HIV infection among ethnic minority IDUs, have also been observed in many foreign countries. An international systematic review and meta-analysis should greatly advance our understanding of these disparities and suggest how they might be ameliorated.          ",HIV Infection in Ethnic Minority IDUs: An International Systematic Review,7554760,R01DA024612,"['Provider ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Developing Countries ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Developing Nation ', ' Developing Country ', ' Review, Systematic (PT) ', ' Disadvantaged ', ' Discrimination (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' Epidemic ', ' Data Set ', ' Dataset ', ' Ethnic group ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Data ', ' International ', ' Europe ', ' Sexual Transmission ', ' transmission process ', ' Transmission ', ' Rate ', ' Development ', ' developmental ', ' Heterosexuals ', ' Future ', ' Geographic Locations ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' racial/ethnic difference ', ' Procedures ', ' Site ', ' Area ', ' Incidence ', ' Injection of therapeutic agent ', ' Injections ', ' Intervention Studies ', ' interventions research ', ' intervention research ', ' caucasian American ', ' white American ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Individual ', ' Numbers ', ' Drug usage ', ' drug use ', ' Methods ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Glare ', ' Developed Countries ', ' Industrialized Nations ', ' Industrialized Countries ', ' Developed Nations ', ' Developed Nation ', ' Developed Country ', ' North America ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Publishing ', ' Recommendation ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Sexual Partners ', ' sex partner ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Arts ', ' Stigmatization ', ' Asia ', ' Time ', ' Australia ', ' Frequencies (time pattern) ', ' Frequency ', ' Pattern ', ' Country ', ' Injecting drug user ', ' Injection Drug User ', ' Services ', ' prevention service ', ' member ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' ethnic difference ', ' Categories ', ' Disease regression ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Code ', ' Coding System ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Accounting ', ' Communities ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' ethnic minority population ', ' ethnic minority ', ' user-friendly ', ' racial and ethnic ', ' racial/ethnic ', ' Health Services Needs ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' ']",NIDA,BETH ISRAEL MEDICAL CTR (NEW YORK),R01,2008,571320,0.06950887935870406
"The Growing Disparity in Illegal Drug Use Across Socioeconomic Strata    DESCRIPTION (provided by applicant): A disparity in illegal drug use that disadvantages individuals in the lower socioeconomic strata has significantly increased in the last two decades. New evidence indicates that this increase results in large part from a changing influence of socioeconomic status (SES) on drug use, and not from a negative influence of drug use on SES that has accumulated over time. However, the SES-related influences responsible for this growing disparity remain largely unknown. . The aims of this study are threefold. First, it will address limitations in current evidence on the growing disparity of illegal drug use across socioeconomic strata. Using the most current, available data the project will (a) update analyses of socioeconomic trends in cocaine past 1998 (b) examine socioeconomic trends up to the present in illegal drugs that have not yet been examined, such as marijuana, methamphetamine, ecstasy, and 'blunts,1 (c) examine whether the growing disparity sterns from differential incidence and/or differential duration of drug use across socioeconomic strata, and (d) examine SES indicators other than education. These analyses will use the National Survey on Drug Use and Health, a nationally- representative, cross-sectional survey of drug use administered yearly, although between 1979 and 1988 it was administered only every third year. Second, the study will predict both changes in the prevalence of illegal drugs over time and also changes in the characteristics of illegal drug users over time. We use a ""Diffusion of Innovation"" framework, which predicts that users of an innovation such as illegal drugs fall into distinct categories such as ""innovators,"" ""early adopters,"" and ""late adopters."" People in each of these categories are theorized to differ from each other in terms of sociodemographic, psychological, and environmental characteristics. Furthermore, the profiles of drug users at one point in time are expected to predict the prevalence of drug use in the future. The third aim of the project is to trace the extent to which the key predictors of illegal drug use, as highlighted by the Diffusion framework, have their roots in the early life course. Using a longitudinal survey that has followed 838 children from 1st grade to age 30, the analysis will examine how far back in the life course current predictors of illegal drug use extend. We expect that many early predictors have not yet been linked to later drug use because the current profile of illegal drug users, which includes factors such as low socioeconomic status, did not emerge until recently. Results from this project will inform policy and intervention programs aimed at reducing the prevalence of illegal drug use across all socioeconomic strata.              ",The Growing Disparity in Illegal Drug Use Across Socioeconomic Strata,7472489,R01DA020575,"['Schools ', ' Social Mobility ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Adopted ', ' Woman ', ' Work ', ' Back ', ' Dorsum ', ' directed attention ', ' directs attention ', ' age group ', ' experience ', ' cohort ', ' intervention program ', ' Categories ', ' Prevention ', ' social ', ' Relative (related person) ', ' Relative ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' falls ', ' Causations ', ' Longitudinal Surveys ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Uncertainty ', ' doubt ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Accounting ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' racial and ethnic ', ' racial/ethnic ', ' stem ', ' Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' ecstasy ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' Diffusion ', ' Diffusion of Innovation ', ' Disadvantaged ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' Educational aspects ', ' Education ', ' Address ', ' Data Set ', ' Dataset ', ' Data ', ' Mentored Research Scientist Development Award ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' Policy Research ', ' Update ', ' trend ', ' Principal Investigator ', ' Characteristics ', ' Process ', ' sex ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' Age ', ' Goals ', ' Health ', ' Health Status ', ' Level of Health ', ' psychologic ', ' psychological ', ' Link ', ' Incidence ', ' Childhood ', ' pediatric ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Fostering ', ' Policies ', ' Drug usage ', ' drug use ', ' Plant Roots ', ' root ', ' Funding ', ' Marihuana ', ' marijuana ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Drug user ', ' Publishing ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' ']",NIDA,UNIVERSITY OF COLORADO DENVER,R01,2008,250131,0.22637589368278796
"PS07-003, Minority HIV/AIDS Research Initiative (MARI)    DESCRIPTION (provided by applicant):   The proposed study's overarching goal is to reduce the ethnic disparities in HIV infection between Hispanic and non-Hispanic youth living in Miami-Dade County, an HIV epicenter. This goal will be accomplished by two aims: AIM 1 is to develop and manualize a one-and-a-half- month streamlined version of an efficacious HIV preventive intervention entitled Familias Unidas; and AIM II is to evaluate the efficacy of the streamlined version of Familias Unidas plus an HIV Prevention School CurriculumTreatment as Usual, relative to the HIV Prevention School Curriculum Treatment as Usual only, in preventing drug use and unprotected sexual behavior, two risk factors for HIV infection. Familias Unidas aims to prevent drug use and unprotected sexual behavior by (a) increasing family functioning, (b) increasing parental monitoring of peer activities, and (c) influencing adolescent social cognitive mechanisms regarding drug use and unsafe sexual behavior. A sample of 240 Hispanic 9th grade adolescents and their primary caregivers will be randomized to one of two conditions: Familias Unidas plus the HIV School Curriculum Treatment as Usual (hereafter refererred to as Familias Unidas) or the HIV Prevention School Curriculum Treatment as Usual only. Two studies have demonstrated the efficacy of an intensive, 9 to 12 month version of Familias Unidas. In the first study, Familias Unidas was shown to be efficacious relative to a no- intervention control condition in increasing family functioning. In the second study, Familias Unidas was found to be efficacious in preventing drug use and unsafe sexual behavior relative to two attention control conditions. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more efficacious than the HIV Prevention School Curriculum Treatment as Usual in preventing adolescent drug use over time and (H2) Familias Unidas will be more efficacious than the HIV Prevention School Curriculum Treatment as Usual in preventing adolescent unprotected sexual behavior over time. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on drug use will be partially mediated by (1) family functioning; (2) parental monitoring of peers; and (3) social cognitive mechanisms regarding drug use; and (H2a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by (1) family functioning; (2) parental monitoring of peers; (3) social cognitive mechanisms regarding unprotected sex; and (4) drug use. The objective of the proposed study is to reduce HIV contraction health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of interventions to reduce drug use, unprotected sexual behavior, and HIV in Hispanic adolescents.           ","PS07-003, Minority HIV/AIDS Research Initiative (MARI)",7497086,U01PS000671,[''],NCHHSTP,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,U01,2008,241887,0.10409011619734354
"Morehouse School of Medicine (M-MIDARP)    DESCRIPTION (provided by applicant): The overall aim of this program is to strengthen and expand the drug abuse and HIV/AIDS prevention research capacity at Morehouse School of Medicine (MSM) by bringing together key academic and community-based programs in the development of an integrated correctional drug abuse and HIV/AIDS prevention research component. This capacity will incorporate training in new research skills and create an aggregation of individual faculty with appropriate community-based agencies as research teams within the criminal justice system. The MSM MIDARP will: 1. Establish opportunities for training and development of drug abuse and HIV/AIDS prevention research interfacing with the Criminal Justice System (CJS) and existing community programs. 2. Construct an integrative culturally competent drug abuse and HIV/AIDS prevention research paradigm which addresses the needs of individuals who have come under the jurisdiction of the criminal justice system by utilizing existing community programs and Evidence-Based Practices. 3. Minimize disparities in community services to reduce recidivism among currently or previously incarcerated individuals. 4. Develop a nexus of organizations among the Georgia Department of Corrections, Georgia Department of Juvenile Justice and community based services that supplements the new research curriculum and faculty service programs, and makes sustainable gains in terms of scholarly publications, effective new service delivery paradigms, and individual client outcomes. 5. Expose young African-American medical students, masters of public health students and undergraduate students to correctional drug abuse and HIV/AIDS prevention community-based research to facilitate their post-graduate career choices. 6.Expand the areas of drug abuse and HIV/AIDS prevention research under investigation at Morehouse School of Medicine to additional indication areas, increase the number of minority physicians and faculty in drug abuse and HIV/AIDS prevention research, and increase the number of supported drug abuse and HIV/AIDS prevention research programs across MSM departments (especially Psychiatry, Family Medicine, Community Health and preventive medicine, and community voices program with its 8 grantees in cities across the country). Our intention is that MSM will be recognized as a local, regional, and national resource and training center for drug abuse and HIV/AIDS prevention for research programs.          ",Morehouse School of Medicine (M-MIDARP),7471975,R24DA021527,"['Educational Curriculum ', ' Curriculum ', ' Cessation of life ', ' Death ', ' ecstasy ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Institution ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Controls ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Address ', ' Preventive ', ' violence prevention ', ' prevent violence ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Jail ', ' Evidence based practice ', ' Advocate ', ' Age-Years ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Master of Public Health ', ' M.P.H. ', ' Master of Science ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Research Infrastructure ', ' Infrastructure ', ' Preparation ', ' Rate ', ' Community Health ', ' Development ', ' developmental ', ' Faculty ', ' Behavioral ', ' Family Practice ', ' family medicine ', ' Support of Research ', ' Female ', ' Female Adolescents ', ' adolescent girl ', ' Male Adolescents ', ' adolescent boy ', ' pandemic disease ', ' pandemic ', ' Intention ', ' Public Domains ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' USA Georgia ', ' Western Asia Georgia ', ' Georgian SSR ', ' Georgian S.S.R. ', ' Georgia SSR ', ' Georgia (Republic) ', ' Age ', ' base ', ' Goals ', ' Grant ', ' improved ', ' Health ', ' Health behavior ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Hepatitis ', ' Alcohol consumption ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV-1 ', ' human T lymphotropic virus III ', ' human T cell leukemia virus III ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Medical ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' Intervention Studies ', ' interventions research ', ' intervention research ', ' Training ', ' Justice ', ' Health Knowledge, Attitudes, Practice ', ' Knowledge, Attitudes, Practice ', ' Knowledge, Attitudes, Behaviors ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Homelessness ', ' unhoused ', ' homeless ', ' Individual ', ' Numbers ', ' Drug usage ', ' drug use ', ' Funding ', ' male ', ' Marihuana ', ' marijuana ', ' men ', "" men's "", ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Mission ', ' Needles ', ' Analysis of Variance ', ' Variance Analyses ', ' Monoclonal Antibody R24 ', ' R24 ', ' R-24 Monoclonal Antibody ', ' MoAb R24 ', ' New York ', ' Personal Satisfaction ', ' well-being ', ' Physicians ', ' Pilot Projects ', ' pilot study ', ' Poverty ', ' Powder dose form ', ' Powders ', ' Preventive Medicine ', ' preventative medicine ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Prisons ', ' Shapes ', ' Contracts ', ' Contracting Opportunities ', ' Psychiatry ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Nature ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Residencies ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' medical schools ', ' school of medicine ', ' medical college ', ' Science ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Knowledge ', ' Life ', ' programs ', ' statistics ', ' Students ', ' Medical Students ', ' Time ', ' Tuberculosis ', ' tuberculous spondyloarthropathy ', ' infection due to Mycobacterium tuberculosis ', ' disseminated tuberculosis ', ' disseminated TB ', ' Mycobacterium tuberculosis infection ', ' Mycobacterium tuberculosis (MTB) infection ', ' Mtb infection [{C0041296}] ', ' MTB infection ', ' M.tuberculosis infection ', ' M. tuberculosis infection ', ' Attitude ', ' Voice ', ' Investigation ', ' Work ', ' Writing ', ' Hour ', ' Protocols documentation ', ' Protocol ', ' System ', ' LOINC Axis 4 System ', ' Country ', ' Behavior ', ' interest ', ' Injecting drug user ', ' Injection Drug User ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Services ', ' Training and Education ', ' experience ', ' professor ', ' Books ', ' condoms ', ' skills ', ' Prevention Research ', ' Community based prevention ', ' member ', ' recidivism ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' repeat offender ', ' multiple offender ', ' habitual offender ', ' Prevention ', ' probation ', ' offender ', ' criminal offender ', ' Human Resources ', ' personnel ', ' Manpower ', ' Reporting ', ' Career Choice ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Cause of Death ', ' parole ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' Administrator ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Research Methodology ', ' Research Methods ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Sampling ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Client ', ' Clinical Research ', ' Clinical Study ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' correctional system ', ' Communicable Diseases ', ' Infectious Disorder ', ' Infectious Diseases and Manifestations ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communities ', ' Community Services ', ' Professional Role ', ' design ', ' designing ', ' Minority ', ' community living ', ' Outcome ', ' Prevention intervention ', ' Population ', ' community based service ', ' ethnic minority population ', ' ethnic minority ', ' Nexus (resin cement) ', ' ']",NIDA,MOREHOUSE SCHOOL OF MEDICINE,R24,2008,462556,0.12824035441533166
"Tailored Youth Drug Intervention in Primary Care DESCRIPTION (provided by applicant):     Preventing the initiation, and reducing the escalation of marijuana use among adolescents can have a major impact on the development of problem behaviors and health consequences in adulthood. The varying factors associated with initiation and escalation of marijuana use among adolescents (age 12-18) speaks to the importance of tailoring preventive approaches based on individual risk factors. Brief motivational interventions (BMI) have been demonstrated to be effective in reducing drug use (i.e., marijuana, alcohol, and tobacco) among adolescents and young adults. Typically, BMIs are delivered by a clinician; however, more recently, computers have been used successfully to deliver BMI in an interactive, graphically engaging format. The primary care setting represents an underutilized venue for prevention interventions addressing drug use/abuse among youth. This study will take place in three HRSA-funded Bureau of Primary Health Care community health clinics located in Flint, Michigan, a city with a diverse and medically under-served population. The purpose of this five-year study is to: (1) develop and refine promising, empirically-derived, BMI prevention/intervention modules delivered by a clinician or a computer to target marijuana use, and (2) test the effectiveness of BMI in preventing initiation/escalation of marijuana use among youth in community health clinics. The proposed BMI prevention/interventions are innovative because: a) they incorporate tailoring technology based on assessment of the adolescents' behaviors; and b) they incorporate prevention messages for those who have not initiated use, and intervention messages for those who are current users. This randomized controlled trial will screen 1,710 adolescents in primary care clinics over 30 months. A random sample of the approximately 70% who screen negative for past year marijuana use will be selected to participate in the study (n=450); all subjects who screen positive for past year use will be enrolled in the study (n=450). These 900 subjects will be stratified by gender, age, and past year marijuana use and randomized to one of three conditions: 1) computer-delivered brief motivational approach (BMI-C) (n=300; 150 non-users: prevention, 150 users: intervention); 2) therapist-delivered brief motivational approach (BMI-T) (n=300; 150 non-users, 150 users); or 3) a NIDA drug education booklet (DPB) (n=300; 150 non-users, 150 users). Primary outcomes will be evaluated at 3-, 6- and 12-months and include marijuana, alcohol, tobacco and other drug use. Key moderators of effectiveness will be examined, including behavioral intentions, self-efficacy, stage of change, school involvement, susceptibility to peer pressure, and potential health consequences (e.g., STD/HIV risk behaviors). This project will provide the critical first step toward the implementation of tailored marijuana prevention and intervention in primary care clinics. ",Tailored Youth Drug Intervention in Primary Care,7463669,R01DA020075,"['Crime ', ' Mental Depression ', ' depression ', ' health disparity ', ' health disparities ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Effectiveness ', ' Purpose ', ' prevent ', ' preventing ', ' Legal ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Low income ', ' Educational aspects ', ' Education ', ' Elements ', ' Pyrococcus kodakaraensis TIP protein ', ' Pyrococcus kodakaraensis TBP-interacting protein ', ' Pyrococcus kodakaraensis Pk-TIP protein ', ' Address ', ' Preventive ', ' Caring ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Qualifying ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Range ', ' Enrollment ', ' enroll ', ' Rate ', ' Principal Investigator ', ' Teenagers ', ' teen years ', ' Teen ', ' Process ', ' Community Health ', ' Development ', ' developmental ', ' Behavioral ', ' Family ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescent Behavior ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' General Practitioners ', ' Generalists ', ' suicidal behavior ', ' suicide behavior ', ' Age ', ' base ', ' Goals ', ' Aggressive behavior ', ' Aggression ', ' improved ', ' Happiness ', ' positive attitude ', ' Health ', ' Health Maintenance Organizations ', ' Prepaid Group Health Organizations ', ' Health Services ', ' health care service ', ' Recording of previous events ', ' History ', ' Alcohols ', ' Alcohol Chemical Class ', ' Left ', ' Depth ', ' Medical ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Institute of Medicine (U.S.) ', ' NAS/IOM ', ' Institute of Medicine ', ' Insurance ', ' Intervention Studies ', ' interventions research ', ' intervention research ', ' Predisposition ', ' Susceptibility ', ' Screening procedure ', ' screenings ', ' screening ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Rural ', ' Family history of ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Drug usage ', ' drug use ', ' Funding ', ' Manuals ', ' Marihuana ', ' marijuana ', ' Mentors ', ' Methods ', ' Michigan ', ' Problem behavior ', ' behavioral problem ', ' Neighborhoods ', ' Collaborations ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Pamphlets ', ' Brochures ', ' Booklets ', ' Parents ', ' Physicians ', "" Physicians' Offices "", ' pressure ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Staging ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Condition ', ' Nature ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Schools ', ' Social Problems ', ' social disturbance ', ' Life ', ' programs ', ' Arts ', ' Technology ', ' Testing ', ' Time ', ' Tobacco ', ' Attention Deficit Disorder ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' United States Health Resources and Services Administration ', ' Health Resources and Services Administration ', ' HRSA ', ' day ', ' Dependence ', ' Clinic ', ' Nodal ', ' Techniques ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' behavior change ', ' contextual factors ', ' Application Context ', ' interest ', ' skills training ', ' Peer Pressure ', ' age group ', ' American ', ' experience ', ' success ', ' high school ', ' care seeking ', ' Self Efficacy ', ' Prevention program ', ' prevention service ', ' peer ', ' Patient Self-Report ', ' Self-Report ', ' social skills ', ' social competency ', ' social competence ', ' interpersonal competency ', ' interpersonal competence ', ' deviant ', ' deviancy ', ' motivational enhancement therapy ', ' motivational interview ', ' Prevention ', ' Modality ', ' Reporting ', ' Gender ', ' Privacy ', ' universal prevention ', ' universal preventive measure ', ' universal preventive interventions ', ' universal interventions ', ' selective prevention ', ' selective preventive measure ', ' selective preventive intervention ', ' selected prevention ', ' Generic Drugs ', ' generic ', ' Nonproprietary Drugs ', ' Health Care Costs ', ' Healthcare Costs ', ' Health Costs ', ' Alcohol abuse ', ' problem drinking ', ' problem alcohol use ', ' hazardous alcohol use ', ' ethanol abuse ', ' alcohol problem ', ' Community Healthcare ', ' Community Health Care ', ' depressive symptoms ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' Illicit Drugs ', ' Healthcare ', ' health care ', ' Population Heterogeneity ', ' heterogeneous population ', ' diverse populations ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Modeling ', ' Sampling ', ' Uninsured ', ' Youth ', ' Youth 10-21 ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cannabis ', ' Hemp Plant ', ' Communities ', ' early /brief intervention /therapy ', ' cost ', ' adolescent drug use ', ' youth drug use ', ' adolescent substance use ', ' youth substance use ', ' computerized ', ' Underserved Population ', ' underserved people ', ' under served population ', ' design ', ' designing ', ' Outcome ', ' alcohol misuse ', ' unhealthy alcohol use ', ' ethanol misuse ', ' Prevention intervention ', ' Population ', ' aged ', ' Consumption ', ' Individual Differences ', ' innovation ', ' innovative ', ' innovate ', ' family influence ', ' medically underserved ', ' trial comparing ', ' compare effectiveness ', ' motivational intervention ', ' addiction ', ' addictive disorder ', ' Computers ', ' Conflict (Psychology) ', ' Conflict ', ' Drops ', ' ']",NIDA,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2008,585961,0.0221674919206028
"Research Training in the Prevention of Drug Abuse & AIDS in Communities of Color    DESCRIPTION (provided by applicant): This revised application for a MIDARP program at Howard University describes a mentoring program in drug abuse research and AIDS prevention in communities of color, which is designed to increase the capacity of faculty and students at Howard to conduct rigorous and competitive research in the prevention of drug abuse and HIV/AIDS in communities of color. The program will emphasize training in transdisciplinary research on relationships between environmental stress, biological responses, risk behaviors and health outcomes and will utilize collaborations with senior investigators in research intensive universities to mentor Howard faculty investigators. The MIDARP will also work closely with existing programs that link Howard faculty and students to research training opportunities to (1) increase knowledge and interest in drug abuse and AIDS prevention research among faculty and students in these programs and (2) utilize the resources of these programs to expand the range of training opportunities available to MIDARP investigators and students. Howard students will be introduced to drug abuse and AIDS prevention research and career development by augmenting existing drug abuse courses in the College of Arts and Sciences and the curriculum for medical, basic science, nursing, and pharmacy students to include information on drug abuse and AIDS prevention research. They will also fund a pre-doctoral dissertation stipend and recruit students to serve as research assistants in the MIDARP pilot studies. The unique strengths of the program include the opportunity to (1) integrate education regarding drug abuse and AIDS prevention research into existing research training programs for faculty and students;(2) train individuals in diverse disciplines such as the health professions and sciences (i.e., medicine, basic sciences, pharmacy, nursing) who are less likely to pursue research careers in drug abuse and AIDS prevention research; and (3) support transdisciplinary research in drug use and AIDS prevention based on strong existing university research programs in genetics, physiology, and psychobiology. A transdisciplinary approach will be reflected in the MIDARP leadership that includes a Director who is a behavioral scientist specializing in research on environmental stress, drug use, and AIDS risk in communities of color and a Deputy Director who is an immunogeneticist with expertise in microbiology, and founding Director of the Human Genome Project at Howard University.          ",Research Training in the Prevention of Drug Abuse & AIDS in Communities of Color,7496244,R24DA021470,"['Educational Curriculum ', ' Curriculum ', ' Achievement ', ' Achievement Attainment ', ' Ally ', ' Dentistry ', ' drug abuse prevention ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Institution ', ' District of Columbia ', ' DC Washington ', ' D.C. Washington ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Continuing Education ', ' Continuance of education ', ' Graduate Education ', ' Electronic Mail ', ' Email ', ' E-Mail ', ' Eligibility Determination ', ' Protocol Screening ', ' Eligibility ', ' Environment ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Equilibrium ', ' balance function ', ' balance ', ' biological adaptation to stress ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Allied Health Sciences ', "" Doctor's Degree "", ' Doctorate Degree ', "" Master's Degree "", ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Range ', ' Research Infrastructure ', ' Infrastructure ', ' Research Training ', ' Enrollment ', ' enroll ', ' Senior Scientist ', ' Training and Infrastructure ', ' Monitor ', ' Principal Investigator ', ' Authorization documentation ', ' Permission ', ' Authorization ', ' Development ', ' developmental ', ' Faculty ', ' Behavioral ', ' Advisory Committees ', ' Task Forces ', ' Foundations ', ' Health Professional ', ' Healthcare professional ', ' Health Care Professional ', ' USA Georgia ', ' Western Asia Georgia ', ' Georgian SSR ', ' Georgian S.S.R. ', ' Georgia SSR ', ' Georgia (Republic) ', ' base ', ' career ', ' role model ', ' sociology/anthropology ', ' Goals ', ' Grant ', ' Health ', ' Health Occupations ', ' health science profession ', ' Health Professions ', ' Heart Rate ', ' Cardiac Chronotropism ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Human Genome Project ', ' Depth ', ' Area ', ' Biological ', ' Physiological ', ' Physiologic ', ' Medical ', ' Link ', ' Ensure ', ' Interview ', ' Evaluation ', ' Training ', ' Laws ', ' Leadership ', ' Discipline ', ' Individual ', ' Numbers ', ' Educational workshop ', ' Workshop ', ' Measurement ', ' Development Plans ', ' Drug usage ', ' drug use ', ' Funding ', ' Medicine ', ' Mentors ', ' Mentorship ', ' Methods ', ' Microbiology ', ' Collaborations ', ' Letters ', ' Nurses ', ' Discipline of Nursing ', ' Nursing Profession ', ' Nursing Field ', ' Nursing ', ' Object Attachment ', ' Psychological Bonding ', ' Object Relationship ', ' Bonding (Psychology) ', ' Pamphlets ', ' Brochures ', ' Booklets ', ' Pharmacy facility ', ' Pharmacies ', ' Pharmacology ', ' Genetic ', ' Physiology ', ' Pilot Projects ', ' pilot study ', ' Exposure to ', ' Psychiatry ', ' Psychology ', ' Publications ', ' Scientific Publication ', ' Recommendation ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Appendix ', ' Schools ', ' medical schools ', ' school of medicine ', ' medical college ', ' Science ', ' Secondary Schools ', ' Architecture ', ' Engineering / Architecture ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Sociology ', ' Knowledge ', ' lectures ', ' programs ', ' Arts ', ' Stress ', ' Students ', ' Medical Students ', ' Nursing Students ', ' Pupil Nurses ', ' Pharmacy Students ', ' Surveys ', ' Survey Instrument ', ' Educational process of instructing ', ' Teaching ', ' Scientist ', ' Time ', ' Training Activity ', ' Training Programs ', ' Universities ', ' Violence ', ' violent behavior ', ' violent ', ' Work ', ' Writing ', ' Award ', ' Techniques ', ' Country ', ' Behavioral Research ', ' Behavioral Sciences ', ' interest ', ' college ', ' collegiate ', ' Services ', ' Blood Pressure ', ' American ', ' experience ', ' stressor ', ' success ', ' professor ', ' computer science ', ' cohort ', ' skills ', ' Participant ', ' Prevention Research ', ' member ', ' Basic Science ', ' Basic Research ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Businesses ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' psychobiology ', ' biopsychology ', ' biological basis of behavior ', ' response ', ' Clinical Research ', ' Clinical Study ', ' Color ', ' Communication ', ' Communities ', ' design ', ' designing ', ' Outcome ', ' Population ', ' pre-doctoral ', ' predoctoral ', ' predoc ', ' pre-doc ', ' Historically Black Colleges and Universities ', ' Historically Black University ', ' Historically Black Institution ', ' Historically Black Colleges ', ' HBCUs ', ' Consultations ', ' ']",NIDA,HOWARD UNIVERSITY,R24,2008,471115,0.15242078635463338
"Long-Term Consequences of Exposure to Family Violence    DESCRIPTION (provided by applicant): The objective of the proposed research is to identify the extent to which, and the mechanisms through which, exposure to violence in the family might disrupt individual development in adolescence, with consequences that cascade over the life course and affect a subsequent generation. Exposure to family violence is conceptualized broadly to include domestic violence, child abuse, family conflict and exposure to multiple forms of violence. Key outcomes include public health targets of drug use, HIV/AIDS risk and violence. Guided by a developmental life-span model the study will employ prospective data from three generations of subjects in the Rochester Youth Development Study (RYDS). Generation 2, or G2 are the original RYDS cohort of 1000 urban adolescents followed from early adolescence to their early thirties. Their parents, G1 were also interviewed during the first 10 years of the study. Their children (G3) are followed from early childhood into adolescence. Measurement is multi-agent and multimethod, including self-report, observational and official measurement. Specific aims are (1) To describe the incidence and prevalence of types of family violence exposure in two consecutive generations of an urban, community-based sample with a substantial number of high-risk and minority males and females (2) To examine the adolescent impact of different types of violence exposure (and of multiple  exposure) on drug use, risk for HIV/AIDS and other problem behaviors, as well as pro-social competencies. (3) To examine if G2 exposure to family violence leads to drug use and other problems in emerging adulthood, either directly or indirectly via its consequences on adolescent development. (4) To examine long-term consequences of family violence exposure on consolidation of adult roles by the early 30's, especially stable work and family formation and avoidance of drug use and criminal involvement. (5) To examine intergenerational continuity and discontinuity in exposure to family violence. To examine these aims, several statistical strategies including growth curve modeling and full and limited information SEM will be used.         ",Long-Term Consequences of Exposure to Family Violence,7434404,R01DA020344,"['Exposure to ', ' Disruption ', ' Prospective Studies ', ' public health medicine (field) ', ' Public Health ', ' Nature ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Schools ', ' self esteem ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Life ', ' Victimization ', ' Traumatic Stress Disorders ', ' Stress Disorders ', ' Time ', ' Videotape ', ' Violence ', ' violent behavior ', ' violent ', ' Work ', ' Achievement ', ' Achievement Attainment ', ' Healthy People 2010 ', ' Mental Depression ', ' depression ', ' health disparity ', ' health disparities ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Disadvantaged ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Environment ', ' Address ', ' Symptoms ', ' Ethnic group ', ' Social Network ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Range ', ' Child Abuse and Neglect ', ' child maltreatment ', ' Childhood maltreatment ', ' transmission process ', ' Transmission ', ' Rate ', ' Process ', ' sex ', ' Development ', ' developmental ', ' Family ', ' Family Relationship ', ' Family Relations ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Pathway interactions ', ' pathway ', ' Affect ', ' Age ', ' base ', ' Aggressive behavior ', ' Aggression ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Area ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Family Violence ', ' Domestic Violence ', ' Link ', ' Incidence ', ' Infection ', ' Institutes ', ' Interview ', ' Ireland ', ' Irish Free State ', ' Eire ', ' Childhood ', ' pediatric ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Discipline ', ' Individual ', ' Numbers ', ' young adult ', ' young adulthood ', ' adult youth ', ' Longevity ', ' lifespan ', ' life span ', ' Length of Life ', ' Measurement ', ' Drug usage ', ' drug use ', ' male ', ' Marriage ', ' Problem behavior ', ' behavioral problem ', ' Study models ', ' Sexual abuse ', ' sex abuse ', ' Parents ', ' Dimensions ', ' Severities ', ' Home environment ', ' Home ', ' Source ', ' Pattern ', ' Behavior ', ' experience ', ' intergenerational ', ' early childhood ', ' NIH Program Announcements ', ' Program Announcement ', ' Patient Self-Report ', ' Self-Report ', ' social skills ', ' social competency ', ' social competence ', ' interpersonal competency ', ' interpersonal competence ', ' Prevention ', ' emotional abuse ', ' mental abuse ', ' Psychological abuse ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' anti social ', ' antisocial ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Generations ', ' Measures ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child Abuse ', ' Childhood Abuse ', ' Child Development ', ' Infant and Child Development ', ' Parenting behavior ', ' Parenting ', ' Caregivers ', ' Care Givers ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Latino ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Sampling ', ' Adolescent Development ', ' Youth ', ' Youth 10-21 ', ' theories ', ' Cohort Studies ', ' Concurrent Studies ', ' Communities ', ' neglect ', ' design ', ' designing ', ' next generation ', ' Minority ', ' maltreatment ', ' mistreatment ', ' resilience ', ' Outcome ', ' Prevalence ', ' prospective ', ' Impairment ', ' Conflict (Psychology) ', ' Conflict ', ' ']",NIDA,STATE UNIVERSITY OF NEW YORK AT ALBANY,R01,2008,229422,0.017946967746105106
"Role of Race in Criminal Justice Referrals to Treatment    DESCRIPTION (provided by applicant): The criminal justice system has become the primary source of referrals to drug treatment. Despite substantial evidence that minorities, particularly African Americans, are over-represented in the drug arrestee population, they remain a relatively small share of criminal justice referrals. It has yet to be determined if this lower representation is a function of racial and ethnic disparities in the criminal justice system or an artifact of some common case-level factors that reduce minority eligibility for treatment referral. We propose to examine the adjudication of drug offenders in California from 1982- 2005 to determine the extent to which race/ethnicity has played a role in final disposition and referral to drug treatment. California represents a unique environment in which to examine these associations because of its demographic and regional diversity, availability of detailed administrative data representing a census of individuals arrested and processed, and adoption of two important policies - drug courts and diversion - that promote treatment in lieu of incarceration. The proposed study significantly improves existing research by considering temporal and geographic patterns in disparities at each stage of the adjudication process within a single state subject to the same rule of law. It comprehensively considers the role of race/ethnicity at each stage of the adjudication process and the net effect on the final placement of minorities in treatment, and so may identify why previous studies have provided inconsistent results. Finally, by considering the impact of restorative justice policies, such as drug courts and diversion, on the processing of drug offenders by race/ethnicity, this project will assist policymakers with efforts to reduce disparities in the criminal justice and treatment system. The elimination of health disparities is an overarching goal of Healthy People 2010. The criminal justice system is critical to eliminating disparities because minorities, particularly African Americans, are substantially over-represented in this population and because the criminal justice system is the largest referral source to treatment. A careful examination of the adjudication process for drug offenders will make it possible to determine if differential access to treatment truly exists among arrestees and what factors have caused it. Further, by examining trends in adjudication practices using a large panel data set in California, this study will be able to explicitly consider whether recent policy reforms aimed at improving access to treatment particularly among minorities have indeed done so.           ",Role of Race in Criminal Justice Referrals to Treatment,7466656,R01DA022719,"['Healthy People 2010 ', ' health disparity ', ' health disparities ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Eligibility Determination ', ' Protocol Screening ', ' Eligibility ', ' Environment ', ' Data Set ', ' Dataset ', ' Data ', ' Improve Access ', ' trend ', ' Process ', ' Placement ', ' Development ', ' developmental ', ' Adoption ', ' Guidelines ', ' court ', ' Goals ', ' improved ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Recording of previous events ', ' History ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Variant ', ' Variation ', ' Justice ', ' Laws ', ' Individual ', ' Policies ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Noise ', ' Play ', ' Staging ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Condition ', ' Research ', ' Role ', ' social role ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Violence ', ' violent behavior ', ' violent ', ' Source ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' contextual factors ', ' Application Context ', ' California ', ' adjudication ', ' adjudicative process and procedure ', ' offender ', ' criminal offender ', ' Sorting - Cell Movement ', ' sorting ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Censuses ', ' County ', ' Admission activity ', ' Admission ', ' parole ', ' Drug Courts ', ' Morphologic artifacts ', ' Artifacts ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Minority ', ' Outcome ', ' Population ', ' racial and ethnic disparities ', ' ']",NIDA,RAND CORPORATION,R01,2008,298503,0.09882567964943394
"Collaborative Research on Drug Abuse    DESCRIPTION (provided by applicant): This P01 develops and applies state-of-the-art methods to analyze existing but under-utilized drug abuse databases in collaboration with their owners. We address contemporary, theoretical, and applied issues in drug abuse research to understand intersections between substance abuse and AIDS risk behaviors as well as minority and gender-based health disparities. We work with dozens of investigators from drug & social policy, epidemiology, health sciences, medicine, nursing, psychiatry, psychology, public health, and social work who own exciting substance abuse data to develop models that test current theories, especially on epidemiology, prevention, intervention, and treatment of drug abuse, using modern multivariate methods to control for measurement errors, biases, and other confounds. The Models and Methods Project develops psychometric and statistical analytic techniques that hold special promise for improving the quality of drug abuse and AIDS research. The At-Risk Project studies substance abuse related data sets on vulnerable populations (substance abusers, homeless people, individuals who are HIV positive or who have AIDS, victims of domestic abuse, runaways, gang members, and others at high risk for AIDS or drug abuse) with methods to control sampling, measurement, distributional and other biases. The Community Project studies drug abuse etiology, adult consequences, HIV risk, intergenerational processes, general deviance, and related issues in large community-based samples, and develops and tests explanatory theories using models that permit separation of common from specific effects, control for artifacts, etc. The Core Project oversees and integrates all components, hosts visiting scholars, provides computer facilities, and sponsors a mentoring program for disadvantaged students. The substantive part of the Models Project and the At-Risk and Community Projects will be developing and testing integrative theories that can be applied across different populations. The findings from their studies will lead to greater understanding of precursors and concomitants of substance abuse and HIV/AIDS risk and transmission. In turn, these findings will guide development of effective interventions to reduce negative health outcomes and treatment disparities in community, ethnic, and vulnerable populations, and provide guidance on how these may be alleviated.      PROGRAM CHARACTERISTICS          ",Collaborative Research on Drug Abuse,7502053,P01DA001070,[''],NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,P01,2008,1065557,0.06373110537308126
"Social networks and HIV risk among rural drug users    DESCRIPTION (provided by applicant):  This application is in response to PA-06-478, ""Research on Rural Mental Health and Drug Abuse Disorders"". One of the research areas highlighted by this PA is the examination of rural HIV transmission using social network analysis. The overall goal of the study is to examine the prevalence, incidence, and risk factors for HIV and other blood borne infections (BBIs) such as hepatitis B (HBV) and C (HCV) among rural Appalachian drug users using social network analysis and multilevel modeling. HIV continues to be a major public health problem in the United States, especially among drug users. However, little is known about HIV in rural areas in which there are marked health disparities. Therefore, given that studies among urban drug users have found that social network indicators are robust predictors of HIV risk, both social network and individual characteristics will be measured for their association with HIV risk among rural drug users. The specific aims are: 1) To determine the prevalence and incidence of HIV, HCV and HBV among rural injection and non- injection drug users; 2) To examine HIV and other BBI risk among rural injection and non-injection drug users; and 3) To examine longitudinal changes in rural HIV, HCV and HBV risk at 6-months, 12-months and 18- months post-baseline. To meet these aims, a sample 500 rural injection and non-injection drug users will be recruited using respondent driven sampling (RDS). In addition to biologic testing for HIV, HCV and HBV, rural participants will be given an interviewer-administered questionnaire pertaining to their social networks (drug, sexual and support networks), sociodemographics, drug use, HIV risk behaviors, psychiatric diagnoses, intravention and norms. Since individuals will be nested within networks, data will be analyzed using multilevel random effects regression that allows for the simultaneous examination of social network and individual-level risk. Consistent with the priorities of the NIDA AIDS Research Program, this proposal will explore the social network structure in a rural drug using population in order to better understand how network factors may affect HIV risk in rural areas using an innovative multilevel approach. Results from the proposed study will inform the design and implementation of HIV interventions in rural areas and help to determine the appropriate population for which to target such activities in order to reduce the morbidity and mortality associated with HIV and other BBIs.       Although HIV remains a significant public health problem in the United States, especially among drug users, little is known about HIV risk in rural areas such as Appalachia. It has been shown in urban populations that relationships among drug users, also known as social networks, are important predictors of HIV risk. Therefore, this study seeks to characterize rural HIV risk by measuring both social network and individual behaviors in order to inform prevention activities in health resource-deprived rural areas.          ",Social networks and HIV risk among rural drug users,7418878,R01DA024598,"['health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Epidemic ', ' Social Network ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' transmission process ', ' Transmission ', ' Principal Investigator ', ' Characteristics ', ' Face ', ' facial ', ' faces ', ' Affect ', ' rural area ', ' urban area ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Health Resources ', ' Hepatitis B ', ' serum hepatitis ', ' infection with hepatitis B virus ', ' infection with HBV ', ' Viral Hepatitis B ', ' Hepatitis B Infection ', ' Hepatitis B Virus ', ' Homologous Serum Hepatitis Virus ', ' HBV ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Area ', ' Incidence ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' Interviewer ', ' Interview ', ' Hepatitis C virus ', ' Hepatitus C ', ' HCV ', ' Kentucky ', ' Individual ', ' Rural ', ' Drug usage ', ' drug use ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' Respondent ', ' Object Attachment ', ' Psychological Bonding ', ' Object Relationship ', ' Bonding (Psychology) ', ' Drug Prescriptions ', ' Drug Prescribing ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Questionnaires ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Risk ', ' Risk Factors ', ' Rural Population ', ' Appalachian Region ', ' Appalachia ', ' Serologic tests ', ' serology ', ' Serological Tests ', ' Individual Adjustment ', ' Psychiatric Diagnosis ', ' Research Priority ', ' programs ', ' Testing ', ' Thinking, function ', ' thoughts ', ' Thinking ', ' Time ', ' United States ', ' Urban Population ', ' Automobile Driving ', ' driving ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' Behavior ', ' Injecting drug user ', ' Injection Drug User ', ' Blood ', ' Blood Reticuloendothelial System ', ' Seroprevalences ', ' Structure ', ' Participant ', ' Disease regression ', ' Prevention ', ' Reporting ', ' Medical Surveillance ', ' Epidemiology / Surveillance ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Measures ', ' multilevel analysis ', ' multilevel modeling ', ' multilevel model ', ' methods to study multiple-level influences ', ' Pathway Analysis ', ' Network Analysis ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Sampling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' design ', ' designing ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2008,488124,0.12666251430322556
"Clinical and Social Implications of Cost Sharing for Cancer Drugs    DESCRIPTION (provided by applicant): Dr. Yu-Ning Wong, a Medical Oncologist at Fox Chase Cancer Center is dedicated to a career in cancer health services research. Her goal is to develop a multidisciplinary research program to understand the impact of insurance design on cancer drug utilization and clinical outcomes. This Career Development Award will provide the means to take two important steps towards accomplishing this goal. First, it will allow for additional intensive mentored education and training in public policy research, health economics, and advanced statistical methods that will augment the candidate's previous rigorous training in epidemiology, biostatistics, and clinical medicine. Second, it will support the development of an original clinical research program using rigorous epidemiologic, econometric and survey methods to examine the impact of prescription drug insurance coverage on cancer outcomes. As new costly cancer drugs are introduced, patients with both public and private insurance are facing higher out- of-pocket costs. Cost sharing between insurers and patients (though co-payments and deductibles) has been traditionally used to control costs based on an expectation that unnecessary health care utilization will be reduced. However this expectation may result in worse socioeconomic disparities in care since some patients may be unable to afford highly effective cancer treatments. The candidate proposes three complementary studies to address the important, unanswered questions about the impact of cost sharing on cancer outcomes. Project A is a conjoint analysis-based survey to measure how patients make decisions among treatments of varying efficacy, toxicity and cost. Project B uses the results from Project A in a decision analysis model to measure the sensitivity of clinical outcomes to price and patient preferences. This will also allow us to determine if is possible to improve clinical outcomes by using low cost sharing to increase adherence to high value treatments. Project C is a natural experiment using insurance claims to measure the effect of insurance design and sociodemographic factors on the receipt of a new, expensive anti-nausea medication and subsequent outcomes. This research program will triangulate on the nexus of issues central to the understanding of cost sharing on cancer drug utilization and clinical outcomes and form the foundation for the candidate's transition to an independent investigator in cancer health services research. This project will have broad implications for the financing of high cost medical interventions because it will help policy makers, insurers and physicians understand how current models of cost sharing may contribute to socioeconomic disparities in cancer care. Our results may suggest consideration of a novel benefit design that encourages patients to make decisions based on relative value, rather than cost alone.           ",Clinical and Social Implications of Cost Sharing for Cancer Drugs,7572061,K07CA136995,"['Cost Control ', ' Cost Containment ', ' Cost Measures ', ' Decision Analysis ', ' Decision Analyses ', ' Decision Making ', ' Deductibles ', ' aprepitant ', ' Diffusion ', ' Drug Utilization ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Caring ', ' Adherence (attribute) ', ' Adherence ', ' Data ', ' Policy Research ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Cancer Patient ', ' Fox Chase Cancer Center ', ' Observational Study ', ' Principal Investigator ', ' prescription document ', ' Characteristics ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Development ', ' developmental ', ' Adoption ', ' Foundations ', ' Affect ', ' Patient Care ', ' Patient Care Delivery ', ' base ', ' career ', ' Elderly ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' improved ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Clinical ', ' Medical ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Insurance ', ' Insurance Carriers ', ' Insurers ', ' Training ', ' Uninsured Medical Expense ', ' total medical expenditure ', ' medical expenses not covered by insurance ', ' Uninsured Medical Fees (not covered) ', ' Uncovered Uninsured Medical Expense ', ' Uncovered Medical Expenses ', ' Out-of-Pocket Expense ', ' Individual ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' Policy Maker ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Mentors ', ' Methods ', ' Nausea ', ' Medical Oncologist ', ' Patients ', ' Physicians ', ' Antiemetics ', ' Antiemetic Drugs ', ' Antiemetic Agents ', ' Anti-emetics ', ' prescription procedure ', ' Drug Prescriptions ', ' Drug Prescribing ', ' Probability ', ' Antineoplastic Agents ', ' anticancer drug ', ' anticancer agent ', ' Tumor-Specific Treatment Agents ', ' Neoplastic Disease Chemotherapeutic Agents ', ' Cancer Drug ', ' Antineoplastics ', ' Antineoplastic Drugs ', ' Anti-Cancer Agents ', ' Public Policy ', ' Supportive care ', ' Supportive Therapy ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Patient Preferences ', ' Insurance Coverage ', ' Insurance Status ', ' programs ', ' Survey Methodology ', ' Survey Method ', ' Surveys ', ' Survey Instrument ', ' United States ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Training and Education ', ' Toxic effect ', ' Toxicities ', ' expectation ', ' novel ', ' payment ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' social ', ' Measures ', ' Price ', ' pricing ', ' Relative (related person) ', ' Relative ', ' Statistical Methods ', ' Treatment outcome ', ' Cost Sharing ', ' Healthcare ', ' health care ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Modeling ', ' Treatment Cost ', ' Underinsured ', ' Chronically Ill ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Clinical Medicine ', ' Clinical Medical Sciences ', ' Clinical Research ', ' Clinical Study ', ' cancer therapy ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' cancer care ', ' Vulnerable Populations ', ' vulnerable group ', ' cost ', ' health economics ', ' design ', ' designing ', ' older patient ', ' elderly patient ', ' Outcome ', ' Natural experiment ', ' innovation ', ' innovative ', ' innovate ', ' chemotherapy ', ' Nexus (resin cement) ', ' ']",NCI,FOX CHASE CANCER CENTER,K07,2008,143378,0.027485458307407232
"The Center for the Study and Prevention of Drug Use    DESCRIPTION (provided by applicant):     This proposal for the Center for Study and Prevention of Drug Use is submitted by Morgan State University and seeks funding under the PAR-02-016 mechanism in response to the PA entitled ""Minority Institutions' Drug Abuse Research Development Program"" (MIDARP). The proposed Center will be an inter-institutional collaborative effort involving Morgan State University, a minority institution, and research intensive universities and programmatic initiatives that focus on and specialize in research on drug use and disparities associated with drug use. The Center seeks to build on the collaborative relationships established through the Center to increase the capacity of Morgan State, its faculty and its students to conduct rigorous drug use research with and emphasis on drug use epidemiology, public health, and health disparities related to drug use. In order to actualize the mission of the Center, four components were developed which address the necessary aspects of creating a drug use research center. 1) The Faculty Development Plan, which seeks to advance Morgan faculty by allowing them to engage in off-site collaborative research with individuals specializing in drug research. 2) A second aspect is the Student Development Plan, which seeks to expose, educate and, train minority students in the area of drug use research. 3) The research arm of the project includes a primary and four developmental pilot project, allowing researchers at Morgan to begin using their present expertise and investigating topics in the area of drug use and disparities related to drug use. 4) Overseeing, each of the areas is the proposed plan for the Administrative Units and Center Organization. Through this component collaborative relationships, research projects, and faculty and student development will be monitored and enhanced. As a result of the Center faculty at Morgan State will be further enhanced regarding their ability to conduct rigorous research independently, specifically submitting R01's. Further, Morgan will be sufficiently capable of training students for careers in drug use research by developing a structured program in drug research, and the administrative staff will have the skills necessary to support the research staff in all endeavors related to research projects. In sum, the Center will be; self-sustaining and capable of producing future research focused on drug use research.               ",The Center for the Study and Prevention of Drug Use,7499694,R24DA019805,"['drug abuse prevention ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' health disparities ', ' Commit ', ' Institution ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Elements ', ' Eligibility Determination ', ' Protocol Screening ', ' Eligibility ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Research Infrastructure ', ' Infrastructure ', ' Research Training ', ' Sum ', ' Enrollment ', ' enroll ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' Monitor ', ' Preparation ', ' Principal Investigator ', ' Development ', ' developmental ', ' Faculty ', ' Support of Research ', ' Future ', ' Affect ', ' career ', ' Grant ', ' Recording of previous events ', ' History ', ' Site ', ' Area ', ' Link ', ' Internships ', ' Ensure ', ' Training ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Individual ', ' Numbers ', ' Development Plans ', ' Drug usage ', ' drug use ', ' Funding ', ' Maryland ', ' Mentors ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Mission ', ' New Jersey ', ' New York ', ' Collaborations ', ' Pennsylvania ', ' Pilot Projects ', ' pilot study ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Rest ', ' Knowledge ', ' programs ', ' Students ', ' Scientist ', ' Universities ', ' Washington ', ' Writing ', ' Award ', ' Upper arm ', ' Country ', ' Baltimore ', ' Behavior ', ' interest ', ' experience ', ' high school ', ' Structure ', ' skills ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' falls ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' forging ', ' Minority ', ' Historically Black Colleges and Universities ', ' Historically Black University ', ' Historically Black Institution ', ' Historically Black Colleges ', ' HBCUs ', ' ']",NIDA,MORGAN STATE UNIVERSITY,R24,2008,757925,0.2289119318721305
"Drugs, sexual impulsivity, HIV: Psychosocial and cognitive risk factors of YMSM    DESCRIPTION (provided by applicant): Unprotected sexual intercourse between men constitutes 58% of all reported cases of AIDS and 80% of HIV cases 1,2. Rates of HIV infection among 15 to 24 year olds continue to increase with MSM behavior remaining the leading cause of HIV infection among adolescent males 1,2. Over 90% of YMSM have reported having more than one sexual partner in the past 6 months and between 33% and 49% have had unprotected anal intercourse during the same time3. Studies show that use of stimulants, particularly methamphetamine, may influence risky sexual practices and contribute to the most recent wave of HIV and other sexually transmitted infections (STIs)4-6. Systematic development of theory has been identified as a crucial step in efficacious intervention development, but previous conceptual models have focused on a relatively limited array of explanatory constructs. However, Social Action Theory (SAT)7 provides a promising model for examining the risk behavior of YMSM, because it includes individual as well as social and contextual determinants. SAT remains to be tested for use in the field of HIV and with YMSM, because this model was originally conceived as a general health promotion model for the adult population. Using data from the Dr. Kipke's NIDA funded ""Healthy Young Men Study"" (HYM), this study will conduct multivariate analysis to test this model for use with the YMSM population. The specific aims of this study are to: 1) To empirically validate the chain of relationships depicted in Social Action Theory to determine if the theory addresses the interaction of individual, contextual, and social correlates of sexual and drug risk taking behaviors as they relate to YMSM; and 2) To further validate SAT by testing and incorporating competing theoretical relationships depicted in other behavioral theory models to develop a comprehensive theory of the social, psychosocial and cognitive risk factors for drug use, sexual impulsivity, and HIV among YMSM to guide prevention intervention efforts. . This study will contribute to the objectives of the AIDS-Science Track Award for Research Transition by 1) supporting a New Researcher; 2) addressing the NIDA research objective in the area of HIV, drug abuse, impulsivity, and coping strategies of an at-risk, under represented population; and 3) through refinement of a comprehensive theoretical model, we will provide a platform for developing interventions that address risk behavior related to HIV transmission among YMSM. PUBLIC HEALTH RELEVANCE: This study will contribute to effective HIV interventions for at-risk youth by developing a model to understand how environmental risk factors, impulsivity, and coping strategies converge into drug abuse and sexual risk taking.           Proposal Narrative This study will contribute to effective HIV interventions for at-risk youth by developing a model to understand how environmental risk factors, impulsivity, and coping strategies converge into drug abuse and sexual risk taking.","Drugs, sexual impulsivity, HIV: Psychosocial and cognitive risk factors of YMSM",7622723,R03DA024976,"['Data Analyses ', ' Data Analysis ', ' Risk Reduction ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' Data ', ' High Prevalence ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Range ', ' Cognitive ', ' transmission process ', ' Transmission ', ' Rate ', ' Development ', ' developmental ', ' Heterosexuals ', ' Behavioral ', ' Male Adolescents ', ' adolescent boy ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Age ', ' base ', ' career ', ' Goals ', ' Health ', ' Health behavior ', ' Health Promotion ', ' Salutogenesis ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Area ', ' psychologic ', ' psychological ', ' Institutes ', ' Evaluation ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Longitudinal Studies ', ' long-term study ', ' Drug usage ', ' drug use ', ' Funding ', ' men ', "" men's "", ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Theoretical model ', ' Theoretic Models ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Shapes ', ' public health medicine (field) ', ' Public Health ', ' Anus ', ' Anal ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Risk-Taking ', ' Science ', ' Sexual Partners ', ' sex partner ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Life ', ' Anti-HIV Agents ', ' antiAIDS agent ', ' Anti-Human Immunodeficiency Virus Agents ', ' Anti-HIV Drugs ', ' Anti-AIDS Drugs ', ' Anti-AIDS Agents ', ' AIDS Drugs ', ' Testing ', ' Complex ', ' Award ', ' Behavior ', ' psychosocial ', ' metropolitan ', ' cohort ', ' peer ', ' NIH Program Announcements ', ' Program Announcement ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Reporting ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' health belief ', ' health-related belief ', ' Impulsivity ', ' Case Study ', ' case report ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' response ', ' Youth ', ' Youth 10-21 ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Classification ', ' Systematics ', ' Coitus ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Communities ', ' Behavioral Model ', ' men who have sex with men ', ' men who have sex with other men ', ' design ', ' designing ', ' coping ', ' Guide prevention ', ' Prevention intervention ', ' Population ', ' Prevalence ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' social cognitive theory ', ' social learning theory ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R03,2008,168715,0.050969097749700466
"Spatial Variations in IDU HIV Risk: Relationship to Structural Interventions    DESCRIPTION (provided by applicant): The likelihood that illicit drug users will engage in drug-related HIV risk behaviors or suffer adverse drug-related health outcomes varies considerably across neighborhoods. While an emerging line of research has investigated whether particular neighborhood-level characteristics (e.g., presence of dilapidated housing and social disorder) determines neighborhood-level variation in these drug-related behaviors and health outcomes, no research has yet studied whether syringe access (SA) programs or drug-related criminal justice (D-RCJ) activities contribute to neighborhood-level variations in drug-related behaviors and health outcomes among illicit drug users, including injection drug users (IDUs). This absence is striking: (1) SA programs and D-RCJ activities affect patterns of drug-related health behaviors, outcomes, and service use; (2) SA programs and D- RCJ activities are place-based, structural interventions: they are unevenly distributed across neighborhoods and shape the local context in which IDUs use drugs; and (3) D-RCJ activities (and possibly SA programs) exert different impacts on drug-related HIV risk behaviors and health service use among IDUs of different racial/ethnic groups. Explaining racial/ethnic variations in drug-related HIV risk and health service use is a NIDA priority. Current measures of SA programs and D-RCJ activities, however, preclude studying whether these interventions shape geographic variation in drug-related HIV risk behaviors, health outcomes and service use among IDUs. The proposed exploratory study will achieve 3 aims by analyzing existing data: to (1a) Construct new measures of SA programs and D-RCJ activities as place-based, structural, and multidimensional interventions; and (1b) Apply these measures to describe variations in SA programs and D- RCJ activities over time (1995-2006) across NYC's 42 health districts. By applying spatial analysis methods we will calculate, for each NYC health district and year, spatial access to syringes and to SA programs (overall and by program type); and intensity of drug-related arrest, incarceration, and police surveillance. (2) Use multilevel methods to explore whether variations in these measures across health districts and time are related to variations among IDUs in drug-related HIV risk behaviors and health service use across districts and time. (3) Explore if variations in these district-level measures create variations in drug-related HIV risk behaviors and service use, both within and between racial/ethnic groups of IDUs. The proposed project will lay the foundations for future investigations of the ways that SA programs and D-RCJ activities shape neighborhood- level variations in a wide range of health behaviors (e.g., HIV sexual risk), outcomes (e.g., HIV transmission), and service use (e.g., drug treatment entry) among IDU populations in multiple cities. Research based on these measures may provide important insight into how to modify SA programs and D-RCJ activities so as to reduce morbidity and mortality among drug users, their sex partners, and neighbors. Public Health Relevance Statement Rates of drug-related HIV risk behaviors and adverse drug-related health outcomes vary across neighborhoods in a city. No research has yet explored whether syringe access (SA) programs or drug-related criminal justice (D-RCJ) activities affect this neighborhood-level variation. The proposed project will construct measures of SA programs and D-RCJ activities that will allow us to explore whether these programs and activities create neighborhood-level variation in key drug-related health behaviors, outcomes, and service use in a city, and will empirically test whether changes in SA programs and D-RCJ activities in one US city (NYC) are associated with (1) neighborhood-level variation in drug injectors' drug-related HIV risk behaviors and health service use and (2) racial/ethnic variations in these outcomes. Project-created measures of SA programs and D-RCJ activities can be applied to other cities, and can be used to analyze neighborhood-level variations in a wide range of health behaviors, outcomes, and service use among injectors (e.g., sexual risk behaviors, HIV or HCV transmission, drug treatment entry). Research based on these measures may provide important insight into how to modify SA programs and D-RCJ activities so as to reduce morbidity and mortality among drug users, their sex partners, and neighbors. Given concerns that SA programs adversely affect local quality of life, project measures can also be used to empirically test the relationship between SA program presence in a neighborhood and local crime rates and other adverse social outcomes.          ",Spatial Variations in IDU HIV Risk: Relationship to Structural Interventions,7493043,R21DA023391,"['Crime ', ' Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' geographic difference ', ' geographic variation ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Legal ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Ethnic group ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Range ', ' transmission process ', ' Transmission ', ' Rate ', ' Characteristics ', ' Foundations ', ' Future ', ' Affect ', ' base ', ' Health ', ' Health behavior ', ' Health Services ', ' health care service ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Housing ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Variant ', ' Variation ', ' Income ', ' Economical Income ', ' Economic Income ', ' insight ', ' Linear Models ', ' Individual ', ' Numbers ', ' Legal Status ', ' Inequality ', ' Drug usage ', ' drug use ', ' Needle-Exchange Programs ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Funding ', ' Drug Metabolic Detoxication ', ' detoxification ', ' Metabolism of Toxic Agents ', ' Metabolic Drug Detoxications ', ' Drug Metabolic Detoxification ', ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' National Research Council (U.S.) ', ' National Research Council ', ' Neighborhoods ', ' Pharmacy facility ', ' Pharmacies ', ' Drug Prescriptions ', ' Drug Prescribing ', ' Shapes ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Quality of life ', ' QOL ', ' Condition ', ' Nature ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Rosa ', ' Rose ', ' Sales ', ' Sexual Partners ', ' sex partner ', ' Knowledge ', ' Life ', ' programs ', ' statistics ', ' Employee Strikes ', ' Strikes ', ' Syringes ', ' Testing ', ' Time ', ' Investigation ', ' Source ', ' Pattern ', ' Location ', ' Behavior ', ' Health behavior outcomes ', ' Injecting drug user ', ' Injection Drug User ', ' Services ', ' Participant ', ' Modality ', ' social ', ' Medical Surveillance ', ' Epidemiology / Surveillance ', ' Measures ', ' Needle Sharing ', ' Syringe Sharing ', ' Needlesharing ', ' Police ', ' Criminal Justice ', ' Illicit Drugs ', ' Latino ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' Hepatitis C Transmission ', ' hepatitis C virus transmission ', ' HCV Transmission ', ' Outcome ', ' drug distribution ', ' Population ', ' administrative database ', ' administrative data base ', ' racial and ethnic ', ' racial/ethnic ', ' ']",NIDA,EMORY UNIVERSITY,R21,2008,177295,0.05989522887805168
"Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth    DESCRIPTION (provided by applicant):  The overriding purpose of this study is to develop and test an intervention for reducing substance use and risky sexual behaviors among youth involved in juvenile drug court. Juvenile drug court provides an excellent setting in which to pursue the key study objectives by providing access to a well identified high risk population. Second, in addition to frequent judicial oversight, juvenile drug courts include several features that can enhance intervention effectiveness, sustainability, and potential for adoption. In addition, the fact that all juvenile drug courts have community-based treatment components and that such courts have been disseminated nationwide suggests the possibility of eventual widespread adoption if the proposed intervention is effective. The proposed intervention integrates evidence-based protocols for contingency management (CM) for substance abusing youth and family engagement strategies, with an evidence-informed family systems intervention for sexual risk originally developed to address substance use and sexual risk behaviors in HIV+ youth. These three interventions will be integrated into an efficient intervention that, if effective, can be amenable to adoption by juvenile drug courts. Following protocol development and beta testing, 160 drug court youth and their families will be randomized to the experimental intervention condition (HIV Risk Reduction or ""HRR"") versus Drug Court with Community Services (DC) conditions. Key outcomes will be assessed through 12-months post-baseline using a multi-method approach that will include assessment of substance use, risky sexual behaviors, criminal behavior, and participation in HIV counseling and testing services. Specific aims include: 1: Adapt existing intervention and training protocols into a single, efficient HRR intervention, beta test this HHR protocol with four youth in juvenile drug court and their families, and revise treatment and research protocols accordingly; 2: Conduct a randomized trial with 160 youth in juvenile drug court and their families to examine youth-level intervention effects (i.e., on substance use, sexual risk behavior, HIV counseling and testing, delinquent behavior) in comparison to DC through 12- months post referral and assess intervention fidelity. 3. If results suggest a positive HRR treatment effect, revise the intervention and training protocols in preparation for an effectiveness study and extended follow-up study. Importantly, the proposed study will (1) consider the multiple levels of influence on juvenile drug use, criminal justice involvement, and HIV risk behaviors, (2) integrate a drug abuse and HIV prevention intervention for youth in the criminal justice system with drug-related offenses, (3) address health disparities by targeting a primarily minority population of youth, and (4) increase referrals to HIV testing and counseling of drug court-involved youth. This study is designed to reduce HIV risk by addressing the potent interaction of drug use and risky sexual behaviors in drug court youth with evidence-based treatment components to maximize the likelihood of reversing these youths' adverse behavioral trajectories.      PUBLIC HEALTH RELEVANCE: The proposed study is designed to gain knowledge about effective interventions for reducing HIV risk in a high risk population. Reducing HIV risk by effectively targeting substance use and risky sexual behaviors and by locating even a small number of HIV-positive youth could favorably impact society at multiple levels (individual, family, peer, community, fiscal).           PROJECT NARRATIVE The proposed study is designed to gain knowledge about effective interventions for reducing HIV risk in a high risk population. Reducing HIV risk by effectively targeting substance use and risky sexual behaviors and by locating even a small number of HIV-positive youth could favorably impact society at multiple levels (individual, family, peer, community, fiscal).",Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth,7577308,R01DA025880,"['Counseling ', ' critical developmental period ', ' Risk Reduction ', ' health disparity ', ' health disparities ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Institution ', ' Effectiveness ', ' Purpose ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Evidence based practice ', ' Cost Effectiveness Analysis ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Effectiveness of Interventions ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Enrollment ', ' enroll ', ' Preparation ', ' Rate ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Behavioral ', ' Family ', ' Adoption ', ' Follow-Up Studies ', ' Followup Studies ', ' Evidence based treatment ', ' base ', ' court ', ' criminal behavior ', ' Label ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Randomized Controlled Clinical Trials ', ' juvenile delinquent ', ' Young offender ', ' Juvenile Offender ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Numbers ', ' Drug usage ', ' drug use ', ' Risk Reduction Behavior ', ' Lifestyle Risk Reduction ', ' Methods ', ' Educational Intervention ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Collaborations ', ' Staging ', ' public health medicine (field) ', ' Public Health ', ' Condition ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Societies ', ' Knowledge ', ' Testing ', ' United States Public Health Service ', ' USPHS ', ' Public Health Service ', ' Adopted ', ' Work ', ' Protocols documentation ', ' Protocol ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Services ', ' peer ', ' contingency management ', ' offender ', ' criminal offender ', ' Reporting ', ' Medical Surveillance ', ' Epidemiology / Surveillance ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Measures ', ' Drug Courts ', ' Criminal Justice ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Youth ', ' Youth 10-21 ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Clinical Trials ', ' clinical investigation ', ' Communities ', ' Community Services ', ' adolescent substance abuse ', ' youth substance abuse ', ' design ', ' designing ', ' Minority ', ' Outcome ', ' Prevention intervention ', ' Population ', ' treatment effect ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' ']",NIDA,MEDICAL UNIVERSITY OF SOUTH CAROLINA,R01,2008,316246,0.04091109874558734
"Community Vulnerability and Responses to IDU-Related HIV  DESCRIPTION (provided by applicant): In this competing continuation, we will conduct a longitudinal study (1993-2007) of 96 large metropolitan areas to study trends and predictors of changes in the population prevalence of drug injectors, HIV) prevalence among injectors, and related prevention programs. In stage one of this project, we developed ways to estimate the population density of injection drug use and HIV prevalence rates in metropolitan areas. We showed that per capita injection drug use increased during the 1990s in many localities, including Baltimore and Salt Lake City. HIV prevalence rates among drug injectors increased in Baltimore and some other areas. In many metropolitan areas, drug injection and HIV rates among injectors declined. The extent to which local HIV prevention programs reached drug injectors also varied widely: 3 metropolitan areas provided treatment to 20% or more of their injectors, while 13 areas reached less than 5%. HIV counseling and testing rates also varied widely. In cross-sectional analyses, we showed that local government budgetary decisions, social and economic factors, and drug abuse interventions were related to injection drug users per capita, HIV revalence among drug injectors, and the presence and size of various programs to prevent HIV among drug injectors. We will build upon our existing data and construct a database for these 96 metropolitan areas containing annual estimates from 1993 - 2007 of drug injectors per capita; HIV prevalence, incident AIDS cases and AIDS mortality among drug injectors; program availability and size; socioeconomic conditions, and government budgetary allocations. We will (1) describe patterns of change over time in prevention programs and epidemiology. We will use longitudinal analysis methods to study (2) how changing socioeconomic conditions, epidemiologic need, budgetary constraints and choices, and policy choices are related to subsequent HIV prevention programming; and (3) how all these variables are related to later changes in (a) drug injectors per capita, (b) HIV prevalence and AIDS among drug injectors, (c) drug abuse treatment and other programs for drug injectors, and (d) racial/ethnic disparities in appropriate indicators. We will use these analyses to develop a well-theorized scientific understanding of forces that shape metropolitan area HIV/AIDS epidemics, rates of drug injectors per capita, and prevention programs. The resulting scientific knowledge base can help develop programs and policies so as to avoid epidemics and, if needed, control them.         ",Community Vulnerability and Responses to IDU-Related HIV,7478800,R01DA013336,"['Counseling ', ' Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Heroin ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Disease Outbreaks ', ' Outbreaks ', ' prevent ', ' preventing ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Advocate ', ' Data ', ' trend ', ' Rate ', ' Process ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Government ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Area ', ' Phase ', ' Variant ', ' Variation ', ' Economic Factors ', ' Economical Factors ', ' Incidence ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Individual ', ' Longitudinal Studies ', ' long-term study ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Policies ', ' Drug usage ', ' drug use ', ' Needle-Exchange Programs ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Methods ', ' Mortality Vital Statistics ', ' Mortality ', ' Movement ', ' body movement ', ' Local Government ', ' Neighborhoods ', ' New York ', ' Multicenter Studies ', ' Population Density ', ' human population density ', ' Staging ', ' Shapes ', ' public health medicine (field) ', ' Public Health ', ' Condition ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Risk ', ' Science ', ' Sodium Chloride ', ' salt ', ' Sodium chloride (NaCl) ', ' Knowledge ', ' programs ', ' Employee Strikes ', ' Strikes ', ' Syringes ', ' Testing ', ' Southeastern Asia ', ' Southeast Asia ', ' Time ', ' Event ', ' Distant ', ' Pattern ', ' size ', ' Baltimore ', ' contextual factors ', ' Application Context ', ' interest ', ' Injecting drug user ', ' Injection Drug User ', ' metropolitan ', ' knowledge base ', ' knowledgebase ', ' Budgets ', ' Burn injury ', ' Burns ', ' Prevention Research ', ' Prevention program ', ' treatment program ', ' Religion and Spirituality ', ' religious ', ' deviant ', ' deviancy ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Police ', ' falls ', ' outreach program ', ' response ', ' theories ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Communities ', ' comparison group ', ' Outcome ', ' Population ', ' Prevalence ', ' Natural experiment ', ' racial and ethnic disparities ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R01,2008,595431,0.22464773436225408
"Barriers to Treatment-based HIV Prevention for IDU Couples    DESCRIPTION (provided by applicant): Despite recent advances in HIV prevention, injecting drug users (IDUs) in the U.S. still account for 1/3 of new infections. Racial/ethnic disparities in injection drug use also continue to cause a disproportionate share of new HIV cases among minorities and women. This proposal targets a vulnerable and understudied population of IDUs - minority, heterosexual, IDU couples (i.e. partnered IDUs). While research on partnered IDUs is scarce, existing literature indicates that partnered IDUs are at high risk for HIV from both drug- related and sexual risk behaviors. Partnered IDUs, especially partnered women IDUs, also have limited success in reducing drug use, accessing or completing drug abuse treatment, and maintaining treatment outcomes (reduced drug use, safer drug-use practices, safer sex). This profile of partnered IDUs has important implications for treatment-based HIV prevention. Drug abuse treatment is an effective method for reducing drug-and sex-related HIV risk among IDUs. A recent NIDA publication concludes that ""drug abuse treatment is HIV prevention."" However, the median proportion of IDUs who access treatment in the U.S. is extremely low - less than 9%. Clearly, the full efficacy of HIV prevention cannot be realized unless more IDUs enter treatment. Since a substantial number of IDUs are sexually partnered with other IDUs (more than 40%, according to out own NYC data), understanding and overcoming barriers to successful treatment and treatment-based HIV prevention among partnered IDUs will have a substantial impact on reducing drug use and HIV risk, especially among minority women. This qualitative study of IDU couples and treatment providers focuses on two sets of barriers to drug treatment and treatment-based HIV risk reduction among African American and Latino heterosexual IDU couples in NYC: (1) relationship dynamics among partnered IDUs that deter treatment entry, retention or the maintenance of outcomes; and (2) couples-specific structural barriers in the treatment system that further inhibit treatment entry, retention, and the maintenance of outcomes. We are also interested in (3) how these two kinds of barriers interact. Findings from the proposed research will inform subsequent work to quantify these barriers and develop and evaluate programs to overcome them. This study is proposed by a new investigator and utilizes the R-21 mechanism. PUBLIC HEALTH STATEMENT HIV transmission among injection drug users (IDUs) continues to be an important public health issue. Despite recent advances in HIV prevention, injection drug users in the U.S. still account for 1/3 of all new infections. Racial/ethnic disparities in injection drug use also continue to cause a disproportionate share of infections. The proposed study primarily targets African American and Latino IDUs who are partnered in intimate relationships. While research on partnered IDUs is scarce, existing literature indicates that they are at high risk for HIV from both drug-related and sexual risk behaviors. In addition, they have limited success in reducing drug use, accessing or completing drug abuse treatment and maintaining treatment outcomes (reduced drug use, safer drug use practices, safer sex). The proposed study will contribute to an understanding of interpersonal and structural barriers to drug treatment and treatment-mediated HIV prevention and lead to recommendations for needed improvements.          ",Barriers to Treatment-based HIV Prevention for IDU Couples,7487442,R21DA022960,"['Couples ', ' Data Reporting ', ' Risk Reduction ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' transmission process ', ' Transmission ', ' Rate ', ' Principal Investigator ', ' sex ', ' Development ', ' developmental ', ' Heterosexuals ', ' Ethnography ', ' ethnographic ', ' base ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Left ', ' Site ', ' Area ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Numbers ', ' Literature ', ' Policies ', ' Drug usage ', ' drug use ', ' Risk Reduction Behavior ', ' Lifestyle Risk Reduction ', ' Maintenance ', ' men ', "" men's "", ' Methods ', ' Neighborhoods ', ' New York City ', ' Pilot Projects ', ' pilot study ', ' Shapes ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Recommendation ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Knowledge ', ' programs ', ' Target Populations ', ' Testing ', ' Translating ', ' Attitude ', ' Woman ', ' Work ', ' System ', ' LOINC Axis 4 System ', ' Behavior Therapy ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' interest ', ' Injecting drug user ', ' Injection Drug User ', ' experience ', ' success ', ' metropolitan ', ' condoms ', ' Reporting ', ' Needle Sharing ', ' Syringe Sharing ', ' Needlesharing ', ' Treatment outcome ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Health Benefit ', ' Latino ', ' Mediating ', ' Personal Communication ', ' Interpersonal Communication ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Sampling ', ' Classification ', ' Systematics ', ' Accounting ', ' Minority ', ' protective behavior ', ' Outcome ', ' Population ', ' safer sex ', ' racial and ethnic disparities ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R21,2008,178973,0.2080351955797551
"Gender Differences in Healthcare and Drug Treatment Utilization among Drug Users    DESCRIPTION (provided by applicant): Over the course of the HIV/AIDS epidemic, women (particularly African-American and Hispanic women) have been increasingly affected. Women now account for 1 in every 3 newly reported cases of HIV infection in the U.S., with two major modes of transmission: heterosexual contact and injection drug use. Research has documented a gender disparity in health care and drug treatment utilization. For example, compared with men, drug-using women receive less medical and psychiatric services, although they have poorer physical and mental health. Drug-using women also have lower retention and treatment completion rates than men in substance abuse treatment. In addition, drug-using women with HIV are less likely than men to receive HIV medication and to adhere to HAART. The factors contributing to these gender differences in minority communities are not fully understood and deserve elucidation through research. The proposed study, using existing dual-site longitudinal data, will examine factors related to gender differences in health care and drug use treatment utilization among Puerto Rican IDUs and crack smokers, a group at high risk for HIV. The two sites studied (New York and Puerto Rico) will provide a comparison of gender disparities in health care, for the same ethnic group in two communities with different resource contexts. The specific aims of the proposed study are: 1) To examine, by gender, factors associated with health care utilization among Puerto Rican drug users in NY and PR; 2) to identify (a) factors mediating the relationship between gender and health care utilization, and (b) interaction effects with gender in the relationships with health care utilization; 3) to examine, by gender, factors associated with drug treatment utilization; 4) to identify (a) factors mediating the relationship between gender and drug treatment utilization, and (b) interaction effects with gender in the relationships with drug treatment utilization; and 5) to assess how the relationships above (#1 - #4) vary between two different health resource environments. In addition, the study will assess whether predictors of HIV medication use differ between women and men over time. The major statistical analyses used will be: multiple logistic regression and hierarchical linear modeling (for longitudinal analysis). Findings will be useful in developing gender-specific interventions to improve health care and drug treatment utilization in women. Gender disparities in health care (including drug treatment) utilization are important public health issues. In particular, among minority drug-using populations, women, as compared to men, receive less medical and psychiatric services, although they experience poorer physical and mental health. However, the factors contributing to these gender differences in minority communities remain under-studied. The proposed study will contribute to an understanding of gender-differentiated healthcare behaviors, and further lead to recommendations to narrow the gender gap.             ",Gender Differences in Healthcare and Drug Treatment Utilization among Drug Users,7477952,R03DA022918,"['Counseling ', ' Risk Reduction ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Environment ', ' Address ', ' Length ', ' Epidemic ', ' Symptoms ', ' Data Set ', ' Dataset ', ' Ethnic group ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Adherence (attribute) ', ' Adherence ', ' Data ', ' Range ', ' Enrollment ', ' enroll ', ' transmission process ', ' Transmission ', ' trend ', ' Rate ', ' Characteristics ', ' Heterosexuals ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Affect ', ' base ', ' improved ', ' Health Resources ', ' Health Services ', ' health care service ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seroprevalence ', ' Site ', ' Medical ', ' Logistic Regressions ', ' Injection of therapeutic agent ', ' Injections ', ' Childhood ', ' pediatric ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Linear Models ', ' Individual ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' Literature ', ' Policies ', ' Living Arrangement ', ' Drug usage ', ' drug use ', ' Needle-Exchange Programs ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Marital Status ', ' men ', "" men's "", ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health Services ', ' Mental Hygiene Services ', ' Methadone ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl- ', ' Mortality Vital Statistics ', ' Mortality ', ' New York ', ' New York City ', ' Smoker ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Puerto Rican ', ' Puerto Rico ', ' Condition ', ' Recommendation ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sexual Partners ', ' sex partner ', ' Social support ', ' social support network ', ' Knowledge ', ' Life ', ' Testing ', ' Time ', ' Treatment Protocols ', ' Treatment Schedule ', ' Treatment Regimen ', ' Woman ', ' Hour ', ' Severities ', ' Behavior ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Injecting drug user ', ' Injection Drug User ', ' Services ', ' AIDS/HIV diagnosis ', ' experience ', ' Self Efficacy ', ' Prevention program ', ' Reporting ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Gender ', ' Measures ', ' Admission activity ', ' Admission ', ' Crack Cocaine ', ' free base cocaine ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Case Study ', ' case report ', ' Healthcare ', ' health care ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Highly Active Antiretroviral Therapy ', ' highly active anti-retroviral therapy ', ' HAART ', ' Accounting ', ' Acculturation ', ' Cultural Assimilation ', ' Communities ', ' Community Services ', ' pediatric trauma ', ' childhood trauma ', ' adolescent trauma ', ' Minority ', ' Population ', ' ethnic minority population ', ' ethnic minority ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R03,2008,71589,0.08708573955510976
"Service Use, ATI Program Outcomes, and Pro-Social Change This application details a proposal for a prospective longitudinal panel study with a random sample of 360 individuals attending alternative to incarceration (ATI) programs in New York City (NYC) that serve drug- involved offenders. The proposed study focuses on (1) the impact of utilization of formal healthcare and psychosocial services on outcomes of ATI program completion, recidivism, technical violations (i.e., law- breaking behaviors not resulting in re-incarceration), and pro-social change (e.g., fulfilling child- and elder- caretaking roles); and (2) factors affecting service utilization among ATI program participants. The study fulfills several recommendations from the Blue Ribbon Task Force on Health Service Research at NIDA, including broadening both (a) the venues of drug abuse services researchto include programs in ""nontraditional"" settings, especially the criminal justice system, and (b) the range of needs and characteristics of subgroups that are studied in order to address a fuller ""continuum of care and patient groups."" The Task Force's recommendations echoed other calls regarding the need to elucidate mediators of success of treatment, especially those in nontraditional settings such as criminal justice programs for drug-involved offenders.Also consistent with the Task Force report, the proposed research will employ new data analysis methods for causal inference using observational data. The significance and feasibility of the proposed study are substantiated by findings from a pilot study successfully completed by the investigators. For the proposed study, we will recruit individuals at the start of their participation in ATI programs designed for adult, drug-involved offenders in NYC, conducting structured interviews every 3 months over the course of 18 months for each participant. Aims, hypotheses, and measurements are guided by the Network Episode Model, an innovative model that conceptualizes access and attendance of formal services as a time-varying behavior driven by level of need and shaped by dynamic processes involving individual/social context factors and service system experiences. The proposed study is designed to achieve the following primary aims: (1) To examine the causal relationship between service utilization and (a) ATI program completion, (b) recidivism, (c) technical violations, and (d) pro-social change; and (2) To identify and estimate the causal impact of factors that influence access and utilization of formal services among ATI participants. Findings will generate substantive and practical implications for researchers and professionals in the areas of drug abuse, services research, criminal justice, and public health in developing and testing future interventions and programs for drug-involved offenders. The proposed study will be conducted by Dr. Elwin Wu and Dr. Nabila EI-Bassel of the Social Intervention Group at the Columbia University School of Social Work. ","Service Use, ATI Program Outcomes, and Pro-Social Change",7388862,R01DA019496,"['Affect ', ' Age ', ' criminal behavior ', ' Elderly ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Goals ', ' improved ', ' Health ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Site ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Medical ', ' Randomized Clinical Trials ', ' Interview ', ' Laws ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Individual ', ' Trust ', ' Literature ', ' satisfaction ', ' Measurement ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' men ', "" men's "", ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Mentors ', ' Mentorship ', ' Methods ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Motivation ', ' New York City ', ' Collaborations ', ' Therapeutic ', ' Patients ', ' Perception ', ' Pilot Projects ', ' pilot study ', ' Poverty ', ' Shapes ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Condition ', ' Recommendation ', ' Recruitment Activity ', ' recruit ', ' Relapse ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Schools ', ' Social Change ', ' Social transformation ', ' Social modification ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Problems ', ' social disturbance ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Psychiatric Social Work ', ' psychosocial service ', ' Psychiatric Social Service ', ' sociologist ', ' Consensus ', ' Life ', ' programs ', ' Target Populations ', ' Testing ', ' Time ', ' Universities ', ' Attitude ', ' Woman ', ' Work ', ' Severities ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Behavioral Research ', ' psychosocial ', ' Services ', ' drug abuse education ', ' drug use education ', ' experience ', ' success ', ' professor ', ' knowledge base ', ' knowledgebase ', ' intervention program ', ' California ', ' Structure ', ' Participant ', ' Prevention Research ', ' recidivism ', ' Diversion Program ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' offender ', ' criminal offender ', ' Reporting ', ' social ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Gender ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Drug Courts ', ' Criminal Justice ', ' Illicit Drugs ', ' Healthcare ', ' health care ', ' Outcome Measure ', ' Modeling ', ' Sampling ', ' driving behavior ', ' response ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' cost ', ' design ', ' designing ', ' Outcome ', ' Population ', ' prospective ', ' Trauma ', ' innovation ', ' innovative ', ' innovate ', ' service utilization ', ' addiction ', ' addictive disorder ', ' Consultations ', ' Continuity of Patient Care ', ' Continuum of Care ', ' Continuity of Care ', ' Data Analyses ', ' Data Analysis ', ' Provider ', ' health disparity ', ' health disparities ', ' Dropout ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Employment ', ' Address ', ' Social Network ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Range ', ' Subgroup ', ' Rate ', ' Principal Investigator ', ' Characteristics ', ' Process ', ' Face ', ' facial ', ' faces ', ' Advisory Committees ', ' Task Forces ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' ']",NIDA,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2008,344711,0.05683189616172595
"Morehouse School of Medicine (M-MIDARP) The overall aim of this program is to strengthen and expand the drug abuse and HIV/AIDS prevention research capacity at Morehouse School of Medicine (MSM) by bringing together key academic and community-based programs in the development of an integrated correctional drug abuse and HIV/AIDS prevention research component. This capacity will incorporate training in new research skills and create an aggregation of individual faculty with appropriate community-based agencies as research teams within the criminal justice system. The MSM MIDARP will:1. Establish opportunities for training and development of drug abuse and HIV/AIDS prevention research interfacing with the Criminal Justice System (CJS) and existing community programs. 2. Construct an integrative culturally competent drug abuse and HIV/AIDS prevention research paradigm which addresses the needs of individuals who have come under the jurisdiction of the criminal justice system by utilizing existing community programs and Evidence-Based Practices. 3. Minimize disparities in community services to reduce recidivism among currently or previously incarcerated individuals. 4. Develop a nexus of organizations among the Georgia Department of Corrections, Georgia Department of Juvenile Justice and community based services that supplements the new research curriculum and faculty service programs, and makes sustainable gains in terms of scholarly publications, effective new service delivery paradigms, and individual client outcomes. 5. Expose young African-American medical students, masters of public health students and undergraduate students to correctional drug abuse and HIV/AIDS prevention community-based research to facilitate their post-graduate career choices. 6.Expand the areas of drug abuse and HIV/AIDS prevention research under investigation at Morehouse School of Medicine to additional indication areas, increase the number of minority physicians and faculty in drug abuse and HIV/AIDS prevention research, and increase the number of supported drug abuse and HIV/AIDS prevention research programs across MSM departments (especially Psychiatry, Family Medicine, Community Health and preventive medicine, and community voices program with its 8 grantees in cities across the country). Our intention is that MSM will be recognized as a local, regional, and national resource and training center for drug abuse and HIV/AIDS prevention for research programs. ",Morehouse School of Medicine (M-MIDARP),7854104,R24DA021527,"['Educational Curriculum ', ' Curriculum ', ' Public Health Students ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Address ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Evidence based practice ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Master of Public Health ', ' M.P.H. ', ' Master of Science ', ' Research Infrastructure ', ' Infrastructure ', ' Community Health ', ' Development ', ' developmental ', ' Faculty ', ' Family Practice ', ' family medicine ', ' Intention ', ' base ', ' improved ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Intervention Studies ', ' interventions research ', ' intervention research ', ' Training ', ' Justice ', ' Individual ', ' Methods ', ' Physicians ', ' Preventive Medicine ', ' preventative medicine ', ' Psychiatry ', ' Publications ', ' Scientific Publication ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Resources ', ' Research Resources ', ' medical schools ', ' school of medicine ', ' medical college ', ' programs ', ' Students ', ' Medical Students ', ' Voice ', ' Investigation ', ' System ', ' LOINC Axis 4 System ', ' Country ', ' interest ', ' Services ', ' skills ', ' Prevention Research ', ' Community based prevention ', ' recidivism ', ' Career Choice ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Research Methodology ', ' Research Methods ', ' Cities ', ' Client ', ' Clinical Research ', ' Clinical Study ', ' correctional system ', ' Communities ', ' Community Services ', ' design ', ' designing ', ' Minority ', ' Outcome ', ' Population ', ' community based service ', ' ']",NIDA,MOREHOUSE SCHOOL OF MEDICINE,R24,2009,21762,0.12824035441533166
"Clinical and Social Implications of Cost Sharing for Cancer Drugs    DESCRIPTION (provided by applicant): Dr. Yu-Ning Wong, a Medical Oncologist at Fox Chase Cancer Center is dedicated to a career in cancer health services research. Her goal is to develop a multidisciplinary research program to understand the impact of insurance design on cancer drug utilization and clinical outcomes. This Career Development Award will provide the means to take two important steps towards accomplishing this goal. First, it will allow for additional intensive mentored education and training in public policy research, health economics, and advanced statistical methods that will augment the candidate's previous rigorous training in epidemiology, biostatistics, and clinical medicine. Second, it will support the development of an original clinical research program using rigorous epidemiologic, econometric and survey methods to examine the impact of prescription drug insurance coverage on cancer outcomes. As new costly cancer drugs are introduced, patients with both public and private insurance are facing higher out- of-pocket costs. Cost sharing between insurers and patients (though co-payments and deductibles) has been traditionally used to control costs based on an expectation that unnecessary health care utilization will be reduced. However this expectation may result in worse socioeconomic disparities in care since some patients may be unable to afford highly effective cancer treatments. The candidate proposes three complementary studies to address the important, unanswered questions about the impact of cost sharing on cancer outcomes. Project A is a conjoint analysis-based survey to measure how patients make decisions among treatments of varying efficacy, toxicity and cost. Project B uses the results from Project A in a decision analysis model to measure the sensitivity of clinical outcomes to price and patient preferences. This will also allow us to determine if is possible to improve clinical outcomes by using low cost sharing to increase adherence to high value treatments. Project C is a natural experiment using insurance claims to measure the effect of insurance design and sociodemographic factors on the receipt of a new, expensive anti-nausea medication and subsequent outcomes. This research program will triangulate on the nexus of issues central to the understanding of cost sharing on cancer drug utilization and clinical outcomes and form the foundation for the candidate's transition to an independent investigator in cancer health services research. This project will have broad implications for the financing of high cost medical interventions because it will help policy makers, insurers and physicians understand how current models of cost sharing may contribute to socioeconomic disparities in cancer care. Our results may suggest consideration of a novel benefit design that encourages patients to make decisions based on relative value, rather than cost alone.           ",Clinical and Social Implications of Cost Sharing for Cancer Drugs,7694277,K07CA136995,"['Cost Control ', ' Cost Containment ', ' Decision Analysis ', ' Decision Analyses ', ' Decision Making ', ' Deductibles ', ' aprepitant ', ' Diffusion ', ' Drug Utilization ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Caring ', ' Adherence (attribute) ', ' Adherence ', ' Data ', ' Policy Research ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Cancer Patient ', ' Fox Chase Cancer Center ', ' Observational Study ', ' Principal Investigator ', ' Characteristics ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Development ', ' developmental ', ' Adoption ', ' Foundations ', ' Affect ', ' Patient Care ', ' Patient Care Delivery ', ' base ', ' career ', ' Elderly ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' improved ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Clinical ', ' Medical ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Insurance ', ' Insurance Carriers ', ' Insurers ', ' Training ', ' Uninsured Medical Expense ', ' total medical expenditure ', ' medical expenses not covered by insurance ', ' Uninsured Medical Fees (not covered) ', ' Uncovered Uninsured Medical Expense ', ' Uncovered Medical Expenses ', ' Out-of-Pocket Expense ', ' Individual ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' Policy Maker ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Mentors ', ' Methods ', ' Nausea ', ' Medical Oncologist ', ' Patients ', ' Physicians ', ' Antiemetics ', ' Antiemetic Drugs ', ' Antiemetic Agents ', ' Anti-emetics ', ' Probability ', ' Antineoplastic Agents ', ' anticancer drug ', ' anticancer agent ', ' Tumor-Specific Treatment Agents ', ' Neoplastic Disease Chemotherapeutic Agents ', ' Cancer Drug ', ' Antineoplastics ', ' Antineoplastic Drugs ', ' Anti-Cancer Agents ', ' Public Policy ', ' Supportive care ', ' Supportive Therapy ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Patient Preferences ', ' Insurance Coverage ', ' Insurance Status ', ' programs ', ' Survey Methodology ', ' Survey Method ', ' Surveys ', ' Survey Instrument ', ' United States ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Training and Education ', ' Toxic effect ', ' Toxicities ', ' expectation ', ' novel ', ' payment ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Measures ', ' Price ', ' pricing ', ' Relative (related person) ', ' Relative ', ' Statistical Methods ', ' Treatment outcome ', ' Cost Sharing ', ' Drug Insurance ', ' Healthcare ', ' health care ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Modeling ', ' Treatment Cost ', ' Underinsured ', ' Chronically Ill ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Clinical Medicine ', ' Clinical Medical Sciences ', ' Clinical Research ', ' Clinical Study ', ' cancer therapy ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' cancer care ', ' Vulnerable Populations ', ' vulnerable group ', ' cost ', ' health economics ', ' design ', ' designing ', ' older patient ', ' elderly patient ', ' Outcome ', ' Natural experiment ', ' innovation ', ' innovative ', ' innovate ', ' chemotherapy ', ' social implication ', ' ']",NCI,FOX CHASE CANCER CENTER,K07,2009,143359,0.027485458307407232
"Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth    DESCRIPTION (provided by applicant): The proposed study's overarching goal is to reduce the ethnic disparities in illicit drug use, cigarette use, and HIV between Hispanic and non-Hispanic youth. This goal will be accomplished by four aims: AIM 1 is to evaluate the effectiveness of Familias Unidas, relative to Community Practice (i.e., standard prevention services), in preventing illicit drug use; AIM 2 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing cigarette use; AIM 3 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing unprotected sexual behavior; and AIM 4 is to assess the extent to which family functioning mediates the effects of the intervention on illicit drug use, cigarette use, and unprotected sexual behavior. Twenty four middle schools with a total sample of 744 Hispanic adolescents from a wide geographic area of Miami-Dade County will be randomized using a block design to one of two conditions: Familias Unidas or Community Practice. The Familias Unidas intervention has been evaluated and found to be efficacious in two separate randomized controlled trials. In the first study (Pantin et al., 2003), Familias Unidas was shown to be efficacious relative to a no intervention control condition in increasing family functioning and reducing behavior problems (Prado et al., 2006), risk factors for youth illicit drug use and unprotected sex. In the second randomized controlled trial (Prado et al., in press), Familias Unidas was found to be efficacious, relative to two attention control conditions, in preventing cigarette use and illicit drug use. Familias Unidas was also found to be efficacious relative to both of the control conditions in preventing/reducing unprotected sexual behavior at last sexual intercourse. Finally, family functioning was found to mediate the effects of intervention condition on the outcomes. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more effective than Community Practice in reducing illicit drug use over time; (H2) Familias Unidas will be more effective than Community Practice in reducing cigarette use over time; and (H3) Familias Unidas will be more effective than Community Practice in reducing unprotected sexual behavior over time. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on illicit drug use will be partially mediated by family functioning; (H2a) the effect of Familias Unidas on cigarette use will be partially mediated by family functioning and (H3a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by family functioning. PUBLIC HEALTH RELEVANCE: The objective of the proposed study is to reduce illicit drug use, cigarette use, and unsafe sexual behavior health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, cigarette use, unprotected sexual behavior, and HIV in Hispanic adolescents.                 The objective of the proposed study is to reduce illicit drug use, cigarette use, and unsafe sexual behavior health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, cigarette use, unprotected sexual behavior, and HIV in Hispanic adolescents.",Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth,7779101,R01DA025192,"['health disparity ', ' health disparities ', ' Effectiveness ', ' prevent ', ' preventing ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Ethnic group ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Clinical Trials Design ', ' trial design ', ' Community Practice ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Development ', ' developmental ', ' Family ', ' Guidelines ', ' Geographic Locations ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Age ', ' Goals ', ' improved ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Family Study ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Randomized Controlled Clinical Trials ', ' Training ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Linear Models ', ' Drug usage ', ' drug use ', ' Americas ', ' Manuals ', ' Problem behavior ', ' behavioral problem ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Amphetamines ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Benzeneethanamine, alpha-methyl-, (+-)- ', ' Educational Intervention ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Parents ', ' Staging ', ' public health medicine (field) ', ' Public Health ', ' Publishing ', ' Risk Factors ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Societies ', ' Knowledge ', ' Testing ', ' Time ', ' United States ', ' Attention ', ' parental monitoring ', ' parent monitoring ', ' Parenting behavior ', ' Parenting ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Modeling ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Coitus ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Accounting ', ' Communication ', ' Communities ', ' effectiveness trial ', ' adolescent substance use ', ' youth substance use ', ' design ', ' designing ', ' efficacy trial ', ' Outcome ', ' Adolescent Risk Behavior ', ' Youth Risk Behavior ', ' Population ', ' parental involvement ', ' Frequencies (time pattern) ', ' Frequency ', ' Dependence ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Behavior Therapy ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' meetings ', ' middle school ', ' Cigarette ', ' Prevention Research ', ' prevention service ', ' peer ', ' Categories ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' County ', ' Relative (related person) ', ' Relative ', ' public health relevance ', ' community setting ', ' effective intervention ', ' primary outcome ', ' intervention effect ', ' substance use prevention ', ' prevent substance use ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2009,99898,0.14666618696440634
"Community Vulnerability and Responses to Drug-User-Related HIV/AIDS    DESCRIPTION (provided by applicant): This is a competing continuation application for the Community Vulnerability and Responses to Drug-User- Related HIV/AIDS study of why large US metropolitan areas vary over time in their vulnerability to HIV/AIDS among drug users and in their responses-i.e., in policies and programs that may affect the epidemic. Drug use and HIV epidemics change over time. In the last funding period, we showed that HIV prevalence in the 96 largest US metropolitan areas declined among injection drug users (IDUs) from 1992 to 2002, and that the population prevalence of IDUs declined in these areas from 1992 to 2000, but then began to rise again. We also showed that metropolitan areas varied in these trajectories, and that a variety of social and policy forces shaped IDU prevalence, racial disparities in IDU prevalence, HIV prevalence among IDUs, racial disparities in AIDS prevalence among IDUs, drug abuse treatment coverage, and syringe exchange access and coverage. Ominously, our recent analyses indicate that the prevalence of IDUs among youth (aged 15 - 29) has begun to rise. Further, as others have shown, HIV has spread widely among NIDUs (non-injecting users of heroin, cocaine, crack, amphetamines or methamphetamine) in some metropolitan areas. These changes are occurring against the backdrop of an economy that has recently shifted from slow to rapid decline, a shift that will lead to great difficulty in maintaining, let alone expanding, services for drug users. Therefore, the Specific Aims of this proposed continuation are: 1. To describe trends, in the 96 largest US metropolitan areas from 1992 - 2012, in (a) critical epidemiologic outcomes (population prevalence of IDUs and NIDUs, and particularly their prevalence among youth; and, among IDUs, HIV prevalence, late-diagnosis HIV cases, and AIDS incidence and mortality) as well as in (b) the implementation of evidence-based drug- related interventions (drug abuse treatment, syringe exchange, HIV counseling and testing) and (c) non- evidence-based drug-related interventions (incarceration and arrests of drug users). 2. To understand how macro-social contexts (e.g., economic changes, social integration, racial residential segregation) and epidemiologic need affect interventions; how interventions and macro-social contexts together affect epidemiologic contexts; how some interventions (e.g., arrests, incarceration) affect others (e.g., syringe exchange coverage); and how some epidemiologic outcomes (e.g., prevalence of young IDUs) affect others (e.g., HIV prevalence). 3. To develop an integrated theory, using agent based modeling, of how these processes interact and thus what the impacts of various intervention mixes are likely to be in given social contexts. 4. To disseminate estimates, results and theoretical understandings to public health agencies and continue to advise them on how they might respond.    PUBLIC HEALTH RELEVANCE: This project will estimate changes in injection and non-injection drug use, in HIV, AIDS and AIDS mortality rates among injection drug users, and in drug- and HIV-related interventions among drug users, in 96 large metropolitan areas over a 21-year period (1992 - 2012). We will investigate how these epidemics and interventions affect one another, and how macro-contextual factors like economic and social conditions shape them both. We will identify metropolitan areas in which serious drug use, HIV or AIDS epidemics are emerging, and offer state and local health departments and drug agencies the best information available on policies and programs that might reduce these epidemics. Our findings will also help national public health agencies, including the CDC and SAMHSA, and other researchers, plan a mixture of evidence-based programs and policies to reduce the forces that lead to high-risk drug use and the associated HIV and AIDS epidemics.           Public Health Relevance Statement This project will estimate changes in injection and non-injection drug use, in HIV, AIDS and AIDS mortality rates among injection drug users, and in drug- and HIV-related interventions among drug users, in 96 large metropolitan areas over a 21-year period (1992 - 2012). We will investigate how these epidemics and interventions affect one another, and how macro-contextual factors like economic and social conditions shape them both. We will identify metropolitan areas in which serious drug use, HIV or AIDS epidemics are emerging, and offer state and local health departments and drug agencies the best information available on policies and programs that might reduce these epidemics. Our findings will also help national public health agencies, including the CDC and SAMHSA, and other researchers, plan a mixture of evidence-based programs and policies to reduce the forces that lead to high-risk drug use and the associated HIV and AIDS epidemics.",Community Vulnerability and Responses to Drug-User-Related HIV/AIDS,7755310,R01DA013336,"['cost effectiveness ', ' Counseling ', ' Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Data Analyses ', ' Data Analysis ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Heroin ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Diagnosis ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economic Conditions ', ' Economical Conditions ', ' Economics ', ' Environment ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Caring ', ' Data ', ' Resolution ', ' International AIDS ', ' Monitor ', ' transmission process ', ' Transmission ', ' trend ', ' Process ', ' Development ', ' developmental ', ' Fright ', ' Fear ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' Affect ', ' Age ', ' base ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seroprevalence ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Phase ', ' Variant ', ' Variation ', ' Medical ', ' racism ', ' Incidence ', ' Injection of therapeutic agent ', ' Injections ', ' Health Insurance ', ' Laws ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' insight ', ' Individual ', ' Longitudinal Studies ', ' long-term study ', ' Populations at Risk ', ' Policies ', ' Drug usage ', ' drug use ', ' Progress Reports ', ' Needle-Exchange Programs ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Funding ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Methods ', ' Mexico ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' Amphetamines ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Benzeneethanamine, alpha-methyl-, (+-)- ', ' Local Government ', ' New York ', ' Political Activities ', ' Politics ', ' Population Characteristics ', ' Population Density ', ' human population density ', ' Shapes ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Punishment ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Social Change ', ' Social transformation ', ' Social modification ', ' Social Conditions ', ' Societal Conditions ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Policies ', ' Knowledge ', ' Life ', ' Insurance Coverage ', ' Insurance Status ', ' programs ', ' Syringes ', ' Testing ', ' Time ', ' Unemployment ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Distant ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Country ', ' contextual factors ', ' Application Context ', ' Injecting drug user ', ' Injection Drug User ', ' Services ', ' experience ', ' social integration ', ' AIDS diagnosis ', ' metropolitan ', ' Heroin Users ', ' Budgets ', ' Prevention program ', ' social movement ', ' models and simulation ', ' model-based simulation ', ' Categories ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Gender ', ' Measures ', ' segregation ', ' Racial Segregation ', ' Police ', ' Crack Cocaine ', ' free base cocaine ', ' falls ', ' symposium ', ' conference ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' response ', ' Youth ', ' Youth 10-21 ', ' theories ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Highly Active Antiretroviral Therapy ', ' highly active anti-retroviral therapy ', ' HAART ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' HIV diagnosis ', ' Cohort Studies ', ' Concurrent Studies ', ' Communities ', ' Foreclosure ', ' Outcome ', ' Population ', ' Prevalence ', ' aged ', ' Evidence based program ', ' racial and ethnic ', ' racial/ethnic ', ' comparative ', ' racial and ethnic disparities ', ' high risk ', ' public health relevance ', ' evidence base ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R01,2009,662106,0.18893656527139835
"National Hispanic Science Network on Drug Abuse (NHSN) Annual Conference    DESCRIPTION (provided by applicant): This R13 meetings grant application seeks support for five yearly three-day stand alone conferences to be held at selected locations beginning in the fall of 2009. This proposal reflects a collaborative initiative between Louisiana State University Health Sciences Center and the National Hispanic Science Network on Drug Abuse (NHSN), based at the University of Miami. The annual scientific conferences help to accomplish the NHSN mission of fostering both interdisciplinary and translational research, by promoting dialogue between biologic, social, behavioral, and cultural scientists and disseminating findings back to the field. Previous conferences, supported through a NIDA-funded contract, have been an effective platform for developing the aims of the NHSN, with particular emphasis on mentoring and training Hispanic graduate students and early career scientists. The aims of the conferences will be: A) to advance science in the area of drug abuse research and its co-morbid conditions, particularly as it impacts on the Hispanic population. It will promote bidirectional translational research ranging from bench to community and a trans-disciplinary cross-fertilization of ideas among scientists from all fields of drug abuse helping to establish future research priorities. B) To foster the development of Hispanic researchers, with emphasis in areas related to drug abuse research by facilitating the development of integrated and continuous collaborative and mentoring networks. Funding is requested to support participation for 50 trainees/early career scientists and 20 research scientists presenting in the scientific panels. An average of 150 participants, representing the field from the national and international scientific communities, are expected at each yearly conference, including members of the global research community whose interests encompass a multifaceted approach to understanding the factors underlying health disparities as they pertain to drug use and abuse ranging from epidemiology to environmental health, psychology, sociology, health policy, neuroscience and other biomedical sciences, and epigenetics. The first conference proposed ""Integrating Population, Laboratory, and Clinical Sciences in Minority Health"" will be hosted by the University of Miami, from December 1-3, 2009. The format of the conference aims to provide ample opportunity for discussion, networking, and collaboration discussions as well as development of new ideas related to training and mentoring of the next generation of researchers in the field of drug abuse. The themes, scientific content, and program for each conference will be developed by a Scientific Conference committee comprised of NHSN members, NIH officials, and federal liaisons. The themes will be directly related to NIDA's strategic plan and the NIH blueprint, addressing timely topics and developing challenges in the field. PUBLIC HEALTH RELEVANCE: The Annual National Hispanic Science Network on Drug Abuse Conference provides multidisciplinary scientists in drug abuse and related fields interested in advancing science, particularly as it pertains to the Hispanic population, to have a collegial exchange providing a forum for discussion and dissemination of research findings and an opportunity for networking and mentoring trainees in the area of drug abuse research. This unique opportunity will promote bidirectional translational research ranging from bench to community and a trans-disciplinary cross-fertilization of ideas among scientists from all fields of drug abuse. The PI and the organizing committee are confident that the proposed conferences will serve as a platform to establish future research priorities for the field of drug abuse as it pertains to the Hispanic population.            Project narrative  The Annual National Hispanic Science Network on Drug Abuse Conference provides multidisciplinary   scientists in drug abuse and related fields interested in advancing science, particularly as it pertains   to the Hispanic population to have a collegial exchange providing a forum for discussion and   dissemination of research findings and an opportunity for networking and mentoring trainees in the   area of drug abuse research. This unique opportunity will promote bidirectional translational   research ranging from bench to community and a trans-disciplinary cross-fertilization of ideas   among scientists from all fields of drug abuse. The PI and the organizing committee are confident   that the proposed conferences will serve as a platform to establish future research priorities for the   field of drug abuse as it pertains to the Hispanic population.    ",National Hispanic Science Network on Drug Abuse (NHSN) Annual Conference,7673090,R13DA026647,"['health disparity ', ' health disparities ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Environmental Health ', ' Environmental Health Science ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Applications Grants ', ' Grant Proposals ', ' Health Sciences ', ' International ', ' Strategic Planning ', ' Clinical Sciences ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Translational Research ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Development ', ' developmental ', ' Behavioral ', ' Fertilization ', ' Fertility/Fertilization ', ' Future ', ' base ', ' career ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' minority health ', ' Area ', ' Training ', ' Laboratories ', ' Louisiana ', ' Fostering ', ' Drug usage ', ' drug use ', ' Funding ', ' Mentors ', ' Mission ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Neurosciences ', ' Collaborations ', ' Health Psychology ', ' Contracts ', ' Contracting Opportunities ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Science ', ' Sociology ', ' Research Priority ', ' programs ', ' Scientist ', ' Universities ', ' Location ', ' Back ', ' Dorsum ', ' interest ', ' meetings ', ' Participant ', ' member ', ' graduate student ', ' social ', ' falls ', ' symposium ', ' conference ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Communities ', ' dissemination research ', ' next generation ', ' Population ', ' multidisciplinary ', ' public health relevance ', ' ']",NIDA,LSU HEALTH SCIENCES CENTER,R13,2009,135036,0.0829885288088024
"PRESCRIBING PSYCHOTROPIC DRUGS TO YOUTH: CULTURAL FACTORS IN PARENTAL ATTITUDES    DESCRIPTION (provided by applicant): This project proposes the first study to examine whether culturally related constructs explain ethnic and racial differences in parents' willingness to prescribe psychotropic drugs to youth. Despite 20 years of increasing prescriptions to minors, Black and Latino children remain half as likely as White children to receive medication. Socio-demographic and clinical variables do not account for the difference, which parallels findings of greater Black and Latino skepticism toward psychotropic medication. ""Cultural factors"" are said to explain the difference, but they have rarely been theorized or measured directly in large non-clinical and clinical samples of parents. Familism, traditionalism, fatalism, religiosity, beliefs about causes of youth disorders, perceived psychiatric medication treatment of youth stigma, acceptability of corporal punishment, and acceptability of psychotropic medication may be such factors. If so, then they should mediate the relationship between ethnicity/race and willingness to prescribe. The study will test this assumption using attitudinal and socio-demographic data collected during telephone interviews in English and Spanish with 1224 Black, Latino, and White parents or guardians of 5-17-year-old children, drawn by random-digit dialing from one ethnically diverse South Florida county. The sample will be stratified by ethnicity and race, with each of three equal-sized strata (n=408) further equally stratified by presence (n=204) or absence (n=204) in household of children with emotional or behavior problems, enabling adequate group comparisons to test - both in a general population sample of parents and in a sample of parents whose children might be referred for mental health treatment evaluation - the mediating role of culturally related constructs within a structural equation model. Potentially moderating influences of gender and SES on the model will also be tested. By increasing our ability to interpret ethnic and racial group differences more accurately, we may improve the cultural competence and fit of preventive and clinical interventions aimed at culturally diverse families. Moreover, given an uncertain benefit-to-risk ratio of psychotropic prescriptions to youth, it remains undetermined whether at a population level ethnic and racial differences should be understood as a health disparity favoring the majority because of White youths' greater exposure to drugs' benefits, or, conversely, as a public health advantage for minority youths because of their lesser exposure to drugs' risks. This study takes a logical first step toward exploring culturally embedded reasons for the majority's enthusiasm as well as for minorities' skepticism. PUBLIC HEALTH RELEVANCE: This is the first research to date that directly addresses various potential cultural factors that may mediate, in parents, the decision to have psychotropic drugs prescribed to their children. Authors have often suggested that cultural factors play a role in producing observed differences in prescription rates among ethnic and racial groups, but no model so far has specified these possible factors and their relationships. If cultural factors impact psychotropic drug prescription practices with youth, this study will be help to understand these factors more accurately, which could lead to improved outreach, educational, and clinical interventions for families and youths with mental health problems.          ",PRESCRIBING PSYCHOTROPIC DRUGS TO YOUTH: CULTURAL FACTORS IN PARENTAL ATTITUDES,7685527,R21MH084832,"['Data Analyses ', ' Data Analysis ', ' health disparity ', ' health disparities ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Preventive ', ' Ethnic group ', ' Data ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Family ', ' Female ', ' Florida ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' racial/ethnic difference ', ' improved ', ' Household ', ' Clinical ', ' Specific qualifier value ', ' Specified ', ' Medical ', ' Telephone Interviews ', ' Evaluation ', ' Distress ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Problem behavior ', ' behavioral problem ', ' Minor ', ' Respondent ', ' Odds Ratio ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Parents ', ' Play ', ' Drug Prescriptions ', ' Drug Prescribing ', ' Exposure to ', ' Psychotropic Drugs ', ' Psychopharmaceuticals ', ' Psychoactive Drugs ', ' Psychoactive Compound ', ' Psychoactive Agents ', ' public health medicine (field) ', ' Public Health ', ' Punishment ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Risk ', ' Role ', ' social role ', ' Stigmata ', ' Knowledge ', ' Testing ', ' Attitude ', ' Dimensions ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' Country ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Belief ', ' Equation ', ' Digit structure ', ' Digit ', ' Proxy ', ' cultural competence ', ' parental role ', ' parent role ', ' Agreement ', ' outreach ', ' General Population ', ' General Public ', ' County ', ' Gender ', ' Measures ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Emotional ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Latino ', ' Mediating ', ' Modeling ', ' Sampling ', ' social stigma ', ' stigma ', ' Youth ', ' Youth 10-21 ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Accounting ', ' comparison group ', ' design ', ' designing ', ' Minority ', ' willingness ', ' Outcome ', ' Population ', ' 17 year old ', ' seventeen year old ', ' age 17 years ', ' 18 year old ', ' eighteen year old ', ' age 18 years ', ' racial and ethnic ', ' racial/ethnic ', ' public health relevance ', ' ']",NIMH,FLORIDA INTERNATIONAL UNIVERSITY,R21,2009,129600,0.03896925970284357
"Morehouse School of Medicine (M-MIDARP)    DESCRIPTION (provided by applicant): The overall aim of this program is to strengthen and expand the drug abuse and HIV/AIDS prevention research capacity at Morehouse School of Medicine (MSM) by bringing together key academic and community-based programs in the development of an integrated correctional drug abuse and HIV/AIDS prevention research component. This capacity will incorporate training in new research skills and create an aggregation of individual faculty with appropriate community-based agencies as research teams within the criminal justice system. The MSM MIDARP will: 1. Establish opportunities for training and development of drug abuse and HIV/AIDS prevention research interfacing with the Criminal Justice System (CJS) and existing community programs. 2. Construct an integrative culturally competent drug abuse and HIV/AIDS prevention research paradigm which addresses the needs of individuals who have come under the jurisdiction of the criminal justice system by utilizing existing community programs and Evidence-Based Practices. 3. Minimize disparities in community services to reduce recidivism among currently or previously incarcerated individuals. 4. Develop a nexus of organizations among the Georgia Department of Corrections, Georgia Department of Juvenile Justice and community based services that supplements the new research curriculum and faculty service programs, and makes sustainable gains in terms of scholarly publications, effective new service delivery paradigms, and individual client outcomes. 5. Expose young African-American medical students, masters of public health students and undergraduate students to correctional drug abuse and HIV/AIDS prevention community-based research to facilitate their post-graduate career choices. 6.Expand the areas of drug abuse and HIV/AIDS prevention research under investigation at Morehouse School of Medicine to additional indication areas, increase the number of minority physicians and faculty in drug abuse and HIV/AIDS prevention research, and increase the number of supported drug abuse and HIV/AIDS prevention research programs across MSM departments (especially Psychiatry, Family Medicine, Community Health and preventive medicine, and community voices program with its 8 grantees in cities across the country). Our intention is that MSM will be recognized as a local, regional, and national resource and training center for drug abuse and HIV/AIDS prevention for research programs.          ",Morehouse School of Medicine (M-MIDARP),7760293,R24DA021527,"['Marijuana Smoking ', ' marijuana use ', ' men ', "" men's "", ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Mission ', ' Needles ', ' Analysis of Variance ', ' Variance Analyses ', ' Monoclonal Antibody R24 ', ' R24 ', ' R-24 Monoclonal Antibody ', ' MoAb R24 ', ' New York ', ' Personal Satisfaction ', ' well-being ', ' Physicians ', ' Pilot Projects ', ' pilot study ', ' Poverty ', ' Powder dose form ', ' Powders ', ' Preventive Medicine ', ' preventative medicine ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Prisons ', ' Shapes ', ' Contracts ', ' Contracting Opportunities ', ' Psychiatry ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Nature ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Research Support ', ' Residencies ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' medical schools ', ' school of medicine ', ' medical college ', ' Science ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Knowledge ', ' Life ', ' programs ', ' statistics ', ' Students ', ' Medical Students ', ' Time ', ' Tuberculosis ', ' tuberculous spondyloarthropathy ', ' infection due to Mycobacterium tuberculosis ', ' disseminated tuberculosis ', ' disseminated TB ', ' Mycobacterium tuberculosis infection ', ' Mycobacterium tuberculosis (MTB) infection ', ' Mtb infection [{C0041296}] ', ' MTB infection ', ' M.tuberculosis infection ', ' M. tuberculosis infection ', ' Attitude ', ' Voice ', ' Investigation ', ' Work ', ' Writing ', ' Hour ', ' Protocols documentation ', ' Protocol ', ' System ', ' LOINC Axis 4 System ', ' Country ', ' Behavior ', ' interest ', ' Injecting drug user ', ' Injection Drug User ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' meetings ', ' Services ', ' Training and Education ', ' experience ', ' professor ', ' Books ', ' condoms ', ' skills ', ' Prevention Research ', ' Community based prevention ', ' member ', ' recidivism ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' repeat offender ', ' multiple offender ', ' habitual offender ', ' Prevention ', ' probation ', ' offender ', ' criminal offender ', ' Human Resources ', ' personnel ', ' Manpower ', ' Reporting ', ' Career Choice ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Cause of Death ', ' parole ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' Administrator ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Research Methodology ', ' Research Methods ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Sampling ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Client ', ' Clinical Research ', ' Clinical Study ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' correctional system ', ' Communicable Diseases ', ' Infectious Disorder ', ' Infectious Diseases and Manifestations ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communities ', ' Community Services ', ' Professional Role ', ' design ', ' designing ', ' Minority ', ' community living ', ' Outcome ', ' Population ', ' 13 year old ', ' thirteen year old ', ' age 13 years ', ' community based service ', ' ethnic minority population ', ' ethnic minority ', ' high risk ', ' effective intervention ', ' substance use prevention ', ' prevent substance use ', ' consistent condom use ', ' cocaine use ', ' Educational Curriculum ', ' Curriculum ', ' Cessation of life ', ' Death ', ' Public Health Students ', ' ecstasy ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' substance abuse prevention ', ' substance abuse control ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Institution ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Controls ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Address ', ' Preventive ', ' violence prevention ', ' prevent violence ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Jail ', ' Evidence based practice ', ' Advocate ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Master of Public Health ', ' M.P.H. ', ' Master of Science ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Research Infrastructure ', ' Infrastructure ', ' Preparation ', ' Community Health ', ' Development ', ' developmental ', ' Faculty ', ' Behavioral ', ' Family Practice ', ' family medicine ', ' Female ', ' Female Adolescents ', ' adolescent girl ', ' Male Adolescents ', ' adolescent boy ', ' pandemic disease ', ' pandemic ', ' Intention ', ' Public Domains ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' Age ', ' base ', ' Goals ', ' Grant ', ' improved ', ' Health ', ' Health behavior ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Hepatitis ', ' Alcohol consumption ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Medical ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' Intervention Studies ', ' interventions research ', ' intervention research ', ' Training ', ' Justice ', ' Health Knowledge, Attitudes, Practice ', ' Knowledge, Attitudes, Practice ', ' Knowledge, Attitudes, Behaviors ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Homelessness ', ' unhoused ', ' homeless ', ' Individual ', ' Drug usage ', ' drug use ', ' Funding ', ' male ', ' Marihuana ', ' marijuana ', ' ']",NIDA,MOREHOUSE SCHOOL OF MEDICINE,R24,2009,28903,0.12824035441533166
"Effect of Prescription Drug Benefits on Cardiovascular Outcomes in the Elderly  In 2006, the United States implemented the Medicare Modernization Act, which expanded prescription drug coverage for Medicare beneficiaries at an estimated cost of $768 billion dollars over the next decade. Improved access to drug benefits may improve cardiovascular outcomes for the elderly by providing financial access to effective therapy. However, there is limited research about the impact of prescription drug coverage on health outcomes. In addition, although black enrollees have been found to have markedly lower use of antihypertensive, lipid-lowering and anti-platelet medications, little is known about the role of prescription drug coverage as a mediator of racial and socioeconomic disparities in cardiovascular outcomes.             In this project, we will investigate the effect of prescription drug benefits on the use of appropriate secondary preventive medication and achievement of favorable clinical outcomes among Medicare managed care enrollees with cardiovascular disease. The project will also assess the role of prescription drug coverage in explaining racial and socioeconomic disparities in cardiovascular outcomes.  Effective drugs, such as aspirin, beta-blockers, statins, and ace-inhibitors, are a cornerstone in the prevention and treatment of heart disease, yet over half of appropriate patients do not receive them. The cost of chronic drug therapy is a substantial barrier for elderly patients who have lower fixed incomes and sizable out-of- pocket spending on health care. This study will assess the effect of prescription drug coverage on outcomes of care for elderly patients with coronary heart disease.",Effect of Prescription Drug Benefits on Cardiovascular Outcomes in the Elderly,7837986,RC1AG036158,"['coronary disorder ', ' Coronary Disease ', ' Coronary heart disease ', ' Achievement Attainment ', ' Achievement ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Favorable Clinical Outcome ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Preventive ', ' Dataset ', ' Data Set ', ' Caring ', ' Adherence ', ' Adherence (attribute) ', ' Improve Access ', ' Resource Sharing ', ' enroll ', ' Enrollment ', ' Coronary ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' socioeconomics ', ' beneficiary ', ' Faculty ', ' beta-Adrenergic Receptor Blockaders ', ' beta-Adrenergic Blocking Agents ', ' beta blocker ', ' Adrenergic beta-Blockers ', ' Adrenergic beta-Antagonists ', ' human subject ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' improved ', ' Health ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' health insurance for disabled ', ' Title 18 ', ' Health Maintenance Organizations ', ' Prepaid Group Health Organizations ', ' Health Planning ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Heart Diseases ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Hospitalization ', ' Acute ', ' Chronic ', ' Clinical ', ' biogerontology ', ' Gerontology ', ' Incidence ', ' Economical Income ', ' Economic Income ', ' Income ', ' white American ', ' caucasian American ', ' Life Expectancy ', ' Individual ', ' Lipids ', ' beta-Lipoprotein Cholesterol ', ' Low Density Lipoprotein Cholesterol ', ' LDL Cholesterol ', ' LDL Cholesterol Lipoproteins ', ' Funding ', ' Modernization ', ' Mortality ', ' Mortality Vital Statistics ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Myocardial Infarction ', ' Persons ', ' Kininase II Inhibitors ', ' Kininase II Antagonists ', ' Angiotensin-Converting Enzyme Antagonists ', ' Angiotensin I-Converting Enzyme Inhibitors ', ' ACE Inhibitors ', ' Angiotensin-Converting Enzyme Inhibitors ', ' Paper ', ' Patients ', ' inhibitor ', ' inhibitor/antagonist ', ' Drug Prescribing ', ' Drug Prescriptions ', ' Hypotensives ', ' Hypotensive Drugs ', ' Hypotensive Agent ', ' Antihypertensives ', ' Antihypertensive Drugs ', ' Anti-Hypertensives ', ' Anti-Hypertensive Drugs ', ' Anti-Hypertensive Agents ', ' Antihypertensive Agents ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' school of medicine ', ' medical college ', ' medical schools ', ' Arts ', ' Measurin ', ' Extren ', ' Entericin ', ' Empirin ', ' Ecotrin ', ' Aspergum ', ' Acetylsalicylic Acid ', ' 2-(Acetyloxy)benzoic Acid ', ' Aspirin ', ' United States ', ' Universities ', ' Woman ', ' Event ', ' LOINC Axis 4 System ', ' System ', ' sq. ft ', ' square foot ', ' thrombocyte/platelet ', ' Thrombocytes ', ' Platelets Reticuloendothelial System ', ' Platelets ', ' Marrow platelet ', "" Hayem's elementary corpuscle "", "" Deetjeen's body "", "" Bizzozero's corpuscle/cell "", ' Blood Platelets ', ' American ', ' experience ', ' research facility ', ' Budgets ', ' Secure ', ' copayment ', ' Prevention ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular system (all sites) ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardiovascular system ', ' Cause of Death ', ' Gender ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' human subject protection ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Data Protection ', ' information security ', ' Data awareness ', ' Data Security ', ' health care ', ' Healthcare ', ' Managed Care ', ' Accounting ', ' co-morbidity ', ' Comorbidity ', ' Complement C3a ', ' C3a ', ' C3 a ', ' Complement 3a ', ' cost ', ' designing ', ' design ', ' Minority ', ' elderly patient ', ' older patient ', ' Outcome ', ' Population ', ' Linux ', ' advanced system ', ' high risk ', ' effective treatment ', ' effective therapy ', ' sharing data ', ' Computers ', ' information privacy ', ' Confidentiality ', ' ']",NIA,BROWN UNIVERSITY,RC1,2009,498387,0.07815164609359107
"Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users    DESCRIPTION (provided by applicant): This is a second revision of a competitive renewal R01 proposal of the NEURO-HIV Epidemiologic Study in response to NIDA PAS-07-115 (Non-injection Dug Abuse and HIV/AIDS). The primary study aim is to evaluate the ability of Integrated Family and Cognitive-Behavioral Therapy-HIV Prevention Intervention (IFCBT-HIVPI) to prevent HIV among adult non-injection and injection drug users. Over a 12 week intervention interval, the IFCBT-HIVPI model coordinates the delivery of cognitive- behavioral components during 12 group sessions with a couples and family systems component during 4 couples/family sessions to address HIV risk and protective factors across multiple ecological systems. IFCBT-HIVPI main effects on primary (HIV sexual risk behaviors and HIV drug taking risk behaviors) and secondary (HIV, Chlamydia, gonorrhea, and trichomoniasis incidences and legal involvement, academic achievement, and employment) outcome domains will be evaluated. We also seek to elucidate the degree to which the development of attitudinal and behavior change skills targeted by IFCBT-HIVPI (e.g., rational beliefs, problem solving skill, adaptive couples' communication) result in post-intervention reductions of HIV, sexually transmitted infections (STIs), and HIV risk behaviors. The possibility of effect-modification is also considered with a focus on route of drug administration status (i.e., non-injector/injector), neuropsychological (e.g., executive function), and demographic (i.e., African American/white) factors. The proposed study will randomly assign 360 HIV-negative non-injection and injection drug users recruited from the original NEURO-HIV Epidemiologic Study sample to experimental (IFCBT-HIVPI) and comparison (Brief Psychoeducation Curriculum on HIV Prevention; BPEC-HIV) conditions. The composition of the original NEURO-HIV Epidemiologic Study sample provides the basis to stratify the randomized trial sample across gender and two race/ethnicity (i.e., African American and white) groups by route of drug administration status. An assessment battery comprised of a standardized interview on HIV risk behavior, neuropsychological tests, tools to assess attitudes and behavior change skills targeted by IFCBT-HIVPI, drug and STI urine testing, and serologic tests of HIV will be administered before, during, and after the intervention interval across 18-month post-intervention follow-up. Additional preliminary analyses will be conducted on the randomized trial data to: (1) derive session-by-session measures on mechanisms of change targeted by IFCBT-HIVPI via videotape coding methods; (2) characterize mechanisms of change trajectories that may then be evaluated as plausible intervention moderators if present; and (3) estimate intervention cost-effectiveness. The lack of research on science-based prevention interventions for HIV continues to be a serious gap in the literature with recent HIV trends highlighting significant health disparities, particularly among African American non-injection drug users. If successful, the proposed project should help to identify specific attitudinal and behavior change skills targeted by cognitive- behavioral and couples/family systems interventions that foster subsequent reductions in HIV, STIs and HIV risk behaviors among adult drug users at heightened disease risk. PUBLIC HEALTH RELEVANCE: Recent estimates suggest that a majority of the 40,000 new cases of HIV reported annually in the US are attributable largely to sexual risk behavior associated with non-injection drug use. Additionally, African American drug users exhibit substantial HIV health disparities with African American females being 21 times more likely to contract HIV than white females. The proposed project is designed to address critical gaps in the HIV prevention science field by evaluating the ability of an intervention coordinating cognitive-behavioral and couples/family systems components to prevent HIV among adult drug users at heightened disease risk.           PROJECT NARRATIVE. Recent estimates suggest that a majority of the 40,000 new cases of HIV reported annually in the US are attributable largely to sexual risk behavior associated with non-injection drug use. Additionally, African American drug users exhibit substantial HIV health disparities with African American females being 21 times more likely to contract HIV than white females. The proposed project is designed to address critical gaps in the HIV prevention science field by evaluating the ability of an intervention coordinating cognitive-behavioral and couples/family systems components to prevent HIV among adult drug users at heightened disease risk.",Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users,7684997,R01DA014498,"['cost effectiveness ', ' Couples ', ' Educational Curriculum ', ' Curriculum ', ' Demographic Factors ', ' health disparity ', ' health disparities ', ' prevent ', ' preventing ', ' Legal ', ' Drug Administration Routes ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Employment ', ' Address ', ' Data Set ', ' Dataset ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Cognitive ', ' trend ', ' Characteristics ', ' Modification ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Development ', ' developmental ', ' Exhibits ', ' Behavioral ', ' Family ', ' Female ', ' Ecosystem ', ' Ecological Systems ', ' Ecologic Systems ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Pathway interactions ', ' pathway ', ' base ', ' Gonorrhea ', ' Gonococcal Infection ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Randomized Controlled Clinical Trials ', ' Incidence ', ' Injection of therapeutic agent ', ' Injections ', ' Interview ', ' post intervention ', ' Literature ', ' Fostering ', ' Drug usage ', ' drug use ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Methods ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Neuropsychological Tests ', ' Neuropsychologic Tests ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Problem Solving ', ' Contracts ', ' Contracting Opportunities ', ' tool ', ' Drug user ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Risk ', ' Science ', ' Selection Bias ', ' Serologic tests ', ' serology ', ' Serological Tests ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Testing ', ' Time ', ' Trichomonas Infections ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Urine ', ' Urine Urinary System ', ' Videotape ', ' Attitude ', ' System ', ' LOINC Axis 4 System ', ' Belief ', ' behavior change ', ' interest ', ' Injecting drug user ', ' Injection Drug User ', ' skills ', ' disorder risk ', ' disease risk ', ' Prevention ', ' Academic achievement ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Gender ', ' Measures ', ' Code ', ' Coding System ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' Outcome Assessment (Health Care) ', ' Outcomes Assessment ', ' Process Assessment (Health Care) ', ' Process Assessment ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Sampling ', ' psychoeducation ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Client ', ' executive function ', ' executive control ', ' Communication ', ' sex risk ', ' sexual risk behavior ', ' design ', ' designing ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' neuropsychological ', ' public health relevance ', ' group intervention ', ' HIV prevention trial ', ' cognitive behavior therapy ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R01,2009,665569,0.1494038709691358
"Drugs, sexual impulsivity, HIV: Psychosocial and cognitive risk factors of YMSM    DESCRIPTION (provided by applicant): Unprotected sexual intercourse between men constitutes 58% of all reported cases of AIDS and 80% of HIV cases 1,2. Rates of HIV infection among 15 to 24 year olds continue to increase with MSM behavior remaining the leading cause of HIV infection among adolescent males 1,2. Over 90% of YMSM have reported having more than one sexual partner in the past 6 months and between 33% and 49% have had unprotected anal intercourse during the same time3. Studies show that use of stimulants, particularly methamphetamine, may influence risky sexual practices and contribute to the most recent wave of HIV and other sexually transmitted infections (STIs)4-6. Systematic development of theory has been identified as a crucial step in efficacious intervention development, but previous conceptual models have focused on a relatively limited array of explanatory constructs. However, Social Action Theory (SAT)7 provides a promising model for examining the risk behavior of YMSM, because it includes individual as well as social and contextual determinants. SAT remains to be tested for use in the field of HIV and with YMSM, because this model was originally conceived as a general health promotion model for the adult population. Using data from the Dr. Kipke's NIDA funded ""Healthy Young Men Study"" (HYM), this study will conduct multivariate analysis to test this model for use with the YMSM population. The specific aims of this study are to: 1) To empirically validate the chain of relationships depicted in Social Action Theory to determine if the theory addresses the interaction of individual, contextual, and social correlates of sexual and drug risk taking behaviors as they relate to YMSM; and 2) To further validate SAT by testing and incorporating competing theoretical relationships depicted in other behavioral theory models to develop a comprehensive theory of the social, psychosocial and cognitive risk factors for drug use, sexual impulsivity, and HIV among YMSM to guide prevention intervention efforts. . This study will contribute to the objectives of the AIDS-Science Track Award for Research Transition by 1) supporting a New Researcher; 2) addressing the NIDA research objective in the area of HIV, drug abuse, impulsivity, and coping strategies of an at-risk, under represented population; and 3) through refinement of a comprehensive theoretical model, we will provide a platform for developing interventions that address risk behavior related to HIV transmission among YMSM. PUBLIC HEALTH RELEVANCE: This study will contribute to effective HIV interventions for at-risk youth by developing a model to understand how environmental risk factors, impulsivity, and coping strategies converge into drug abuse and sexual risk taking.           Proposal Narrative This study will contribute to effective HIV interventions for at-risk youth by developing a model to understand how environmental risk factors, impulsivity, and coping strategies converge into drug abuse and sexual risk taking.","Drugs, sexual impulsivity, HIV: Psychosocial and cognitive risk factors of YMSM",7685401,R03DA024976,"['Data Analyses ', ' Data Analysis ', ' Risk Reduction ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' Data ', ' High Prevalence ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Cognitive ', ' transmission process ', ' Transmission ', ' Development ', ' developmental ', ' Heterosexuals ', ' Behavioral ', ' Male Adolescents ', ' adolescent boy ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Age ', ' base ', ' career ', ' Goals ', ' Health ', ' Health behavior ', ' Health Promotion ', ' Salutogenesis ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Area ', ' psychologic ', ' psychological ', ' Evaluation ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Longitudinal Studies ', ' long-term study ', ' Drug usage ', ' drug use ', ' Funding ', ' men ', "" men's "", ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Theoretical model ', ' Theoretic Models ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Shapes ', ' Anus ', ' Anal ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Risk-Taking ', ' Science ', ' Sexual Partners ', ' sex partner ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Life ', ' Anti-HIV Agents ', ' antiAIDS agent ', ' Anti-Human Immunodeficiency Virus Agents ', ' Anti-HIV Drugs ', ' Anti-AIDS Drugs ', ' Anti-AIDS Agents ', ' AIDS Drugs ', ' Testing ', ' Complex ', ' Award ', ' Behavior ', ' psychosocial ', ' metropolitan ', ' cohort ', ' peer ', ' NIH Program Announcements ', ' Program Announcement ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Reporting ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' health belief ', ' health-related belief ', ' Impulsivity ', ' Case Study ', ' case report ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' response ', ' Youth ', ' Youth 10-21 ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Classification ', ' Systematics ', ' Coitus ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Communities ', ' sex risk ', ' sexual risk behavior ', ' Behavioral Model ', ' men who have sex with men ', ' men who have sex with other men ', ' design ', ' designing ', ' coping ', ' Guide prevention ', ' Population ', ' Prevalence ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' social cognitive theory ', ' social learning theory ', ' public health relevance ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R03,2009,168543,0.050969097749700466
"Clinical and Social Implications of Cost Sharing for Cancer Drugs    DESCRIPTION (provided by applicant): Dr. Yu-Ning Wong, a Medical Oncologist at Fox Chase Cancer Center is dedicated to a career in cancer health services research. Her goal is to develop a multidisciplinary research program to understand the impact of insurance design on cancer drug utilization and clinical outcomes. This Career Development Award will provide the means to take two important steps towards accomplishing this goal. First, it will allow for additional intensive mentored education and training in public policy research, health economics, and advanced statistical methods that will augment the candidate's previous rigorous training in epidemiology, biostatistics, and clinical medicine. Second, it will support the development of an original clinical research program using rigorous epidemiologic, econometric and survey methods to examine the impact of prescription drug insurance coverage on cancer outcomes. As new costly cancer drugs are introduced, patients with both public and private insurance are facing higher out- of-pocket costs. Cost sharing between insurers and patients (though co-payments and deductibles) has been traditionally used to control costs based on an expectation that unnecessary health care utilization will be reduced. However this expectation may result in worse socioeconomic disparities in care since some patients may be unable to afford highly effective cancer treatments. The candidate proposes three complementary studies to address the important, unanswered questions about the impact of cost sharing on cancer outcomes. Project A is a conjoint analysis-based survey to measure how patients make decisions among treatments of varying efficacy, toxicity and cost. Project B uses the results from Project A in a decision analysis model to measure the sensitivity of clinical outcomes to price and patient preferences. This will also allow us to determine if is possible to improve clinical outcomes by using low cost sharing to increase adherence to high value treatments. Project C is a natural experiment using insurance claims to measure the effect of insurance design and sociodemographic factors on the receipt of a new, expensive anti-nausea medication and subsequent outcomes. This research program will triangulate on the nexus of issues central to the understanding of cost sharing on cancer drug utilization and clinical outcomes and form the foundation for the candidate's transition to an independent investigator in cancer health services research. This project will have broad implications for the financing of high cost medical interventions because it will help policy makers, insurers and physicians understand how current models of cost sharing may contribute to socioeconomic disparities in cancer care. Our results may suggest consideration of a novel benefit design that encourages patients to make decisions based on relative value, rather than cost alone.           ",Clinical and Social Implications of Cost Sharing for Cancer Drugs,7922830,K07CA136995,"['Cost Control ', ' Cost Containment ', ' Decision Analysis ', ' Decision Analyses ', ' Decision Making ', ' Deductibles ', ' aprepitant ', ' Diffusion ', ' Drug Utilization ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Caring ', ' Adherence (attribute) ', ' Adherence ', ' Data ', ' Policy Research ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Cancer Patient ', ' Fox Chase Cancer Center ', ' Observational Study ', ' Principal Investigator ', ' Characteristics ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Development ', ' developmental ', ' Adoption ', ' Foundations ', ' Affect ', ' Patient Care ', ' Patient Care Delivery ', ' base ', ' career ', ' Elderly ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' improved ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Clinical ', ' Medical ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Insurance ', ' Insurance Carriers ', ' Insurers ', ' Training ', ' Uninsured Medical Expense ', ' total medical expenditure ', ' medical expenses not covered by insurance ', ' Uninsured Medical Fees (not covered) ', ' Uncovered Uninsured Medical Expense ', ' Uncovered Medical Expenses ', ' Out-of-Pocket Expense ', ' Individual ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' Policy Maker ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Mentors ', ' Methods ', ' Nausea ', ' Medical Oncologist ', ' Patients ', ' Physicians ', ' Antiemetics ', ' Antiemetic Drugs ', ' Antiemetic Agents ', ' Anti-emetics ', ' Probability ', ' Antineoplastic Agents ', ' anticancer drug ', ' anticancer agent ', ' Tumor-Specific Treatment Agents ', ' Neoplastic Disease Chemotherapeutic Agents ', ' Cancer Drug ', ' Antineoplastics ', ' Antineoplastic Drugs ', ' Anti-Cancer Agents ', ' Public Policy ', ' Supportive care ', ' Supportive Therapy ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Patient Preferences ', ' Insurance Coverage ', ' Insurance Status ', ' programs ', ' Survey Methodology ', ' Survey Method ', ' Surveys ', ' Survey Instrument ', ' United States ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Training and Education ', ' Toxic effect ', ' Toxicities ', ' expectation ', ' novel ', ' payment ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Measures ', ' Price ', ' pricing ', ' Relative (related person) ', ' Relative ', ' Statistical Methods ', ' Treatment outcome ', ' Cost Sharing ', ' Drug Insurance ', ' Healthcare ', ' health care ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Modeling ', ' Treatment Cost ', ' Underinsured ', ' Chronically Ill ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Clinical Medicine ', ' Clinical Medical Sciences ', ' Clinical Research ', ' Clinical Study ', ' cancer therapy ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' cancer care ', ' Vulnerable Populations ', ' vulnerable group ', ' cost ', ' health economics ', ' design ', ' designing ', ' older patient ', ' elderly patient ', ' Outcome ', ' Natural experiment ', ' innovation ', ' innovative ', ' innovate ', ' chemotherapy ', ' social implication ', ' ']",NCI,FOX CHASE CANCER CENTER,K07,2009,108000,0.027485458307407232
"Substance Use and Risky Sex in Highly Vulnerable Populations    DESCRIPTION (provided by applicant):  The proposed project will help me develop the skills and expertise necessary to establish an independent research career focused on the role of substance use in sexual risk-taking behavior and associated adverse reproductive outcomes, especially sexually transmitted infections (STIs). To achieve this goal, I will supplement my graduate training as a developmental psychologist and postdoctoral training in epidemiology with training in sexual risk behavior in vulnerable populations, health disparities associated with race, and career development in longitudinal research methodology. Complementary to these training activities, I propose: 1) secondary data analyses of sexual risk behavior and outcomes using data from an ongoing longitudinal study of the offspring of teenage mothers and a study of women with and without borderline personality disorder (BPD); 2) collection of new data on the offspring of teenage mothers during a 16-year assessment and; 3) a new pilot study of common STIs in this sample (offspring of teenage mothers). The proposed research will form the basis for an R01 application in the third year of the award period. My short term goals are to (1) increase knowledge about risk for STIs, including behavioral dysregulation that may underlie risky sex and risk factors associated with risky sex and associated outcomes, (2) learn new methods of measuring risk behavior and adverse reproductive outcomes, including clinical tests for STIs and  event-level assessments, (3) learn more about health disparities associated with race, and (4) develop the research skills that will enable me to become an independent investigator and obtain NIH funding to support my research, specifically longitudinal data analyses. My long-term career goal is to understand the ecological setting for drug use and sexual risk behaviors in vulnerable populations, and how drug use may contribute to significantly higher rates of unintended pregnancies and STIs in African-American youth. The proposed career development training will take place at the Department of Psychiatry at the University of Pittsburgh School of Medicine. This department provides an outstanding environment for interdisciplinary training by highly collaborative faculty who are leading experts in their chosen fields. PUBLIC HEALTH RELEVANCE:  The proposed research will help identify behavioral risk factors for sexually transmitted infections that are implicated in higher rates of HIV, especially among African-Americans. The results can be used to develop prevention programs aimed at reducing drug use and sexually transmitted infections among vulnerable adolescents and within psychiatric populations.           ",Substance Use and Risky Sex in Highly Vulnerable Populations,7738615,K01DA025734,"['Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Data Analyses ', ' Data Analysis ', ' health disparity ', ' health disparities ', ' Diagnosis ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Environment ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Symptoms ', ' Data ', ' Collection ', ' Principal Investigator ', ' Characteristics ', ' sex ', ' Development ', ' developmental ', ' Faculty ', ' Behavioral ', ' Family ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Age ', ' base ', ' career ', ' Goals ', ' Aggressive behavior ', ' Aggression ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' Clinical ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Training ', ' Childhood ', ' pediatric ', ' Learning ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' teenage mother ', ' teenage mom ', ' teen mother ', ' teen mom ', ' adolescent mother ', ' Longitudinal Studies ', ' long-term study ', ' sexually active ', ' Drug usage ', ' drug use ', ' Reproductive Health ', ' Funding ', ' Methods ', ' Mothers ', ' Multiple Partners ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Neighborhoods ', ' Anger ', ' angry ', ' angers ', ' Personality ', ' Pilot Projects ', ' pilot study ', ' Pregnancy ', ' Gestation ', ' Psychiatry ', ' Psychologist ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Risk-Taking ', ' Role ', ' social role ', ' Schools ', ' medical schools ', ' school of medicine ', ' medical college ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sexual Partners ', ' sex partner ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Knowledge ', ' programs ', ' statistics ', ' Substance Use Disorder ', ' Supervision ', ' Testing ', ' Training Activity ', ' Universities ', ' Unplanned pregnancy ', ' Urine ', ' Urine Urinary System ', ' Woman ', ' Event ', ' Award ', ' Location ', ' Barrier Contraception ', ' Contraceptive Barrier Methods ', ' Barrier Methods ', ' Behavior ', ' Injecting drug user ', ' Injection Drug User ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' meetings ', ' Birth ', ' Parturition ', ' Church ', ' experience ', ' cohort ', ' Gravidity ', ' Borderline Personality Disorder ', ' BPD ', ' skills ', ' Prevention program ', ' offspring ', ' Mediation ', ' Negotiation ', ' Negotiating ', ' Reporting ', ' Contraceptive methods ', ' Inhibition of Fertilization ', ' Fertility Control ', ' Contraception ', ' reproductive ', ' Gender ', ' Measures ', ' Impulsivity ', ' Emotional ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Mediating ', ' Research Methodology ', ' Research Methods ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Sampling ', ' career development ', ' Youth ', ' Youth 10-21 ', ' Adverse event ', ' Adverse Experience ', ' Coitus ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Accounting ', ' Vulnerable Populations ', ' vulnerable group ', ' unintended pregnancy ', ' sex risk ', ' sexual risk behavior ', ' men who have sex with men ', ' men who have sex with other men ', ' Outcome ', ' Population ', ' Prevalence ', ' 17 year old ', ' seventeen year old ', ' age 17 years ', ' post-doctoral training ', ' postdoctoral training ', ' high risk ', ' pregnant ', ' public health relevance ', ' adolescent offspring ', ' population health ', ' ']",NIDA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K01,2009,138250,0.024027442152660384
"Interdisciplinary Research Training Institute on Hispanic Drug Abuse    DESCRIPTION (provided by applicant): The proposed Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse seeks to promote the career development of pre-doctoral, postdoctoral and early career clinically-focused scientists interested in conducting research as it affects the Hispanic population. This comprehensive and coordinated research education program aims at providing research experience and increasing the skills required for development of testable hypothesis, preparation and submission of research applications for appropriate NIH extramural funding (i.e. K01, K08, F31, F32, R03, R21, etc). Building upon the National Hispanic Science Network's Summer Research Training Institute, the IRTI has two short-term goals and two long-term goals as follows: (1) enhancing the fellows' knowledge and skills for conducting interdisciplinary research on drug abuse; (2) increasing the number of early career faculty who establish vibrant and independent programs of drug abuse research, (3) increasing the amount and quality of research on minority health and health disparities; and, (4) improving the health of minorities in part by decreasing minority health disparities. The aims of the IRTI are: 1. Provide an educational training opportunity that will enhance the skills for conducting interdisciplinary Hispanic drug research and developing applications for NIH funding among pre-doctoral, postdoctoral and early career faculty (fellows) through the implementation of a 14 day intensive summer research training program; 2. Execute a mentoring plan that would be organized and structured around a team of interdisciplinary mentors that would be accessible and available to provide selected fellows with focused mentoring and continual support; and 3. Provide a networking structure and process that will assist fellows in building and maintaining relationships and communication with leading experts in the field of Hispanic drug research and fellow peers. Overall, mentoring activities will focus on guiding and assisting the fellows in achieving benchmarks of progress including: a) Academic Career Progress; b) Scientific Publications; c) Scientific Presentations and d) Research Funding. These outcomes will be facilitated through various types of support including: Mentor Commitment, Travel to Mentor Institution, Conferences/Workshops, and IRTI Mentoring Annual Meeting and IRTI Scientific Conference. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research in the interest of public health. The proposed IRTI and its mentorship and networking components will begin to fill the gap in knowledge of how to effectively develop specific incubators that will be successful in growing a special generation of drug abuse research scientists. PUBLIC HEALTH RELEVANCE: The proposed Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse seeks to promote the career development of pre-doctoral, postdoctoral and early career clinically-focused scientists interested in conducting research as it affects the Hispanic population. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research. Interdisciplinary research teams of tomorrow are needed in addressing health disparities, a major public health problem for which new knowledge from several areas of science must be integrated to define and address extant vulnerabilities, and to develop effective prevention and treatment interventions.           PROJECT NARRATIVE The proposed Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse seeks to promote the career development of pre-doctoral, postdoctoral and early career clinically-focused scientists interested in conducting research as it afects the Hispanic population. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research. Interdisciplinary research teams of tomorrow are needed in addressing health disparities, a major public health problem for which new knowledge from several areas of science must be integrated to define and address extant vulnerabilities, and to develop effective prevention and treatment interventions.",Interdisciplinary Research Training Institute on Hispanic Drug Abuse,7629398,R25DA026401,"['health disparity ', ' health disparities ', ' Institution ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Address ', ' Research Training ', ' Extramural Activities ', ' Extramural ', ' EXTMR ', ' Preparation ', ' Process ', ' Development ', ' developmental ', ' Faculty ', ' Affect ', ' base ', ' career ', ' Goals ', ' improved ', ' minority health ', ' Area ', ' Incubators ', ' Institutes ', ' Training ', ' Discipline ', ' Educational workshop ', ' Workshop ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Funding ', ' Mentors ', ' Mentorship ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Nature ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Science ', ' Knowledge ', ' programs ', ' Scientist ', ' Training Programs ', ' Travel ', ' Complex ', ' Benchmarking ', ' Best Practice Analysis ', ' interest ', ' meetings ', ' experience ', ' Structure ', ' skills ', ' peer ', ' Prevention ', ' Generations ', ' symposium ', ' conference ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' career development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communication ', ' Outcome ', ' pre-doctoral ', ' predoctoral ', ' predoc ', ' pre-doc ', ' public health relevance ', ' ']",NIDA,UNIVERSITY OF HOUSTON,R25,2009,315102,0.144606105512944
"HIV Infection in Ethnic Minority IDUs: An International Systematic Review    DESCRIPTION (provided by applicant): Racial/ethnic group disparities in HIV/AIDS are a critical public health issue in the US. These disparities are particularly dramatic with respect to injecting drug use. African-Americans constitute 13% of the US population and 52% of recent US injecting drug use AIDS cases; Hispanics constitute 14% of the US population and 24% of the injecting drug use AIDS cases. These disparities are not the result of more injecting drug users among African-Americans and Hispanics, but of higher rates of HIV infection among African- American and Hispanic IDUs in many areas of the country. Similar disparities-higher rates of HIV infection among ethnic minority IDUs-have also been observed in many foreign countries. Indeed the situation of ethnic minority IDUs in some developing countries can be considered a crisis, with extremely high incidence, prevalence and HIV-related mortality. Disparities have also been observed among non-injecting drug users, with ethnic minority group members having higher rates of HIV infection. The logical next step for addressing these disparities and this epidemiological conundrum is not another individual study, but a systematic review of the large number of relevant studies that have been conducted to date. Our proposed systematic review will use state-of-the-art methods and include the US and the international data on ethnic group differences in HIV infection among drug users. The specific aims include: Developing procedures for combining qualitative and quantitative data from multiple research studies of IDUs in a single geographic area into a ""history of the HIV epidemic among IDUs"" in that area. Determining the frequency of HIV epidemics in which substantial differences in HIV infection have and have not arisen in ethnic minority IDUs vs. ethnic majority IDUs in the US and internationally. Identifying potential causal factors that may generate substantial differences in HIV prevalence among racial/ethnic minority vs. ethnic majority IDUs. Identifying potential causal factors that may perpetuate or reduce differences in HIV infection among racial/ethnic differences over time. Identifying epidemiologic situations in which differences in HIV risk behaviors do or do not statistically ""explain"" differences in HIV infection among racial/ethnic groups of IDUs. The research will also create an extremely rich dataset on HIV infection among ethnic drug uses that will be made available for use by other researchers and HIV prevention service providers. The research addresses one of the most important aspects of HIV/AIDS-the frequent large disparities in HIV infection among ethnic groups in the US and in many other countries. The research will be an innovative application of state of the art methods for systematic review, including extensive searching for published and unpublished studies, quantitative coding of research reports, and applying meta-regression/hierarchical modeling to these problems.       PUBLIC HEALTH RELEVANCE: Higher rates of HIV infection among African-American and Hispanic IDUs are a major health disparity in the US. African-Americans comprise 13% of the US population and 52% of injection drug use AIDS cases, Hispanics 14% of the populations and 24% of cases. Similar disparities, higher rates of HIV infection among ethnic minority IDUs, have also been observed in many foreign countries. An international systematic review and meta-analysis should greatly advance our understanding of these disparities and suggest how they might be ameliorated.          ",HIV Infection in Ethnic Minority IDUs: An International Systematic Review,7649431,R01DA024612,"['Provider ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Developing Countries ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Developing Nation ', ' Developing Country ', ' Disadvantaged ', ' Discrimination (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data Set ', ' Dataset ', ' Ethnic group ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Data ', ' International ', ' Europe ', ' Sexual Transmission ', ' transmission process ', ' Transmission ', ' Development ', ' developmental ', ' Heterosexuals ', ' Future ', ' Geographic Locations ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' racial/ethnic difference ', ' Procedures ', ' Health Services Needs ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' systematic review ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Site ', ' Area ', ' Incidence ', ' Injection of therapeutic agent ', ' Injections ', ' caucasian American ', ' white American ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Individual ', ' Drug usage ', ' drug use ', ' Methods ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Glare ', ' Developed Countries ', ' Industrialized Nations ', ' Industrialized Countries ', ' Developed Nations ', ' Developed Nation ', ' Developed Country ', ' North America ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Publishing ', ' Recommendation ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Sexual Partners ', ' sex partner ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Arts ', ' Stigmatization ', ' Asia ', ' Time ', ' Australia ', ' Frequencies (time pattern) ', ' Frequency ', ' Pattern ', ' Country ', ' Injecting drug user ', ' Injection Drug User ', ' Services ', ' prevention service ', ' member ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' ethnic difference ', ' Categories ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Code ', ' Coding System ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Accounting ', ' Communities ', ' sex risk ', ' sexual risk behavior ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' ethnic minority population ', ' ethnic minority ', ' user-friendly ', ' racial and ethnic ', ' racial/ethnic ', ' public health relevance ', ' non-drug ', ' nondrug ', ' ']",NIDA,BETH ISRAEL MEDICAL CTR (NEW YORK),R01,2009,545434,0.06950887935870406
"African American Female Drug Users: HIV, Health Disparities, & Criminality    DESCRIPTION (provided by applicant): The overall goal of this study is to understand how drug use and criminality are related to health disparities, particularly HIV, and service utilization among African American drug using and non-drug using women across criminal justice status. While drug use is similar across racial groups in the US, African Americans are disproportionately more likely to experience severe health consequences and criminal involvement as a result of drug misuse. Adequate health care may not be received by African American female offenders because they experience the burden of their race, class, gender, and criminal offender status. There is limited scientific data to help understand the linkages between health disparities such as HIV, untreated drug abuse, barriers to service utilization, and status as a criminal offender among African American females. This study is significant because of its potential to identify differences in health disparities and service utilization among African American drug using and non-drug using women in selected levels of criminal justice status (intensive correctional supervision-prison (n=200), moderate correctional supervision-jail (n=200), community supervision-probation (n=200), and no criminal justice involvement (n=200)). All 800 African American females will be followed longitudinally for three 6-month intervals to examine health status and the use of health services across time. The specific aims are: (1) To describe the prevalence of health problems among African American women across criminal justice status and drug use status; (2) To determine the cultural, predisposing, historical health, and potential enabling factors that are predictors of health problems among African American drug using and non-drug using women across criminal justice status over 18 months; (3) To describe the prevalence of untreated health problems, the patterns of health services utilization, and the cultural barriers to service utilization among African American women across criminal justice status and drug use status; and (4) To examine the factors that predict the likelihood of using health services among African American drug using and non-drug using women across criminal justice status over 18 months. The significance of this study includes the potential to provide criminal justice systems-level data for health planning and health policy for prevention, intervention, and treatment of African American female drug users.       This study is significant to the public health field because of its potential to understand the severity of health disparities among African American women across criminal justice status and drug use status and to predict health status and the use of health services over time. This knowledge of African American females can be used as a foundation for future criminal justice systems-level interventions to increase the use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism.          ","African American Female Drug Users: HIV, Health Disparities, & Criminality",7600531,R01DA022967,"['time use ', ' criminal offending ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' ethanol research ', ' alcohol related research ', ' alcohol research ', ' health disparities ', ' health disparity ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economics ', ' Enabling Factors ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Jail ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Fear ', ' Fright ', ' Female ', ' Foundations ', ' Future ', ' base ', ' Goals ', ' Gonococcal Infection ', ' Gonorrhea ', ' Health ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Planning ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Health Services ', ' health care service ', ' Health Status ', ' Level of Health ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Alcohol Chemical Class ', ' Alcohols ', ' Hospitalization ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' Series ', ' racism ', ' Incidence ', ' Inpatients ', ' Interview ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Kentucky ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' Trust ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Literature ', ' drug use ', ' Drug usage ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Multivariate Analyses ', ' Multivariate Analysis ', ' Physicians ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisoner ', ' Prisons ', ' Drug user ', ' Problem drug user ', ' Misuses drugs ', ' Drug abuser ', ' Public Health ', ' public health medicine (field) ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Knowledge ', ' Life ', ' Supervision ', ' Survey Instrument ', ' Surveys ', ' Time ', ' Universities ', ' Woman ', ' Work ', ' Severities ', ' Dependence ', ' Event ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' physical health ', ' physical conditioning ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' Services ', ' Emergency room ', ' Emergency Department ', ' Accident and Emergency department ', ' experience ', ' Seroprevalences ', ' Structure ', ' Participant ', ' recidivism ', ' Program Announcement ', ' NIH Program Announcements ', ' Self-Report ', ' Patient Self-Report ', ' General Public ', ' General Population ', ' probation ', ' criminal offender ', ' offender ', ' Reporting ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' Gender ', ' Female Health ', "" Women's Health "", ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' health care ', ' Healthcare ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Modeling ', ' Sampling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Communities ', ' service utilization ', ' nondrug ', ' non-drug ', ' longitudinal design ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2009,573161,0.17326562535537318
"Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth    DESCRIPTION (provided by applicant): The proposed study's overarching goal is to reduce the ethnic disparities in illicit drug use, cigarette use, and HIV between Hispanic and non-Hispanic youth. This goal will be accomplished by four aims: AIM 1 is to evaluate the effectiveness of Familias Unidas, relative to Community Practice (i.e., standard prevention services), in preventing illicit drug use; AIM 2 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing cigarette use; AIM 3 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing unprotected sexual behavior; and AIM 4 is to assess the extent to which family functioning mediates the effects of the intervention on illicit drug use, cigarette use, and unprotected sexual behavior. Twenty four middle schools with a total sample of 744 Hispanic adolescents from a wide geographic area of Miami-Dade County will be randomized using a block design to one of two conditions: Familias Unidas or Community Practice. The Familias Unidas intervention has been evaluated and found to be efficacious in two separate randomized controlled trials. In the first study (Pantin et al., 2003), Familias Unidas was shown to be efficacious relative to a no intervention control condition in increasing family functioning and reducing behavior problems (Prado et al., 2006), risk factors for youth illicit drug use and unprotected sex. In the second randomized controlled trial (Prado et al., in press), Familias Unidas was found to be efficacious, relative to two attention control conditions, in preventing cigarette use and illicit drug use. Familias Unidas was also found to be efficacious relative to both of the control conditions in preventing/reducing unprotected sexual behavior at last sexual intercourse. Finally, family functioning was found to mediate the effects of intervention condition on the outcomes. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more effective than Community Practice in reducing illicit drug use over time; (H2) Familias Unidas will be more effective than Community Practice in reducing cigarette use over time; and (H3) Familias Unidas will be more effective than Community Practice in reducing unprotected sexual behavior over time. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on illicit drug use will be partially mediated by family functioning; (H2a) the effect of Familias Unidas on cigarette use will be partially mediated by family functioning and (H3a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by family functioning. PUBLIC HEALTH RELEVANCE: The objective of the proposed study is to reduce illicit drug use, cigarette use, and unsafe sexual behavior health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, cigarette use, unprotected sexual behavior, and HIV in Hispanic adolescents.                 The objective of the proposed study is to reduce illicit drug use, cigarette use, and unsafe sexual behavior health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, cigarette use, unprotected sexual behavior, and HIV in Hispanic adolescents.",Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth,7591401,R01DA025192,"['health disparity ', ' health disparities ', ' Effectiveness ', ' prevent ', ' preventing ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Ethnic group ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Clinical Trials Design ', ' trial design ', ' Community Practice ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Development ', ' developmental ', ' Family ', ' Guidelines ', ' Geographic Locations ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Age ', ' Goals ', ' improved ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Family Study ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Randomized Controlled Clinical Trials ', ' Training ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Linear Models ', ' Drug usage ', ' drug use ', ' Americas ', ' Manuals ', ' Problem behavior ', ' behavioral problem ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Amphetamines ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Benzeneethanamine, alpha-methyl-, (+-)- ', ' Educational Intervention ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Parents ', ' Staging ', ' public health medicine (field) ', ' Public Health ', ' Publishing ', ' Risk Factors ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Societies ', ' Knowledge ', ' Testing ', ' Time ', ' United States ', ' Attention ', ' Frequencies (time pattern) ', ' Frequency ', ' Dependence ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Behavior Therapy ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' meetings ', ' middle school ', ' Cigarette ', ' Prevention Research ', ' prevention service ', ' peer ', ' Categories ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' County ', ' Relative (related person) ', ' Relative ', ' parental monitoring ', ' parent monitoring ', ' Parenting behavior ', ' Parenting ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Modeling ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Coitus ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Accounting ', ' Communication ', ' Communities ', ' effectiveness trial ', ' adolescent substance use ', ' youth substance use ', ' design ', ' designing ', ' efficacy trial ', ' Outcome ', ' Adolescent Risk Behavior ', ' Youth Risk Behavior ', ' Population ', ' parental involvement ', ' public health relevance ', ' community setting ', ' effective intervention ', ' primary outcome ', ' intervention effect ', ' substance use prevention ', ' prevent substance use ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2009,682445,0.14666618696440634
"Race and HIV-risk: Contextual and neurocognitive influences on sex partnerships    DESCRIPTION (provided by applicant): The primary aim of this R21 application in response to NIDA's ANSWHR Initiative (PAS-07-381) is to address gaps in literature focused on HIV risk and disparities among females. In the United States as rates have increased among females, the rate of HIV/AIDS diagnoses for African American females approaches 25 times the rate for white females. Despite the broad base of findings documenting health disparities in HIV, extant studies cannot explain why African Americans continue to be disproportionately affected. Currently, there is a hidden HIV epidemic among young adult African American females with no history of substance abuse. These women are at increased risk for contracting HIV by virtue of their social networks. The proposed study requests two years of support for a cross sectional epidemiologic examination of racial/ethnic differences in sexual partnerships among 220 females (110 Black and 110 White) residing in low socioeconomic status (SES) neighborhoods. Guided by ecosocial theory, we seek to explain why these differences exist across race/ethnicity. We will consider the extent to which neighborhood social and economic factors (e.g., drug markets) interact with race/ethnicity to produce different levels of HIV risk. We will expand drug abuse and HIV prevention research by, in addition to considering individual differences, examining the influences of neighborhood drug markets on the sexual behaviors, sexual partnerships and rates of a sexually transmitted disease among young adult females residing in disadvantaged neighborhoods. Finally, the proposed study will move beyond descriptive social epidemiology and into identifying neurocognitive processes that mediate/moderate relationships between neighborhood factors and individual behavior. As, a small yet growing base of research suggests, to the extent that individuals are able to make decisions, solve problems and control impulses, neurocognitive functions may serve as protective factors or pathways through which external social factors influence individual behavior. Identifying social factors that influence partner selection and individual level factors that may serve to reduce the adverse effects of living in disadvantage neighborhoods will inform HIV prevention interventions for African American and underserved women. If successful, the proposed research project: (1) should provide insight into why African American females have higher rates of HIV than their white counterparts; (2) highlight the importance of considering the contextual influences of drugs, that is the influence of drug markets on social structures and sexual norms and behaviors; and (3) identify modifiable individual level factors linking neighborhood social and economic factors to individual HIV risk behaviors.    PUBLIC HEALTH RELEVANCE: Currently, there is a hidden HIV epidemic among young adult African American females with no history of substance abuse. These women are at increased risk for contracting HIV by virtue of their social/sexual networks. If successful, the proposed research project: (1) should provide insight into why African American females have higher rates of HIV than their white counterparts; (2) highlight the importance of considering the contextual influences of drugs, that is how drug markets change social structures and altered sexual norms and behaviors of entire communities; and (3) increase understanding of the processes through which neighborhood factors influence HIV risk.          ",Race and HIV-risk: Contextual and neurocognitive influences on sex partnerships,7554693,R21DA025543,"['Decision Making ', ' health disparity ', ' health disparities ', ' Disadvantaged ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' Economics ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Social Network ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Characteristics ', ' Process ', ' sex ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Fellowship ', ' Female ', ' Social Impacts ', ' Pathway interactions ', ' pathway ', ' Affect ', ' base ', ' racial/ethnic difference ', ' Health ', ' Health behavior ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Peripheral ', ' Area ', ' Economic Factors ', ' Economical Factors ', ' Link ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' insight ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' sexual relationship ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Literature ', ' Inequality ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Marketing ', ' men ', "" men's "", ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Morbidity - disease rate ', ' Morbidity ', ' Neighborhoods ', ' Poverty ', ' Problem Solving ', ' Contracts ', ' Contracting Opportunities ', ' Psychology ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Risk-Taking ', ' Science ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sexual Partners ', ' sex partner ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Social Change ', ' Social transformation ', ' Social modification ', ' Social Characteristics ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Life ', ' Time ', ' Training Programs ', ' United States ', ' Universities ', ' Attention ', ' Woman ', ' Work ', ' Pattern ', ' Behavior ', ' Neurocognitive ', ' psychosocial ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' AIDS/HIV diagnosis ', ' professor ', ' condoms ', ' Structure ', ' Prevention Research ', ' Prevention program ', ' member ', ' drug market ', ' social inequality ', ' economic cost ', ' Reporting ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Cause of Death ', ' Gender ', ' segregation ', ' Racial Segregation ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Modeling ', ' response ', ' deprivation ', ' theories ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' 1 year old ', ' one year old ', ' age 1 year ', ' Communities ', ' sex risk ', ' sexual risk behavior ', ' design ', ' designing ', ' drug distribution ', ' Population ', ' Individual Differences ', ' high risk ', ' public health relevance ', ' Consultations ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R21,2009,204426,0.014044230329847649
"Economic Evaluation of Drug Abuse Treatment and HIV Prevention Services for Pregn    DESCRIPTION (provided by applicant): Economic evaluation of drug abuse treatment and HIV prevention services for pregnant women is critical to identify the most efficient and equitable use of scarce resources. Economic and policy research on the efficiency of drug abuse treatment and HIV prevention services among vulnerable populations such as women, adolescents and members of minority groups is necessary to improve drug abuse and HIV/AIDS services for these vulnerable and underserved populations. While work in this area continues to grow, there is still a dearth of rigorous economic evaluations of such programs, especially those that adhere to quality standards as recommended by the U.S. Panel on Cost Effectiveness in Health and Medicine. The overall objective of this study is to conduct the first economic evaluation of an innovative behavioral approach integrating Motivational Enhancement Therapy with Cognitive Behavioral Therapy (MET-CBT) as compared to standard Brief Advice (BA) within prenatal care to decrease use of a full range of substances (e.g., marijuana, cocaine, methamphetamines, alcohol, nicotine), to reduce HIV risk behavior and to achieve better infant health outcomes (e.g. longer gestations, greater birth weight, reduced medical consequences such as admission and length of stay in the Neonatal Intensive Care Unit (NICU)). The specific aims of this study are: (1) to conduct cost analyses of the MET-CBT and BA intervention arms; (2) to conduct incremental cost-effectiveness analyses of the two interventions (MET-CBT and BA), vis-`-vis each other, in terms of substance use, infant health outcomes and HIV risk reduction; and (3) to conduct incremental cost-utility analyses determining the net cost per Quality-Adjusted Life Year (QALY) saved respectively by each intervention arm (MET-CBT and BA), vis-`-vis each other, in terms of substance use and HIV risk reduction. The proposed research is responsive to PA-07-122 in that it proposes to conduct research related to cost-effectiveness and cost-utility analyses, services costs, methodological research, and the cross-cutting themes of HIV/AIDS and health disparities. The proposed research is grounded in sound microeconomic principles and standardized techniques as reported in the U.S. Panel on Cost Effectiveness in Health and Medicine, and proposes rigorous conceptual and methodological research to improve the evidence base on the unit costs and cost-effectiveness of substance abuse treatment and HIV prevention services. It builds on a NIDA-funded randomized controlled trial (R01-DA019135) of an innovate behavioral approach, which offers a new paradigm of treatment services, integrating MET-CBT within prenatal care compared to standard BA, and offering promise to improve access to and strengthen substance use treatment and HIV prevention services targeted at drug using pregnant women who are highly susceptible to HIV/AIDS.       PUBLIC HEALTH RELEVANCE: Drug abuse and high risk HIV behavior during pregnancy are major public health problems in the United States due to their impact on individual users, their offspring, and surrounding communities. Drug abuse and HIV prevention programs targeting pregnant women have the potential to be cost-effective due to the resultant fewer low-birth-weight babies and perinatal deaths, fewer physical, cognitive and behavioral problems during infancy and childhood, and the significant health benefits that can accrue to the mother. The overall objective of this study is to conduct the first economic evaluation of an innovative behavioral approach integrating Motivational Enhancement Therapy with Cognitive Behavioral Therapy (MET-CBT) as compared to standard Brief Advice (BA) within prenatal care to decrease use of a full range of substances (e.g., marijuana, cocaine, methamphetamines, alcohol, nicotine), to reduce HIV risk behavior and to achieve better infant health outcomes (e.g. longer gestations, greater birth weight, reduced medical consequences such as admission and length of stay in the Neonatal Intensive Care Unit (NICU)).           PROJECT NARRATIVE Drug abuse and high risk HIV behavior during pregnancy are major public health problems in the United States due to their impact on individual users, their offspring, and surrounding communities. Drug abuse and HIV prevention programs targeting pregnant women have the potential to be cost-effective due to the resultant fewer low-birth-weight babies and perinatal deaths, fewer physical, cognitive and behavioral problems during infancy and childhood, and the significant health benefits that can accrue to the mother. The overall objective of this study is to conduct the first economic evaluation of an innovative behavioral approach integrating Motivational Enhancement Therapy with Cognitive Behavioral Therapy (MET-CBT) as compared to standard Brief Advice (BA) within prenatal care to decrease use of a full range of substances (e.g., marijuana, cocaine, methamphetamines, alcohol, nicotine), to reduce HIV risk behavior and to achieve better infant health outcomes (e.g. longer gestations, greater birth weight, reduced medical consequences such as admission and length of stay in the Neonatal Intensive Care Unit (NICU)).",Economic Evaluation of Drug Abuse Treatment and HIV Prevention Services for Pregn,7620286,R01DA025555,"['Cost Analysis ', ' Cost Analyses ', ' cost effectiveness ', ' Costs and Benefits ', ' Costs and Cost Analysis ', ' Costs and Cost Analyses ', ' Cessation of life ', ' Death ', ' Risk Reduction ', ' health disparity ', ' health disparities ', ' Effectiveness ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Economics ', ' Address ', ' Build-it ', ' economic evaluation ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Data ', ' Effectiveness of Interventions ', ' Improve Access ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Policy Research ', ' Cognitive ', ' Facilities and Administrative Costs ', ' Indirect Costs ', ' Evaluation Studies ', ' Behavioral ', ' Advisory Committees ', ' Task Forces ', ' Guidelines ', ' Future ', ' Perinatal ', ' Goals ', ' improved ', ' Health ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Medical ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Infant Health ', ' Low Birth Weight Infant ', ' low birthweight ', ' low birth weight infant human ', ' low birth weight ', ' Neonatal Intensive Care Units ', ' Newborn Intensive Care Units ', ' Ensure ', ' infancy ', ' infantile ', ' Childhood ', ' pediatric ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Measurement ', ' Drug usage ', ' drug use ', ' Funding ', ' Marihuana ', ' marijuana ', ' Medicine ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Problem behavior ', ' behavioral problem ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Mothers ', ' Nicotine ', ' Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)- ', ' Economic Policy ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Pregnancy ', ' Gestation ', ' Pregnant Women ', ' Prenatal care ', ' Contracts ', ' Contracting Opportunities ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Savings ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' programs ', ' sound ', ' Standardization ', ' Translating ', ' United States ', ' Woman ', ' Work ', ' Upper arm ', ' Techniques ', ' Behavior ', ' Services ', ' Birth Weight ', ' Participant ', ' Prevention program ', ' prevention service ', ' member ', ' offspring ', ' motivational enhancement therapy ', ' motivational interview ', ' Prevention ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Measures ', ' Quality-Adjusted Life Years ', ' Relative (related person) ', ' Relative ', ' Admission activity ', ' Admission ', ' smoking cessation ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' Cost Savings ', ' Health Benefit ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' mathematical model ', ' mathematical modeling ', ' Math Models ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Communities ', ' Vulnerable Populations ', ' vulnerable group ', ' life time cost ', ' lifetime cost ', ' cost ', ' Underserved Population ', ' underserved people ', ' under served population ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' high risk ', ' public health relevance ', ' evidence base ', ' cognitive behavior therapy ', ' ']",NIDA,YALE UNIVERSITY,R01,2009,625741,0.026256141220174598
"Screening and Brief Intervention for Latino and non-Latino White Drug Users DESCRIPTION (provided by applicant): This application addresses broad Challenge Area (05): Comparative Effectiveness Research and specific Challenge Topic, 05-DA-104: Comparing Drug Treatment Effectiveness in Ethnic Minority Populations.  Screening, Brief Intervention, and Referral to Treatment (SBIRT) is a comprehensive, integrated public health approach to identify and deliver a spectrum of early detection and treatment services for substance use in general medical care settings.  The effectiveness of SBIRT has been demonstrated in numerous studies, and SBIRT is considered best practice by leading national medical associations for identifying and treating substance misuse even at early states.  However, it is not known if SBIRT is effective for Latino/Hispanic populations, an important gap in knowledge given the large and growing numbers of Latinos, their relatively high drug use prevalence, and the disparities between Latinos and other ethnic/racial groups in terms of substance abuse treatment.  This 2-year study will evaluate the effectiveness of SBIRT for drug use and related factors among 500 Latino and 500 non-Latino Whites visiting a large urban emergency department for various reasons.  A randomized two-group repeated measures design will be used in which drug-related outcomes of an intervention group will be compared to those of an attention-placebo control group.  Participants who report illicit drug use will be recruited from the waiting room of a large hospital Emergency Department, and randomly assigned to one of the two conditions.  The intervention group (Life Shift) will receive SBIRT drug intervention matched to their risk level and drug of choice.  To assess the true effect of the SBIRT intervention (I.e., minus the effects of attention), a control group will receive the same quantity of intervention in the area of driving safety (Shift Gears).  Baseline and 6-month follow-up measures will be collected for all participants, and will include (a) standardized subjective drug use measures, (b) other measures presumed to be targeted by the intervention (e.g., functional status, perceived barriers to change), and (c) a biological sample tested for the presence or absence of multiple illicit drugs to increase the accuracy of subjective abstinence reports at the follow-up.  In addition, driving safety control items will be collected to test the result of the experimental manipulation, with the attention-placebo control group expected to have greater pre-post change on these measures than the SBIRT intervention group.  Latino/White differences in responses to the intervention will be the primary focus of the study.  Generalized estimating equations (GEE) will be sued to test intervention-control group differences in follow-up abstinence rates, and whether experimental group differences hold for both Latinos and non-Latino Whites.  Impact of the intervention on other outcomes including frequency and amount of drug use, functioning in life areas, subsequent health care utilization, and presumed intermediate variables targeted by the intervention will also be analyzed overall and by ethnic group.  Process and implementation variables, (e.g., intervention coverage, observational quality measures, patient satisfaction) will be collected to measure fidelity of implementation, and to assess possible ethnic differences.  This randomized control group study will be the first to establish if screening and brief intervention delivered in primary care settings during a teachable moment can motivate both Latino and non-Latino Whites to reduce drug involvement.  ",Screening and Brief Intervention for Latino and non-Latino White Drug Users,7806343,RC1DA028031,"['Effectiveness ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' Data ', ' Qualifying ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Feasibility Studies ', ' Focus Groups ', ' Goals ', ' Health Care Systems ', ' Healthcare Systems ', ' Screening procedure ', ' drug use ', ' Drug usage ', ' Methods ', ' Patients ', ' Drug user ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Emergency room ', ' Emergency Department ', ' Accident and Emergency department ', ' experience ', ' intervention program ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Latino ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' screening and brief intervention ', ' ']",NIDA,SAN DIEGO STATE UNIVERSITY,RC1,2009,495564,0.12312958655497463
"Research Training in the Prevention of Drug Abuse & AIDS in Communities of Color    DESCRIPTION (provided by applicant): This revised application for a MIDARP program at Howard University describes a mentoring program in drug abuse research and AIDS prevention in communities of color, which is designed to increase the capacity of faculty and students at Howard to conduct rigorous and competitive research in the prevention of drug abuse and HIV/AIDS in communities of color. The program will emphasize training in transdisciplinary research on relationships between environmental stress, biological responses, risk behaviors and health outcomes and will utilize collaborations with senior investigators in research intensive universities to mentor Howard faculty investigators. The MIDARP will also work closely with existing programs that link Howard faculty and students to research training opportunities to (1) increase knowledge and interest in drug abuse and AIDS prevention research among faculty and students in these programs and (2) utilize the resources of these programs to expand the range of training opportunities available to MIDARP investigators and students. Howard students will be introduced to drug abuse and AIDS prevention research and career development by augmenting existing drug abuse courses in the College of Arts and Sciences and the curriculum for medical, basic science, nursing, and pharmacy students to include information on drug abuse and AIDS prevention research. They will also fund a pre-doctoral dissertation stipend and recruit students to serve as research assistants in the MIDARP pilot studies. The unique strengths of the program include the opportunity to (1) integrate education regarding drug abuse and AIDS prevention research into existing research training programs for faculty and students;(2) train individuals in diverse disciplines such as the health professions and sciences (i.e., medicine, basic sciences, pharmacy, nursing) who are less likely to pursue research careers in drug abuse and AIDS prevention research; and (3) support transdisciplinary research in drug use and AIDS prevention based on strong existing university research programs in genetics, physiology, and psychobiology. A transdisciplinary approach will be reflected in the MIDARP leadership that includes a Director who is a behavioral scientist specializing in research on environmental stress, drug use, and AIDS risk in communities of color and a Deputy Director who is an immunogeneticist with expertise in microbiology, and founding Director of the Human Genome Project at Howard University.          ",Research Training in the Prevention of Drug Abuse & AIDS in Communities of Color,7678555,R24DA021470,"['Educational Curriculum ', ' Curriculum ', ' Achievement ', ' Achievement Attainment ', ' Ally ', ' drug abuse prevention ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Electronic Mail ', ' Email ', ' E-Mail ', ' Environment ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Equilibrium ', ' balance function ', ' balance ', ' biological adaptation to stress ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Allied Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Infrastructure ', ' Infrastructure ', ' Research Training ', ' Senior Scientist ', ' Training and Infrastructure ', ' Monitor ', ' Authorization documentation ', ' Permission ', ' Authorization ', ' Development ', ' developmental ', ' Faculty ', ' Behavioral ', ' Advisory Committees ', ' Task Forces ', ' Foundations ', ' base ', ' career ', ' role model ', ' sociology/anthropology ', ' Goals ', ' Grant ', ' Health ', ' Health Occupations ', ' health science profession ', ' Health Professions ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Human Genome Project ', ' Area ', ' Biological ', ' Physiological ', ' Physiologic ', ' Medical ', ' Link ', ' Ensure ', ' Interview ', ' Evaluation ', ' Training ', ' Leadership ', ' Discipline ', ' Individual ', ' Educational workshop ', ' Workshop ', ' Measurement ', ' Development Plans ', ' Drug usage ', ' drug use ', ' Funding ', ' Medicine ', ' Mentors ', ' Mentorship ', ' Methods ', ' Microbiology ', ' Collaborations ', ' Nurses ', ' Discipline of Nursing ', ' Nursing Profession ', ' Nursing Field ', ' Nursing ', ' Pamphlets ', ' Brochures ', ' Booklets ', ' Pharmacy facility ', ' Pharmacies ', ' Pharmacology ', ' Genetic ', ' Physiology ', ' Pilot Projects ', ' pilot study ', ' Exposure to ', ' Psychiatry ', ' Psychology ', ' Publications ', ' Scientific Publication ', ' Recommendation ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Schools ', ' medical schools ', ' school of medicine ', ' medical college ', ' Science ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Sociology ', ' Knowledge ', ' lectures ', ' programs ', ' Arts ', ' Stress ', ' Students ', ' Medical Students ', ' Nursing Students ', ' Pupil Nurses ', ' Pharmacy Students ', ' Surveys ', ' Survey Instrument ', ' Educational process of instructing ', ' Teaching ', ' Scientist ', ' Time ', ' Training Activity ', ' Training Programs ', ' Universities ', ' Violence ', ' violent behavior ', ' violent ', ' Work ', ' Writing ', ' Award ', ' Techniques ', ' Behavioral Research ', ' Behavioral Sciences ', ' interest ', ' meetings ', ' college ', ' collegiate ', ' Services ', ' Blood Pressure ', ' American ', ' experience ', ' stressor ', ' success ', ' professor ', ' cohort ', ' skills ', ' Participant ', ' Prevention Research ', ' member ', ' Basic Science ', ' Basic Research ', ' graduate student ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' career development ', ' psychobiology ', ' biopsychology ', ' biological basis of behavior ', ' response ', ' Clinical Research ', ' Clinical Study ', ' Color ', ' Communication ', ' Communities ', ' design ', ' designing ', ' Outcome ', ' Population ', ' pre-doctoral ', ' predoctoral ', ' predoc ', ' pre-doc ', ' Historically Black Colleges and Universities ', ' Historically Black University ', ' Historically Black Institution ', ' Historically Black Colleges ', ' HBCUs ', ' heart rate variability ', ' Consultations ', ' ']",NIDA,HOWARD UNIVERSITY,R24,2009,471118,0.15242078635463338
"Incarceration Effects on Prevention of Drug Use, STI-HIV and Recidivism Incarcerated women are often affected by childhood abuse, violence, and other difficult life circumstances throughout their life course, and typically come from disproportionately disadvantaged neighborhoods. However, relatively less research has examined how neighborhood characteristics and incarceration interact with inmates' risk factors. Although several criminal justice studies demonstrated that excessive incarceration may exacerbate community disadvantages and instability as a large proportion of residents constantly move between jail and community, the impact of neighborhood disadvantages on inmates' health outcomes, such as drug use and sexual risks have not been examined. Furthermore, while the rate of female incarceration has steadily increased over the past 20 years, previous studies predominantly concern with men, and women's unique life trajectories of incarceration, sexual risks, and drug use have been less understood. The study proposes to examine the impact and consequences of incarceration on the patterns of substance use, risky sexual behaviors, and recidivism among female inmates who are returning to the community from a large urban jail. The proposed conceptual model will be tested explaining the ecological factors associated with incarceration, and the impact of incarceration on drug use, STls/HlV risks, and recidivism among female inmates. To achieve the objectives, the proposed study will conduct: 1) qualitative in-depth interviews with women in jail exploring their experience with incarceration, changes in social networks and support, health  concerns, health care and social services utilization, expected challenges upon release, and needs for successful transition to community life; 2) face-to-face longitudinal surveys with a cohort of female inmates at three time points (baseline in jail, and two weeks and three months post-release) to examine primary outcomes (relapse to drug use, risks for STIs/HlV infection, recidivism), secondary outcomes, and mediators (social network, social support); and 3) multi-level analysis and mapping to explore the effects of neighborhood disadvantage and instability, the rates of incarceration and STIs on women's outcomes. Incarcerated women are often from the poor, minority, urban populations who are most affected by drug abuse and HIV. The rate of female incarceration has dramatically increased in recent years, while the majority of them return to the community along with their health problems. Findings of the research wilt help better understand incarcerated women's complex health, socioeconomic issues and community context, which may contribute to reducing health disparities among women living in disadvantaged neighborhoods.","Incarceration Effects on Prevention of Drug Use, STI-HIV and Recidivism",7884973,R00DA024012,"['drug abuse prevention ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' health disparities ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Disadvantaged ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Employment ', ' Social Network ', ' Jail ', ' Data ', ' Social Health Services ', ' Characteristics ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Exhibits ', ' Female ', ' Affect ', ' Goals ', ' improved ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Infection ', ' Interview ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Drug usage ', ' drug use ', ' Maps ', ' men ', "" men's "", ' Methods ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Neighborhoods ', ' Poverty ', ' Prisoner ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Probability ', ' Relapse ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Social support ', ' social support network ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Life ', ' Testing ', ' Time ', ' Urban Population ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' Complex ', ' Pattern ', ' experience ', ' cohort ', ' recidivism ', ' General Population ', ' General Public ', ' offender ', ' criminal offender ', ' Reporting ', ' social ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' segregation ', ' Racial Segregation ', ' Child Abuse ', ' Childhood Abuse ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Healthcare ', ' health care ', ' Longitudinal Surveys ', ' Modeling ', ' Communities ', ' human capital ', ' reincarceration ', ' Minority ', ' community living ', ' Outcome ', ' Alcohol dependence ', ' alcohol-dependent ', ' alcohol dependency ', ' alcohol addiction ', ' service utilization ', ' high risk ', ' primary outcome ', ' secondary outcome ', ' ']",NIDA,UNIVERSITY OF ILLINOIS AT CHICAGO,R00,2009,249000,0.08478374343868396
"The Growing Disparity in Illegal Drug Use Across Socioeconomic Strata    DESCRIPTION (provided by applicant): A disparity in illegal drug use that disadvantages individuals in the lower socioeconomic strata has significantly increased in the last two decades. New evidence indicates that this increase results in large part from a changing influence of socioeconomic status (SES) on drug use, and not from a negative influence of drug use on SES that has accumulated over time. However, the SES-related influences responsible for this growing disparity remain largely unknown. . The aims of this study are threefold. First, it will address limitations in current evidence on the growing disparity of illegal drug use across socioeconomic strata. Using the most current, available data the project will (a) update analyses of socioeconomic trends in cocaine past 1998 (b) examine socioeconomic trends up to the present in illegal drugs that have not yet been examined, such as marijuana, methamphetamine, ecstasy, and 'blunts,1 (c) examine whether the growing disparity sterns from differential incidence and/or differential duration of drug use across socioeconomic strata, and (d) examine SES indicators other than education. These analyses will use the National Survey on Drug Use and Health, a nationally- representative, cross-sectional survey of drug use administered yearly, although between 1979 and 1988 it was administered only every third year. Second, the study will predict both changes in the prevalence of illegal drugs over time and also changes in the characteristics of illegal drug users over time. We use a ""Diffusion of Innovation"" framework, which predicts that users of an innovation such as illegal drugs fall into distinct categories such as ""innovators,"" ""early adopters,"" and ""late adopters."" People in each of these categories are theorized to differ from each other in terms of sociodemographic, psychological, and environmental characteristics. Furthermore, the profiles of drug users at one point in time are expected to predict the prevalence of drug use in the future. The third aim of the project is to trace the extent to which the key predictors of illegal drug use, as highlighted by the Diffusion framework, have their roots in the early life course. Using a longitudinal survey that has followed 838 children from 1st grade to age 30, the analysis will examine how far back in the life course current predictors of illegal drug use extend. We expect that many early predictors have not yet been linked to later drug use because the current profile of illegal drug users, which includes factors such as low socioeconomic status, did not emerge until recently. Results from this project will inform policy and intervention programs aimed at reducing the prevalence of illegal drug use across all socioeconomic strata.              ",The Growing Disparity in Illegal Drug Use Across Socioeconomic Strata,7658761,R01DA020575,"['Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' ecstasy ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' Diffusion ', ' Diffusion of Innovation ', ' Disadvantaged ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' Educational aspects ', ' Education ', ' Address ', ' Data Set ', ' Dataset ', ' Data ', ' Mentored Research Scientist Development Award ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' Policy Research ', ' Update ', ' trend ', ' Principal Investigator ', ' Characteristics ', ' Process ', ' sex ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' Age ', ' Goals ', ' Health ', ' psychologic ', ' psychological ', ' Link ', ' Incidence ', ' Childhood ', ' pediatric ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Fostering ', ' Policies ', ' Drug usage ', ' drug use ', ' Plant Roots ', ' root ', ' Funding ', ' Marihuana ', ' marijuana ', ' Marijuana Smoking ', ' marijuana use ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Drug user ', ' Publishing ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Schools ', ' Social Mobility ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Adopted ', ' Woman ', ' Work ', ' Back ', ' Dorsum ', ' first grade ', ' directed attention ', ' directs attention ', ' age group ', ' experience ', ' cohort ', ' intervention program ', ' Categories ', ' Prevention ', ' social ', ' Relative (related person) ', ' Relative ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' falls ', ' Longitudinal Surveys ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Uncertainty ', ' doubt ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Accounting ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' racial and ethnic ', ' racial/ethnic ', ' stem ', ' cocaine use ', ' ']",NIDA,UNIVERSITY OF COLORADO DENVER,R01,2009,309605,0.22637589368278796
"HIV - Emergence of Drug Resistance    DESCRIPTION (provided by applicant): This application is to renew a project focused on using mathematical models to understand and predict the emergence of drug resistance to antiretrovirals (ARVs) for the treatment of Human Immunodeficiency Virus (HIV). As the usage rate of ARVs in resource-poor regions is increasing, high levels of drug resistance potentially could emerge and have a devastating impact on public health worldwide, derailing global plans to provide this treatment to many millions of HIV-infected individuals. Our proposed projects will extend the work of the current award, which showed the value of using mathematical models to understand the temporal dynamics of drug-resistant strains of HIV in the United States (US), and for predicting the magnitude of resistance in this setting. In the renewal our work will be extended by combining mathematical modeling with statistical analysis of datasets collected by collaborating groups in the US, Europe and Africa. We will have access to data on drug resistance and important related variables from large scale epidemiological and treatment studies conducted in these three continents. In resource-poor settings, such as Africa, drugs will be limited and thus demand will often greatly exceed supply. We will investigate the problems of allocating ARVs in Africa by using operation research (OR) techniques. We have three Specific Aims. Aim 1: to understand the emergence, explain the present, and predict the evolution of, complex epidemics of drug-resistant strains of HIV in the US and Europe. Aim 2: to predict the evolution of epidemics of drug-resistant strains, as a result of first- line regimens and prophylactic use of ARVs, in Africa. Aim 3: to evaluate the consequences of allocation of scarce HIV healthcare resources in Africa. To achieve this aim we will use models to evaluate the epidemiological and ethical consequences of gender-inequities in access to treatment, assess the epidemiological and ethical impact of treatment priority criteria, and determine healthcare resource allocation strategies that ensure sustainability. Our studies in the renewal will link transmission modeling, OR techniques and statistical analyses; our analyses will take advantage of the extraordinary data sets provided by our collaborators in the US, Europe and Africa.       PUBLIC HEALTH RELEVANCE: The emergence and control of drug-resistant strains of HIV is now a global problem. The epidemiology of this problem is complex, and the future of the HIV epidemic is unknown. Our projects focus on using mathematical models to understand, explain, and predict, the evolution of complex epidemics composed of drug-resistant strains of HIV in the US, Europe and Africa. The rollout of antiretrovirals in Africa is just beginning; however demand for drugs greatly exceeds supply. We will, by using mathematical models, evaluate the epidemiological and ethical consequences of allocation of the scarce supply of antiretrovirals in Africa. Our studies are based upon both mathematical modeling and data analyses. Our analyses will take advantage of the extraordinary data sets provided by our collaborators in the US, Europe and Africa. Our results will have direct relevance for health policy makers.          ",HIV - Emergence of Drug Resistance,7574471,R01AI041935,"['Ensure ', ' Linear Models ', ' Individual ', ' Policy Maker ', ' Multi-Drug Resistance ', ' multidrug resistant ', ' multi-drug resistant ', ' Resistant to multidrug ', ' Resistant to multi-drug ', ' Resistant to Multiple Drug ', ' Resistance to Multiple Drug ', ' Resistance to Multidrug ', ' Resistance to Multi-drug ', ' Multiple Drug Resistant ', ' Multiple Drug Resistance ', ' Multidrug Resistance ', ' Vertical Disease Transmission ', ' mother to child transmission ', ' Vertical Transmission ', ' Reverse Transcriptase Inhibitors ', ' Nucleosides ', ' Operations Research ', ' Paper ', ' Protease Inhibitor ', ' Proteinase Inhibitors ', ' Protease Antagonists ', ' Peptide Peptidohydrolase Inhibitors ', ' Peptide Hydrolase Inhibitors ', ' Peptidase Inhibitors ', ' Endopeptidase Inhibitors ', ' Antiproteases ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Publishing ', ' Research ', ' Research Technics ', ' Research Techniques ', ' Resources ', ' Research Resources ', ' San Francisco ', ' South Africa ', ' Tenofovir ', ' 9-PMPA ', ' 9-(2-phosphonylmethoxypropyl)adenine ', ' 9-(2-phosphonomethoxypropyl)adenine ', ' Treatment Protocols ', ' Treatment Schedule ', ' Treatment Regimen ', ' Trees ', ' Tuberculosis ', ' tuberculous spondyloarthropathy ', ' infection due to Mycobacterium tuberculosis ', ' disseminated tuberculosis ', ' disseminated TB ', ' Mycobacterium tuberculosis infection ', ' Mycobacterium tuberculosis (MTB) infection ', ' Mtb infection [{C0041296}] ', ' MTB infection ', ' M.tuberculosis infection ', ' M. tuberculosis infection ', ' United States ', ' Virus Diseases ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Work ', ' World Health Organization ', ' Zidovudine ', ' azidodeoxythymidine ', ' ZDV ', ' Azidothymidine ', ' AZT (Antiviral) ', ' AZT ', "" 3'-azido-3'-deoxy-thymidine "", "" 3'-Azido-3'-deoxythymidine "", "" 3'-Azido-2',3'-Dideoxythymidine "", ' Complex ', ' Award ', ' prophylactic ', ' Equation ', ' Anti-Retroviral Agents ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' efavirenz ', ' 6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one ', ' multiple drug use ', ' Structure ', ' Abbreviations ', ' Gender ', ' Healthcare ', ' health care ', ' Research Methodology ', ' Research Methods ', ' Resource Allocation ', ' Modeling ', ' Sampling ', ' mathematical model ', ' mathematical modeling ', ' Math Models ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Classification ', ' Systematics ', ' antiretroviral therapy ', ' men who have sex with men ', ' men who have sex with other men ', ' design ', ' designing ', ' Antiretroviral resistance ', ' resistant to antiretroviral ', ' resistant to anti-retroviral ', ' resistant to ARV ', ' resistance to antiretroviral ', ' resistance to anti-retroviral ', ' resistance to ARV ', ' anti-retroviral resistant ', ' anti-retroviral resistance ', ' Antiretroviral resistant ', ' ARV resistant ', ' ARV resistance ', ' Resistance ', ' resistant ', ' public health relevance ', ' resistant strain ', ' resistance strain ', ' Data Analyses ', ' Data Analysis ', ' microbicide ', ' microbicidal ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Drug resistance ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Nevirapine ', ' Viramune ', ' PTPN6 gene ', ' SHP-1L ', ' SHP-1 ', ' SH-PTP1 ', ' PTPN6 ', ' PTP-1C ', ' HPTP1C ', ' HCPH ', ' HCP ', ' non-nucleoside reverse transcriptase inhibitors ', ' nonnucleoside reverse transcriptase inhibitors ', ' non-nucleoside RT inhibitors ', ' NNRTI ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Ethics ', ' ethical ', ' Data Set ', ' Dataset ', ' Data ', ' Interruption ', ' Europe ', ' transmission process ', ' Transmission ', ' Evolution ', ' sex ', ' Female ', ' pandemic disease ', ' pandemic ', ' Stavudine ', ' zerit ', ' Didehydrodeoxythymidine ', ' D4T ', "" 3'-Deoxy-2'-thymidinene "", "" 2'3' didehydrodeoxythymidine "", "" 2',3'-didehydro-3'-deoxy-thymidine "", "" 2',3'-Didehydro-3'-deoxythymidine "", "" 2',3'-Didehydro-2',3'-dideoxythmidine "", ' 1-(2,3-Dideoxy-beta-glycero-pent-2-enofuranosyl)thymine ', ' Future ', ' Africa ', ' base ', ' Grant ', ' Health care facility ', ' Healthcare Facility ', ' Health Facilities ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Prophylactic treatment ', ' Prophylaxis ', ' Prevention Measures ', ' Simplexvirus ', ' human herpesvirus 1 group ', ' Herpesvirus hominis ', ' Herpes labialis Virus ', ' Herpes Simplex Virus ', ' HSV ', ' Link ', ' Lamivudine ', ' 3TC ', ' 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)- ', "" 2',3'-Dideoxy-3'-thiacytidine "", ' ']",NIAID,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2009,724023,0.08382042801068632
"Role of Race in Criminal Justice Referrals to Treatment    DESCRIPTION (provided by applicant): The criminal justice system has become the primary source of referrals to drug treatment. Despite substantial evidence that minorities, particularly African Americans, are over-represented in the drug arrestee population, they remain a relatively small share of criminal justice referrals. It has yet to be determined if this lower representation is a function of racial and ethnic disparities in the criminal justice system or an artifact of some common case-level factors that reduce minority eligibility for treatment referral. We propose to examine the adjudication of drug offenders in California from 1982- 2005 to determine the extent to which race/ethnicity has played a role in final disposition and referral to drug treatment. California represents a unique environment in which to examine these associations because of its demographic and regional diversity, availability of detailed administrative data representing a census of individuals arrested and processed, and adoption of two important policies - drug courts and diversion - that promote treatment in lieu of incarceration. The proposed study significantly improves existing research by considering temporal and geographic patterns in disparities at each stage of the adjudication process within a single state subject to the same rule of law. It comprehensively considers the role of race/ethnicity at each stage of the adjudication process and the net effect on the final placement of minorities in treatment, and so may identify why previous studies have provided inconsistent results. Finally, by considering the impact of restorative justice policies, such as drug courts and diversion, on the processing of drug offenders by race/ethnicity, this project will assist policymakers with efforts to reduce disparities in the criminal justice and treatment system. The elimination of health disparities is an overarching goal of Healthy People 2010. The criminal justice system is critical to eliminating disparities because minorities, particularly African Americans, are substantially over-represented in this population and because the criminal justice system is the largest referral source to treatment. A careful examination of the adjudication process for drug offenders will make it possible to determine if differential access to treatment truly exists among arrestees and what factors have caused it. Further, by examining trends in adjudication practices using a large panel data set in California, this study will be able to explicitly consider whether recent policy reforms aimed at improving access to treatment particularly among minorities have indeed done so.           ",Role of Race in Criminal Justice Referrals to Treatment,7574423,R01DA022719,"['Staging ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Role ', ' social role ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Violence ', ' violent behavior ', ' violent ', ' Source ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' contextual factors ', ' Application Context ', ' California ', ' adjudication ', ' adjudicative process and procedure ', ' offender ', ' criminal offender ', ' Sorting - Cell Movement ', ' sorting ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Censuses ', ' County ', ' Admission activity ', ' Admission ', ' parole ', ' Drug Courts ', ' Morphologic artifacts ', ' Artifacts ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Minority ', ' Outcome ', ' Population ', ' racial and ethnic disparities ', ' Healthy People 2010 ', ' health disparity ', ' health disparities ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Eligibility Determination ', ' Protocol Screening ', ' Eligibility ', ' Environment ', ' Data Set ', ' Dataset ', ' Data ', ' Improve Access ', ' trend ', ' Process ', ' Development ', ' developmental ', ' Adoption ', ' Guidelines ', ' court ', ' Goals ', ' improved ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Recording of previous events ', ' History ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Variant ', ' Variation ', ' Justice ', ' Laws ', ' Individual ', ' Policies ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Noise ', ' Play ', ' ']",NIDA,RAND CORPORATION,R01,2009,344864,0.09882567964943394
"HIV Disparities among Drug Users: Neighborhoods, Neurocognition and Sex Behavior    DESCRIPTION (provided by applicant): This R03 application proposes to conduct secondary data analysis to develop statistical models that explain disparities in HIV/AIDS found among African American and white substance users. In the proposed study, we will employ advance statistical analyses (latent variable mixture models) to consider the separate and synergistic influence of neighborhood factors (drug arrest rates and poverty), substance use patterns and neurocognitive functioning on sexual risk partnerships and, in turn, HIV/AIDS. First, we will evaluate the possible specificity in relationships between distinct neighborhood level factors (segregation, drug markets, poverty) and sexual partnerships and HIV/AIDS. Aim 2 of the study is to model the influence of neighborhood characteristics, substance use patterns, incarceration and neurocognitve functioning on sexual risk partnerships and estimate prevalence and incidence over an18-month period. The third aim is to estimate the magnitude of the association between sexual partnerships and being HIV-infected. The possibility of effect modification is considered with a focus on race and gender. If successful, this project should improve prevention science by: (1) increasing understanding of sexual risk partnerships among drug users and how they vary across race and gender; (2) providing support for considering factors beyond traditional SES indicators when attempting to understand racial disparities in HIV by highlighting the importance of contextual influences of drugs (e.g., rate of drug arrests) on sexual partnerships; and (3) specifying potential neurocognitive processes that might mediate/moderate the relationship between neighborhood, substance use and sexual risk partnerships. This study is the first in a series of innovative studies designed to explain racial disparities and prevent HIV/AIDS among African Americans.       PUBLIC HEALTH RELEVANCE: The intersection between substance use and HIV is a major concern as core and peripheral members of drug networks represent a significant portion of HIV/AIDS cases. Although all persons involved in drug networks are at increased risk for HIV, African Americans tend to be disproportionately affected. Because interventions focused solely on the individual have had limited success in slowing the spread of HIV among African Americans, it is important to elucidate the influence and model the pathways through which social and interpersonal factors influence HIV acquisition.          ","HIV Disparities among Drug Users: Neighborhoods, Neurocognition and Sex Behavior",7603041,R03DA024981,"['Crime ', ' Data Analyses ', ' Data Analysis ', ' Cessation of life ', ' Death ', ' Decision Making ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Disease ', ' disease/disorder ', ' Disorder ', ' prevent ', ' preventing ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Address ', ' Data Set ', ' Dataset ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Data ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' To specify ', ' Characteristics ', ' Process ', ' Modification ', ' Fellowship ', ' Female ', ' Pathway interactions ', ' pathway ', ' Affect ', ' base ', ' improved ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Peripheral ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Specific qualifier value ', ' Specified ', ' Series ', ' Economic Factors ', ' Economical Factors ', ' Incidence ', ' Injection of therapeutic agent ', ' Injections ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Literature ', ' Drug usage ', ' drug use ', ' Funding ', ' Study models ', ' Statistical Models ', ' Probabilistic Models ', ' Multiple Partners ', ' Persons ', ' Neighborhoods ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Paper ', ' Parents ', ' Poverty ', ' Problem Solving ', ' Contracts ', ' Contracting Opportunities ', ' Drug user ', ' Publishing ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Risk ', ' Risk-Taking ', ' Sampling Studies ', ' Science ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Knowledge ', ' sound ', ' Specificity ', ' Time ', ' Investigation ', ' Woman ', ' Work ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' Award ', ' Pattern ', ' Behavior ', ' Neurocognitive ', ' Injecting drug user ', ' Injection Drug User ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Postdoctoral Fellow ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' AIDS/HIV diagnosis ', ' success ', ' member ', ' drug market ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Gender ', ' Measures ', ' segregation ', ' Racial Segregation ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' symposium ', ' conference ', ' Mediating ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Modeling ', ' Sampling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' executive function ', ' executive control ', ' Accounting ', ' Communicable Diseases ', ' Infectious Disorder ', ' Infectious Diseases and Manifestations ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Sex Functioning ', ' sexual functioning ', ' design ', ' designing ', ' Minority ', ' Outcome ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' Neurocognition ', ' person centered ', ' high risk ', ' public health relevance ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R03,2009,123000,0.004599709383627865
"Preventing Drug Abuse and HIV in Hispanic First Offenders Hispanic youth in the juvenile justice system are at increased risk of HIV infection and of using illicit drugs. The proposed studys overarching goal is to reduce the ethnic disparities in illicit drug use and HIV between Hispanic and non-Hispanic youth in the criminal justice system. The proposed 2-year study will be guided by four aims. AIM 1 is to evaluate the efficacy of Familias Unidas, relative to Treatment as Usual in preventing illicit drug use in a sample of Hispanic youth first offenders; AIM 2 is to evaluate the efficacy of Familias Unidas, relative to Treatment as Usual in preventing unsafe sexual behavior; AIM 3 is to evaluate the efficacy of Familias Unidas, relative to Treatment as Usual in reducing the number of subsequent criminal offenses; and AIM 4 is to assess the extent to which family functioning mediates the effects of the intervention on illicit drug use, unsafe sexual behavior, and subsequent criminal offenses. 240 Hispanic adolescent first offenders (age range 13 to 17) and their parents will be randomized to either Familias Unidas or Treatment as Usual. Youth and parent participants will be assed at baseline, post-intervention (i.e., 6-months post baseline), and 12-months post baseline.   The Familias Unidas intervention has been evaluated and found to be efficacious in two randomized trials. In the first study (Pantin et al., 2003), Familias Unidas was shown to be efficacious relative to a no intervention control condition in increasing family functioning and reducing behavior problems. In the second randomized trial (Prado et al., 2007), Familias Unidas was found to be efficacious, relative to two attention control conditions, in reducing illicit drug use and unprotected sexual behavior at last sexual intercourse. In both trials, family functioning was found to mediate the effects of condition on the outcomes. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more efficacious than Treatment as Usual in reducing illicit drug use over time; (H2) Familias Unidas will be more efficacious than Treatment as Usual in reducing unprotected sexual behavior use over time; and (H3) Familias Unidas will be more efficacious than Treatment as Usual in preventing subsequent criminal offenses. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on illicit drug use will be partially mediated by family functioning; (H2a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by family functioning and (H3a) the effect of Familias Unidas on subsequent criminal offenses will be partially mediated by family functioning. The objective of the proposed study is to reduce illicit drug use and unsafe sexual behavior health disparities in Hispanic populations and particularly among youth in the juvenile justice system. The knowledge expected to be gained from this study will aid in the development of efficacious and effective interventions to reduce drug use, unprotected sexual behavior, and HIV in Hispanic adolescents.",Preventing Drug Abuse and HIV in Hispanic First Offenders,7577066,R01DA025894,"['juvenile justice system ', ' effective intervention ', ' treatment as usual ', ' usual care ', ' intervention effect ', ' Age ', ' Attention ', ' Sexual Intercourse ', ' Coitus ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Family ', ' Goals ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Linear Models ', ' Parents ', ' Risk ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Testing ', ' Time ', ' Relative (related person) ', ' Criminal Justice ', ' Illicit Drugs ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Mediating ', ' Youth 10-21 ', ' Youth ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Randomized Controlled Clinical Trials ', ' drug use ', ' Drug usage ', ' behavioral problem ', ' Problem behavior ', ' Knowledge ', ' System ', ' Participant ', ' criminal offender ', ' offender ', ' Sampling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' disparity in health ', ' health disparity ', ' preventing ', ' prevent ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' developmental ', ' Development ', ' post intervention ', ' Outcome ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2009,627410,0.13551991655777793
"Trajectories of Drugs Abuse in High Risk Youth    DESCRIPTION (provided by applicant): We propose to extend the Northwestern Juvenile Project to examine the dynamic relationships among patterns of drug use and disorder, risk and protective factors for drug use and disorder, and adult social role performance as juvenile justice youth age from adolescence to emerging adulthood and young adulthood. This study responds to NIDA's new initiatives on drug abuse, health disparities, and disproportionate minority confinement of African Americans. At year-end 2004, nearly 100,000 juveniles and nearly 2.1 million adults were incarcerated. African Americans comprise 12% of the US population but 40% of incarcerated populations. We are studying a racially/ethnically diverse sample (n=1709; 624 females, 1085 males) in Cook County (Chicago) Illinois, aged 10-18 years at recruitment (1995-1998). Youth are reinterviewed whether they are (re)incarcerated or back in the community. Our goal is to focus on gender differences, racial/ethnic disparities, and the effect of incarceration as we: (1) describe patterns of drug use and disorder --onset, persistence, desistence, and recurrence - as juvenile justice youth age from adolescence to emerging and young adulthood; (2) examine how risk and protective factors (e.g., comorbid mental disorders, adverse life events, availability of illicit drugs) predict, moderate, and mediate patterns of drug use and disorders; and (3) examine the dynamic relationships between patterns of drug use and disorder and adult social role performance (e.g., residential independence [including avoiding incarceration], employment, marriage, parenting, desistance from crime and violence). To analyze the longitudinal data, we will use summary statistics (e.g., prevalence rates, odds ratios), generalized linear mixed-effects models, survival analyses, and Muthen's recently developed extensions of growth mixture models. Extending the Northwestern Juvenile Project allows us to leverage the data already collected to examine the role of incarceration in the development of drug use and disorder, especially among African Americans; to identify risk and protective factors that are potentially malleable; to identify points of intervention at key developmental periods; and to extend theoretical models - developed in general population adolescents -- to correctional populations.           ",Trajectories of Drugs Abuse in High Risk Youth,7665138,R01DA019380,"['8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' correctional system ', ' Accounting ', ' Communities ', ' Minority ', ' Outcome ', ' coping ', ' Population ', ' Prevalence ', ' prospective ', ' Trauma ', ' 18 year old ', ' eighteen year old ', ' age 18 years ', ' Affective ', ' racial and ethnic ', ' racial/ethnic ', ' racial and ethnic disparities ', ' high risk ', ' emerging adulthood ', ' Conflict (Psychology) ', ' Conflict ', ' Drops ', ' Health system ', ' violence prevention ', ' prevent violence ', ' Ethnic group ', ' Jail ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Request for Applications ', ' NIH RFA ', ' Child Abuse and Neglect ', ' child maltreatment ', ' Childhood maltreatment ', ' Cognitive ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' Characteristics ', ' Process ', ' Development ', ' developmental ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Foundations ', ' Freedom ', ' Liberty ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Pathway interactions ', ' pathway ', ' Affect ', ' Injury ', ' Age ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' improved ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Phase ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Domestic Violence ', ' Illinois ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' Justice ', ' juvenile delinquent ', ' Young offender ', ' Juvenile Offender ', ' Psyche structure ', ' mental ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Life Style ', ' Lifestyle ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' African ', ' Longitudinal Studies ', ' long-term study ', ' satisfaction ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Marijuana Smoking ', ' marijuana use ', ' Marriage ', ' Medical Records ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Theoretical model ', ' Theoretic Models ', ' Neighborhoods ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' Odds Ratio ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Parents ', ' cooking ', ' public health medicine (field) ', ' Public Health ', ' Public Policy ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Anxiety ', ' Recommendation ', ' Records ', ' Recurrence ', ' Recurrent ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Schools ', ' self esteem ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Social support ', ' social support network ', ' Life ', ' Victimization ', ' sound ', ' statistics ', ' Substance Use Disorder ', ' Survival Analysis ', ' Survival Analyses ', ' Time ', ' Violence ', ' violent behavior ', ' violent ', ' Attitude ', ' Woman ', ' Event ', ' Pattern ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Back ', ' Dorsum ', ' Behavior ', ' Behavior Disorders ', ' behavioral disorder ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Belief ', ' interest ', ' Services ', ' Surgeon ', ' Performance ', ' Self Efficacy ', ' Budgets ', ' Cigarette ', ' Structure ', ' Participant ', ' peer ', ' NIH Program Announcements ', ' Program Announcement ', ' Population Study ', ' Patient Self-Report ', ' Self-Report ', ' deviant ', ' deviancy ', ' disorder risk ', ' disease risk ', ' General Population ', ' General Public ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' County ', ' Gender ', ' Chicago ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Modeling ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' theories ', ' functional disability ', ' Functional impairment ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' Crime ', ' Healthy People 2010 ', ' health disparity ', ' health disparities ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Educational Status ', ' training status ', ' training level ', ' training achievement ', ' educational level ', ' Educational Achievement ', ' Employment ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2009,1217545,0.15806252262844014
"Intensive Outpatient v. Outpatient Treatment with Buprenorphine among African Ame    DESCRIPTION (provided by applicant):   This application addresses broad Challenge Area (05): Comparative Effectiveness Research, and specific Challenge Topic (05-DA-104): Comparing Drug Treatment Effectiveness in Ethnic Minority Populations Background: Although there is relatively little difference in illicit drug use rates between African Americans and Whites, there is are significant differences in terms of the collateral impact of opiate use on these two communities and wide disparities in their access to treatment. Buprenorphine, a partial mu agonist approved for use the US in 2002 outside of strictly regulated opioid treatment programs, has the potential to reduce the disparity between demand for treatment and treatment access. However it appears from early data on the implementation of buprenorphine in the US that the health disparities faced by African Americans are now extending to this treatment. Indeed, according to SAMHSA over 90 percent of the patients receiving buprenorphine in their evaluation of this treatment were White. Many African Americans in urban areas are unable to find or afford the kind of buprenorphine physician office-based treatment that the approval of buprenorphine was intended to make possible. In Maryland and elsewhere, drug treatment agencies are responding to the disparities in access to buprenorphine treatment by offering grants or contracts to drug treatment programs that have traditionally relied exclusively on psychosocial approaches (""drug-free"" outpatient programs) to treatment. This arrangement has potential to ameliorate the access problem for African Americans, who in Baltimore make up about 80 percent of the city's heroin-using population. But this arrangement has also uncovered knowledge gaps that must be filled to enable both access and optimal patient centered treatment for this population. One such gap concerns what level of psychosocial treatment is appropriate for this population. Second, we need to understand how attitudes of staff at formerly abstinence-oriented programs affect the use of an opioid agonist in terms of retention in treatment and outcomes. Design: This two-group randomized clinical trial will test the effectiveness of intensive outpatient (IOP) v. standard outpatient (OP) treatment in 272 heroin-dependent African American adults receiving buprenorphine in 3 formerly ""drug-free"" programs. Participants will be randomly assigned to one of the two treatment intensity conditions at intake and assessed at baseline, 3-, and 6-months post-baseline to determine treatment retention, frequency and severity of heroin and cocaine use, self-reported HIV-risk, quality of life, and to determine DSM-IV criteria for Full or Partial Remission of Opioid Dependence. Furthermore, patient factors potentially critical for treatment success (e.g., attitudes towards buprenorphine and average buprenorphine dose while in treatment) will be examined to determine their importance in influencing treatment outcomes. Moreover, both patient and staff attitudes and average buprenorphine dose will be evaluated to determine their respective relationships to treatment experiences and treatment retention. Significance, Innovation and Public Health Impact: This study is significant because it will examine the comparative effectiveness of two common counseling approaches offered with buprenorphine in clinics treating large numbers of African Americans, a population with significant need and limited access to this type of effective treatment. Study findings may help to expand the availability of buprenorphine to African Americans, inform providers and policymakers regarding the relative benefits of two levels of intensity of counseling, and inform the field regarding factors associated with optimal buprenorphine utilization and program retention. The use of the DSM-IV criteria for remission as a one of the outcome measures represents an important augmentation of the usual drug abuse research outcome measures, which usually rely primarily upon urine testing results and self-reports of drug use as the primary outcome measure and do not take into account drug- related reductions in clinically significant impairment or distress, despite some continued intermitted drug use. Public Health Statement This study will examine the comparative effectiveness of two common counseling approaches offered with buprenorphine in clinics treating large numbers of African Americans, a population with significant need and limited access to this type of effective treatment which reduces drug use and HIV-risk. Study findings may help to expand the availability of buprenorphine to African Americans, inform providers and policymakers regarding the relative benefits of two levels of intensity of counseling, and inform the field regarding factors associated with optimal buprenorphine utilization and program retention.               PROJECT NARRATIVE Public Health Statement This study will examine the comparative effectiveness of two common counseling approaches offered with buprenorphine in clinics treating large numbers of African Americans, a population with significant need and limited access to this type of effective treatment which reduces drug use and HIV-risk. Study findings may help to expand the availability of buprenorphine to African Americans, inform providers and policymakers regarding the relative benefits of two levels of intensity of counseling, and inform the field regarding factors associated with optimal buprenorphine utilization and program retention.",Intensive Outpatient v. Outpatient Treatment with Buprenorphine among African Ame,7830858,RC1DA028407,"['Population ', ' Alcohol dependence ', ' alcohol-dependent ', ' alcohol dependency ', ' alcohol addiction ', ' innovation ', ' innovative ', ' innovate ', ' Impairment ', ' ethnic minority population ', ' ethnic minority ', ' Abstinence ', ' clinically significant ', ' clinical significance ', ' drug testing ', ' drug detection ', ' patient oriented ', ' patient centered ', ' alcohol research ', ' ethanol research ', ' alcohol related research ', ' comparative effectiveness ', ' addiction ', ' addictive disorder ', ' primary outcome ', ' effective therapy ', ' effective treatment ', ' cocaine use ', ' Counseling ', ' Provider ', ' health disparity ', ' health disparities ', ' Heroin ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Effectiveness ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Preclinical Drug Evaluation ', ' Evaluation Studies, Drug, Preclinical ', ' Evaluation Studies, Drug, Pre-Clinical ', ' Drug Screening ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' Dose ', ' Caring ', ' Data ', ' Intake ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Screening Result ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' base ', ' dosage ', ' urban area ', ' Grant ', ' Health ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Alcohol consumption ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Partial Remission ', ' Area ', ' premature ', ' prematurity ', ' Medical ', ' Randomized Clinical Trials ', ' Insurance ', ' Evaluation ', ' DSM-IV ', ' Diagnostic and Statistical Manual of Mental Disorders-IV ', ' Diagnostic and Statistical Manual of Mental Disorders, 4th edition ', ' DSM4 ', ' Distress ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Individual ', ' African ', ' Opioid ', ' Drug usage ', ' drug use ', ' Funding ', ' Agonist ', ' Maryland ', ' Medicine ', ' Drug Metabolic Detoxication ', ' detoxification ', ' Metabolism of Toxic Agents ', ' Metabolic Drug Detoxications ', ' Drug Metabolic Detoxification ', ' Methadone ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl- ', ' Naltrexone ', ' ReVia ', ' Nemexin ', ' Nalorex ', ' Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5alpha)- ', ' Outpatients ', ' Out-patients ', ' Patients ', ' Physicians ', "" Physicians' Offices "", ' Contracts ', ' Contracting Opportunities ', ' public health medicine (field) ', ' Public Health ', ' Quality of life ', ' QOL ', ' Relapse ', ' Research ', ' Risk ', ' Societies ', ' Opiates ', ' Knowledge ', ' programs ', ' Staff Attitudes ', ' Testing ', ' Treatment Protocols ', ' Treatment Schedule ', ' Treatment Regimen ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Urine ', ' Urine Urinary System ', ' Attitude ', ' Hour ', ' Frequencies (time pattern) ', ' Frequency ', ' Severities ', ' Dependence ', ' Clinic ', ' System ', ' LOINC Axis 4 System ', ' Test Result ', ' Baltimore ', ' Opiate Addiction ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' psychosocial ', ' Outcome Study ', ' Disease remission ', ' Remission ', ' American ', ' experience ', ' success ', ' Cocaine Dependences ', ' Cocaine Addiction ', ' Buprenorphine ', ' 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5alpha,7alpha(S))- ', ' novel ', ' Participant ', ' treatment program ', ' Patient Self-Report ', ' Self-Report ', ' drinking ', ' Reporting ', ' Measures ', ' Relative (related person) ', ' Relative ', ' Treatment outcome ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Outcome Measure ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Sampling ', ' Treatment Effectiveness ', ' response ', ' Cities ', ' Accounting ', ' Communities ', ' effectiveness research ', ' design ', ' designing ', ' Outcome ', ' ']",NIDA,"FRIENDS RESEARCH INSTITUTE, INC.",RC1,2009,498748,0.10744347510969104
"Morehouse School of Medicine (M-MIDARP)    DESCRIPTION (provided by applicant): The overall aim of this program is to strengthen and expand the drug abuse and HIV/AIDS prevention research capacity at Morehouse School of Medicine (MSM) by bringing together key academic and community-based programs in the development of an integrated correctional drug abuse and HIV/AIDS prevention research component. This capacity will incorporate training in new research skills and create an aggregation of individual faculty with appropriate community-based agencies as research teams within the criminal justice system. The MSM MIDARP will: 1. Establish opportunities for training and development of drug abuse and HIV/AIDS prevention research interfacing with the Criminal Justice System (CJS) and existing community programs. 2. Construct an integrative culturally competent drug abuse and HIV/AIDS prevention research paradigm which addresses the needs of individuals who have come under the jurisdiction of the criminal justice system by utilizing existing community programs and Evidence-Based Practices. 3. Minimize disparities in community services to reduce recidivism among currently or previously incarcerated individuals. 4. Develop a nexus of organizations among the Georgia Department of Corrections, Georgia Department of Juvenile Justice and community based services that supplements the new research curriculum and faculty service programs, and makes sustainable gains in terms of scholarly publications, effective new service delivery paradigms, and individual client outcomes. 5. Expose young African-American medical students, masters of public health students and undergraduate students to correctional drug abuse and HIV/AIDS prevention community-based research to facilitate their post-graduate career choices. 6.Expand the areas of drug abuse and HIV/AIDS prevention research under investigation at Morehouse School of Medicine to additional indication areas, increase the number of minority physicians and faculty in drug abuse and HIV/AIDS prevention research, and increase the number of supported drug abuse and HIV/AIDS prevention research programs across MSM departments (especially Psychiatry, Family Medicine, Community Health and preventive medicine, and community voices program with its 8 grantees in cities across the country). Our intention is that MSM will be recognized as a local, regional, and national resource and training center for drug abuse and HIV/AIDS prevention for research programs.          ",Morehouse School of Medicine (M-MIDARP),7647405,R24DA021527,"['Criminal Justice ', ' Research Methodology ', ' Research Methods ', ' Cities ', ' Client ', ' Clinical Research ', ' Clinical Study ', ' correctional system ', ' Communities ', ' Community Services ', ' design ', ' designing ', ' Minority ', ' Outcome ', ' Population ', ' community based service ', ' medical schools ', ' school of medicine ', ' medical college ', ' programs ', ' Students ', ' Medical Students ', ' Voice ', ' Investigation ', ' System ', ' LOINC Axis 4 System ', ' Country ', ' interest ', ' Services ', ' skills ', ' Prevention Research ', ' Community based prevention ', ' recidivism ', ' Career Choice ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Educational Curriculum ', ' Curriculum ', ' Public Health Students ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Address ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Evidence based practice ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Master of Public Health ', ' M.P.H. ', ' Master of Science ', ' Research Infrastructure ', ' Infrastructure ', ' Community Health ', ' Development ', ' developmental ', ' Faculty ', ' Family Practice ', ' family medicine ', ' Intention ', ' base ', ' improved ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Intervention Studies ', ' interventions research ', ' intervention research ', ' Training ', ' Justice ', ' Individual ', ' Methods ', ' Physicians ', ' Preventive Medicine ', ' preventative medicine ', ' Psychiatry ', ' Publications ', ' Scientific Publication ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Resources ', ' Research Resources ', ' ']",NIDA,MOREHOUSE SCHOOL OF MEDICINE,R24,2009,519071,0.12824035441533166
"Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS    DESCRIPTION (provided by applicant): This application is a revision of an application submitted last year in response to PAR-07-379, ""Behavioral and Social Science Research on Understanding and Reducing Health Disparities."" We will analyze the interconnections between coercive mobility (the massive migration between the criminal justice [CJ] system and the community) produced by US drug policies and race disparities in HIV-related sexual risk among a sample of drug offenders in Connecticut (CT). Further, we will examine whether the association between coercive mobility (CM) and HIV-related sexual risk is affected by the degree of social disorganization in the communities in which these offenders reside. We also will study the feasibility of recruiting and following sexual partners of these individuals to better understand the impacts of CM on partners' HIV-related risk. We hypothesize that CM produces race disparities in HIV risk in a number of distinct ways: 1) Blacks are more likely than Whites to be incarcerated, so HIV-related sexual risk associated with CM can produce race disparities in HIV risk even if the effects of CM are the same for both Blacks and Whites; 2) Blacks are more likely than Whites to reside in communities experiencing the disorganizing impacts of CM, so to the extent that social disorganization exacerbates the effects of CM, it will affect the HIV risks of Blacks to a greater degree than Whites; 3) The sexual partners of Blacks are more likely to come from these same socially disorganized communities, furthering the negative impacts of CM for both returning inmates and their partners, and contributing to race disparities in HIV risk among women; and 4) Blacks are more likely to be penalized by drug policies in ways that increase their movement between prison/jail and the community and their vulnerability to its associated harms. We also hypothesize that we will be able to recruit and retain the sexual partners of study participants and conduct exploratory analyses of the impact of CM on their HIV-related sexual risk. An active Community Advisory Board including policymakers and program administrators will assist us in identifying structural interventions to reduce race disparities in HIV based on study findings. PUBLIC HEALTH RELEVANCE: This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.           Narrative This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.","Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS",7691190,R01DA025021,"['Data Analyses ', ' Data Analysis ', ' health disparity ', ' health disparities ', ' Institution ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Environment ', ' Address ', ' Jail ', ' Data ', ' Process ', ' Face ', ' facial ', ' faces ', ' Family ', ' Feasibility Studies ', ' Feedback ', ' Law Enforcement ', ' Affect ', ' base ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Housing ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' In-Migration ', ' Immigrations ', ' Interview ', ' Laws ', ' sexual relationship ', ' Individual ', ' Policies ', ' Movement ', ' body movement ', ' Prisons ', ' Shapes ', ' Public Policy ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Sexual Partners ', ' sex partner ', ' Social Disorganizations ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' programs ', ' Surveys ', ' Survey Instrument ', ' Time ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' Frequencies (time pattern) ', ' Frequency ', ' Awareness ', ' System ', ' LOINC Axis 4 System ', ' contextual factors ', ' Application Context ', ' behavioral/social science ', ' experience ', ' Structure ', ' Participant ', ' disorder prevention ', ' disease prevention ', ' member ', ' offender ', ' criminal offender ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Administrator ', ' Criminal Justice ', ' Sampling ', ' response ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' community reentry ', ' community re-entry ', ' migration ', ' public health relevance ', ' social science research ', ' Connecticut ', ' ']",NIDA,DUKE UNIVERSITY,R01,2009,623988,0.047759867674073975
"Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth    DESCRIPTION (provided by applicant):  The overriding purpose of this study is to develop and test an intervention for reducing substance use and risky sexual behaviors among youth involved in juvenile drug court. Juvenile drug court provides an excellent setting in which to pursue the key study objectives by providing access to a well identified high risk population. Second, in addition to frequent judicial oversight, juvenile drug courts include several features that can enhance intervention effectiveness, sustainability, and potential for adoption. In addition, the fact that all juvenile drug courts have community-based treatment components and that such courts have been disseminated nationwide suggests the possibility of eventual widespread adoption if the proposed intervention is effective. The proposed intervention integrates evidence-based protocols for contingency management (CM) for substance abusing youth and family engagement strategies, with an evidence-informed family systems intervention for sexual risk originally developed to address substance use and sexual risk behaviors in HIV+ youth. These three interventions will be integrated into an efficient intervention that, if effective, can be amenable to adoption by juvenile drug courts. Following protocol development and beta testing, 160 drug court youth and their families will be randomized to the experimental intervention condition (HIV Risk Reduction or ""HRR"") versus Drug Court with Community Services (DC) conditions. Key outcomes will be assessed through 12-months post-baseline using a multi-method approach that will include assessment of substance use, risky sexual behaviors, criminal behavior, and participation in HIV counseling and testing services. Specific aims include: 1: Adapt existing intervention and training protocols into a single, efficient HRR intervention, beta test this HHR protocol with four youth in juvenile drug court and their families, and revise treatment and research protocols accordingly; 2: Conduct a randomized trial with 160 youth in juvenile drug court and their families to examine youth-level intervention effects (i.e., on substance use, sexual risk behavior, HIV counseling and testing, delinquent behavior) in comparison to DC through 12- months post referral and assess intervention fidelity. 3. If results suggest a positive HRR treatment effect, revise the intervention and training protocols in preparation for an effectiveness study and extended follow-up study. Importantly, the proposed study will (1) consider the multiple levels of influence on juvenile drug use, criminal justice involvement, and HIV risk behaviors, (2) integrate a drug abuse and HIV prevention intervention for youth in the criminal justice system with drug-related offenses, (3) address health disparities by targeting a primarily minority population of youth, and (4) increase referrals to HIV testing and counseling of drug court-involved youth. This study is designed to reduce HIV risk by addressing the potent interaction of drug use and risky sexual behaviors in drug court youth with evidence-based treatment components to maximize the likelihood of reversing these youths' adverse behavioral trajectories.      PUBLIC HEALTH RELEVANCE: The proposed study is designed to gain knowledge about effective interventions for reducing HIV risk in a high risk population. Reducing HIV risk by effectively targeting substance use and risky sexual behaviors and by locating even a small number of HIV-positive youth could favorably impact society at multiple levels (individual, family, peer, community, fiscal).           PROJECT NARRATIVE The proposed study is designed to gain knowledge about effective interventions for reducing HIV risk in a high risk population. Reducing HIV risk by effectively targeting substance use and risky sexual behaviors and by locating even a small number of HIV-positive youth could favorably impact society at multiple levels (individual, family, peer, community, fiscal).",Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth,7688641,R01DA025880,"['Counseling ', ' Risk Reduction ', ' health disparity ', ' health disparities ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Institution ', ' Effectiveness ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Evidence based practice ', ' Cost Effectiveness Analysis ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Effectiveness of Interventions ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Enrollment ', ' enroll ', ' Preparation ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Behavioral ', ' Family ', ' Adoption ', ' Follow-Up Studies ', ' Followup Studies ', ' active method ', ' active treatment ', ' active technique ', ' Evidence based treatment ', ' base ', ' court ', ' criminal behavior ', ' Label ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Randomized Controlled Clinical Trials ', ' juvenile delinquent ', ' Young offender ', ' Juvenile Offender ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Drug usage ', ' drug use ', ' Methods ', ' Educational Intervention ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Collaborations ', ' Staging ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Societies ', ' Knowledge ', ' Testing ', ' United States Public Health Service ', ' USPHS ', ' Public Health Service ', ' Adopted ', ' Work ', ' Protocols documentation ', ' Protocol ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Services ', ' peer ', ' community based treatment ', ' contingency management ', ' offender ', ' criminal offender ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Measures ', ' Drug Courts ', ' Criminal Justice ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Youth ', ' Youth 10-21 ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Clinical Trials ', ' clinical investigation ', ' Communities ', ' Community Services ', ' sex risk ', ' sexual risk behavior ', ' adolescent substance abuse ', ' youth substance abuse ', ' design ', ' designing ', ' Minority ', ' Outcome ', ' Population ', ' treatment effect ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' high risk ', ' critical period ', ' public health relevance ', ' effective intervention ', ' evidence base ', ' intervention effect ', ' emerging adulthood ', ' ']",NIDA,MEDICAL UNIVERSITY OF SOUTH CAROLINA,R01,2009,485468,0.04091109874558734
"The Center for the Study and Prevention of Drug Use    DESCRIPTION (provided by applicant):     This proposal for the Center for Study and Prevention of Drug Use is submitted by Morgan State University and seeks funding under the PAR-02-016 mechanism in response to the PA entitled ""Minority Institutions' Drug Abuse Research Development Program"" (MIDARP). The proposed Center will be an inter-institutional collaborative effort involving Morgan State University, a minority institution, and research intensive universities and programmatic initiatives that focus on and specialize in research on drug use and disparities associated with drug use. The Center seeks to build on the collaborative relationships established through the Center to increase the capacity of Morgan State, its faculty and its students to conduct rigorous drug use research with and emphasis on drug use epidemiology, public health, and health disparities related to drug use. In order to actualize the mission of the Center, four components were developed which address the necessary aspects of creating a drug use research center. 1) The Faculty Development Plan, which seeks to advance Morgan faculty by allowing them to engage in off-site collaborative research with individuals specializing in drug research. 2) A second aspect is the Student Development Plan, which seeks to expose, educate and, train minority students in the area of drug use research. 3) The research arm of the project includes a primary and four developmental pilot project, allowing researchers at Morgan to begin using their present expertise and investigating topics in the area of drug use and disparities related to drug use. 4) Overseeing, each of the areas is the proposed plan for the Administrative Units and Center Organization. Through this component collaborative relationships, research projects, and faculty and student development will be monitored and enhanced. As a result of the Center faculty at Morgan State will be further enhanced regarding their ability to conduct rigorous research independently, specifically submitting R01's. Further, Morgan will be sufficiently capable of training students for careers in drug use research by developing a structured program in drug research, and the administrative staff will have the skills necessary to support the research staff in all endeavors related to research projects. In sum, the Center will be; self-sustaining and capable of producing future research focused on drug use research.               ",The Center for the Study and Prevention of Drug Use,7661573,R24DA019805,"['drug abuse prevention ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' health disparities ', ' Commit ', ' Institution ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Elements ', ' Eligibility Determination ', ' Protocol Screening ', ' Eligibility ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Research Infrastructure ', ' Infrastructure ', ' Research Training ', ' Sum ', ' Enrollment ', ' enroll ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' Monitor ', ' Preparation ', ' Principal Investigator ', ' Development ', ' developmental ', ' Faculty ', ' Future ', ' Affect ', ' career ', ' Grant ', ' Recording of previous events ', ' History ', ' Site ', ' Area ', ' Link ', ' Internships ', ' Ensure ', ' Training ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Individual ', ' Development Plans ', ' Drug usage ', ' drug use ', ' Funding ', ' Maryland ', ' Mentors ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Mission ', ' New Jersey ', ' New York ', ' Collaborations ', ' Pennsylvania ', ' Pilot Projects ', ' pilot study ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Research Support ', ' Resources ', ' Research Resources ', ' Rest ', ' Knowledge ', ' programs ', ' Students ', ' Scientist ', ' Universities ', ' Washington ', ' Writing ', ' Award ', ' Upper arm ', ' Country ', ' Baltimore ', ' Behavior ', ' interest ', ' experience ', ' high school ', ' Structure ', ' skills ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' falls ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' forging ', ' Minority ', ' Historically Black Colleges and Universities ', ' Historically Black University ', ' Historically Black Institution ', ' Historically Black Colleges ', ' HBCUs ', ' ']",NIDA,MORGAN STATE UNIVERSITY,R24,2009,695310,0.2289119318721305
"Public Housing Relocations: Impact on Healthcare Access, Drug Use & Sexual Health    DESCRIPTION (provided by applicant):  A rapidly unfolding intervention in Atlanta provides a rare opportunity to advance health services research for a vulnerable population: poor Black drug users. The Atlanta Housing Authority (AHA) is relocating all 5,000 residents of seven concentrated public housing communities to homes spread across Atlanta. Past research indicates that relocates tend to move to census tracts that have markedly better socioeconomic and healthcare environments than their original tracts; however, their social networks and support systems shrink after they move. The AHA relocations thus offer a rare opportunity to deepen scientific knowledge about the ways in which neighborhood, network, and social support factors shape Black drug users' healthcare access and health. Mining this opportunity will advance several NIDA priority areas, but is predicated on rapid funding of this project: three AHA communities (the ""BBT"" communities) have already begun the relocation process, and four others (the ""HHRP"" communities, which include Herndon Homes, Hollywood Court, Roosevelt, and Palmer) will begin to relocate in 2009. Traditional NIH funding cycles are too slow to realize the opportunities presented by the AHA relocations. While we presently have funds to gather pre-relocation data on 150 BBT residents, this sample size is insufficient to explore multilevel hypotheses. A team of two new investigators with a history of collaboration is thus seeking Time Sensitive R21 funds to achieve the following aims: (1) For 200 Black drug-using residents of the four HHRP communities, describe pre-relocation neighborhood, network, and social support characteristics (e.g., spatial access to drug treatment, drug network size, recovery support), and residents' (a) access to and retention in drug treatment, and primary care access; (b) drug use patterns; and (c) sexual risk and sexually transmitted infection (STI) status. We will integrate spatial, survey, and biological data to achieve Aim 1. (2) For 100 ex-residents of the two communities that will relocate first (Herndon Homes and Hollywood Court), assess participants' post-relocation status on the variables listed in Aim 1, and pre-/post-relocation changes in these variables. (3) For the total sample of 350 residents of the HHRP and BBT communities, conduct exploratory cross-sectional analyses of pre-relocation relationships between neighborhoods, network and social support characteristics and participants' (a) access to and retention in drug treatment, and access to primary care; (b) drug use patterns; and (c) sexual risk behaviors and STI infection status. We will also initiate preliminary analyses of the 100 Herndon Homes and Hollywood Court participants' pre-/post-relocation data to explore how changes in exposures relate to changes in outcomes. We will seek R01 funds to conduct a longitudinal study of the 350-member cohort that will test hypotheses generated by the R21. This longitudinal R01 study will establish the direction of relationships identified in the R21 in a sample of sufficient size to draw firm statistical conclusions about topics of major scientific import to NIDA.           Project Narrative The proposed R21 study will advance scientific knowledge in several NIDA priority areas that pertain to racial/ethnic disparities in health service access and health: (1) We will study health service and health outcomes that disproportionately affect poor, Black drug users, namely suboptimal access to, and retention in, drug treatment and poor primary care access; harmful drug use patterns; and HIV/STI sexual risk and STI infections. (2) We are seeking the causes of these outcomes in Black drug users' neighborhoods, networks, and social support systems, thereby expanding the traditional etiologic frame beyond individual-level exposures, and exploring the pathways linking these exposures and outcomes. (3) Our analytic plan will allow us to distinguish the impacts of individual-level processes from those of neighborhood-level processes, a distinction that ecologic analyses alone cannot capture.    ","Public Housing Relocations: Impact on Healthcare Access, Drug Use & Sexual Health",7713943,R21DA027072,"['Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Data Collection ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Environment ', ' Sexual Health ', ' Social Network ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Scientific Advances and Accomplishments ', ' scientific advances ', ' scientific accomplishments ', ' Characteristics ', ' Process ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Future ', ' Pathway interactions ', ' pathway ', ' Affect ', ' court ', ' Grant ', ' Health ', ' Health Services ', ' health care service ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Alcohols ', ' Alcohol Chemical Class ', ' Housing ', ' Area ', ' Phase ', ' Variant ', ' Variation ', ' Biological ', ' Link ', ' Infection ', ' Individual ', ' Recovery ', ' Longitudinal Studies ', ' long-term study ', ' Licensing ', ' Drug usage ', ' drug use ', ' Sample Size ', ' Funding ', ' Mining ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Neighborhoods ', ' Collaborations ', ' Poverty ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Exposure to ', ' Staging ', ' Shapes ', ' Drug user ', ' Drug abuser ', ' Problem drug user ', ' Misuses drugs ', ' Public Housing ', ' Nature ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Rest ', ' Risk ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Social support ', ' social support network ', ' Knowledge ', ' Life ', ' programs ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Radial ', ' Radius ', ' Home environment ', ' Home ', ' Pattern ', ' Communities ', ' Vulnerable Populations ', ' vulnerable group ', ' sex risk ', ' sexual risk behavior ', ' Outcome ', ' Prevalence ', ' racial and ethnic disparities ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' authority ', ' cohort ', ' Participant ', ' treatment program ', ' member ', ' Reporting ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Support System ', ' Social Support System ', ' Censuses ', ' Healthcare ', ' health care ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' ']",NIDA,EMORY UNIVERSITY,R21,2009,308680,0.13845165533102147
"Service Use, ATI Program Outcomes, and Pro-Social Change This application details a proposal for a prospective longitudinal panel study with a random sample of 360 individuals attending alternative to incarceration (ATI) programs in New York City (NYC) that serve drug- involved offenders. The proposed study focuses on (1) the impact of utilization of formal healthcare and psychosocial services on outcomes of ATI program completion, recidivism, technical violations (i.e., law- breaking behaviors not resulting in re-incarceration), and pro-social change (e.g., fulfilling child- and elder- caretaking roles); and (2) factors affecting service utilization among ATI program participants. The study fulfills several recommendations from the Blue Ribbon Task Force on Health Service Research at NIDA, including broadening both (a) the venues of drug abuse services researchto include programs in ""nontraditional"" settings, especially the criminal justice system, and (b) the range of needs and characteristics of subgroups that are studied in order to address a fuller ""continuum of care and patient groups."" The Task Force's recommendations echoed other calls regarding the need to elucidate mediators of success of treatment, especially those in nontraditional settings such as criminal justice programs for drug-involved offenders.Also consistent with the Task Force report, the proposed research will employ new data analysis methods for causal inference using observational data. The significance and feasibility of the proposed study are substantiated by findings from a pilot study successfully completed by the investigators. For the proposed study, we will recruit individuals at the start of their participation in ATI programs designed for adult, drug-involved offenders in NYC, conducting structured interviews every 3 months over the course of 18 months for each participant. Aims, hypotheses, and measurements are guided by the Network Episode Model, an innovative model that conceptualizes access and attendance of formal services as a time-varying behavior driven by level of need and shaped by dynamic processes involving individual/social context factors and service system experiences. The proposed study is designed to achieve the following primary aims: (1) To examine the causal relationship between service utilization and (a) ATI program completion, (b) recidivism, (c) technical violations, and (d) pro-social change; and (2) To identify and estimate the causal impact of factors that influence access and utilization of formal services among ATI participants. Findings will generate substantive and practical implications for researchers and professionals in the areas of drug abuse, services research, criminal justice, and public health in developing and testing future interventions and programs for drug-involved offenders. The proposed study will be conducted by Dr. Elwin Wu and Dr. Nabila EI-Bassel of the Social Intervention Group at the Columbia University School of Social Work. ","Service Use, ATI Program Outcomes, and Pro-Social Change",7589676,R01DA019496,"['Data Analyses ', ' Data Analysis ', ' Provider ', ' health disparity ', ' health disparities ', ' Dropout ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Employment ', ' Address ', ' Social Network ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Subgroup ', ' Principal Investigator ', ' Characteristics ', ' Process ', ' Face ', ' facial ', ' faces ', ' Advisory Committees ', ' Task Forces ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' Affect ', ' Age ', ' criminal behavior ', ' Elderly ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Goals ', ' improved ', ' Health ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Site ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Medical ', ' Randomized Clinical Trials ', ' Interview ', ' Laws ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Individual ', ' Trust ', ' Literature ', ' satisfaction ', ' Measurement ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' men ', "" men's "", ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Mentors ', ' Mentorship ', ' Methods ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Motivation ', ' New York City ', ' Collaborations ', ' Therapeutic ', ' Patients ', ' Perception ', ' Pilot Projects ', ' pilot study ', ' Poverty ', ' Shapes ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recommendation ', ' Recruitment Activity ', ' recruit ', ' Relapse ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Schools ', ' Social Change ', ' Social transformation ', ' Social modification ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Problems ', ' social disturbance ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Psychiatric Social Work ', ' psychosocial service ', ' Psychiatric Social Service ', ' sociologist ', ' Consensus ', ' Life ', ' programs ', ' Target Populations ', ' Testing ', ' Time ', ' Universities ', ' Attitude ', ' Woman ', ' Work ', ' Severities ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Behavioral Research ', ' psychosocial ', ' Services ', ' drug abuse education ', ' drug use education ', ' experience ', ' success ', ' professor ', ' knowledge base ', ' knowledgebase ', ' intervention program ', ' California ', ' Structure ', ' Participant ', ' Prevention Research ', ' recidivism ', ' Diversion Program ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' offender ', ' criminal offender ', ' Reporting ', ' social ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Gender ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Drug Courts ', ' Criminal Justice ', ' Illicit Drugs ', ' Healthcare ', ' health care ', ' Outcome Measure ', ' Modeling ', ' Sampling ', ' driving behavior ', ' response ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' cost ', ' design ', ' designing ', ' Outcome ', ' Population ', ' prospective ', ' Trauma ', ' innovation ', ' innovative ', ' innovate ', ' service utilization ', ' addiction ', ' addictive disorder ', ' group intervention ', ' Consultations ', ' Continuity of Patient Care ', ' Continuum of Care ', ' Continuity of Care ', ' ']",NIDA,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2009,344711,0.05683189616172595
"Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study    DESCRIPTION (provided by applicant): We propose to extend the Northwestern Juvenile Project to examine the developmental patterns of drug use and disorder and risk for HIV/AIDS and other sexually transmitted infections (STIs) as juvenile justice youth age from adolescence to emerging adulthood and young adulthood. This study responds to NIDA's new initiatives in health disparities in HIV/AIDS in minority populations, specifically the nexus of drug abuse, criminal justice involvement, and HIV/AIDS among African Americans.  African Americans comprise 12% of the US population but 40% of incarcerated populations and 50% of new cases of HIV/AIDS. At year-end 2004, nearly 100,000 juveniles and nearly 2.1 million adults were incarcerated. We will continue to study a racially/ethnically diverse sample (n=758; 330 females, 428 males; 412 African Americans, 137 non-Hispanic whites, 207 Hispanics, 2 other race/ethnicity) of persons who were arrested and detained in Cook County (Chicago) Illinois, aged 10-18 years at recruitment (1997-1998). Since recruitment, data have been collected on the development of substance use and disorders, risk and protective factors, and HIV/AIDS risk behaviors. Participants are re-interviewed whether they are (re)incarcerated or back in the community. We propose to conduct annual interviews 10, 11, 12, and 13 years post-baseline, collect records, and test for HIV infection and selected STIs. Focusing on racial/ethnic disparities, gender and age differences, and effects of incarceration, we will: (1) describe patterns of drug use and disorder - onset, persistence, desistence, and recurrence -- as juvenile justice youth age from adolescence to emerging adulthood and young adulthood; (2) describe patterns of HIV/AIDS risk behaviors during this same period; (3) describe the prevalence and incidence of HIV infection and other STIs; and (4) examine the relationship between drug use and disorder and HIV/AIDS risk behaviors. Extending the Northwestern Juvenile Project allows us to leverage the data already collected to examine health disparities and the role of disproportionate minority confinement in the development of drug use and disorder and HIV/AIDS risk; to identify risk and protective factors that are potentially malleable; to identify points of intervention at key developmental periods; and to extend theoretical models - developed in general population adolescents - to correctional populations.           ","Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study",7600339,R01DA022953,"['Healthy People 2010 ', ' health disparity ', ' health disparities ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' violence prevention ', ' prevent violence ', ' Social Network ', ' Jail ', ' Data ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' Characteristics ', ' sex ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Authorization documentation ', ' Permission ', ' Authorization ', ' Development ', ' developmental ', ' transcription mediated amplification ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Freedom ', ' Liberty ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Injury ', ' Age ', ' racial/ethnic difference ', ' Gonorrhea ', ' Gonococcal Infection ', ' improved ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Herpes Simplex Infections ', ' Herpesvirus hominis disease ', ' Herpes simplex disease ', ' Herpes Simplex ', ' Recording of previous events ', ' History ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV-1 ', ' human T lymphotropic virus III ', ' human T cell leukemia virus III ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Illinois ', ' Incidence ', ' Infection ', ' Human Papillomavirus ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Injection of therapeutic agent ', ' Injections ', ' Interview ', ' Screening procedure ', ' screenings ', ' screening ', ' Justice ', ' Kinetics ', ' Individual ', ' Longitudinal Studies ', ' long-term study ', ' Drug usage ', ' drug use ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Methods ', ' Theoretical model ', ' Theoretic Models ', ' Persons ', ' Needles ', ' Neighborhoods ', ' Neisseria gonorrhoeae ', ' N.gonorrhoeae ', ' N. gonorrhoeae ', ' Gonococcus ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' Liquid substance ', ' liquid ', ' fluid ', ' Antibodies ', ' Prisons ', ' cooking ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Anus ', ' Anal ', ' Recommendation ', ' Records ', ' Recurrence ', ' Recurrent ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Saliva ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Specimen ', ' Research Specimen ', ' Life ', ' Substance Use Disorder ', ' Syphilis ', ' great pox ', ' Tattooing ', ' Tattooings ', ' Technology ', ' Testing ', ' Time ', ' Trichomonas Infections ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Ulcer ', ' Ulceration ', ' Urine ', ' Urine Urinary System ', ' Vagina ', ' Vaginal ', ' Viral hepatitis ', ' Woman ', ' Work ', ' Frequencies (time pattern) ', ' Frequency ', ' Dependence ', ' Event ', ' Oral ', ' Route ', ' Pattern ', ' Techniques ', ' Location ', ' Back ', ' Dorsum ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' interest ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Services ', ' Genital system ', ' urogenital system (genital part) ', ' Genital ', ' Surgeon ', ' American ', ' Participant ', ' health record ', ' NIH Program Announcements ', ' Program Announcement ', ' Patient Self-Report ', ' Self-Report ', ' high risk behavior ', ' deviant ', ' deviancy ', ' disorder risk ', ' disease risk ', ' General Population ', ' General Public ', ' intravenous drug use ', ' age difference ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Cervical dysplasia ', ' Cervix Dysplasia ', ' County ', ' Gender ', ' Chicago ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia trachomatis ', ' Rickettsia trachomae ', ' Needle Sharing ', ' Syringe Sharing ', ' Needlesharing ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Accounting ', ' Communities ', ' sex risk ', ' sexual risk behavior ', ' Minority ', ' Outcome ', ' Population ', ' Prevalence ', ' racial and ethnic disparities ', ' FDA approved ', ' emerging adulthood ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2009,1175105,0.10348631909936978
"PS07-003, Minority HIV/AIDS Research Initiative (MARI)    DESCRIPTION (provided by applicant):   The proposed study's overarching goal is to reduce the ethnic disparities in HIV infection between Hispanic and non-Hispanic youth living in Miami-Dade County, an HIV epicenter. This goal will be accomplished by two aims: AIM 1 is to develop and manualize a one-and-a-half- month streamlined version of an efficacious HIV preventive intervention entitled Familias Unidas; and AIM II is to evaluate the efficacy of the streamlined version of Familias Unidas plus an HIV Prevention School CurriculumTreatment as Usual, relative to the HIV Prevention School Curriculum Treatment as Usual only, in preventing drug use and unprotected sexual behavior, two risk factors for HIV infection. Familias Unidas aims to prevent drug use and unprotected sexual behavior by (a) increasing family functioning, (b) increasing parental monitoring of peer activities, and (c) influencing adolescent social cognitive mechanisms regarding drug use and unsafe sexual behavior. A sample of 240 Hispanic 9th grade adolescents and their primary caregivers will be randomized to one of two conditions: Familias Unidas plus the HIV School Curriculum Treatment as Usual (hereafter refererred to as Familias Unidas) or the HIV Prevention School Curriculum Treatment as Usual only. Two studies have demonstrated the efficacy of an intensive, 9 to 12 month version of Familias Unidas. In the first study, Familias Unidas was shown to be efficacious relative to a no- intervention control condition in increasing family functioning. In the second study, Familias Unidas was found to be efficacious in preventing drug use and unsafe sexual behavior relative to two attention control conditions. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more efficacious than the HIV Prevention School Curriculum Treatment as Usual in preventing adolescent drug use over time and (H2) Familias Unidas will be more efficacious than the HIV Prevention School Curriculum Treatment as Usual in preventing adolescent unprotected sexual behavior over time. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on drug use will be partially mediated by (1) family functioning; (2) parental monitoring of peers; and (3) social cognitive mechanisms regarding drug use; and (H2a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by (1) family functioning; (2) parental monitoring of peers; (3) social cognitive mechanisms regarding unprotected sex; and (4) drug use. The objective of the proposed study is to reduce HIV contraction health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of interventions to reduce drug use, unprotected sexual behavior, and HIV in Hispanic adolescents.           ","PS07-003, Minority HIV/AIDS Research Initiative (MARI)",7683175,U01PS000671,[''],NCHHSTP,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,U01,2009,272956,0.10409011619734354
"Navigator Enhanced Case Management for Jail Inmates    DESCRIPTION (provided by applicant): Each year, there are over 600 unduplicated HIV-infected persons incarcerated in the San Francisco jail and almost two-thirds released with HIV-focused discharge planning were reincarcerated within 1 year. More than half of HIV-infected jail inmates are diagnosed with mental health conditions severe enough to require medication and a similar proportion report substance abuse disorders at the time of detention. While some community-based services exist, there remains a critical need exists to improve linkages to care and adherence to care plans for HIV-infected adults as they move between community and jai. An effective service delivery model used in similar high-needs populations exists, but has not been tested with HIV-infected drug users leaving jails - Navigator case management. Base on harm reduction, motivational interviewing and general social work principles, this model uses assertive community treatment and a highly proactive approach to facilitate adherence to a comprehensive care plan designed to address a client's multiple needs. Case managers work with paraprofessional peer navigators to help clients make better use of available resources, more effectively communicate with providers, sustain care over time and successfully connect with multiple service provider sectors. In this study, we propose to tailor this approach to meet the needs of HIV-infected individuals with substance abuse and mental health issues, pilot test the intervention and assessment procedures and then conduct a randomized study in which 360 HIV-infected men and women leaving jail. Specifically, participants will receive either Navigator case management delivered by the non-profit San Francisco Pre-Trial Diversion project or the standard of care currently provided to transitioning inmates, 90- days of as-needed case management provided by the San Francisco Department of Public Health's Forensic AIDS Project. We will test the effectiveness of the intervention in reducing sexual and drug-related HIV transmission risk, increasing HIV medication adherence, reducing drug dependence and reducing reincarceration. Finally, we will characterize both the Navigator and Forensic AIDS Project intervention processes and conduct exploratory analyses of the mediators of HIV transmission risk and risk reduction and HIV-related adherence among HIV+ individuals leaving jail. Our study is highly innovative because no interventions exist that are proven effective with this population - HIV-infected individuals with drug use and mental health issues. This study will also contribute to the field of HIV prevention by incorporating risk reduction counseling alongside more traditional case management support services. PUBLIC HEALTH RELEVANCE: HIV-infected adults incarcerated in the United States criminal justice system are predominantly active drug users and disproportionately people of color. The complex interplay of poverty, race, lack of education and sanctions--rather than treatment--for addictions reinforces returns to the criminal justice system and pervasive health disparities for HIV-infected individuals. Underlying behaviors that lead to repeated incarceration closely correlate with behaviors that are associated with HIV transmission and increased morbidity and mortality from HIV. In drug addicted adults, recidivism is driven by drug relapse and illegal activities associated with drug use, failure to engage and remain in mental health treatment or failure to break free from social instability in the form of homelessness and joblessness. This study proposes to assess whether a method of case management proven effective for similar populations can ensuring services to successfully and permanently break the cycle of incarceration, drug abuse and HIV transmission risk behavior among HIV-infected individuals leaving jail.              NARRATIVE HIV-infected adults incarcerated in the United States criminal justice system are predominantly active drug users and disproportionately people of color. The complex interplay of poverty, race, lack of education and sanctions--rather than treatment--for addictions reinforces returns to the criminal justice system and pervasive health disparities for HIV-infected individuals. Underlying behaviors that lead to repeated incarceration closely correlate with behaviors that are associated with HIV transmission and increased morbidity and mortality from HIV. In drug addicted adults, recidivism is driven by drug relapse and illegal activities associated with drug use, failure to engage and remain in mental health treatment or failure to break free from social instability in the form of homelessness and joblessness. This study proposes to assess whether a method of case management proven effective for similar populations can ensuring services to successfully and permanently break the cycle of incarceration, drug abuse and HIV transmission risk behavior among HIV-infected individuals leaving jail.",Navigator Enhanced Case Management for Jail Inmates,7742573,R01DA027209,"['Risk ', ' San Francisco ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Societies ', ' Life ', ' programs ', ' Testing ', ' Time ', ' Unemployment ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' United States ', ' Woman ', ' Work ', ' Complex ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Viral ', ' meetings ', ' Services ', ' Participant ', ' peer ', ' Harm Reduction ', ' Harm Minimization ', ' recidivism ', ' high risk behavior ', ' motivational enhancement therapy ', ' motivational interview ', ' Case Manager ', ' Case Management Nurse ', ' Care Manager ', ' drug addict ', ' Reporting ', ' social ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' County ', ' Case Management ', ' Criminal Justice ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Client ', ' Color ', ' Communities ', ' Comprehensive Health Care ', ' comprehensive care ', ' Comprehensive Healthcare ', ' cost ', ' drug relapse ', ' reincarceration ', ' design ', ' designing ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' community based service ', ' addiction ', ' addictive disorder ', ' public health relevance ', ' standard of care ', ' treatment adherence ', ' efficacy testing ', ' ImProv ', ' Counseling ', ' Risk Reduction ', ' Provider ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Diagnosis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Vent ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Caring ', ' Jail ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Adherence (attribute) ', ' Adherence ', ' Effectiveness of Interventions ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' transmission process ', ' Transmission ', ' Process ', ' medication compliance ', ' medication adherence ', ' Forensic Medicine ', ' Forensics ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' base ', ' improved ', ' Procedures ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Housing ', ' Left ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Medical ', ' Ensure ', ' Failure (biologic function) ', ' failure ', ' FLR ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Homelessness ', ' unhoused ', ' homeless ', ' Individual ', ' Drug usage ', ' drug use ', ' men ', "" men's "", ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' Persons ', ' Poverty ', ' Prisoner ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisons ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Relapse ', ' Resources ', ' Research Resources ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2009,520117,0.12698386697695813
"Stress and Drug Use Vulnerability in Rural African Americans    DESCRIPTION (provided by applicant): The impact that drug addictions have on health disparities impacting at-risk African Americans who reside in the rural South are grossly understudied. While there is strong evidence linking drug use and abuse to violent behaviors, injuries, mental health, and physical health problems, it is unclear how African Americans are disproportionately at risk given their relatively low incidence rates of drug use and abuse. There is a growing body of literature linking stress and the subsequent activation of the hypothalamic-pituitary-adrenal (HPA) axis to addictions. Given the considerable heterogeneity within drug-related phenotypes and limited evidence of large-magnitude single gene influences, stress dysregulation will be investigated as an endophenotype for clarifying the more subtle relationship between specific genes and drug use vulnerability. This study will pursue two specific aims using innovative experimental methodologies from drug abuse, molecular genetics, endocrinology, social psychology, and cross-cultural research: (1) Investigate whether genotype interacts with environmental variables (GxE) to affect physiological responses to acute stress; and (2) Investigate whether stress dysregulation predicts drug related attitudes, craving, and history of drug use. Acute stress will be elicited via the Trier Social Stress Test. Subjects (N = 100) will be randomly assigned into one of two speech tasks: (a) shoplifting or (b) experience of discrimination. Measured variables will include genotype (CRH and CRHR1), hormones (cortisol and DHEA), autonomic measures (galvanic skin conductance and heart rate variability), chronic environmental stressors, implicit drug-related cognitions, drug craving, and drug use history. It is envisioned that this proposed study can initiate a multidisciplinary program of research aimed at investigating gene by environment (GxE) influences on drug use vulnerability. Empirical research in this area is needed in order to gain insight into the biopsychosocial risk factors that have the capacity to inform theory, research, prevention, and treatment in the area of drug addictions.      PUBLIC HEALTH RELEVANCE: African American drug use and abuse behaviors are often characterized by oversimplified models that are rooted in research studies that rarely include them. This proposal seeks to take a multidimensional approach (e.g., genetics, endocrinology, psychology, culture, social environment) towards investigating mechanisms that may increase drug use vulnerability in at-risk African American adults who reside in the rural South. Such research is needed in order to inform theory, research, prevention, and intervention efforts aimed at elimination health disparities that disproportionately impact this community.           PROJECT NARRATIVE African American drug use and abuse behaviors are often characterized by oversimplified models that are rooted in research studies that rarely include them. This proposal seeks to take a multidimensional approach (e.g., genetics, endocrinology, psychology, culture, social environment) towards investigating mechanisms that may increase drug use vulnerability in at-risk African American adults who reside in the rural South. Such research is needed in order to inform theory, research, prevention, and intervention efforts aimed at elimination health disparities that disproportionately impact this community.",Stress and Drug Use Vulnerability in Rural African Americans,7762080,R03DA027481,"['Corticotropin-Releasing Hormone ', ' corticotropin releasing hormone ', ' Corticotropin-Releasing Hormone-41 ', ' Corticotropin-Releasing Factor-41 ', ' Corticotropin-Releasing Factor ', ' Corticoliberin ', ' CRF-41 ', ' ACTH-Releasing Factor ', ' Crime ', ' Cessation of life ', ' Death ', ' dehydroepiandrosterone ', ' Therapeutic Dehydroepiandrosterone ', ' Prasterone ', ' Dehydroisoandrosterone ', ' DHEA ', ' Androstenolone ', ' Androst-5-en-17-one, 3-hydroxy-, (3beta)- ', ' 5-Androsten-3-beta-hydroxy-17-one ', ' 3beta-Hydroxyandrost-5-en-17-one ', ' drug abuse prevention ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' health disparities ', ' Discrimination (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' CRH gene ', ' CRH ', ' Endocrinology ', ' Metabolism and Endocrinology ', ' Environment ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Chronic stress ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Exhibits ', ' Behavioral ', ' Feedback ', ' Adrenal Glands ', ' suprarenal gland ', ' Adrenals ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Galvanic Skin Response ', ' skin conductance ', ' Skin Electric Conductance ', ' Psychogalvanic Reflex ', ' Electrodermal Response ', ' Output ', ' Affect ', ' Genes ', ' Genotype ', ' Injury ', ' base ', ' human subject ', ' Heterogeneity ', ' Recording of previous events ', ' History ', ' Hormones ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Chemotherapy-Hormones/Steroids ', ' Hydrocortisone ', ' Therapeutic Hydrocortisone ', ' Proctocort ', ' Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)- ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Area ', ' Chronic ', ' Biological ', ' Physiological ', ' Physiologic ', ' Hypothalamic structure ', ' hypothalamic ', ' Hypothalamus ', ' Link ', ' Incidence ', ' Laboratories ', ' Psyche structure ', ' mental ', ' disability ', ' insight ', ' Stimulus ', ' Recovery ', ' Literature ', ' Rural ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Measurement ', ' Drug usage ', ' drug use ', ' Plant Roots ', ' root ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methodology ', ' Method LOINC Axis 6 ', ' Endocrinologist ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Mortality Vital Statistics ', ' Mortality ', ' Neighborhoods ', ' Perception ', ' Periodicity ', ' Rhythmicity ', ' Cyclicity ', ' Phenotype ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Pilot Projects ', ' pilot study ', ' Pituitary Gland ', ' Pituitary Nervous System ', ' Pituitary ', ' Hypophysis Cerebri ', ' Hypophysis ', ' Psychology ', ' Social Psychology ', ' Relapse ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Empirical Research ', ' programs ', ' Speech ', ' Stress ', ' Violence ', ' violent behavior ', ' violent ', ' Attitude ', ' Severities ', ' Complex ', ' Dependence ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' Behavior ', ' physical conditioning ', ' physical health ', ' drug craving ', ' Corticotropin-Releasing Hormone Receptors ', ' Corticotropin Releasing-Factor Receptors ', ' CRH Receptors ', ' CRF Receptors ', ' environmental stressor ', ' experience ', ' hypothalamic-pituitary-adrenal axis ', ' hypothalmus-pituitary-adrenal axis ', ' hypothalamic-pituitary-adrenal (HPA) axis ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' novel ', ' Prevention Research ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Measures ', ' Relative (related person) ', ' Relative ', ' acute stress ', ' Regulation ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Molecular Genetics ', ' Modeling ', ' Sampling ', ' behavioral health ', ' craving ', ' response ', ' theories ', ' Circadian Rhythms ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cognition ', ' Communities ', ' burden of illness ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' design ', ' designing ', ' Violent injury ', ' Violence injury ', ' biopsychosocial ', ' Population ', ' Trier Social Stress Test ', ' Consumption ', ' Individual Differences ', ' innovation ', ' innovative ', ' innovate ', ' multidisciplinary ', ' endophenotype ', ' addiction ', ' addictive disorder ', ' public health relevance ', ' heart rate variability ', ' biological systems ', ' ']",NIDA,UNIVERSITY OF GEORGIA,R03,2009,241047,0.18637856948282527
"In-home prevention of SA risks for Native teen families    DESCRIPTION (provided by applicant): The overarching goal of this Competitive Revision [Notice Number (NOT-OD-09-058) and Notice Title (""NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications"")] is to expand the scope of our current grant, ""In-Home Prevention of Substance Abuse Risks for Native Teen Families,"" (NIDA 5R01DA019042; FOA: PA-07-070) that is assessing the efficacy of the ""Family Spirit"" (FS) prenatal and early childhood home- visiting intervention delivered by American Indian (AI) paraprofessionals to AI teen mothers and their children. The current FS intervention is designed to promote mothers' effective parenting practices, reduce maternal drug use, and improve maternal and child outcomes associated with lifetime drug use. The Revision will research current drug use patterns and parenting practices of men who fathered a child with and/or are male partners of AI teen mothers enrolled in the current trial and work with communities to design a data-driven, culturally informed FS supplemental intervention for fathers. Specific aims are to: 1) describe drug use patterns of AI fathers/male partners; 2) explore fathers' and community stakeholders' beliefs and motivations regarding drug use and fatherhood; 3) examine relationships between fathers' drug use patterns and fathering practices; and 4) design a FS fathers curriculum targeting: a) drug refusal and avoidance; b) effective parenting; c) job readiness, and d) improved home environments. At the time of submission of this Competitive Revision, the sample for the current grant (N=322 mother/child pairs) is recruited and randomized to the FS Intervention + Optimized Standard Care vs. Optimized Standard Care alone. At baseline, expectant AI teen mothers at ~32 weeks gestation from four southwestern reservation communities were 12-19 years old and reported high rates of lifetime drug use. This study aims to recruit 120 fathers (30 from each site) evenly distributed across treatment and control groups and 40 community experts (10 from each site) to advise the intervention development process. Research methods will combine in-depth qualitative research processes with state-of-the-art ACASI technologies to maximize data quality and accelerate transmittal, analysis, and dissemination of findings. Long-term expected outcomes are to reduce persistent AI behavioral health disparities related to drug use over the life course of young AI parents and their offspring.      PUBLIC HEALTH RELEVANCE: Given American Indian males' known risks for drug use and their impact on partners and children's drug-related outcomes, there is an urgent need to identify effective intervention strategies for young American Indian fathers. First-time fatherhood may provide a pivotal developmental time point for behavioral redirection and decrease related behavioral risks for partners/spouses and children.              Project Narrative (Relevance) Given American Indian males' known risks for drug use and their impact on partners and children's drug-related outcomes, there is an urgent need to identify effective intervention strategies for young American Indian fathers. First-time fatherhood may provide a pivotal developmental time point for behavioral redirection and decrease related behavioral risks for partners/spouses and children.",In-home prevention of SA risks for Native teen families,7809180,R01DA019042,"['Educational Curriculum ', ' Curriculum ', ' Data Collection ', ' substance abuse prevention ', ' substance abuse control ', ' health disparity ', ' health disparities ', ' Readiness ', ' Preparedness ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Enrollment ', ' enroll ', ' Teenagers ', ' teen years ', ' Teen ', ' Process ', ' Development ', ' developmental ', ' Behavioral ', ' Family ', ' Fathers ', ' Spouses ', ' Married Persons ', ' Goals ', ' Grant ', ' improved ', ' House Call ', ' Home Visits ', ' Site ', ' Training ', ' Health Knowledge, Attitudes, Practice ', ' Knowledge, Attitudes, Practice ', ' Knowledge, Attitudes, Behaviors ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' teenage mother ', ' teenage mom ', ' teen mother ', ' teen mom ', ' adolescent mother ', ' Recovery ', ' Data Quality ', ' Drug usage ', ' drug use ', ' Funding ', ' male ', ' American Indians ', ' American Indian ', ' men ', "" men's "", ' Mothers ', ' Motivation ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Occupations ', ' Professional Postions ', ' Jobs ', ' Parents ', ' Pregnancy ', ' Gestation ', ' fatherhood ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Risk ', ' Arts ', ' Technology ', ' Time ', ' Work ', ' Frequencies (time pattern) ', ' Frequency ', ' Home environment ', ' Home ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Belief ', ' maternal drug use ', ' early childhood ', ' prenatal ', ' unborn ', ' offspring ', ' parental role ', ' parent role ', ' indian reservation ', ' tribal reservation ', ' reservation community ', ' native american reservation ', ' nation reservation ', ' american indian reservation ', ' high risk behavior ', ' Prevention ', ' Reporting ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Parenting behavior ', ' Parenting ', ' Research Methodology ', ' Research Methods ', ' Sampling ', ' behavioral health ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' Qualitative Research ', ' Home visitation ', ' home visit ', ' time use ', ' design ', ' designing ', ' Outcome ', ' 19 year old ', ' nineteen year old ', ' age 19 years ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' public health relevance ', ' effective intervention ', ' standard care ', ' standard treatment ', ' Control Groups ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R01,2009,780538,0.12601496036389573
"Collaborative Research on Drug Abuse    DESCRIPTION (provided by applicant): This P01 develops and applies state-of-the-art methods to analyze existing but under-utilized drug abuse databases in collaboration with their owners. We address contemporary, theoretical, and applied issues in drug abuse research to understand intersections between substance abuse and AIDS risk behaviors as well as minority and gender-based health disparities. We work with dozens of investigators from drug & social policy, epidemiology, health sciences, medicine, nursing, psychiatry, psychology, public health, and social work who own exciting substance abuse data to develop models that test current theories, especially on epidemiology, prevention, intervention, and treatment of drug abuse, using modern multivariate methods to control for measurement errors, biases, and other confounds. The Models and Methods Project develops psychometric and statistical analytic techniques that hold special promise for improving the quality of drug abuse and AIDS research. The At-Risk Project studies substance abuse related data sets on vulnerable populations (substance abusers, homeless people, individuals who are HIV positive or who have AIDS, victims of domestic abuse, runaways, gang members, and others at high risk for AIDS or drug abuse) with methods to control sampling, measurement, distributional and other biases. The Community Project studies drug abuse etiology, adult consequences, HIV risk, intergenerational processes, general deviance, and related issues in large community-based samples, and develops and tests explanatory theories using models that permit separation of common from specific effects, control for artifacts, etc. The Core Project oversees and integrates all components, hosts visiting scholars, provides computer facilities, and sponsors a mentoring program for disadvantaged students. The substantive part of the Models Project and the At-Risk and Community Projects will be developing and testing integrative theories that can be applied across different populations. The findings from their studies will lead to greater understanding of precursors and concomitants of substance abuse and HIV/AIDS risk and transmission. In turn, these findings will guide development of effective interventions to reduce negative health outcomes and treatment disparities in community, ethnic, and vulnerable populations, and provide guidance on how these may be alleviated.      PROGRAM CHARACTERISTICS          ",Collaborative Research on Drug Abuse,7687376,P01DA001070,[''],NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,P01,2009,1094325,0.06373110537308126
"Drug Abuse and Crime Across the Life Course in an African American Population    DESCRIPTION (provided by applicant): African Americans are disproportionately represented in national crime statistics for arrests and incarceration as well as victimization, particularly for drug-related and violent offenses. Their involvement in crime often represents only one component of a well-recognized cluster of negative experiences and circumstances including drug use problems, socioeconomic disadvantage and poor physical and mental health, sometimes evident in childhood. The cost to individuals, families, and society is enormous, yet we know little about the development of these patterns across the life course. Despite these evident disparities, few studies have examined the development of drug use and criminal behaviors over time within African American community populations, especially into mid adulthood. We intend to study the timing and sources of risk over the life span to better understand the disparities in health and social consequences related to criminal justice issues among African Americans. To that end, we request support to analyze existing crime and drug data covering 35 years in the lives of a cohort of first grade, African American children from inner city Chicago. This prospective developmental study (the Woodlawn project) began in 1966-67, with the most recent follow up in 2002-3 at ages 42-43, and interim assessments in adolescence and early adulthood (age 32-33). The study population had high levels of drug use and criminal activity in adulthood. In the proposed project, we will focus on interrelationships of drug abuse and crime, examining predictors and consequences of drug abuse, criminal activity, and involvement with the criminal justice system. Using data from cohort members, mothers, interviewers, and official criminal records, we will identify 1) patterns of drug use and criminal behaviors over the life course; 2) individual and contextual predictors of later drug use, criminal activity/behaviors, and involvement with the criminal justice system; 3) social, economic, and health consequences of drug use, criminal behaviors, and involvement in the criminal justice system. Of particular interest is how drug use in adolescence and early adulthood relates to the risk of being arrested and incarcerated and, conversely, how early arrests and incarceration influence later drug use and criminal behaviors. This information will further our understanding of the etiology and consequences of crime and drug use into mid adulthood, and inform the design of interventions at various stages along the life course.             ",Drug Abuse and Crime Across the Life Course in an African American Population,7586197,R01DA022366,"['Crime ', ' Disadvantaged ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' low socioeconomic status ', ' Address ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' NIH RFA ', ' Request for Applications ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' socioeconomics ', ' developmental ', ' Development ', ' Behavioral ', ' Family ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' Female ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' pathway ', ' Pathway interactions ', ' Affect ', ' Age ', ' base ', ' criminal behavior ', ' Health ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Interviewer ', ' race discrimination ', ' racial discrimination ', ' pediatric ', ' Childhood ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Individual ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' drug use ', ' Drug usage ', ' male ', "" men's "", ' men ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Mortality ', ' Mortality Vital Statistics ', ' Mothers ', ' Neighborhoods ', ' well-being ', ' Personal Satisfaction ', ' Staging ', ' Records ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Societies ', ' Life ', ' Victimization ', ' statistics ', ' Time ', ' Time Study ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Unemployment ', ' violent behavior ', ' violent ', ' Violence ', ' Woman ', ' Complex ', ' Source ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' Behavior ', ' interest ', ' 1st grade ', ' first grade ', ' inner city ', ' experience ', ' social integration ', ' cohort ', ' intervention program ', ' member ', ' Population Study ', ' social ', ' Gender ', ' Chicago ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' abstracting ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' Mediating ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' Sampling ', ' Communities ', ' cost ', ' health economics ', ' Social Functioning ', ' designing ', ' design ', ' Outcome ', ' Population ', ' prospective ', ' treatment design ', ' intervention design ', ' therapy design ', ' early adulthood ', ' emerging adult ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R01,2009,466759,0.19747166288874865
"Trajectories of Drugs Abuse in High Risk Youth We propose to extend the Northwestern Juvenile Project to examine the dynamic relationships among patterns of drug use and disorder, risk and protective factors for drug use and disorder, and adult social role performance as juvenile justice youth age from adolescence to emerging adulthood and young adulthood. This study responds to NIDA's new initiatives on drug abuse, health disparities, and disproportionate minority confinement of African Americans. At year-end 2004, nearly 100,000 juveniles and nearly 2.1 million adults were incarcerated. African Americans comprise 12% of the US population but 40% of incarcerated populations. We are studying a racially/ethnically diverse sample (n=1709; 624 females, 1085 males) in Cook County (Chicago) Illinois, aged 10-18 years at recruitment (1995-1998). Youth are reinterviewed whether they are (re)incarcerated or back in the community. Our goal is to focus on gender differences, racial/ethnic disparities, and the effect of incarceration as we: (1) describe patterns of drug use and disorder --onset, persistence, desistence, andrecurrence - asjuvenile justice youth agefrom adolescence to emerging and young adulthood; (2) examine how risk and protective factors (e.g., comorbid mental disorders, adverse life events, availability of illicit drugs) predict, moderate, and mediate patterns of drug use and disorders; and (3) examine the dynamic relationships between patterns of drug use and disorder and adult social role performance (e.g., residential independence [including avoiding incarceration], employment, marriage, parenting, desistance from crime and violence). To analyze the longitudinal data, we will use summary statistics (e.g., prevalence rates, odds ratios), generalized linear mixed-effects models, survival analyses, and Muthen's recently developed extensions of growth mixture models. Extending the Northwestern Juvenile Project allows us to leverage the data already collected to examine the role of incarceration in the development of drug use and disorder, especially among African Americans; to identify risk and protective factors that are potentially malleable; to identify points of intervention at key developmental periods; and to extend theoretical models developed in general population adolescents -- to correctional populations. ",Trajectories of Drugs Abuse in High Risk Youth,7881883,R01DA019380,"['Justice ', ' juvenile delinquent ', ' Young offender ', ' Juvenile Offender ', ' Psyche structure ', ' mental ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Life Style ', ' Lifestyle ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' African ', ' Longitudinal Studies ', ' long-term study ', ' satisfaction ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Marijuana Smoking ', ' marijuana use ', ' Marriage ', ' Medical Records ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Theoretical model ', ' Theoretic Models ', ' Neighborhoods ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' Odds Ratio ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Parents ', ' cooking ', ' public health medicine (field) ', ' Public Health ', ' Public Policy ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Anxiety ', ' Recommendation ', ' Records ', ' Recurrence ', ' Recurrent ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Schools ', ' self esteem ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Social support ', ' social support network ', ' Life ', ' Victimization ', ' sound ', ' statistics ', ' Substance Use Disorder ', ' Survival Analysis ', ' Survival Analyses ', ' Time ', ' Violence ', ' violent behavior ', ' violent ', ' Attitude ', ' Woman ', ' Event ', ' Pattern ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Back ', ' Dorsum ', ' Behavior ', ' Behavior Disorders ', ' behavioral disorder ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Belief ', ' interest ', ' Services ', ' Surgeon ', ' Performance ', ' Self Efficacy ', ' Budgets ', ' Cigarette ', ' Structure ', ' Participant ', ' peer ', ' NIH Program Announcements ', ' Program Announcement ', ' Population Study ', ' Patient Self-Report ', ' Self-Report ', ' deviant ', ' deviancy ', ' disorder risk ', ' disease risk ', ' General Population ', ' General Public ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' County ', ' Gender ', ' Chicago ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Parenting behavior ', ' Parenting ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Modeling ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' theories ', ' functional disability ', ' Functional impairment ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' correctional system ', ' Accounting ', ' Communities ', ' Minority ', ' Outcome ', ' coping ', ' Population ', ' Prevalence ', ' prospective ', ' Trauma ', ' 18 year old ', ' eighteen year old ', ' age 18 years ', ' Affective ', ' racial and ethnic ', ' racial/ethnic ', ' racial and ethnic disparities ', ' high risk ', ' emerging adulthood ', ' Conflict (Psychology) ', ' Conflict ', ' Drops ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Foundations ', ' Freedom ', ' Liberty ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Pathway interactions ', ' pathway ', ' Affect ', ' Injury ', ' Age ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' improved ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Phase ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Domestic Violence ', ' Illinois ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' Crime ', ' Healthy People 2010 ', ' health disparity ', ' health disparities ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Educational Status ', ' training status ', ' training level ', ' training achievement ', ' educational level ', ' Educational Achievement ', ' Employment ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Health system ', ' violence prevention ', ' prevent violence ', ' Ethnic group ', ' Jail ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Request for Applications ', ' NIH RFA ', ' Child Abuse and Neglect ', ' child maltreatment ', ' Childhood maltreatment ', ' Cognitive ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' Characteristics ', ' Process ', ' Development ', ' developmental ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2009,37264,0.15806252262844014
"Development of Behavioral and Social Interventions that Reduce Stigma and Improve    DESCRIPTION (provided by applicant):  This application addresses the broad Challenge Area (01) Behavior, Behavioral Change, and Prevention and the specific Challenge Topic, 01-DA-106: Development of behavioral and social interventions that reduce stigma and improve quality and accessibility of health care services in low resource settings. We will evaluate a pharmacy-based pilot intervention that combines rapid HIV testing with other preventive screening services including blood pressure, glucose, and cholesterol screening. This pilot targeted to injection drug users (IDUs) who purchase syringes from pharmacies via the New York State Expanded Syringe Access Program (ESAP) - a program aimed at increasing sterile syringe access to help reduce HIV transmission. By combining HIV testing with less stigmatizing screening services and offering testing to all pharmacy patrons instead of singling out drug users, the likelihood of reducing HIV testing and drug use-associated stigma will increase. Although HIV testing is increasingly accessible and new testing technologies are available, HIV testing rates are low in the black and Hispanic community, especially among IDUs at risk for HIV and many other infectious and chronic diseases. Structural barriers (i.e., lack of health insurance) in the black and Hispanic community, especially among IDUs may limit access to regular health care/ preventive services. Access barriers are compounded by stigma associated with getting an HIV test that may identify an individual as a drug user and/or someone who engages in socially unacceptable behavior. Thus, this proposed study aims to 1) qualitatively evaluate HIV testing and chronic disease screening in pharmacies, 2) compare/contrast correlates of agreeing to a HIV test vs. not among IDU syringe customers and their peers and 3) qualitatively compare/contrast HIV testing with comprehensive screening services pharmacy (intervention) vs. HIV testing only pharmacy (control). To accomplish these aims, we propose to conduct in-depth interviews among key stakeholders to inform development of study materials, IDU/peer survey and pharmacy staff surveys. We will recruit 2 ESAP-registered Harlem pharmacies (1 intervention and 1 control) where our current work has developed the infrastructure to perform on-site screening services. Among the intervention and control pharmacies, 798 (518 non-drug using, 70 drug-using +3 networks/ drug user) pharmacy customers will be recruited. We will adapt a previously developed training module to train pharmacy personnel on how to engage pharmacy customers. Customers from the intervention pharmacy will complete a brief attitude scale on attitudes toward HIV, IDUs and stigma, watch an educational video on the importance of health screening (particularly HIV testing), participate in desired screening services and undergo a structured 20-minute ACASI that repeats the attitudes scale. Customers in the control pharmacy will only undergo HIV testing and a structured 20-minute ACASI survey. Semi-structured surveys will be administered to all pharmacy staff to ascertain impact of on-site prevention services on pharmacy personnel and business flow. We will use standard qualitative analytic techniques and GEE to account for clustering in quantitative analyses. The proposed research is highly significant in that it aims to explore a pilot intervention that involves expanding pharmacy services to include HIV testing and to determine if offering HIV testing within a comprehensive prevention approach that includes less stigmatizing screening tests (i.e., blood pressure, glucose and cholesterol screening) increases HIV testing among injection drug users who purchase syringes in pharmacies and their peers (drug-using and/or non-drug using). We will be using new HIV testing technologies and bringing technological innovations and treatment modalities to low-income communities in New York City. If successful, this model can be duplicated not only throughout other high-risk neighborhoods in New York, but in several other cities and states. If our findings are positive, broader public health impact could follow. Pharmacists can partner with clinicians and other health care providers to offer an integrative approach to HIV testing to high-risk injection drug using populations and to other groups with limited access to health care services such as the uninsured and undocumented immigrants. Adoption of this integrative approach to HIV testing on a larger scale could also be implemented and reduce many of the access and stigmatization barriers experienced in marginalized populations for HIV testing while simultaneously increasing and improving general health and well-being by targeting chronic disease outcomes that disproportionately affect marginalized populations.               NARRATIVE The proposed research is highly significant in that it aims to explore a pilot intervention that involves expanding pharmacy services to include HIV testing and to determine if offering HIV testing within a comprehensive prevention approach that includes less stigmatizing screening tests (i.e., blood pressure, glucose and cholesterol screening) increases HIV testing among injection drug users who purchase syringes in pharmacies and their peers (drug-using and/or non-drug using). We will be using new HIV testing technologies and bringing technological innovations and treatment modalities to low-income communities in New York City. If successful, this model can be duplicated not only throughout other high-risk neighborhoods in New York, but in several other cities and states. If our findings are positive, broader public health impact could follow. Pharmacists can partner with clinicians and other health care providers to offer an integrative approach to HIV testing to high-risk injection drug using populations and to other groups with limited access to health care services such as the uninsured and undocumented immigrants. Adoption of this integrative approach to HIV testing on a larger scale could also be implemented and reduce many of the access and stigmatization barriers experienced in marginalized populations for HIV testing while simultaneously increasing and improving general health and well-being by targeting chronic disease outcomes that disproportionately affect marginalized populations.",Development of Behavioral and Social Interventions that Reduce Stigma and Improve,7821247,RC1DA028284,"['health care delivery ', ' health services delivery ', ' Healthcare Delivery ', ' Health Sciences, Allied and Health Services Delivery ', ' health disparity ', ' health disparities ', ' Diabetes Mellitus ', ' diabetes ', ' Discrimination (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' Effectiveness ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Low income ', ' Address ', ' Preventive ', ' Research Infrastructure ', ' Infrastructure ', ' Enrollment ', ' enroll ', ' transmission process ', ' Transmission ', ' Development ', ' developmental ', ' Behavioral ', ' Adoption ', ' Affect ', ' Patient Care ', ' Patient Care Delivery ', ' Glucose ', ' Dextrose ', ' D-Glucose ', ' base ', ' improved ', ' Health ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Services ', ' health care service ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Health Status ', ' Level of Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' hypercholesterolemia ', ' Hypercholesteremia ', ' Site ', ' Area ', ' Hypertension ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Link ', ' Injection of therapeutic agent ', ' Injections ', ' Health Insurance ', ' Interview ', ' Screening procedure ', ' screenings ', ' screening ', ' Training ', ' Individual ', ' Policy Maker ', ' Drug usage ', ' drug use ', ' uptake ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Neighborhoods ', ' New York ', ' New York City ', ' Immigrant ', ' Patients ', ' Perception ', ' Personal Satisfaction ', ' well-being ', ' Pharmaceutical Services ', ' Pharmacy Services ', ' Pharmaceutic Services ', ' Pharmacy facility ', ' Pharmacies ', ' Pharmacists ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Stigmata ', ' Life ', ' programs ', ' Stigmatization ', ' Surveys ', ' Survey Instrument ', ' Syringes ', ' Technology ', ' Testing ', ' Vaccination ', ' Attitude ', ' Work ', ' Hour ', ' Dependence ', ' Upper arm ', ' Techniques ', ' Location ', ' Behavior ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Equation ', ' Injecting drug user ', ' Injection Drug User ', ' Services ', ' Blood Pressure ', ' experience ', ' Sterility ', ' sterile ', ' Structure ', ' Disease Outcome ', ' prevention service ', ' peer ', ' member ', ' technological innovation ', ' Prevention ', ' Modality ', ' Human Resources ', ' personnel ', ' Manpower ', ' Reporting ', ' social ', ' Positioning Attribute ', ' Position ', ' Cholesterol ', ' Cholest-5-en-3-ol (3beta)- ', ' Businesses ', ' Healthcare ', ' health care ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Chronic Disease ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Uninsured ', ' social stigma ', ' stigma ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Accounting ', ' Communities ', ' Preventive screening ', ' sex risk ', ' sexual risk behavior ', ' cost effective ', ' cost-effective ', ' Prevention approach ', ' Approaches to prevention ', ' Population ', ' demographics ', ' service intervention ', ' high risk ', ' non-drug ', ' nondrug ', ' flexibility ', ' flexible ', ' ']",NIDA,COLUMBIA UNIVERSITY HEALTH SCIENCES,RC1,2009,499884,0.07976322334687413
"DIDARP at the University of Puerto Rico School of Public Health    DESCRIPTION (provided by applicant): Our goal is to enhance our capacity to conduct drug abuse research with criminal justice populations from a public health perspective, at the University of Puerto Rico, Graduate School of Public Health. Our research development strategy centers on developing proficiency in research competencies in a critical mass of faculty that will cohesively pursue epidemiological and health services research relevant to engaging and retaining in community drug treatment re-entering inmates with histories of a substance use disorder. The program will provide as well opportunities to develop research capacity in students at different stages in their education and to encourage them to engage in drug abuse research careers. The research projects submitted with this application will explore individual and drug treatment provider factors that may predict entry and retention in community drug treatment for re-entering ex-offenders with a substance use problem. The proposed projects should contribute to address the disproportionate prevalence of untreated substance use problems in incarcerated populations as well as the large proportion of untreated ex-offenders that become re-addicted and who are re-incarcerated shortly after release The research projects include three pilot and one developmental project that address NIDA research priorities such as the services needs of special populations and studies of service providers. We expect MIDARP support to enhance our capacity to engage in NIH funded drug abuse research of relevance to addressing disparities borne by Latinos with a substance use disorder. To reach our goal, we have established the following aims: 1) Provide leadership, support, and coordination to increase the number of Latino faculty and students capable of successfully conducting drug abuse research relevant to a criminal justice context. 2) Enhance institutional and extra- institutional resources that sustain the successful planning, financing, and conduct of drug abuse research. 3) Disseminate research findings in a timely and effective fashion to the research community, to the academic programs, and to other stakeholders involved in addressing the drug treatment needs of ex- offenders with a substance use problem. PUBLIC HEALTH RELEVANCE (See instructions): We expect to build a synergestic cluster of faculty, students, and academic leaders that have expressed a growing interest in the public health impact of problems associated with drug abuse in the criminal justice population.              ",DIDARP at the University of Puerto Rico School of Public Health,7754956,R24DA024868,"['Provider ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Development ', ' developmental ', ' Faculty ', ' career ', ' Goals ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Recording of previous events ', ' History ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Leadership ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Funding ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Staging ', ' public health medicine (field) ', ' Public Health ', ' Puerto Rico ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Resources ', ' Research Resources ', ' Public Health Schools ', ' Research Priority ', ' programs ', ' Students ', ' Substance Use Disorder ', ' Universities ', ' interest ', ' Services ', ' named group ', ' Special Population ', ' Population Study ', ' offender ', ' criminal offender ', ' Criminal Justice ', ' Latino ', ' Communities ', ' Instruction ', ' Population ', ' Prevalence ', ' public health relevance ', ' ']",NIDA,UNIVERSITY OF PUERTO RICO MED SCIENCES,R24,2009,523707,0.05136316483987521
"Social networks and HIV risk among rural drug users    DESCRIPTION (provided by applicant):  This application is in response to PA-06-478, ""Research on Rural Mental Health and Drug Abuse Disorders"". One of the research areas highlighted by this PA is the examination of rural HIV transmission using social network analysis. The overall goal of the study is to examine the prevalence, incidence, and risk factors for HIV and other blood borne infections (BBIs) such as hepatitis B (HBV) and C (HCV) among rural Appalachian drug users using social network analysis and multilevel modeling. HIV continues to be a major public health problem in the United States, especially among drug users. However, little is known about HIV in rural areas in which there are marked health disparities. Therefore, given that studies among urban drug users have found that social network indicators are robust predictors of HIV risk, both social network and individual characteristics will be measured for their association with HIV risk among rural drug users. The specific aims are: 1) To determine the prevalence and incidence of HIV, HCV and HBV among rural injection and non- injection drug users; 2) To examine HIV and other BBI risk among rural injection and non-injection drug users; and 3) To examine longitudinal changes in rural HIV, HCV and HBV risk at 6-months, 12-months and 18- months post-baseline. To meet these aims, a sample 500 rural injection and non-injection drug users will be recruited using respondent driven sampling (RDS). In addition to biologic testing for HIV, HCV and HBV, rural participants will be given an interviewer-administered questionnaire pertaining to their social networks (drug, sexual and support networks), sociodemographics, drug use, HIV risk behaviors, psychiatric diagnoses, intravention and norms. Since individuals will be nested within networks, data will be analyzed using multilevel random effects regression that allows for the simultaneous examination of social network and individual-level risk. Consistent with the priorities of the NIDA AIDS Research Program, this proposal will explore the social network structure in a rural drug using population in order to better understand how network factors may affect HIV risk in rural areas using an innovative multilevel approach. Results from the proposed study will inform the design and implementation of HIV interventions in rural areas and help to determine the appropriate population for which to target such activities in order to reduce the morbidity and mortality associated with HIV and other BBIs.       Although HIV remains a significant public health problem in the United States, especially among drug users, little is known about HIV risk in rural areas such as Appalachia. It has been shown in urban populations that relationships among drug users, also known as social networks, are important predictors of HIV risk. Therefore, this study seeks to characterize rural HIV risk by measuring both social network and individual behaviors in order to inform prevention activities in health resource-deprived rural areas.          ",Social networks and HIV risk among rural drug users,7603045,R01DA024598,"['health disparities ', ' health disparity ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' disease/disorder ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Social Network ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Transmission ', ' transmission process ', ' Principal Investigator ', ' Characteristics ', ' facial ', ' faces ', ' Face ', ' Affect ', ' rural area ', ' urban area ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health Resources ', ' Hepatitis B ', ' serum hepatitis ', ' infection with hepatitis B virus ', ' infection with HBV ', ' Viral Hepatitis B ', ' Hepatitis B Infection ', ' Hepatitis B Virus ', ' Homologous Serum Hepatitis Virus ', ' HBV ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Area ', ' Incidence ', ' Infection ', ' Injections ', ' Injection of therapeutic agent ', ' Interviewer ', ' Interview ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Kentucky ', ' Individual ', ' Rural ', ' drug use ', ' Drug usage ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Morbidity ', ' Morbidity - disease rate ', ' Mortality ', ' Mortality Vital Statistics ', ' Respondent ', ' Drug Prescribing ', ' Drug Prescriptions ', ' Drug user ', ' Public Health ', ' public health medicine (field) ', ' Questionnaires ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Risk ', ' Risk Factors ', ' Rural Population ', ' Appalachia ', ' Appalachian Region ', ' serology ', ' Serological Tests ', ' Serologic tests ', ' Individual Adjustment ', ' Psychiatric Diagnosis ', ' Research Priority ', ' programs ', ' Testing ', ' Time ', ' United States ', ' Urban Population ', ' driving ', ' Automobile Driving ', ' bear ', ' Ursidae ', ' Bears ', ' Ursidae Family ', ' Behavior ', ' Injection Drug User ', ' Injecting drug user ', ' meetings ', ' Blood Reticuloendothelial System ', ' Blood ', ' Seroprevalences ', ' Structure ', ' Participant ', ' Prevention ', ' Reporting ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Measures ', ' multilevel modeling ', ' multilevel model ', ' methods to study multiple-level influences ', ' multilevel analysis ', ' Network Analysis ', ' Pathway Analysis ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Modeling ', ' Sampling ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Communities ', ' designing ', ' design ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' high risk ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2009,607327,0.12666251430322556
"Brief Strategic Family Therapy versus Treatment as Usual: Extended Follow-up for    DESCRIPTION (provided by applicant): The primary goal this project is to examine the long-term effects of outpatient treatments for illicit drug using adolescents. Specifically, this study proposes to complete a follow-up assessment with a sample of 379 young adults that participated in a recently completed effectiveness trial to examine the differential effectiveness of brief strategic family therapy (BSFT) and treatment as usual (TAU) in the rates of substance use, externalizing behaviors (including arrests and sexually risky behaviors), time in restricted settings (e.g., residential treatment, detention), and improvements in family functioning. The proposed study is designed to fill a knowledge gap regarding the long term effects of outpatient treatments for adolescent drug users and has implications for furthering research on both family therapy as well as treatment as usual in community agencies. Moreover, this study is particularly relevant for community-based agencies, and - as such - has broad implications for practice in outpatient adolescent substance abuse treatment. Also, the proposed sample includes a sizable population of African American and Hispanics participants. As such, the findings will be relevant for Hispanic and African American adolescent drug users, and will permit the evaluation of the long term impact of the interventions (BSFT and TAU) on specific racial/ethnic groups: African Americans, Hispanics and non-Hispanic Whites.      PUBLIC HEALTH RELEVANCE: The primary goal this project is to examine the long-term effects of different outpatient treatments (brief strategic family therapy and treatment as usual) for illicit drug using adolescents. Given the stability and persistence of drug use over time, examining distal outcomes is critical for identifying effective strategies for preventing adult drug dependent careers. Moreover, the results of this study will have broad implications for practice in outpatient adolescent substance abuse treatment, and will be essential in furthering research on both family therapy as well as treatment as usual in community agencies.           Project Narrative The primary goal this project is to examine the long term effects of different outpatient treatments (brief strategic family therapy and treatment as usual) for illicit drug using adolescents. Given the stability and persistence of drug use over time, examining distal outcomes is critical for identifying effective strategies for preventing adult drug dependent careers. Moreover, the results of this study will have broad implications for practice in outpatient adolescent substance abuse treatment, and will be essential in furthering research on both family therapy as well as treatment as usual in community agencies.",Brief Strategic Family Therapy versus Treatment as Usual: Extended Follow-up for,7853866,RC2DA028864,"['health disparity ', ' health disparities ', ' Diagnosis ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Effectiveness ', ' prevent ', ' preventing ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Symptoms ', ' Ethnic group ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Teenagers ', ' teen years ', ' Teen ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Family ', ' Family psychotherapy ', ' Family Therapy ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Age ', ' base ', ' career ', ' Goals ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Alcohols ', ' Alcohol Chemical Class ', ' Distal ', ' Area ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Evaluation ', ' DSM-IV ', ' Diagnostic and Statistical Manual of Mental Disorders-IV ', ' Diagnostic and Statistical Manual of Mental Disorders, 4th edition ', ' DSM4 ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Literature ', ' Long-Term Effects ', ' Longterm Effects ', ' Drug usage ', ' drug use ', ' Outpatients ', ' Out-patients ', ' Parents ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Residential Treatment ', ' Risk-Taking ', ' Knowledge ', ' Time ', ' Tobacco ', ' Lifestyle-related condition ', ' Lifestyle-Related Problem ', ' Lifestyle-Related Disorder ', ' Behavior-Related Problem ', ' Behavior-Related Disorder ', ' Behavior ', ' Outcome Study ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Participant ', ' Patient Self-Report ', ' Self-Report ', ' General Population ', ' General Public ', ' Marijuana Dependence ', ' Cannabis Dependence ', ' Reporting ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' brief intervention ', ' brief treatment ', ' brief therapy ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' effectiveness trial ', ' adolescent substance abuse ', ' youth substance abuse ', ' adolescent drug use ', ' youth drug use ', ' Clinical Trials Network ', ' design ', ' designing ', ' externalizing behavior ', ' Clinical effectiveness ', ' Outcome ', ' Population ', ' National Institute on Alcohol Abuse and Alcoholism ', ' NIAAA ', ' 14 year old ', ' fourteen year old ', ' age 14 years ', ' Abstinence ', ' racial and ethnic ', ' racial/ethnic ', ' public health relevance ', ' effective therapy ', ' effective treatment ', ' treatment as usual ', ' usual care ', ' emerging adult ', ' early adulthood ', ' follow up assessment ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,RC2,2009,879405,0.04430701521913563
"Brief Strategic Family Therapy versus Treatment as Usual: Extended Follow-up for    DESCRIPTION (provided by applicant): The primary goal this project is to examine the long-term effects of outpatient treatments for illicit drug using adolescents. Specifically, this study proposes to complete a follow-up assessment with a sample of 379 young adults that participated in a recently completed effectiveness trial to examine the differential effectiveness of brief strategic family therapy (BSFT) and treatment as usual (TAU) in the rates of substance use, externalizing behaviors (including arrests and sexually risky behaviors), time in restricted settings (e.g., residential treatment, detention), and improvements in family functioning. The proposed study is designed to fill a knowledge gap regarding the long term effects of outpatient treatments for adolescent drug users and has implications for furthering research on both family therapy as well as treatment as usual in community agencies. Moreover, this study is particularly relevant for community-based agencies, and - as such - has broad implications for practice in outpatient adolescent substance abuse treatment. Also, the proposed sample includes a sizable population of African American and Hispanics participants. As such, the findings will be relevant for Hispanic and African American adolescent drug users, and will permit the evaluation of the long term impact of the interventions (BSFT and TAU) on specific racial/ethnic groups: African Americans, Hispanics and non-Hispanic Whites.      PUBLIC HEALTH RELEVANCE: The primary goal this project is to examine the long-term effects of different outpatient treatments (brief strategic family therapy and treatment as usual) for illicit drug using adolescents. Given the stability and persistence of drug use over time, examining distal outcomes is critical for identifying effective strategies for preventing adult drug dependent careers. Moreover, the results of this study will have broad implications for practice in outpatient adolescent substance abuse treatment, and will be essential in furthering research on both family therapy as well as treatment as usual in community agencies.           Project Narrative The primary goal this project is to examine the long term effects of different outpatient treatments (brief strategic family therapy and treatment as usual) for illicit drug using adolescents. Given the stability and persistence of drug use over time, examining distal outcomes is critical for identifying effective strategies for preventing adult drug dependent careers. Moreover, the results of this study will have broad implications for practice in outpatient adolescent substance abuse treatment, and will be essential in furthering research on both family therapy as well as treatment as usual in community agencies.",Brief Strategic Family Therapy versus Treatment as Usual: Extended Follow-up for,7941743,RC2DA028864,"['young adult ', ' young adulthood ', ' adult youth ', ' Literature ', ' Long-Term Effects ', ' Longterm Effects ', ' Drug usage ', ' drug use ', ' substance abuse treatment ', ' substance abuse therapy ', ' Outpatients ', ' Out-patients ', ' Parents ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Residential Treatment ', ' Risk-Taking ', ' Knowledge ', ' Time ', ' Tobacco ', ' Lifestyle-related condition ', ' Lifestyle-Related Problem ', ' Lifestyle-Related Disorder ', ' Behavior-Related Problem ', ' Behavior-Related Disorder ', ' Behavior ', ' Outcome Study ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Participant ', ' Patient Self-Report ', ' Self-Report ', ' General Population ', ' General Public ', ' Marijuana Dependence ', ' Cannabis Dependence ', ' Reporting ', ' brief intervention ', ' brief treatment ', ' brief therapy ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' effectiveness trial ', ' adolescent substance abuse ', ' youth substance abuse ', ' adolescent drug use ', ' youth drug use ', ' Clinical Trials Network ', ' design ', ' designing ', ' externalizing behavior ', ' Clinical effectiveness ', ' Outcome ', ' Population ', ' National Institute on Alcohol Abuse and Alcoholism ', ' NIAAA ', ' 14 year old ', ' fourteen year old ', ' age 14 years ', ' Abstinence ', ' racial and ethnic ', ' racial/ethnic ', ' public health relevance ', ' effective therapy ', ' effective treatment ', ' treatment as usual ', ' usual care ', ' emerging adult ', ' early adulthood ', ' follow up assessment ', ' health disparity ', ' health disparities ', ' Diagnosis ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Effectiveness ', ' prevent ', ' preventing ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Symptoms ', ' Ethnic group ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Teenagers ', ' teen years ', ' Teen ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Family ', ' Family psychotherapy ', ' Family Therapy ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Age ', ' base ', ' career ', ' Goals ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Alcohols ', ' Alcohol Chemical Class ', ' Distal ', ' Area ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Evaluation ', ' DSM-IV ', ' Diagnostic and Statistical Manual of Mental Disorders-IV ', ' Diagnostic and Statistical Manual of Mental Disorders, 4th edition ', ' DSM4 ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,RC2,2010,678379,0.04430701521913563
"PS07-003, Minority HIV/AIDS Research Initiative (MARI)    DESCRIPTION (provided by applicant):   The proposed study's overarching goal is to reduce the ethnic disparities in HIV infection between Hispanic and non-Hispanic youth living in Miami-Dade County, an HIV epicenter. This goal will be accomplished by two aims: AIM 1 is to develop and manualize a one-and-a-half- month streamlined version of an efficacious HIV preventive intervention entitled Familias Unidas; and AIM II is to evaluate the efficacy of the streamlined version of Familias Unidas plus an HIV Prevention School CurriculumTreatment as Usual, relative to the HIV Prevention School Curriculum Treatment as Usual only, in preventing drug use and unprotected sexual behavior, two risk factors for HIV infection. Familias Unidas aims to prevent drug use and unprotected sexual behavior by (a) increasing family functioning, (b) increasing parental monitoring of peer activities, and (c) influencing adolescent social cognitive mechanisms regarding drug use and unsafe sexual behavior. A sample of 240 Hispanic 9th grade adolescents and their primary caregivers will be randomized to one of two conditions: Familias Unidas plus the HIV School Curriculum Treatment as Usual (hereafter refererred to as Familias Unidas) or the HIV Prevention School Curriculum Treatment as Usual only. Two studies have demonstrated the efficacy of an intensive, 9 to 12 month version of Familias Unidas. In the first study, Familias Unidas was shown to be efficacious relative to a no- intervention control condition in increasing family functioning. In the second study, Familias Unidas was found to be efficacious in preventing drug use and unsafe sexual behavior relative to two attention control conditions. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more efficacious than the HIV Prevention School Curriculum Treatment as Usual in preventing adolescent drug use over time and (H2) Familias Unidas will be more efficacious than the HIV Prevention School Curriculum Treatment as Usual in preventing adolescent unprotected sexual behavior over time. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on drug use will be partially mediated by (1) family functioning; (2) parental monitoring of peers; and (3) social cognitive mechanisms regarding drug use; and (H2a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by (1) family functioning; (2) parental monitoring of peers; (3) social cognitive mechanisms regarding unprotected sex; and (4) drug use. The objective of the proposed study is to reduce HIV contraction health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of interventions to reduce drug use, unprotected sexual behavior, and HIV in Hispanic adolescents.           ","PS07-003, Minority HIV/AIDS Research Initiative (MARI)",7922504,U01PS000671,[''],NCHHSTP,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,U01,2010,306816,0.10409011619734354
"Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study    DESCRIPTION (provided by applicant): We propose to extend the Northwestern Juvenile Project to examine the developmental patterns of drug use and disorder and risk for HIV/AIDS and other sexually transmitted infections (STIs) as juvenile justice youth age from adolescence to emerging adulthood and young adulthood. This study responds to NIDA's new initiatives in health disparities in HIV/AIDS in minority populations, specifically the nexus of drug abuse, criminal justice involvement, and HIV/AIDS among African Americans.  African Americans comprise 12% of the US population but 40% of incarcerated populations and 50% of new cases of HIV/AIDS. At year-end 2004, nearly 100,000 juveniles and nearly 2.1 million adults were incarcerated. We will continue to study a racially/ethnically diverse sample (n=758; 330 females, 428 males; 412 African Americans, 137 non-Hispanic whites, 207 Hispanics, 2 other race/ethnicity) of persons who were arrested and detained in Cook County (Chicago) Illinois, aged 10-18 years at recruitment (1997-1998). Since recruitment, data have been collected on the development of substance use and disorders, risk and protective factors, and HIV/AIDS risk behaviors. Participants are re-interviewed whether they are (re)incarcerated or back in the community. We propose to conduct annual interviews 10, 11, 12, and 13 years post-baseline, collect records, and test for HIV infection and selected STIs. Focusing on racial/ethnic disparities, gender and age differences, and effects of incarceration, we will: (1) describe patterns of drug use and disorder - onset, persistence, desistence, and recurrence -- as juvenile justice youth age from adolescence to emerging adulthood and young adulthood; (2) describe patterns of HIV/AIDS risk behaviors during this same period; (3) describe the prevalence and incidence of HIV infection and other STIs; and (4) examine the relationship between drug use and disorder and HIV/AIDS risk behaviors. Extending the Northwestern Juvenile Project allows us to leverage the data already collected to examine health disparities and the role of disproportionate minority confinement in the development of drug use and disorder and HIV/AIDS risk; to identify risk and protective factors that are potentially malleable; to identify points of intervention at key developmental periods; and to extend theoretical models - developed in general population adolescents - to correctional populations.           ","Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study",7841732,R01DA022953,"['health disparity ', ' health disparities ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' violence prevention ', ' prevent violence ', ' Social Network ', ' Jail ', ' Data ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' Characteristics ', ' sex ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Authorization documentation ', ' Permission ', ' Authorization ', ' Development ', ' developmental ', ' transcription mediated amplification ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Freedom ', ' Liberty ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Injury ', ' Age ', ' racial/ethnic difference ', ' Gonorrhea ', ' Gonococcal Infection ', ' improved ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Herpes Simplex Infections ', ' Herpesvirus hominis disease ', ' Herpes simplex disease ', ' Herpes Simplex ', ' Recording of previous events ', ' History ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV-1 ', ' human T lymphotropic virus III ', ' human T cell leukemia virus III ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Illinois ', ' Incidence ', ' Infection ', ' Human Papillomavirus ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Injection of therapeutic agent ', ' Injections ', ' Interview ', ' Screening procedure ', ' screenings ', ' screening ', ' Justice ', ' Kinetics ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Longitudinal Studies ', ' long-term study ', ' Drug usage ', ' drug use ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Methods ', ' Theoretical model ', ' Theoretic Models ', ' Persons ', ' Needles ', ' Neighborhoods ', ' Neisseria gonorrhoeae ', ' N.gonorrhoeae ', ' N. gonorrhoeae ', ' Gonococcus ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' Liquid substance ', ' liquid ', ' fluid ', ' Antibodies ', ' Prisons ', ' cooking ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Anus ', ' Anal ', ' Recommendation ', ' Records ', ' Recurrence ', ' Recurrent ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Saliva ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Specimen ', ' Research Specimen ', ' Life ', ' Substance Use Disorder ', ' Syphilis ', ' great pox ', ' Tattooing ', ' Tattooings ', ' Technology ', ' Testing ', ' Time ', ' Trichomonas Infections ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Ulcer ', ' Ulceration ', ' Urine ', ' Urine Urinary System ', ' Vagina ', ' Vaginal ', ' Viral hepatitis ', ' Woman ', ' Work ', ' Frequencies (time pattern) ', ' Frequency ', ' Dependence ', ' Event ', ' Oral ', ' Route ', ' Pattern ', ' Techniques ', ' Location ', ' Back ', ' Dorsum ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' interest ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Services ', ' Genital system ', ' urogenital system (genital part) ', ' Genital ', ' Surgeon ', ' American ', ' Participant ', ' health record ', ' NIH Program Announcements ', ' Program Announcement ', ' Patient Self-Report ', ' Self-Report ', ' high risk behavior ', ' deviant ', ' deviancy ', ' disorder risk ', ' disease risk ', ' General Population ', ' General Public ', ' intravenous drug use ', ' age difference ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Cervical dysplasia ', ' Cervix Dysplasia ', ' County ', ' Gender ', ' Chicago ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia trachomatis ', ' Rickettsia trachomae ', ' Needle Sharing ', ' Syringe Sharing ', ' Needlesharing ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Accounting ', ' Communities ', ' sex risk ', ' sexual risk behavior ', ' Minority ', ' Outcome ', ' Population ', ' Prevalence ', ' racial and ethnic disparities ', ' FDA approved ', ' emerging adulthood ', ' Healthy People 2010 ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2010,992255,0.10348631909936978
"Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study    DESCRIPTION (provided by applicant):  The overall goal of this project is to address how disproportionate confinement of racial/ethnic minorities-especially African Americans-affects health disparities in the HIV/AIDS epidemic. African Americans comprise only 13% of the general population, but about 40% of incarcerated youth and adults and 50% of new cases of HIV/AIDS. Yet, large multisite national longitudinal studies of HIV/AIDS focus on high- risk samples such as men who have sex with men (MACS), women infected with HIV and other ""at-risk"" females (WIHS), and infected women and their infants (WITS). These studies do not include adolescents, do not sample correctional populations, and do not examine the effect of incarceration on HIV/AIDS. Most studies of incarcerated populations are cross-sectional and provide limited information on the effects of incarceration.  To continue to address this key omission in the literature, we propose to extend the Northwestern Juvenile Project, a longitudinal study of 1829 juvenile justice youth, enrolled at age 10-18 years (1172 males, 657 females; 1005 African Americans, 296 non-Hispanic whites, 524 Hispanics, and 4 ""other"" race/ethnicity). Currently, the HIV/AIDS component of the project (RO1 DA022953) includes only a subsample (n=743) and 10-, 11-, 12-, and 13-year follow-up interviews. We now propose to (1) study the entire sample (originally 1829, now 1678); (2) conduct 3 additional annual interviews (14-, 15-, and 16-year follow-ups), at which time participants will be aged 26-34 years; (3) collect official records to cross-validate self-reported data (on STI status, arrests, incarceration history, and services received); (4) test the entire sample for HIV infection, chlamydia, and gonorrhea; and (5) administer a new module on incarceration, release, and re-entry. Participants are re-interviewed whether they are re-incarcerated or back in the community. Using data collected in prior phases and the additional interviews, we will examine patterns of drug use, drug use disorder, HIV/AIDS risk and infection from adolescence (ages 10-17 years) to emerging adulthood (ages 18-24 years) and young adulthood (age 25 and older). Our Specific Aims focus on how incarceration, release, and re-entry (e.g., age[s] incarcerated, number of incarcerations, length of incarcerations, amount of time spent in the community between incarcerations) affect the following: (1) drug use behaviors (including the number and types of substances used, frequency of use, and route of administration) and drug use disorders (onset, persistence, desistance, and recurrence); (2) HIV/AIDS sex risk behaviors (including unprotected anal or vaginal receptive sex and trading sex for drugs) and injection-risk behaviors; (3) prevalence and incidence of HIV infection and other STIs; (4) the relationship between patterns of drug use and disorder and HIV/AIDS risk behaviors, especially how risk and protective factors predict, moderate, and mediate these relationships.  This study responds to the initiatives of NIDA, NIAAA, and other NIH institutes to reduce health disparities in HIV/AIDS in minority populations.      PUBLIC HEALTH RELEVANCE: Racial/ethnic minorities suffer disproportionately from the HIV/AIDS epidemic and are disproportionately incarcerated. To address health disparities in HIV/AIDS, we must study correctional populations, which increased from nearly 1.8 million in 1997 to over 2.2 million by mid-year 2006. The proposed study will guide public health policy by investigating how incarceration affects the development of substance use and disorder and HIV/AIDS; identifying risk and protective factors that are potentially malleable; identifying points of intervention during key developmental periods; and extending current conceptual models to include incarceration, release, and reentry.          Relevance: Racial/ethnic minorities suffer disproportionately from the HIV/AIDS epidemic and are disproportionately incarcerated. To address health disparities in HIV/AIDS, we must study correctional populations, which increased from nearly 1.8 million in 1997 to over 2.2 million by mid-year 2006. The proposed study will guide public health policy by investigating how incarceration affects the development of substance use and disorder and HIV/AIDS; identifying risk and protective factors that are potentially malleable;  identifying points of intervention during key developmental periods; and extending current conceptual models to include incarceration, release, and reentry.","Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study",7841392,R01DA028763,"['Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Injecting drug user ', ' Injection Drug User ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Services ', ' Genital system ', ' urogenital system (genital part) ', ' Genital ', ' Surgeon ', ' age group ', ' experience ', ' high school ', ' Participant ', ' health record ', ' NIH Program Announcements ', ' Program Announcement ', ' Patient Self-Report ', ' Self-Report ', ' high risk behavior ', ' deviant ', ' deviancy ', ' General Population ', ' General Public ', ' probation ', ' offender ', ' criminal offender ', ' intravenous drug use ', ' age difference ', ' Academic achievement ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Cervical dysplasia ', ' Cervix Dysplasia ', ' County ', ' Gender ', ' Chicago ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Admission activity ', ' Admission ', ' parole ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia trachomatis ', ' Rickettsia trachomae ', ' Needle Sharing ', ' Syringe Sharing ', ' Needlesharing ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Enzyme Immunoassay ', ' Enzyme Linked Immunoassay Immunologic ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Longitudinal Surveys ', ' Mediating ', ' Risk Assessment ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cohort Studies ', ' Concurrent Studies ', ' Accounting ', ' Communities ', ' sex risk ', ' sexual risk behavior ', ' cost ', ' violent offender ', ' men who have sex with men ', ' men who have sex with other men ', ' national surveillance ', ' Minority ', ' alcohol and other drug ', ' Outcome ', ' juvenile justice system ', ' Adolescent Risk Behavior ', ' Youth Risk Behavior ', ' Population ', ' Prevalence ', ' aged ', ' prospective ', ' National Institute on Alcohol Abuse and Alcoholism ', ' NIAAA ', ' innovation ', ' innovative ', ' innovate ', ' 18 year old ', ' eighteen year old ', ' age 18 years ', ' racial and ethnic ', ' racial/ethnic ', ' service utilization ', ' Social Network ', ' Jail ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Request for Applications ', ' NIH RFA ', ' Subgroup ', ' Child Abuse and Neglect ', ' child maltreatment ', ' Childhood maltreatment ', ' Enrollment ', ' enroll ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' Monitor ', ' transmission process ', ' Transmission ', ' Characteristics ', ' Process ', ' sex ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Authorization documentation ', ' Permission ', ' Authorization ', ' Development ', ' developmental ', ' Heterosexuals ', ' transcription mediated amplification ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Freedom ', ' Liberty ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Age ', ' racial/ethnic difference ', ' Goals ', ' Gonorrhea ', ' Gonococcal Infection ', ' Grant ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Health Services ', ' health care service ', ' Herpes Simplex Infections ', ' Herpesvirus hominis disease ', ' Herpes simplex disease ', ' Herpes Simplex ', ' alcohol use disorder ', ' ethanol use disorder ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV-1 ', ' human T lymphotropic virus III ', ' human T cell leukemia virus III ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' Alcohols ', ' Alcohol Chemical Class ', ' Housing ', ' Area ', ' Clinical ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Phase ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Illinois ', ' Incidence ', ' Infant ', ' Infection ', ' Human Papillomavirus ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Injection of therapeutic agent ', ' Injections ', ' Institute of Medicine (U.S.) ', ' NAS/IOM ', ' Institute of Medicine ', ' Institutes ', ' Interview ', ' Screening procedure ', ' screenings ', ' screening ', ' Judgment ', ' Justice ', ' Kinetics ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Life Style ', ' Lifestyle ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Literature ', ' Longitudinal Studies ', ' long-term study ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Persons ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Needles ', ' Neighborhoods ', ' Neisseria gonorrhoeae ', ' N.gonorrhoeae ', ' N. gonorrhoeae ', ' Gonococcus ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' Liquid substance ', ' liquid ', ' fluid ', ' Antibodies ', ' Prisons ', ' Staging ', ' Contracts ', ' Contracting Opportunities ', ' cooking ', ' public health medicine (field) ', ' Public Health ', ' Publishing ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Anus ', ' Anal ', ' Recommendation ', ' Records ', ' Recurrence ', ' Recurrent ', ' Research ', ' Risk ', ' Risk Factors ', ' Saliva ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Specimen ', ' Research Specimen ', ' Social support ', ' social support network ', ' Solutions ', ' Knowledge ', ' Life ', ' statistics ', ' Substance Use Disorder ', ' Surveys ', ' Survey Instrument ', ' Syphilis ', ' great pox ', ' Technology ', ' Testing ', ' Time ', ' Trichomonas Infections ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Ulcer ', ' Ulceration ', ' United States ', ' Urine ', ' Urine Urinary System ', ' Vagina ', ' Vaginal ', ' Viral hepatitis ', ' Woman ', ' Work ', ' Frequencies (time pattern) ', ' Frequency ', ' Complex ', ' Dependence ', ' Event ', ' Oral ', ' Source ', ' Route ', ' Pattern ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Back ', ' Dorsum ', ' Beds ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' interest ', ' racial and ethnic disparities ', ' high risk ', ' public health relevance ', ' FDA approved ', ' emerging adulthood ', ' surveillance data ', ' surveillance study ', ' Crime ', ' Cessation of life ', ' Death ', ' Decision Making ', ' Healthy People 2010 ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Electronics ', ' Employment ', ' Address ', ' Length ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Ethnic group ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2010,599895,0.07413678356562207
"Preventing Drug Abuse and HIV in Hispanic First Offenders Hispanic youth in the juvenile justice system are at increased risk of HIV infection and of using illicit drugs. The proposed studys overarching goal is to reduce the ethnic disparities in illicit drug use and HIV between Hispanic and non-Hispanic youth in the criminal justice system. The proposed 2-year study will be guided by four aims. AIM 1 is to evaluate the efficacy of Familias Unidas, relative to Treatment as Usual in preventing illicit drug use in a sample of Hispanic youth first offenders; AIM 2 is to evaluate the efficacy of Familias Unidas, relative to Treatment as Usual in preventing unsafe sexual behavior; AIM 3 is to evaluate the efficacy of Familias Unidas, relative to Treatment as Usual in reducing the number of subsequent criminal offenses; and AIM 4 is to assess the extent to which family functioning mediates the effects of the intervention on illicit drug use, unsafe sexual behavior, and subsequent criminal offenses. 240 Hispanic adolescent first offenders (age range 13 to 17) and their parents will be randomized to either Familias Unidas or Treatment as Usual. Youth and parent participants will be assed at baseline, post-intervention (i.e., 6-months post baseline), and 12-months post baseline.   The Familias Unidas intervention has been evaluated and found to be efficacious in two randomized trials. In the first study (Pantin et al., 2003), Familias Unidas was shown to be efficacious relative to a no intervention control condition in increasing family functioning and reducing behavior problems. In the second randomized trial (Prado et al., 2007), Familias Unidas was found to be efficacious, relative to two attention control conditions, in reducing illicit drug use and unprotected sexual behavior at last sexual intercourse. In both trials, family functioning was found to mediate the effects of condition on the outcomes. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more efficacious than Treatment as Usual in reducing illicit drug use over time; (H2) Familias Unidas will be more efficacious than Treatment as Usual in reducing unprotected sexual behavior use over time; and (H3) Familias Unidas will be more efficacious than Treatment as Usual in preventing subsequent criminal offenses. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on illicit drug use will be partially mediated by family functioning; (H2a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by family functioning and (H3a) the effect of Familias Unidas on subsequent criminal offenses will be partially mediated by family functioning.   The objective of the proposed study is to reduce illicit drug use and unsafe sexual behavior health disparities in Hispanic populations and particularly among youth in the juvenile justice setting. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, unprotected sexual behavior, and HIV in Hispanic adolescents.",Preventing Drug Abuse and HIV in Hispanic First Offenders,7894960,R01DA025894,"['Accounting ', ' Age ', ' Americas ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Amphetamines ', ' assault ', ' Attention ', ' Behavior ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Sexual Intercourse ', ' Coitus ', ' Communication ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economics ', ' ethnicity group ', ' Ethnic group ', ' Family ', ' Goals ', ' Hand ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Justice ', ' delinquent youth ', ' Young offender ', ' Juvenile Offender ', ' juvenile delinquent ', ' Latin America ', ' Linear Models ', ' Minority Groups ', ' Parents ', ' Public Health ', ' Publishing ', ' Risk ', ' Risk-Taking ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Testing ', ' Stealing ', ' Theft ', ' Time ', ' United States ', ' County ', ' Relative (related person) ', ' Parenting behavior ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' Illicit Drugs ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Mediating ', ' Youth 10-21 ', ' Youth ', ' base ', ' improved ', ' Family Study ', ' Area ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' drug use ', ' Drug usage ', ' behavioral problem ', ' Problem behavior ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Knowledge ', ' Dependence ', ' System ', ' Country ', ' Cigarette ', ' Participant ', ' peer ', ' Categories ', ' Prevention ', ' criminal offender ', ' offender ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' parent monitoring ', ' parental monitoring ', ' Modeling ', ' Sampling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' disparity in health ', ' health disparity ', ' preventing ', ' prevent ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Process ', ' developmental ', ' Development ', ' post intervention ', ' youth drug use ', ' adolescent drug use ', ' Outcome ', ' juvenile justice system ', ' Population ', ' parental involvement ', ' effective intervention ', ' treatment as usual ', ' usual care ', ' early adolescence ', ' intervention effect ', ' randomized trial ', ' Randomization trial ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2010,650633,0.13551991655777793
"Race and HIV-risk: Contextual and neurocognitive influences on sex partnerships    DESCRIPTION (provided by applicant): The primary aim of this R21 application in response to NIDA's ANSWHR Initiative (PAS-07-381) is to address gaps in literature focused on HIV risk and disparities among females. In the United States as rates have increased among females, the rate of HIV/AIDS diagnoses for African American females approaches 25 times the rate for white females. Despite the broad base of findings documenting health disparities in HIV, extant studies cannot explain why African Americans continue to be disproportionately affected. Currently, there is a hidden HIV epidemic among young adult African American females with no history of substance abuse. These women are at increased risk for contracting HIV by virtue of their social networks. The proposed study requests two years of support for a cross sectional epidemiologic examination of racial/ethnic differences in sexual partnerships among 220 females (110 Black and 110 White) residing in low socioeconomic status (SES) neighborhoods. Guided by ecosocial theory, we seek to explain why these differences exist across race/ethnicity. We will consider the extent to which neighborhood social and economic factors (e.g., drug markets) interact with race/ethnicity to produce different levels of HIV risk. We will expand drug abuse and HIV prevention research by, in addition to considering individual differences, examining the influences of neighborhood drug markets on the sexual behaviors, sexual partnerships and rates of a sexually transmitted disease among young adult females residing in disadvantaged neighborhoods. Finally, the proposed study will move beyond descriptive social epidemiology and into identifying neurocognitive processes that mediate/moderate relationships between neighborhood factors and individual behavior. As, a small yet growing base of research suggests, to the extent that individuals are able to make decisions, solve problems and control impulses, neurocognitive functions may serve as protective factors or pathways through which external social factors influence individual behavior. Identifying social factors that influence partner selection and individual level factors that may serve to reduce the adverse effects of living in disadvantage neighborhoods will inform HIV prevention interventions for African American and underserved women. If successful, the proposed research project: (1) should provide insight into why African American females have higher rates of HIV than their white counterparts; (2) highlight the importance of considering the contextual influences of drugs, that is the influence of drug markets on social structures and sexual norms and behaviors; and (3) identify modifiable individual level factors linking neighborhood social and economic factors to individual HIV risk behaviors.    PUBLIC HEALTH RELEVANCE: Currently, there is a hidden HIV epidemic among young adult African American females with no history of substance abuse. These women are at increased risk for contracting HIV by virtue of their social/sexual networks. If successful, the proposed research project: (1) should provide insight into why African American females have higher rates of HIV than their white counterparts; (2) highlight the importance of considering the contextual influences of drugs, that is how drug markets change social structures and altered sexual norms and behaviors of entire communities; and (3) increase understanding of the processes through which neighborhood factors influence HIV risk.          ",Race and HIV-risk: Contextual and neurocognitive influences on sex partnerships,7851232,R21DA025543,"['Decision Making ', ' health disparity ', ' health disparities ', ' Disadvantaged ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' Economics ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Social Network ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Characteristics ', ' Process ', ' sex ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Fellowship ', ' Female ', ' Social Impacts ', ' Pathway interactions ', ' pathway ', ' Affect ', ' base ', ' racial/ethnic difference ', ' Health ', ' Health behavior ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Peripheral ', ' Area ', ' Economic Factors ', ' Economical Factors ', ' Link ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' insight ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' sexual relationship ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Literature ', ' Inequality ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Marketing ', ' men ', "" men's "", ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Morbidity - disease rate ', ' Morbidity ', ' Neighborhoods ', ' Poverty ', ' Problem Solving ', ' Contracts ', ' Contracting Opportunities ', ' Psychology ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Risk-Taking ', ' Science ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sexual Partners ', ' sex partner ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Social Change ', ' Social transformation ', ' Social modification ', ' Social Characteristics ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Life ', ' Time ', ' Training Programs ', ' United States ', ' Universities ', ' Attention ', ' Woman ', ' Work ', ' Pattern ', ' Behavior ', ' Neurocognitive ', ' psychosocial ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' AIDS/HIV diagnosis ', ' professor ', ' condoms ', ' Structure ', ' Prevention Research ', ' Prevention program ', ' member ', ' drug market ', ' social inequality ', ' economic cost ', ' Reporting ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Cause of Death ', ' Gender ', ' segregation ', ' Racial Segregation ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Modeling ', ' response ', ' deprivation ', ' theories ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' 1 year old ', ' one year old ', ' age 1 year ', ' Communities ', ' sex risk ', ' sexual risk behavior ', ' design ', ' designing ', ' drug distribution ', ' Population ', ' Individual Differences ', ' high risk ', ' public health relevance ', ' Consultations ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R21,2010,246574,0.014044230329847649
"Interdisciplinary Research Training Institute on Hispanic Drug Abuse    DESCRIPTION (provided by applicant): The proposed Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse seeks to promote the career development of pre-doctoral, postdoctoral and early career clinically-focused scientists interested in conducting research as it affects the Hispanic population. This comprehensive and coordinated research education program aims at providing research experience and increasing the skills required for development of testable hypothesis, preparation and submission of research applications for appropriate NIH extramural funding (i.e. K01, K08, F31, F32, R03, R21, etc). Building upon the National Hispanic Science Network's Summer Research Training Institute, the IRTI has two short-term goals and two long-term goals as follows: (1) enhancing the fellows' knowledge and skills for conducting interdisciplinary research on drug abuse; (2) increasing the number of early career faculty who establish vibrant and independent programs of drug abuse research, (3) increasing the amount and quality of research on minority health and health disparities; and, (4) improving the health of minorities in part by decreasing minority health disparities. The aims of the IRTI are: 1. Provide an educational training opportunity that will enhance the skills for conducting interdisciplinary Hispanic drug research and developing applications for NIH funding among pre-doctoral, postdoctoral and early career faculty (fellows) through the implementation of a 14 day intensive summer research training program; 2. Execute a mentoring plan that would be organized and structured around a team of interdisciplinary mentors that would be accessible and available to provide selected fellows with focused mentoring and continual support; and 3. Provide a networking structure and process that will assist fellows in building and maintaining relationships and communication with leading experts in the field of Hispanic drug research and fellow peers. Overall, mentoring activities will focus on guiding and assisting the fellows in achieving benchmarks of progress including: a) Academic Career Progress; b) Scientific Publications; c) Scientific Presentations and d) Research Funding. These outcomes will be facilitated through various types of support including: Mentor Commitment, Travel to Mentor Institution, Conferences/Workshops, and IRTI Mentoring Annual Meeting and IRTI Scientific Conference. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research in the interest of public health. The proposed IRTI and its mentorship and networking components will begin to fill the gap in knowledge of how to effectively develop specific incubators that will be successful in growing a special generation of drug abuse research scientists. PUBLIC HEALTH RELEVANCE: The proposed Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse seeks to promote the career development of pre-doctoral, postdoctoral and early career clinically-focused scientists interested in conducting research as it affects the Hispanic population. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research. Interdisciplinary research teams of tomorrow are needed in addressing health disparities, a major public health problem for which new knowledge from several areas of science must be integrated to define and address extant vulnerabilities, and to develop effective prevention and treatment interventions.           PROJECT NARRATIVE The proposed Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse seeks to promote the career development of pre-doctoral, postdoctoral and early career clinically-focused scientists interested in conducting research as it afects the Hispanic population. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research. Interdisciplinary research teams of tomorrow are needed in addressing health disparities, a major public health problem for which new knowledge from several areas of science must be integrated to define and address extant vulnerabilities, and to develop effective prevention and treatment interventions.",Interdisciplinary Research Training Institute on Hispanic Drug Abuse,7898838,R25DA026401,"['health disparity ', ' health disparities ', ' Institution ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Address ', ' Research Training ', ' Extramural Activities ', ' Extramural ', ' EXTMR ', ' Preparation ', ' Process ', ' Development ', ' developmental ', ' Faculty ', ' Affect ', ' base ', ' career ', ' Goals ', ' improved ', ' minority health ', ' Area ', ' Incubators ', ' Institutes ', ' Training ', ' Discipline ', ' Educational workshop ', ' Workshop ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Funding ', ' Mentors ', ' Mentorship ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Nature ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Science ', ' Knowledge ', ' programs ', ' Scientist ', ' Training Programs ', ' Travel ', ' Complex ', ' Benchmarking ', ' Best Practice Analysis ', ' interest ', ' meetings ', ' experience ', ' Structure ', ' skills ', ' peer ', ' Prevention ', ' Generations ', ' symposium ', ' conference ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' career development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communication ', ' Outcome ', ' pre-doctoral ', ' predoctoral ', ' predoc ', ' pre-doc ', ' public health relevance ', ' ']",NIDA,UNIVERSITY OF HOUSTON,R25,2010,335136,0.144606105512944
"National Hispanic Science Network on Drug Abuse (NHSN) Annual Conference    DESCRIPTION (provided by applicant): This R13 meetings grant application seeks support for five yearly three-day stand alone conferences to be held at selected locations beginning in the fall of 2009. This proposal reflects a collaborative initiative between Louisiana State University Health Sciences Center and the National Hispanic Science Network on Drug Abuse (NHSN), based at the University of Miami. The annual scientific conferences help to accomplish the NHSN mission of fostering both interdisciplinary and translational research, by promoting dialogue between biologic, social, behavioral, and cultural scientists and disseminating findings back to the field. Previous conferences, supported through a NIDA-funded contract, have been an effective platform for developing the aims of the NHSN, with particular emphasis on mentoring and training Hispanic graduate students and early career scientists. The aims of the conferences will be: A) to advance science in the area of drug abuse research and its co-morbid conditions, particularly as it impacts on the Hispanic population. It will promote bidirectional translational research ranging from bench to community and a trans-disciplinary cross-fertilization of ideas among scientists from all fields of drug abuse helping to establish future research priorities. B) To foster the development of Hispanic researchers, with emphasis in areas related to drug abuse research by facilitating the development of integrated and continuous collaborative and mentoring networks. Funding is requested to support participation for 50 trainees/early career scientists and 20 research scientists presenting in the scientific panels. An average of 150 participants, representing the field from the national and international scientific communities, are expected at each yearly conference, including members of the global research community whose interests encompass a multifaceted approach to understanding the factors underlying health disparities as they pertain to drug use and abuse ranging from epidemiology to environmental health, psychology, sociology, health policy, neuroscience and other biomedical sciences, and epigenetics. The first conference proposed ""Integrating Population, Laboratory, and Clinical Sciences in Minority Health"" will be hosted by the University of Miami, from December 1-3, 2009. The format of the conference aims to provide ample opportunity for discussion, networking, and collaboration discussions as well as development of new ideas related to training and mentoring of the next generation of researchers in the field of drug abuse. The themes, scientific content, and program for each conference will be developed by a Scientific Conference committee comprised of NHSN members, NIH officials, and federal liaisons. The themes will be directly related to NIDA's strategic plan and the NIH blueprint, addressing timely topics and developing challenges in the field. PUBLIC HEALTH RELEVANCE: The Annual National Hispanic Science Network on Drug Abuse Conference provides multidisciplinary scientists in drug abuse and related fields interested in advancing science, particularly as it pertains to the Hispanic population, to have a collegial exchange providing a forum for discussion and dissemination of research findings and an opportunity for networking and mentoring trainees in the area of drug abuse research. This unique opportunity will promote bidirectional translational research ranging from bench to community and a trans-disciplinary cross-fertilization of ideas among scientists from all fields of drug abuse. The PI and the organizing committee are confident that the proposed conferences will serve as a platform to establish future research priorities for the field of drug abuse as it pertains to the Hispanic population.            Project narrative  The Annual National Hispanic Science Network on Drug Abuse Conference provides multidisciplinary   scientists in drug abuse and related fields interested in advancing science, particularly as it pertains   to the Hispanic population to have a collegial exchange providing a forum for discussion and   dissemination of research findings and an opportunity for networking and mentoring trainees in the   area of drug abuse research. This unique opportunity will promote bidirectional translational   research ranging from bench to community and a trans-disciplinary cross-fertilization of ideas   among scientists from all fields of drug abuse. The PI and the organizing committee are confident   that the proposed conferences will serve as a platform to establish future research priorities for the   field of drug abuse as it pertains to the Hispanic population.    ",National Hispanic Science Network on Drug Abuse (NHSN) Annual Conference,7777400,R13DA026647,"['health disparity ', ' health disparities ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Environmental Health ', ' Environmental Health Science ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Applications Grants ', ' Grant Proposals ', ' Health Sciences ', ' International ', ' Strategic Planning ', ' Clinical Sciences ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Translational Research ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Development ', ' developmental ', ' Behavioral ', ' Fertilization ', ' Fertility/Fertilization ', ' Future ', ' base ', ' career ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' minority health ', ' Area ', ' Training ', ' Laboratories ', ' Louisiana ', ' Fostering ', ' Drug usage ', ' drug use ', ' Funding ', ' Mentors ', ' Mission ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Neurosciences ', ' Collaborations ', ' Health Psychology ', ' Contracts ', ' Contracting Opportunities ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Science ', ' Sociology ', ' Research Priority ', ' programs ', ' Scientist ', ' Universities ', ' Location ', ' Back ', ' Dorsum ', ' interest ', ' meetings ', ' Participant ', ' member ', ' graduate student ', ' social ', ' falls ', ' symposium ', ' conference ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Communities ', ' dissemination research ', ' next generation ', ' Population ', ' multidisciplinary ', ' public health relevance ', ' ']",NIDA,LSU HEALTH SCIENCES CENTER,R13,2010,140116,0.0829885288088024
"HIV - Emergence of Drug Resistance    DESCRIPTION (provided by applicant): This application is to renew a project focused on using mathematical models to understand and predict the emergence of drug resistance to antiretrovirals (ARVs) for the treatment of Human Immunodeficiency Virus (HIV). As the usage rate of ARVs in resource-poor regions is increasing, high levels of drug resistance potentially could emerge and have a devastating impact on public health worldwide, derailing global plans to provide this treatment to many millions of HIV-infected individuals. Our proposed projects will extend the work of the current award, which showed the value of using mathematical models to understand the temporal dynamics of drug-resistant strains of HIV in the United States (US), and for predicting the magnitude of resistance in this setting. In the renewal our work will be extended by combining mathematical modeling with statistical analysis of datasets collected by collaborating groups in the US, Europe and Africa. We will have access to data on drug resistance and important related variables from large scale epidemiological and treatment studies conducted in these three continents. In resource-poor settings, such as Africa, drugs will be limited and thus demand will often greatly exceed supply. We will investigate the problems of allocating ARVs in Africa by using operation research (OR) techniques. We have three Specific Aims. Aim 1: to understand the emergence, explain the present, and predict the evolution of, complex epidemics of drug-resistant strains of HIV in the US and Europe. Aim 2: to predict the evolution of epidemics of drug-resistant strains, as a result of first- line regimens and prophylactic use of ARVs, in Africa. Aim 3: to evaluate the consequences of allocation of scarce HIV healthcare resources in Africa. To achieve this aim we will use models to evaluate the epidemiological and ethical consequences of gender-inequities in access to treatment, assess the epidemiological and ethical impact of treatment priority criteria, and determine healthcare resource allocation strategies that ensure sustainability. Our studies in the renewal will link transmission modeling, OR techniques and statistical analyses; our analyses will take advantage of the extraordinary data sets provided by our collaborators in the US, Europe and Africa.       PUBLIC HEALTH RELEVANCE: The emergence and control of drug-resistant strains of HIV is now a global problem. The epidemiology of this problem is complex, and the future of the HIV epidemic is unknown. Our projects focus on using mathematical models to understand, explain, and predict, the evolution of complex epidemics composed of drug-resistant strains of HIV in the US, Europe and Africa. The rollout of antiretrovirals in Africa is just beginning; however demand for drugs greatly exceeds supply. We will, by using mathematical models, evaluate the epidemiological and ethical consequences of allocation of the scarce supply of antiretrovirals in Africa. Our studies are based upon both mathematical modeling and data analyses. Our analyses will take advantage of the extraordinary data sets provided by our collaborators in the US, Europe and Africa. Our results will have direct relevance for health policy makers.          ",HIV - Emergence of Drug Resistance,7797488,R01AI041935,"['Data Analyses ', ' Data Analysis ', ' microbicide ', ' microbicidal ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Drug resistance ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Nevirapine ', ' Viramune ', ' PTPN6 gene ', ' SHP-1L ', ' SHP-1 ', ' SH-PTP1 ', ' PTPN6 ', ' PTP-1C ', ' HPTP1C ', ' HCPH ', ' HCP ', ' non-nucleoside reverse transcriptase inhibitors ', ' nonnucleoside reverse transcriptase inhibitors ', ' non-nucleoside RT inhibitors ', ' NNRTI ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Ethics ', ' ethical ', ' Data Set ', ' Dataset ', ' Data ', ' Interruption ', ' Europe ', ' transmission process ', ' Transmission ', ' Evolution ', ' sex ', ' Female ', ' pandemic disease ', ' pandemic ', ' Stavudine ', ' zerit ', ' Didehydrodeoxythymidine ', ' D4T ', "" 3'-Deoxy-2'-thymidinene "", "" 2'3' didehydrodeoxythymidine "", "" 2',3'-didehydro-3'-deoxy-thymidine "", "" 2',3'-Didehydro-3'-deoxythymidine "", "" 2',3'-Didehydro-2',3'-dideoxythmidine "", ' 1-(2,3-Dideoxy-beta-glycero-pent-2-enofuranosyl)thymine ', ' Future ', ' Africa ', ' base ', ' Grant ', ' Health care facility ', ' Healthcare Facility ', ' Health Facilities ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Prophylactic treatment ', ' Prophylaxis ', ' Prevention Measures ', ' Simplexvirus ', ' human herpesvirus 1 group ', ' Herpesvirus hominis ', ' Herpes labialis Virus ', ' Herpes Simplex Virus ', ' HSV ', ' Link ', ' Lamivudine ', ' 3TC ', ' 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)- ', "" 2',3'-Dideoxy-3'-thiacytidine "", ' Ensure ', ' Linear Models ', ' Individual ', ' Policy Maker ', ' Multi-Drug Resistance ', ' multidrug resistant ', ' multi-drug resistant ', ' Resistant to multidrug ', ' Resistant to multi-drug ', ' Resistant to Multiple Drug ', ' Resistance to Multiple Drug ', ' Resistance to Multidrug ', ' Resistance to Multi-drug ', ' Multiple Drug Resistant ', ' Multiple Drug Resistance ', ' Multidrug Resistance ', ' Vertical Disease Transmission ', ' mother to child transmission ', ' Vertical Transmission ', ' Reverse Transcriptase Inhibitors ', ' Nucleosides ', ' Operations Research ', ' Paper ', ' Protease Inhibitor ', ' Proteinase Inhibitors ', ' Protease Antagonists ', ' Peptide Peptidohydrolase Inhibitors ', ' Peptide Hydrolase Inhibitors ', ' Peptidase Inhibitors ', ' Endopeptidase Inhibitors ', ' Antiproteases ', ' public health medicine (field) ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Publishing ', ' Research ', ' Research Technics ', ' Research Techniques ', ' Resources ', ' Research Resources ', ' San Francisco ', ' South Africa ', ' Tenofovir ', ' 9-PMPA ', ' 9-(2-phosphonylmethoxypropyl)adenine ', ' 9-(2-phosphonomethoxypropyl)adenine ', ' Trees ', ' Tuberculosis ', ' tuberculous spondyloarthropathy ', ' infection due to Mycobacterium tuberculosis ', ' disseminated tuberculosis ', ' disseminated TB ', ' Mycobacterium tuberculosis infection ', ' Mycobacterium tuberculosis (MTB) infection ', ' Mtb infection [{C0041296}] ', ' MTB infection ', ' M.tuberculosis infection ', ' M. tuberculosis infection ', ' United States ', ' Virus Diseases ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Work ', ' World Health Organization ', ' Zidovudine ', ' azidodeoxythymidine ', ' ZDV ', ' Azidothymidine ', ' AZT (Antiviral) ', ' AZT ', "" 3'-azido-3'-deoxy-thymidine "", "" 3'-Azido-3'-deoxythymidine "", "" 3'-Azido-2',3'-Dideoxythymidine "", ' Complex ', ' Award ', ' prophylactic ', ' Equation ', ' Anti-Retroviral Agents ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' efavirenz ', ' 6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one ', ' multiple drug use ', ' Structure ', ' Abbreviations ', ' Gender ', ' Healthcare ', ' health care ', ' Research Methodology ', ' Research Methods ', ' Resource Allocation ', ' Modeling ', ' Sampling ', ' mathematical model ', ' mathematical modeling ', ' Math Models ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Classification ', ' Systematics ', ' antiretroviral therapy ', ' men who have sex with men ', ' men who have sex with other men ', ' design ', ' designing ', ' Antiretroviral resistance ', ' resistant to antiretroviral ', ' resistant to anti-retroviral ', ' resistant to ARV ', ' resistance to antiretroviral ', ' resistance to anti-retroviral ', ' resistance to ARV ', ' anti-retroviral resistant ', ' anti-retroviral resistance ', ' Antiretroviral resistant ', ' ARV resistant ', ' ARV resistance ', ' Resistance ', ' resistant ', ' public health relevance ', ' resistant strain ', ' resistance strain ', ' Regimen ', ' ']",NIAID,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2010,713348,0.08382042801068632
"Role of Race in Criminal Justice Referrals to Treatment    DESCRIPTION (provided by applicant): The criminal justice system has become the primary source of referrals to drug treatment. Despite substantial evidence that minorities, particularly African Americans, are over-represented in the drug arrestee population, they remain a relatively small share of criminal justice referrals. It has yet to be determined if this lower representation is a function of racial and ethnic disparities in the criminal justice system or an artifact of some common case-level factors that reduce minority eligibility for treatment referral. We propose to examine the adjudication of drug offenders in California from 1982- 2005 to determine the extent to which race/ethnicity has played a role in final disposition and referral to drug treatment. California represents a unique environment in which to examine these associations because of its demographic and regional diversity, availability of detailed administrative data representing a census of individuals arrested and processed, and adoption of two important policies - drug courts and diversion - that promote treatment in lieu of incarceration. The proposed study significantly improves existing research by considering temporal and geographic patterns in disparities at each stage of the adjudication process within a single state subject to the same rule of law. It comprehensively considers the role of race/ethnicity at each stage of the adjudication process and the net effect on the final placement of minorities in treatment, and so may identify why previous studies have provided inconsistent results. Finally, by considering the impact of restorative justice policies, such as drug courts and diversion, on the processing of drug offenders by race/ethnicity, this project will assist policymakers with efforts to reduce disparities in the criminal justice and treatment system. The elimination of health disparities is an overarching goal of Healthy People 2010. The criminal justice system is critical to eliminating disparities because minorities, particularly African Americans, are substantially over-represented in this population and because the criminal justice system is the largest referral source to treatment. A careful examination of the adjudication process for drug offenders will make it possible to determine if differential access to treatment truly exists among arrestees and what factors have caused it. Further, by examining trends in adjudication practices using a large panel data set in California, this study will be able to explicitly consider whether recent policy reforms aimed at improving access to treatment particularly among minorities have indeed done so.           ",Role of Race in Criminal Justice Referrals to Treatment,7794862,R01DA022719,"['Healthy People 2010 ', ' health disparity ', ' health disparities ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Eligibility Determination ', ' Protocol Screening ', ' Eligibility ', ' Environment ', ' Data Set ', ' Dataset ', ' Data ', ' Improve Access ', ' trend ', ' Process ', ' Development ', ' developmental ', ' Adoption ', ' Guidelines ', ' court ', ' Goals ', ' improved ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Recording of previous events ', ' History ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Variant ', ' Variation ', ' Justice ', ' Laws ', ' Individual ', ' Policies ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' substance abuse treatment ', ' substance abuse therapy ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Noise ', ' Play ', ' Staging ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Role ', ' social role ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Violence ', ' violent behavior ', ' violent ', ' Source ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' contextual factors ', ' Application Context ', ' California ', ' adjudication ', ' adjudicative process and procedure ', ' offender ', ' criminal offender ', ' Sorting - Cell Movement ', ' sorting ', ' Censuses ', ' County ', ' Admission activity ', ' Admission ', ' parole ', ' Drug Courts ', ' Morphologic artifacts ', ' Artifacts ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Minority ', ' Outcome ', ' Population ', ' racial and ethnic disparities ', ' ']",NIDA,RAND CORPORATION,R01,2010,147864,0.09882567964943394
"African American Female Drug Users: HIV, Health Disparities, & Criminality    DESCRIPTION (provided by applicant): The overall goal of this study is to understand how drug use and criminality are related to health disparities, particularly HIV, and service utilization among African American drug using and non-drug using women across criminal justice status. While drug use is similar across racial groups in the US, African Americans are disproportionately more likely to experience severe health consequences and criminal involvement as a result of drug misuse. Adequate health care may not be received by African American female offenders because they experience the burden of their race, class, gender, and criminal offender status. There is limited scientific data to help understand the linkages between health disparities such as HIV, untreated drug abuse, barriers to service utilization, and status as a criminal offender among African American females. This study is significant because of its potential to identify differences in health disparities and service utilization among African American drug using and non-drug using women in selected levels of criminal justice status (intensive correctional supervision-prison (n=200), moderate correctional supervision-jail (n=200), community supervision-probation (n=200), and no criminal justice involvement (n=200)). All 800 African American females will be followed longitudinally for three 6-month intervals to examine health status and the use of health services across time. The specific aims are: (1) To describe the prevalence of health problems among African American women across criminal justice status and drug use status; (2) To determine the cultural, predisposing, historical health, and potential enabling factors that are predictors of health problems among African American drug using and non-drug using women across criminal justice status over 18 months; (3) To describe the prevalence of untreated health problems, the patterns of health services utilization, and the cultural barriers to service utilization among African American women across criminal justice status and drug use status; and (4) To examine the factors that predict the likelihood of using health services among African American drug using and non-drug using women across criminal justice status over 18 months. The significance of this study includes the potential to provide criminal justice systems-level data for health planning and health policy for prevention, intervention, and treatment of African American female drug users.       This study is significant to the public health field because of its potential to understand the severity of health disparities among African American women across criminal justice status and drug use status and to predict health status and the use of health services over time. This knowledge of African American females can be used as a foundation for future criminal justice systems-level interventions to increase the use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism.          ","African American Female Drug Users: HIV, Health Disparities, & Criminality",7752806,R01DA022967,"['health disparity ', ' health disparities ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Enabling Factors ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Jail ', ' Data ', ' Applications Grants ', ' Grant Proposals ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Development ', ' developmental ', ' Fright ', ' Fear ', ' Female ', ' Foundations ', ' Future ', ' base ', ' Goals ', ' Gonorrhea ', ' Gonococcal Infection ', ' Health ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Planning ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Health Services ', ' health care service ', ' Health Status ', ' Level of Health ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Alcohols ', ' Alcohol Chemical Class ', ' Hospitalization ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Medical ', ' Series ', ' racism ', ' Incidence ', ' Inpatients ', ' Interview ', ' Hepatitis C virus ', ' Hepatitus C ', ' HCV ', ' Kentucky ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Trust ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' Literature ', ' Drug usage ', ' drug use ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' substance abuse treatment ', ' substance abuse therapy ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Physicians ', ' Prisoner ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisons ', ' Drug user ', ' Drug abuser ', ' Problem drug user ', ' Misuses drugs ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Knowledge ', ' Life ', ' Supervision ', ' Surveys ', ' Survey Instrument ', ' Time ', ' Universities ', ' Woman ', ' Work ', ' Severities ', ' Dependence ', ' Event ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' physical conditioning ', ' physical health ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Services ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' experience ', ' Seroprevalences ', ' Structure ', ' Participant ', ' recidivism ', ' NIH Program Announcements ', ' Program Announcement ', ' Patient Self-Report ', ' Self-Report ', ' General Population ', ' General Public ', ' probation ', ' offender ', ' criminal offender ', ' Reporting ', ' Gender ', "" Women's Health "", ' Female Health ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Healthcare ', ' health care ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' time use ', ' criminal offending ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' alcohol research ', ' ethanol research ', ' alcohol related research ', ' service utilization ', ' non-drug ', ' nondrug ', ' longitudinal design ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2010,579622,0.17326562535537318
"Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS    DESCRIPTION (provided by applicant): This application is a revision of an application submitted last year in response to PAR-07-379, ""Behavioral and Social Science Research on Understanding and Reducing Health Disparities."" We will analyze the interconnections between coercive mobility (the massive migration between the criminal justice [CJ] system and the community) produced by US drug policies and race disparities in HIV-related sexual risk among a sample of drug offenders in Connecticut (CT). Further, we will examine whether the association between coercive mobility (CM) and HIV-related sexual risk is affected by the degree of social disorganization in the communities in which these offenders reside. We also will study the feasibility of recruiting and following sexual partners of these individuals to better understand the impacts of CM on partners' HIV-related risk. We hypothesize that CM produces race disparities in HIV risk in a number of distinct ways: 1) Blacks are more likely than Whites to be incarcerated, so HIV-related sexual risk associated with CM can produce race disparities in HIV risk even if the effects of CM are the same for both Blacks and Whites; 2) Blacks are more likely than Whites to reside in communities experiencing the disorganizing impacts of CM, so to the extent that social disorganization exacerbates the effects of CM, it will affect the HIV risks of Blacks to a greater degree than Whites; 3) The sexual partners of Blacks are more likely to come from these same socially disorganized communities, furthering the negative impacts of CM for both returning inmates and their partners, and contributing to race disparities in HIV risk among women; and 4) Blacks are more likely to be penalized by drug policies in ways that increase their movement between prison/jail and the community and their vulnerability to its associated harms. We also hypothesize that we will be able to recruit and retain the sexual partners of study participants and conduct exploratory analyses of the impact of CM on their HIV-related sexual risk. An active Community Advisory Board including policymakers and program administrators will assist us in identifying structural interventions to reduce race disparities in HIV based on study findings. PUBLIC HEALTH RELEVANCE: This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.           Narrative This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.","Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS",8068592,R01DA025021,"['Data Analyses ', ' Data Analysis ', ' health disparity ', ' health disparities ', ' Institution ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Environment ', ' Address ', ' Jail ', ' Data ', ' Process ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Face ', ' facial ', ' faces ', ' Family ', ' Feasibility Studies ', ' Feedback ', ' Law Enforcement ', ' Affect ', ' base ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Housing ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' In-Migration ', ' Immigrations ', ' Interview ', ' Laws ', ' sexual relationship ', ' Individual ', ' Policies ', ' Movement ', ' body movement ', ' Prisons ', ' Shapes ', ' Public Policy ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Sexual Partners ', ' sex partner ', ' Social Disorganizations ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' programs ', ' Surveys ', ' Survey Instrument ', ' Time ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' Frequencies (time pattern) ', ' Frequency ', ' Awareness ', ' System ', ' LOINC Axis 4 System ', ' contextual factors ', ' Application Context ', ' behavioral/social science ', ' experience ', ' Structure ', ' Participant ', ' disorder prevention ', ' disease prevention ', ' member ', ' offender ', ' criminal offender ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Administrator ', ' Criminal Justice ', ' Sampling ', ' response ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' community reentry ', ' community re-entry ', ' migration ', ' public health relevance ', ' social science research ', ' Connecticut ', ' ']",NIDA,AMERICAN UNIVERSITY,R01,2010,43237,0.047759867674073975
"Rural and Urban African American Cocaine Users' Perceived Need for Care    DESCRIPTION (provided by applicant): We seek to study the factors associated with rural/urban differences in perceived need for both drug abuse treatment and HIV testing because these are complementary services which could be integrated within formal drug abuse treatment programs or other locations to better meet the needs of African American cocaine users. We focus on perceived need among African American cocaine users because of their low rates of drug abuse treatment and HIV testing nationally as well as their demonstrated low perceived need for drug abuse treatment, high rates of risky sexual behaviors, and aversion to seeking HIV testing at local health departments in our prior research. Given that our prior natural history research did not include any urban areas, we do not know whether the low rates of drug abuse treatment and HIV testing among rural Arkansans are specific to rural residents (e.g., whether there is a disparity in access for rural African Americans) or whether urban African American cocaine users differ in other critical factors. To address these issues, we plan to conduct a community-based mixed methods study of African American cocaine users residing in rural and urban areas of Arkansas. Specifically, we propose a sequential mixed-method design, with qualitative key informant interviews conducted first (30 rural, 30 urban), followed by larger-scale, structured interviews (200 rural, 200 urban) using standardized instruments, pertinent measures from our prior rural health services and HIV research, and newly developed questions based on our initial qualitative work. Respondent-Driven Sampling (RDS), a variant of snowball sampling, will be used to identify and recruit participants. The primary aims of the study are: 1) Using qualitative methods, to describe rural/urban differences in pathways to drug use and drug use cultures, perceptions of access to drug abuse treatment and HIV testing, awareness and perceptions of what constitutes drug abuse treatment and HIV testing, and preferences for formal or informal drug abuse treatment and the site or location of HIV testing; 2) Using quantitative and qualitative methods, to compare and contrast rural and urban cocaine users' perceived need for drug abuse treatment and HIV testing and key predisposing, enabling, health, and other factors which could impede or facilitate perceived need; and 3) Using quantitative methods, to investigate whether rural/urban differences in perceived need for drug abuse treatment and HIV testing are mediated by key predisposing, enabling, and health factors as well as treatment and testing awareness and preferences. The knowledge gained from this project will enable health policy makers, treatment program managers, and providers to make more informed decisions about how to encourage and facilitate the utilization of drug abuse treatment and HIV testing among African American cocaine users in the Southern U.S., an underserved and high risk population.      PUBLIC HEALTH RELEVANCE: Of public health concern are the low rates of drug abuse treatment and high rates of HIV among African American cocaine users, especially in the Southern U.S. The knowledge gained from the proposed research would enable managers of public and behavioral health systems to make more informed decisions about how to target and tailor culturally sensitive messages aimed at increasing awareness of the benefits of drug abuse treatment and HIV testing. The proposed research would also provide new insight into whether HIV testing should be integrated within drug abuse treatment facilities to better meet the needs of rural as well as urban African American cocaine users.           PROJECT NARRATIVE Of public health concern are the low rates of drug abuse treatment and high rates of HIV among African American cocaine users, especially in the Southern U.S. The knowledge gained from the proposed research would enable managers of public and behavioral health systems to make more informed decisions about how to target and tailor culturally sensitive messages aimed at increasing awareness of the benefits of drug abuse treatment and HIV testing. The proposed research would also provide new insight into whether HIV testing should be integrated within drug abuse treatment facilities to better meet the needs of rural as well as urban African American cocaine users.",Rural and Urban African American Cocaine Users' Perceived Need for Care,7992035,R01DA026837,"['Provider ', ' health disparity ', ' health disparities ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Environment ', ' Address ', ' Health system ', ' Caring ', ' Qualitative Methods ', ' Data ', ' Improve Access ', ' informant ', ' Pathway interactions ', ' pathway ', ' Natural History ', ' base ', ' rural area ', ' urban area ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Health Services ', ' health care service ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Health Status ', ' Level of Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Site ', ' Variant ', ' Variation ', ' Medical ', ' Incentives ', ' inducement ', ' Interview ', ' Kentucky ', ' Dental ', ' Psyche structure ', ' mental ', ' insight ', ' Cocaine Users ', ' Rural ', ' Policy Maker ', ' Drug usage ', ' drug use ', ' Marihuana ', ' marijuana ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Methods ', ' Persons ', ' Respondent ', ' Ohio ', ' Perception ', ' Physicians ', ' public health medicine (field) ', ' Public Health ', ' instrument ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Resources ', ' Research Resources ', ' Rural Health Services ', ' Stigmata ', ' Knowledge ', ' programs ', ' Arkansas ', ' Testing ', ' Work ', ' Clinic ', ' Awareness ', ' Source ', ' Location ', ' meetings ', ' Services ', ' preference ', ' Structure ', ' Participant ', ' treatment program ', ' social ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Measures ', ' Privacy ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Mediating ', ' Sampling ', ' behavioral health ', ' social stigma ', ' stigma ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Communities ', ' Behavioral Model ', ' design ', ' designing ', ' Minority ', ' Population ', ' treatment site ', ' service utilization ', ' high risk ', ' public health relevance ', ' ']",NIDA,UNIV OF ARKANSAS FOR MED SCIS,R01,2010,520790,0.15968770068252294
"Clinical and Social Implications of Cost Sharing for Cancer Drugs    DESCRIPTION (provided by applicant): Dr. Yu-Ning Wong, a Medical Oncologist at Fox Chase Cancer Center is dedicated to a career in cancer health services research. Her goal is to develop a multidisciplinary research program to understand the impact of insurance design on cancer drug utilization and clinical outcomes. This Career Development Award will provide the means to take two important steps towards accomplishing this goal. First, it will allow for additional intensive mentored education and training in public policy research, health economics, and advanced statistical methods that will augment the candidate's previous rigorous training in epidemiology, biostatistics, and clinical medicine. Second, it will support the development of an original clinical research program using rigorous epidemiologic, econometric and survey methods to examine the impact of prescription drug insurance coverage on cancer outcomes. As new costly cancer drugs are introduced, patients with both public and private insurance are facing higher out- of-pocket costs. Cost sharing between insurers and patients (though co-payments and deductibles) has been traditionally used to control costs based on an expectation that unnecessary health care utilization will be reduced. However this expectation may result in worse socioeconomic disparities in care since some patients may be unable to afford highly effective cancer treatments. The candidate proposes three complementary studies to address the important, unanswered questions about the impact of cost sharing on cancer outcomes. Project A is a conjoint analysis-based survey to measure how patients make decisions among treatments of varying efficacy, toxicity and cost. Project B uses the results from Project A in a decision analysis model to measure the sensitivity of clinical outcomes to price and patient preferences. This will also allow us to determine if is possible to improve clinical outcomes by using low cost sharing to increase adherence to high value treatments. Project C is a natural experiment using insurance claims to measure the effect of insurance design and sociodemographic factors on the receipt of a new, expensive anti-nausea medication and subsequent outcomes. This research program will triangulate on the nexus of issues central to the understanding of cost sharing on cancer drug utilization and clinical outcomes and form the foundation for the candidate's transition to an independent investigator in cancer health services research. This project will have broad implications for the financing of high cost medical interventions because it will help policy makers, insurers and physicians understand how current models of cost sharing may contribute to socioeconomic disparities in cancer care. Our results may suggest consideration of a novel benefit design that encourages patients to make decisions based on relative value, rather than cost alone.           ",Clinical and Social Implications of Cost Sharing for Cancer Drugs,7923351,K07CA136995,"['Cost Control ', ' Cost Containment ', ' Decision Analysis ', ' Decision Analyses ', ' Decision Making ', ' Deductibles ', ' aprepitant ', ' Diffusion ', ' Drug Utilization ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Caring ', ' Adherence (attribute) ', ' Adherence ', ' Data ', ' Policy Research ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Cancer Patient ', ' Fox Chase Cancer Center ', ' Observational Study ', ' Principal Investigator ', ' Characteristics ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Development ', ' developmental ', ' Adoption ', ' Foundations ', ' Affect ', ' Patient Care ', ' Patient Care Delivery ', ' base ', ' career ', ' Elderly ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' improved ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Clinical ', ' Medical ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Insurance ', ' Insurance Carriers ', ' Insurers ', ' Training ', ' Uninsured Medical Expense ', ' total medical expenditure ', ' medical expenses not covered by insurance ', ' Uninsured Medical Fees (not covered) ', ' Uncovered Uninsured Medical Expense ', ' Uncovered Medical Expenses ', ' Out-of-Pocket Expense ', ' Individual ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' Policy Maker ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Mentors ', ' Methods ', ' Nausea ', ' Medical Oncologist ', ' Patients ', ' Physicians ', ' Antiemetics ', ' Antiemetic Drugs ', ' Antiemetic Agents ', ' Anti-emetics ', ' Probability ', ' Antineoplastic Agents ', ' anticancer drug ', ' anticancer agent ', ' Tumor-Specific Treatment Agents ', ' Neoplastic Disease Chemotherapeutic Agents ', ' Cancer Drug ', ' Antineoplastics ', ' Antineoplastic Drugs ', ' Anti-Cancer Agents ', ' Public Policy ', ' Supportive care ', ' Supportive Therapy ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Patient Preferences ', ' Insurance Coverage ', ' Insurance Status ', ' programs ', ' Survey Methodology ', ' Survey Method ', ' Surveys ', ' Survey Instrument ', ' United States ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Training and Education ', ' Toxic effect ', ' Toxicities ', ' expectation ', ' novel ', ' payment ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Measures ', ' Price ', ' pricing ', ' Relative (related person) ', ' Relative ', ' Statistical Methods ', ' Treatment outcome ', ' Cost Sharing ', ' Drug Insurance ', ' Healthcare ', ' health care ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Modeling ', ' Treatment Cost ', ' Underinsured ', ' Chronically Ill ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Clinical Medicine ', ' Clinical Medical Sciences ', ' Clinical Research ', ' Clinical Study ', ' cancer therapy ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' cancer care ', ' Vulnerable Populations ', ' vulnerable group ', ' cost ', ' health economics ', ' design ', ' designing ', ' older patient ', ' elderly patient ', ' Outcome ', ' Natural experiment ', ' innovation ', ' innovative ', ' innovate ', ' chemotherapy ', ' social implication ', ' ']",NCI,FOX CHASE CANCER CENTER,K07,2010,143678,0.027485458307407232
"Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study DESCRIPTION (provided by applicant):  The overall goal of this project is to address how disproportionate confinement of racial/ethnic minorities-especially African Americans-affects health disparities in the HIV/AIDS epidemic. African Americans comprise only 13% of the general population, but about 40% of incarcerated youth and adults and 50% of new cases of HIV/AIDS. Yet, large multisite national longitudinal studies of HIV/AIDS focus on high- risk samples such as men who have sex with men (MACS), women infected with HIV and other ""at-risk"" females (WIHS), and infected women and their infants (WITS). These studies do not include adolescents, do not sample correctional populations, and do not examine the effect of incarceration on HIV/AIDS. Most studies of incarcerated populations are cross-sectional and provide limited information on the effects of incarceration.  To continue to address this key omission in the literature, we propose to extend the Northwestern Juvenile Project, a longitudinal study of 1829 juvenile justice youth, enrolled at age 10-18 years (1172 males, 657 females; 1005 African Americans, 296 non-Hispanic whites, 524 Hispanics, and 4 ""other"" race/ethnicity). Currently, the HIV/AIDS component of the project (RO1 DA022953) includes only a subsample (n=743) and 10-, 11-, 12-, and 13-year follow-up interviews. We now propose to (1) study the entire sample (originally 1829, now 1678); (2) conduct 3 additional annual interviews (14-, 15-, and 16-year follow-ups), at which time participants will be aged 26-34 years; (3) collect official records to cross-validate self-reported data (on STI status, arrests, incarceration history, and services received); (4) test the entire sample for HIV infection, chlamydia, and gonorrhea; and (5) administer a new module on incarceration, release, and re-entry. Participants are re-interviewed whether they are re-incarcerated or back in the community. Using data collected in prior phases and the additional interviews, we will examine patterns of drug use, drug use disorder, HIV/AIDS risk and infection from adolescence (ages 10-17 years) to emerging adulthood (ages 18-24 years) and young adulthood (age 25 and older). Our Specific Aims focus on how incarceration, release, and re-entry (e.g., age[s] incarcerated, number of incarcerations, length of incarcerations, amount of time spent in the community between incarcerations) affect the following: (1) drug use behaviors (including the number and types of substances used, frequency of use, and route of administration) and drug use disorders (onset, persistence, desistance, and recurrence); (2) HIV/AIDS sex risk behaviors (including unprotected anal or vaginal receptive sex and trading sex for drugs) and injection-risk behaviors; (3) prevalence and incidence of HIV infection and other STIs; (4) the relationship between patterns of drug use and disorder and HIV/AIDS risk behaviors, especially how risk and protective factors predict, moderate, and mediate these relationships.  This study responds to the initiatives of NIDA, NIAAA, and other NIH institutes to reduce health disparities in HIV/AIDS in minority populations. PUBLIC HEALTH RELEVANCE: Racial/ethnic minorities suffer disproportionately from the HIV/AIDS epidemic and are disproportionately incarcerated. To address health disparities in HIV/AIDS, we must study correctional populations, which increased from nearly 1.8 million in 1997 to over 2.2 million by mid-year 2006. The proposed study will guide public health policy by investigating how incarceration affects the development of substance use and disorder and HIV/AIDS; identifying risk and protective factors that are potentially malleable; identifying points of intervention during key developmental periods; and extending current conceptual models to include incarceration, release, and reentry.","Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study",8109565,R01DA028763,"['Crime ', ' Death ', ' Cessation of life ', ' Decision Making ', ' Healthy People 2010 ', ' health disparities ', ' health disparity ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Electronics ', ' Employment ', ' Address ', ' Length ', ' Epidemic ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Ethnic group ', ' Social Network ', ' Jail ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' NIH RFA ', ' Request for Applications ', ' Subgroup ', ' child maltreatment ', ' Childhood maltreatment ', ' Child Abuse and Neglect ', ' enroll ', ' Enrollment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' underserved minority ', ' under-represented minority ', ' Underrepresented Minority ', ' Monitor ', ' Transmission ', ' transmission process ', ' Characteristics ', ' Process ', ' sex ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Permission ', ' Authorization ', ' Authorization documentation ', ' developmental ', ' Development ', ' Heterosexuals ', ' transcription mediated amplification ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' Female ', ' Liberty ', ' Freedom ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' racial/ethnic difference ', ' Goals ', ' Gonococcal Infection ', ' Gonorrhea ', ' Aging ', ' Grant ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Health Services ', ' health care service ', ' Herpesvirus hominis disease ', ' Herpes simplex disease ', ' Herpes Simplex ', ' Herpes Simplex Infections ', ' ethanol use disorder ', ' alcohol use disorder ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' human T lymphotropic virus III ', ' human T cell leukemia virus III ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' HIV-1 ', ' Alcohol Chemical Class ', ' Alcohols ', ' Housing ', ' Area ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Illinois ', ' Incidence ', ' Infant ', ' Infection ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Human Papillomavirus ', ' Injections ', ' Injection of therapeutic agent ', ' NAS/IOM ', ' Institute of Medicine ', ' Institute of Medicine (U.S.) ', ' Institutes ', ' Interview ', ' Screening procedure ', ' Judgment ', ' Justice ', ' Kinetics ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Length of Stay ', ' Lifestyle ', ' Life Style ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' Literature ', ' long-term study ', ' Longitudinal Studies ', ' drug use ', ' Drug usage ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' male ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Needles ', ' Neighborhoods ', ' N.gonorrhoeae ', ' N. gonorrhoeae ', ' Gonococcus ', ' Neisseria gonorrhoeae ', ' disorder onset ', ' disease onset ', ' Onset of illness ', ' liquid ', ' fluid ', ' Liquid substance ', ' Antibodies ', ' Prisons ', ' Staging ', ' Contracting Opportunities ', ' Contracts ', ' cooking ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Anal ', ' Anus ', ' Recommendation ', ' Records ', ' Recurrent ', ' Recurrence ', ' Research ', ' Risk ', ' Risk Factors ', ' Saliva ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sex Characteristics ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Research Specimen ', ' Specimen ', ' social support network ', ' Social support ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Concurrent Studies ', ' Cohort Studies ', ' Accounting ', ' Communities ', ' sexual risk behavior ', ' sex risk ', ' cost ', ' violent offender ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' national surveillance ', ' Minority ', ' alcohol and other drug ', ' Outcome ', ' juvenile justice system ', ' Youth Risk Behavior ', ' Adolescent Risk Behavior ', ' Population ', ' Prevalence ', ' aged ', ' prospective ', ' NIAAA ', ' National Institute on Alcohol Abuse and Alcoholism ', ' innovative ', ' innovate ', ' innovation ', ' eighteen year old ', ' age 18 years ', ' 18 year old ', ' racial/ethnic ', ' racial and ethnic ', ' service utilization ', ' racial and ethnic disparities ', ' high risk ', ' public health relevance ', ' FDA approved ', ' emerging adulthood ', ' surveillance data ', ' surveillance study ', ' Solutions ', ' Knowledge ', ' Life ', ' statistics ', ' Substance Use Disorder ', ' Survey Instrument ', ' Surveys ', ' great pox ', ' Syphilis ', ' Technology ', ' Testing ', ' Time ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Trichomonas Infections ', ' Ulceration ', ' Ulcer ', ' United States ', ' Urine Urinary System ', ' Urine ', ' Vaginal ', ' Vagina ', ' hepatitis virus infection ', ' Viral hepatitis ', ' Woman ', ' Work ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Dependence ', ' Event ', ' Oral ', ' Source ', ' Route ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Dorsum ', ' Back ', ' Beds ', ' Behavior ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' interest ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Injection Drug User ', ' Injecting drug user ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' Services ', ' urogenital system (genital part) ', ' Genital ', ' Genital system ', ' Surgeon ', ' age group ', ' experience ', ' high school ', ' Participant ', ' health record ', ' Program Announcement ', ' NIH Program Announcements ', ' Self-Report ', ' Patient Self-Report ', ' high risk behavior ', ' deviancy ', ' deviant ', ' General Public ', ' General Population ', ' probation ', ' criminal offender ', ' offender ', ' intravenous drug use ', ' age difference ', ' Academic achievement ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Cervix Dysplasia ', ' Cervical dysplasia ', ' County ', ' Gender ', ' Chicago ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Admission ', ' Admission activity ', ' parole ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' Rickettsia trachomae ', ' Chlamydia trachomatis ', ' Needle Sharing ', ' Syringe Sharing ', ' Needlesharing ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Illicit Drugs ', ' Enzyme Linked Immunoassay Immunologic ', ' Enzyme Immunoassay ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Longitudinal Surveys ', ' Mediating ', ' Risk Assessment ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Modeling ', ' Sampling ', ' Youth 10-21 ', ' Youth ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2010,200000,0.1173319122085367
"Public Housing Relocations: Impact on Healthcare Access, Drug Use & Sexual Health    DESCRIPTION (provided by applicant):  A rapidly unfolding intervention in Atlanta provides a rare opportunity to advance health services research for a vulnerable population: poor Black drug users. The Atlanta Housing Authority (AHA) is relocating all 5,000 residents of seven concentrated public housing communities to homes spread across Atlanta. Past research indicates that relocates tend to move to census tracts that have markedly better socioeconomic and healthcare environments than their original tracts; however, their social networks and support systems shrink after they move. The AHA relocations thus offer a rare opportunity to deepen scientific knowledge about the ways in which neighborhood, network, and social support factors shape Black drug users' healthcare access and health. Mining this opportunity will advance several NIDA priority areas, but is predicated on rapid funding of this project: three AHA communities (the ""BBT"" communities) have already begun the relocation process, and four others (the ""HHRP"" communities, which include Herndon Homes, Hollywood Court, Roosevelt, and Palmer) will begin to relocate in 2009. Traditional NIH funding cycles are too slow to realize the opportunities presented by the AHA relocations. While we presently have funds to gather pre-relocation data on 150 BBT residents, this sample size is insufficient to explore multilevel hypotheses. A team of two new investigators with a history of collaboration is thus seeking Time Sensitive R21 funds to achieve the following aims: (1) For 200 Black drug-using residents of the four HHRP communities, describe pre-relocation neighborhood, network, and social support characteristics (e.g., spatial access to drug treatment, drug network size, recovery support), and residents' (a) access to and retention in drug treatment, and primary care access; (b) drug use patterns; and (c) sexual risk and sexually transmitted infection (STI) status. We will integrate spatial, survey, and biological data to achieve Aim 1. (2) For 100 ex-residents of the two communities that will relocate first (Herndon Homes and Hollywood Court), assess participants' post-relocation status on the variables listed in Aim 1, and pre-/post-relocation changes in these variables. (3) For the total sample of 350 residents of the HHRP and BBT communities, conduct exploratory cross-sectional analyses of pre-relocation relationships between neighborhoods, network and social support characteristics and participants' (a) access to and retention in drug treatment, and access to primary care; (b) drug use patterns; and (c) sexual risk behaviors and STI infection status. We will also initiate preliminary analyses of the 100 Herndon Homes and Hollywood Court participants' pre-/post-relocation data to explore how changes in exposures relate to changes in outcomes. We will seek R01 funds to conduct a longitudinal study of the 350-member cohort that will test hypotheses generated by the R21. This longitudinal R01 study will establish the direction of relationships identified in the R21 in a sample of sufficient size to draw firm statistical conclusions about topics of major scientific import to NIDA.           Project Narrative The proposed R21 study will advance scientific knowledge in several NIDA priority areas that pertain to racial/ethnic disparities in health service access and health: (1) We will study health service and health outcomes that disproportionately affect poor, Black drug users, namely suboptimal access to, and retention in, drug treatment and poor primary care access; harmful drug use patterns; and HIV/STI sexual risk and STI infections. (2) We are seeking the causes of these outcomes in Black drug users' neighborhoods, networks, and social support systems, thereby expanding the traditional etiologic frame beyond individual-level exposures, and exploring the pathways linking these exposures and outcomes. (3) Our analytic plan will allow us to distinguish the impacts of individual-level processes from those of neighborhood-level processes, a distinction that ecologic analyses alone cannot capture.    ","Public Housing Relocations: Impact on Healthcare Access, Drug Use & Sexual Health",7790521,R21DA027072,"['Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Data Collection ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Environment ', ' Sexual Health ', ' Social Network ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Scientific Advances and Accomplishments ', ' scientific advances ', ' scientific accomplishments ', ' Characteristics ', ' Process ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Future ', ' Pathway interactions ', ' pathway ', ' Affect ', ' court ', ' Grant ', ' Health ', ' Health Services ', ' health care service ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Alcohols ', ' Alcohol Chemical Class ', ' Housing ', ' Area ', ' Phase ', ' Variant ', ' Variation ', ' Biological ', ' Link ', ' Infection ', ' Individual ', ' Recovery ', ' Longitudinal Studies ', ' long-term study ', ' Licensing ', ' Drug usage ', ' drug use ', ' Sample Size ', ' Funding ', ' Mining ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Neighborhoods ', ' Collaborations ', ' Poverty ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Exposure to ', ' Staging ', ' Shapes ', ' Drug user ', ' Drug abuser ', ' Problem drug user ', ' Misuses drugs ', ' Public Housing ', ' Nature ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Rest ', ' Risk ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Social support ', ' social support network ', ' Knowledge ', ' Life ', ' programs ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Radial ', ' Radius ', ' Home environment ', ' Home ', ' Pattern ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' authority ', ' cohort ', ' Participant ', ' treatment program ', ' member ', ' Reporting ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Support System ', ' Social Support System ', ' Censuses ', ' Healthcare ', ' health care ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' Vulnerable Populations ', ' vulnerable group ', ' sex risk ', ' sexual risk behavior ', ' Outcome ', ' Prevalence ', ' racial and ethnic disparities ', ' ']",NIDA,EMORY UNIVERSITY,R21,2010,115088,0.13845165533102147
"Substance Use and Risky Sex in Highly Vulnerable Populations    DESCRIPTION (provided by applicant):  The proposed project will help me develop the skills and expertise necessary to establish an independent research career focused on the role of substance use in sexual risk-taking behavior and associated adverse reproductive outcomes, especially sexually transmitted infections (STIs). To achieve this goal, I will supplement my graduate training as a developmental psychologist and postdoctoral training in epidemiology with training in sexual risk behavior in vulnerable populations, health disparities associated with race, and career development in longitudinal research methodology. Complementary to these training activities, I propose: 1) secondary data analyses of sexual risk behavior and outcomes using data from an ongoing longitudinal study of the offspring of teenage mothers and a study of women with and without borderline personality disorder (BPD); 2) collection of new data on the offspring of teenage mothers during a 16-year assessment and; 3) a new pilot study of common STIs in this sample (offspring of teenage mothers). The proposed research will form the basis for an R01 application in the third year of the award period. My short term goals are to (1) increase knowledge about risk for STIs, including behavioral dysregulation that may underlie risky sex and risk factors associated with risky sex and associated outcomes, (2) learn new methods of measuring risk behavior and adverse reproductive outcomes, including clinical tests for STIs and  event-level assessments, (3) learn more about health disparities associated with race, and (4) develop the research skills that will enable me to become an independent investigator and obtain NIH funding to support my research, specifically longitudinal data analyses. My long-term career goal is to understand the ecological setting for drug use and sexual risk behaviors in vulnerable populations, and how drug use may contribute to significantly higher rates of unintended pregnancies and STIs in African-American youth. The proposed career development training will take place at the Department of Psychiatry at the University of Pittsburgh School of Medicine. This department provides an outstanding environment for interdisciplinary training by highly collaborative faculty who are leading experts in their chosen fields. PUBLIC HEALTH RELEVANCE:  The proposed research will help identify behavioral risk factors for sexually transmitted infections that are implicated in higher rates of HIV, especially among African-Americans. The results can be used to develop prevention programs aimed at reducing drug use and sexually transmitted infections among vulnerable adolescents and within psychiatric populations.           ",Substance Use and Risky Sex in Highly Vulnerable Populations,7923084,K01DA025734,"['Knowledge ', ' programs ', ' statistics ', ' Substance Use Disorder ', ' Supervision ', ' Testing ', ' Training Activity ', ' Universities ', ' Unplanned pregnancy ', ' Urine ', ' Urine Urinary System ', ' Woman ', ' Event ', ' Award ', ' Location ', ' Barrier Contraception ', ' Contraceptive Barrier Methods ', ' Barrier Methods ', ' Behavior ', ' Injecting drug user ', ' Injection Drug User ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' meetings ', ' Birth ', ' Parturition ', ' Church ', ' experience ', ' cohort ', ' Gravidity ', ' Borderline Personality Disorder ', ' BPD ', ' skills ', ' Prevention program ', ' offspring ', ' Mediation ', ' Negotiation ', ' Negotiating ', ' Reporting ', ' Contraceptive methods ', ' Inhibition of Fertilization ', ' Fertility Control ', ' Contraception ', ' reproductive ', ' Gender ', ' Measures ', ' Impulsivity ', ' Emotional ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Mediating ', ' Research Methodology ', ' Research Methods ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Sampling ', ' career development ', ' Youth ', ' Youth 10-21 ', ' Adverse event ', ' Adverse Experience ', ' Coitus ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Accounting ', ' Vulnerable Populations ', ' vulnerable group ', ' unintended pregnancy ', ' sex risk ', ' sexual risk behavior ', ' men who have sex with men ', ' men who have sex with other men ', ' Outcome ', ' Population ', ' Prevalence ', ' 17 year old ', ' seventeen year old ', ' age 17 years ', ' post-doctoral training ', ' postdoctoral training ', ' high risk ', ' pregnant ', ' public health relevance ', ' adolescent offspring ', ' population health ', ' adverse outcome ', ' adverse consequence ', ' Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Data Analyses ', ' Data Analysis ', ' health disparity ', ' health disparities ', ' Diagnosis ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Environment ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Symptoms ', ' Data ', ' Collection ', ' Principal Investigator ', ' Characteristics ', ' sex ', ' Development ', ' developmental ', ' Faculty ', ' Behavioral ', ' Family ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Age ', ' base ', ' career ', ' Goals ', ' Aggressive behavior ', ' Aggression ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' Clinical ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Training ', ' Childhood ', ' pediatric ', ' Learning ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' teenage mother ', ' teenage mom ', ' teen mother ', ' teen mom ', ' adolescent mother ', ' Longitudinal Studies ', ' long-term study ', ' sexually active ', ' Drug usage ', ' drug use ', ' Reproductive Health ', ' Funding ', ' Methods ', ' Mothers ', ' Multiple Partners ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Neighborhoods ', ' Anger ', ' angry ', ' angers ', ' Personality ', ' Pilot Projects ', ' pilot study ', ' Pregnancy ', ' Gestation ', ' Psychiatry ', ' Psychologist ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Risk-Taking ', ' Role ', ' social role ', ' Schools ', ' medical schools ', ' school of medicine ', ' medical college ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sexual Partners ', ' sex partner ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' ']",NIDA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K01,2010,140326,0.024027442152660384
"Morehouse School of Medicine (M-MIDARP) The overall aim of this program is to strengthen and expand the drug abuse and HIV/AIDS prevention research capacity at Morehouse School of Medicine (MSM) by bringing together key academic and community-based programs in the development of an integrated correctional drug abuse and HIV/AIDS prevention research component. This capacity will incorporate training in new research skills and create an aggregation of individual faculty with appropriate community-based agencies as research teams within the criminal justice system. The MSM MIDARP will:1. Establish opportunities for training and development of drug abuse and HIV/AIDS prevention research interfacing with the Criminal Justice System (CJS) and existing community programs. 2. Construct an integrative culturally competent drug abuse and HIV/AIDS prevention research paradigm which addresses the needs of individuals who have come under the jurisdiction of the criminal justice system by utilizing existing community programs and Evidence-Based Practices. 3. Minimize disparities in community services to reduce recidivism among currently or previously incarcerated individuals. 4. Develop a nexus of organizations among the Georgia Department of Corrections, Georgia Department of Juvenile Justice and community based services that supplements the new research curriculum and faculty service programs, and makes sustainable gains in terms of scholarly publications, effective new service delivery paradigms, and individual client outcomes. 5. Expose young African-American medical students, masters of public health students and undergraduate students to correctional drug abuse and HIV/AIDS prevention community-based research to facilitate their post-graduate career choices. 6.Expand the areas of drug abuse and HIV/AIDS prevention research under investigation at Morehouse School of Medicine to additional indication areas, increase the number of minority physicians and faculty in drug abuse and HIV/AIDS prevention research, and increase the number of supported drug abuse and HIV/AIDS prevention research programs across MSM departments (especially Psychiatry, Family Medicine, Community Health and preventive medicine, and community voices program with its 8 grantees in cities across the country). Our intention is that MSM will be recognized as a local, regional, and national resource and training center for drug abuse and HIV/AIDS prevention for research programs. ",Morehouse School of Medicine (M-MIDARP),8073769,R24DA021527,"['Intention ', ' base ', ' improved ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Intervention Studies ', ' interventions research ', ' intervention research ', ' Training ', ' Justice ', ' Individual ', ' Methods ', ' Physicians ', ' Preventive Medicine ', ' preventative medicine ', ' Psychiatry ', ' Publications ', ' Scientific Publication ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Resources ', ' Research Resources ', ' medical schools ', ' school of medicine ', ' medical college ', ' programs ', ' Students ', ' Medical Students ', ' Voice ', ' Investigation ', ' System ', ' LOINC Axis 4 System ', ' Country ', ' interest ', ' Services ', ' skills ', ' Prevention Research ', ' Community based prevention ', ' recidivism ', ' Career Choice ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Research Methodology ', ' Research Methods ', ' Cities ', ' Client ', ' Clinical Research ', ' Clinical Study ', ' correctional system ', ' Communities ', ' Community Services ', ' design ', ' designing ', ' Minority ', ' Outcome ', ' Population ', ' community based service ', ' Educational Curriculum ', ' Curriculum ', ' Public Health Students ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Address ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Evidence based practice ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Master of Public Health ', ' M.P.H. ', ' Master of Science ', ' Research Infrastructure ', ' Infrastructure ', ' Community Health ', ' Development ', ' developmental ', ' Faculty ', ' Family Practice ', ' family medicine ', ' ']",NIDA,MOREHOUSE SCHOOL OF MEDICINE,R24,2010,114545,0.12824035441533166
"In-Home Prevention of SA risks in Native Teen Families    DESCRIPTION (provided by applicant): The overall goal of ""In-Home Prevention of Substance Abuse Risks for Native Teen Families,"" (NIDA 5R01DA019042) and this renewal is to assess the efficacy of the ""Family Spirit"" (FS) intervention, a prenatal and early childhood home visiting program, delivered by American Indian (AI) paraprofessionals to AI teen mothers and their children. The FS intervention is designed to promote mother's effective parenting practices and reduce maternal and child emotional and behavioral risks for lifetime drug abuse. At the time of submission, we have recruited our entire sample (N=322), who at baseline are expectant AI teens, ages 12-19 years and < 32 weeks gestation from four southwestern AI reservation communities. Participants have been randomized 1:1 to the FS Intervention + Optimized Standard Care vs. Optimized Standard Care. This renewal will allow us to assess the FS intervention until 6 years postpartum, through the critical developmental time period when teen mothers transition to adulthood and their children begin school. High rates of teen child-rearing and drug use are intertwined perpetuators of multigenerational family problems in American Indian communities. Successful prevention interventions targeting effective parenting and maternal drug use prevention with AI teen mothers can change the trajectory of young mothers' and their children's lifetime risks for drug use, and help break the cycle of multi-generational family problems in reservation communities. The goal of this renewal is to extend the assessment period until 6 years post-partum to determine the impact of the FS intervention on longer-term maternal and child outcomes related to lifetime drug use risk. The expanded and extended assessment battery will assess mothers' parenting skills and children's developmental status from birth to 6 years postpartum; mothers' drug use from <32 weeks gestation to 6 years post-partum; and explore moderators and mediators of study outcome. This trial is the first to investigate the impact of a paraprofessional-delivered, early childhood home visiting intervention on lifetime multi-generational (mother-child) drug use risk. This study addresses extremely important behavior health and illicit drug use issues among AI teen mothers and their offspring in communities located on reservation or trust lands. Demonstrating the effective use of Native paraprofessionals will be an innovation in the home-visiting intervention field, and is a critical design element to be tested in low-resource communities that suffer nursing shortages, have few trained Native interventionists, and expressed preferences for indigenous providers.      PUBLIC HEALTH RELEVANCE:  This study addresses critical behavioral health disparities and drug abuse among American Indian teen mothers and their children in communities located on reservation lands. If the aims are achieved, scientific knowledge and clinical practice will be advanced in several areas important to early intervention with teen mothers in this and similar populations, and to prevention of behavior problems in young children that lead to adolescent and adult drug use.                          ",In-Home Prevention of SA risks in Native Teen Families,7987489,R01DA019042,"['Provider ', ' drug abuse prevention ', ' drug use prevention ', ' drug addiction prevention ', ' substance abuse prevention ', ' substance abuse control ', ' health disparity ', ' health disparities ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Educational Status ', ' training status ', ' training level ', ' training achievement ', ' educational level ', ' Educational Achievement ', ' Elements ', ' Address ', ' Symptoms ', ' Ethnic group ', ' Data ', ' Indigenous ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Reservations ', ' Lifetime Risk ', ' Monitor ', ' Teenagers ', ' teen years ', ' Teen ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Development ', ' developmental ', ' Behavioral ', ' Family ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Age ', ' Goals ', ' improved ', ' Health behavior ', ' Health education ', ' Health Tutoring ', ' Health Instruction ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Alcohols ', ' Alcohol Chemical Class ', ' House Call ', ' Home Visits ', ' Area ', ' Healed ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' indexing ', ' Infant ', ' Training ', ' Childhood ', ' pediatric ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Life Experience ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' teenage mother ', ' teenage mom ', ' teen mother ', ' teen mom ', ' adolescent mother ', ' Trust ', ' Control Locus ', ' Measurement ', ' Drug usage ', ' drug use ', ' American Indians ', ' American Indian ', ' Marihuana ', ' marijuana ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Problem behavior ', ' behavioral problem ', ' Mothers ', ' Discipline of Nursing ', ' Nursing Profession ', ' Nursing Field ', ' Nursing ', ' Parents ', ' Pregnancy ', ' Gestation ', ' Problem Solving ', ' Recruitment Activity ', ' recruit ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Safety ', ' Schools ', ' Knowledge ', ' programs ', ' Stress ', ' Supervision ', ' Testing ', ' Time ', ' Work ', ' Home environment ', ' Home ', ' Behavior ', ' maternal drug use ', ' Outcome Study ', ' interest ', ' preference ', ' Birth Intervals ', ' Birth Spacing ', ' Birth ', ' Parturition ', ' early childhood ', ' Self Efficacy ', ' prenatal ', ' unborn ', ' skills ', ' Participant ', ' offspring ', ' indian reservation ', ' tribal reservation ', ' reservation community ', ' native american reservation ', ' nation reservation ', ' american indian reservation ', ' Toddler ', ' Prevention ', ' social ', ' Measures ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child Behavior ', ' Child Rearing ', ' childrearing ', ' Emotional ', ' Parenting behavior ', ' Parenting ', ' depressive symptoms ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' Illicit Drugs ', ' Postpartum Period ', ' Postpartum ', ' Sampling ', ' behavioral health ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' Home visitation ', ' home visit ', ' healing ', ' dissemination research ', ' reservation-based ', ' design ', ' designing ', ' Outcome ', ' coping ', ' young mother ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' child bearing ', ' childbearing ', ' bearing children ', ' bear children ', ' Early treatment ', ' early therapy ', ' early intervention ', ' public health relevance ', ' evidence base ', ' standard care ', ' standard treatment ', ' clinical practice ', ' comparative efficacy ', ' compare efficacy ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R01,2010,499927,0.11428451018129408
"Development of Behavioral and Social Interventions that Reduce Stigma and Improve    DESCRIPTION (provided by applicant):  This application addresses the broad Challenge Area (01) Behavior, Behavioral Change, and Prevention and the specific Challenge Topic, 01-DA-106: Development of behavioral and social interventions that reduce stigma and improve quality and accessibility of health care services in low resource settings. We will evaluate a pharmacy-based pilot intervention that combines rapid HIV testing with other preventive screening services including blood pressure, glucose, and cholesterol screening. This pilot targeted to injection drug users (IDUs) who purchase syringes from pharmacies via the New York State Expanded Syringe Access Program (ESAP) - a program aimed at increasing sterile syringe access to help reduce HIV transmission. By combining HIV testing with less stigmatizing screening services and offering testing to all pharmacy patrons instead of singling out drug users, the likelihood of reducing HIV testing and drug use-associated stigma will increase. Although HIV testing is increasingly accessible and new testing technologies are available, HIV testing rates are low in the black and Hispanic community, especially among IDUs at risk for HIV and many other infectious and chronic diseases. Structural barriers (i.e., lack of health insurance) in the black and Hispanic community, especially among IDUs may limit access to regular health care/ preventive services. Access barriers are compounded by stigma associated with getting an HIV test that may identify an individual as a drug user and/or someone who engages in socially unacceptable behavior. Thus, this proposed study aims to 1) qualitatively evaluate HIV testing and chronic disease screening in pharmacies, 2) compare/contrast correlates of agreeing to a HIV test vs. not among IDU syringe customers and their peers and 3) qualitatively compare/contrast HIV testing with comprehensive screening services pharmacy (intervention) vs. HIV testing only pharmacy (control). To accomplish these aims, we propose to conduct in-depth interviews among key stakeholders to inform development of study materials, IDU/peer survey and pharmacy staff surveys. We will recruit 2 ESAP-registered Harlem pharmacies (1 intervention and 1 control) where our current work has developed the infrastructure to perform on-site screening services. Among the intervention and control pharmacies, 798 (518 non-drug using, 70 drug-using +3 networks/ drug user) pharmacy customers will be recruited. We will adapt a previously developed training module to train pharmacy personnel on how to engage pharmacy customers. Customers from the intervention pharmacy will complete a brief attitude scale on attitudes toward HIV, IDUs and stigma, watch an educational video on the importance of health screening (particularly HIV testing), participate in desired screening services and undergo a structured 20-minute ACASI that repeats the attitudes scale. Customers in the control pharmacy will only undergo HIV testing and a structured 20-minute ACASI survey. Semi-structured surveys will be administered to all pharmacy staff to ascertain impact of on-site prevention services on pharmacy personnel and business flow. We will use standard qualitative analytic techniques and GEE to account for clustering in quantitative analyses. The proposed research is highly significant in that it aims to explore a pilot intervention that involves expanding pharmacy services to include HIV testing and to determine if offering HIV testing within a comprehensive prevention approach that includes less stigmatizing screening tests (i.e., blood pressure, glucose and cholesterol screening) increases HIV testing among injection drug users who purchase syringes in pharmacies and their peers (drug-using and/or non-drug using). We will be using new HIV testing technologies and bringing technological innovations and treatment modalities to low-income communities in New York City. If successful, this model can be duplicated not only throughout other high-risk neighborhoods in New York, but in several other cities and states. If our findings are positive, broader public health impact could follow. Pharmacists can partner with clinicians and other health care providers to offer an integrative approach to HIV testing to high-risk injection drug using populations and to other groups with limited access to health care services such as the uninsured and undocumented immigrants. Adoption of this integrative approach to HIV testing on a larger scale could also be implemented and reduce many of the access and stigmatization barriers experienced in marginalized populations for HIV testing while simultaneously increasing and improving general health and well-being by targeting chronic disease outcomes that disproportionately affect marginalized populations.               NARRATIVE The proposed research is highly significant in that it aims to explore a pilot intervention that involves expanding pharmacy services to include HIV testing and to determine if offering HIV testing within a comprehensive prevention approach that includes less stigmatizing screening tests (i.e., blood pressure, glucose and cholesterol screening) increases HIV testing among injection drug users who purchase syringes in pharmacies and their peers (drug-using and/or non-drug using). We will be using new HIV testing technologies and bringing technological innovations and treatment modalities to low-income communities in New York City. If successful, this model can be duplicated not only throughout other high-risk neighborhoods in New York, but in several other cities and states. If our findings are positive, broader public health impact could follow. Pharmacists can partner with clinicians and other health care providers to offer an integrative approach to HIV testing to high-risk injection drug using populations and to other groups with limited access to health care services such as the uninsured and undocumented immigrants. Adoption of this integrative approach to HIV testing on a larger scale could also be implemented and reduce many of the access and stigmatization barriers experienced in marginalized populations for HIV testing while simultaneously increasing and improving general health and well-being by targeting chronic disease outcomes that disproportionately affect marginalized populations.",Development of Behavioral and Social Interventions that Reduce Stigma and Improve,7938703,RC1DA028284,"['health care delivery ', ' health services delivery ', ' Healthcare Delivery ', ' Health Sciences, Allied and Health Services Delivery ', ' health disparity ', ' health disparities ', ' Diabetes Mellitus ', ' diabetes ', ' Discrimination (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' Effectiveness ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Low income ', ' Address ', ' Preventive ', ' Research Infrastructure ', ' Infrastructure ', ' Enrollment ', ' enroll ', ' transmission process ', ' Transmission ', ' Development ', ' developmental ', ' Behavioral ', ' Adoption ', ' Affect ', ' Patient Care ', ' Patient Care Delivery ', ' Glucose ', ' Dextrose ', ' D-Glucose ', ' base ', ' improved ', ' Health ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Services ', ' health care service ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Health Status ', ' Level of Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' hypercholesterolemia ', ' Hypercholesteremia ', ' Site ', ' Area ', ' Hypertension ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Link ', ' Injection of therapeutic agent ', ' Injections ', ' Health Insurance ', ' Interview ', ' Screening procedure ', ' screenings ', ' screening ', ' Training ', ' Individual ', ' Policy Maker ', ' Drug usage ', ' drug use ', ' uptake ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Neighborhoods ', ' New York ', ' New York City ', ' Immigrant ', ' Patients ', ' Perception ', ' Personal Satisfaction ', ' well-being ', ' Pharmaceutical Services ', ' Pharmacy Services ', ' Pharmaceutic Services ', ' Pharmacy facility ', ' Pharmacies ', ' Pharmacists ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Stigmata ', ' Life ', ' programs ', ' Stigmatization ', ' Surveys ', ' Survey Instrument ', ' Syringes ', ' Technology ', ' Testing ', ' Vaccination ', ' Attitude ', ' Work ', ' Hour ', ' Dependence ', ' Techniques ', ' Location ', ' Behavior ', ' Equation ', ' Injecting drug user ', ' Injection Drug User ', ' Services ', ' Blood Pressure ', ' experience ', ' Sterility ', ' sterile ', ' Structure ', ' Disease Outcome ', ' prevention service ', ' peer ', ' member ', ' technological innovation ', ' Prevention ', ' Modality ', ' Human Resources ', ' personnel ', ' Manpower ', ' Reporting ', ' social ', ' Positioning Attribute ', ' Position ', ' Cholesterol ', ' Cholest-5-en-3-ol (3beta)- ', ' Businesses ', ' Healthcare ', ' health care ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Chronic Disease ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Uninsured ', ' social stigma ', ' stigma ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Accounting ', ' Communities ', ' Preventive screening ', ' sex risk ', ' sexual risk behavior ', ' cost effective ', ' cost-effective ', ' Prevention approach ', ' Approaches to prevention ', ' Population ', ' demographics ', ' service intervention ', ' high risk ', ' non-drug ', ' nondrug ', ' flexibility ', ' flexible ', ' arm ', ' operation ', ' ']",NIDA,COLUMBIA UNIVERSITY HEALTH SCIENCES,RC1,2010,499997,0.07976322334687413
"Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth    DESCRIPTION (provided by applicant): The proposed study's overarching goal is to reduce the ethnic disparities in illicit drug use, cigarette use, and HIV between Hispanic and non-Hispanic youth. This goal will be accomplished by four aims: AIM 1 is to evaluate the effectiveness of Familias Unidas, relative to Community Practice (i.e., standard prevention services), in preventing illicit drug use; AIM 2 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing cigarette use; AIM 3 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing unprotected sexual behavior; and AIM 4 is to assess the extent to which family functioning mediates the effects of the intervention on illicit drug use, cigarette use, and unprotected sexual behavior. Twenty four middle schools with a total sample of 744 Hispanic adolescents from a wide geographic area of Miami-Dade County will be randomized using a block design to one of two conditions: Familias Unidas or Community Practice. The Familias Unidas intervention has been evaluated and found to be efficacious in two separate randomized controlled trials. In the first study (Pantin et al., 2003), Familias Unidas was shown to be efficacious relative to a no intervention control condition in increasing family functioning and reducing behavior problems (Prado et al., 2006), risk factors for youth illicit drug use and unprotected sex. In the second randomized controlled trial (Prado et al., in press), Familias Unidas was found to be efficacious, relative to two attention control conditions, in preventing cigarette use and illicit drug use. Familias Unidas was also found to be efficacious relative to both of the control conditions in preventing/reducing unprotected sexual behavior at last sexual intercourse. Finally, family functioning was found to mediate the effects of intervention condition on the outcomes. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more effective than Community Practice in reducing illicit drug use over time; (H2) Familias Unidas will be more effective than Community Practice in reducing cigarette use over time; and (H3) Familias Unidas will be more effective than Community Practice in reducing unprotected sexual behavior over time. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on illicit drug use will be partially mediated by family functioning; (H2a) the effect of Familias Unidas on cigarette use will be partially mediated by family functioning and (H3a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by family functioning. PUBLIC HEALTH RELEVANCE: The objective of the proposed study is to reduce illicit drug use, cigarette use, and unsafe sexual behavior health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, cigarette use, unprotected sexual behavior, and HIV in Hispanic adolescents.                 The objective of the proposed study is to reduce illicit drug use, cigarette use, and unsafe sexual behavior health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, cigarette use, unprotected sexual behavior, and HIV in Hispanic adolescents.",Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth,8101469,R01DA025192,"['health disparity ', ' health disparities ', ' Effectiveness ', ' prevent ', ' preventing ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Ethnic group ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Clinical Trials Design ', ' trial design ', ' Community Practice ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Development ', ' developmental ', ' Family ', ' Guidelines ', ' Geographic Locations ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Age ', ' Goals ', ' improved ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Family Study ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Training ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Linear Models ', ' Drug usage ', ' drug use ', ' Americas ', ' Manuals ', ' Problem behavior ', ' behavioral problem ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Amphetamines ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Benzeneethanamine, alpha-methyl-, (+-)- ', ' Educational Intervention ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Parents ', ' Staging ', ' public health medicine (field) ', ' Public Health ', ' Publishing ', ' Risk Factors ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Societies ', ' Knowledge ', ' Testing ', ' Time ', ' United States ', ' Attention ', ' Frequencies (time pattern) ', ' Frequency ', ' Dependence ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Behavior Therapy ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' meetings ', ' middle school ', ' Cigarette ', ' Prevention Research ', ' prevention service ', ' peer ', ' Categories ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' County ', ' Relative (related person) ', ' Relative ', ' parental monitoring ', ' parent monitoring ', ' Parenting behavior ', ' Parenting ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Modeling ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Coitus ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Accounting ', ' Communication ', ' Communities ', ' effectiveness trial ', ' adolescent substance use ', ' youth substance use ', ' design ', ' designing ', ' efficacy trial ', ' Outcome ', ' Adolescent Risk Behavior ', ' Youth Risk Behavior ', ' Population ', ' parental involvement ', ' public health relevance ', ' community setting ', ' effective intervention ', ' primary outcome ', ' intervention effect ', ' substance use prevention ', ' prevent substance use ', ' randomized trial ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2010,30600,0.14666618696440634
"Research Training in the Prevention of Drug Abuse & AIDS in Communities of Color    DESCRIPTION (provided by applicant): This revised application for a MIDARP program at Howard University describes a mentoring program in drug abuse research and AIDS prevention in communities of color, which is designed to increase the capacity of faculty and students at Howard to conduct rigorous and competitive research in the prevention of drug abuse and HIV/AIDS in communities of color. The program will emphasize training in transdisciplinary research on relationships between environmental stress, biological responses, risk behaviors and health outcomes and will utilize collaborations with senior investigators in research intensive universities to mentor Howard faculty investigators. The MIDARP will also work closely with existing programs that link Howard faculty and students to research training opportunities to (1) increase knowledge and interest in drug abuse and AIDS prevention research among faculty and students in these programs and (2) utilize the resources of these programs to expand the range of training opportunities available to MIDARP investigators and students. Howard students will be introduced to drug abuse and AIDS prevention research and career development by augmenting existing drug abuse courses in the College of Arts and Sciences and the curriculum for medical, basic science, nursing, and pharmacy students to include information on drug abuse and AIDS prevention research. They will also fund a pre-doctoral dissertation stipend and recruit students to serve as research assistants in the MIDARP pilot studies. The unique strengths of the program include the opportunity to (1) integrate education regarding drug abuse and AIDS prevention research into existing research training programs for faculty and students;(2) train individuals in diverse disciplines such as the health professions and sciences (i.e., medicine, basic sciences, pharmacy, nursing) who are less likely to pursue research careers in drug abuse and AIDS prevention research; and (3) support transdisciplinary research in drug use and AIDS prevention based on strong existing university research programs in genetics, physiology, and psychobiology. A transdisciplinary approach will be reflected in the MIDARP leadership that includes a Director who is a behavioral scientist specializing in research on environmental stress, drug use, and AIDS risk in communities of color and a Deputy Director who is an immunogeneticist with expertise in microbiology, and founding Director of the Human Genome Project at Howard University.          ",Research Training in the Prevention of Drug Abuse & AIDS in Communities of Color,7891185,R24DA021470,"['recruit ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Schools ', ' medical schools ', ' school of medicine ', ' medical college ', ' Science ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Sociology ', ' Knowledge ', ' lectures ', ' programs ', ' Arts ', ' Stress ', ' Students ', ' Medical Students ', ' Nursing Students ', ' Pupil Nurses ', ' Pharmacy Students ', ' Surveys ', ' Survey Instrument ', ' Educational process of instructing ', ' Teaching ', ' Scientist ', ' Time ', ' Training Activity ', ' Training Programs ', ' Universities ', ' Violence ', ' violent behavior ', ' violent ', ' Work ', ' Writing ', ' Award ', ' Techniques ', ' Behavioral Research ', ' Behavioral Sciences ', ' interest ', ' meetings ', ' college ', ' collegiate ', ' Services ', ' Blood Pressure ', ' American ', ' experience ', ' stressor ', ' success ', ' professor ', ' cohort ', ' skills ', ' Participant ', ' Prevention Research ', ' member ', ' Basic Science ', ' Basic Research ', ' graduate student ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' career development ', ' psychobiology ', ' biopsychology ', ' biological basis of behavior ', ' response ', ' Clinical Research ', ' Clinical Study ', ' Color ', ' Communication ', ' Communities ', ' design ', ' designing ', ' Outcome ', ' Population ', ' pre-doctoral ', ' predoctoral ', ' predoc ', ' pre-doc ', ' Historically Black Colleges and Universities ', ' Historically Black University ', ' Historically Black Institution ', ' Historically Black Colleges ', ' HBCUs ', ' heart rate variability ', ' Consultations ', ' Educational Curriculum ', ' Curriculum ', ' Achievement ', ' Achievement Attainment ', ' Ally ', ' drug abuse prevention ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Electronic Mail ', ' Email ', ' E-Mail ', ' Environment ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Equilibrium ', ' balance function ', ' balance ', ' biological adaptation to stress ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Allied Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Infrastructure ', ' Infrastructure ', ' Research Training ', ' Senior Scientist ', ' Training and Infrastructure ', ' Monitor ', ' Authorization documentation ', ' Permission ', ' Authorization ', ' Development ', ' developmental ', ' Faculty ', ' Behavioral ', ' Advisory Committees ', ' Task Forces ', ' Foundations ', ' base ', ' career ', ' role model ', ' sociology/anthropology ', ' Goals ', ' Grant ', ' Health ', ' Health Occupations ', ' health science profession ', ' Health Professions ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Human Genome Project ', ' Area ', ' Biological ', ' Physiological ', ' Physiologic ', ' Medical ', ' Link ', ' Ensure ', ' Interview ', ' Evaluation ', ' Training ', ' Leadership ', ' Discipline ', ' Individual ', ' Educational workshop ', ' Workshop ', ' Measurement ', ' Development Plans ', ' Drug usage ', ' drug use ', ' Funding ', ' Medicine ', ' Mentors ', ' Mentorship ', ' Methods ', ' Microbiology ', ' Collaborations ', ' Nurses ', ' Discipline of Nursing ', ' Nursing Profession ', ' Nursing Field ', ' Nursing ', ' Pamphlets ', ' Brochures ', ' Booklets ', ' Pharmacy facility ', ' Pharmacies ', ' Pharmacology ', ' Genetic ', ' Physiology ', ' Pilot Projects ', ' pilot study ', ' Exposure to ', ' Psychiatry ', ' Psychology ', ' Publications ', ' Scientific Publication ', ' Recommendation ', ' Recruitment Activity ', ' ']",NIDA,HOWARD UNIVERSITY,R24,2010,804585,0.15242078635463338
"Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users    DESCRIPTION (provided by applicant): This is a second revision of a competitive renewal R01 proposal of the NEURO-HIV Epidemiologic Study in response to NIDA PAS-07-115 (Non-injection Dug Abuse and HIV/AIDS). The primary study aim is to evaluate the ability of Integrated Family and Cognitive-Behavioral Therapy-HIV Prevention Intervention (IFCBT-HIVPI) to prevent HIV among adult non-injection and injection drug users. Over a 12 week intervention interval, the IFCBT-HIVPI model coordinates the delivery of cognitive- behavioral components during 12 group sessions with a couples and family systems component during 4 couples/family sessions to address HIV risk and protective factors across multiple ecological systems. IFCBT-HIVPI main effects on primary (HIV sexual risk behaviors and HIV drug taking risk behaviors) and secondary (HIV, Chlamydia, gonorrhea, and trichomoniasis incidences and legal involvement, academic achievement, and employment) outcome domains will be evaluated. We also seek to elucidate the degree to which the development of attitudinal and behavior change skills targeted by IFCBT-HIVPI (e.g., rational beliefs, problem solving skill, adaptive couples' communication) result in post-intervention reductions of HIV, sexually transmitted infections (STIs), and HIV risk behaviors. The possibility of effect-modification is also considered with a focus on route of drug administration status (i.e., non-injector/injector), neuropsychological (e.g., executive function), and demographic (i.e., African American/white) factors. The proposed study will randomly assign 360 HIV-negative non-injection and injection drug users recruited from the original NEURO-HIV Epidemiologic Study sample to experimental (IFCBT-HIVPI) and comparison (Brief Psychoeducation Curriculum on HIV Prevention; BPEC-HIV) conditions. The composition of the original NEURO-HIV Epidemiologic Study sample provides the basis to stratify the randomized trial sample across gender and two race/ethnicity (i.e., African American and white) groups by route of drug administration status. An assessment battery comprised of a standardized interview on HIV risk behavior, neuropsychological tests, tools to assess attitudes and behavior change skills targeted by IFCBT-HIVPI, drug and STI urine testing, and serologic tests of HIV will be administered before, during, and after the intervention interval across 18-month post-intervention follow-up. Additional preliminary analyses will be conducted on the randomized trial data to: (1) derive session-by-session measures on mechanisms of change targeted by IFCBT-HIVPI via videotape coding methods; (2) characterize mechanisms of change trajectories that may then be evaluated as plausible intervention moderators if present; and (3) estimate intervention cost-effectiveness. The lack of research on science-based prevention interventions for HIV continues to be a serious gap in the literature with recent HIV trends highlighting significant health disparities, particularly among African American non-injection drug users. If successful, the proposed project should help to identify specific attitudinal and behavior change skills targeted by cognitive- behavioral and couples/family systems interventions that foster subsequent reductions in HIV, STIs and HIV risk behaviors among adult drug users at heightened disease risk. PUBLIC HEALTH RELEVANCE: Recent estimates suggest that a majority of the 40,000 new cases of HIV reported annually in the US are attributable largely to sexual risk behavior associated with non-injection drug use. Additionally, African American drug users exhibit substantial HIV health disparities with African American females being 21 times more likely to contract HIV than white females. The proposed project is designed to address critical gaps in the HIV prevention science field by evaluating the ability of an intervention coordinating cognitive-behavioral and couples/family systems components to prevent HIV among adult drug users at heightened disease risk.           PROJECT NARRATIVE. Recent estimates suggest that a majority of the 40,000 new cases of HIV reported annually in the US are attributable largely to sexual risk behavior associated with non-injection drug use. Additionally, African American drug users exhibit substantial HIV health disparities with African American females being 21 times more likely to contract HIV than white females. The proposed project is designed to address critical gaps in the HIV prevention science field by evaluating the ability of an intervention coordinating cognitive-behavioral and couples/family systems components to prevent HIV among adult drug users at heightened disease risk.",Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users,7779393,R01DA014498,"['cost effectiveness ', ' Couples ', ' Educational Curriculum ', ' Curriculum ', ' Demographic Factors ', ' health disparity ', ' health disparities ', ' prevent ', ' preventing ', ' Legal ', ' Drug Administration Routes ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Employment ', ' Address ', ' Data Set ', ' Dataset ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Cognitive ', ' trend ', ' Characteristics ', ' Modification ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Development ', ' developmental ', ' Exhibits ', ' Behavioral ', ' Family ', ' Female ', ' Ecosystem ', ' Ecological Systems ', ' Ecologic Systems ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Pathway interactions ', ' pathway ', ' base ', ' Gonorrhea ', ' Gonococcal Infection ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Incidence ', ' Injection of therapeutic agent ', ' Injections ', ' Interview ', ' post intervention ', ' Literature ', ' Fostering ', ' Drug usage ', ' drug use ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Methods ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Neuropsychological Tests ', ' Neuropsychologic Tests ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Problem Solving ', ' Contracts ', ' Contracting Opportunities ', ' tool ', ' Drug user ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Risk ', ' Science ', ' Selection Bias ', ' Serologic tests ', ' serology ', ' Serological Tests ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Testing ', ' Time ', ' Trichomonas Infections ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Urine ', ' Urine Urinary System ', ' Videotape ', ' Attitude ', ' System ', ' LOINC Axis 4 System ', ' Belief ', ' behavior change ', ' interest ', ' Injecting drug user ', ' Injection Drug User ', ' skills ', ' disorder risk ', ' disease risk ', ' Prevention ', ' Academic achievement ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Gender ', ' Measures ', ' Code ', ' Coding System ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' Outcome Assessment (Health Care) ', ' Outcomes Assessment ', ' Process Assessment (Health Care) ', ' Process Assessment ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Sampling ', ' psychoeducation ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Client ', ' Cognitive Therapy ', ' cognitive behavioral treatment ', ' cognitive behavioral therapy ', ' cognitive behavioral modification ', ' cognitive behavioral intervention ', ' cognitive behavior therapy ', ' cognitive behavior modification ', ' cognitive behavior intervention ', ' Cognitive Psychotherapy ', ' Cognition Therapy ', ' executive function ', ' executive control ', ' Communication ', ' sex risk ', ' sexual risk behavior ', ' design ', ' designing ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' neuropsychological ', ' public health relevance ', ' group intervention ', ' HIV prevention trial ', ' randomized trial ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R01,2010,690540,0.1494038709691358
"Factors for enhanced neurotoxicity in methamphetamine abuse in HIV infection    DESCRIPTION (provided by applicant): This application is submitted in response to PAR-09-011 Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) requested by the National Institute on Drug Abuse (NIDA). This proposed research program is timely since it focuses on two ofthe major health disparity issues in Hawaii, namely, methamphetamine abuse and HIV infection. Recent surveys indicate that Native Hawaiians or other Pacific islanders have the highest rate of methamphetamine use among persons aged 12 or older in the United States. Although HIV/AIDS infection rate is relatively low in Hawaii compared to other major metropolis, the rates are increasing among Hawaiians. This DIDARP will include two primary and one pilot research projects that will focus on mechanisms and factors that might enhance neurotoxicity associated with methamphetamine of HIV. We aim to enhance the capacity for drug abuse research at UH by creating this small translational research team. This group will take advantage and build on the expertise of the few but outstanding existing clinical drug abuse and HIV researchers and basic scientists. We aim to enable UH to develop a strong clinical and translational drug abuse research program. To complement these projects, we additionally propose training and career development activities that wil offer exciting opportunities for DIDARP investigators and others at UH through the Administrative and Training Core. The Faculty in the Core will provide guidance and mentorship for these junior faculty and graduate students, through infrastructure support, educational courses, seminars, and a dedicated DIDARP website, We have obtained institutional support for two additional graduate students for the program. We also have recruited 4 distinguished External Advisory Committee members with expertise related to the proposed research; each has enthusiastically agreed to provide their advice and letter of support for the development of this DIDARP at UH. PUBLIC HEALTH RELEVANCE (See instructions); The current proposal attempts to strengthen drug abuse and HIV research capacity by developing translational research teams at the University of Hawaii, and to train junior investigators and students in drug abuse and HIV research.          ",Factors for enhanced neurotoxicity in methamphetamine abuse in HIV infection,7754961,R24DA027318,"['Committee Members ', ' dopamine transporter ', ' dopamine transporter proteins ', ' DAT dopamine transporter ', ' health disparity ', ' health disparities ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Institution ', ' Brain region ', ' DNA Nucleotidylexotransferase ', ' Terminal Deoxyribonucleotidyltransferase ', ' Terminal Deoxyribonucleotidyl Transferase ', ' Terminal Deoxynucleotidyltransferase ', ' Terminal Deoxynucleotidyl Transferase ', ' Terminal Addition Enzyme ', ' EC 2.7.7.31 ', ' Desoxynucleotidyltransferase ', ' Desoxynucleotidyl Transferase ', ' Deoxynucleotidyltransferase ', ' Deoxynucleotidyl Transferase ', ' prevent ', ' preventing ', ' Dopamine ', ' Hydroxytyramine ', ' 4-(2-Aminoethyl)-1,2-benzenediol ', ' 3,4-Dihydroxyphenethylamine ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Peroxonitrite ', ' peroxynitrite ', ' methamphetamine abuse ', ' Equilibrium ', ' balance function ', ' balance ', ' Intake ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Native Hawaiian or Other Pacific Islander ', ' Quantitative Reverse Transcriptase PCR ', ' qRTPCR ', ' Quantitative RTPCR ', ' Research Infrastructure ', ' Infrastructure ', ' Supplementation ', ' Rodent Model ', ' Translational Research ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Knock-out ', ' Knockout ', ' Development ', ' developmental ', ' Faculty ', ' Family ', ' Malnutrition ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Advisory Committees ', ' Task Forces ', ' enhancing factor ', ' Glucosephosphate Dehydrogenase ', ' Glucose-6-Phosphate Dehydrogenase ', ' EC 1.1.1.49 ', ' Age ', ' Glutathione ', ' gamma-L-Glutamyl-L-Cysteinylglycine ', ' gamma-L-Glu-L-Cys-Gly ', ' Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)- ', ' glutathione peroxidase ', ' Organ ', ' Label ', ' Guanine ', ' 2-amino-1,7-dihydro-6H-purin-6-one ', ' 2-Amino-6-Hydroxypurine ', ' Hawaii ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Hydrogen Peroxide ', ' Hydroperoxide ', ' Hydrogen Peroxide (H2O2) ', ' H2O2 ', ' Clinical ', ' Long-Term Potentiation ', ' Knockout Mice ', ' Null Mouse ', ' Knock-out Mice ', ' Hypoxanthines ', ' Infection ', ' Iodide Peroxidase ', ' Tyrosine Iodinase ', ' Thyroperoxidase ', ' Thyroid Peroxidase ', ' Monoiodotyrosine Deiodinase ', ' Monodeiodinase ', ' Iodotyrosine Deiodinase ', ' Iodotyrosine Deiodase ', ' Iodoperoxidase (Heme Type) ', ' Iodinase ', ' EC 1.11.1.8 ', ' Deiodinase ', "" 5'-Deiodinase "", ' Predisposition ', ' Susceptibility ', ' Training ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' insight ', ' web site ', ' website ', ' selenium deficiency ', ' Oxidative Stress ', ' selenophosphate synthetase ', ' Amino Acids ', ' aminoacid ', ' Memory ', ' Mentorship ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Movement ', ' body movement ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Persons ', ' Needles ', ' AIDS neuropathy ', ' neuroAIDS ', ' nervous system disorder ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' Neurotoxins ', ' neurotoxicant ', ' Nitric Oxide ', ' endothelial cell derived relaxing factor ', ' Nitrogen Protoxide ', ' Nitrogen Monoxide ', ' Mononitrogen Monoxide ', ' Endothelium-Derived Nitric Oxide ', ' Endogenous Nitrate Vasodilator ', ' Letters ', ' Micronutrients ', ' Oxidation-Reduction ', ' oxidation reduction reaction ', ' Redox ', ' Animals ', ' Genetic ', ' Antidotes ', ' Theriacs ', ' Hawaiian population ', ' Hawaiian ', ' Impaired cognition ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Drug abuser ', ' Problem drug user ', ' Misuses drugs ', ' Antioxidants ', ' anti-oxidant ', ' Heavy Metals ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Selenium ', ' Se element ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Life ', ' programs ', ' Students ', ' Surveys ', ' Survey Instrument ', ' tat Protein ', ' Transactivating Regulatory Protein ', ' Trans-Activator of Transcription of HIV ', ' Trans-Activation of Transcription Protein ', ' Scientist ', ' Trans-Activation (Genetics) ', ' Transactivation ', ' United States ', ' Universities ', ' Virus Diseases ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' intraperitoneal ', ' System ', ' LOINC Axis 4 System ', ' Viral ', ' Excitatory Postsynaptic Potentials ', ' EPSP ', ' Mood Disorders ', ' Affective Disorders ', ' neuroprotection ', ' Reverse Transcriptase Polymerase Chain Reaction ', ' reverse transcriptase PCR ', ' RTPCR ', ' RT-PCR ', ' monoamine ', ' reuptake ', ' Toxic effect ', ' Toxicities ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Brain Diseases ', ' Intracranial Central Nervous System Disorders ', ' Intracranial CNS Disorders ', ' Encephalon Diseases ', ' Brain Disorders ', ' member ', ' graduate student ', ' Abbreviations ', ' Carrier Proteins ', ' Transporter Protein ', ' Transport Proteins ', ' Selenocysteine ', ' 3-selenyl-L-alanine ', ' 3-Selenylalanine ', ' selenoprotein ', ' Cells ', ' dopaminergic neuron ', ' Dopamine neuron ', ' DA Neuron ', ' Oxidants ', ' electron acceptor ', ' Oxidizing Agents ', ' career development ', ' Property ', ' LOINC Axis 2 Property ', ' response ', ' thioredoxin reductase ', ' Neuraxis ', ' Central Nervous System ', ' CNS Nervous System ', ' Complement ', ' Complement Proteins ', ' Dietary Selenium ', ' Instruction ', ' Neuronal Injury ', ' neuron injury ', ' methamphetamine exposure ', ' meth exposure ', ' Population ', ' small hairpin RNA ', ' short hairpin RNA ', ' shRNA ', ' Cell model ', ' Cellular model ', ' neurotoxicity ', ' neuronal toxicity ', ' neuron toxicity ', ' selenoenzyme ', ' dopamine toxicity ', ' neuronal survival ', ' public health relevance ', ' non-drug ', ' nondrug ', ' ']",NIDA,UNIVERSITY OF HAWAII AT MANOA,R24,2010,472500,0.13516613646182707
"Social networks and HIV risk among rural drug users    DESCRIPTION (provided by applicant):  This application is in response to PA-06-478, ""Research on Rural Mental Health and Drug Abuse Disorders"". One of the research areas highlighted by this PA is the examination of rural HIV transmission using social network analysis. The overall goal of the study is to examine the prevalence, incidence, and risk factors for HIV and other blood borne infections (BBIs) such as hepatitis B (HBV) and C (HCV) among rural Appalachian drug users using social network analysis and multilevel modeling. HIV continues to be a major public health problem in the United States, especially among drug users. However, little is known about HIV in rural areas in which there are marked health disparities. Therefore, given that studies among urban drug users have found that social network indicators are robust predictors of HIV risk, both social network and individual characteristics will be measured for their association with HIV risk among rural drug users. The specific aims are: 1) To determine the prevalence and incidence of HIV, HCV and HBV among rural injection and non- injection drug users; 2) To examine HIV and other BBI risk among rural injection and non-injection drug users; and 3) To examine longitudinal changes in rural HIV, HCV and HBV risk at 6-months, 12-months and 18- months post-baseline. To meet these aims, a sample 500 rural injection and non-injection drug users will be recruited using respondent driven sampling (RDS). In addition to biologic testing for HIV, HCV and HBV, rural participants will be given an interviewer-administered questionnaire pertaining to their social networks (drug, sexual and support networks), sociodemographics, drug use, HIV risk behaviors, psychiatric diagnoses, intravention and norms. Since individuals will be nested within networks, data will be analyzed using multilevel random effects regression that allows for the simultaneous examination of social network and individual-level risk. Consistent with the priorities of the NIDA AIDS Research Program, this proposal will explore the social network structure in a rural drug using population in order to better understand how network factors may affect HIV risk in rural areas using an innovative multilevel approach. Results from the proposed study will inform the design and implementation of HIV interventions in rural areas and help to determine the appropriate population for which to target such activities in order to reduce the morbidity and mortality associated with HIV and other BBIs.       Although HIV remains a significant public health problem in the United States, especially among drug users, little is known about HIV risk in rural areas such as Appalachia. It has been shown in urban populations that relationships among drug users, also known as social networks, are important predictors of HIV risk. Therefore, this study seeks to characterize rural HIV risk by measuring both social network and individual behaviors in order to inform prevention activities in health resource-deprived rural areas.          ",Social networks and HIV risk among rural drug users,7765565,R01DA024598,"['Urban Population ', ' Automobile Driving ', ' driving ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' Behavior ', ' Injecting drug user ', ' Injection Drug User ', ' meetings ', ' Blood ', ' Blood Reticuloendothelial System ', ' Seroprevalences ', ' Structure ', ' Participant ', ' Prevention ', ' Reporting ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Measures ', ' multilevel analysis ', ' multilevel modeling ', ' multilevel model ', ' methods to study multiple-level influences ', ' Pathway Analysis ', ' Network Analysis ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Sampling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' design ', ' designing ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' high risk ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Epidemic ', ' Social Network ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' transmission process ', ' Transmission ', ' Principal Investigator ', ' Characteristics ', ' Face ', ' facial ', ' faces ', ' Affect ', ' rural area ', ' urban area ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Health Resources ', ' Hepatitis B ', ' serum hepatitis ', ' infection with hepatitis B virus ', ' infection with HBV ', ' Viral Hepatitis B ', ' Hepatitis B Infection ', ' Hepatitis B Virus ', ' Homologous Serum Hepatitis Virus ', ' HBV ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Area ', ' Incidence ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' Interviewer ', ' Interview ', ' Hepatitis C virus ', ' Hepatitus C ', ' HCV ', ' Kentucky ', ' Individual ', ' Rural ', ' Drug usage ', ' drug use ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' Respondent ', ' Drug Prescriptions ', ' Drug Prescribing ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Questionnaires ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Risk ', ' Risk Factors ', ' Rural Population ', ' Appalachian Region ', ' Appalachia ', ' Serologic tests ', ' serology ', ' Serological Tests ', ' Individual Adjustment ', ' Psychiatric Diagnosis ', ' Research Priority ', ' programs ', ' Testing ', ' Time ', ' United States ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2010,627278,0.12666251430322556
"Understanding Racial Disparities in Teen Methamphetamine Use Despite a voluminous number of studies documenting the nature and extent of teen methamphetamine use in the United States, relatively few studies have provided a comprehensive portrait of the risk and protective factors associated with adolescent meth use. One salient omission is the lack of studies that provide insight into the well-documented race gap in teen methamphetamine use: Native American teens are at much greater risk of use and abuse of methamphetamines than non-Hispanic whites. This fact is exacerbated by evidence that meth use is associated with a heightened risk of engaging in behaviors such as IV drug use and unprotected sexual practices that are correlated with contracting HIV/AIDS. Indeed, research from the Centers for Disease Control and Prevention provides evidence that Native Americans are at a heightened risk of contracting HIV/AIDS relative to non-Hispanic whites. Clearly, there are important gaps in our knowledge and understanding of why methamphetamine use/abuse is distributed differentially among adolescents, and there is a need for research that specifically focuses on explaining the ""race-gap"" between Native American and non Hispanic white teens in America with regards to both meth use and the associations between meth use and behaviors associated with risk of exposure to HIV/AIDS. The present study, by addressing these knowledge gaps, will facilitate understanding into why the race gap in such behavior exists and can direct targeted intervention and prevention programs that address such health disparities between Native American and non-Hispanic white teens. The long-term goal of the research team is to continue to explore how racial and economic stratification serves to produce health disparities, in order to reduce race and economic based disparities. The objective of this application is threefold: a) to identify the social risk and protective factors associated with both meth use generally and those factors that serve to delineate racial/ethnic differences in use specifically; b) to apply the stress process model/General Strain Theory to expand our understanding of both meth use and racial differences in use; and c) to explore the association between meth use and risky sexual behaviors and how race serves as a potential moderator. The central hvpothesis of this application is that differences in stress exposure will predict both individual and race-based variation in meth use, abuse, and related risky behaviors (IV drug use/unprotected sex) with personal and social resources serving to moderate the stresssubstance use association. The plan is to fill this knowledge gap by pursuing the following two specific aims: a) utilize the stress process modei/GST framework to identify the social risk and protective factors associated with the initiation, use, and abuse/dependence of meth use among both males and females, non-Hispanic whites and Native American adolescents who attend public schools in Montana; and b) evaluate the stress process modei/GST framework as an explanation for predicting risky sexual practices and the potential role of race and meth use as moderators. In order to accomplish these objectives, one wave of data will be collected, entailing the use of a self-administered questionnaire of a targeted sample of approximately 900 ninth and tenth grade boys and girls attending three high schools in Montana. The proposed research is significant because it is expected to provide fundamental knowledge necessary in order to construct efficacious interventions and prevention efforts designed to reduce the adolescent Native American-white race gap in meth use, and risky behaviors associated with HIV/AIDS. This proposed research is significant because it is expected to provide fundamental knowledge necessary in order to construct efficacious interventions and prevention efforts designed to reduce the adolescent Native Americanwhite race gap in meth use, IV drug use and risky sexual behaviors associated with contracting HIVIAIDS. This research will provide a vertical step in understanding how the stress process modei/GST can be utilized to understand and redress racial differences in methamphetamine use and its association with risky behaviors (sexual and IV drug use) related to HIV/AIDS transmission and should facilitate additional research into understanding the Native American-white race gap in other substance use and related HIV/AIDS associated risk behaviors. It is also expected that the present study would provide further clarification and refinement of the stress process and GST theories utility for explaining drug use. Further, the present research could facilitate the development of general prevention and intervention programs beyond those that currently are employed as the dominant strategy to reduce teen meth use, such as the notable Montana Meth Project. Rather than replace such programs, the development of new programs could supplement existing prevention efforts by approaching the problem from a different theoretical orientation.",Understanding Racial Disparities in Teen Methamphetamine Use,7869900,R03DA029212,"['Educational aspects ', ' Education ', ' Environment ', ' Address ', ' methamphetamine abuse ', ' Paranoia ', ' Paranoid Disorders ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Stratification ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Self-Administered ', ' Teenagers ', ' teen years ', ' Teen ', ' Process ', ' Development ', ' developmental ', ' Methamphetamine dependence ', ' methamphetamine addiction ', ' meth dependence [{C1533217}] ', ' meth addiction ', ' METH dependence ', ' METH addiction [{C1533217}] ', ' Female ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' base ', ' criminal behavior ', ' racial/ethnic difference ', ' Goals ', ' Aggressive behavior ', ' Aggression ', ' improved ', ' Area ', ' Variant ', ' Variation ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' insight ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Literature ', ' Fostering ', ' Inequality ', ' Drug usage ', ' drug use ', ' Americas ', ' male ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Montana ', ' Respondent ', ' Native Americans ', ' Psychotic Disorders ', ' Psychoses ', ' public health medicine (field) ', ' Public Health ', ' Questionnaires ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Anxiety ', ' Nature ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Schools ', ' Science ', ' Social Characteristics ', ' Sociology ', ' Knowledge ', ' statistics ', ' Stress ', ' Survey Methodology ', ' Survey Method ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' United States ', ' Investigation ', ' Work ', ' Dependence ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' high school ', ' Prevention program ', ' tenth grade ', ' high school sophomore ', ' racial difference ', ' race differences ', ' Prevention ', ' social ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' County ', ' Criminal Justice ', ' Illicit Drugs ', ' Modeling ', ' Sampling ', ' Adolescent Development ', ' boys ', ' girls ', ' response ', ' Youth ', ' Youth 10-21 ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Portraits ', ' design ', ' designing ', ' Outcome ', ' Evidence based intervention ', ' racial and ethnic ', ' racial/ethnic ', ' public health relevance ', ' adverse outcome ', ' adverse consequence ', ' Data Collection ', ' Mental Depression ', ' depression ', ' health disparity ', ' health disparities ', ' Effectiveness ', ' Legal ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' ']",NIDA,MONTANA STATE UNIVERSITY - BOZEMAN,R03,2010,71250,0.034103952870873554
"Morehouse School of Medicine (M-MIDARP)    DESCRIPTION (provided by applicant): The overall aim of this program is to strengthen and expand the drug abuse and HIV/AIDS prevention research capacity at Morehouse School of Medicine (MSM) by bringing together key academic and community-based programs in the development of an integrated correctional drug abuse and HIV/AIDS prevention research component. This capacity will incorporate training in new research skills and create an aggregation of individual faculty with appropriate community-based agencies as research teams within the criminal justice system. The MSM MIDARP will: 1. Establish opportunities for training and development of drug abuse and HIV/AIDS prevention research interfacing with the Criminal Justice System (CJS) and existing community programs. 2. Construct an integrative culturally competent drug abuse and HIV/AIDS prevention research paradigm which addresses the needs of individuals who have come under the jurisdiction of the criminal justice system by utilizing existing community programs and Evidence-Based Practices. 3. Minimize disparities in community services to reduce recidivism among currently or previously incarcerated individuals. 4. Develop a nexus of organizations among the Georgia Department of Corrections, Georgia Department of Juvenile Justice and community based services that supplements the new research curriculum and faculty service programs, and makes sustainable gains in terms of scholarly publications, effective new service delivery paradigms, and individual client outcomes. 5. Expose young African-American medical students, masters of public health students and undergraduate students to correctional drug abuse and HIV/AIDS prevention community-based research to facilitate their post-graduate career choices. 6.Expand the areas of drug abuse and HIV/AIDS prevention research under investigation at Morehouse School of Medicine to additional indication areas, increase the number of minority physicians and faculty in drug abuse and HIV/AIDS prevention research, and increase the number of supported drug abuse and HIV/AIDS prevention research programs across MSM departments (especially Psychiatry, Family Medicine, Community Health and preventive medicine, and community voices program with its 8 grantees in cities across the country). Our intention is that MSM will be recognized as a local, regional, and national resource and training center for drug abuse and HIV/AIDS prevention for research programs.          ",Morehouse School of Medicine (M-MIDARP),8079274,R24DA021527,"['Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Intervention Studies ', ' interventions research ', ' intervention research ', ' Training ', ' Justice ', ' Individual ', ' Methods ', ' Physicians ', ' Preventive Medicine ', ' preventative medicine ', ' Psychiatry ', ' Publications ', ' Scientific Publication ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Resources ', ' Research Resources ', ' medical schools ', ' school of medicine ', ' medical college ', ' programs ', ' Students ', ' Medical Students ', ' Voice ', ' Investigation ', ' System ', ' LOINC Axis 4 System ', ' Country ', ' interest ', ' Services ', ' skills ', ' Prevention Research ', ' Community based prevention ', ' recidivism ', ' Career Choice ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Research Methodology ', ' Research Methods ', ' Cities ', ' Client ', ' Clinical Research ', ' Clinical Study ', ' correctional system ', ' Communities ', ' Community Services ', ' design ', ' designing ', ' Minority ', ' Outcome ', ' Population ', ' community based service ', ' Educational Curriculum ', ' Curriculum ', ' Public Health Students ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Address ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Evidence based practice ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Master of Public Health ', ' M.P.H. ', ' Master of Science ', ' Research Infrastructure ', ' Infrastructure ', ' Community Health ', ' Development ', ' developmental ', ' Faculty ', ' Family Practice ', ' family medicine ', ' Intention ', ' base ', ' improved ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Gap Junctions ', ' ']",NIDA,MOREHOUSE SCHOOL OF MEDICINE,R24,2010,17442,0.12824035441533166
"Effect of Prescription Drug Benefits on Cardiovascular Outcomes in the Elderly  In 2006, the United States implemented the Medicare Modernization Act, which expanded prescription drug coverage for Medicare beneficiaries at an estimated cost of $768 billion dollars over the next decade. Improved access to drug benefits may improve cardiovascular outcomes for the elderly by providing financial access to effective therapy. However, there is limited research about the impact of prescription drug coverage on health outcomes. In addition, although black enrollees have been found to have markedly lower use of antihypertensive, lipid-lowering and anti-platelet medications, little is known about the role of prescription drug coverage as a mediator of racial and socioeconomic disparities in cardiovascular outcomes.             In this project, we will investigate the effect of prescription drug benefits on the use of appropriate secondary preventive medication and achievement of favorable clinical outcomes among Medicare managed care enrollees with cardiovascular disease. The project will also assess the role of prescription drug coverage in explaining racial and socioeconomic disparities in cardiovascular outcomes.  Effective drugs, such as aspirin, beta-blockers, statins, and ace-inhibitors, are a cornerstone in the prevention and treatment of heart disease, yet over half of appropriate patients do not receive them. The cost of chronic drug therapy is a substantial barrier for elderly patients who have lower fixed incomes and sizable out-of- pocket spending on health care. This study will assess the effect of prescription drug coverage on outcomes of care for elderly patients with coronary heart disease.",Effect of Prescription Drug Benefits on Cardiovascular Outcomes in the Elderly,7942866,RC1AG036158,"['Coronary heart disease ', ' coronary disorder ', ' Coronary Disease ', ' Achievement ', ' Achievement Attainment ', ' Pharmacotherapy ', ' Drug Therapy ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Favorable Clinical Outcome ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Preventive ', ' Data Set ', ' Dataset ', ' Caring ', ' Adherence (attribute) ', ' Adherence ', ' Improve Access ', ' Enrollment ', ' enroll ', ' Coronary ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' beneficiary ', ' Adrenergic beta-Antagonists ', ' beta-Adrenergic Receptor Blockaders ', ' beta-Adrenergic Blocking Agents ', ' beta blocker ', ' Adrenergic beta-Blockers ', ' Elderly ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' improved ', ' Health ', ' Medicare ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Health Maintenance Organizations ', ' Prepaid Group Health Organizations ', ' Health Planning ', ' Heart Diseases ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Hospitalization ', ' Acute ', ' Chronic ', ' Clinical ', ' Incidence ', ' Income ', ' Economical Income ', ' Economic Income ', ' caucasian American ', ' white American ', ' Life Expectancy ', ' Individual ', ' Lipids ', ' LDL Cholesterol Lipoproteins ', ' beta-Lipoprotein Cholesterol ', ' Low Density Lipoprotein Cholesterol ', ' LDL Cholesterol ', ' Modernization ', ' Mortality Vital Statistics ', ' Mortality ', ' Myocardial Infarction ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Angiotensin-Converting Enzyme Inhibitors ', ' Kininase II Inhibitors ', ' Kininase II Antagonists ', ' Angiotensin-Converting Enzyme Antagonists ', ' Angiotensin I-Converting Enzyme Inhibitors ', ' ACE Inhibitors ', ' Patients ', ' inhibitor/antagonist ', ' inhibitor ', ' Drug Prescriptions ', ' Drug Prescribing ', ' Antihypertensive Agents ', ' Hypotensives ', ' Hypotensive Drugs ', ' Hypotensive Agent ', ' Antihypertensives ', ' Antihypertensive Drugs ', ' Anti-Hypertensives ', ' Anti-Hypertensive Drugs ', ' Anti-Hypertensive Agents ', ' Research ', ' Risk ', ' Role ', ' social role ', ' Aspirin ', ' Measurin ', ' Extren ', ' Entericin ', ' Empirin ', ' Ecotrin ', ' Aspergum ', ' Acetylsalicylic Acid ', ' 2-(Acetyloxy)benzoic Acid ', ' United States ', ' Event ', ' Blood Platelets ', ' thrombocyte/platelet ', ' Thrombocytes ', ' Platelets Reticuloendothelial System ', ' Platelets ', ' Marrow platelet ', "" Hayem's elementary corpuscle "", "" Deetjeen's body "", "" Bizzozero's corpuscle/cell "", ' American ', ' experience ', ' copayment ', ' Prevention ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular system (all sites) ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cause of Death ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Healthcare ', ' health care ', ' Managed Care ', ' Accounting ', ' Comorbidity ', ' co-morbidity ', ' cost ', ' design ', ' designing ', ' older patient ', ' elderly patient ', ' Outcome ', ' Population ', ' high risk ', ' effective therapy ', ' effective treatment ', ' ']",NIA,BROWN UNIVERSITY,RC1,2010,469865,0.07815164609359107
"Collaborative Research on Drug Abuse    DESCRIPTION (provided by applicant): This P01 develops and applies state-of-the-art methods to analyze existing but under-utilized drug abuse databases in collaboration with their owners. We address contemporary, theoretical, and applied issues in drug abuse research to understand intersections between substance abuse and AIDS risk behaviors as well as minority and gender-based health disparities. We work with dozens of investigators from drug & social policy, epidemiology, health sciences, medicine, nursing, psychiatry, psychology, public health, and social work who own exciting substance abuse data to develop models that test current theories, especially on epidemiology, prevention, intervention, and treatment of drug abuse, using modern multivariate methods to control for measurement errors, biases, and other confounds. The Models and Methods Project develops psychometric and statistical analytic techniques that hold special promise for improving the quality of drug abuse and AIDS research. The At-Risk Project studies substance abuse related data sets on vulnerable populations (substance abusers, homeless people, individuals who are HIV positive or who have AIDS, victims of domestic abuse, runaways, gang members, and others at high risk for AIDS or drug abuse) with methods to control sampling, measurement, distributional and other biases. The Community Project studies drug abuse etiology, adult consequences, HIV risk, intergenerational processes, general deviance, and related issues in large community-based samples, and develops and tests explanatory theories using models that permit separation of common from specific effects, control for artifacts, etc. The Core Project oversees and integrates all components, hosts visiting scholars, provides computer facilities, and sponsors a mentoring program for disadvantaged students. The substantive part of the Models Project and the At-Risk and Community Projects will be developing and testing integrative theories that can be applied across different populations. The findings from their studies will lead to greater understanding of precursors and concomitants of substance abuse and HIV/AIDS risk and transmission. In turn, these findings will guide development of effective interventions to reduce negative health outcomes and treatment disparities in community, ethnic, and vulnerable populations, and provide guidance on how these may be alleviated.     ",Collaborative Research on Drug Abuse,7910487,P01DA001070,[''],NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,P01,2010,1046164,0.06373110537308126
"Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth    DESCRIPTION (provided by applicant):  The overriding purpose of this study is to develop and test an intervention for reducing substance use and risky sexual behaviors among youth involved in juvenile drug court. Juvenile drug court provides an excellent setting in which to pursue the key study objectives by providing access to a well identified high risk population. Second, in addition to frequent judicial oversight, juvenile drug courts include several features that can enhance intervention effectiveness, sustainability, and potential for adoption. In addition, the fact that all juvenile drug courts have community-based treatment components and that such courts have been disseminated nationwide suggests the possibility of eventual widespread adoption if the proposed intervention is effective. The proposed intervention integrates evidence-based protocols for contingency management (CM) for substance abusing youth and family engagement strategies, with an evidence-informed family systems intervention for sexual risk originally developed to address substance use and sexual risk behaviors in HIV+ youth. These three interventions will be integrated into an efficient intervention that, if effective, can be amenable to adoption by juvenile drug courts. Following protocol development and beta testing, 160 drug court youth and their families will be randomized to the experimental intervention condition (HIV Risk Reduction or ""HRR"") versus Drug Court with Community Services (DC) conditions. Key outcomes will be assessed through 12-months post-baseline using a multi-method approach that will include assessment of substance use, risky sexual behaviors, criminal behavior, and participation in HIV counseling and testing services. Specific aims include: 1: Adapt existing intervention and training protocols into a single, efficient HRR intervention, beta test this HHR protocol with four youth in juvenile drug court and their families, and revise treatment and research protocols accordingly; 2: Conduct a randomized trial with 160 youth in juvenile drug court and their families to examine youth-level intervention effects (i.e., on substance use, sexual risk behavior, HIV counseling and testing, delinquent behavior) in comparison to DC through 12- months post referral and assess intervention fidelity. 3. If results suggest a positive HRR treatment effect, revise the intervention and training protocols in preparation for an effectiveness study and extended follow-up study. Importantly, the proposed study will (1) consider the multiple levels of influence on juvenile drug use, criminal justice involvement, and HIV risk behaviors, (2) integrate a drug abuse and HIV prevention intervention for youth in the criminal justice system with drug-related offenses, (3) address health disparities by targeting a primarily minority population of youth, and (4) increase referrals to HIV testing and counseling of drug court-involved youth. This study is designed to reduce HIV risk by addressing the potent interaction of drug use and risky sexual behaviors in drug court youth with evidence-based treatment components to maximize the likelihood of reversing these youths' adverse behavioral trajectories.      PUBLIC HEALTH RELEVANCE: The proposed study is designed to gain knowledge about effective interventions for reducing HIV risk in a high risk population. Reducing HIV risk by effectively targeting substance use and risky sexual behaviors and by locating even a small number of HIV-positive youth could favorably impact society at multiple levels (individual, family, peer, community, fiscal).           PROJECT NARRATIVE The proposed study is designed to gain knowledge about effective interventions for reducing HIV risk in a high risk population. Reducing HIV risk by effectively targeting substance use and risky sexual behaviors and by locating even a small number of HIV-positive youth could favorably impact society at multiple levels (individual, family, peer, community, fiscal).",Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth,7880603,R01DA025880,"['Counseling ', ' Risk Reduction ', ' health disparity ', ' health disparities ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Institution ', ' Effectiveness ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Evidence based practice ', ' Cost Effectiveness Analysis ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Effectiveness of Interventions ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Enrollment ', ' enroll ', ' Preparation ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Behavioral ', ' Family ', ' Adoption ', ' Follow-Up Studies ', ' Followup Studies ', ' active method ', ' active treatment ', ' active technique ', ' Evidence based treatment ', ' base ', ' court ', ' criminal behavior ', ' Label ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' juvenile delinquent ', ' Young offender ', ' Juvenile Offender ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Drug usage ', ' drug use ', ' Methods ', ' Educational Intervention ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Collaborations ', ' Staging ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Societies ', ' Knowledge ', ' Testing ', ' United States Public Health Service ', ' USPHS ', ' Public Health Service ', ' Adopted ', ' Work ', ' Protocols documentation ', ' Protocol ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Services ', ' peer ', ' community based treatment ', ' contingency management ', ' offender ', ' criminal offender ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Measures ', ' Drug Courts ', ' Criminal Justice ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Youth ', ' Youth 10-21 ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Clinical Trials ', ' clinical investigation ', ' Communities ', ' Community Services ', ' sex risk ', ' sexual risk behavior ', ' adolescent substance abuse ', ' youth substance abuse ', ' design ', ' designing ', ' Minority ', ' Outcome ', ' Population ', ' treatment effect ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' high risk ', ' critical period ', ' public health relevance ', ' effective intervention ', ' evidence base ', ' intervention effect ', ' emerging adulthood ', ' randomized trial ', ' ']",NIDA,MEDICAL UNIVERSITY OF SOUTH CAROLINA,R01,2010,476170,0.04091109874558734
"Intensive Outpatient v. Outpatient Treatment with Buprenorphine among African Ame    DESCRIPTION (provided by applicant):   This application addresses broad Challenge Area (05): Comparative Effectiveness Research, and specific Challenge Topic (05-DA-104): Comparing Drug Treatment Effectiveness in Ethnic Minority Populations Background: Although there is relatively little difference in illicit drug use rates between African Americans and Whites, there is are significant differences in terms of the collateral impact of opiate use on these two communities and wide disparities in their access to treatment. Buprenorphine, a partial mu agonist approved for use the US in 2002 outside of strictly regulated opioid treatment programs, has the potential to reduce the disparity between demand for treatment and treatment access. However it appears from early data on the implementation of buprenorphine in the US that the health disparities faced by African Americans are now extending to this treatment. Indeed, according to SAMHSA over 90 percent of the patients receiving buprenorphine in their evaluation of this treatment were White. Many African Americans in urban areas are unable to find or afford the kind of buprenorphine physician office-based treatment that the approval of buprenorphine was intended to make possible. In Maryland and elsewhere, drug treatment agencies are responding to the disparities in access to buprenorphine treatment by offering grants or contracts to drug treatment programs that have traditionally relied exclusively on psychosocial approaches (""drug-free"" outpatient programs) to treatment. This arrangement has potential to ameliorate the access problem for African Americans, who in Baltimore make up about 80 percent of the city's heroin-using population. But this arrangement has also uncovered knowledge gaps that must be filled to enable both access and optimal patient centered treatment for this population. One such gap concerns what level of psychosocial treatment is appropriate for this population. Second, we need to understand how attitudes of staff at formerly abstinence-oriented programs affect the use of an opioid agonist in terms of retention in treatment and outcomes. Design: This two-group randomized clinical trial will test the effectiveness of intensive outpatient (IOP) v. standard outpatient (OP) treatment in 272 heroin-dependent African American adults receiving buprenorphine in 3 formerly ""drug-free"" programs. Participants will be randomly assigned to one of the two treatment intensity conditions at intake and assessed at baseline, 3-, and 6-months post-baseline to determine treatment retention, frequency and severity of heroin and cocaine use, self-reported HIV-risk, quality of life, and to determine DSM-IV criteria for Full or Partial Remission of Opioid Dependence. Furthermore, patient factors potentially critical for treatment success (e.g., attitudes towards buprenorphine and average buprenorphine dose while in treatment) will be examined to determine their importance in influencing treatment outcomes. Moreover, both patient and staff attitudes and average buprenorphine dose will be evaluated to determine their respective relationships to treatment experiences and treatment retention. Significance, Innovation and Public Health Impact: This study is significant because it will examine the comparative effectiveness of two common counseling approaches offered with buprenorphine in clinics treating large numbers of African Americans, a population with significant need and limited access to this type of effective treatment. Study findings may help to expand the availability of buprenorphine to African Americans, inform providers and policymakers regarding the relative benefits of two levels of intensity of counseling, and inform the field regarding factors associated with optimal buprenorphine utilization and program retention. The use of the DSM-IV criteria for remission as a one of the outcome measures represents an important augmentation of the usual drug abuse research outcome measures, which usually rely primarily upon urine testing results and self-reports of drug use as the primary outcome measure and do not take into account drug- related reductions in clinically significant impairment or distress, despite some continued intermitted drug use. Public Health Statement This study will examine the comparative effectiveness of two common counseling approaches offered with buprenorphine in clinics treating large numbers of African Americans, a population with significant need and limited access to this type of effective treatment which reduces drug use and HIV-risk. Study findings may help to expand the availability of buprenorphine to African Americans, inform providers and policymakers regarding the relative benefits of two levels of intensity of counseling, and inform the field regarding factors associated with optimal buprenorphine utilization and program retention.               PROJECT NARRATIVE Public Health Statement This study will examine the comparative effectiveness of two common counseling approaches offered with buprenorphine in clinics treating large numbers of African Americans, a population with significant need and limited access to this type of effective treatment which reduces drug use and HIV-risk. Study findings may help to expand the availability of buprenorphine to African Americans, inform providers and policymakers regarding the relative benefits of two levels of intensity of counseling, and inform the field regarding factors associated with optimal buprenorphine utilization and program retention.",Intensive Outpatient v. Outpatient Treatment with Buprenorphine among African Ame,7943892,RC1DA028407,"['Counseling ', ' Provider ', ' health disparity ', ' health disparities ', ' Heroin ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Effectiveness ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Preclinical Drug Evaluation ', ' Evaluation Studies, Drug, Preclinical ', ' Evaluation Studies, Drug, Pre-Clinical ', ' Drug Screening ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' Dose ', ' Caring ', ' Data ', ' Intake ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Screening Result ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' base ', ' dosage ', ' urban area ', ' Grant ', ' Health ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Alcohol consumption ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Partial Remission ', ' Area ', ' premature ', ' prematurity ', ' Medical ', ' Randomized Clinical Trials ', ' Insurance ', ' Evaluation ', ' DSM-IV ', ' Diagnostic and Statistical Manual of Mental Disorders-IV ', ' Diagnostic and Statistical Manual of Mental Disorders, 4th edition ', ' DSM4 ', ' Distress ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Individual ', ' African ', ' Opioid ', ' Drug usage ', ' drug use ', ' Funding ', ' Agonist ', ' Maryland ', ' Medicine ', ' Drug Metabolic Detoxication ', ' detoxification ', ' Metabolism of Toxic Agents ', ' Metabolic Drug Detoxications ', ' Drug Metabolic Detoxification ', ' Methadone ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl- ', ' Naltrexone ', ' ReVia ', ' Nemexin ', ' Nalorex ', ' Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5alpha)- ', ' Outpatients ', ' Out-patients ', ' Patients ', ' Physicians ', "" Physicians' Offices "", ' Contracts ', ' Contracting Opportunities ', ' public health medicine (field) ', ' Public Health ', ' Quality of life ', ' QOL ', ' Relapse ', ' Research ', ' Risk ', ' Societies ', ' Opiates ', ' Knowledge ', ' programs ', ' Staff Attitudes ', ' Testing ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Urine ', ' Urine Urinary System ', ' Attitude ', ' Hour ', ' Frequencies (time pattern) ', ' Frequency ', ' Severities ', ' Dependence ', ' Clinic ', ' System ', ' LOINC Axis 4 System ', ' Test Result ', ' Baltimore ', ' Opiate Addiction ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' psychosocial ', ' Outcome Study ', ' Disease remission ', ' Remission ', ' American ', ' experience ', ' success ', ' Cocaine Dependences ', ' Cocaine Addiction ', ' Buprenorphine ', ' 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5alpha,7alpha(S))- ', ' novel ', ' Participant ', ' treatment program ', ' Patient Self-Report ', ' Self-Report ', ' drinking ', ' Reporting ', ' Measures ', ' Relative (related person) ', ' Relative ', ' Treatment outcome ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Outcome Measure ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Sampling ', ' Treatment Effectiveness ', ' response ', ' Cities ', ' Accounting ', ' Communities ', ' effectiveness research ', ' design ', ' designing ', ' Outcome ', ' Population ', ' Alcohol dependence ', ' alcohol-dependent ', ' alcohol dependency ', ' alcohol addiction ', ' innovation ', ' innovative ', ' innovate ', ' Impairment ', ' ethnic minority population ', ' ethnic minority ', ' Abstinence ', ' clinically significant ', ' clinical significance ', ' drug testing ', ' drug detection ', ' patient oriented ', ' patient centered ', ' alcohol research ', ' ethanol research ', ' alcohol related research ', ' comparative effectiveness ', ' addiction ', ' addictive disorder ', ' primary outcome ', ' effective therapy ', ' effective treatment ', ' cocaine use ', ' Regimen ', ' ']",NIDA,"FRIENDS RESEARCH INSTITUTE, INC.",RC1,2010,491343,0.10744347510969104
"The Logics for HIV Risk among Street-Based Heroin Injectors    DESCRIPTION (provided by applicant): We propose to develop a theoretically and ethnographically informed model of ""HIV risk environment"" for public health intervention by identifying the key structural forces, institutional processes, and socio-cultural constraints that shape HIV behaviors among inner-city street-based drug users. We will examine the social processes that drive the logics for HIV transmission behaviors among street-based injection drug users (IDUs) in two cities, Philadelphia and San Francisco, that span a strategic range of the demographic, economic, political, and cultural factors affecting inner-city poverty in the United States. Building on long-term, continuous participant-observation ethnographic fieldwork in the shooting encampments of ethnically and generationally bounded social networks of heroin injectors and crack smokers in San Francisco as well as pilot research in Philadelphia at open-air drug markets and shooting galleries, we will document patterns of: 1) law enforcement and criminal justice; 2) poverty and income generating opportunities (including legal and illegal labor markets and public subsidies); 3) illegal drug markets and polydrug availability; 4) racialized ethnic boundaries and conflicts; 5) gender/sexuality boundaries that delimit social networks; 6) oppositional sub-cultural identities that trap IDUs into counterproductive relationships with the services that are meant to help or contain them; 7) violence and insecurity; 8) access to clinical care, public health prevention messages, and social services; 9) access to ecological and basic survival needs infrastructures including transportation systems, food, and shelter from inclement weather. An experienced ethnographic team in both cities will collect data on individual-level HIV risk behaviors at fieldsites that we have successfully maintained on the parent grant for more than 12 years in San Francisco and recently established in Philadelphia (core N of each network=15-20 at any given time, peripheral N=10-15 in each fieldsite; 2 sites in Philadephia and 2 in San Francisco). The project will administer a set of procedures for cross-methodological collaboration with epidemiologists who are the Principal Investigators on long-term, large quantitative data sets documenting street-based drug users in both cities. This will enable us to examine the representativity of our ethnographic data on individual street-based drug users and to explore the generalizability of our analysis of the larger social structural processes that promote or constrain risky injection and sexual practices. It will also bring one of the largest and oldest NIDA-funded data sets on IDUs in San Francisco, an exceptionally high-tech, wealthy, culturally diverse, and liberal city into an illustrative contrast and dialogue with another large NIDA-supported quantitative data set of street-based drug users in the city of Philadelphia, one of the nation's poorest deindustrialized metropolises, with a declining population of largely native-born white, Latino (primarily Puerto Rican) and African American ethnic groups.      PUBLIC HEALTH RELEVANCE: Untangling the complex web of factors that render inner city poverty environments exceptionally risky for HIV infection and addiction will help public health outreach workers and clinicians develop more innovative structural and targeted interventions to reach larger numbers of low income high-risk populations with more effective and convincing messages. Upstream interventions that alter neighborhood-level risk environments can cost-effectively encourage drug users to change their behaviors for pragmatic reasons without necessarily requiring a conscious or willful choice. Our findings will also identify strategic institutions and programs that often operate at cross purposes or fail to coordinate with public health HIV risk reduction priorities (including law enforcement, criminal justice, employment training, public housing, food kitchens, shelters, schools, and churches) but which represent productive sites for multi-service HIV prevention interventions.           Relevance: Untangling the complex web of factors that render inner city poverty environments exceptionally risky for HIV infection and addiction will help public health outreach workers and clinicians develop more innovative structural and targeted interventions to reach larger numbers of low income high-risk populations with more effective and convincing messages. Upstream interventions that alter neighborhood-level risk environments can cost-effectively encourage drug users to change their behaviors for pragmatic reasons without necessarily requiring a conscious or willful choice. Our findings will also identify strategic institutions and programs that often operate at cross purposes or fail to coordinate with public health HIV risk reduction priorities (including law enforcement, criminal justice, employment training, public housing, food kitchens, shelters, schools, and churches) but which represent productive sites for multi-service HIV prevention interventions.",The Logics for HIV Risk among Street-Based Heroin Injectors,7839409,R01DA010164,"['Church ', ' experience ', ' skills ', ' Participant ', ' drug market ', ' Agreement ', ' social inequality ', ' outreach ', ' Prevention ', ' social ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Gender ', ' Native-Born ', ' Native People ', ' Indigenous Population ', ' Child Abuse ', ' Childhood Abuse ', ' Regulation ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Latino ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' theories ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' cost ', ' design ', ' designing ', ' remediation ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' analytical tool ', ' addiction ', ' addictive disorder ', ' parent grant ', ' high risk ', ' public health relevance ', ' clinical care ', ' Conflict (Psychology) ', ' Conflict ', ' Data Collection ', ' Decision Making ', ' Risk Reduction ', ' Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' Heroin ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Institution ', ' prevent ', ' preventing ', ' Legal ', ' Drug Compounding ', ' Drug Preparation ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Low income ', ' Economic Conditions ', ' Economical Conditions ', ' Economics ', ' Employment ', ' Environment ', ' Environment and Public Health ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data Set ', ' Dataset ', ' Ethnic group ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Shelter facility ', ' shelter-housing ', ' shelter ', ' Social Network ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Research Infrastructure ', ' Infrastructure ', ' Epidemiologist ', ' transmission process ', ' Transmission ', ' Principal Investigator ', ' Process ', ' sex ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Face ', ' facial ', ' faces ', ' Behavioral ', ' Ethnography ', ' ethnographic ', ' Law Enforcement ', ' Food ', ' Clinical Services ', ' Affect ', ' Age ', ' base ', ' Procedures ', ' Air ', ' Health ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Peripheral ', ' Distal ', ' Site ', ' Link ', ' Income ', ' Economical Income ', ' Economic Income ', ' Injection of therapeutic agent ', ' Injections ', ' Training ', ' Laboratories ', ' Conscious ', ' Consciousness ', ' Individual ', ' Literature ', ' Logic ', ' Logistics ', ' Policies ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Marketing ', ' Medicine ', ' Methods ', ' Neighborhoods ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Collaborations ', ' Philadelphia ', ' Cultural Anthropology ', ' Poverty ', ' Shapes ', ' Smoker ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Public Housing ', ' Puerto Rican ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' San Francisco ', ' Schools ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sexuality ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Sciences ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Socialization ', ' Consensus ', ' Knowledge ', ' programs ', ' Time ', ' Transportation ', ' Unemployment ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' United States ', ' Attention ', ' Violence ', ' violent behavior ', ' violent ', ' Investigation ', ' Weather ', ' Complex ', ' Awareness ', ' Source ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' Behavior ', ' interest ', ' Injecting drug user ', ' Injection Drug User ', ' inner city ', ' Services ', ' preference ', ' ']",NIDA,UNIVERSITY OF PENNSYLVANIA,R01,2010,418513,0.08096065609070376
"Navigator Enhanced Case Management for Jail Inmates    DESCRIPTION (provided by applicant): Each year, there are over 600 unduplicated HIV-infected persons incarcerated in the San Francisco jail and almost two-thirds released with HIV-focused discharge planning were reincarcerated within 1 year. More than half of HIV-infected jail inmates are diagnosed with mental health conditions severe enough to require medication and a similar proportion report substance abuse disorders at the time of detention. While some community-based services exist, there remains a critical need exists to improve linkages to care and adherence to care plans for HIV-infected adults as they move between community and jai. An effective service delivery model used in similar high-needs populations exists, but has not been tested with HIV-infected drug users leaving jails - Navigator case management. Base on harm reduction, motivational interviewing and general social work principles, this model uses assertive community treatment and a highly proactive approach to facilitate adherence to a comprehensive care plan designed to address a client's multiple needs. Case managers work with paraprofessional peer navigators to help clients make better use of available resources, more effectively communicate with providers, sustain care over time and successfully connect with multiple service provider sectors. In this study, we propose to tailor this approach to meet the needs of HIV-infected individuals with substance abuse and mental health issues, pilot test the intervention and assessment procedures and then conduct a randomized study in which 360 HIV-infected men and women leaving jail. Specifically, participants will receive either Navigator case management delivered by the non-profit San Francisco Pre-Trial Diversion project or the standard of care currently provided to transitioning inmates, 90- days of as-needed case management provided by the San Francisco Department of Public Health's Forensic AIDS Project. We will test the effectiveness of the intervention in reducing sexual and drug-related HIV transmission risk, increasing HIV medication adherence, reducing drug dependence and reducing reincarceration. Finally, we will characterize both the Navigator and Forensic AIDS Project intervention processes and conduct exploratory analyses of the mediators of HIV transmission risk and risk reduction and HIV-related adherence among HIV+ individuals leaving jail. Our study is highly innovative because no interventions exist that are proven effective with this population - HIV-infected individuals with drug use and mental health issues. This study will also contribute to the field of HIV prevention by incorporating risk reduction counseling alongside more traditional case management support services. PUBLIC HEALTH RELEVANCE: HIV-infected adults incarcerated in the United States criminal justice system are predominantly active drug users and disproportionately people of color. The complex interplay of poverty, race, lack of education and sanctions--rather than treatment--for addictions reinforces returns to the criminal justice system and pervasive health disparities for HIV-infected individuals. Underlying behaviors that lead to repeated incarceration closely correlate with behaviors that are associated with HIV transmission and increased morbidity and mortality from HIV. In drug addicted adults, recidivism is driven by drug relapse and illegal activities associated with drug use, failure to engage and remain in mental health treatment or failure to break free from social instability in the form of homelessness and joblessness. This study proposes to assess whether a method of case management proven effective for similar populations can ensuring services to successfully and permanently break the cycle of incarceration, drug abuse and HIV transmission risk behavior among HIV-infected individuals leaving jail.              NARRATIVE HIV-infected adults incarcerated in the United States criminal justice system are predominantly active drug users and disproportionately people of color. The complex interplay of poverty, race, lack of education and sanctions--rather than treatment--for addictions reinforces returns to the criminal justice system and pervasive health disparities for HIV-infected individuals. Underlying behaviors that lead to repeated incarceration closely correlate with behaviors that are associated with HIV transmission and increased morbidity and mortality from HIV. In drug addicted adults, recidivism is driven by drug relapse and illegal activities associated with drug use, failure to engage and remain in mental health treatment or failure to break free from social instability in the form of homelessness and joblessness. This study proposes to assess whether a method of case management proven effective for similar populations can ensuring services to successfully and permanently break the cycle of incarceration, drug abuse and HIV transmission risk behavior among HIV-infected individuals leaving jail.",Navigator Enhanced Case Management for Jail Inmates,7895009,R01DA027209,"['Counseling ', ' Risk Reduction ', ' Provider ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Diagnosis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Vent ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Caring ', ' Jail ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Adherence (attribute) ', ' Adherence ', ' Effectiveness of Interventions ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' transmission process ', ' Transmission ', ' Process ', ' medication compliance ', ' medication adherence ', ' Forensic Medicine ', ' Forensics ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' base ', ' improved ', ' Procedures ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Housing ', ' Left ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Medical ', ' Ensure ', ' Failure (biologic function) ', ' failure ', ' FLR ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Homelessness ', ' unhoused ', ' homeless ', ' Individual ', ' Drug usage ', ' drug use ', ' men ', "" men's "", ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' Persons ', ' Poverty ', ' Prisoner ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisons ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Relapse ', ' Resources ', ' Research Resources ', ' Risk ', ' San Francisco ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Societies ', ' Life ', ' programs ', ' Testing ', ' Time ', ' Unemployment ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' United States ', ' Woman ', ' Work ', ' Complex ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Viral ', ' meetings ', ' Services ', ' Participant ', ' peer ', ' Harm Reduction ', ' Harm Minimization ', ' recidivism ', ' high risk behavior ', ' motivational enhancement therapy ', ' motivational interview ', ' Case Manager ', ' Case Management Nurse ', ' Care Manager ', ' drug addict ', ' Reporting ', ' social ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' County ', ' Case Management ', ' Criminal Justice ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Client ', ' Color ', ' Communities ', ' Comprehensive Health Care ', ' comprehensive care ', ' Comprehensive Healthcare ', ' cost ', ' drug relapse ', ' reincarceration ', ' design ', ' designing ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' community based service ', ' addiction ', ' addictive disorder ', ' public health relevance ', ' standard of care ', ' treatment adherence ', ' efficacy testing ', ' ImProv ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2010,494904,0.12698386697695813
"DIDARP at the University of Puerto Rico School of Public Health    DESCRIPTION (provided by applicant): Our goal is to enhance our capacity to conduct drug abuse research with criminal justice populations from a public health perspective, at the University of Puerto Rico, Graduate School of Public Health. Our research development strategy centers on developing proficiency in research competencies in a critical mass of faculty that will cohesively pursue epidemiological and health services research relevant to engaging and retaining in community drug treatment re-entering inmates with histories of a substance use disorder. The program will provide as well opportunities to develop research capacity in students at different stages in their education and to encourage them to engage in drug abuse research careers. The research projects submitted with this application will explore individual and drug treatment provider factors that may predict entry and retention in community drug treatment for re-entering ex-offenders with a substance use problem. The proposed projects should contribute to address the disproportionate prevalence of untreated substance use problems in incarcerated populations as well as the large proportion of untreated ex-offenders that become re-addicted and who are re-incarcerated shortly after release The research projects include three pilot and one developmental project that address NIDA research priorities such as the services needs of special populations and studies of service providers. We expect MIDARP support to enhance our capacity to engage in NIH funded drug abuse research of relevance to addressing disparities borne by Latinos with a substance use disorder. To reach our goal, we have established the following aims: 1) Provide leadership, support, and coordination to increase the number of Latino faculty and students capable of successfully conducting drug abuse research relevant to a criminal justice context. 2) Enhance institutional and extra- institutional resources that sustain the successful planning, financing, and conduct of drug abuse research. 3) Disseminate research findings in a timely and effective fashion to the research community, to the academic programs, and to other stakeholders involved in addressing the drug treatment needs of ex- offenders with a substance use problem. PUBLIC HEALTH RELEVANCE (See instructions): We expect to build a synergestic cluster of faculty, students, and academic leaders that have expressed a growing interest in the public health impact of problems associated with drug abuse in the criminal justice population.              ",DIDARP at the University of Puerto Rico School of Public Health,7914389,R24DA024868,"['Provider ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Development ', ' developmental ', ' Faculty ', ' career ', ' Goals ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Recording of previous events ', ' History ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Leadership ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Funding ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Staging ', ' public health medicine (field) ', ' Public Health ', ' Puerto Rico ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Resources ', ' Research Resources ', ' Public Health Schools ', ' Research Priority ', ' programs ', ' Students ', ' Substance Use Disorder ', ' Universities ', ' interest ', ' Services ', ' named group ', ' Special Population ', ' Population Study ', ' offender ', ' criminal offender ', ' Criminal Justice ', ' Latino ', ' Communities ', ' Instruction ', ' Population ', ' Prevalence ', ' public health relevance ', ' ']",NIDA,UNIVERSITY OF PUERTO RICO MED SCIENCES,R24,2010,523190,0.05136316483987521
"Research Training in the Prevention of Drug Abuse & AIDS in Communities of Color This revised application for a MIDARP program at Howard University describes the Research Training Program in Drug Abuse and AIDS Prevention in Communities of Color which is designed to increase the capacity of faculty and students at Howard to conduct rigorous and competitive research in the prevention of drug abuse and HIV/AIDS in communities of color. The program will emphasize training in transdisciplinary research on relationships between environmental stress, biological responses, risk behaviors and health outcomes and will utilize collaborations with senior investigators in research intensive universities to mentor Howard faculty investigators. The MIDARP will also work closely with existing programs that link Howard faculty and students to research training opportunities to (1) increase knowledge and interest in drug abuse and AIDS prevention research among faculty and students in these programs and (2) utilize the resources of these programs to expand the range of training opportunities available to MIDARP investigators and students. Howard students will be introduced to drug abuse and AIDS prevention research and career development by augmenting existing drug abuse courses in the College of Arts and Sciences and the curriculum for medical, basic science, nursing, and pharmacy students to include information on drug abuse and AIDS prevention research.. We will also fund a pre-doctoral dissertation stipend and recruit students to serve as research assistants in the MIDARP pilot studies. The unique strengths of the program include the opportunity to (1) integrate education regarding drug abuse and AIDS prevention research into existing research training programs for faculty and students;(2) train individuals in diverse disciplines such as the health professions and sciences (i.e., medicine, basic sciences, pharmacy, nursing) who are less likely to pursue research careers in drug abuse and AIDS prevention research; and (3) support transdisciplinary research in drug use and AIDS prevention based on strong existing University research programs in genetics, physiology, and psychobiology. A transdisciplinary approach will be reflected in the MIDARP leadership that includes a Director who is a behavioral scientist specializing in research on environmental stress, drug use, and AIDS risk in communities of color and a Deputy Director who is an immunogeneticist with expertise in microbiology, and founding Director of the Human Genome Project at Howard University. ",Research Training in the Prevention of Drug Abuse & AIDS in Communities of Color,8101474,R24DA021470,"['Curriculum ', ' Educational Curriculum ', ' Achievement Attainment ', ' Achievement ', ' Ally ', ' prevent drug use ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' health disparities ', ' health disparity ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Email ', ' E-Mail ', ' Electronic Mail ', ' Environment ', ' Address ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' balance function ', ' balance ', ' Equilibrium ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' biological adaptation to stress ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Allied Health Sciences ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Infrastructure ', ' Research Infrastructure ', ' Research Training ', ' Senior Scientist ', ' Training and Infrastructure ', ' Monitor ', ' Permission ', ' Authorization ', ' Authorization documentation ', ' developmental ', ' Development ', ' Faculty ', ' Behavioral ', ' Task Forces ', ' Advisory Committees ', ' Foundations ', ' base ', ' career ', ' role model ', ' sociology/anthropology ', ' Goals ', ' Grant ', ' Health ', ' Health Occupations ', ' health science profession ', ' Health Professions ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Human Genome Project ', ' Area ', ' Biological ', ' Physiologic ', ' Physiological ', ' Medical ', ' Link ', ' Ensure ', ' Interview ', ' Evaluation ', ' Training ', ' Leadership ', ' Discipline ', ' Individual ', ' Workshop ', ' Educational workshop ', ' Measurement ', ' Development Plans ', ' drug use ', ' Drug usage ', ' Funding ', ' Medicine ', ' Mentors ', ' Mentorship ', ' Methods ', ' Microbiology ', ' Collaborations ', ' Nurses ', ' Nursing Profession ', ' Nursing Field ', ' Nursing ', ' Discipline of Nursing ', ' Brochures ', ' Booklets ', ' Pamphlets ', ' Pharmacies ', ' Pharmacy facility ', ' Pharmacology ', ' Genetic ', ' Physiology ', ' pilot study ', ' Pilot Projects ', ' Exposure to ', ' Psychiatry ', ' Psychology ', ' Scientific Publication ', ' Publications ', ' Recommendation ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Schools ', ' school of medicine ', ' medical college ', ' medical schools ', ' Science ', ' Social Work ', ' Social Service ', ' Social work (field) ', ' Sociology ', ' Knowledge ', ' lectures ', ' programs ', ' Arts ', ' Stress ', ' Students ', ' Medical Students ', ' Pupil Nurses ', ' Nursing Students ', ' Pharmacy Students ', ' Survey Instrument ', ' Surveys ', ' Teaching ', ' Educational process of instructing ', ' Scientist ', ' Time ', ' Training Activity ', ' Training Programs ', ' Universities ', ' violent behavior ', ' violent ', ' Violence ', ' Work ', ' Writing ', ' Award ', ' Techniques ', ' Behavioral Research ', ' Behavioral Sciences ', ' interest ', ' meetings ', ' collegiate ', ' college ', ' Services ', ' Blood Pressure ', ' American ', ' experience ', ' stressor ', ' success ', ' professor ', ' cohort ', ' skills ', ' Participant ', ' Prevention Research ', ' member ', ' Basic Research ', ' Basic Science ', ' graduate student ', ' Prevention ', ' social ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' career development ', ' biopsychology ', ' biological basis of behavior ', ' psychobiology ', ' response ', ' Clinical Study ', ' Clinical Research ', ' Color ', ' Communication ', ' Communities ', ' designing ', ' design ', ' Outcome ', ' Population ', ' predoctoral ', ' predoc ', ' pre-doc ', ' pre-doctoral ', ' Historically Black University ', ' Historically Black Institution ', ' Historically Black Colleges ', ' HBCUs ', ' Historically Black Colleges and Universities ', ' heart rate variability ', ' Consultations ', ' ']",NIDA,HOWARD UNIVERSITY,R24,2010,48816,0.15182662680398612
"Drugs, sexual impulsivity, HIV: Psychosocial and cognitive risk factors of YMSM    DESCRIPTION (provided by applicant): Unprotected sexual intercourse between men constitutes 58% of all reported cases of AIDS and 80% of HIV cases 1,2. Rates of HIV infection among 15 to 24 year olds continue to increase with MSM behavior remaining the leading cause of HIV infection among adolescent males 1,2. Over 90% of YMSM have reported having more than one sexual partner in the past 6 months and between 33% and 49% have had unprotected anal intercourse during the same time3. Studies show that use of stimulants, particularly methamphetamine, may influence risky sexual practices and contribute to the most recent wave of HIV and other sexually transmitted infections (STIs)4-6. Systematic development of theory has been identified as a crucial step in efficacious intervention development, but previous conceptual models have focused on a relatively limited array of explanatory constructs. However, Social Action Theory (SAT)7 provides a promising model for examining the risk behavior of YMSM, because it includes individual as well as social and contextual determinants. SAT remains to be tested for use in the field of HIV and with YMSM, because this model was originally conceived as a general health promotion model for the adult population. Using data from the Dr. Kipke's NIDA funded ""Healthy Young Men Study"" (HYM), this study will conduct multivariate analysis to test this model for use with the YMSM population. The specific aims of this study are to: 1) To empirically validate the chain of relationships depicted in Social Action Theory to determine if the theory addresses the interaction of individual, contextual, and social correlates of sexual and drug risk taking behaviors as they relate to YMSM; and 2) To further validate SAT by testing and incorporating competing theoretical relationships depicted in other behavioral theory models to develop a comprehensive theory of the social, psychosocial and cognitive risk factors for drug use, sexual impulsivity, and HIV among YMSM to guide prevention intervention efforts. . This study will contribute to the objectives of the AIDS-Science Track Award for Research Transition by 1) supporting a New Researcher; 2) addressing the NIDA research objective in the area of HIV, drug abuse, impulsivity, and coping strategies of an at-risk, under represented population; and 3) through refinement of a comprehensive theoretical model, we will provide a platform for developing interventions that address risk behavior related to HIV transmission among YMSM. PUBLIC HEALTH RELEVANCE: This study will contribute to effective HIV interventions for at-risk youth by developing a model to understand how environmental risk factors, impulsivity, and coping strategies converge into drug abuse and sexual risk taking.           Proposal Narrative This study will contribute to effective HIV interventions for at-risk youth by developing a model to understand how environmental risk factors, impulsivity, and coping strategies converge into drug abuse and sexual risk taking.","Drugs, sexual impulsivity, HIV: Psychosocial and cognitive risk factors of YMSM",8089023,R03DA024976,"['Data Analyses ', ' Data Analysis ', ' Risk Reduction ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' Data ', ' High Prevalence ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Cognitive ', ' transmission process ', ' Transmission ', ' Development ', ' developmental ', ' Heterosexuals ', ' Behavioral ', ' Male Adolescents ', ' adolescent boy ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Age ', ' base ', ' career ', ' Goals ', ' Health ', ' Health behavior ', ' Health Promotion ', ' Salutogenesis ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Area ', ' psychologic ', ' psychological ', ' Evaluation ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Longitudinal Studies ', ' long-term study ', ' Drug usage ', ' drug use ', ' Funding ', ' men ', "" men's "", ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Theoretical model ', ' Theoretic Models ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Shapes ', ' Anus ', ' Anal ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Risk-Taking ', ' Science ', ' Sexual Partners ', ' sex partner ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Life ', ' Anti-HIV Agents ', ' antiAIDS agent ', ' Anti-Human Immunodeficiency Virus Agents ', ' Anti-HIV Drugs ', ' Anti-AIDS Drugs ', ' Anti-AIDS Agents ', ' AIDS Drugs ', ' Testing ', ' Complex ', ' Award ', ' Behavior ', ' psychosocial ', ' metropolitan ', ' cohort ', ' peer ', ' NIH Program Announcements ', ' Program Announcement ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Reporting ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' health belief ', ' health-related belief ', ' Impulsivity ', ' Case Study ', ' case report ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' response ', ' Youth ', ' Youth 10-21 ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Coitus ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Communities ', ' sex risk ', ' sexual risk behavior ', ' Behavioral Model ', ' men who have sex with men ', ' men who have sex with other men ', ' design ', ' designing ', ' coping ', ' Guide prevention ', ' Population ', ' Prevalence ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' social cognitive theory ', ' social learning theory ', ' public health relevance ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R03,2010,7020,0.050969097749700466
"African American Female Drug Users: HIV, Health Disparities, & Criminality The overall goal of this study is to understand how drug use and criminality are related to health disparities, particularly HIV, and service utilization among African American drug using and non-drug using women across criminal justice status. While drug use is similar across racial groups in the US, African Americans are disproportionately more likely to experience severe health consequences and criminal involvemement as a result of drug misuse. Adequate health care may not be received by African American female offenders because they experience the burden of their race, class, gender, and criminal offender status. There is limited scientific data to help understand the linkages between health disparities such as HIV, untreated drug abuse, barriers to service utilization, and status as a criminial offender among African American females. This study is significant because of its potential to identify differences in health disparities and service utilization among African American drug using and non-drug using women in selected levels of criminal justice status (intensive correctional supervision-prison (n=200), moderate correctional supervision-jail (n=200), community supervision-probation (n=200), and no criminal justice involvement (n=200)). All 800 African American females will be followed logitudinally for three 6-month intervals to examine health status and the use of health services across time. The specific aims are: (1) To describe the prevalence of health problems among African American women across criminal justice status and drug use status; (2) To determine the cultural, predisposing, historical health, and potential enabling factors that are predictors of health problems among African American drug using and non-drug using women across criminal justice status over 18 months; (3) To describe the prevalence of untreated health problems, the patterns of health services utilization, and the cultural barriers to service utilization among African American women across criminal justice status and drug use status; and (4) To examine the factors that predict the likelihood of using health services among African American drug using and non-drug using women across criminal justice status over 18 months. The significance of this study includes the potential to provide criminal justice systems-level data for health planning and health policy for prevention, intervention, and treatment of African American female drug users. This study is significant to the public health field because of its potential to understand the severity of health disparities among African American women across criminal justice status and drug use status and to predict health status and the use of health services over time. This knowledge of African American females can be used as a foundation for future criminal justice systems-level interventions to increase the use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism. ","African American Female Drug Users: HIV, Health Disparities, & Criminality",8045927,R01DA022967,"['health disparity ', ' health disparities ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Enabling Factors ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Jail ', ' Data ', ' Applications Grants ', ' Grant Proposals ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Development ', ' developmental ', ' Fright ', ' Fear ', ' Female ', ' Foundations ', ' Future ', ' base ', ' Goals ', ' Gonorrhea ', ' Gonococcal Infection ', ' Health ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Planning ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Health Services ', ' health care service ', ' Health Status ', ' Level of Health ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Alcohols ', ' Alcohol Chemical Class ', ' Hospitalization ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Medical ', ' Series ', ' racism ', ' Incidence ', ' Inpatients ', ' Interview ', ' Hepatitis C virus ', ' Hepatitus C ', ' HCV ', ' Kentucky ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Trust ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' Literature ', ' Drug usage ', ' drug use ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' substance abuse treatment ', ' substance abuse therapy ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Physicians ', ' Prisoner ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisons ', ' Drug user ', ' Drug abuser ', ' Problem drug user ', ' Misuses drugs ', ' public health medicine (field) ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Knowledge ', ' Life ', ' Supervision ', ' Surveys ', ' Survey Instrument ', ' Time ', ' Universities ', ' Woman ', ' Work ', ' Severities ', ' Dependence ', ' Event ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' physical conditioning ', ' physical health ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Services ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' experience ', ' Seroprevalences ', ' Structure ', ' Participant ', ' recidivism ', ' NIH Program Announcements ', ' Program Announcement ', ' Patient Self-Report ', ' Self-Report ', ' General Population ', ' General Public ', ' probation ', ' offender ', ' criminal offender ', ' Reporting ', ' Gender ', "" Women's Health "", ' Female Health ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Healthcare ', ' health care ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' time use ', ' criminal offending ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' alcohol research ', ' ethanol research ', ' alcohol related research ', ' service utilization ', ' non-drug ', ' nondrug ', ' longitudinal design ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2010,74787,0.17369702321618338
"Drug Use Among Hispanic Emerging Adults    DESCRIPTION (provided by applicant): Among Hispanic adolescents, cultural factors such as acculturation, perceived discrimination, and acculturative stress are risk factors for drug use. Previous studies suggest that the effects of acculturation on drug use may be mediated by family functioning; when adolescents acculturate more rapidly than their parents, the parent- child acculturation discrepancy can lead to breakdowns in family communication and cohesion and increases in family conflict, which in turn can lead to risky behaviors such as drug use among the adolescents. Although there is considerable information about the role of family acculturation patterns in drug use among Hispanic adolescents, we do not know how family acculturation patterns affect adolescents as they transition into the next stage of life, emerging adulthood. Emerging adulthood, a provisional stage in which young adults try out adult roles but may not become firmly entrenched in them, is characterized by identity exploration, residential instability, self-focus, a subjective feeling of being between adolescence and true adulthood, and increased opportunities. In general, individuals who navigate this transition smoothly emerge with a more developed sense of identity, successful interpersonal relationships, new life roles, and minimal levels of substance use. However, the high level of independence and low level of social constraints that occur during emerging adulthood also make this a high-risk period for drug use and other problem behaviors. Understanding how factors in adolescence affect drug use in early adulthood can lead to better intervention efforts for adolescents. More research is needed to determine how cultural factors influence the transition to emerging adulthood among Hispanics and to identify the risk factors for escalation of drug use during this pivotal transition. This continuation application proposes to follow an established cohort of Hispanic adolescents (12th graders in the 2008-2009 school year) for an additional 4 years to identify the predictors of their drug use trajectories during the transition to emerging adulthood. The Specific Aims of the proposed research are the following: (1) Conduct an additional 4 annual surveys of the participants; (2) Construct individual growth curves to describe their use of tobacco, alcohol, marijuana, and other drugs; (3) Identify the predictors of the growth curve parameters, including cultural factors, peer factors, substance use during high school, psychological factors, and demographic factors; (4) Evaluate emerging adulthood variables as potential mediators of these influences, including identity exploration, experimentation / possibilities, instability (residential mobility, role transitions), self-focus, and subjective experience of being in-between adolescence and adulthood; and (5) Make recommendations for the development of improved health education messages to prevent drug use among acculturating Hispanics during the transition to emerging adulthood.      PUBLIC HEALTH RELEVANCE: This application addresses the public health goals of preventing and reducing substance use among young adults. It also aims to reduce health disparities by identifying risk and protective factors that are specific to Hispanics.           This application addresses the public health goals of preventing and reducing substance use among young adults. It also aims to reduce health disparities by identifying risk and protective factors that are specific to Hispanics.",Drug Use Among Hispanic Emerging Adults,7786352,R01DA016310,"['Conflict (Psychology) ', ' Conflict ', ' Demographic Factors ', ' Dependency (Psychology) ', ' emotional dependency ', ' Dependency ', ' health disparity ', ' health disparities ', ' Discrimination (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' prevent ', ' preventing ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Employment ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data Set ', ' Dataset ', ' Data ', ' Development ', ' developmental ', ' Feeling ', ' feelings ', ' Extended Family ', ' Family ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' Pathway interactions ', ' pathway ', ' Affect ', ' career ', ' Friendships ', ' role model ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' improved ', ' Health behavior ', ' Health education ', ' Health Tutoring ', ' Health Instruction ', ' Hispanic Americans ', ' Spanish Americans ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Training ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Longitudinal Studies ', ' long-term study ', ' Los Angeles ', ' Drug usage ', ' drug use ', ' Mainstreaming (Education) ', ' achievement Mainstream Education ', ' Mainstreaming ', ' Educational Mainstreaming ', ' Marihuana ', ' marijuana ', ' Marriage ', ' Mexican Americans ', ' Chicanos ', ' Chicanas ', ' Problem behavior ', ' behavioral problem ', ' Immigrant ', ' Parent-Child Relations ', ' parent offspring interaction ', ' parent child interaction ', ' Parent-Child Relationship ', ' Parents ', ' Platelet Factor 4 ', ' platelet factor IV ', ' gamma-Thromboglobulin ', ' Small Inducible Cytokine Subfamily B, Member 4 ', ' Small Inducible Cytokine B4 ', ' Recombinant Platelet Factor 4 ', ' Heparin Neutralizing Protein ', ' Factor 4 ', ' Chemokine (C-X-C motif) Ligand 4 ', ' Blood platelet factor 4 ', ' Blood Platelet Factor IV ', ' Antiheparin Factor ', ' Staging ', ' Psychological Factors ', ' Psychosocial Factor ', ' psychosocial variables ', ' public health medicine (field) ', ' Public Health ', ' Recommendation ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Residential Mobility ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Schools ', ' Societies ', ' Life ', ' Stress ', ' Students ', ' Surveys ', ' Survey Instrument ', ' Violence ', ' violent behavior ', ' violent ', ' Home environment ', ' Home ', ' Pattern ', ' Behavior ', ' Occupational ', ' Tobacco use ', ' Tobacco Consumption ', ' college ', ' collegiate ', ' behavioral/social science ', ' experience ', ' cohesion ', ' high school ', ' cohort ', ' Participant ', ' peer ', ' family structure ', ' cultural values ', ' social ', ' Friends ', ' Gender ', ' Generations ', ' Measures ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' parental monitoring ', ' parent monitoring ', ' Emotional ', ' Assimilations ', ' Family member ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Deterioration ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' ethnic discrimination ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Acculturation ', ' Cultural Assimilation ', ' Communication ', ' Outcome ', ' Population ', ' 18 year old ', ' eighteen year old ', ' age 18 years ', ' high risk ', ' public health relevance ', ' social science research ', ' emerging adult ', ' early adulthood ', ' emerging adulthood ', ' ']",NIDA,CLAREMONT GRADUATE UNIVERSITY,R01,2010,38542,0.06875639554894068
"Economic Evaluation of Drug Abuse Treatment and HIV Prevention Services for Pregn    DESCRIPTION (provided by applicant): Economic evaluation of drug abuse treatment and HIV prevention services for pregnant women is critical to identify the most efficient and equitable use of scarce resources. Economic and policy research on the efficiency of drug abuse treatment and HIV prevention services among vulnerable populations such as women, adolescents and members of minority groups is necessary to improve drug abuse and HIV/AIDS services for these vulnerable and underserved populations. While work in this area continues to grow, there is still a dearth of rigorous economic evaluations of such programs, especially those that adhere to quality standards as recommended by the U.S. Panel on Cost Effectiveness in Health and Medicine. The overall objective of this study is to conduct the first economic evaluation of an innovative behavioral approach integrating Motivational Enhancement Therapy with Cognitive Behavioral Therapy (MET-CBT) as compared to standard Brief Advice (BA) within prenatal care to decrease use of a full range of substances (e.g., marijuana, cocaine, methamphetamines, alcohol, nicotine), to reduce HIV risk behavior and to achieve better infant health outcomes (e.g. longer gestations, greater birth weight, reduced medical consequences such as admission and length of stay in the Neonatal Intensive Care Unit (NICU)). The specific aims of this study are: (1) to conduct cost analyses of the MET-CBT and BA intervention arms; (2) to conduct incremental cost-effectiveness analyses of the two interventions (MET-CBT and BA), vis-`-vis each other, in terms of substance use, infant health outcomes and HIV risk reduction; and (3) to conduct incremental cost-utility analyses determining the net cost per Quality-Adjusted Life Year (QALY) saved respectively by each intervention arm (MET-CBT and BA), vis-`-vis each other, in terms of substance use and HIV risk reduction. The proposed research is responsive to PA-07-122 in that it proposes to conduct research related to cost-effectiveness and cost-utility analyses, services costs, methodological research, and the cross-cutting themes of HIV/AIDS and health disparities. The proposed research is grounded in sound microeconomic principles and standardized techniques as reported in the U.S. Panel on Cost Effectiveness in Health and Medicine, and proposes rigorous conceptual and methodological research to improve the evidence base on the unit costs and cost-effectiveness of substance abuse treatment and HIV prevention services. It builds on a NIDA-funded randomized controlled trial (R01-DA019135) of an innovate behavioral approach, which offers a new paradigm of treatment services, integrating MET-CBT within prenatal care compared to standard BA, and offering promise to improve access to and strengthen substance use treatment and HIV prevention services targeted at drug using pregnant women who are highly susceptible to HIV/AIDS.       PUBLIC HEALTH RELEVANCE: Drug abuse and high risk HIV behavior during pregnancy are major public health problems in the United States due to their impact on individual users, their offspring, and surrounding communities. Drug abuse and HIV prevention programs targeting pregnant women have the potential to be cost-effective due to the resultant fewer low-birth-weight babies and perinatal deaths, fewer physical, cognitive and behavioral problems during infancy and childhood, and the significant health benefits that can accrue to the mother. The overall objective of this study is to conduct the first economic evaluation of an innovative behavioral approach integrating Motivational Enhancement Therapy with Cognitive Behavioral Therapy (MET-CBT) as compared to standard Brief Advice (BA) within prenatal care to decrease use of a full range of substances (e.g., marijuana, cocaine, methamphetamines, alcohol, nicotine), to reduce HIV risk behavior and to achieve better infant health outcomes (e.g. longer gestations, greater birth weight, reduced medical consequences such as admission and length of stay in the Neonatal Intensive Care Unit (NICU)).           PROJECT NARRATIVE Drug abuse and high risk HIV behavior during pregnancy are major public health problems in the United States due to their impact on individual users, their offspring, and surrounding communities. Drug abuse and HIV prevention programs targeting pregnant women have the potential to be cost-effective due to the resultant fewer low-birth-weight babies and perinatal deaths, fewer physical, cognitive and behavioral problems during infancy and childhood, and the significant health benefits that can accrue to the mother. The overall objective of this study is to conduct the first economic evaluation of an innovative behavioral approach integrating Motivational Enhancement Therapy with Cognitive Behavioral Therapy (MET-CBT) as compared to standard Brief Advice (BA) within prenatal care to decrease use of a full range of substances (e.g., marijuana, cocaine, methamphetamines, alcohol, nicotine), to reduce HIV risk behavior and to achieve better infant health outcomes (e.g. longer gestations, greater birth weight, reduced medical consequences such as admission and length of stay in the Neonatal Intensive Care Unit (NICU)).",Economic Evaluation of Drug Abuse Treatment and HIV Prevention Services for Pregn,7756675,R01DA025555,"['cognitive behavioral treatment ', ' cognitive behavioral therapy ', ' cognitive behavioral modification ', ' cognitive behavioral intervention ', ' cognitive behavior therapy ', ' cognitive behavior modification ', ' cognitive behavior intervention ', ' Cognitive Psychotherapy ', ' Cognition Therapy ', ' Communities ', ' Vulnerable Populations ', ' vulnerable group ', ' life time cost ', ' lifetime cost ', ' cost ', ' Underserved Population ', ' underserved people ', ' under served population ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' high risk ', ' public health relevance ', ' evidence base ', ' brief advice ', ' arm ', ' Cost Analysis ', ' Cost Analyses ', ' cost effectiveness ', ' Costs and Benefits ', ' Costs and Cost Analysis ', ' Costs and Cost Analyses ', ' Cessation of life ', ' Death ', ' Risk Reduction ', ' health disparity ', ' health disparities ', ' Effectiveness ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Economics ', ' Address ', ' Build-it ', ' economic evaluation ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Data ', ' Effectiveness of Interventions ', ' Improve Access ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Policy Research ', ' Cognitive ', ' Facilities and Administrative Costs ', ' Indirect Costs ', ' Evaluation Studies ', ' Behavioral ', ' Advisory Committees ', ' Task Forces ', ' Guidelines ', ' Future ', ' Perinatal ', ' Goals ', ' improved ', ' Health ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Medical ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Infant Health ', ' Low Birth Weight Infant ', ' low birthweight ', ' low birth weight infant human ', ' low birth weight ', ' Neonatal Intensive Care Units ', ' Newborn Intensive Care Units ', ' Ensure ', ' infancy ', ' infantile ', ' Childhood ', ' pediatric ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Measurement ', ' Drug usage ', ' drug use ', ' Funding ', ' Marihuana ', ' marijuana ', ' Medicine ', ' substance abuse treatment ', ' substance abuse therapy ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Problem behavior ', ' behavioral problem ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Mothers ', ' Nicotine ', ' Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)- ', ' Economic Policy ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Pregnancy ', ' Gestation ', ' Pregnant Women ', ' Prenatal care ', ' Contracts ', ' Contracting Opportunities ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Savings ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' programs ', ' sound ', ' Standardization ', ' Translating ', ' United States ', ' Woman ', ' Work ', ' Techniques ', ' Behavior ', ' Services ', ' Birth Weight ', ' Participant ', ' Prevention program ', ' prevention service ', ' member ', ' offspring ', ' motivational enhancement therapy ', ' motivational interview ', ' Prevention ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Measures ', ' Quality-Adjusted Life Years ', ' Relative (related person) ', ' Relative ', ' Admission activity ', ' Admission ', ' smoking cessation ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' Cost Savings ', ' Health Benefit ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' mathematical model ', ' mathematical modeling ', ' Math Models ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Cognitive Therapy ', ' ']",NIDA,YALE UNIVERSITY,R01,2010,665606,0.026256141220174598
"Linking State Data to Identify Unmet Need for Drug Treatment in Women Aged 15-49    DESCRIPTION (provided by applicant): Drug treatment programs know who they serve, but can only estimate who they do not serve; the inability to accurately measure unmet treatment need, especially among women of reproductive age, is a key barrier to developing interventions to reduce drug-related health consequences for women, their children, and society. This proposal describes an innovative collaboration to link two existing independent state data systems to create a new, unique longitudinal, epidemiologic database that combines drug treatment data with hospital utilization and health outcomes data, to broadly identify drug-related problems and the prevalence of unmet treatment need, and to track drug-related health outcomes among Massachusetts women of reproductive age and their children. For the first time, women in need of drug treatment services who did not receive them will be individually identifiable, allowing for better estimation and description of unmet need. The new linked data will permit assessment of disparities among women with met and unmet treatment need through multiple sources of data, including using a tested algorithm to identify drug diagnoses in hospital data. Moreover, the linked data will allow the examination of subsequent health outcomes among women ages 15-49, and birth outcomes among their children. The two data sources to be linked are: (1) the population-based MA Pregnancy to Early Life Longitudinal (PELL) data system that includes vital records (births, fetal deaths and deaths); hospital discharge, observational stay, and emergency department visit records; and the MA Birth Defects Registry; and (2) the MA Bureau of Substance Abuse Services (BSAS) treatment data system that contains treatment records for over 25,000 annual admissions of women of reproductive age to BSAS-funded substance abuse treatment facilities. The three broad study aims are: 1. Link PELL data to the MDPH-BSAS Treatment Database and verify linkages. 2. Develop and pilot methods a) among all MA women of reproductive age, identify women with drug abuse or dependence (2002-2007), assess unmet need for treatment services, and characterize disparities in treatment use; b) among MA women who had deliveries (2003-2006), describe the pattern of identification and treatment of drug problems in the periods before, during, and after pregnancy, assess unmet need for drug treatment by timing, and characterize pregnancy outcomes; and c) among MA women with an identified drug problem develop preliminary multivariate models with predisposing and enabling factors predicting receipt of treatment, and, among women who delivered, risk for prematurity. 3. Develop an R01 proposal to describe the impact of substance abuse and treatment on women's and children's health, based on bivariate and multivariate analyses proposed for this study and a tandem NIH/NIAAA study.      PUBLIC HEALTH RELEVANCE: This innovative public-private collaboration links two existing independent state data systems (BSAS and PELL) to create a new, unique longitudinal and epidemiologic database that combines drug treatment data with hospital utilization and health outcomes data, to broadly identify drug-related problems and the prevalence of unmet treatment need, and to track drug-related health and birth outcomes among Massachusetts women of reproductive age. For the first time, women in need of drug treatment services who did not receive them will be individually identifiable, allowing for accurate estimation and description of unmet need, a critical step to improve state drug treatment programs for women of reproductive age.           Project Narrative This innovative public-private collaboration links two existing independent state data systems (BSAS and PELL) to create a new, unique longitudinal and epidemiologic database that combines drug treatment data with hospital utilization and health outcomes data, to broadly identify drug-related problems and the prevalence of unmet treatment need, and to track drug-related health and birth outcomes among Massachusetts women of reproductive age. For the first time, women in need of drug treatment services who did not receive them will be individually identifiable, allowing for accurate estimation and description of unmet need, a critical step to improve state drug treatment programs for women of reproductive age.",Linking State Data to Identify Unmet Need for Drug Treatment in Women Aged 15-49,7990765,R21DA027181,"['Data Sources ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Enabling Factors ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data Set ', ' Dataset ', ' Data ', ' Premature Birth ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Characteristics ', ' Fetal Death ', ' fetus death ', ' Age ', ' base ', ' improved ', ' Health ', ' Recording of previous events ', ' History ', ' Hospital Records ', ' Hospitals ', ' Pediatric Hospitals ', "" Children's Hospital "", ' Algorithms ', ' premature ', ' prematurity ', ' Link ', ' Infant ', ' Information Systems ', ' Information Technology Systems ', ' IT Systems ', ' Data Systems ', ' Individual ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Funding ', ' Massachusetts ', ' Maternal Health ', ' substance abuse treatment ', ' substance abuse therapy ', ' Methods ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Mothers ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Collaborations ', ' Pregnancy ', ' Gestation ', ' Pregnancy Outcome ', ' Companions ', ' public health medicine (field) ', ' Public Health ', ' Records ', ' Registries ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Public Health Schools ', ' Societies ', ' Life ', ' programs ', ' Testing ', ' Time ', ' Universities ', ' Woman ', ' Frequencies (time pattern) ', ' Frequency ', ' Dependence ', ' Pattern ', ' Visit ', ' meetings ', ' Services ', ' Needs Assessment ', ' Birth Records ', ' Birth ', ' Parturition ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' hospital utilization ', ' Boston ', ' treatment program ', ' Modality ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' reproductive ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Congenital Abnormality ', ' Molecular Genetic Abnormality ', ' Congenital Malformation ', ' Congenital Deformity ', ' Congenital Defects ', ' Congenital Anatomical Abnormality ', ' Congenital Anatomic Abnormality ', ' Birth Defects ', ' Measures ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child health care ', ' Child Health ', ' Admission activity ', ' Admission ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' alcohol abuse therapy ', ' alcohol treatment ', ' alcohol abuse treatment ', ' time use ', ' Outcome ', ' alcohol related problem ', ' Drug Abuse Treatment Services ', ' Population ', ' Prevalence ', ' aged ', ' administrative database ', ' administrative data base ', ' innovation ', ' innovative ', ' innovate ', ' clinically significant ', ' clinical significance ', ' treatment effect ', ' Early treatment ', ' early therapy ', ' early intervention ', ' public health relevance ', ' population based ', ' public-private partnership ', ' ']",NIDA,BOSTON UNIVERSITY MEDICAL CAMPUS,R21,2010,231563,0.10441650620674646
"Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS    DESCRIPTION (provided by applicant): This application is a revision of an application submitted last year in response to PAR-07-379, ""Behavioral and Social Science Research on Understanding and Reducing Health Disparities."" We will analyze the interconnections between coercive mobility (the massive migration between the criminal justice [CJ] system and the community) produced by US drug policies and race disparities in HIV-related sexual risk among a sample of drug offenders in Connecticut (CT). Further, we will examine whether the association between coercive mobility (CM) and HIV-related sexual risk is affected by the degree of social disorganization in the communities in which these offenders reside. We also will study the feasibility of recruiting and following sexual partners of these individuals to better understand the impacts of CM on partners' HIV-related risk. We hypothesize that CM produces race disparities in HIV risk in a number of distinct ways: 1) Blacks are more likely than Whites to be incarcerated, so HIV-related sexual risk associated with CM can produce race disparities in HIV risk even if the effects of CM are the same for both Blacks and Whites; 2) Blacks are more likely than Whites to reside in communities experiencing the disorganizing impacts of CM, so to the extent that social disorganization exacerbates the effects of CM, it will affect the HIV risks of Blacks to a greater degree than Whites; 3) The sexual partners of Blacks are more likely to come from these same socially disorganized communities, furthering the negative impacts of CM for both returning inmates and their partners, and contributing to race disparities in HIV risk among women; and 4) Blacks are more likely to be penalized by drug policies in ways that increase their movement between prison/jail and the community and their vulnerability to its associated harms. We also hypothesize that we will be able to recruit and retain the sexual partners of study participants and conduct exploratory analyses of the impact of CM on their HIV-related sexual risk. An active Community Advisory Board including policymakers and program administrators will assist us in identifying structural interventions to reduce race disparities in HIV based on study findings. PUBLIC HEALTH RELEVANCE: This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.           Narrative This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.","Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS",7931874,R01DA025021,"['HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Housing ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' In-Migration ', ' Immigrations ', ' Interview ', ' Laws ', ' sexual relationship ', ' Individual ', ' Policies ', ' Movement ', ' body movement ', ' Prisons ', ' Shapes ', ' Public Policy ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Sexual Partners ', ' sex partner ', ' Social Disorganizations ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' programs ', ' Surveys ', ' Survey Instrument ', ' Time ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' Frequencies (time pattern) ', ' Frequency ', ' Awareness ', ' System ', ' LOINC Axis 4 System ', ' contextual factors ', ' Application Context ', ' behavioral/social science ', ' experience ', ' Structure ', ' Participant ', ' disorder prevention ', ' disease prevention ', ' member ', ' offender ', ' criminal offender ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Administrator ', ' Criminal Justice ', ' Sampling ', ' response ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Communities ', ' community reentry ', ' community re-entry ', ' migration ', ' public health relevance ', ' social science research ', ' Connecticut ', ' Data Analyses ', ' Data Analysis ', ' health disparity ', ' health disparities ', ' Institution ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Environment ', ' Address ', ' Jail ', ' Data ', ' Process ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Face ', ' facial ', ' faces ', ' Family ', ' Feasibility Studies ', ' Feedback ', ' Law Enforcement ', ' Affect ', ' base ', ' Recording of previous events ', ' History ', ' ']",NIDA,AMERICAN UNIVERSITY,R01,2010,681282,0.047759867674073975
"Incarceration Effects on Prevention of Drug Use, STI-HIV and Recidivism Incarcerated women are often affected by childhood abuse, violence, and other difficult life circumstances throughout their life course, and typically come from disproportionately disadvantaged neighborhoods. However, relatively less research has examined how neighborhood characteristics and incarceration interact with inmates' risk factors. Although several criminal justice studies demonstrated that excessive incarceration may exacerbate community disadvantages and instability as a large proportion of residents constantly move between jail and community, the impact of neighborhood disadvantages on inmates' health outcomes, such as drug use and sexual risks have not been examined. Furthermore, while the rate of female incarceration has steadily increased over the past 20 years, previous studies predominantly concern with men, and women's unique life trajectories of incarceration, sexual risks, and drug use have been less understood. The study proposes to examine the impact and consequences of incarceration on the patterns of substance use, risky sexual behaviors, and recidivism among female inmates who are returning to the community from a large urban jail. The proposed conceptual model will be tested explaining the ecological factors associated with incarceration, and the impact of incarceration on drug use, STls/HlV risks, and recidivism among female inmates. To achieve the objectives, the proposed study will conduct: 1) qualitative in-depth interviews with women in jail exploring their experience with incarceration, changes in social networks and support, health  concerns, health care and social services utilization, expected challenges upon release, and needs for successful transition to community life; 2) face-to-face longitudinal surveys with a cohort of female inmates at three time points (baseline in jail, and two weeks and three months post-release) to examine primary outcomes (relapse to drug use, risks for STIs/HlV infection, recidivism), secondary outcomes, and mediators (social network, social support); and 3) multi-level analysis and mapping to explore the effects of neighborhood disadvantage and instability, the rates of incarceration and STIs on women's outcomes. Incarcerated women are often from the poor, minority, urban populations who are most affected by drug  abuse and HIV. The rate of female incarceration has dramatically increased in recent years, while the  majority of them return to the community along with their health problems. Findings of the research wilt help  better understand incarcerated women's complex health, socioeconomic issues and community context,  which may contribute to reducing health disparities among women living in disadvantaged neighborhoods.","Incarceration Effects on Prevention of Drug Use, STI-HIV and Recidivism",7925645,R00DA024012,"['drug abuse prevention ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' health disparities ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Disadvantaged ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Educational aspects ', ' Education ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Employment ', ' Social Network ', ' Jail ', ' Data ', ' Social Health Services ', ' Characteristics ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Exhibits ', ' Female ', ' Affect ', ' Goals ', ' improved ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Infection ', ' Interview ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Drug usage ', ' drug use ', ' Maps ', ' men ', "" men's "", ' Methods ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Neighborhoods ', ' Poverty ', ' Prisoner ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Probability ', ' Relapse ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Social support ', ' social support network ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Life ', ' Testing ', ' Time ', ' Urban Population ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' Complex ', ' Pattern ', ' experience ', ' cohort ', ' recidivism ', ' General Population ', ' General Public ', ' offender ', ' criminal offender ', ' Reporting ', ' social ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' segregation ', ' Racial Segregation ', ' Child Abuse ', ' Childhood Abuse ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Healthcare ', ' health care ', ' Longitudinal Surveys ', ' Modeling ', ' Communities ', ' human capital ', ' reincarceration ', ' Minority ', ' community living ', ' Outcome ', ' Alcohol dependence ', ' alcohol-dependent ', ' alcohol dependency ', ' alcohol addiction ', ' service utilization ', ' high risk ', ' primary outcome ', ' secondary outcome ', ' ']",NIDA,UNIVERSITY OF ILLINOIS AT CHICAGO,R00,2010,246507,0.08478374343868396
"Morehouse School of Medicine (M-MIDARP)    DESCRIPTION (provided by applicant): The overall aim of this program is to strengthen and expand the drug abuse and HIV/AIDS prevention research capacity at Morehouse School of Medicine (MSM) by bringing together key academic and community-based programs in the development of an integrated correctional drug abuse and HIV/AIDS prevention research component. This capacity will incorporate training in new research skills and create an aggregation of individual faculty with appropriate community-based agencies as research teams within the criminal justice system. The MSM MIDARP will: 1. Establish opportunities for training and development of drug abuse and HIV/AIDS prevention research interfacing with the Criminal Justice System (CJS) and existing community programs. 2. Construct an integrative culturally competent drug abuse and HIV/AIDS prevention research paradigm which addresses the needs of individuals who have come under the jurisdiction of the criminal justice system by utilizing existing community programs and Evidence-Based Practices. 3. Minimize disparities in community services to reduce recidivism among currently or previously incarcerated individuals. 4. Develop a nexus of organizations among the Georgia Department of Corrections, Georgia Department of Juvenile Justice and community based services that supplements the new research curriculum and faculty service programs, and makes sustainable gains in terms of scholarly publications, effective new service delivery paradigms, and individual client outcomes. 5. Expose young African-American medical students, masters of public health students and undergraduate students to correctional drug abuse and HIV/AIDS prevention community-based research to facilitate their post-graduate career choices. 6.Expand the areas of drug abuse and HIV/AIDS prevention research under investigation at Morehouse School of Medicine to additional indication areas, increase the number of minority physicians and faculty in drug abuse and HIV/AIDS prevention research, and increase the number of supported drug abuse and HIV/AIDS prevention research programs across MSM departments (especially Psychiatry, Family Medicine, Community Health and preventive medicine, and community voices program with its 8 grantees in cities across the country). Our intention is that MSM will be recognized as a local, regional, and national resource and training center for drug abuse and HIV/AIDS prevention for research programs.          ",Morehouse School of Medicine (M-MIDARP),7867842,R24DA021527,"['Educational Curriculum ', ' Curriculum ', ' Public Health Students ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Address ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Evidence based practice ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Master of Public Health ', ' M.P.H. ', ' Master of Science ', ' Research Infrastructure ', ' Infrastructure ', ' Community Health ', ' Development ', ' developmental ', ' Faculty ', ' Family Practice ', ' family medicine ', ' Intention ', ' base ', ' improved ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Intervention Studies ', ' interventions research ', ' intervention research ', ' Training ', ' Justice ', ' Individual ', ' Methods ', ' Physicians ', ' Preventive Medicine ', ' preventative medicine ', ' Psychiatry ', ' Publications ', ' Scientific Publication ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Resources ', ' Research Resources ', ' medical schools ', ' school of medicine ', ' medical college ', ' programs ', ' Students ', ' Medical Students ', ' Voice ', ' Investigation ', ' System ', ' LOINC Axis 4 System ', ' Country ', ' interest ', ' Services ', ' skills ', ' Prevention Research ', ' Community based prevention ', ' recidivism ', ' Career Choice ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Research Methodology ', ' Research Methods ', ' Cities ', ' Client ', ' Clinical Research ', ' Clinical Study ', ' correctional system ', ' Communities ', ' Community Services ', ' design ', ' designing ', ' Minority ', ' Outcome ', ' Population ', ' community based service ', ' ']",NIDA,MOREHOUSE SCHOOL OF MEDICINE,R24,2010,459711,0.12824035441533166
"Trajectories of Drugs Abuse in High Risk Youth    DESCRIPTION (provided by applicant): We propose to extend the Northwestern Juvenile Project to examine the dynamic relationships among patterns of drug use and disorder, risk and protective factors for drug use and disorder, and adult social role performance as juvenile justice youth age from adolescence to emerging adulthood and young adulthood. This study responds to NIDA's new initiatives on drug abuse, health disparities, and disproportionate minority confinement of African Americans. At year-end 2004, nearly 100,000 juveniles and nearly 2.1 million adults were incarcerated. African Americans comprise 12% of the US population but 40% of incarcerated populations. We are studying a racially/ethnically diverse sample (n=1709; 624 females, 1085 males) in Cook County (Chicago) Illinois, aged 10-18 years at recruitment (1995-1998). Youth are reinterviewed whether they are (re)incarcerated or back in the community. Our goal is to focus on gender differences, racial/ethnic disparities, and the effect of incarceration as we: (1) describe patterns of drug use and disorder --onset, persistence, desistence, and recurrence - as juvenile justice youth age from adolescence to emerging and young adulthood; (2) examine how risk and protective factors (e.g., comorbid mental disorders, adverse life events, availability of illicit drugs) predict, moderate, and mediate patterns of drug use and disorders; and (3) examine the dynamic relationships between patterns of drug use and disorder and adult social role performance (e.g., residential independence [including avoiding incarceration], employment, marriage, parenting, desistance from crime and violence). To analyze the longitudinal data, we will use summary statistics (e.g., prevalence rates, odds ratios), generalized linear mixed-effects models, survival analyses, and Muthen's recently developed extensions of growth mixture models. Extending the Northwestern Juvenile Project allows us to leverage the data already collected to examine the role of incarceration in the development of drug use and disorder, especially among African Americans; to identify risk and protective factors that are potentially malleable; to identify points of intervention at key developmental periods; and to extend theoretical models - developed in general population adolescents -- to correctional populations.           ",Trajectories of Drugs Abuse in High Risk Youth,7903981,R01DA019380,"['Employment ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Health system ', ' violence prevention ', ' prevent violence ', ' Ethnic group ', ' Jail ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Request for Applications ', ' NIH RFA ', ' Child Abuse and Neglect ', ' child maltreatment ', ' Childhood maltreatment ', ' Cognitive ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' Characteristics ', ' Process ', ' Development ', ' developmental ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Foundations ', ' Freedom ', ' Liberty ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Pathway interactions ', ' pathway ', ' Affect ', ' Injury ', ' Age ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' improved ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Phase ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Domestic Violence ', ' Illinois ', ' Infection ', ' Injection of therapeutic agent ', ' Injections ', ' Justice ', ' juvenile delinquent ', ' Young offender ', ' Juvenile Offender ', ' Psyche structure ', ' mental ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Life Style ', ' Lifestyle ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' African ', ' Longitudinal Studies ', ' long-term study ', ' satisfaction ', ' Drug usage ', ' drug use ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' male ', ' Marijuana Smoking ', ' marijuana use ', ' Marriage ', ' Medical Records ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Theoretical model ', ' Theoretic Models ', ' Neighborhoods ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' Odds Ratio ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Parents ', ' cooking ', ' public health medicine (field) ', ' Public Health ', ' Public Policy ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Anxiety ', ' Recommendation ', ' Records ', ' Recurrence ', ' Recurrent ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Schools ', ' self esteem ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Social support ', ' social support network ', ' Life ', ' Victimization ', ' sound ', ' statistics ', ' Substance Use Disorder ', ' Survival Analysis ', ' Survival Analyses ', ' Time ', ' Violence ', ' violent behavior ', ' violent ', ' Attitude ', ' Woman ', ' Event ', ' Pattern ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Back ', ' Dorsum ', ' Behavior ', ' Behavior Disorders ', ' behavioral disorder ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Belief ', ' interest ', ' Services ', ' Surgeon ', ' Performance ', ' Self Efficacy ', ' Budgets ', ' Cigarette ', ' Structure ', ' Participant ', ' peer ', ' NIH Program Announcements ', ' Program Announcement ', ' Population Study ', ' Patient Self-Report ', ' Self-Report ', ' deviant ', ' deviancy ', ' disorder risk ', ' disease risk ', ' General Population ', ' General Public ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' County ', ' Gender ', ' Chicago ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Parenting behavior ', ' Parenting ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Modeling ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' theories ', ' functional disability ', ' Functional impairment ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' correctional system ', ' Accounting ', ' Communities ', ' Minority ', ' Outcome ', ' coping ', ' Population ', ' Prevalence ', ' prospective ', ' Trauma ', ' 18 year old ', ' eighteen year old ', ' age 18 years ', ' Affective ', ' racial and ethnic ', ' racial/ethnic ', ' racial and ethnic disparities ', ' high risk ', ' emerging adulthood ', ' Conflict (Psychology) ', ' Conflict ', ' Drops ', ' Crime ', ' Healthy People 2010 ', ' health disparity ', ' health disparities ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Educational Status ', ' training status ', ' training level ', ' training achievement ', ' educational level ', ' Educational Achievement ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2010,597187,0.15806252262844014
"HIV Infection in Ethnic Minority IDUs: An International Systematic Review    DESCRIPTION (provided by applicant): Racial/ethnic group disparities in HIV/AIDS are a critical public health issue in the US. These disparities are particularly dramatic with respect to injecting drug use. African-Americans constitute 13% of the US population and 52% of recent US injecting drug use AIDS cases; Hispanics constitute 14% of the US population and 24% of the injecting drug use AIDS cases. These disparities are not the result of more injecting drug users among African-Americans and Hispanics, but of higher rates of HIV infection among African- American and Hispanic IDUs in many areas of the country. Similar disparities-higher rates of HIV infection among ethnic minority IDUs-have also been observed in many foreign countries. Indeed the situation of ethnic minority IDUs in some developing countries can be considered a crisis, with extremely high incidence, prevalence and HIV-related mortality. Disparities have also been observed among non-injecting drug users, with ethnic minority group members having higher rates of HIV infection. The logical next step for addressing these disparities and this epidemiological conundrum is not another individual study, but a systematic review of the large number of relevant studies that have been conducted to date. Our proposed systematic review will use state-of-the-art methods and include the US and the international data on ethnic group differences in HIV infection among drug users. The specific aims include: Developing procedures for combining qualitative and quantitative data from multiple research studies of IDUs in a single geographic area into a ""history of the HIV epidemic among IDUs"" in that area. Determining the frequency of HIV epidemics in which substantial differences in HIV infection have and have not arisen in ethnic minority IDUs vs. ethnic majority IDUs in the US and internationally. Identifying potential causal factors that may generate substantial differences in HIV prevalence among racial/ethnic minority vs. ethnic majority IDUs. Identifying potential causal factors that may perpetuate or reduce differences in HIV infection among racial/ethnic differences over time. Identifying epidemiologic situations in which differences in HIV risk behaviors do or do not statistically ""explain"" differences in HIV infection among racial/ethnic groups of IDUs. The research will also create an extremely rich dataset on HIV infection among ethnic drug uses that will be made available for use by other researchers and HIV prevention service providers. The research addresses one of the most important aspects of HIV/AIDS-the frequent large disparities in HIV infection among ethnic groups in the US and in many other countries. The research will be an innovative application of state of the art methods for systematic review, including extensive searching for published and unpublished studies, quantitative coding of research reports, and applying meta-regression/hierarchical modeling to these problems.       PUBLIC HEALTH RELEVANCE: Higher rates of HIV infection among African-American and Hispanic IDUs are a major health disparity in the US. African-Americans comprise 13% of the US population and 52% of injection drug use AIDS cases, Hispanics 14% of the populations and 24% of cases. Similar disparities, higher rates of HIV infection among ethnic minority IDUs, have also been observed in many foreign countries. An international systematic review and meta-analysis should greatly advance our understanding of these disparities and suggest how they might be ameliorated.          ",HIV Infection in Ethnic Minority IDUs: An International Systematic Review,7901007,R01DA024612,"['Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Accounting ', ' Communities ', ' sex risk ', ' sexual risk behavior ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' ethnic minority population ', ' ethnic minority ', ' user-friendly ', ' racial and ethnic ', ' racial/ethnic ', ' public health relevance ', ' non-drug ', ' nondrug ', ' Provider ', ' health disparity ', ' health disparities ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Developing Countries ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Developing Nation ', ' Developing Country ', ' Disadvantaged ', ' Discrimination (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data Set ', ' Dataset ', ' Ethnic group ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Data ', ' International ', ' Europe ', ' Sexual Transmission ', ' transmission process ', ' Transmission ', ' Development ', ' developmental ', ' Heterosexuals ', ' Future ', ' Geographic Locations ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' racial/ethnic difference ', ' Procedures ', ' Health Services Needs ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' systematic review ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Site ', ' Area ', ' Incidence ', ' Injection of therapeutic agent ', ' Injections ', ' caucasian American ', ' white American ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Individual ', ' Drug usage ', ' drug use ', ' Methods ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Glare ', ' North America ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Publishing ', ' Recommendation ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Sexual Partners ', ' sex partner ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Arts ', ' Stigmatization ', ' Asia ', ' Time ', ' Australia ', ' Frequencies (time pattern) ', ' Frequency ', ' Pattern ', ' Country ', ' Injecting drug user ', ' Injection Drug User ', ' Services ', ' prevention service ', ' member ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' ethnic difference ', ' Categories ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Code ', ' Coding System ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' ']",NIDA,BETH ISRAEL MEDICAL CTR (NEW YORK),R01,2010,549319,0.06950887935870406
"Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth    DESCRIPTION (provided by applicant): The proposed study's overarching goal is to reduce the ethnic disparities in illicit drug use, cigarette use, and HIV between Hispanic and non-Hispanic youth. This goal will be accomplished by four aims: AIM 1 is to evaluate the effectiveness of Familias Unidas, relative to Community Practice (i.e., standard prevention services), in preventing illicit drug use; AIM 2 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing cigarette use; AIM 3 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing unprotected sexual behavior; and AIM 4 is to assess the extent to which family functioning mediates the effects of the intervention on illicit drug use, cigarette use, and unprotected sexual behavior. Twenty four middle schools with a total sample of 744 Hispanic adolescents from a wide geographic area of Miami-Dade County will be randomized using a block design to one of two conditions: Familias Unidas or Community Practice. The Familias Unidas intervention has been evaluated and found to be efficacious in two separate randomized controlled trials. In the first study (Pantin et al., 2003), Familias Unidas was shown to be efficacious relative to a no intervention control condition in increasing family functioning and reducing behavior problems (Prado et al., 2006), risk factors for youth illicit drug use and unprotected sex. In the second randomized controlled trial (Prado et al., in press), Familias Unidas was found to be efficacious, relative to two attention control conditions, in preventing cigarette use and illicit drug use. Familias Unidas was also found to be efficacious relative to both of the control conditions in preventing/reducing unprotected sexual behavior at last sexual intercourse. Finally, family functioning was found to mediate the effects of intervention condition on the outcomes. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more effective than Community Practice in reducing illicit drug use over time; (H2) Familias Unidas will be more effective than Community Practice in reducing cigarette use over time; and (H3) Familias Unidas will be more effective than Community Practice in reducing unprotected sexual behavior over time. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on illicit drug use will be partially mediated by family functioning; (H2a) the effect of Familias Unidas on cigarette use will be partially mediated by family functioning and (H3a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by family functioning. PUBLIC HEALTH RELEVANCE: The objective of the proposed study is to reduce illicit drug use, cigarette use, and unsafe sexual behavior health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, cigarette use, unprotected sexual behavior, and HIV in Hispanic adolescents.                 The objective of the proposed study is to reduce illicit drug use, cigarette use, and unsafe sexual behavior health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, cigarette use, unprotected sexual behavior, and HIV in Hispanic adolescents.",Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth,7744051,R01DA025192,"['health disparity ', ' health disparities ', ' Effectiveness ', ' prevent ', ' preventing ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Ethnic group ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Clinical Trials Design ', ' trial design ', ' Community Practice ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Development ', ' developmental ', ' Family ', ' Guidelines ', ' Geographic Locations ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Age ', ' Goals ', ' improved ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Family Study ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Training ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Linear Models ', ' Drug usage ', ' drug use ', ' Americas ', ' Manuals ', ' Problem behavior ', ' behavioral problem ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Amphetamines ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Benzeneethanamine, alpha-methyl-, (+-)- ', ' Educational Intervention ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Parents ', ' Staging ', ' public health medicine (field) ', ' Public Health ', ' Publishing ', ' Risk Factors ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Societies ', ' Knowledge ', ' Testing ', ' Time ', ' United States ', ' Attention ', ' Frequencies (time pattern) ', ' Frequency ', ' Dependence ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' Behavior Therapy ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' meetings ', ' middle school ', ' Cigarette ', ' Prevention Research ', ' prevention service ', ' peer ', ' Categories ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' County ', ' Relative (related person) ', ' Relative ', ' parental monitoring ', ' parent monitoring ', ' Parenting behavior ', ' Parenting ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Modeling ', ' Sampling ', ' Youth ', ' Youth 10-21 ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Coitus ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Accounting ', ' Communication ', ' Communities ', ' effectiveness trial ', ' adolescent substance use ', ' youth substance use ', ' design ', ' designing ', ' efficacy trial ', ' Outcome ', ' Adolescent Risk Behavior ', ' Youth Risk Behavior ', ' Population ', ' parental involvement ', ' public health relevance ', ' community setting ', ' effective intervention ', ' primary outcome ', ' intervention effect ', ' substance use prevention ', ' prevent substance use ', ' randomized trial ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2010,849496,0.14666618696440634
"Drug Abuse and Crime Across the Life Course in an African American Population    DESCRIPTION (provided by applicant): African Americans are disproportionately represented in national crime statistics for arrests and incarceration as well as victimization, particularly for drug-related and violent offenses. Their involvement in crime often represents only one component of a well-recognized cluster of negative experiences and circumstances including drug use problems, socioeconomic disadvantage and poor physical and mental health, sometimes evident in childhood. The cost to individuals, families, and society is enormous, yet we know little about the development of these patterns across the life course. Despite these evident disparities, few studies have examined the development of drug use and criminal behaviors over time within African American community populations, especially into mid adulthood. We intend to study the timing and sources of risk over the life span to better understand the disparities in health and social consequences related to criminal justice issues among African Americans. To that end, we request support to analyze existing crime and drug data covering 35 years in the lives of a cohort of first grade, African American children from inner city Chicago. This prospective developmental study (the Woodlawn project) began in 1966-67, with the most recent follow up in 2002-3 at ages 42-43, and interim assessments in adolescence and early adulthood (age 32-33). The study population had high levels of drug use and criminal activity in adulthood. In the proposed project, we will focus on interrelationships of drug abuse and crime, examining predictors and consequences of drug abuse, criminal activity, and involvement with the criminal justice system. Using data from cohort members, mothers, interviewers, and official criminal records, we will identify 1) patterns of drug use and criminal behaviors over the life course; 2) individual and contextual predictors of later drug use, criminal activity/behaviors, and involvement with the criminal justice system; 3) social, economic, and health consequences of drug use, criminal behaviors, and involvement in the criminal justice system. Of particular interest is how drug use in adolescence and early adulthood relates to the risk of being arrested and incarcerated and, conversely, how early arrests and incarceration influence later drug use and criminal behaviors. This information will further our understanding of the etiology and consequences of crime and drug use into mid adulthood, and inform the design of interventions at various stages along the life course.             ",Drug Abuse and Crime Across the Life Course in an African American Population,7755368,R01DA022366,"['Crime ', ' Disadvantaged ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' Address ', ' Data ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Request for Applications ', ' NIH RFA ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Development ', ' developmental ', ' Behavioral ', ' Family ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Pathway interactions ', ' pathway ', ' Affect ', ' Age ', ' base ', ' criminal behavior ', ' Health ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Interviewer ', ' racial discrimination ', ' race discrimination ', ' Childhood ', ' pediatric ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Individual ', ' Longevity ', ' lifespan ', ' life span ', ' Length of Life ', ' Drug usage ', ' drug use ', ' male ', ' men ', "" men's "", ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Mortality Vital Statistics ', ' Mortality ', ' Mothers ', ' Neighborhoods ', ' Personal Satisfaction ', ' well-being ', ' Staging ', ' Records ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Societies ', ' Life ', ' Victimization ', ' statistics ', ' Time ', ' Time Study ', ' Unemployment ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' Complex ', ' Source ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Behavior ', ' interest ', ' first grade ', ' inner city ', ' experience ', ' social integration ', ' cohort ', ' intervention program ', ' member ', ' Population Study ', ' social ', ' Gender ', ' Chicago ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Mediating ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Sampling ', ' Communities ', ' cost ', ' health economics ', ' Social Functioning ', ' design ', ' designing ', ' Outcome ', ' Population ', ' prospective ', ' therapy design ', ' treatment design ', ' intervention design ', ' emerging adult ', ' early adulthood ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R01,2010,475959,0.19747166288874865
"Community Vulnerability and Responses to Drug-User-Related HIV/AIDS    DESCRIPTION (provided by applicant): This is a competing continuation application for the Community Vulnerability and Responses to Drug-User- Related HIV/AIDS study of why large US metropolitan areas vary over time in their vulnerability to HIV/AIDS among drug users and in their responses-i.e., in policies and programs that may affect the epidemic. Drug use and HIV epidemics change over time. In the last funding period, we showed that HIV prevalence in the 96 largest US metropolitan areas declined among injection drug users (IDUs) from 1992 to 2002, and that the population prevalence of IDUs declined in these areas from 1992 to 2000, but then began to rise again. We also showed that metropolitan areas varied in these trajectories, and that a variety of social and policy forces shaped IDU prevalence, racial disparities in IDU prevalence, HIV prevalence among IDUs, racial disparities in AIDS prevalence among IDUs, drug abuse treatment coverage, and syringe exchange access and coverage. Ominously, our recent analyses indicate that the prevalence of IDUs among youth (aged 15 - 29) has begun to rise. Further, as others have shown, HIV has spread widely among NIDUs (non-injecting users of heroin, cocaine, crack, amphetamines or methamphetamine) in some metropolitan areas. These changes are occurring against the backdrop of an economy that has recently shifted from slow to rapid decline, a shift that will lead to great difficulty in maintaining, let alone expanding, services for drug users. Therefore, the Specific Aims of this proposed continuation are: 1. To describe trends, in the 96 largest US metropolitan areas from 1992 - 2012, in (a) critical epidemiologic outcomes (population prevalence of IDUs and NIDUs, and particularly their prevalence among youth; and, among IDUs, HIV prevalence, late-diagnosis HIV cases, and AIDS incidence and mortality) as well as in (b) the implementation of evidence-based drug- related interventions (drug abuse treatment, syringe exchange, HIV counseling and testing) and (c) non- evidence-based drug-related interventions (incarceration and arrests of drug users). 2. To understand how macro-social contexts (e.g., economic changes, social integration, racial residential segregation) and epidemiologic need affect interventions; how interventions and macro-social contexts together affect epidemiologic contexts; how some interventions (e.g., arrests, incarceration) affect others (e.g., syringe exchange coverage); and how some epidemiologic outcomes (e.g., prevalence of young IDUs) affect others (e.g., HIV prevalence). 3. To develop an integrated theory, using agent based modeling, of how these processes interact and thus what the impacts of various intervention mixes are likely to be in given social contexts. 4. To disseminate estimates, results and theoretical understandings to public health agencies and continue to advise them on how they might respond.    PUBLIC HEALTH RELEVANCE: This project will estimate changes in injection and non-injection drug use, in HIV, AIDS and AIDS mortality rates among injection drug users, and in drug- and HIV-related interventions among drug users, in 96 large metropolitan areas over a 21-year period (1992 - 2012). We will investigate how these epidemics and interventions affect one another, and how macro-contextual factors like economic and social conditions shape them both. We will identify metropolitan areas in which serious drug use, HIV or AIDS epidemics are emerging, and offer state and local health departments and drug agencies the best information available on policies and programs that might reduce these epidemics. Our findings will also help national public health agencies, including the CDC and SAMHSA, and other researchers, plan a mixture of evidence-based programs and policies to reduce the forces that lead to high-risk drug use and the associated HIV and AIDS epidemics.           Public Health Relevance Statement This project will estimate changes in injection and non-injection drug use, in HIV, AIDS and AIDS mortality rates among injection drug users, and in drug- and HIV-related interventions among drug users, in 96 large metropolitan areas over a 21-year period (1992 - 2012). We will investigate how these epidemics and interventions affect one another, and how macro-contextual factors like economic and social conditions shape them both. We will identify metropolitan areas in which serious drug use, HIV or AIDS epidemics are emerging, and offer state and local health departments and drug agencies the best information available on policies and programs that might reduce these epidemics. Our findings will also help national public health agencies, including the CDC and SAMHSA, and other researchers, plan a mixture of evidence-based programs and policies to reduce the forces that lead to high-risk drug use and the associated HIV and AIDS epidemics.",Community Vulnerability and Responses to Drug-User-Related HIV/AIDS,7895659,R01DA013336,"['Development ', ' developmental ', ' Fright ', ' Fear ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Future ', ' Affect ', ' Age ', ' base ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seroprevalence ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Phase ', ' Variant ', ' Variation ', ' Medical ', ' racism ', ' Incidence ', ' Injection of therapeutic agent ', ' Injections ', ' Health Insurance ', ' Laws ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' insight ', ' Individual ', ' Longitudinal Studies ', ' long-term study ', ' Populations at Risk ', ' Policies ', ' Drug usage ', ' drug use ', ' Progress Reports ', ' Needle-Exchange Programs ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Funding ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Methods ', ' Mexico ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' Amphetamines ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Benzeneethanamine, alpha-methyl-, (+-)- ', ' Local Government ', ' New York ', ' Political Activities ', ' Politics ', ' Population Characteristics ', ' Population Density ', ' human population density ', ' Shapes ', ' Drug user ', ' public health medicine (field) ', ' Public Health ', ' Punishment ', ' Recruitment Activity ', ' recruit ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Social Change ', ' Social transformation ', ' Social modification ', ' Social Conditions ', ' Societal Conditions ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Policies ', ' Knowledge ', ' Life ', ' Insurance Coverage ', ' Insurance Status ', ' programs ', ' Syringes ', ' Testing ', ' Time ', ' Unemployment ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Distant ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Country ', ' contextual factors ', ' Application Context ', ' Injecting drug user ', ' Injection Drug User ', ' Services ', ' experience ', ' social integration ', ' AIDS diagnosis ', ' metropolitan ', ' Heroin Users ', ' Budgets ', ' Prevention program ', ' social movement ', ' models and simulation ', ' model-based simulation ', ' Categories ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Gender ', ' Measures ', ' segregation ', ' Racial Segregation ', ' Police ', ' Crack Cocaine ', ' free base cocaine ', ' falls ', ' symposium ', ' conference ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Modeling ', ' response ', ' Youth ', ' Youth 10-21 ', ' theories ', ' Cities ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Highly Active Antiretroviral Therapy ', ' highly active anti-retroviral therapy ', ' HAART ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' HIV diagnosis ', ' Cohort Studies ', ' Concurrent Studies ', ' Communities ', ' Foreclosure ', ' Outcome ', ' Population ', ' Prevalence ', ' aged ', ' Evidence based program ', ' racial and ethnic ', ' racial/ethnic ', ' comparative ', ' racial and ethnic disparities ', ' high risk ', ' public health relevance ', ' evidence base ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' cost effectiveness ', ' Counseling ', ' Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Data Analyses ', ' Data Analysis ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Heroin ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Diagnosis ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economic Conditions ', ' Economical Conditions ', ' Economics ', ' Environment ', ' Address ', ' Epidemic ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Caring ', ' Data ', ' Resolution ', ' International AIDS ', ' Monitor ', ' transmission process ', ' Transmission ', ' trend ', ' Process ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R01,2010,645902,0.18893656527139835
"Stress and Drug Use Vulnerability in Rural African Americans    DESCRIPTION (provided by applicant): The impact that drug addictions have on health disparities impacting at-risk African Americans who reside in the rural South are grossly understudied. While there is strong evidence linking drug use and abuse to violent behaviors, injuries, mental health, and physical health problems, it is unclear how African Americans are disproportionately at risk given their relatively low incidence rates of drug use and abuse. There is a growing body of literature linking stress and the subsequent activation of the hypothalamic-pituitary-adrenal (HPA) axis to addictions. Given the considerable heterogeneity within drug-related phenotypes and limited evidence of large-magnitude single gene influences, stress dysregulation will be investigated as an endophenotype for clarifying the more subtle relationship between specific genes and drug use vulnerability. This study will pursue two specific aims using innovative experimental methodologies from drug abuse, molecular genetics, endocrinology, social psychology, and cross-cultural research: (1) Investigate whether genotype interacts with environmental variables (GxE) to affect physiological responses to acute stress; and (2) Investigate whether stress dysregulation predicts drug related attitudes, craving, and history of drug use. Acute stress will be elicited via the Trier Social Stress Test. Subjects (N = 100) will be randomly assigned into one of two speech tasks: (a) shoplifting or (b) experience of discrimination. Measured variables will include genotype (CRH and CRHR1), hormones (cortisol and DHEA), autonomic measures (galvanic skin conductance and heart rate variability), chronic environmental stressors, implicit drug-related cognitions, drug craving, and drug use history. It is envisioned that this proposed study can initiate a multidisciplinary program of research aimed at investigating gene by environment (GxE) influences on drug use vulnerability. Empirical research in this area is needed in order to gain insight into the biopsychosocial risk factors that have the capacity to inform theory, research, prevention, and treatment in the area of drug addictions.      PUBLIC HEALTH RELEVANCE: African American drug use and abuse behaviors are often characterized by oversimplified models that are rooted in research studies that rarely include them. This proposal seeks to take a multidimensional approach (e.g., genetics, endocrinology, psychology, culture, social environment) towards investigating mechanisms that may increase drug use vulnerability in at-risk African American adults who reside in the rural South. Such research is needed in order to inform theory, research, prevention, and intervention efforts aimed at elimination health disparities that disproportionately impact this community.           PROJECT NARRATIVE African American drug use and abuse behaviors are often characterized by oversimplified models that are rooted in research studies that rarely include them. This proposal seeks to take a multidimensional approach (e.g., genetics, endocrinology, psychology, culture, social environment) towards investigating mechanisms that may increase drug use vulnerability in at-risk African American adults who reside in the rural South. Such research is needed in order to inform theory, research, prevention, and intervention efforts aimed at elimination health disparities that disproportionately impact this community.",Stress and Drug Use Vulnerability in Rural African Americans,7924142,R03DA027481,"['Corticotropin-Releasing Hormone ', ' corticotropin releasing hormone ', ' Corticotropin-Releasing Hormone-41 ', ' Corticotropin-Releasing Factor-41 ', ' Corticotropin-Releasing Factor ', ' Corticoliberin ', ' CRF-41 ', ' ACTH-Releasing Factor ', ' Crime ', ' Cessation of life ', ' Death ', ' dehydroepiandrosterone ', ' Therapeutic Dehydroepiandrosterone ', ' Prasterone ', ' Dehydroisoandrosterone ', ' DHEA ', ' Androstenolone ', ' Androst-5-en-17-one, 3-hydroxy-, (3beta)- ', ' 5-Androsten-3-beta-hydroxy-17-one ', ' 3beta-Hydroxyandrost-5-en-17-one ', ' drug abuse prevention ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' health disparities ', ' Discrimination (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' CRH gene ', ' CRH ', ' Endocrinology ', ' Metabolism and Endocrinology ', ' Environment ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Chronic stress ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Exhibits ', ' Behavioral ', ' Feedback ', ' Adrenal Glands ', ' suprarenal gland ', ' Adrenals ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Galvanic Skin Response ', ' skin conductance ', ' Skin Electric Conductance ', ' Psychogalvanic Reflex ', ' Electrodermal Response ', ' Output ', ' Affect ', ' Genes ', ' Genotype ', ' Injury ', ' base ', ' human subject ', ' Heterogeneity ', ' Recording of previous events ', ' History ', ' Hormones ', ' Therapeutic Hormone ', ' Endocrine Gland Secretion ', ' Chemotherapy-Hormones/Steroids ', ' Hydrocortisone ', ' Therapeutic Hydrocortisone ', ' Proctocort ', ' Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)- ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Area ', ' Chronic ', ' Biological ', ' Physiological ', ' Physiologic ', ' Hypothalamic structure ', ' hypothalamic ', ' Hypothalamus ', ' Link ', ' Incidence ', ' Laboratories ', ' Psyche structure ', ' mental ', ' disability ', ' insight ', ' Stimulus ', ' Recovery ', ' Literature ', ' Rural ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Measurement ', ' Drug usage ', ' drug use ', ' Plant Roots ', ' root ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methodology ', ' Method LOINC Axis 6 ', ' Endocrinologist ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Mortality Vital Statistics ', ' Mortality ', ' Neighborhoods ', ' Perception ', ' Periodicity ', ' Rhythmicity ', ' Cyclicity ', ' Phenotype ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Pilot Projects ', ' pilot study ', ' Pituitary Gland ', ' Pituitary Nervous System ', ' Pituitary ', ' Hypophysis Cerebri ', ' Hypophysis ', ' Psychology ', ' Social Psychology ', ' Relapse ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Empirical Research ', ' programs ', ' Speech ', ' Stress ', ' Violence ', ' violent behavior ', ' violent ', ' Attitude ', ' Severities ', ' Complex ', ' Dependence ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' Behavior ', ' physical conditioning ', ' physical health ', ' drug craving ', ' Corticotropin-Releasing Hormone Receptors ', ' Corticotropin Releasing-Factor Receptors ', ' CRH Receptors ', ' CRF Receptors ', ' environmental stressor ', ' experience ', ' hypothalamic-pituitary-adrenal axis ', ' hypothalmus-pituitary-adrenal axis ', ' hypothalamic-pituitary-adrenal (HPA) axis ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' novel ', ' Prevention Research ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Measures ', ' Relative (related person) ', ' Relative ', ' acute stress ', ' Regulation ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Molecular Genetics ', ' Modeling ', ' Sampling ', ' behavioral health ', ' craving ', ' response ', ' theories ', ' Circadian Rhythms ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cognition ', ' Communities ', ' burden of illness ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' design ', ' designing ', ' Violent injury ', ' Violence injury ', ' biopsychosocial ', ' Population ', ' Trier Social Stress Test ', ' Consumption ', ' Individual Differences ', ' innovation ', ' innovative ', ' innovate ', ' multidisciplinary ', ' endophenotype ', ' addiction ', ' addictive disorder ', ' public health relevance ', ' heart rate variability ', ' biological systems ', ' ']",NIDA,UNIVERSITY OF GEORGIA,R03,2010,230636,0.18637856948282527
"Text Messaging Adherence Assessment & Intervention Tool for Rural HIV+ Drug Users    DESCRIPTION (provided by applicant): This is a new application under PAS-10-098, Technology-based Adherence Interventions for Substance Abusing Populations with HIV (R34). New methods to promote HIV treatment adherence are needed for drug users, ethnic minorities, and women, who reside outside major metropolitan areas who have worse health outcomes. Familiar technological devices such as mobile phones could overcome some of the health disparities seen among rural HIV+ patients. In this project, investigators will develop and test the feasibility and promise of a text messaging system that uses Ecological Momentary Assessment (EMA) methods to detect nonadherence and drug use episodes, then immediately intervenes to improve HIV treatment adherence (both medication adherence and treatment engagement) in drug users living with HIV/AIDS. Using formative research with the targeted patients and partnership with a technology developer, we will develop the application and administrative system, Treatment Extension by Text (Text). Text will assess routine adherence, allow users to report critical events, and respond to randomly timed queries about adherence, drug use, and drug craving. When the Text EMA application detects threats to adherence, it will deliver a personalized, tailored intervention text message chosen by the participant. These customized messages will remind the user to take medications on time and reduce drug use. Investigators will pilot test the new adherence tool against treatment as usual over a three month period in a small pilot randomized trial to determine the feasibility, acceptability, and promise of Text. This R34 is a Stage 1b/2a project in the Stage Model of Behavioral Therapy Development in that it will develop novel interventions and methods, and generate preliminary estimates of effect sizes that will determine whether a larger, more expensive clinical trial with a longer follow-up period and evaluation of cost-effectiveness is warranted. By using technology to assess and detect episodes of nonadherence, drug use, and drug craving in real time, the project will deliver an intervention ""on the fly"" in time to help the person resume medication adherence before health damages occur. If successful, Text has the possibility of rapid scale-up for further trials across the rural U.S. to follow.      PUBLIC HEALTH RELEVANCE: This project will develop and pilot test a text messaging system for mobile phones to assess HIV treatment adherence, quickly detect problems as they occur, and send personalized intervention messages to help rural and non-urban drug using patients achieve HIV medication adherence and interrupt drug use. This intervention could be scaled up quickly as a novel, sustainable approach to maintaining treatment adherence. Lessons learned could hasten the development of interventions for other chronic diseases in the U.S.              This project will develop and pilot test a text messaging system for mobile phones to assess HIV treatment adherence, quickly detect problems as they occur, and send personalized intervention messages to help rural and non-urban drug using patients achieve HIV medication adherence and interrupt drug use. This intervention could be scaled up quickly as a novel, sustainable approach to maintaining treatment adherence. Lessons learned could hasten the development of interventions for other chronic diseases in the U.S.            ",Text Messaging Adherence Assessment & Intervention Tool for Rural HIV+ Drug Users,8140731,R34DA031640,"['seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' Treatment Failure ', ' randomized trial ', ' Phone ', ' Telephone ', ' Ethnic group ', ' Rural ', ' usual care ', ' treatment as usual ', ' Consent ', ' Penetration ', ' Evaluation ', ' Health ', ' high risk ', ' Viral Load ', ' Viral Burden ', ' Viral Load result ', ' Methods ', ' Reporting ', ' LOINC Axis 4 System ', ' System ', ' novel ', ' Area ', ' Modeling ', ' Devices ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research ', ' ethnic minority ', ' ethnic minority population ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' tool ', ' Persons ', ' Drug user ', ' base ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Participant ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Time ', ' Pattern ', ' Life ', ' programs ', ' health disparities ', ' health disparity ', ' Woman ', ' Interview ', ' Testing ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Event ', ' drug use ', ' Drug usage ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' improved ', ' developmental ', ' Development ', ' Staging ', ' clinical investigation ', ' Clinical Trials ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Structure ', ' Learning ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Caring ', ' Population ', ' Address ', ' Adoption ', ' Technology ', ' trend ', ' Text ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' Visit ', ' residence ', ' Morbidity ', ' Morbidity - disease rate ', ' scale up ', ' Patients ', ' Fostering ', ' Outcome ', ' Pharmacies ', ' Pharmacy facility ', ' response ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Focus Groups ', ' cost effectiveness ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Adherence ', ' Adherence (attribute) ', ' usability ', ' Program Announcement ', ' NIH Program Announcements ', ' Poverty ', ' Communities ', ' Stigmata ', ' Clinic ', ' Pill ', ' pill (pharmacologic) ', ' drug craving ', ' Dropout ', ' stigma ', ' social stigma ', ' Mobile Phones ', ' Car Phone ', ' medication adherence ', ' medication compliance ', ' metropolitan ', ' treatment adherence ', ' pilot trial ', ' treatment center ', ' Transportation ', ' ']",NIDA,UNIVERSITY OF VIRGINIA,R34,2011,346500,0.11426002001962016
"PS07-003, Minority HIV/AIDS Research Initiative (MARI)    DESCRIPTION (provided by applicant):   The proposed study's overarching goal is to reduce the ethnic disparities in HIV infection between Hispanic and non-Hispanic youth living in Miami-Dade County, an HIV epicenter. This goal will be accomplished by two aims: AIM 1 is to develop and manualize a one-and-a-half- month streamlined version of an efficacious HIV preventive intervention entitled Familias Unidas; and AIM II is to evaluate the efficacy of the streamlined version of Familias Unidas plus an HIV Prevention School CurriculumTreatment as Usual, relative to the HIV Prevention School Curriculum Treatment as Usual only, in preventing drug use and unprotected sexual behavior, two risk factors for HIV infection. Familias Unidas aims to prevent drug use and unprotected sexual behavior by (a) increasing family functioning, (b) increasing parental monitoring of peer activities, and (c) influencing adolescent social cognitive mechanisms regarding drug use and unsafe sexual behavior. A sample of 240 Hispanic 9th grade adolescents and their primary caregivers will be randomized to one of two conditions: Familias Unidas plus the HIV School Curriculum Treatment as Usual (hereafter refererred to as Familias Unidas) or the HIV Prevention School Curriculum Treatment as Usual only. Two studies have demonstrated the efficacy of an intensive, 9 to 12 month version of Familias Unidas. In the first study, Familias Unidas was shown to be efficacious relative to a no- intervention control condition in increasing family functioning. In the second study, Familias Unidas was found to be efficacious in preventing drug use and unsafe sexual behavior relative to two attention control conditions. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more efficacious than the HIV Prevention School Curriculum Treatment as Usual in preventing adolescent drug use over time and (H2) Familias Unidas will be more efficacious than the HIV Prevention School Curriculum Treatment as Usual in preventing adolescent unprotected sexual behavior over time. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on drug use will be partially mediated by (1) family functioning; (2) parental monitoring of peers; and (3) social cognitive mechanisms regarding drug use; and (H2a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by (1) family functioning; (2) parental monitoring of peers; (3) social cognitive mechanisms regarding unprotected sex; and (4) drug use. The objective of the proposed study is to reduce HIV contraction health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of interventions to reduce drug use, unprotected sexual behavior, and HIV in Hispanic adolescents.           ","PS07-003, Minority HIV/AIDS Research Initiative (MARI)",8307267,U01PS000671,[''],NCHHSTP,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,U01,2011,295000,0.10409011619734354
"Developmental Pathways to Substance Use Across European & Asian American Youth    DESCRIPTION (provided by applicant): As one of the fastest growing ethnic minority groups in the United States, alcohol and drug use in American Americans has increasingly been recognized as a public health problem. Emerging research has documented biological, psychosocial, and cultural factors that are associated with alcohol use in Asian American youth adults (Hendershot et al., 2005). However, existing studies have neither adopted a developmental perspective to study the emergence of alcohol use and problems in Asian American during late adolescence, nor have they tested whether prior findings can be generalized to predict drug use and problems. Concurrently, evidence from a separate line of research has suggested that effects of parenting are often different across Asian and European American youth. Numerous studies, for example, have suggested that authoritarian parenting style has beneficial effects in Asian American youth, but detrimental effects in European American youth on outcomes such as academic performance and socio-emotional competence. Subsequent research has indicated that parental constructs such as emotional support and psychological control may also have differential effects across Asian and European American youth (e.g., Chao & Tseng, 2002). Despite these findings, no published study has documented differential effects of parenting on alcohol and drug use across Asian and European American youth. Thus, the overarching goal of this study is to examine moderation effects by ethnicity on the association between parenting and alcohol and drug use outcomes in a longitudinal sample of Asian and European American youth. Specifically, the proposed study will test whether parental emotional support, psychological control and monitoring have differential effects on alcohol and drug use outcomes across Asian and European American youth. Data will be drawn from 97 Asian American and 255 European American youth who participated in the Developmental Pathway Project. Structural equation modeling and factor analysis techniques will be used to test (1) whether parental emotional support, psychological control, and monitoring in 7th grade will differentially predict alcohol and drug use outcomes in 9th and 12th grade across Asian and European American youth; (2) whether developmental pathways from parenting to alcohol and drug use outcomes (via school achievement and peer substance use in 8th grade) are different across Asian and European American youth; and (3) whether the hypothesized moderation effects by ethnicity can be attributed to different interpretation of parenting, as suggested by prior research (e.g., Chao & Aque, 2009). Results from the proposed study can be used to guide the development of culturally sensitive prevention and intervention programs for alcohol and drug use in Asian American youth.      PUBLIC HEALTH RELEVANCE: The proposed project addresses a strategic goal of the National Institute of Drug Abuse (NIDA) on the prevention of alcohol and drug use through understanding risk and protective factors in adolescence, a developmental stage during which substance use increases over time. This project also addresses NIDA's cross-cutting priorities of decreasing health disparity related to drug addiction and training new investigators from a diverse (including minority) background. The ultimate goal of this project is to limit substance use initiation and problematic use through the development of culturally sensitive prevention and intervention programs for Asian American youth.                The proposed project addresses a strategic goal of the National Institute of Drug Abuse (NIDA) on the prevention of alcohol and drug use through understanding risk and protective factors in adolescence, a developmental stage during which substance use increases over time. This project also addresses NIDA's cross-cutting priorities of decreasing health disparity related to drug addiction and training new investigators from a diverse (including minority) background. The ultimate goal of this project is to limit substance use initiation and problematic use through the development of culturally sensitive prevention and intervention programs for Asian American youth.",Developmental Pathways to Substance Use Across European & Asian American Youth,8198736,F31AA020700,"['South Asian ', ' alcohol and other drug ', ' Influentials ', ' root ', ' Plant Roots ', ' ethnic minority ', ' ethnic minority population ', ' adolescent smoking ', ' Asian Americans ', ' Parenting behavior ', ' Parenting ', ' Achievement Attainment ', ' Achievement ', ' Teaching ', ' Educational process of instructing ', ' European ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' psychosocial ', ' Students ', ' parent monitoring ', ' parental monitoring ', ' Adopted ', ' Ethnic group ', ' health disparities ', ' health disparity ', ' Discipline ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Minority ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Child Behavior ', ' college student ', ' university student ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Caucasoid Race ', ' behavioral problem ', ' Problem behavior ', ' Prevention program ', ' Aggression ', ' Aggressive behavior ', ' intervention program ', ' problem drinking ', ' problem alcohol use ', ' hazardous alcohol use ', ' ethanol abuse ', ' alcohol problem ', ' Alcohol abuse ', ' Publishing ', ' prospective ', ' Training ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Emotional ', ' Stress ', ' Chinese ', ' Chinese People ', ' drug use ', ' Drug usage ', ' Parents ', ' skills ', ' young adulthood ', ' adult youth ', ' young adult ', ' Schools ', ' United States ', ' Risk Factors ', ' youth alcohol consumption ', ' underage alcohol use ', ' underage alcohol consumption ', ' under age alcohol use ', ' under age alcohol consumption ', ' teenager alcohol use ', ' teenage drinking ', ' teenage alcohol use ', ' teen drinking ', ' drinking during adolescence ', ' alcohol use during adolescence ', ' alcohol intake among adolescents ', ' alcohol during adolescence ', ' adolescent drinking ', ' adolescent alcohol use ', ' adolescent alcohol consumption ', ' Youth Drinking ', ' underage drinking ', ' Time ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Individual ', ' psychological ', ' psychologic ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Youth 10-21 ', ' Youth ', ' Equation ', ' Life ', ' Modeling ', ' Data ', ' Caucasians ', ' Structure ', ' American ', ' designing ', ' design ', ' Competence ', ' Outcome ', ' Public Health ', ' public health medicine (field) ', ' Biological ', ' Mediating ', ' Sampling ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Monitor ', ' Link ', ' programs ', ' Genetic ', ' Performance ', ' Testing ', ' Population ', ' Address ', ' Risk ', ' Techniques ', ' Reporting ', ' Staging ', ' developmental ', ' Development ', ' peer ', ' Work ', ' Research ', ' Goals ', ' oriental ', ' Asians ', ' social role ', ' Role ', ' pathway ', ' Pathway interactions ', ' alcohol use prevention ', ' deter alcohol use ', ' reduce adolescent alcohol ', ' intimacy ', ' intimate behavior ', ' alcohol metabolism ', ' Ethanol Metabolism ', ' early adolescence ', ' Factor Analyses ', ' Factor Analysis ', ' ']",NIAAA,UNIVERSITY OF WASHINGTON,F31,2011,41800,0.04673628077970282
"Clinical and Social Implications of Cost Sharing for Cancer Drugs    DESCRIPTION (provided by applicant): Dr. Yu-Ning Wong, a Medical Oncologist at Fox Chase Cancer Center is dedicated to a career in cancer health services research. Her goal is to develop a multidisciplinary research program to understand the impact of insurance design on cancer drug utilization and clinical outcomes. This Career Development Award will provide the means to take two important steps towards accomplishing this goal. First, it will allow for additional intensive mentored education and training in public policy research, health economics, and advanced statistical methods that will augment the candidate's previous rigorous training in epidemiology, biostatistics, and clinical medicine. Second, it will support the development of an original clinical research program using rigorous epidemiologic, econometric and survey methods to examine the impact of prescription drug insurance coverage on cancer outcomes. As new costly cancer drugs are introduced, patients with both public and private insurance are facing higher out- of-pocket costs. Cost sharing between insurers and patients (though co-payments and deductibles) has been traditionally used to control costs based on an expectation that unnecessary health care utilization will be reduced. However this expectation may result in worse socioeconomic disparities in care since some patients may be unable to afford highly effective cancer treatments. The candidate proposes three complementary studies to address the important, unanswered questions about the impact of cost sharing on cancer outcomes. Project A is a conjoint analysis-based survey to measure how patients make decisions among treatments of varying efficacy, toxicity and cost. Project B uses the results from Project A in a decision analysis model to measure the sensitivity of clinical outcomes to price and patient preferences. This will also allow us to determine if is possible to improve clinical outcomes by using low cost sharing to increase adherence to high value treatments. Project C is a natural experiment using insurance claims to measure the effect of insurance design and sociodemographic factors on the receipt of a new, expensive anti-nausea medication and subsequent outcomes. This research program will triangulate on the nexus of issues central to the understanding of cost sharing on cancer drug utilization and clinical outcomes and form the foundation for the candidate's transition to an independent investigator in cancer health services research. This project will have broad implications for the financing of high cost medical interventions because it will help policy makers, insurers and physicians understand how current models of cost sharing may contribute to socioeconomic disparities in cancer care. Our results may suggest consideration of a novel benefit design that encourages patients to make decisions based on relative value, rather than cost alone.           ",Clinical and Social Implications of Cost Sharing for Cancer Drugs,8145573,K07CA136995,"['payment ', ' health economics ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Public Policy ', ' cancer care ', ' Treatment Cost ', ' older patient ', ' elderly patient ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Price ', ' pricing ', ' chemotherapy ', ' Surveys ', ' Survey Instrument ', ' Vulnerable Populations ', ' vulnerable group ', ' Antineoplastic Agents ', ' anticancer drug ', ' anticancer agent ', ' Tumor-Specific Treatment Agents ', ' Neoplastic Disease Chemotherapeutic Agents ', ' Cancer Drug ', ' Antineoplastics ', ' Antineoplastic Drugs ', ' Anti-Cancer Agents ', ' Adoption ', ' Probability ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Decision Making ', ' career ', ' Observational Study ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Insurance ', ' Drug Utilization ', ' Nausea ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Antiemetics ', ' Antiemetic Drugs ', ' Antiemetic Agents ', ' Anti-emetics ', ' Policy Research ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Statistical Methods ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' Healthcare Systems ', ' Health Care Systems ', ' Policy Maker ', ' Survey Methodology ', ' Survey Method ', ' Diffusion ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Training and Education ', ' Patient Preferences ', ' Chronically Ill ', ' Research ', ' Healthcare ', ' health care ', ' Patients ', ' United States ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Medical ', ' novel ', ' Individual ', ' base ', ' Elderly ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Affect ', ' expectation ', ' Clinical ', ' programs ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Toxic effect ', ' Toxicities ', ' Measures ', ' Mentors ', ' Goals ', ' Methods ', ' cancer therapy ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' Development ', ' developmental ', ' Modeling ', ' Characteristics ', ' Data ', ' Adherence (attribute) ', ' Adherence ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Relative (related person) ', ' Relative ', ' Cancer Patient ', ' Treatment outcome ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Outcome ', ' Address ', ' Patient Care ', ' Patient Care Delivery ', ' Physicians ', ' design ', ' designing ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Clinical Research ', ' Clinical Study ', ' Foundations ', ' Risk ', ' cost ', ' improved ', ' Caring ', ' Principal Investigator ', ' innovation ', ' innovative ', ' innovate ', ' Clinical Medicine ', ' Clinical Medical Sciences ', ' Training ', ' Fox Chase Cancer Center ', ' Cost Control ', ' Cost Containment ', ' Insurance Coverage ', ' Insurance Status ', ' aprepitant ', ' social implication ', ' Natural experiment ', ' Insurance Carriers ', ' Insurers ', ' Deductibles ', ' Drug Insurance ', ' Uninsured Medical Expense ', ' total medical expenditure ', ' medical expenses not covered by insurance ', ' Uninsured Medical Fees (not covered) ', ' Uncovered Uninsured Medical Expense ', ' Uncovered Medical Expenses ', ' Out-of-Pocket Expense ', ' Decision Analysis ', ' Decision Analyses ', ' Underinsured ', ' Cost Sharing ', ' Supportive care ', ' Supportive Therapy ', ' Medical Oncologist ', ' ']",NCI,FOX CHASE CANCER CENTER,K07,2011,144018,0.027485458307407232
"Community Vulnerability and Responses to Drug-User-Related HIV/AIDS    DESCRIPTION (provided by applicant): This is a competing continuation application for the Community Vulnerability and Responses to Drug-User- Related HIV/AIDS study of why large US metropolitan areas vary over time in their vulnerability to HIV/AIDS among drug users and in their responses-i.e., in policies and programs that may affect the epidemic. Drug use and HIV epidemics change over time. In the last funding period, we showed that HIV prevalence in the 96 largest US metropolitan areas declined among injection drug users (IDUs) from 1992 to 2002, and that the population prevalence of IDUs declined in these areas from 1992 to 2000, but then began to rise again. We also showed that metropolitan areas varied in these trajectories, and that a variety of social and policy forces shaped IDU prevalence, racial disparities in IDU prevalence, HIV prevalence among IDUs, racial disparities in AIDS prevalence among IDUs, drug abuse treatment coverage, and syringe exchange access and coverage. Ominously, our recent analyses indicate that the prevalence of IDUs among youth (aged 15 - 29) has begun to rise. Further, as others have shown, HIV has spread widely among NIDUs (non-injecting users of heroin, cocaine, crack, amphetamines or methamphetamine) in some metropolitan areas. These changes are occurring against the backdrop of an economy that has recently shifted from slow to rapid decline, a shift that will lead to great difficulty in maintaining, let alone expanding, services for drug users. Therefore, the Specific Aims of this proposed continuation are: 1. To describe trends, in the 96 largest US metropolitan areas from 1992 - 2012, in (a) critical epidemiologic outcomes (population prevalence of IDUs and NIDUs, and particularly their prevalence among youth; and, among IDUs, HIV prevalence, late-diagnosis HIV cases, and AIDS incidence and mortality) as well as in (b) the implementation of evidence-based drug- related interventions (drug abuse treatment, syringe exchange, HIV counseling and testing) and (c) non- evidence-based drug-related interventions (incarceration and arrests of drug users). 2. To understand how macro-social contexts (e.g., economic changes, social integration, racial residential segregation) and epidemiologic need affect interventions; how interventions and macro-social contexts together affect epidemiologic contexts; how some interventions (e.g., arrests, incarceration) affect others (e.g., syringe exchange coverage); and how some epidemiologic outcomes (e.g., prevalence of young IDUs) affect others (e.g., HIV prevalence). 3. To develop an integrated theory, using agent based modeling, of how these processes interact and thus what the impacts of various intervention mixes are likely to be in given social contexts. 4. To disseminate estimates, results and theoretical understandings to public health agencies and continue to advise them on how they might respond.    PUBLIC HEALTH RELEVANCE: This project will estimate changes in injection and non-injection drug use, in HIV, AIDS and AIDS mortality rates among injection drug users, and in drug- and HIV-related interventions among drug users, in 96 large metropolitan areas over a 21-year period (1992 - 2012). We will investigate how these epidemics and interventions affect one another, and how macro-contextual factors like economic and social conditions shape them both. We will identify metropolitan areas in which serious drug use, HIV or AIDS epidemics are emerging, and offer state and local health departments and drug agencies the best information available on policies and programs that might reduce these epidemics. Our findings will also help national public health agencies, including the CDC and SAMHSA, and other researchers, plan a mixture of evidence-based programs and policies to reduce the forces that lead to high-risk drug use and the associated HIV and AIDS epidemics.          Public Health Relevance Statement  This project will estimate changes in injection and non-injection drug use, in HIV, AIDS and AIDS mortality  rates among injection drug users, and in drug- and HIV-related interventions among drug users, in 96 large  metropolitan areas over a 21-year period (1992 - 2012). We will investigate how these epidemics and  interventions affect one another, and how macro-contextual factors like economic and social conditions shape  them both. We will identify metropolitan areas in which serious drug use, HIV or AIDS epidemics are emerging,  and offer state and local health departments and drug agencies the best information available on policies and  programs that might reduce these epidemics. Our findings will also help national public health agencies,  including the CDC and SAMHSA, and other researchers, plan a mixture of evidence-based programs and  policies to reduce the forces that lead to high-risk drug use and the associated HIV and AIDS epidemics.",Community Vulnerability and Responses to Drug-User-Related HIV/AIDS,8045484,R01DA013336,"['Age ', ' experience ', ' Pattern ', ' comparative ', ' Environment ', ' Variant ', ' Variation ', ' Life ', ' Affect ', ' Medical ', ' Funding ', ' Individual ', ' System ', ' LOINC Axis 4 System ', ' Communities ', ' Time ', ' insight ', ' Knowledge ', ' Populations at Risk ', ' high risk ', ' Testing ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' racial and ethnic disparities ', ' Social Policies ', ' Social Conditions ', ' Societal Conditions ', ' Evidence based program ', ' contextual factors ', ' Application Context ', ' Punishment ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS diagnosis ', ' social movement ', ' Unemployment ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Foreclosure ', ' models and simulation ', ' model-based simulation ', ' Health Insurance ', ' racial/ethnic difference ', ' Syringes ', ' Heroin ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Injecting drug user ', ' Injection Drug User ', ' metropolitan ', ' racial and ethnic ', ' racial/ethnic ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Political Activities ', ' Politics ', ' racism ', ' Insurance Coverage ', ' Insurance Status ', ' HIV diagnosis ', ' Highly Active Antiretroviral Therapy ', ' highly active anti-retroviral therapy ', ' HAART ', ' Police ', ' Local Government ', ' Amphetamines ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Benzeneethanamine, alpha-methyl-, (+-)- ', ' Heroin Users ', ' Population Characteristics ', ' social integration ', ' Needle-Exchange Programs ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Counseling ', ' Cities ', ' Prevention ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Recruitment Activity ', ' recruit ', ' Budgets ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' transmission process ', ' Transmission ', ' Mexico ', ' Country ', ' Measures ', ' Drug usage ', ' drug use ', ' Monitor ', ' Resources ', ' Research Resources ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Diagnosis ', ' Address ', ' Progress Reports ', ' Caring ', ' New York ', ' theories ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Youth ', ' Youth 10-21 ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Data Analyses ', ' Data Analysis ', ' Shapes ', ' Injection of therapeutic agent ', ' Injections ', ' Longitudinal Studies ', ' long-term study ', ' Health ', ' Cohort Studies ', ' Concurrent Studies ', ' Categories ', ' falls ', ' Epidemic ', ' Population ', ' Research Design ', ' study design ', ' Study Type ', ' Distant ', ' public health relevance ', ' Resolution ', ' programs ', ' Outcome ', ' Mortality Vital Statistics ', ' Mortality ', ' Data ', ' Economics ', ' Incidence ', ' aged ', ' Research ', ' Methods ', ' Learning ', ' Prevalence ', ' Morbidity - disease rate ', ' Morbidity ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Services ', ' social ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Area ', ' evidence base ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Risk ', ' Modeling ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' public health medicine (field) ', ' Public Health ', ' Development ', ' developmental ', ' Phase ', ' Future ', ' response ', ' Process ', ' Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' base ', ' Gender ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' Crack Cocaine ', ' free base cocaine ', ' Prevention program ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Social Change ', ' Social transformation ', ' Social modification ', ' HIV Seroprevalence ', ' segregation ', ' Racial Segregation ', ' Laws ', ' Economic Conditions ', ' Economical Conditions ', ' Population Density ', ' human population density ', ' International AIDS ', ' trend ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Policies ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Fright ', ' Fear ', ' cost effectiveness ', ' Drug user ', ' symposium ', ' conference ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R01,2011,635039,0.18893656527139835
"The Logics for HIV Risk among Street-Based Heroin Injectors    DESCRIPTION (provided by applicant): We propose to develop a theoretically and ethnographically informed model of ""HIV risk environment"" for public health intervention by identifying the key structural forces, institutional processes, and socio-cultural constraints that shape HIV behaviors among inner-city street-based drug users. We will examine the social processes that drive the logics for HIV transmission behaviors among street-based injection drug users (IDUs) in two cities, Philadelphia and San Francisco, that span a strategic range of the demographic, economic, political, and cultural factors affecting inner-city poverty in the United States. Building on long-term, continuous participant-observation ethnographic fieldwork in the shooting encampments of ethnically and generationally bounded social networks of heroin injectors and crack smokers in San Francisco as well as pilot research in Philadelphia at open-air drug markets and shooting galleries, we will document patterns of: 1) law enforcement and criminal justice; 2) poverty and income generating opportunities (including legal and illegal labor markets and public subsidies); 3) illegal drug markets and polydrug availability; 4) racialized ethnic boundaries and conflicts; 5) gender/sexuality boundaries that delimit social networks; 6) oppositional sub-cultural identities that trap IDUs into counterproductive relationships with the services that are meant to help or contain them; 7) violence and insecurity; 8) access to clinical care, public health prevention messages, and social services; 9) access to ecological and basic survival needs infrastructures including transportation systems, food, and shelter from inclement weather. An experienced ethnographic team in both cities will collect data on individual-level HIV risk behaviors at fieldsites that we have successfully maintained on the parent grant for more than 12 years in San Francisco and recently established in Philadelphia (core N of each network=15-20 at any given time, peripheral N=10-15 in each fieldsite; 2 sites in Philadephia and 2 in San Francisco). The project will administer a set of procedures for cross-methodological collaboration with epidemiologists who are the Principal Investigators on long-term, large quantitative data sets documenting street-based drug users in both cities. This will enable us to examine the representativity of our ethnographic data on individual street-based drug users and to explore the generalizability of our analysis of the larger social structural processes that promote or constrain risky injection and sexual practices. It will also bring one of the largest and oldest NIDA-funded data sets on IDUs in San Francisco, an exceptionally high-tech, wealthy, culturally diverse, and liberal city into an illustrative contrast and dialogue with another large NIDA-supported quantitative data set of street-based drug users in the city of Philadelphia, one of the nation's poorest deindustrialized metropolises, with a declining population of largely native-born white, Latino (primarily Puerto Rican) and African American ethnic groups.      PUBLIC HEALTH RELEVANCE: Untangling the complex web of factors that render inner city poverty environments exceptionally risky for HIV infection and addiction will help public health outreach workers and clinicians develop more innovative structural and targeted interventions to reach larger numbers of low income high-risk populations with more effective and convincing messages. Upstream interventions that alter neighborhood-level risk environments can cost-effectively encourage drug users to change their behaviors for pragmatic reasons without necessarily requiring a conscious or willful choice. Our findings will also identify strategic institutions and programs that often operate at cross purposes or fail to coordinate with public health HIV risk reduction priorities (including law enforcement, criminal justice, employment training, public housing, food kitchens, shelters, schools, and churches) but which represent productive sites for multi-service HIV prevention interventions.           Relevance: Untangling the complex web of factors that render inner city poverty environments exceptionally risky for HIV infection and addiction will help public health outreach workers and clinicians develop more innovative structural and targeted interventions to reach larger numbers of low income high-risk populations with more effective and convincing messages. Upstream interventions that alter neighborhood-level risk environments can cost-effectively encourage drug users to change their behaviors for pragmatic reasons without necessarily requiring a conscious or willful choice. Our findings will also identify strategic institutions and programs that often operate at cross purposes or fail to coordinate with public health HIV risk reduction priorities (including law enforcement, criminal justice, employment training, public housing, food kitchens, shelters, schools, and churches) but which represent productive sites for multi-service HIV prevention interventions.",The Logics for HIV Risk among Street-Based Heroin Injectors,8016034,R01DA010164,"['socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Drug Compounding ', ' Drug Preparation ', ' Income ', ' Economical Income ', ' Economic Income ', ' Law Enforcement ', ' Social Network ', ' Violence ', ' violent behavior ', ' violent ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Logic ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' clinical care ', ' Agreement ', ' Poverty ', ' Church ', ' remediation ', ' Ethnic group ', ' Epidemiologist ', ' Air ', ' Conscious ', ' Consciousness ', ' Cultural Anthropology ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Public Housing ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' parent grant ', ' Smoker ', ' Logistics ', ' Unemployment ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Legal ', ' analytical tool ', ' Latino ', ' Low income ', ' Sexuality ', ' Risk Reduction ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' Heroin ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Injecting drug user ', ' Injection Drug User ', ' Philadelphia ', ' Child Abuse ', ' Childhood Abuse ', ' Gender ', ' inner city ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Marketing ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Awareness ', ' Environment and Public Health ', ' Clinical Services ', ' drug market ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Transportation ', ' United States Public Health Service ', ' USPHS ', ' Public Health Service ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Decision Making ', ' Shelter facility ', ' shelter-housing ', ' shelter ', ' Face ', ' facial ', ' faces ', ' outreach ', ' Neighborhoods ', ' social inequality ', ' addiction ', ' addictive disorder ', ' Drug usage ', ' drug use ', ' transmission process ', ' Transmission ', ' Data Set ', ' Dataset ', ' Cities ', ' Peripheral ', ' Literature ', ' Employment ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Shapes ', ' Puerto Rican ', ' Medicine ', ' public health relevance ', ' interest ', ' Research Infrastructure ', ' Infrastructure ', ' Health ', ' Modeling ', ' cost ', ' skills ', ' Institution ', ' Social Sciences ', ' Time ', ' experience ', ' Data ', ' Resources ', ' Research Resources ', ' Behavioral ', ' Economics ', ' Individual ', ' Pattern ', ' Training ', ' Complex ', ' System ', ' LOINC Axis 4 System ', ' Environment ', ' Site ', ' Participant ', ' design ', ' designing ', ' base ', ' Prevention ', ' Principal Investigator ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Age ', ' Conflict (Psychology) ', ' Conflict ', ' Behavior ', ' Laboratories ', ' Methods ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Regulation ', ' Funding ', ' Economic Conditions ', ' Economical Conditions ', ' Knowledge ', ' Services ', ' Research ', ' Investigation ', ' Population ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Native-Born ', ' Native People ', ' Indigenous Population ', ' Schools ', ' Policies ', ' Affect ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Location ', ' innovation ', ' innovative ', ' innovate ', ' Ethnography ', ' ethnographic ', ' Weather ', ' theories ', ' high risk ', ' social ', ' Attention ', ' programs ', ' Process ', ' Injection of therapeutic agent ', ' Injections ', ' public health medicine (field) ', ' Public Health ', ' United States ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Data Collection ', ' Risk ', ' Link ', ' prevent ', ' preventing ', ' Source ', ' sex ', ' Collaborations ', ' Procedures ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' San Francisco ', ' Socialization ', ' Distal ', ' preference ', ' cost effective ', ' cost-effective ', ' Criminal Justice ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Food ', ' Drug user ', ' Consensus ', ' ']",NIDA,UNIVERSITY OF PENNSYLVANIA,R01,2011,399785,0.08096065609070376
"Factors for enhanced neurotoxicity in methamphetamine abuse in HIV infection    DESCRIPTION (provided by applicant): This application is submitted in response to PAR-09-011 Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) requested by the National Institute on Drug Abuse (NIDA). This proposed research program is timely since it focuses on two ofthe major health disparity issues in Hawaii, namely, methamphetamine abuse and HIV infection. Recent surveys indicate that Native Hawaiians or other Pacific islanders have the highest rate of methamphetamine use among persons aged 12 or older in the United States. Although HIV/AIDS infection rate is relatively low in Hawaii compared to other major metropolis, the rates are increasing among Hawaiians. This DIDARP will include two primary and one pilot research projects that will focus on mechanisms and factors that might enhance neurotoxicity associated with methamphetamine of HIV. We aim to enhance the capacity for drug abuse research at UH by creating this small translational research team. This group will take advantage and build on the expertise of the few but outstanding existing clinical drug abuse and HIV researchers and basic scientists. We aim to enable UH to develop a strong clinical and translational drug abuse research program. To complement these projects, we additionally propose training and career development activities that wil offer exciting opportunities for DIDARP investigators and others at UH through the Administrative and Training Core. The Faculty in the Core will provide guidance and mentorship for these junior faculty and graduate students, through infrastructure support, educational courses, seminars, and a dedicated DIDARP website, We have obtained institutional support for two additional graduate students for the program. We also have recruited 4 distinguished External Advisory Committee members with expertise related to the proposed research; each has enthusiastically agreed to provide their advice and letter of support for the development of this DIDARP at UH. PUBLIC HEALTH RELEVANCE (See instructions); The current proposal attempts to strengthen drug abuse and HIV research capacity by developing translational research teams at the University of Hawaii, and to train junior investigators and students in drug abuse and HIV research.          ",Factors for enhanced neurotoxicity in methamphetamine abuse in HIV infection,8036077,R24DA027318,"['Mood Disorders ', ' Affective Disorders ', ' Trans-Activation (Genetics) ', ' Transactivation ', ' Quantitative Reverse Transcriptase PCR ', ' qRTPCR ', ' Quantitative RTPCR ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' developmental disease/disorder ', ' developmental disorder ', ' non-drug ', ' nondrug ', ' DNA Nucleotidylexotransferase ', ' Terminal Deoxyribonucleotidyltransferase ', ' Terminal Deoxyribonucleotidyl Transferase ', ' Terminal Deoxynucleotidyltransferase ', ' Terminal Deoxynucleotidyl Transferase ', ' Terminal Addition Enzyme ', ' EC 2.7.7.31 ', ' Desoxynucleotidyltransferase ', ' Desoxynucleotidyl Transferase ', ' Deoxynucleotidyltransferase ', ' Deoxynucleotidyl Transferase ', ' Native Hawaiian or Other Pacific Islander ', ' enhancing factor ', ' methamphetamine abuse ', ' Guanine ', ' 2-amino-1,7-dihydro-6H-purin-6-one ', ' 2-Amino-6-Hydroxypurine ', ' neurotoxicity ', ' neuronal toxicity ', ' neuron toxicity ', ' neuronal survival ', ' Micronutrients ', ' Heavy Metals ', ' Needles ', ' AIDS neuropathy ', ' neuroAIDS ', ' Carrier Proteins ', ' Transporter Protein ', ' Transport Proteins ', ' dopamine transporter ', ' dopamine transporter proteins ', ' DAT dopamine transporter ', ' Neurotoxins ', ' neurotoxicant ', ' Hawaii ', ' Hypoxanthines ', ' selenoprotein ', ' reuptake ', ' Committee Members ', ' Neuronal Injury ', ' neuron injury ', ' Long-Term Potentiation ', ' monoamine ', ' Antidotes ', ' Theriacs ', ' intraperitoneal ', ' selenium deficiency ', ' selenophosphate synthetase ', ' Selenocysteine ', ' 3-selenyl-L-alanine ', ' 3-Selenylalanine ', ' Peroxonitrite ', ' peroxynitrite ', ' Selenium ', ' Se element ', ' Glucosephosphate Dehydrogenase ', ' Glucose-6-Phosphate Dehydrogenase ', ' EC 1.1.1.49 ', ' dopamine toxicity ', ' Instruction ', ' Research ', ' Clinical ', ' selenoenzyme ', ' response ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' health disparity ', ' health disparities ', ' Population ', ' Genetic ', ' Training ', ' Property ', ' LOINC Axis 2 Property ', ' Iodide Peroxidase ', ' Tyrosine Iodinase ', ' Thyroperoxidase ', ' Thyroid Peroxidase ', ' Monoiodotyrosine Deiodinase ', ' Monodeiodinase ', ' Iodotyrosine Deiodinase ', ' Iodotyrosine Deiodase ', ' Iodoperoxidase (Heme Type) ', ' Iodinase ', ' EC 1.11.1.8 ', ' Deiodinase ', "" 5'-Deiodinase "", ' graduate student ', ' Toxic effect ', ' Toxicities ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' programs ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Equilibrium ', ' balance function ', ' balance ', ' prevent ', ' preventing ', ' Proteins ', ' gene product ', ' Role ', ' social role ', ' Brain Diseases ', ' Intracranial Central Nervous System Disorders ', ' Intracranial CNS Disorders ', ' Encephalon Diseases ', ' Brain Disorders ', ' Impaired cognition ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' insight ', ' Predisposition ', ' Susceptibility ', ' Institution ', ' Infection ', ' Movement ', ' body movement ', ' Animals ', ' Dietary Selenium ', ' Life ', ' United States ', ' Universities ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Development ', ' developmental ', ' Cells ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Health ', ' Knock-out ', ' Knockout ', ' Learning ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Memory ', ' member ', ' Complement ', ' Complement Proteins ', ' Hawaiian population ', ' Hawaiian ', ' System ', ' LOINC Axis 4 System ', ' Family ', ' Glutathione ', ' gamma-L-Glutamyl-L-Cysteinylglycine ', ' gamma-L-Glu-L-Cys-Gly ', ' Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)- ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Hydrogen Peroxide ', ' Hydroperoxide ', ' Hydrogen Peroxide (H2O2) ', ' H2O2 ', ' glutathione peroxidase ', ' methamphetamine exposure ', ' meth exposure ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' web site ', ' website ', ' Oxidation-Reduction ', ' oxidation reduction reaction ', ' Redox ', ' Cell model ', ' Cellular model ', ' Nitric Oxide ', ' endothelial cell derived relaxing factor ', ' Nitrogen Protoxide ', ' Nitrogen Monoxide ', ' Mononitrogen Monoxide ', ' Endothelium-Derived Nitric Oxide ', ' Endogenous Nitrate Vasodilator ', ' career development ', ' Advisory Committees ', ' Task Forces ', ' Rodent Model ', ' Letters ', ' Oxidative Stress ', ' Dopamine ', ' Hydroxytyramine ', ' 4-(2-Aminoethyl)-1,2-benzenediol ', ' 3,4-Dihydroxyphenethylamine ', ' thioredoxin reductase ', ' Oxidants ', ' electron acceptor ', ' Oxidizing Agents ', ' Malnutrition ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Persons ', ' Supplementation ', ' Viral ', ' Antioxidants ', ' anti-oxidant ', ' small hairpin RNA ', ' short hairpin RNA ', ' shRNA ', ' Neuraxis ', ' Central Nervous System ', ' CNS Nervous System ', ' Reverse Transcriptase Polymerase Chain Reaction ', ' reverse transcriptase PCR ', ' RTPCR ', ' RT-PCR ', ' Intake ', ' Excitatory Postsynaptic Potentials ', ' EPSP ', ' Faculty ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Students ', ' Amino Acids ', ' aminoacid ', ' Knockout Mice ', ' Null Mouse ', ' Knock-out Mice ', ' Virus Diseases ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Abbreviations ', ' Brain region ', ' Mentorship ', ' aged ', ' Translational Research ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Surveys ', ' Survey Instrument ', ' dopaminergic neuron ', ' Dopamine neuron ', ' DA Neuron ', ' Organ ', ' Label ', ' neuroprotection ', ' Research Infrastructure ', ' Infrastructure ', ' Recruitment Activity ', ' recruit ', ' nervous system disorder ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' Scientist ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' ']",NIDA,UNIVERSITY OF HAWAII AT MANOA,R24,2011,458325,0.13516613646182707
"Morehouse School of Medicine (M-MIDARP)    DESCRIPTION (provided by applicant): The overall aim of this program is to strengthen and expand the drug abuse and HIV/AIDS prevention research capacity at Morehouse School of Medicine (MSM) by bringing together key academic and community-based programs in the development of an integrated correctional drug abuse and HIV/AIDS prevention research component. This capacity will incorporate training in new research skills and create an aggregation of individual faculty with appropriate community-based agencies as research teams within the criminal justice system. The MSM MIDARP will: 1. Establish opportunities for training and development of drug abuse and HIV/AIDS prevention research interfacing with the Criminal Justice System (CJS) and existing community programs. 2. Construct an integrative culturally competent drug abuse and HIV/AIDS prevention research paradigm which addresses the needs of individuals who have come under the jurisdiction of the criminal justice system by utilizing existing community programs and Evidence-Based Practices. 3. Minimize disparities in community services to reduce recidivism among currently or previously incarcerated individuals. 4. Develop a nexus of organizations among the Georgia Department of Corrections, Georgia Department of Juvenile Justice and community based services that supplements the new research curriculum and faculty service programs, and makes sustainable gains in terms of scholarly publications, effective new service delivery paradigms, and individual client outcomes. 5. Expose young African-American medical students, masters of public health students and undergraduate students to correctional drug abuse and HIV/AIDS prevention community-based research to facilitate their post-graduate career choices. 6.Expand the areas of drug abuse and HIV/AIDS prevention research under investigation at Morehouse School of Medicine to additional indication areas, increase the number of minority physicians and faculty in drug abuse and HIV/AIDS prevention research, and increase the number of supported drug abuse and HIV/AIDS prevention research programs across MSM departments (especially Psychiatry, Family Medicine, Community Health and preventive medicine, and community voices program with its 8 grantees in cities across the country). Our intention is that MSM will be recognized as a local, regional, and national resource and training center for drug abuse and HIV/AIDS prevention for research programs.          ",Morehouse School of Medicine (M-MIDARP),8073490,R24DA021527,"['Client ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Intervention Studies ', ' interventions research ', ' intervention research ', ' Students ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Minority ', ' Faculty ', ' skills ', ' Community Health ', ' Justice ', ' Country ', ' Investigation ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Individual ', ' Address ', ' base ', ' Psychiatry ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Publications ', ' Scientific Publication ', ' Training ', ' Educational Curriculum ', ' Curriculum ', ' Population ', ' Development ', ' developmental ', ' Area ', ' Research Infrastructure ', ' Infrastructure ', ' interest ', ' programs ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Physicians ', ' System ', ' LOINC Axis 4 System ', ' improved ', ' Prevention ', ' Services ', ' medical schools ', ' school of medicine ', ' medical college ', ' Resources ', ' Research Resources ', ' Clinical Research ', ' Clinical Study ', ' design ', ' designing ', ' Methods ', ' Outcome ', ' Communities ', ' Research ', ' Medical Students ', ' Master of Science ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' recidivism ', ' Evidence based practice ', ' Master of Public Health ', ' M.P.H. ', ' community based service ', ' Family Practice ', ' family medicine ', ' Public Health Students ', ' Preventive Medicine ', ' preventative medicine ', ' Community Services ', ' correctional system ', ' Career Choice ', ' Cities ', ' Community based prevention ', ' Intention ', ' Prevention Research ', ' Voice ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Criminal Justice ', ' ']",NIDA,MOREHOUSE SCHOOL OF MEDICINE,R24,2011,524576,0.12824035441533166
"Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS    DESCRIPTION (provided by applicant): This application is a revision of an application submitted last year in response to PAR-07-379, ""Behavioral and Social Science Research on Understanding and Reducing Health Disparities."" We will analyze the interconnections between coercive mobility (the massive migration between the criminal justice [CJ] system and the community) produced by US drug policies and race disparities in HIV-related sexual risk among a sample of drug offenders in Connecticut (CT). Further, we will examine whether the association between coercive mobility (CM) and HIV-related sexual risk is affected by the degree of social disorganization in the communities in which these offenders reside. We also will study the feasibility of recruiting and following sexual partners of these individuals to better understand the impacts of CM on partners' HIV-related risk. We hypothesize that CM produces race disparities in HIV risk in a number of distinct ways: 1) Blacks are more likely than Whites to be incarcerated, so HIV-related sexual risk associated with CM can produce race disparities in HIV risk even if the effects of CM are the same for both Blacks and Whites; 2) Blacks are more likely than Whites to reside in communities experiencing the disorganizing impacts of CM, so to the extent that social disorganization exacerbates the effects of CM, it will affect the HIV risks of Blacks to a greater degree than Whites; 3) The sexual partners of Blacks are more likely to come from these same socially disorganized communities, furthering the negative impacts of CM for both returning inmates and their partners, and contributing to race disparities in HIV risk among women; and 4) Blacks are more likely to be penalized by drug policies in ways that increase their movement between prison/jail and the community and their vulnerability to its associated harms. We also hypothesize that we will be able to recruit and retain the sexual partners of study participants and conduct exploratory analyses of the impact of CM on their HIV-related sexual risk. An active Community Advisory Board including policymakers and program administrators will assist us in identifying structural interventions to reduce race disparities in HIV based on study findings. PUBLIC HEALTH RELEVANCE: This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.           Narrative This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.","Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS",8266958,R01DA025021,"['Law Enforcement ', ' behavioral/social science ', ' community reentry ', ' community re-entry ', ' offender ', ' criminal offender ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Administrator ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Sexual Partners ', ' sex partner ', ' Shapes ', ' Face ', ' facial ', ' faces ', ' social science research ', ' Interview ', ' Criminal Justice ', ' Public Policy ', ' contextual factors ', ' Application Context ', ' Prisons ', ' In-Migration ', ' Immigrations ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Feasibility Studies ', ' Jail ', ' Policies ', ' Surveys ', ' Survey Instrument ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' Affect ', ' social ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' health disparity ', ' health disparities ', ' Structure ', ' Woman ', ' Data ', ' Institution ', ' theories ', ' Sampling ', ' disorder prevention ', ' disease prevention ', ' Laws ', ' Recording of previous events ', ' History ', ' Housing ', ' migration ', ' System ', ' LOINC Axis 4 System ', ' Family ', ' programs ', ' base ', ' Recruitment Activity ', ' recruit ', ' Address ', ' Communities ', ' Data Analyses ', ' Data Analysis ', ' member ', ' Participant ', ' Awareness ', ' Individual ', ' Frequencies (time pattern) ', ' Frequency ', ' Movement ', ' body movement ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Feedback ', ' Risk ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Health ', ' Area ', ' Process ', ' experience ', ' Time ', ' response ', ' Environment ', ' Research ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' sexual relationship ', ' Social Disorganizations ', ' Connecticut ', ' ']",NIDA,AMERICAN UNIVERSITY,R01,2011,27097,0.047759867674073975
"Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth    DESCRIPTION (provided by applicant): The proposed study's overarching goal is to reduce the ethnic disparities in illicit drug use, cigarette use, and HIV between Hispanic and non-Hispanic youth. This goal will be accomplished by four aims: AIM 1 is to evaluate the effectiveness of Familias Unidas, relative to Community Practice (i.e., standard prevention services), in preventing illicit drug use; AIM 2 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing cigarette use; AIM 3 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing unprotected sexual behavior; and AIM 4 is to assess the extent to which family functioning mediates the effects of the intervention on illicit drug use, cigarette use, and unprotected sexual behavior. Twenty four middle schools with a total sample of 744 Hispanic adolescents from a wide geographic area of Miami-Dade County will be randomized using a block design to one of two conditions: Familias Unidas or Community Practice. The Familias Unidas intervention has been evaluated and found to be efficacious in two separate randomized controlled trials. In the first study (Pantin et al., 2003), Familias Unidas was shown to be efficacious relative to a no intervention control condition in increasing family functioning and reducing behavior problems (Prado et al., 2006), risk factors for youth illicit drug use and unprotected sex. In the second randomized controlled trial (Prado et al., in press), Familias Unidas was found to be efficacious, relative to two attention control conditions, in preventing cigarette use and illicit drug use. Familias Unidas was also found to be efficacious relative to both of the control conditions in preventing/reducing unprotected sexual behavior at last sexual intercourse. Finally, family functioning was found to mediate the effects of intervention condition on the outcomes. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more effective than Community Practice in reducing illicit drug use over time; (H2) Familias Unidas will be more effective than Community Practice in reducing cigarette use over time; and (H3) Familias Unidas will be more effective than Community Practice in reducing unprotected sexual behavior over time. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on illicit drug use will be partially mediated by family functioning; (H2a) the effect of Familias Unidas on cigarette use will be partially mediated by family functioning and (H3a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by family functioning. PUBLIC HEALTH RELEVANCE: The objective of the proposed study is to reduce illicit drug use, cigarette use, and unsafe sexual behavior health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, cigarette use, unprotected sexual behavior, and HIV in Hispanic adolescents.                 The objective of the proposed study is to reduce illicit drug use, cigarette use, and unsafe sexual behavior health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, cigarette use, unprotected sexual behavior, and HIV in Hispanic adolescents.",Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth,8016037,R01DA025192,"['Americas ', ' Community Practice ', ' community setting ', ' Problem behavior ', ' behavioral problem ', ' Ethnic group ', ' primary outcome ', ' Substance Addiction ', ' Substance Dependence ', ' efficacy trial ', ' Parents ', ' health disparity ', ' health disparities ', ' Adolescent Risk Behavior ', ' Youth Risk Behavior ', ' Clinical Trials Design ', ' trial design ', ' peer ', ' Linear Models ', ' parental monitoring ', ' parent monitoring ', ' effectiveness trial ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' parental involvement ', ' adolescent substance use ', ' youth substance use ', ' substance use prevention ', ' prevent substance use ', ' County ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Societies ', ' Coitus ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' effective intervention ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Amphetamines ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Benzeneethanamine, alpha-methyl-, (+-)- ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Drug usage ', ' drug use ', ' Illicit Drugs ', ' Prevention Research ', ' Guidelines ', ' Communication ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' intervention effect ', ' Geographic Locations ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Behavior Therapy ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Health ', ' Modeling ', ' Time ', ' Communities ', ' Reporting ', ' Relative (related person) ', ' Relative ', ' Goals ', ' meetings ', ' Training ', ' improved ', ' Family ', ' Parenting behavior ', ' Parenting ', ' design ', ' designing ', ' System ', ' LOINC Axis 4 System ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Age ', ' Behavior ', ' Development ', ' developmental ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Outcome ', ' Knowledge ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' randomized trial ', ' Effectiveness ', ' Testing ', ' Categories ', ' Publishing ', ' Population ', ' Accounting ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Youth ', ' Youth 10-21 ', ' Cigarette ', ' Staging ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Educational Intervention ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Frequencies (time pattern) ', ' Frequency ', ' Risk Factors ', ' Sampling ', ' Attention ', ' Mediating ', ' public health medicine (field) ', ' Public Health ', ' United States ', ' prevent ', ' preventing ', ' Family Study ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' prevention service ', ' Manuals ', ' caucasian American ', ' white American ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' middle school ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2011,779584,0.14666618696440634
"Navigator Enhanced Case Management for Jail Inmates    DESCRIPTION (provided by applicant): Each year, there are over 600 unduplicated HIV-infected persons incarcerated in the San Francisco jail and almost two-thirds released with HIV-focused discharge planning were reincarcerated within 1 year. More than half of HIV-infected jail inmates are diagnosed with mental health conditions severe enough to require medication and a similar proportion report substance abuse disorders at the time of detention. While some community-based services exist, there remains a critical need exists to improve linkages to care and adherence to care plans for HIV-infected adults as they move between community and jai. An effective service delivery model used in similar high-needs populations exists, but has not been tested with HIV-infected drug users leaving jails - Navigator case management. Base on harm reduction, motivational interviewing and general social work principles, this model uses assertive community treatment and a highly proactive approach to facilitate adherence to a comprehensive care plan designed to address a client's multiple needs. Case managers work with paraprofessional peer navigators to help clients make better use of available resources, more effectively communicate with providers, sustain care over time and successfully connect with multiple service provider sectors. In this study, we propose to tailor this approach to meet the needs of HIV-infected individuals with substance abuse and mental health issues, pilot test the intervention and assessment procedures and then conduct a randomized study in which 360 HIV-infected men and women leaving jail. Specifically, participants will receive either Navigator case management delivered by the non-profit San Francisco Pre-Trial Diversion project or the standard of care currently provided to transitioning inmates, 90- days of as-needed case management provided by the San Francisco Department of Public Health's Forensic AIDS Project. We will test the effectiveness of the intervention in reducing sexual and drug-related HIV transmission risk, increasing HIV medication adherence, reducing drug dependence and reducing reincarceration. Finally, we will characterize both the Navigator and Forensic AIDS Project intervention processes and conduct exploratory analyses of the mediators of HIV transmission risk and risk reduction and HIV-related adherence among HIV+ individuals leaving jail. Our study is highly innovative because no interventions exist that are proven effective with this population - HIV-infected individuals with drug use and mental health issues. This study will also contribute to the field of HIV prevention by incorporating risk reduction counseling alongside more traditional case management support services. PUBLIC HEALTH RELEVANCE: HIV-infected adults incarcerated in the United States criminal justice system are predominantly active drug users and disproportionately people of color. The complex interplay of poverty, race, lack of education and sanctions--rather than treatment--for addictions reinforces returns to the criminal justice system and pervasive health disparities for HIV-infected individuals. Underlying behaviors that lead to repeated incarceration closely correlate with behaviors that are associated with HIV transmission and increased morbidity and mortality from HIV. In drug addicted adults, recidivism is driven by drug relapse and illegal activities associated with drug use, failure to engage and remain in mental health treatment or failure to break free from social instability in the form of homelessness and joblessness. This study proposes to assess whether a method of case management proven effective for similar populations can ensuring services to successfully and permanently break the cycle of incarceration, drug abuse and HIV transmission risk behavior among HIV-infected individuals leaving jail.              NARRATIVE HIV-infected adults incarcerated in the United States criminal justice system are predominantly active drug users and disproportionately people of color. The complex interplay of poverty, race, lack of education and sanctions--rather than treatment--for addictions reinforces returns to the criminal justice system and pervasive health disparities for HIV-infected individuals. Underlying behaviors that lead to repeated incarceration closely correlate with behaviors that are associated with HIV transmission and increased morbidity and mortality from HIV. In drug addicted adults, recidivism is driven by drug relapse and illegal activities associated with drug use, failure to engage and remain in mental health treatment or failure to break free from social instability in the form of homelessness and joblessness. This study proposes to assess whether a method of case management proven effective for similar populations can ensuring services to successfully and permanently break the cycle of incarceration, drug abuse and HIV transmission risk behavior among HIV-infected individuals leaving jail.",Navigator Enhanced Case Management for Jail Inmates,8084217,R01DA027209,"['Effectiveness of Interventions ', ' Harm Reduction ', ' Harm Minimization ', ' Client ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Risk Reduction ', ' standard of care ', ' Housing ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Address ', ' base ', ' Ensure ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Health ', ' men ', "" men's "", ' Methods ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' medication compliance ', ' medication adherence ', ' transmission process ', ' Transmission ', ' United States ', ' Woman ', ' Persons ', ' Diagnosis ', ' design ', ' designing ', ' Left ', ' Behavior ', ' Work ', ' Time ', ' Participant ', ' Risk ', ' Procedures ', ' Communities ', ' Process ', ' Societies ', ' Complex ', ' programs ', ' improved ', ' Testing ', ' cost ', ' Drug usage ', ' drug use ', ' Medical ', ' Failure (biologic function) ', ' failure ', ' FLR ', ' Color ', ' System ', ' LOINC Axis 4 System ', ' Disease ', ' disease/disorder ', ' Disorder ', ' public health relevance ', ' Individual ', ' Mortality Vital Statistics ', ' Mortality ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' public health medicine (field) ', ' Public Health ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' addiction ', ' addictive disorder ', ' Provider ', ' health disparity ', ' health disparities ', ' Viral ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Counseling ', ' Relapse ', ' treatment adherence ', ' County ', ' social ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Educational aspects ', ' Education ', ' peer ', ' Morbidity - disease rate ', ' Morbidity ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Services ', ' Adherence (attribute) ', ' Adherence ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Caring ', ' Reporting ', ' Population ', ' meetings ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' innovation ', ' innovative ', ' innovate ', ' efficacy testing ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Resources ', ' Research Resources ', ' Modeling ', ' Unemployment ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Prisoner ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Forensic Medicine ', ' Forensics ', ' high risk behavior ', ' Case Manager ', ' Case Management Nurse ', ' Care Manager ', ' recidivism ', ' Jail ', ' community based service ', ' drug addict ', ' drug relapse ', ' Prisons ', ' Homelessness ', ' unhoused ', ' homeless ', ' Poverty ', ' Case Management ', ' Vent ', ' Comprehensive Health Care ', ' comprehensive care ', ' Comprehensive Healthcare ', ' San Francisco ', ' reincarceration ', ' motivational enhancement therapy ', ' motivational interview ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Criminal Justice ', ' Drug user ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2011,473656,0.12698386697695813
"Research Training in the Prevention of Drug Abuse & AIDS in Communities of Color    DESCRIPTION (provided by applicant): This revised application for a MIDARP program at Howard University describes a mentoring program in drug abuse research and AIDS prevention in communities of color, which is designed to increase the capacity of faculty and students at Howard to conduct rigorous and competitive research in the prevention of drug abuse and HIV/AIDS in communities of color. The program will emphasize training in transdisciplinary research on relationships between environmental stress, biological responses, risk behaviors and health outcomes and will utilize collaborations with senior investigators in research intensive universities to mentor Howard faculty investigators. The MIDARP will also work closely with existing programs that link Howard faculty and students to research training opportunities to (1) increase knowledge and interest in drug abuse and AIDS prevention research among faculty and students in these programs and (2) utilize the resources of these programs to expand the range of training opportunities available to MIDARP investigators and students. Howard students will be introduced to drug abuse and AIDS prevention research and career development by augmenting existing drug abuse courses in the College of Arts and Sciences and the curriculum for medical, basic science, nursing, and pharmacy students to include information on drug abuse and AIDS prevention research. They will also fund a pre-doctoral dissertation stipend and recruit students to serve as research assistants in the MIDARP pilot studies. The unique strengths of the program include the opportunity to (1) integrate education regarding drug abuse and AIDS prevention research into existing research training programs for faculty and students;(2) train individuals in diverse disciplines such as the health professions and sciences (i.e., medicine, basic sciences, pharmacy, nursing) who are less likely to pursue research careers in drug abuse and AIDS prevention research; and (3) support transdisciplinary research in drug use and AIDS prevention based on strong existing university research programs in genetics, physiology, and psychobiology. A transdisciplinary approach will be reflected in the MIDARP leadership that includes a Director who is a behavioral scientist specializing in research on environmental stress, drug use, and AIDS risk in communities of color and a Deputy Director who is an immunogeneticist with expertise in microbiology, and founding Director of the Human Genome Project at Howard University.          ",Research Training in the Prevention of Drug Abuse & AIDS in Communities of Color,8112567,R24DA021470,"['Nursing Students ', ' Pupil Nurses ', ' lectures ', ' Arts ', ' Authorization documentation ', ' Permission ', ' Authorization ', ' Prevention Research ', ' Psychology ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Color ', ' Behavioral Sciences ', ' Psychiatry ', ' Historically Black Colleges and Universities ', ' Historically Black University ', ' Historically Black Institution ', ' Historically Black Colleges ', ' HBCUs ', ' Violence ', ' violent behavior ', ' violent ', ' Training Activity ', ' Behavioral Research ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Training and Infrastructure ', ' Research Training ', ' Achievement ', ' Achievement Attainment ', ' Mentorship ', ' Recommendation ', ' Medical Students ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' role model ', ' Blood Pressure ', ' Leadership ', ' college ', ' collegiate ', ' graduate student ', ' Discipline of Nursing ', ' Nursing Profession ', ' Nursing Field ', ' Nursing ', ' Drug usage ', ' drug use ', ' Discipline ', ' stressor ', ' pre-doctoral ', ' predoctoral ', ' predoc ', ' pre-doc ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' health disparity ', ' health disparities ', ' Educational process of instructing ', ' Teaching ', ' Medicine ', ' cohort ', ' response ', ' Monitor ', ' medical schools ', ' school of medicine ', ' medical college ', ' Techniques ', ' Measurement ', ' Mentors ', ' Communities ', ' Physiology ', ' Microbiology ', ' Training ', ' Training Programs ', ' Risk ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Goals ', ' Research Infrastructure ', ' Infrastructure ', ' Environment ', ' Students ', ' Recruitment Activity ', ' recruit ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Equilibrium ', ' balance function ', ' balance ', ' programs ', ' Collaborations ', ' Population ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Foundations ', ' Physiological ', ' Physiologic ', ' American ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Publications ', ' Scientific Publication ', ' Funding ', ' Knowledge ', ' Biological ', ' Advisory Committees ', ' Task Forces ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Clinical Research ', ' Clinical Study ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Individual ', ' experience ', ' base ', ' professor ', ' Science ', ' Educational aspects ', ' Education ', ' Link ', ' Address ', ' Methods ', ' Pilot Projects ', ' pilot study ', ' Services ', ' Work ', ' Communication ', ' Area ', ' Pharmacology ', ' biological adaptation to stress ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' Stress ', ' Faculty ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Exposure to ', ' Educational Curriculum ', ' Curriculum ', ' Consultations ', ' Award ', ' success ', ' design ', ' designing ', ' Genetic ', ' interest ', ' Health ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Scientist ', ' Medical ', ' Evaluation ', ' Participant ', ' Writing ', ' Time ', ' Development ', ' developmental ', ' Outcome ', ' Surveys ', ' Survey Instrument ', ' Prevention ', ' career development ', ' Basic Science ', ' Basic Research ', ' Schools ', ' Ensure ', ' Educational workshop ', ' Workshop ', ' Pharmacy Students ', ' career ', ' meetings ', ' Grant ', ' Behavioral ', ' Research ', ' member ', ' Resources ', ' Research Resources ', ' Universities ', ' Interview ', ' skills ', ' Development Plans ', ' Senior Scientist ', ' sociology/anthropology ', ' drug abuse prevention ', ' drug use prevention ', ' drug addiction prevention ', ' Allied Health Sciences ', ' psychobiology ', ' biopsychology ', ' biological basis of behavior ', ' Ally ', ' Health Occupations ', ' health science profession ', ' Health Professions ', ' heart rate variability ', ' Human Genome Project ', ' Pharmacy facility ', ' Pharmacies ', ' Social Sciences ', ' Electronic Mail ', ' Email ', ' E-Mail ', ' Sociology ', ' Pamphlets ', ' Brochures ', ' Booklets ', ' ']",NIDA,HOWARD UNIVERSITY,R24,2011,657344,0.15242078635463338
"Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users    DESCRIPTION (provided by applicant): This is a second revision of a competitive renewal R01 proposal of the NEURO-HIV Epidemiologic Study in response to NIDA PAS-07-115 (Non-injection Dug Abuse and HIV/AIDS). The primary study aim is to evaluate the ability of Integrated Family and Cognitive-Behavioral Therapy-HIV Prevention Intervention (IFCBT-HIVPI) to prevent HIV among adult non-injection and injection drug users. Over a 12 week intervention interval, the IFCBT-HIVPI model coordinates the delivery of cognitive- behavioral components during 12 group sessions with a couples and family systems component during 4 couples/family sessions to address HIV risk and protective factors across multiple ecological systems. IFCBT-HIVPI main effects on primary (HIV sexual risk behaviors and HIV drug taking risk behaviors) and secondary (HIV, Chlamydia, gonorrhea, and trichomoniasis incidences and legal involvement, academic achievement, and employment) outcome domains will be evaluated. We also seek to elucidate the degree to which the development of attitudinal and behavior change skills targeted by IFCBT-HIVPI (e.g., rational beliefs, problem solving skill, adaptive couples' communication) result in post-intervention reductions of HIV, sexually transmitted infections (STIs), and HIV risk behaviors. The possibility of effect-modification is also considered with a focus on route of drug administration status (i.e., non-injector/injector), neuropsychological (e.g., executive function), and demographic (i.e., African American/white) factors. The proposed study will randomly assign 360 HIV-negative non-injection and injection drug users recruited from the original NEURO-HIV Epidemiologic Study sample to experimental (IFCBT-HIVPI) and comparison (Brief Psychoeducation Curriculum on HIV Prevention; BPEC-HIV) conditions. The composition of the original NEURO-HIV Epidemiologic Study sample provides the basis to stratify the randomized trial sample across gender and two race/ethnicity (i.e., African American and white) groups by route of drug administration status. An assessment battery comprised of a standardized interview on HIV risk behavior, neuropsychological tests, tools to assess attitudes and behavior change skills targeted by IFCBT-HIVPI, drug and STI urine testing, and serologic tests of HIV will be administered before, during, and after the intervention interval across 18-month post-intervention follow-up. Additional preliminary analyses will be conducted on the randomized trial data to: (1) derive session-by-session measures on mechanisms of change targeted by IFCBT-HIVPI via videotape coding methods; (2) characterize mechanisms of change trajectories that may then be evaluated as plausible intervention moderators if present; and (3) estimate intervention cost-effectiveness. The lack of research on science-based prevention interventions for HIV continues to be a serious gap in the literature with recent HIV trends highlighting significant health disparities, particularly among African American non-injection drug users. If successful, the proposed project should help to identify specific attitudinal and behavior change skills targeted by cognitive- behavioral and couples/family systems interventions that foster subsequent reductions in HIV, STIs and HIV risk behaviors among adult drug users at heightened disease risk. PUBLIC HEALTH RELEVANCE: Recent estimates suggest that a majority of the 40,000 new cases of HIV reported annually in the US are attributable largely to sexual risk behavior associated with non-injection drug use. Additionally, African American drug users exhibit substantial HIV health disparities with African American females being 21 times more likely to contract HIV than white females. The proposed project is designed to address critical gaps in the HIV prevention science field by evaluating the ability of an intervention coordinating cognitive-behavioral and couples/family systems components to prevent HIV among adult drug users at heightened disease risk.           PROJECT NARRATIVE. Recent estimates suggest that a majority of the 40,000 new cases of HIV reported annually in the US are attributable largely to sexual risk behavior associated with non-injection drug use. Additionally, African American drug users exhibit substantial HIV health disparities with African American females being 21 times more likely to contract HIV than white females. The proposed project is designed to address critical gaps in the HIV prevention science field by evaluating the ability of an intervention coordinating cognitive-behavioral and couples/family systems components to prevent HIV among adult drug users at heightened disease risk.",Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users,8267262,R01DA014498,"['Selection Bias ', ' Gonorrhea ', ' Gonococcal Infection ', ' Outcome Assessment (Health Care) ', ' Outcomes Assessment ', ' Demographic Factors ', ' Serologic tests ', ' serology ', ' Serological Tests ', ' executive function ', ' executive control ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Gender ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' intervention effect ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' group intervention ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Videotape ', ' sex risk ', ' sexual risk behavior ', ' trend ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' randomized trial ', ' HIV prevention trial ', ' Drug usage ', ' drug use ', ' Injection of therapeutic agent ', ' Injections ', ' Attitude ', ' cost effectiveness ', ' Client ', ' Interview ', ' Academic achievement ', ' Drug user ', ' Ecosystem ', ' Ecological Systems ', ' Ecologic Systems ', ' Injecting drug user ', ' Injection Drug User ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' neuropsychological ', ' Couples ', ' Employment ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Cognitive Therapy ', ' cognitive behavioral treatment ', ' cognitive behavioral therapy ', ' cognitive behavioral modification ', ' cognitive behavioral intervention ', ' cognitive behavior therapy ', ' cognitive behavior modification ', ' cognitive behavior intervention ', ' Cognitive Psychotherapy ', ' Cognition Therapy ', ' Legal ', ' post intervention ', ' Urine ', ' Urine Urinary System ', ' Belief ', ' Problem Solving ', ' Pathway interactions ', ' pathway ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' health disparity ', ' health disparities ', ' disorder risk ', ' disease risk ', ' Mediating ', ' Data ', ' Fostering ', ' Sampling ', ' Reporting ', ' Incidence ', ' behavior change ', ' prevent ', ' preventing ', ' Female ', ' Testing ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' System ', ' LOINC Axis 4 System ', ' Characteristics ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Family ', ' base ', ' Neuropsychological Tests ', ' Neuropsychologic Tests ', ' Contracts ', ' Contracting Opportunities ', ' Prevention ', ' Recruitment Activity ', ' recruit ', ' Address ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Exhibits ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Cognitive ', ' Data Set ', ' Dataset ', ' Modification ', ' skills ', ' Modeling ', ' Educational Curriculum ', ' Curriculum ', ' Measures ', ' tool ', ' Development ', ' developmental ', ' Behavioral ', ' Literature ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Code ', ' Coding System ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' innovation ', ' innovative ', ' innovate ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Risk ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Health ', ' design ', ' designing ', ' Science ', ' Time ', ' response ', ' Outcome ', ' interest ', ' Research ', ' Methods ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' psychoeducation ', ' Communication ', ' Trichomonas Infections ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Process Assessment (Health Care) ', ' Process Assessment ', ' Drug Administration Routes ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R01,2011,30024,0.1494038709691358
"Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth    DESCRIPTION (provided by applicant):  The overriding purpose of this study is to develop and test an intervention for reducing substance use and risky sexual behaviors among youth involved in juvenile drug court. Juvenile drug court provides an excellent setting in which to pursue the key study objectives by providing access to a well identified high risk population. Second, in addition to frequent judicial oversight, juvenile drug courts include several features that can enhance intervention effectiveness, sustainability, and potential for adoption. In addition, the fact that all juvenile drug courts have community-based treatment components and that such courts have been disseminated nationwide suggests the possibility of eventual widespread adoption if the proposed intervention is effective. The proposed intervention integrates evidence-based protocols for contingency management (CM) for substance abusing youth and family engagement strategies, with an evidence-informed family systems intervention for sexual risk originally developed to address substance use and sexual risk behaviors in HIV+ youth. These three interventions will be integrated into an efficient intervention that, if effective, can be amenable to adoption by juvenile drug courts. Following protocol development and beta testing, 160 drug court youth and their families will be randomized to the experimental intervention condition (HIV Risk Reduction or ""HRR"") versus Drug Court with Community Services (DC) conditions. Key outcomes will be assessed through 12-months post-baseline using a multi-method approach that will include assessment of substance use, risky sexual behaviors, criminal behavior, and participation in HIV counseling and testing services. Specific aims include: 1: Adapt existing intervention and training protocols into a single, efficient HRR intervention, beta test this HHR protocol with four youth in juvenile drug court and their families, and revise treatment and research protocols accordingly; 2: Conduct a randomized trial with 160 youth in juvenile drug court and their families to examine youth-level intervention effects (i.e., on substance use, sexual risk behavior, HIV counseling and testing, delinquent behavior) in comparison to DC through 12- months post referral and assess intervention fidelity. 3. If results suggest a positive HRR treatment effect, revise the intervention and training protocols in preparation for an effectiveness study and extended follow-up study. Importantly, the proposed study will (1) consider the multiple levels of influence on juvenile drug use, criminal justice involvement, and HIV risk behaviors, (2) integrate a drug abuse and HIV prevention intervention for youth in the criminal justice system with drug-related offenses, (3) address health disparities by targeting a primarily minority population of youth, and (4) increase referrals to HIV testing and counseling of drug court-involved youth. This study is designed to reduce HIV risk by addressing the potent interaction of drug use and risky sexual behaviors in drug court youth with evidence-based treatment components to maximize the likelihood of reversing these youths' adverse behavioral trajectories.      PUBLIC HEALTH RELEVANCE: The proposed study is designed to gain knowledge about effective interventions for reducing HIV risk in a high risk population. Reducing HIV risk by effectively targeting substance use and risky sexual behaviors and by locating even a small number of HIV-positive youth could favorably impact society at multiple levels (individual, family, peer, community, fiscal).           PROJECT NARRATIVE The proposed study is designed to gain knowledge about effective interventions for reducing HIV risk in a high risk population. Reducing HIV risk by effectively targeting substance use and risky sexual behaviors and by locating even a small number of HIV-positive youth could favorably impact society at multiple levels (individual, family, peer, community, fiscal).",Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth,8329847,R01DA025880,"['community based treatment ', ' juvenile delinquent ', ' Young offender ', ' Juvenile Offender ', ' contingency management ', ' offender ', ' criminal offender ', ' Evidence based practice ', ' adolescent substance abuse ', ' youth substance abuse ', ' Cost Effectiveness Analysis ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effective analysis ', ' Cost Effective Analyses ', ' peer ', ' treatment effect ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Adoption ', ' intervention effect ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' sex risk ', ' sexual risk behavior ', ' Counseling ', ' Youth ', ' Youth 10-21 ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' randomized trial ', ' court ', ' United States Public Health Service ', ' USPHS ', ' Public Health Service ', ' Criminal Justice ', ' Effectiveness of Interventions ', ' Evidence based treatment ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' active method ', ' active treatment ', ' active technique ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug usage ', ' drug use ', ' Societies ', ' Protocols documentation ', ' Protocol ', ' Label ', ' Institution ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Behavior ', ' high risk ', ' design ', ' designing ', ' effective intervention ', ' critical period ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Measures ', ' Educational Intervention ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' evidence base ', ' Community Services ', ' Clinical Trials ', ' clinical investigation ', ' protocol development ', ' Minority ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' disorder prevention ', ' disease prevention ', ' Adopted ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Risk Reduction ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' base ', ' health disparity ', ' health disparities ', ' Knowledge ', ' Preparation ', ' Population ', ' Staging ', ' Recruitment Activity ', ' recruit ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Address ', ' Work ', ' Effectiveness ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Individual ', ' Behavioral ', ' Reporting ', ' Methods ', ' System ', ' LOINC Axis 4 System ', ' Communities ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Services ', ' Testing ', ' Enrollment ', ' enroll ', ' public health relevance ', ' Outcome ', ' Family ', ' Research Design ', ' study design ', ' Study Type ', ' Collaborations ', ' Risk ', ' Research ', ' emerging adulthood ', ' criminal behavior ', ' Drug Courts ', ' ']",NIDA,MEDICAL UNIVERSITY OF SOUTH CAROLINA,R01,2011,37146,0.04091109874558734
"HIV - Emergence of Drug Resistance    DESCRIPTION (provided by applicant): This application is to renew a project focused on using mathematical models to understand and predict the emergence of drug resistance to antiretrovirals (ARVs) for the treatment of Human Immunodeficiency Virus (HIV). As the usage rate of ARVs in resource-poor regions is increasing, high levels of drug resistance potentially could emerge and have a devastating impact on public health worldwide, derailing global plans to provide this treatment to many millions of HIV-infected individuals. Our proposed projects will extend the work of the current award, which showed the value of using mathematical models to understand the temporal dynamics of drug-resistant strains of HIV in the United States (US), and for predicting the magnitude of resistance in this setting. In the renewal our work will be extended by combining mathematical modeling with statistical analysis of datasets collected by collaborating groups in the US, Europe and Africa. We will have access to data on drug resistance and important related variables from large scale epidemiological and treatment studies conducted in these three continents. In resource-poor settings, such as Africa, drugs will be limited and thus demand will often greatly exceed supply. We will investigate the problems of allocating ARVs in Africa by using operation research (OR) techniques. We have three Specific Aims. Aim 1: to understand the emergence, explain the present, and predict the evolution of, complex epidemics of drug-resistant strains of HIV in the US and Europe. Aim 2: to predict the evolution of epidemics of drug-resistant strains, as a result of first- line regimens and prophylactic use of ARVs, in Africa. Aim 3: to evaluate the consequences of allocation of scarce HIV healthcare resources in Africa. To achieve this aim we will use models to evaluate the epidemiological and ethical consequences of gender-inequities in access to treatment, assess the epidemiological and ethical impact of treatment priority criteria, and determine healthcare resource allocation strategies that ensure sustainability. Our studies in the renewal will link transmission modeling, OR techniques and statistical analyses; our analyses will take advantage of the extraordinary data sets provided by our collaborators in the US, Europe and Africa.       PUBLIC HEALTH RELEVANCE: The emergence and control of drug-resistant strains of HIV is now a global problem. The epidemiology of this problem is complex, and the future of the HIV epidemic is unknown. Our projects focus on using mathematical models to understand, explain, and predict, the evolution of complex epidemics composed of drug-resistant strains of HIV in the US, Europe and Africa. The rollout of antiretrovirals in Africa is just beginning; however demand for drugs greatly exceeds supply. We will, by using mathematical models, evaluate the epidemiological and ethical consequences of allocation of the scarce supply of antiretrovirals in Africa. Our studies are based upon both mathematical modeling and data analyses. Our analyses will take advantage of the extraordinary data sets provided by our collaborators in the US, Europe and Africa. Our results will have direct relevance for health policy makers.          ",HIV - Emergence of Drug Resistance,8048080,R01AI041935,"['Ensure ', ' Modeling ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Structure ', ' Healthcare ', ' health care ', ' Work ', ' transmission process ', ' Transmission ', ' Link ', ' Complex ', ' United States ', ' public health relevance ', ' Resources ', ' Research Resources ', ' Publications ', ' Scientific Publication ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Female ', ' Sampling ', ' Award ', ' public health medicine (field) ', ' Public Health ', ' base ', ' Research ', ' Recording of previous events ', ' History ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Data ', ' multiple drug use ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Individual ', ' prophylactic ', ' resistant strain ', ' resistance strain ', ' Health care facility ', ' Healthcare Facility ', ' Health Facilities ', ' Protease Inhibitor ', ' Proteinase Inhibitors ', ' Protease Antagonists ', ' Peptide Peptidohydrolase Inhibitors ', ' Peptide Hydrolase Inhibitors ', ' Peptidase Inhibitors ', ' Endopeptidase Inhibitors ', ' Antiproteases ', ' Interruption ', ' microbicide ', ' microbicidal ', ' Europe ', ' World Health Organization ', ' Simplexvirus ', ' human herpesvirus 1 group ', ' Herpesvirus hominis ', ' Herpes labialis Virus ', ' Herpes Simplex Virus ', ' HSV ', ' Vertical Disease Transmission ', ' mother to child transmission ', ' Vertical Transmission ', ' South Africa ', ' non-nucleoside reverse transcriptase inhibitors ', ' nonnucleoside reverse transcriptase inhibitors ', ' non-nucleoside RT inhibitors ', ' NNRTI ', ' PTPN6 gene ', ' SHP-1L ', ' SHP-1 ', ' SH-PTP1 ', ' PTPN6 ', ' PTP-1C ', ' HPTP1C ', ' HCPH ', ' HCP ', ' Linear Models ', ' Nucleosides ', ' Resource Allocation ', ' Operations Research ', ' Lamivudine ', ' 3TC ', ' 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)- ', "" 2',3'-Dideoxy-3'-thiacytidine "", ' Africa ', ' efavirenz ', ' 6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one ', ' Prophylactic treatment ', ' Prophylaxis ', ' Prevention Measures ', ' Reverse Transcriptase Inhibitors ', ' men who have sex with men ', ' men who have sex with other men ', ' Tenofovir ', ' 9-PMPA ', ' 9-(2-phosphonylmethoxypropyl)adenine ', ' 9-(2-phosphonomethoxypropyl)adenine ', ' Classification ', ' Systematics ', ' sex ', ' Grant ', ' Evolution ', ' Future ', ' mathematical model ', ' mathematical modeling ', ' Math Models ', ' Ethics ', ' ethical ', ' Regimen ', ' Data Set ', ' Dataset ', ' Data Analyses ', ' Data Analysis ', ' Epidemic ', ' Drug Design ', ' Resistance ', ' resistant ', ' Publishing ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Gender ', ' Virus Diseases ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Trees ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Research Technics ', ' Research Techniques ', ' Nevirapine ', ' Viramune ', ' Tuberculosis ', ' tuberculous spondyloarthropathy ', ' infection due to Mycobacterium tuberculosis ', ' disseminated tuberculosis ', ' disseminated TB ', ' Mycobacterium tuberculosis infection ', ' Mycobacterium tuberculosis (MTB) infection ', ' Mtb infection [{C0041296}] ', ' MTB infection ', ' M.tuberculosis infection ', ' M. tuberculosis infection ', ' antiretroviral therapy ', ' Policy Maker ', ' Anti-Retroviral Agents ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' Multi-Drug Resistance ', ' multidrug resistant ', ' multi-drug resistant ', ' Resistant to multidrug ', ' Resistant to multi-drug ', ' Resistant to Multiple Drug ', ' Resistance to Multiple Drug ', ' Resistance to Multidrug ', ' Resistance to Multi-drug ', ' Multiple Drug Resistant ', ' Multiple Drug Resistance ', ' Multidrug Resistance ', ' San Francisco ', ' Research Methodology ', ' Research Methods ', ' Paper ', ' pandemic disease ', ' pandemic ', ' Zidovudine ', ' azidodeoxythymidine ', ' ZDV ', ' Azidothymidine ', ' AZT (Antiviral) ', ' AZT ', "" 3'-azido-3'-deoxy-thymidine "", "" 3'-Azido-3'-deoxythymidine "", "" 3'-Azido-2',3'-Dideoxythymidine "", ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Stavudine ', ' zerit ', ' Didehydrodeoxythymidine ', ' D4T ', "" 3'-Deoxy-2'-thymidinene "", "" 2'3' didehydrodeoxythymidine "", "" 2',3'-didehydro-3'-deoxy-thymidine "", "" 2',3'-Didehydro-3'-deoxythymidine "", "" 2',3'-Didehydro-2',3'-dideoxythmidine "", ' 1-(2,3-Dideoxy-beta-glycero-pent-2-enofuranosyl)thymine ', ' Abbreviations ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Drug resistance ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Equation ', ' ']",NIAID,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2011,695913,0.08382042801068632
"Economic Evaluation of Drug Abuse Treatment and HIV Prevention Services for Pregn    DESCRIPTION (provided by applicant): Economic evaluation of drug abuse treatment and HIV prevention services for pregnant women is critical to identify the most efficient and equitable use of scarce resources. Economic and policy research on the efficiency of drug abuse treatment and HIV prevention services among vulnerable populations such as women, adolescents and members of minority groups is necessary to improve drug abuse and HIV/AIDS services for these vulnerable and underserved populations. While work in this area continues to grow, there is still a dearth of rigorous economic evaluations of such programs, especially those that adhere to quality standards as recommended by the U.S. Panel on Cost Effectiveness in Health and Medicine. The overall objective of this study is to conduct the first economic evaluation of an innovative behavioral approach integrating Motivational Enhancement Therapy with Cognitive Behavioral Therapy (MET-CBT) as compared to standard Brief Advice (BA) within prenatal care to decrease use of a full range of substances (e.g., marijuana, cocaine, methamphetamines, alcohol, nicotine), to reduce HIV risk behavior and to achieve better infant health outcomes (e.g. longer gestations, greater birth weight, reduced medical consequences such as admission and length of stay in the Neonatal Intensive Care Unit (NICU)). The specific aims of this study are: (1) to conduct cost analyses of the MET-CBT and BA intervention arms; (2) to conduct incremental cost-effectiveness analyses of the two interventions (MET-CBT and BA), vis-`-vis each other, in terms of substance use, infant health outcomes and HIV risk reduction; and (3) to conduct incremental cost-utility analyses determining the net cost per Quality-Adjusted Life Year (QALY) saved respectively by each intervention arm (MET-CBT and BA), vis-`-vis each other, in terms of substance use and HIV risk reduction. The proposed research is responsive to PA-07-122 in that it proposes to conduct research related to cost-effectiveness and cost-utility analyses, services costs, methodological research, and the cross-cutting themes of HIV/AIDS and health disparities. The proposed research is grounded in sound microeconomic principles and standardized techniques as reported in the U.S. Panel on Cost Effectiveness in Health and Medicine, and proposes rigorous conceptual and methodological research to improve the evidence base on the unit costs and cost-effectiveness of substance abuse treatment and HIV prevention services. It builds on a NIDA-funded randomized controlled trial (R01-DA019135) of an innovate behavioral approach, which offers a new paradigm of treatment services, integrating MET-CBT within prenatal care compared to standard BA, and offering promise to improve access to and strengthen substance use treatment and HIV prevention services targeted at drug using pregnant women who are highly susceptible to HIV/AIDS.       PUBLIC HEALTH RELEVANCE: Drug abuse and high risk HIV behavior during pregnancy are major public health problems in the United States due to their impact on individual users, their offspring, and surrounding communities. Drug abuse and HIV prevention programs targeting pregnant women have the potential to be cost-effective due to the resultant fewer low-birth-weight babies and perinatal deaths, fewer physical, cognitive and behavioral problems during infancy and childhood, and the significant health benefits that can accrue to the mother. The overall objective of this study is to conduct the first economic evaluation of an innovative behavioral approach integrating Motivational Enhancement Therapy with Cognitive Behavioral Therapy (MET-CBT) as compared to standard Brief Advice (BA) within prenatal care to decrease use of a full range of substances (e.g., marijuana, cocaine, methamphetamines, alcohol, nicotine), to reduce HIV risk behavior and to achieve better infant health outcomes (e.g. longer gestations, greater birth weight, reduced medical consequences such as admission and length of stay in the Neonatal Intensive Care Unit (NICU)).           PROJECT NARRATIVE Drug abuse and high risk HIV behavior during pregnancy are major public health problems in the United States due to their impact on individual users, their offspring, and surrounding communities. Drug abuse and HIV prevention programs targeting pregnant women have the potential to be cost-effective due to the resultant fewer low-birth-weight babies and perinatal deaths, fewer physical, cognitive and behavioral problems during infancy and childhood, and the significant health benefits that can accrue to the mother. The overall objective of this study is to conduct the first economic evaluation of an innovative behavioral approach integrating Motivational Enhancement Therapy with Cognitive Behavioral Therapy (MET-CBT) as compared to standard Brief Advice (BA) within prenatal care to decrease use of a full range of substances (e.g., marijuana, cocaine, methamphetamines, alcohol, nicotine), to reduce HIV risk behavior and to achieve better infant health outcomes (e.g. longer gestations, greater birth weight, reduced medical consequences such as admission and length of stay in the Neonatal Intensive Care Unit (NICU)).",Economic Evaluation of Drug Abuse Treatment and HIV Prevention Services for Pregn,8013340,R01DA025555,"['arm ', ' Quality-Adjusted Life Years ', ' Effectiveness of Interventions ', ' Costs and Benefits ', ' Problem behavior ', ' behavioral problem ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' mathematical model ', ' mathematical modeling ', ' Math Models ', ' Neonatal Intensive Care Units ', ' Newborn Intensive Care Units ', ' life time cost ', ' lifetime cost ', ' Services ', ' Low Birth Weight Infant ', ' low birthweight ', ' low birth weight infant human ', ' low birth weight ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Alcohols ', ' Alcohol Chemical Class ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Pregnant Women ', ' Evaluation Studies ', ' Standardization ', ' Policy Research ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Risk Reduction ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' brief advice ', ' health disparity ', ' health disparities ', ' Birth Weight ', ' Facilities and Administrative Costs ', ' Indirect Costs ', ' Effectiveness ', ' Savings ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Admission activity ', ' Admission ', ' smoking cessation ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' Marihuana ', ' marijuana ', ' Prenatal care ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' cost effectiveness ', ' Direct Costs ', ' evidence base ', ' Build-it ', ' Mothers ', ' Nicotine ', ' Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)- ', ' Infant Health ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Perinatal ', ' Cost Analysis ', ' Cost Analyses ', ' sound ', ' Vulnerable Populations ', ' vulnerable group ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Economic Policy ', ' offspring ', ' Drug usage ', ' drug use ', ' Guidelines ', ' infancy ', ' infantile ', ' Pregnancy ', ' Gestation ', ' cost ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Cognitive Therapy ', ' cognitive behavioral treatment ', ' cognitive behavioral therapy ', ' cognitive behavioral modification ', ' cognitive behavioral intervention ', ' cognitive behavior therapy ', ' cognitive behavior modification ', ' cognitive behavior intervention ', ' Cognitive Psychotherapy ', ' Cognition Therapy ', ' Resources ', ' Research Resources ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' innovation ', ' innovative ', ' innovate ', ' Prevention program ', ' Cognitive ', ' United States ', ' Improve Access ', ' Medicine ', ' Health ', ' Health Benefit ', ' programs ', ' Relative (related person) ', ' Relative ', ' Cessation of life ', ' Death ', ' Behavior ', ' Economics ', ' Behavioral ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Underserved Population ', ' underserved people ', ' under served population ', ' Outcome ', ' Area ', ' Individual ', ' Participant ', ' Goals ', ' Contracts ', ' Contracting Opportunities ', ' Measurement ', ' Cost Savings ', ' Prevention ', ' Work ', ' Data ', ' Translating ', ' Address ', ' Reporting ', ' Funding ', ' Childhood ', ' pediatric ', ' Future ', ' Measures ', ' public health relevance ', ' economic evaluation ', ' Costs and Cost Analysis ', ' Costs and Cost Analyses ', ' Ensure ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Medical ', ' Research ', ' Techniques ', ' member ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Risk ', ' high risk ', ' Communities ', ' Woman ', ' public health medicine (field) ', ' Public Health ', ' Methods ', ' improved ', ' NIDA ', ' motivational enhancement therapy ', ' motivational interview ', ' prevention service ', ' substance abuse treatment ', ' substance abuse therapy ', ' cost effective ', ' cost-effective ', ' Methodology ', ' Method LOINC Axis 6 ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' ']",NIDA,YALE UNIVERSITY,R01,2011,664795,0.026256141220174598
"Social networks and HIV risk among rural drug users    DESCRIPTION (provided by applicant):  This application is in response to PA-06-478, ""Research on Rural Mental Health and Drug Abuse Disorders"". One of the research areas highlighted by this PA is the examination of rural HIV transmission using social network analysis. The overall goal of the study is to examine the prevalence, incidence, and risk factors for HIV and other blood borne infections (BBIs) such as hepatitis B (HBV) and C (HCV) among rural Appalachian drug users using social network analysis and multilevel modeling. HIV continues to be a major public health problem in the United States, especially among drug users. However, little is known about HIV in rural areas in which there are marked health disparities. Therefore, given that studies among urban drug users have found that social network indicators are robust predictors of HIV risk, both social network and individual characteristics will be measured for their association with HIV risk among rural drug users. The specific aims are: 1) To determine the prevalence and incidence of HIV, HCV and HBV among rural injection and non- injection drug users; 2) To examine HIV and other BBI risk among rural injection and non-injection drug users; and 3) To examine longitudinal changes in rural HIV, HCV and HBV risk at 6-months, 12-months and 18- months post-baseline. To meet these aims, a sample 500 rural injection and non-injection drug users will be recruited using respondent driven sampling (RDS). In addition to biologic testing for HIV, HCV and HBV, rural participants will be given an interviewer-administered questionnaire pertaining to their social networks (drug, sexual and support networks), sociodemographics, drug use, HIV risk behaviors, psychiatric diagnoses, intravention and norms. Since individuals will be nested within networks, data will be analyzed using multilevel random effects regression that allows for the simultaneous examination of social network and individual-level risk. Consistent with the priorities of the NIDA AIDS Research Program, this proposal will explore the social network structure in a rural drug using population in order to better understand how network factors may affect HIV risk in rural areas using an innovative multilevel approach. Results from the proposed study will inform the design and implementation of HIV interventions in rural areas and help to determine the appropriate population for which to target such activities in order to reduce the morbidity and mortality associated with HIV and other BBIs.       Although HIV remains a significant public health problem in the United States, especially among drug users, little is known about HIV risk in rural areas such as Appalachia. It has been shown in urban populations that relationships among drug users, also known as social networks, are important predictors of HIV risk. Therefore, this study seeks to characterize rural HIV risk by measuring both social network and individual behaviors in order to inform prevention activities in health resource-deprived rural areas.          ",Social networks and HIV risk among rural drug users,8013901,R01DA024598,"['Questionnaires ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Social Network ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Serologic tests ', ' serology ', ' Serological Tests ', ' Hepatitis B Virus ', ' Homologous Serum Hepatitis Virus ', ' HBV ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pathway Analysis ', ' Network Analysis ', ' health disparity ', ' health disparities ', ' urban area ', ' Injecting drug user ', ' Injection Drug User ', ' Rural Population ', ' Hepatitis B ', ' serum hepatitis ', ' infection with hepatitis B virus ', ' infection with HBV ', ' Viral Hepatitis B ', ' Hepatitis B Infection ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Health Resources ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Appalachian Region ', ' Appalachia ', ' Urban Population ', ' Individual Adjustment ', ' Kentucky ', ' Injection of therapeutic agent ', ' Injections ', ' Hepatitis C virus ', ' Hepatitus C ', ' HCV ', ' Drug usage ', ' drug use ', ' Drug Prescriptions ', ' Drug Prescribing ', ' Respondent ', ' transmission process ', ' Transmission ', ' innovation ', ' innovative ', ' innovate ', ' Incidence ', ' Research Priority ', ' Epidemic ', ' United States ', ' Psychiatric Diagnosis ', ' Goals ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' programs ', ' multilevel analysis ', ' multilevel modeling ', ' multilevel model ', ' methods to study multiple-level influences ', ' meetings ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Behavior ', ' Population ', ' response ', ' Modeling ', ' Interviewer ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Area ', ' Individual ', ' Principal Investigator ', ' Participant ', ' Time ', ' Blood ', ' Blood Reticuloendothelial System ', ' Prevention ', ' Affect ', ' Research ', ' Morbidity - disease rate ', ' Morbidity ', ' rural area ', ' Reporting ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Testing ', ' Measures ', ' design ', ' designing ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Characteristics ', ' Interview ', ' Rural ', ' Risk ', ' Mortality Vital Statistics ', ' Mortality ', ' Risk Factors ', ' high risk ', ' Communities ', ' Infection ', ' Sampling ', ' Recruitment Activity ', ' recruit ', ' Data ', ' Structure ', ' public health medicine (field) ', ' Public Health ', ' Prevalence ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Automobile Driving ', ' driving ', ' Seroprevalences ', ' disorder prevention ', ' disease prevention ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Drug user ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2011,577058,0.12666251430322556
"African American Female Drug Users: HIV, Health Disparities, & Criminality    DESCRIPTION (provided by applicant): The overall goal of this study is to understand how drug use and criminality are related to health disparities, particularly HIV, and service utilization among African American drug using and non-drug using women across criminal justice status. While drug use is similar across racial groups in the US, African Americans are disproportionately more likely to experience severe health consequences and criminal involvement as a result of drug misuse. Adequate health care may not be received by African American female offenders because they experience the burden of their race, class, gender, and criminal offender status. There is limited scientific data to help understand the linkages between health disparities such as HIV, untreated drug abuse, barriers to service utilization, and status as a criminal offender among African American females. This study is significant because of its potential to identify differences in health disparities and service utilization among African American drug using and non-drug using women in selected levels of criminal justice status (intensive correctional supervision-prison (n=200), moderate correctional supervision-jail (n=200), community supervision-probation (n=200), and no criminal justice involvement (n=200)). All 800 African American females will be followed longitudinally for three 6-month intervals to examine health status and the use of health services across time. The specific aims are: (1) To describe the prevalence of health problems among African American women across criminal justice status and drug use status; (2) To determine the cultural, predisposing, historical health, and potential enabling factors that are predictors of health problems among African American drug using and non-drug using women across criminal justice status over 18 months; (3) To describe the prevalence of untreated health problems, the patterns of health services utilization, and the cultural barriers to service utilization among African American women across criminal justice status and drug use status; and (4) To examine the factors that predict the likelihood of using health services among African American drug using and non-drug using women across criminal justice status over 18 months. The significance of this study includes the potential to provide criminal justice systems-level data for health planning and health policy for prevention, intervention, and treatment of African American female drug users.       This study is significant to the public health field because of its potential to understand the severity of health disparities among African American women across criminal justice status and drug use status and to predict health status and the use of health services over time. This knowledge of African American females can be used as a foundation for future criminal justice systems-level interventions to increase the use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism.          ","African American Female Drug Users: HIV, Health Disparities, & Criminality",8013539,R01DA022967,"['Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Health Services ', ' health care service ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Applications Grants ', ' Grant Proposals ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Health Status ', ' Level of Health ', ' Inpatients ', ' Gonorrhea ', ' Gonococcal Infection ', ' probation ', ' non-drug ', ' nondrug ', ' Trust ', ' Services ', ' Alcohols ', ' Alcohol Chemical Class ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' physical conditioning ', ' physical health ', ' Hospitalization ', ' service utilization ', ' Prisoner ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', "" Women's Health "", ' Female Health ', ' Patient Self-Report ', ' Self-Report ', ' offender ', ' criminal offender ', ' Healthcare ', ' health care ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' health disparity ', ' health disparities ', ' criminal offending ', ' Gender ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Enabling Factors ', ' recidivism ', ' Surveys ', ' Survey Instrument ', ' racism ', ' Jail ', ' Kentucky ', ' Physicians ', ' probationer ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' alcohol research ', ' ethanol research ', ' alcohol related research ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Health Planning ', ' Prisons ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' longitudinal design ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Hepatitis C virus ', ' Hepatitus C ', ' HCV ', ' Drug usage ', ' drug use ', ' Female ', ' Literature ', ' innovation ', ' innovative ', ' innovate ', ' Incidence ', ' Drug abuser ', ' Problem drug user ', ' Misuses drugs ', ' Health ', ' Goals ', ' Time ', ' Mediating ', ' Severities ', ' Pattern ', ' Economics ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' base ', ' Event ', ' Modeling ', ' Individual ', ' Participant ', ' Data ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Work ', ' Development ', ' developmental ', ' Series ', ' time use ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Reporting ', ' Life ', ' Knowledge ', ' Future ', ' Dependence ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Medical ', ' Interview ', ' Research ', ' Universities ', ' Foundations ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Location ', ' experience ', ' Communities ', ' Woman ', ' System ', ' LOINC Axis 4 System ', ' Sampling ', ' Recruitment Activity ', ' recruit ', ' Structure ', ' public health medicine (field) ', ' Public Health ', ' Population ', ' Prevalence ', ' General Population ', ' General Public ', ' NIH Program Announcements ', ' Program Announcement ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Supervision ', ' Fright ', ' Fear ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' substance abuse treatment ', ' substance abuse therapy ', ' Seroprevalences ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' Criminal Justice ', ' Drug user ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2011,579576,0.17326562535537318
"Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth    DESCRIPTION (provided by applicant):  The overriding purpose of this study is to develop and test an intervention for reducing substance use and risky sexual behaviors among youth involved in juvenile drug court. Juvenile drug court provides an excellent setting in which to pursue the key study objectives by providing access to a well identified high risk population. Second, in addition to frequent judicial oversight, juvenile drug courts include several features that can enhance intervention effectiveness, sustainability, and potential for adoption. In addition, the fact that all juvenile drug courts have community-based treatment components and that such courts have been disseminated nationwide suggests the possibility of eventual widespread adoption if the proposed intervention is effective. The proposed intervention integrates evidence-based protocols for contingency management (CM) for substance abusing youth and family engagement strategies, with an evidence-informed family systems intervention for sexual risk originally developed to address substance use and sexual risk behaviors in HIV+ youth. These three interventions will be integrated into an efficient intervention that, if effective, can be amenable to adoption by juvenile drug courts. Following protocol development and beta testing, 160 drug court youth and their families will be randomized to the experimental intervention condition (HIV Risk Reduction or ""HRR"") versus Drug Court with Community Services (DC) conditions. Key outcomes will be assessed through 12-months post-baseline using a multi-method approach that will include assessment of substance use, risky sexual behaviors, criminal behavior, and participation in HIV counseling and testing services. Specific aims include: 1: Adapt existing intervention and training protocols into a single, efficient HRR intervention, beta test this HHR protocol with four youth in juvenile drug court and their families, and revise treatment and research protocols accordingly; 2: Conduct a randomized trial with 160 youth in juvenile drug court and their families to examine youth-level intervention effects (i.e., on substance use, sexual risk behavior, HIV counseling and testing, delinquent behavior) in comparison to DC through 12- months post referral and assess intervention fidelity. 3. If results suggest a positive HRR treatment effect, revise the intervention and training protocols in preparation for an effectiveness study and extended follow-up study. Importantly, the proposed study will (1) consider the multiple levels of influence on juvenile drug use, criminal justice involvement, and HIV risk behaviors, (2) integrate a drug abuse and HIV prevention intervention for youth in the criminal justice system with drug-related offenses, (3) address health disparities by targeting a primarily minority population of youth, and (4) increase referrals to HIV testing and counseling of drug court-involved youth. This study is designed to reduce HIV risk by addressing the potent interaction of drug use and risky sexual behaviors in drug court youth with evidence-based treatment components to maximize the likelihood of reversing these youths' adverse behavioral trajectories.      PUBLIC HEALTH RELEVANCE: The proposed study is designed to gain knowledge about effective interventions for reducing HIV risk in a high risk population. Reducing HIV risk by effectively targeting substance use and risky sexual behaviors and by locating even a small number of HIV-positive youth could favorably impact society at multiple levels (individual, family, peer, community, fiscal).           PROJECT NARRATIVE The proposed study is designed to gain knowledge about effective interventions for reducing HIV risk in a high risk population. Reducing HIV risk by effectively targeting substance use and risky sexual behaviors and by locating even a small number of HIV-positive youth could favorably impact society at multiple levels (individual, family, peer, community, fiscal).",Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth,8091426,R01DA025880,"['community based treatment ', ' Effectiveness of Interventions ', ' juvenile delinquent ', ' Young offender ', ' Juvenile Offender ', ' Risk Reduction ', ' disorder prevention ', ' disease prevention ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Educational Intervention ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Population ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Individual ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' public health relevance ', ' Research Design ', ' study design ', ' Study Type ', ' Collaborations ', ' Evidence based treatment ', ' Measures ', ' high risk ', ' Minority ', ' treatment effect ', ' Clinical Trials ', ' clinical investigation ', ' critical period ', ' System ', ' LOINC Axis 4 System ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' health disparity ', ' health disparities ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Communities ', ' Youth ', ' Youth 10-21 ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Preparation ', ' Institution ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Behavior ', ' Adopted ', ' intervention effect ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Outcome ', ' Staging ', ' base ', ' Enrollment ', ' enroll ', ' Label ', ' evidence base ', ' contingency management ', ' Risk ', ' Societies ', ' Drug usage ', ' drug use ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Address ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' Protocols documentation ', ' Protocol ', ' Family ', ' Recruitment Activity ', ' recruit ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Counseling ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' offender ', ' criminal offender ', ' peer ', ' Adoption ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' effective intervention ', ' Reporting ', ' Research ', ' Work ', ' Behavioral ', ' Effectiveness ', ' Methods ', ' Testing ', ' adolescent substance abuse ', ' youth substance abuse ', ' randomized trial ', ' active method ', ' active treatment ', ' active technique ', ' design ', ' designing ', ' Knowledge ', ' Services ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Cost Effectiveness Analysis ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effective analysis ', ' Cost Effective Analyses ', ' court ', ' protocol development ', ' Evidence based practice ', ' United States Public Health Service ', ' USPHS ', ' Public Health Service ', ' Community Services ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' sex risk ', ' sexual risk behavior ', ' emerging adulthood ', ' criminal behavior ', ' Drug Courts ', ' Criminal Justice ', ' ']",NIDA,MEDICAL UNIVERSITY OF SOUTH CAROLINA,R01,2011,298528,0.04091109874558734
"Rural and Urban African American Cocaine Users' Perceived Need for Care    DESCRIPTION (provided by applicant): We seek to study the factors associated with rural/urban differences in perceived need for both drug abuse treatment and HIV testing because these are complementary services which could be integrated within formal drug abuse treatment programs or other locations to better meet the needs of African American cocaine users. We focus on perceived need among African American cocaine users because of their low rates of drug abuse treatment and HIV testing nationally as well as their demonstrated low perceived need for drug abuse treatment, high rates of risky sexual behaviors, and aversion to seeking HIV testing at local health departments in our prior research. Given that our prior natural history research did not include any urban areas, we do not know whether the low rates of drug abuse treatment and HIV testing among rural Arkansans are specific to rural residents (e.g., whether there is a disparity in access for rural African Americans) or whether urban African American cocaine users differ in other critical factors. To address these issues, we plan to conduct a community-based mixed methods study of African American cocaine users residing in rural and urban areas of Arkansas. Specifically, we propose a sequential mixed-method design, with qualitative key informant interviews conducted first (30 rural, 30 urban), followed by larger-scale, structured interviews (200 rural, 200 urban) using standardized instruments, pertinent measures from our prior rural health services and HIV research, and newly developed questions based on our initial qualitative work. Respondent-Driven Sampling (RDS), a variant of snowball sampling, will be used to identify and recruit participants. The primary aims of the study are: 1) Using qualitative methods, to describe rural/urban differences in pathways to drug use and drug use cultures, perceptions of access to drug abuse treatment and HIV testing, awareness and perceptions of what constitutes drug abuse treatment and HIV testing, and preferences for formal or informal drug abuse treatment and the site or location of HIV testing; 2) Using quantitative and qualitative methods, to compare and contrast rural and urban cocaine users' perceived need for drug abuse treatment and HIV testing and key predisposing, enabling, health, and other factors which could impede or facilitate perceived need; and 3) Using quantitative methods, to investigate whether rural/urban differences in perceived need for drug abuse treatment and HIV testing are mediated by key predisposing, enabling, and health factors as well as treatment and testing awareness and preferences. The knowledge gained from this project will enable health policy makers, treatment program managers, and providers to make more informed decisions about how to encourage and facilitate the utilization of drug abuse treatment and HIV testing among African American cocaine users in the Southern U.S., an underserved and high risk population.      PUBLIC HEALTH RELEVANCE: Of public health concern are the low rates of drug abuse treatment and high rates of HIV among African American cocaine users, especially in the Southern U.S. The knowledge gained from the proposed research would enable managers of public and behavioral health systems to make more informed decisions about how to target and tailor culturally sensitive messages aimed at increasing awareness of the benefits of drug abuse treatment and HIV testing. The proposed research would also provide new insight into whether HIV testing should be integrated within drug abuse treatment facilities to better meet the needs of rural as well as urban African American cocaine users.           PROJECT NARRATIVE Of public health concern are the low rates of drug abuse treatment and high rates of HIV among African American cocaine users, especially in the Southern U.S. The knowledge gained from the proposed research would enable managers of public and behavioral health systems to make more informed decisions about how to target and tailor culturally sensitive messages aimed at increasing awareness of the benefits of drug abuse treatment and HIV testing. The proposed research would also provide new insight into whether HIV testing should be integrated within drug abuse treatment facilities to better meet the needs of rural as well as urban African American cocaine users.",Rural and Urban African American Cocaine Users' Perceived Need for Care,8103883,R01DA026837,"['Qualitative Methods ', ' Stigmata ', ' treatment program ', ' Dental ', ' Health system ', ' Health Status ', ' Level of Health ', ' social stigma ', ' stigma ', ' Rural ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Awareness ', ' preference ', ' Perception ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Respondent ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' behavioral health ', ' Policy Maker ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Ohio ', ' Communities ', ' Health ', ' Provider ', ' instrument ', ' Psyche structure ', ' mental ', ' Population ', ' Natural History ', ' social ', ' Source ', ' Data ', ' Research ', ' Variant ', ' Variation ', ' Illicit Drugs ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Location ', ' Knowledge ', ' base ', ' Testing ', ' informant ', ' Health Services ', ' health care service ', ' Pathway interactions ', ' pathway ', ' Services ', ' Address ', ' Drug usage ', ' drug use ', ' Mediating ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Structure ', ' service utilization ', ' Measures ', ' design ', ' designing ', ' Minority ', ' Methods ', ' Interview ', ' Incentives ', ' inducement ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' health disparity ', ' health disparities ', ' Resources ', ' Research Resources ', ' insight ', ' public health relevance ', ' high risk ', ' Participant ', ' Environment ', ' Clinic ', ' Recruitment Activity ', ' recruit ', ' Work ', ' Caring ', ' Medical ', ' Persons ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' meetings ', ' programs ', ' Sampling ', ' Physicians ', ' Site ', ' public health medicine (field) ', ' Public Health ', ' Privacy ', ' treatment site ', ' urban area ', ' Behavioral Model ', ' Rural Health Services ', ' Marihuana ', ' marijuana ', ' Arkansas ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Improve Access ', ' rural area ', ' Cocaine Users ', ' Kentucky ', ' ']",NIDA,UNIV OF ARKANSAS FOR MED SCIS,R01,2011,640247,0.15968770068252294
"HIV Infection in Ethnic Minority IDUs: An International Systematic Review    DESCRIPTION (provided by applicant): Racial/ethnic group disparities in HIV/AIDS are a critical public health issue in the US. These disparities are particularly dramatic with respect to injecting drug use. African-Americans constitute 13% of the US population and 52% of recent US injecting drug use AIDS cases; Hispanics constitute 14% of the US population and 24% of the injecting drug use AIDS cases. These disparities are not the result of more injecting drug users among African-Americans and Hispanics, but of higher rates of HIV infection among African- American and Hispanic IDUs in many areas of the country. Similar disparities-higher rates of HIV infection among ethnic minority IDUs-have also been observed in many foreign countries. Indeed the situation of ethnic minority IDUs in some developing countries can be considered a crisis, with extremely high incidence, prevalence and HIV-related mortality. Disparities have also been observed among non-injecting drug users, with ethnic minority group members having higher rates of HIV infection. The logical next step for addressing these disparities and this epidemiological conundrum is not another individual study, but a systematic review of the large number of relevant studies that have been conducted to date. Our proposed systematic review will use state-of-the-art methods and include the US and the international data on ethnic group differences in HIV infection among drug users. The specific aims include: Developing procedures for combining qualitative and quantitative data from multiple research studies of IDUs in a single geographic area into a ""history of the HIV epidemic among IDUs"" in that area. Determining the frequency of HIV epidemics in which substantial differences in HIV infection have and have not arisen in ethnic minority IDUs vs. ethnic majority IDUs in the US and internationally. Identifying potential causal factors that may generate substantial differences in HIV prevalence among racial/ethnic minority vs. ethnic majority IDUs. Identifying potential causal factors that may perpetuate or reduce differences in HIV infection among racial/ethnic differences over time. Identifying epidemiologic situations in which differences in HIV risk behaviors do or do not statistically ""explain"" differences in HIV infection among racial/ethnic groups of IDUs. The research will also create an extremely rich dataset on HIV infection among ethnic drug uses that will be made available for use by other researchers and HIV prevention service providers. The research addresses one of the most important aspects of HIV/AIDS-the frequent large disparities in HIV infection among ethnic groups in the US and in many other countries. The research will be an innovative application of state of the art methods for systematic review, including extensive searching for published and unpublished studies, quantitative coding of research reports, and applying meta-regression/hierarchical modeling to these problems.       PUBLIC HEALTH RELEVANCE: Higher rates of HIV infection among African-American and Hispanic IDUs are a major health disparity in the US. African-Americans comprise 13% of the US population and 52% of injection drug use AIDS cases, Hispanics 14% of the populations and 24% of cases. Similar disparities, higher rates of HIV infection among ethnic minority IDUs, have also been observed in many foreign countries. An international systematic review and meta-analysis should greatly advance our understanding of these disparities and suggest how they might be ameliorated.          ",HIV Infection in Ethnic Minority IDUs: An International Systematic Review,8103176,R01DA024612,"['Hepatitis C ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Asia ', ' ethnic minority population ', ' ethnic minority ', ' user-friendly ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Glare ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Health Services Needs ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Drug usage ', ' drug use ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Geographic Locations ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Developing Countries ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Developing Nation ', ' Developing Country ', ' non-drug ', ' nondrug ', ' North America ', ' Ethnic group ', ' repository ', ' Europe ', ' Communities ', ' racial and ethnic ', ' racial/ethnic ', ' Provider ', ' Code ', ' Coding System ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Recommendation ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' innovation ', ' innovative ', ' innovate ', ' Accounting ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data Set ', ' Dataset ', ' Learning ', ' Mortality Vital Statistics ', ' Mortality ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Injection of therapeutic agent ', ' Injections ', ' Disadvantaged ', ' Discrimination (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' Procedures ', ' Recording of previous events ', ' History ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Epidemic ', ' International ', ' Categories ', ' transmission process ', ' Transmission ', ' Services ', ' Methods ', ' ethnic difference ', ' Morbidity - disease rate ', ' Morbidity ', ' Individual ', ' Frequencies (time pattern) ', ' Frequency ', ' Research ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' health disparity ', ' health disparities ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Modeling ', ' Population ', ' Data ', ' Time ', ' public health relevance ', ' Country ', ' Area ', ' Prevalence ', ' member ', ' Development ', ' developmental ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Reporting ', ' Pattern ', ' Address ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' racial/ethnic difference ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Publishing ', ' Risk ', ' Incidence ', ' Site ', ' public health medicine (field) ', ' Public Health ', ' Sexual Transmission ', ' systematic review ', ' Injecting drug user ', ' Injection Drug User ', ' Sexual Partners ', ' sex partner ', ' Stigmatization ', ' Australia ', ' Heterosexuals ', ' prevention service ', ' caucasian American ', ' white American ', ' Drug user ', ' ']",NIDA,BETH ISRAEL MEDICAL CTR (NEW YORK),R01,2011,381562,0.06950887935870406
"Substance Use and Risky Sex in Highly Vulnerable Populations    DESCRIPTION (provided by applicant):  The proposed project will help me develop the skills and expertise necessary to establish an independent research career focused on the role of substance use in sexual risk-taking behavior and associated adverse reproductive outcomes, especially sexually transmitted infections (STIs). To achieve this goal, I will supplement my graduate training as a developmental psychologist and postdoctoral training in epidemiology with training in sexual risk behavior in vulnerable populations, health disparities associated with race, and career development in longitudinal research methodology. Complementary to these training activities, I propose: 1) secondary data analyses of sexual risk behavior and outcomes using data from an ongoing longitudinal study of the offspring of teenage mothers and a study of women with and without borderline personality disorder (BPD); 2) collection of new data on the offspring of teenage mothers during a 16-year assessment and; 3) a new pilot study of common STIs in this sample (offspring of teenage mothers). The proposed research will form the basis for an R01 application in the third year of the award period. My short term goals are to (1) increase knowledge about risk for STIs, including behavioral dysregulation that may underlie risky sex and risk factors associated with risky sex and associated outcomes, (2) learn new methods of measuring risk behavior and adverse reproductive outcomes, including clinical tests for STIs and  event-level assessments, (3) learn more about health disparities associated with race, and (4) develop the research skills that will enable me to become an independent investigator and obtain NIH funding to support my research, specifically longitudinal data analyses. My long-term career goal is to understand the ecological setting for drug use and sexual risk behaviors in vulnerable populations, and how drug use may contribute to significantly higher rates of unintended pregnancies and STIs in African-American youth. The proposed career development training will take place at the Department of Psychiatry at the University of Pittsburgh School of Medicine. This department provides an outstanding environment for interdisciplinary training by highly collaborative faculty who are leading experts in their chosen fields. PUBLIC HEALTH RELEVANCE:  The proposed research will help identify behavioral risk factors for sexually transmitted infections that are implicated in higher rates of HIV, especially among African-Americans. The results can be used to develop prevention programs aimed at reducing drug use and sexually transmitted infections among vulnerable adolescents and within psychiatric populations.           ",Substance Use and Risky Sex in Highly Vulnerable Populations,8123213,K01DA025734,"['Substance Use Disorder ', ' Impulsivity ', ' Church ', ' adverse outcome ', ' adverse consequence ', ' Cross-Sectional Studies ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' population health ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Psychiatry ', ' Training Activity ', ' Aggressive behavior ', ' Aggression ', ' post-doctoral training ', ' postdoctoral training ', ' Universities ', ' Award ', ' Goals ', ' Data ', ' Risk ', ' Population ', ' programs ', ' Individual ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' medical schools ', ' school of medicine ', ' medical college ', ' Schools ', ' Outcome ', ' adolescent offspring ', ' Accounting ', ' Testing ', ' experience ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Birth ', ' Parturition ', ' Methods ', ' Symptoms ', ' Measures ', ' Vulnerable Populations ', ' vulnerable group ', ' Reproductive Health ', ' Research Methodology ', ' Research Methods ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' HIV Seropositivity ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' Adverse event ', ' Adverse Experience ', ' Personality ', ' offspring ', ' Multiple Partners ', ' reproductive ', ' statistics ', ' Sexual Partners ', ' sex partner ', ' Mothers ', ' sex risk ', ' sexual risk behavior ', ' Urine ', ' Urine Urinary System ', ' pregnant ', ' Emotional ', ' Supervision ', ' Psychologist ', ' Pregnancy ', ' Gestation ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Prevalence ', ' Health ', ' Faculty ', ' meetings ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' skills ', ' high risk ', ' Age ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Collection ', ' Longitudinal Studies ', ' long-term study ', ' Gender ', ' Childhood ', ' pediatric ', ' Behavior ', ' Location ', ' Family ', ' Sampling ', ' Development ', ' developmental ', ' Youth ', ' Youth 10-21 ', ' Funding ', ' Learning ', ' Principal Investigator ', ' Drug usage ', ' drug use ', ' Environment ', ' Diagnosis ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Prevention program ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Recording of previous events ', ' History ', ' Data Analyses ', ' Data Analysis ', ' Mediating ', ' Neighborhoods ', ' career development ', ' Clinical ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' cohort ', ' Woman ', ' Pilot Projects ', ' pilot study ', ' Risk Factors ', ' Knowledge ', ' Behavioral ', ' Event ', ' Reporting ', ' Role ', ' social role ', ' career ', ' Characteristics ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' sex ', ' Mediation ', ' Negotiation ', ' Negotiating ', ' base ', ' Research ', ' Risk-Taking ', ' Training ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' health disparity ', ' health disparities ', ' unintended pregnancy ', ' Unplanned pregnancy ', ' Injecting drug user ', ' Injection Drug User ', ' teenage mother ', ' teenage mom ', ' teen mother ', ' teen mom ', ' adolescent mother ', ' Contraceptive methods ', ' Inhibition of Fertilization ', ' Fertility Control ', ' Contraception ', ' Gravidity ', ' Barrier Contraception ', ' Contraceptive Barrier Methods ', ' Barrier Methods ', ' Coitus ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Sex Factors ', ' men who have sex with men ', ' men who have sex with other men ', ' sexually active ', ' 17 year old ', ' seventeen year old ', ' age 17 years ', ' Anger ', ' angry ', ' angers ', ' Borderline Personality Disorder ', ' BPD ', ' ']",NIDA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K01,2011,142310,0.024027442152660384
"Trajectories of Drugs Abuse in High Risk Youth    DESCRIPTION (provided by applicant): We propose to extend the Northwestern Juvenile Project to examine the dynamic relationships among patterns of drug use and disorder, risk and protective factors for drug use and disorder, and adult social role performance as juvenile justice youth age from adolescence to emerging adulthood and young adulthood. This study responds to NIDA's new initiatives on drug abuse, health disparities, and disproportionate minority confinement of African Americans. At year-end 2004, nearly 100,000 juveniles and nearly 2.1 million adults were incarcerated. African Americans comprise 12% of the US population but 40% of incarcerated populations. We are studying a racially/ethnically diverse sample (n=1709; 624 females, 1085 males) in Cook County (Chicago) Illinois, aged 10-18 years at recruitment (1995-1998). Youth are reinterviewed whether they are (re)incarcerated or back in the community. Our goal is to focus on gender differences, racial/ethnic disparities, and the effect of incarceration as we: (1) describe patterns of drug use and disorder --onset, persistence, desistence, and recurrence - as juvenile justice youth age from adolescence to emerging and young adulthood; (2) examine how risk and protective factors (e.g., comorbid mental disorders, adverse life events, availability of illicit drugs) predict, moderate, and mediate patterns of drug use and disorders; and (3) examine the dynamic relationships between patterns of drug use and disorder and adult social role performance (e.g., residential independence [including avoiding incarceration], employment, marriage, parenting, desistance from crime and violence). To analyze the longitudinal data, we will use summary statistics (e.g., prevalence rates, odds ratios), generalized linear mixed-effects models, survival analyses, and Muthen's recently developed extensions of growth mixture models. Extending the Northwestern Juvenile Project allows us to leverage the data already collected to examine the role of incarceration in the development of drug use and disorder, especially among African Americans; to identify risk and protective factors that are potentially malleable; to identify points of intervention at key developmental periods; and to extend theoretical models - developed in general population adolescents -- to correctional populations.           ",Trajectories of Drugs Abuse in High Risk Youth,8132557,R01DA019380,"['Victimization ', ' Healthy People 2010 ', ' juvenile delinquent ', ' Young offender ', ' Juvenile Offender ', ' racial and ethnic disparities ', ' Justice ', ' Crime ', ' Cigarette ', ' Educational Status ', ' training status ', ' training level ', ' training achievement ', ' educational level ', ' Educational Achievement ', ' Public Policy ', ' Anxiety Disorders ', ' Request for Applications ', ' NIH RFA ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Population ', ' Risk Factors ', ' Participant ', ' Back ', ' Dorsum ', ' Attitude ', ' Phase ', ' Reporting ', ' Foundations ', ' high risk ', ' Techniques ', ' young adult ', ' young adulthood ', ' adult youth ', ' Services ', ' Accounting ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Sampling ', ' male ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Funding ', ' public health medicine (field) ', ' Public Health ', ' Economics ', ' Health ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Prevalence ', ' Development ', ' developmental ', ' Outcome ', ' Process ', ' Recurrence ', ' Recurrent ', ' Schools ', ' Pathway interactions ', ' pathway ', ' interest ', ' Individual ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Female ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' disorder risk ', ' disease risk ', ' Life ', ' Recommendation ', ' Infection ', ' theories ', ' Injection of therapeutic agent ', ' Injections ', ' Event ', ' Violence ', ' violent behavior ', ' violent ', ' Pattern ', ' improved ', ' Area ', ' Affect ', ' Drops ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Social support ', ' social support network ', ' Patient Self-Report ', ' Self-Report ', ' Recording of previous events ', ' History ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' statistics ', ' Characteristics ', ' prospective ', ' Behavior ', ' Data ', ' Structure ', ' Substance Use Disorder ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Role ', ' social role ', ' Goals ', ' Research ', ' Longitudinal Studies ', ' long-term study ', ' Drug usage ', ' drug use ', ' Performance ', ' Risk ', ' System ', ' LOINC Axis 4 System ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' deviant ', ' deviancy ', ' social ', ' Mediating ', ' Belief ', ' Modeling ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Communities ', ' racial and ethnic ', ' racial/ethnic ', ' Psyche structure ', ' mental ', ' Parenting behavior ', ' Parenting ', ' Illicit Drugs ', ' 18 year old ', ' eighteen year old ', ' age 18 years ', ' African ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Illinois ', ' Theoretical model ', ' Theoretic Models ', ' Freedom ', ' Liberty ', ' Records ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Ethnic group ', ' Self Efficacy ', ' Psychotic Disorders ', ' Psychoses ', ' Budgets ', ' Employment ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' County ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Odds Ratio ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' functional disability ', ' Functional impairment ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' health disparity ', ' health disparities ', ' Conflict (Psychology) ', ' Conflict ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' Surgeon ', ' sound ', ' Alcohols ', ' Alcohol Chemical Class ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Gender ', ' Chicago ', ' peer ', ' satisfaction ', ' Health system ', ' Youth ', ' Youth 10-21 ', ' Impaired cognition ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' NIH Program Announcements ', ' Program Announcement ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Mood Disorders ', ' Affective Disorders ', ' Life Style ', ' Lifestyle ', ' General Population ', ' General Public ', ' Neighborhoods ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Epidemic ', ' Population Study ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Trauma ', ' aged ', ' Marijuana Smoking ', ' marijuana use ', ' Medical Records ', ' Age ', ' Address ', ' Time ', ' Survival Analysis ', ' Survival Analyses ', ' Woman ', ' Minority ', ' Domestic Violence ', ' Marriage ', ' Child Abuse and Neglect ', ' child maltreatment ', ' Childhood maltreatment ', ' self esteem ', ' injury prevention ', ' factor A ', "" Co(beta)-cyano-7''-(2-methyl)adeninylcobamide "", ' correctional system ', ' violence prevention ', ' prevent violence ', ' Behavior Disorders ', ' behavioral disorder ', ' cooking ', ' emerging adulthood ', ' Drug Use Disorder ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Criminal Justice ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2011,411928,0.15806252262844014
"The Development of a Video-Enhanced Drug Prevention Program for Rural Native Hawa    DESCRIPTION (provided by applicant): Research has indicated that Native Hawaiian youth have significantly higher rates of drug use than their non-Hawaiian counterparts (e.g., Wong, Klingle, & Price, 2004; Mayeda, Hishinuma, Nishimura, Garcia- Santiago, & Mark, 2006), and that these differences are particularly pronounced in rural settings (Lai & Saka, 2005). Despite these findings, there have been very few drug prevention programs developed and evaluated specifically for these youth (Edwards, Giroux, & Okamoto, in press; Rehuher, Hiramatsu, & Helm, 2008). Therefore, the purpose of this exploratory research proposal is to develop and pilot test curricular components of a video-based, culturally-grounded drug prevention program for rural Native Hawaiian youth. This will be accomplished through three specific aims. AIM 1 is to create 3-5 video vignettes focused on relevant drug related problem situations of rural Hawaiian youth. The vignettes will focus on common and difficult drug offer situations for these youth, as well as the range of responses to each situation, established from prior NIDA- funded research (5 K01 DA019884). AIM 2 is to develop the accompanying drug prevention curricular components to compliment the video vignettes developed in Aim 1. AIM 3 is to pilot test the resulting curricular components for program feasibility and measurement, using a combination of focus group interviews with stakeholders (e.g., Hawaiian youth, youth-serving practitioners) and selected classroom implementation within four middle schools. Comparison of the intervention components against four attentional-control schools will be conducted, in order to estimate effect sizes for a future large-scale, randomized controlled trial (to be implemented as part of a future R01 grant).      PUBLIC HEALTH RELEVANCE: Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have been shown to have higher rates of alcohol consumption and smoking compared with other ethnic groups (Office of Minority Health, 2009), research focused on drug prevention of these individuals is important to improve public health both in Hawai'i and on the Mainland U.S. This study actively engages rural communities in the development of the curricular components of a drug prevention intervention for Hawaiian youth, promoting the overall utility and effectiveness of those components. Further, the findings from this study will point to the core content of prevention interventions for Hawaiian youth in rural communities, which may be applicable to other ethnic youth populations in Hawai'i and the Pacific Rim, as well as Native youth populations on the Mainland U.S.           Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have been shown to have higher rates of alcohol consumption and smoking compared with other ethnic groups (Office of Minority Health, 2009), research focused on drug prevention of these individuals is important to improve public health both in Hawai'i and on the Mainland U.S. This study actively engages rural communities in the development of the curricular components of a drug prevention intervention for Hawaiian youth, promoting the overall utility and effectiveness of those components. Further, the findings from this study will point to the core content of prevention interventions for Hawaiian youth in rural communities, which may be applicable to other ethnic youth populations in Hawai'i and the Pacific Rim, as well as Native youth populations on the Mainland U.S.         ",The Development of a Video-Enhanced Drug Prevention Program for Rural Native Hawa,8092917,R34DA031306,"['Group Interviews ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' American Indian and Alaska Native ', ' native youth ', ' Videotape ', ' minority health ', ' Drug Prevention Program ', ' middle school ', ' rural area ', ' Rural Community ', ' Rural Health ', ' pricing ', ' Price ', ' Accountability ', ' Hawaiian ', ' Hawaiian population ', ' Indigenous ', ' health disparities ', ' health disparity ', ' Prevention ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Population ', ' Curriculum ', ' Educational Curriculum ', ' Individual ', ' Research ', ' Foundations ', ' Public Health ', ' public health medicine (field) ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Future ', ' Grant ', ' Production ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Testing ', ' developmental ', ' Development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' drug use ', ' Drug usage ', ' Effectiveness ', ' Research Proposals ', ' improved ', ' novel ', ' Research Resources ', ' Resources ', ' base ', ' programs ', ' response ', ' Measurement ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Schools ', ' Rural ', ' Funding ', ' Focus Groups ', ' Smoking ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' Test Result ', ' Ethnic group ', ' Youth 10-21 ', ' Youth ', ' etoh use ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Island ', ' Outcome Study ', ' ']",NIDA,HAWAII PACIFIC UNIVERSITY,R34,2011,202671,0.09063652823251121
"Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS    DESCRIPTION (provided by applicant): This application is a revision of an application submitted last year in response to PAR-07-379, ""Behavioral and Social Science Research on Understanding and Reducing Health Disparities."" We will analyze the interconnections between coercive mobility (the massive migration between the criminal justice [CJ] system and the community) produced by US drug policies and race disparities in HIV-related sexual risk among a sample of drug offenders in Connecticut (CT). Further, we will examine whether the association between coercive mobility (CM) and HIV-related sexual risk is affected by the degree of social disorganization in the communities in which these offenders reside. We also will study the feasibility of recruiting and following sexual partners of these individuals to better understand the impacts of CM on partners' HIV-related risk. We hypothesize that CM produces race disparities in HIV risk in a number of distinct ways: 1) Blacks are more likely than Whites to be incarcerated, so HIV-related sexual risk associated with CM can produce race disparities in HIV risk even if the effects of CM are the same for both Blacks and Whites; 2) Blacks are more likely than Whites to reside in communities experiencing the disorganizing impacts of CM, so to the extent that social disorganization exacerbates the effects of CM, it will affect the HIV risks of Blacks to a greater degree than Whites; 3) The sexual partners of Blacks are more likely to come from these same socially disorganized communities, furthering the negative impacts of CM for both returning inmates and their partners, and contributing to race disparities in HIV risk among women; and 4) Blacks are more likely to be penalized by drug policies in ways that increase their movement between prison/jail and the community and their vulnerability to its associated harms. We also hypothesize that we will be able to recruit and retain the sexual partners of study participants and conduct exploratory analyses of the impact of CM on their HIV-related sexual risk. An active Community Advisory Board including policymakers and program administrators will assist us in identifying structural interventions to reduce race disparities in HIV based on study findings. PUBLIC HEALTH RELEVANCE: This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.           Narrative This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.","Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS",8117250,R01DA025021,"['Law Enforcement ', ' behavioral/social science ', ' Public Policy ', ' Administrator ', ' Laws ', ' community reentry ', ' community re-entry ', ' contextual factors ', ' Application Context ', ' offender ', ' criminal offender ', ' Feasibility Studies ', ' disorder prevention ', ' disease prevention ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' In-Migration ', ' Immigrations ', ' Sexual Partners ', ' sex partner ', ' Housing ', ' Recording of previous events ', ' History ', ' Woman ', ' theories ', ' Policies ', ' social ', ' Movement ', ' body movement ', ' member ', ' Research ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' base ', ' Family ', ' Surveys ', ' Survey Instrument ', ' Area ', ' Risk ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Individual ', ' Environment ', ' Recruitment Activity ', ' recruit ', ' Health ', ' Affect ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Structure ', ' experience ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Data ', ' Time ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' programs ', ' Interview ', ' Frequencies (time pattern) ', ' Frequency ', ' Sampling ', ' Data Analyses ', ' Data Analysis ', ' Awareness ', ' Participant ', ' Shapes ', ' Communities ', ' Feedback ', ' response ', ' Address ', ' System ', ' LOINC Axis 4 System ', ' Process ', ' Institution ', ' migration ', ' Face ', ' facial ', ' faces ', ' health disparity ', ' health disparities ', ' social science research ', ' Jail ', ' sexual relationship ', ' Prisons ', ' Social Disorganizations ', ' Connecticut ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Criminal Justice ', ' ']",NIDA,AMERICAN UNIVERSITY,R01,2011,704276,0.047759867674073975
"Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users    DESCRIPTION (provided by applicant): This is a second revision of a competitive renewal R01 proposal of the NEURO-HIV Epidemiologic Study in response to NIDA PAS-07-115 (Non-injection Dug Abuse and HIV/AIDS). The primary study aim is to evaluate the ability of Integrated Family and Cognitive-Behavioral Therapy-HIV Prevention Intervention (IFCBT-HIVPI) to prevent HIV among adult non-injection and injection drug users. Over a 12 week intervention interval, the IFCBT-HIVPI model coordinates the delivery of cognitive- behavioral components during 12 group sessions with a couples and family systems component during 4 couples/family sessions to address HIV risk and protective factors across multiple ecological systems. IFCBT-HIVPI main effects on primary (HIV sexual risk behaviors and HIV drug taking risk behaviors) and secondary (HIV, Chlamydia, gonorrhea, and trichomoniasis incidences and legal involvement, academic achievement, and employment) outcome domains will be evaluated. We also seek to elucidate the degree to which the development of attitudinal and behavior change skills targeted by IFCBT-HIVPI (e.g., rational beliefs, problem solving skill, adaptive couples' communication) result in post-intervention reductions of HIV, sexually transmitted infections (STIs), and HIV risk behaviors. The possibility of effect-modification is also considered with a focus on route of drug administration status (i.e., non-injector/injector), neuropsychological (e.g., executive function), and demographic (i.e., African American/white) factors. The proposed study will randomly assign 360 HIV-negative non-injection and injection drug users recruited from the original NEURO-HIV Epidemiologic Study sample to experimental (IFCBT-HIVPI) and comparison (Brief Psychoeducation Curriculum on HIV Prevention; BPEC-HIV) conditions. The composition of the original NEURO-HIV Epidemiologic Study sample provides the basis to stratify the randomized trial sample across gender and two race/ethnicity (i.e., African American and white) groups by route of drug administration status. An assessment battery comprised of a standardized interview on HIV risk behavior, neuropsychological tests, tools to assess attitudes and behavior change skills targeted by IFCBT-HIVPI, drug and STI urine testing, and serologic tests of HIV will be administered before, during, and after the intervention interval across 18-month post-intervention follow-up. Additional preliminary analyses will be conducted on the randomized trial data to: (1) derive session-by-session measures on mechanisms of change targeted by IFCBT-HIVPI via videotape coding methods; (2) characterize mechanisms of change trajectories that may then be evaluated as plausible intervention moderators if present; and (3) estimate intervention cost-effectiveness. The lack of research on science-based prevention interventions for HIV continues to be a serious gap in the literature with recent HIV trends highlighting significant health disparities, particularly among African American non-injection drug users. If successful, the proposed project should help to identify specific attitudinal and behavior change skills targeted by cognitive- behavioral and couples/family systems interventions that foster subsequent reductions in HIV, STIs and HIV risk behaviors among adult drug users at heightened disease risk. PUBLIC HEALTH RELEVANCE: Recent estimates suggest that a majority of the 40,000 new cases of HIV reported annually in the US are attributable largely to sexual risk behavior associated with non-injection drug use. Additionally, African American drug users exhibit substantial HIV health disparities with African American females being 21 times more likely to contract HIV than white females. The proposed project is designed to address critical gaps in the HIV prevention science field by evaluating the ability of an intervention coordinating cognitive-behavioral and couples/family systems components to prevent HIV among adult drug users at heightened disease risk.           PROJECT NARRATIVE. Recent estimates suggest that a majority of the 40,000 new cases of HIV reported annually in the US are attributable largely to sexual risk behavior associated with non-injection drug use. Additionally, African American drug users exhibit substantial HIV health disparities with African American females being 21 times more likely to contract HIV than white females. The proposed project is designed to address critical gaps in the HIV prevention science field by evaluating the ability of an intervention coordinating cognitive-behavioral and couples/family systems components to prevent HIV among adult drug users at heightened disease risk.",Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users,8040954,R01DA014498,"['Selection Bias ', ' Gonorrhea ', ' Gonococcal Infection ', ' behavior change ', ' neuropsychological ', ' executive function ', ' executive control ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Legal ', ' Serologic tests ', ' serology ', ' Serological Tests ', ' Outcome Assessment (Health Care) ', ' Outcomes Assessment ', ' Demographic Factors ', ' Ecosystem ', ' Ecological Systems ', ' Ecologic Systems ', ' HIV prevention trial ', ' Injecting drug user ', ' Injection Drug User ', ' Academic achievement ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Videotape ', ' psychoeducation ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' Client ', ' Trichomonas Infections ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Sampling ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Outcome ', ' Characteristics ', ' innovation ', ' innovative ', ' innovate ', ' System ', ' LOINC Axis 4 System ', ' Female ', ' Cognitive ', ' Prevention ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' health disparity ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Science ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' health disparities ', ' Communication ', ' response ', ' base ', ' Data ', ' Code ', ' Coding System ', ' Data Set ', ' Dataset ', ' Modeling ', ' Literature ', ' Incidence ', ' Measures ', ' Reporting ', ' Injection of therapeutic agent ', ' Injections ', ' Research ', ' Risk ', ' Couples ', ' Behavioral ', ' Mediating ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' prevent ', ' preventing ', ' Family ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Testing ', ' design ', ' designing ', ' skills ', ' Development ', ' developmental ', ' tool ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Time ', ' Pathway interactions ', ' pathway ', ' Health ', ' interest ', ' Problem Solving ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Recruitment Activity ', ' recruit ', ' Exhibits ', ' Methods ', ' Address ', ' Modification ', ' Interview ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Gender ', ' intervention effect ', ' Employment ', ' group intervention ', ' Cognitive Therapy ', ' cognitive behavioral treatment ', ' cognitive behavioral therapy ', ' cognitive behavioral modification ', ' cognitive behavioral intervention ', ' cognitive behavior therapy ', ' cognitive behavior modification ', ' cognitive behavior intervention ', ' Cognitive Psychotherapy ', ' Cognition Therapy ', ' Urine ', ' Urine Urinary System ', ' post intervention ', ' sex risk ', ' sexual risk behavior ', ' Contracts ', ' Contracting Opportunities ', ' trend ', ' Educational Curriculum ', ' Curriculum ', ' Fostering ', ' Attitude ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Drug usage ', ' drug use ', ' disorder risk ', ' disease risk ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Process Assessment (Health Care) ', ' Process Assessment ', ' Belief ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Drug Administration Routes ', ' cost effectiveness ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Drug user ', ' Neuropsychological Tests ', ' Neuropsychologic Tests ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' randomized trial ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R01,2011,689409,0.1494038709691358
"National Hispanic Science Network on Drug Abuse (NHSN) Annual Conference    DESCRIPTION (provided by applicant): This R13 meetings grant application seeks support for five yearly three-day stand alone conferences to be held at selected locations beginning in the fall of 2009. This proposal reflects a collaborative initiative between Louisiana State University Health Sciences Center and the National Hispanic Science Network on Drug Abuse (NHSN), based at the University of Miami. The annual scientific conferences help to accomplish the NHSN mission of fostering both interdisciplinary and translational research, by promoting dialogue between biologic, social, behavioral, and cultural scientists and disseminating findings back to the field. Previous conferences, supported through a NIDA-funded contract, have been an effective platform for developing the aims of the NHSN, with particular emphasis on mentoring and training Hispanic graduate students and early career scientists. The aims of the conferences will be: A) to advance science in the area of drug abuse research and its co-morbid conditions, particularly as it impacts on the Hispanic population. It will promote bidirectional translational research ranging from bench to community and a trans-disciplinary cross-fertilization of ideas among scientists from all fields of drug abuse helping to establish future research priorities. B) To foster the development of Hispanic researchers, with emphasis in areas related to drug abuse research by facilitating the development of integrated and continuous collaborative and mentoring networks. Funding is requested to support participation for 50 trainees/early career scientists and 20 research scientists presenting in the scientific panels. An average of 150 participants, representing the field from the national and international scientific communities, are expected at each yearly conference, including members of the global research community whose interests encompass a multifaceted approach to understanding the factors underlying health disparities as they pertain to drug use and abuse ranging from epidemiology to environmental health, psychology, sociology, health policy, neuroscience and other biomedical sciences, and epigenetics. The first conference proposed ""Integrating Population, Laboratory, and Clinical Sciences in Minority Health"" will be hosted by the University of Miami, from December 1-3, 2009. The format of the conference aims to provide ample opportunity for discussion, networking, and collaboration discussions as well as development of new ideas related to training and mentoring of the next generation of researchers in the field of drug abuse. The themes, scientific content, and program for each conference will be developed by a Scientific Conference committee comprised of NHSN members, NIH officials, and federal liaisons. The themes will be directly related to NIDA's strategic plan and the NIH blueprint, addressing timely topics and developing challenges in the field. PUBLIC HEALTH RELEVANCE: The Annual National Hispanic Science Network on Drug Abuse Conference provides multidisciplinary scientists in drug abuse and related fields interested in advancing science, particularly as it pertains to the Hispanic population, to have a collegial exchange providing a forum for discussion and dissemination of research findings and an opportunity for networking and mentoring trainees in the area of drug abuse research. This unique opportunity will promote bidirectional translational research ranging from bench to community and a trans-disciplinary cross-fertilization of ideas among scientists from all fields of drug abuse. The PI and the organizing committee are confident that the proposed conferences will serve as a platform to establish future research priorities for the field of drug abuse as it pertains to the Hispanic population.            Project narrative  The Annual National Hispanic Science Network on Drug Abuse Conference provides multidisciplinary   scientists in drug abuse and related fields interested in advancing science, particularly as it pertains   to the Hispanic population to have a collegial exchange providing a forum for discussion and   dissemination of research findings and an opportunity for networking and mentoring trainees in the   area of drug abuse research. This unique opportunity will promote bidirectional translational   research ranging from bench to community and a trans-disciplinary cross-fertilization of ideas   among scientists from all fields of drug abuse. The PI and the organizing committee are confident   that the proposed conferences will serve as a platform to establish future research priorities for the   field of drug abuse as it pertains to the Hispanic population.    ",National Hispanic Science Network on Drug Abuse (NHSN) Annual Conference,8072055,R13DA026647,"['Clinical Sciences ', ' health disparity ', ' health disparities ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Contracts ', ' Contracting Opportunities ', ' Back ', ' Dorsum ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' falls ', ' Strategic Planning ', ' Fostering ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Science ', ' Funding ', ' Neurosciences ', ' graduate student ', ' symposium ', ' conference ', ' International ', ' member ', ' multidisciplinary ', ' Translational Research ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Applications Grants ', ' Grant Proposals ', ' Mentors ', ' next generation ', ' Behavioral ', ' Mission ', ' programs ', ' Communities ', ' Health ', ' Collaborations ', ' Population ', ' Scientist ', ' Training ', ' Address ', ' Participant ', ' interest ', ' social ', ' Drug usage ', ' drug use ', ' base ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Development ', ' developmental ', ' Area ', ' Location ', ' Laboratories ', ' meetings ', ' Research ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' career ', ' Universities ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Health Psychology ', ' dissemination research ', ' Fertilization ', ' Fertility/Fertilization ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Health Sciences ', ' Sociology ', ' minority health ', ' Environmental Health ', ' Environmental Health Science ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Louisiana ', ' ']",NIDA,LSU HEALTH SCIENCES CENTER,R13,2011,144321,0.0829885288088024
"Linking State Data to Identify Unmet Need for Drug Treatment in Women Aged 15-49    DESCRIPTION (provided by applicant): Drug treatment programs know who they serve, but can only estimate who they do not serve; the inability to accurately measure unmet treatment need, especially among women of reproductive age, is a key barrier to developing interventions to reduce drug-related health consequences for women, their children, and society. This proposal describes an innovative collaboration to link two existing independent state data systems to create a new, unique longitudinal, epidemiologic database that combines drug treatment data with hospital utilization and health outcomes data, to broadly identify drug-related problems and the prevalence of unmet treatment need, and to track drug-related health outcomes among Massachusetts women of reproductive age and their children. For the first time, women in need of drug treatment services who did not receive them will be individually identifiable, allowing for better estimation and description of unmet need. The new linked data will permit assessment of disparities among women with met and unmet treatment need through multiple sources of data, including using a tested algorithm to identify drug diagnoses in hospital data. Moreover, the linked data will allow the examination of subsequent health outcomes among women ages 15-49, and birth outcomes among their children. The two data sources to be linked are: (1) the population-based MA Pregnancy to Early Life Longitudinal (PELL) data system that includes vital records (births, fetal deaths and deaths); hospital discharge, observational stay, and emergency department visit records; and the MA Birth Defects Registry; and (2) the MA Bureau of Substance Abuse Services (BSAS) treatment data system that contains treatment records for over 25,000 annual admissions of women of reproductive age to BSAS-funded substance abuse treatment facilities. The three broad study aims are: 1. Link PELL data to the MDPH-BSAS Treatment Database and verify linkages. 2. Develop and pilot methods a) among all MA women of reproductive age, identify women with drug abuse or dependence (2002-2007), assess unmet need for treatment services, and characterize disparities in treatment use; b) among MA women who had deliveries (2003-2006), describe the pattern of identification and treatment of drug problems in the periods before, during, and after pregnancy, assess unmet need for drug treatment by timing, and characterize pregnancy outcomes; and c) among MA women with an identified drug problem develop preliminary multivariate models with predisposing and enabling factors predicting receipt of treatment, and, among women who delivered, risk for prematurity. 3. Develop an R01 proposal to describe the impact of substance abuse and treatment on women's and children's health, based on bivariate and multivariate analyses proposed for this study and a tandem NIH/NIAAA study.      PUBLIC HEALTH RELEVANCE: This innovative public-private collaboration links two existing independent state data systems (BSAS and PELL) to create a new, unique longitudinal and epidemiologic database that combines drug treatment data with hospital utilization and health outcomes data, to broadly identify drug-related problems and the prevalence of unmet treatment need, and to track drug-related health and birth outcomes among Massachusetts women of reproductive age. For the first time, women in need of drug treatment services who did not receive them will be individually identifiable, allowing for accurate estimation and description of unmet need, a critical step to improve state drug treatment programs for women of reproductive age.           Project Narrative This innovative public-private collaboration links two existing independent state data systems (BSAS and PELL) to create a new, unique longitudinal and epidemiologic database that combines drug treatment data with hospital utilization and health outcomes data, to broadly identify drug-related problems and the prevalence of unmet treatment need, and to track drug-related health and birth outcomes among Massachusetts women of reproductive age. For the first time, women in need of drug treatment services who did not receive them will be individually identifiable, allowing for accurate estimation and description of unmet need, a critical step to improve state drug treatment programs for women of reproductive age.",Linking State Data to Identify Unmet Need for Drug Treatment in Women Aged 15-49,8119664,R21DA027181,"['Public Health Schools ', ' Information Systems ', ' Information Technology Systems ', ' IT Systems ', ' Data Systems ', ' Massachusetts ', ' Maternal Health ', ' Child health care ', ' Child Health ', ' Boston ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' Reproductive History ', ' Reproductive Issues ', ' Reproductive History Epidemiology ', ' Reproductive Factors ', ' Admission activity ', ' Admission ', ' National Institute on Alcohol Abuse and Alcoholism ', ' NIAAA ', ' Companions ', ' Pediatric Hospitals ', "" Children's Hospital "", ' Hospital Records ', ' Registries ', ' time use ', ' Premature Birth ', ' preterm delivery ', ' premature delivery ', ' premature childbirth ', ' Preterm Birth ', ' Fetal Death ', ' fetus death ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' reproductive ', ' premature ', ' prematurity ', ' Records ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' aged ', ' Birth ', ' Parturition ', ' Mothers ', ' treatment program ', ' clinically significant ', ' clinical significance ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Infant ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Modality ', ' Dependence ', ' treatment effect ', ' Early treatment ', ' early therapy ', ' early intervention ', ' Data Sources ', ' Pregnancy ', ' Gestation ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Prevalence ', ' Services ', ' Pattern ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Hospitals ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Woman ', ' Life ', ' improved ', ' Recording of previous events ', ' History ', ' Characteristics ', ' innovation ', ' innovative ', ' innovate ', ' Societies ', ' Risk ', ' Cessation of life ', ' Death ', ' Health ', ' Time ', ' Outcome ', ' Methods ', ' Population ', ' Congenital Abnormality ', ' Molecular Genetic Abnormality ', ' Congenital Malformation ', ' Congenital Deformity ', ' Congenital Defects ', ' Congenital Anatomical Abnormality ', ' Congenital Anatomic Abnormality ', ' Birth Defects ', ' Visit ', ' Pregnancy Outcome ', ' Testing ', ' Collaborations ', ' Modeling ', ' Measures ', ' base ', ' Age ', ' Funding ', ' Individual ', ' meetings ', ' Diagnosis ', ' Algorithms ', ' Address ', ' Data Set ', ' Dataset ', ' programs ', ' public health medicine (field) ', ' Public Health ', ' Link ', ' Frequencies (time pattern) ', ' Frequency ', ' public health relevance ', ' substance abuse treatment ', ' substance abuse therapy ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' population based ', ' Data ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Universities ', ' hospital utilization ', ' alcohol abuse therapy ', ' alcohol treatment ', ' alcohol abuse treatment ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Needs Assessment ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Enabling Factors ', ' alcohol related problem ', ' Drug Abuse Treatment Services ', ' public-private partnership ', ' Birth Records ', ' administrative database ', ' administrative data base ', ' Predisposing Factor ', ' ']",NIDA,BOSTON UNIVERSITY MEDICAL CAMPUS,R21,2011,188332,0.10441650620674646
"Collaborative Research on Drug Abuse    DESCRIPTION (provided by applicant): This P01 develops and applies state-of-the-art methods to analyze existing but under-utilized drug abuse databases in collaboration with their owners. We address contemporary, theoretical, and applied issues in drug abuse research to understand intersections between substance abuse and AIDS risk behaviors as well as minority and gender-based health disparities. We work with dozens of investigators from drug & social policy, epidemiology, health sciences, medicine, nursing, psychiatry, psychology, public health, and social work who own exciting substance abuse data to develop models that test current theories, especially on epidemiology, prevention, intervention, and treatment of drug abuse, using modern multivariate methods to control for measurement errors, biases, and other confounds. The Models and Methods Project develops psychometric and statistical analytic techniques that hold special promise for improving the quality of drug abuse and AIDS research. The At-Risk Project studies substance abuse related data sets on vulnerable populations (substance abusers, homeless people, individuals who are HIV positive or who have AIDS, victims of domestic abuse, runaways, gang members, and others at high risk for AIDS or drug abuse) with methods to control sampling, measurement, distributional and other biases. The Community Project studies drug abuse etiology, adult consequences, HIV risk, intergenerational processes, general deviance, and related issues in large community-based samples, and develops and tests explanatory theories using models that permit separation of common from specific effects, control for artifacts, etc. The Core Project oversees and integrates all components, hosts visiting scholars, provides computer facilities, and sponsors a mentoring program for disadvantaged students. The substantive part of the Models Project and the At-Risk and Community Projects will be developing and testing integrative theories that can be applied across different populations. The findings from their studies will lead to greater understanding of precursors and concomitants of substance abuse and HIV/AIDS risk and transmission. In turn, these findings will guide development of effective interventions to reduce negative health outcomes and treatment disparities in community, ethnic, and vulnerable populations, and provide guidance on how these may be alleviated.     ",Collaborative Research on Drug Abuse,8119008,P01DA001070,[''],NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,P01,2011,1041326,0.06373110537308126
"Incarceration Effects on Prevention of Drug Use, STI-HIV and Recidivism Incarcerated women are often affected by childhood abuse, violence, and other difficult life circumstances throughout their life course, and typically come from disproportionately disadvantaged neighborhoods. However, relatively less research has examined how neighborhood characteristics and incarceration interact with inmates' risk factors. Although several criminal justice studies demonstrated that excessive incarceration may exacerbate community disadvantages and instability as a large proportion of residents constantly move between jail and community, the impact of neighborhood disadvantages on inmates' health outcomes, such as drug use and sexual risks have not been examined. Furthermore, while the rate of female incarceration has steadily increased over the past 20 years, previous studies predominantly concern with men, and women's unique life trajectories of incarceration, sexual risks, and drug use have been less understood. The study proposes to examine the impact and consequences of incarceration on the patterns of substance use, risky sexual behaviors, and recidivism among female inmates who are returning to the community from a large urban jail. The proposed conceptual model will be tested explaining the ecological factors associated with incarceration, and the impact of incarceration on drug use, STls/HlV risks, and recidivism among female inmates. To achieve the objectives, the proposed study will conduct: 1) qualitative in-depth interviews with women in jail exploring their experience with incarceration, changes in social networks and support, health  concerns, health care and social services utilization, expected challenges upon release, and needs for successful transition to community life; 2) face-to-face longitudinal surveys with a cohort of female inmates at three time points (baseline in jail, and two weeks and three months post-release) to examine primary outcomes (relapse to drug use, risks for STIs/HlV infection, recidivism), secondary outcomes, and mediators (social network, social support); and 3) multi-level analysis and mapping to explore the effects of neighborhood disadvantage and instability, the rates of incarceration and STIs on women's outcomes. Incarcerated women are often from the poor, minority, urban populations who are most affected by drug  abuse and HIV. The rate of female incarceration has dramatically increased in recent years, while the  majority of them return to the community along with their health problems. Findings of the research wilt help  better understand incarcerated women's complex health, socioeconomic issues and community context,  which may contribute to reducing health disparities among women living in disadvantaged neighborhoods.","Incarceration Effects on Prevention of Drug Use, STI-HIV and Recidivism",8118597,R00DA024012,"['Alcohol dependence ', ' alcohol-dependent ', ' alcohol dependency ', ' alcohol addiction ', ' Poverty ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Social Network ', ' Violence ', ' violent behavior ', ' violent ', ' offender ', ' criminal offender ', ' Disadvantaged ', ' Social support ', ' social support network ', ' service utilization ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' segregation ', ' Racial Segregation ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Educational aspects ', ' Education ', ' General Population ', ' General Public ', ' secondary outcome ', ' Employment ', ' Prisoner ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Social work (field) ', ' Social Work ', ' Social Service ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' human capital ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' primary outcome ', ' Probability ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Life ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Maps ', ' Healthcare ', ' health care ', ' Data ', ' Relapse ', ' socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Pattern ', ' Methods ', ' Reporting ', ' Infection ', ' Modeling ', ' cohort ', ' high risk ', ' Health ', ' Woman ', ' Risk ', ' improved ', ' Characteristics ', ' Complex ', ' Female ', ' Testing ', ' Exhibits ', ' experience ', ' Affect ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Time ', ' Outcome ', ' Minority ', ' Goals ', ' Drug usage ', ' drug use ', ' Interview ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Resources ', ' Research Resources ', ' Neighborhoods ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' men ', "" men's "", ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Research ', ' Risk Factors ', ' Individual ', ' Communities ', ' health disparity ', ' health disparities ', ' Child Abuse ', ' Childhood Abuse ', ' drug abuse prevention ', ' drug use prevention ', ' drug addiction prevention ', ' Longitudinal Surveys ', ' recidivism ', ' Jail ', ' community living ', ' Urban Population ', ' Social Health Services ', ' reincarceration ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Criminal Justice ', ' ']",NIDA,UNIVERSITY OF ILLINOIS AT CHICAGO,R00,2011,238693,0.08478374343868396
"Drug Abuse and Crime Across the Life Course in an African American Population    DESCRIPTION (provided by applicant): African Americans are disproportionately represented in national crime statistics for arrests and incarceration as well as victimization, particularly for drug-related and violent offenses. Their involvement in crime often represents only one component of a well-recognized cluster of negative experiences and circumstances including drug use problems, socioeconomic disadvantage and poor physical and mental health, sometimes evident in childhood. The cost to individuals, families, and society is enormous, yet we know little about the development of these patterns across the life course. Despite these evident disparities, few studies have examined the development of drug use and criminal behaviors over time within African American community populations, especially into mid adulthood. We intend to study the timing and sources of risk over the life span to better understand the disparities in health and social consequences related to criminal justice issues among African Americans. To that end, we request support to analyze existing crime and drug data covering 35 years in the lives of a cohort of first grade, African American children from inner city Chicago. This prospective developmental study (the Woodlawn project) began in 1966-67, with the most recent follow up in 2002-3 at ages 42-43, and interim assessments in adolescence and early adulthood (age 32-33). The study population had high levels of drug use and criminal activity in adulthood. In the proposed project, we will focus on interrelationships of drug abuse and crime, examining predictors and consequences of drug abuse, criminal activity, and involvement with the criminal justice system. Using data from cohort members, mothers, interviewers, and official criminal records, we will identify 1) patterns of drug use and criminal behaviors over the life course; 2) individual and contextual predictors of later drug use, criminal activity/behaviors, and involvement with the criminal justice system; 3) social, economic, and health consequences of drug use, criminal behaviors, and involvement in the criminal justice system. Of particular interest is how drug use in adolescence and early adulthood relates to the risk of being arrested and incarcerated and, conversely, how early arrests and incarceration influence later drug use and criminal behaviors. This information will further our understanding of the etiology and consequences of crime and drug use into mid adulthood, and inform the design of interventions at various stages along the life course.             ",Drug Abuse and Crime Across the Life Course in an African American Population,8013895,R01DA022366,"['socioeconomics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' Victimization ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Violence ', ' violent behavior ', ' violent ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' men ', "" men's "", ' Records ', ' Personal Satisfaction ', ' well-being ', ' Chicago ', ' Unemployment ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' physical conditioning ', ' physical health ', ' Social Functioning ', ' health economics ', ' statistics ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' intervention program ', ' Gender ', ' inner city ', ' Time Study ', ' Request for Applications ', ' NIH RFA ', ' Population Study ', ' Societies ', ' racial discrimination ', ' race discrimination ', ' Mothers ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' first grade ', ' Crime ', ' social integration ', ' Neighborhoods ', ' therapy design ', ' treatment design ', ' intervention design ', ' Drug usage ', ' drug use ', ' cost ', ' Resources ', ' Research Resources ', ' Female ', ' Prevention program ', ' male ', ' Health ', ' prospective ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Time ', ' Role ', ' social role ', ' Pathway interactions ', ' pathway ', ' cohort ', ' Behavior ', ' Population ', ' Interviewer ', ' Behavioral ', ' Pattern ', ' Complex ', ' Outcome ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Family ', ' Individual ', ' base ', ' Development ', ' developmental ', ' Affect ', ' Research ', ' emerging adult ', ' early adulthood ', ' Age ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Address ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Life ', ' Childhood ', ' pediatric ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Learning ', ' design ', ' designing ', ' Staging ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Mediating ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' member ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Risk ', ' Mortality Vital Statistics ', ' Mortality ', ' Risk Factors ', ' experience ', ' Longevity ', ' lifespan ', ' life span ', ' Length of Life ', ' Communities ', ' Woman ', ' System ', ' LOINC Axis 4 System ', ' Sampling ', ' social ', ' Data ', ' interest ', ' Source ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Disadvantaged ', ' criminal behavior ', ' Criminal Justice ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R01,2011,475527,0.19747166288874865
"Understanding Racial Disparities in Teen Methamphetamine Use Despite a voluminous number of studies documenting the nature and extent of teen methamphetamine use in the United States, relatively few studies have provided a comprehensive portrait of the risk and protective factors associated with adolescent meth use. One salient omission is the lack of studies that provide insight into the well-documented race gap in teen methamphetamine use: Native American teens are at much greater risk of use and abuse of methamphetamines than non-Hispanic whites. This fact is exacerbated by evidence that meth use is associated with a heightened risk of engaging in behaviors such as IV drug use and unprotected sexual practices that are correlated with contracting HIV/AIDS. Indeed, research from the Centers for Disease Control and Prevention provides evidence that Native Americans are at a heightened risk of contracting HIV/AIDS relative to non-Hispanic whites. Clearly, there are important gaps in our knowledge and understanding of why methamphetamine use/abuse is distributed differentially among adolescents, and there is a need for research that specifically focuses on explaining the ""race-gap"" between Native American and non Hispanic white teens in America with regards to both meth use and the associations between meth use and behaviors associated with risk of exposure to HIV/AIDS. The present study, by addressing these knowledge gaps, will facilitate understanding into why the race gap in such behavior exists and can direct targeted intervention and prevention programs that address such health disparities between Native American and non-Hispanic white teens. The long-term goal of the research team is to continue to explore how racial and economic stratification serves to produce health disparities, in order to reduce race and economic based disparities. The objective of this application is threefold: a) to identify the social risk and protective factors associated with both meth use generally and those factors that serve to delineate racial/ethnic differences in use specifically; b) to apply the stress process model/General Strain Theory to expand our understanding of both meth use and racial differences in use; and c) to explore the association between meth use and risky sexual behaviors and how race serves as a potential moderator. The central hvpothesis of this application is that differences in stress exposure will predict both individual and race-based variation in meth use, abuse, and related risky behaviors (IV drug use/unprotected sex) with personal and social resources serving to moderate the stresssubstance use association. The plan is to fill this knowledge gap by pursuing the following two specific aims: a) utilize the stress process modei/GST framework to identify the social risk and protective factors associated with the initiation, use, and abuse/dependence of meth use among both males and females, non-Hispanic whites and Native American adolescents who attend public schools in Montana; and b) evaluate the stress process modei/GST framework as an explanation for predicting risky sexual practices and the potential role of race and meth use as moderators. In order to accomplish these objectives, one wave of data will be collected, entailing the use of a self-administered questionnaire of a targeted sample of approximately 900 ninth and tenth grade boys and girls attending three high schools in Montana. The proposed research is significant because it is expected to provide fundamental knowledge necessary in order to construct efficacious interventions and prevention efforts designed to reduce the adolescent Native American-white race gap in meth use, and risky behaviors associated with HIV/AIDS.  This proposed research is significant because it is expected to provide fundamental knowledge necessary in order to construct efficacious interventions and prevention efforts designed to reduce the adolescent Native Americanwhite race gap in meth use, IV drug use and risky sexual behaviors associated with contracting HIVIAIDS. This research will provide a vertical step in understanding how the stress process modei/GST can be utilized to understand and redress racial differences in methamphetamine use and its association with risky behaviors (sexual and IV drug use) related to HIV/AIDS transmission and should facilitate additional research into understanding the Native American-white race gap in other substance use and related HIV/AIDS associated risk behaviors. It is also expected that the present study would provide further clarification and refinement of the stress process and GST theories utility for explaining drug use. Further, the present research could facilitate the development of general prevention and intervention programs beyond those that currently are employed as the dominant strategy to reduce teen meth use, such as the notable Montana Meth Project. Rather than replace such programs, the development of new programs could supplement existing prevention efforts by approaching the problem from a different theoretical orientation.",Understanding Racial Disparities in Teen Methamphetamine Use,8075602,R03DA029212,"['racial and ethnic ', ' racial/ethnic ', ' Methamphetamine dependence ', ' methamphetamine addiction ', ' meth dependence [{C1533217}] ', ' meth addiction ', ' METH dependence ', ' METH addiction [{C1533217}] ', ' Prevention program ', ' Stratification ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Self-Administered ', ' Questionnaires ', ' Contracts ', ' Contracting Opportunities ', ' Intravenous ', ' statistics ', ' Americas ', ' stressor ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' disorder prevention ', ' disease prevention ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Anxiety ', ' Youth ', ' Youth 10-21 ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Stress ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Economics ', ' Dependence ', ' Mental Depression ', ' depression ', ' Area ', ' Teenagers ', ' teen years ', ' Teen ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Female ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' girls ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Utility Theories ', ' Evidence based intervention ', ' Individual ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Literature ', ' design ', ' designing ', ' Research ', ' Knowledge ', ' Educational aspects ', ' Education ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Variant ', ' Variation ', ' health disparity ', ' health disparities ', ' transmission process ', ' Transmission ', ' social ', ' public health medicine (field) ', ' Public Health ', ' United States ', ' Nature ', ' Drug usage ', ' drug use ', ' insight ', ' Health ', ' Resources ', ' Research Resources ', ' Process ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Data ', ' male ', ' Risk ', ' Sampling ', ' Behavior ', ' Respondent ', ' programs ', ' Development ', ' developmental ', ' Gender ', ' Address ', ' Goals ', ' response ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Life ', ' Schools ', ' Environment ', ' theories ', ' Diagnosis ', ' County ', ' Role ', ' social role ', ' Testing ', ' Surveys ', ' Survey Instrument ', ' Modeling ', ' Prevention ', ' Work ', ' base ', ' Investigation ', ' Relative (related person) ', ' Relative ', ' Exposure to ', ' Outcome ', ' Fostering ', ' Science ', ' methamphetamine abuse ', ' Legal ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' racial/ethnic difference ', ' Survey Methodology ', ' Survey Method ', ' Sexual Health ', ' Paranoia ', ' Paranoid Disorders ', ' Inequality ', ' Portraits ', ' ninth grade ', ' high school freshman ', ' tenth grade ', ' high school sophomore ', ' racial difference ', ' race differences ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Social Characteristics ', ' adverse outcome ', ' adverse consequence ', ' Native Americans ', ' intravenous drug use ', ' Cocaine ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Illicit Drugs ', ' boys ', ' Program Development ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' rural area ', ' Sociology ', ' Aggressive behavior ', ' Aggression ', ' Montana ', ' Psychotic Disorders ', ' Psychoses ', ' criminal behavior ', ' Needle Sharing ', ' Syringe Sharing ', ' Needlesharing ', ' high school ', ' intervention program ', ' ']",NIDA,MONTANA STATE UNIVERSITY - BOZEMAN,R03,2011,69113,0.034103952870873554
"Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study DESCRIPTION (provided by applicant):  The overall goal of this project is to address how disproportionate confinement of racial/ethnic minorities-especially African Americans-affects health disparities in the HIV/AIDS epidemic. African Americans comprise only 13% of the general population, but about 40% of incarcerated youth and adults and 50% of new cases of HIV/AIDS. Yet, large multisite national longitudinal studies of HIV/AIDS focus on high- risk samples such as men who have sex with men (MACS), women infected with HIV and other ""at-risk"" females (WIHS), and infected women and their infants (WITS). These studies do not include adolescents, do not sample correctional populations, and do not examine the effect of incarceration on HIV/AIDS. Most studies of incarcerated populations are cross-sectional and provide limited information on the effects of incarceration.  To continue to address this key omission in the literature, we propose to extend the Northwestern Juvenile Project, a longitudinal study of 1829 juvenile justice youth, enrolled at age 10-18 years (1172 males, 657 females; 1005 African Americans, 296 non-Hispanic whites, 524 Hispanics, and 4 ""other"" race/ethnicity). Currently, the HIV/AIDS component of the project (RO1 DA022953) includes only a subsample (n=743) and 10-, 11-, 12-, and 13-year follow-up interviews. We now propose to (1) study the entire sample (originally 1829, now 1678); (2) conduct 3 additional annual interviews (14-, 15-, and 16-year follow-ups), at which time participants will be aged 26-34 years; (3) collect official records to cross-validate self-reported data (on STI status, arrests, incarceration history, and services received); (4) test the entire sample for HIV infection, chlamydia, and gonorrhea; and (5) administer a new module on incarceration, release, and re-entry. Participants are re-interviewed whether they are re-incarcerated or back in the community. Using data collected in prior phases and the additional interviews, we will examine patterns of drug use, drug use disorder, HIV/AIDS risk and infection from adolescence (ages 10-17 years) to emerging adulthood (ages 18-24 years) and young adulthood (age 25 and older). Our Specific Aims focus on how incarceration, release, and re-entry (e.g., age[s] incarcerated, number of incarcerations, length of incarcerations, amount of time spent in the community between incarcerations) affect the following: (1) drug use behaviors (including the number and types of substances used, frequency of use, and route of administration) and drug use disorders (onset, persistence, desistance, and recurrence); (2) HIV/AIDS sex risk behaviors (including unprotected anal or vaginal receptive sex and trading sex for drugs) and injection-risk behaviors; (3) prevalence and incidence of HIV infection and other STIs; (4) the relationship between patterns of drug use and disorder and HIV/AIDS risk behaviors, especially how risk and protective factors predict, moderate, and mediate these relationships.  This study responds to the initiatives of NIDA, NIAAA, and other NIH institutes to reduce health disparities in HIV/AIDS in minority populations. PUBLIC HEALTH RELEVANCE: Racial/ethnic minorities suffer disproportionately from the HIV/AIDS epidemic and are disproportionately incarcerated. To address health disparities in HIV/AIDS, we must study correctional populations, which increased from nearly 1.8 million in 1997 to over 2.2 million by mid-year 2006. The proposed study will guide public health policy by investigating how incarceration affects the development of substance use and disorder and HIV/AIDS; identifying risk and protective factors that are potentially malleable; identifying points of intervention during key developmental periods; and extending current conceptual models to include incarceration, release, and reentry.","Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study",8038403,R01DA028763,"['Judgment ', ' surveillance data ', ' Health Services ', ' health care service ', ' Onset of illness ', ' disorder onset ', ' disease onset ', ' Social Network ', ' racial and ethnic disparities ', ' Authorization documentation ', ' Permission ', ' Authorization ', ' Gonorrhea ', ' Gonococcal Infection ', ' Substance Use Disorder ', ' probation ', ' Human Papillomavirus ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Institute of Medicine (U.S.) ', ' NAS/IOM ', ' Institute of Medicine ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Justice ', ' Vagina ', ' Vaginal ', ' Freedom ', ' Liberty ', ' Anus ', ' Anal ', ' Chicago ', ' deviant ', ' deviancy ', ' HIV-1 ', ' human T lymphotropic virus III ', ' human T cell leukemia virus III ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' National Institute on Alcohol Abuse and Alcoholism ', ' NIAAA ', ' 18 year old ', ' eighteen year old ', ' age 18 years ', ' service utilization ', ' Ulcer ', ' Ulceration ', ' alcohol and other drug ', ' racial/ethnic difference ', ' Herpes Simplex Infections ', ' Herpesvirus hominis disease ', ' Herpes simplex disease ', ' Herpes Simplex ', ' high risk behavior ', ' offender ', ' criminal offender ', ' Needles ', ' Syphilis ', ' great pox ', ' Adolescent Risk Behavior ', ' Youth Risk Behavior ', ' Cervical dysplasia ', ' Cervix Dysplasia ', ' transcription mediated amplification ', ' Injecting drug user ', ' Injection Drug User ', ' Academic achievement ', ' age difference ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' racial and ethnic ', ' racial/ethnic ', ' Longitudinal Surveys ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Chlamydia trachomatis ', ' Rickettsia trachomae ', ' Child Abuse and Neglect ', ' child maltreatment ', ' Childhood maltreatment ', ' Admission activity ', ' Admission ', ' Not Hispanic or Latino ', ' Non-Hispanic ', ' Request for Applications ', ' NIH RFA ', ' Jail ', ' Neisseria gonorrhoeae ', ' N.gonorrhoeae ', ' N. gonorrhoeae ', ' Gonococcus ', ' national surveillance ', ' Healthy People 2010 ', ' Illinois ', ' Underrepresented Minority ', ' underserved minority ', ' under-represented minority ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' men who have sex with men ', ' men who have sex with other men ', ' Prisons ', ' Crime ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' surveillance study ', ' Genital system ', ' urogenital system (genital part) ', ' Genital ', ' health record ', ' Trichomonas Infections ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Neighborhoods ', ' Phase ', ' Goals ', ' Pattern ', ' Recording of previous events ', ' History ', ' Life ', ' Area ', ' Participant ', ' public health medicine (field) ', ' Public Health ', ' Risk Assessment ', ' Communities ', ' high risk ', ' Clinical ', ' Methods ', ' Length ', ' Literature ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Event ', ' Adult ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Subgroup ', ' Affect ', ' Heterosexuals ', ' Frequencies (time pattern) ', ' Frequency ', ' Ethnic group ', ' Time ', ' sex ', ' Age ', ' innovation ', ' innovative ', ' innovate ', ' Saliva ', ' Incidence ', ' health disparity ', ' health disparities ', ' Modeling ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Behavior ', ' Child ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Research ', ' Development ', ' developmental ', ' experience ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Cessation of life ', ' Death ', ' Data ', ' Population ', ' Epidemic ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Enrollment ', ' enroll ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Address ', ' Sampling ', ' Reporting ', ' Individual ', ' Outcome ', ' County ', ' Source ', ' Surveys ', ' Survey Instrument ', ' Health ', ' Recommendation ', ' Kinetics ', ' Characteristics ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' intravenous drug use ', ' Back ', ' Dorsum ', ' Monitor ', ' Funding ', ' Woman ', ' Grant ', ' Risk ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Work ', ' aged ', ' Techniques ', ' Recurrence ', ' Recurrent ', ' Process ', ' Infection ', ' interest ', ' Female ', ' Publishing ', ' Aging ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Complex ', ' Mediating ', ' Antibodies ', ' Screening procedure ', ' screenings ', ' screening ', ' Services ', ' Accounting ', ' Staging ', ' Risk Factors ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Testing ', ' Records ', ' System ', ' LOINC Axis 4 System ', ' transmission process ', ' Transmission ', ' Illicit Drugs ', ' alcohol use disorder ', ' ethanol use disorder ', ' Minority Groups ', ' Ethnic and Racial Minorities ', ' Employment ', ' cooking ', ' Urine ', ' Urine Urinary System ', ' sex risk ', ' sexual risk behavior ', ' African ', ' Contracts ', ' Contracting Opportunities ', ' Surgeon ', ' Enzyme Immunoassay ', ' Enzyme Linked Immunoassay Immunologic ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' emerging adulthood ', ' Liquid substance ', ' liquid ', ' fluid ', ' Viral hepatitis ', ' Longitudinal Studies ', ' long-term study ', ' NIH Program Announcements ', ' Program Announcement ', ' Drug Use Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Interview ', ' Oral ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Persons ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Alcohols ', ' Alcohol Chemical Class ', ' Sex Characteristics ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Injection of therapeutic agent ', ' Injections ', ' FDA approved ', ' Cohort Studies ', ' Concurrent Studies ', ' Electronics ', ' Youth ', ' Youth 10-21 ', ' Patient Self-Report ', ' Self-Report ', ' Specimen ', ' Research Specimen ', ' parole ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Institutes ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Needle Sharing ', ' Syringe Sharing ', ' Needlesharing ', ' Prevalence ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' cost effective ', ' cost-effective ', ' Drug usage ', ' drug use ', ' General Population ', ' General Public ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Housing ', ' Life Style ', ' Lifestyle ', ' juvenile justice system ', ' Route ', ' Minority ', ' age group ', ' male ', ' young adult ', ' young adulthood ', ' adult youth ', ' Solutions ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Infant ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Decision Making ', ' Social support ', ' social support network ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' middle school ', ' high school ', ' prospective ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' statistics ', ' Dependence ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2011,1377055,0.1173319122085367
"Couple HIV prevention for drug-involved male offenders: An Effectiveness Trial     DESCRIPTION (provided by applicant): The proposed study responds to PA-09-236 entitled ""HIV/AIDS, Drug Use, and Vulnerable Populations."" This study is a randomized controlled trial (RCT) that will rigorously evaluate the implementation, effectiveness and cost-effectiveness of a couple-based integrated HIV/STI and drug abuse prevention intervention (Connect II) with drug-involved male offenders charged with misdemeanors and their primary female sexual partners, implemented by frontline providers in Criminal Court, Community Court or Probation (CCP) sites in the Bronx, NY, compared to CCP standard treatment of care services (TAU). The primary outcomes are biologically confirmed sexually transmitted infections (STIs) and self-reported condom use. This study will yield important data on implementation factors associated with effectiveness of the proposed intervention in real world resource-constrained criminal justice settings. The proposed CCP study sites are located in the South Bronx, the poorest Congressional District in the U.S. with 96% of residents identifying as Black or Latino. The South Bronx has an HIV prevalence rate of 2.6%. Research has found that 12% of men on probation in New York City are HIV positive. Though the criminal justice system is recognized as the epicenter of the epidemic in the U.S., few, if any, HIV prevention interventions have been developed for the huge number of male offenders under community supervision who represent 90% of the corrections population. No HIV/STI prevention services are currently provided at the proposed CCP sites. The proposed intervention is designed to address this critical gap in services. Connect II was found to be efficacious among drug-involved couples in reducing risky drug and sexual behaviors and drug use. In the proposed study we aim to advance the knowledge of implementation science by testing the effectiveness and cost-effectiveness of Connect II delivered by frontline providers in the real world settings of CCP sites with 240 drug-involved male offenders and their female partners (N=480 participants). Eligible couples will be randomly assigned to either (1) a 4-session Connect II delivered to both partners together + TAU delivered to male participant alone, or (2) a TAU control condition delivered to the male participant. Repeated assessments will occur at baseline and 3, 6, and 12-months post intervention. The study will be conducted by Dr. Nabila El-Bassel, Dr. Louisa Gilbert, and an investigative team from Columbia University in collaboration with Michael Rempel from the Center for Court Innovation and the New York City Department of Probation. If found to be effective, Connect II may be scaled up in community criminal justice settings nationwide to curb the spread of HIV/STIs and to reduce HIV disparities in heavily impacted communities like the South Bronx.        PUBLIC HEALTH RELEVANCE:  This study addresses the significant public health threat of HIV and other STIs among drug- involved male offenders under community supervision and their female partners. This study will evaluate the implementation, effectiveness and cost-effectiveness of a brief couple-based HIV and drug abuse prevention intervention for drug-involved male offenders and their female partners delivered by frontline providers in Criminal/Community Court and Probation sites in the South Bronx, the poorest congressional district in the U.S. If found to be effective, the proposed brief intervention may be scaled up to community criminal justice sites nationwide to curb the spread of HIV/STIs and reduce HIV disparities.                       This study addresses the significant public health threat of HIV and other STIs among drug- involved male offenders under community supervision and their female partners. This study will evaluate the implementation, effectiveness and cost-effectiveness of a brief couple-based HIV and drug abuse prevention intervention for drug-involved male offenders and their female partners delivered by frontline providers in Criminal/Community Court and Probation sites in the South Bronx, the poorest congressional district in the U.S. If found to be effective, the proposed brief intervention may be scaled up to community criminal justice sites nationwide to curb the spread of HIV/STIs and reduce HIV disparities.                    ",Couple HIV prevention for drug-involved male offenders: An Effectiveness Trial,8402455,R01DA033168,"['Subsaharan Africa ', ' Sub-Saharan Africa ', ' Africa South of the Sahara ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Drug Utilization ', ' Female ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Epidemic ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Couples ', ' Communities ', ' Client ', ' cost effectiveness ', ' Charge ', ' New York City ', ' Manuals ', ' Medicine ', ' Methods ', ' male ', "" men's "", ' men ', ' Institutes ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' Supervision ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Public Health ', ' public health medicine (field) ', ' court ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' base ', ' Criminal Justice ', ' Treatment outcome ', ' Caring ', ' Latino ', ' Time ', ' sex partner ', ' Sexual Partners ', ' Work ', ' Universities ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Testing ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Scientist ', ' Letters ', ' Services ', ' psychosocial ', ' Consult ', ' Collaborations ', ' Outcome Study ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Knowledge ', ' improved ', ' drug use ', ' Drug usage ', ' Site ', ' theories ', ' prevent drug use ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Prevention ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' probation ', ' criminal offender ', ' offender ', ' Self-Report ', ' Patient Self-Report ', ' Modeling ', ' Effectiveness ', ' professor ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' Prevent infection ', ' Infection prevention ', ' Participant ', ' recidivism ', ' prevention service ', ' LOINC Axis 4 System ', ' System ', ' condoms ', ' effectiveness trial ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' post intervention ', ' Characteristics ', ' cost ', ' efficacy research ', ' Subgroup ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Data ', ' Address ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Cost Effectiveness Analysis ', ' Provider ', ' vulnerable group ', ' Vulnerable Populations ', ' designing ', ' design ', ' demographics ', ' Population ', ' probationer ', ' evidence base ', ' Prevalence ', ' secondary outcome ', ' community setting ', ' scale up ', ' standard treatment ', ' standard care ', ' implementation science ', ' primary outcome ', ' innovative ', ' innovate ', ' innovation ', ' ']",NIDA,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2012,706068,0.06663132506651143
"The Development of a Video-Enhanced Drug Prevention Program for Rural Native Hawa    DESCRIPTION (provided by applicant): Research has indicated that Native Hawaiian youth have significantly higher rates of drug use than their non-Hawaiian counterparts (e.g., Wong, Klingle, & Price, 2004; Mayeda, Hishinuma, Nishimura, Garcia- Santiago, & Mark, 2006), and that these differences are particularly pronounced in rural settings (Lai & Saka, 2005). Despite these findings, there have been very few drug prevention programs developed and evaluated specifically for these youth (Edwards, Giroux, & Okamoto, in press; Rehuher, Hiramatsu, & Helm, 2008). Therefore, the purpose of this exploratory research proposal is to develop and pilot test curricular components of a video-based, culturally-grounded drug prevention program for rural Native Hawaiian youth. This will be accomplished through three specific aims. AIM 1 is to create 3-5 video vignettes focused on relevant drug related problem situations of rural Hawaiian youth. The vignettes will focus on common and difficult drug offer situations for these youth, as well as the range of responses to each situation, established from prior NIDA- funded research (5 K01 DA019884). AIM 2 is to develop the accompanying drug prevention curricular components to compliment the video vignettes developed in Aim 1. AIM 3 is to pilot test the resulting curricular components for program feasibility and measurement, using a combination of focus group interviews with stakeholders (e.g., Hawaiian youth, youth-serving practitioners) and selected classroom implementation within four middle schools. Comparison of the intervention components against four attentional-control schools will be conducted, in order to estimate effect sizes for a future large-scale, randomized controlled trial (to be implemented as part of a future R01 grant).      PUBLIC HEALTH RELEVANCE: Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have been shown to have higher rates of alcohol consumption and smoking compared with other ethnic groups (Office of Minority Health, 2009), research focused on drug prevention of these individuals is important to improve public health both in Hawai'i and on the Mainland U.S. This study actively engages rural communities in the development of the curricular components of a drug prevention intervention for Hawaiian youth, promoting the overall utility and effectiveness of those components. Further, the findings from this study will point to the core content of prevention interventions for Hawaiian youth in rural communities, which may be applicable to other ethnic youth populations in Hawai'i and the Pacific Rim, as well as Native youth populations on the Mainland U.S.           Project Narrative  Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have been shown to have higher rates of alcohol consumption and smoking compared with other ethnic groups (Office of Minority Health, 2009), research focused on drug prevention of these individuals is important to improve public health both in Hawai'i and on the Mainland U.S. This study actively engages rural communities in the development of the curricular components of a drug prevention intervention for Hawaiian youth, promoting the overall utility and effectiveness of those components. Further, the findings from this study will point to the core content of prevention interventions for Hawaiian youth in rural communities, which may be applicable to other ethnic youth populations in Hawai'i and the Pacific Rim, as well as Native youth populations on the Mainland U.S.",The Development of a Video-Enhanced Drug Prevention Program for Rural Native Hawa,8234073,R34DA031306,"['etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Curriculum ', ' Educational Curriculum ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Ethnic group ', ' Focus Groups ', ' Foundations ', ' Future ', ' Grant ', ' Group Interviews ', ' Island ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Production ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Research Proposals ', ' Research Resources ', ' Resources ', ' Rural Health ', ' Schools ', ' Smoking ', ' Testing ', ' Videotape ', ' Accountability ', ' pricing ', ' Price ', ' Rural Community ', ' Youth 10-21 ', ' Youth ', ' base ', ' rural area ', ' improved ', ' Individual ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Measurement ', ' drug use ', ' Drug usage ', ' Funding ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Hawaiian ', ' Hawaiian population ', ' programs ', ' Test Result ', ' Outcome Study ', ' middle school ', ' novel ', ' Prevention ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Effectiveness ', ' Indigenous ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' American Indian and Alaska Native ', ' developmental ', ' Development ', ' minority health ', ' Population ', ' Drug Prevention Program ', ' native youth ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' public health relevance ', ' ']",NIDA,HAWAII PACIFIC UNIVERSITY,R34,2012,179572,0.09063652823251121
"The Logics for HIV Risk among Street-Based Heroin Injectors    DESCRIPTION (provided by applicant): We propose to develop a theoretically and ethnographically informed model of ""HIV risk environment"" for public health intervention by identifying the key structural forces, institutional processes, and socio-cultural constraints that shape HIV behaviors among inner-city street-based drug users. We will examine the social processes that drive the logics for HIV transmission behaviors among street-based injection drug users (IDUs) in two cities, Philadelphia and San Francisco, that span a strategic range of the demographic, economic, political, and cultural factors affecting inner-city poverty in the United States. Building on long-term, continuous participant-observation ethnographic fieldwork in the shooting encampments of ethnically and generationally bounded social networks of heroin injectors and crack smokers in San Francisco as well as pilot research in Philadelphia at open-air drug markets and shooting galleries, we will document patterns of: 1) law enforcement and criminal justice; 2) poverty and income generating opportunities (including legal and illegal labor markets and public subsidies); 3) illegal drug markets and polydrug availability; 4) racialized ethnic boundaries and conflicts; 5) gender/sexuality boundaries that delimit social networks; 6) oppositional sub-cultural identities that trap IDUs into counterproductive relationships with the services that are meant to help or contain them; 7) violence and insecurity; 8) access to clinical care, public health prevention messages, and social services; 9) access to ecological and basic survival needs infrastructures including transportation systems, food, and shelter from inclement weather. An experienced ethnographic team in both cities will collect data on individual-level HIV risk behaviors at fieldsites that we have successfully maintained on the parent grant for more than 12 years in San Francisco and recently established in Philadelphia (core N of each network=15-20 at any given time, peripheral N=10-15 in each fieldsite; 2 sites in Philadephia and 2 in San Francisco). The project will administer a set of procedures for cross-methodological collaboration with epidemiologists who are the Principal Investigators on long-term, large quantitative data sets documenting street-based drug users in both cities. This will enable us to examine the representativity of our ethnographic data on individual street-based drug users and to explore the generalizability of our analysis of the larger social structural processes that promote or constrain risky injection and sexual practices. It will also bring one of the largest and oldest NIDA-funded data sets on IDUs in San Francisco, an exceptionally high-tech, wealthy, culturally diverse, and liberal city into an illustrative contrast and dialogue with another large NIDA-supported quantitative data set of street-based drug users in the city of Philadelphia, one of the nation's poorest deindustrialized metropolises, with a declining population of largely native-born white, Latino (primarily Puerto Rican) and African American ethnic groups.      PUBLIC HEALTH RELEVANCE: Untangling the complex web of factors that render inner city poverty environments exceptionally risky for HIV infection and addiction will help public health outreach workers and clinicians develop more innovative structural and targeted interventions to reach larger numbers of low income high-risk populations with more effective and convincing messages. Upstream interventions that alter neighborhood-level risk environments can cost-effectively encourage drug users to change their behaviors for pragmatic reasons without necessarily requiring a conscious or willful choice. Our findings will also identify strategic institutions and programs that often operate at cross purposes or fail to coordinate with public health HIV risk reduction priorities (including law enforcement, criminal justice, employment training, public housing, food kitchens, shelters, schools, and churches) but which represent productive sites for multi-service HIV prevention interventions.           Relevance: Untangling the complex web of factors that render inner city poverty environments exceptionally risky for HIV infection and addiction will help public health outreach workers and clinicians develop more innovative structural and targeted interventions to reach larger numbers of low income high-risk populations with more effective and convincing messages. Upstream interventions that alter neighborhood-level risk environments can cost-effectively encourage drug users to change their behaviors for pragmatic reasons without necessarily requiring a conscious or willful choice. Our findings will also identify strategic institutions and programs that often operate at cross purposes or fail to coordinate with public health HIV risk reduction priorities (including law enforcement, criminal justice, employment training, public housing, food kitchens, shelters, schools, and churches) but which represent productive sites for multi-service HIV prevention interventions.",The Logics for HIV Risk among Street-Based Heroin Injectors,8262168,R01DA010164,"['Affect ', ' Age ', ' Air ', ' Cultural Anthropology ', ' Attention ', ' Awareness ', ' bear ', ' Ursidae ', ' Bears ', ' Ursidae Family ', ' Behavior ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Childhood Abuse ', ' Child Abuse ', ' Cities ', ' Conflict ', ' Conflict (Psychology) ', ' Data Collection ', ' Decision Making ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Drug Preparation ', ' Drug Compounding ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economical Conditions ', ' Economic Conditions ', ' Economics ', ' Employment ', ' Environment ', ' Environment and Public Health ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Ethnic group ', ' facial ', ' faces ', ' Face ', ' Food ', ' Health ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Health Services Research ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Economical Income ', ' Economic Income ', ' Income ', ' Injections ', ' Injection of therapeutic agent ', ' Laboratories ', ' Literature ', ' Logic ', ' Marketing ', ' Medicine ', ' Methods ', ' Neighborhoods ', ' Philadelphia ', ' Poverty ', ' Public Health ', ' public health medicine (field) ', ' Public Housing ', ' Puerto Rican ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' San Francisco ', ' Schools ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Sexuality ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Social Sciences ', ' Social Work ', ' Social Service ', ' Social work (field) ', ' Socialization ', ' Time ', ' Transportation ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Unemployment ', ' United States ', ' USPHS ', ' Public Health Service ', ' United States Public Health Service ', ' violent behavior ', ' violent ', ' Violence ', ' Weather ', ' Gender ', ' Native People ', ' Indigenous Population ', ' Native-Born ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' Latino ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Dataset ', ' Data Set ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' shelter-housing ', ' shelter ', ' Shelter facility ', ' Social Network ', ' ethnographic ', ' Ethnography ', ' Law Enforcement ', ' base ', ' Procedures ', ' Peripheral ', ' Distal ', ' Site ', ' Link ', ' Training ', ' Consciousness ', ' Conscious ', ' Individual ', ' Logistics ', ' Policies ', ' drug use ', ' Drug usage ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' Shapes ', ' Smoker ', ' Drug user ', ' Consensus ', ' Knowledge ', ' programs ', ' Investigation ', ' Complex ', ' Source ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' interest ', ' Injection Drug User ', ' Injecting drug user ', ' inner city ', ' Services ', ' preference ', ' Church ', ' experience ', ' skills ', ' Participant ', ' drug market ', ' Agreement ', ' social inequality ', ' outreach ', ' Prevention ', ' social ', ' Regulation ', ' Modeling ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Risk Reduction ', ' Institution ', ' preventing ', ' prevent ', ' Legal ', ' Low income ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' Infrastructure ', ' Research Infrastructure ', ' Epidemiologist ', ' Transmission ', ' transmission process ', ' Principal Investigator ', ' Process ', ' sex ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' socioeconomics ', ' Behavioral ', ' Clinical Services ', ' cost ', ' designing ', ' design ', ' remediation ', ' cost-effective ', ' cost effective ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' analytical tool ', ' addictive disorder ', ' addiction ', ' parent grant ', ' high risk ', ' public health relevance ', ' clinical care ', ' ']",NIDA,UNIVERSITY OF PENNSYLVANIA,R01,2012,391802,0.08096065609070376
"National Hispanic Science Network on Drug Abuse (NHSN) Annual Conference Abstract  This R13 meetings grant application seeks support for five yearly three-day stand alone conferences to be held at selected locations beginning in the fall of 2009. This proposal reflects a collaborative initiative between Louisiana State University Health Sciences Center and the National Hispanic Science Network on Drug Abuse (NHSN), based at the University of Miami. The annual scientific conferences help to accomplish the NHSN mission of fostering both interdisciplinary and translational research, by promoting dialogue between biologic, social, behavioral, and cultural scientists and disseminating findings back to the field. Previous conferences, supported through a NIDA-funded contract, have been an effective platform for developing the aims of the NHSN, with particular emphasis on mentoring and training Hispanic graduate students and early career scientists.    The aims of the conferences will be: A) to advance science in the area of drug abuse research and its co-morbid conditions, particularly as it impacts on the Hispanic population. It will promote bidirectional translational research ranging from bench to community and a trans-disciplinary cross-fertilization of ideas among scientists from all fields of drug abuse helping to establish future research priorities. B) To foster the development of Hispanic researchers, with emphasis in areas related to drug abuse research by facilitating the development of integrated and continuous collaborative and mentoring networks. Funding is requested to support participation for 50 trainees/early career scientists and 20 research scientists presenting in the scientific panels. An average of 150 participants, representing the field from the national and international scientific communities, are expected at each yearly conference, including members of the global research community whose interests encompass a multifaceted approach to understanding the factors underlying health disparities as they pertain to drug use and abuse ranging from epidemiology to environmental health, psychology, sociology, health policy, neuroscience and other biomedical sciences, and epigenetics.    The first conference proposed ""Integrating Population, Laboratory, and Clinical Sciences in Minority Health"" will be hosted by the University of Miami, from December 1-3, 2009. The format of the conference aims to provide ample opportunity for discussion, networking, and collaboration discussions as well as development of new ideas related to training and mentoring of the next generation of researchers in the field of drug abuse. The themes, scientific content, and program for each conference will be developed by a Scientific Conference committee comprised of NHSN members, NIH officials, and federal liaisons. The themes will be directly related to NIDA's strategic plan and the NIH blueprint, addressing timely topics and developing challenges in the field. Project narrative  The Annual National Hispanic Science Network on Drug Abuse Conference provides multidisciplinary scientists in drug abuse and related fields interested in advancing science, particularly as it pertains to the Hispanic population, to have a collegial exchange providing a forum for discussion and dissemination of research findings and an opportunity for networking and mentoring trainees in the area of drug abuse research. This unique opportunity will promote bidirectional translational research ranging from bench to community and a trans-disciplinary cross-fertilization of ideas among scientists from all fields of drug abuse. The PI and the organizing committee are confident that the proposed conferences will serve as a platform to establish future research priorities for the field of drug abuse as it pertains to the Hispanic population.",National Hispanic Science Network on Drug Abuse (NHSN) Annual Conference,8255640,R13DA026647,"['abstracting ', ' Dorsum ', ' Back ', ' Communities ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Environmental Health Science ', ' Environmental Health ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Fertility/Fertilization ', ' Fertilization ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Geographic Locations ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' Laboratories ', ' Louisiana ', ' Mentors ', ' Mission ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Neurosciences ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Science ', ' self help organization ', ' Self-Help Groups ', ' Support Groups ', ' Sociology ', ' Universities ', ' Gender ', ' falls ', ' conference ', ' symposium ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' base ', ' career ', ' Area ', ' Training ', ' Discipline ', ' Fostering ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' drug use ', ' Drug usage ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Collaborations ', ' Health Psychology ', ' Contracting Opportunities ', ' Contracts ', ' programs ', ' Scientist ', ' Location ', ' interest ', ' meetings ', ' Participant ', ' peer ', ' member ', ' graduate student ', ' social ', ' health disparities ', ' health disparity ', ' Address ', ' Grant Proposals ', ' Applications Grants ', ' Health Sciences ', ' International ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Strategic Planning ', ' Clinical Sciences ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' developmental ', ' Development ', ' Behavioral ', ' minority health ', ' dissemination research ', ' next generation ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' multidisciplinary ', ' ']",NIDA,LSU HEALTH SCIENCES CENTER,R13,2012,145637,0.053419674228157465
"""African American Offenders: Drug Use, Mental Health and HIV Risk""     DESCRIPTION (provided by applicant):  The primary goal of this K08 award is to further develop a productive independent research career in drug abuse research. The training and career development plan will enhance Dr. Stevens-Watkins's research experience in primary data collection with prisoners focused on drug use, mental health, and HIV thus resulting in the clarification of the specific aims of an R01 submission in years 4 and 5. The proposed training objectives are: (1) to receive training in the epidemiology of drug abuse, mental health, and HIV as they relate to health disparities among African Americans; (2) to further develop expertise in research with special populations, biostatistics, and advanced quantitative analyses including non-linear, categorical models, and structural equation modeling; (3) to use the data collected in the proposed research plan as pilot data for an R01 research proposal. The specified training goals are aligned with the research aims and compliment the clinical experience of the candidate. Dr. Stevens-Watkins will be sponsored by her established mentors, Drs. Carl Leukefeld and Carrie Oser, both with expertise in drug abuse and HIV research. Of high significance, HIV has recently been termed a ""crisis"" in the African American community. The overall goal of the proposed research plan is to better understand the complex and dynamic relationship between drug use, mental health, and HIV risk among African American male prisoners nearing community re-entry. The specific aims are (1) to explore drug use, symptoms of depression and anxiety, and HIV risk behaviors among African American male inmates by conducting a thorough literature review and devising an analytical model using biostatics multivariate analytic techniques with available data; (2) to identify prevalence, incidence, and predictors of drug use disorders, anxiety, depressive disorders and HIV sexual risk behaviors among 205 incarcerated African American men; (3) to examine the knowledge, patterns, and perceived cultural and community barriers to utilizing individual and health resources and their relationship to substance abuse recovery and HIV risk behaviors among 205 African American men upon release from prison. Baseline data will be collected in prison and follow-up data collection will occur when participants have been released in the community after 3-months. The proposed research plan will offer HIV testing and counseling to an at-risk population that has historically been difficult to engage in research and HIV testing, subsequently significantly impacting public health by possibly preventing the spread of HIV. The candidate's immediate career goals include published manuscripts and R01 funding by the end of K08 funding, with an ultimate career goal of becoming an independent clinical drug abuse researcher. This proposal includes an outstanding mentoring team, as well as a feasible training and research plan utilizing resources offered by both Spalding University and the University of Kentucky.        PUBLIC HEALTH RELEVANCE:  The proposed project has significant public health implications for reducing the spread of HIV among the African American community by offering testing and by targeting men exiting prison, re-entering the community. The proposed project will generate an improved understanding of the complex relationship between drug use, mental health, and HIV risk among an at-risk group.                           The proposed project has significant public health implications for reducing the spread of HIV among the African American community by offering testing and by targeting men exiting prison, re-entering the community. The proposed project will generate an improved understanding of the complex relationship between drug use, mental health, and HIV risk among an at-risk group.                        ","""African American Offenders: Drug Use, Mental Health and HIV Risk""",8328062,K08DA032296,"['Biostatistics ', ' Biometrics ', ' Biometry ', ' Award ', ' Anxiety ', ' Environment ', ' Drug Use Disorder ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Goals ', ' Health ', ' Health Resources ', ' Communities ', ' Counseling ', ' Data Analysis ', ' Data Analyses ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' depression ', ' Mental Depression ', ' Depressive disorder ', ' Data Collection ', ' Methods ', ' male ', ' Mental Hygiene Services ', ' Mental Health Services ', ' Kentucky ', ' Interview ', ' Structural Models ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', "" men's "", ' men ', ' Mentors ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incidence ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Housing ', ' Research Proposals ', ' Psychologist ', ' Risk ', ' Research Resources ', ' Resources ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisoner ', ' Prisons ', ' Pre-Post Tests ', ' Research ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' improved ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Phase ', ' Specified ', ' Specific qualifier value ', ' Chronic ', ' Clinical ', ' career ', ' Mediating ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' depressive symptoms ', ' Universities ', ' Testing ', ' social support network ', ' Social support ', ' Writing ', ' Complex ', ' Protocol ', ' Protocols documentation ', ' Equation ', ' Review Literature ', ' Knowledge ', ' Life ', ' Pattern ', ' Techniques ', ' Populations at Risk ', ' Development Plans ', ' Training ', ' psychological ', ' psychologic ', ' racism ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' drug use ', ' Drug usage ', ' Funding ', ' Recovery ', ' Individual ', ' health disparities ', ' health disparity ', ' career development ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' criminal offender ', ' offender ', ' Modeling ', ' intravenous drug use ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' impression ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' Participant ', ' Manuscripts ', ' experience ', ' Special Population ', ' named group ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Process ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' sexual risk behavior ', ' sex risk ', ' Data ', ' preventing ', ' prevent ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Research Training ', ' Symptoms ', ' correctional system ', ' drug detection ', ' drug testing ', ' public health research ', ' high risk ', ' Outcome ', ' Prevalence ', ' community re-entry ', ' community reentry ', ' ']",NIDA,SPALDING UNIVERSITY,K08,2012,147950,0.1519249786989318
"The Development of a Video-Enhanced Drug Prevention Program for Rural Native Hawa    DESCRIPTION (provided by applicant): Research has indicated that Native Hawaiian youth have significantly higher rates of drug use than their non-Hawaiian counterparts (e.g., Wong, Klingle, & Price, 2004; Mayeda, Hishinuma, Nishimura, Garcia- Santiago, & Mark, 2006), and that these differences are particularly pronounced in rural settings (Lai & Saka, 2005). Despite these findings, there have been very few drug prevention programs developed and evaluated specifically for these youth (Edwards, Giroux, & Okamoto, in press; Rehuher, Hiramatsu, & Helm, 2008). Therefore, the purpose of this exploratory research proposal is to develop and pilot test curricular components of a video-based, culturally-grounded drug prevention program for rural Native Hawaiian youth. This will be accomplished through three specific aims. AIM 1 is to create 3-5 video vignettes focused on relevant drug related problem situations of rural Hawaiian youth. The vignettes will focus on common and difficult drug offer situations for these youth, as well as the range of responses to each situation, established from prior NIDA- funded research (5 K01 DA019884). AIM 2 is to develop the accompanying drug prevention curricular components to compliment the video vignettes developed in Aim 1. AIM 3 is to pilot test the resulting curricular components for program feasibility and measurement, using a combination of focus group interviews with stakeholders (e.g., Hawaiian youth, youth-serving practitioners) and selected classroom implementation within four middle schools. Comparison of the intervention components against four attentional-control schools will be conducted, in order to estimate effect sizes for a future large-scale, randomized controlled trial (to be implemented as part of a future R01 grant).      PUBLIC HEALTH RELEVANCE: Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have been shown to have higher rates of alcohol consumption and smoking compared with other ethnic groups (Office of Minority Health, 2009), research focused on drug prevention of these individuals is important to improve public health both in Hawai'i and on the Mainland U.S. This study actively engages rural communities in the development of the curricular components of a drug prevention intervention for Hawaiian youth, promoting the overall utility and effectiveness of those components. Further, the findings from this study will point to the core content of prevention interventions for Hawaiian youth in rural communities, which may be applicable to other ethnic youth populations in Hawai'i and the Pacific Rim, as well as Native youth populations on the Mainland U.S.           Project Narrative  Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have been shown to have higher rates of alcohol consumption and smoking compared with other ethnic groups (Office of Minority Health, 2009), research focused on drug prevention of these individuals is important to improve public health both in Hawai'i and on the Mainland U.S. This study actively engages rural communities in the development of the curricular components of a drug prevention intervention for Hawaiian youth, promoting the overall utility and effectiveness of those components. Further, the findings from this study will point to the core content of prevention interventions for Hawaiian youth in rural communities, which may be applicable to other ethnic youth populations in Hawai'i and the Pacific Rim, as well as Native youth populations on the Mainland U.S.",The Development of a Video-Enhanced Drug Prevention Program for Rural Native Hawa,8471443,R34DA031306,"['etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Curriculum ', ' Educational Curriculum ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Ethnic group ', ' Focus Groups ', ' Foundations ', ' Future ', ' Grant ', ' Group Interviews ', ' Island ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Production ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Research Proposals ', ' Research Resources ', ' Resources ', ' Rural Health ', ' Schools ', ' Smoking ', ' Testing ', ' Videotape ', ' Accountability ', ' pricing ', ' Price ', ' Rural Community ', ' Youth 10-21 ', ' Youth ', ' base ', ' rural area ', ' improved ', ' Individual ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Measurement ', ' drug use ', ' Drug usage ', ' Funding ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Hawaiian ', ' Hawaiian population ', ' programs ', ' Test Result ', ' Outcome Study ', ' middle school ', ' novel ', ' Prevention ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Effectiveness ', ' Indigenous ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' American Indian and Alaska Native ', ' developmental ', ' Development ', ' minority health ', ' Population ', ' Drug Prevention Program ', ' native youth ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' public health relevance ', ' ']",NIDA,HAWAII PACIFIC UNIVERSITY,R34,2012,16200,0.09063652823251121
"Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users    DESCRIPTION (provided by applicant): This is a second revision of a competitive renewal R01 proposal of the NEURO-HIV Epidemiologic Study in response to NIDA PAS-07-115 (Non-injection Dug Abuse and HIV/AIDS). The primary study aim is to evaluate the ability of Integrated Family and Cognitive-Behavioral Therapy-HIV Prevention Intervention (IFCBT-HIVPI) to prevent HIV among adult non-injection and injection drug users. Over a 12 week intervention interval, the IFCBT-HIVPI model coordinates the delivery of cognitive- behavioral components during 12 group sessions with a couples and family systems component during 4 couples/family sessions to address HIV risk and protective factors across multiple ecological systems. IFCBT-HIVPI main effects on primary (HIV sexual risk behaviors and HIV drug taking risk behaviors) and secondary (HIV, Chlamydia, gonorrhea, and trichomoniasis incidences and legal involvement, academic achievement, and employment) outcome domains will be evaluated. We also seek to elucidate the degree to which the development of attitudinal and behavior change skills targeted by IFCBT-HIVPI (e.g., rational beliefs, problem solving skill, adaptive couples' communication) result in post-intervention reductions of HIV, sexually transmitted infections (STIs), and HIV risk behaviors. The possibility of effect-modification is also considered with a focus on route of drug administration status (i.e., non-injector/injector), neuropsychological (e.g., executive function), and demographic (i.e., African American/white) factors. The proposed study will randomly assign 360 HIV-negative non-injection and injection drug users recruited from the original NEURO-HIV Epidemiologic Study sample to experimental (IFCBT-HIVPI) and comparison (Brief Psychoeducation Curriculum on HIV Prevention; BPEC-HIV) conditions. The composition of the original NEURO-HIV Epidemiologic Study sample provides the basis to stratify the randomized trial sample across gender and two race/ethnicity (i.e., African American and white) groups by route of drug administration status. An assessment battery comprised of a standardized interview on HIV risk behavior, neuropsychological tests, tools to assess attitudes and behavior change skills targeted by IFCBT-HIVPI, drug and STI urine testing, and serologic tests of HIV will be administered before, during, and after the intervention interval across 18-month post-intervention follow-up. Additional preliminary analyses will be conducted on the randomized trial data to: (1) derive session-by-session measures on mechanisms of change targeted by IFCBT-HIVPI via videotape coding methods; (2) characterize mechanisms of change trajectories that may then be evaluated as plausible intervention moderators if present; and (3) estimate intervention cost-effectiveness. The lack of research on science-based prevention interventions for HIV continues to be a serious gap in the literature with recent HIV trends highlighting significant health disparities, particularly among African American non-injection drug users. If successful, the proposed project should help to identify specific attitudinal and behavior change skills targeted by cognitive- behavioral and couples/family systems interventions that foster subsequent reductions in HIV, STIs and HIV risk behaviors among adult drug users at heightened disease risk. PUBLIC HEALTH RELEVANCE: Recent estimates suggest that a majority of the 40,000 new cases of HIV reported annually in the US are attributable largely to sexual risk behavior associated with non-injection drug use. Additionally, African American drug users exhibit substantial HIV health disparities with African American females being 21 times more likely to contract HIV than white females. The proposed project is designed to address critical gaps in the HIV prevention science field by evaluating the ability of an intervention coordinating cognitive-behavioral and couples/family systems components to prevent HIV among adult drug users at heightened disease risk.           PROJECT NARRATIVE. Recent estimates suggest that a majority of the 40,000 new cases of HIV reported annually in the US are attributable largely to sexual risk behavior associated with non-injection drug use. Additionally, African American drug users exhibit substantial HIV health disparities with African American females being 21 times more likely to contract HIV than white females. The proposed project is designed to address critical gaps in the HIV prevention science field by evaluating the ability of an intervention coordinating cognitive-behavioral and couples/family systems components to prevent HIV among adult drug users at heightened disease risk.",Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users,8467329,R01DA014498,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Attitude ', ' Belief ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' Client ', ' cognitive behavioral treatment ', ' cognitive behavioral therapy ', ' cognitive behavioral modification ', ' cognitive behavioral intervention ', ' cognitive behavior therapy ', ' cognitive behavior modification ', ' cognitive behavior intervention ', ' Cognitive Psychotherapy ', ' Cognition Therapy ', ' Cognitive Therapy ', ' Communication ', ' cost effectiveness ', ' Couples ', ' Curriculum ', ' Educational Curriculum ', ' Demographic Factors ', ' Drug Administration Routes ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Employment ', ' Exhibits ', ' Family ', ' Female ', ' Gonococcal Infection ', ' Gonorrhea ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incidence ', ' Injections ', ' Injection of therapeutic agent ', ' Interview ', ' Literature ', ' Methods ', ' Neuropsychologic Tests ', ' Neuropsychological Tests ', ' Problem Solving ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Risk ', ' Science ', ' Selection Bias ', ' serology ', ' Serological Tests ', ' Serologic tests ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Testing ', ' Time ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Trichomonas Infections ', ' Urine Urinary System ', ' Urine ', ' Videotape ', ' Gender ', ' Measures ', ' Outcomes Assessment ', ' Outcome Assessment (Health Care) ', ' Process Assessment ', ' Process Assessment (Health Care) ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Dataset ', ' Data Set ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Ecological Systems ', ' Ecologic Systems ', ' Ecosystem ', ' base ', ' Fostering ', ' drug use ', ' Drug usage ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Contracting Opportunities ', ' Contracts ', ' tool ', ' Drug user ', ' LOINC Axis 4 System ', ' System ', ' behavior change ', ' interest ', ' Injection Drug User ', ' Injecting drug user ', ' skills ', ' disease risk ', ' disorder risk ', ' Prevention ', ' Academic achievement ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Coding System ', ' Code ', ' Modeling ', ' Sampling ', ' psychoeducation ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' executive control ', ' executive function ', ' health disparities ', ' health disparity ', ' preventing ', ' prevent ', ' Legal ', ' Address ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Cognitive ', ' trend ', ' Characteristics ', ' Modification ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' post intervention ', ' sexual risk behavior ', ' sex risk ', ' designing ', ' design ', ' Outcome ', ' innovative ', ' innovate ', ' innovation ', ' neuropsychological ', ' group intervention ', ' HIV prevention trial ', ' intervention effect ', ' randomized trial ', ' ']",NIDA,UNIVERSITY OF FLORIDA,R01,2012,604651,0.1494038709691358
"Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study DESCRIPTION (provided by applicant): The overall goal of this project is to address how disproportionate confinement of racial/ethnic minorities-especially African Americans-affects health disparities in the HIV/AIDS epidemic. African Americans comprise only 13% of the general population, but about 40% of incarcerated youth and adults and 50% of new cases of HIV/AIDS. Yet, large multisite national longitudinal studies of HIV/AIDS focus on high- risk samples such as men who have sex with men (MACS), women infected with HIV and other ""at-risk"" females (WIHS), and infected women and their infants (WITS). These studies do not include adolescents, do not sample correctional populations, and do not examine the effect of incarceration on HIV/AIDS. Most studies of incarcerated populations are cross-sectional and provide limited information on the effects of incarceration. To continue to address this key omission in the literature, we propose to extend the Northwestern Juvenile Project, a longitudinal study of 1829 juvenile justice youth, enrolled at age 10-18 years (1172 males, 657 females; 1005 African Americans, 296 non-Hispanic whites, 524 Hispanics, and 4 ""other"" race/ethnicity). Currently, the HIV/AIDS component of the project (RO1 DA022953) includes only a subsample (n=743) and 10-, 11-, 12-, and 13-year follow-up interviews. We now propose to (1) study the entire sample (originally 1829, now 1678); (2) conduct 3 additional annual interviews (14-, 15-, and 16-year follow-ups), at which time participants will be aged 26-34 years; (3) collect official records to cross-validate self-reported data (on STI status, arrests, incarceration history, and services received); (4) test the entire sample for HIV infection, chlamydia, and gonorrhea; and (5) administer a new module on incarceration, release, and re-entry. Participants are re-interviewed whether they are re-incarcerated or back in the community. Using data collected in prior phases and the additional interviews, we will examine patterns of drug use, drug use disorder, HIV/AIDS risk and infection from adolescence (ages 10-17 years) to emerging adulthood (ages 18-24 years) and young adulthood (age 25 and older). Our Specific Aims focus on how incarceration, release, and re-entry (e.g., age[s] incarcerated, number of incarcerations, length of incarcerations, amount of time spent in the community between incarcerations) affect the following: (1) drug use behaviors (including the number and types of substances used, frequency of use, and route of administration) and drug use disorders (onset, persistence, desistance, and recurrence); (2) HIV/AIDS sex risk behaviors (including unprotected anal or vaginal receptive sex and trading sex for drugs) and injection-risk behaviors; (3) prevalence and incidence of HIV infection and other STIs; (4) the relationship between patterns of drug use and disorder and HIV/AIDS risk behaviors, especially how risk and protective factors predict, moderate, and mediate these relationships. This study responds to the initiatives of NIDA, NIAAA, and other NIH institutes to reduce health disparities in HIV/AIDS in minority populations. PUBLIC HEALTH RELEVANCE: Racial/ethnic minorities suffer disproportionately from the HIV/AIDS epidemic and are disproportionately incarcerated. To address health disparities in HIV/AIDS, we must study correctional populations, which increased from nearly 1.8 million in 1997 to over 2.2 million by mid-year 2006. The proposed study will guide public health policy by investigating how incarceration affects the development of substance use and disorder and HIV/AIDS; identifying risk and protective factors that are potentially malleable; identifying points of intervention during key developmental periods; and extending current conceptual models to include incarceration, release, and reentry.","Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study",8213564,R01DA028763,"['Accounting ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Aging ', ' ethanol use disorder ', ' alcohol use disorder ', ' Alcohol Chemical Class ', ' Alcohols ', ' Antibodies ', ' Anal ', ' Anus ', ' Dorsum ', ' Back ', ' Behavior ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cervix Dysplasia ', ' Cervical dysplasia ', ' Chicago ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' Rickettsia trachomae ', ' Chlamydia trachomatis ', ' Concurrent Studies ', ' Cohort Studies ', ' Communities ', ' Crime ', ' Death ', ' Cessation of life ', ' Decision Making ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Electronics ', ' Employment ', ' Epidemic ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Ethnic group ', ' Female ', ' Liberty ', ' Freedom ', ' Goals ', ' Gonococcal Infection ', ' Gonorrhea ', ' Grant ', ' Health ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' health care service ', ' Health Services ', ' Herpesvirus hominis disease ', ' Herpes simplex disease ', ' Herpes Simplex ', ' Herpes Simplex Infections ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' human T lymphotropic virus III ', ' human T cell leukemia virus III ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' HIV-1 ', ' Housing ', ' Illinois ', ' Incidence ', ' Infant ', ' Infection ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Human Papillomavirus ', ' Injections ', ' Injection of therapeutic agent ', ' NAS/IOM ', ' Institute of Medicine ', ' Institute of Medicine (U.S.) ', ' Institutes ', ' Interview ', ' Judgment ', ' Justice ', ' Kinetics ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Length of Stay ', ' Lifestyle ', ' Life Style ', ' Literature ', ' long-term study ', ' Longitudinal Studies ', ' male ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Needles ', ' Neighborhoods ', ' N.gonorrhoeae ', ' N. gonorrhoeae ', ' Gonococcus ', ' Neisseria gonorrhoeae ', ' Prisons ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Recommendation ', ' Records ', ' Recurrent ', ' Recurrence ', ' Research ', ' Risk ', ' Risk Factors ', ' Saliva ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sex Characteristics ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' social support network ', ' Social support ', ' Solutions ', ' statistics ', ' Substance Use Disorder ', ' Survey Instrument ', ' Surveys ', ' great pox ', ' Syphilis ', ' Testing ', ' Time ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Trichomonas Infections ', ' Ulceration ', ' Ulcer ', ' Urine Urinary System ', ' Urine ', ' Vaginal ', ' Vagina ', ' hepatitis virus infection ', ' Viral hepatitis ', ' Woman ', ' Work ', ' County ', ' Syringe Sharing ', ' Needlesharing ', ' Needle Sharing ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Illicit Drugs ', ' Enzyme Linked Immunoassay Immunologic ', ' Enzyme Immunoassay ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Longitudinal Surveys ', ' Mediating ', ' Risk Assessment ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' Social Network ', ' racial/ethnic difference ', ' Area ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' screenings ', ' screening ', ' Screening procedure ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' African ', ' drug use ', ' Drug usage ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' disorder onset ', ' disease onset ', ' Onset of illness ', ' liquid ', ' fluid ', ' Liquid substance ', ' Staging ', ' Contracting Opportunities ', ' Contracts ', ' cooking ', ' Research Specimen ', ' Specimen ', ' Life ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Dependence ', ' Event ', ' Oral ', ' Source ', ' Route ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' Injection Drug User ', ' Injecting drug user ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' middle school ', ' Services ', ' urogenital system (genital part) ', ' Genital ', ' Genital system ', ' Surgeon ', ' age group ', ' experience ', ' high school ', ' Participant ', ' health record ', ' Program Announcement ', ' NIH Program Announcements ', ' Self-Report ', ' Patient Self-Report ', ' high risk behavior ', ' deviancy ', ' deviant ', ' General Public ', ' General Population ', ' probation ', ' criminal offender ', ' offender ', ' intravenous drug use ', ' age difference ', ' Academic achievement ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Admission ', ' Admission activity ', ' parole ', ' Modeling ', ' Sampling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Healthy People 2010 ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Length ', ' Jail ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' NIH RFA ', ' Request for Applications ', ' Subgroup ', ' child maltreatment ', ' Childhood maltreatment ', ' Child Abuse and Neglect ', ' enroll ', ' Enrollment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' underserved minority ', ' under-represented minority ', ' Underrepresented Minority ', ' Monitor ', ' Transmission ', ' transmission process ', ' Characteristics ', ' Process ', ' sex ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Permission ', ' Authorization ', ' Authorization documentation ', ' developmental ', ' Development ', ' Heterosexuals ', ' transcription mediated amplification ', ' sexual risk behavior ', ' sex risk ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' national surveillance ', ' Minority ', ' alcohol and other drug ', ' Outcome ', ' cost-effective ', ' cost effective ', ' juvenile justice system ', ' Youth Risk Behavior ', ' Adolescent Risk Behavior ', ' Population ', ' Prevalence ', ' aged ', ' prospective ', ' NIAAA ', ' National Institute on Alcohol Abuse and Alcoholism ', ' innovative ', ' innovate ', ' innovation ', ' eighteen year old ', ' age 18 years ', ' 18 year old ', ' racial/ethnic ', ' racial and ethnic ', ' service utilization ', ' racial and ethnic disparities ', ' high risk ', ' FDA approved ', ' emerging adulthood ', ' surveillance data ', ' surveillance study ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2012,2588461,0.1173319122085367
"Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS    DESCRIPTION (provided by applicant): This application is a revision of an application submitted last year in response to PAR-07-379, ""Behavioral and Social Science Research on Understanding and Reducing Health Disparities."" We will analyze the interconnections between coercive mobility (the massive migration between the criminal justice [CJ] system and the community) produced by US drug policies and race disparities in HIV-related sexual risk among a sample of drug offenders in Connecticut (CT). Further, we will examine whether the association between coercive mobility (CM) and HIV-related sexual risk is affected by the degree of social disorganization in the communities in which these offenders reside. We also will study the feasibility of recruiting and following sexual partners of these individuals to better understand the impacts of CM on partners' HIV-related risk. We hypothesize that CM produces race disparities in HIV risk in a number of distinct ways: 1) Blacks are more likely than Whites to be incarcerated, so HIV-related sexual risk associated with CM can produce race disparities in HIV risk even if the effects of CM are the same for both Blacks and Whites; 2) Blacks are more likely than Whites to reside in communities experiencing the disorganizing impacts of CM, so to the extent that social disorganization exacerbates the effects of CM, it will affect the HIV risks of Blacks to a greater degree than Whites; 3) The sexual partners of Blacks are more likely to come from these same socially disorganized communities, furthering the negative impacts of CM for both returning inmates and their partners, and contributing to race disparities in HIV risk among women; and 4) Blacks are more likely to be penalized by drug policies in ways that increase their movement between prison/jail and the community and their vulnerability to its associated harms. We also hypothesize that we will be able to recruit and retain the sexual partners of study participants and conduct exploratory analyses of the impact of CM on their HIV-related sexual risk. An active Community Advisory Board including policymakers and program administrators will assist us in identifying structural interventions to reduce race disparities in HIV based on study findings. PUBLIC HEALTH RELEVANCE: This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.           Narrative This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.","Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS",8471385,R01DA025021,"['Affect ', ' Awareness ', ' Communities ', ' Connecticut ', ' Data Analysis ', ' Data Analyses ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' facial ', ' faces ', ' Face ', ' Family ', ' Feasibility Studies ', ' Feedback ', ' Health ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Housing ', ' Immigrations ', ' In-Migration ', ' Interview ', ' Laws ', ' body movement ', ' Movement ', ' Prisons ', ' Public Policy ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' sex partner ', ' Sexual Partners ', ' Social Disorganizations ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Survey Instrument ', ' Surveys ', ' Time ', ' Woman ', ' Administrator ', ' Criminal Justice ', ' Law Enforcement ', ' base ', ' Area ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Individual ', ' Policies ', ' Shapes ', ' programs ', ' Frequency ', ' Frequencies (time pattern) ', ' LOINC Axis 4 System ', ' System ', ' Application Context ', ' contextual factors ', ' behavioral/social science ', ' experience ', ' Structure ', ' Participant ', ' disease prevention ', ' disorder prevention ', ' member ', ' criminal offender ', ' offender ', ' social ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Sampling ', ' response ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Institution ', ' Address ', ' Jail ', ' Data ', ' Process ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' socioeconomics ', ' sexual relationship ', ' community re-entry ', ' community reentry ', ' migration ', ' social science research ', ' ']",NIDA,AMERICAN UNIVERSITY,R01,2012,27097,0.047759867674073975
"Prescription drugs misuse and risky sexual behaviors among YMSM in Philadelphia     DESCRIPTION (provided by applicant): Non-medical use of prescription drugs (NMUPD), i.e. opioids, tranquilizers, or stimulants, is a serious and growing public health problem in the U.S. Most data on NMUPD among young adults is limited to the heterosexual college population while significant knowledge gaps exist regarding NMUPD among young men who have sex with men (YMSM). Given the well-established intersection of drug use and risky sexual behaviors and high rates of HIV infections in YMSM, the purpose of this study is to examine the relationship between these drugs and physical, sexual and psychological health of YMSM. YMSM have unique concerns for health risks, such as depression, suicide, bullying, victimization, homelessness, and homophobia, but little is known of their intersection with NMUPD. Many YMSM experience normative pressures that encourage risky behaviors. At the same time, some forms of social support and resilience may buffer against negative effects of stressors. Significant gaps exist in our understanding of how these factors relate to problematic patterns of NMUPD, and whether they modify engagement in risky sexual behaviors. The objective of this study is to contribute directly to our understanding of the social factors that influence NMUPD and risky sexual behaviors among YMSM. The long-term goal of the study is to guide public health practitioners towards developing strategies that will prevent negative effects of NMUPD on YMSM, including reducing disparities in rates of HIV infection among YMSM. The study will investigate the central hypothesis of a deleterious relationship between NMUPD and physical, sexual, and psychological health of YMSM. The central hypothesis will be tested by pursuing three specific aims: Aim 1: Determine patterns of NMUPD and risky sexual behavior among YMSM in Philadelphia; Aim 2: Determine the risk and protective factors contributing to NMUPD and risky sexual behavior among YMSM; Aim 3: Explore the social contexts of NMPUD. Aims 1 and 2 will be addressed by recruiting 190 YMSM ages 18-29 in Philadelphia who have recently misused prescription drugs. Aim 3 will be addressed by selecting a subsample of 25 YMSM for a qualitative study. This approach is innovative because it utilizes a conceptual framework that combines a minority stress model and theories of social norms, social support, and resilience; it focuses on a critical cohort of under-researched, hard-to-reach population; and it employs two research methodologies. The proposed research is significant because it is expected to advance and expand our understanding of the effects of an emerging phenomena (i.e., prescription drug misuse) on adverse consequences of sexual activity. It will also contribute to a better understanding of the role of social determinants on dug use and risky sexual behavior. Such knowledge may inform the development of evidence-based strategies that will prevent adverse health and psychological effects of NMUPD on YMSM and their communities in Philadelphia and elsewhere in the U.S.        PUBLIC HEALTH RELEVANCE: The proposed research is relevant to the part of the Department of Health and Human Services (DHHS) mission that pertains to implementation of a research agenda designed to advance knowledge related to understanding sexual minorities health and health disparities. The proposed research is relevant to the part of National Institute of Drug Abuse (NIDA) mission pertaining to studies that address past and current risk and protective factors, including unique dimensions associated with drug use and abuse and other HIV risk behaviors among vulnerable youth, such as YMSM.                      The proposed research is relevant to the part of the Department of Health and Human Services (DHHS) mission that pertains to implementation of a research agenda designed to advance knowledge related to understanding sexual minorities health and health disparities. The proposed research is relevant to the part of National Institute of Drug Abuse (NIDA) mission pertaining to studies that address past and current risk and protective factors, including unique dimensions associated with drug use and abuse and other HIV risk behaviors among vulnerable youth, such as YMSM.                    ",Prescription drugs misuse and risky sexual behaviors among YMSM in Philadelphia,8410703,R36DA034543,"['Buffers ', ' Accounting ', ' Alcohol Chemical Class ', ' Alcohols ', ' Age ', ' Exhibits ', ' Goals ', ' Health ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Communities ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Mission ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Life Experience ', ' Literature ', ' Research ', ' Risk Factors ', ' Risk ', ' Stress ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Risk-Taking ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Public Health ', ' public health medicine (field) ', ' social role ', ' Role ', ' pressure ', ' recruit ', ' Recruitment Activity ', ' Play ', ' Drug Prescribing ', ' Drug Prescriptions ', ' Philadelphia ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' violent behavior ', ' violent ', ' Violence ', ' Youth 10-21 ', ' Youth ', ' Illicit Drugs ', ' Research Methods ', ' Research Methodology ', ' Time ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' United States Department of Health and Human Services ', ' Department of Health and Human Services ', ' United States Dept. of Health and Human Services ', ' tranquilizer ', ' Tranquillizing Drugs ', ' Ataractics ', ' Tranquilizing Agents ', ' Tobacco ', ' social support network ', ' Social support ', ' Work ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Testing ', ' interest ', ' Knowledge ', ' Stigmata ', ' Dimensions ', ' Victimization ', ' collegiate ', ' college ', ' Anal Sex ', ' Pattern ', ' bully ', ' bullying ', ' Community Physician ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' unhoused ', ' homeless ', ' Homelessness ', ' Opioid ', ' Policies ', ' Masculine ', ' Individual ', ' drug use ', ' Drug usage ', ' Policy Maker ', ' young adulthood ', ' adult youth ', ' young adult ', ' race discrimination ', ' racial discrimination ', ' Medical ', ' Reporting ', ' theories ', ' social ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' stigma ', ' social stigma ', ' health disparities ', ' health disparity ', ' Modeling ', ' physical health ', ' physical conditioning ', ' stressor ', ' experience ', ' cohort ', ' peer ', ' prescription drug misuse ', ' misuse of prescription only drugs ', ' member ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' depression and suicidality ', ' Depression and Suicide ', ' minority health ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' developmental ', ' Development ', ' scientific advances ', ' scientific accomplishments ', ' Scientific Advances and Accomplishments ', ' Heterosexuals ', ' aged ', ' Chronic stress ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Address ', ' Data ', ' Qualitative Research ', ' preventing ', ' prevent ', ' Sexual Health ', ' designing ', ' design ', ' innovative ', ' innovate ', ' innovation ', ' Population ', ' evidence base ', ' adverse consequence ', ' adverse outcome ', ' resilience ', ' Minority ', ' sexual minority ', ' ']",NIDA,DREXEL UNIVERSITY,R36,2012,52902,0.07544479244868968
"Social networks and HIV risk among rural drug users    DESCRIPTION (provided by applicant):  This application is in response to PA-06-478, ""Research on Rural Mental Health and Drug Abuse Disorders"". One of the research areas highlighted by this PA is the examination of rural HIV transmission using social network analysis. The overall goal of the study is to examine the prevalence, incidence, and risk factors for HIV and other blood borne infections (BBIs) such as hepatitis B (HBV) and C (HCV) among rural Appalachian drug users using social network analysis and multilevel modeling. HIV continues to be a major public health problem in the United States, especially among drug users. However, little is known about HIV in rural areas in which there are marked health disparities. Therefore, given that studies among urban drug users have found that social network indicators are robust predictors of HIV risk, both social network and individual characteristics will be measured for their association with HIV risk among rural drug users. The specific aims are: 1) To determine the prevalence and incidence of HIV, HCV and HBV among rural injection and non- injection drug users; 2) To examine HIV and other BBI risk among rural injection and non-injection drug users; and 3) To examine longitudinal changes in rural HIV, HCV and HBV risk at 6-months, 12-months and 18- months post-baseline. To meet these aims, a sample 500 rural injection and non-injection drug users will be recruited using respondent driven sampling (RDS). In addition to biologic testing for HIV, HCV and HBV, rural participants will be given an interviewer-administered questionnaire pertaining to their social networks (drug, sexual and support networks), sociodemographics, drug use, HIV risk behaviors, psychiatric diagnoses, intravention and norms. Since individuals will be nested within networks, data will be analyzed using multilevel random effects regression that allows for the simultaneous examination of social network and individual-level risk. Consistent with the priorities of the NIDA AIDS Research Program, this proposal will explore the social network structure in a rural drug using population in order to better understand how network factors may affect HIV risk in rural areas using an innovative multilevel approach. Results from the proposed study will inform the design and implementation of HIV interventions in rural areas and help to determine the appropriate population for which to target such activities in order to reduce the morbidity and mortality associated with HIV and other BBIs.       Although HIV remains a significant public health problem in the United States, especially among drug users, little is known about HIV risk in rural areas such as Appalachia. It has been shown in urban populations that relationships among drug users, also known as social networks, are important predictors of HIV risk. Therefore, this study seeks to characterize rural HIV risk by measuring both social network and individual behaviors in order to inform prevention activities in health resource-deprived rural areas.          ",Social networks and HIV risk among rural drug users,8220787,R01DA024598,"['Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' Affect ', ' Appalachia ', ' Appalachian Region ', ' driving ', ' Automobile Driving ', ' Behavior ', ' Blood Reticuloendothelial System ', ' Blood ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' disease/disorder ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health Resources ', ' serum hepatitis ', ' infection with hepatitis B virus ', ' infection with HBV ', ' Viral Hepatitis B ', ' Hepatitis B Infection ', ' Hepatitis B ', ' Homologous Serum Hepatitis Virus ', ' HBV ', ' Hepatitis B Virus ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incidence ', ' Infection ', ' Injections ', ' Injection of therapeutic agent ', ' Interviewer ', ' Interview ', ' Kentucky ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Morbidity ', ' Morbidity - disease rate ', ' Mortality ', ' Mortality Vital Statistics ', ' Drug Prescribing ', ' Drug Prescriptions ', ' Public Health ', ' public health medicine (field) ', ' Questionnaires ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Risk ', ' Risk Factors ', ' Rural Population ', ' serology ', ' Serological Tests ', ' Serologic tests ', ' Testing ', ' Time ', ' United States ', ' Urban Population ', ' Measures ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Social Network ', ' rural area ', ' urban area ', ' Area ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Individual ', ' Rural ', ' drug use ', ' Drug usage ', ' Respondent ', ' Drug user ', ' Individual Adjustment ', ' Psychiatric Diagnosis ', ' Research Priority ', ' programs ', ' Injection Drug User ', ' Injecting drug user ', ' meetings ', ' Seroprevalences ', ' Structure ', ' Participant ', ' disease prevention ', ' disorder prevention ', ' Prevention ', ' Reporting ', ' multilevel modeling ', ' multilevel model ', ' methods to study multiple-level influences ', ' multilevel analysis ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Transmission ', ' transmission process ', ' Principal Investigator ', ' Characteristics ', ' designing ', ' design ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' high risk ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2012,326837,0.12666251430322556
"Text Messaging Adherence Assessment & Intervention Tool for Rural HIV+ Drug Users    DESCRIPTION (provided by applicant): This is a new application under PAS-10-098, Technology-based Adherence Interventions for Substance Abusing Populations with HIV (R34). New methods to promote HIV treatment adherence are needed for drug users, ethnic minorities, and women, who reside outside major metropolitan areas who have worse health outcomes. Familiar technological devices such as mobile phones could overcome some of the health disparities seen among rural HIV+ patients. In this project, investigators will develop and test the feasibility and promise of a text messaging system that uses Ecological Momentary Assessment (EMA) methods to detect nonadherence and drug use episodes, then immediately intervenes to improve HIV treatment adherence (both medication adherence and treatment engagement) in drug users living with HIV/AIDS. Using formative research with the targeted patients and partnership with a technology developer, we will develop the application and administrative system, Treatment Extension by Text (Text). Text will assess routine adherence, allow users to report critical events, and respond to randomly timed queries about adherence, drug use, and drug craving. When the Text EMA application detects threats to adherence, it will deliver a personalized, tailored intervention text message chosen by the participant. These customized messages will remind the user to take medications on time and reduce drug use. Investigators will pilot test the new adherence tool against treatment as usual over a three month period in a small pilot randomized trial to determine the feasibility, acceptability, and promise of Text. This R34 is a Stage 1b/2a project in the Stage Model of Behavioral Therapy Development in that it will develop novel interventions and methods, and generate preliminary estimates of effect sizes that will determine whether a larger, more expensive clinical trial with a longer follow-up period and evaluation of cost-effectiveness is warranted. By using technology to assess and detect episodes of nonadherence, drug use, and drug craving in real time, the project will deliver an intervention ""on the fly"" in time to help the person resume medication adherence before health damages occur. If successful, Text has the possibility of rapid scale-up for further trials across the rural U.S. to follow.      PUBLIC HEALTH RELEVANCE: This project will develop and pilot test a text messaging system for mobile phones to assess HIV treatment adherence, quickly detect problems as they occur, and send personalized intervention messages to help rural and non-urban drug using patients achieve HIV medication adherence and interrupt drug use. This intervention could be scaled up quickly as a novel, sustainable approach to maintaining treatment adherence. Lessons learned could hasten the development of interventions for other chronic diseases in the U.S.              Relevance to Public Health This project will develop and pilot test a text messaging system for mobile phones to assess HIV treatment adherence, quickly detect problems as they occur, and send personalized intervention messages to help rural and non-urban drug using patients achieve HIV medication adherence and interrupt drug use. This intervention could be scaled up quickly as a novel, sustainable approach to maintaining treatment adherence. Lessons learned could hasten the development of interventions for other chronic diseases in the U.S.",Text Messaging Adherence Assessment & Intervention Tool for Rural HIV+ Drug Users,8241014,R34DA031640,"['Adoption ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Chronic Disease ', ' clinical investigation ', ' Clinical Trials ', ' Communities ', ' cost effectiveness ', ' Dropout ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Ethnic group ', ' Focus Groups ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' Interview ', ' Learning ', ' Methods ', ' Morbidity ', ' Morbidity - disease rate ', ' Persons ', ' Patients ', ' Pharmacies ', ' Pharmacy facility ', ' Poverty ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Technology ', ' Phone ', ' Telephone ', ' Testing ', ' Time ', ' Transportation ', ' Woman ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Caring ', ' Treatment Failure ', ' base ', ' improved ', ' Area ', ' Penetration ', ' Evaluation ', ' residence ', ' Rural ', ' Fostering ', ' drug use ', ' Drug usage ', ' Staging ', ' tool ', ' Drug user ', ' Stigmata ', ' Life ', ' programs ', ' Viral Load ', ' Viral Burden ', ' Viral Load result ', ' Event ', ' Clinic ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' Visit ', ' drug craving ', ' metropolitan ', ' Structure ', ' novel ', ' Participant ', ' Program Announcement ', ' NIH Program Announcements ', ' Devices ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Modeling ', ' response ', ' stigma ', ' social stigma ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Pill ', ' pill (pharmacologic) ', ' Mobile Phones ', ' Car Phone ', ' health disparities ', ' health disparity ', ' Address ', ' Adherence ', ' Adherence (attribute) ', ' Consent ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' trend ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Text ', ' developmental ', ' Development ', ' medication adherence ', ' medication compliance ', ' pilot trial ', ' treatment center ', ' Outcome ', ' scale up ', ' Population ', ' ethnic minority ', ' ethnic minority population ', ' usability ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' high risk ', ' public health relevance ', ' usual care ', ' treatment as usual ', ' treatment adherence ', ' randomized trial ', ' ']",NIDA,UNIVERSITY OF VIRGINIA,R34,2012,346500,0.11426002001962016
"Interdisciplinary Research Training Institute on Hispanic Drug Abuse    DESCRIPTION (provided by applicant): The proposed Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse seeks to promote the career development of pre-doctoral, postdoctoral and early career clinically-focused scientists interested in conducting research as it affects the Hispanic population. This comprehensive and coordinated research education program aims at providing research experience and increasing the skills required for development of testable hypothesis, preparation and submission of research applications for appropriate NIH extramural funding (i.e. K01, K08, F31, F32, R03, R21, etc). Building upon the National Hispanic Science Network's Summer Research Training Institute, the IRTI has two short-term goals and two long-term goals as follows: (1) enhancing the fellows' knowledge and skills for conducting interdisciplinary research on drug abuse; (2) increasing the number of early career faculty who establish vibrant and independent programs of drug abuse research, (3) increasing the amount and quality of research on minority health and health disparities; and, (4) improving the health of minorities in part by decreasing minority health disparities. The aims of the IRTI are: 1. Provide an educational training opportunity that will enhance the skills for conducting interdisciplinary Hispanic drug research and developing applications for NIH funding among pre-doctoral, postdoctoral and early career faculty (fellows) through the implementation of a 14 day intensive summer research training program; 2. Execute a mentoring plan that would be organized and structured around a team of interdisciplinary mentors that would be accessible and available to provide selected fellows with focused mentoring and continual support; and 3. Provide a networking structure and process that will assist fellows in building and maintaining relationships and communication with leading experts in the field of Hispanic drug research and fellow peers. Overall, mentoring activities will focus on guiding and assisting the fellows in achieving benchmarks of progress including: a) Academic Career Progress; b) Scientific Publications; c) Scientific Presentations and d) Research Funding. These outcomes will be facilitated through various types of support including: Mentor Commitment, Travel to Mentor Institution, Conferences/Workshops, and IRTI Mentoring Annual Meeting and IRTI Scientific Conference. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research in the interest of public health. The proposed IRTI and its mentorship and networking components will begin to fill the gap in knowledge of how to effectively develop specific incubators that will be successful in growing a special generation of drug abuse research scientists. PUBLIC HEALTH RELEVANCE: The proposed Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse seeks to promote the career development of pre-doctoral, postdoctoral and early career clinically-focused scientists interested in conducting research as it affects the Hispanic population. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research. Interdisciplinary research teams of tomorrow are needed in addressing health disparities, a major public health problem for which new knowledge from several areas of science must be integrated to define and address extant vulnerabilities, and to develop effective prevention and treatment interventions.           PROJECT NARRATIVE The proposed Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse seeks to promote the career development of pre-doctoral, postdoctoral and early career clinically-focused scientists interested in conducting research as it afects the Hispanic population. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research. Interdisciplinary research teams of tomorrow are needed in addressing health disparities, a major public health problem for which new knowledge from several areas of science must be integrated to define and address extant vulnerabilities, and to develop effective prevention and treatment interventions.",Interdisciplinary Research Training Institute on Hispanic Drug Abuse,8306243,R25DA026401,"['Affect ', ' Communication ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Faculty ', ' Goals ', ' Health ', ' Incubators ', ' Institutes ', ' Mentors ', ' Mentorship ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Public Health ', ' public health medicine (field) ', ' Scientific Publication ', ' Publications ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Science ', ' Training Programs ', ' Travel ', ' Generations ', ' conference ', ' symposium ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' base ', ' career ', ' improved ', ' Area ', ' Training ', ' Discipline ', ' Workshop ', ' Educational workshop ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Funding ', ' Nature ', ' Knowledge ', ' programs ', ' Scientist ', ' Complex ', ' Best Practice Analysis ', ' Benchmarking ', ' interest ', ' meetings ', ' experience ', ' Structure ', ' skills ', ' peer ', ' Prevention ', ' career development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Institution ', ' Address ', ' Research Training ', ' Extramural ', ' EXTMR ', ' Extramural Activities ', ' Preparation ', ' Process ', ' developmental ', ' Development ', ' minority health ', ' Outcome ', ' predoctoral ', ' predoc ', ' pre-doc ', ' pre-doctoral ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R25,2012,315436,0.144606105512944
"Navigator Enhanced Case Management for Jail Inmates    DESCRIPTION (provided by applicant): Each year, there are over 600 unduplicated HIV-infected persons incarcerated in the San Francisco jail and almost two-thirds released with HIV-focused discharge planning were reincarcerated within 1 year. More than half of HIV-infected jail inmates are diagnosed with mental health conditions severe enough to require medication and a similar proportion report substance abuse disorders at the time of detention. While some community-based services exist, there remains a critical need exists to improve linkages to care and adherence to care plans for HIV-infected adults as they move between community and jai. An effective service delivery model used in similar high-needs populations exists, but has not been tested with HIV-infected drug users leaving jails - Navigator case management. Base on harm reduction, motivational interviewing and general social work principles, this model uses assertive community treatment and a highly proactive approach to facilitate adherence to a comprehensive care plan designed to address a client's multiple needs. Case managers work with paraprofessional peer navigators to help clients make better use of available resources, more effectively communicate with providers, sustain care over time and successfully connect with multiple service provider sectors. In this study, we propose to tailor this approach to meet the needs of HIV-infected individuals with substance abuse and mental health issues, pilot test the intervention and assessment procedures and then conduct a randomized study in which 360 HIV-infected men and women leaving jail. Specifically, participants will receive either Navigator case management delivered by the non-profit San Francisco Pre-Trial Diversion project or the standard of care currently provided to transitioning inmates, 90- days of as-needed case management provided by the San Francisco Department of Public Health's Forensic AIDS Project. We will test the effectiveness of the intervention in reducing sexual and drug-related HIV transmission risk, increasing HIV medication adherence, reducing drug dependence and reducing reincarceration. Finally, we will characterize both the Navigator and Forensic AIDS Project intervention processes and conduct exploratory analyses of the mediators of HIV transmission risk and risk reduction and HIV-related adherence among HIV+ individuals leaving jail. Our study is highly innovative because no interventions exist that are proven effective with this population - HIV-infected individuals with drug use and mental health issues. This study will also contribute to the field of HIV prevention by incorporating risk reduction counseling alongside more traditional case management support services. PUBLIC HEALTH RELEVANCE: HIV-infected adults incarcerated in the United States criminal justice system are predominantly active drug users and disproportionately people of color. The complex interplay of poverty, race, lack of education and sanctions--rather than treatment--for addictions reinforces returns to the criminal justice system and pervasive health disparities for HIV-infected individuals. Underlying behaviors that lead to repeated incarceration closely correlate with behaviors that are associated with HIV transmission and increased morbidity and mortality from HIV. In drug addicted adults, recidivism is driven by drug relapse and illegal activities associated with drug use, failure to engage and remain in mental health treatment or failure to break free from social instability in the form of homelessness and joblessness. This study proposes to assess whether a method of case management proven effective for similar populations can ensuring services to successfully and permanently break the cycle of incarceration, drug abuse and HIV transmission risk behavior among HIV-infected individuals leaving jail.              NARRATIVE HIV-infected adults incarcerated in the United States criminal justice system are predominantly active drug users and disproportionately people of color. The complex interplay of poverty, race, lack of education and sanctions--rather than treatment--for addictions reinforces returns to the criminal justice system and pervasive health disparities for HIV-infected individuals. Underlying behaviors that lead to repeated incarceration closely correlate with behaviors that are associated with HIV transmission and increased morbidity and mortality from HIV. In drug addicted adults, recidivism is driven by drug relapse and illegal activities associated with drug use, failure to engage and remain in mental health treatment or failure to break free from social instability in the form of homelessness and joblessness. This study proposes to assess whether a method of case management proven effective for similar populations can ensuring services to successfully and permanently break the cycle of incarceration, drug abuse and HIV transmission risk behavior among HIV-infected individuals leaving jail.",Navigator Enhanced Case Management for Jail Inmates,8274779,R01DA027209,"['Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Behavior ', ' Client ', ' Color ', ' Communities ', ' comprehensive care ', ' Comprehensive Healthcare ', ' Comprehensive Health Care ', ' Counseling ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Forensics ', ' Forensic Medicine ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Housing ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', "" men's "", ' men ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Morbidity ', ' Morbidity - disease rate ', ' Mortality ', ' Mortality Vital Statistics ', ' Persons ', ' Poverty ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisoner ', ' Prisons ', ' Public Health ', ' public health medicine (field) ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Relapse ', ' Research Resources ', ' Resources ', ' Risk ', ' San Francisco ', ' Social Work ', ' Social Service ', ' Social work (field) ', ' Societies ', ' Testing ', ' Time ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Unemployment ', ' United States ', ' Woman ', ' Work ', ' County ', ' Case Management ', ' Criminal Justice ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Vent ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Caring ', ' base ', ' improved ', ' Procedures ', ' Left ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' Ensure ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' unhoused ', ' homeless ', ' Homelessness ', ' Individual ', ' drug use ', ' Drug usage ', ' Drug user ', ' programs ', ' Complex ', ' LOINC Axis 4 System ', ' System ', ' Viral ', ' meetings ', ' Services ', ' Participant ', ' peer ', ' Harm Minimization ', ' Harm Reduction ', ' recidivism ', ' high risk behavior ', ' motivational interview ', ' motivational enhancement therapy ', ' Case Management Nurse ', ' Care Manager ', ' Case Manager ', ' drug addict ', ' Reporting ', ' social ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Risk Reduction ', ' Provider ', ' health disparities ', ' health disparity ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Jail ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Adherence ', ' Adherence (attribute) ', ' Effectiveness of Interventions ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Transmission ', ' transmission process ', ' Process ', ' medication adherence ', ' medication compliance ', ' cost ', ' drug relapse ', ' reincarceration ', ' designing ', ' design ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' community based service ', ' addictive disorder ', ' addiction ', ' public health relevance ', ' standard of care ', ' treatment adherence ', ' efficacy testing ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2012,447830,0.12698386697695813
"Natural History of HIV Infection In Injection Drug Users     DESCRIPTION (provided by applicant): HIV-infected injection drug users (IDUs) represent a marginalized population with substantial disparities in health care access and outcomes. With improved survival due to highly active antiretroviral therapy (HAART), HIV has transformed into a chronic disease. In addition to HIV disease, IDUs also suffer from a syndemic of other chronic diseases including substance abuse, mental health disorders, and non-AIDS comorbidities. Proposed is a continuation of the ALIVE cohort study, among the largest, longest-running and productive IDU cohorts worldwide, and which has followed disadvantaged, primarily African American IDUs in Baltimore, MD since 1988. With advancing age and multimorbidity, the comprehensiveness of care will increasingly determine HIV-infected IDUs quality and quantity of life. We hypothesize that the key determinants of optimal HIV care (e.g., active drug use, provider relationships, social networks, neighborhood factors) may also determine effective comprehensive care for HIV-infected IDUs. While this cohort has and continues to be a platform for an array of studies all critical to addressing questions about the long-term course and consequences of HIV disease and its treatment among IDUs, this proposal emphasizes: 1) improved identification of HIV-infected IDUs most likely to respond optimally to ART. We will examine longitudinal trajectories of drug use and HIV RNA to define membership in optimal vs. sub-optimal response groups, and then quantitatively identify behavioral and clinical correlates and qualitatively examine barriers and coping mechanisms which underlie the ability to optimally respond. 2) To investigate the determinants and consequences of comprehensive care for HIV-infected IDUs from patient, clinical and societal perspectives. Comprehensive care for HIV-infected IDUs extends beyond HIV-focused aspects to include care for chronic comorbid diseases, substance abuse, and mental health conditions. We propose a framework that considers measures of effective comprehensive care from patient (perceived effectiveness), clinical (adherence to quality care indicators) and societal (service utilization) points of view. Building on prior investigation of individual-, provider-, and neighborhood-level factors associated with HAART effectiveness, we will identify determinants of quality comprehensive care. Extending our multi-level framework in this proposal, we will also evaluate the role of social networks (e.g. 'care-engaged' network members) on comprehensive care. Finally, we examine comprehensive care effectiveness in relation to patient-reported (quality-of-life), clinica (multimorbidity, physical performance) and societal (QALYs) outcomes. To achieve these aims, we continue biannual visits with interview, exam, and biospecimen collection supplemented by medical record review and registry linkage. The ALIVE study remains well-positioned to address the emerging issues confronting the healthy aging of HIV-infected IDUs, namely optimizing long-term ART and enhancing comprehensiveness of care.        PUBLIC HEALTH RELEVANCE: This proposal addresses the primary issues confronting the healthy aging of HIV-infected injection drug users, namely optimizing long-term antiretroviral therapy and enhancing the comprehensiveness of care, not just for HIV disease, but also for substance abuse, mental health conditions, and chronic diseases. Nested in the long- standing ALIVE cohort study, the proposed aims will improve understanding of effective comprehensive care from patient, clinical and societal perspectives, and will inform strategies to optimize care and improve outcomes for persons aging with HIV infection.              This proposal addresses the primary issues confronting the healthy aging of HIV-infected injection drug users, namely optimizing long-term antiretroviral therapy and enhancing the comprehensiveness of care, not just for HIV disease, but also for substance abuse, mental health conditions, and chronic diseases. Nested in the long- standing ALIVE cohort study, the proposed aims will improve understanding of effective comprehensive care from patient, clinical and societal perspectives, and will inform strategies to optimize care and improve outcomes for persons aging with HIV infection.            ",Natural History of HIV Infection In Injection Drug Users,8263479,R56DA004334,"['lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Baltimore ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' Aging ', ' Environment ', ' Health Services Accessibility ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Heterogeneity ', ' Grant ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Chronic Disease ', ' co-morbidity ', ' Comorbidity ', ' Communities ', ' Concurrent Studies ', ' Cohort Studies ', ' Disadvantaged ', ' disease/disorder ', ' Disorder ', ' Disease ', ' comprehensive care ', ' Comprehensive Healthcare ', ' Comprehensive Health Care ', ' Data Collection ', ' Methods ', ' Medical Records ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Mortality ', ' Mortality Vital Statistics ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' Interview ', ' Method LOINC Axis 6 ', ' Methodology ', ' long-term study ', ' Longitudinal Studies ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incidence ', ' Risk ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Running ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' QOL ', ' Quality of life ', ' Scientific Publication ', ' Publications ', ' Qualitative Evaluations ', ' social role ', ' Role ', ' Neighborhoods ', ' Persons ', ' Relapse ', ' Registries ', ' Phenotype ', ' Patients ', ' Peer Review ', ' smoking cessation ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' Quality-Adjusted Life Years ', ' Malignant ', ' Malignant - descriptor ', ' Chronic ', ' Natural History ', ' Social Network ', ' Caring ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' base ', ' Clinical ', ' Treatment outcome ', ' health care ', ' Healthcare ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' improved ', ' Measures ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' Published Comment ', ' Intravenous ', ' Complex ', ' Life ', ' Disorder Management ', ' Disease Management ', ' frailty ', ' tool ', ' uptake ', ' Training and Education ', ' Collaborations ', ' Investigation ', ' Individual ', ' drug use ', ' Drug usage ', ' Metabolic ', ' Funding ', ' Evaluation ', ' Link ', ' highly active anti-retroviral therapy ', ' HAART ', ' Highly Active Antiretroviral Therapy ', ' Modeling ', ' Effectiveness ', ' multisubstance abuse ', ' polysubstance abuse ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Reporting ', ' QOC ', ' Quality of Care ', ' response ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' Visit ', ' Physical Function ', ' cohort ', ' Performance ', ' Neurocognitive ', ' experience ', ' Injection Drug User ', ' Injecting drug user ', ' success ', ' member ', ' Position ', ' Positioning Attribute ', ' Behavioral ', ' prospective ', ' Monitor ', ' Collection ', ' antiretroviral therapy ', ' trend ', ' Address ', ' Consequences of HIV ', ' Infrastructure ', ' Research Infrastructure ', ' Interruption ', ' Provider ', ' Adherence ', ' Adherence (attribute) ', ' treatment response ', ' Outcome ', ' hepatitis C virus vaccine ', ' HCV Vaccine ', ' healthy aging ', ' service utilization ', ' Clinical effectiveness ', ' Population ', ' Chronic Care ', ' coping mechanism ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R56,2012,1630400,0.030422923259024848
"Brief intervention for drug-using rural women at high-risk for HIV/HCV     DESCRIPTION (provided by applicant): The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high-risk for HIV and HCV. This project has potential to make a significant contribution to science by advancing knowledge about the health disparities, high-risk behaviors (injection drug use, sex risk), and service utilization of this high-risk, vulnerable, an understudied group of women during a time of emerging and significant public health risk in an Appalachian rural setting. This project will incorporate standardized screening (NIDA-modified ASSIST) to identify high-risk rural women drug users from jails, including injectors. Consenting women (N=350) will be asked to participate in a baseline interview, and will then be randomly assigned to one of two study groups: (1) HIV Education (HIV- Ed n=175) which includes the NIDA standard pre and post-test counseling, HIV and HCV rapid testing, and an information packet on existing community drug abuse and HIV/HCV resources; or (2) Motivational Interviewing- based HIV Risk Reduction (MI-HIV n=175) which, in addition to what is received in the HIV-Ed group, also includes an evidence-based brief intervention for high-risk women focused on an individualized plan for enhancing motivation to reduce risk behaviors and to use health and behavioral health services in the community. Specific aims include: (1) to compare the effectiveness of an evidence-based HIV risk reduction intervention (MI-HIV) to HIV Education (NIDA Standard) in reducing sex risk behaviors, injection practices, and drug use among a culturally unique sample of disadvantaged, drug-using rural women at high-risk for HIV and HCV; and (2) to examine MI-HIV Intervention engagement as a predictor of community health and behavioral health service utilization (including drug treatment and mental health) at follow-up among disadvantaged, drug- using rural women at high risk for HIV and HCV. This project is innovative because it 1) targets a high-risk and understudied group of women, 2) uses brief intervention to not only reduce risk behavior but also to enhance motivation for using community health and behavioral health resources, and 3) utilizes a real-world setting to identify high-risk women drug users. The long-term goal of this study is to increase access to health and behavioral health services in order to improve the quality of health of high-risk rural women.        PUBLIC HEALTH RELEVANCE: The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high risk for HIV and HCV. This project has potential to make a significant contribution to science by providing knowledge about the health, risk behaviors, and service utilization of a vulnerable and understudied group of women during a time of emerging and significant public health risk in a rural Appalachian setting. Successful completion of the aims of this project will advance the delivery of a low-cost, potentially high impact intervention with implications for a number of other real world settings (such as criminal justice venues) where other disadvantaged high-risk drug users can be identified and targeted for intervention.                      The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high risk for HIV and HCV. This project has potential to make a significant contribution to science by providing knowledge about the health, risk behaviors, and service utilization of a vulnerable and understudied group of women during a time of emerging and significant public health risk in a rural Appalachian setting. Successful completion of the aims of this project will advance the delivery of a low-cost, potentially high impact intervention with implications for a number of other real world settings (such as criminal justice venues) where other disadvantaged high-risk drug users can be identified and targeted for intervention.                    ",Brief intervention for drug-using rural women at high-risk for HIV/HCV,8409992,R01DA033866,"['United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Appalachia ', ' Appalachian Region ', ' Health Services ', ' health care service ', ' Goals ', ' Education ', ' Educational aspects ', ' Health ', ' Health Resources ', ' Counseling ', ' Community Services ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Communities ', ' Disadvantaged ', ' Kentucky ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Interview ', ' Injections ', ' Injection of therapeutic agent ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Public Health ', ' public health medicine (field) ', ' Random Selection ', ' Random Allocation ', ' Pre-Post Tests ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Motivation ', ' Woman ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Walkers ', ' base ', ' Criminal Justice ', ' rural area ', ' health care ', ' Healthcare ', ' Time ', ' Science ', ' Testing ', ' Staging ', ' Opiates ', ' Drug user ', ' Services ', ' Pattern ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Educational Intervention ', ' Knowledge ', ' Rural ', ' improved ', ' drug use ', ' Drug usage ', ' Area ', ' women at high risk ', ' High Risk Woman ', ' Female Groups ', "" Women's Group "", ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Screening procedure ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' motivational interview ', ' motivational enhancement therapy ', ' behavioral health ', ' health disparities ', ' health disparity ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' outreach ', ' response ', ' Reporting ', ' high risk behavior ', ' Sampling ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' Participant ', ' Country ', ' treatment planning ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' sexual risk behavior ', ' sex risk ', ' cost ', ' comparison group ', ' Community Health ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Address ', ' Risk Reduction ', ' drug resource ', ' Jail ', ' Consent ', ' vulnerable group ', ' Vulnerable Populations ', ' compare effectiveness ', ' high risk ', ' designing ', ' design ', ' innovative ', ' innovate ', ' innovation ', ' prescription opiate ', ' evidence base ', ' Prevalence ', ' service utilization ', ' Evidence based intervention ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2012,524714,0.10753914495794752
"Clinical and Social Implications of Cost Sharing for Cancer Drugs    DESCRIPTION (provided by applicant): Dr. Yu-Ning Wong, a Medical Oncologist at Fox Chase Cancer Center is dedicated to a career in cancer health services research. Her goal is to develop a multidisciplinary research program to understand the impact of insurance design on cancer drug utilization and clinical outcomes. This Career Development Award will provide the means to take two important steps towards accomplishing this goal. First, it will allow for additional intensive mentored education and training in public policy research, health economics, and advanced statistical methods that will augment the candidate's previous rigorous training in epidemiology, biostatistics, and clinical medicine. Second, it will support the development of an original clinical research program using rigorous epidemiologic, econometric and survey methods to examine the impact of prescription drug insurance coverage on cancer outcomes. As new costly cancer drugs are introduced, patients with both public and private insurance are facing higher out- of-pocket costs. Cost sharing between insurers and patients (though co-payments and deductibles) has been traditionally used to control costs based on an expectation that unnecessary health care utilization will be reduced. However this expectation may result in worse socioeconomic disparities in care since some patients may be unable to afford highly effective cancer treatments. The candidate proposes three complementary studies to address the important, unanswered questions about the impact of cost sharing on cancer outcomes. Project A is a conjoint analysis-based survey to measure how patients make decisions among treatments of varying efficacy, toxicity and cost. Project B uses the results from Project A in a decision analysis model to measure the sensitivity of clinical outcomes to price and patient preferences. This will also allow us to determine if is possible to improve clinical outcomes by using low cost sharing to increase adherence to high value treatments. Project C is a natural experiment using insurance claims to measure the effect of insurance design and sociodemographic factors on the receipt of a new, expensive anti-nausea medication and subsequent outcomes. This research program will triangulate on the nexus of issues central to the understanding of cost sharing on cancer drug utilization and clinical outcomes and form the foundation for the candidate's transition to an independent investigator in cancer health services research. This project will have broad implications for the financing of high cost medical interventions because it will help policy makers, insurers and physicians understand how current models of cost sharing may contribute to socioeconomic disparities in cancer care. Our results may suggest consideration of a novel benefit design that encourages patients to make decisions based on relative value, rather than cost alone.           ",Clinical and Social Implications of Cost Sharing for Cancer Drugs,8304322,K07CA136995,"['Adoption ', ' Affect ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Antiemetic Drugs ', ' Antiemetic Agents ', ' Anti-emetics ', ' Antiemetics ', ' anticancer drug ', ' anticancer agent ', ' Tumor-Specific Treatment Agents ', ' Neoplastic Disease Chemotherapeutic Agents ', ' Cancer Drug ', ' Antineoplastics ', ' Antineoplastic Drugs ', ' Anti-Cancer Agents ', ' Antineoplastic Agents ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Chronically Ill ', ' Clinical Medical Sciences ', ' Clinical Medicine ', ' Clinical Study ', ' Clinical Research ', ' Cost Containment ', ' Cost Control ', ' Decision Analyses ', ' Decision Analysis ', ' Decision Making ', ' Deductibles ', ' Diffusion ', ' Drug Utilization ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Foundations ', ' Patient Care Delivery ', ' Patient Care ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health Care Systems ', ' Healthcare Systems ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Health Services Research ', ' Insurance ', ' Insurers ', ' Insurance Carriers ', ' Mentors ', ' Methods ', ' Nausea ', ' Patients ', ' Physicians ', ' Probability ', ' Public Policy ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Survey Method ', ' Survey Methodology ', ' Survey Instrument ', ' Surveys ', ' United States ', ' Measures ', ' pricing ', ' Price ', ' Relative ', ' Relative (related person) ', ' Treatment outcome ', ' Cost Sharing ', ' Drug Insurance ', ' health care ', ' Healthcare ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' Treatment Cost ', ' Underinsured ', ' Caring ', ' base ', ' career ', ' improved ', ' Clinical ', ' Medical ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Gap Junctions ', ' Training ', ' total medical expenditure ', ' medical expenses not covered by insurance ', ' Uninsured Medical Fees (not covered) ', ' Uncovered Uninsured Medical Expense ', ' Uncovered Medical Expenses ', ' Out-of-Pocket Expense ', ' Uninsured Medical Expense ', ' Individual ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Policy Maker ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Medical Oncologist ', ' Supportive Therapy ', ' Supportive care ', ' Patient Preferences ', ' Insurance Status ', ' Insurance Coverage ', ' programs ', ' Training and Education ', ' Toxicities ', ' Toxic effect ', ' expectation ', ' novel ', ' payment ', ' Statistical Methods ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' cancer therapy ', ' cancer care ', ' vulnerable group ', ' Vulnerable Populations ', ' aprepitant ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' low socioeconomic status ', ' Address ', ' Adherence ', ' Adherence (attribute) ', ' Data ', ' Policy Research ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' K-Series Research Career Programs ', ' Cancer Patient ', ' Fox Chase Cancer Center ', ' Observational Study ', ' Principal Investigator ', ' Characteristics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' socioeconomics ', ' developmental ', ' Development ', ' cost ', ' health economics ', ' designing ', ' design ', ' elderly patient ', ' older patient ', ' Outcome ', ' Natural experiment ', ' innovative ', ' innovate ', ' innovation ', ' chemotherapy ', ' social implication ', ' ']",NCI,FOX CHASE CANCER CENTER,K07,2012,144018,0.027485458307407232
"Rural and Urban African American Cocaine Users' Perceived Need for Care    DESCRIPTION (provided by applicant): We seek to study the factors associated with rural/urban differences in perceived need for both drug abuse treatment and HIV testing because these are complementary services which could be integrated within formal drug abuse treatment programs or other locations to better meet the needs of African American cocaine users. We focus on perceived need among African American cocaine users because of their low rates of drug abuse treatment and HIV testing nationally as well as their demonstrated low perceived need for drug abuse treatment, high rates of risky sexual behaviors, and aversion to seeking HIV testing at local health departments in our prior research. Given that our prior natural history research did not include any urban areas, we do not know whether the low rates of drug abuse treatment and HIV testing among rural Arkansans are specific to rural residents (e.g., whether there is a disparity in access for rural African Americans) or whether urban African American cocaine users differ in other critical factors. To address these issues, we plan to conduct a community-based mixed methods study of African American cocaine users residing in rural and urban areas of Arkansas. Specifically, we propose a sequential mixed-method design, with qualitative key informant interviews conducted first (30 rural, 30 urban), followed by larger-scale, structured interviews (200 rural, 200 urban) using standardized instruments, pertinent measures from our prior rural health services and HIV research, and newly developed questions based on our initial qualitative work. Respondent-Driven Sampling (RDS), a variant of snowball sampling, will be used to identify and recruit participants. The primary aims of the study are: 1) Using qualitative methods, to describe rural/urban differences in pathways to drug use and drug use cultures, perceptions of access to drug abuse treatment and HIV testing, awareness and perceptions of what constitutes drug abuse treatment and HIV testing, and preferences for formal or informal drug abuse treatment and the site or location of HIV testing; 2) Using quantitative and qualitative methods, to compare and contrast rural and urban cocaine users' perceived need for drug abuse treatment and HIV testing and key predisposing, enabling, health, and other factors which could impede or facilitate perceived need; and 3) Using quantitative methods, to investigate whether rural/urban differences in perceived need for drug abuse treatment and HIV testing are mediated by key predisposing, enabling, and health factors as well as treatment and testing awareness and preferences. The knowledge gained from this project will enable health policy makers, treatment program managers, and providers to make more informed decisions about how to encourage and facilitate the utilization of drug abuse treatment and HIV testing among African American cocaine users in the Southern U.S., an underserved and high risk population.      PUBLIC HEALTH RELEVANCE: Of public health concern are the low rates of drug abuse treatment and high rates of HIV among African American cocaine users, especially in the Southern U.S. The knowledge gained from the proposed research would enable managers of public and behavioral health systems to make more informed decisions about how to target and tailor culturally sensitive messages aimed at increasing awareness of the benefits of drug abuse treatment and HIV testing. The proposed research would also provide new insight into whether HIV testing should be integrated within drug abuse treatment facilities to better meet the needs of rural as well as urban African American cocaine users.           PROJECT NARRATIVE Of public health concern are the low rates of drug abuse treatment and high rates of HIV among African American cocaine users, especially in the Southern U.S. The knowledge gained from the proposed research would enable managers of public and behavioral health systems to make more informed decisions about how to target and tailor culturally sensitive messages aimed at increasing awareness of the benefits of drug abuse treatment and HIV testing. The proposed research would also provide new insight into whether HIV testing should be integrated within drug abuse treatment facilities to better meet the needs of rural as well as urban African American cocaine users.",Rural and Urban African American Cocaine Users' Perceived Need for Care,8274834,R01DA026837,"['Arkansas ', ' Awareness ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Cocaine ', ' Communities ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' Health ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' health care service ', ' Health Services ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Health Services Accessibility ', ' Level of Health ', ' Health Status ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' inducement ', ' Incentives ', ' Interview ', ' Kentucky ', ' marijuana ', ' Marihuana ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Methamphetamine ', ' Methods ', ' Persons ', ' Ohio ', ' Perception ', ' Physicians ', ' Public Health ', ' public health medicine (field) ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Research Resources ', ' Resources ', ' Rural Health Services ', ' Testing ', ' Work ', ' Measures ', ' Privacy ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Illicit Drugs ', ' Mediating ', ' Caring ', ' Natural History ', ' base ', ' rural area ', ' urban area ', ' Site ', ' Variation ', ' Variant ', ' Medical ', ' Dental ', ' mental ', ' Psyche structure ', ' insight ', ' Cocaine Users ', ' Rural ', ' Policy Maker ', ' drug use ', ' Drug usage ', ' Respondent ', ' instrument ', ' Stigmata ', ' Knowledge ', ' programs ', ' Clinic ', ' Source ', ' Location ', ' meetings ', ' Services ', ' preference ', ' Structure ', ' Participant ', ' treatment program ', ' social ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' Sampling ', ' behavioral health ', ' stigma ', ' social stigma ', ' Provider ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Health system ', ' Qualitative Methods ', ' Data ', ' Improve Access ', ' informant ', ' pathway ', ' Pathway interactions ', ' Behavioral Model ', ' designing ', ' design ', ' Minority ', ' Population ', ' treatment site ', ' service utilization ', ' high risk ', ' public health relevance ', ' ']",NIDA,UNIV OF ARKANSAS FOR MED SCIS,R01,2012,138477,0.15968770068252294
"Research Training in the Prevention of Drug Abuse & AIDS in Communities of Color This revised application for a MIDARP program at Howard University describes the Research Training  Program in Drug Abuse and AIDS Prevention in Communities of Color which is designed to increase the  capacity of faculty and students at Howard to conduct rigorous and competitive research in the prevention of  drug abuse and HIV/AIDS in communities of color. The program will emphasize training in transdisciplinary  research on relationships between environmental stress, biological responses, risk behaviors and health  outcomes and will utilize collaborations with senior investigators in research intensive universities to mentor  Howard faculty investigators. The MIDARP will also work closely with existing programs that link Howard  faculty and students to research training opportunities to (1) increase knowledge and interest in drug abuse  and AIDS prevention research among faculty and students in these programs and (2) utilize the resources of  these programs to expand the range of training opportunities available to MIDARP investigators and  students. Howard students will be introduced to drug abuse and AIDS prevention research and career  development by augmenting existing drug abuse courses in the College of Arts and Sciences and the  curriculum for medical, basic science, nursing, and pharmacy students to include information on drug abuse  and AIDS prevention research.. We will also fund a pre-doctoral dissertation stipend and recruit students to  serve as research assistants in the MIDARP pilot studies. The unique strengths of the program include the  opportunity to (1) integrate education regarding drug abuse and AIDS prevention research into existing  research training programs for faculty and students;(2) train individuals in diverse disciplines such as the  health professions and sciences (i.e., medicine, basic sciences, pharmacy, nursing) who are less likely to  pursue research careers in drug abuse and AIDS prevention research; and (3) support transdisciplinary  research in drug use and AIDS prevention based on strong existing University research programs in  genetics, physiology, and psychobiology. A transdisciplinary approach will be reflected in the MIDARP  leadership that includes a Director who is a behavioral scientist specializing in research on environmental  stress, drug use, and AIDS risk in communities of color and a Deputy Director who is an immunogeneticist  with expertise in microbiology, and founding Director of the Human Genome Project at Howard University. ",Research Training in the Prevention of Drug Abuse & AIDS in Communities of Color,8311025,R24DA021470,"['Achievement Attainment ', ' Achievement ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' Arts ', ' Award ', ' Behavioral Research ', ' Behavioral Sciences ', ' Blood Pressure ', ' Clinical Study ', ' Clinical Research ', ' Color ', ' Communication ', ' Communities ', ' Consultations ', ' Curriculum ', ' Educational Curriculum ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Email ', ' E-Mail ', ' Electronic Mail ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' balance function ', ' balance ', ' Equilibrium ', ' Faculty ', ' Foundations ', ' Goals ', ' Grant ', ' Health ', ' health science profession ', ' Health Professions ', ' Health Occupations ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Human Genome Project ', ' Interview ', ' Leadership ', ' Medicine ', ' Mentors ', ' Mentorship ', ' Methods ', ' Microbiology ', ' Nursing Profession ', ' Nursing Field ', ' Nursing ', ' Discipline of Nursing ', ' Brochures ', ' Booklets ', ' Pamphlets ', ' Pharmacies ', ' Pharmacy facility ', ' Pharmacology ', ' Physiology ', ' pilot study ', ' Pilot Projects ', ' Psychiatry ', ' Psychology ', ' Scientific Publication ', ' Publications ', ' Recommendation ', ' recruit ', ' Recruitment Activity ', ' Research ', ' R&D ', ' R & D ', ' Development and Research ', ' research and development ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Schools ', ' school of medicine ', ' medical college ', ' medical schools ', ' Science ', ' Social Sciences ', ' Social Work ', ' Social Service ', ' Social work (field) ', ' Sociology ', ' Stress ', ' Students ', ' Medical Students ', ' Pupil Nurses ', ' Nursing Students ', ' Pharmacy Students ', ' Survey Instrument ', ' Surveys ', ' Teaching ', ' Educational process of instructing ', ' Time ', ' Training Activity ', ' Training Programs ', ' Universities ', ' violent behavior ', ' violent ', ' Violence ', ' Work ', ' Writing ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' biological adaptation to stress ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Task Forces ', ' Advisory Committees ', ' base ', ' career ', ' role model ', ' sociology/anthropology ', ' Area ', ' Biological ', ' Physiologic ', ' Physiological ', ' Medical ', ' Link ', ' Ensure ', ' Evaluation ', ' Training ', ' Discipline ', ' Individual ', ' Workshop ', ' Educational workshop ', ' Measurement ', ' Development Plans ', ' drug use ', ' Drug usage ', ' Funding ', ' Collaborations ', ' Genetic ', ' Exposure to ', ' Knowledge ', ' lectures ', ' programs ', ' Scientist ', ' Techniques ', ' interest ', ' meetings ', ' collegiate ', ' college ', ' Services ', ' American ', ' experience ', ' stressor ', ' success ', ' professor ', ' cohort ', ' skills ', ' Participant ', ' Prevention Research ', ' member ', ' Basic Research ', ' Basic Science ', ' graduate student ', ' Prevention ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' career development ', ' biopsychology ', ' biological basis of behavior ', ' psychobiology ', ' response ', ' Ally ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' health disparities ', ' health disparity ', ' Address ', ' Allied Health Sciences ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Infrastructure ', ' Research Infrastructure ', ' Research Training ', ' Senior Scientist ', ' Training and Infrastructure ', ' Monitor ', ' Permission ', ' Authorization ', ' Authorization documentation ', ' developmental ', ' Development ', ' Behavioral ', ' designing ', ' design ', ' Outcome ', ' Population ', ' predoctoral ', ' predoc ', ' pre-doc ', ' pre-doctoral ', ' Historically Black University ', ' Historically Black Institution ', ' Historically Black Colleges ', ' HBCUs ', ' Historically Black Colleges and Universities ', ' heart rate variability ', ' undergraduate student ', ' ']",NIDA,HOWARD UNIVERSITY,R24,2012,450051,0.15182662680398612
"Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth    DESCRIPTION (provided by applicant): The proposed study's overarching goal is to reduce the ethnic disparities in illicit drug use, cigarette use, and HIV between Hispanic and non-Hispanic youth. This goal will be accomplished by four aims: AIM 1 is to evaluate the effectiveness of Familias Unidas, relative to Community Practice (i.e., standard prevention services), in preventing illicit drug use; AIM 2 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing cigarette use; AIM 3 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing unprotected sexual behavior; and AIM 4 is to assess the extent to which family functioning mediates the effects of the intervention on illicit drug use, cigarette use, and unprotected sexual behavior. Twenty four middle schools with a total sample of 744 Hispanic adolescents from a wide geographic area of Miami-Dade County will be randomized using a block design to one of two conditions: Familias Unidas or Community Practice. The Familias Unidas intervention has been evaluated and found to be efficacious in two separate randomized controlled trials. In the first study (Pantin et al., 2003), Familias Unidas was shown to be efficacious relative to a no intervention control condition in increasing family functioning and reducing behavior problems (Prado et al., 2006), risk factors for youth illicit drug use and unprotected sex. In the second randomized controlled trial (Prado et al., in press), Familias Unidas was found to be efficacious, relative to two attention control conditions, in preventing cigarette use and illicit drug use. Familias Unidas was also found to be efficacious relative to both of the control conditions in preventing/reducing unprotected sexual behavior at last sexual intercourse. Finally, family functioning was found to mediate the effects of intervention condition on the outcomes. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more effective than Community Practice in reducing illicit drug use over time; (H2) Familias Unidas will be more effective than Community Practice in reducing cigarette use over time; and (H3) Familias Unidas will be more effective than Community Practice in reducing unprotected sexual behavior over time. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on illicit drug use will be partially mediated by family functioning; (H2a) the effect of Familias Unidas on cigarette use will be partially mediated by family functioning and (H3a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by family functioning. PUBLIC HEALTH RELEVANCE: The objective of the proposed study is to reduce illicit drug use, cigarette use, and unsafe sexual behavior health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, cigarette use, unprotected sexual behavior, and HIV in Hispanic adolescents.                 The objective of the proposed study is to reduce illicit drug use, cigarette use, and unsafe sexual behavior health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, cigarette use, unprotected sexual behavior, and HIV in Hispanic adolescents.",Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth,8212157,R01DA025192,"['Accounting ', ' Age ', ' Americas ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Benzeneethanamine, alpha-methyl-, (+-)- ', ' Amphetamines ', ' Attention ', ' Behavior ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Coitus ', ' Communication ', ' Communities ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Ethnic group ', ' Family ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Geographic Locations ', ' Goals ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Linear Models ', ' Manuals ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Parents ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Risk Factors ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Societies ', ' Substance Dependence ', ' Substance Addiction ', ' Testing ', ' Time ', ' United States ', ' County ', ' Relative ', ' Relative (related person) ', ' Parenting ', ' Parenting behavior ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Illicit Drugs ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Mediating ', ' Youth 10-21 ', ' Youth ', ' Guidelines ', ' improved ', ' Family Study ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Training ', ' white American ', ' caucasian American ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' drug use ', ' Drug usage ', ' behavioral problem ', ' Problem behavior ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Educational Intervention ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Staging ', ' Knowledge ', ' Frequency ', ' Frequencies (time pattern) ', ' LOINC Axis 4 System ', ' System ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' meetings ', ' middle school ', ' Cigarette ', ' Prevention Research ', ' prevention service ', ' peer ', ' Categories ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' parent monitoring ', ' parental monitoring ', ' Modeling ', ' Sampling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Effectiveness ', ' preventing ', ' prevent ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' trial design ', ' Clinical Trials Design ', ' Community Practice ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' developmental ', ' Development ', ' effectiveness trial ', ' youth substance use ', ' adolescent substance use ', ' designing ', ' design ', ' efficacy trial ', ' Outcome ', ' Youth Risk Behavior ', ' Adolescent Risk Behavior ', ' Population ', ' parental involvement ', ' community setting ', ' effective intervention ', ' primary outcome ', ' intervention effect ', ' prevent substance use ', ' substance use prevention ', ' randomized trial ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2012,754291,0.14666618696440634
"African American Female Drug Users: HIV, Health Disparities, & Criminality    DESCRIPTION (provided by applicant): The overall goal of this study is to understand how drug use and criminality are related to health disparities, particularly HIV, and service utilization among African American drug using and non-drug using women across criminal justice status. While drug use is similar across racial groups in the US, African Americans are disproportionately more likely to experience severe health consequences and criminal involvement as a result of drug misuse. Adequate health care may not be received by African American female offenders because they experience the burden of their race, class, gender, and criminal offender status. There is limited scientific data to help understand the linkages between health disparities such as HIV, untreated drug abuse, barriers to service utilization, and status as a criminal offender among African American females. This study is significant because of its potential to identify differences in health disparities and service utilization among African American drug using and non-drug using women in selected levels of criminal justice status (intensive correctional supervision-prison (n=200), moderate correctional supervision-jail (n=200), community supervision-probation (n=200), and no criminal justice involvement (n=200)). All 800 African American females will be followed longitudinally for three 6-month intervals to examine health status and the use of health services across time. The specific aims are: (1) To describe the prevalence of health problems among African American women across criminal justice status and drug use status; (2) To determine the cultural, predisposing, historical health, and potential enabling factors that are predictors of health problems among African American drug using and non-drug using women across criminal justice status over 18 months; (3) To describe the prevalence of untreated health problems, the patterns of health services utilization, and the cultural barriers to service utilization among African American women across criminal justice status and drug use status; and (4) To examine the factors that predict the likelihood of using health services among African American drug using and non-drug using women across criminal justice status over 18 months. The significance of this study includes the potential to provide criminal justice systems-level data for health planning and health policy for prevention, intervention, and treatment of African American female drug users.       This study is significant to the public health field because of its potential to understand the severity of health disparities among African American women across criminal justice status and drug use status and to predict health status and the use of health services over time. This knowledge of African American females can be used as a foundation for future criminal justice systems-level interventions to increase the use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism.          ","African American Female Drug Users: HIV, Health Disparities, & Criminality",8212557,R01DA022967,"['Alcohol Chemical Class ', ' Alcohols ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' Communities ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economics ', ' Enabling Factors ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Fear ', ' Fright ', ' Female ', ' Foundations ', ' Future ', ' Goals ', ' Gonococcal Infection ', ' Gonorrhea ', ' Health ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' Health Planning ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' health care service ', ' Health Services ', ' Level of Health ', ' Health Status ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Hospitalization ', ' Incidence ', ' Inpatients ', ' Interview ', ' Kentucky ', ' Literature ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Multivariate Analyses ', ' Multivariate Analysis ', ' Physicians ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisoner ', ' Prisons ', ' Public Health ', ' public health medicine (field) ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Supervision ', ' Survey Instrument ', ' Surveys ', ' Time ', ' Universities ', ' Woman ', ' Work ', ' Gender ', ' Female Health ', "" Women's Health "", ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' health care ', ' Healthcare ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' base ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' Series ', ' racism ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' Trust ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' drug use ', ' Drug usage ', ' Drug user ', ' Problem drug user ', ' Misuses drugs ', ' Drug abuser ', ' Knowledge ', ' Life ', ' Severities ', ' Dependence ', ' Event ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' physical health ', ' physical conditioning ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' Services ', ' Emergency room ', ' Emergency Department ', ' Accident and Emergency department ', ' experience ', ' Seroprevalences ', ' Structure ', ' Participant ', ' recidivism ', ' Program Announcement ', ' NIH Program Announcements ', ' Self-Report ', ' Patient Self-Report ', ' General Public ', ' General Population ', ' probation ', ' criminal offender ', ' offender ', ' Reporting ', ' Modeling ', ' Sampling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Jail ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' substance abuse therapy ', ' substance abuse treatment ', ' time use ', ' probationer ', ' criminal offending ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' ethanol research ', ' alcohol related research ', ' alcohol research ', ' service utilization ', ' nondrug ', ' non-drug ', ' longitudinal design ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2012,327307,0.17326562535537318
"Factors for enhanced neurotoxicity in methamphetamine abuse in HIV infection    DESCRIPTION (provided by applicant): This application is submitted in response to PAR-09-011 Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) requested by the National Institute on Drug Abuse (NIDA). This proposed research program is timely since it focuses on two ofthe major health disparity issues in Hawaii, namely, methamphetamine abuse and HIV infection. Recent surveys indicate that Native Hawaiians or other Pacific islanders have the highest rate of methamphetamine use among persons aged 12 or older in the United States. Although HIV/AIDS infection rate is relatively low in Hawaii compared to other major metropolis, the rates are increasing among Hawaiians. This DIDARP will include two primary and one pilot research projects that will focus on mechanisms and factors that might enhance neurotoxicity associated with methamphetamine of HIV. We aim to enhance the capacity for drug abuse research at UH by creating this small translational research team. This group will take advantage and build on the expertise of the few but outstanding existing clinical drug abuse and HIV researchers and basic scientists. We aim to enable UH to develop a strong clinical and translational drug abuse research program. To complement these projects, we additionally propose training and career development activities that wil offer exciting opportunities for DIDARP investigators and others at UH through the Administrative and Training Core. The Faculty in the Core will provide guidance and mentorship for these junior faculty and graduate students, through infrastructure support, educational courses, seminars, and a dedicated DIDARP website, We have obtained institutional support for two additional graduate students for the program. We also have recruited 4 distinguished External Advisory Committee members with expertise related to the proposed research; each has enthusiastically agreed to provide their advice and letter of support for the development of this DIDARP at UH. PUBLIC HEALTH RELEVANCE (See instructions); The current proposal attempts to strengthen drug abuse and HIV research capacity by developing translational research teams at the University of Hawaii, and to train junior investigators and students in drug abuse and HIV research.          ",Factors for enhanced neurotoxicity in methamphetamine abuse in HIV infection,8215952,R24DA027318,"['Abbreviations ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' aminoacid ', ' Amino Acids ', ' Animals ', ' Theriacs ', ' Antidotes ', ' anti-oxidant ', ' Antioxidants ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Intracranial Central Nervous System Disorders ', ' Intracranial CNS Disorders ', ' Encephalon Diseases ', ' Brain Disorders ', ' Brain Diseases ', ' Transporter Protein ', ' Transport Proteins ', ' Carrier Proteins ', ' Cells ', ' Complement Proteins ', ' Complement ', ' Terminal Deoxyribonucleotidyltransferase ', ' Terminal Deoxyribonucleotidyl Transferase ', ' Terminal Deoxynucleotidyltransferase ', ' Terminal Deoxynucleotidyl Transferase ', ' Terminal Addition Enzyme ', ' EC 2.7.7.31 ', ' Desoxynucleotidyltransferase ', ' Desoxynucleotidyl Transferase ', ' Deoxynucleotidyltransferase ', ' Deoxynucleotidyl Transferase ', ' DNA Nucleotidylexotransferase ', ' Hydroxytyramine ', ' 4-(2-Aminoethyl)-1,2-benzenediol ', ' 3,4-Dihydroxyphenethylamine ', ' Dopamine ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' balance function ', ' balance ', ' Equilibrium ', ' Faculty ', ' Family ', ' Glucose-6-Phosphate Dehydrogenase ', ' EC 1.1.1.49 ', ' Glucosephosphate Dehydrogenase ', ' gamma-L-Glutamyl-L-Cysteinylglycine ', ' gamma-L-Glu-L-Cys-Gly ', ' Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)- ', ' Glutathione ', ' glutathione peroxidase ', ' 2-amino-1,7-dihydro-6H-purin-6-one ', ' 2-Amino-6-Hydroxypurine ', ' Guanine ', ' Hawaii ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Hydroperoxide ', ' Hydrogen Peroxide (H2O2) ', ' H2O2 ', ' Hydrogen Peroxide ', ' Hypoxanthines ', ' Infection ', ' Tyrosine Iodinase ', ' Thyroperoxidase ', ' Thyroid Peroxidase ', ' Monoiodotyrosine Deiodinase ', ' Monodeiodinase ', ' Iodotyrosine Deiodinase ', ' Iodotyrosine Deiodase ', ' Iodoperoxidase (Heme Type) ', ' Iodinase ', ' EC 1.11.1.8 ', ' Deiodinase ', "" 5'-Deiodinase "", ' Iodide Peroxidase ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Memory ', ' Mentorship ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Methamphetamine ', ' body movement ', ' Movement ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Persons ', ' Needles ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' nervous system disorder ', ' neurotoxicant ', ' Neurotoxins ', ' endothelial cell derived relaxing factor ', ' Nitrogen Protoxide ', ' Nitrogen Monoxide ', ' Mononitrogen Monoxide ', ' Endothelium-Derived Nitric Oxide ', ' Endogenous Nitrate Vasodilator ', ' Nitric Oxide ', ' oxidation reduction reaction ', ' Redox ', ' Oxidation-Reduction ', ' gene product ', ' Proteins ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Se element ', ' Selenium ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Students ', ' Survey Instrument ', ' Surveys ', ' Transactivation ', ' Trans-Activation (Genetics) ', ' United States ', ' Universities ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Virus Diseases ', ' 3-selenyl-L-alanine ', ' 3-Selenylalanine ', ' Selenocysteine ', ' selenoprotein ', ' electron acceptor ', ' Oxidizing Agents ', ' Oxidants ', ' dopamine transporter proteins ', ' DAT dopamine transporter ', ' dopamine transporter ', ' peroxynitrite ', ' Peroxonitrite ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Malnutrition ', ' Task Forces ', ' Advisory Committees ', ' enhancing factor ', ' Organ ', ' Label ', ' Clinical ', ' Long-Term Potentiation ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Susceptibility ', ' Predisposition ', ' Training ', ' insight ', ' selenium deficiency ', ' Oxidative Stress ', ' selenophosphate synthetase ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' neuroAIDS ', ' AIDS neuropathy ', ' Letters ', ' Micronutrients ', ' Genetic ', ' Hawaiian ', ' Hawaiian population ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Impaired cognition ', ' Heavy Metals ', ' Life ', ' programs ', ' Scientist ', ' intraperitoneal ', ' LOINC Axis 4 System ', ' System ', ' Viral ', ' EPSP ', ' Excitatory Postsynaptic Potentials ', ' Affective Disorders ', ' Mood Disorders ', ' neuroprotection ', ' reverse transcriptase PCR ', ' RTPCR ', ' RT-PCR ', ' Reverse Transcriptase Polymerase Chain Reaction ', ' monoamine ', ' reuptake ', ' Toxicities ', ' Toxic effect ', ' member ', ' graduate student ', ' Dopamine neuron ', ' DA Neuron ', ' dopaminergic neuron ', ' career development ', ' LOINC Axis 2 Property ', ' Property ', ' response ', ' thioredoxin reductase ', ' Central Nervous System ', ' CNS Nervous System ', ' Neuraxis ', ' developmental disorder ', ' developmental disease/disorder ', ' Committee Members ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Institution ', ' Brain region ', ' preventing ', ' prevent ', ' methamphetamine abuse ', ' Intake ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Native Hawaiian or Other Pacific Islander ', ' qRTPCR ', ' Quantitative RTPCR ', ' Quantitative Reverse Transcriptase PCR ', ' Infrastructure ', ' Research Infrastructure ', ' Supplementation ', ' Rodent Model ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' Knockout ', ' Knock-out ', ' developmental ', ' Development ', ' website ', ' web site ', ' Dietary Selenium ', ' Instruction ', ' neuron injury ', ' Neuronal Injury ', ' meth exposure ', ' methamphetamine exposure ', ' Population ', ' aged ', ' short hairpin RNA ', ' shRNA ', ' small hairpin RNA ', ' Cellular model ', ' Cell model ', ' neuronal toxicity ', ' neuron toxicity ', ' neurotoxicity ', ' selenoenzyme ', ' dopamine toxicity ', ' neuronal survival ', ' nondrug ', ' non-drug ', ' ']",NIDA,UNIVERSITY OF HAWAII AT MANOA,R24,2012,444710,0.13516613646182707
"Collaborative Research on Drug Abuse    DESCRIPTION (provided by applicant): This P01 develops and applies state-of-the-art methods to analyze existing but under-utilized drug abuse databases in collaboration with their owners. We address contemporary, theoretical, and applied issues in drug abuse research to understand intersections between substance abuse and AIDS risk behaviors as well as minority and gender-based health disparities. We work with dozens of investigators from drug & social policy, epidemiology, health sciences, medicine, nursing, psychiatry, psychology, public health, and social work who own exciting substance abuse data to develop models that test current theories, especially on epidemiology, prevention, intervention, and treatment of drug abuse, using modern multivariate methods to control for measurement errors, biases, and other confounds. The Models and Methods Project develops psychometric and statistical analytic techniques that hold special promise for improving the quality of drug abuse and AIDS research. The At-Risk Project studies substance abuse related data sets on vulnerable populations (substance abusers, homeless people, individuals who are HIV positive or who have AIDS, victims of domestic abuse, runaways, gang members, and others at high risk for AIDS or drug abuse) with methods to control sampling, measurement, distributional and other biases. The Community Project studies drug abuse etiology, adult consequences, HIV risk, intergenerational processes, general deviance, and related issues in large community-based samples, and develops and tests explanatory theories using models that permit separation of common from specific effects, control for artifacts, etc. The Core Project oversees and integrates all components, hosts visiting scholars, provides computer facilities, and sponsors a mentoring program for disadvantaged students. The substantive part of the Models Project and the At-Risk and Community Projects will be developing and testing integrative theories that can be applied across different populations. The findings from their studies will lead to greater understanding of precursors and concomitants of substance abuse and HIV/AIDS risk and transmission. In turn, these findings will guide development of effective interventions to reduce negative health outcomes and treatment disparities in community, ethnic, and vulnerable populations, and provide guidance on how these may be alleviated.     ",Collaborative Research on Drug Abuse,8539138,P01DA001070,[''],NIDA,UNIVERSITY OF CALIFORNIA LOS ANGELES,P01,2012,153998,0.06373110537308126
"Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study DESCRIPTION (provided by applicant): The overall goal of this project is to address how disproportionate confinement of racial/ethnic minorities-especially African Americans-affects health disparities in the HIV/AIDS epidemic. African Americans comprise only 13% of the general population, but about 40% of incarcerated youth and adults and 50% of new cases of HIV/AIDS. Yet, large multisite national longitudinal studies of HIV/AIDS focus on high- risk samples such as men who have sex with men (MACS), women infected with HIV and other ""at-risk"" females (WIHS), and infected women and their infants (WITS). These studies do not include adolescents, do not sample correctional populations, and do not examine the effect of incarceration on HIV/AIDS. Most studies of incarcerated populations are cross-sectional and provide limited information on the effects of incarceration. To continue to address this key omission in the literature, we propose to extend the Northwestern Juvenile Project, a longitudinal study of 1829 juvenile justice youth, enrolled at age 10-18 years (1172 males, 657 females; 1005 African Americans, 296 non-Hispanic whites, 524 Hispanics, and 4 ""other"" race/ethnicity). Currently, the HIV/AIDS component of the project (RO1 DA022953) includes only a subsample (n=743) and 10-, 11-, 12-, and 13-year follow-up interviews. We now propose to (1) study the entire sample (originally 1829, now 1678); (2) conduct 3 additional annual interviews (14-, 15-, and 16-year follow-ups), at which time participants will be aged 26-34 years; (3) collect official records to cross-validate self-reported data (on STI status, arrests, incarceration history, and services received); (4) test the entire sample for HIV infection, chlamydia, and gonorrhea; and (5) administer a new module on incarceration, release, and re-entry. Participants are re-interviewed whether they are re-incarcerated or back in the community. Using data collected in prior phases and the additional interviews, we will examine patterns of drug use, drug use disorder, HIV/AIDS risk and infection from adolescence (ages 10-17 years) to emerging adulthood (ages 18-24 years) and young adulthood (age 25 and older). Our Specific Aims focus on how incarceration, release, and re-entry (e.g., age[s] incarcerated, number of incarcerations, length of incarcerations, amount of time spent in the community between incarcerations) affect the following: (1) drug use behaviors (including the number and types of substances used, frequency of use, and route of administration) and drug use disorders (onset, persistence, desistance, and recurrence); (2) HIV/AIDS sex risk behaviors (including unprotected anal or vaginal receptive sex and trading sex for drugs) and injection-risk behaviors; (3) prevalence and incidence of HIV infection and other STIs; (4) the relationship between patterns of drug use and disorder and HIV/AIDS risk behaviors, especially how risk and protective factors predict, moderate, and mediate these relationships. This study responds to the initiatives of NIDA, NIAAA, and other NIH institutes to reduce health disparities in HIV/AIDS in minority populations. PUBLIC HEALTH RELEVANCE: Racial/ethnic minorities suffer disproportionately from the HIV/AIDS epidemic and are disproportionately incarcerated. To address health disparities in HIV/AIDS, we must study correctional populations, which increased from nearly 1.8 million in 1997 to over 2.2 million by mid-year 2006. The proposed study will guide public health policy by investigating how incarceration affects the development of substance use and disorder and HIV/AIDS; identifying risk and protective factors that are potentially malleable; identifying points of intervention during key developmental periods; and extending current conceptual models to include incarceration, release, and reentry.","Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study",8470298,R01DA028763,"['Accounting ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Aging ', ' ethanol use disorder ', ' alcohol use disorder ', ' Alcohol Chemical Class ', ' Alcohols ', ' Antibodies ', ' Anal ', ' Anus ', ' Dorsum ', ' Back ', ' Behavior ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cervix Dysplasia ', ' Cervical dysplasia ', ' Chicago ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' Rickettsia trachomae ', ' Chlamydia trachomatis ', ' Concurrent Studies ', ' Cohort Studies ', ' Communities ', ' Crime ', ' Death ', ' Cessation of life ', ' Decision Making ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Electronics ', ' Employment ', ' Epidemic ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Ethnic group ', ' Female ', ' Liberty ', ' Freedom ', ' Goals ', ' Gonococcal Infection ', ' Gonorrhea ', ' Grant ', ' Health ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' health care service ', ' Health Services ', ' Herpesvirus hominis disease ', ' Herpes simplex disease ', ' Herpes Simplex ', ' Herpes Simplex Infections ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' human T lymphotropic virus III ', ' human T cell leukemia virus III ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' HIV-1 ', ' Housing ', ' Illinois ', ' Incidence ', ' Infant ', ' Infection ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Human Papillomavirus ', ' Injections ', ' Injection of therapeutic agent ', ' NAS/IOM ', ' Institute of Medicine ', ' Institute of Medicine (U.S.) ', ' Institutes ', ' Interview ', ' Judgment ', ' Justice ', ' Kinetics ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Length of Stay ', ' Lifestyle ', ' Life Style ', ' Literature ', ' long-term study ', ' Longitudinal Studies ', ' male ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Needles ', ' Neighborhoods ', ' N.gonorrhoeae ', ' N. gonorrhoeae ', ' Gonococcus ', ' Neisseria gonorrhoeae ', ' Prisons ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Recommendation ', ' Records ', ' Recurrent ', ' Recurrence ', ' Research ', ' Risk ', ' Risk Factors ', ' Saliva ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sex Characteristics ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' social support network ', ' Social support ', ' Solutions ', ' statistics ', ' Substance Use Disorder ', ' Survey Instrument ', ' Surveys ', ' great pox ', ' Syphilis ', ' Testing ', ' Time ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Trichomonas Infections ', ' Ulceration ', ' Ulcer ', ' Urine Urinary System ', ' Urine ', ' Vaginal ', ' Vagina ', ' hepatitis virus infection ', ' Viral hepatitis ', ' Woman ', ' Work ', ' County ', ' Syringe Sharing ', ' Needlesharing ', ' Needle Sharing ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Illicit Drugs ', ' Enzyme Linked Immunoassay Immunologic ', ' Enzyme Immunoassay ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Longitudinal Surveys ', ' Mediating ', ' Risk Assessment ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' Social Network ', ' racial/ethnic difference ', ' Area ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' screenings ', ' screening ', ' Screening procedure ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' African ', ' drug use ', ' Drug usage ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' disorder onset ', ' disease onset ', ' Onset of illness ', ' liquid ', ' fluid ', ' Liquid substance ', ' Staging ', ' Contracting Opportunities ', ' Contracts ', ' cooking ', ' Research Specimen ', ' Specimen ', ' Life ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Dependence ', ' Event ', ' Oral ', ' Source ', ' Route ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' Injection Drug User ', ' Injecting drug user ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' middle school ', ' Services ', ' urogenital system (genital part) ', ' Genital ', ' Genital system ', ' Surgeon ', ' age group ', ' experience ', ' high school ', ' Participant ', ' health record ', ' Program Announcement ', ' NIH Program Announcements ', ' Self-Report ', ' Patient Self-Report ', ' high risk behavior ', ' deviancy ', ' deviant ', ' General Public ', ' General Population ', ' probation ', ' criminal offender ', ' offender ', ' intravenous drug use ', ' age difference ', ' Academic achievement ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Admission ', ' Admission activity ', ' parole ', ' Modeling ', ' Sampling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Healthy People 2010 ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Length ', ' Jail ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' NIH RFA ', ' Request for Applications ', ' Subgroup ', ' child maltreatment ', ' Childhood maltreatment ', ' Child Abuse and Neglect ', ' enroll ', ' Enrollment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' underserved minority ', ' under-represented minority ', ' Underrepresented Minority ', ' Monitor ', ' Transmission ', ' transmission process ', ' Characteristics ', ' Process ', ' sex ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Permission ', ' Authorization ', ' Authorization documentation ', ' developmental ', ' Development ', ' Heterosexuals ', ' transcription mediated amplification ', ' sexual risk behavior ', ' sex risk ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' national surveillance ', ' Minority ', ' alcohol and other drug ', ' Outcome ', ' cost-effective ', ' cost effective ', ' juvenile justice system ', ' Youth Risk Behavior ', ' Adolescent Risk Behavior ', ' Population ', ' Prevalence ', ' aged ', ' prospective ', ' NIAAA ', ' National Institute on Alcohol Abuse and Alcoholism ', ' innovative ', ' innovate ', ' innovation ', ' eighteen year old ', ' age 18 years ', ' 18 year old ', ' racial/ethnic ', ' racial and ethnic ', ' service utilization ', ' racial and ethnic disparities ', ' high risk ', ' FDA approved ', ' emerging adulthood ', ' surveillance data ', ' surveillance study ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2012,24159,0.1173319122085367
"Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS    DESCRIPTION (provided by applicant): This application is a revision of an application submitted last year in response to PAR-07-379, ""Behavioral and Social Science Research on Understanding and Reducing Health Disparities."" We will analyze the interconnections between coercive mobility (the massive migration between the criminal justice [CJ] system and the community) produced by US drug policies and race disparities in HIV-related sexual risk among a sample of drug offenders in Connecticut (CT). Further, we will examine whether the association between coercive mobility (CM) and HIV-related sexual risk is affected by the degree of social disorganization in the communities in which these offenders reside. We also will study the feasibility of recruiting and following sexual partners of these individuals to better understand the impacts of CM on partners' HIV-related risk. We hypothesize that CM produces race disparities in HIV risk in a number of distinct ways: 1) Blacks are more likely than Whites to be incarcerated, so HIV-related sexual risk associated with CM can produce race disparities in HIV risk even if the effects of CM are the same for both Blacks and Whites; 2) Blacks are more likely than Whites to reside in communities experiencing the disorganizing impacts of CM, so to the extent that social disorganization exacerbates the effects of CM, it will affect the HIV risks of Blacks to a greater degree than Whites; 3) The sexual partners of Blacks are more likely to come from these same socially disorganized communities, furthering the negative impacts of CM for both returning inmates and their partners, and contributing to race disparities in HIV risk among women; and 4) Blacks are more likely to be penalized by drug policies in ways that increase their movement between prison/jail and the community and their vulnerability to its associated harms. We also hypothesize that we will be able to recruit and retain the sexual partners of study participants and conduct exploratory analyses of the impact of CM on their HIV-related sexual risk. An active Community Advisory Board including policymakers and program administrators will assist us in identifying structural interventions to reduce race disparities in HIV based on study findings. PUBLIC HEALTH RELEVANCE: This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.           Narrative This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.","Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS",8441251,R01DA025021,"['Affect ', ' Awareness ', ' Communities ', ' Connecticut ', ' Data Analysis ', ' Data Analyses ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' facial ', ' faces ', ' Face ', ' Family ', ' Feasibility Studies ', ' Feedback ', ' Health ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Housing ', ' Immigrations ', ' In-Migration ', ' Interview ', ' Laws ', ' body movement ', ' Movement ', ' Prisons ', ' Public Policy ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' sex partner ', ' Sexual Partners ', ' Social Disorganizations ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Survey Instrument ', ' Surveys ', ' Time ', ' Woman ', ' Administrator ', ' Criminal Justice ', ' Law Enforcement ', ' base ', ' Area ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Individual ', ' Policies ', ' Shapes ', ' programs ', ' Frequency ', ' Frequencies (time pattern) ', ' LOINC Axis 4 System ', ' System ', ' Application Context ', ' contextual factors ', ' behavioral/social science ', ' experience ', ' Structure ', ' Participant ', ' disease prevention ', ' disorder prevention ', ' member ', ' criminal offender ', ' offender ', ' social ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Sampling ', ' response ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Institution ', ' Address ', ' Jail ', ' Data ', ' Process ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' socioeconomics ', ' sexual relationship ', ' community re-entry ', ' community reentry ', ' migration ', ' social science research ', ' ']",NIDA,AMERICAN UNIVERSITY,R01,2012,101330,0.047759867674073975
"Substance Use and Risky Sex in Highly Vulnerable Populations The proposed project will help me develop the skills and expertise necessary to establish an independent research career focused on the role of substance use in sexual risk-taking behavior and associated adverse reproductive outcomes, especially sexually transmitted infections (STIs). To achieve this goal, I will supplement my graduate training as a developmental psychologist and post-doctoral training in epidemiology with training in sexual risk behavior in vulnerable populations, health disparities associated with race, and career development in longitudinal research methodology. Complementary to these training activities, I propose: 1) secondary data analyses of sexual risk behavior and outcomes using data from an ongoing longitudinal study of the offspring of teenage mothers and a study of women with and without borderline personality disorder (BPD); 2) collection of new data on the offspring of teenage mothers during a 16-year assessment and; 3) a new pilot study of common STIs in this sample (offspring of teenage mothers). The proposed research will form the basis for an ROI application in the third year of the award period. My short term goals are to (1) increase knowledge about risk for STIs, including behavioral dysregulation that may underlie risky sex and risk factors associated with risky sex and associated outcomes, (2) learn new methods of measuring risk behavior and adverse reproductive outcomes, including clinical tests for STIs and event-level assessments, (3) learn more about health disparities associated with race, and (4) develop the research skills that will enable me to become an independent investigator and obtain NIH funding to support my research, specifically longitudinal data analyses. My long-term career goal is to understand the ecological setting for drug use and sexual risk behaviors in vulnerable populations, and how drug use may contribute to significantly higher rates of unintended pregnancies and STIs in African-American youth. The proposed career development training will take place at the Department of Psychiatry at the University of Pittsburgh School of Medicine. This department provides an outstanding environment for interdisciplinary training by highly collaborative faculty who are leading experts in their chosen fields. RELEVANCE (See Instructions): The proposed research will help identify behavioral risk factors for sexually transmitted infections that are implicated in higher rates of HIV, especially among African-Americans. The results can be used to develop prevention programs aimed at reducing drug use and sexually transmitted infections among vulnerable adolescents and within psychiatric populations.  ",Substance Use and Risky Sex in Highly Vulnerable Populations,8311750,K01DA025734,"['Accounting ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Age ', ' Aggression ', ' Aggressive behavior ', ' angry ', ' angers ', ' Anger ', ' Award ', ' Contraceptive Barrier Methods ', ' Barrier Methods ', ' Barrier Contraception ', ' Behavior ', ' Parturition ', ' Birth ', ' BPD ', ' Borderline Personality Disorder ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Coitus ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Data Analysis ', ' Data Analyses ', ' Diagnosis ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Faculty ', ' Family ', ' Goals ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' Learning ', ' long-term study ', ' Longitudinal Studies ', ' Methods ', ' Mothers ', ' Multiple Partners ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Neighborhoods ', ' Personality ', ' pilot study ', ' Pilot Projects ', ' Gestation ', ' Pregnancy ', ' Psychiatry ', ' Psychologist ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' Risk-Taking ', ' social role ', ' Role ', ' Schools ', ' school of medicine ', ' medical college ', ' medical schools ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Sex Factors ', ' sex partner ', ' Sexual Partners ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' statistics ', ' Substance Use Disorder ', ' Supervision ', ' Testing ', ' Training Activity ', ' Universities ', ' Unplanned pregnancy ', ' Urine Urinary System ', ' Urine ', ' Woman ', ' Gender ', ' Measures ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Mediating ', ' Research Methods ', ' Research Methodology ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' base ', ' career ', ' Clinical ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Training ', ' pediatric ', ' Childhood ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' teenage mom ', ' teen mother ', ' teen mom ', ' adolescent mother ', ' teenage mother ', ' sexually active ', ' drug use ', ' Drug usage ', ' Reproductive Health ', ' Funding ', ' Knowledge ', ' programs ', ' Event ', ' Location ', ' Injection Drug User ', ' Injecting drug user ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' meetings ', ' Church ', ' experience ', ' cohort ', ' Gravidity ', ' skills ', ' Prevention program ', ' offspring ', ' Negotiation ', ' Negotiating ', ' Mediation ', ' Reporting ', ' Inhibition of Fertilization ', ' Fertility Control ', ' Contraception ', ' Contraceptive methods ', ' reproductive ', ' Impulsivity ', ' Emotional ', ' Sampling ', ' career development ', ' Adverse Experience ', ' Adverse event ', ' vulnerable group ', ' Vulnerable Populations ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Symptoms ', ' Data ', ' Collection ', ' Principal Investigator ', ' Characteristics ', ' sex ', ' developmental ', ' Development ', ' Behavioral ', ' unintended pregnancy ', ' Instruction ', ' sexual risk behavior ', ' sex risk ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' Outcome ', ' Population ', ' Prevalence ', ' seventeen year old ', ' age 17 years ', ' 17 year old ', ' postdoctoral training ', ' post-doctoral training ', ' high risk ', ' pregnant ', ' adolescent offspring ', ' population health ', ' adverse consequence ', ' adverse outcome ', ' ']",NIDA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K01,2012,142449,0.023817970403377783
"Drug Use Among Hispanic Emerging Adults    DESCRIPTION (provided by applicant): Among Hispanic adolescents, cultural factors such as acculturation, perceived discrimination, and acculturative stress are risk factors for drug use. Previous studies suggest that the effects of acculturation on drug use may be mediated by family functioning; when adolescents acculturate more rapidly than their parents, the parent- child acculturation discrepancy can lead to breakdowns in family communication and cohesion and increases in family conflict, which in turn can lead to risky behaviors such as drug use among the adolescents. Although there is considerable information about the role of family acculturation patterns in drug use among Hispanic adolescents, we do not know how family acculturation patterns affect adolescents as they transition into the next stage of life, emerging adulthood. Emerging adulthood, a provisional stage in which young adults try out adult roles but may not become firmly entrenched in them, is characterized by identity exploration, residential instability, self-focus, a subjective feeling of being between adolescence and true adulthood, and increased opportunities. In general, individuals who navigate this transition smoothly emerge with a more developed sense of identity, successful interpersonal relationships, new life roles, and minimal levels of substance use. However, the high level of independence and low level of social constraints that occur during emerging adulthood also make this a high-risk period for drug use and other problem behaviors. Understanding how factors in adolescence affect drug use in early adulthood can lead to better intervention efforts for adolescents. More research is needed to determine how cultural factors influence the transition to emerging adulthood among Hispanics and to identify the risk factors for escalation of drug use during this pivotal transition. This continuation application proposes to follow an established cohort of Hispanic adolescents (12th graders in the 2008-2009 school year) for an additional 4 years to identify the predictors of their drug use trajectories during the transition to emerging adulthood. The Specific Aims of the proposed research are the following: (1) Conduct an additional 4 annual surveys of the participants; (2) Construct individual growth curves to describe their use of tobacco, alcohol, marijuana, and other drugs; (3) Identify the predictors of the growth curve parameters, including cultural factors, peer factors, substance use during high school, psychological factors, and demographic factors; (4) Evaluate emerging adulthood variables as potential mediators of these influences, including identity exploration, experimentation / possibilities, instability (residential mobility, role transitions), self-focus, and subjective experience of being in-between adolescence and adulthood; and (5) Make recommendations for the development of improved health education messages to prevent drug use among acculturating Hispanics during the transition to emerging adulthood. PUBLIC HEALTH RELEVANCE: This application addresses the public health goals of preventing and reducing substance use among young adults. It also aims to reduce health disparities by identifying risk and protective factors that are specific to Hispanics.           This application addresses the public health goals of preventing and reducing substance use among young adults. It also aims to reduce health disparities by identifying risk and protective factors that are specific to Hispanics.",Drug Use Among Hispanic Emerging Adults,8225214,R01DA016310,"['Cultural Assimilation ', ' Acculturation ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Alcohol Chemical Class ', ' Alcohols ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Communication ', ' Conflict ', ' Conflict (Psychology) ', ' Demographic Factors ', ' emotional dependency ', ' Dependency ', ' Dependency (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' Discrimination (Psychology) ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Employment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Extended Family ', ' Family ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' Health Tutoring ', ' Health Instruction ', ' Health education ', ' Spanish Americans ', ' Hispanic Americans ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' long-term study ', ' Longitudinal Studies ', ' Los Angeles ', ' achievement Mainstream Education ', ' Mainstreaming ', ' Educational Mainstreaming ', ' Mainstreaming (Education) ', ' marijuana ', ' Marihuana ', ' Marriage ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' parent offspring interaction ', ' parent child interaction ', ' Parent-Child Relationship ', ' Parent-Child Relations ', ' Parents ', ' Psychological Factors ', ' psychosocial variables ', ' Psychosocial Factor ', ' Public Health ', ' public health medicine (field) ', ' Recommendation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Residential Mobility ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Schools ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sex Characteristics ', ' Societies ', ' Stress ', ' Students ', ' Survey Instrument ', ' Surveys ', ' Friends ', ' Gender ', ' Generations ', ' Assimilations ', ' Family member ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' career ', ' Friendships ', ' role model ', ' improved ', ' Area ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Training ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' drug use ', ' Drug usage ', ' behavioral problem ', ' Problem behavior ', ' Immigrant ', ' Staging ', ' Life ', ' Home ', ' Home environment ', ' Pattern ', ' Occupational ', ' Tobacco Consumption ', ' Tobacco use ', ' behavioral/social science ', ' experience ', ' cohesion ', ' high school ', ' cohort ', ' Participant ', ' peer ', ' family structure ', ' cultural values ', ' social ', ' parent monitoring ', ' parental monitoring ', ' Emotional ', ' Deterioration ', ' ethnic discrimination ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' preventing ', ' prevent ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Data ', ' developmental ', ' Development ', ' feelings ', ' Feeling ', ' pathway ', ' Pathway interactions ', ' Population ', ' high risk ', ' social science research ', ' early adulthood ', ' emerging adult ', ' emerging adulthood ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2012,614705,0.06875639554894068
"Morehouse School of Medicine (M-MIDARP) The overall aim of this program is to strengthen and expand the drug abuse and HIV/AIDS prevention research capacity at Morehouse School of Medicine (MSM) by bringing together key academic and community-based programs in the development of an integrated correctional drug abuse and HIV/AIDS prevention research component. This capacity will incorporate training in new research skills and create an aggregation of individual faculty with appropriate community-based agencies as research teams within the criminal justice system. The MSM MIDARP will:1. Establish opportunities for training and development of drug abuse and HIV/AIDS prevention research interfacing with the Criminal Justice System (CJS) and existing community programs. 2. Construct an integrative culturally competent drug abuse and HIV/AIDS prevention research paradigm which addresses the needs of individuals who have come under the jurisdiction of the criminal justice system by utilizing existing community programs and Evidence-Based Practices. 3. Minimize disparities in community services to reduce recidivism among currently or previously incarcerated individuals. 4. Develop a nexus of organizations among the Georgia Department of Corrections, Georgia Department of Juvenile Justice and community based services that supplements the new research curriculum and faculty service programs, and makes sustainable gains in terms of scholarly publications, effective new service delivery paradigms, and individual client outcomes. 5. Expose young African-American medical students, masters of public health students and undergraduate students to correctional drug abuse and HIV/AIDS prevention community-based research to facilitate their post-graduate career choices. 6.Expand the areas of drug abuse and HIV/AIDS prevention research under investigation at Morehouse School of Medicine to additional indication areas, increase the number of minority physicians and faculty in drug abuse and HIV/AIDS prevention research, and increase the number of supported drug abuse and HIV/AIDS prevention research programs across MSM departments (especially Psychiatry, Family Medicine, Community Health and preventive medicine, and community voices program with its 8 grantees in cities across the country). Our intention is that MSM will be recognized as a local, regional, and national resource and training center for drug abuse and HIV/AIDS prevention for research programs. ",Morehouse School of Medicine (M-MIDARP),8269933,R24DA021527,"['Career Choice ', ' Cities ', ' Client ', ' Clinical Study ', ' Clinical Research ', ' Communities ', ' Community Services ', ' Curriculum ', ' Educational Curriculum ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Faculty ', ' family medicine ', ' Family Practice ', ' interventions research ', ' intervention research ', ' Intervention Studies ', ' Justice ', ' Methods ', ' Physicians ', ' preventative medicine ', ' Preventive Medicine ', ' Psychiatry ', ' Scientific Publication ', ' Publications ', ' Research ', ' R&D ', ' R & D ', ' Development and Research ', ' research and development ', ' Research Resources ', ' Resources ', ' Students ', ' Medical Students ', ' Voice ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' Intention ', ' base ', ' improved ', ' Area ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Gap Junctions ', ' Training ', ' Individual ', ' programs ', ' Investigation ', ' LOINC Axis 4 System ', ' System ', ' Country ', ' interest ', ' Services ', ' skills ', ' Prevention Research ', ' Community based prevention ', ' recidivism ', ' Prevention ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' correctional system ', ' Public Health Students ', ' Address ', ' Evidence based practice ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' M.P.H. ', ' Master of Public Health ', ' Master of Science ', ' Infrastructure ', ' Research Infrastructure ', ' Community Health ', ' developmental ', ' Development ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' Population ', ' community based service ', ' Morehouse School of Medicine ', ' undergraduate student ', ' ']",NIDA,MOREHOUSE SCHOOL OF MEDICINE,R24,2012,381062,0.12824035441533166
"Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS    DESCRIPTION (provided by applicant): This application is a revision of an application submitted last year in response to PAR-07-379, ""Behavioral and Social Science Research on Understanding and Reducing Health Disparities."" We will analyze the interconnections between coercive mobility (the massive migration between the criminal justice [CJ] system and the community) produced by US drug policies and race disparities in HIV-related sexual risk among a sample of drug offenders in Connecticut (CT). Further, we will examine whether the association between coercive mobility (CM) and HIV-related sexual risk is affected by the degree of social disorganization in the communities in which these offenders reside. We also will study the feasibility of recruiting and following sexual partners of these individuals to better understand the impacts of CM on partners' HIV-related risk. We hypothesize that CM produces race disparities in HIV risk in a number of distinct ways: 1) Blacks are more likely than Whites to be incarcerated, so HIV-related sexual risk associated with CM can produce race disparities in HIV risk even if the effects of CM are the same for both Blacks and Whites; 2) Blacks are more likely than Whites to reside in communities experiencing the disorganizing impacts of CM, so to the extent that social disorganization exacerbates the effects of CM, it will affect the HIV risks of Blacks to a greater degree than Whites; 3) The sexual partners of Blacks are more likely to come from these same socially disorganized communities, furthering the negative impacts of CM for both returning inmates and their partners, and contributing to race disparities in HIV risk among women; and 4) Blacks are more likely to be penalized by drug policies in ways that increase their movement between prison/jail and the community and their vulnerability to its associated harms. We also hypothesize that we will be able to recruit and retain the sexual partners of study participants and conduct exploratory analyses of the impact of CM on their HIV-related sexual risk. An active Community Advisory Board including policymakers and program administrators will assist us in identifying structural interventions to reduce race disparities in HIV based on study findings. PUBLIC HEALTH RELEVANCE: This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.           Narrative This research will examine the interconnections among drug policies in the US, coercive mobility (massive migration in and out of the criminal justice system), and race disparities in HIV-related sexual risk. It will suggest potential structural interventions for addressing the movement between prison/jail and the community, including drug policy reforms, with the potential to reduce race disparities in HIV/AIDS.","Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS",8287139,R01DA025021,"['Affect ', ' Awareness ', ' Communities ', ' Connecticut ', ' Data Analysis ', ' Data Analyses ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' facial ', ' faces ', ' Face ', ' Family ', ' Feasibility Studies ', ' Feedback ', ' Health ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Housing ', ' Immigrations ', ' In-Migration ', ' Interview ', ' Laws ', ' body movement ', ' Movement ', ' Prisons ', ' Public Policy ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' sex partner ', ' Sexual Partners ', ' Social Disorganizations ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Survey Instrument ', ' Surveys ', ' Time ', ' Woman ', ' Administrator ', ' Criminal Justice ', ' Law Enforcement ', ' base ', ' Area ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Individual ', ' Policies ', ' Shapes ', ' programs ', ' Frequency ', ' Frequencies (time pattern) ', ' LOINC Axis 4 System ', ' System ', ' Application Context ', ' contextual factors ', ' behavioral/social science ', ' experience ', ' Structure ', ' Participant ', ' disease prevention ', ' disorder prevention ', ' member ', ' criminal offender ', ' offender ', ' social ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Sampling ', ' response ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Institution ', ' Address ', ' Jail ', ' Data ', ' Process ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' socioeconomics ', ' sexual relationship ', ' community re-entry ', ' community reentry ', ' migration ', ' social science research ', ' ']",NIDA,AMERICAN UNIVERSITY,R01,2012,641709,0.047759867674073975
"Modifiable Disparities in Treatment for Rheumatoid Arthritis  Project Summary. Disparities exist in all aspects of health care and have profound effects on health and the utilization of health services, including medications. Reducing disparities requires a detailed understanding of these causes. While disparities in many chronic conditions have been explored, little work has focused on rheumatoid arthritis (RA), the most common systemic rheumatic disease which is associated with increased mortality, disability and nearly 20 billion dollars in annual medical care costs in the US. RA drug treatment can substantially reduce pain and disability, and recommendations include disease-modifying anti-rheumatic drugs (DMARDs) for all patients. Several community-based studies document that only 30-60% of patients with RA receive DMARDs and that older age, black race and lower socioeconomic status all associate with under-use of DMARDs. Without a better understanding of these disparities, interventions are substantially hindered. The first aim of this research will examine geographic, ethnic, and socioeconomic disparities in RA treatment in nationally representative samples. We will use large representative national surveys with linked health care claims and/or geocoded Census information to gain a clearer picture of regional disparities in DMARD use, to determine whether both individual level and neighborhood level socioeconomic factors as well as and race and ethnicity play a role, and to identify how access to care affects prescribing. This information will allow us to assess how much of the variation in DMARD use can be explained by modifiable factors. The second aim will determine whether positive and negative changes in drug insurance status relate to changes in DMARD use for RA. Research supports the contention that gains and losses in insurance affect the use of all aspects of health services. We will analyze the new Medicare Part D drug coverage as well as information from younger patients enrolled in a longitudinal cohort of RA patients with over twenty years of data to assess how drug insurance affects access to DMARDs for RA. The third aim will identify ecologic and health system factors associated with disparities in the use of DMARDs for RA. Economically vulnerable neighborhoods, such as those with low rates of English as a primary language or low home ownership rates, and greater distance to rheumatologists and hospitals may all negatively impact disparities in RA care. We will work with linked utilization and geocoded data for enrollees with RA from several statewide health care insurance plans. In the final aim, we will survey patients to determine the attitudes, beliefs, and knowledge that contribute to disparities in DMARD use for RA. Neither the prior aims nor previous studies have incorporated information about patient's attitudes, beliefs, and knowledge into models of RA treatment disparities. We will purposefully sample patients with RA who do and do not receive DMARDs to determine whether they have been offered DMARDs in the past, their understanding of risks and benefits from these agents, and the usual sources of information they consult for making treatment decisions.  Project Narrative. The data collected in these four aims will answer key questions about disparities in RA care. As well, by focusing on potentially modifiable risk factors, the information collected will point directly toward strategies for reducing disparities in DMARD use.",Modifiable Disparities in Treatment for Rheumatoid Arthritis,8298604,R01AR056215,"['Affect ', ' Age ', ' Antirheumatic Drugs ', ' Anti-Rheumatic Drugs ', ' Anti-Rheumatic Agents ', ' Antirheumatic Agents ', ' Inflammatory Arthritis ', ' Atrophic Arthritis ', ' Rheumatoid Arthritis ', ' Bronchial Asthma ', ' Asthma ', ' Attitude ', ' Belief ', ' Black race ', ' Blue Cross ', ' Blue Shield ', ' Censuses ', ' Cities ', ' Communities ', ' co-morbidity ', ' Comorbidity ', ' Data Sources ', ' diabetes ', ' Diabetes Mellitus ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' disabled people ', ' disabled ', ' Persons with Disabilities ', ' People with Disabilities ', ' Handicapped ', ' Disabled Population ', ' Disabled Persons ', ' Health ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' health care service ', ' Health Services ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Health Services Accessibility ', ' Hospitals ', ' Household ', ' immunosuppressive ', ' Immunosuppressants ', ' Immunosuppressive Agents ', ' Economical Income ', ' Economic Income ', ' Income ', ' Infant ', ' Insurance ', ' Health Insurance ', ' Language ', ' Photoradiation ', ' Light ', ' Mortality ', ' Mortality Vital Statistics ', ' Neighborhoods ', ' Ownership ', ' Painful ', ' Pain ', ' Patients ', ' Pharmacies ', ' Pharmacy facility ', "" Physician's Role "", ' Play ', ' Drug Prescribing ', ' Drug Prescriptions ', ' Primary Care Physician ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Recommendation ', ' Research ', ' Research Proposals ', ' Research Support ', ' Rheumatic Diseases ', ' Musculoskeletal Pain Disorder ', ' Rheumatism ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Socioeconomic Factors ', ' Survey Instrument ', ' Surveys ', ' Phone ', ' Telephone ', ' Work ', ' Gender ', ' Drug Insurance ', ' health care ', ' Healthcare ', ' Medical Care Costs ', ' Specialist ', ' Caring ', ' Ecological Systems ', ' Ecologic Systems ', ' Ecosystem ', ' base ', ' improved ', ' Chronic ', ' Variation ', ' Variant ', ' Link ', ' disability ', ' insight ', ' Individual ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Inequality ', ' drug use ', ' Drug usage ', ' Disease-Modifying Antirheumatic Drugs ', ' DMARDs ', ' DMARD ', ' Disease-Modifying Second-Line Drugs ', ' root ', ' Plant Roots ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Knowledge ', ' Life ', ' Insurance Status ', ' Insurance Coverage ', ' National Ambulatory Medical Care Survey ', ' Complex ', ' Home ', ' Home environment ', ' Source ', ' Pattern ', ' Consult ', ' cohort ', ' Toxicities ', ' Toxic effect ', ' Benefits and Risks ', ' Reporting ', ' Modeling ', ' Sampling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' low socioeconomic status ', ' Low income ', ' Health system ', ' Data ', ' enroll ', ' Enrollment ', ' Characteristics ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' socioeconomics ', ' beneficiary ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' modifiable risk ', ' patient population ', ' rheumatologist ', ' ']",NIAMS,BRIGHAM AND WOMEN'S HOSPITAL,R01,2012,583444,0.023357130072414658
"Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth    DESCRIPTION (provided by applicant):  The overriding purpose of this study is to develop and test an intervention for reducing substance use and risky sexual behaviors among youth involved in juvenile drug court. Juvenile drug court provides an excellent setting in which to pursue the key study objectives by providing access to a well identified high risk population. Second, in addition to frequent judicial oversight, juvenile drug courts include several features that can enhance intervention effectiveness, sustainability, and potential for adoption. In addition, the fact that all juvenile drug courts have community-based treatment components and that such courts have been disseminated nationwide suggests the possibility of eventual widespread adoption if the proposed intervention is effective. The proposed intervention integrates evidence-based protocols for contingency management (CM) for substance abusing youth and family engagement strategies, with an evidence-informed family systems intervention for sexual risk originally developed to address substance use and sexual risk behaviors in HIV+ youth. These three interventions will be integrated into an efficient intervention that, if effective, can be amenable to adoption by juvenile drug courts. Following protocol development and beta testing, 160 drug court youth and their families will be randomized to the experimental intervention condition (HIV Risk Reduction or ""HRR"") versus Drug Court with Community Services (DC) conditions. Key outcomes will be assessed through 12-months post-baseline using a multi-method approach that will include assessment of substance use, risky sexual behaviors, criminal behavior, and participation in HIV counseling and testing services. Specific aims include: 1: Adapt existing intervention and training protocols into a single, efficient HRR intervention, beta test this HHR protocol with four youth in juvenile drug court and their families, and revise treatment and research protocols accordingly; 2: Conduct a randomized trial with 160 youth in juvenile drug court and their families to examine youth-level intervention effects (i.e., on substance use, sexual risk behavior, HIV counseling and testing, delinquent behavior) in comparison to DC through 12- months post referral and assess intervention fidelity. 3. If results suggest a positive HRR treatment effect, revise the intervention and training protocols in preparation for an effectiveness study and extended follow-up study. Importantly, the proposed study will (1) consider the multiple levels of influence on juvenile drug use, criminal justice involvement, and HIV risk behaviors, (2) integrate a drug abuse and HIV prevention intervention for youth in the criminal justice system with drug-related offenses, (3) address health disparities by targeting a primarily minority population of youth, and (4) increase referrals to HIV testing and counseling of drug court-involved youth. This study is designed to reduce HIV risk by addressing the potent interaction of drug use and risky sexual behaviors in drug court youth with evidence-based treatment components to maximize the likelihood of reversing these youths' adverse behavioral trajectories.      PUBLIC HEALTH RELEVANCE: The proposed study is designed to gain knowledge about effective interventions for reducing HIV risk in a high risk population. Reducing HIV risk by effectively targeting substance use and risky sexual behaviors and by locating even a small number of HIV-positive youth could favorably impact society at multiple levels (individual, family, peer, community, fiscal).           PROJECT NARRATIVE The proposed study is designed to gain knowledge about effective interventions for reducing HIV risk in a high risk population. Reducing HIV risk by effectively targeting substance use and risky sexual behaviors and by locating even a small number of HIV-positive youth could favorably impact society at multiple levels (individual, family, peer, community, fiscal).",Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth,8288905,R01DA025880,"['Adoption ', ' Behavior ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' clinical investigation ', ' Clinical Trials ', ' Communities ', ' Community Services ', ' Counseling ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Family ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Health Services Research ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' Young offender ', ' Juvenile Offender ', ' juvenile delinquent ', ' Methods ', ' recruit ', ' Recruitment Activity ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Societies ', ' Testing ', ' USPHS ', ' Public Health Service ', ' United States Public Health Service ', ' Work ', ' Measures ', ' Criminal Justice ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' base ', ' court ', ' criminal behavior ', ' Label ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' drug use ', ' Drug usage ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Educational Intervention ', ' Collaborations ', ' Staging ', ' Knowledge ', ' Adopted ', ' Protocol ', ' Protocols documentation ', ' LOINC Axis 4 System ', ' System ', ' Services ', ' disease prevention ', ' disorder prevention ', ' peer ', ' community based treatment ', ' contingency management ', ' criminal offender ', ' offender ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Drug Courts ', ' protocol development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Risk Reduction ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Institution ', ' Effectiveness ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Address ', ' Evidence based practice ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Cost Effectiveness Analysis ', ' Effectiveness of Interventions ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' enroll ', ' Enrollment ', ' Preparation ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Behavioral ', ' active treatment ', ' active technique ', ' active method ', ' Evidence based treatment ', ' sexual risk behavior ', ' sex risk ', ' youth substance abuse ', ' adolescent substance abuse ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' Population ', ' treatment effect ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' high risk ', ' critical period ', ' public health relevance ', ' effective intervention ', ' evidence base ', ' intervention effect ', ' emerging adulthood ', ' randomized trial ', ' ']",NIDA,MEDICAL UNIVERSITY OF SOUTH CAROLINA,R01,2012,221642,0.04091109874558734
"Community Vulnerability and Responses to Drug-User-Related HIV/AIDS DESCRIPTION (provided by applicant): This is a competing continuation application for the Community Vulnerability and Responses to Drug-User- Related HIV/AIDS study of why large US metropolitan areas vary over time in their vulnerability to HIV/AIDS among drug users and in their responses-i.e., in policies and programs that may affect the epidemic. Drug use and HIV epidemics change over time. In the last funding period, we showed that HIV prevalence in the 96 largest US metropolitan areas declined among injection drug users (IDUs) from 1992 to 2002, and that the population prevalence of IDUs declined in these areas from 1992 to 2000, but then began to rise again. We also showed that metropolitan areas varied in these trajectories, and that a variety of social and policy forces shaped IDU prevalence, racial disparities in IDU prevalence, HIV prevalence among IDUs, racial disparities in AIDS prevalence among IDUs, drug abuse treatment coverage, and syringe exchange access and coverage. Ominously, our recent analyses indicate that the prevalence of IDUs among youth (aged 15 - 29) has begun to rise. Further, as others have shown, HIV has spread widely among NIDUs (non-injecting users of heroin, cocaine, crack, amphetamines or methamphetamine) in some metropolitan areas. These changes are occurring against the backdrop of an economy that has recently shifted from slow to rapid decline, a shift that will lead to great difficulty in maintaining, let alone expanding, services for drug users. Therefore, the Specific Aims of this proposed continuation are: 1. To describe trends, in the 96 largest US metropolitan areas from 1992 - 2012, in (a) critical epidemiologic outcomes (population prevalence of IDUs and NIDUs, and particularly their prevalence among youth; and, among IDUs, HIV prevalence, late-diagnosis HIV cases, and AIDS incidence and mortality) as well as in (b) the implementation of evidence-based drug- related interventions (drug abuse treatment, syringe exchange, HIV counseling and testing) and (c) non- evidence-based drug-related interventions (incarceration and arrests of drug users). 2. To understand how macro-social contexts (e.g., economic changes, social integration, racial residential segregation) and epidemiologic need affect interventions; how interventions and macro-social contexts together affect epidemiologic contexts; how some interventions (e.g., arrests, incarceration) affect others (e.g., syringe exchange coverage); and how some epidemiologic outcomes (e.g., prevalence of young IDUs) affect others (e.g., HIV prevalence). 3. To develop an integrated theory, using agent based modeling, of how these processes interact and thus what the impacts of various intervention mixes are likely to be in given social contexts. 4. To disseminate estimates, results and theoretical understandings to public health agencies and continue to advise them on how they might respond.  PUBLIC HEALTH RELEVANCE: This project will estimate changes in injection and non-injection drug use, in HIV, AIDS and AIDS mortality rates among injection drug users, and in drug- and HIV-related interventions among drug users, in 96 large metropolitan areas over a 21-year period (1992 - 2012). We will investigate how these epidemics and interventions affect one another, and how macro-contextual factors like economic and social conditions shape them both. We will identify metropolitan areas in which serious drug use, HIV or AIDS epidemics are emerging, and offer state and local health departments and drug agencies the best information available on policies and programs that might reduce these epidemics. Our findings will also help national public health agencies, including the CDC and SAMHSA, and other researchers, plan a mixture of evidence-based programs and policies to reduce the forces that lead to high-risk drug use and the associated HIV and AIDS epidemics. Public Health Relevance Statement  This project will estimate changes in injection and non-injection drug use, in HIV, AIDS and AIDS mortality  rates among injection drug users, and in drug- and HIV-related interventions among drug users, in 96 large  metropolitan areas over a 21-year period (1992 - 2012). We will investigate how these epidemics and  interventions affect one another, and how macro-contextual factors like economic and social conditions shape  them both. We will identify metropolitan areas in which serious drug use, HIV or AIDS epidemics are emerging,  and offer state and local health departments and drug agencies the best information available on policies and  programs that might reduce these epidemics. Our findings will also help national public health agencies,  including the CDC and SAMHSA, and other researchers, plan a mixture of evidence-based programs and  policies to reduce the forces that lead to high-risk drug use and the associated HIV and AIDS epidemics.",Community Vulnerability and Responses to Drug-User-Related HIV/AIDS,8261952,R01DA013336,"['Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Benzeneethanamine, alpha-methyl-, (+-)- ', ' Amphetamines ', ' Budgets ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Cities ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Cocaine ', ' Concurrent Studies ', ' Cohort Studies ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' cost effectiveness ', ' Counseling ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Data Analysis ', ' Data Analyses ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Diagnosis ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economical Conditions ', ' Economic Conditions ', ' Economics ', ' Environment ', ' Epidemic ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Fear ', ' Fright ', ' Future ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' HIV Seroprevalence ', ' Incidence ', ' Injections ', ' Injection of therapeutic agent ', ' Health Insurance ', ' Laws ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' long-term study ', ' Longitudinal Studies ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Methamphetamine ', ' Methods ', ' Mexico ', ' Morbidity ', ' Morbidity - disease rate ', ' Mortality ', ' Mortality Vital Statistics ', ' Local Government ', ' New York ', ' Political Activities ', ' Politics ', ' Population Characteristics ', ' human population density ', ' Population Density ', ' Public Health ', ' public health medicine (field) ', ' Punishment ', ' recruit ', ' Recruitment Activity ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sex Characteristics ', ' Social transformation ', ' Social modification ', ' Social Change ', ' Societal Conditions ', ' Social Conditions ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Social Policies ', ' Syringes ', ' Testing ', ' Time ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Unemployment ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' United States Substance Abuse and Mental Health Services Administration ', ' Gender ', ' Measures ', ' Racial Segregation ', ' segregation ', ' Police ', ' free base cocaine ', ' Crack Cocaine ', ' falls ', ' conference ', ' symposium ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Caring ', ' base ', ' racial/ethnic difference ', ' Area ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' Variation ', ' Variant ', ' Medical ', ' racism ', ' insight ', ' Individual ', ' Populations at Risk ', ' Policies ', ' drug use ', ' Drug usage ', ' Progress Reports ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Needle-Exchange Programs ', ' Funding ', ' Shapes ', ' Drug user ', ' Knowledge ', ' Life ', ' Insurance Status ', ' Insurance Coverage ', ' programs ', ' Distant ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' Country ', ' Application Context ', ' contextual factors ', ' Injection Drug User ', ' Injecting drug user ', ' Services ', ' experience ', ' social integration ', ' AIDS diagnosis ', ' metropolitan ', ' Heroin Users ', ' Prevention program ', ' social movement ', ' model-based simulation ', ' models and simulation ', ' Categories ', ' Prevention ', ' social ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Modeling ', ' response ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' highly active anti-retroviral therapy ', ' HAART ', ' Highly Active Antiretroviral Therapy ', ' HIV diagnosis ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Address ', ' Data ', ' Resolution ', ' International AIDS ', ' Monitor ', ' Transmission ', ' transmission process ', ' trend ', ' Process ', ' developmental ', ' Development ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' Foreclosure ', ' Outcome ', ' Population ', ' Prevalence ', ' aged ', ' Evidence based program ', ' racial/ethnic ', ' racial and ethnic ', ' comparative ', ' racial and ethnic disparities ', ' high risk ', ' public health relevance ', ' evidence base ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R01,2012,616131,0.18893656527139835
"Economic Evaluation of Drug Abuse Treatment and HIV Prevention Services for Pregn DESCRIPTION (provided by applicant): Economic evaluation of drug abuse treatment and HIV prevention services for pregnant women is critical to identify the most efficient and equitable use of scarce resources. Economic and policy research on the efficiency of drug abuse treatment and HIV prevention services among vulnerable populations such as women, adolescents and members of minority groups is necessary to improve drug abuse and HIV/AIDS services for these vulnerable and underserved populations. While work in this area continues to grow, there is still a dearth of rigorous economic evaluations of such programs, especially those that adhere to quality standards as recommended by the U.S. Panel on Cost Effectiveness in Health and Medicine. The overall objective of this study is to conduct the first economic evaluation of an innovative behavioral approach integrating Motivational Enhancement Therapy with Cognitive Behavioral Therapy (MET-CBT) as compared to standard Brief Advice (BA) within prenatal care to decrease use of a full range of substances (e.g., marijuana, cocaine, methamphetamines, alcohol, nicotine), to reduce HIV risk behavior and to achieve better infant health outcomes (e.g. longer gestations, greater birth weight, reduced medical consequences such as admission and length of stay in the Neonatal Intensive Care Unit (NICU)). The specific aims of this study are: (1) to conduct cost analyses of the MET-CBT and BA intervention arms; (2) to conduct incremental cost-effectiveness analyses of the two interventions (MET-CBT and BA), vis-`-vis each other, in terms of substance use, infant health outcomes and HIV risk reduction; and (3) to conduct incremental cost-utility analyses determining the net cost per Quality-Adjusted Life Year (QALY) saved respectively by each intervention arm (MET-CBT and BA), vis-`-vis each other, in terms of substance use and HIV risk reduction. The proposed research is responsive to PA-07-122 in that it proposes to conduct research related to cost-effectiveness and cost-utility analyses, services costs, methodological research, and the cross-cutting themes of HIV/AIDS and health disparities. The proposed research is grounded in sound microeconomic principles and standardized techniques as reported in the U.S. Panel on Cost Effectiveness in Health and Medicine, and proposes rigorous conceptual and methodological research to improve the evidence base on the unit costs and cost-effectiveness of substance abuse treatment and HIV prevention services. It builds on a NIDA-funded randomized controlled trial (R01-DA019135) of an innovate behavioral approach, which offers a new paradigm of treatment services, integrating MET-CBT within prenatal care compared to standard BA, and offering promise to improve access to and strengthen substance use treatment and HIV prevention services targeted at drug using pregnant women who are highly susceptible to HIV/AIDS.        PROJECT NARRATIVE Drug abuse and high risk HIV behavior during pregnancy are major public health problems in the United States due to their impact on individual users, their offspring, and surrounding communities. Drug abuse and HIV prevention programs targeting pregnant women have the potential to be cost-effective due to the resultant fewer low-birth-weight babies and perinatal deaths, fewer physical, cognitive and behavioral problems during infancy and childhood, and the significant health benefits that can accrue to the mother. The overall objective of this study is to conduct the first economic evaluation of an innovative behavioral approach integrating Motivational Enhancement Therapy with Cognitive Behavioral Therapy (MET-CBT) as compared to standard Brief Advice (BA) within prenatal care to decrease use of a full range of substances (e.g., marijuana, cocaine, methamphetamines, alcohol, nicotine), to reduce HIV risk behavior and to achieve better infant health outcomes (e.g. longer gestations, greater birth weight, reduced medical consequences such as admission and length of stay in the Neonatal Intensive Care Unit (NICU)).",Economic Evaluation of Drug Abuse Treatment and HIV Prevention Services for Pregn,8787848,R01DA025555,[''],NIDA,UNIVERSITY OF PENNSYLVANIA,R01,2012,663385,0.012176497278779718
"Rural and Urban African American Cocaine Users' Perceived Need for Care    DESCRIPTION (provided by applicant): We seek to study the factors associated with rural/urban differences in perceived need for both drug abuse treatment and HIV testing because these are complementary services which could be integrated within formal drug abuse treatment programs or other locations to better meet the needs of African American cocaine users. We focus on perceived need among African American cocaine users because of their low rates of drug abuse treatment and HIV testing nationally as well as their demonstrated low perceived need for drug abuse treatment, high rates of risky sexual behaviors, and aversion to seeking HIV testing at local health departments in our prior research. Given that our prior natural history research did not include any urban areas, we do not know whether the low rates of drug abuse treatment and HIV testing among rural Arkansans are specific to rural residents (e.g., whether there is a disparity in access for rural African Americans) or whether urban African American cocaine users differ in other critical factors. To address these issues, we plan to conduct a community-based mixed methods study of African American cocaine users residing in rural and urban areas of Arkansas. Specifically, we propose a sequential mixed-method design, with qualitative key informant interviews conducted first (30 rural, 30 urban), followed by larger-scale, structured interviews (200 rural, 200 urban) using standardized instruments, pertinent measures from our prior rural health services and HIV research, and newly developed questions based on our initial qualitative work. Respondent-Driven Sampling (RDS), a variant of snowball sampling, will be used to identify and recruit participants. The primary aims of the study are: 1) Using qualitative methods, to describe rural/urban differences in pathways to drug use and drug use cultures, perceptions of access to drug abuse treatment and HIV testing, awareness and perceptions of what constitutes drug abuse treatment and HIV testing, and preferences for formal or informal drug abuse treatment and the site or location of HIV testing; 2) Using quantitative and qualitative methods, to compare and contrast rural and urban cocaine users' perceived need for drug abuse treatment and HIV testing and key predisposing, enabling, health, and other factors which could impede or facilitate perceived need; and 3) Using quantitative methods, to investigate whether rural/urban differences in perceived need for drug abuse treatment and HIV testing are mediated by key predisposing, enabling, and health factors as well as treatment and testing awareness and preferences. The knowledge gained from this project will enable health policy makers, treatment program managers, and providers to make more informed decisions about how to encourage and facilitate the utilization of drug abuse treatment and HIV testing among African American cocaine users in the Southern U.S., an underserved and high risk population.      PUBLIC HEALTH RELEVANCE: Of public health concern are the low rates of drug abuse treatment and high rates of HIV among African American cocaine users, especially in the Southern U.S. The knowledge gained from the proposed research would enable managers of public and behavioral health systems to make more informed decisions about how to target and tailor culturally sensitive messages aimed at increasing awareness of the benefits of drug abuse treatment and HIV testing. The proposed research would also provide new insight into whether HIV testing should be integrated within drug abuse treatment facilities to better meet the needs of rural as well as urban African American cocaine users.           PROJECT NARRATIVE Of public health concern are the low rates of drug abuse treatment and high rates of HIV among African American cocaine users, especially in the Southern U.S. The knowledge gained from the proposed research would enable managers of public and behavioral health systems to make more informed decisions about how to target and tailor culturally sensitive messages aimed at increasing awareness of the benefits of drug abuse treatment and HIV testing. The proposed research would also provide new insight into whether HIV testing should be integrated within drug abuse treatment facilities to better meet the needs of rural as well as urban African American cocaine users.",Rural and Urban African American Cocaine Users' Perceived Need for Care,8578836,R01DA026837,[''],NIDA,UNIVERSITY OF KENTUCKY,R01,2012,169551,0.15968770068252294
"Developmental Pathways to Substance Use Across European & Asian American Youth    DESCRIPTION (provided by applicant): As one of the fastest growing ethnic minority groups in the United States, alcohol and drug use in American Americans has increasingly been recognized as a public health problem. Emerging research has documented biological, psychosocial, and cultural factors that are associated with alcohol use in Asian American youth adults (Hendershot et al., 2005). However, existing studies have neither adopted a developmental perspective to study the emergence of alcohol use and problems in Asian American during late adolescence, nor have they tested whether prior findings can be generalized to predict drug use and problems. Concurrently, evidence from a separate line of research has suggested that effects of parenting are often different across Asian and European American youth. Numerous studies, for example, have suggested that authoritarian parenting style has beneficial effects in Asian American youth, but detrimental effects in European American youth on outcomes such as academic performance and socio-emotional competence. Subsequent research has indicated that parental constructs such as emotional support and psychological control may also have differential effects across Asian and European American youth (e.g., Chao & Tseng, 2002). Despite these findings, no published study has documented differential effects of parenting on alcohol and drug use across Asian and European American youth. Thus, the overarching goal of this study is to examine moderation effects by ethnicity on the association between parenting and alcohol and drug use outcomes in a longitudinal sample of Asian and European American youth. Specifically, the proposed study will test whether parental emotional support, psychological control and monitoring have differential effects on alcohol and drug use outcomes across Asian and European American youth. Data will be drawn from 97 Asian American and 255 European American youth who participated in the Developmental Pathway Project. Structural equation modeling and factor analysis techniques will be used to test (1) whether parental emotional support, psychological control, and monitoring in 7th grade will differentially predict alcohol and drug use outcomes in 9th and 12th grade across Asian and European American youth; (2) whether developmental pathways from parenting to alcohol and drug use outcomes (via school achievement and peer substance use in 8th grade) are different across Asian and European American youth; and (3) whether the hypothesized moderation effects by ethnicity can be attributed to different interpretation of parenting, as suggested by prior research (e.g., Chao & Aque, 2009). Results from the proposed study can be used to guide the development of culturally sensitive prevention and intervention programs for alcohol and drug use in Asian American youth.       The proposed project addresses a strategic goal of the National Institute of Drug Abuse (NIDA) on the prevention of alcohol and drug use through understanding risk and protective factors in adolescence, a developmental stage during which substance use increases over time. This project also addresses NIDA's cross-cutting priorities of decreasing health disparity related to drug addiction and training new investigators from a diverse (including minority) background. The ultimate goal of this project is to limit substance use initiation and problematic use through the development of culturally sensitive prevention and intervention programs for Asian American youth.",Developmental Pathways to Substance Use Across European & Asian American Youth,8328574,F31AA020700,"['white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Caucasoid Race ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Aggression ', ' Aggressive behavior ', ' Asian Americans ', ' Achievement Attainment ', ' Achievement ', ' Goals ', ' Ethnic group ', ' Child Behavior ', ' youngster ', ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Influentials ', ' Schools ', ' Students ', ' Risk Factors ', ' Teaching ', ' Educational process of instructing ', ' Stress ', ' Risk ', ' Public Health ', ' public health medicine (field) ', ' social role ', ' Role ', ' Publishing ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Parents ', ' Research ', ' problem drinking ', ' problem alcohol use ', ' hazardous alcohol use ', ' ethanol abuse ', ' alcohol problem ', ' Alcohol abuse ', ' Youth 10-21 ', ' Youth ', ' Chinese ', ' Chinese People ', ' Mediating ', ' Competence ', ' Biological ', ' Factor Analyses ', ' Factor Analysis ', ' Parenting behavior ', ' Parenting ', ' Testing ', ' Caucasians ', ' Time ', ' Work ', ' oriental ', ' Asians ', ' United States ', ' behavioral problem ', ' Problem behavior ', ' programs ', ' Equation ', ' Staging ', ' psychosocial ', ' American ', ' Life ', ' Techniques ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Adopted ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' European ', ' young adulthood ', ' adult youth ', ' young adult ', ' Discipline ', ' Training ', ' psychological ', ' psychologic ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Link ', ' root ', ' Plant Roots ', ' drug use ', ' Drug usage ', ' Genetic ', ' Individual ', ' health disparities ', ' health disparity ', ' Reporting ', ' Modeling ', ' Sampling ', ' youth alcohol consumption ', ' underage alcohol use ', ' underage alcohol consumption ', ' under age alcohol use ', ' under age alcohol consumption ', ' teenager alcohol use ', ' teenage drinking ', ' teenage alcohol use ', ' teen drinking ', ' drinking during adolescence ', ' alcohol use during adolescence ', ' alcohol intake among adolescents ', ' alcohol during adolescence ', ' adolescent drinking ', ' adolescent alcohol use ', ' adolescent alcohol consumption ', ' Youth Drinking ', ' underage drinking ', ' Emotional ', ' college student ', ' university student ', ' parent monitoring ', ' parental monitoring ', ' intimacy ', ' intimate behavior ', ' skills ', ' Structure ', ' peer ', ' Prevention program ', ' alcohol metabolism ', ' Ethanol Metabolism ', ' Performance ', ' intervention program ', ' pathway ', ' Pathway interactions ', ' developmental ', ' Development ', ' Population ', ' Monitor ', ' adolescent smoking ', ' Data ', ' South Asian ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Address ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Minority ', ' alcohol use prevention ', ' deter alcohol use ', ' prospective ', ' designing ', ' design ', ' early adolescence ', ' Outcome ', ' reduce adolescent alcohol ', ' ethnic minority ', ' ethnic minority population ', ' alcohol and other drug ', ' ']",NIAAA,UNIVERSITY OF WASHINGTON,F31,2012,42232,0.04928523229381242
"HIV - Emergence of Drug Resistance    DESCRIPTION (provided by applicant): This application is to renew a project focused on using mathematical models to understand and predict the emergence of drug resistance to antiretrovirals (ARVs) for the treatment of Human Immunodeficiency Virus (HIV). As the usage rate of ARVs in resource-poor regions is increasing, high levels of drug resistance potentially could emerge and have a devastating impact on public health worldwide, derailing global plans to provide this treatment to many millions of HIV-infected individuals. Our proposed projects will extend the work of the current award, which showed the value of using mathematical models to understand the temporal dynamics of drug-resistant strains of HIV in the United States (US), and for predicting the magnitude of resistance in this setting. In the renewal our work will be extended by combining mathematical modeling with statistical analysis of datasets collected by collaborating groups in the US, Europe and Africa. We will have access to data on drug resistance and important related variables from large scale epidemiological and treatment studies conducted in these three continents. In resource-poor settings, such as Africa, drugs will be limited and thus demand will often greatly exceed supply. We will investigate the problems of allocating ARVs in Africa by using operation research (OR) techniques. We have three Specific Aims. Aim 1: to understand the emergence, explain the present, and predict the evolution of, complex epidemics of drug-resistant strains of HIV in the US and Europe. Aim 2: to predict the evolution of epidemics of drug-resistant strains, as a result of first- line regimens and prophylactic use of ARVs, in Africa. Aim 3: to evaluate the consequences of allocation of scarce HIV healthcare resources in Africa. To achieve this aim we will use models to evaluate the epidemiological and ethical consequences of gender-inequities in access to treatment, assess the epidemiological and ethical impact of treatment priority criteria, and determine healthcare resource allocation strategies that ensure sustainability. Our studies in the renewal will link transmission modeling, OR techniques and statistical analyses; our analyses will take advantage of the extraordinary data sets provided by our collaborators in the US, Europe and Africa.       PUBLIC HEALTH RELEVANCE: The emergence and control of drug-resistant strains of HIV is now a global problem. The epidemiology of this problem is complex, and the future of the HIV epidemic is unknown. Our projects focus on using mathematical models to understand, explain, and predict, the evolution of complex epidemics composed of drug-resistant strains of HIV in the US, Europe and Africa. The rollout of antiretrovirals in Africa is just beginning; however demand for drugs greatly exceeds supply. We will, by using mathematical models, evaluate the epidemiological and ethical consequences of allocation of the scarce supply of antiretrovirals in Africa. Our studies are based upon both mathematical modeling and data analyses. Our analyses will take advantage of the extraordinary data sets provided by our collaborators in the US, Europe and Africa. Our results will have direct relevance for health policy makers.          ",HIV - Emergence of Drug Resistance,8232132,R01AI041935,"['Abbreviations ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' Africa ', ' Award ', ' Systematics ', ' Classification ', ' Data Analysis ', ' Data Analyses ', ' Drug Design ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' ethical ', ' Ethics ', ' Europe ', ' Evolution ', ' Female ', ' Future ', ' Grant ', ' Healthcare Facility ', ' Health Facilities ', ' Health care facility ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Health Services Accessibility ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Linear Models ', ' Nucleosides ', ' Operations Research ', ' Paper ', ' Proteinase Inhibitors ', ' Protease Antagonists ', ' Peptide Peptidohydrolase Inhibitors ', ' Peptide Hydrolase Inhibitors ', ' Peptidase Inhibitors ', ' Endopeptidase Inhibitors ', ' Antiproteases ', ' Protease Inhibitor ', ' Public Health ', ' public health medicine (field) ', ' Scientific Publication ', ' Publications ', ' Publishing ', ' Research ', ' Research Techniques ', ' Research Technics ', ' Research Resources ', ' Resources ', ' San Francisco ', ' South Africa ', ' Trees ', ' tuberculous spondyloarthropathy ', ' infection due to Mycobacterium tuberculosis ', ' disseminated tuberculosis ', ' disseminated TB ', ' Mycobacterium tuberculosis infection ', ' Mycobacterium tuberculosis (MTB) infection ', ' Mtb infection [{C0041296}] ', ' MTB infection ', ' M.tuberculosis infection ', ' M. tuberculosis infection ', ' Tuberculosis ', ' United States ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Virus Diseases ', ' Work ', ' World Health Organization ', ' azidodeoxythymidine ', ' ZDV ', ' Azidothymidine ', ' AZT (Antiviral) ', ' AZT ', "" 3'-azido-3'-deoxy-thymidine "", "" 3'-Azido-3'-deoxythymidine "", "" 3'-Azido-2',3'-Dideoxythymidine "", ' Zidovudine ', ' Gender ', ' health care ', ' Healthcare ', ' Research Methods ', ' Research Methodology ', ' Resource Allocation ', ' Viramune ', ' Nevirapine ', ' Dataset ', ' Data Set ', ' zerit ', ' Didehydrodeoxythymidine ', ' D4T ', "" 3'-Deoxy-2'-thymidinene "", "" 2'3' didehydrodeoxythymidine "", "" 2',3'-didehydro-3'-deoxy-thymidine "", "" 2',3'-Didehydro-3'-deoxythymidine "", "" 2',3'-Didehydro-2',3'-dideoxythmidine "", ' 1-(2,3-Dideoxy-beta-glycero-pent-2-enofuranosyl)thymine ', ' Stavudine ', ' base ', ' Prophylaxis ', ' Prevention Measures ', ' Prophylactic treatment ', ' human herpesvirus 1 group ', ' Herpesvirus hominis ', ' Herpes labialis Virus ', ' Herpes Simplex Virus ', ' HSV ', ' Simplexvirus ', ' Link ', ' 3TC ', ' 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)- ', "" 2',3'-Dideoxy-3'-thiacytidine "", ' Lamivudine ', ' Ensure ', ' Individual ', ' Policy Maker ', ' multidrug resistant ', ' multi-drug resistant ', ' Resistant to multidrug ', ' Resistant to multi-drug ', ' Resistant to Multiple Drug ', ' Resistance to Multiple Drug ', ' Resistance to Multidrug ', ' Resistance to Multi-drug ', ' Multiple Drug Resistant ', ' Multiple Drug Resistance ', ' Multidrug Resistance ', ' Multi-Drug Resistance ', ' mother to child transmission ', ' Vertical Transmission ', ' Vertical Disease Transmission ', ' Reverse Transcriptase Inhibitors ', ' 9-PMPA ', ' 9-(2-phosphonylmethoxypropyl)adenine ', ' 9-(2-phosphonomethoxypropyl)adenine ', ' Tenofovir ', ' Complex ', ' prophylactic ', ' Equation ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' Anti-Retroviral Agents ', ' 6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one ', ' efavirenz ', ' multiple drug use ', ' Structure ', ' Modeling ', ' Sampling ', ' mathematical modeling ', ' Math Models ', ' mathematical model ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' microbicidal ', ' microbicide ', ' SHP-1L ', ' SHP-1 ', ' SH-PTP1 ', ' PTPN6 ', ' PTP-1C ', ' HPTP1C ', ' HCPH ', ' HCP ', ' PTPN6 gene ', ' nonnucleoside reverse transcriptase inhibitors ', ' non-nucleoside RT inhibitors ', ' NNRTI ', ' non-nucleoside reverse transcriptase inhibitors ', ' Data ', ' Interruption ', ' Transmission ', ' transmission process ', ' sex ', ' pandemic ', ' pandemic disease ', ' antiretroviral therapy ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' resistant ', ' Resistance ', ' public health relevance ', ' resistance strain ', ' resistant strain ', ' Regimen ', ' ']",NIAID,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2012,670826,0.08382042801068632
"Prescription drugs misuse and risky sexual behaviors among YMSM in Philadelphia DESCRIPTION (provided by applicant): Non-medical use of prescription drugs (NMUPD), i.e. opioids, tranquilizers, or stimulants, is a serious and growing public health problem in the U.S. Most data on NMUPD among young adults is limited to the heterosexual college population while significant knowledge gaps exist regarding NMUPD among young men who have sex with men (YMSM). Given the well-established intersection of drug use and risky sexual behaviors and high rates of HIV infections in YMSM, the purpose of this study is to examine the relationship between these drugs and physical, sexual and psychological health of YMSM. YMSM have unique concerns for health risks, such as depression, suicide, bullying, victimization, homelessness, and homophobia, but little is known of their intersection with NMUPD. Many YMSM experience normative pressures that encourage risky behaviors. At the same time, some forms of social support and resilience may buffer against negative effects of stressors. Significant gaps exist in our understanding of how these factors relate to problematic patterns of NMUPD, and whether they modify engagement in risky sexual behaviors. The objective of this study is to contribute directly to our understanding of the social factors that influence NMUPD and risky sexual behaviors among YMSM. The long-term goal of the study is to guide public health practitioners towards developing strategies that will prevent negative effects of NMUPD on YMSM, including reducing disparities in rates of HIV infection among YMSM. The study will investigate the central hypothesis of a deleterious relationship between NMUPD and physical, sexual, and psychological health of YMSM. The central hypothesis will be tested by pursuing three specific aims: Aim 1: Determine patterns of NMUPD and risky sexual behavior among YMSM in Philadelphia; Aim 2: Determine the risk and protective factors contributing to NMUPD and risky sexual behavior among YMSM; Aim 3: Explore the social contexts of NMPUD. Aims 1 and 2 will be addressed by recruiting 190 YMSM ages 18-29 in Philadelphia who have recently misused prescription drugs. Aim 3 will be addressed by selecting a subsample of 25 YMSM for a qualitative study. This approach is innovative because it utilizes a conceptual framework that combines a minority stress model and theories of social norms, social support, and resilience; it focuses on a critical cohort of under-researched, hard-to-reach population; and it employs two research methodologies. The proposed research is significant because it is expected to advance and expand our understanding of the effects of an emerging phenomena (i.e., prescription drug misuse) on adverse consequences of sexual activity. It will also contribute to a better understanding of the role of social determinants on dug use and risky sexual behavior. Such knowledge may inform the development of evidence-based strategies that will prevent adverse health and psychological effects of NMUPD on YMSM and their communities in Philadelphia and elsewhere in the U.S.         The proposed research is relevant to the part of the Department of Health and Human Services (DHHS) mission that pertains to implementation of a research agenda designed to advance knowledge related to understanding sexual minorities health and health disparities. The proposed research is relevant to the part of National Institute of Drug Abuse (NIDA) mission pertaining to studies that address past and current risk and protective factors, including unique dimensions associated with drug use and abuse and other HIV risk behaviors among vulnerable youth, such as YMSM.",Prescription drugs misuse and risky sexual behaviors among YMSM in Philadelphia,8959646,R36DA034543,[''],NIDA,SAN DIEGO STATE UNIVERSITY,R36,2013,5291,0.04582569203240005
"Drug Use Among Hispanic Emerging Adults    DESCRIPTION (provided by applicant): Among Hispanic adolescents, cultural factors such as acculturation, perceived discrimination, and acculturative stress are risk factors for drug use. Previous studies suggest that the effects of acculturation on drug use may be mediated by family functioning; when adolescents acculturate more rapidly than their parents, the parent- child acculturation discrepancy can lead to breakdowns in family communication and cohesion and increases in family conflict, which in turn can lead to risky behaviors such as drug use among the adolescents. Although there is considerable information about the role of family acculturation patterns in drug use among Hispanic adolescents, we do not know how family acculturation patterns affect adolescents as they transition into the next stage of life, emerging adulthood. Emerging adulthood, a provisional stage in which young adults try out adult roles but may not become firmly entrenched in them, is characterized by identity exploration, residential instability, self-focus, a subjective feeling of being between adolescence and true adulthood, and increased opportunities. In general, individuals who navigate this transition smoothly emerge with a more developed sense of identity, successful interpersonal relationships, new life roles, and minimal levels of substance use. However, the high level of independence and low level of social constraints that occur during emerging adulthood also make this a high-risk period for drug use and other problem behaviors. Understanding how factors in adolescence affect drug use in early adulthood can lead to better intervention efforts for adolescents. More research is needed to determine how cultural factors influence the transition to emerging adulthood among Hispanics and to identify the risk factors for escalation of drug use during this pivotal transition. This continuation application proposes to follow an established cohort of Hispanic adolescents (12th graders in the 2008-2009 school year) for an additional 4 years to identify the predictors of their drug use trajectories during the transition to emerging adulthood. The Specific Aims of the proposed research are the following: (1) Conduct an additional 4 annual surveys of the participants; (2) Construct individual growth curves to describe their use of tobacco, alcohol, marijuana, and other drugs; (3) Identify the predictors of the growth curve parameters, including cultural factors, peer factors, substance use during high school, psychological factors, and demographic factors; (4) Evaluate emerging adulthood variables as potential mediators of these influences, including identity exploration, experimentation / possibilities, instability (residential mobility, role transitions), self-focus, and subjective experience of being in-between adolescence and adulthood; and (5) Make recommendations for the development of improved health education messages to prevent drug use among acculturating Hispanics during the transition to emerging adulthood.  PUBLIC HEALTH RELEVANCE: This application addresses the public health goals of preventing and reducing substance use among young adults. It also aims to reduce health disparities by identifying risk and protective factors that are specific to Hispanics.         ",Drug Use Among Hispanic Emerging Adults,8415541,R01DA016310,"['Cultural Assimilation ', ' Acculturation ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Alcohol Chemical Class ', ' Alcohols ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Communication ', ' Conflict ', ' Conflict (Psychology) ', ' Demographic Factors ', ' emotional dependency ', ' Dependency ', ' Dependency (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' Discrimination (Psychology) ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Employment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Extended Family ', ' Family ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' Health Tutoring ', ' Health Instruction ', ' Health education ', ' Spanish Americans ', ' Hispanic Americans ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' long-term study ', ' Longitudinal Studies ', ' Los Angeles ', ' achievement Mainstream Education ', ' Mainstreaming ', ' Educational Mainstreaming ', ' Mainstreaming (Education) ', ' marijuana ', ' Marihuana ', ' Marriage ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' parent offspring interaction ', ' parent child interaction ', ' Parent-Child Relationship ', ' Parent-Child Relations ', ' Parents ', ' Psychological Factors ', ' psychosocial variables ', ' Psychosocial Factor ', ' Public Health ', ' public health medicine (field) ', ' Recommendation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Residential Mobility ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Schools ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sex Characteristics ', ' Societies ', ' Stress ', ' Students ', ' Survey Instrument ', ' Surveys ', ' Friends ', ' Gender ', ' Generations ', ' Assimilations ', ' Family member ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' career ', ' Friendships ', ' role model ', ' improved ', ' Area ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Training ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' drug use ', ' Drug usage ', ' behavioral problem ', ' Problem behavior ', ' Immigrant ', ' Staging ', ' Life ', ' Home ', ' Home environment ', ' Pattern ', ' Occupational ', ' Tobacco Consumption ', ' Tobacco use ', ' behavioral/social science ', ' experience ', ' cohesion ', ' high school ', ' cohort ', ' Participant ', ' peer ', ' family structure ', ' cultural values ', ' high school junior ', ' 11th grade ', ' eleventh grade ', ' social ', ' parent monitoring ', ' parental monitoring ', ' Emotional ', ' Deterioration ', ' ethnic discrimination ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' prevent drug use ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' health disparities ', ' health disparity ', ' preventing ', ' prevent ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Data ', ' developmental ', ' Development ', ' feelings ', ' Feeling ', ' pathway ', ' Pathway interactions ', ' Population ', ' high risk ', ' social science research ', ' early adulthood ', ' emerging adult ', ' emerging adulthood ', ' reduced substance use ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2013,573204,0.0842436992388866
"Substance Use and Risky Sex in Highly Vulnerable Populations The proposed project will help me develop the skills and expertise necessary to establish an independent research career focused on the role of substance use in sexual risk-taking behavior and associated adverse reproductive outcomes, especially sexually transmitted infections (STIs). To achieve this goal, I will supplement my graduate training as a developmental psychologist and post-doctoral training in epidemiology with training in sexual risk behavior in vulnerable populations, health disparities associated with race, and career development in longitudinal research methodology. Complementary to these training activities, I propose: 1) secondary data analyses of sexual risk behavior and outcomes using data from an ongoing longitudinal study of the offspring of teenage mothers and a study of women with and without borderline personality disorder (BPD); 2) collection of new data on the offspring of teenage mothers during a 16-year assessment and; 3) a new pilot study of common STIs in this sample (offspring of teenage mothers). The proposed research will form the basis for an ROI application in the third year of the award period. My short term goals are to (1) increase knowledge about risk for STIs, including behavioral dysregulation that may underlie risky sex and risk factors associated with risky sex and associated outcomes, (2) learn new methods of measuring risk behavior and adverse reproductive outcomes, including clinical tests for STIs and event-level assessments, (3) learn more about health disparities associated with race, and (4) develop the research skills that will enable me to become an independent investigator and obtain NIH funding to support my research, specifically longitudinal data analyses. My long-term career goal is to understand the ecological setting for drug use and sexual risk behaviors in vulnerable populations, and how drug use may contribute to significantly higher rates of unintended pregnancies and STIs in African-American youth. The proposed career development training will take place at the Department of Psychiatry at the University of Pittsburgh School of Medicine. This department provides an outstanding environment for interdisciplinary training by highly collaborative faculty who are leading experts in their chosen fields. RELEVANCE (See Instructions): The proposed research will help identify behavioral risk factors for sexually transmitted infections that are implicated in higher rates of HIV, especially among African-Americans. The results can be used to develop prevention programs aimed at reducing drug use and sexually transmitted infections among vulnerable adolescents and within psychiatric populations.  ",Substance Use and Risky Sex in Highly Vulnerable Populations,8521222,K01DA025734,"['Accounting ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Age ', ' Aggression ', ' Aggressive behavior ', ' angry ', ' angers ', ' Anger ', ' Award ', ' Contraceptive Barrier Methods ', ' Barrier Methods ', ' Barrier Contraception ', ' Behavior ', ' Parturition ', ' Birth ', ' BPD ', ' Borderline Personality Disorder ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Coitus ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Data Analysis ', ' Data Analyses ', ' Diagnosis ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Faculty ', ' Family ', ' Goals ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' Learning ', ' long-term study ', ' Longitudinal Studies ', ' Methods ', ' Mothers ', ' Multiple Partners ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Neighborhoods ', ' Personality ', ' pilot study ', ' Pilot Projects ', ' Gestation ', ' Pregnancy ', ' Psychiatry ', ' Psychologist ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' Risk-Taking ', ' social role ', ' Role ', ' Schools ', ' school of medicine ', ' medical college ', ' medical schools ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Sex Factors ', ' sex partner ', ' Sexual Partners ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' statistics ', ' Substance Use Disorder ', ' Supervision ', ' Testing ', ' Training Activity ', ' Universities ', ' Unplanned pregnancy ', ' Urine Urinary System ', ' Urine ', ' Woman ', ' Gender ', ' Measures ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Mediating ', ' Research Methods ', ' Research Methodology ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' base ', ' career ', ' Clinical ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Training ', ' pediatric ', ' Childhood ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' teenage mom ', ' teen mother ', ' teen mom ', ' adolescent mother ', ' teenage mother ', ' sexually active ', ' drug use ', ' Drug usage ', ' Reproductive Health ', ' Funding ', ' Knowledge ', ' programs ', ' Event ', ' Location ', ' Injection Drug User ', ' Injecting drug user ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' meetings ', ' Church ', ' experience ', ' cohort ', ' Gravidity ', ' skills ', ' Prevention program ', ' offspring ', ' Negotiation ', ' Negotiating ', ' Mediation ', ' Reporting ', ' Inhibition of Fertilization ', ' Fertility Control ', ' Contraception ', ' Contraceptive methods ', ' reproductive ', ' Impulsivity ', ' Emotional ', ' Sampling ', ' career development ', ' Adverse Experience ', ' Adverse event ', ' vulnerable group ', ' Vulnerable Populations ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Symptoms ', ' Data ', ' Collection ', ' Principal Investigator ', ' Characteristics ', ' sex ', ' developmental ', ' Development ', ' Behavioral ', ' unintended pregnancy ', ' Instruction ', ' sexual risk behavior ', ' sex risk ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' Outcome ', ' Population ', ' Prevalence ', ' seventeen year old ', ' age 17 years ', ' 17 year old ', ' postdoctoral training ', ' post-doctoral training ', ' high risk ', ' pregnant ', ' adolescent offspring ', ' population health ', ' adverse consequence ', ' adverse outcome ', ' ']",NIDA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K01,2013,140975,0.023817970403377783
"Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS)     DESCRIPTION (provided by applicant):  There is a critical need to develop a diverse pool of highly trained clinician scholars to foster the development of biomedical, behavioral and clinical research related to drug abuse, addiction, and HIV prevention and treatment in general medical settings. Patients who abuse substances are more likely to be seen in general medical settings such as emergency departments (ED), general medical primary care clinics and inpatient wards, HIV and adolescent health clinics, and women's health centers. These patients often present with a complex array of acute consequences and complications (e.g. intoxication, overdose, withdrawal, trauma and infectious diseases) of substance use as well as chronic conditions such as HIV disease, hepatitis, pulmonary and cardiovascular disease. Objectives: The Yale-Drug Abuse, Addiction, and HIV Research Scholars (DAHRS) program provides a comprehensive three year post-doctorate, interdisciplinary, Mentored Career Development Program to improve drug abuse, addiction, and HIV medical outcomes integrating prevention and treatment in general medical settings including ED, primary care, HIV, adolescent, and women's health clinics. Specifically, Yale-DAHRS will: [Aim 1] Develop clinician scientists with the knowledge, skills, and ability to become independent investigators, generating findings of practical value with significant impact to improve health outcomes of patients with and at risk for drug abuse, addiction, and HIV; [Aim 2] Develop future leaders by providing Scholars with leadership tools and skills and creating individualized programs to ensure success in leading multidisciplinary research teams in studying drug abuse, addiction and HIV, and implementation and integration of research findings into general medical settings; and [Aim 3] Enhance the diversity of drug abuse, addiction, and HIV researchers. Addressing women and minority faculty under representation will enhance the diversity of investigators and research topics, broaden perspectives in setting research priorities, increase clinical trial participation, and expand knowledge. Working synergistically with Yale's established training programs in drug abuse, HIV and clinical investigation, Yale- DAHRS will capitalize on existing academic infrastructure and expertise to ensure success. Unique, features include: (1) An interdisciplinary, diverse faculty of independent researchers in illicit and prescription drug abuse and addiction, tobacco, alcohol, HIV, and medical complexities such as pain and hepatitis C; (2) Synergy with well established, high quality post-doctoral training programs at Yale; (3) The use of clinical informatics for data collection, data management, diagnostic tool development, and information dissemination; and (4) The integration of such diverse fields as public health, informatics, clinical epidemiology, systems engineering and demography with the traditional clinical sciences of internal medicine, emergency medicine, HIV medicine, pediatrics, obstetrics and gynecology, psychiatry, and psychology; (5) Established clinical research laboratories, including the Yale-New Haven Hospital, a tertiary care center for southern New England and a community hospital for the Greater New Haven Area, serving an ethnically, racially, culturally, and economically diverse population, a Veterans Affairs Medical Center and community treatment centers such as the APT Foundation and Federally Qualified Health Centers; (6) Synergies with established research centers and institutes such as the Center for Interdisciplinary Research on AIDS and the Veterans Aging Cohort on HIV. Career Development Plan: Yale-DAHRS is a three year research training program that will prepare a total of six clinician investigators for careers focusing on drug abuse, addiction, and HIV in general medical settings during its first funding cycle. Scholars will earn the Master in Health Sciences degree, combining rigorous training in research methodology, statistics and design with seminars in topics related to drug abuse, addiction, and HIV content, leadership, grant writing and responsible conduct of research. Candidates will complete published mentored research project(s) and prepare an application for the next career step; i.e. NIH R21, R03, R15, R34 mechanism. The collaboration of the multidisciplinary faculty and the combined robust strengths of two principal investigators from Emergency and Internal Medicine, both with extensive experience mentoring and as independent funded investigators will drive the Yale-DAHRS program. Potential Research Projects: Multiple research projects are ""shovel ready"" for Scholar training and can be completed within our allotted time frame, such as secondary data analysis using national large datasets e.g. VA Aging Cohort (HIV); risk factors, prevention and treatment of prescription drug abuse, office-based treatment of opioid dependence with buprenorphine, systematic reviews and meta-analyses, creation of cost effective evaluation models for patients with drug abuse, addiction and HIV including prescription drug abuse; investigation of gender and racial/ethnic disparities in identification and treatment interventions and outcomes; evaluation of screening, and treatment initiation in special populations (i.e. adolescent-elderly, veterans, incarcerated, HIV); comparison of models of screening, brief intervention and referral to treatment (SBIRT) delivery by providers and other innovative technologies; effectiveness and implementation of SBIRT science in general medicine practice with acute and chronic medical complexities.         PUBLIC HEALTH RELEVANCE:  Drug abuse, addiction, and HIV are significant public health issues, as they affect the health and well-being of a large portion of the population; have substantial negative health outcomes on individuals; and are extremely costly to the health care system. An investment in research to improve substance abuse and medical health outcomes is greatly needed. The proposed Yale-Drug Abuse, Addiction, and HIV Research Scholars (DAHRS) program focusing on general medical settings with patients throughout the life cycle will provide a three year post-doctoral, interdisciplinary, Mentored Career Development Program training six clinician-scientists for independent research careers in the field of drug abuse, addiction, and HIV through integration of prevention and treatment in general medical settings.            ","Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS)",8510031,K12DA033312,"['Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Alcohol Chemical Class ', ' Alcohols ', ' Behavioral Research ', ' Biomedical Research ', ' 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5alpha,7alpha(S))- ', ' Buprenorphine ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Clinical Informatics ', ' Clinical Study ', ' Clinical Research ', ' clinical investigation ', ' Clinical Trials ', ' Infectious Disorder ', ' Infectious Diseases and Manifestations ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communicable Diseases ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' Population Studies / Demography ', ' Demography ', ' disease/disorder ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Emergency Medicine ', ' Engineering ', ' Faculty ', ' Foundations ', ' Future ', ' Grant ', ' Gynecology ', ' Health ', ' Hepatitis ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Hospitals ', ' Community Hospitals ', ' Information Dissemination ', ' Inpatients ', ' Institutes ', ' Internal Medicine ', ' Laboratories ', ' Leadership ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Medicine ', ' Mentors ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Northeastern United States ', ' New England ', ' Obstetrics ', ' Discipline of obstetrics ', ' Overdose ', ' Painful ', ' Pain ', ' Patients ', ' Pediatrics ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Psychiatry ', ' Psychology ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' Science ', ' statistics ', ' Time ', ' Tobacco ', ' Training Programs ', ' Veterans ', ' Woman ', ' Work ', ' Writing ', ' Gender ', ' Female Health ', "" Women's Health "", ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Research Methods ', ' Research Methodology ', ' Dataset ', ' Data Set ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' base ', ' career ', ' improved ', ' Area ', ' Acute ', ' Chronic ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Ensure ', ' Evaluation ', ' Training ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Withdrawal ', ' Fostering ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Development Plans ', ' Funding ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' tool ', ' Diagnostic ', ' Research Priority ', ' Knowledge ', ' programs ', ' Scientist ', ' Investigation ', ' Complex ', ' Clinic ', ' LOINC Axis 4 System ', ' System ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' Opiate Addiction ', ' Emergency room ', ' Emergency Department ', ' Accident and Emergency department ', ' Medical center ', ' innovative technologies ', ' data management ', ' experience ', ' Special Population ', ' named group ', ' success ', ' cohort ', ' skills ', ' Prevention ', ' Intoxication ', ' prescription drug abuse ', ' Modeling ', ' career development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' consumer informatics ', ' Health Informatics ', ' Public Health Informatics ', ' Provider ', ' Effectiveness ', ' ward ', ' Address ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Health Sciences ', ' Scholars Program ', ' NCI Scholars Program ', ' Infrastructure ', ' Research Infrastructure ', ' Research Training ', ' Clinical Sciences ', ' Principal Investigator ', ' developmental ', ' Development ', ' Federally Qualified Health Center ', ' systematic review ', ' treatment center ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' cost-effective ', ' cost effective ', ' Trauma ', ' tertiary care ', ' postdoctoral training ', ' post-doctoral training ', ' clinical epidemiology ', ' addictive disorder ', ' addiction ', ' tool development ', ' racial and ethnic disparities ', ' screening, brief intervention, and referral to treatment ', ' SBIRT ', ' screening, brief intervention, referral, and treatment ', ' responsible research conduct ', ' screening ', ' ']",NIDA,YALE UNIVERSITY,K12,2013,508074,0.10922386071168934
"The Development of a Video-Enhanced Drug Prevention Program for Rural Native Hawa    DESCRIPTION (provided by applicant): Research has indicated that Native Hawaiian youth have significantly higher rates of drug use than their non-Hawaiian counterparts (e.g., Wong, Klingle, & Price, 2004; Mayeda, Hishinuma, Nishimura, Garcia- Santiago, & Mark, 2006), and that these differences are particularly pronounced in rural settings (Lai & Saka, 2005). Despite these findings, there have been very few drug prevention programs developed and evaluated specifically for these youth (Edwards, Giroux, & Okamoto, in press; Rehuher, Hiramatsu, & Helm, 2008). Therefore, the purpose of this exploratory research proposal is to develop and pilot test curricular components of a video-based, culturally-grounded drug prevention program for rural Native Hawaiian youth. This will be accomplished through three specific aims. AIM 1 is to create 3-5 video vignettes focused on relevant drug related problem situations of rural Hawaiian youth. The vignettes will focus on common and difficult drug offer situations for these youth, as well as the range of responses to each situation, established from prior NIDA- funded research (5 K01 DA019884). AIM 2 is to develop the accompanying drug prevention curricular components to compliment the video vignettes developed in Aim 1. AIM 3 is to pilot test the resulting curricular components for program feasibility and measurement, using a combination of focus group interviews with stakeholders (e.g., Hawaiian youth, youth-serving practitioners) and selected classroom implementation within four middle schools. Comparison of the intervention components against four attentional-control schools will be conducted, in order to estimate effect sizes for a future large-scale, randomized controlled trial (to be implemented as part of a future R01 grant).       PUBLIC HEALTH RELEVANCE: Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have been shown to have higher rates of alcohol consumption and smoking compared with other ethnic groups (Office of Minority Health, 2009), research focused on drug prevention of these individuals is important to improve public health both in Hawai'i and on the Mainland U.S. This study actively engages rural communities in the development of the curricular components of a drug prevention intervention for Hawaiian youth, promoting the overall utility and effectiveness of those components. Further, the findings from this study will point to the core content of prevention interventions for Hawaiian youth in rural communities, which may be applicable to other ethnic youth populations in Hawai'i and the Pacific Rim, as well as Native youth populations on the Mainland U.S.         ",The Development of a Video-Enhanced Drug Prevention Program for Rural Native Hawa,8434894,R34DA031306,"['etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Curriculum ', ' Educational Curriculum ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Ethnic group ', ' Focus Groups ', ' Foundations ', ' Future ', ' Grant ', ' Group Interviews ', ' Island ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Production ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Research Proposals ', ' Research Resources ', ' Resources ', ' Rural Health ', ' Schools ', ' Smoking ', ' Testing ', ' Videotape ', ' Accountability ', ' pricing ', ' Price ', ' Rural Community ', ' Youth 10-21 ', ' Youth ', ' base ', ' rural area ', ' improved ', ' Individual ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Measurement ', ' drug use ', ' Drug usage ', ' Funding ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Hawaiian ', ' Hawaiian population ', ' programs ', ' Test Result ', ' Outcome Study ', ' middle school ', ' novel ', ' Prevention ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Effectiveness ', ' Indigenous ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' American Indian and Alaska Native ', ' developmental ', ' Development ', ' minority health ', ' Population ', ' Drug Prevention Program ', ' native youth ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' public health relevance ', ' ']",NIDA,HAWAII PACIFIC UNIVERSITY,R34,2013,150254,0.10748684686714759
"Interdisciplinary Research Training Institute on Hispanic Drug Abuse    DESCRIPTION (provided by applicant): The proposed Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse seeks to promote the career development of pre-doctoral, postdoctoral and early career clinically-focused scientists interested in conducting research as it affects the Hispanic population. This comprehensive and coordinated research education program aims at providing research experience and increasing the skills required for development of testable hypothesis, preparation and submission of research applications for appropriate NIH extramural funding (i.e. K01, K08, F31, F32, R03, R21, etc). Building upon the National Hispanic Science Network's Summer Research Training Institute, the IRTI has two short-term goals and two long-term goals as follows: (1) enhancing the fellows' knowledge and skills for conducting interdisciplinary research on drug abuse; (2) increasing the number of early career faculty who establish vibrant and independent programs of drug abuse research, (3) increasing the amount and quality of research on minority health and health disparities; and, (4) improving the health of minorities in part by decreasing minority health disparities. The aims of the IRTI are: 1. Provide an educational training opportunity that will enhance the skills for conducting interdisciplinary Hispanic drug research and developing applications for NIH funding among pre-doctoral, postdoctoral and early career faculty (fellows) through the implementation of a 14 day intensive summer research training program; 2. Execute a mentoring plan that would be organized and structured around a team of interdisciplinary mentors that would be accessible and available to provide selected fellows with focused mentoring and continual support; and 3. Provide a networking structure and process that will assist fellows in building and maintaining relationships and communication with leading experts in the field of Hispanic drug research and fellow peers. Overall, mentoring activities will focus on guiding and assisting the fellows in achieving benchmarks of progress including: a) Academic Career Progress; b) Scientific Publications; c) Scientific Presentations and d) Research Funding. These outcomes will be facilitated through various types of support including: Mentor Commitment, Travel to Mentor Institution, Conferences/Workshops, and IRTI Mentoring Annual Meeting and IRTI Scientific Conference. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research in the interest of public health. The proposed IRTI and its mentorship and networking components will begin to fill the gap in knowledge of how to effectively develop specific incubators that will be successful in growing a special generation of drug abuse research scientists. PUBLIC HEALTH RELEVANCE: The proposed Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse seeks to promote the career development of pre-doctoral, postdoctoral and early career clinically-focused scientists interested in conducting research as it affects the Hispanic population. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research. Interdisciplinary research teams of tomorrow are needed in addressing health disparities, a major public health problem for which new knowledge from several areas of science must be integrated to define and address extant vulnerabilities, and to develop effective prevention and treatment interventions.           PROJECT NARRATIVE The proposed Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse seeks to promote the career development of pre-doctoral, postdoctoral and early career clinically-focused scientists interested in conducting research as it afects the Hispanic population. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research. Interdisciplinary research teams of tomorrow are needed in addressing health disparities, a major public health problem for which new knowledge from several areas of science must be integrated to define and address extant vulnerabilities, and to develop effective prevention and treatment interventions.",Interdisciplinary Research Training Institute on Hispanic Drug Abuse,8517062,R25DA026401,"['Affect ', ' Communication ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Faculty ', ' Goals ', ' Health ', ' Incubators ', ' Institutes ', ' Mentors ', ' Mentorship ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Public Health ', ' public health medicine (field) ', ' Scientific Publication ', ' Publications ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Science ', ' Training Programs ', ' Travel ', ' Generations ', ' conference ', ' symposium ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' base ', ' career ', ' improved ', ' Area ', ' Training ', ' Discipline ', ' Workshop ', ' Educational workshop ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Funding ', ' Nature ', ' Knowledge ', ' programs ', ' Scientist ', ' Complex ', ' Best Practice Analysis ', ' Benchmarking ', ' interest ', ' meetings ', ' experience ', ' Structure ', ' skills ', ' peer ', ' Prevention ', ' career development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Institution ', ' Address ', ' Research Training ', ' Extramural ', ' EXTMR ', ' Extramural Activities ', ' Preparation ', ' Process ', ' developmental ', ' Development ', ' minority health ', ' Outcome ', ' predoctoral ', ' predoc ', ' pre-doc ', ' pre-doctoral ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R25,2013,224658,0.144606105512944
"Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users    DESCRIPTION (provided by applicant): This is a second revision of a competitive renewal R01 proposal of the NEURO-HIV Epidemiologic Study in response to NIDA PAS-07-115 (Non-injection Dug Abuse and HIV/AIDS). The primary study aim is to evaluate the ability of Integrated Family and Cognitive-Behavioral Therapy-HIV Prevention Intervention (IFCBT-HIVPI) to prevent HIV among adult non-injection and injection drug users. Over a 12 week intervention interval, the IFCBT-HIVPI model coordinates the delivery of cognitive- behavioral components during 12 group sessions with a couples and family systems component during 4 couples/family sessions to address HIV risk and protective factors across multiple ecological systems. IFCBT-HIVPI main effects on primary (HIV sexual risk behaviors and HIV drug taking risk behaviors) and secondary (HIV, Chlamydia, gonorrhea, and trichomoniasis incidences and legal involvement, academic achievement, and employment) outcome domains will be evaluated. We also seek to elucidate the degree to which the development of attitudinal and behavior change skills targeted by IFCBT-HIVPI (e.g., rational beliefs, problem solving skill, adaptive couples' communication) result in post-intervention reductions of HIV, sexually transmitted infections (STIs), and HIV risk behaviors. The possibility of effect-modification is also considered with a focus on route of drug administration status (i.e., non-injector/injector), neuropsychological (e.g., executive function), and demographic (i.e., African American/white) factors. The proposed study will randomly assign 360 HIV-negative non-injection and injection drug users recruited from the original NEURO-HIV Epidemiologic Study sample to experimental (IFCBT-HIVPI) and comparison (Brief Psychoeducation Curriculum on HIV Prevention; BPEC-HIV) conditions. The composition of the original NEURO-HIV Epidemiologic Study sample provides the basis to stratify the randomized trial sample across gender and two race/ethnicity (i.e., African American and white) groups by route of drug administration status. An assessment battery comprised of a standardized interview on HIV risk behavior, neuropsychological tests, tools to assess attitudes and behavior change skills targeted by IFCBT-HIVPI, drug and STI urine testing, and serologic tests of HIV will be administered before, during, and after the intervention interval across 18-month post-intervention follow-up. Additional preliminary analyses will be conducted on the randomized trial data to: (1) derive session-by-session measures on mechanisms of change targeted by IFCBT-HIVPI via videotape coding methods; (2) characterize mechanisms of change trajectories that may then be evaluated as plausible intervention moderators if present; and (3) estimate intervention cost-effectiveness. The lack of research on science-based prevention interventions for HIV continues to be a serious gap in the literature with recent HIV trends highlighting significant health disparities, particularly among African American non-injection drug users. If successful, the proposed project should help to identify specific attitudinal and behavior change skills targeted by cognitive- behavioral and couples/family systems interventions that foster subsequent reductions in HIV, STIs and HIV risk behaviors among adult drug users at heightened disease risk.  PUBLIC HEALTH RELEVANCE: Recent estimates suggest that a majority of the 40,000 new cases of HIV reported annually in the US are attributable largely to sexual risk behavior associated with non-injection drug use. Additionally, African American drug users exhibit substantial HIV health disparities with African American females being 21 times more likely to contract HIV than white females. The proposed project is designed to address critical gaps in the HIV prevention science field by evaluating the ability of an intervention coordinating cognitive-behavioral and couples/family systems components to prevent HIV among adult drug users at heightened disease risk.         ",Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users,8453479,R01DA014498,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Attitude ', ' Belief ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' Client ', ' cognitive behavioral treatment ', ' cognitive behavioral therapy ', ' cognitive behavioral modification ', ' cognitive behavioral intervention ', ' cognitive behavior therapy ', ' cognitive behavior modification ', ' cognitive behavior intervention ', ' Cognitive Psychotherapy ', ' Cognition Therapy ', ' Cognitive Therapy ', ' Communication ', ' cost effectiveness ', ' Couples ', ' Curriculum ', ' Educational Curriculum ', ' Demographic Factors ', ' Drug Administration Routes ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Employment ', ' Exhibits ', ' Family ', ' Female ', ' Gonococcal Infection ', ' Gonorrhea ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incidence ', ' Injections ', ' Injection of therapeutic agent ', ' Interview ', ' Literature ', ' Methods ', ' Neuropsychologic Tests ', ' Neuropsychological Tests ', ' Problem Solving ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Science ', ' Selection Bias ', ' serology ', ' Serological Tests ', ' Serologic tests ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Testing ', ' Time ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Trichomonas Infections ', ' Urine Urinary System ', ' Urine ', ' Videotape ', ' Gender ', ' Measures ', ' Outcomes Assessment ', ' Outcome Assessment (Health Care) ', ' Process Assessment ', ' Process Assessment (Health Care) ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Dataset ', ' Data Set ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Ecological Systems ', ' Ecologic Systems ', ' Ecosystem ', ' base ', ' Fostering ', ' drug use ', ' Drug usage ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Contracting Opportunities ', ' Contracts ', ' tool ', ' Drug user ', ' LOINC Axis 4 System ', ' System ', ' behavior change ', ' interest ', ' Injection Drug User ', ' Injecting drug user ', ' skills ', ' disease risk ', ' disorder risk ', ' Prevention ', ' Academic achievement ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' Coding System ', ' Code ', ' Modeling ', ' Sampling ', ' psychoeducation ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' executive control ', ' executive function ', ' health disparities ', ' health disparity ', ' preventing ', ' prevent ', ' Legal ', ' Address ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Cognitive ', ' trend ', ' Characteristics ', ' Modification ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' post intervention ', ' sexual risk behavior ', ' sex risk ', ' designing ', ' design ', ' Outcome ', ' innovative ', ' innovate ', ' innovation ', ' neuropsychological ', ' group intervention ', ' HIV prevention trial ', ' intervention effect ', ' randomized trial ', ' ']",NIDA,UNIVERSITY OF FLORIDA,R01,2013,470496,0.14700297589822237
"Brief intervention for drug-using rural women at high-risk for HIV/HCV     DESCRIPTION (provided by applicant): The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high-risk for HIV and HCV. This project has potential to make a significant contribution to science by advancing knowledge about the health disparities, high-risk behaviors (injection drug use, sex risk), and service utilization of this high-risk, vulnerable, an understudied group of women during a time of emerging and significant public health risk in an Appalachian rural setting. This project will incorporate standardized screening (NIDA-modified ASSIST) to identify high-risk rural women drug users from jails, including injectors. Consenting women (N=350) will be asked to participate in a baseline interview, and will then be randomly assigned to one of two study groups: (1) HIV Education (HIV- Ed n=175) which includes the NIDA standard pre and post-test counseling, HIV and HCV rapid testing, and an information packet on existing community drug abuse and HIV/HCV resources; or (2) Motivational Interviewing- based HIV Risk Reduction (MI-HIV n=175) which, in addition to what is received in the HIV-Ed group, also includes an evidence-based brief intervention for high-risk women focused on an individualized plan for enhancing motivation to reduce risk behaviors and to use health and behavioral health services in the community. Specific aims include: (1) to compare the effectiveness of an evidence-based HIV risk reduction intervention (MI-HIV) to HIV Education (NIDA Standard) in reducing sex risk behaviors, injection practices, and drug use among a culturally unique sample of disadvantaged, drug-using rural women at high-risk for HIV and HCV; and (2) to examine MI-HIV Intervention engagement as a predictor of community health and behavioral health service utilization (including drug treatment and mental health) at follow-up among disadvantaged, drug- using rural women at high risk for HIV and HCV. This project is innovative because it 1) targets a high-risk and understudied group of women, 2) uses brief intervention to not only reduce risk behavior but also to enhance motivation for using community health and behavioral health resources, and 3) utilizes a real-world setting to identify high-risk women drug users. The long-term goal of this study is to increase access to health and behavioral health services in order to improve the quality of health of high-risk rural women.          The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high risk for HIV and HCV. This project has potential to make a significant contribution to science by providing knowledge about the health, risk behaviors, and service utilization of a vulnerable and understudied group of women during a time of emerging and significant public health risk in a rural Appalachian setting. Successful completion of the aims of this project will advance the delivery of a low-cost, potentially high impact intervention with implications for a number of other real world settings (such as criminal justice venues) where other disadvantaged high-risk drug users can be identified and targeted for intervention.                    ",Brief intervention for drug-using rural women at high-risk for HIV/HCV,8507200,R01DA033866,"['Appalachia ', ' Appalachian Region ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Community Services ', ' Counseling ', ' Disadvantaged ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Goals ', ' Health ', ' Health Resources ', ' health care service ', ' Health Services ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Injections ', ' Injection of therapeutic agent ', ' Interview ', ' Kentucky ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Motivation ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Pre-Post Tests ', ' Public Health ', ' public health medicine (field) ', ' Random Selection ', ' Random Allocation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Science ', ' Testing ', ' Time ', ' Walkers ', ' Woman ', ' Criminal Justice ', ' health care ', ' Healthcare ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' base ', ' rural area ', ' improved ', ' Area ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Rural ', ' drug use ', ' Drug usage ', ' women at high risk ', ' High Risk Woman ', ' Female Groups ', "" Women's Group "", ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Educational Intervention ', ' Staging ', ' Drug user ', ' Opiates ', ' Knowledge ', ' Pattern ', ' Country ', ' Services ', ' treatment planning ', ' Participant ', ' high risk behavior ', ' motivational interview ', ' motivational enhancement therapy ', ' outreach ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' Sampling ', ' behavioral health ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' drug resource ', ' vulnerable group ', ' Vulnerable Populations ', ' Risk Reduction ', ' health disparities ', ' health disparity ', ' Address ', ' Jail ', ' Consent ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Community Health ', ' comparison group ', ' sexual risk behavior ', ' sex risk ', ' cost ', ' designing ', ' design ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' Evidence based intervention ', ' compare effectiveness ', ' service utilization ', ' high risk ', ' evidence base ', ' prescription opiate ', ' screening ', ' injection drug use ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2013,538592,0.12069110669681299
"National Hispanic Science Network on Drug Abuse (NHSN) Annual Conference Abstract  This R13 meetings grant application seeks support for five yearly three-day stand alone conferences to be held at selected locations beginning in the fall of 2009. This proposal reflects a collaborative initiative between Louisiana State University Health Sciences Center and the National Hispanic Science Network on Drug Abuse (NHSN), based at the University of Miami. The annual scientific conferences help to accomplish the NHSN mission of fostering both interdisciplinary and translational research, by promoting dialogue between biologic, social, behavioral, and cultural scientists and disseminating findings back to the field. Previous conferences, supported through a NIDA-funded contract, have been an effective platform for developing the aims of the NHSN, with particular emphasis on mentoring and training Hispanic graduate students and early career scientists.    The aims of the conferences will be: A) to advance science in the area of drug abuse research and its co-morbid conditions, particularly as it impacts on the Hispanic population. It will promote bidirectional translational research ranging from bench to community and a trans-disciplinary cross-fertilization of ideas among scientists from all fields of drug abuse helping to establish future research priorities. B) To foster the development of Hispanic researchers, with emphasis in areas related to drug abuse research by facilitating the development of integrated and continuous collaborative and mentoring networks. Funding is requested to support participation for 50 trainees/early career scientists and 20 research scientists presenting in the scientific panels. An average of 150 participants, representing the field from the national and international scientific communities, are expected at each yearly conference, including members of the global research community whose interests encompass a multifaceted approach to understanding the factors underlying health disparities as they pertain to drug use and abuse ranging from epidemiology to environmental health, psychology, sociology, health policy, neuroscience and other biomedical sciences, and epigenetics.    The first conference proposed ""Integrating Population, Laboratory, and Clinical Sciences in Minority Health"" will be hosted by the University of Miami, from December 1-3, 2009. The format of the conference aims to provide ample opportunity for discussion, networking, and collaboration discussions as well as development of new ideas related to training and mentoring of the next generation of researchers in the field of drug abuse. The themes, scientific content, and program for each conference will be developed by a Scientific Conference committee comprised of NHSN members, NIH officials, and federal liaisons. The themes will be directly related to NIDA's strategic plan and the NIH blueprint, addressing timely topics and developing challenges in the field. Project narrative  The Annual National Hispanic Science Network on Drug Abuse Conference provides multidisciplinary scientists in drug abuse and related fields interested in advancing science, particularly as it pertains to the Hispanic population, to have a collegial exchange providing a forum for discussion and dissemination of research findings and an opportunity for networking and mentoring trainees in the area of drug abuse research. This unique opportunity will promote bidirectional translational research ranging from bench to community and a trans-disciplinary cross-fertilization of ideas among scientists from all fields of drug abuse. The PI and the organizing committee are confident that the proposed conferences will serve as a platform to establish future research priorities for the field of drug abuse as it pertains to the Hispanic population.",National Hispanic Science Network on Drug Abuse (NHSN) Annual Conference,8468151,R13DA026647,"['abstracting ', ' Dorsum ', ' Back ', ' Communities ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Environmental Health Science ', ' Environmental Health ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Fertility/Fertilization ', ' Fertilization ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Geographic Locations ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' Laboratories ', ' Louisiana ', ' Mentors ', ' Mission ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Neurosciences ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Science ', ' self help organization ', ' Self-Help Groups ', ' Support Groups ', ' Sociology ', ' Universities ', ' Gender ', ' falls ', ' conference ', ' symposium ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' base ', ' career ', ' Area ', ' Training ', ' Discipline ', ' Fostering ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' drug use ', ' Drug usage ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Collaborations ', ' Health Psychology ', ' Contracting Opportunities ', ' Contracts ', ' programs ', ' Scientist ', ' Location ', ' interest ', ' meetings ', ' Participant ', ' peer ', ' member ', ' graduate student ', ' social ', ' health disparities ', ' health disparity ', ' Address ', ' Grant Proposals ', ' Applications Grants ', ' Health Sciences ', ' International ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Strategic Planning ', ' Clinical Sciences ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' developmental ', ' Development ', ' Behavioral ', ' minority health ', ' dissemination research ', ' next generation ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' multidisciplinary ', ' ']",NIDA,LSU HEALTH SCIENCES CENTER,R13,2013,80649,0.053419674228157465
"Contextualizing & responding to HIV risk behaviors among Black drug offenders     DESCRIPTION (provided by applicant): Formerly incarcerated Black drug offenders are at an elevated risk for HIV infection. Despite substantial research expressing the need for HIV prevention services for ex-offenders post-release, this population has limited access to quality programming and services related to HIV risk reduction. This K01 application seeks to inform and adapt an HIV risk reduction intervention to address the needs of formerly incarcerated Black drug offenders who are being released from prisons in the New York City metropolitan area. This application supports the Principal Investigator's interest in becoming an independent behavioral scientist specializing in HIV prevention intervention development and adaptation. The proposed mentorship and training program will focus on the following key areas: mixed methods research; adaptation science; and intervention implementation. The proposed study will occur in three phases implemented over the course of five years. The formative phase will consist of survey administration on HIV literacy, needs and barriers to practicing protective behaviors, and HIV testing from 120 recently released Black drug offenders. Also during this phase, in-depth interviews with a subsample of 24 participants (12 male and 12 female participants) will also be conducted to gather more comprehensive information exploring needs and barriers to practicing HIV protective behaviors. The intervention development and adaptation phase, will consist of analyzing data from the survey research and in-depth interviews to tailor it for use with recently released Black drug offenders. In phase 3, the feasibility and acceptability of the adapted intervention will be pilot tested using a randomized clinical trial with 64 participants who are randomized to the adapted intervention or an Enhanced Referral Intervention arm. Building on the Information-Motivation and Behavioral Skills Model, this study will address the following specific aims: 1) To examine individual-level, environmental and contextual factors that affect HIV risk-related behaviors (i.e. illicit drug use and risky sexual behavior) among formerly incarcerated Black male and female drug offenders; 2) To adapt Project START, an HIV risk reduction intervention for formerly incarcerated men, using data gathered from Aim 1, to increase access to HIV testing and address drivers of HIV vulnerability among recently released Black male and female drug offenders; and 3) To pilot test the feasibility and acceptability of the adapted Project START using a randomized clinical trial with 64 participants (32 men, 32 women). The proposed study will utilize a mixed-methods approach to investigate drivers of HIV risk among recently released Black drug offenders. By providing more contextual information on risk behaviors, future evidence-based approaches can be developed and rapidly deployed, advancing HIV prevention science, and providing essential support for a vulnerable population that consistently experiences barriers in accessing HIV prevention services.         PUBLIC HEALTH RELEVANCE: This K01 application seeks to inform and adapt an HIV risk reduction intervention to address the needs of formerly incarcerated Black drug offenders who are being released from prisons in the New York City metropolitan area. The proposed mentorship and training program will focus on the following key areas: mixed methods research; adaptation science; and intervention implementation. A mixed methods approach will be used to conceptualize HIV risk related behaviors among this population, resulting in the development of a novel approach to better understanding and ultimately addressing racial disparities in HIV prevalence.                    ",Contextualizing & responding to HIV risk behaviors among Black drug offenders,8603594,K01DA036411,"['Affect ', ' Behavior ', ' Behavioral Research ', ' Communities ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Data Analysis ', ' Data Analyses ', ' Diagnosis ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Eyeball ', ' Eye ', ' Female ', ' Future ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Housing ', ' Interview ', ' literacy ', ' male ', "" men's "", ' men ', ' Mentors ', ' Mentorship ', ' Methods ', ' Study models ', ' Motivation ', ' New York City ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisoner ', ' Prisons ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Risk ', ' Science ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Training Programs ', ' United States ', ' Woman ', ' Gender ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' Illicit Drugs ', ' Research Methods ', ' Research Methodology ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' improved ', ' Area ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' Randomized Clinical Trials ', ' Training ', ' Individual ', ' drug use ', ' Drug usage ', ' Drug user ', ' Knowledge ', ' programs ', ' Scientist ', ' Home ', ' Home environment ', ' Application Context ', ' contextual factors ', ' interest ', ' Services ', ' experience ', ' metropolitan ', ' skills ', ' Participant ', ' prevention service ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' criminal offender ', ' offender ', ' HIV risk ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' Risk Reduction ', ' health disparities ', ' health disparity ', ' Commit ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Institution ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Address ', ' Data ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' Mentored Research Scientist Development Award ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Transmission ', ' transmission process ', ' Principal Investigator ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Behavioral ', ' Prevention education ', ' neglect ', ' protective behavior ', ' new approaches ', ' novel strategy ', ' novel approaches ', ' novel strategies ', ' Guide prevention ', ' Population ', ' Prevalence ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' public health relevance ', ' evidence base ', ' arm ', ' drug offender ', ' ']",NIDA,COLUMBIA UNIVERSITY HEALTH SCIENCES,K01,2013,142075,0.0825246084870777
"Developmental Pathways to Substance Use Across European & Asian American Youth DESCRIPTION (provided by applicant): As one of the fastest growing ethnic minority groups in the United States, alcohol and drug use in American Americans has increasingly been recognized as a public health problem. Emerging research has documented biological, psychosocial, and cultural factors that are associated with alcohol use in Asian American youth adults (Hendershot et al., 2005). However, existing studies have neither adopted a developmental perspective to study the emergence of alcohol use and problems in Asian American during late adolescence, nor have they tested whether prior findings can be generalized to predict drug use and problems. Concurrently, evidence from a separate line of research has suggested that effects of parenting are often different across Asian and European American youth. Numerous studies, for example, have suggested that authoritarian parenting style has beneficial effects in Asian American youth, but detrimental effects in European American youth on outcomes such as academic performance and socio-emotional competence. Subsequent research has indicated that parental constructs such as emotional support and psychological control may also have differential effects across Asian and European American youth (e.g., Chao & Tseng, 2002). Despite these findings, no published study has documented differential effects of parenting on alcohol and drug use across Asian and European American youth. Thus, the overarching goal of this study is to examine moderation effects by ethnicity on the association between parenting and alcohol and drug use outcomes in a longitudinal sample of Asian and European American youth. Specifically, the proposed study will test whether parental emotional support, psychological control and monitoring have differential effects on alcohol and drug use outcomes across Asian and European American youth. Data will be drawn from 97 Asian American and 255 European American youth who participated in the Developmental Pathway Project. Structural equation modeling and factor analysis techniques will be used to test (1) whether parental emotional support, psychological control, and monitoring in 7th grade will differentially predict alcohol and drug use outcomes in 9th and 12th grade across Asian and European American youth; (2) whether developmental pathways from parenting to alcohol and drug use outcomes (via school achievement and peer substance use in 8th grade) are different across Asian and European American youth; and (3) whether the hypothesized moderation effects by ethnicity can be attributed to different interpretation of parenting, as suggested by prior research (e.g., Chao & Aque, 2009). Results from the proposed study can be used to guide the development of culturally sensitive prevention and intervention programs for alcohol and drug use in Asian American youth. The proposed project addresses a strategic goal of the National Institute of Drug Abuse (NIDA) on the prevention of alcohol and drug use through understanding risk and protective factors in adolescence, a developmental stage during which substance use increases over time. This project also addresses NIDA's cross-cutting priorities of decreasing health disparity related to drug addiction and training new investigators from a diverse (including minority) background. The ultimate goal of this project is to limit substance use initiation and problematic use through the development of culturally sensitive prevention and intervention programs for Asian American youth.",Developmental Pathways to Substance Use Across European & Asian American Youth,8516912,F31AA020700,"['Achievement Attainment ', ' Achievement ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Aggression ', ' Aggressive behavior ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Asian Americans ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Caucasoid Race ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Child Behavior ', ' Ethnic group ', ' Goals ', ' Influentials ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Parents ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Schools ', ' Stress ', ' Students ', ' Teaching ', ' Educational process of instructing ', ' Testing ', ' Time ', ' United States ', ' Caucasians ', ' Work ', ' oriental ', ' Asians ', ' Parenting ', ' Parenting behavior ', ' problem drinking ', ' problem alcohol use ', ' hazardous alcohol use ', ' ethanol abuse ', ' alcohol problem ', ' Alcohol abuse ', ' Factor Analyses ', ' Factor Analysis ', ' Competence ', ' Mediating ', ' Youth 10-21 ', ' Youth ', ' Chinese ', ' Chinese People ', ' Biological ', ' psychological ', ' psychologic ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Link ', ' Training ', ' Discipline ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' European ', ' drug use ', ' Drug usage ', ' root ', ' Plant Roots ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' behavioral problem ', ' Problem behavior ', ' Genetic ', ' Staging ', ' Life ', ' programs ', ' Adopted ', ' Techniques ', ' psychosocial ', ' Equation ', ' American ', ' Performance ', ' college student ', ' university student ', ' intervention program ', ' Structure ', ' alcohol metabolism ', ' Ethanol Metabolism ', ' skills ', ' Prevention program ', ' peer ', ' intimacy ', ' intimate behavior ', ' 7th grade ', ' seventh grade ', ' 8th grade ', ' eighth grade ', ' high school freshman ', ' 9th grade ', ' ninth grade ', ' high school senior ', ' 12th grade ', ' twelfth grade ', ' youth alcohol consumption ', ' underage alcohol use ', ' underage alcohol consumption ', ' under age alcohol use ', ' under age alcohol consumption ', ' teenager alcohol use ', ' teenage drinking ', ' teenage alcohol use ', ' teen drinking ', ' drinking during adolescence ', ' alcohol use during adolescence ', ' alcohol intake among adolescents ', ' alcohol during adolescence ', ' adolescent drinking ', ' adolescent alcohol use ', ' adolescent alcohol consumption ', ' Youth Drinking ', ' underage drinking ', ' Reporting ', ' parent monitoring ', ' parental monitoring ', ' Emotional ', ' Modeling ', ' Sampling ', ' health disparities ', ' health disparity ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' South Asian ', ' Monitor ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' adolescent smoking ', ' designing ', ' design ', ' Minority ', ' alcohol and other drug ', ' Outcome ', ' Population ', ' prospective ', ' ethnic minority ', ' ethnic minority population ', ' early adolescence ', ' reduce adolescent alcohol ', ' alcohol use prevention ', ' deter alcohol use ', ' ']",NIAAA,UNIVERSITY OF WASHINGTON,F31,2013,38560,0.04928523229381242
"Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users    DESCRIPTION (provided by applicant): This is a second revision of a competitive renewal R01 proposal of the NEURO-HIV Epidemiologic Study in response to NIDA PAS-07-115 (Non-injection Dug Abuse and HIV/AIDS). The primary study aim is to evaluate the ability of Integrated Family and Cognitive-Behavioral Therapy-HIV Prevention Intervention (IFCBT-HIVPI) to prevent HIV among adult non-injection and injection drug users. Over a 12 week intervention interval, the IFCBT-HIVPI model coordinates the delivery of cognitive- behavioral components during 12 group sessions with a couples and family systems component during 4 couples/family sessions to address HIV risk and protective factors across multiple ecological systems. IFCBT-HIVPI main effects on primary (HIV sexual risk behaviors and HIV drug taking risk behaviors) and secondary (HIV, Chlamydia, gonorrhea, and trichomoniasis incidences and legal involvement, academic achievement, and employment) outcome domains will be evaluated. We also seek to elucidate the degree to which the development of attitudinal and behavior change skills targeted by IFCBT-HIVPI (e.g., rational beliefs, problem solving skill, adaptive couples' communication) result in post-intervention reductions of HIV, sexually transmitted infections (STIs), and HIV risk behaviors. The possibility of effect-modification is also considered with a focus on route of drug administration status (i.e., non-injector/injector), neuropsychological (e.g., executive function), and demographic (i.e., African American/white) factors. The proposed study will randomly assign 360 HIV-negative non-injection and injection drug users recruited from the original NEURO-HIV Epidemiologic Study sample to experimental (IFCBT-HIVPI) and comparison (Brief Psychoeducation Curriculum on HIV Prevention; BPEC-HIV) conditions. The composition of the original NEURO-HIV Epidemiologic Study sample provides the basis to stratify the randomized trial sample across gender and two race/ethnicity (i.e., African American and white) groups by route of drug administration status. An assessment battery comprised of a standardized interview on HIV risk behavior, neuropsychological tests, tools to assess attitudes and behavior change skills targeted by IFCBT-HIVPI, drug and STI urine testing, and serologic tests of HIV will be administered before, during, and after the intervention interval across 18-month post-intervention follow-up. Additional preliminary analyses will be conducted on the randomized trial data to: (1) derive session-by-session measures on mechanisms of change targeted by IFCBT-HIVPI via videotape coding methods; (2) characterize mechanisms of change trajectories that may then be evaluated as plausible intervention moderators if present; and (3) estimate intervention cost-effectiveness. The lack of research on science-based prevention interventions for HIV continues to be a serious gap in the literature with recent HIV trends highlighting significant health disparities, particularly among African American non-injection drug users. If successful, the proposed project should help to identify specific attitudinal and behavior change skills targeted by cognitive- behavioral and couples/family systems interventions that foster subsequent reductions in HIV, STIs and HIV risk behaviors among adult drug users at heightened disease risk.  PUBLIC HEALTH RELEVANCE: Recent estimates suggest that a majority of the 40,000 new cases of HIV reported annually in the US are attributable largely to sexual risk behavior associated with non-injection drug use. Additionally, African American drug users exhibit substantial HIV health disparities with African American females being 21 times more likely to contract HIV than white females. The proposed project is designed to address critical gaps in the HIV prevention science field by evaluating the ability of an intervention coordinating cognitive-behavioral and couples/family systems components to prevent HIV among adult drug users at heightened disease risk.         ",Randomized Trial of IFCBT-HIVPI to Prevent HIV Among Non-Injection Drug Users,8657183,R01DA014498,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Attitude ', ' Belief ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' Client ', ' cognitive behavioral treatment ', ' cognitive behavioral therapy ', ' cognitive behavioral modification ', ' cognitive behavioral intervention ', ' cognitive behavior therapy ', ' cognitive behavior modification ', ' cognitive behavior intervention ', ' Cognitive Psychotherapy ', ' Cognition Therapy ', ' Cognitive Therapy ', ' Communication ', ' cost effectiveness ', ' Couples ', ' Curriculum ', ' Educational Curriculum ', ' Demographic Factors ', ' Drug Administration Routes ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Employment ', ' Exhibits ', ' Family ', ' Female ', ' Gonococcal Infection ', ' Gonorrhea ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incidence ', ' Injections ', ' Injection of therapeutic agent ', ' Interview ', ' Literature ', ' Methods ', ' Neuropsychologic Tests ', ' Neuropsychological Tests ', ' Problem Solving ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Science ', ' Selection Bias ', ' serology ', ' Serological Tests ', ' Serologic tests ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Testing ', ' Time ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Trichomonas Infections ', ' Urine Urinary System ', ' Urine ', ' Videotape ', ' Gender ', ' Measures ', ' Outcomes Assessment ', ' Outcome Assessment (Health Care) ', ' Process Assessment ', ' Process Assessment (Health Care) ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Dataset ', ' Data Set ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Ecological Systems ', ' Ecologic Systems ', ' Ecosystem ', ' base ', ' Fostering ', ' drug use ', ' Drug usage ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Contracting Opportunities ', ' Contracts ', ' tool ', ' Drug user ', ' LOINC Axis 4 System ', ' System ', ' behavior change ', ' interest ', ' Injection Drug User ', ' Injecting drug user ', ' skills ', ' disease risk ', ' disorder risk ', ' Prevention ', ' Academic achievement ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' Coding System ', ' Code ', ' Modeling ', ' Sampling ', ' psychoeducation ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' executive control ', ' executive function ', ' health disparities ', ' health disparity ', ' preventing ', ' prevent ', ' Legal ', ' Address ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Cognitive ', ' trend ', ' Characteristics ', ' Modification ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' post intervention ', ' sexual risk behavior ', ' sex risk ', ' designing ', ' design ', ' Outcome ', ' innovative ', ' innovate ', ' innovation ', ' neuropsychological ', ' group intervention ', ' HIV prevention trial ', ' intervention effect ', ' randomized trial ', ' ']",NIDA,UNIVERSITY OF FLORIDA,R01,2013,9180,0.14700297589822237
"Natural History of HIV Infection In Injection Drug Users     DESCRIPTION (provided by applicant): HIV-infected injection drug users (IDUs) represent a marginalized population with substantial disparities in health care access and outcomes. With improved survival due to highly active antiretroviral therapy (HAART), HIV has transformed into a chronic disease. In addition to HIV disease, IDUs also suffer from a syndemic of other chronic diseases including substance abuse, mental health disorders, and non-AIDS comorbidities. Proposed is a continuation of the ALIVE cohort study, among the largest, longest-running and productive IDU cohorts worldwide, and which has followed disadvantaged, primarily African American IDUs in Baltimore, MD since 1988. With advancing age and multimorbidity, the comprehensiveness of care will increasingly determine HIV-infected IDUs quality and quantity of life. We hypothesize that the key determinants of optimal HIV care (e.g., active drug use, provider relationships, social networks, neighborhood factors) may also determine effective comprehensive care for HIV-infected IDUs. While this cohort has and continues to be a platform for an array of studies all critical to addressing questions about the long-term course and consequences of HIV disease and its treatment among IDUs, this proposal emphasizes: 1) improved identification of HIV-infected IDUs most likely to respond optimally to ART. We will examine longitudinal trajectories of drug use and HIV RNA to define membership in optimal vs. sub-optimal response groups, and then quantitatively identify behavioral and clinical correlates and qualitatively examine barriers and coping mechanisms which underlie the ability to optimally respond. 2) To investigate the determinants and consequences of comprehensive care for HIV-infected IDUs from patient, clinical and societal perspectives. Comprehensive care for HIV-infected IDUs extends beyond HIV-focused aspects to include care for chronic comorbid diseases, substance abuse, and mental health conditions. We propose a framework that considers measures of effective comprehensive care from patient (perceived effectiveness), clinical (adherence to quality care indicators) and societal (service utilization) points of view. Building on prior investigation of individual-, provider-, and neighborhood-level factors associated with HAART effectiveness, we will identify determinants of quality comprehensive care. Extending our multi-level framework in this proposal, we will also evaluate the role of social networks (e.g. 'care-engaged' network members) on comprehensive care. Finally, we examine comprehensive care effectiveness in relation to patient-reported (quality-of-life), clinica (multimorbidity, physical performance) and societal (QALYs) outcomes. To achieve these aims, we continue biannual visits with interview, exam, and biospecimen collection supplemented by medical record review and registry linkage. The ALIVE study remains well-positioned to address the emerging issues confronting the healthy aging of HIV-infected IDUs, namely optimizing long-term ART and enhancing comprehensiveness of care.          This proposal addresses the primary issues confronting the healthy aging of HIV-infected injection drug users, namely optimizing long-term antiretroviral therapy and enhancing the comprehensiveness of care, not just for HIV disease, but also for substance abuse, mental health conditions, and chronic diseases. Nested in the long- standing ALIVE cohort study, the proposed aims will improve understanding of effective comprehensive care from patient, clinical and societal perspectives, and will inform strategies to optimize care and improve outcomes for persons aging with HIV infection.            ",Natural History of HIV Infection In Injection Drug Users,8410549,R56DA004334,"['Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Baltimore ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Concurrent Studies ', ' Cohort Studies ', ' Communities ', ' co-morbidity ', ' Comorbidity ', ' comprehensive care ', ' Comprehensive Healthcare ', ' Comprehensive Health Care ', ' Data Collection ', ' Disadvantaged ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Environment ', ' Grant ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Health Services Accessibility ', ' Heterogeneity ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incidence ', ' Interview ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' long-term study ', ' Longitudinal Studies ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Medical Records ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Mortality ', ' Mortality Vital Statistics ', ' Persons ', ' Neighborhoods ', ' Patients ', ' Peer Review ', ' Phenotype ', ' Scientific Publication ', ' Publications ', ' Qualitative Evaluations ', ' QOL ', ' Quality of life ', ' Registries ', ' Relapse ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' social role ', ' Role ', ' Running ', ' Measures ', ' Quality-Adjusted Life Years ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' smoking cessation ', ' Treatment outcome ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' health care ', ' Healthcare ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Caring ', ' Social Network ', ' Natural History ', ' base ', ' improved ', ' Chronic ', ' Clinical ', ' Malignant ', ' Malignant - descriptor ', ' Link ', ' Evaluation ', ' Individual ', ' drug use ', ' Drug usage ', ' Funding ', ' uptake ', ' Collaborations ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' Published Comment ', ' Metabolic ', ' tool ', ' Intravenous ', ' Life ', ' Disorder Management ', ' Disease Management ', ' frailty ', ' Investigation ', ' Complex ', ' Physical Function ', ' Neurocognitive ', ' Visit ', ' Injection Drug User ', ' Injecting drug user ', ' Training and Education ', ' experience ', ' Performance ', ' success ', ' cohort ', ' member ', ' Reporting ', ' Position ', ' Positioning Attribute ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' multisubstance abuse ', ' polysubstance abuse ', ' Modeling ', ' QOC ', ' Quality of Care ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' highly active anti-retroviral therapy ', ' HAART ', ' Highly Active Antiretroviral Therapy ', ' Provider ', ' Effectiveness ', ' Address ', ' Adherence ', ' Adherence (attribute) ', ' Consequences of HIV ', ' Interruption ', ' Infrastructure ', ' Research Infrastructure ', ' Collection ', ' Monitor ', ' trend ', ' Behavioral ', ' antiretroviral therapy ', ' hepatitis C virus vaccine ', ' HCV Vaccine ', ' Clinical effectiveness ', ' Outcome ', ' Population ', ' Chronic Care ', ' prospective ', ' service utilization ', ' healthy aging ', ' treatment response ', ' coping mechanism ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,R56,2013,1572631,0.039503203878288165
"Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth    DESCRIPTION (provided by applicant): The proposed study's overarching goal is to reduce the ethnic disparities in illicit drug use, cigarette use, and HIV between Hispanic and non-Hispanic youth. This goal will be accomplished by four aims: AIM 1 is to evaluate the effectiveness of Familias Unidas, relative to Community Practice (i.e., standard prevention services), in preventing illicit drug use; AIM 2 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing cigarette use; AIM 3 is to evaluate the effectiveness of Familias Unidas, relative to Community Control, in preventing unprotected sexual behavior; and AIM 4 is to assess the extent to which family functioning mediates the effects of the intervention on illicit drug use, cigarette use, and unprotected sexual behavior. Twenty four middle schools with a total sample of 744 Hispanic adolescents from a wide geographic area of Miami-Dade County will be randomized using a block design to one of two conditions: Familias Unidas or Community Practice. The Familias Unidas intervention has been evaluated and found to be efficacious in two separate randomized controlled trials. In the first study (Pantin et al., 2003), Familias Unidas was shown to be efficacious relative to a no intervention control condition in increasing family functioning and reducing behavior problems (Prado et al., 2006), risk factors for youth illicit drug use and unprotected sex. In the second randomized controlled trial (Prado et al., in press), Familias Unidas was found to be efficacious, relative to two attention control conditions, in preventing cigarette use and illicit drug use. Familias Unidas was also found to be efficacious relative to both of the control conditions in preventing/reducing unprotected sexual behavior at last sexual intercourse. Finally, family functioning was found to mediate the effects of intervention condition on the outcomes. Hierarchical Linear Modeling (HLM) will be used to test: (H1) Familias Unidas will be more effective than Community Practice in reducing illicit drug use over time; (H2) Familias Unidas will be more effective than Community Practice in reducing cigarette use over time; and (H3) Familias Unidas will be more effective than Community Practice in reducing unprotected sexual behavior over time. Additionally HLM will be used to determine whether (H1a) the effect of Familias Unidas on illicit drug use will be partially mediated by family functioning; (H2a) the effect of Familias Unidas on cigarette use will be partially mediated by family functioning and (H3a) the effect of Familias Unidas on unprotected sexual behavior will be partially mediated by family functioning.  PUBLIC HEALTH RELEVANCE: The objective of the proposed study is to reduce illicit drug use, cigarette use, and unsafe sexual behavior health disparities in Hispanic populations. The knowledge expected to be gained from this study will aid in the development of effective interventions to reduce drug use, cigarette use, unprotected sexual behavior, and HIV in Hispanic adolescents.               ",Familias Unidas Stage III Study: Preventing Substance Abuse in Hispanic Youth,8409805,R01DA025192,"['Accounting ', ' Age ', ' Americas ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Benzeneethanamine, alpha-methyl-, (+-)- ', ' Amphetamines ', ' Attention ', ' Behavior ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Sexual Intercourse ', ' Human Sexual Intercourse ', ' Coitus ', ' Communication ', ' Communities ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Ethnic group ', ' Family ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Geographic Locations ', ' Goals ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Linear Models ', ' Manuals ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Parents ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Risk Factors ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Societies ', ' Substance Dependence ', ' Substance Addiction ', ' Testing ', ' Time ', ' United States ', ' County ', ' Relative ', ' Relative (related person) ', ' Parenting ', ' Parenting behavior ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Illicit Drugs ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Mediating ', ' Youth 10-21 ', ' Youth ', ' Guidelines ', ' improved ', ' Family Study ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Training ', ' white American ', ' caucasian American ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' drug use ', ' Drug usage ', ' behavioral problem ', ' Problem behavior ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Educational Intervention ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Staging ', ' Knowledge ', ' Frequency ', ' Frequencies (time pattern) ', ' LOINC Axis 4 System ', ' System ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' meetings ', ' middle school ', ' Cigarette ', ' Prevention Research ', ' prevention service ', ' peer ', ' Categories ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' parent monitoring ', ' parental monitoring ', ' Modeling ', ' Sampling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Effectiveness ', ' preventing ', ' prevent ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' trial design ', ' Clinical Trials Design ', ' Community Practice ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' developmental ', ' Development ', ' effectiveness trial ', ' youth substance use ', ' adolescent substance use ', ' designing ', ' design ', ' efficacy trial ', ' Outcome ', ' Youth Risk Behavior ', ' Adolescent Risk Behavior ', ' Population ', ' parental involvement ', ' community setting ', ' effective intervention ', ' primary outcome ', ' intervention effect ', ' prevent substance use ', ' substance use prevention ', ' randomized trial ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2013,712283,0.13953397803232517
"The Logics for HIV Risk among Street-Based Heroin Injectors    DESCRIPTION (provided by applicant): We propose to develop a theoretically and ethnographically informed model of ""HIV risk environment"" for public health intervention by identifying the key structural forces, institutional processes, and socio-cultural constraints that shape HIV behaviors among inner-city street-based drug users. We will examine the social processes that drive the logics for HIV transmission behaviors among street-based injection drug users (IDUs) in two cities, Philadelphia and San Francisco, that span a strategic range of the demographic, economic, political, and cultural factors affecting inner-city poverty in the United States. Building on long-term, continuous participant-observation ethnographic fieldwork in the shooting encampments of ethnically and generationally bounded social networks of heroin injectors and crack smokers in San Francisco as well as pilot research in Philadelphia at open-air drug markets and shooting galleries, we will document patterns of: 1) law enforcement and criminal justice; 2) poverty and income generating opportunities (including legal and illegal labor markets and public subsidies); 3) illegal drug markets and polydrug availability; 4) racialized ethnic boundaries and conflicts; 5) gender/sexuality boundaries that delimit social networks; 6) oppositional sub-cultural identities that trap IDUs into counterproductive relationships with the services that are meant to help or contain them; 7) violence and insecurity; 8) access to clinical care, public health prevention messages, and social services; 9) access to ecological and basic survival needs infrastructures including transportation systems, food, and shelter from inclement weather. An experienced ethnographic team in both cities will collect data on individual-level HIV risk behaviors at fieldsites that we have successfully maintained on the parent grant for more than 12 years in San Francisco and recently established in Philadelphia (core N of each network=15-20 at any given time, peripheral N=10-15 in each fieldsite; 2 sites in Philadephia and 2 in San Francisco). The project will administer a set of procedures for cross-methodological collaboration with epidemiologists who are the Principal Investigators on long-term, large quantitative data sets documenting street-based drug users in both cities. This will enable us to examine the representativity of our ethnographic data on individual street-based drug users and to explore the generalizability of our analysis of the larger social structural processes that promote or constrain risky injection and sexual practices. It will also bring one of the largest and oldest NIDA-funded data sets on IDUs in San Francisco, an exceptionally high-tech, wealthy, culturally diverse, and liberal city into an illustrative contrast and dialogue with another large NIDA-supported quantitative data set of street-based drug users in the city of Philadelphia, one of the nation's poorest deindustrialized metropolises, with a declining population of largely native-born white, Latino (primarily Puerto Rican) and African American ethnic groups.       PUBLIC HEALTH RELEVANCE: Untangling the complex web of factors that render inner city poverty environments exceptionally risky for HIV infection and addiction will help public health outreach workers and clinicians develop more innovative structural and targeted interventions to reach larger numbers of low income high-risk populations with more effective and convincing messages. Upstream interventions that alter neighborhood-level risk environments can cost-effectively encourage drug users to change their behaviors for pragmatic reasons without necessarily requiring a conscious or willful choice. Our findings will also identify strategic institutions and programs that often operate at cross purposes or fail to coordinate with public health HIV risk reduction priorities (including law enforcement, criminal justice, employment training, public housing, food kitchens, shelters, schools, and churches) but which represent productive sites for multi-service HIV prevention interventions.         ",The Logics for HIV Risk among Street-Based Heroin Injectors,8465205,R01DA010164,"['Affect ', ' Age ', ' Air ', ' Cultural Anthropology ', ' Attention ', ' Awareness ', ' bear ', ' Ursidae ', ' Bears ', ' Ursidae Family ', ' Behavior ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Childhood Abuse ', ' Child Abuse ', ' Cities ', ' Conflict ', ' Conflict (Psychology) ', ' Data Collection ', ' Decision Making ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Drug Preparation ', ' Drug Compounding ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economical Conditions ', ' Economic Conditions ', ' Economics ', ' Employment ', ' Environment ', ' Environment and Public Health ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Ethnic group ', ' facial ', ' faces ', ' Face ', ' Food ', ' Health ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Health Services Research ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Economical Income ', ' Economic Income ', ' Income ', ' Injections ', ' Injection of therapeutic agent ', ' Laboratories ', ' Literature ', ' Logic ', ' Marketing ', ' Medicine ', ' Methods ', ' Neighborhoods ', ' Philadelphia ', ' Poverty ', ' Public Health ', ' public health medicine (field) ', ' Public Housing ', ' Puerto Rican ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' San Francisco ', ' Schools ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Sexuality ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Social Sciences ', ' Social Work ', ' Social Service ', ' Social work (field) ', ' Socialization ', ' Time ', ' Transportation ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Unemployment ', ' United States ', ' USPHS ', ' Public Health Service ', ' United States Public Health Service ', ' violent behavior ', ' violent ', ' Violence ', ' Weather ', ' Gender ', ' Native People ', ' Indigenous Population ', ' Native-Born ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' Latino ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Dataset ', ' Data Set ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' shelter-housing ', ' shelter ', ' Shelter facility ', ' Social Network ', ' ethnographic ', ' Ethnography ', ' Law Enforcement ', ' base ', ' Procedures ', ' Peripheral ', ' Distal ', ' Site ', ' Link ', ' Training ', ' Consciousness ', ' Conscious ', ' Individual ', ' Logistics ', ' Policies ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' Shapes ', ' Smoker ', ' Drug user ', ' Consensus ', ' Knowledge ', ' programs ', ' Investigation ', ' Complex ', ' Source ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' interest ', ' Injection Drug User ', ' Injecting drug user ', ' inner city ', ' Services ', ' preference ', ' Church ', ' experience ', ' skills ', ' Participant ', ' drug market ', ' Agreement ', ' social inequality ', ' outreach ', ' Prevention ', ' social ', ' HIV risk ', ' Regulation ', ' Modeling ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Risk Reduction ', ' Institution ', ' preventing ', ' prevent ', ' Legal ', ' Low income ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' Infrastructure ', ' Research Infrastructure ', ' Epidemiologist ', ' Transmission ', ' transmission process ', ' Principal Investigator ', ' Process ', ' sex ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' socioeconomics ', ' Behavioral ', ' Clinical Services ', ' cost ', ' designing ', ' design ', ' remediation ', ' cost-effective ', ' cost effective ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' analytical tool ', ' addictive disorder ', ' addiction ', ' parent grant ', ' high risk ', ' public health relevance ', ' clinical care ', ' injection drug use ', ' ']",NIDA,UNIVERSITY OF PENNSYLVANIA,R01,2013,376221,0.09809855060978054
"Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study DESCRIPTION (provided by applicant): The overall goal of this project is to address how disproportionate confinement of racial/ethnic minorities-especially African Americans-affects health disparities in the HIV/AIDS epidemic. African Americans comprise only 13% of the general population, but about 40% of incarcerated youth and adults and 50% of new cases of HIV/AIDS. Yet, large multisite national longitudinal studies of HIV/AIDS focus on high- risk samples such as men who have sex with men (MACS), women infected with HIV and other ""at-risk"" females (WIHS), and infected women and their infants (WITS). These studies do not include adolescents, do not sample correctional populations, and do not examine the effect of incarceration on HIV/AIDS. Most studies of incarcerated populations are cross-sectional and provide limited information on the effects of incarceration. To continue to address this key omission in the literature, we propose to extend the Northwestern Juvenile Project, a longitudinal study of 1829 juvenile justice youth, enrolled at age 10-18 years (1172 males, 657 females; 1005 African Americans, 296 non-Hispanic whites, 524 Hispanics, and 4 ""other"" race/ethnicity). Currently, the HIV/AIDS component of the project (RO1 DA022953) includes only a subsample (n=743) and 10-, 11-, 12-, and 13-year follow-up interviews. We now propose to (1) study the entire sample (originally 1829, now 1678); (2) conduct 3 additional annual interviews (14-, 15-, and 16-year follow-ups), at which time participants will be aged 26-34 years; (3) collect official records to cross-validate self-reported data (on STI status, arrests, incarceration history, and services received); (4) test the entire sample for HIV infection, chlamydia, and gonorrhea; and (5) administer a new module on incarceration, release, and re-entry. Participants are re-interviewed whether they are re-incarcerated or back in the community. Using data collected in prior phases and the additional interviews, we will examine patterns of drug use, drug use disorder, HIV/AIDS risk and infection from adolescence (ages 10-17 years) to emerging adulthood (ages 18-24 years) and young adulthood (age 25 and older). Our Specific Aims focus on how incarceration, release, and re-entry (e.g., age[s] incarcerated, number of incarcerations, length of incarcerations, amount of time spent in the community between incarcerations) affect the following: (1) drug use behaviors (including the number and types of substances used, frequency of use, and route of administration) and drug use disorders (onset, persistence, desistance, and recurrence); (2) HIV/AIDS sex risk behaviors (including unprotected anal or vaginal receptive sex and trading sex for drugs) and injection-risk behaviors; (3) prevalence and incidence of HIV infection and other STIs; (4) the relationship between patterns of drug use and disorder and HIV/AIDS risk behaviors, especially how risk and protective factors predict, moderate, and mediate these relationships. This study responds to the initiatives of NIDA, NIAAA, and other NIH institutes to reduce health disparities in HIV/AIDS in minority populations. PUBLIC HEALTH RELEVANCE: Racial/ethnic minorities suffer disproportionately from the HIV/AIDS epidemic and are disproportionately incarcerated. To address health disparities in HIV/AIDS, we must study correctional populations, which increased from nearly 1.8 million in 1997 to over 2.2 million by mid-year 2006. The proposed study will guide public health policy by investigating how incarceration affects the development of substance use and disorder and HIV/AIDS; identifying risk and protective factors that are potentially malleable; identifying points of intervention during key developmental periods; and extending current conceptual models to include incarceration, release, and reentry.","Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study",8435536,R01DA028763,"['Accounting ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Aging ', ' ethanol use disorder ', ' alcohol use disorder ', ' Alcohol Chemical Class ', ' Alcohols ', ' Antibodies ', ' Anal ', ' Anus ', ' Dorsum ', ' Back ', ' Behavior ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cervix Dysplasia ', ' Cervical dysplasia ', ' Chicago ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' Rickettsia trachomae ', ' Chlamydia trachomatis ', ' Concurrent Studies ', ' Cohort Studies ', ' Communities ', ' Crime ', ' Death ', ' Cessation of life ', ' Decision Making ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Electronics ', ' Employment ', ' Epidemic ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Ethnic group ', ' Female ', ' Liberty ', ' Freedom ', ' Goals ', ' Gonococcal Infection ', ' Gonorrhea ', ' Grant ', ' Health ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' health care service ', ' Health Services ', ' Herpesvirus hominis disease ', ' Herpes simplex disease ', ' Herpes Simplex ', ' Herpes Simplex Infections ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' human T lymphotropic virus III ', ' human T cell leukemia virus III ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' HIV-1 ', ' Housing ', ' Illinois ', ' Incidence ', ' Infant ', ' Infection ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Human Papillomavirus ', ' Injections ', ' Injection of therapeutic agent ', ' NAS/IOM ', ' Institute of Medicine ', ' Institute of Medicine (U.S.) ', ' Institutes ', ' Interview ', ' Judgment ', ' Justice ', ' Kinetics ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Length of Stay ', ' Lifestyle ', ' Life Style ', ' Literature ', ' long-term study ', ' Longitudinal Studies ', ' male ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Needles ', ' Neighborhoods ', ' N.gonorrhoeae ', ' N. gonorrhoeae ', ' Gonococcus ', ' Neisseria gonorrhoeae ', ' Prisons ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Recommendation ', ' Records ', ' Recurrent ', ' Recurrence ', ' Research ', ' Risk ', ' Risk Factors ', ' Saliva ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sex Characteristics ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' social support network ', ' Social support ', ' Solutions ', ' statistics ', ' Substance Use Disorder ', ' Survey Instrument ', ' Surveys ', ' great pox ', ' Syphilis ', ' Testing ', ' Time ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Trichomonas Infections ', ' Ulceration ', ' Ulcer ', ' Urine Urinary System ', ' Urine ', ' Vaginal ', ' Vagina ', ' hepatitis virus infection ', ' Viral hepatitis ', ' Woman ', ' Work ', ' County ', ' Syringe Sharing ', ' Needlesharing ', ' Needle Sharing ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Illicit Drugs ', ' Enzyme Linked Immunoassay Immunologic ', ' Enzyme Immunoassay ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Longitudinal Surveys ', ' Mediating ', ' Risk Assessment ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' Social Network ', ' racial/ethnic difference ', ' Area ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' African ', ' drug use ', ' Drug usage ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' disorder onset ', ' disease onset ', ' Onset of illness ', ' liquid ', ' fluid ', ' Liquid substance ', ' Staging ', ' Contracting Opportunities ', ' Contracts ', ' cooking ', ' Research Specimen ', ' Specimen ', ' Life ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Dependence ', ' Event ', ' Oral ', ' Source ', ' Route ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' Injection Drug User ', ' Injecting drug user ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' middle school ', ' Services ', ' urogenital system (genital part) ', ' Genital ', ' Genital system ', ' Surgeon ', ' age group ', ' experience ', ' high school ', ' Participant ', ' health record ', ' Program Announcement ', ' NIH Program Announcements ', ' Self-Report ', ' Patient Self-Report ', ' high risk behavior ', ' deviancy ', ' deviant ', ' General Public ', ' General Population ', ' probation ', ' criminal offender ', ' offender ', ' intravenous drug use ', ' age difference ', ' Academic achievement ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Admission ', ' Admission activity ', ' parole ', ' Modeling ', ' Sampling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Healthy People 2010 ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Length ', ' Jail ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' NIH RFA ', ' Request for Applications ', ' Subgroup ', ' child maltreatment ', ' Childhood maltreatment ', ' Child Abuse and Neglect ', ' enroll ', ' Enrollment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' underserved minority ', ' under-represented minority ', ' Underrepresented Minority ', ' Monitor ', ' Transmission ', ' transmission process ', ' Characteristics ', ' Process ', ' sex ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Permission ', ' Authorization ', ' Authorization documentation ', ' developmental ', ' Development ', ' Heterosexuals ', ' transcription mediated amplification ', ' sexual risk behavior ', ' sex risk ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' national surveillance ', ' Minority ', ' alcohol and other drug ', ' Outcome ', ' cost-effective ', ' cost effective ', ' juvenile justice system ', ' Youth Risk Behavior ', ' Adolescent Risk Behavior ', ' Population ', ' Prevalence ', ' aged ', ' prospective ', ' NIAAA ', ' National Institute on Alcohol Abuse and Alcoholism ', ' innovative ', ' innovate ', ' innovation ', ' eighteen year old ', ' age 18 years ', ' 18 year old ', ' racial/ethnic ', ' racial and ethnic ', ' service utilization ', ' racial and ethnic disparities ', ' high risk ', ' FDA approved ', ' emerging adulthood ', ' surveillance data ', ' surveillance study ', ' screening ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2013,2564234,0.1173319122085367
"Community Vulnerability and Responses to Drug-User-Related HIV/AIDS DESCRIPTION (provided by applicant): This is a competing continuation application for the Community Vulnerability and Responses to Drug-User- Related HIV/AIDS study of why large US metropolitan areas vary over time in their vulnerability to HIV/AIDS among drug users and in their responses-i.e., in policies and programs that may affect the epidemic. Drug use and HIV epidemics change over time. In the last funding period, we showed that HIV prevalence in the 96 largest US metropolitan areas declined among injection drug users (IDUs) from 1992 to 2002, and that the population prevalence of IDUs declined in these areas from 1992 to 2000, but then began to rise again. We also showed that metropolitan areas varied in these trajectories, and that a variety of social and policy forces shaped IDU prevalence, racial disparities in IDU prevalence, HIV prevalence among IDUs, racial disparities in AIDS prevalence among IDUs, drug abuse treatment coverage, and syringe exchange access and coverage. Ominously, our recent analyses indicate that the prevalence of IDUs among youth (aged 15 - 29) has begun to rise. Further, as others have shown, HIV has spread widely among NIDUs (non-injecting users of heroin, cocaine, crack, amphetamines or methamphetamine) in some metropolitan areas. These changes are occurring against the backdrop of an economy that has recently shifted from slow to rapid decline, a shift that will lead to great difficulty in maintaining, let alone expanding, services for drug users. Therefore, the Specific Aims of this proposed continuation are: 1. To describe trends, in the 96 largest US metropolitan areas from 1992 - 2012, in (a) critical epidemiologic outcomes (population prevalence of IDUs and NIDUs, and particularly their prevalence among youth; and, among IDUs, HIV prevalence, late-diagnosis HIV cases, and AIDS incidence and mortality) as well as in (b) the implementation of evidence-based drug- related interventions (drug abuse treatment, syringe exchange, HIV counseling and testing) and (c) non- evidence-based drug-related interventions (incarceration and arrests of drug users). 2. To understand how macro-social contexts (e.g., economic changes, social integration, racial residential segregation) and epidemiologic need affect interventions; how interventions and macro-social contexts together affect epidemiologic contexts; how some interventions (e.g., arrests, incarceration) affect others (e.g., syringe exchange coverage); and how some epidemiologic outcomes (e.g., prevalence of young IDUs) affect others (e.g., HIV prevalence). 3. To develop an integrated theory, using agent based modeling, of how these processes interact and thus what the impacts of various intervention mixes are likely to be in given social contexts. 4. To disseminate estimates, results and theoretical understandings to public health agencies and continue to advise them on how they might respond.   PUBLIC HEALTH RELEVANCE: This project will estimate changes in injection and non-injection drug use, in HIV, AIDS and AIDS mortality rates among injection drug users, and in drug- and HIV-related interventions among drug users, in 96 large metropolitan areas over a 21-year period (1992 - 2012). We will investigate how these epidemics and interventions affect one another, and how macro-contextual factors like economic and social conditions shape them both. We will identify metropolitan areas in which serious drug use, HIV or AIDS epidemics are emerging, and offer state and local health departments and drug agencies the best information available on policies and programs that might reduce these epidemics. Our findings will also help national public health agencies, including the CDC and SAMHSA, and other researchers, plan a mixture of evidence-based programs and policies to reduce the forces that lead to high-risk drug use and the associated HIV and AIDS epidemics.",Community Vulnerability and Responses to Drug-User-Related HIV/AIDS,8454521,R01DA013336,"['Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Benzeneethanamine, alpha-methyl-, (+-)- ', ' Amphetamines ', ' Budgets ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Cities ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Cocaine ', ' Concurrent Studies ', ' Cohort Studies ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' cost effectiveness ', ' Counseling ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Data Analysis ', ' Data Analyses ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Diagnosis ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economical Conditions ', ' Economic Conditions ', ' Economics ', ' Environment ', ' Epidemic ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Fear ', ' Fright ', ' Future ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' HIV Seroprevalence ', ' Incidence ', ' Injections ', ' Injection of therapeutic agent ', ' Health Insurance ', ' Laws ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' long-term study ', ' Longitudinal Studies ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Methamphetamine ', ' Methods ', ' Mexico ', ' Morbidity ', ' Morbidity - disease rate ', ' Mortality ', ' Mortality Vital Statistics ', ' Local Government ', ' New York ', ' Political Activities ', ' Politics ', ' Population Characteristics ', ' human population density ', ' Population Density ', ' Public Health ', ' public health medicine (field) ', ' Punishment ', ' recruit ', ' Recruitment Activity ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sex Characteristics ', ' Social transformation ', ' Social modification ', ' Social Change ', ' Societal Conditions ', ' Social Conditions ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Social Policies ', ' Syringes ', ' Testing ', ' Time ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Unemployment ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' United States Substance Abuse and Mental Health Services Administration ', ' Gender ', ' Measures ', ' Racial Segregation ', ' segregation ', ' Police ', ' free base cocaine ', ' Crack Cocaine ', ' falls ', ' convention ', ' conference ', ' symposium ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Caring ', ' base ', ' racial/ethnic difference ', ' Area ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' Variation ', ' Variant ', ' Medical ', ' racism ', ' insight ', ' Individual ', ' Populations at Risk ', ' Policies ', ' drug use ', ' Drug usage ', ' Progress Reports ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Needle-Exchange Programs ', ' Funding ', ' Shapes ', ' Drug user ', ' Knowledge ', ' Life ', ' Insurance Status ', ' Insurance Coverage ', ' programs ', ' Distant ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' Country ', ' Application Context ', ' contextual factors ', ' Injection Drug User ', ' Injecting drug user ', ' Services ', ' experience ', ' social integration ', ' AIDS diagnosis ', ' metropolitan ', ' Heroin Users ', ' Prevention program ', ' social movement ', ' model-based simulation ', ' models and simulation ', ' Categories ', ' Prevention ', ' social ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' Modeling ', ' response ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' highly active anti-retroviral therapy ', ' HAART ', ' Highly Active Antiretroviral Therapy ', ' HIV diagnosis ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Address ', ' Data ', ' Resolution ', ' International AIDS ', ' Monitor ', ' Transmission ', ' transmission process ', ' trend ', ' Process ', ' developmental ', ' Development ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' Foreclosure ', ' Outcome ', ' Population ', ' Prevalence ', ' aged ', ' Evidence based program ', ' racial/ethnic ', ' racial and ethnic ', ' comparative ', ' racial and ethnic disparities ', ' high risk ', ' evidence base ', ' injection drug use ', ' ']",NIDA,"NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.",R01,2013,575955,0.18352211047329467
"Stress and Drug Use Vulnerability in the African American Community     DESCRIPTION (provided by applicant): The impacts that drug addictions have on health disparities that adversely affect African Americans are grossly understudied. While there is strong evidence linking drug abuse to poor health and problem behaviors in the African American community, the progression of drug abuse is inconsistent (i.e., relatively late initiation and heavy use in the 30s) with national norms and remains unclear. Exposure to chronic stress and the subsequent activation of the hypothalamic-pituitary-adrenal (HPA) axis has been connected to drug addictions and poor health outcomes. This association is of particular importance since residents in these communities are exposed to many of the risk factors associated with the onset of drug abuse: familial risk, deprived social environment, unemployment, substandard education, low-to-no socioeconomic status, and enduring exposure to experiences of racism and discrimination. Repeated exposure to environmental stressors will lead to 'wear-and-tear' on the body's regulatory system and have profound implications on HPA functioning and the subsequent risk of developing an addiction. This study will pursue three primary aims: (1) Investigate HPA reactivity to acute stress as a predictor of current drug use severity. (2) Investigate trajectories of HPA regulation (level and circadian rhythm) as a predicto of drug use vulnerability across time. (3) Investigate delay discounting as a moderator between trajectories of HPA regulation and drug use vulnerability across time. This study will enroll 350 African American adults (ages 18-21) who reside in the southeastern U.S. and utilize a prospective longitudinal research design that consists of a laboratory assessment involving the Trier Social Stress Test, three in-home assessments that include clinical interviews and behavioral tasks, and six internet assessments that track drug use and related risk factors across a 2-year period. Primary independent variables include environmental stressors, stress-related biomarkers (i.e., salivary cortical, salivary DHEA, heart rate variability, and galvanic skn resistance), and delay discounting. Primary dependent variables include drug use, severity of drug use disorders, and drug use consequences. This study is highly innovative for three primary reasons: (1) A longitudinal research design will be used for the first time to investigate trajectories of HPA regulation as a predictor of drug use vulnerability; (2) The use of multiple indicators of the stress regulatory system, clinical interviews, and a novel behavioral task provides a more nuanced understanding of the research aims; and (3) This study focuses on an understudied population that suffers from drug-related health disparities, but are rarely included in cutting edge laboratory research. It is envisioned that this approach will uncover latent-curve trajectories of stress deregulation as a predictor of drug use vulnerability in this population. Findings from this study will identify causal mechanisms of drug addictions that will advance theory, research, prevention, and treatments aimed at addressing this growing public health problem.         PUBLIC HEALTH RELEVANCE: The development of drug abuse in the African American community is often characterized by oversimplified models that are rooted in research studies that rarely include African Americans. This study will identify mechanisms that influence drug use vulnerability in at-risk African American adults who reside in the southeastern U.S. Such research is needed to develop socially and culturally informed prevention and treatment programs aimed at reducing drug-related health disparities that continue to plague African Americans.            ",Stress and Drug Use Vulnerability in the African American Community,8422295,R01DA034739,"['Cultural Assimilation ', ' Acculturation ', ' suprarenal gland ', ' Adrenals ', ' Adrenal Glands ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Belief ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Circadian Rhythms ', ' Communities ', ' Crime ', ' Death ', ' Cessation of life ', ' Therapeutic Dehydroepiandrosterone ', ' Prasterone ', ' Dehydroisoandrosterone ', ' DHEA ', ' Androstenolone ', ' Androst-5-en-17-one, 3-hydroxy-, (3beta)- ', ' 5-Androsten-3-beta-hydroxy-17-one ', ' 3beta-Hydroxyandrost-5-en-17-one ', ' dehydroepiandrosterone ', ' Discrimination ', ' Cognitive Discrimination ', ' Discrimination (Psychology) ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Downregulation ', ' Down-Regulation (Physiology) ', ' Down-Regulation ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economics ', ' Education ', ' Educational aspects ', ' Au element ', ' Gold ', ' Health ', ' Health behavior ', ' Therapeutic Hydrocortisone ', ' Proctocort ', ' Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)- ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Hydrocortisone ', ' hypothalamic ', ' Hypothalamus ', ' Hypothalamic structure ', ' Incidence ', ' Interview ', ' Laboratories ', ' Laboratory Research ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Mortality ', ' Mortality Vital Statistics ', ' Neighborhoods ', ' pilot study ', ' Pilot Projects ', ' Pituitary Nervous System ', ' Pituitary ', ' Hypophysis Cerebri ', ' Hypophysis ', ' Pituitary Gland ', ' Yersinia pestis disease ', ' Plague ', ' Psychopharmaceuticals ', ' Psychoactive Drugs ', ' Psychoactive Compound ', ' Psychoactive Agents ', ' Psychotropic Drugs ', ' Public Health ', ' public health medicine (field) ', ' recruit ', ' Recruitment Activity ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Rewards ', ' Risk ', ' Risk Factors ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Stress ', ' Survey Instrument ', ' Surveys ', ' Time ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Unemployment ', ' violent behavior ', ' violent ', ' Violence ', ' Measures ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Illicit Drugs ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' improved ', ' Left ', ' Clinical ', ' racism ', ' Link ', ' mental ', ' Psyche structure ', ' disability ', ' Stimulus ', ' Spiritualities ', ' Spirituality ', ' Recovery ', ' Rural ', ' drug use ', ' Drug usage ', ' root ', ' Plant Roots ', ' Funding ', ' behavioral problem ', ' Problem behavior ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Exposure to ', ' Severities ', ' Salivary ', ' Home ', ' Home environment ', ' LOINC Axis 4 System ', ' System ', ' environmental stressor ', ' experience ', ' hypothalmus-pituitary-adrenal axis ', ' hypothalamic-pituitary-adrenal (HPA) axis ', ' hypothalamic-pituitary-adrenal axis ', ' novel ', ' Prevention Research ', ' Prevention program ', ' treatment program ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Impulsivity ', ' acute stress ', ' Regulation ', ' Modeling ', ' response ', ' theories ', ' health disparities ', ' health disparity ', ' Address ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Chronic stress ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' enroll ', ' Enrollment ', ' developmental ', ' Development ', ' Behavioral ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' Clinical assessments ', ' Outcome ', ' discounting ', ' Population ', ' prospective ', ' Trier Social Stress Test ', ' innovative ', ' innovate ', ' innovation ', ' resistant ', ' Resistance ', ' addictive disorder ', ' addiction ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' heart rate variability ', ' constriction ', ' longitudinal design ', ' burden of injury ', ' ']",NIDA,UNIVERSITY OF HOUSTON,R01,2013,442781,0.21249262221003148
"Couple HIV prevention for drug-involved male offenders: An Effectiveness Trial     DESCRIPTION (provided by applicant): The proposed study responds to PA-09-236 entitled ""HIV/AIDS, Drug Use, and Vulnerable Populations."" This study is a randomized controlled trial (RCT) that will rigorously evaluate the implementation, effectiveness and cost-effectiveness of a couple-based integrated HIV/STI and drug abuse prevention intervention (Connect II) with drug-involved male offenders charged with misdemeanors and their primary female sexual partners, implemented by frontline providers in Criminal Court, Community Court or Probation (CCP) sites in the Bronx, NY, compared to CCP standard treatment of care services (TAU). The primary outcomes are biologically confirmed sexually transmitted infections (STIs) and self-reported condom use. This study will yield important data on implementation factors associated with effectiveness of the proposed intervention in real world resource-constrained criminal justice settings. The proposed CCP study sites are located in the South Bronx, the poorest Congressional District in the U.S. with 96% of residents identifying as Black or Latino. The South Bronx has an HIV prevalence rate of 2.6%. Research has found that 12% of men on probation in New York City are HIV positive. Though the criminal justice system is recognized as the epicenter of the epidemic in the U.S., few, if any, HIV prevention interventions have been developed for the huge number of male offenders under community supervision who represent 90% of the corrections population. No HIV/STI prevention services are currently provided at the proposed CCP sites. The proposed intervention is designed to address this critical gap in services. Connect II was found to be efficacious among drug-involved couples in reducing risky drug and sexual behaviors and drug use. In the proposed study we aim to advance the knowledge of implementation science by testing the effectiveness and cost-effectiveness of Connect II delivered by frontline providers in the real world settings of CCP sites with 240 drug-involved male offenders and their female partners (N=480 participants). Eligible couples will be randomly assigned to either (1) a 4-session Connect II delivered to both partners together + TAU delivered to male participant alone, or (2) a TAU control condition delivered to the male participant. Repeated assessments will occur at baseline and 3, 6, and 12-months post intervention. The study will be conducted by Dr. Nabila El-Bassel, Dr. Louisa Gilbert, and an investigative team from Columbia University in collaboration with Michael Rempel from the Center for Court Innovation and the New York City Department of Probation. If found to be effective, Connect II may be scaled up in community criminal justice settings nationwide to curb the spread of HIV/STIs and to reduce HIV disparities in heavily impacted communities like the South Bronx.         PUBLIC HEALTH RELEVANCE:  This study addresses the significant public health threat of HIV and other STIs among drug- involved male offenders under community supervision and their female partners. This study will evaluate the implementation, effectiveness and cost-effectiveness of a brief couple-based HIV and drug abuse prevention intervention for drug-involved male offenders and their female partners delivered by frontline providers in Criminal/Community Court and Probation sites in the South Bronx, the poorest congressional district in the U.S. If found to be effective, the proposed brief intervention may be scaled up to community criminal justice sites nationwide to curb the spread of HIV/STIs and reduce HIV disparities.                    ",Couple HIV prevention for drug-involved male offenders: An Effectiveness Trial,8517073,R01DA033168,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Subsaharan Africa ', ' Sub-Saharan Africa ', ' Africa South of the Sahara ', ' Charge ', ' Client ', ' Communities ', ' cost effectiveness ', ' Couples ', ' Drug Utilization ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Female ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Health Services Research ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' Institutes ', ' male ', ' Manuals ', ' Medicine ', "" men's "", ' men ', ' Methods ', ' New York City ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' sex partner ', ' Sexual Partners ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Supervision ', ' Testing ', ' Time ', ' Universities ', ' Work ', ' Treatment outcome ', ' Criminal Justice ', ' Latino ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Caring ', ' base ', ' court ', ' improved ', ' Site ', ' drug use ', ' Drug usage ', ' Collaborations ', ' Letters ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Knowledge ', ' Scientist ', ' LOINC Axis 4 System ', ' System ', ' psychosocial ', ' Outcome Study ', ' Prevent infection ', ' Infection prevention ', ' Consult ', ' Services ', ' professor ', ' condoms ', ' Participant ', ' prevention service ', ' recidivism ', ' Self-Report ', ' Patient Self-Report ', ' Prevention ', ' probation ', ' criminal offender ', ' offender ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' Modeling ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' Provider ', ' prevent drug use ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' Effectiveness ', ' Address ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Cost Effectiveness Analysis ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Subgroup ', ' Characteristics ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' post intervention ', ' effectiveness trial ', ' cost ', ' efficacy research ', ' designing ', ' design ', ' probationer ', ' scale up ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' demographics ', ' implementation science ', ' public health relevance ', ' community setting ', ' evidence base ', ' primary outcome ', ' secondary outcome ', ' standard treatment ', ' standard care ', ' ']",NIDA,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2013,648645,0.06416710644856985
"Drug and HIV Risk Among Latino Immigrant Day Laborers in Baltimore     DESCRIPTION (provided by applicant): Latino immigrant day laborers (LIDLs) are at heightened risk for drug abuse and dependence as a result of their unique social, situational and contextual circumstances. Low rates of access and utilization of drug treatment and health services and the high mobility of this primarily single and undocumented male population is of great  public health relevance due to their potential to act as a ""bridge for infection"" in the spred of HIV and other blood borne pathogens within the Latino community. Yet data regarding the characteristics of this hard-to-reach population and their involvement in drug and sexual risk behavior is sparse. Even less is known about the experiences of LIDLs that settle in ""new settlement destinations"" or areas without a prior presence of a Latino community. For LIDLs who migrate to new settlement cities, exposure to risk factors may be even higher due to lack of family and conventional sex partners. The emphasis of this study is on how the context of a new immigrant settlement as well as individual and migration factors impact the drug use patterns of three groups of LIDLs: premigration drug initiators (current drug users who initiated use before migration), postmigration drug initiators (current drug users who initiated use in the U.S.) and non-drug users (no drug use in the last year). Comparing patterns of use between these three groups will identify distinct risk and protective factors that have implications for use as interventional components. Baltimore is an optimal context to examine drug initiation and use among LIDLs as Latinos represent the fastest growing ethnic group in the city and have experienced nearly doubling of HIV/AIDS incidence in the last decade. Using social ecology theory, this social epidemiological study will identify, recruit and interview 75 LIDLs. Respondents will be recruited from identified day labor sites in Baltimore. Using an ethnographic methodological approach, an adaptive sampling methodology will be implemented with elements of field intensive outreach, Rapid Assessment for Response and Evaluation, and targeted snowball sampling. Data will be collected from three groups of LIDLs: premigration drug initiators (n=25); postmigration drug initiators (n=25); and, non-drug users (n=25) (no drug use in the last year). Findings regarding the diffusion of HIV-related risks as well as drug practices may challenge traditional modes of treatment and shift clinical practice paradigms by indicating important points for prevention and intervention with this understudied population. To further understand these drug use patterns and adverse health behaviors, this study will: 1.Characterize qualitatively the drug use (initiation, patterns and practices) and drug and sexual risk behaviors among male LIDLs in Baltimore; 2. Identify and provide a detailed qualitative description of risk and protective factors associated with individual characteristics (background characteristics, perceived discrimination, acculturative stress) and migration factors among male LIDLs in Baltimore; 3. Document the unique contextual factors within a new immigrant settlement community that contribute to the emergence of adverse health related drug and sexual risk behavior.        PUBLIC HEALTH RELEVANCE: The public health significance of this proposed research lies in the target population - the potential of Latino immigrant day laborers to act as a ""bridge for infection"" in the spread of HIV and other blood-borne pathogens within the Latino community, including non-drug using populations. Data will also contribute significantly to the development of targeted interventions and public health programming for this mobile population.            ",Drug and HIV Risk Among Latino Immigrant Day Laborers in Baltimore,8581762,R03DA034096,"['epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Dorsum ', ' Back ', ' Baltimore ', ' California ', ' Cities ', ' Communities ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Diffusion ', ' Disadvantaged ', ' Discrimination ', ' Cognitive Discrimination ', ' Discrimination (Psychology) ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Utilization ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environmental Science ', ' Ecology ', ' Elements ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Ethnic group ', ' Family ', ' Health ', ' Health behavior ', ' health care service ', ' Health Services ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Immigrations ', ' In-Migration ', ' Incidence ', ' Infection ', ' Interview ', ' Literature ', ' male ', ' Method LOINC Axis 6 ', ' Methodology ', ' Neighborhoods ', ' Professional Postions ', ' Jobs ', ' Occupations ', ' Poverty ', ' Public Health ', ' public health medicine (field) ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Risk ', ' Risk Factors ', ' Risk-Taking ', ' sex partner ', ' Sexual Partners ', ' Stress ', ' Target Populations ', ' Texas ', ' Travel ', ' United States ', ' Work ', ' Destinations ', ' problem drinking ', ' problem alcohol use ', ' hazardous alcohol use ', ' ethanol abuse ', ' alcohol problem ', ' Alcohol abuse ', ' Illicit Drugs ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Latino ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' ethnographic ', ' Ethnography ', ' Site ', ' Area ', ' Diffuse ', ' Bloodborne Pathogens ', ' Blood-Borne Pathogens ', ' Evaluation ', ' residence ', ' Individual ', ' drug use ', ' Drug usage ', ' Respondent ', ' Immigrant ', ' Exposure to ', ' Contracting Opportunities ', ' Contracts ', ' Drug user ', ' Nature ', ' Life ', ' programs ', ' Dimensions ', ' Pattern ', ' Country ', ' Application Context ', ' contextual factors ', ' experience ', ' knowledgebase ', ' knowledge base ', ' Negotiation ', ' Negotiating ', ' Mediation ', ' outreach ', ' social ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' Sampling ', ' response ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Low income ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Data ', ' High Prevalence ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' trend ', ' Characteristics ', ' developmental ', ' Development ', ' sexual risk behavior ', ' sex risk ', ' working males ', ' male workers ', ' working men ', ' Outcome ', ' Population ', ' migration ', ' high risk ', ' public health relevance ', ' nondrug ', ' non-drug ', ' clinical practice ', ' ']",NIDA,UNIVERSITY OF MARYLAND BALTIMORE,R03,2013,109369,0.16976440946954371
"Comparative Effectiveness Research Diffusion and Mental Health Care Disparities     DESCRIPTION (provided by applicant): Comparative Effectiveness Research (CER) compares benefits and risks of different treatments. However, little is known about the impact of large-scale CER implementation as conceived in the 2010 Affordable Care Act (ACA) on equity in health care across racial/ethnic groups. Identifying the influence of FDA risk warnings on disparities in psychotropic drug use provides a platform to understand how CER will influence disparities in certain situations. Disparity methods have typically not taken into account specific recommendations and warnings on effectiveness and safety. With the advent of the ACA and continued concern over persistent disparities, it is imperative that disparities research continues to evolve to incorporate lessons learned from CER.  We capitalize upon time trends in warnings and advisories to understand disparities in diffusion with the intention of identifying policies tht might avert the negative equity consequences of incorporating CER into routine practice. Specifically, we 1) Track changes in antidepressant use among youth and antipsychotic drug use among youth and adults by racial/ethnic group as they are influenced by CER-generated risk warnings and advisories; 2) Assess whether specific information in FDA warnings influenced disparity trends in a) treatments recommended by CER-generated evidence (e.g., fluoxetine use and metabolic screening for antipsychotic users); and b) psychotropic drug use that is potentially harmful (e.g., olanzapine use); and 3) Identify how provider characteristics an HMO enrollment act as mechanisms that underlie the differential diffusion of CER via health risk warnings.  We implement the Institute of Medicine (IOM) definition of healthcare disparities in order to capture trends in disparities over time, overlaying timelines of warnings and recommendations related to antidepressant and antipsychotic drugs. We adapt IOM methods by decomposing disparities in overall drug use into disparities in specific categories of use mentioned by FDA warnings as carrying particular risk or benefit. If we find racial/ethnic disparities in diffusion of risk warnings and advisories, this suggests policymakers should focus on improving uptake of CER among minorities. If we identify that certain providers and HMO membership influences disparities in diffusion, this will lead to recommendations for policymakers of actionable policies to avert the negative equity consequences of incorporating CER into routine practice.         PUBLIC HEALTH RELEVANCE: In this proposed project, we intend to examine whether specific information in FDA warnings influenced disparity trends in psychotropic drug use and mental health care and to identify how provider characteristics and HMO enrollment act as mechanisms that underlie the differential diffusion of CER via health risk warnings. Identifying the influence of FDA risk warnings on trends in psychotropic drug use and related health care provides a platform to understand how CER will influence disparities and will help us to assess whether information regarding the risks and benefits of medications are being equitably disseminated. Our examination of how an increased reliance on CER will likely influence disparities in treatment after health care reform will provide policymakers with actionable information that might avert the negative equity consequences of incorporating CER into routine practice.            ",Comparative Effectiveness Research Diffusion and Mental Health Care Disparities,8578898,R01HS021486,[''],AHRQ,CAMBRIDGE HEALTH ALLIANCE,R01,2013,228715,0.13187221068872973
"Phase 2 Study of Hemin for Treatment and Prevention of Porphyria Attacks  PROJECT ABSTRACT/SUMMARY Hemin for injection (Panhematin"", Lundbeck) was the first drug approved under the Orphan Drug Act. Its approval in 1971 for the amelioration of acute attacks of acute intermittent porphyria was based on published reports of biochemical efficacy and evident benefit in numerous individual cases and case series rather than adequately powered, randomized, controlled studies. Therefore its efficacy has remained in question especially in an era of evidence-based medicine. Moreover, the narrow approved indications (only women with cyclic attacks), a requirement for an initial trial of glucose loading, a wide dose range of 1-4 mg/kg, and a method for reconstitution of the lyophilized product with sterile water have impaired its clinical usefullness. It is increasingly recognized that additional clinical studies are needed to address these longstanding issues and considerable disparities between product labeling and current expert recommendations. A Phase 2 study to be conducted by at least 5 centers in the Porphyrias Consortium (supported by NIDDK and part of the NIH Rare Diseases Clinical Research Network - RDCRN) aims to improve the evidence base for this treatment for acute porphyric attacks. This randomized, blinded placebo-controlled study will compare treatment with Panhematin"" 4 mg/kg daily plus glucose for 4 days to treatment with glucose alone in 30-40 patients with acute attacks of porphyria. The consortium investigators have experience in conducting controlled studies in porphyrias, including studies in patients with acute attacks. The RDCRN supports development of study materials, web-based data entry, data warehousing, and monitoring at multiple study sites, and has established a data and safety monitoring board. The manufacturer has committed drug for the study. The American Porphyria Foundation, a longstanding and effective patient support group that is also part of the Consortium, will assist with patient recruitment. Infrastructure at all sites will include facilities of NIH-funded Clinical and Translational Science Awards. An investigator IND application (IND#13,929) has been approved. An analgous study is being developed to assess the use of Panhematin"" for prevention of porphyric attacks, since there is even less evidence for this use of the drug. Additionally, single-patient controlled crossover studies are planned to address the problem that response to a preventive regimen is variable, unpredictable and difficult to assess for individual patients. This project will provide the first high quality evidence for efficacy and safety of the drug viewed as the most important available treatment for acute attacks of porphyria.  PROJECT NARRATIVE Hemin for injection (Panhematin"", Lundbeck) was the first drug approved under the Orphan Drug Act, but its efficacy has remained in question because controlled studies are lacking. A randomized, blinded controlled study will compare treatment with Panhematin"" 4mg/kg daily plus glucose for 4 days to treatment with glucose alone in 30-40 patients with acute attacks of porphyria, and will be conducted within the Porphyrias Consortium. This revised project now proposes an additional analogous controlled study on the use of Panhematin"" to prevent attacks and studies of efficacy in individual patients, and will provide high quality evidence for efficacy and safety of the drug viewed as the most important available treatment for acute attacks of porphyria.",Phase 2 Study of Hemin for Treatment and Prevention of Porphyria Attacks,8569008,R01FD003720,[''],FDA,UNIVERSITY OF TEXAS MED BR GALVESTON,R01,2013,342601,0.06934508470594906
"""African American Offenders: Drug Use, Mental Health and HIV Risk""     DESCRIPTION (provided by applicant):  The primary goal of this K08 award is to further develop a productive independent research career in drug abuse research. The training and career development plan will enhance Dr. Stevens-Watkins's research experience in primary data collection with prisoners focused on drug use, mental health, and HIV thus resulting in the clarification of the specific aims of an R01 submission in years 4 and 5. The proposed training objectives are: (1) to receive training in the epidemiology of drug abuse, mental health, and HIV as they relate to health disparities among African Americans; (2) to further develop expertise in research with special populations, biostatistics, and advanced quantitative analyses including non-linear, categorical models, and structural equation modeling; (3) to use the data collected in the proposed research plan as pilot data for an R01 research proposal. The specified training goals are aligned with the research aims and compliment the clinical experience of the candidate. Dr. Stevens-Watkins will be sponsored by her established mentors, Drs. Carl Leukefeld and Carrie Oser, both with expertise in drug abuse and HIV research. Of high significance, HIV has recently been termed a ""crisis"" in the African American community. The overall goal of the proposed research plan is to better understand the complex and dynamic relationship between drug use, mental health, and HIV risk among African American male prisoners nearing community re-entry. The specific aims are (1) to explore drug use, symptoms of depression and anxiety, and HIV risk behaviors among African American male inmates by conducting a thorough literature review and devising an analytical model using biostatics multivariate analytic techniques with available data; (2) to identify prevalence, incidence, and predictors of drug use disorders, anxiety, depressive disorders and HIV sexual risk behaviors among 205 incarcerated African American men; (3) to examine the knowledge, patterns, and perceived cultural and community barriers to utilizing individual and health resources and their relationship to substance abuse recovery and HIV risk behaviors among 205 African American men upon release from prison. Baseline data will be collected in prison and follow-up data collection will occur when participants have been released in the community after 3-months. The proposed research plan will offer HIV testing and counseling to an at-risk population that has historically been difficult to engage in research and HIV testing, subsequently significantly impacting public health by possibly preventing the spread of HIV. The candidate's immediate career goals include published manuscripts and R01 funding by the end of K08 funding, with an ultimate career goal of becoming an independent clinical drug abuse researcher. This proposal includes an outstanding mentoring team, as well as a feasible training and research plan utilizing resources offered by both Spalding University and the University of Kentucky.           The proposed project has significant public health implications for reducing the spread of HIV among the African American community by offering testing and by targeting men exiting prison, re-entering the community. The proposed project will generate an improved understanding of the complex relationship between drug use, mental health, and HIV risk among an at-risk group.                        ","""African American Offenders: Drug Use, Mental Health and HIV Risk""",8463155,K08DA032296,"['Anxiety ', ' Award ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Communities ', ' Counseling ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' depression ', ' Mental Depression ', ' Depressive disorder ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Goals ', ' Health ', ' Health Resources ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Housing ', ' Incidence ', ' Interview ', ' Kentucky ', ' male ', "" men's "", ' men ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Mental Hygiene Services ', ' Mental Health Services ', ' Mentors ', ' Methods ', ' Structural Models ', ' Pre-Post Tests ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisoner ', ' Prisons ', ' Psychologist ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Proposals ', ' Research Resources ', ' Resources ', ' Risk ', ' social support network ', ' Social support ', ' Testing ', ' Universities ', ' Writing ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' depressive symptoms ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' psychological ', ' psychologic ', ' racism ', ' Training ', ' Individual ', ' Recovery ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Populations at Risk ', ' Development Plans ', ' drug use ', ' Drug usage ', ' Funding ', ' Review Literature ', ' Knowledge ', ' Life ', ' Complex ', ' Protocol ', ' Protocols documentation ', ' Pattern ', ' Techniques ', ' Equation ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' experience ', ' impression ', ' Special Population ', ' named group ', ' Manuscripts ', ' Participant ', ' criminal offender ', ' offender ', ' intravenous drug use ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' HIV risk ', ' Modeling ', ' career development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' correctional system ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' preventing ', ' prevent ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Symptoms ', ' Data ', ' Research Training ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' sexual risk behavior ', ' sex risk ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' community re-entry ', ' community reentry ', ' Outcome ', ' Prevalence ', ' drug detection ', ' drug testing ', ' high risk ', ' public health research ', ' ']",NIDA,SPALDING UNIVERSITY,K08,2013,1630,0.1550195541722535
"Navigator Enhanced Case Management for Jail Inmates    DESCRIPTION (provided by applicant): Each year, there are over 600 unduplicated HIV-infected persons incarcerated in the San Francisco jail and almost two-thirds released with HIV-focused discharge planning were reincarcerated within 1 year. More than half of HIV-infected jail inmates are diagnosed with mental health conditions severe enough to require medication and a similar proportion report substance abuse disorders at the time of detention. While some community-based services exist, there remains a critical need exists to improve linkages to care and adherence to care plans for HIV-infected adults as they move between community and jai. An effective service delivery model used in similar high-needs populations exists, but has not been tested with HIV-infected drug users leaving jails - Navigator case management. Base on harm reduction, motivational interviewing and general social work principles, this model uses assertive community treatment and a highly proactive approach to facilitate adherence to a comprehensive care plan designed to address a client's multiple needs. Case managers work with paraprofessional peer navigators to help clients make better use of available resources, more effectively communicate with providers, sustain care over time and successfully connect with multiple service provider sectors. In this study, we propose to tailor this approach to meet the needs of HIV-infected individuals with substance abuse and mental health issues, pilot test the intervention and assessment procedures and then conduct a randomized study in which 360 HIV-infected men and women leaving jail. Specifically, participants will receive either Navigator case management delivered by the non-profit San Francisco Pre-Trial Diversion project or the standard of care currently provided to transitioning inmates, 90- days of as-needed case management provided by the San Francisco Department of Public Health's Forensic AIDS Project. We will test the effectiveness of the intervention in reducing sexual and drug-related HIV transmission risk, increasing HIV medication adherence, reducing drug dependence and reducing reincarceration. Finally, we will characterize both the Navigator and Forensic AIDS Project intervention processes and conduct exploratory analyses of the mediators of HIV transmission risk and risk reduction and HIV-related adherence among HIV+ individuals leaving jail. Our study is highly innovative because no interventions exist that are proven effective with this population - HIV-infected individuals with drug use and mental health issues. This study will also contribute to the field of HIV prevention by incorporating risk reduction counseling alongside more traditional case management support services.  PUBLIC HEALTH RELEVANCE: HIV-infected adults incarcerated in the United States criminal justice system are predominantly active drug users and disproportionately people of color. The complex interplay of poverty, race, lack of education and sanctions--rather than treatment--for addictions reinforces returns to the criminal justice system and pervasive health disparities for HIV-infected individuals. Underlying behaviors that lead to repeated incarceration closely correlate with behaviors that are associated with HIV transmission and increased morbidity and mortality from HIV. In drug addicted adults, recidivism is driven by drug relapse and illegal activities associated with drug use, failure to engage and remain in mental health treatment or failure to break free from social instability in the form of homelessness and joblessness. This study proposes to assess whether a method of case management proven effective for similar populations can ensuring services to successfully and permanently break the cycle of incarceration, drug abuse and HIV transmission risk behavior among HIV-infected individuals leaving jail.            ",Navigator Enhanced Case Management for Jail Inmates,8469451,R01DA027209,"['Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Behavior ', ' Client ', ' Color ', ' Communities ', ' comprehensive care ', ' Comprehensive Healthcare ', ' Comprehensive Health Care ', ' Counseling ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Forensics ', ' Forensic Medicine ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Housing ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', "" men's "", ' men ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Morbidity ', ' Morbidity - disease rate ', ' Mortality ', ' Mortality Vital Statistics ', ' Persons ', ' Poverty ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisoner ', ' Prisons ', ' Public Health ', ' public health medicine (field) ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Relapse ', ' Research Resources ', ' Resources ', ' Risk ', ' San Francisco ', ' Social Work ', ' Social Service ', ' Social work (field) ', ' Societies ', ' Testing ', ' Time ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Unemployment ', ' United States ', ' Woman ', ' Work ', ' County ', ' Case Management ', ' Criminal Justice ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Vent ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Caring ', ' base ', ' improved ', ' Procedures ', ' Left ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' Ensure ', ' failure ', ' FLR ', ' Failure (biologic function) ', ' unhoused ', ' homeless ', ' Homelessness ', ' Individual ', ' drug use ', ' Drug usage ', ' Drug user ', ' programs ', ' Complex ', ' LOINC Axis 4 System ', ' System ', ' Viral ', ' meetings ', ' Services ', ' Participant ', ' peer ', ' Harm Minimization ', ' Harm Reduction ', ' recidivism ', ' high risk behavior ', ' motivational interview ', ' motivational enhancement therapy ', ' Case Management Nurse ', ' Care Manager ', ' Case Manager ', ' drug addict ', ' Reporting ', ' social ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Risk Reduction ', ' Provider ', ' health disparities ', ' health disparity ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Jail ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Adherence ', ' Adherence (attribute) ', ' Effectiveness of Interventions ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Transmission ', ' transmission process ', ' Process ', ' medication adherence ', ' medication compliance ', ' cost ', ' drug relapse ', ' reincarceration ', ' designing ', ' design ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' community based service ', ' addictive disorder ', ' addiction ', ' public health relevance ', ' standard of care ', ' treatment adherence ', ' efficacy testing ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2013,409711,0.09246530017608598
"Factors for enhanced neurotoxicity in methamphetamine abuse in HIV infection    DESCRIPTION (provided by applicant): This application is submitted in response to PAR-09-011 Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) requested by the National Institute on Drug Abuse (NIDA). This proposed research program is timely since it focuses on two ofthe major health disparity issues in Hawaii, namely, methamphetamine abuse and HIV infection. Recent surveys indicate that Native Hawaiians or other Pacific islanders have the highest rate of methamphetamine use among persons aged 12 or older in the United States. Although HIV/AIDS infection rate is relatively low in Hawaii compared to other major metropolis, the rates are increasing among Hawaiians. This DIDARP will include two primary and one pilot research projects that will focus on mechanisms and factors that might enhance neurotoxicity associated with methamphetamine of HIV. We aim to enhance the capacity for drug abuse research at UH by creating this small translational research team. This group will take advantage and build on the expertise of the few but outstanding existing clinical drug abuse and HIV researchers and basic scientists. We aim to enable UH to develop a strong clinical and translational drug abuse research program. To complement these projects, we additionally propose training and career development activities that wil offer exciting opportunities for DIDARP investigators and others at UH through the Administrative and Training Core. The Faculty in the Core will provide guidance and mentorship for these junior faculty and graduate students, through infrastructure support, educational courses, seminars, and a dedicated DIDARP website, We have obtained institutional support for two additional graduate students for the program. We also have recruited 4 distinguished External Advisory Committee members with expertise related to the proposed research; each has enthusiastically agreed to provide their advice and letter of support for the development of this DIDARP at UH.  PUBLIC HEALTH RELEVANCE (See instructions); The current proposal attempts to strengthen drug abuse and HIV research capacity by developing translational research teams at the University of Hawaii, and to train junior investigators and students in drug abuse and HIV research.         ",Factors for enhanced neurotoxicity in methamphetamine abuse in HIV infection,8417730,R24DA027318,"['Abbreviations ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' aminoacid ', ' Amino Acids ', ' Animals ', ' Theriacs ', ' Antidotes ', ' anti-oxidant ', ' Antioxidants ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Intracranial Central Nervous System Disorders ', ' Intracranial CNS Disorders ', ' Encephalon Diseases ', ' Brain Disorders ', ' Brain Diseases ', ' Transporter Protein ', ' Transport Proteins ', ' Carrier Proteins ', ' Cells ', ' Complement Proteins ', ' Complement ', ' Terminal Deoxyribonucleotidyltransferase ', ' Terminal Deoxyribonucleotidyl Transferase ', ' Terminal Deoxynucleotidyltransferase ', ' Terminal Deoxynucleotidyl Transferase ', ' Terminal Addition Enzyme ', ' EC 2.7.7.31 ', ' Desoxynucleotidyltransferase ', ' Desoxynucleotidyl Transferase ', ' Deoxynucleotidyltransferase ', ' Deoxynucleotidyl Transferase ', ' DNA Nucleotidylexotransferase ', ' Hydroxytyramine ', ' 4-(2-Aminoethyl)-1,2-benzenediol ', ' 3,4-Dihydroxyphenethylamine ', ' Dopamine ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' balance function ', ' balance ', ' Equilibrium ', ' Faculty ', ' Family ', ' Glucose-6-Phosphate Dehydrogenase ', ' EC 1.1.1.49 ', ' Glucosephosphate Dehydrogenase ', ' gamma-L-Glutamyl-L-Cysteinylglycine ', ' gamma-L-Glu-L-Cys-Gly ', ' Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)- ', ' Glutathione ', ' glutathione peroxidase ', ' 2-amino-1,7-dihydro-6H-purin-6-one ', ' 2-Amino-6-Hydroxypurine ', ' Guanine ', ' Hawaii ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Hydroperoxide ', ' Hydrogen Peroxide (H2O2) ', ' H2O2 ', ' Hydrogen Peroxide ', ' Hypoxanthines ', ' Infection ', ' Tyrosine Iodinase ', ' Thyroperoxidase ', ' Thyroid Peroxidase ', ' Monoiodotyrosine Deiodinase ', ' Monodeiodinase ', ' Iodotyrosine Deiodinase ', ' Iodotyrosine Deiodase ', ' Iodoperoxidase (Heme Type) ', ' Iodinase ', ' EC 1.11.1.8 ', ' Deiodinase ', "" 5'-Deiodinase "", ' Iodide Peroxidase ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Memory ', ' Mentorship ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Methamphetamine ', ' body movement ', ' Movement ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Persons ', ' Needles ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' nervous system disorder ', ' neurotoxicant ', ' Neurotoxins ', ' endothelial cell derived relaxing factor ', ' Nitrogen Protoxide ', ' Nitrogen Monoxide ', ' Mononitrogen Monoxide ', ' Endothelium-Derived Nitric Oxide ', ' Endogenous Nitrate Vasodilator ', ' Nitric Oxide ', ' oxidation reduction reaction ', ' Redox ', ' Oxidation-Reduction ', ' gene product ', ' Proteins ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Se element ', ' Selenium ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Students ', ' Survey Instrument ', ' Surveys ', ' Transactivation ', ' Trans-Activation (Genetics) ', ' United States ', ' Universities ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Virus Diseases ', ' 3-selenyl-L-alanine ', ' 3-Selenylalanine ', ' Selenocysteine ', ' selenoprotein ', ' electron acceptor ', ' Oxidizing Agents ', ' Oxidants ', ' dopamine transporter proteins ', ' DAT dopamine transporter ', ' dopamine transporter ', ' peroxynitrite ', ' Peroxonitrite ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Malnutrition ', ' Task Forces ', ' Advisory Committees ', ' enhancing factor ', ' Organ ', ' Label ', ' Clinical ', ' Long-Term Potentiation ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Susceptibility ', ' Predisposition ', ' Training ', ' insight ', ' selenium deficiency ', ' Oxidative Stress ', ' selenophosphate synthetase ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' neuroAIDS ', ' AIDS neuropathy ', ' Letters ', ' Micronutrients ', ' Genetic ', ' Hawaiian ', ' Hawaiian population ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Impaired cognition ', ' Heavy Metals ', ' Life ', ' programs ', ' Scientist ', ' intraperitoneal ', ' LOINC Axis 4 System ', ' System ', ' Viral ', ' EPSP ', ' Excitatory Postsynaptic Potentials ', ' Affective Disorders ', ' Mood Disorders ', ' neuroprotection ', ' reverse transcriptase PCR ', ' RTPCR ', ' RT-PCR ', ' Reverse Transcriptase Polymerase Chain Reaction ', ' monoamine ', ' reuptake ', ' Toxicities ', ' Toxic effect ', ' member ', ' graduate student ', ' Dopamine neuron ', ' DA Neuron ', ' dopaminergic neuron ', ' career development ', ' LOINC Axis 2 Property ', ' Property ', ' response ', ' thioredoxin reductase ', ' Central Nervous System ', ' CNS Nervous System ', ' Neuraxis ', ' developmental disorder ', ' developmental disease/disorder ', ' Committee Members ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Institution ', ' Brain region ', ' preventing ', ' prevent ', ' methamphetamine abuse ', ' Intake ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Native Hawaiian or Other Pacific Islander ', ' qRTPCR ', ' Quantitative RTPCR ', ' Quantitative Reverse Transcriptase PCR ', ' Infrastructure ', ' Research Infrastructure ', ' Supplementation ', ' Rodent Model ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' Knockout ', ' Knock-out ', ' developmental ', ' Development ', ' website ', ' web site ', ' Dietary Selenium ', ' Instruction ', ' neuron injury ', ' Neuronal Injury ', ' meth exposure ', ' methamphetamine exposure ', ' Population ', ' aged ', ' short hairpin RNA ', ' shRNA ', ' small hairpin RNA ', ' Cellular model ', ' Cell model ', ' neuronal toxicity ', ' neuron toxicity ', ' neurotoxicity ', ' selenoenzyme ', ' dopamine toxicity ', ' neuronal survival ', ' public health relevance ', ' nondrug ', ' non-drug ', ' ']",NIDA,UNIVERSITY OF HAWAII AT MANOA,R24,2013,414202,0.13516613646182707
"African American Offenders: Drug Use, Mental Health and HIV Risk DESCRIPTION (provided by applicant): The primary goal of this K08 award is to further develop a productive independent research career in drug abuse research. The training and career development plan will enhance Dr. Stevens-Watkins's research experience in primary data collection with prisoners focused on drug use, mental health, and HIV thus resulting in the clarification of the specific aims of an R01 submission in years 4 and 5. The proposed training objectives are: (1) to receive training in the epidemiology of drug abuse, mental health, and HIV as they relate to health disparities among African Americans; (2) to further develop expertise in research with special populations, biostatistics, and advanced quantitative analyses including non-linear, categorical models, and structural equation modeling; (3) to use the data collected in the proposed research plan as pilot data for an R01 research proposal. The specified training goals are aligned with the research aims and compliment the clinical experience of the candidate. Dr. Stevens-Watkins will be sponsored by her established mentors, Drs. Carl Leukefeld and Carrie Oser, both with expertise in drug abuse and HIV research. Of high significance, HIV has recently been termed a ""crisis"" in the African American community. The overall goal of the proposed research plan is to better understand the complex and dynamic relationship between drug use, mental health, and HIV risk among African American male prisoners nearing community re-entry. The specific aims are (1) to explore drug use, symptoms of depression and anxiety, and HIV risk behaviors among African American male inmates by conducting a thorough literature review and devising an analytical model using biostatics multivariate analytic techniques with available data; (2) to identify prevalence, incidence, and predictors of drug use disorders, anxiety, depressive disorders and HIV sexual risk behaviors among 205 incarcerated African American men; (3) to examine the knowledge, patterns, and perceived cultural and community barriers to utilizing individual and health resources and their relationship to substance abuse recovery and HIV risk behaviors among 205 African American men upon release from prison. Baseline data will be collected in prison and follow-up data collection will occur when participants have been released in the community after 3-months. The proposed research plan will offer HIV testing and counseling to an at-risk population that has historically been difficult to engage in research and HIV testing, subsequently significantly impacting public health by possibly preventing the spread of HIV. The candidate's immediate career goals include published manuscripts and R01 funding by the end of K08 funding, with an ultimate career goal of becoming an independent clinical drug abuse researcher. This proposal includes an outstanding mentoring team, as well as a feasible training and research plan utilizing resources offered by both Spalding University and the University of Kentucky. The proposed project has significant public health implications for reducing the spread of HIV among the African American community by offering testing and by targeting men exiting prison, re-entering the community. The proposed project will generate an improved understanding of the complex relationship between drug use, mental health, and HIV risk among an at-risk group.","African American Offenders: Drug Use, Mental Health and HIV Risk",8708259,K08DA032296,"['Anxiety ', ' Award ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Communities ', ' Counseling ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' depression ', ' Mental Depression ', ' Depressive disorder ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Goals ', ' Health ', ' Health Resources ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Housing ', ' Incidence ', ' Interview ', ' Kentucky ', ' male ', "" men's "", ' men ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Mental Hygiene Services ', ' Mental Health Services ', ' Mentors ', ' Methods ', ' Structural Models ', ' Pre-Post Tests ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisoner ', ' Prisons ', ' Psychologist ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Proposals ', ' Research Resources ', ' Resources ', ' Risk ', ' social support network ', ' Social support ', ' Testing ', ' Universities ', ' Writing ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' depressive symptoms ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' psychological ', ' psychologic ', ' racism ', ' Training ', ' Individual ', ' Recovery ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Populations at Risk ', ' Development Plans ', ' drug use ', ' Drug usage ', ' Funding ', ' Review Literature ', ' Knowledge ', ' Life ', ' Complex ', ' Protocol ', ' Protocols documentation ', ' Pattern ', ' Techniques ', ' Equation ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' experience ', ' impression ', ' Special Population ', ' named group ', ' Manuscripts ', ' Participant ', ' criminal offender ', ' offender ', ' intravenous drug use ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' HIV risk ', ' Modeling ', ' career development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' correctional system ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' preventing ', ' prevent ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Symptoms ', ' Data ', ' Research Training ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' sexual risk behavior ', ' sex risk ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' community re-entry ', ' community reentry ', ' Outcome ', ' Prevalence ', ' drug detection ', ' drug testing ', ' high risk ', ' public health research ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,K08,2013,143368,0.1550195541722535
"Social Networks and HIV Risk Behaviors of Special Populations of Drug Users     DESCRIPTION (provided by applicant): The primary goal of this resubmitted K02 application is to further develop Dr. Carrie Oser's productive independent research career and to augment her research focus on HIV, substance abuse treatment, crime, and health disparities by gaining new training on social networks and HIV intervention development. The K02 builds upon her focus on special populations, including both rural drug users and African American drug users. The proposed training goals will provide new instruction in social networks, HIV intervention development, and the responsible conduct of research. The specific aims are: (1) to identify HIV and HCV risk and longitudinal changes in risk in the social networks of 503 rural out-of-treatment drug using women, as compared to men; and (2) to examine the effect of social networks, including structure (e.g., size, density), function (e.g., emotional and instrument support), and content (e.g., attitudes towards physicians), on HIV and HCV risk behaviors and health services utilization among African American drug using women, as compared to men, across criminal justice status. This significant and innovative study will have strong public healt impacts and will support NIDA's Health Disparities Initiative because of its potential to contribut to our understanding of the cultural and social network correlates of health disparities among both rural and African American drug users. In addition, this study improves upon the methodological limitations of previous research findings by examining various social networks (e.g., egocentric, dyadic, and sociocentric) and using longitudinal data in multilevel models. This proposed project will allow for a practical application of the substantive knowledge and analytical skills acquired from the K02 training activities and will ultimately culminate in the development of forthcoming investigator initiated NIDA grant applications. Specifically, these findings will be used as a foundation for future HIV social networks based intervention to increase special populations' use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism.         PUBLIC HEALTH RELEVANCE: This study is significant to the public health field because of its potential to understand the individual, cultural, and social network factors associated with HI and HCV risk behaviors among two special populations - rural drug users and African American drug users. These findings will be used as a foundation for developing social network based HIV interventions to increase special populations' use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism.                ",Social Networks and HIV Risk Behaviors of Special Populations of Drug Users,8599228,K02DA035116,"['Accounting ', ' Attitude ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Crime ', ' Data Collection ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Female ', ' Foundations ', ' Future ', ' Goals ', ' Grant ', ' Health ', ' health care service ', ' Health Services ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Kentucky ', ' male ', "" men's "", ' men ', ' Method LOINC Axis 6 ', ' Methodology ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Roxicodone ', ' Oxycontin ', ' Oxycodone SR ', ' Oxycodeinon ', ' Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5alpha)- ', ' Dihydrohydroxycodeinone ', ' Oxycodone ', ' Physicians ', ' Drug Prescribing ', ' Drug Prescriptions ', ' Prisons ', ' Public Health ', ' public health medicine (field) ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Training Activity ', ' Woman ', ' Gender ', ' Measures ', ' falls ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' health care ', ' Healthcare ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Social Network ', ' career ', ' density ', ' rural area ', ' urban area ', ' improved ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' Link ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Training ', ' Spiritualities ', ' Spirituality ', ' Individual ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Rural ', ' drug use ', ' Drug usage ', ' Drug user ', ' instrument ', ' Knowledge ', ' Life ', ' LOINC Axis 4 System ', ' System ', ' SNAP ', ' S-nitro-N-acetylpenicillamine ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' Services ', ' experience ', ' Special Population ', ' named group ', ' Structure ', ' skills ', ' disease prevention ', ' disorder prevention ', ' recidivism ', ' Self-Report ', ' Patient Self-Report ', ' probation ', ' social ', ' HIV risk ', ' multilevel modeling ', ' multilevel model ', ' methods to study multiple-level influences ', ' multilevel analysis ', ' Emotional ', ' Network Analysis ', ' Pathway Analysis ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' HIV diagnosis ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' K02 Award ', ' Independent Scientist Award ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Strategic Planning ', ' developmental ', ' Development ', ' substance abuse therapy ', ' substance abuse treatment ', ' Instruction ', ' willingness ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' application in practice ', ' practical application ', ' Network-based ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' high risk ', ' public health relevance ', ' responsible research conduct ', ' injection drug use ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,K02,2013,115827,0.1196814521075345
"Brief intervention for drug-using rural women at high-risk for HIV/HCV     DESCRIPTION (provided by applicant): The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high-risk for HIV and HCV. This project has potential to make a significant contribution to science by advancing knowledge about the health disparities, high-risk behaviors (injection drug use, sex risk), and service utilization of this high-risk, vulnerable, an understudied group of women during a time of emerging and significant public health risk in an Appalachian rural setting. This project will incorporate standardized screening (NIDA-modified ASSIST) to identify high-risk rural women drug users from jails, including injectors. Consenting women (N=350) will be asked to participate in a baseline interview, and will then be randomly assigned to one of two study groups: (1) HIV Education (HIV- Ed n=175) which includes the NIDA standard pre and post-test counseling, HIV and HCV rapid testing, and an information packet on existing community drug abuse and HIV/HCV resources; or (2) Motivational Interviewing- based HIV Risk Reduction (MI-HIV n=175) which, in addition to what is received in the HIV-Ed group, also includes an evidence-based brief intervention for high-risk women focused on an individualized plan for enhancing motivation to reduce risk behaviors and to use health and behavioral health services in the community. Specific aims include: (1) to compare the effectiveness of an evidence-based HIV risk reduction intervention (MI-HIV) to HIV Education (NIDA Standard) in reducing sex risk behaviors, injection practices, and drug use among a culturally unique sample of disadvantaged, drug-using rural women at high-risk for HIV and HCV; and (2) to examine MI-HIV Intervention engagement as a predictor of community health and behavioral health service utilization (including drug treatment and mental health) at follow-up among disadvantaged, drug- using rural women at high risk for HIV and HCV. This project is innovative because it 1) targets a high-risk and understudied group of women, 2) uses brief intervention to not only reduce risk behavior but also to enhance motivation for using community health and behavioral health resources, and 3) utilizes a real-world setting to identify high-risk women drug users. The long-term goal of this study is to increase access to health and behavioral health services in order to improve the quality of health of high-risk rural women.          The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high risk for HIV and HCV. This project has potential to make a significant contribution to science by providing knowledge about the health, risk behaviors, and service utilization of a vulnerable and understudied group of women during a time of emerging and significant public health risk in a rural Appalachian setting. Successful completion of the aims of this project will advance the delivery of a low-cost, potentially high impact intervention with implications for a number of other real world settings (such as criminal justice venues) where other disadvantaged high-risk drug users can be identified and targeted for intervention.                    ",Brief intervention for drug-using rural women at high-risk for HIV/HCV,8667415,R01DA033866,"['Appalachia ', ' Appalachian Region ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Community Services ', ' Counseling ', ' Disadvantaged ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Goals ', ' Health ', ' Health Resources ', ' health care service ', ' Health Services ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Injections ', ' Injection of therapeutic agent ', ' Interview ', ' Kentucky ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Motivation ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Pre-Post Tests ', ' Public Health ', ' public health medicine (field) ', ' Random Selection ', ' Random Allocation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Science ', ' Testing ', ' Time ', ' Walkers ', ' Woman ', ' Criminal Justice ', ' health care ', ' Healthcare ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' base ', ' rural area ', ' improved ', ' Area ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Rural ', ' drug use ', ' Drug usage ', ' women at high risk ', ' High Risk Woman ', ' Female Groups ', "" Women's Group "", ' Training Intervention ', ' instructional intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Educational Intervention ', ' Staging ', ' Drug user ', ' Opiates ', ' Knowledge ', ' Pattern ', ' Country ', ' Services ', ' treatment planning ', ' Participant ', ' high risk behavior ', ' motivational interview ', ' motivational enhancement therapy ', ' outreach ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' Sampling ', ' behavioral health ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' drug resource ', ' vulnerable group ', ' Vulnerable Populations ', ' Risk Reduction ', ' health disparities ', ' health disparity ', ' Address ', ' Jail ', ' Consent ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Community Health ', ' comparison group ', ' sexual risk behavior ', ' sex risk ', ' cost ', ' designing ', ' design ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' Evidence based intervention ', ' compare effectiveness ', ' service utilization ', ' high risk ', ' evidence base ', ' prescription opiate ', ' screening ', ' injection drug use ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2014,576017,0.12069110669681299
"Couple HIV prevention for drug-involved male offenders: An Effectiveness Trial     DESCRIPTION (provided by applicant): The proposed study responds to PA-09-236 entitled ""HIV/AIDS, Drug Use, and Vulnerable Populations."" This study is a randomized controlled trial (RCT) that will rigorously evaluate the implementation, effectiveness and cost-effectiveness of a couple-based integrated HIV/STI and drug abuse prevention intervention (Connect II) with drug-involved male offenders charged with misdemeanors and their primary female sexual partners, implemented by frontline providers in Criminal Court, Community Court or Probation (CCP) sites in the Bronx, NY, compared to CCP standard treatment of care services (TAU). The primary outcomes are biologically confirmed sexually transmitted infections (STIs) and self-reported condom use. This study will yield important data on implementation factors associated with effectiveness of the proposed intervention in real world resource-constrained criminal justice settings. The proposed CCP study sites are located in the South Bronx, the poorest Congressional District in the U.S. with 96% of residents identifying as Black or Latino. The South Bronx has an HIV prevalence rate of 2.6%. Research has found that 12% of men on probation in New York City are HIV positive. Though the criminal justice system is recognized as the epicenter of the epidemic in the U.S., few, if any, HIV prevention interventions have been developed for the huge number of male offenders under community supervision who represent 90% of the corrections population. No HIV/STI prevention services are currently provided at the proposed CCP sites. The proposed intervention is designed to address this critical gap in services. Connect II was found to be efficacious among drug-involved couples in reducing risky drug and sexual behaviors and drug use. In the proposed study we aim to advance the knowledge of implementation science by testing the effectiveness and cost-effectiveness of Connect II delivered by frontline providers in the real world settings of CCP sites with 240 drug-involved male offenders and their female partners (N=480 participants). Eligible couples will be randomly assigned to either (1) a 4-session Connect II delivered to both partners together + TAU delivered to male participant alone, or (2) a TAU control condition delivered to the male participant. Repeated assessments will occur at baseline and 3, 6, and 12-months post intervention. The study will be conducted by Dr. Nabila El-Bassel, Dr. Louisa Gilbert, and an investigative team from Columbia University in collaboration with Michael Rempel from the Center for Court Innovation and the New York City Department of Probation. If found to be effective, Connect II may be scaled up in community criminal justice settings nationwide to curb the spread of HIV/STIs and to reduce HIV disparities in heavily impacted communities like the South Bronx.         PUBLIC HEALTH RELEVANCE:  This study addresses the significant public health threat of HIV and other STIs among drug- involved male offenders under community supervision and their female partners. This study will evaluate the implementation, effectiveness and cost-effectiveness of a brief couple-based HIV and drug abuse prevention intervention for drug-involved male offenders and their female partners delivered by frontline providers in Criminal/Community Court and Probation sites in the South Bronx, the poorest congressional district in the U.S. If found to be effective, the proposed brief intervention may be scaled up to community criminal justice sites nationwide to curb the spread of HIV/STIs and reduce HIV disparities.                    ",Couple HIV prevention for drug-involved male offenders: An Effectiveness Trial,8699177,R01DA033168,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Subsaharan Africa ', ' Sub-Saharan Africa ', ' Africa South of the Sahara ', ' Charge ', ' Client ', ' Communities ', ' cost effectiveness ', ' Couples ', ' Drug Utilization ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Female ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Health Services Research ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' Institutes ', ' male ', ' Manuals ', ' Medicine ', "" men's "", ' men ', ' Methods ', ' New York City ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' sex partner ', ' Sexual Partners ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Supervision ', ' Testing ', ' Time ', ' Universities ', ' Work ', ' Treatment outcome ', ' Criminal Justice ', ' Latino ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Caring ', ' base ', ' court ', ' improved ', ' Site ', ' drug use ', ' Drug usage ', ' Collaborations ', ' Letters ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Knowledge ', ' Scientist ', ' LOINC Axis 4 System ', ' System ', ' psychosocial ', ' Outcome Study ', ' Prevent infection ', ' Infection prevention ', ' Consult ', ' Services ', ' professor ', ' condoms ', ' Participant ', ' prevention service ', ' recidivism ', ' Self-Report ', ' Patient Self-Report ', ' Prevention ', ' probation ', ' criminal offender ', ' offender ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' Modeling ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' Provider ', ' prevent drug use ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' Effectiveness ', ' Address ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Cost Effectiveness Analysis ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Subgroup ', ' Characteristics ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' post intervention ', ' effectiveness trial ', ' cost ', ' efficacy research ', ' designing ', ' design ', ' probationer ', ' scale up ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' demographics ', ' implementation science ', ' public health relevance ', ' community setting ', ' evidence base ', ' primary outcome ', ' secondary outcome ', ' standard treatment ', ' standard care ', ' ']",NIDA,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2014,666274,0.06416710644856985
"Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study DESCRIPTION (provided by applicant): The overall goal of this project is to address how disproportionate confinement of racial/ethnic minorities-especially African Americans-affects health disparities in the HIV/AIDS epidemic. African Americans comprise only 13% of the general population, but about 40% of incarcerated youth and adults and 50% of new cases of HIV/AIDS. Yet, large multisite national longitudinal studies of HIV/AIDS focus on high- risk samples such as men who have sex with men (MACS), women infected with HIV and other ""at-risk"" females (WIHS), and infected women and their infants (WITS). These studies do not include adolescents, do not sample correctional populations, and do not examine the effect of incarceration on HIV/AIDS. Most studies of incarcerated populations are cross-sectional and provide limited information on the effects of incarceration. To continue to address this key omission in the literature, we propose to extend the Northwestern Juvenile Project, a longitudinal study of 1829 juvenile justice youth, enrolled at age 10-18 years (1172 males, 657 females; 1005 African Americans, 296 non-Hispanic whites, 524 Hispanics, and 4 ""other"" race/ethnicity). Currently, the HIV/AIDS component of the project (RO1 DA022953) includes only a subsample (n=743) and 10-, 11-, 12-, and 13-year follow-up interviews. We now propose to (1) study the entire sample (originally 1829, now 1678); (2) conduct 3 additional annual interviews (14-, 15-, and 16-year follow-ups), at which time participants will be aged 26-34 years; (3) collect official records to cross-validate self-reported data (on STI status, arrests, incarceration history, and services received); (4) test the entire sample for HIV infection, chlamydia, and gonorrhea; and (5) administer a new module on incarceration, release, and re-entry. Participants are re-interviewed whether they are re-incarcerated or back in the community. Using data collected in prior phases and the additional interviews, we will examine patterns of drug use, drug use disorder, HIV/AIDS risk and infection from adolescence (ages 10-17 years) to emerging adulthood (ages 18-24 years) and young adulthood (age 25 and older). Our Specific Aims focus on how incarceration, release, and re-entry (e.g., age[s] incarcerated, number of incarcerations, length of incarcerations, amount of time spent in the community between incarcerations) affect the following: (1) drug use behaviors (including the number and types of substances used, frequency of use, and route of administration) and drug use disorders (onset, persistence, desistance, and recurrence); (2) HIV/AIDS sex risk behaviors (including unprotected anal or vaginal receptive sex and trading sex for drugs) and injection-risk behaviors; (3) prevalence and incidence of HIV infection and other STIs; (4) the relationship between patterns of drug use and disorder and HIV/AIDS risk behaviors, especially how risk and protective factors predict, moderate, and mediate these relationships. This study responds to the initiatives of NIDA, NIAAA, and other NIH institutes to reduce health disparities in HIV/AIDS in minority populations. PUBLIC HEALTH RELEVANCE: Racial/ethnic minorities suffer disproportionately from the HIV/AIDS epidemic and are disproportionately incarcerated. To address health disparities in HIV/AIDS, we must study correctional populations, which increased from nearly 1.8 million in 1997 to over 2.2 million by mid-year 2006. The proposed study will guide public health policy by investigating how incarceration affects the development of substance use and disorder and HIV/AIDS; identifying risk and protective factors that are potentially malleable; identifying points of intervention during key developmental periods; and extending current conceptual models to include incarceration, release, and reentry.","Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study",8588301,R01DA028763,"['Accounting ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Aging ', ' ethanol use disorder ', ' alcohol use disorder ', ' Alcohol Chemical Class ', ' Alcohols ', ' Antibodies ', ' Anal ', ' Anus ', ' Dorsum ', ' Back ', ' Behavior ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cervix Dysplasia ', ' Cervical dysplasia ', ' Chicago ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' Rickettsia trachomae ', ' Chlamydia trachomatis ', ' Concurrent Studies ', ' Cohort Studies ', ' Communities ', ' Crime ', ' Death ', ' Cessation of life ', ' Decision Making ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Electronics ', ' Employment ', ' Epidemic ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Ethnic group ', ' Female ', ' Liberty ', ' Freedom ', ' Goals ', ' Gonococcal Infection ', ' Gonorrhea ', ' Grant ', ' Health ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' health care service ', ' Health Services ', ' Herpesvirus hominis disease ', ' Herpes simplex disease ', ' Herpes Simplex ', ' Herpes Simplex Infections ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' human T lymphotropic virus III ', ' human T cell leukemia virus III ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' HIV-1 ', ' Housing ', ' Illinois ', ' Incidence ', ' Infant ', ' Infection ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Human Papillomavirus ', ' Injections ', ' Injection of therapeutic agent ', ' NAS/IOM ', ' Institute of Medicine ', ' Institute of Medicine (U.S.) ', ' Institutes ', ' Interview ', ' Judgment ', ' Justice ', ' Kinetics ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Length of Stay ', ' Lifestyle ', ' Life Style ', ' Literature ', ' long-term study ', ' Longitudinal Studies ', ' male ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Needles ', ' Neighborhoods ', ' N.gonorrhoeae ', ' N. gonorrhoeae ', ' Gonococcus ', ' Neisseria gonorrhoeae ', ' Prisons ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Recommendation ', ' Records ', ' Recurrent ', ' Recurrence ', ' Research ', ' Risk ', ' Risk Factors ', ' Saliva ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sex Characteristics ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' social support network ', ' Social support ', ' Solutions ', ' statistics ', ' Substance Use Disorder ', ' Survey Instrument ', ' Surveys ', ' great pox ', ' Syphilis ', ' Testing ', ' Time ', ' trichomoniasis ', ' Trichomonosis ', ' Disease due to Trichomonadidae ', ' Trichomonas Infections ', ' Ulceration ', ' Ulcer ', ' Urine Urinary System ', ' Urine ', ' Vaginal ', ' Vagina ', ' hepatitis virus infection ', ' Viral hepatitis ', ' Woman ', ' Work ', ' County ', ' Syringe Sharing ', ' Needlesharing ', ' Needle Sharing ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Illicit Drugs ', ' Enzyme Linked Immunoassay Immunologic ', ' Enzyme Immunoassay ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Longitudinal Surveys ', ' Mediating ', ' Risk Assessment ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' Social Network ', ' racial/ethnic difference ', ' Area ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' African ', ' drug use ', ' Drug usage ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' disorder onset ', ' disease onset ', ' Onset of illness ', ' liquid ', ' fluid ', ' Liquid substance ', ' Staging ', ' Contracting Opportunities ', ' Contracts ', ' cooking ', ' Research Specimen ', ' Specimen ', ' Life ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Dependence ', ' Event ', ' Oral ', ' Source ', ' Route ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' Injection Drug User ', ' Injecting drug user ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' Services ', ' urogenital system (genital part) ', ' Genital ', ' Genital system ', ' Surgeon ', ' age group ', ' experience ', ' high school ', ' Participant ', ' health record ', ' Program Announcement ', ' NIH Program Announcements ', ' Self-Report ', ' Patient Self-Report ', ' high risk behavior ', ' deviancy ', ' deviant ', ' General Public ', ' General Population ', ' probation ', ' criminal offender ', ' offender ', ' intravenous drug use ', ' age difference ', ' Academic achievement ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Admission ', ' Admission activity ', ' parole ', ' Modeling ', ' Sampling ', ' middle school ', ' junior high ', ' junior high school ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Healthy People 2010 ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Length ', ' Jail ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' NIH RFA ', ' Request for Applications ', ' Subgroup ', ' child maltreatment ', ' Childhood maltreatment ', ' Child Abuse and Neglect ', ' enroll ', ' Enrollment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' underserved minority ', ' under-represented minority ', ' Underrepresented Populations ', ' Underrepresented Groups ', ' Underrepresented Minority ', ' Monitor ', ' Transmission ', ' transmission process ', ' Characteristics ', ' Process ', ' sex ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Permission ', ' Authorization ', ' Authorization documentation ', ' developmental ', ' Development ', ' Heterosexuals ', ' transcription mediated amplification ', ' sexual risk behavior ', ' sex risk ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' national surveillance ', ' Minority ', ' alcohol and other drug ', ' Outcome ', ' cost-effective ', ' cost effective ', ' juvenile justice system ', ' Youth Risk Behavior ', ' Adolescent Risk Behavior ', ' Population ', ' Prevalence ', ' aged ', ' prospective ', ' NIAAA ', ' National Institute on Alcohol Abuse and Alcoholism ', ' innovative ', ' innovate ', ' innovation ', ' eighteen year old ', ' age 18 years ', ' 18 year old ', ' racial/ethnic ', ' racial and ethnic ', ' service utilization ', ' racial and ethnic disparities ', ' high risk ', ' FDA approved ', ' emerging adulthood ', ' surveillance data ', ' surveillance study ', ' screening ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2014,2148163,0.1173319122085367
"Stress and Drug Use Vulnerability in the African American Community     DESCRIPTION (provided by applicant): The impacts that drug addictions have on health disparities that adversely affect African Americans are grossly understudied. While there is strong evidence linking drug abuse to poor health and problem behaviors in the African American community, the progression of drug abuse is inconsistent (i.e., relatively late initiation and heavy use in the 30s) with national norms and remains unclear. Exposure to chronic stress and the subsequent activation of the hypothalamic-pituitary-adrenal (HPA) axis has been connected to drug addictions and poor health outcomes. This association is of particular importance since residents in these communities are exposed to many of the risk factors associated with the onset of drug abuse: familial risk, deprived social environment, unemployment, substandard education, low-to-no socioeconomic status, and enduring exposure to experiences of racism and discrimination. Repeated exposure to environmental stressors will lead to 'wear-and-tear' on the body's regulatory system and have profound implications on HPA functioning and the subsequent risk of developing an addiction. This study will pursue three primary aims: (1) Investigate HPA reactivity to acute stress as a predictor of current drug use severity. (2) Investigate trajectories of HPA regulation (level and circadian rhythm) as a predicto of drug use vulnerability across time. (3) Investigate delay discounting as a moderator between trajectories of HPA regulation and drug use vulnerability across time. This study will enroll 350 African American adults (ages 18-21) who reside in the southeastern U.S. and utilize a prospective longitudinal research design that consists of a laboratory assessment involving the Trier Social Stress Test, three in-home assessments that include clinical interviews and behavioral tasks, and six internet assessments that track drug use and related risk factors across a 2-year period. Primary independent variables include environmental stressors, stress-related biomarkers (i.e., salivary cortical, salivary DHEA, heart rate variability, and galvanic skn resistance), and delay discounting. Primary dependent variables include drug use, severity of drug use disorders, and drug use consequences. This study is highly innovative for three primary reasons: (1) A longitudinal research design will be used for the first time to investigate trajectories of HPA regulation as a predictor of drug use vulnerability; (2) The use of multiple indicators of the stress regulatory system, clinical interviews, and a novel behavioral task provides a more nuanced understanding of the research aims; and (3) This study focuses on an understudied population that suffers from drug-related health disparities, but are rarely included in cutting edge laboratory research. It is envisioned that this approach will uncover latent-curve trajectories of stress deregulation as a predictor of drug use vulnerability in this population. Findings from this study will identify causal mechanisms of drug addictions that will advance theory, research, prevention, and treatments aimed at addressing this growing public health problem.         PUBLIC HEALTH RELEVANCE: The development of drug abuse in the African American community is often characterized by oversimplified models that are rooted in research studies that rarely include African Americans. This study will identify mechanisms that influence drug use vulnerability in at-risk African American adults who reside in the southeastern U.S. Such research is needed to develop socially and culturally informed prevention and treatment programs aimed at reducing drug-related health disparities that continue to plague African Americans.            ",Stress and Drug Use Vulnerability in the African American Community,8640132,R01DA034739,"['Cultural Assimilation ', ' Acculturation ', ' suprarenal gland ', ' Adrenals ', ' Adrenal Glands ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Belief ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Circadian Rhythms ', ' Communities ', ' Crime ', ' Death ', ' Cessation of life ', ' Therapeutic Dehydroepiandrosterone ', ' Prasterone ', ' Dehydroisoandrosterone ', ' DHEA ', ' Androstenolone ', ' Androst-5-en-17-one, 3-hydroxy-, (3beta)- ', ' 5-Androsten-3-beta-hydroxy-17-one ', ' 3beta-Hydroxyandrost-5-en-17-one ', ' dehydroepiandrosterone ', ' Discrimination ', ' Cognitive Discrimination ', ' Discrimination (Psychology) ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Downregulation ', ' Down-Regulation (Physiology) ', ' Down-Regulation ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economics ', ' Education ', ' Educational aspects ', ' Au element ', ' Gold ', ' Health ', ' Health behavior ', ' Therapeutic Hydrocortisone ', ' Proctocort ', ' Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)- ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Hydrocortisone ', ' hypothalamic ', ' Hypothalamus ', ' Hypothalamic structure ', ' Incidence ', ' Interview ', ' Laboratories ', ' Laboratory Research ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Mortality ', ' Mortality Vital Statistics ', ' Neighborhoods ', ' pilot study ', ' Pilot Projects ', ' Pituitary Nervous System ', ' Pituitary ', ' Hypophysis Cerebri ', ' Hypophysis ', ' Pituitary Gland ', ' Yersinia pestis disease ', ' Plague ', ' Psychopharmaceuticals ', ' Psychoactive Drugs ', ' Psychoactive Compound ', ' Psychoactive Agents ', ' Psychotropic Drugs ', ' Public Health ', ' public health medicine (field) ', ' recruit ', ' Recruitment Activity ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Rewards ', ' Risk ', ' Risk Factors ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Stress ', ' Survey Instrument ', ' Surveys ', ' Time ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Unemployment ', ' violent behavior ', ' violent ', ' Violence ', ' Measures ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Illicit Drugs ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' improved ', ' Left ', ' Clinical ', ' racism ', ' Link ', ' mental ', ' Psyche structure ', ' disability ', ' Stimulus ', ' Spiritualities ', ' Spirituality ', ' Recovery ', ' Rural ', ' drug use ', ' Drug usage ', ' root ', ' Plant Roots ', ' Funding ', ' behavioral problem ', ' Problem behavior ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Exposure to ', ' Severities ', ' Salivary ', ' Home ', ' Home environment ', ' LOINC Axis 4 System ', ' System ', ' environmental stressor ', ' experience ', ' hypothalmus-pituitary-adrenal axis ', ' hypothalamic-pituitary-adrenal (HPA) axis ', ' hypothalamic-pituitary-adrenal axis ', ' novel ', ' Prevention Research ', ' Prevention program ', ' treatment program ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Impulsivity ', ' acute stress ', ' Regulation ', ' Modeling ', ' response ', ' theories ', ' health disparities ', ' health disparity ', ' Address ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Chronic stress ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' enroll ', ' Enrollment ', ' developmental ', ' Development ', ' Behavioral ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' Clinical assessments ', ' Outcome ', ' discounting ', ' Population ', ' prospective ', ' Trier Social Stress Test ', ' innovative ', ' innovate ', ' innovation ', ' resistant ', ' Resistance ', ' addictive disorder ', ' addiction ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' heart rate variability ', ' constriction ', ' longitudinal design ', ' burden of injury ', ' ']",NIDA,UNIVERSITY OF HOUSTON,R01,2014,569305,0.21249262221003148
"African American Offenders: Drug Use, Mental Health and HIV Risk     DESCRIPTION (provided by applicant):  The primary goal of this K08 award is to further develop a productive independent research career in drug abuse research. The training and career development plan will enhance Dr. Stevens-Watkins's research experience in primary data collection with prisoners focused on drug use, mental health, and HIV thus resulting in the clarification of the specific aims of an R01 submission in years 4 and 5. The proposed training objectives are: (1) to receive training in the epidemiology of drug abuse, mental health, and HIV as they relate to health disparities among African Americans; (2) to further develop expertise in research with special populations, biostatistics, and advanced quantitative analyses including non-linear, categorical models, and structural equation modeling; (3) to use the data collected in the proposed research plan as pilot data for an R01 research proposal. The specified training goals are aligned with the research aims and compliment the clinical experience of the candidate. Dr. Stevens-Watkins will be sponsored by her established mentors, Drs. Carl Leukefeld and Carrie Oser, both with expertise in drug abuse and HIV research. Of high significance, HIV has recently been termed a ""crisis"" in the African American community. The overall goal of the proposed research plan is to better understand the complex and dynamic relationship between drug use, mental health, and HIV risk among African American male prisoners nearing community re-entry. The specific aims are (1) to explore drug use, symptoms of depression and anxiety, and HIV risk behaviors among African American male inmates by conducting a thorough literature review and devising an analytical model using biostatics multivariate analytic techniques with available data; (2) to identify prevalence, incidence, and predictors of drug use disorders, anxiety, depressive disorders and HIV sexual risk behaviors among 205 incarcerated African American men; (3) to examine the knowledge, patterns, and perceived cultural and community barriers to utilizing individual and health resources and their relationship to substance abuse recovery and HIV risk behaviors among 205 African American men upon release from prison. Baseline data will be collected in prison and follow-up data collection will occur when participants have been released in the community after 3-months. The proposed research plan will offer HIV testing and counseling to an at-risk population that has historically been difficult to engage in research and HIV testing, subsequently significantly impacting public health by possibly preventing the spread of HIV. The candidate's immediate career goals include published manuscripts and R01 funding by the end of K08 funding, with an ultimate career goal of becoming an independent clinical drug abuse researcher. This proposal includes an outstanding mentoring team, as well as a feasible training and research plan utilizing resources offered by both Spalding University and the University of Kentucky.           The proposed project has significant public health implications for reducing the spread of HIV among the African American community by offering testing and by targeting men exiting prison, re-entering the community. The proposed project will generate an improved understanding of the complex relationship between drug use, mental health, and HIV risk among an at-risk group.                        ","African American Offenders: Drug Use, Mental Health and HIV Risk",8653955,K08DA032296,"['Anxiety ', ' Award ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Career Path ', ' Career Choice ', ' Communities ', ' Counseling ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' depression ', ' Mental Depression ', ' Depressive disorder ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Goals ', ' Health ', ' Health Resources ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Housing ', ' Incidence ', ' Interview ', ' Kentucky ', ' male ', "" men's "", ' men ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Mental Hygiene Services ', ' Mental Health Services ', ' Mentors ', ' Methods ', ' Structural Models ', ' Pre-Post Tests ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisoner ', ' Prisons ', ' Psychologist ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Proposals ', ' Research Resources ', ' Resources ', ' Risk ', ' social support network ', ' Social support ', ' Testing ', ' Universities ', ' Writing ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' depressive symptoms ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' psychological ', ' psychologic ', ' racism ', ' Training ', ' Individual ', ' Recovery ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Populations at Risk ', ' Development Plans ', ' drug use ', ' Drug usage ', ' Funding ', ' Review Literature ', ' Knowledge ', ' Life ', ' Complex ', ' Protocol ', ' Protocols documentation ', ' Pattern ', ' Techniques ', ' Equation ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' experience ', ' impression ', ' Special Population ', ' named group ', ' Manuscripts ', ' Participant ', ' criminal offender ', ' offender ', ' intravenous drug use ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' HIV risk ', ' Modeling ', ' career development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' correctional system ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' preventing ', ' prevent ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Symptoms ', ' Data ', ' Research Training ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' sexual risk behavior ', ' sex risk ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' community re-entry ', ' community reentry ', ' Outcome ', ' Prevalence ', ' drug detection ', ' drug testing ', ' high risk ', ' public health research ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,K08,2014,135099,0.1550195541722535
"Social Networks and HIV Risk Behaviors of Special Populations of Drug Users     DESCRIPTION (provided by applicant): The primary goal of this resubmitted K02 application is to further develop Dr. Carrie Oser's productive independent research career and to augment her research focus on HIV, substance abuse treatment, crime, and health disparities by gaining new training on social networks and HIV intervention development. The K02 builds upon her focus on special populations, including both rural drug users and African American drug users. The proposed training goals will provide new instruction in social networks, HIV intervention development, and the responsible conduct of research. The specific aims are: (1) to identify HIV and HCV risk and longitudinal changes in risk in the social networks of 503 rural out-of-treatment drug using women, as compared to men; and (2) to examine the effect of social networks, including structure (e.g., size, density), function (e.g., emotional and instrument support), and content (e.g., attitudes towards physicians), on HIV and HCV risk behaviors and health services utilization among African American drug using women, as compared to men, across criminal justice status. This significant and innovative study will have strong public healt impacts and will support NIDA's Health Disparities Initiative because of its potential to contribut to our understanding of the cultural and social network correlates of health disparities among both rural and African American drug users. In addition, this study improves upon the methodological limitations of previous research findings by examining various social networks (e.g., egocentric, dyadic, and sociocentric) and using longitudinal data in multilevel models. This proposed project will allow for a practical application of the substantive knowledge and analytical skills acquired from the K02 training activities and will ultimately culminate in the development of forthcoming investigator initiated NIDA grant applications. Specifically, these findings will be used as a foundation for future HIV social networks based intervention to increase special populations' use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism.         PUBLIC HEALTH RELEVANCE: This study is significant to the public health field because of its potential to understand the individual, cultural, and social network factors associated with HI and HCV risk behaviors among two special populations - rural drug users and African American drug users. These findings will be used as a foundation for developing social network based HIV interventions to increase special populations' use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism.                ",Social Networks and HIV Risk Behaviors of Special Populations of Drug Users,8691771,K02DA035116,"['Accounting ', ' Attitude ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Crime ', ' Data Collection ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Female ', ' Foundations ', ' Future ', ' Goals ', ' Grant ', ' Health ', ' health care service ', ' Health Services ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Kentucky ', ' male ', "" men's "", ' men ', ' Method LOINC Axis 6 ', ' Methodology ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Roxicodone ', ' Oxycontin ', ' Oxycodone SR ', ' Oxycodeinon ', ' Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5alpha)- ', ' Dihydrohydroxycodeinone ', ' Oxycodone ', ' Physicians ', ' Drug Prescribing ', ' Drug Prescriptions ', ' Prisons ', ' Public Health ', ' public health medicine (field) ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Training Activity ', ' Woman ', ' Gender ', ' Measures ', ' falls ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' health care ', ' Healthcare ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Social Network ', ' career ', ' density ', ' rural area ', ' urban area ', ' improved ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' Link ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Training ', ' Spiritualities ', ' Spirituality ', ' Individual ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Rural ', ' drug use ', ' Drug usage ', ' Drug user ', ' instrument ', ' Knowledge ', ' Life ', ' LOINC Axis 4 System ', ' System ', ' SNAP ', ' S-nitro-N-acetylpenicillamine ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' Services ', ' experience ', ' Special Population ', ' named group ', ' Structure ', ' skills ', ' disease prevention ', ' disorder prevention ', ' recidivism ', ' Self-Report ', ' Patient Self-Report ', ' probation ', ' social ', ' HIV risk ', ' multilevel modeling ', ' multilevel model ', ' methods to study multiple-level influences ', ' multilevel analysis ', ' Emotional ', ' Network Analysis ', ' Pathway Analysis ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' HIV diagnosis ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' K02 Award ', ' Independent Scientist Award ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Strategic Planning ', ' developmental ', ' Development ', ' substance abuse therapy ', ' substance abuse treatment ', ' Instruction ', ' willingness ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' application in practice ', ' practical application ', ' Network-based ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' high risk ', ' public health relevance ', ' responsible research conduct ', ' injection drug use ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,K02,2014,115827,0.1196814521075345
"The Logics for HIV Risk among Street-Based Heroin Injectors    DESCRIPTION (provided by applicant): We propose to develop a theoretically and ethnographically informed model of ""HIV risk environment"" for public health intervention by identifying the key structural forces, institutional processes, and socio-cultural constraints that shape HIV behaviors among inner-city street-based drug users. We will examine the social processes that drive the logics for HIV transmission behaviors among street-based injection drug users (IDUs) in two cities, Philadelphia and San Francisco, that span a strategic range of the demographic, economic, political, and cultural factors affecting inner-city poverty in the United States. Building on long-term, continuous participant-observation ethnographic fieldwork in the shooting encampments of ethnically and generationally bounded social networks of heroin injectors and crack smokers in San Francisco as well as pilot research in Philadelphia at open-air drug markets and shooting galleries, we will document patterns of: 1) law enforcement and criminal justice; 2) poverty and income generating opportunities (including legal and illegal labor markets and public subsidies); 3) illegal drug markets and polydrug availability; 4) racialized ethnic boundaries and conflicts; 5) gender/sexuality boundaries that delimit social networks; 6) oppositional sub-cultural identities that trap IDUs into counterproductive relationships with the services that are meant to help or contain them; 7) violence and insecurity; 8) access to clinical care, public health prevention messages, and social services; 9) access to ecological and basic survival needs infrastructures including transportation systems, food, and shelter from inclement weather. An experienced ethnographic team in both cities will collect data on individual-level HIV risk behaviors at fieldsites that we have successfully maintained on the parent grant for more than 12 years in San Francisco and recently established in Philadelphia (core N of each network=15-20 at any given time, peripheral N=10-15 in each fieldsite; 2 sites in Philadephia and 2 in San Francisco). The project will administer a set of procedures for cross-methodological collaboration with epidemiologists who are the Principal Investigators on long-term, large quantitative data sets documenting street-based drug users in both cities. This will enable us to examine the representativity of our ethnographic data on individual street-based drug users and to explore the generalizability of our analysis of the larger social structural processes that promote or constrain risky injection and sexual practices. It will also bring one of the largest and oldest NIDA-funded data sets on IDUs in San Francisco, an exceptionally high-tech, wealthy, culturally diverse, and liberal city into an illustrative contrast and dialogue with another large NIDA-supported quantitative data set of street-based drug users in the city of Philadelphia, one of the nation's poorest deindustrialized metropolises, with a declining population of largely native-born white, Latino (primarily Puerto Rican) and African American ethnic groups.        Untangling the complex web of factors that render inner city poverty environments exceptionally risky for HIV infection and addiction will help public health outreach workers and clinicians develop more innovative structural and targeted interventions to reach larger numbers of low income high-risk populations with more effective and convincing messages. Upstream interventions that alter neighborhood-level risk environments can cost-effectively encourage drug users to change their behaviors for pragmatic reasons without necessarily requiring a conscious or willful choice. Our findings will also identify strategic institutions and programs that often operate at cross purposes or fail to coordinate with public health HIV risk reduction priorities (including law enforcement, criminal justice, employment training, public housing, food kitchens, shelters, schools, and churches) but which represent productive sites for multi-service HIV prevention interventions.         ",The Logics for HIV Risk among Street-Based Heroin Injectors,8688204,R01DA010164,"['Puerto Rican ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' San Francisco ', ' Schools ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Sexuality ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Social Sciences ', ' Social Work ', ' Social Service ', ' Social work (field) ', ' Socialization ', ' Time ', ' Transportation ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Unemployment ', ' United States ', ' USPHS ', ' Public Health Service ', ' United States Public Health Service ', ' violent behavior ', ' violent ', ' Violence ', ' Weather ', ' Gender ', ' Native People ', ' Indigenous Population ', ' Native-Born ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' Latino ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Dataset ', ' Data Set ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' shelter-housing ', ' shelter ', ' Shelter facility ', ' Social Network ', ' ethnographic ', ' Ethnography ', ' Law Enforcement ', ' base ', ' Procedures ', ' Peripheral ', ' Distal ', ' Site ', ' Link ', ' Training ', ' Consciousness ', ' Conscious ', ' Individual ', ' Logistics ', ' Policies ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' Shapes ', ' Smoker ', ' Drug user ', ' Consensus ', ' Knowledge ', ' programs ', ' Investigation ', ' Complex ', ' Source ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' interest ', ' Injection Drug User ', ' Injecting drug user ', ' inner city ', ' Services ', ' preference ', ' Church ', ' experience ', ' skills ', ' Participant ', ' drug market ', ' Agreement ', ' social inequality ', ' outreach ', ' Prevention ', ' social ', ' HIV risk ', ' Regulation ', ' Modeling ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Risk Reduction ', ' Institution ', ' preventing ', ' prevent ', ' Legal ', ' Low income ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' Infrastructure ', ' Research Infrastructure ', ' Epidemiologist ', ' Transmission ', ' transmission process ', ' Principal Investigator ', ' Process ', ' sex ', ' socioeconomically ', ' socioeconomic ', ' socio-economic ', ' socio economic ', ' socioeconomics ', ' Behavioral ', ' Clinical Services ', ' cost ', ' designing ', ' design ', ' remediation ', ' cost-effective ', ' cost effective ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' analytical tool ', ' addictive disorder ', ' addiction ', ' parent grant ', ' high risk ', ' clinical care ', ' injection drug use ', ' Affect ', ' Age ', ' Air ', ' Cultural Anthropology ', ' Attention ', ' Awareness ', ' bear ', ' Ursidae ', ' Bears ', ' Ursidae Family ', ' Behavior ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Childhood Abuse ', ' Child Abuse ', ' Cities ', ' Conflict ', ' Conflict (Psychology) ', ' Data Collection ', ' Decision Making ', ' Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, diacetate (ester) ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Drug Preparation ', ' Drug Compounding ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economical Conditions ', ' Economic Conditions ', ' Economics ', ' Employment ', ' Environment ', ' Environment and Public Health ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Ethnic group ', ' facial ', ' faces ', ' Face ', ' Food ', ' Health ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Health Services Research ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Economical Income ', ' Economic Income ', ' Income ', ' Injections ', ' Injection of therapeutic agent ', ' Laboratories ', ' Literature ', ' Logic ', ' Marketing ', ' Medicine ', ' Methods ', ' Neighborhoods ', ' Philadelphia ', ' Poverty ', ' Public Health ', ' public health medicine (field) ', ' Public Housing ', ' ']",NIDA,UNIVERSITY OF PENNSYLVANIA,R01,2014,391993,0.09809855060978054
"Strengthening Hispanic Families via NIDA Prevention Science  This application requests 5 years of K01 support to accelerate the NIDA-focused interdisciplinary research career development of Dr. Ruben Parra-Cardona, a clinician-researcher who seeks to become an independent NIDA prevention researcher committed to underserved Hispanic adolescents and families. His current research evaluates a cultural adaptation of an evidence-based parenting intervention for at-risk Hispanic families with young children (ages 4-11), for which there is potential distal NIDA impact such as reduced risk of starting to smoke tobacco or to use other drugs. Complete evidence on distal benefits of early randomized trial interventions of this type cannot be seen unless the scale of research shifts upward, as in multi-site trials, and unless the measurements include bio-assays to confirm self-report drug use, with probes for potential gene- intervention interactions. Based on the proposed K01 career training objectives, the applicant will acquire the necessary skills to develop an interdisciplinary program of prevention research, informed by epidemiological and biomedical science. During 75% protected time for career development toward independent R01 project leadership, core learning objectives will be met (e.g., RCR, FCOI, grants management). In addition to its core, the training plan has 5 tracks: (1) enhanced mastery of small sample parenting intervention research; (2) enhanced mastery of research design and measurements for larger sample multi-site NIDA prevention research on youth developmental trajectories leading toward NIDA outcomes; (3) enhanced mastery of data analysis for interdependent observations from multiple sites; (4) new learning about integration of biological assays in NIDA family intervention and prevention research via collaborations with expert NIH toxicologists and genetics researchers; (5) mastery of electronic technology complements to current 'in person' intervention delivery and program impact assessment. The proposed award is crucial now that the applicant has become K01-eligible via permanent residency. His college has guaranteed protected time for this K01 career acceleration through structured mentoring program led by a NIDA K05 Senior Scientist, backed by a strong local team of federally funded co-mentors, as well as scientific advisors. Through the proposed K01 award, Dr. Parra-Cardona will gain mastery of the theory and research approaches now being refined by quantitative developmental scientists in new lines of NIDA prevention research. The training plan includes guided readings, coursework, among other activities leading to publications. A prevention pilot study will serve as a 'preliminary study' for a NIDA R01 grant proposal planned for Year 4 of the proposed award. PUBLIC HEALTH RELEVANCE: This application is responsive to NIH and NIDA's strategic plans highlighting the need to implement interdisciplinary programs of research aimed at preventing young people from ever using drugs, as well as ensuring that at-risk and underserved minority populations benefit from these scientific efforts. PUBLIC HEALTH RELEVANCE: NIH and NIDA strategic goals stress (1) encouraging more minority scientists to pursue research careers bolstering their chances of R01 project success, and (2) interdisciplinary research programs on preventing young people from ever using drugs, and ensuring that at-risk and underserved minority populations benefit from these scientific efforts. The proposed K01 award is directly responsive to these strategic goals.            ",Strengthening Hispanic Families via NIDA Prevention Science,8618227,K01DA036747,"['Acceleration ', ' Age ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Award ', ' Dorsum ', ' Back ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Complement Proteins ', ' Complement ', ' Cuban American ', ' Data Analysis ', ' Data Analyses ', ' depression ', ' Mental Depression ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Electronics ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Family ', ' Foundations ', ' Future ', ' Genes ', ' Goals ', ' Grant ', ' Health ', ' interventions research ', ' interventional study ', ' interventional research ', ' intervention research ', ' Intervention Studies ', ' Leadership ', ' Learning ', ' marijuana use ', ' Marijuana Smoking ', ' Mentors ', ' Method LOINC Axis 6 ', ' Methodology ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' Michigan ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Oregon ', ' Parents ', ' pilot study ', ' Pilot Projects ', ' Scientific Publication ', ' Publications ', ' Puerto Rican ', ' Reading ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Residencies ', ' Risk ', ' Science ', ' Smoke ', ' Stress ', ' Target Populations ', ' Technology ', ' Testing ', ' Time ', ' Tobacco ', ' United States ', ' Generations ', ' Parenting ', ' Parenting behavior ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Youth 10-21 ', ' Youth ', ' base ', ' career ', ' Distal ', ' Site ', ' Biological ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Ensure ', ' Training ', ' Stimulus ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' African ', ' school age ', ' School-Age Population ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' drug use ', ' Drug usage ', ' Sample Size ', ' Genetic Research ', ' Funding ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Genetic ', ' Research Specimen ', ' Specimen ', ' Empirical Research ', ' Life ', ' programs ', ' Scientist ', ' LOINC Axis 4 System ', ' System ', ' meetings ', ' collegiate ', ' college ', ' American ', ' experience ', ' stressor ', ' success ', ' Cigarette ', ' Structure ', ' skills ', ' simulation ', ' Participant ', ' Prevention Research ', ' Population Study ', ' Self-Report ', ' Patient Self-Report ', ' cultural values ', ' episodic drinking ', ' binge alcohol consumption ', ' binge drinking ', ' heavy alcohol use ', ' extreme drinking ', ' excessive ethanol ingestion ', ' excessive drinking ', ' excessive alcohol intake ', ' excessive alcohol ingestion ', ' excessive alcohol consumption ', ' excess ethanol ingestion ', ' excess alcohol ingestion ', ' excess alcohol consumption ', ' drink heavily ', ' Heavy Drinking ', ' Prevention ', ' Reporting ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' RuCl2(C6H6)(dmso) ', ' RuBen ', ' Ruthenium Ben ', ' Modeling ', ' Sampling ', ' career development ', ' response ', ' theories ', ' middle school ', ' junior high ', ' junior high school ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Commit ', ' preventing ', ' prevent ', ' Low income ', ' Address ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' High Prevalence ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' Mentored Research Scientist Development Award ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' NIH RFA ', ' Request for Applications ', ' Strategic Planning ', ' Senior Scientist ', ' underserved minority ', ' under-represented minority ', ' Underrepresented Populations ', ' Underrepresented Groups ', ' Underrepresented Minority ', ' Monitor ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' early onset ', ' cost ', ' early initiation drug use ', ' early onset drug use ', ' Minority ', ' efficacy evaluation ', ' willingness ', ' externalizing behavior ', ' Outcome ', ' Population ', ' Prevalence ', ' treatment design ', ' intervention design ', ' therapy design ', ' high risk ', ' public health relevance ', ' evidence base ', ' multi-site trial ', ' intervention effect ', ' randomized trial ', ' reduced substance use ', ' ']",NIDA,MICHIGAN STATE UNIVERSITY,K01,2014,177428,0.06448522081204047
"Drug Use Among Hispanic Emerging Adults    DESCRIPTION (provided by applicant): Among Hispanic adolescents, cultural factors such as acculturation, perceived discrimination, and acculturative stress are risk factors for drug use. Previous studies suggest that the effects of acculturation on drug use may be mediated by family functioning; when adolescents acculturate more rapidly than their parents, the parent- child acculturation discrepancy can lead to breakdowns in family communication and cohesion and increases in family conflict, which in turn can lead to risky behaviors such as drug use among the adolescents. Although there is considerable information about the role of family acculturation patterns in drug use among Hispanic adolescents, we do not know how family acculturation patterns affect adolescents as they transition into the next stage of life, emerging adulthood. Emerging adulthood, a provisional stage in which young adults try out adult roles but may not become firmly entrenched in them, is characterized by identity exploration, residential instability, self-focus, a subjective feeling of being between adolescence and true adulthood, and increased opportunities. In general, individuals who navigate this transition smoothly emerge with a more developed sense of identity, successful interpersonal relationships, new life roles, and minimal levels of substance use. However, the high level of independence and low level of social constraints that occur during emerging adulthood also make this a high-risk period for drug use and other problem behaviors. Understanding how factors in adolescence affect drug use in early adulthood can lead to better intervention efforts for adolescents. More research is needed to determine how cultural factors influence the transition to emerging adulthood among Hispanics and to identify the risk factors for escalation of drug use during this pivotal transition. This continuation application proposes to follow an established cohort of Hispanic adolescents (12th graders in the 2008-2009 school year) for an additional 4 years to identify the predictors of their drug use trajectories during the transition to emerging adulthood. The Specific Aims of the proposed research are the following: (1) Conduct an additional 4 annual surveys of the participants; (2) Construct individual growth curves to describe their use of tobacco, alcohol, marijuana, and other drugs; (3) Identify the predictors of the growth curve parameters, including cultural factors, peer factors, substance use during high school, psychological factors, and demographic factors; (4) Evaluate emerging adulthood variables as potential mediators of these influences, including identity exploration, experimentation / possibilities, instability (residential mobility, role transitions), self-focus, and subjective experience of being in-between adolescence and adulthood; and (5) Make recommendations for the development of improved health education messages to prevent drug use among acculturating Hispanics during the transition to emerging adulthood.  PUBLIC HEALTH RELEVANCE: This application addresses the public health goals of preventing and reducing substance use among young adults. It also aims to reduce health disparities by identifying risk and protective factors that are specific to Hispanics.         ",Drug Use Among Hispanic Emerging Adults,8606203,R01DA016310,"['Cultural Assimilation ', ' Acculturation ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Alcohol Chemical Class ', ' Alcohols ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' Communication ', ' Conflict ', ' Conflict (Psychology) ', ' Demographic Factors ', ' emotional dependency ', ' Dependency ', ' Dependency (Psychology) ', ' Discrimination ', ' Cognitive Discrimination ', ' Discrimination (Psychology) ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Employment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Extended Family ', ' Family ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' Health Tutoring ', ' Health Instruction ', ' Health education ', ' Spanish Americans ', ' Hispanic Americans ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' long-term study ', ' Longitudinal Studies ', ' Los Angeles ', ' achievement Mainstream Education ', ' Mainstreaming ', ' Educational Mainstreaming ', ' Mainstreaming (Education) ', ' marijuana ', ' Marihuana ', ' Marriage ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' parent offspring interaction ', ' parent child interaction ', ' Parent-Child Relationship ', ' Parent-Child Relations ', ' Parents ', ' Psychological Factors ', ' psychosocial variables ', ' Psychosocial Factor ', ' Public Health ', ' public health medicine (field) ', ' Recommendation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Residential Mobility ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Schools ', ' sexual dimorphism (noncellular) ', ' gender difference ', ' Sex Differences ', ' Sex Characteristics ', ' Societies ', ' Stress ', ' Students ', ' Survey Instrument ', ' Surveys ', ' Friends ', ' Gender ', ' Generations ', ' Assimilations ', ' Family member ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' career ', ' Friendships ', ' role model ', ' improved ', ' Area ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Training ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' drug use ', ' Drug usage ', ' behavioral problem ', ' Problem behavior ', ' Immigrant ', ' Staging ', ' Life ', ' Home ', ' Home environment ', ' Pattern ', ' Occupational ', ' Tobacco Consumption ', ' Tobacco use ', ' behavioral/social science ', ' experience ', ' cohesion ', ' high school ', ' cohort ', ' Participant ', ' peer ', ' family structure ', ' cultural values ', ' high school junior ', ' 11th grade ', ' eleventh grade ', ' social ', ' parent monitoring ', ' parental monitoring ', ' Emotional ', ' Deterioration ', ' ethnic discrimination ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' prevent drug use ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' health disparities ', ' health disparity ', ' preventing ', ' prevent ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Data ', ' developmental ', ' Development ', ' feelings ', ' Feeling ', ' pathway ', ' Pathway interactions ', ' Population ', ' high risk ', ' social science research ', ' early adulthood ', ' emerging adult ', ' emerging adulthood ', ' reduced substance use ', ' Adolescent and Young Adult ', ' High School Student ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2014,514752,0.0842436992388866
"Factors for enhanced neurotoxicity in methamphetamine abuse in HIV infection    DESCRIPTION (provided by applicant): This application is submitted in response to PAR-09-011 Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) requested by the National Institute on Drug Abuse (NIDA). This proposed research program is timely since it focuses on two ofthe major health disparity issues in Hawaii, namely, methamphetamine abuse and HIV infection. Recent surveys indicate that Native Hawaiians or other Pacific islanders have the highest rate of methamphetamine use among persons aged 12 or older in the United States. Although HIV/AIDS infection rate is relatively low in Hawaii compared to other major metropolis, the rates are increasing among Hawaiians. This DIDARP will include two primary and one pilot research projects that will focus on mechanisms and factors that might enhance neurotoxicity associated with methamphetamine of HIV. We aim to enhance the capacity for drug abuse research at UH by creating this small translational research team. This group will take advantage and build on the expertise of the few but outstanding existing clinical drug abuse and HIV researchers and basic scientists. We aim to enable UH to develop a strong clinical and translational drug abuse research program. To complement these projects, we additionally propose training and career development activities that wil offer exciting opportunities for DIDARP investigators and others at UH through the Administrative and Training Core. The Faculty in the Core will provide guidance and mentorship for these junior faculty and graduate students, through infrastructure support, educational courses, seminars, and a dedicated DIDARP website, We have obtained institutional support for two additional graduate students for the program. We also have recruited 4 distinguished External Advisory Committee members with expertise related to the proposed research; each has enthusiastically agreed to provide their advice and letter of support for the development of this DIDARP at UH.  PUBLIC HEALTH RELEVANCE (See instructions); The current proposal attempts to strengthen drug abuse and HIV research capacity by developing translational research teams at the University of Hawaii, and to train junior investigators and students in drug abuse and HIV research.         ",Factors for enhanced neurotoxicity in methamphetamine abuse in HIV infection,8603230,R24DA027318,"['Abbreviations ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' aminoacid ', ' Amino Acids ', ' Animals ', ' Theriacs ', ' Antidotes ', ' anti-oxidant ', ' Antioxidants ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Intracranial Central Nervous System Disorders ', ' Intracranial CNS Disorders ', ' Encephalon Diseases ', ' Brain Disorders ', ' Brain Diseases ', ' Transporter Protein ', ' Transport Proteins ', ' Carrier Proteins ', ' Cells ', ' Complement Proteins ', ' Complement ', ' Terminal Deoxyribonucleotidyltransferase ', ' Terminal Deoxyribonucleotidyl Transferase ', ' Terminal Deoxynucleotidyltransferase ', ' Terminal Deoxynucleotidyl Transferase ', ' Terminal Addition Enzyme ', ' EC 2.7.7.31 ', ' Desoxynucleotidyltransferase ', ' Desoxynucleotidyl Transferase ', ' Deoxynucleotidyltransferase ', ' Deoxynucleotidyl Transferase ', ' DNA Nucleotidylexotransferase ', ' Hydroxytyramine ', ' 4-(2-Aminoethyl)-1,2-benzenediol ', ' 3,4-Dihydroxyphenethylamine ', ' Dopamine ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' balance function ', ' balance ', ' Equilibrium ', ' Faculty ', ' Family ', ' Glucose-6-Phosphate Dehydrogenase ', ' EC 1.1.1.49 ', ' Glucosephosphate Dehydrogenase ', ' gamma-L-Glutamyl-L-Cysteinylglycine ', ' gamma-L-Glu-L-Cys-Gly ', ' Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)- ', ' Glutathione ', ' glutathione peroxidase ', ' 2-amino-1,7-dihydro-6H-purin-6-one ', ' 2-Amino-6-Hydroxypurine ', ' Guanine ', ' Hawaii ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Hydroperoxide ', ' Hydrogen Peroxide (H2O2) ', ' H2O2 ', ' Hydrogen Peroxide ', ' Hypoxanthines ', ' Infection ', ' Tyrosine Iodinase ', ' Thyroperoxidase ', ' Thyroid Peroxidase ', ' Monoiodotyrosine Deiodinase ', ' Monodeiodinase ', ' Iodotyrosine Deiodinase ', ' Iodotyrosine Deiodase ', ' Iodoperoxidase (Heme Type) ', ' Iodinase ', ' EC 1.11.1.8 ', ' Deiodinase ', "" 5'-Deiodinase "", ' Iodide Peroxidase ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Memory ', ' Mentorship ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Methamphetamine ', ' body movement ', ' Movement ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Persons ', ' Needles ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' nervous system disorder ', ' neurotoxicant ', ' Neurotoxins ', ' endothelial cell derived relaxing factor ', ' Nitrogen Protoxide ', ' Nitrogen Monoxide ', ' Mononitrogen Monoxide ', ' Endothelium-Derived Nitric Oxide ', ' Endogenous Nitrate Vasodilator ', ' Nitric Oxide ', ' oxidation reduction reaction ', ' Redox ', ' Oxidation-Reduction ', ' gene product ', ' Proteins ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Se element ', ' Selenium ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Students ', ' Survey Instrument ', ' Surveys ', ' Transactivation ', ' Trans-Activation (Genetics) ', ' United States ', ' Universities ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Virus Diseases ', ' 3-selenyl-L-alanine ', ' 3-Selenylalanine ', ' Selenocysteine ', ' selenoprotein ', ' electron acceptor ', ' Oxidizing Agents ', ' Oxidants ', ' dopamine transporter proteins ', ' DAT dopamine transporter ', ' dopamine transporter ', ' peroxynitrite ', ' Peroxonitrite ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Malnutrition ', ' Task Forces ', ' Advisory Committees ', ' enhancing factor ', ' Organ ', ' Label ', ' Clinical ', ' Long-Term Potentiation ', ' Null Mouse ', ' Knock-out Mice ', ' Knockout Mice ', ' Susceptibility ', ' Predisposition ', ' Training ', ' insight ', ' selenium deficiency ', ' Oxidative Stress ', ' selenophosphate synthetase ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' neuroAIDS ', ' AIDS neuropathy ', ' Letters ', ' Micronutrients ', ' Genetic ', ' Hawaiian ', ' Hawaiian population ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Impaired cognition ', ' Heavy Metals ', ' Life ', ' programs ', ' Scientist ', ' intraperitoneal ', ' LOINC Axis 4 System ', ' System ', ' Viral ', ' EPSP ', ' Excitatory Postsynaptic Potentials ', ' Affective Disorders ', ' Mood Disorders ', ' neuroprotection ', ' reverse transcriptase PCR ', ' RTPCR ', ' RT-PCR ', ' Reverse Transcriptase Polymerase Chain Reaction ', ' monoamine ', ' reuptake ', ' Toxicities ', ' Toxic effect ', ' member ', ' graduate student ', ' Dopamine neuron ', ' DA Neuron ', ' dopaminergic neuron ', ' career development ', ' LOINC Axis 2 Property ', ' Property ', ' response ', ' thioredoxin reductase ', ' Central Nervous System ', ' CNS Nervous System ', ' Neuraxis ', ' developmental disorder ', ' developmental disease/disorder ', ' Committee Members ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Institution ', ' Brain region ', ' preventing ', ' prevent ', ' methamphetamine abuse ', ' Intake ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Native Hawaiian or Other Pacific Islander ', ' qRTPCR ', ' Quantitative RTPCR ', ' Quantitative Reverse Transcriptase PCR ', ' Infrastructure ', ' Research Infrastructure ', ' Supplementation ', ' Rodent Model ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' Knockout ', ' Knock-out ', ' developmental ', ' Development ', ' website ', ' web site ', ' Dietary Selenium ', ' Instruction ', ' neuron injury ', ' Neuronal Injury ', ' meth exposure ', ' methamphetamine exposure ', ' Population ', ' aged ', ' short hairpin RNA ', ' shRNA ', ' small hairpin RNA ', ' Cellular model ', ' Cell model ', ' neuronal toxicity ', ' neuron toxicity ', ' neurotoxicity ', ' selenoenzyme ', ' dopamine toxicity ', ' neuronal survival ', ' public health relevance ', ' nondrug ', ' non-drug ', ' ']",NIDA,UNIVERSITY OF HAWAII AT MANOA,R24,2014,418524,0.13516613646182707
"Epidemiology, Prevention and Treatment of HCV in Young Adult Persons who Inject Drugs in non-urban New Mexico     DESCRIPTION (provided by applicant): The hepatitis C virus (HCV) epidemic in the U.S. is concentrated in people who inject drugs (PWID). Increasing reports of HCV including outbreaks of HCV in young adult PWID in non-urban locales have prompted concerns about an expanding epidemic. Several investigations suggest that that these spikes in HCV infection are linked to sharp increases in prescription opiate use that has been trending in the U.S, and which have resulted in young adults transitioning from prescription opiates to injection use, particularly heroin. Young adult PWID in non-urban areas may be at increased risk of infection, from the combination of high viral infectivity and high prevalence of HCV in injecting groups, together with a lack of knowledge regarding infection routes and effective prevention. New Mexico is one of the states leading recorded increases in HCV in young adults, ranking 2nd in the CDC's Emerging Infections Program (EIP), Hepatitis Surveillance Demonstration Sites project, in 2011 for the number and rate of HCV cases reported. Heroin, prescription opioids, and other drugs are also accounting for this state having one of the highest overdose rates in the country. Between October 2013 and March 2014, the New Mexico Department of Health recorded 211 cases of HCV among young adults in a pilot surveillance study, demonstrating the gravity of the problem. To address the need for prevention, care and treatment services against HCV in this population, we propose epidemiological and service uptake research in two regions of New Mexico where young adult PWID have been impacted by drug use and HCV. We will initiate a prospective cohort study of young adult non-urban PWID who will be recruited and followed in two health regions of New Mexico (the South West and North East) to: (1) gather epidemiologic data on risk behaviors, drug use patterns, injection networks, prevention needs, and health service utilization; (2) to refer young adult PWID to HCV care services, as well as other prevention and treatment opportunities including harm reduction and drug treatment, and assess rates of successful linkage, including the  cascade of care; (3) to examine factors that may contribute to non-treatment, poor adherence, and failure to achieve SVR among young adult PWID with chronic HCV infection; and (4) assess reinfection events among young adult PWID who are treated for HCV and achieve SVR. Our proposal, which we refer to in this application as New Mexico H-TIPS, will also include testing and referrals for HIV and HBV co-infections as well. A collaborative group of public health and clinical specialists linked with a strong prevention and clinical service infrastructure in New Mexico will ensure successful implementation of this research. Results from this proposed research will impact a diverse young population disproportionately at risk for HCV and reduce health disparities in a region highly impacted by drug use and HCV.         PUBLIC HEALTH RELEVANCE: This proposed three-year research plan seeks to assess the epidemiology of HCV infection in young adult people who inject drugs (PWID) in non-urban areas of New Mexico. The proposed New Mexico H-TIPS project will study factors that will inform effective and integrated care and prevention models for this high-risk population. We have significant expertise in working with the target population, including recruitment and retention and in identifying HCV infection, which together with a unique infrastructure for preventive and clinical services in New Mexico, including HCV and drug treatment make this proposal highly likely to succeed. This research will contribute significantly to further knowledge of  combination  HCV prevention, and how to impact population prevalence and incidence of HCV in New Mexico and elsewhere.            ","Epidemiology, Prevention and Treatment of HCV in Young Adult Persons who Inject Drugs in non-urban New Mexico",8843617,U18PS004568,[''],NCHHSTP,UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,U18,2014,299973,0.0839915446261307
"Southern Ohio Prevents Hepatitis Project (StOPHeP)     DESCRIPTION (provided by applicant): The overall goal of this project is to develop an integrated comprehensive approach for detection, prevention, linkage to care and treatment for hepatitis C (HCV) among young adults (18-30 years old) who have a history of injection drug use (people who inject drugs, PWID) and live in 21 non-urban southern Ohio counties. We will accomplish this by collaborating with addiction treatment providers, public health agencies, and syringe exchange programs in the target areas to identify, test, refer and link PWID to prevention and treatment services. The target area includes 21 suburban (large fringe metro, small metro) and rural (micropolitian, non-core) counties in southern Ohio, 18 of which are classified as Appalachian. To develop and implement a comprehensive strategy to address the high prevalence of HCV in southern Ohio, we will 1) identify and describe the demographic characteristics and risk behaviors and injection networks of young non-urban PWID, and test them for HCV, hepatitis B (HBV) and HIV; 2) use Peer Navigators to link young non-urban PWID to addiction treatment programs and to primary care, mental health and specialty treatment (infectious diseases, hepatology), including linkage to health insurance through the Affordable Care Act and expanded Ohio Medicaid; 3) use Peer Navigators to provide education on safe injection practices to prevent hepatitis and HIV; and link PWID to syringe exchange programs as available in target communities; 4) use a closed social networking site (SNS) to provide peer-facilitated support for the uninfected prevention group (Prevention Room) and for the linkage-to-care group for PWID with HBV, HCV and/or HIV infection (Treatment Room); available both online and via smartphone; and 5) perform follow-up assessment and re-testing of study participants for HCV within 12 months of study entry to determine rates of new HCV infection and reinfection after successful treatment. Since the majority of the target counties are in Appalachia, this proposal will address healthcare inequities that are endemic to this region, and will provide data on which to base future public health initiatives to reduce HCV among young non-urban PWID.         PUBLIC HEALTH RELEVANCE: Narrative Injection drug use (IDU) among young adults in rural areas and the resultant epidemic of chronic hepatitis C has become a significant public health problem, but there are few data about the demographics and risk behaviors of rural IDUs to inform public health policies and practice. The use of Peer Navigators and social media will enable us to provide peer support for isolated individuals and ensure study retention and linkage to care. Moreover, linkage to prevention, drug treatment and medical care including infectious disease care for chronic viral infections  will provide data on the outcomes of these efforts in a rural setting.            ",Southern Ohio Prevents Hepatitis Project (StOPHeP),8842531,U18PS004566,[''],NCHHSTP,UNIVERSITY OF CINCINNATI,U18,2014,299859,0.07656359361115665
"Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS)     DESCRIPTION (provided by applicant):  There is a critical need to develop a diverse pool of highly trained clinician scholars to foster the development of biomedical, behavioral and clinical research related to drug abuse, addiction, and HIV prevention and treatment in general medical settings. Patients who abuse substances are more likely to be seen in general medical settings such as emergency departments (ED), general medical primary care clinics and inpatient wards, HIV and adolescent health clinics, and women's health centers. These patients often present with a complex array of acute consequences and complications (e.g. intoxication, overdose, withdrawal, trauma and infectious diseases) of substance use as well as chronic conditions such as HIV disease, hepatitis, pulmonary and cardiovascular disease. Objectives: The Yale-Drug Abuse, Addiction, and HIV Research Scholars (DAHRS) program provides a comprehensive three year post-doctorate, interdisciplinary, Mentored Career Development Program to improve drug abuse, addiction, and HIV medical outcomes integrating prevention and treatment in general medical settings including ED, primary care, HIV, adolescent, and women's health clinics. Specifically, Yale-DAHRS will: [Aim 1] Develop clinician scientists with the knowledge, skills, and ability to become independent investigators, generating findings of practical value with significant impact to improve health outcomes of patients with and at risk for drug abuse, addiction, and HIV; [Aim 2] Develop future leaders by providing Scholars with leadership tools and skills and creating individualized programs to ensure success in leading multidisciplinary research teams in studying drug abuse, addiction and HIV, and implementation and integration of research findings into general medical settings; and [Aim 3] Enhance the diversity of drug abuse, addiction, and HIV researchers. Addressing women and minority faculty under representation will enhance the diversity of investigators and research topics, broaden perspectives in setting research priorities, increase clinical trial participation, and expand knowledge. Working synergistically with Yale's established training programs in drug abuse, HIV and clinical investigation, Yale- DAHRS will capitalize on existing academic infrastructure and expertise to ensure success. Unique, features include: (1) An interdisciplinary, diverse faculty of independent researchers in illicit and prescription drug abuse and addiction, tobacco, alcohol, HIV, and medical complexities such as pain and hepatitis C; (2) Synergy with well established, high quality post-doctoral training programs at Yale; (3) The use of clinical informatics for data collection, data management, diagnostic tool development, and information dissemination; and (4) The integration of such diverse fields as public health, informatics, clinical epidemiology, systems engineering and demography with the traditional clinical sciences of internal medicine, emergency medicine, HIV medicine, pediatrics, obstetrics and gynecology, psychiatry, and psychology; (5) Established clinical research laboratories, including the Yale-New Haven Hospital, a tertiary care center for southern New England and a community hospital for the Greater New Haven Area, serving an ethnically, racially, culturally, and economically diverse population, a Veterans Affairs Medical Center and community treatment centers such as the APT Foundation and Federally Qualified Health Centers; (6) Synergies with established research centers and institutes such as the Center for Interdisciplinary Research on AIDS and the Veterans Aging Cohort on HIV. Career Development Plan: Yale-DAHRS is a three year research training program that will prepare a total of six clinician investigators for careers focusing on drug abuse, addiction, and HIV in general medical settings during its first funding cycle. Scholars will earn the Master in Health Sciences degree, combining rigorous training in research methodology, statistics and design with seminars in topics related to drug abuse, addiction, and HIV content, leadership, grant writing and responsible conduct of research. Candidates will complete published mentored research project(s) and prepare an application for the next career step; i.e. NIH R21, R03, R15, R34 mechanism. The collaboration of the multidisciplinary faculty and the combined robust strengths of two principal investigators from Emergency and Internal Medicine, both with extensive experience mentoring and as independent funded investigators will drive the Yale-DAHRS program. Potential Research Projects: Multiple research projects are ""shovel ready"" for Scholar training and can be completed within our allotted time frame, such as secondary data analysis using national large datasets e.g. VA Aging Cohort (HIV); risk factors, prevention and treatment of prescription drug abuse, office-based treatment of opioid dependence with buprenorphine, systematic reviews and meta-analyses, creation of cost effective evaluation models for patients with drug abuse, addiction and HIV including prescription drug abuse; investigation of gender and racial/ethnic disparities in identification and treatment interventions and outcomes; evaluation of screening, and treatment initiation in special populations (i.e. adolescent-elderly, veterans, incarcerated, HIV); comparison of models of screening, brief intervention and referral to treatment (SBIRT) delivery by providers and other innovative technologies; effectiveness and implementation of SBIRT science in general medicine practice with acute and chronic medical complexities.         PUBLIC HEALTH RELEVANCE:  Drug abuse, addiction, and HIV are significant public health issues, as they affect the health and well-being of a large portion of the population; have substantial negative health outcomes on individuals; and are extremely costly to the health care system. An investment in research to improve substance abuse and medical health outcomes is greatly needed. The proposed Yale-Drug Abuse, Addiction, and HIV Research Scholars (DAHRS) program focusing on general medical settings with patients throughout the life cycle will provide a three year post-doctoral, interdisciplinary, Mentored Career Development Program training six clinician-scientists for independent research careers in the field of drug abuse, addiction, and HIV through integration of prevention and treatment in general medical settings.            ","Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS)",8650799,K12DA033312,"['Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Alcohol Chemical Class ', ' Alcohols ', ' Behavioral Research ', ' Biomedical Research ', ' 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5alpha,7alpha(S))- ', ' Buprenorphine ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Clinical Informatics ', ' Clinical Study ', ' Clinical Research ', ' clinical investigation ', ' Clinical Trials ', ' Infectious Disorder ', ' Infectious Diseases and Manifestations ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communicable Diseases ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' Population Studies / Demography ', ' Demography ', ' disease/disorder ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Emergency Medicine ', ' Engineering ', ' Faculty ', ' Foundations ', ' Future ', ' Grant ', ' Gynecology ', ' Health ', ' Hepatitis ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Hospitals ', ' Community Hospitals ', ' Information Dissemination ', ' Inpatients ', ' Institutes ', ' Internal Medicine ', ' Laboratories ', ' Leadership ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Medicine ', ' Mentors ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Northeastern United States ', ' New England ', ' Obstetrics ', ' Discipline of obstetrics ', ' Overdose ', ' Painful ', ' Pain ', ' Patients ', ' Pediatrics ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Psychiatry ', ' Psychology ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' Science ', ' statistics ', ' Time ', ' Tobacco ', ' Training Programs ', ' Veterans ', ' Woman ', ' Work ', ' Writing ', ' Gender ', ' Female Health ', "" Women's Health "", ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Research Methods ', ' Research Methodology ', ' Dataset ', ' Data Set ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' base ', ' career ', ' improved ', ' Area ', ' Acute ', ' Chronic ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Ensure ', ' Evaluation ', ' Training ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Withdrawal ', ' Fostering ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Development Plans ', ' Funding ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' tool ', ' Diagnostic ', ' Research Priority ', ' Knowledge ', ' programs ', ' Scientist ', ' Investigation ', ' Complex ', ' Clinic ', ' LOINC Axis 4 System ', ' System ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' Opiate Addiction ', ' Emergency room ', ' Emergency Department ', ' Accident and Emergency department ', ' Medical center ', ' innovative technologies ', ' data management ', ' experience ', ' Special Population ', ' named group ', ' success ', ' cohort ', ' skills ', ' Prevention ', ' Intoxication ', ' prescription drug abuse ', ' Modeling ', ' career development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' consumer informatics ', ' Health Informatics ', ' Public Health Informatics ', ' Provider ', ' Effectiveness ', ' ward ', ' Address ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Health Sciences ', ' Scholars Program ', ' NCI Scholars Program ', ' Infrastructure ', ' Research Infrastructure ', ' Research Training ', ' Clinical Sciences ', ' Principal Investigator ', ' developmental ', ' Development ', ' Federally Qualified Health Center ', ' systematic review ', ' treatment center ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' cost-effective ', ' cost effective ', ' Trauma ', ' tertiary care ', ' postdoctoral training ', ' post-doctoral training ', ' clinical epidemiology ', ' addictive disorder ', ' addiction ', ' tool development ', ' racial and ethnic disparities ', ' screening, brief intervention, and referral to treatment ', ' SBIRT ', ' screening, brief intervention, referral, and treatment ', ' responsible research conduct ', ' screening ', ' ']",NIDA,YALE UNIVERSITY,K12,2014,501788,0.10922386071168934
"Cohort Studies on HIV/AIDS and Substance Abuse in Miami     DESCRIPTION (provided by applicant): Liver disease is a major cause of death in HIV infected persons in the United States. While advances in antiretroviral therapy have significantly reduced HIV-related mortality, co-infection with hepatitis C virus (HCV), is widespread and accelerates progression of liver fibrosis to cirrhosis and liver carcinoma. In addition, substance abuse accelerates HIV disease, and may facilitate progression of liver fibrosis. The primary goal of this proposal is to continue to follow the existing Miami Adult Studies on HIV (MASH) cohort, its specimen repository and database, and expand it from the current 881 to 1,500 study participants. The purpose is to generate collaborative studies to investigate the impact of cocaine, by far the most prevalent drug of abuse in South Florida, on HIV infection, HIV/HCV co-infection, and on long-term morbidity with a focus on liver disease in this population with disparities in access to care. HIV and HCV un-infected cocaine users and non-users will also be recruited to allow determination of the impact of cocaine use alone, as well as the interaction of cocaine use with HIV, HCV, and HIV/HCV co-infection. As new and more effective treatments and access to care for HIV, HCV and drug abuse become available, maintaining a well- characterized cohort, specimen repository and database will create a strong resource platform for current and future collaborative research. Observing the uptake of new HCV treatments and potential new cocaine cessation programs in this at-risk population with health disparities will provide data on barriers and facilitators to effective treatments to prevent long-term morbidity and mortality. We have followed the MASH cohort of 881 participants for up to 12 years with excellent retention rates, and have created a specimen repository and a database. The MASH cohort in Miami is unique because it will be a mostly Hispanic cohort with a large number of African Americans, women, non-injector drug users, with predominantly heterosexual HIV- transmission etiology. We propose to (1) compare the progression of liver fibrosis over four years among cocaine users and non-users in HIV+/HCV-, HIV+/HCV+, HIV-/HCV+, and HIV-/HCV-, using a novel non- invasive diagnostic device, the Magnetic Resonance Elastography (MRE). We also propose to (2) compare the pattern over four years of biomarkers and identify genetic markers associated with the mechanisms of liver fibrosis among cocaine users and non-users. Understanding the role of cocaine use in the context of HIV and HIV/HCV co-infections and lack of lasting effects of treatments for cocaine use cessation are crucial in order to gain insights into the pathogenesis and disease outcomes, and to provide the basis for identifying antifibrotic therapies such as oxidative stress, which are amenable to intervention. These studies will be critical for program development, appropriate interventions, and for improving health in this population.         PUBLIC HEALTH RELEVANCE: Understanding the role of cocaine use in the context of HIV, HCV and HIV/HCV co-infections with focus on progression of liver fibrosis, is crucial in gaining insights into the disease pathogenesis, outcomes, and the role of co-morbidities and health disparities of this population. This research will provide evidence-based information for program development and evaluation, appropriate and effective interventions, and for improving health in this population.            ",Cohort Studies on HIV/AIDS and Substance Abuse in Miami,8985966,U01DA040381,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Alcohol Chemical Class ', ' Alcohols ', ' Animals ', ' Cause of Death ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Cocaine ', ' Cocaine Abuse ', ' Concurrent Studies ', ' Cohort Studies ', ' co-morbidity ', ' Comorbidity ', ' Death ', ' Cessation of life ', ' disease/disorder ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Florida ', ' Future ', ' Genetic Markers ', ' genetic biomarker ', ' Goals ', ' Health ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Health Services Accessibility ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' liver carcinoma ', ' Liver Cells Carcinoma ', ' Hepatoma ', ' Hepatocellular cancer ', ' Hepatocellular Carcinoma ', ' Primary carcinoma of the liver cells ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Immunity ', ' immunosuppression ', ' immune suppression ', ' Immunosuppressive Effect ', ' Immunosuppressions (Physiology) ', ' Immunosuppression Effect ', ' Natural immunosuppression ', ' In Vitro ', ' Laboratories ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' liver disorder ', ' hepatopathy ', ' hepatic disease ', ' Hepatic Disorder ', ' Liver diseases ', ' Morbidity ', ' Morbidity - disease rate ', ' Mortality ', ' Mortality Vital Statistics ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Program Development ', ' Program Evaluation ', ' QOL ', ' Quality of life ', ' recruit ', ' Recruitment Activity ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Research Resources ', ' Resources ', ' Risk Factors ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' United States ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Virus Diseases ', ' Woman ', ' cytokine ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Malnutrition ', ' Treatment Failure ', ' base ', ' improved ', ' Area ', ' Clinical ', ' Animal Experiments ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' insight ', ' Stimulus ', ' Cocaine Users ', ' hepatic fibrosis ', ' Liver Fibrosis ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Populations at Risk ', ' Oxidative Stress ', ' Funding ', ' uptake ', ' Metabolic ', ' Drug user ', ' chronic liver disorder ', ' chronic hepatic disorder ', ' chronic hepatic disease ', ' chronic liver disease ', ' Diagnostic ', ' Nature ', ' Research Specimen ', ' Specimen ', ' programs ', ' Pattern ', ' MonoS ', ' Mono-S ', ' interest ', ' fibrogenesis ', ' cohort ', ' Disease Outcome ', ' novel ', ' Participant ', ' Devices ', ' Pathogenesis ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' repository ', ' time interval ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' preventing ', ' prevent ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Data ', ' Prognostic/Survival Factor ', ' General Prognostic Factor ', ' Prognostic Factor ', ' Magnetic Resonance Elastography ', ' Transmission ', ' transmission process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Heterosexuals ', ' Behavioral ', ' cirrhotic ', ' Cirrhosis ', ' antiretroviral therapy ', ' Outcome ', ' Population ', ' treatment effect ', ' drugs of abuse ', ' drugs abused ', ' abused drugs ', ' drug of abuse ', ' public health relevance ', ' effective intervention ', ' evidence base ', ' FDA approved ', ' effective treatment ', ' effective therapy ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' cocaine use ', ' ']",NIDA,FLORIDA INTERNATIONAL UNIVERSITY,U01,2015,1116569,0.03301287487101885
"Health Consequences of Drug Use and IPV Trajectories for Young Latinas     DESCRIPTION (provided by applicant):  Few empirical studies have documented the life trajectories of gang-affiliated adolescent females and the long- term health consequences of adolescent drug use and partner violence victimization. The purpose of this study is to identify and determine how distinct drug use and intimate partner violence victimization trajectories that emerge in adolescence through young adulthood contribute to physical and mental health outcomes among Mexican American women within the context of a highly disadvantaged community. This group of women are particularly vulnerable given they have low rates of access and utilization of health care, are the most likely age group to be uninsured, and represent a nexus of risk, vulnerability and potentially high costs to communities given their reproductive and sexual health stage of life. This application proposes a 15 year follow up of a cohort of Mexican American adolescent females previously identified in a CDC funded study who were affiliated with male gang members during their adolescence and involved in high rates of drug use and victims of intimate partner violence. Building upon the research teams previous studies and using analytical tools from the theory of gender and power and social bonding theory, this application will implement a concurrent mixed methods nested design approach to provide a comprehensive understanding of the long-term consequences of drug use and IPV. The sample will consist of 300 young adult Mexican-American females. The specific aims for this study are: 1) determine the prevalence of physical (cardiovascular and metabolic risk markers and STI infection) and mental (depression, PTSD, anxiety/stress) health outcomes; 2) identify and characterize distinct drug use and IPV trajectories from adolescence through young adulthood; 3) determine whether sexual relationship power and family social bonds during distinct age-graded stages alter drug use and IPV trajectories and health outcomes; and 4) characterize qualitatively the culture and community context and their influence on drug use and IPV trajectories over the life course. This research will have an important positive impact by identifying women who are at the highest risk for developing harmful drug and IPV trajectories as they transition into young adulthood. In doing this, we will lay the foundation for identifying critical points of behavioral intervention during key age-graded periods as well as culturally and contextually appropriate values and strategies that will reduce health disparities among similar high-risk female populations that have gone underrepresented in existing research.         PUBLIC HEALTH RELEVANCE:  This application seek a comprehensive understanding of the long term health consequences of drug use and intimate partner violence victimization physical and mental health outcomes among a vulnerable cohort of Mexican-American females recruited over 15 years ago who were affiliated with male gang members during their adolescence. The study will provide a unique opportunity to investigate detrimental life trajectories contributing t the prevalence of cardiovascular and metabolic risk markers, infection, depression, PTSD, anxiety and stress within a marginalized and underserved community context. Findings will contribute to policy discourse that can lead to the development of innovative public health programs and campaigns that will reduce health disparities among minority women. PHS 398/2590 (Rev. 11/07) Page Continuation Format Page            ",Health Consequences of Drug Use and IPV Trajectories for Young Latinas,8964849,R01DA039269,"['Accounting ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adolescent girl ', ' Female Adolescents ', ' Age ', ' Anxiety ', ' Attention ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular system (all sites) ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardiovascular system ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Complement Proteins ', ' Complement ', ' Decision Making ', ' depression ', ' Mental Depression ', ' Disadvantaged ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Family ', ' Female ', ' Foundations ', ' Health ', ' Heterogeneity ', ' Infection ', ' knowledge of results ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Longterm Effects ', ' Long-Term Effects ', ' male ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' Neighborhoods ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Public Health ', ' public health medicine (field) ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Risk ', ' Stress ', ' traumatic neurosis ', ' Posttraumatic Stress Disorders ', ' Posttraumatic Neuroses ', ' Post-Traumatic Neuroses ', ' PTSD ', ' Post-Traumatic Stress Disorders ', ' violent behavior ', ' violent ', ' Violence ', ' Woman ', ' Friends ', ' Gender ', ' Female Health ', "" Women's Health "", ' health care ', ' Healthcare ', ' Latino ', ' Uninsured ', ' Youth 10-21 ', ' Youth ', ' Caring ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Gap Junctions ', ' mental ', ' Psyche structure ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' young adulthood ', ' adult youth ', ' young adult ', ' Policies ', ' drug use ', ' Drug usage ', ' Female Groups ', "" Women's Group "", ' Wife ', ' Reproductive Health ', ' Funding ', ' Metabolic ', ' Staging ', ' Shapes ', ' Sister ', ' syndrome x ', ' pre-diabetes ', ' Prediabetic State ', ' Prediabetes ', ' Prediabetes syndrome ', ' Knowledge ', ' Life ', ' programs ', ' Victimization ', ' physical health ', ' physical conditioning ', ' Services ', ' age group ', ' cohort ', ' member ', ' gang ', ' social ', ' social bonding ', ' social attachment ', ' Sampling ', ' girls ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Latinas ', ' Latina ', ' health disparities ', ' health disparity ', ' Low income ', ' Address ', ' Health system ', ' Sexual Health ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Risk Marker ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' violent partner ', ' problem, partner, abuse, violent ', ' partner violence ', ' sexual relationship ', ' cost ', ' youth drug use ', ' adolescent drug use ', ' intimate partner violence ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' analytical tool ', ' high risk ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' young man ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2015,636528,0.11929657389475455
"The Development and Evaluation of the Ho'ouna Pono Drug Prevention Curriculum     DESCRIPTION (provided by applicant): Research has indicated that Native Hawaiian youth have significantly higher rates of drug use than their non-Hawaiian counterparts (e.g., Wong, Klingle, & Price, 2004; Mayeda, Hishinuma, Nishimura, Garcia- Santiago, & Mark, 2006; Nishimura, Hishinuma, & Goebert, 2013), and that these differences are particularly pronounced in rural settings (Lai & Saka, 2005). Despite these findings, there have been very few drug prevention programs developed and evaluated specifically for these youth (Edwards, Giroux, & Okamoto, 2010; Rehuher, Hiramatsu, & Helm, 2008). Therefore, the purpose of this research proposal is to complete the development of a video-enhanced, culturally grounded, school-based drug prevention curriculum for rural Native Hawaiian youth (Ho'ouna Pono), and to evaluate the curriculum across all public middle/intermediate schools on Hawai'i Island. This will be accomplished through three specific aims. AIM 1 (Year 1) is to complete the Ho'ouna Pono drug prevention curriculum initially developed and validated in a NIDA-funded translational pilot/feasibility study (R34 DA031306). To date, five professionally filmed video vignettes depicting drug-related problem situations specific to rural Hawaiian youth and seven interactive classroom lessons have been created, implemented in randomly selected intervention schools, and preliminarily evaluated using a pre-test, post-test control group design. Aim 1 enhances and builds upon this work by producing two new video vignettes, re-editing a ""Behind the Scenes"" video, developing new classroom curricular components, and synthesizing the new content with the existing curriculum. AIM 2 (Years 2-3) is to evaluate the fully conceived curriculum across all middle/intermediate schools on Hawai'i Island (N = 15) using a dynamic wait- listed control group design (Brown, Wyman, Guo, & Pea, 2006). AIM 3 (Year 4) is to assess community, systemic, and curricular factors related to the implementation, adoption, and sustainability of the curriculum within public middle/intermediate schools on Hawaii Island. PUBLIC HEALTH RELEVANCE: Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have recently been shown to have significantly higher rates of drug use compared with other ethnic groups (Wu et al., 2013), research focused on drug prevention of these individuals is important to improve public health both in Hawai'i and on the Mainland U.S. This study actively engages rural communities in the full-scale development and evaluation of the Ho'ouna Pono drug prevention curriculum for Hawaiian youth, promoting the overall utility and effectiveness of the intervention. Further, the findings from this study will point to the core content of prevention interventions for Hawaiian youth in rural communities, which should be applicable to other ethnic youth populations in Hawaii and the Pacific Rim, as well as Native youth populations on the Mainland U.S.",The Development and Evaluation of the Ho'ouna Pono Drug Prevention Curriculum,9085947,R01DA037836,"['Adoption ', ' Communities ', ' Control Groups ', ' Curriculum ', ' Educational Curriculum ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Ethnic group ', ' Feasibility Studies ', ' Hawaii ', ' Health ', ' Island ', ' Pre-Post Tests ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Research Proposals ', ' Rural Health ', ' Schools ', ' Science ', ' Testing ', ' Time ', ' Waiting Lists ', ' Work ', ' Measures ', ' pricing ', ' Price ', ' Film ', ' Rural Community ', ' Youth 10-21 ', ' Youth ', ' base ', ' improved ', ' Evaluation ', ' Individual ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' drug use ', ' Drug usage ', ' Funding ', ' Hawaiian ', ' Hawaiian population ', ' Outcome Study ', ' cohort ', ' Prevention Research ', ' Prevention ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Address ', ' Effectiveness of Interventions ', ' Indigenous ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' designing ', ' design ', ' Population ', ' Drug Prevention Program ', ' native youth ', ' community based participatory research ', ' intervention effect ', ' efficacy testing ', ' health equity ', ' ']",NIDA,HAWAII PACIFIC UNIVERSITY,R01,2015,7236,0.11304276041447972
"Health disparity in pharmacogenomics: African American SNPs and drug metabolism DESCRIPTION (provided by applicant): As pharmacogenomics moves from bench-top to bed-side, African Americans have been left out of the advances personalized medicine holds. To date, African Americans have been largely absent from the numerous pharmacogenetic studies that identify predictive single nucleotide polymorphisms (SNPs) that are being used clinically to improve care. As we move toward more comprehensive bioinformatics and high- throughput methods of evaluating the genome for functionally relevant SNPs that affect drug phenotypes, we are also producing a growing health disparity in the translation of these findings into the clinic for African Americans. Current genomic methods are trying to reach beyond genome-wide association in hopes of finding biological plausibility to genetic findings. This search has led to the use of expression quantitative trait loci (eQTLs) as a tool in pharmacogenetic association studies. SNPs labeled as eQTLs have intrinsic biological plausibility since they are significantly associated with changes in gene expression. However, no liver eQTL studies have been conducted in African Americans. By using liver-specific eQTLs, we will discover SNPs that affect drug metabolizing enzymes (DMEs), which will have wide-spread scientific and clinical impact; given that most drugs currently prescribed undergo some form of hepatic metabolism. Because of the increase genetic diversity found in African Americans, they may carry population specific SNPs can never be found by pharmacogenomics studies in populations of European-descent alone. Without African American focused pharmacogenomics studies we risk excluding African Americans from personalized medicine. We plan to use primary hepatocytes to conduct gene expression studies both before and after drug enzyme induction to identify genes that are differentially expressed. Drug enzyme induction is driven by increased gene transcription; therefore, by focusing on the genes that are differentially expressed after induction we can pin-point the drivers (i.e. genes) that regulate drug metabolizing enzymes. We will then look at SNPs within and in close proximity to these genes to determine if any are associated with differences in gene expression (dubbed DI-eQTLs). We will then look to see if these DI-eQTLs are associated with pharmacokinetic measures in the same set of cell cultures, affectedly preforming a pharmacokinetic and a pharmacogenetic study in the same individual. We hypothesize that drug enzyme induction will provide us with DI-eQTLs that are strongly associated to drug pharmacokinetics, a clinically relevant phenotype. To validate these findings we will query publically available data to look for an enrichment of our DI-eQTLs within the most strongly associated SNPs in pharmacogenomic GWAS data. The association between genotype, gene expression and drug pharmacokinetics in African Americans has never been conducted before and will provide an invaluable resource for pharmacogenomics and clinical pharmacology, as well as clinical translation in this understudied population. PUBLIC HEALTH RELEVANCE: The proposed studies will help identify genetic mutations that affect drug metabolism in African Americans, an under-studied population in pharmacogenomics. The discovery of these novel mutations will lead to better dosing of drugs that require the liver for metabolism and potentially less side-effects from these medications. By studying the genetic mutations that affect drug metabolism in African Americans we can more fully incorporate this population into personalized medicine.",Health disparity in pharmacogenomics: African American SNPs and drug metabolism,8890217,R01MD009217,"['Accounting ', ' Affect ', ' Africa ', ' Age ', ' Engineering / Architecture ', ' Architecture ', ' Beds ', ' Biology ', ' cell culture ', ' Cell Culture Techniques ', ' Cells ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' Enzyme Induction ', ' Enzymes ', ' Gene Expression ', ' Genes ', ' Genome ', ' Genotype ', ' Health ', ' In Vitro ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Linkage Disequilibrium ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' Medicine ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Pharmacogenetics ', ' Pharmacokinetics ', ' Drug Kinetics ', ' Pharmacology ', ' Clinical Pharmacology ', ' Phenotype ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Translations ', ' Drug Side Effects ', ' Adverse drug effect ', ' Genetic Variation ', ' Genetic Diversity ', ' Variation (Genetics) ', ' white race ', ' Occidental ', ' Caucasoid Race ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Caucasians ', ' Measures ', ' Treatment outcome ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Caring ', ' DNA Sequence ', ' Label ', ' improved ', ' Hepatic ', ' Left ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Ensure ', ' Liver Cells ', ' Hepatic Parenchymal Cell ', ' Hepatic Cells ', ' Hepatocyte ', ' Individual ', ' African ', ' European ', ' drug use ', ' Drug usage ', ' Genetic ', ' tool ', ' Complex ', ' Side ', ' Clinic ', ' LOINC Axis 4 System ', ' System ', ' American ', ' QTL ', ' Quantitative Trait Loci ', ' trait ', ' Structure ', ' novel ', ' Population Study ', ' drug metabolism ', ' drug clearance ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Coding System ', ' Code ', ' Regulation ', ' Sampling ', ' response ', ' Adverse Experience ', ' Adverse event ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Adverse effects ', ' Genomics ', ' Pharmacogenomics ', ' Bio-Informatics ', ' Bioinformatics ', ' health disparities ', ' health disparity ', ' preventing ', ' prevent ', ' liver metabolism ', ' Dose ', ' DNA Sequence Alteration ', ' Data ', ' Regulatory Pathway ', ' Resolution ', ' in vivo ', ' Process ', ' protein function ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' Minority ', ' cost-effective ', ' cost effective ', ' Population ', ' clinical relevance ', ' clinically relevant ', ' clinical care ', ' personalized treatment ', ' personalized therapy ', ' personalized medicine ', ' ']",NIMHD,UNIVERSITY OF CHICAGO,R01,2015,399296,0.07890808701269215
"Brief intervention for drug-using rural women at high-risk for HIV/HCV DESCRIPTION (provided by applicant): The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high-risk for HIV and HCV. This project has potential to make a significant contribution to science by advancing knowledge about the health disparities, high-risk behaviors (injection drug use, sex risk), and service utilization of this high-risk, vulnerable, an understudied group of women during a time of emerging and significant public health risk in an Appalachian rural setting. This project will incorporate standardized screening (NIDA-modified ASSIST) to identify high-risk rural women drug users from jails, including injectors. Consenting women (N=350) will be asked to participate in a baseline interview, and will then be randomly assigned to one of two study groups: (1) HIV Education (HIV- Ed n=175) which includes the NIDA standard pre and post-test counseling, HIV and HCV rapid testing, and an information packet on existing community drug abuse and HIV/HCV resources; or (2) Motivational Interviewing- based HIV Risk Reduction (MI-HIV n=175) which, in addition to what is received in the HIV-Ed group, also includes an evidence-based brief intervention for high-risk women focused on an individualized plan for enhancing motivation to reduce risk behaviors and to use health and behavioral health services in the community. Specific aims include: (1) to compare the effectiveness of an evidence-based HIV risk reduction intervention (MI-HIV) to HIV Education (NIDA Standard) in reducing sex risk behaviors, injection practices, and drug use among a culturally unique sample of disadvantaged, drug-using rural women at high-risk for HIV and HCV; and (2) to examine MI-HIV Intervention engagement as a predictor of community health and behavioral health service utilization (including drug treatment and mental health) at follow-up among disadvantaged, drug- using rural women at high risk for HIV and HCV. This project is innovative because it 1) targets a high-risk and understudied group of women, 2) uses brief intervention to not only reduce risk behavior but also to enhance motivation for using community health and behavioral health resources, and 3) utilizes a real-world setting to identify high-risk women drug users. The long-term goal of this study is to increase access to health and behavioral health services in order to improve the quality of health of high-risk rural women. The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high risk for HIV and HCV. This project has potential to make a significant contribution to science by providing knowledge about the health, risk behaviors, and service utilization of a vulnerable and understudied group of women during a time of emerging and significant public health risk in a rural Appalachian setting. Successful completion of the aims of this project will advance the delivery of a low-cost, potentially high impact intervention with implications for a number of other real world settings (such as criminal justice venues) where other disadvantaged high-risk drug users can be identified and targeted for intervention.",Brief intervention for drug-using rural women at high-risk for HIV/HCV,9045757,R01DA033866,"['Appalachia ', ' Appalachian Region ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Community Services ', ' Counseling ', ' Disadvantaged ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Goals ', ' Health ', ' Health Resources ', ' health care service ', ' Health Services ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Injections ', ' Injection of therapeutic agent ', ' Interview ', ' Kentucky ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Motivation ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Pre-Post Tests ', ' Public Health ', ' public health medicine (field) ', ' Random Selection ', ' Random Allocation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Science ', ' Testing ', ' Time ', ' Walkers ', ' Woman ', ' Criminal Justice ', ' health care ', ' Healthcare ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' base ', ' rural area ', ' improved ', ' Area ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Rural ', ' drug use ', ' Drug usage ', ' women at high risk ', ' High Risk Woman ', ' Female Groups ', "" Women's Group "", ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Educational Intervention ', ' Staging ', ' Drug user ', ' Opiates ', ' Knowledge ', ' Pattern ', ' Country ', ' Services ', ' treatment planning ', ' Participant ', ' high risk behavior ', ' motivational interview ', ' motivational enhancement therapy ', ' outreach ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' Sampling ', ' behavioral health ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' drug resource ', ' vulnerable group ', ' Vulnerable Populations ', ' Risk Reduction ', ' health disparities ', ' health disparity ', ' Address ', ' Jail ', ' Consent ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Community Health ', ' comparison group ', ' sexual risk behavior ', ' sex risk ', ' cost ', ' designing ', ' design ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' Evidence based intervention ', ' compare effectiveness ', ' service utilization ', ' high risk ', ' evidence base ', ' prescription opiate ', ' screening ', ' injection drug use ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2015,66477,0.12069110669681299
"Stress and Drug Use Vulnerability in the African American Community DESCRIPTION (provided by applicant): The impacts that drug addictions have on health disparities that adversely affect African Americans are grossly understudied. While there is strong evidence linking drug abuse to poor health and problem behaviors in the African American community, the progression of drug abuse is inconsistent (i.e., relatively late initiation and heavy use in the 30s) with national norms and remains unclear. Exposure to chronic stress and the subsequent activation of the hypothalamic-pituitary-adrenal (HPA) axis has been connected to drug addictions and poor health outcomes. This association is of particular importance since residents in these communities are exposed to many of the risk factors associated with the onset of drug abuse: familial risk, deprived social environment, unemployment, substandard education, low-to-no socioeconomic status, and enduring exposure to experiences of racism and discrimination. Repeated exposure to environmental stressors will lead to 'wear-and-tear' on the body's regulatory system and have profound implications on HPA functioning and the subsequent risk of developing an addiction. This study will pursue three primary aims: (1) Investigate HPA reactivity to acute stress as a predictor of current drug use severity. (2) Investigate trajectories of HPA regulation (level and circadian rhythm) as a predicto of drug use vulnerability across time. (3) Investigate delay discounting as a moderator between trajectories of HPA regulation and drug use vulnerability across time. This study will enroll 350 African American adults (ages 18-21) who reside in the southeastern U.S. and utilize a prospective longitudinal research design that consists of a laboratory assessment involving the Trier Social Stress Test, three in-home assessments that include clinical interviews and behavioral tasks, and six internet assessments that track drug use and related risk factors across a 2-year period. Primary independent variables include environmental stressors, stress-related biomarkers (i.e., salivary cortical, salivary DHEA, heart rate variability, and galvanic skn resistance), and delay discounting. Primary dependent variables include drug use, severity of drug use disorders, and drug use consequences. This study is highly innovative for three primary reasons: (1) A longitudinal research design will be used for the first time to investigate trajectories of HPA regulation as a predictor of drug use vulnerability; (2) The use of multiple indicators of the stress regulatory system, clinical interviews, and a novel behavioral task provides a more nuanced understanding of the research aims; and (3) This study focuses on an understudied population that suffers from drug-related health disparities, but are rarely included in cutting edge laboratory research. It is envisioned that this approach will uncover latent-curve trajectories of stress deregulation as a predictor of drug use vulnerability in this population. Findings from this study will identify causal mechanisms of drug addictions that will advance theory, research, prevention, and treatments aimed at addressing this growing public health problem. PUBLIC HEALTH RELEVANCE: The development of drug abuse in the African American community is often characterized by oversimplified models that are rooted in research studies that rarely include African Americans. This study will identify mechanisms that influence drug use vulnerability in at-risk African American adults who reside in the southeastern U.S. Such research is needed to develop socially and culturally informed prevention and treatment programs aimed at reducing drug-related health disparities that continue to plague African Americans.",Stress and Drug Use Vulnerability in the African American Community,8782617,R01DA034739,"['Cultural Assimilation ', ' Acculturation ', ' suprarenal gland ', ' Adrenals ', ' Adrenal Glands ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Belief ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Circadian Rhythms ', ' Communities ', ' Crime ', ' Death ', ' Cessation of life ', ' Therapeutic Dehydroepiandrosterone ', ' Prasterone ', ' Dehydroisoandrosterone ', ' DHEA ', ' Androstenolone ', ' Androst-5-en-17-one, 3-hydroxy-, (3beta)- ', ' 5-Androsten-3-beta-hydroxy-17-one ', ' 3beta-Hydroxyandrost-5-en-17-one ', ' dehydroepiandrosterone ', ' Discrimination ', ' Cognitive Discrimination ', ' Discrimination (Psychology) ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Downregulation ', ' Down-Regulation (Physiology) ', ' Down-Regulation ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Au element ', ' Gold ', ' Health ', ' Health behavior ', ' Therapeutic Hydrocortisone ', ' Proctocort ', ' Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)- ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Hydrocortisone ', ' hypothalamic ', ' Hypothalamus ', ' Hypothalamic structure ', ' Incidence ', ' Interview ', ' Laboratories ', ' Laboratory Research ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Mortality ', ' Mortality Vital Statistics ', ' Neighborhoods ', ' pilot study ', ' Pilot Projects ', ' Pituitary Nervous System ', ' Pituitary ', ' Hypophysis Cerebri ', ' Hypophysis ', ' Pituitary Gland ', ' Yersinia pestis disease ', ' Plague ', ' Psychopharmaceuticals ', ' Psychoactive Drugs ', ' Psychoactive Compound ', ' Psychoactive Agents ', ' Psychotropic Drugs ', ' Public Health ', ' public health medicine (field) ', ' recruit ', ' Recruitment Activity ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Rewards ', ' Risk ', ' Risk Factors ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Stress ', ' Survey Instrument ', ' Surveys ', ' Time ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Unemployment ', ' violent behavior ', ' violent ', ' Violence ', ' Measures ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Illicit Drugs ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' improved ', ' Left ', ' Clinical ', ' racism ', ' Link ', ' mental ', ' Psyche structure ', ' disability ', ' Stimulus ', ' Spiritualities ', ' Spirituality ', ' Recovery ', ' Rural ', ' drug use ', ' Drug usage ', ' root ', ' Plant Roots ', ' Funding ', ' behavioral problem ', ' Problem behavior ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Exposure to ', ' Severities ', ' Salivary ', ' Home ', ' Home environment ', ' LOINC Axis 4 System ', ' System ', ' environmental stressor ', ' experience ', ' hypothalmus-pituitary-adrenal axis ', ' hypothalamic-pituitary-adrenal (HPA) axis ', ' hypothalamic-pituitary-adrenal axis ', ' novel ', ' Prevention Research ', ' Prevention program ', ' treatment program ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Impulsivity ', ' acute stress ', ' Regulation ', ' Modeling ', ' response ', ' theories ', ' health disparities ', ' health disparity ', ' Address ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Chronic stress ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' enroll ', ' Enrollment ', ' developmental ', ' Development ', ' Behavioral ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' Clinical assessments ', ' Outcome ', ' discounting ', ' Population ', ' prospective ', ' Trier Social Stress Test ', ' innovative ', ' innovate ', ' innovation ', ' resistant ', ' Resistance ', ' addictive disorder ', ' addiction ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' heart rate variability ', ' constriction ', ' longitudinal design ', ' burden of injury ', ' ']",NIDA,UNIVERSITY OF HOUSTON,R01,2015,618831,0.21249262221003148
"Contextualizing & responding to HIV risk behaviors among Black drug offenders DESCRIPTION (provided by applicant): Formerly incarcerated Black drug offenders are at an elevated risk for HIV infection. Despite substantial research expressing the need for HIV prevention services for ex-offenders post-release, this population has limited access to quality programming and services related to HIV risk reduction. This K01 application seeks to inform and adapt an HIV risk reduction intervention to address the needs of formerly incarcerated Black drug offenders who are being released from prisons in the New York City metropolitan area. This application supports the Principal Investigator's interest in becoming an independent behavioral scientist specializing in HIV prevention intervention development and adaptation. The proposed mentorship and training program will focus on the following key areas: mixed methods research; adaptation science; and intervention implementation. The proposed study will occur in three phases implemented over the course of five years. The formative phase will consist of survey administration on HIV literacy, needs and barriers to practicing protective behaviors, and HIV testing from 120 recently released Black drug offenders. Also during this phase, in-depth interviews with a subsample of 24 participants (12 male and 12 female participants) will also be conducted to gather more comprehensive information exploring needs and barriers to practicing HIV protective behaviors. The intervention development and adaptation phase, will consist of analyzing data from the survey research and in-depth interviews to tailor it for use with recently released Black drug offenders. In phase 3, the feasibility and acceptability of the adapted intervention will be pilot tested using a randomized clinical trial with 64 participants who are randomized to the adapted intervention or an Enhanced Referral Intervention arm. Building on the Information-Motivation and Behavioral Skills Model, this study will address the following specific aims: 1) To examine individual-level, environmental and contextual factors that affect HIV risk-related behaviors (i.e. illicit drug use and risky sexual behavior) among formerly incarcerated Black male and female drug offenders; 2) To adapt Project START, an HIV risk reduction intervention for formerly incarcerated men, using data gathered from Aim 1, to increase access to HIV testing and address drivers of HIV vulnerability among recently released Black male and female drug offenders; and 3) To pilot test the feasibility and acceptability of the adapted Project START using a randomized clinical trial with 64 participants (32 men, 32 women). The proposed study will utilize a mixed-methods approach to investigate drivers of HIV risk among recently released Black drug offenders. By providing more contextual information on risk behaviors, future evidence-based approaches can be developed and rapidly deployed, advancing HIV prevention science, and providing essential support for a vulnerable population that consistently experiences barriers in accessing HIV prevention services. PUBLIC HEALTH RELEVANCE: This K01 application seeks to inform and adapt an HIV risk reduction intervention to address the needs of formerly incarcerated Black drug offenders who are being released from prisons in the New York City metropolitan area. The proposed mentorship and training program will focus on the following key areas: mixed methods research; adaptation science; and intervention implementation. A mixed methods approach will be used to conceptualize HIV risk related behaviors among this population, resulting in the development of a novel approach to better understanding and ultimately addressing racial disparities in HIV prevalence.",Contextualizing & responding to HIV risk behaviors among Black drug offenders,8862442,K01DA036411,"['Affect ', ' Behavior ', ' Behavioral Research ', ' Communities ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Data Analysis ', ' Data Analyses ', ' Diagnosis ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Eyeball ', ' Eye ', ' Female ', ' Future ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Housing ', ' Interview ', ' literacy ', ' male ', "" men's "", ' men ', ' Mentors ', ' Mentorship ', ' Methods ', ' Study models ', ' Motivation ', ' New York City ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisoner ', ' Prisons ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Risk ', ' Science ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Training Programs ', ' United States ', ' Woman ', ' Gender ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' Illicit Drugs ', ' Research Methods ', ' Research Methodology ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' improved ', ' Area ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' Randomized Clinical Trials ', ' Training ', ' Individual ', ' drug use ', ' Drug usage ', ' Drug user ', ' Knowledge ', ' programs ', ' Scientist ', ' Home ', ' Home environment ', ' Application Context ', ' contextual factors ', ' interest ', ' Services ', ' experience ', ' metropolitan ', ' skills ', ' Participant ', ' prevention service ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' criminal offender ', ' offender ', ' HIV risk ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' Risk Reduction ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Institution ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Address ', ' Data ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' Mentored Research Scientist Development Award ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Transmission ', ' transmission process ', ' Principal Investigator ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Behavioral ', ' Prevention education ', ' neglect ', ' protective behavior ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Guide prevention ', ' Population ', ' Prevalence ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' evidence base ', ' arm ', ' drug offender ', ' ']",NIDA,COLUMBIA UNIVERSITY HEALTH SCIENCES,K01,2015,164215,0.0825246084870777
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network     DESCRIPTION:  The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years.         PUBLIC HEALTH RELEVANCE: This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.            ",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,8976311,UG1DA015815,"['etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' American Indian ', ' American Indians ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Cities ', ' clinical investigation ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' disease/disorder ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Education ', ' Educational aspects ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' health care service ', ' Health Services ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl- ', ' Methadone ', ' Methods ', ' Narcanti ', ' Narcan ', ' Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)- ', ' Naloxone ', ' Persons ', ' Oregon ', ' Overdose ', ' Patients ', ' Peer Review ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' public health medicine (field) ', ' Scientific Publication ', ' Publications ', ' recruit ', ' Recruitment Activity ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Rural Health ', ' Safety ', ' San Francisco ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Social Workers ', ' Substance Use Disorder ', ' Testing ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' Medical ', ' Link ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Training ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Licensing ', ' Opioid ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Therapeutic ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocol ', ' Protocols documentation ', ' Country ', ' Services ', ' experience ', ' care delivery ', ' Participant ', ' treatment program ', ' member ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' behavioral health ', ' QOC ', ' Quality of Care ', ' protocol development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' patient registry ', ' Provider ', ' prevent drug use ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' health disparities ', ' health disparity ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Research Training ', ' Ancillary Study ', ' Clinical Data ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' designing ', ' design ', ' urban American Indian ', ' urban native american ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addictive disorder ', ' addiction ', ' public health relevance ', ' evidence base ', ' patient population ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2015,756158,0.08695097140668363
"Mentoring researchers on drug abuse and HIV DESCRIPTION (provided by applicant): Drug users with and at-risk for HIV continue to have poor access to health care and poor treatment outcomes. In addition, opioid addiction involving prescription opioids has skyrocketed. In this proposal for a mid-career investigator award, Dr. Chinazo Cunningham proposes to address the opioid epidemic and its intersection with HIV infection by: 1) becoming an internationally recognized leader in the field of drug abuse and HIV, expanding her research to include advanced research methods (comparative effectiveness research [CER] methods and complex clinical trials methods); 2) developing a standardized and structured mentorship approach to mentor junior investigators to conduct patient-oriented research related to drug abuse and/or HIV infection; and 3) becoming an effective leader in academic medicine, ensuring that the institutional infrastructure facilitates junior investigators obtaining skills necessary to become independent investigators. To achieve these goals, Dr. Cunningham will participate in courses and national conferences, have directed readings, and regularly meet with national leaders in related fields. Dr. Cunningham will particularly focus on mentoring women and racial/ethnic minorities-two groups who are under-represented in senior positions in academic medicine and NIH-funded research. Dr. Cunningham will utilize her existing research program as a foundation for which she will provide mentoring and expand her research skills to include CER and complex clinical trials methods. The aims of her research are to: 1) test the efficacy of a 16-week abstinence-reinforcing contingency management intervention on HIV viral load suppression among opioid-dependent HIV-infected individuals, using a randomized controlled trial design; and 2) examine mechanisms of achieving viral load suppression with the abstinence-reinforcing contingency management intervention. Dr. Cunningham's future research will include the establishment of a comprehensive ""live"" database of all opioid users within a large urban medical center. This database will be used to examine health outcomes associated with types of opioid use and to develop and test interventions focused on opioid use. Dr. Cunningham's long-term career objective is to improve access to care and health outcomes among drug-abusing populations with or at-risk for HIV infection by developing interventions that can reduce their disparities in health care and health. PUBLIC HEALTH RELEVANCE: This application for a K24 mid-career investigator award seeks to provide support to Dr. Chinazo Cunningham to provide excellent mentorship, effective leadership, and expand her current research to include advanced research methods (comparative effectiveness research methods and complex clinical trials methods). Dr. Cunningham will mentor junior investigators in the areas of drug abuse and HIV, with an emphasis on providing mentorship to racial/ethnic minorities and women. Dr. Cunningham will use her existing research project as a foundation to provide much of her mentorship. In addition, expanding her research to include comparative effectiveness research and complex clinical trials focused on opioid use will allow her to conduct new research and provide additional mentorship that can ultimately improve health outcomes of drug users with and at-risk for HIV.",Mentoring researchers on drug abuse and HIV,8824505,K24DA036955,"['Award ', ' Behavior ', ' 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5alpha,7alpha(S))- ', ' Buprenorphine ', ' clinical investigation ', ' Clinical Trials ', ' 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- ', ' Cocaine ', ' Color ', ' Communities ', ' Control Groups ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Feedback ', ' Foundations ', ' Goals ', ' Health ', ' healthcare service availability ', ' healthcare service access ', ' healthcare access availability ', ' health services availability ', ' health care service availability ', ' health care service access ', ' health care availability ', ' care access ', ' availability of services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Availability of Health Services ', ' Accessibility of health care ', ' Access to Healthcare ', ' Access to Health Care ', ' Access to Care ', ' Health Services Accessibility ', ' Hematology Testing ', ' Hematological Tests ', ' Hematologic Tests ', ' Blood Tests ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' inducement ', ' Incentives ', ' Leadership ', ' Medical Records ', ' Medicine ', ' Mentors ', ' Mentorship ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl- ', ' Methadone ', ' Methods ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Roxicodone ', ' Oxycontin ', ' Oxycodone SR ', ' Oxycodeinon ', ' Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5alpha)- ', ' Dihydrohydroxycodeinone ', ' Oxycodone ', ' Patients ', ' Public Health ', ' public health medicine (field) ', ' Questionnaires ', ' Reading ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Support ', ' Risk ', ' Testing ', ' Toxicology ', ' Urine Urinary System ', ' Urine ', ' Woman ', ' Treatment outcome ', ' conference ', ' symposium ', ' health care ', ' Healthcare ', ' Research Methods ', ' Research Methodology ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Caring ', ' base ', ' career ', ' improved ', ' Area ', ' Ensure ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Opioid ', ' drug use ', ' Drug usage ', ' T4 Lymphocyte Count ', ' CD4+ Counts ', ' CD4+ Cell Counts ', ' CD4 Lymphocyte Count ', ' Funding ', ' Agonist ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Smoker ', ' Drug user ', ' Opiates ', ' Life ', ' programs ', ' Viral Load ', ' Viral Burden ', ' Viral Load result ', ' Complex ', ' Neurocognitive ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' Opiate Addiction ', ' meetings ', ' Medical center ', ' Performance ', ' success ', ' Structure ', ' skills ', ' Participant ', ' contingency management ', ' Position ', ' Positioning Attribute ', ' HIV risk ', ' voucher ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' highly active anti-retroviral therapy ', ' HAART ', ' Highly Active Antiretroviral Therapy ', ' patient oriented study ', ' patient oriented research ', ' Pill ', ' pill (pharmacologic) ', ' therapy adherence ', ' Smoking and Tobacco Use Cessation Interventions ', ' Smoking Cessation Intervention ', ' Address ', ' Adherence ', ' Adherence (attribute) ', ' Data ', ' Improve Access ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Infrastructure ', ' Research Infrastructure ', ' enroll ', ' Enrollment ', ' effectiveness research ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Outcome ', ' Population ', ' Abstinence ', ' comparative effectiveness ', ' primary outcome ', ' secondary outcome ', ' efficacy testing ', ' cocaine use ', ' prescription opioid ', ' ']",NIDA,ALBERT EINSTEIN COLLEGE OF MEDICINE,K24,2015,77427,0.11979102193138146
"Risk Factors for AIDS among Drug Users: Getting Close to Zero     DESCRIPTION: UNAIDS has announced a goal of Getting to Zero New HIV infections and Secretary Clinton has announced a goal of an AIDS free generation. Completely eliminating new HIV infections may not be possible in any large population of persons at high risk for HIV, but combined prevention, including treatment as prevention (TasP) may permit getting very close to zero new HIV infections. Psychoactive drug use generates many impediments getting close to zero. Drug use can lead to HIV infection through both sharing injection equipment and through drug use related unsafe sexual behavior. Drug use may also interfere with accessing and adhering to antiretroviral therapy (ART). Psychoactive drug use is also strongly associated with higher rates of HIV infection among racial/ethnic minorities. In this research, we will examine whether combined prevention can get close to zero new HIV infections among injecting and non-injecting drug users in New York City, including whether getting close to zero can minimize racial/ethnic disparities.  If combined prevention does lead to getting close to zero new infections drug users in NYC. This will require a) an analytic description of combined prevention, b) a clear conceptualization of getting close to zero, and c) new metrics and methods for assessing being close to zero.  We will study getting close to zero new HIV infections for drug users in NYC through four specific aims: 1. Determine the extent to which combined prevention  is getting close to zero for injecting related transmission of HIV in NYC. Develop new metrics for measuring a CtZ situation for injecting-related transmission and how racial/ethnic disparities might be minimized. 2. Conduct mathematical modeling, using biomarkers for high injecting risk (HCV infection) and high sexual risk (HSV-2 infection) and behavioral data to analyze HIV infection among PWID in terms of: 1) the PWID population as a whole, 2) disparities among major racial/ethnic groups, 3) sustainability for maintaining a CTZ situation with combined prevention, and 4) injecting related vs. sexual transmission of HIV among PWID. 3. Determine the extent to which ""combined prevention"" is reducing drug related sexual (DRS) transmission of HIV among non-injecting drug users (NIDUs) and PWID in NYC. Develop new metrics for measuring the potential for continuing sexual transmission and assess coverage of Treatment as Prevention (TasP) among NIDUs. Monitor trends in HSV-2 infection as a continuing driver of drug use sexual transmission. 4. Utilize geospatial analysis to characterize ""hotspots"" for continuing transmission of HIV among drug users in NYC, including potential geographic overlap between injecting related and sexual transmission of HIV, and racial/ethnic and HIV service characteristics of hotspots.  We will accomplish these aims through interviews and HIV, HCV, and HSV-2 testing of 600 subjects per year and continuation of our long-standing collaborations with the NY City and State Health Departments.         PUBLIC HEALTH RELEVANCE: UNAIDS has announced a goal of ""getting to zero"" new HIV infections and the US government has announced a parallel goal of achieving ""an AIDS free generation. We will study whether combined prevention leads to ""getting close to zero"" new HIV infections for injecting and non-injecting drug users in New York City. This will include developing bio-behavioral metrics for use in getting close to zero, mathematical modeling, and identifying geographic ""hotspots"" of persistent probability of HIV transmission.                     ",Risk Factors for AIDS among Drug Users: Getting Close to Zero,8846354,R01DA003574,"['Monitor ', ' Transmission ', ' transmission process ', ' trend ', ' Characteristics ', ' Process ', ' Behavioral ', ' antiretroviral therapy ', ' Outcome ', ' Population ', ' Prevalence ', ' racial/ethnic ', ' racial and ethnic ', ' racial and ethnic disparities ', ' high risk ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' Cities ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Equipment ', ' Ethnic group ', ' Geographic Locations ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Goals ', ' Government ', ' Health ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' human alphaherpesvirus 2 ', ' herpes simplex ii ', ' Human herpes simplex virus type 2 ', ' Human (alpha) herpes virus 2 ', ' Herpesvirus progenitalis ', ' Herpesvirus 2 (alpha), Human ', ' Herpes Simplex Virus Type 2 ', ' Herpes Simplex Virus 2 ', ' HSV2 ', ' HSV-2 ', ' HHV-2 ', ' Human Herpesvirus 2 ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' HIV Seroprevalence ', ' Housing ', ' Incidence ', ' Economical Income ', ' Economic Income ', ' Income ', ' Infection ', ' Injections ', ' Injection of therapeutic agent ', ' Institutes ', ' Interview ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Persons ', ' New York ', ' New York City ', ' Probability ', ' Psychopharmaceuticals ', ' Psychoactive Drugs ', ' Psychoactive Compound ', ' Psychoactive Agents ', ' Psychotropic Drugs ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Social Marketing ', ' Syringes ', ' Testing ', ' Vaccines ', ' Gender ', ' Generations ', ' Measures ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Caring ', ' improved ', ' Area ', ' Phase ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Susceptibility ', ' Predisposition ', ' drug use ', ' Drug usage ', ' Collaborations ', ' Drug user ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' Services ', ' experience ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' Anti-Retroviral Agents ', ' c new ', ' condoms ', ' Prevention program ', ' Shares syringes ', ' Prevention ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' Modeling ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' mathematical model ', ' Data ', ' High Prevalence ', ' Sexual Transmission ', ' ']",NIDA,BETH ISRAEL MEDICAL CTR (NEW YORK),R01,2015,651735,0.10540491543263228
"African American Offenders: Drug Use, Mental Health and HIV Risk DESCRIPTION (provided by applicant):  The primary goal of this K08 award is to further develop a productive independent research career in drug abuse research. The training and career development plan will enhance Dr. Stevens-Watkins's research experience in primary data collection with prisoners focused on drug use, mental health, and HIV thus resulting in the clarification of the specific aims of an R01 submission in years 4 and 5. The proposed training objectives are: (1) to receive training in the epidemiology of drug abuse, mental health, and HIV as they relate to health disparities among African Americans; (2) to further develop expertise in research with special populations, biostatistics, and advanced quantitative analyses including non-linear, categorical models, and structural equation modeling; (3) to use the data collected in the proposed research plan as pilot data for an R01 research proposal. The specified training goals are aligned with the research aims and compliment the clinical experience of the candidate. Dr. Stevens-Watkins will be sponsored by her established mentors, Drs. Carl Leukefeld and Carrie Oser, both with expertise in drug abuse and HIV research. Of high significance, HIV has recently been termed a ""crisis"" in the African American community. The overall goal of the proposed research plan is to better understand the complex and dynamic relationship between drug use, mental health, and HIV risk among African American male prisoners nearing community re-entry. The specific aims are (1) to explore drug use, symptoms of depression and anxiety, and HIV risk behaviors among African American male inmates by conducting a thorough literature review and devising an analytical model using biostatics multivariate analytic techniques with available data; (2) to identify prevalence, incidence, and predictors of drug use disorders, anxiety, depressive disorders and HIV sexual risk behaviors among 205 incarcerated African American men; (3) to examine the knowledge, patterns, and perceived cultural and community barriers to utilizing individual and health resources and their relationship to substance abuse recovery and HIV risk behaviors among 205 African American men upon release from prison. Baseline data will be collected in prison and follow-up data collection will occur when participants have been released in the community after 3-months. The proposed research plan will offer HIV testing and counseling to an at-risk population that has historically been difficult to engage in research and HIV testing, subsequently significantly impacting public health by possibly preventing the spread of HIV. The candidate's immediate career goals include published manuscripts and R01 funding by the end of K08 funding, with an ultimate career goal of becoming an independent clinical drug abuse researcher. This proposal includes an outstanding mentoring team, as well as a feasible training and research plan utilizing resources offered by both Spalding University and the University of Kentucky. The proposed project has significant public health implications for reducing the spread of HIV among the African American community by offering testing and by targeting men exiting prison, re-entering the community. The proposed project will generate an improved understanding of the complex relationship between drug use, mental health, and HIV risk among an at-risk group.","African American Offenders: Drug Use, Mental Health and HIV Risk",8846086,K08DA032296,"['Anxiety ', ' Award ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Career Path ', ' Career Choice ', ' Communities ', ' Counseling ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' depression ', ' Mental Depression ', ' Depressive disorder ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Goals ', ' Health ', ' Health Resources ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Housing ', ' Incidence ', ' Interview ', ' Kentucky ', ' male ', "" men's "", ' men ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Mental Hygiene Services ', ' Mental Health Services ', ' Mentors ', ' Methods ', ' Structural Models ', ' Pre-Post Tests ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisoner ', ' Prisons ', ' Psychologist ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Proposals ', ' Research Resources ', ' Resources ', ' Risk ', ' social support network ', ' Social support ', ' Testing ', ' Universities ', ' Writing ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' depressive symptoms ', ' Mediating ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' psychological ', ' psychologic ', ' racism ', ' Training ', ' Individual ', ' Recovery ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Populations at Risk ', ' Development Plans ', ' drug use ', ' Drug usage ', ' Funding ', ' Review Literature ', ' Knowledge ', ' Life ', ' Complex ', ' Protocol ', ' Protocols documentation ', ' Pattern ', ' Techniques ', ' Equation ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' experience ', ' impression ', ' Special Population ', ' named group ', ' Manuscripts ', ' Participant ', ' criminal offender ', ' offender ', ' intravenous drug use ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' HIV risk ', ' Modeling ', ' career development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' correctional system ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' preventing ', ' prevent ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Data ', ' Research Training ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' sexual risk behavior ', ' sex risk ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' community re-entry ', ' community reentry ', ' Outcome ', ' Prevalence ', ' drug detection ', ' drug testing ', ' high risk ', ' public health research ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,K08,2015,135099,0.1550195541722535
"Methamphetamine Research Program at Meharry Medical College DESCRIPTION (provided by applicant): The long-range goal of the proposed DIDARP program described in this application is to continue to increase the capacity of Meharry Medical College to conduct rigorous research in substance use disorders with an [ emphasis on health disparities and underserved populations. The research program will seek to understand the molecular underpinnings of acute and chronic methamphetamine (METH) exposure alone and in conjunction with human immunodeficiency virus (HIV) infection. We also plan to strengthen pur intellectual environment and enhance the interest levels of trainees and faculty in drug abuse research. New for this j application is the proposal to introduce training on screening and brief interventions for substance misuse to medical students, residents and faculty in the Family and Community Medicine clinics. The Specific Aims of the Meharry Medical College DIDARP Program during the next five years are: 1. To publish at least 20 or more peer-reviewed publications in high-impact journals in drug abuse research; 2. To submit 5 or more grant applications in drug abuse research by Year-03 of the award period; | 3. To acquire 3 or more investigator-initiated awards by the end of year-05; and 4. To stimulate additional faculty and trainee interest in drug abuse research by curricula enhancement, ' seminars and symposia. . Three projects are proposed, one primary proposal and two pilot projects. In the primary project, Dr. CV. ] Dash will seek to understand the link between METH abuse and HIV infection. In the first pilot project, Dr. J. Shawn Goodwin will study how METH abuse alters dopamine signaling by altering the dopamine transporter residency in lipid rafts. In second pilot project, Dr. Khilber and her collaborators which includes the PI and the Chair of Family and Community Medicine, Dr. Roger Zoorob, will test the effects of a tiered training program on screening, brief intervention and referral to treatment (SBIRT) for substance misuse fo ",Methamphetamine Research Program at Meharry Medical College,8830957,R24DA036420,"['Anxiety ', ' Award ', ' Awareness ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Community Medicine ', ' Curriculum ', ' Educational Curriculum ', ' Death ', ' Cessation of life ', ' Disadvantaged ', ' Hydroxytyramine ', ' 4-(2-Aminoethyl)-1,2-benzenediol ', ' 3,4-Dihydroxyphenethylamine ', ' Dopamine ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Environment ', ' Faculty ', ' family medicine ', ' Family Practice ', ' Goals ', ' Grant ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Economical Income ', ' Economic Income ', ' Income ', ' Industry ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Benzeneethanamine, N,alpha-dimethyl-, (S)- ', ' Methamphetamine ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Mission ', ' neurobiological ', ' Neurobiology ', ' neuronal ', ' Neurocyte ', ' Neural Cell ', ' Nerve Unit ', ' Nerve Cells ', ' Neurons ', ' Peer Review ', ' pilot study ', ' Pilot Projects ', ' Poverty ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Scientific Publication ', ' Publications ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Residencies ', ' social role ', ' Role ', ' school of medicine ', ' medical college ', ' medical schools ', ' Self Medication ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Students ', ' Medical Students ', ' Substance Use Disorder ', ' Teaching ', ' Educational process of instructing ', ' Tennessee ', ' Testing ', ' Training Programs ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Virus Diseases ', ' Work ', ' conference ', ' symposium ', ' dopamine transporter proteins ', ' DAT dopamine transporter ', ' dopamine transporter ', ' Magazine ', ' Journals ', ' base ', ' improved ', ' Acute ', ' Chronic ', ' Clinical ', ' Medical ', ' Series ', ' Link ', ' Training ', ' insight ', ' Individual ', ' Rural ', ' Life ', ' programs ', ' Scientist ', ' Investigation ', ' Clinic ', ' Country ', ' Amentia ', ' Dementia ', ' interest ', ' collegiate ', ' college ', ' Emergency room ', ' Emergency Department ', ' Accident and Emergency department ', ' experience ', ' skills ', ' novel ', ' Basic Research ', ' Basic Science ', ' Self-Report ', ' Patient Self-Report ', ' graduate student ', ' Admission ', ' Admission activity ', ' career development ', ' lipid raft ', ' Sphingolipid-Cholesterol Rafts ', ' Sphingolipid Microdomains ', ' Cell Membrane Lipid Rafts ', ' Membrane Microdomains ', ' health disparities ', ' health disparity ', ' Metabolic Pathway ', ' Address ', ' methamphetamine abuse ', ' Drug Treatment Centers ', ' Drug Abuse Treatment Centers ', ' Drug Rehabilitation Centers ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Grant Proposals ', ' Applications Grants ', ' Subgroup ', ' Neurosciences Research ', ' Pharmacological Treatment ', ' Molecular ', ' developmental ', ' Development ', ' methamphetamine addiction ', ' meth dependence [{C1533217}] ', ' meth addiction ', ' METH dependence ', ' METH addiction [{C1533217}] ', ' Methamphetamine dependence ', ' Behavioral ', ' Healthcare professional ', ' Health Care Professional ', ' Health Professional ', ' pathway ', ' Pathway interactions ', ' underserved people ', ' under served population ', ' Underserved Population ', ' meth exposure ', ' methamphetamine exposure ', ' therapeutic target ', ' addictive disorder ', ' addiction ', ' effective intervention ', ' primary care setting ', ' screening and brief intervention ', ' screening, brief intervention, and referral to treatment ', ' SBIRT ', ' screening, brief intervention, referral, and treatment ', ' ']",NIDA,MEHARRY MEDICAL COLLEGE,R24,2015,458326,0.04533793193897472
"Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS) DESCRIPTION (provided by applicant):  There is a critical need to develop a diverse pool of highly trained clinician scholars to foster the development of biomedical, behavioral and clinical research related to drug abuse, addiction, and HIV prevention and treatment in general medical settings. Patients who abuse substances are more likely to be seen in general medical settings such as emergency departments (ED), general medical primary care clinics and inpatient wards, HIV and adolescent health clinics, and women's health centers. These patients often present with a complex array of acute consequences and complications (e.g. intoxication, overdose, withdrawal, trauma and infectious diseases) of substance use as well as chronic conditions such as HIV disease, hepatitis, pulmonary and cardiovascular disease. Objectives: The Yale-Drug Abuse, Addiction, and HIV Research Scholars (DAHRS) program provides a comprehensive three year post-doctorate, interdisciplinary, Mentored Career Development Program to improve drug abuse, addiction, and HIV medical outcomes integrating prevention and treatment in general medical settings including ED, primary care, HIV, adolescent, and women's health clinics. Specifically, Yale-DAHRS will: [Aim 1] Develop clinician scientists with the knowledge, skills, and ability to become independent investigators, generating findings of practical value with significant impact to improve health outcomes of patients with and at risk for drug abuse, addiction, and HIV; [Aim 2] Develop future leaders by providing Scholars with leadership tools and skills and creating individualized programs to ensure success in leading multidisciplinary research teams in studying drug abuse, addiction and HIV, and implementation and integration of research findings into general medical settings; and [Aim 3] Enhance the diversity of drug abuse, addiction, and HIV researchers. Addressing women and minority faculty under representation will enhance the diversity of investigators and research topics, broaden perspectives in setting research priorities, increase clinical trial participation, and expand knowledge. Working synergistically with Yale's established training programs in drug abuse, HIV and clinical investigation, Yale- DAHRS will capitalize on existing academic infrastructure and expertise to ensure success. Unique, features include: (1) An interdisciplinary, diverse faculty of independent researchers in illicit and prescription drug abuse and addiction, tobacco, alcohol, HIV, and medical complexities such as pain and hepatitis C; (2) Synergy with well established, high quality post-doctoral training programs at Yale; (3) The use of clinical informatics for data collection, data management, diagnostic tool development, and information dissemination; and (4) The integration of such diverse fields as public health, informatics, clinical epidemiology, systems engineering and demography with the traditional clinical sciences of internal medicine, emergency medicine, HIV medicine, pediatrics, obstetrics and gynecology, psychiatry, and psychology; (5) Established clinical research laboratories, including the Yale-New Haven Hospital, a tertiary care center for southern New England and a community hospital for the Greater New Haven Area, serving an ethnically, racially, culturally, and economically diverse population, a Veterans Affairs Medical Center and community treatment centers such as the APT Foundation and Federally Qualified Health Centers; (6) Synergies with established research centers and institutes such as the Center for Interdisciplinary Research on AIDS and the Veterans Aging Cohort on HIV. Career Development Plan: Yale-DAHRS is a three year research training program that will prepare a total of six clinician investigators for careers focusing on drug abuse, addiction, and HIV in general medical settings during its first funding cycle. Scholars will earn the Master in Health Sciences degree, combining rigorous training in research methodology, statistics and design with seminars in topics related to drug abuse, addiction, and HIV content, leadership, grant writing and responsible conduct of research. Candidates will complete published mentored research project(s) and prepare an application for the next career step; i.e. NIH R21, R03, R15, R34 mechanism. The collaboration of the multidisciplinary faculty and the combined robust strengths of two principal investigators from Emergency and Internal Medicine, both with extensive experience mentoring and as independent funded investigators will drive the Yale-DAHRS program. Potential Research Projects: Multiple research projects are ""shovel ready"" for Scholar training and can be completed within our allotted time frame, such as secondary data analysis using national large datasets e.g. VA Aging Cohort (HIV); risk factors, prevention and treatment of prescription drug abuse, office-based treatment of opioid dependence with buprenorphine, systematic reviews and meta-analyses, creation of cost effective evaluation models for patients with drug abuse, addiction and HIV including prescription drug abuse; investigation of gender and racial/ethnic disparities in identification and treatment interventions and outcomes; evaluation of screening, and treatment initiation in special populations (i.e. adolescent-elderly, veterans, incarcerated, HIV); comparison of models of screening, brief intervention and referral to treatment (SBIRT) delivery by providers and other innovative technologies; effectiveness and implementation of SBIRT science in general medicine practice with acute and chronic medical complexities. PUBLIC HEALTH RELEVANCE:  Drug abuse, addiction, and HIV are significant public health issues, as they affect the health and well-being of a large portion of the population; have substantial negative health outcomes on individuals; and are extremely costly to the health care system. An investment in research to improve substance abuse and medical health outcomes is greatly needed. The proposed Yale-Drug Abuse, Addiction, and HIV Research Scholars (DAHRS) program focusing on general medical settings with patients throughout the life cycle will provide a three year post-doctoral, interdisciplinary, Mentored Career Development Program training six clinician-scientists for independent research careers in the field of drug abuse, addiction, and HIV through integration of prevention and treatment in general medical settings.","Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS)",8829809,K12DA033312,"['Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Alcohol Chemical Class ', ' Alcohols ', ' Behavioral Research ', ' Biomedical Research ', ' 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5alpha,7alpha(S))- ', ' Buprenorphine ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Clinical Informatics ', ' Clinical Study ', ' Clinical Research ', ' clinical investigation ', ' Clinical Trials ', ' Infectious Disorder ', ' Infectious Diseases and Manifestations ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communicable Diseases ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' Population Studies / Demography ', ' Demography ', ' disease/disorder ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Emergency Medicine ', ' Engineering ', ' Faculty ', ' Foundations ', ' Future ', ' Grant ', ' Gynecology ', ' Health ', ' Hepatitis ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Hospitals ', ' Community Hospitals ', ' Information Dissemination ', ' Inpatients ', ' Institutes ', ' Internal Medicine ', ' Laboratories ', ' Leadership ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Medicine ', ' Mentors ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Northeastern United States ', ' New England ', ' Obstetrics ', ' Discipline of obstetrics ', ' Overdose ', ' Painful ', ' Pain ', ' Patients ', ' Pediatrics ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Psychiatry ', ' Psychology ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' Science ', ' statistics ', ' Time ', ' Tobacco ', ' Training Programs ', ' Veterans ', ' Woman ', ' Work ', ' Writing ', ' Gender ', ' Female Health ', "" Women's Health "", ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Research Methods ', ' Research Methodology ', ' Dataset ', ' Data Set ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' base ', ' career ', ' improved ', ' Area ', ' Acute ', ' Chronic ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Ensure ', ' Evaluation ', ' Training ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Withdrawal ', ' Fostering ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Development Plans ', ' Funding ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' tool ', ' Diagnostic ', ' Research Priority ', ' Knowledge ', ' programs ', ' Scientist ', ' Investigation ', ' Complex ', ' Clinic ', ' LOINC Axis 4 System ', ' System ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' Opiate Addiction ', ' Emergency room ', ' Emergency Department ', ' Accident and Emergency department ', ' Medical center ', ' innovative technologies ', ' data management ', ' experience ', ' Special Population ', ' named group ', ' success ', ' cohort ', ' skills ', ' Prevention ', ' Intoxication ', ' prescription drug abuse ', ' Modeling ', ' career development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' consumer informatics ', ' Health Informatics ', ' Public Health Informatics ', ' Provider ', ' Effectiveness ', ' ward ', ' Address ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Health Sciences ', ' Scholars Program ', ' NCI Scholars Program ', ' Infrastructure ', ' Research Infrastructure ', ' Research Training ', ' Clinical Sciences ', ' Principal Investigator ', ' developmental ', ' Development ', ' Federally Qualified Health Center ', ' systematic review ', ' treatment center ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' cost-effective ', ' cost effective ', ' Trauma ', ' tertiary care ', ' postdoctoral training ', ' post-doctoral training ', ' clinical epidemiology ', ' addictive disorder ', ' addiction ', ' tool development ', ' racial and ethnic disparities ', ' screening, brief intervention, and referral to treatment ', ' SBIRT ', ' screening, brief intervention, referral, and treatment ', ' responsible research conduct ', ' young woman ', ' screening ', ' ']",NIDA,YALE UNIVERSITY,K12,2015,524976,0.10922386071168934
"Couple HIV prevention for drug-involved male offenders: An Effectiveness Trial DESCRIPTION (provided by applicant): The proposed study responds to PA-09-236 entitled ""HIV/AIDS, Drug Use, and Vulnerable Populations."" This study is a randomized controlled trial (RCT) that will rigorously evaluate the implementation, effectiveness and cost-effectiveness of a couple-based integrated HIV/STI and drug abuse prevention intervention (Connect II) with drug-involved male offenders charged with misdemeanors and their primary female sexual partners, implemented by frontline providers in Criminal Court, Community Court or Probation (CCP) sites in the Bronx, NY, compared to CCP standard treatment of care services (TAU). The primary outcomes are biologically confirmed sexually transmitted infections (STIs) and self-reported condom use. This study will yield important data on implementation factors associated with effectiveness of the proposed intervention in real world resource-constrained criminal justice settings. The proposed CCP study sites are located in the South Bronx, the poorest Congressional District in the U.S. with 96% of residents identifying as Black or Latino. The South Bronx has an HIV prevalence rate of 2.6%. Research has found that 12% of men on probation in New York City are HIV positive. Though the criminal justice system is recognized as the epicenter of the epidemic in the U.S., few, if any, HIV prevention interventions have been developed for the huge number of male offenders under community supervision who represent 90% of the corrections population. No HIV/STI prevention services are currently provided at the proposed CCP sites. The proposed intervention is designed to address this critical gap in services. Connect II was found to be efficacious among drug-involved couples in reducing risky drug and sexual behaviors and drug use. In the proposed study we aim to advance the knowledge of implementation science by testing the effectiveness and cost-effectiveness of Connect II delivered by frontline providers in the real world settings of CCP sites with 240 drug-involved male offenders and their female partners (N=480 participants). Eligible couples will be randomly assigned to either (1) a 4-session Connect II delivered to both partners together + TAU delivered to male participant alone, or (2) a TAU control condition delivered to the male participant. Repeated assessments will occur at baseline and 3, 6, and 12-months post intervention. The study will be conducted by Dr. Nabila El-Bassel, Dr. Louisa Gilbert, and an investigative team from Columbia University in collaboration with Michael Rempel from the Center for Court Innovation and the New York City Department of Probation. If found to be effective, Connect II may be scaled up in community criminal justice settings nationwide to curb the spread of HIV/STIs and to reduce HIV disparities in heavily impacted communities like the South Bronx. PUBLIC HEALTH RELEVANCE:  This study addresses the significant public health threat of HIV and other STIs among drug- involved male offenders under community supervision and their female partners. This study will evaluate the implementation, effectiveness and cost-effectiveness of a brief couple-based HIV and drug abuse prevention intervention for drug-involved male offenders and their female partners delivered by frontline providers in Criminal/Community Court and Probation sites in the South Bronx, the poorest congressional district in the U.S. If found to be effective, the proposed brief intervention may be scaled up to community criminal justice sites nationwide to curb the spread of HIV/STIs and reduce HIV disparities.",Couple HIV prevention for drug-involved male offenders: An Effectiveness Trial,8892127,R01DA033168,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Subsaharan Africa ', ' Sub-Saharan Africa ', ' Africa South of the Sahara ', ' Charge ', ' Client ', ' Communities ', ' cost effectiveness ', ' Couples ', ' Drug Utilization ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Female ', ' Health ', ' services research ', ' Medical Care Research ', ' Healthcare Research ', ' Health Services Evaluation ', ' Health Care Research ', ' Health Services Research ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' seropositive (AIDS test) ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' Institutes ', ' male ', ' Manuals ', ' Medicine ', "" men's "", ' men ', ' Methods ', ' New York City ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' sex partner ', ' Sexual Partners ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Supervision ', ' Testing ', ' Time ', ' Universities ', ' Work ', ' Treatment outcome ', ' Criminal Justice ', ' Latino ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Caring ', ' base ', ' court ', ' improved ', ' Site ', ' drug use ', ' Drug usage ', ' Collaborations ', ' Letters ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Knowledge ', ' Scientist ', ' LOINC Axis 4 System ', ' System ', ' psychosocial ', ' Outcome Study ', ' Prevent infection ', ' Infection prevention ', ' Consult ', ' Services ', ' professor ', ' condoms ', ' Participant ', ' prevention service ', ' recidivism ', ' Self-Report ', ' Patient Self-Report ', ' Prevention ', ' probation ', ' criminal offender ', ' offender ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' Modeling ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' Provider ', ' prevent drug use ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' Effectiveness ', ' Address ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Cost Effectiveness Analysis ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Subgroup ', ' Characteristics ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' post intervention ', ' effectiveness trial ', ' cost ', ' efficacy research ', ' designing ', ' design ', ' probationer ', ' scale up ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' demographics ', ' implementation science ', ' community setting ', ' evidence base ', ' primary outcome ', ' secondary outcome ', ' standard treatment ', ' standard care ', ' ']",NIDA,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2015,644544,0.06416710644856985
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network     DESCRIPTION:  The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PUBLIC HEALTH RELEVANCE: This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9128802,UG1DA015815,"['etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' American Indian ', ' American Indians ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Cities ', ' clinical investigation ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' disease/disorder ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Education ', ' Educational aspects ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' health care service ', ' Health Services ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl- ', ' Methadone ', ' Methods ', ' Narcanti ', ' Narcan ', ' Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)- ', ' Naloxone ', ' Persons ', ' Oregon ', ' Overdose ', ' Patients ', ' Peer Review ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' public health medicine (field) ', ' Scientific Publication ', ' Publications ', ' recruit ', ' Recruitment Activity ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Rural Health ', ' Safety ', ' San Francisco ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Social Workers ', ' Substance Use Disorder ', ' Testing ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' Medical ', ' Link ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Training ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Licensing ', ' Opioid ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Therapeutic ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocol ', ' Protocols documentation ', ' Country ', ' Services ', ' experience ', ' care delivery ', ' Participant ', ' treatment program ', ' member ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' behavioral health ', ' QOC ', ' Quality of Care ', ' protocol development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' patient registry ', ' Provider ', ' prevent drug use ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' health disparities ', ' health disparity ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Research Training ', ' Ancillary Study ', ' Clinical Data ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' designing ', ' design ', ' urban American Indian ', ' urban native american ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addictive disorder ', ' addiction ', ' evidence base ', ' patient population ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2015,198851,0.08695097140668363
"Age-Varying Effects in the Epidemiology of Drug Abuse     DESCRIPTION (provided by applicant): To improve the efficiency and efficacy of drug abuse interventions, an understanding of the age-related changes in behavior prevalences, comorbidities, and health disparities, and the evolving role of various risk factors from adolescence through middle adulthood, is crucial. Today there is an unprecedented amount of existing high-quality data that have enormous potential to shed new light on these issues. Many of these data sets are nationally representative, drawn from populations that span a wide range of ages. New methods now exist to tap those data in order to address important, new scientific questions about drug use, abuse, and dependence (drug UAD) from a developmental perspective. To this end, we propose the innovative application of the time-varying effect model (TVEM) to data from two complementary national studies of health risk behaviors: The National Longitudinal Study of Adolescent Health (N=20,745) and the 2012 National Survey on Drug Use and Health (N=63,809). TVEM flexibly estimates behavior prevalences and associations among variables as continuous, flexible functions of age. Specifically, the specific aims for this projec are as follows. (1) To model flexible, age-varying trends in drug UAD from adolescence into middle adulthood. We will estimate rates of alcohol, tobacco, marijuana, and other drug use, abuse and dependence as a complex function of continuous age from ages 12 to 50. Trends will be estimated across sex and race/ethnicity to document age-varying health disparities. (2) To elucidate the age-varying role of mental health problems in the course of drug UAD from adolescence into middle adulthood. We will examine how depressive symptoms and suicidal ideation are differentially associated with drug UAD as a continuous, complex function from ages 12 to 50. (3) To estimate age-varying effects of early and concurrent risk factors on drug UAD from adolescence into middle adulthood. We will examine how and when specific risk and protective factors are associated with drug UAD from ages 12 to 50. We will consider early risk factors at the individual, parent, peer, school, and community levels, as well as concurrent factors such as marriage and parenthood. (4) To examine contributors to health disparities in drug use. To advance understanding of the developmental course of health disparities, we will examine sex and race/ethnicity as moderators of (a) age-varying comorbidities of drug UAD and mental health problems and (b) age-varying associations between risk factors and drug UAD. This project will provide knowledge about the developmental course of drug UAD and related health disparities, allowing prevention scientists and clinicians to design interventions that matc the most promising mechanisms of change to the most appropriate age period within population subgroups. To maximize the project's overall impact, we will actively disseminate this promising new analytic approach to drug abuse researchers.         PUBLIC HEALTH RELEVANCE: Existing national data have been used extensively to advance understanding of drug use, abuse, and dependence; comorbidities with mental health problems; the role of early and concurrent risk factors; and health disparities. However, empirical studies and behavioral theory have been largely silent on how these issues evolve continuously across age. This project will apply a new data analytic approach to existing cross- sectional and panel data to gain new insight into nuanced, age-related changes from adolescence through mid-adulthood, shedding light on ways to tailor interventions to individuals to increase intervention efficiency and efficacy to reduce drug abuse and its related consequences.                ",Age-Varying Effects in the Epidemiology of Drug Abuse,8940295,R01DA039854,"['Accounting ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Age ', ' Alcohol Chemical Class ', ' Alcohols ', ' Behavior ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' co-morbidity ', ' Comorbidity ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Employment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Health ', ' Photoradiation ', ' Light ', ' long-term study ', ' Longitudinal Studies ', ' marijuana ', ' Marihuana ', ' Marital Status ', ' Marriage ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Paper ', ' Parents ', ' Public Health ', ' public health medicine (field) ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Schools ', ' Survey Instrument ', ' Surveys ', ' Time ', ' Tobacco ', ' United States ', ' Work ', ' Gender ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' depressive symptoms ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Dataset ', ' Data Set ', ' improved ', ' Distal ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' insight ', ' Individual ', ' Workshop ', ' Educational workshop ', ' Data Quality ', ' drug use ', ' Drug usage ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Knowledge ', ' Scientist ', ' thoughts about suicide ', ' suicide ideation ', ' suicidal thinking ', ' suicidal ideation ', ' Suicidal thoughts ', ' Feeling suicidal ', ' Complex ', ' Dependence ', ' collegiate ', ' college ', ' Intercept ', ' peer ', ' Prevention ', ' psychological distress ', ' Modeling ', ' response ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Address ', ' Data ', ' Subgroup ', ' enroll ', ' Enrollment ', ' trend ', ' teen years ', ' Teen ', ' Teenagers ', ' Process ', ' sex ', ' developmental ', ' Development ', ' age dependent ', ' age related ', ' attributable death ', ' attributable mortality ', ' cost ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Treatment Efficacy ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' treatment design ', ' intervention design ', ' therapy design ', ' public health relevance ', ' effective intervention ', ' flexible ', ' flexibility ', ' ']",NIDA,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2015,226050,0.21078522912097405
"Epidemiology, Prevention and Treatment of HCV in Young Adult Persons who Inject Drugs in non-urban New Mexico     DESCRIPTION (provided by applicant): The hepatitis C virus (HCV) epidemic in the U.S. is concentrated in people who inject drugs (PWID). Increasing reports of HCV including outbreaks of HCV in young adult PWID in non-urban locales have prompted concerns about an expanding epidemic. Several investigations suggest that that these spikes in HCV infection are linked to sharp increases in prescription opiate use that has been trending in the U.S, and which have resulted in young adults transitioning from prescription opiates to injection use, particularly heroin. Young adult PWID in non-urban areas may be at increased risk of infection, from the combination of high viral infectivity and high prevalence of HCV in injecting groups, together with a lack of knowledge regarding infection routes and effective prevention. New Mexico is one of the states leading recorded increases in HCV in young adults, ranking 2nd in the CDC's Emerging Infections Program (EIP), Hepatitis Surveillance Demonstration Sites project, in 2011 for the number and rate of HCV cases reported. Heroin, prescription opioids, and other drugs are also accounting for this state having one of the highest overdose rates in the country. Between October 2013 and March 2014, the New Mexico Department of Health recorded 211 cases of HCV among young adults in a pilot surveillance study, demonstrating the gravity of the problem. To address the need for prevention, care and treatment services against HCV in this population, we propose epidemiological and service uptake research in two regions of New Mexico where young adult PWID have been impacted by drug use and HCV. We will initiate a prospective cohort study of young adult non-urban PWID who will be recruited and followed in two health regions of New Mexico (the South West and North East) to: (1) gather epidemiologic data on risk behaviors, drug use patterns, injection networks, prevention needs, and health service utilization; (2) to refer young adult PWID to HCV care services, as well as other prevention and treatment opportunities including harm reduction and drug treatment, and assess rates of successful linkage, including the  cascade of care; (3) to examine factors that may contribute to non-treatment, poor adherence, and failure to achieve SVR among young adult PWID with chronic HCV infection; and (4) assess reinfection events among young adult PWID who are treated for HCV and achieve SVR. Our proposal, which we refer to in this application as New Mexico H-TIPS, will also include testing and referrals for HIV and HBV co-infections as well. A collaborative group of public health and clinical specialists linked with a strong prevention and clinical service infrastructure in New Mexico will ensure successful implementation of this research. Results from this proposed research will impact a diverse young population disproportionately at risk for HCV and reduce health disparities in a region highly impacted by drug use and HCV. PUBLIC HEALTH RELEVANCE: This proposed three-year research plan seeks to assess the epidemiology of HCV infection in young adult people who inject drugs (PWID) in non-urban areas of New Mexico. The proposed New Mexico H-TIPS project will study factors that will inform effective and integrated care and prevention models for this high-risk population. We have significant expertise in working with the target population, including recruitment and retention and in identifying HCV infection, which together with a unique infrastructure for preventive and clinical services in New Mexico, including HCV and drug treatment make this proposal highly likely to succeed. This research will contribute significantly to further knowledge of  combination  HCV prevention, and how to impact population prevalence and incidence of HCV in New Mexico and elsewhere.","Epidemiology, Prevention and Treatment of HCV in Young Adult Persons who Inject Drugs in non-urban New Mexico",8917031,U18PS004568,[''],NCHHSTP,UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,U18,2015,305451,0.0839915446261307
"Interdisciplinary Research Training Institute on Hispanic Drug Abuse     DESCRIPTION (provided by applicant): This application requests continued support of the Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse (5 R25DA026401) that has developed and implemented a research education program aimed at promoting the career development of pre-doctoral and early career clinically focused scientists interested in conducting research that affects the Hispanic population. This comprehensive and coordinated effort focuses on providing research experience and increasing the skills required for the preparation and submission of competitive research applications for NIH extramural funding. This renewal application expands the scope of the IRTI program to include international clinically focused fellows from Mexico. Building upon the success and accomplishments of the existing IRTI, the specific aims of the IRTI are to (1) Continue to provide an improved educational training opportunity to enhance the skills for conducting interdisciplinary Hispanic drug research and developing applications for NIH funding among pre-doctoral, postdoctoral and early career faculty members (fellows) through the implementation of an 11-day intensive summer research training program; (2) Expand the scope of the IRTI program to include international, clinically focused fellows from Mexico that will serve to strengthen their capacity o conduct independent drug research and provide opportunities for U.S. and Mexico fellows to share knowledge that may develop into research activities aimed at enhancing bi-national public health efforts to address drug abuse and addiction; (3) Continue to execute an improved mentoring plan structured around a team of interdisciplinary senior faculty mentors who would be accessible and available to provide selected fellows with focused mentoring and continued support; (4) Continue to provide an improved networking structure and process that will assist fellows in building and maintaining relationships and communication with leading experts in the field of Hispanic drug research and fellow peers. Mentoring activities will focus on guiding and assisting the fellows in achieving benchmarks of progress including: a) Academic Career Progress; b) Scientific Publications; c) Scientific Presentations; and d) Research Funding. These outcomes will be facilitated through various types of support provided by the IRTI including: Mentor Commitment, Travel to Mentor Institution, E-Mentoring Technologies, Conferences/Workshops, and IRTI Mentoring Annual Meeting. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research in the interest of public health. Building upon the existing mentoring and networking success, the proposed IRTI renewal will continue to fill the gap in knowledge on how to develop effective research incubators that will increase the number of minority drug abuse researchers.         PUBLIC HEALTH RELEVANCE: This application seeks funding to continue the Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse that seeks to promote the career development of underrepresented pre-doctoral, postdoctoral and early career clinically-focused scientists in the U.S. and Mexico interested in conducting research as it affects the Hispanic population. Hispanics face unique health challenges, and efforts to increase the number of well-qualified researchers prepared to conduct clinical research are vital to reducing health disparities among this underserved population. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive clinical research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitae the conduct of interdisciplinary drug abuse research.            ",Interdisciplinary Research Training Institute on Hispanic Drug Abuse,8852010,R25DA026401,"['Affect ', ' Clinical Study ', ' Clinical Research ', ' Communication ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Environment ', ' facial ', ' faces ', ' Face ', ' Faculty ', ' Goals ', ' Health ', ' Incubators ', ' Institutes ', ' Leadership ', ' Mentors ', ' Mentorship ', ' Mexico ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Public Health ', ' public health medicine (field) ', ' Scientific Publication ', ' Publications ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Technology ', ' Training Programs ', ' Travel ', ' Work ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Competence ', ' conference ', ' symposium ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' base ', ' career ', ' improved ', ' Training ', ' Discipline ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Workshop ', ' Educational workshop ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Research Activity ', ' drug use ', ' Drug usage ', ' Funding ', ' Nature ', ' Knowledge ', ' programs ', ' Scientist ', ' Complex ', ' Best Practice Analysis ', ' Benchmarking ', ' interest ', ' meetings ', ' experience ', ' success ', ' Self Efficacy ', ' Structure ', ' skills ', ' peer ', ' member ', ' Negotiation ', ' Negotiating ', ' Mediation ', ' career development ', ' psychosocial development ', ' theories ', ' health disparities ', ' health disparity ', ' Institution ', ' Address ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' International ', ' Qualifying ', ' NIH RFA ', ' Request for Applications ', ' Research Training ', ' Extramural ', ' EXTMR ', ' Extramural Activities ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' Preparation ', ' Process ', ' developmental ', ' Development ', ' minority health ', ' underserved people ', ' under served population ', ' Underserved Population ', ' next generation ', ' Minority ', ' Outcome ', ' Population ', ' predoctoral ', ' predoc ', ' pre-doc ', ' pre-doctoral ', ' public health relevance ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R25,2015,342481,0.13783565054063016
"The Development and Evaluation of the Ho'ouna Pono Drug Prevention Curriculum     DESCRIPTION (provided by applicant): Research has indicated that Native Hawaiian youth have significantly higher rates of drug use than their non-Hawaiian counterparts (e.g., Wong, Klingle, & Price, 2004; Mayeda, Hishinuma, Nishimura, Garcia- Santiago, & Mark, 2006; Nishimura, Hishinuma, & Goebert, 2013), and that these differences are particularly pronounced in rural settings (Lai & Saka, 2005). Despite these findings, there have been very few drug prevention programs developed and evaluated specifically for these youth (Edwards, Giroux, & Okamoto, 2010; Rehuher, Hiramatsu, & Helm, 2008). Therefore, the purpose of this research proposal is to complete the development of a video-enhanced, culturally grounded, school-based drug prevention curriculum for rural Native Hawaiian youth (Ho'ouna Pono), and to evaluate the curriculum across all public middle/intermediate schools on Hawai'i Island. This will be accomplished through three specific aims. AIM 1 (Year 1) is to complete the Ho'ouna Pono drug prevention curriculum initially developed and validated in a NIDA-funded translational pilot/feasibility study (R34 DA031306). To date, five professionally filmed video vignettes depicting drug-related problem situations specific to rural Hawaiian youth and seven interactive classroom lessons have been created, implemented in randomly selected intervention schools, and preliminarily evaluated using a pre-test, post-test control group design. Aim 1 enhances and builds upon this work by producing two new video vignettes, re-editing a ""Behind the Scenes"" video, developing new classroom curricular components, and synthesizing the new content with the existing curriculum. AIM 2 (Years 2-3) is to evaluate the fully conceived curriculum across all middle/intermediate schools on Hawai'i Island (N = 15) using a dynamic wait- listed control group design (Brown, Wyman, Guo, & Pea, 2006). AIM 3 (Year 4) is to assess community, systemic, and curricular factors related to the implementation, adoption, and sustainability of the curriculum within public middle/intermediate schools on Hawaii Island.         PUBLIC HEALTH RELEVANCE: Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have recently been shown to have significantly higher rates of drug use compared with other ethnic groups (Wu et al., 2013), research focused on drug prevention of these individuals is important to improve public health both in Hawai'i and on the Mainland U.S. This study actively engages rural communities in the full-scale development and evaluation of the Ho'ouna Pono drug prevention curriculum for Hawaiian youth, promoting the overall utility and effectiveness of the intervention. Further, the findings from this study will point to the core content of prevention interventions for Hawaiian youth in rural communities, which should be applicable to other ethnic youth populations in Hawaii and the Pacific Rim, as well as Native youth populations on the Mainland U.S.                ",The Development and Evaluation of the Ho'ouna Pono Drug Prevention Curriculum,8848653,R01DA037836,"['Adoption ', ' Communities ', ' Control Groups ', ' Curriculum ', ' Educational Curriculum ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Ethnic group ', ' Feasibility Studies ', ' Hawaii ', ' Island ', ' Pre-Post Tests ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Research Proposals ', ' Rural Health ', ' Schools ', ' Science ', ' Testing ', ' Time ', ' Waiting Lists ', ' Work ', ' Measures ', ' pricing ', ' Price ', ' Film ', ' Rural Community ', ' Youth 10-21 ', ' Youth ', ' base ', ' improved ', ' Evaluation ', ' Individual ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' drug use ', ' Drug usage ', ' Funding ', ' Hawaiian ', ' Hawaiian population ', ' Outcome Study ', ' cohort ', ' Prevention Research ', ' Prevention ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' Address ', ' Effectiveness of Interventions ', ' Indigenous ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' designing ', ' design ', ' Population ', ' Drug Prevention Program ', ' native youth ', ' community based participatory research ', ' public health relevance ', ' intervention effect ', ' efficacy testing ', ' health equity ', ' ']",NIDA,HAWAII PACIFIC UNIVERSITY,R01,2015,392060,0.11304276041447972
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network     DESCRIPTION:  The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years.         PUBLIC HEALTH RELEVANCE: This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.            ",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9117842,UG1DA015815,"['etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' American Indian ', ' American Indians ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Cities ', ' clinical investigation ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' disease/disorder ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Education ', ' Educational aspects ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' health care service ', ' Health Services ', ' non-A, non-B hepatitis ', ' non-A non-B hepatitis ', ' non A, non B hepatitis ', ' non A non B hepatitis ', ' hepatitis nonA nonB ', ' hepatitis non A non B ', ' PT-NANBH ', ' Non-B Hepatitis Parenterally-Transmitted Non-A ', ' NANBH ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl- ', ' Methadone ', ' Methods ', ' Narcanti ', ' Narcan ', ' Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)- ', ' Naloxone ', ' Persons ', ' Oregon ', ' Overdose ', ' Patients ', ' Peer Review ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' public health medicine (field) ', ' Scientific Publication ', ' Publications ', ' recruit ', ' Recruitment Activity ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Rural Health ', ' Safety ', ' San Francisco ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Social Workers ', ' Substance Use Disorder ', ' Testing ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' Medical ', ' Link ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Training ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Licensing ', ' Opioid ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Therapeutic ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocol ', ' Protocols documentation ', ' Country ', ' Services ', ' experience ', ' care delivery ', ' Participant ', ' treatment program ', ' member ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' behavioral health ', ' QOC ', ' Quality of Care ', ' protocol development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' patient registry ', ' Provider ', ' prevent drug use ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' health disparities ', ' health disparity ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Research Training ', ' Ancillary Study ', ' Clinical Data ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' designing ', ' design ', ' urban American Indian ', ' urban native american ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addictive disorder ', ' addiction ', ' public health relevance ', ' evidence base ', ' patient population ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2015,870391,0.08695097140668363
"Social Networks and HIV Risk Behaviors of Special Populations of Drug Users DESCRIPTION (provided by applicant): The primary goal of this resubmitted K02 application is to further develop Dr. Carrie Oser's productive independent research career and to augment her research focus on HIV, substance abuse treatment, crime, and health disparities by gaining new training on social networks and HIV intervention development. The K02 builds upon her focus on special populations, including both rural drug users and African American drug users. The proposed training goals will provide new instruction in social networks, HIV intervention development, and the responsible conduct of research. The specific aims are: (1) to identify HIV and HCV risk and longitudinal changes in risk in the social networks of 503 rural out-of-treatment drug using women, as compared to men; and (2) to examine the effect of social networks, including structure (e.g., size, density), function (e.g., emotional and instrument support), and content (e.g., attitudes towards physicians), on HIV and HCV risk behaviors and health services utilization among African American drug using women, as compared to men, across criminal justice status. This significant and innovative study will have strong public healt impacts and will support NIDA's Health Disparities Initiative because of its potential to contribut to our understanding of the cultural and social network correlates of health disparities among both rural and African American drug users. In addition, this study improves upon the methodological limitations of previous research findings by examining various social networks (e.g., egocentric, dyadic, and sociocentric) and using longitudinal data in multilevel models. This proposed project will allow for a practical application of the substantive knowledge and analytical skills acquired from the K02 training activities and will ultimately culminate in the development of forthcoming investigator initiated NIDA grant applications. Specifically, these findings will be used as a foundation for future HIV social networks based intervention to increase special populations' use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism. PUBLIC HEALTH RELEVANCE: This study is significant to the public health field because of its potential to understand the individual, cultural, and social network factors associated with HI and HCV risk behaviors among two special populations - rural drug users and African American drug users. These findings will be used as a foundation for developing social network based HIV interventions to increase special populations' use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism.",Social Networks and HIV Risk Behaviors of Special Populations of Drug Users,8867192,K02DA035116,"['Accounting ', ' Attitude ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Crime ', ' Data Collection ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Female ', ' Foundations ', ' Future ', ' Goals ', ' Grant ', ' Health ', ' health care service ', ' Health Services ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Kentucky ', ' male ', "" men's "", ' men ', ' Method LOINC Axis 6 ', ' Methodology ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Roxicodone ', ' Oxycontin ', ' Oxycodone SR ', ' Oxycodeinon ', ' Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5alpha)- ', ' Dihydrohydroxycodeinone ', ' Oxycodone ', ' Physicians ', ' Drug Prescribing ', ' Drug Prescriptions ', ' Prisons ', ' Public Health ', ' public health medicine (field) ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Training Activity ', ' Woman ', ' Gender ', ' Measures ', ' falls ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' health care ', ' Healthcare ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Social Network ', ' career ', ' density ', ' rural area ', ' urban area ', ' improved ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' Link ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Training ', ' Spiritualities ', ' Spirituality ', ' Individual ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Rural ', ' drug use ', ' Drug usage ', ' Drug user ', ' instrument ', ' Knowledge ', ' Life ', ' LOINC Axis 4 System ', ' System ', ' SNAP ', ' S-nitro-N-acetylpenicillamine ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' Services ', ' experience ', ' Special Population ', ' named group ', ' Structure ', ' skills ', ' disease prevention ', ' disorder prevention ', ' recidivism ', ' Self-Report ', ' Patient Self-Report ', ' probation ', ' social ', ' HIV risk ', ' multilevel modeling ', ' multilevel model ', ' methods to study multiple-level influences ', ' multilevel analysis ', ' Emotional ', ' Network Analysis ', ' Pathway Analysis ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' HIV diagnosis ', ' health disparities ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' K02 Award ', ' Independent Scientist Award ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Strategic Planning ', ' developmental ', ' Development ', ' substance abuse therapy ', ' substance abuse treatment ', ' Instruction ', ' willingness ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' application in practice ', ' practical application ', ' Network-based ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' high risk ', ' responsible research conduct ', ' injection drug use ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,K02,2015,115827,0.1196814521075345
"Southern Ohio Prevents Hepatitis Project (StOPHeP)     DESCRIPTION (provided by applicant): The overall goal of this project is to develop an integrated comprehensive approach for detection, prevention, linkage to care and treatment for hepatitis C (HCV) among young adults (18-30 years old) who have a history of injection drug use (people who inject drugs, PWID) and live in 21 non-urban southern Ohio counties. We will accomplish this by collaborating with addiction treatment providers, public health agencies, and syringe exchange programs in the target areas to identify, test, refer and link PWID to prevention and treatment services. The target area includes 21 suburban (large fringe metro, small metro) and rural (micropolitian, non-core) counties in southern Ohio, 18 of which are classified as Appalachian. To develop and implement a comprehensive strategy to address the high prevalence of HCV in southern Ohio, we will 1) identify and describe the demographic characteristics and risk behaviors and injection networks of young non-urban PWID, and test them for HCV, hepatitis B (HBV) and HIV; 2) use Peer Navigators to link young non-urban PWID to addiction treatment programs and to primary care, mental health and specialty treatment (infectious diseases, hepatology), including linkage to health insurance through the Affordable Care Act and expanded Ohio Medicaid; 3) use Peer Navigators to provide education on safe injection practices to prevent hepatitis and HIV; and link PWID to syringe exchange programs as available in target communities; 4) use a closed social networking site (SNS) to provide peer-facilitated support for the uninfected prevention group (Prevention Room) and for the linkage-to-care group for PWID with HBV, HCV and/or HIV infection (Treatment Room); available both online and via smartphone; and 5) perform follow-up assessment and re-testing of study participants for HCV within 12 months of study entry to determine rates of new HCV infection and reinfection after successful treatment. Since the majority of the target counties are in Appalachia, this proposal will address healthcare inequities that are endemic to this region, and will provide data on which to base future public health initiatives to reduce HCV among young non-urban PWID. PUBLIC HEALTH RELEVANCE: Narrative Injection drug use (IDU) among young adults in rural areas and the resultant epidemic of chronic hepatitis C has become a significant public health problem, but there are few data about the demographics and risk behaviors of rural IDUs to inform public health policies and practice. The use of Peer Navigators and social media will enable us to provide peer support for isolated individuals and ensure study retention and linkage to care. Moreover, linkage to prevention, drug treatment and medical care including infectious disease care for chronic viral infections  will provide data on the outcomes of these efforts in a rural setting.",Southern Ohio Prevents Hepatitis Project (StOPHeP),8917030,U18PS004566,[''],NCHHSTP,UNIVERSITY OF CINCINNATI,U18,2015,354447,0.07656359361115665
"Brief intervention for drug-using rural women at high-risk for HIV/HCV DESCRIPTION (provided by applicant): The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high-risk for HIV and HCV. This project has potential to make a significant contribution to science by advancing knowledge about the health disparities, high-risk behaviors (injection drug use, sex risk), and service utilization of this high-risk, vulnerable, an understudied group of women during a time of emerging and significant public health risk in an Appalachian rural setting. This project will incorporate standardized screening (NIDA-modified ASSIST) to identify high-risk rural women drug users from jails, including injectors. Consenting women (N=350) will be asked to participate in a baseline interview, and will then be randomly assigned to one of two study groups: (1) HIV Education (HIV- Ed n=175) which includes the NIDA standard pre and post-test counseling, HIV and HCV rapid testing, and an information packet on existing community drug abuse and HIV/HCV resources; or (2) Motivational Interviewing- based HIV Risk Reduction (MI-HIV n=175) which, in addition to what is received in the HIV-Ed group, also includes an evidence-based brief intervention for high-risk women focused on an individualized plan for enhancing motivation to reduce risk behaviors and to use health and behavioral health services in the community. Specific aims include: (1) to compare the effectiveness of an evidence-based HIV risk reduction intervention (MI-HIV) to HIV Education (NIDA Standard) in reducing sex risk behaviors, injection practices, and drug use among a culturally unique sample of disadvantaged, drug-using rural women at high-risk for HIV and HCV; and (2) to examine MI-HIV Intervention engagement as a predictor of community health and behavioral health service utilization (including drug treatment and mental health) at follow-up among disadvantaged, drug- using rural women at high risk for HIV and HCV. This project is innovative because it 1) targets a high-risk and understudied group of women, 2) uses brief intervention to not only reduce risk behavior but also to enhance motivation for using community health and behavioral health resources, and 3) utilizes a real-world setting to identify high-risk women drug users. The long-term goal of this study is to increase access to health and behavioral health services in order to improve the quality of health of high-risk rural women. The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high risk for HIV and HCV. This project has potential to make a significant contribution to science by providing knowledge about the health, risk behaviors, and service utilization of a vulnerable and understudied group of women during a time of emerging and significant public health risk in a rural Appalachian setting. Successful completion of the aims of this project will advance the delivery of a low-cost, potentially high impact intervention with implications for a number of other real world settings (such as criminal justice venues) where other disadvantaged high-risk drug users can be identified and targeted for intervention.",Brief intervention for drug-using rural women at high-risk for HIV/HCV,8868967,R01DA033866,"['Appalachia ', ' Appalachian Region ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Community Services ', ' Counseling ', ' Disadvantaged ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Education ', ' Educational aspects ', ' Goals ', ' Health ', ' Health Resources ', ' health care service ', ' Health Services ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Injections ', ' Injection of therapeutic agent ', ' Interview ', ' Kentucky ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Motivation ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Pre-Post Tests ', ' Public Health ', ' public health medicine (field) ', ' Random Selection ', ' Random Allocation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Science ', ' Testing ', ' Time ', ' Walkers ', ' Woman ', ' Criminal Justice ', ' health care ', ' Healthcare ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' base ', ' rural area ', ' improved ', ' Area ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' healthcare utilization ', ' healthcare service utilization ', ' health services utilization ', ' Health Care Utilization ', ' health care service utilization ', ' Rural ', ' drug use ', ' Drug usage ', ' women at high risk ', ' High Risk Woman ', ' Female Groups ', "" Women's Group "", ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Educational Intervention ', ' Staging ', ' Drug user ', ' Opiates ', ' Knowledge ', ' Pattern ', ' Country ', ' Services ', ' treatment planning ', ' Participant ', ' high risk behavior ', ' motivational interview ', ' motivational enhancement therapy ', ' outreach ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' Sampling ', ' behavioral health ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' drug resource ', ' vulnerable group ', ' Vulnerable Populations ', ' Risk Reduction ', ' health disparities ', ' health disparity ', ' Address ', ' Jail ', ' Consent ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Community Health ', ' comparison group ', ' sexual risk behavior ', ' sex risk ', ' cost ', ' designing ', ' design ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' Evidence based intervention ', ' compare effectiveness ', ' service utilization ', ' high risk ', ' evidence base ', ' prescription opiate ', ' screening ', ' injection drug use ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2015,537382,0.12069110669681299
"Drug abuse and jobs: racial disparities in labor force participation and outcomes     DESCRIPTION (provided by applicant): This project addresses the impact of problem drug use (defined as frequency of use, misuse, and dependence) on labor force participation and job-related problems in a nationally representative longitudinal sample of United States adults. A key objective is to investigate racial/ethnic disparities in these associations. Both the US Substance Abuse and Mental Health Services Administration (SAMHSA) National Outcomes Measure and the NIDA Clinical Trials Network have identified employment as an area in need of improved research and intervention. Yet, important gaps remain in our understanding of the population-level impact of problem drug use on labor force participation and the extent to which this impact is disproportionately shouldered by race/ethnic minorities. Also, it remains to be shown if and how much recovery from problem drug use improves employment outcomes for all workers.  Research evidence shows that racial/ethnic minorities are more likely to have higher unemployment rates and unfair labor market experiences. Also, they suffer more social consequences, such as greater likelihood of involvement with the child welfare or criminal justice systems when they misuse, abuse or are dependent on drugs. However, it is unclear whether these disproportionate consequences of problem drug use extend to, or contribute to, the observed racial/ethnic disparities in employment outcomes. The proposed study answers these questions using the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a nationally representative household survey with an oversample of racial/ethnic minority adults (n=43,093 wave 1 and n=34,653 followed up in wave 2). NESARC collects detailed consumption information on timing and quantities of alcohol, marijuana, stimulants, opioids and depressants. The Specific Aims are:  1: To investigate the impact of problem drug use on labor force participation, to determine whether this impact differs among racial/ethnic minorities, and to evaluate whether recovery from problem drug use can mitigate this impact. We hypothesize that problem drug use will be negatively associated with labor force participation and that Black, Native American/Alaskan Native and Hispanic individuals will be disproportionately affected by these adverse effects. We also hypothesize that recovery from problem drug use will be associated with improved labor force participation at wave 2, but racial/ethnic minorities will benefit less from the positive effects of recovery.  2: To investigat, among labor force participants, the impact of problem drug use on employment outcomes and to investigate racial/ethnic disparities. Our hypotheses are that problem drug use will be associated with job loss and job-related conflict, and racial/ethnic minorities will be disproportionately affected by these effects. Impact: Determining the extent of racial/ethnic disparities in the job consequences of problem drug use is necessary to guide future work to uncover and address mechanisms underlying these disparities.         PUBLIC HEALTH RELEVANCE: The project will identify which drug use phenotypes across the spectrum of problem use are most strongly associated with adverse job outcomes. This will enable more refined targeting of drug abuse programs and workplace interventions to mitigate these outcomes. Also, determining the extent of racial/ethnic disparities in the job-related consequences of problem drug use and whether or not recovery can improve job outcomes among drug users is necessary to guide researchers, program planners and policy makers.            ",Drug abuse and jobs: racial disparities in labor force participation and outcomes,8804066,R03DA038697,"['Work-Site ', ' Work Place ', ' Work Location ', ' Job Site ', ' Job Setting ', ' Job Place ', ' Job Location ', ' Job Environment ', ' Workplace ', ' racial/ethnic difference ', ' improved ', ' Area ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' Recovery ', ' young adulthood ', ' adult youth ', ' young adult ', ' Policy Maker ', ' Opioid ', ' Policies ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' drug use ', ' Drug usage ', ' tobacco abuse ', ' Native Americans ', ' Staging ', ' Drug user ', ' programs ', ' Frequency ', ' Frequencies (time pattern) ', ' Dependence ', ' LOINC Axis 4 System ', ' System ', ' Remission ', ' Disease remission ', ' experience ', ' Alaskan Native American ', ' Performance ', ' intervention program ', ' Participant ', ' Program Announcement ', ' NIH Program Announcements ', ' Prevention ', ' social ', ' Sampling ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Adverse effects ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' prevent drug use ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' health disparities ', ' health disparity ', ' Address ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Strategic Planning ', ' Occupational Epidemiology ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' labor force participation ', ' health economics ', ' Clinical Trials Network ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' Population ', ' Consumption ', ' ethnic minority ', ' ethnic minority population ', ' economic outcome ', ' racial and ethnic disparities ', ' public health relevance ', ' population based ', ' clinical practice ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Alcohol Chemical Class ', ' Alcohols ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' adolescent welfare ', ' Child Welfare ', ' Conflict ', ' Conflict (Psychology) ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economics ', ' Employment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Faculty ', ' Future ', ' health care service ', ' Health Services ', ' Household ', ' Labor Forces ', ' marijuana ', ' Marihuana ', ' Marketing ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Professional Positions ', ' Jobs ', ' Occupations ', ' Phenotype ', ' Prejudice ', ' Public Health Practice ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Shoulder ', ' Sociology ', ' Survey Instrument ', ' Surveys ', ' Time ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Unemployment ', ' United States ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' United States Substance Abuse and Mental Health Services Administration ', ' Work ', ' Treatment outcome ', ' problem drinking ', ' problem alcohol use ', ' hazardous alcohol use ', ' ethanol abuse ', ' alcohol problem ', ' Alcohol abuse ', ' Criminal Justice ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Outcome Measure ', ' work setting ', ' work environment ', ' Worksite ', ' ']",NIDA,HARVARD SCHOOL OF PUBLIC HEALTH,R03,2015,80750,0.21434616884473773
"Strengthening Hispanic Families via NIDA Prevention Science DESCRIPTION (provided by applicant): These application requests 5 years of K01 support to accelerate the NIDA-focused interdisciplinary research career development of Dr. Ruben Parra-Cardona, a clinician-researcher who seeks to become an independent NIDA prevention researcher committed to underserved Hispanic adolescents and families. His current research evaluates a cultural adaptation of an evidence-based parenting intervention for at-risk Hispanic families with young children (ages 4-11), for which there is potential distal NIDA impact such as reduced risk of starting to smoke tobacco or to use other drugs. Complete evidence on distal benefits of early randomized trial interventions of this type cannot be seen unless the scale of research shifts upward, as in multi-site trials, and unless the measurements include bio-assays to confirm self-report drug use, with probes for potential gene- intervention interactions. Based on the proposed K01 career training objectives, the applicant will acquire the necessary skills to develop an interdisciplinary program of prevention research, informed by epidemiological and biomedical science. During 75% protected time for career development toward independent R01 project leadership, core learning objectives will be met (e.g., RCR, FCOI, grants management). In addition to its core, the training plan has 5 tracks: (1) enhanced mastery of small sample parenting intervention research; (2) enhanced mastery of research design and measurements for larger sample multi-site NIDA prevention research on youth developmental trajectories leading toward NIDA outcomes; (3) enhanced mastery of data analysis for interdependent observations from multiple sites; (4) new learning about integration of biological assays in NIDA family intervention and prevention research via collaborations with expert NIH toxicologists and genetics researchers; (5) mastery of electronic technology complements to current 'in person' intervention delivery and program impact assessment. The proposed award is crucial now that the applicant has become K01-eligible via permanent residency. His college has guaranteed protected time for this K01 career acceleration through structured mentoring program led by a NIDA K05 Senior Scientist, backed by a strong local team of federally funded co-mentors, as well as scientific advisors. Through the proposed K01 award, Dr. Parra-Cardona will gain mastery of the theory and research approaches now being refined by quantitative developmental scientists in new lines of NIDA prevention research. The training plan includes guided readings, coursework, among other activities leading to publications. A prevention pilot study will serve as a 'preliminary study' for a NIDA R01 grant proposal planned for Year 4 of the proposed award. This application is responsive to NIH and NIDA's strategic plans highlighting the need to implement interdisciplinary programs of research aimed at preventing young people from ever using drugs, as well as ensuring that at-risk and underserved minority populations benefit from these scientific efforts. PUBLIC HEALTH RELEVANCE: NIH and NIDA strategic goals stress (1) encouraging more minority scientists to pursue research careers bolstering their chances of R01 project success, and (2) interdisciplinary research programs on preventing young people from ever using drugs, and ensuring that at-risk and underserved minority populations benefit from these scientific efforts. The proposed K01 award is directly responsive to these strategic goals.",Strengthening Hispanic Families via NIDA Prevention Science,8828158,K01DA036747,"['Acceleration ', ' Age ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Award ', ' Dorsum ', ' Back ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' childrearing ', ' Child Rearing ', ' Complement Proteins ', ' Complement ', ' Cuban American ', ' Data Analysis ', ' Data Analyses ', ' depression ', ' Mental Depression ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Electronics ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Family ', ' Foundations ', ' Future ', ' Genes ', ' Goals ', ' Grant ', ' Health ', ' interventions research ', ' interventional study ', ' interventional research ', ' intervention research ', ' Intervention Studies ', ' Leadership ', ' Learning ', ' Mentors ', ' Method LOINC Axis 6 ', ' Methodology ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' Michigan ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Oregon ', ' Parents ', ' pilot study ', ' Pilot Projects ', ' Scientific Publication ', ' Publications ', ' Puerto Rican ', ' Reading ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Residencies ', ' Risk ', ' Science ', ' Smoke ', ' Stress ', ' Target Populations ', ' Technology ', ' Testing ', ' Time ', ' Tobacco ', ' United States ', ' Generations ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Youth 10-21 ', ' Youth ', ' base ', ' career ', ' Distal ', ' Site ', ' Biological ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Ensure ', ' Training ', ' Stimulus ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' African ', ' school age ', ' School-Age Population ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' drug use ', ' Drug usage ', ' Sample Size ', ' Genetic Research ', ' Funding ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Genetic ', ' Research Specimen ', ' Specimen ', ' Empirical Research ', ' Life ', ' programs ', ' Scientist ', ' LOINC Axis 4 System ', ' System ', ' meetings ', ' collegiate ', ' college ', ' American ', ' experience ', ' stressor ', ' success ', ' Cigarette ', ' Structure ', ' skills ', ' simulation ', ' Participant ', ' Prevention Research ', ' Population Study ', ' Self-Report ', ' Patient Self-Report ', ' cultural values ', ' episodic drinking ', ' binge alcohol consumption ', ' binge drinking ', ' heavy alcohol use ', ' extreme drinking ', ' excessive ethanol ingestion ', ' excessive drinking ', ' excessive alcohol intake ', ' excessive alcohol ingestion ', ' excessive alcohol consumption ', ' excess ethanol ingestion ', ' excess alcohol ingestion ', ' excess alcohol consumption ', ' drink heavily ', ' Heavy Drinking ', ' Prevention ', ' Reporting ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' Ruthenium Ben ', ' RuCl2(C6H6)(dmso) ', ' RuBen ', ' Modeling ', ' Sampling ', ' career development ', ' response ', ' theories ', ' middle school ', ' junior high ', ' junior high school ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' health disparities ', ' health disparity ', ' preventing ', ' prevent ', ' Low income ', ' Address ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' High Prevalence ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' Mentored Research Scientist Development Award ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' NIH RFA ', ' Request for Applications ', ' Strategic Planning ', ' Senior Scientist ', ' underserved minority ', ' under-represented minority ', ' Underrepresented Populations ', ' Underrepresented Groups ', ' Underrepresented Minority ', ' Monitor ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' early onset ', ' cost ', ' early initiation drug use ', ' early onset drug use ', ' Minority ', ' efficacy evaluation ', ' willingness ', ' externalizing behavior ', ' Outcome ', ' Population ', ' Prevalence ', ' treatment design ', ' intervention design ', ' therapy design ', ' high risk ', ' public health relevance ', ' evidence base ', ' multi-site trial ', ' intervention effect ', ' randomized trial ', ' reduced substance use ', ' ']",NIDA,MICHIGAN STATE UNIVERSITY,K01,2015,177438,0.06448522081204047
"Comparative Effectiveness Research Diffusion and Mental Health Care Disparities DESCRIPTION (provided by applicant): Comparative Effectiveness Research (CER) compares benefits and risks of different treatments. However, little is known about the impact of large-scale CER implementation as conceived in the 2010 Affordable Care Act (ACA) on equity in health care across racial/ethnic groups. Identifying the influence of FDA risk warnings on disparities in psychotropic drug use provides a platform to understand how CER will influence disparities in certain situations. Disparity methods have typically not taken into account specific recommendations and warnings on effectiveness and safety. With the advent of the ACA and continued concern over persistent disparities, it is imperative that disparities research continues to evolve to incorporate lessons learned from CER.  We capitalize upon time trends in warnings and advisories to understand disparities in diffusion with the intention of identifying policies tht might avert the negative equity consequences of incorporating CER into routine practice. Specifically, we 1) Track changes in antidepressant use among youth and antipsychotic drug use among youth and adults by racial/ethnic group as they are influenced by CER-generated risk warnings and advisories; 2) Assess whether specific information in FDA warnings influenced disparity trends in a) treatments recommended by CER-generated evidence (e.g., fluoxetine use and metabolic screening for antipsychotic users); and b) psychotropic drug use that is potentially harmful (e.g., olanzapine use); and 3) Identify how provider characteristics an HMO enrollment act as mechanisms that underlie the differential diffusion of CER via health risk warnings.  We implement the Institute of Medicine (IOM) definition of healthcare disparities in order to capture trends in disparities over time, overlaying timelines of warnings and recommendations related to antidepressant and antipsychotic drugs. We adapt IOM methods by decomposing disparities in overall drug use into disparities in specific categories of use mentioned by FDA warnings as carrying particular risk or benefit. If we find racial/ethnic disparities in diffusion of risk warnings and advisories, this suggests policymakers should focus on improving uptake of CER among minorities. If we identify that certain providers and HMO membership influences disparities in diffusion, this will lead to recommendations for policymakers of actionable policies to avert the negative equity consequences of incorporating CER into routine practice. PUBLIC HEALTH RELEVANCE: In this proposed project, we intend to examine whether specific information in FDA warnings influenced disparity trends in psychotropic drug use and mental health care and to identify how provider characteristics and HMO enrollment act as mechanisms that underlie the differential diffusion of CER via health risk warnings. Identifying the influence of FDA risk warnings on trends in psychotropic drug use and related health care provides a platform to understand how CER will influence disparities and will help us to assess whether information regarding the risks and benefits of medications are being equitably disseminated. Our examination of how an increased reliance on CER will likely influence disparities in treatment after health care reform will provide policymakers with actionable information that might avert the negative equity consequences of incorporating CER into routine practice.",Comparative Effectiveness Research Diffusion and Mental Health Care Disparities,8882222,R01HS021486,[''],AHRQ,CAMBRIDGE HEALTH ALLIANCE,R01,2015,249153,0.13187221068872973
"Southern Ohio Prevents Hepatitis Project (StOPHeP)     DESCRIPTION (provided by applicant): The overall goal of this project is to develop an integrated comprehensive approach for detection, prevention, linkage to care and treatment for hepatitis C (HCV) among young adults (18-30 years old) who have a history of injection drug use (people who inject drugs, PWID) and live in 21 non-urban southern Ohio counties. We will accomplish this by collaborating with addiction treatment providers, public health agencies, and syringe exchange programs in the target areas to identify, test, refer and link PWID to prevention and treatment services. The target area includes 21 suburban (large fringe metro, small metro) and rural (micropolitian, non-core) counties in southern Ohio, 18 of which are classified as Appalachian. To develop and implement a comprehensive strategy to address the high prevalence of HCV in southern Ohio, we will 1) identify and describe the demographic characteristics and risk behaviors and injection networks of young non-urban PWID, and test them for HCV, hepatitis B (HBV) and HIV; 2) use Peer Navigators to link young non-urban PWID to addiction treatment programs and to primary care, mental health and specialty treatment (infectious diseases, hepatology), including linkage to health insurance through the Affordable Care Act and expanded Ohio Medicaid; 3) use Peer Navigators to provide education on safe injection practices to prevent hepatitis and HIV; and link PWID to syringe exchange programs as available in target communities; 4) use a closed social networking site (SNS) to provide peer-facilitated support for the uninfected prevention group (Prevention Room) and for the linkage-to-care group for PWID with HBV, HCV and/or HIV infection (Treatment Room); available both online and via smartphone; and 5) perform follow-up assessment and re-testing of study participants for HCV within 12 months of study entry to determine rates of new HCV infection and reinfection after successful treatment. Since the majority of the target counties are in Appalachia, this proposal will address healthcare inequities that are endemic to this region, and will provide data on which to base future public health initiatives to reduce HCV among young non-urban PWID. PUBLIC HEALTH RELEVANCE: Narrative Injection drug use (IDU) among young adults in rural areas and the resultant epidemic of chronic hepatitis C has become a significant public health problem, but there are few data about the demographics and risk behaviors of rural IDUs to inform public health policies and practice. The use of Peer Navigators and social media will enable us to provide peer support for isolated individuals and ensure study retention and linkage to care. Moreover, linkage to prevention, drug treatment and medical care including infectious disease care for chronic viral infections  will provide data on the outcomes of these efforts in a rural setting.",Southern Ohio Prevents Hepatitis Project (StOPHeP),9102800,U18PS004566,[''],NCHHSTP,UNIVERSITY OF CINCINNATI,U18,2016,300000,0.07656359361115665
"Drug abuse and jobs: racial disparities in labor force participation and outcomes DESCRIPTION (provided by applicant): This project addresses the impact of problem drug use (defined as frequency of use, misuse, and dependence) on labor force participation and job-related problems in a nationally representative longitudinal sample of United States adults. A key objective is to investigate racial/ethnic disparities in these associations. Both the US Substance Abuse and Mental Health Services Administration (SAMHSA) National Outcomes Measure and the NIDA Clinical Trials Network have identified employment as an area in need of improved research and intervention. Yet, important gaps remain in our understanding of the population-level impact of problem drug use on labor force participation and the extent to which this impact is disproportionately shouldered by race/ethnic minorities. Also, it remains to be shown if and how much recovery from problem drug use improves employment outcomes for all workers.  Research evidence shows that racial/ethnic minorities are more likely to have higher unemployment rates and unfair labor market experiences. Also, they suffer more social consequences, such as greater likelihood of involvement with the child welfare or criminal justice systems when they misuse, abuse or are dependent on drugs. However, it is unclear whether these disproportionate consequences of problem drug use extend to, or contribute to, the observed racial/ethnic disparities in employment outcomes. The proposed study answers these questions using the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a nationally representative household survey with an oversample of racial/ethnic minority adults (n=43,093 wave 1 and n=34,653 followed up in wave 2). NESARC collects detailed consumption information on timing and quantities of alcohol, marijuana, stimulants, opioids and depressants. The Specific Aims are:  1: To investigate the impact of problem drug use on labor force participation, to determine whether this impact differs among racial/ethnic minorities, and to evaluate whether recovery from problem drug use can mitigate this impact. We hypothesize that problem drug use will be negatively associated with labor force participation and that Black, Native American/Alaskan Native and Hispanic individuals will be disproportionately affected by these adverse effects. We also hypothesize that recovery from problem drug use will be associated with improved labor force participation at wave 2, but racial/ethnic minorities will benefit less from the positive effects of recovery.  2: To investigat, among labor force participants, the impact of problem drug use on employment outcomes and to investigate racial/ethnic disparities. Our hypotheses are that problem drug use will be associated with job loss and job-related conflict, and racial/ethnic minorities will be disproportionately affected by these effects. Impact: Determining the extent of racial/ethnic disparities in the job consequences of problem drug use is necessary to guide future work to uncover and address mechanisms underlying these disparities. PUBLIC HEALTH RELEVANCE: The project will identify which drug use phenotypes across the spectrum of problem use are most strongly associated with adverse job outcomes. This will enable more refined targeting of drug abuse programs and workplace interventions to mitigate these outcomes. Also, determining the extent of racial/ethnic disparities in the job-related consequences of problem drug use and whether or not recovery can improve job outcomes among drug users is necessary to guide researchers, program planners and policy makers.",Drug abuse and jobs: racial disparities in labor force participation and outcomes,9020221,R03DA038697,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Alcohol Chemical Class ', ' Alcohols ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' child well being ', ' adolescent welfare ', ' Child Welfare ', ' Conflict ', ' Conflict (Psychology) ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economics ', ' Employment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Faculty ', ' Future ', ' Health ', ' Health Services ', ' Household ', ' Labor Forces ', ' marihuana ', ' Marijuana ', ' Marketing ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Professional Positions ', ' Jobs ', ' Occupations ', ' Phenotype ', ' Prejudice ', ' Public Health Practice ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Shoulder ', ' Sociology ', ' Survey Instrument ', ' Surveys ', ' Time ', ' Unemployment ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' United States ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Work ', ' Treatment outcome ', ' Alcohol abuse ', ' problematic alcohol use ', ' problematic alcohol consumption ', ' problem drinking ', ' problem alcohol use ', ' hazardous alcohol use ', ' ethanol abuse ', ' alcohol problem ', ' Criminal Justice ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Outcome Measure ', ' Workplace ', ' work setting ', ' Worksite ', ' Work-Site ', ' Work Place ', ' Work Location ', ' Job Site ', ' Job Setting ', ' Job Place ', ' Job Location ', ' improved ', ' Area ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' Recovery ', ' young adulthood ', ' adult youth ', ' young adult ', ' Policy Maker ', ' Opioid ', ' Policies ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' drug use ', ' Drug usage ', ' tobacco abuse ', ' Native Americans ', ' Staging ', ' Drug user ', ' programs ', ' Frequencies ', ' Dependence ', ' System ', ' Remission ', ' Disease remission ', ' experience ', ' Alaskan Native American ', ' Performance ', ' intervention program ', ' Participant ', ' Program Announcement ', ' NIH Program Announcements ', ' ethnicity difference ', ' ethnic difference ', ' Prevention ', ' social ', ' Sampling ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Adverse effects ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' disparity in health ', ' health disparity ', ' Address ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Strategic Planning ', ' Occupation Epidemiology ', ' Occupational Epidemiology ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' labor force participation ', ' health economics ', ' Clinical Trials Network ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' Population ', ' Consumption ', ' ethnic minority population ', ' ethnic minority ', ' racial and ethnic ', ' economic outcome ', ' racial and ethnic disparities ', ' population based ', ' clinical practice ', ' racial disparity ', ' race disparity ', ' disparities in race ', ' ']",NIDA,HARVARD SCHOOL OF PUBLIC HEALTH,R03,2016,79942,0.21434616884473773
"Stress and Drug Use Vulnerability in the African American Community DESCRIPTION (provided by applicant): The impacts that drug addictions have on health disparities that adversely affect African Americans are grossly understudied. While there is strong evidence linking drug abuse to poor health and problem behaviors in the African American community, the progression of drug abuse is inconsistent (i.e., relatively late initiation and heavy use in the 30s) with national norms and remains unclear. Exposure to chronic stress and the subsequent activation of the hypothalamic-pituitary-adrenal (HPA) axis has been connected to drug addictions and poor health outcomes. This association is of particular importance since residents in these communities are exposed to many of the risk factors associated with the onset of drug abuse: familial risk, deprived social environment, unemployment, substandard education, low-to-no socioeconomic status, and enduring exposure to experiences of racism and discrimination. Repeated exposure to environmental stressors will lead to 'wear-and-tear' on the body's regulatory system and have profound implications on HPA functioning and the subsequent risk of developing an addiction. This study will pursue three primary aims: (1) Investigate HPA reactivity to acute stress as a predictor of current drug use severity. (2) Investigate trajectories of HPA regulation (level and circadian rhythm) as a predicto of drug use vulnerability across time. (3) Investigate delay discounting as a moderator between trajectories of HPA regulation and drug use vulnerability across time. This study will enroll 350 African American adults (ages 18-21) who reside in the southeastern U.S. and utilize a prospective longitudinal research design that consists of a laboratory assessment involving the Trier Social Stress Test, three in-home assessments that include clinical interviews and behavioral tasks, and six internet assessments that track drug use and related risk factors across a 2-year period. Primary independent variables include environmental stressors, stress-related biomarkers (i.e., salivary cortical, salivary DHEA, heart rate variability, and galvanic skn resistance), and delay discounting. Primary dependent variables include drug use, severity of drug use disorders, and drug use consequences. This study is highly innovative for three primary reasons: (1) A longitudinal research design will be used for the first time to investigate trajectories of HPA regulation as a predictor of drug use vulnerability; (2) The use of multiple indicators of the stress regulatory system, clinical interviews, and a novel behavioral task provides a more nuanced understanding of the research aims; and (3) This study focuses on an understudied population that suffers from drug-related health disparities, but are rarely included in cutting edge laboratory research. It is envisioned that this approach will uncover latent-curve trajectories of stress deregulation as a predictor of drug use vulnerability in this population. Findings from this study will identify causal mechanisms of drug addictions that will advance theory, research, prevention, and treatments aimed at addressing this growing public health problem. PUBLIC HEALTH RELEVANCE: The development of drug abuse in the African American community is often characterized by oversimplified models that are rooted in research studies that rarely include African Americans. This study will identify mechanisms that influence drug use vulnerability in at-risk African American adults who reside in the southeastern U.S. Such research is needed to develop socially and culturally informed prevention and treatment programs aimed at reducing drug-related health disparities that continue to plague African Americans.",Stress and Drug Use Vulnerability in the African American Community,8994725,R01DA034739,"['Cultural Assimilation ', ' Acculturation ', ' suprarenal gland ', ' Adrenals ', ' Adrenal Glands ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' Age ', ' Belief ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Circadian Rhythms ', ' Communities ', ' Crime ', ' Death ', ' Cessation of life ', ' Therapeutic Dehydroepiandrosterone ', ' Prasterone ', ' Dehydroisoandrosterone ', ' DHEA ', ' Androstenolone ', ' dehydroepiandrosterone ', ' Cognitive Discrimination ', ' Discrimination ', ' Disorder ', ' Disease ', ' Downregulation ', ' Down-Regulation ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Educational aspects ', ' Education ', ' Au element ', ' Gold ', ' Health ', ' Health behavior ', ' Proctocort ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Hydrocortisone ', ' hypothalamic ', ' Hypothalamus ', ' Hypothalamic structure ', ' Incidence ', ' Interview ', ' Laboratories ', ' Laboratory Research ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' mortality ', ' Neighborhoods ', ' pilot study ', ' Pilot Projects ', ' Pituitary Nervous System ', ' Pituitary ', ' Hypophysis Cerebri ', ' Hypophysis ', ' Pituitary Gland ', ' Yersinia pestis disease ', ' Plague ', ' Psychopharmaceuticals ', ' Psychoactive Drugs ', ' Psychoactive Compound ', ' Psychoactive Agents ', ' Psychotropic Drugs ', ' Public Health ', ' recruit ', ' active recruitment ', ' Recruitment Activity ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Rewards ', ' Risk ', ' Risk Factors ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Stress ', ' Survey Instrument ', ' Surveys ', ' Time ', ' Unemployment ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Violence ', ' violent behavior ', ' violent ', ' Measures ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' improved ', ' Left ', ' Clinical ', ' racism ', ' Link ', ' mental ', ' Psyche structure ', ' disability ', ' Stimulus ', ' Spiritualities ', ' Spirituality ', ' Recovery ', ' Rural ', ' drug use ', ' Drug usage ', ' root ', ' Plant Roots ', ' Funding ', ' behavioral problem ', ' Problem behavior ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Exposure to ', ' Severities ', ' Salivary ', ' Home ', ' Home environment ', ' System ', ' environmental stressor ', ' experience ', ' hypothalmus-pituitary-adrenal axis ', ' hypothalamic-pituitary-adrenal (HPA) axis ', ' hypothalamic-pituitary-adrenal axis ', ' novel ', ' Prevention Research ', ' Prevention program ', ' treatment program ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Impulsivity ', ' acute stress ', ' Regulation ', ' Modeling ', ' response ', ' theories ', ' disparity in health ', ' health disparity ', ' Address ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Chronic stress ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' enroll ', ' Enrollment ', ' developmental ', ' Development ', ' Behavioral ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' Clinical assessments ', ' Outcome ', ' discounting ', ' Population ', ' prospective ', ' Trier Social Stress Test ', ' innovation ', ' innovative ', ' innovate ', ' Resistance ', ' resistant ', ' addiction ', ' addictive disorder ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' heart rate variability ', ' constriction ', ' longitudinal design ', ' injury burden ', ' behavioral economics ', ' drug use vulnerability ', ' vulnerability to drug use ', ' illicit drug use ', ' ']",NIDA,UNIVERSITY OF HOUSTON,R01,2016,490108,0.21249262221003148
"Methamphetamine Research Program at Meharry Medical College DESCRIPTION (provided by applicant): The long-range goal of the proposed DIDARP program described in this application is to continue to increase the capacity of Meharry Medical College to conduct rigorous research in substance use disorders with an [ emphasis on health disparities and underserved populations. The research program will seek to understand the molecular underpinnings of acute and chronic methamphetamine (METH) exposure alone and in conjunction with human immunodeficiency virus (HIV) infection. We also plan to strengthen pur intellectual environment and enhance the interest levels of trainees and faculty in drug abuse research. New for this j application is the proposal to introduce training on screening and brief interventions for substance misuse to medical students, residents and faculty in the Family and Community Medicine clinics. The Specific Aims of the Meharry Medical College DIDARP Program during the next five years are: 1. To publish at least 20 or more peer-reviewed publications in high-impact journals in drug abuse research; 2. To submit 5 or more grant applications in drug abuse research by Year-03 of the award period; | 3. To acquire 3 or more investigator-initiated awards by the end of year-05; and 4. To stimulate additional faculty and trainee interest in drug abuse research by curricula enhancement, ' seminars and symposia. . Three projects are proposed, one primary proposal and two pilot projects. In the primary project, Dr. CV. ] Dash will seek to understand the link between METH abuse and HIV infection. In the first pilot project, Dr. J. Shawn Goodwin will study how METH abuse alters dopamine signaling by altering the dopamine transporter residency in lipid rafts. In second pilot project, Dr. Khilber and her collaborators which includes the PI and the Chair of Family and Community Medicine, Dr. Roger Zoorob, will test the effects of a tiered training program on screening, brief intervention and referral to treatment (SBIRT) for substance misuse fo ",Methamphetamine Research Program at Meharry Medical College,8982228,R24DA036420,"['Anxiety ', ' Award ', ' Awareness ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Community Medicine ', ' Disadvantaged ', ' Hydroxytyramine ', ' Dopamine ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' Faculty ', ' family medicine ', ' Family Practice ', ' Goals ', ' Grant ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Economical Income ', ' Economic Income ', ' Income ', ' Industry ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Methamphetamine ', ' Mission ', ' neurobiological ', ' Neurobiology ', ' Peer Review ', ' pilot study ', ' Pilot Projects ', ' Poverty ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Scientific Publication ', ' Publications ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Residencies ', ' social role ', ' Role ', ' school of medicine ', ' medical college ', ' medical schools ', ' Self Medication ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Medical Students ', ' Substance Use Disorder ', ' Teaching ', ' Educational process of instructing ', ' Tennessee ', ' Testing ', ' Training Programs ', ' Virus Diseases ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Work ', ' symposium ', ' symposia ', ' summit ', ' convention ', ' conference ', ' dopamine transporter ', ' DAT dopamine transporter ', ' Journals ', ' Magazine ', ' base ', ' improved ', ' Acute ', ' Chronic ', ' Clinical ', ' Medical ', ' Series ', ' Link ', ' Training ', ' insight ', ' Individual ', ' Rural ', ' Life ', ' programs ', ' Scientist ', ' Investigation ', ' Clinic ', ' Country ', ' Amentia ', ' Dementia ', ' interest ', ' collegiate ', ' college ', ' Emergency room ', ' Emergency Department ', ' Accident and Emergency department ', ' experience ', ' neuronal loss ', ' neuronal death ', ' neuronal cell loss ', ' neuronal cell death ', ' neuron death ', ' neuron cell loss ', ' neuron cell death ', ' nerve cell loss ', ' nerve cell death ', ' neuron loss ', ' skills ', ' novel ', ' Basic Research ', ' Basic Science ', ' Self-Report ', ' Patient Self-Report ', ' graduate student ', ' Admission ', ' Admission activity ', ' career development ', ' lipid raft ', ' Sphingolipid-Cholesterol Rafts ', ' Sphingolipid Microdomains ', ' Cell Membrane Lipid Rafts ', ' Membrane Microdomains ', ' disparity in health ', ' health disparity ', ' Metabolic Pathway ', ' Address ', ' meth abuse ', ' methamphetamine abuse ', ' Drug Treatment Centers ', ' Drug Abuse Treatment Centers ', ' Drug Rehabilitation Centers ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Grant Proposals ', ' Applications Grants ', ' Subgroup ', ' Neurosciences Research ', ' Pharmacological Treatment ', ' Molecular ', ' developmental ', ' Development ', ' methamphetamine addiction ', ' meth addiction ', ' addiction to methamphetamine ', ' METH dependence ', ' Methamphetamine dependence ', ' Behavioral ', ' Healthcare professional ', ' Health Care Professional ', ' Health Professional ', ' pathway ', ' Pathway interactions ', ' underserved people ', ' under served population ', ' Underserved Population ', ' methamphetamine exposure ', ' meth exposure ', ' ethnic minority population ', ' ethnic minority ', ' racial and ethnic ', ' therapeutic target ', ' addiction ', ' addictive disorder ', ' effective intervention ', ' primary care setting ', ' screening and brief intervention ', ' screening, brief intervention, referral, and treatment ', ' screening, brief intervention, and referral to treatment ', ' SBIRT ', ' methamphetamine use ', ' methamphetamine using ', ' METH using ', ' METH use ', ' curriculum enhancement ', ' curriculum expansion ', ' curricular enrichment ', ' education research ', ' methamphetamine effect ', ' METH effect ', ' minority student ', ' substance misuse ', ' ']",NIDA,MEHARRY MEDICAL COLLEGE,R24,2016,453742,0.04533793193897472
"Social Networks and HIV Risk Behaviors of Special Populations of Drug Users DESCRIPTION (provided by applicant): The primary goal of this resubmitted K02 application is to further develop Dr. Carrie Oser's productive independent research career and to augment her research focus on HIV, substance abuse treatment, crime, and health disparities by gaining new training on social networks and HIV intervention development. The K02 builds upon her focus on special populations, including both rural drug users and African American drug users. The proposed training goals will provide new instruction in social networks, HIV intervention development, and the responsible conduct of research. The specific aims are: (1) to identify HIV and HCV risk and longitudinal changes in risk in the social networks of 503 rural out-of-treatment drug using women, as compared to men; and (2) to examine the effect of social networks, including structure (e.g., size, density), function (e.g., emotional and instrument support), and content (e.g., attitudes towards physicians), on HIV and HCV risk behaviors and health services utilization among African American drug using women, as compared to men, across criminal justice status. This significant and innovative study will have strong public healt impacts and will support NIDA's Health Disparities Initiative because of its potential to contribut to our understanding of the cultural and social network correlates of health disparities among both rural and African American drug users. In addition, this study improves upon the methodological limitations of previous research findings by examining various social networks (e.g., egocentric, dyadic, and sociocentric) and using longitudinal data in multilevel models. This proposed project will allow for a practical application of the substantive knowledge and analytical skills acquired from the K02 training activities and will ultimately culminate in the development of forthcoming investigator initiated NIDA grant applications. Specifically, these findings will be used as a foundation for future HIV social networks based intervention to increase special populations' use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism. PUBLIC HEALTH RELEVANCE: This study is significant to the public health field because of its potential to understand the individual, cultural, and social network factors associated with HI and HCV risk behaviors among two special populations - rural drug users and African American drug users. These findings will be used as a foundation for developing social network based HIV interventions to increase special populations' use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism.",Social Networks and HIV Risk Behaviors of Special Populations of Drug Users,9088432,K02DA035116,"['Accounting ', ' Attitude ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Crime ', ' Data Collection ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Female ', ' Foundations ', ' Future ', ' Goals ', ' Grant ', ' Health ', ' Health Services ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Kentucky ', ' male ', "" men's "", ' men ', ' Methodology ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Roxicodone ', ' Oxycontin ', ' Oxycodone SR ', ' Oxycodeinon ', ' Dihydrohydroxycodeinone ', ' Oxycodone ', ' Physicians ', ' Drug Prescribing ', ' Drug Prescriptions ', ' Prisons ', ' Public Health ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' training module ', ' Training Activity ', ' Woman ', ' Gender ', ' Measures ', ' falls ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Social Network ', ' career ', ' density ', ' rural area ', ' urban area ', ' improved ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' Link ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Training ', ' Spiritualities ', ' Spirituality ', ' Individual ', ' Rural ', ' drug use ', ' Drug usage ', ' Drug user ', ' instrument ', ' Knowledge ', ' Life ', ' System ', ' SNAP ', ' S-nitro-N-acetylpenicillamine ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' Services ', ' experience ', ' Special Population ', ' named group ', ' Structure ', ' skills ', ' disease prevention ', ' disorder prevention ', ' recidivism ', ' Self-Report ', ' Patient Self-Report ', ' probation ', ' social ', ' HIV risk ', ' multilevel modeling ', ' multilevel model ', ' methods to study multiple-level influences ', ' multilevel analysis ', ' Emotional ', ' Network Analysis ', ' Pathway Analysis ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' HIV diagnosis ', ' disparity in health ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' K02 Award ', ' Independent Scientist Award ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Strategic Planning ', ' developmental ', ' Development ', ' substance abuse therapy ', ' substance abuse treatment ', ' Instruction ', ' willingness ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' practical application ', ' application in practice ', ' Network-based ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' high risk ', ' responsible research conduct ', ' injection drug use ', ' support network ', ' HIV/HCV ', ' HIV/Hepatitis C ', ' Preventive healthcare ', ' Preventive health care ', ' Preventative healthcare ', ' Preventative health care ', ' health service use ', ' health service utilization ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,K02,2016,115827,0.1196814521075345
"Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM) PROJECT SUMMARY/ABSTRACT  This application is for a competing renewal of the Center for Prevention Implementation Methodology for HIV and Drug Abuse, a NIDA P30 Center of Excellence. The number of new HIV cases in the US remains stable at 56,000 per year and continues to disproportionately affect some groups, including young men who have sex with men (YMSM), especially from racial/ethnic minorities. The purpose of this methodology center is to develop new methodologies that can be used by federal and local agencies and communities to reduce HIV incidence. Biomedical interventions and strategies, including pre-exposure prophylaxis (PrEP), rapid testing for HIV and early and consistent treatment for persons who are HIV positive (Treatment as Prevention, TasP) have been shown to have high efficacy and effectiveness in reducing HIV transmission, but there remains a giant gap between what research knows and what services needed to reduce population level incidence of HIV. The major premise of this application is that the effective biomedical to reduce HIV incidence and disparities are in hand, but success will only be achieved when they are implemented in ways that meet individual, community, and health care delivery system needs. This methods proposal addresses this major gap between research and practice through implementation science and methodology, focusing on innovative ways to address the complex, mulitilevel interactions needed to implement HIV prevention programs effectively. Two Cores, an Administrative Core and an Innovative Implementation Methods Core for HIV and Drug Abuse will carry out this work.  Aim 1 is to develop innovative methods to maximize the impact of implementation research in HIV prevention. We do this through an extended set of systems science and engineering methods that focus on improving the measurement of implementation, the modeling of implementation strategies, and the testing of implementation strategies through rigorous trials. Five qualifying grants support this work.  Aim 2 is to apply these innovative methods to close the gap between existing research, policy, and practice for HIV prevention. In addition to working closely with our five qualifying grants, we work locally with municipal Departments of Public Health and the federal Substance Abuse and Mental Health Services Administration (SAMHSA) HIV programs to identify and prioritize gaps in knowledge, find optimal implementation strategies for reduction of HIV transmission, and design the next large implementation trials.  Aim 3 is to disseminate methods and train/mentor leaders at the intersection of HIV prevention, implementation science, and drug abuse fields to improve implementation of HIV prevention programs. This involves mentoring the early career researchers, publishing, and providing training to networks of HIV and drug abuse researchers. PROJECT NARRATIVE There are numerous rigorously evaluated prevention programs involving biomedical interventions for preventing HIV that have demonstrated impact in efficacy and effectiveness trials. Pre-exposure prophylaxis, HIV testing, and early and consistent antiretroviral treatment have high potential for preventing HIV infections, but these are yet to be implemented sufficiently in racial/ethnic minority communities. This Ce-PIM addresses the critical methods gaps that are holding back the movement of these programs from research to practice.",Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM),9204281,P30DA027828,"['Affect ', ' Age ', ' Dorsum ', ' Back ', ' Biomedical Research ', ' Communities ', ' Decision Making ', ' health services delivery ', ' Healthcare Delivery ', ' health care delivery ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Cognitive Discrimination ', ' Discrimination ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Engineering ', ' ethnicity group ', ' Ethnic group ', ' Feedback ', ' Gender Identity ', ' Goals ', ' Grant ', ' Hand ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' Incidence ', ' extended care ', ' Long-Term Care ', ' Mentors ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Methamphetamine ', ' Methods ', ' Methodology ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' body movement ', ' Movement ', ' Persons ', ' Play ', ' Public Health ', ' Publishing ', ' QOL ', ' Quality of life ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Science ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Seeds ', ' sociobehavioral ', ' sociobehavior ', ' Social Behavior ', ' Technology ', ' Testing ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Virus ', ' General Viruses ', ' Vision ', ' visual function ', ' Sight ', ' Work ', ' ranpirnase ', ' P30 Protein ', ' P30 ', ' P-30 Protein ', ' Gender ', ' Generations ', ' Community Healthcare ', ' Community Health Care ', ' ecstasy ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' base ', ' career ', ' improved ', ' Prophylaxis ', ' Prophylactic treatment ', ' Sexual Orientation ', ' Sex Orientation ', ' Training ', ' Individual ', ' Measurement ', ' drug use ', ' Drug usage ', ' Ethnicity ', ' Ethnic Origin ', ' tool ', ' Knowledge ', ' Life ', ' programs ', ' Viral Load ', ' Viral Burden ', ' Viral Load result ', ' Complex ', ' Pattern ', ' System ', ' meetings ', ' Services ', ' success ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' Anti-Retroviral Agents ', ' novel ', ' Prevention program ', ' research in practice ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Prevention ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' Early identification ', ' Modeling ', ' stigma ', ' social stigma ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' scientific organization ', ' Effectiveness ', ' preventing ', ' prevent ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Address ', ' High Prevalence ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Policy Research ', ' Qualifying ', ' Transmission ', ' transmission process ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' socioeconomics ', ' developmental ', ' Development ', ' effectiveness trial ', ' implementation trial ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' implementation research ', ' designing ', ' design ', ' next generation ', ' efficacy trial ', ' Outcome ', ' Prevention approach ', ' Approaches to prevention ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' ethnic minority population ', ' ethnic minority ', ' Early treatment ', ' early therapy ', ' racial and ethnic ', ' implementation science ', ' research to practice ', ' research into practice ', ' cocaine use ', ' young men who have sex with men ', ' YMSM ', ' black men who have sex with men ', ' black MSM ', ' BMSM ', ' support tools ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,P30,2016,1335760,0.08917754346937293
"Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African Americans The Center for Translational and Prevention Science (CTAPS) was funded in 2009 to inform the development of prevention programs for rural African American youth through investigations of gene-environment (G-E) interplay on drug use and HIV-related behavior. The proposed continuation augments CTAPS' scientific agenda to better address racial disparities in drug use and HIV-related behavior that affect rural African Americans. Emerging research suggests that exposure to chronic stress affects the functioning of inflammatory, neuroendocrine, and neurocognitive systems beginning in childhood and adolescence. The negative consequences of chronic stress affect health-related behaviors and forecast chronic diseases of aging. Emerging evidence suggests that these processes also may affect youth and young adults' development of drug misuse and HIV related behavior. The Center will sponsor a new generation of research on (a) the neuroendocrine, inflammatory, and neurocognitive pathways through which exposure to stress among rural African American youth and young adults creates vulnerabilities to drug use and HIV-related behavior, (b), the malleable risk and protective processes that affect underlying vulnerability mechanisms , and (c) the translation of findings into new and refined preventive interventions for youth in general and rural African American youth in particular. The CTAPS will pursue these scientific goals via providing infrastructure for three support cores (Inflammation/Neuroendocrine, Neurocognitive, Biostatistics) that will enrich data from data from Core projects and pilot projects and a Pilot Core. CTAPS will facilitate communication among Center-affiliated investigators, support core directors, and core project Pis; oversee administration of Center-wide budgets and operations; provide infrastructure and administrative support for three support cores and a Pilot Core. CTAPS will spur progress via a transdisciplinary work group system designed to facilitate transdisciplinary collaboration and to organize the allocation of Center resources and disseminate research findings to multiple stakeholders including researchers, policy makers, educational organizations, and the public. RELEVANCE (See instructions): The proposed Center is designed to investigate how chronic stress that rural African American's experience in childhood and adolescence affects drug misuse and HIV-related behavior in young adulthood. The Center's work will contribute to the development of prevention programs that target vulnerabilities to drug use and HIV related behavior that may be developing ""under the skin"" in phsyiolobical and neurological systems.",Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African Americans,9279453,P30DA027827,"['teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' Affect ', ' Aging ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Behavior ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Budgets ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Cataloging ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Communication ', ' Communities ', ' diabetes ', ' Diabetes Mellitus ', ' Environment ', ' Genes ', ' Genotype ', ' Goals ', ' Grant ', ' Health ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heart Diseases ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Inflammation ', ' Institutes ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Mentors ', ' Mission ', ' Neuroendocrine System ', ' Neuroendocrine ', ' Neurosecretory Systems ', ' pilot study ', ' Pilot Projects ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Support ', ' Research Resources ', ' Resources ', ' Science ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Seeds ', ' Stress ', ' Teaching ', ' Educational process of instructing ', ' Translations ', ' Universities ', ' Work ', ' Generations ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Resource Allocation ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Youth ', ' Youth 10-21 ', ' base ', ' career ', ' Physiologic ', ' Physiological ', ' Neurological ', ' Neurologic ', ' Link ', ' pediatric ', ' Childhood ', ' young adulthood ', ' adult youth ', ' young adult ', ' Rural ', ' Policy Maker ', ' Fostering ', ' drug use ', ' Drug usage ', ' Funding ', ' genetically predisposed ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Exposure to ', ' Inflammatory ', ' Catalogs ', ' programs ', ' Scientist ', ' Investigation ', ' System ', ' Neurocognitive ', ' experience ', ' transdisciplinary collaboration ', ' interdisciplinary collaboration ', ' Participant ', ' Prevention program ', ' outreach ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Prevention ', ' HIV risk ', ' Interventional trial ', ' Intervention Trial ', ' Modeling ', ' response ', ' Skin ', ' Address ', ' Chronic stress ', ' Biostatistics Core ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' Infrastructure ', ' Research Infrastructure ', ' Resource Sharing ', ' Collection ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' work group ', ' working group ', ' minority health ', ' Instruction ', ' implementation research ', ' designing ', ' design ', ' innovation ', ' innovative ', ' innovate ', ' malleable risk ', ' inflammatory marker ', ' inflammation marker ', ' operation ', ' racial disparity ', ' race disparity ', ' disparities in race ', ' drug use vulnerability ', ' vulnerability to drug use ', ' drug misuse ', ' ']",NIDA,UNIVERSITY OF GEORGIA,P30,2016,53438,0.11683494687913223
"Strengthening Hispanic Families via NIDA Prevention Science DESCRIPTION (provided by applicant): These application requests 5 years of K01 support to accelerate the NIDA-focused interdisciplinary research career development of Dr. Ruben Parra-Cardona, a clinician-researcher who seeks to become an independent NIDA prevention researcher committed to underserved Hispanic adolescents and families. His current research evaluates a cultural adaptation of an evidence-based parenting intervention for at-risk Hispanic families with young children (ages 4-11), for which there is potential distal NIDA impact such as reduced risk of starting to smoke tobacco or to use other drugs. Complete evidence on distal benefits of early randomized trial interventions of this type cannot be seen unless the scale of research shifts upward, as in multi-site trials, and unless the measurements include bio-assays to confirm self-report drug use, with probes for potential gene- intervention interactions. Based on the proposed K01 career training objectives, the applicant will acquire the necessary skills to develop an interdisciplinary program of prevention research, informed by epidemiological and biomedical science. During 75% protected time for career development toward independent R01 project leadership, core learning objectives will be met (e.g., RCR, FCOI, grants management). In addition to its core, the training plan has 5 tracks: (1) enhanced mastery of small sample parenting intervention research; (2) enhanced mastery of research design and measurements for larger sample multi-site NIDA prevention research on youth developmental trajectories leading toward NIDA outcomes; (3) enhanced mastery of data analysis for interdependent observations from multiple sites; (4) new learning about integration of biological assays in NIDA family intervention and prevention research via collaborations with expert NIH toxicologists and genetics researchers; (5) mastery of electronic technology complements to current 'in person' intervention delivery and program impact assessment. The proposed award is crucial now that the applicant has become K01-eligible via permanent residency. His college has guaranteed protected time for this K01 career acceleration through structured mentoring program led by a NIDA K05 Senior Scientist, backed by a strong local team of federally funded co-mentors, as well as scientific advisors. Through the proposed K01 award, Dr. Parra-Cardona will gain mastery of the theory and research approaches now being refined by quantitative developmental scientists in new lines of NIDA prevention research. The training plan includes guided readings, coursework, among other activities leading to publications. A prevention pilot study will serve as a 'preliminary study' for a NIDA R01 grant proposal planned for Year 4 of the proposed award. This application is responsive to NIH and NIDA's strategic plans highlighting the need to implement interdisciplinary programs of research aimed at preventing young people from ever using drugs, as well as ensuring that at-risk and underserved minority populations benefit from these scientific efforts. PUBLIC HEALTH RELEVANCE: NIH and NIDA strategic goals stress (1) encouraging more minority scientists to pursue research careers bolstering their chances of R01 project success, and (2) interdisciplinary research programs on preventing young people from ever using drugs, and ensuring that at-risk and underserved minority populations benefit from these scientific efforts. The proposed K01 award is directly responsive to these strategic goals.",Strengthening Hispanic Families via NIDA Prevention Science,9036980,K01DA036747,"['Acceleration ', ' Age ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Award ', ' Dorsum ', ' Back ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' childrearing ', ' Parenting behavior ', ' Parenting ', ' Child Rearing ', ' Complement Proteins ', ' Complement ', ' Cuban American ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' depression ', ' Mental Depression ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' electronic device ', ' Electronics ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Family ', ' Foundations ', ' Future ', ' Genes ', ' Goals ', ' Grant ', ' Health ', ' interventions research ', ' interventional study ', ' interventional research ', ' intervention research ', ' Intervention Studies ', ' Leadership ', ' Learning ', ' Mentors ', ' Methodology ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' Michigan ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Oregon ', ' Parents ', ' pilot study ', ' Pilot Projects ', ' Scientific Publication ', ' Publications ', ' Puerto Rican ', ' Reading ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Residencies ', ' Risk ', ' Science ', ' Smoke ', ' Stress ', ' Target Populations ', ' Technology ', ' Testing ', ' Time ', ' Tobacco ', ' United States ', ' Generations ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Population Heterogeneity ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Youth ', ' Youth 10-21 ', ' base ', ' career ', ' Distal ', ' Site ', ' Biological ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Ensure ', ' Training ', ' Stimulus ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' African ', ' school age ', ' School-Age Population ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' drug use ', ' Drug usage ', ' Sample Size ', ' Genetic Research ', ' Funding ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Genetic ', ' Research Specimen ', ' Specimen ', ' Empirical Research ', ' Life ', ' programs ', ' Scientist ', ' System ', ' meetings ', ' collegiate ', ' college ', ' American ', ' experience ', ' stressor ', ' success ', ' Cigarette ', ' Structure ', ' skills ', ' simulation ', ' Participant ', ' Prevention Research ', ' Self-Report ', ' Patient Self-Report ', ' cultural values ', ' episodic drinking ', ' binge alcohol consumption ', ' binge drinking ', ' heavy alcohol use ', ' extreme drinking ', ' excessive ethanol ingestion ', ' excessive drinking ', ' excessive alcohol intake ', ' excessive alcohol ingestion ', ' excessive alcohol consumption ', ' excess ethanol ingestion ', ' excess alcohol ingestion ', ' excess alcohol consumption ', ' drink heavily ', ' Heavy Drinking ', ' Prevention ', ' Reporting ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' Modeling ', ' Sampling ', ' career development ', ' response ', ' theories ', ' middle school ', ' junior high ', ' junior high school ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' disparity in health ', ' health disparity ', ' preventing ', ' prevent ', ' Low income ', ' Address ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' High Prevalence ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' Mentored Research Scientist Development Award ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' NIH RFA ', ' Request for Applications ', ' Strategic Planning ', ' Senior Scientist ', ' Monitor ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' early onset ', ' cost ', ' early initiation drug use ', ' early onset drug use ', ' efficacy evaluation ', ' willingness ', ' externalizing behavior ', ' Outcome ', ' Population ', ' Prevalence ', ' therapy design ', ' treatment design ', ' intervention design ', ' high risk ', ' public health relevance ', ' evidence base ', ' multi-site trial ', ' intervention effect ', ' randomized trial ', ' Randomization trial ', ' reduced substance use ', ' substance use reduction ', ' reduction in substance use ', ' Prevention trial ', ' marijuana use ', ' cannabis use ', ' underserved minority ', ' minority scientist ', ' ']",NIDA,MICHIGAN STATE UNIVERSITY,K01,2016,176129,0.06448522081204047
"Health Consequences of Drug Use and IPV Trajectories for Young Latinas     DESCRIPTION (provided by applicant):  Few empirical studies have documented the life trajectories of gang-affiliated adolescent females and the long- term health consequences of adolescent drug use and partner violence victimization. The purpose of this study is to identify and determine how distinct drug use and intimate partner violence victimization trajectories that emerge in adolescence through young adulthood contribute to physical and mental health outcomes among Mexican American women within the context of a highly disadvantaged community. This group of women are particularly vulnerable given they have low rates of access and utilization of health care, are the most likely age group to be uninsured, and represent a nexus of risk, vulnerability and potentially high costs to communities given their reproductive and sexual health stage of life. This application proposes a 15 year follow up of a cohort of Mexican American adolescent females previously identified in a CDC funded study who were affiliated with male gang members during their adolescence and involved in high rates of drug use and victims of intimate partner violence. Building upon the research teams previous studies and using analytical tools from the theory of gender and power and social bonding theory, this application will implement a concurrent mixed methods nested design approach to provide a comprehensive understanding of the long-term consequences of drug use and IPV. The sample will consist of 300 young adult Mexican-American females. The specific aims for this study are: 1) determine the prevalence of physical (cardiovascular and metabolic risk markers and STI infection) and mental (depression, PTSD, anxiety/stress) health outcomes; 2) identify and characterize distinct drug use and IPV trajectories from adolescence through young adulthood; 3) determine whether sexual relationship power and family social bonds during distinct age-graded stages alter drug use and IPV trajectories and health outcomes; and 4) characterize qualitatively the culture and community context and their influence on drug use and IPV trajectories over the life course. This research will have an important positive impact by identifying women who are at the highest risk for developing harmful drug and IPV trajectories as they transition into young adulthood. In doing this, we will lay the foundation for identifying critical points of behavioral intervention during key age-graded periods as well as culturally and contextually appropriate values and strategies that will reduce health disparities among similar high-risk female populations that have gone underrepresented in existing research. PUBLIC HEALTH RELEVANCE:  This application seek a comprehensive understanding of the long term health consequences of drug use and intimate partner violence victimization physical and mental health outcomes among a vulnerable cohort of Mexican-American females recruited over 15 years ago who were affiliated with male gang members during their adolescence. The study will provide a unique opportunity to investigate detrimental life trajectories contributing t the prevalence of cardiovascular and metabolic risk markers, infection, depression, PTSD, anxiety and stress within a marginalized and underserved community context. Findings will contribute to policy discourse that can lead to the development of innovative public health programs and campaigns that will reduce health disparities among minority women. PHS 398/2590 (Rev. 11/07) Page Continuation Format Page",Health Consequences of Drug Use and IPV Trajectories for Young Latinas,9277610,R01DA039269,"['Accounting ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adolescent girl ', ' Female Adolescents ', ' Age ', ' Anxiety ', ' Attention ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardio-vascular ', ' Cardiovascular system ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Complement Proteins ', ' Complement ', ' Decision Making ', ' depression ', ' Mental Depression ', ' Disadvantaged ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Family ', ' Female ', ' Foundations ', ' Health ', ' Heterogeneity ', ' Infection ', ' knowledge of results ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Longterm Effects ', ' Long-Term Effects ', ' male ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' Neighborhoods ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Public Health ', ' recruit ', ' active recruitment ', ' Recruitment Activity ', ' Research ', ' Risk ', ' Stress ', ' traumatic neurosis ', ' Posttraumatic Stress Disorders ', ' Posttraumatic Neuroses ', ' Post-Traumatic Neuroses ', ' PTSD ', ' Post-Traumatic Stress Disorders ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' Friends ', ' Gender ', "" Women's Health "", ' Female Health ', ' Latino ', ' Uninsured ', ' Youth ', ' Youth 10-21 ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Gap Junctions ', ' mental ', ' Psyche structure ', ' healthcare utilization ', ' healthcare service utilization ', ' healthcare service use ', ' health care service use ', ' Health Care Utilization ', ' health care service utilization ', ' young adulthood ', ' adult youth ', ' young adult ', ' Policies ', ' drug use ', ' Drug usage ', ' Female Groups ', "" Women's Group "", ' Wife ', ' Reproductive Health ', ' Funding ', ' Metabolic ', ' Staging ', ' Shapes ', ' Sister ', ' syndrome x ', ' pre-diabetes ', ' Prediabetic State ', ' Prediabetes ', ' Prediabetes syndrome ', ' Knowledge ', ' Life ', ' programs ', ' physical health ', ' physical conditioning ', ' age group ', ' cohort ', ' member ', ' gang ', ' social ', ' social bonding ', ' social attachment ', ' Sampling ', ' girls ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Latinas ', ' Latina ', ' disparity in health ', ' health disparity ', ' Low income ', ' Address ', ' Health system ', ' Sexual Health ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Risk Marker ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' violent partner ', ' partner violence ', ' sexual relationship ', ' cost ', ' youth drug use ', ' adolescent drug use ', ' intimate partner violence ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' analytical tool ', ' high risk ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' young man ', ' adolescent men ', ' adolescent man ', ' violence victimization ', ' Affordable Care Act ', ' Obamacare ', ' health care service ', ' healthcare service ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2016,46200,0.11929657389475455
"African American Offenders: Drug Use, Mental Health and HIV Risk DESCRIPTION (provided by applicant):  The primary goal of this K08 award is to further develop a productive independent research career in drug abuse research. The training and career development plan will enhance Dr. Stevens-Watkins's research experience in primary data collection with prisoners focused on drug use, mental health, and HIV thus resulting in the clarification of the specific aims of an R01 submission in years 4 and 5. The proposed training objectives are: (1) to receive training in the epidemiology of drug abuse, mental health, and HIV as they relate to health disparities among African Americans; (2) to further develop expertise in research with special populations, biostatistics, and advanced quantitative analyses including non-linear, categorical models, and structural equation modeling; (3) to use the data collected in the proposed research plan as pilot data for an R01 research proposal. The specified training goals are aligned with the research aims and compliment the clinical experience of the candidate. Dr. Stevens-Watkins will be sponsored by her established mentors, Drs. Carl Leukefeld and Carrie Oser, both with expertise in drug abuse and HIV research. Of high significance, HIV has recently been termed a ""crisis"" in the African American community. The overall goal of the proposed research plan is to better understand the complex and dynamic relationship between drug use, mental health, and HIV risk among African American male prisoners nearing community re-entry. The specific aims are (1) to explore drug use, symptoms of depression and anxiety, and HIV risk behaviors among African American male inmates by conducting a thorough literature review and devising an analytical model using biostatics multivariate analytic techniques with available data; (2) to identify prevalence, incidence, and predictors of drug use disorders, anxiety, depressive disorders and HIV sexual risk behaviors among 205 incarcerated African American men; (3) to examine the knowledge, patterns, and perceived cultural and community barriers to utilizing individual and health resources and their relationship to substance abuse recovery and HIV risk behaviors among 205 African American men upon release from prison. Baseline data will be collected in prison and follow-up data collection will occur when participants have been released in the community after 3-months. The proposed research plan will offer HIV testing and counseling to an at-risk population that has historically been difficult to engage in research and HIV testing, subsequently significantly impacting public health by possibly preventing the spread of HIV. The candidate's immediate career goals include published manuscripts and R01 funding by the end of K08 funding, with an ultimate career goal of becoming an independent clinical drug abuse researcher. This proposal includes an outstanding mentoring team, as well as a feasible training and research plan utilizing resources offered by both Spalding University and the University of Kentucky. The proposed project has significant public health implications for reducing the spread of HIV among the African American community by offering testing and by targeting men exiting prison, re-entering the community. The proposed project will generate an improved understanding of the complex relationship between drug use, mental health, and HIV risk among an at-risk group.","African American Offenders: Drug Use, Mental Health and HIV Risk",9058010,K08DA032296,"['Anxiety ', ' Award ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' career track ', ' career pathway ', ' career interest ', ' career aspiration ', ' Career Path ', ' Career Choice ', ' Communities ', ' Counseling ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' depression ', ' Mental Depression ', ' Depressive disorder ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Goals ', ' Health ', ' Health Resources ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Housing ', ' Incidence ', ' Interview ', ' Kentucky ', ' male ', "" men's "", ' men ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Mental Hygiene Services ', ' Mental Health Services ', ' Mentors ', ' Methods ', ' Structural Models ', ' Pre-Post Tests ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisoner ', ' Prisons ', ' Psychologist ', ' Public Health ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Proposals ', ' Research Resources ', ' Resources ', ' Risk ', ' social support network ', ' Social support ', ' Testing ', ' Universities ', ' Writing ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' depressive symptoms ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' career ', ' improved ', ' Chronic ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' psychological ', ' psychologic ', ' racism ', ' Training ', ' Individual ', ' Recovery ', ' Populations at Risk ', ' Development Plans ', ' drug use ', ' Drug usage ', ' Funding ', ' Review Literature ', ' Knowledge ', ' Life ', ' Complex ', ' Protocol ', ' Protocols documentation ', ' Pattern ', ' Techniques ', ' Equation ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' experience ', ' impression ', ' Special Population ', ' named group ', ' Manuscripts ', ' Participant ', ' criminal offender ', ' offender ', ' intravenous drug use ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' HIV risk ', ' Modeling ', ' career development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' correctional system ', ' disparity in health ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' preventing ', ' prevent ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Data ', ' Research Training ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' sexual risk behavior ', ' sex risk ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' community re-entry ', ' community reentry ', ' Outcome ', ' Prevalence ', ' drug testing ', ' drug detection ', ' high risk ', ' public health research ', ' anxiety symptoms ', ' anxious symptom ', ' health service use ', ' health service utilization ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,K08,2016,144850,0.1550195541722535
"Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS) DESCRIPTION (provided by applicant):  There is a critical need to develop a diverse pool of highly trained clinician scholars to foster the development of biomedical, behavioral and clinical research related to drug abuse, addiction, and HIV prevention and treatment in general medical settings. Patients who abuse substances are more likely to be seen in general medical settings such as emergency departments (ED), general medical primary care clinics and inpatient wards, HIV and adolescent health clinics, and women's health centers. These patients often present with a complex array of acute consequences and complications (e.g. intoxication, overdose, withdrawal, trauma and infectious diseases) of substance use as well as chronic conditions such as HIV disease, hepatitis, pulmonary and cardiovascular disease. Objectives: The Yale-Drug Abuse, Addiction, and HIV Research Scholars (DAHRS) program provides a comprehensive three year post-doctorate, interdisciplinary, Mentored Career Development Program to improve drug abuse, addiction, and HIV medical outcomes integrating prevention and treatment in general medical settings including ED, primary care, HIV, adolescent, and women's health clinics. Specifically, Yale-DAHRS will: [Aim 1] Develop clinician scientists with the knowledge, skills, and ability to become independent investigators, generating findings of practical value with significant impact to improve health outcomes of patients with and at risk for drug abuse, addiction, and HIV; [Aim 2] Develop future leaders by providing Scholars with leadership tools and skills and creating individualized programs to ensure success in leading multidisciplinary research teams in studying drug abuse, addiction and HIV, and implementation and integration of research findings into general medical settings; and [Aim 3] Enhance the diversity of drug abuse, addiction, and HIV researchers. Addressing women and minority faculty under representation will enhance the diversity of investigators and research topics, broaden perspectives in setting research priorities, increase clinical trial participation, and expand knowledge. Working synergistically with Yale's established training programs in drug abuse, HIV and clinical investigation, Yale- DAHRS will capitalize on existing academic infrastructure and expertise to ensure success. Unique, features include: (1) An interdisciplinary, diverse faculty of independent researchers in illicit and prescription drug abuse and addiction, tobacco, alcohol, HIV, and medical complexities such as pain and hepatitis C; (2) Synergy with well established, high quality post-doctoral training programs at Yale; (3) The use of clinical informatics for data collection, data management, diagnostic tool development, and information dissemination; and (4) The integration of such diverse fields as public health, informatics, clinical epidemiology, systems engineering and demography with the traditional clinical sciences of internal medicine, emergency medicine, HIV medicine, pediatrics, obstetrics and gynecology, psychiatry, and psychology; (5) Established clinical research laboratories, including the Yale-New Haven Hospital, a tertiary care center for southern New England and a community hospital for the Greater New Haven Area, serving an ethnically, racially, culturally, and economically diverse population, a Veterans Affairs Medical Center and community treatment centers such as the APT Foundation and Federally Qualified Health Centers; (6) Synergies with established research centers and institutes such as the Center for Interdisciplinary Research on AIDS and the Veterans Aging Cohort on HIV. Career Development Plan: Yale-DAHRS is a three year research training program that will prepare a total of six clinician investigators for careers focusing on drug abuse, addiction, and HIV in general medical settings during its first funding cycle. Scholars will earn the Master in Health Sciences degree, combining rigorous training in research methodology, statistics and design with seminars in topics related to drug abuse, addiction, and HIV content, leadership, grant writing and responsible conduct of research. Candidates will complete published mentored research project(s) and prepare an application for the next career step; i.e. NIH R21, R03, R15, R34 mechanism. The collaboration of the multidisciplinary faculty and the combined robust strengths of two principal investigators from Emergency and Internal Medicine, both with extensive experience mentoring and as independent funded investigators will drive the Yale-DAHRS program. Potential Research Projects: Multiple research projects are ""shovel ready"" for Scholar training and can be completed within our allotted time frame, such as secondary data analysis using national large datasets e.g. VA Aging Cohort (HIV); risk factors, prevention and treatment of prescription drug abuse, office-based treatment of opioid dependence with buprenorphine, systematic reviews and meta-analyses, creation of cost effective evaluation models for patients with drug abuse, addiction and HIV including prescription drug abuse; investigation of gender and racial/ethnic disparities in identification and treatment interventions and outcomes; evaluation of screening, and treatment initiation in special populations (i.e. adolescent-elderly, veterans, incarcerated, HIV); comparison of models of screening, brief intervention and referral to treatment (SBIRT) delivery by providers and other innovative technologies; effectiveness and implementation of SBIRT science in general medicine practice with acute and chronic medical complexities. PUBLIC HEALTH RELEVANCE:  Drug abuse, addiction, and HIV are significant public health issues, as they affect the health and well-being of a large portion of the population; have substantial negative health outcomes on individuals; and are extremely costly to the health care system. An investment in research to improve substance abuse and medical health outcomes is greatly needed. The proposed Yale-Drug Abuse, Addiction, and HIV Research Scholars (DAHRS) program focusing on general medical settings with patients throughout the life cycle will provide a three year post-doctoral, interdisciplinary, Mentored Career Development Program training six clinician-scientists for independent research careers in the field of drug abuse, addiction, and HIV through integration of prevention and treatment in general medical settings.","Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS)",9084527,K12DA033312,"['Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Alcohol Chemical Class ', ' Alcohols ', ' Behavioral Research ', ' Biomedical Research ', ' Buprenorphine ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Clinical Informatics ', ' Clinical Study ', ' Clinical Research ', ' Clinical Trials ', ' Infectious Disorder ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communicable Diseases ', ' Communities ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' Demography ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Emergency Medicine ', ' Engineering ', ' Faculty ', ' Foundations ', ' Future ', ' Grant ', ' Gynecology ', ' Health ', ' Hepatitis ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Hospitals ', ' Community Hospitals ', ' dissemination of results ', ' Information Dissemination ', ' Inpatients ', ' Institutes ', ' Internal Medicine ', ' Laboratories ', ' Leadership ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Medicine ', ' Mentors ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Northeastern United States ', ' New England ', ' Obstetrics ', ' Discipline of obstetrics ', ' Overdose ', ' Painful ', ' Pain ', ' Patients ', ' Pediatrics ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Psychiatry ', ' Psychology ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' Science ', ' statistics ', ' Time ', ' Tobacco ', ' Training Programs ', ' Veterans ', ' Woman ', ' Work ', ' Writing ', ' Gender ', "" Women's Health "", ' Female Health ', ' Population Heterogeneity ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Research Methodology ', ' Research Methods ', ' Data Set ', ' Dataset ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' base ', ' career ', ' improved ', ' Area ', ' Acute ', ' Chronic ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Ensure ', ' Evaluation ', ' Training ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Withdrawal ', ' Fostering ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Development Plans ', ' Funding ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' tool ', ' Diagnostic ', ' Research Priority ', ' Knowledge ', ' programs ', ' Scientist ', ' Investigation ', ' Complex ', ' Clinic ', ' System ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' Opiate Addiction ', ' Emergency room ', ' Emergency Department ', ' Accident and Emergency department ', ' Medical center ', ' innovative technologies ', ' data management ', ' experience ', ' Special Population ', ' named group ', ' success ', ' cohort ', ' skills ', ' Prevention ', ' Intoxication ', ' prescription drug abuse ', ' Modeling ', ' career development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' consumer informatics ', ' Health Informatics ', ' Public Health Informatics ', ' Provider ', ' Effectiveness ', ' ward ', ' Address ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Drug Addiction ', ' Health Sciences ', ' Scholars Program ', ' NCI Scholars Program ', ' Infrastructure ', ' Research Infrastructure ', ' Research Training ', ' Clinical Sciences ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Patient-Focused Outcomes ', ' Principal Investigator ', ' developmental ', ' Development ', ' Federally Qualified Health Center ', ' systematic review ', ' treatment center ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' cost effective ', ' cost-effective ', ' Trauma ', ' tertiary care ', ' post-doctoral training ', ' postdoctoral training ', ' clinical epidemiology ', ' addiction ', ' addictive disorder ', ' tool development ', ' racial and ethnic disparities ', ' screening, brief intervention, referral, and treatment ', ' screening, brief intervention, and referral to treatment ', ' SBIRT ', ' responsible research conduct ', ' young woman ', ' adolescent women ', ' adolescent woman ', ' screening ', ' clinical investigation ', ' adolescent health ', ' ']",NIDA,YALE UNIVERSITY,K12,2016,487614,0.10922386071168934
"Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African Americans The Center for Translational and Prevention Science (CTAPS) was funded in 2009 to inform the development of prevention programs for rural African American youth through investigations of gene-environment (G-E) interplay on drug use and HIV-related behavior. The proposed continuation augments CTAPS' scientific agenda to better address racial disparities in drug use and HIV-related behavior that affect rural African Americans. Emerging research suggests that exposure to chronic stress affects the functioning of inflammatory, neuroendocrine, and neurocognitive systems beginning in childhood and adolescence. The negative consequences of chronic stress affect health-related behaviors and forecast chronic diseases of aging. Emerging evidence suggests that these processes also may affect youth and young adults' development of drug misuse and HIV related behavior. The Center will sponsor a new generation of research on (a) the neuroendocrine, inflammatory, and neurocognitive pathways through which exposure to stress among rural African American youth and young adults creates vulnerabilities to drug use and HIV-related behavior, (b), the malleable risk and protective processes that affect underlying vulnerability mechanisms , and (c) the translation of findings into new and refined preventive interventions for youth in general and rural African American youth in particular. The CTAPS will pursue these scientific goals via providing infrastructure for three support cores (Inflammation/Neuroendocrine, Neurocognitive, Biostatistics) that will enrich data from data from Core projects and pilot projects and a Pilot Core. CTAPS will facilitate communication among Center-affiliated investigators, support core directors, and core project Pis; oversee administration of Center-wide budgets and operations; provide infrastructure and administrative support for three support cores and a Pilot Core. CTAPS will spur progress via a transdisciplinary work group system designed to facilitate transdisciplinary collaboration and to organize the allocation of Center resources and disseminate research findings to multiple stakeholders including researchers, policy makers, educational organizations, and the public. RELEVANCE (See instructions): The proposed Center is designed to investigate how chronic stress that rural African American's experience in childhood and adolescence affects drug misuse and HIV-related behavior in young adulthood. The Center's work will contribute to the development of prevention programs that target vulnerabilities to drug use and HIV related behavior that may be developing ""under the skin"" in phsyiolobical and neurological systems.",Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African Americans,9306505,P30DA027827,"['teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' Affect ', ' Aging ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Behavior ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Budgets ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Cataloging ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Communication ', ' Communities ', ' diabetes ', ' Diabetes Mellitus ', ' Environment ', ' Genes ', ' Genotype ', ' Goals ', ' Grant ', ' Health ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heart Diseases ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Inflammation ', ' Institutes ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Mentors ', ' Mission ', ' Neuroendocrine System ', ' Neuroendocrine ', ' Neurosecretory Systems ', ' pilot study ', ' Pilot Projects ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Support ', ' Research Resources ', ' Resources ', ' Science ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Seeds ', ' Stress ', ' Teaching ', ' Educational process of instructing ', ' Translations ', ' Universities ', ' Work ', ' Generations ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Resource Allocation ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Youth ', ' Youth 10-21 ', ' base ', ' career ', ' Physiologic ', ' Physiological ', ' Neurological ', ' Neurologic ', ' Link ', ' pediatric ', ' Childhood ', ' young adulthood ', ' adult youth ', ' young adult ', ' Rural ', ' Policy Maker ', ' Fostering ', ' drug use ', ' Drug usage ', ' Funding ', ' genetically predisposed ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Exposure to ', ' Inflammatory ', ' Catalogs ', ' programs ', ' Scientist ', ' Investigation ', ' System ', ' Neurocognitive ', ' experience ', ' transdisciplinary collaboration ', ' interdisciplinary collaboration ', ' Participant ', ' Prevention program ', ' outreach ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Prevention ', ' HIV risk ', ' Interventional trial ', ' Intervention Trial ', ' Modeling ', ' response ', ' Skin ', ' Address ', ' Chronic stress ', ' Biostatistics Core ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' Infrastructure ', ' Research Infrastructure ', ' Resource Sharing ', ' Collection ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' work group ', ' working group ', ' minority health ', ' Instruction ', ' implementation research ', ' designing ', ' design ', ' innovation ', ' innovative ', ' innovate ', ' malleable risk ', ' inflammatory marker ', ' inflammation marker ', ' operation ', ' racial disparity ', ' race disparity ', ' disparities in race ', ' drug use vulnerability ', ' vulnerability to drug use ', ' drug misuse ', ' ']",NIDA,UNIVERSITY OF GEORGIA,P30,2016,100000,0.11683494687913223
"Couple HIV prevention for drug-involved male offenders: An Effectiveness Trial DESCRIPTION (provided by applicant): The proposed study responds to PA-09-236 entitled ""HIV/AIDS, Drug Use, and Vulnerable Populations."" This study is a randomized controlled trial (RCT) that will rigorously evaluate the implementation, effectiveness and cost-effectiveness of a couple-based integrated HIV/STI and drug abuse prevention intervention (Connect II) with drug-involved male offenders charged with misdemeanors and their primary female sexual partners, implemented by frontline providers in Criminal Court, Community Court or Probation (CCP) sites in the Bronx, NY, compared to CCP standard treatment of care services (TAU). The primary outcomes are biologically confirmed sexually transmitted infections (STIs) and self-reported condom use. This study will yield important data on implementation factors associated with effectiveness of the proposed intervention in real world resource-constrained criminal justice settings. The proposed CCP study sites are located in the South Bronx, the poorest Congressional District in the U.S. with 96% of residents identifying as Black or Latino. The South Bronx has an HIV prevalence rate of 2.6%. Research has found that 12% of men on probation in New York City are HIV positive. Though the criminal justice system is recognized as the epicenter of the epidemic in the U.S., few, if any, HIV prevention interventions have been developed for the huge number of male offenders under community supervision who represent 90% of the corrections population. No HIV/STI prevention services are currently provided at the proposed CCP sites. The proposed intervention is designed to address this critical gap in services. Connect II was found to be efficacious among drug-involved couples in reducing risky drug and sexual behaviors and drug use. In the proposed study we aim to advance the knowledge of implementation science by testing the effectiveness and cost-effectiveness of Connect II delivered by frontline providers in the real world settings of CCP sites with 240 drug-involved male offenders and their female partners (N=480 participants). Eligible couples will be randomly assigned to either (1) a 4-session Connect II delivered to both partners together + TAU delivered to male participant alone, or (2) a TAU control condition delivered to the male participant. Repeated assessments will occur at baseline and 3, 6, and 12-months post intervention. The study will be conducted by Dr. Nabila El-Bassel, Dr. Louisa Gilbert, and an investigative team from Columbia University in collaboration with Michael Rempel from the Center for Court Innovation and the New York City Department of Probation. If found to be effective, Connect II may be scaled up in community criminal justice settings nationwide to curb the spread of HIV/STIs and to reduce HIV disparities in heavily impacted communities like the South Bronx. PUBLIC HEALTH RELEVANCE:  This study addresses the significant public health threat of HIV and other STIs among drug- involved male offenders under community supervision and their female partners. This study will evaluate the implementation, effectiveness and cost-effectiveness of a brief couple-based HIV and drug abuse prevention intervention for drug-involved male offenders and their female partners delivered by frontline providers in Criminal/Community Court and Probation sites in the South Bronx, the poorest congressional district in the U.S. If found to be effective, the proposed brief intervention may be scaled up to community criminal justice sites nationwide to curb the spread of HIV/STIs and reduce HIV disparities.",Couple HIV prevention for drug-involved male offenders: An Effectiveness Trial,9128572,R01DA033168,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Subsaharan Africa ', ' Sub-Saharan Africa ', ' Africa South of the Sahara ', ' Charge ', ' Client ', ' Communities ', ' cost effectiveness ', ' Couples ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Female ', ' Health ', ' services research ', ' Medical Care Research ', ' Health Services Evaluation ', ' Health Services Research ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' Institutes ', ' male ', ' Manuals ', ' Medicine ', "" men's "", ' men ', ' Methods ', ' New York City ', ' Public Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' sex partner ', ' Sexual Partners ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Supervision ', ' Testing ', ' Time ', ' Universities ', ' Work ', ' Treatment outcome ', ' Criminal Justice ', ' Latino ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Caring ', ' base ', ' court ', ' improved ', ' Site ', ' drug use ', ' Drug usage ', ' Collaborations ', ' Letters ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Knowledge ', ' Scientist ', ' System ', ' psychosocial ', ' Outcome Study ', ' Prevent infection ', ' Infection prevention ', ' Consult ', ' Services ', ' professor ', ' condoms ', ' Participant ', ' prevention service ', ' recidivism ', ' Self-Report ', ' Patient Self-Report ', ' Prevention ', ' probation ', ' criminal offender ', ' offender ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' Modeling ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' Provider ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' Effectiveness ', ' Address ', ' cost-effectiveness analysis ', ' cost-effective analysis ', ' cost efficient analysis ', ' cost effectiveness analyses ', ' cost effective analysis ', ' Cost Effective Analyses ', ' Cost Effectiveness Analysis ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Subgroup ', ' Characteristics ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' post intervention ', ' effectiveness trial ', ' cost ', ' efficacy research ', ' designing ', ' design ', ' probationer ', ' scale up ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' demographics ', ' implementation science ', ' community setting ', ' evidence base ', ' primary outcome ', ' secondary outcome ', ' standard care ', ' standard treatment ', ' ']",NIDA,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2016,634839,0.06416710644856985
"Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care Hispanic adolescents in the U.S. experience significant health disparities, particularly as it relates to drug use, unsafe sexual behaviors and sexually transmitted infections (STIs). In spite of these disparities, a paucity of effective preventive interventions exist for Hispanic adolescents, and even fewer have been disseminated widely (IOM/NRC, 2009). Given that primary care settings are increasingly becoming the entry-point through which parents bring youth with behavioral health concerns, adolescent primary care settings represent ideal, yet underutilized, settings in which to disseminate evidence-based preventive interventions. Preventive interventions which target risk and protective factors within the family, the most proximal and fundamental social system influencing human behavior, have been found to be among the most efficacious interventions in preventing and reducing drug use and sexual risk behaviors.  Familias Unidas is a Hispanic-specific, family-based intervention found to be efficacious and effective in preventing and reducing drug use, sexual risk behaviors, and self-reported STIs. Familias Unidas has been cited by the Institute of Medicine report on Preventing, Emotional, and Behavioral among Young People as ready for broad dissemination (IOM/NRC, 2009). To date, however, Familias Unidas has been only tested for efficacy and effectiveness in schools and has not been evaluated for efficacy/effectiveness in primary care. We have adapted and evaluated Familias Unidas for online delivery; successfully retaining 80% of Hispanic parents and their youth (recruited from schools) in the online, eHealth adaptation of Familias Unidas. We have also demonstrated the feasibility and acceptability of delivering eHealth Familas Unidas in primary care.  Evaluating innovative eHealth family-based interventions for Hispanic youth whose feasibility and acceptability is established in primary care settings is timely and of high public health significance. Therefore, the proposed study's overarching aim is to evaluate the relative effectiveness and cost effectiveness of eHealth Familias Unidas, compared to a referral to the National Institute Drug Abuses (NIDA) online information page for parents of Hispanic youth (referred hereafter as NIDA Online Information). To test the effectiveness of eHealth Familias Unidas Primary Care in preventing drug use, unprotected sexual behavior, and STIs in a universal sample of Hispanic youth, this study will randomize 456 Hispanic youth and their parents to eHealth Familias Unidas or to NIDA Online Information. Participants will be assessed at baseline, 6, 12, 24, and 36 months post baseline. Study hypotheses are that: 1) eHealth Familias Unidas will be effective, relative to NIDA Online Information, in preventing/reducing drug use, unprotected sexual behavior, and STI incidence in Hispanic adolescents over time and 2) Intervention effects will be partially mediated by family functioning for drug use and unprotected sexual behavior and by family functioning and unprotected sexual behavior for STI incidence. The cost effectiveness of eHealth Familias Unidas over a three year follow up will also be estimated. The proposed study will evaluate the effectiveness of an eHealth adaptation of an evidence-based face-to- face preventive intervention for Hispanic youth, in preventing drug use, sexual risk behaviors, and sexually transmitted diseases in primary care settings. The knowledge expected to be gained in this study will have strong implications for the delivery of prevention interventions in primary care, as well as contribute to the reduction of drug and sexual risk behavior related to disparities seen in Hispanic youth.",Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care,9175553,R01DA040756,"['Cultural Assimilation ', ' Acculturation ', ' Behavior ', ' behavioral disorder ', ' Behavior Disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' climatic ', ' Meteorological Climate ', ' Climate ', ' Conflict ', ' Conflict (Psychology) ', ' cost effectiveness ', ' Counselor ', ' Professional counselor ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Family ', ' Gonococcal Infection ', ' Gonorrhea ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Modern Man ', ' Human ', ' Incidence ', ' NAS/IOM ', ' Institute of Medicine ', ' Institute of Medicine (U.S.) ', ' Leadership ', ' Parents ', ' Physicians ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Psychiatric/Mental Health Nursing ', ' Mental Health Nursing ', ' Psychiatric Nursing ', ' Public Health ', ' recruit ', ' active recruitment ', ' Recruitment Activity ', ' Risk ', ' Schools ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Staff Attitudes ', ' Testing ', ' Time ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Latino ', ' Mediating ', ' Youth ', ' Youth 10-21 ', ' Caring ', ' base ', ' improved ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' pediatric ', ' Childhood ', ' Emotional disorder ', ' drug use ', ' Drug usage ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Knowledge ', ' Frequencies ', ' Clinic ', ' System ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' Psychiatric Nurse ', ' Mental Health Nurse ', ' Nurse Psychotherapist ', ' experience ', ' Participant ', ' member ', ' Self-Report ', ' Patient Self-Report ', ' Reporting ', ' social ', ' Emotional ', ' Sampling ', ' behavioral health ', ' middle school ', ' junior high ', ' junior high school ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' disparity in health ', ' health disparity ', ' Effectiveness ', ' preventing ', ' prevent ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Behavioral ', ' Healthcare professional ', ' Health Care Professional ', ' Health Professional ', ' sexual risk behavior ', ' sex risk ', ' care systems ', ' Outcome ', ' cost effective ', ' cost-effective ', ' innovation ', ' innovative ', ' innovate ', ' evidence base ', ' primary care setting ', ' intervention effect ', ' efficacy testing ', ' eHealth ', ' e-Health ', ' parent-adolescent communication ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2016,800374,0.07929300962446643
"Health Consequences of Drug Use and IPV Trajectories for Young Latinas     DESCRIPTION (provided by applicant):  Few empirical studies have documented the life trajectories of gang-affiliated adolescent females and the long- term health consequences of adolescent drug use and partner violence victimization. The purpose of this study is to identify and determine how distinct drug use and intimate partner violence victimization trajectories that emerge in adolescence through young adulthood contribute to physical and mental health outcomes among Mexican American women within the context of a highly disadvantaged community. This group of women are particularly vulnerable given they have low rates of access and utilization of health care, are the most likely age group to be uninsured, and represent a nexus of risk, vulnerability and potentially high costs to communities given their reproductive and sexual health stage of life. This application proposes a 15 year follow up of a cohort of Mexican American adolescent females previously identified in a CDC funded study who were affiliated with male gang members during their adolescence and involved in high rates of drug use and victims of intimate partner violence. Building upon the research teams previous studies and using analytical tools from the theory of gender and power and social bonding theory, this application will implement a concurrent mixed methods nested design approach to provide a comprehensive understanding of the long-term consequences of drug use and IPV. The sample will consist of 300 young adult Mexican-American females. The specific aims for this study are: 1) determine the prevalence of physical (cardiovascular and metabolic risk markers and STI infection) and mental (depression, PTSD, anxiety/stress) health outcomes; 2) identify and characterize distinct drug use and IPV trajectories from adolescence through young adulthood; 3) determine whether sexual relationship power and family social bonds during distinct age-graded stages alter drug use and IPV trajectories and health outcomes; and 4) characterize qualitatively the culture and community context and their influence on drug use and IPV trajectories over the life course. This research will have an important positive impact by identifying women who are at the highest risk for developing harmful drug and IPV trajectories as they transition into young adulthood. In doing this, we will lay the foundation for identifying critical points of behavioral intervention during key age-graded periods as well as culturally and contextually appropriate values and strategies that will reduce health disparities among similar high-risk female populations that have gone underrepresented in existing research. PUBLIC HEALTH RELEVANCE:  This application seek a comprehensive understanding of the long term health consequences of drug use and intimate partner violence victimization physical and mental health outcomes among a vulnerable cohort of Mexican-American females recruited over 15 years ago who were affiliated with male gang members during their adolescence. The study will provide a unique opportunity to investigate detrimental life trajectories contributing t the prevalence of cardiovascular and metabolic risk markers, infection, depression, PTSD, anxiety and stress within a marginalized and underserved community context. Findings will contribute to policy discourse that can lead to the development of innovative public health programs and campaigns that will reduce health disparities among minority women. PHS 398/2590 (Rev. 11/07) Page Continuation Format Page",Health Consequences of Drug Use and IPV Trajectories for Young Latinas,9096033,R01DA039269,"['Accounting ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adolescent girl ', ' Female Adolescents ', ' Age ', ' Anxiety ', ' Attention ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardio-vascular ', ' Cardiovascular system ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Complement Proteins ', ' Complement ', ' Decision Making ', ' depression ', ' Mental Depression ', ' Disadvantaged ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Family ', ' Female ', ' Foundations ', ' Health ', ' Heterogeneity ', ' Infection ', ' knowledge of results ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Longterm Effects ', ' Long-Term Effects ', ' male ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' Neighborhoods ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Public Health ', ' recruit ', ' active recruitment ', ' Recruitment Activity ', ' Research ', ' Risk ', ' Stress ', ' traumatic neurosis ', ' Posttraumatic Stress Disorders ', ' Posttraumatic Neuroses ', ' Post-Traumatic Neuroses ', ' PTSD ', ' Post-Traumatic Stress Disorders ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' Friends ', ' Gender ', "" Women's Health "", ' Female Health ', ' Latino ', ' Uninsured ', ' Youth ', ' Youth 10-21 ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Gap Junctions ', ' mental ', ' Psyche structure ', ' healthcare utilization ', ' healthcare service utilization ', ' healthcare service use ', ' health care service use ', ' Health Care Utilization ', ' health care service utilization ', ' young adulthood ', ' adult youth ', ' young adult ', ' Policies ', ' drug use ', ' Drug usage ', ' Female Groups ', "" Women's Group "", ' Wife ', ' Reproductive Health ', ' Funding ', ' Metabolic ', ' Staging ', ' Shapes ', ' Sister ', ' syndrome x ', ' pre-diabetes ', ' Prediabetic State ', ' Prediabetes ', ' Prediabetes syndrome ', ' Knowledge ', ' Life ', ' programs ', ' physical health ', ' physical conditioning ', ' age group ', ' cohort ', ' member ', ' gang ', ' social ', ' social bonding ', ' social attachment ', ' Sampling ', ' girls ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Latinas ', ' Latina ', ' disparity in health ', ' health disparity ', ' Low income ', ' Address ', ' Health system ', ' Sexual Health ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Risk Marker ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' violent partner ', ' partner violence ', ' sexual relationship ', ' cost ', ' youth drug use ', ' adolescent drug use ', ' intimate partner violence ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' analytical tool ', ' high risk ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' young man ', ' adolescent men ', ' adolescent man ', ' violence victimization ', ' Affordable Care Act ', ' Obamacare ', ' health care service ', ' healthcare service ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2016,652395,0.11929657389475455
"Age-Varying Effects in the Epidemiology of Drug Abuse     DESCRIPTION (provided by applicant): To improve the efficiency and efficacy of drug abuse interventions, an understanding of the age-related changes in behavior prevalences, comorbidities, and health disparities, and the evolving role of various risk factors from adolescence through middle adulthood, is crucial. Today there is an unprecedented amount of existing high-quality data that have enormous potential to shed new light on these issues. Many of these data sets are nationally representative, drawn from populations that span a wide range of ages. New methods now exist to tap those data in order to address important, new scientific questions about drug use, abuse, and dependence (drug UAD) from a developmental perspective. To this end, we propose the innovative application of the time-varying effect model (TVEM) to data from two complementary national studies of health risk behaviors: The National Longitudinal Study of Adolescent Health (N=20,745) and the 2012 National Survey on Drug Use and Health (N=63,809). TVEM flexibly estimates behavior prevalences and associations among variables as continuous, flexible functions of age. Specifically, the specific aims for this projec are as follows. (1) To model flexible, age-varying trends in drug UAD from adolescence into middle adulthood. We will estimate rates of alcohol, tobacco, marijuana, and other drug use, abuse and dependence as a complex function of continuous age from ages 12 to 50. Trends will be estimated across sex and race/ethnicity to document age-varying health disparities. (2) To elucidate the age-varying role of mental health problems in the course of drug UAD from adolescence into middle adulthood. We will examine how depressive symptoms and suicidal ideation are differentially associated with drug UAD as a continuous, complex function from ages 12 to 50. (3) To estimate age-varying effects of early and concurrent risk factors on drug UAD from adolescence into middle adulthood. We will examine how and when specific risk and protective factors are associated with drug UAD from ages 12 to 50. We will consider early risk factors at the individual, parent, peer, school, and community levels, as well as concurrent factors such as marriage and parenthood. (4) To examine contributors to health disparities in drug use. To advance understanding of the developmental course of health disparities, we will examine sex and race/ethnicity as moderators of (a) age-varying comorbidities of drug UAD and mental health problems and (b) age-varying associations between risk factors and drug UAD. This project will provide knowledge about the developmental course of drug UAD and related health disparities, allowing prevention scientists and clinicians to design interventions that matc the most promising mechanisms of change to the most appropriate age period within population subgroups. To maximize the project's overall impact, we will actively disseminate this promising new analytic approach to drug abuse researchers.         PUBLIC HEALTH RELEVANCE: Existing national data have been used extensively to advance understanding of drug use, abuse, and dependence; comorbidities with mental health problems; the role of early and concurrent risk factors; and health disparities. However, empirical studies and behavioral theory have been largely silent on how these issues evolve continuously across age. This project will apply a new data analytic approach to existing cross- sectional and panel data to gain new insight into nuanced, age-related changes from adolescence through mid-adulthood, shedding light on ways to tailor interventions to individuals to increase intervention efficiency and efficacy to reduce drug abuse and its related consequences.                ",Age-Varying Effects in the Epidemiology of Drug Abuse,9093771,R01DA039854,"['Accounting ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Age ', ' Alcohol Chemical Class ', ' Alcohols ', ' Behavior ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' co-morbidity ', ' Comorbidity ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Employment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Health ', ' Photoradiation ', ' Light ', ' long-term study ', ' Longitudinal Studies ', ' marihuana ', ' Marijuana ', ' Marital Status ', ' Marriage ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Paper ', ' Parents ', ' Public Health ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Schools ', ' Survey Instrument ', ' Surveys ', ' Time ', ' Tobacco ', ' United States ', ' Work ', ' Gender ', ' depressive symptoms ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Data Set ', ' Dataset ', ' improved ', ' Distal ', ' insight ', ' Individual ', ' Workshop ', ' Educational workshop ', ' Data Quality ', ' drug use ', ' Drug usage ', ' Ethnicity ', ' Ethnic Origin ', ' Knowledge ', ' Scientist ', ' thoughts about suicide ', ' suicide ideation ', ' suicidal thinking ', ' suicidal ideation ', ' Suicidal thoughts ', ' Feeling suicidal ', ' Complex ', ' Dependence ', ' collegiate ', ' college ', ' Intercept ', ' peer ', ' Prevention ', ' psychological distress ', ' Modeling ', ' response ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' disparity in health ', ' health disparity ', ' Address ', ' Data ', ' Subgroup ', ' enroll ', ' Enrollment ', ' trend ', ' teen years ', ' Teen ', ' Teenagers ', ' Process ', ' sex ', ' developmental ', ' Development ', ' age dependent ', ' age related ', ' attributable death ', ' attributable mortality ', ' cost ', ' Treatment Efficacy ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' therapy design ', ' treatment design ', ' intervention design ', ' public health relevance ', ' effective intervention ', ' flexibility ', ' flexible ', ' behavioral study ', ' behavior study ', ' Data Analytics ', ' Developmental Course ', ' adolescent health ', ' ']",NIDA,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2016,223789,0.21078522912097405
"Contextualizing & responding to HIV risk behaviors among Black drug offenders DESCRIPTION (provided by applicant): Formerly incarcerated Black drug offenders are at an elevated risk for HIV infection. Despite substantial research expressing the need for HIV prevention services for ex-offenders post-release, this population has limited access to quality programming and services related to HIV risk reduction. This K01 application seeks to inform and adapt an HIV risk reduction intervention to address the needs of formerly incarcerated Black drug offenders who are being released from prisons in the New York City metropolitan area. This application supports the Principal Investigator's interest in becoming an independent behavioral scientist specializing in HIV prevention intervention development and adaptation. The proposed mentorship and training program will focus on the following key areas: mixed methods research; adaptation science; and intervention implementation. The proposed study will occur in three phases implemented over the course of five years. The formative phase will consist of survey administration on HIV literacy, needs and barriers to practicing protective behaviors, and HIV testing from 120 recently released Black drug offenders. Also during this phase, in-depth interviews with a subsample of 24 participants (12 male and 12 female participants) will also be conducted to gather more comprehensive information exploring needs and barriers to practicing HIV protective behaviors. The intervention development and adaptation phase, will consist of analyzing data from the survey research and in-depth interviews to tailor it for use with recently released Black drug offenders. In phase 3, the feasibility and acceptability of the adapted intervention will be pilot tested using a randomized clinical trial with 64 participants who are randomized to the adapted intervention or an Enhanced Referral Intervention arm. Building on the Information-Motivation and Behavioral Skills Model, this study will address the following specific aims: 1) To examine individual-level, environmental and contextual factors that affect HIV risk-related behaviors (i.e. illicit drug use and risky sexual behavior) among formerly incarcerated Black male and female drug offenders; 2) To adapt Project START, an HIV risk reduction intervention for formerly incarcerated men, using data gathered from Aim 1, to increase access to HIV testing and address drivers of HIV vulnerability among recently released Black male and female drug offenders; and 3) To pilot test the feasibility and acceptability of the adapted Project START using a randomized clinical trial with 64 participants (32 men, 32 women). The proposed study will utilize a mixed-methods approach to investigate drivers of HIV risk among recently released Black drug offenders. By providing more contextual information on risk behaviors, future evidence-based approaches can be developed and rapidly deployed, advancing HIV prevention science, and providing essential support for a vulnerable population that consistently experiences barriers in accessing HIV prevention services. PUBLIC HEALTH RELEVANCE: This K01 application seeks to inform and adapt an HIV risk reduction intervention to address the needs of formerly incarcerated Black drug offenders who are being released from prisons in the New York City metropolitan area. The proposed mentorship and training program will focus on the following key areas: mixed methods research; adaptation science; and intervention implementation. A mixed methods approach will be used to conceptualize HIV risk related behaviors among this population, resulting in the development of a novel approach to better understanding and ultimately addressing racial disparities in HIV prevalence.",Contextualizing & responding to HIV risk behaviors among Black drug offenders,9095268,K01DA036411,"['Affect ', ' Behavior ', ' Behavioral Research ', ' Communities ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Diagnosis ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Eyeball ', ' Eye ', ' Female ', ' Future ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Housing ', ' Interview ', ' literacy ', ' male ', "" men's "", ' men ', ' Mentors ', ' Mentorship ', ' Methods ', ' Study models ', ' Motivation ', ' New York City ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisoner ', ' Prisons ', ' Public Health ', ' Research ', ' Risk ', ' Science ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Training Programs ', ' United States ', ' Woman ', ' Gender ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Criminal Justice ', ' Research Methodology ', ' Research Methods ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' improved ', ' Area ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' Randomized Clinical Trials ', ' Training ', ' Individual ', ' Drug user ', ' Knowledge ', ' programs ', ' Scientist ', ' Home ', ' Home environment ', ' Application Context ', ' contextual factors ', ' interest ', ' Services ', ' experience ', ' metropolitan ', ' skills ', ' Participant ', ' prevention service ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' criminal offender ', ' offender ', ' HIV risk ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' Risk Reduction ', ' disparity in health ', ' health disparity ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' high risk sexual behavior ', ' Institution ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Address ', ' Data ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' Mentored Research Scientist Development Award ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Transmission ', ' transmission process ', ' Principal Investigator ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Behavioral ', ' Prevention education ', ' neglect ', ' protective behavior ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Guide prevention ', ' Population ', ' Prevalence ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' evidence base ', ' arm ', ' drug offender ', ' racial disparity ', ' race disparity ', ' disparities in race ', ' illicit drug use ', ' ']",NIDA,COLUMBIA UNIVERSITY HEALTH SCIENCES,K01,2016,123934,0.0825246084870777
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network     DESCRIPTION:  The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PUBLIC HEALTH RELEVANCE: This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9242858,UG1DA015815,"['etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' American Indian ', ' American Indians ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Educational aspects ', ' Education ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methadone ', ' Methods ', ' Narcanti ', ' Narcan ', ' Naloxone ', ' Persons ', ' Oregon ', ' Overdose ', ' Patients ', ' Peer Review ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' Scientific Publication ', ' Publications ', ' recruit ', ' active recruitment ', ' Recruitment Activity ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Rural Health ', ' Safety ', ' San Francisco ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Social Workers ', ' Substance Use Disorder ', ' Testing ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Healthcare ', ' health care ', ' HIV vaccine ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' Caring ', ' base ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' Medical ', ' Link ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Training ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Licensing ', ' Opioid ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Therapeutic ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocol ', ' Protocols documentation ', ' Country ', ' Services ', ' experience ', ' care delivery ', ' Participant ', ' treatment program ', ' member ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' behavioral health ', ' QOC ', ' Quality of Care ', ' protocol development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' patient registry ', ' Provider ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' disparity in health ', ' health disparity ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Research Training ', ' Ancillary Study ', ' Clinical Data ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' designing ', ' design ', ' urban American Indian ', ' urban native american ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addiction ', ' addictive disorder ', ' evidence base ', ' patient population ', ' Amalgam ', ' leadership development ', ' HIV/HCV ', ' HIV/Hepatitis C ', ' health care service ', ' healthcare service ', ' health service use ', ' health service utilization ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2016,224441,0.08695097140668363
"Mentoring researchers on drug abuse and HIV DESCRIPTION (provided by applicant): Drug users with and at-risk for HIV continue to have poor access to health care and poor treatment outcomes. In addition, opioid addiction involving prescription opioids has skyrocketed. In this proposal for a mid-career investigator award, Dr. Chinazo Cunningham proposes to address the opioid epidemic and its intersection with HIV infection by: 1) becoming an internationally recognized leader in the field of drug abuse and HIV, expanding her research to include advanced research methods (comparative effectiveness research [CER] methods and complex clinical trials methods); 2) developing a standardized and structured mentorship approach to mentor junior investigators to conduct patient-oriented research related to drug abuse and/or HIV infection; and 3) becoming an effective leader in academic medicine, ensuring that the institutional infrastructure facilitates junior investigators obtaining skills necessary to become independent investigators. To achieve these goals, Dr. Cunningham will participate in courses and national conferences, have directed readings, and regularly meet with national leaders in related fields. Dr. Cunningham will particularly focus on mentoring women and racial/ethnic minorities-two groups who are under-represented in senior positions in academic medicine and NIH-funded research. Dr. Cunningham will utilize her existing research program as a foundation for which she will provide mentoring and expand her research skills to include CER and complex clinical trials methods. The aims of her research are to: 1) test the efficacy of a 16-week abstinence-reinforcing contingency management intervention on HIV viral load suppression among opioid-dependent HIV-infected individuals, using a randomized controlled trial design; and 2) examine mechanisms of achieving viral load suppression with the abstinence-reinforcing contingency management intervention. Dr. Cunningham's future research will include the establishment of a comprehensive ""live"" database of all opioid users within a large urban medical center. This database will be used to examine health outcomes associated with types of opioid use and to develop and test interventions focused on opioid use. Dr. Cunningham's long-term career objective is to improve access to care and health outcomes among drug-abusing populations with or at-risk for HIV infection by developing interventions that can reduce their disparities in health care and health. PUBLIC HEALTH RELEVANCE: This application for a K24 mid-career investigator award seeks to provide support to Dr. Chinazo Cunningham to provide excellent mentorship, effective leadership, and expand her current research to include advanced research methods (comparative effectiveness research methods and complex clinical trials methods). Dr. Cunningham will mentor junior investigators in the areas of drug abuse and HIV, with an emphasis on providing mentorship to racial/ethnic minorities and women. Dr. Cunningham will use her existing research project as a foundation to provide much of her mentorship. In addition, expanding her research to include comparative effectiveness research and complex clinical trials focused on opioid use will allow her to conduct new research and provide additional mentorship that can ultimately improve health outcomes of drug users with and at-risk for HIV.",Mentoring researchers on drug abuse and HIV,9036367,K24DA036955,"['Award ', ' Behavior ', ' Buprenorphine ', ' Clinical Trials ', ' Cocaine ', ' Color ', ' Communities ', ' Control Groups ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Feedback ', ' Foundations ', ' Goals ', ' Health ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Hematology Testing ', ' Hematological Tests ', ' Hematologic Tests ', ' Blood Tests ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incentives ', ' Leadership ', ' Medical Records ', ' Medicine ', ' Mentors ', ' Mentorship ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methadone ', ' Methods ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Roxicodone ', ' Oxycontin ', ' Oxycodone SR ', ' Oxycodeinon ', ' Dihydrohydroxycodeinone ', ' Oxycodone ', ' Patients ', ' Public Health ', ' Questionnaires ', ' Reading ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Support ', ' Risk ', ' Testing ', ' Toxicology ', ' Urine ', ' Urine Urinary System ', ' Woman ', ' Treatment outcome ', ' symposium ', ' symposia ', ' summit ', ' convention ', ' conference ', ' Healthcare ', ' health care ', ' Research Methodology ', ' Research Methods ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Caring ', ' base ', ' career ', ' improved ', ' Area ', ' Ensure ', ' Individual ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Opioid ', ' drug use ', ' Drug usage ', ' T4 Lymphocyte Count ', ' CD4+ Counts ', ' CD4+ Cell Counts ', ' CD4 Lymphocyte Count ', ' Funding ', ' Agonist ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Smoker ', ' Drug user ', ' Opiates ', ' Life ', ' programs ', ' Viral Load ', ' Viral Burden ', ' Viral Load result ', ' Complex ', ' Neurocognitive ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' Opiate Addiction ', ' meetings ', ' Medical center ', ' Performance ', ' success ', ' Structure ', ' skills ', ' Participant ', ' contingency management ', ' Position ', ' Positioning Attribute ', ' HIV risk ', ' voucher ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' highly active anti-retroviral therapy ', ' HAART ', ' Highly Active Antiretroviral Therapy ', ' patient oriented study ', ' patient oriented research ', ' pill ', ' disparity in health ', ' health disparity ', ' therapy adherence ', ' Smoking and Tobacco Use Cessation Interventions ', ' Smoking Cessation Intervention ', ' Address ', ' Adherence ', ' Data ', ' Improve Access ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Infrastructure ', ' Research Infrastructure ', ' enroll ', ' Enrollment ', ' effectiveness research ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Outcome ', ' Population ', ' ethnic minority population ', ' ethnic minority ', ' Abstinence ', ' racial and ethnic ', ' comparative effectiveness ', ' primary outcome ', ' secondary outcome ', ' efficacy testing ', ' cocaine use ', ' prescription opioid ', ' trial design ', ' improved outcome ', ' opioid use ', ' health care availability ', ' healthcare service access ', ' healthcare access ', ' health care service availability ', ' health care service access ', ' accessibility to healthcare ', ' accessibility to health care ', ' accessibility of health care ', ' access to healthcare ', ' access to health care ', ' ']",NIDA,"ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",K24,2016,185824,0.11979102193138146
"Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border     DESCRIPTION (provided by applicant): The proposed project is a research collaboration between the University of Texas at El Paso, The Alliance for Border Collaborative and Program Comparers to adapt, implement, and evaluate a multi-level, community-based, HIV prevention intervention (Project Encuentro). The intervention will target active heroin and crack users and consists of increasing access to HIV testing via a social network HIV testing component and reducing sexual and drug use risk via a peer network brief behavioral Intervention. Encuentro also consists of conducting community awareness meeting to target structural factors affecting HIV risk. The intervention was developed in an area severely affected by violence and stigma towards drug users, El Salvador, which makes it particularly suitable for adaptation to meet the needs of drug users living in the proposed intervention site, the U.S.-Mexico border. The proposed intervention site also has been severely affected by violence which has curtailed any prior attempts to reduce the risk drug users' HIV risk. Violence has worsened structural factors which affect HIV risk such as, increasing police persecution and stigma and reducing access to resources. In our proposed project, we will engage in formative research to understand the context of HIV risk of drug users in the border region post violence and adapt the intervention accordingly. Findings will allow us to tailor intervention components to meet the needs of drug users in the region. Subsequently, we propose to test intervention effectiveness and evaluate implementation barriers and facilitators. To accomplish our project aims we will use a mixed qualitative, quantitative approach. We will begin with a formative phase by conducting in-depth interviews with drug users (n = 40) living in the region to understand how the context of drug use risk changed as a result of the violence and will administer a social network survey (n = 200) to characterize the configuration of risk networks. Findings will yield the necessary information to culturally adapt the intervention to meet the needs of drug users in the region and will help us focus our recruitment efforts where the riskiest networks are located. After the intervention is adapted with the help of our community advisory board and our community coalition, we will implement the intervention and will assess the effectiveness and reach via 6 cross-sectional surveys administered to drug users (n=1,200). We will assess the process of implementation by conducting ethnographic field notes of all intervention activities including community engagement and CAB and coalition meetings. We will assess the fidelity and quality of the intervention. Lastly, we will conduct key informant interviews with key stakeholders involved in the project and interviews and observations will be coded to reflect key systems factors related to successful implementation of intervention components in two intervention sites (El Paso, Texas and Ciudad Juarez, Mexico). Findings will be highly significant as we will be conducting parallel research on the effectiveness of interventions shown to be effective in Latino drug users in two very different contexts: El Salvador and the U.S-Mexico border. Findings will elucidate implementation challenges and barriers and such information can then be used to assess the effectiveness of diverse implementation strategies in organizations working to serve the needs of Latino drug users.         PUBLIC HEALTH RELEVANCE: Findings will be highly significant as we will be conducting parallel research on the effectiveness of interventions shown to be effective in Latino drug users in two very different contexts: El Salvador and the U.S- Mexico border.        ",Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border,9129437,U01MD010657,"['liquid ', ' fluid ', ' Liquid substance ', ' Drug user ', ' Life ', ' programs ', ' Event ', ' Side ', ' System ', ' Country ', ' meetings ', ' experience ', ' metropolitan ', ' Participant ', ' member ', ' Prevention ', ' social ', ' HIV risk ', ' Coding System ', ' Code ', ' response ', ' stigma ', ' social stigma ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Risk Reduction ', ' disparity in health ', ' health disparity ', ' Effectiveness ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Address ', ' Effectiveness of Interventions ', ' International ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' Process ', ' sex ', ' informant ', ' substance abuse therapy ', ' substance abuse treatment ', ' designing ', ' design ', ' community organizations ', ' community based participatory research ', ' participatory action research ', ' community based research ', ' community based design ', ' implementation science ', ' combat ', ' public health relevance ', ' injection drug use ', ' peer networks ', ' violent crime ', ' Affect ', ' Awareness ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Cities ', ' Communities ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' El Salvador ', ' Epidemic ', ' Equipment ', ' Explosion ', ' facial ', ' faces ', ' Face ', ' Fear ', ' Fright ', ' Feedback ', ' Goals ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Immigrations ', ' In-Migration ', ' Injections ', ' Injection of therapeutic agent ', ' Interview ', ' Mexico ', ' Mission ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' social support network ', ' Social support ', ' Survey Instrument ', ' Surveys ', ' Syringes ', ' Testing ', ' Texas ', ' Time ', ' Universities ', ' Violence ', ' violent behavior ', ' violent ', ' Work ', ' Police ', ' Latino ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Social Network ', ' Ethnography ', ' ethnographic ', ' Workplace ', ' work setting ', ' Worksite ', ' Work-Site ', ' Work Place ', ' Work Location ', ' Job Site ', ' Job Setting ', ' Job Place ', ' Job Location ', ' base ', ' Site ', ' Area ', ' Phase ', ' Series ', ' Evaluation ', ' Border Crossings ', ' drug use ', ' Drug usage ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Needle-Exchange Programs ', ' Collaborations ', ' ']",NIMHD,UNIVERSITY OF TEXAS EL PASO,U01,2016,440795,0.136020208412757
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network     DESCRIPTION:  The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PUBLIC HEALTH RELEVANCE: This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9118130,UG1DA015815,"['etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' American Indian ', ' American Indians ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Educational aspects ', ' Education ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methadone ', ' Methods ', ' Narcanti ', ' Narcan ', ' Naloxone ', ' Persons ', ' Oregon ', ' Overdose ', ' Patients ', ' Peer Review ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' Scientific Publication ', ' Publications ', ' recruit ', ' active recruitment ', ' Recruitment Activity ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Rural Health ', ' Safety ', ' San Francisco ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Social Workers ', ' Substance Use Disorder ', ' Testing ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Healthcare ', ' health care ', ' HIV vaccine ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' Caring ', ' base ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' Medical ', ' Link ', ' Hepatitus C ', ' HCV ', ' Hepatitis C virus ', ' Training ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Licensing ', ' Opioid ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Therapeutic ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocol ', ' Protocols documentation ', ' Country ', ' Services ', ' experience ', ' care delivery ', ' Participant ', ' treatment program ', ' member ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' behavioral health ', ' QOC ', ' Quality of Care ', ' protocol development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' patient registry ', ' Provider ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' disparity in health ', ' health disparity ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Research Training ', ' Ancillary Study ', ' Clinical Data ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' designing ', ' design ', ' urban American Indian ', ' urban native american ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addiction ', ' addictive disorder ', ' evidence base ', ' patient population ', ' Amalgam ', ' leadership development ', ' HIV/HCV ', ' HIV/Hepatitis C ', ' health care service ', ' healthcare service ', ' health service use ', ' health service utilization ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2016,1742625,0.08695097140668363
"Brief intervention for drug-using rural women at high-risk for HIV/HCV DESCRIPTION (provided by applicant): The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high-risk for HIV and HCV. This project has potential to make a significant contribution to science by advancing knowledge about the health disparities, high-risk behaviors (injection drug use, sex risk), and service utilization of this high-risk, vulnerable, an understudied group of women during a time of emerging and significant public health risk in an Appalachian rural setting. This project will incorporate standardized screening (NIDA-modified ASSIST) to identify high-risk rural women drug users from jails, including injectors. Consenting women (N=350) will be asked to participate in a baseline interview, and will then be randomly assigned to one of two study groups: (1) HIV Education (HIV- Ed n=175) which includes the NIDA standard pre and post-test counseling, HIV and HCV rapid testing, and an information packet on existing community drug abuse and HIV/HCV resources; or (2) Motivational Interviewing- based HIV Risk Reduction (MI-HIV n=175) which, in addition to what is received in the HIV-Ed group, also includes an evidence-based brief intervention for high-risk women focused on an individualized plan for enhancing motivation to reduce risk behaviors and to use health and behavioral health services in the community. Specific aims include: (1) to compare the effectiveness of an evidence-based HIV risk reduction intervention (MI-HIV) to HIV Education (NIDA Standard) in reducing sex risk behaviors, injection practices, and drug use among a culturally unique sample of disadvantaged, drug-using rural women at high-risk for HIV and HCV; and (2) to examine MI-HIV Intervention engagement as a predictor of community health and behavioral health service utilization (including drug treatment and mental health) at follow-up among disadvantaged, drug- using rural women at high risk for HIV and HCV. This project is innovative because it 1) targets a high-risk and understudied group of women, 2) uses brief intervention to not only reduce risk behavior but also to enhance motivation for using community health and behavioral health resources, and 3) utilizes a real-world setting to identify high-risk women drug users. The long-term goal of this study is to increase access to health and behavioral health services in order to improve the quality of health of high-risk rural women. The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high risk for HIV and HCV. This project has potential to make a significant contribution to science by providing knowledge about the health, risk behaviors, and service utilization of a vulnerable and understudied group of women during a time of emerging and significant public health risk in a rural Appalachian setting. Successful completion of the aims of this project will advance the delivery of a low-cost, potentially high impact intervention with implications for a number of other real world settings (such as criminal justice venues) where other disadvantaged high-risk drug users can be identified and targeted for intervention.",Brief intervention for drug-using rural women at high-risk for HIV/HCV,9089979,R01DA033866,"['drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Educational aspects ', ' Education ', ' Goals ', ' Health ', ' Health Resources ', ' Health Services ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Injections ', ' Injection of therapeutic agent ', ' Interview ', ' Kentucky ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Motivation ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Pre-Post Tests ', ' Public Health ', ' Random Selection ', ' Random Allocation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Science ', ' Testing ', ' Time ', ' Walkers ', ' Woman ', ' Criminal Justice ', ' Healthcare ', ' health care ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' base ', ' rural area ', ' improved ', ' Area ', ' Rural ', ' drug use ', ' Drug usage ', ' women at high risk ', ' High Risk Woman ', ' Female Groups ', "" Women's Group "", ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Educational Intervention ', ' Staging ', ' Drug user ', ' Opiates ', ' Knowledge ', ' Pattern ', ' Country ', ' Services ', ' treatment planning ', ' Participant ', ' high risk behavior ', ' motivational interview ', ' motivational enhancement therapy ', ' outreach ', ' Reporting ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' AIDS/HIV problem ', ' HIV risk ', ' brief treatment ', ' brief therapy ', ' brief intervention ', ' Sampling ', ' behavioral health ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' Risk Reduction ', ' disparity in health ', ' health disparity ', ' Address ', ' Jail ', ' Consent ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Community Health ', ' comparison group ', ' sexual risk behavior ', ' sex risk ', ' cost ', ' designing ', ' design ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' Evidence based intervention ', ' compare effectiveness ', ' service utilization ', ' high risk ', ' evidence base ', ' prescription opiate ', ' screening ', ' injection drug use ', ' HIV/HCV ', ' HIV/Hepatitis C ', ' health service use ', ' health service utilization ', ' Appalachia ', ' Appalachian Region ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Community Services ', ' Counseling ', ' Disadvantaged ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,R01,2016,514704,0.12069110669681299
"Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African Americans The Center for Translational and Prevention Science (CTAPS) was funded in 2009 to inform the development of prevention programs for rural African American youth through investigations of gene-environment (G-E) interplay on drug use and HIV-related behavior. The proposed continuation augments CTAPS' scientific agenda to better address racial disparities in drug use and HIV-related behavior that affect rural African Americans. Emerging research suggests that exposure to chronic stress affects the functioning of inflammatory, neuroendocrine, and neurocognitive systems beginning in childhood and adolescence. The negative consequences of chronic stress affect health-related behaviors and forecast chronic diseases of aging. Emerging evidence suggests that these processes also may affect youth and young adults' development of drug misuse and HIV related behavior. The Center will sponsor a new generation of research on (a) the neuroendocrine, inflammatory, and neurocognitive pathways through which exposure to stress among rural African American youth and young adults creates vulnerabilities to drug use and HIV-related behavior, (b), the malleable risk and protective processes that affect underlying vulnerability mechanisms , and (c) the translation of findings into new and refined preventive interventions for youth in general and rural African American youth in particular. The CTAPS will pursue these scientific goals via providing infrastructure for three support cores (Inflammation/Neuroendocrine, Neurocognitive, Biostatistics) that will enrich data from data from Core projects and pilot projects and a Pilot Core. CTAPS will facilitate communication among Center-affiliated investigators, support core directors, and core project PIs; oversee administration of Center-wide budgets and operations; provide infrastructure and administrative support for three support cores and a Pilot Core. CTAPS will spur progress via a transdisciplinary work group system designed to facilitate transdisciplinary collaboration and to organize the allocation of Center resources and disseminate research findings to multiple stakeholders including researchers, policy makers, educational organizations, and the public. The proposed Center is designed to investigate how chronic stress that rural African American's experience in childhood and adolescence affects drug misuse and HIV-related behavior in young adulthood. The Center's work will contribute to the development of prevention programs that target vulnerabilities to drug use and HIV related behavior that may be developing ""under the skin"" in phsyiolobical and neurological systems.",Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African Americans,9100702,P30DA027827,"['Biometry ', ' designing ', ' work group ', ' developmental ', ' pathway ', ' Infrastructure ', ' adult youth ', ' young adulthood ', ' drug use ', ' Preventative intervention ', ' Prevention intervention ', ' preventional intervention strategy ', ' Prevention ', ' transdisciplinary collaboration ', ' Funding ', ' System ', ' experience ', ' Neurocognitive ', ' young adult ', ' Rural ', ' Policy Maker ', ' interdisciplinary collaboration ', ' Drug usage ', ' Investigation ', ' pilot study ', ' Neurologic ', ' Prevention program ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Exposure to ', ' Acquired Immunodeficiency Syndrome Virus ', ' HTLV-III ', ' Human Immunodeficiency Viruses ', ' Human T-Cell Leukemia Virus Type III ', ' Inflammatory ', ' Childhood ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Lymphotropic Virus Type III ', ' LAV-HTLV-III ', ' Youth 10-21 ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' Skin ', ' black American ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' Neuroendocrine ', ' Neuroendocrine System ', ' Neurological ', ' Researchers ', ' Research Resources ', ' pediatric ', ' Investigators ', ' Preventive Intervention ', ' Data ', ' Process ', ' Development ', ' Research Infrastructure ', ' 12-20 years old ', ' adolescence (12-20) ', ' teenage ', ' Pathway interactions ', ' design ', ' working group ', ' drug use vulnerability ', ' operation ', ' Address ', ' racial disparity ', ' Chronic stress ', ' drug misuse ', ' Biometrics ', ' Biostatistics ', ' Chronic Illness ', ' chronic disorder ', ' HIV ', ' Inflammation ', ' vulnerability to drug use ', ' Science ', ' disparities in race ', ' race disparity ', ' Research ', ' malleable risk ', ' Research Personnel ', ' Resources ', ' Aging ', ' Behavior ', ' Communication ', ' Adolescence ', ' Generations ', ' Pilot Projects ', ' Affect ', ' African American ', ' Health ', ' Goals ', ' Work ', ' Translations ', ' Environment ', ' Youth ', ' Chronic Disease ', ' Genes ', ' Neurosecretory Systems ', ' Budgets ', ' Stress ', ' ']",NIDA,UNIVERSITY OF GEORGIA,P30,2016,868355,0.11723799670551475
"Epidemiology, Prevention and Treatment of HCV in Young Adult Persons who Inject Drugs in non-urban New Mexico     DESCRIPTION (provided by applicant): The hepatitis C virus (HCV) epidemic in the U.S. is concentrated in people who inject drugs (PWID). Increasing reports of HCV including outbreaks of HCV in young adult PWID in non-urban locales have prompted concerns about an expanding epidemic. Several investigations suggest that that these spikes in HCV infection are linked to sharp increases in prescription opiate use that has been trending in the U.S, and which have resulted in young adults transitioning from prescription opiates to injection use, particularly heroin. Young adult PWID in non-urban areas may be at increased risk of infection, from the combination of high viral infectivity and high prevalence of HCV in injecting groups, together with a lack of knowledge regarding infection routes and effective prevention. New Mexico is one of the states leading recorded increases in HCV in young adults, ranking 2nd in the CDC's Emerging Infections Program (EIP), Hepatitis Surveillance Demonstration Sites project, in 2011 for the number and rate of HCV cases reported. Heroin, prescription opioids, and other drugs are also accounting for this state having one of the highest overdose rates in the country. Between October 2013 and March 2014, the New Mexico Department of Health recorded 211 cases of HCV among young adults in a pilot surveillance study, demonstrating the gravity of the problem. To address the need for prevention, care and treatment services against HCV in this population, we propose epidemiological and service uptake research in two regions of New Mexico where young adult PWID have been impacted by drug use and HCV. We will initiate a prospective cohort study of young adult non-urban PWID who will be recruited and followed in two health regions of New Mexico (the South West and North East) to: (1) gather epidemiologic data on risk behaviors, drug use patterns, injection networks, prevention needs, and health service utilization; (2) to refer young adult PWID to HCV care services, as well as other prevention and treatment opportunities including harm reduction and drug treatment, and assess rates of successful linkage, including the  cascade of care; (3) to examine factors that may contribute to non-treatment, poor adherence, and failure to achieve SVR among young adult PWID with chronic HCV infection; and (4) assess reinfection events among young adult PWID who are treated for HCV and achieve SVR. Our proposal, which we refer to in this application as New Mexico H-TIPS, will also include testing and referrals for HIV and HBV co-infections as well. A collaborative group of public health and clinical specialists linked with a strong prevention and clinical service infrastructure in New Mexico will ensure successful implementation of this research. Results from this proposed research will impact a diverse young population disproportionately at risk for HCV and reduce health disparities in a region highly impacted by drug use and HCV. PUBLIC HEALTH RELEVANCE: This proposed three-year research plan seeks to assess the epidemiology of HCV infection in young adult people who inject drugs (PWID) in non-urban areas of New Mexico. The proposed New Mexico H-TIPS project will study factors that will inform effective and integrated care and prevention models for this high-risk population. We have significant expertise in working with the target population, including recruitment and retention and in identifying HCV infection, which together with a unique infrastructure for preventive and clinical services in New Mexico, including HCV and drug treatment make this proposal highly likely to succeed. This research will contribute significantly to further knowledge of  combination  HCV prevention, and how to impact population prevalence and incidence of HCV in New Mexico and elsewhere.","Epidemiology, Prevention and Treatment of HCV in Young Adult Persons who Inject Drugs in non-urban New Mexico",9102801,U18PS004568,[''],NCHHSTP,UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,U18,2016,299996,0.0839915446261307
"Health disparity in pharmacogenomics: African American SNPs and drug metabolism DESCRIPTION (provided by applicant): As pharmacogenomics moves from bench-top to bed-side, African Americans have been left out of the advances personalized medicine holds. To date, African Americans have been largely absent from the numerous pharmacogenetic studies that identify predictive single nucleotide polymorphisms (SNPs) that are being used clinically to improve care. As we move toward more comprehensive bioinformatics and high- throughput methods of evaluating the genome for functionally relevant SNPs that affect drug phenotypes, we are also producing a growing health disparity in the translation of these findings into the clinic for African Americans. Current genomic methods are trying to reach beyond genome-wide association in hopes of finding biological plausibility to genetic findings. This search has led to the use of expression quantitative trait loci (eQTLs) as a tool in pharmacogenetic association studies. SNPs labeled as eQTLs have intrinsic biological plausibility since they are significantly associated with changes in gene expression. However, no liver eQTL studies have been conducted in African Americans. By using liver-specific eQTLs, we will discover SNPs that affect drug metabolizing enzymes (DMEs), which will have wide-spread scientific and clinical impact; given that most drugs currently prescribed undergo some form of hepatic metabolism. Because of the increase genetic diversity found in African Americans, they may carry population specific SNPs can never be found by pharmacogenomics studies in populations of European-descent alone. Without African American focused pharmacogenomics studies we risk excluding African Americans from personalized medicine. We plan to use primary hepatocytes to conduct gene expression studies both before and after drug enzyme induction to identify genes that are differentially expressed. Drug enzyme induction is driven by increased gene transcription; therefore, by focusing on the genes that are differentially expressed after induction we can pin-point the drivers (i.e. genes) that regulate drug metabolizing enzymes. We will then look at SNPs within and in close proximity to these genes to determine if any are associated with differences in gene expression (dubbed DI-eQTLs). We will then look to see if these DI-eQTLs are associated with pharmacokinetic measures in the same set of cell cultures, affectedly preforming a pharmacokinetic and a pharmacogenetic study in the same individual. We hypothesize that drug enzyme induction will provide us with DI-eQTLs that are strongly associated to drug pharmacokinetics, a clinically relevant phenotype. To validate these findings we will query publically available data to look for an enrichment of our DI-eQTLs within the most strongly associated SNPs in pharmacogenomic GWAS data. The association between genotype, gene expression and drug pharmacokinetics in African Americans has never been conducted before and will provide an invaluable resource for pharmacogenomics and clinical pharmacology, as well as clinical translation in this understudied population. PUBLIC HEALTH RELEVANCE: The proposed studies will help identify genetic mutations that affect drug metabolism in African Americans, an under-studied population in pharmacogenomics. The discovery of these novel mutations will lead to better dosing of drugs that require the liver for metabolism and potentially less side-effects from these medications. By studying the genetic mutations that affect drug metabolism in African Americans we can more fully incorporate this population into personalized medicine.",Health disparity in pharmacogenomics: African American SNPs and drug metabolism,9046395,R01MD009217,"['Accounting ', ' Affect ', ' Africa ', ' Age ', ' Engineering / Architecture ', ' Architecture ', ' Beds ', ' Biology ', ' cell culture ', ' Cell Culture Techniques ', ' Cell Body ', ' Cells ', ' Disorder ', ' Disease ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' Enzyme Induction ', ' Enzyme Gene ', ' Enzymes ', ' Gene Expression ', ' Genes ', ' Genome ', ' Genotype ', ' Health ', ' In Vitro ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Linkage Disequilibrium ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' Medicine ', ' Methods ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Pharmacogenetics ', ' Pharmacokinetics ', ' Drug Kinetics ', ' Pharmacology ', ' Clinical Pharmacology ', ' Phenotype ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Translations ', ' Adverse drug effect ', ' Drug Side Effects ', ' Variation (Genetics) ', ' Genetic Variation ', ' Genetic Diversity ', ' Caucasians ', ' white race ', ' Occidental ', ' Caucasoid Race ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Measures ', ' Treatment outcome ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Caring ', ' DNA Sequence ', ' Label ', ' improved ', ' Left ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Ensure ', ' Liver Cells ', ' Hepatic Parenchymal Cell ', ' Hepatic Cells ', ' Hepatocyte ', ' Individual ', ' African ', ' European ', ' drug use ', ' Drug usage ', ' Genetic ', ' tool ', ' Complex ', ' Side ', ' Clinic ', ' System ', ' American ', ' QTL ', ' Quantitative Trait Loci ', ' trait ', ' Structure ', ' novel ', ' drug metabolism ', ' drug clearance ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Coding System ', ' Code ', ' Regulation ', ' Sampling ', ' response ', ' Adverse Experience ', ' Adverse event ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Adverse effects ', ' Genomics ', ' Pharmacogenomics ', ' Bio-Informatics ', ' Bioinformatics ', ' disparity in health ', ' health disparity ', ' preventing ', ' prevent ', ' hepatic metabolism ', ' liver metabolism ', ' Dose ', ' genomic alteration ', ' Sequence Alteration ', ' Genetic mutation ', ' DNA mutation ', ' DNA Alteration ', ' DNA Sequence Alteration ', ' Data ', ' predictive of drug response ', ' prediction of response ', ' Prediction of Response to Therapy ', ' Regulatory Pathway ', ' Resolution ', ' in vivo ', ' Process ', ' protein function ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' Minority ', ' cost effective ', ' cost-effective ', ' Population ', ' clinically relevant ', ' clinical relevance ', ' clinical care ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' predicting response ', ' response prediction ', ' predictor of response ', ' predictive response ', ' study population ', ' ']",NIMHD,UNIVERSITY OF CHICAGO,R01,2016,65173,0.07890808701269215
"Family impact on drug use and HIV risk behavior in Hispanic sexual minority youth     DESCRIPTION (provided by applicant): Adolescence is a period in which many risk behaviors tend to peak leading to adverse health outcomes, such as HIV infection. Hispanic adolescents have been shown to be at particularly high risk. Hispanic HIV incidence rates in 2010 were three times higher than non-Hispanic rates with 79% of male cases attributed to same-sex sexual contact. From 2007 to 2010, the greatest increase in Hispanic HIV rates was seen among those aged 13-24. Furthermore, drug use and unprotected sex are disproportionately high in Hispanic sexual minority youth (HSMY) (e.g., men who have sex with men, lesbian, bisexual) compared to white heterosexual youths. Limited understanding of the mechanisms driving these disparities has resulted in a lack of evidence-based interventions targeting these risk behaviors in HSMY. Family relationships have consistently shown to significantly impact these behaviors in both sexual minorities and Hispanic adolescents alike. [For example, parental awareness and support of youth's sexual identity is associated with drug use and unprotected sex.] Accordingly, the Institute of Medicine has recommended further research examine the role of family life in HSMY risk behaviors. This [mixed methods] study will use participants of [6] randomized control trials examining the relative efficacy of the Familias Unidas family-based intervention. By improving family functioning processes such as parent-child communication and parental involvement, the intervention has been efficacious in preventing and reducing drug use and unprotected sex in Hispanic adolescents. Participants reporting any sexual contact with a person of the same sex (i.e., HSMY) will be examined. [Quantitative data from five studies will be combined and analyzed using integrative data analysis (IDA) methods to account] for cohort and study-level differences across trials to minimize bias. [Participants for the qualitative study will be recruited from a currently ongoing trial.] Using past 90-day illicit drug use and past 90- day unprotected sex as primary outcomes, [quantitative analyses] will: a) test the simultaneous effects of complex social, family and individual-level factors on the primary outcomes among HSMY participants; b) assess intervention efficacy by comparing the change in primary outcomes among intervention and control groups. The qualitative study will explore HSMY experiences regarding disclosure of their sexual identities and] experiences in the intervention. [Using a mixed methods study design, results from quantitative and qualitative data will produce meta-inferences that will shed light on the role of family in HSMY sexual and drug risk behaviors to guide] the future development or adaption of preventive interventions for HSMY. The applicant will be guided by an experienced sponsorship team and engage in meaningful training activities to: increase content area HSMY health knowledge; expand skills (IDA, qualitative methods, intervention development); and promote professional growth through conference presentations and collaborative projects. The [combined research and training will ensure] the applicant a successful future as an independent researcher.         PUBLIC HEALTH RELEVANCE: Hispanic and sexual minority (e.g., gay, MSM, bisexual) adolescents are each recognized high-risk population subgroups, disproportionately engaging in HIV risk behaviors and drug use; however, minimal research has examined these behaviors among adolescents with both minority identities. Identifying modifiable risk and protective factors that impact these behaviors is a necessary first step to developing evidence-based preventive interventions tailored to this vulnerable population. This [mixed methods] study will sample [Hispanic sexual minority youth] (HSMY) participants from [multiple] intervention trials assessing the efficacy of Familias Unidas (a Hispanic-specific, family-centered intervention designed to reduce HIV risk behaviors and drug use among Hispanic adolescents) to: a) evaluate the impact of various aspects of a youth's social environment, focusing on the role of family on unprotected sex and drug use in HSMY; b) determine if the Familias Unidas intervention was more efficacious than control conditions in reducing unprotected sex and drug use for HSMY participants; and c) describe the unique experiences of HSMY who participated in the Familias Unidas intervention [and their experiences disclosing their sexual identity] through qualitative interviews.        ",Family impact on drug use and HIV risk behavior in Hispanic sexual minority youth,9065071,F31DA040562,"['Accounting ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' driving ', ' Automobile Driving ', ' Awareness ', ' Behavior ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' childrearing ', ' Parenting behavior ', ' Parenting ', ' Child Rearing ', ' Concurrent Studies ', ' Cohort Studies ', ' Control Groups ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Information Disclosure ', ' Disclosure ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Family ', ' Family Relations ', ' Family Relationship ', ' Future ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incidence ', ' NAS/IOM ', ' Institute of Medicine ', ' Institute of Medicine (U.S.) ', ' Interview ', ' Photoradiation ', ' Light ', ' male ', ' Methods ', ' Persons ', ' parent offspring interaction ', ' parent child interaction ', ' Parent-Child Relationship ', ' Parent-Child Relations ', ' Parents ', ' Public Health ', ' recruit ', ' active recruitment ', ' Recruitment Activity ', ' Registries ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Target Populations ', ' Testing ', ' Time ', ' training module ', ' Training Activity ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' symposium ', ' symposia ', ' summit ', ' convention ', ' conference ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Youth ', ' Youth 10-21 ', ' Caring ', ' base ', ' Bi-sexual ', ' Bisexual ', ' improved ', ' Area ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Sexual Orientation ', ' Sex Orientation ', ' Randomized Clinical Trials ', ' Ensure ', ' Individual ', ' drug use ', ' Drug usage ', ' Gays ', ' Lesbian ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Life ', ' Complex ', ' health knowledge ', ' Application Context ', ' contextual factors ', ' Equation ', ' Unprotected Sex ', ' High-Risk Sex ', ' Unsafe Sex ', ' experience ', ' cohesion ', ' cohort ', ' skills ', ' Participant ', ' Reporting ', ' social ', ' HIV risk ', ' parent monitoring ', ' parental monitoring ', ' parent-child communication ', ' Interventional trial ', ' Intervention Trial ', ' Emotional ', ' Modeling ', ' Sampling ', ' parent influence ', ' parental influence ', ' response ', ' theories ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' preventing ', ' prevent ', ' qualitative reasoning ', ' Qualitative Methods ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' Research Training ', ' Subgroup ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Process ', ' sex ', ' developmental ', ' Development ', ' Heterosexuals ', ' systematic review ', ' youth drug use ', ' adolescent drug use ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' designing ', ' design ', ' Minority ', ' Treatment Efficacy ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Outcome ', ' Adolescent Risk Behavior ', ' risk behavior in youth ', ' adolescent risk taking ', ' Youth Risk Behavior ', ' Population ', ' aged ', ' innovation ', ' innovative ', ' innovate ', ' modifiable risk ', ' parental involvement ', ' Evidence based intervention ', ' Evidence based program ', ' therapy design ', ' treatment design ', ' intervention design ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' high risk ', ' public health relevance ', ' evidence base ', ' primary outcome ', ' HIV/STD ', ' STI/HIV ', ' STD/HIV ', ' HIV/STI ', ' sexual minority ', ' Same-sex ', ' family support ', ' parent-adolescent communication ', ' adolescent health ', ' illicit drug use ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,F31,2016,37176,0.06118889661118566
"The Development and Evaluation of the Ho'ouna Pono Drug Prevention Curriculum     DESCRIPTION (provided by applicant): Research has indicated that Native Hawaiian youth have significantly higher rates of drug use than their non-Hawaiian counterparts (e.g., Wong, Klingle, & Price, 2004; Mayeda, Hishinuma, Nishimura, Garcia- Santiago, & Mark, 2006; Nishimura, Hishinuma, & Goebert, 2013), and that these differences are particularly pronounced in rural settings (Lai & Saka, 2005). Despite these findings, there have been very few drug prevention programs developed and evaluated specifically for these youth (Edwards, Giroux, & Okamoto, 2010; Rehuher, Hiramatsu, & Helm, 2008). Therefore, the purpose of this research proposal is to complete the development of a video-enhanced, culturally grounded, school-based drug prevention curriculum for rural Native Hawaiian youth (Ho'ouna Pono), and to evaluate the curriculum across all public middle/intermediate schools on Hawai'i Island. This will be accomplished through three specific aims. AIM 1 (Year 1) is to complete the Ho'ouna Pono drug prevention curriculum initially developed and validated in a NIDA-funded translational pilot/feasibility study (R34 DA031306). To date, five professionally filmed video vignettes depicting drug-related problem situations specific to rural Hawaiian youth and seven interactive classroom lessons have been created, implemented in randomly selected intervention schools, and preliminarily evaluated using a pre-test, post-test control group design. Aim 1 enhances and builds upon this work by producing two new video vignettes, re-editing a ""Behind the Scenes"" video, developing new classroom curricular components, and synthesizing the new content with the existing curriculum. AIM 2 (Years 2-3) is to evaluate the fully conceived curriculum across all middle/intermediate schools on Hawai'i Island (N = 15) using a dynamic wait- listed control group design (Brown, Wyman, Guo, & Pea, 2006). AIM 3 (Year 4) is to assess community, systemic, and curricular factors related to the implementation, adoption, and sustainability of the curriculum within public middle/intermediate schools on Hawaii Island. PUBLIC HEALTH RELEVANCE: Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have recently been shown to have significantly higher rates of drug use compared with other ethnic groups (Wu et al., 2013), research focused on drug prevention of these individuals is important to improve public health both in Hawai'i and on the Mainland U.S. This study actively engages rural communities in the full-scale development and evaluation of the Ho'ouna Pono drug prevention curriculum for Hawaiian youth, promoting the overall utility and effectiveness of the intervention. Further, the findings from this study will point to the core content of prevention interventions for Hawaiian youth in rural communities, which should be applicable to other ethnic youth populations in Hawaii and the Pacific Rim, as well as Native youth populations on the Mainland U.S.",The Development and Evaluation of the Ho'ouna Pono Drug Prevention Curriculum,9089963,R01DA037836,"['Adoption ', ' Communities ', ' Control Groups ', ' lesson plans ', ' Curriculum ', ' Educational Curriculum ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' ethnicity group ', ' Ethnic group ', ' Feasibility Studies ', ' Hawaii ', ' Health ', ' Island ', ' Pre-Post Tests ', ' Public Health ', ' Research ', ' Research Proposals ', ' Rural Health ', ' Schools ', ' Science ', ' Testing ', ' Time ', ' Waiting Lists ', ' Work ', ' Measures ', ' Price ', ' pricing ', ' Film ', ' Rural Community ', ' Youth ', ' Youth 10-21 ', ' base ', ' improved ', ' Evaluation ', ' Individual ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' drug use ', ' Drug usage ', ' Funding ', ' Hawaiian ', ' Hawaiian population ', ' Outcome Study ', ' cohort ', ' Prevention Research ', ' Prevention ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' disparity in health ', ' health disparity ', ' Address ', ' Effectiveness of Interventions ', ' Indigenous ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' designing ', ' design ', ' Population ', ' Drug Prevention Program ', ' native youth ', ' community based participatory research ', ' participatory action research ', ' community based research ', ' community based design ', ' intervention effect ', ' efficacy testing ', ' health equity ', ' ']",NIDA,HAWAII PACIFIC UNIVERSITY,R01,2016,401299,0.11304276041447972
"Prescription drug monitoring programs and opioid-related harm     DESCRIPTION (provided by applicant):  Fatal overdoses related to drug use have increased nearly 600% in the past three decades, and are now the country's leading cause of injury death. This rise has been largely driven by prescription opioid (PO) overdoses, which account for more deaths than heroin, cocaine and stimulants combined. Prescription drug monitoring programs (PDMPs), state-level databases to which pharmacy dispensers must report prescription information when certain medications are dispensed, have been advanced as tools to reduce PO-related harm. Four critical questions must be answered to determine whether PDMPs reduce PO-related harm: (1) What is the impact of PDMPs on health outcomes? While some studies suggest that PDMPs using best practices are effective in reducing ""doctor shopping"", most existing research has not examined the role of PDMPs in reducing PO-related harm, and the few that have, present inconsistent findings. (2) Do variations in PDMP characteristics affect outcomes? Existing research largely treats presence of a PDMP as a binary variable, without considering state variation in PDMP operational characteristics that have been recommended by experts as ""best practices"". (3) Who benefits the most from PDMPs? The benefit of PDMPs is likely concentrated among groups with a medical need for POs, and residents of more affluent areas. Both of these groups are more likely to access POs through their medical providers, and to receive referrals to evidence- based treatment in the case of PO-related harm. (4) Can PDMPs have unintended negative outcomes? If not implemented as part of an integrated strategy to reduce opioid-related harm, the reduction in prescriptions associated with PDMPs could potentially lead to transition to heroin use among those who abuse POs. Transitions to heroin use may be a particular concern in less affluent areas, where rates of PO-related harm are higher, and access to evidence-based treatment for PO dependence is lower. This study has two aims: (1) to test the relation between implementation of""best practice"" PDMP features and change in the rate of hospitalizations due to PO overdose (POD) and heroin overdose (HOD); and (2) to test whether the relationship between implementation of PDMP ""best practice"" characteristics and POD and HOD differed by medical need and socioeconomic characteristics of population groups. To address these aims, a typology of PDMP characteristics will be developed, including number of drug schedules reported, frequency of data reporting, proactive provision of data to authorized users, requirements for user training, registration, and data accessing, and interstate data sharing. Hospital inpatient overdose data geocoded to the zip code level will be obtained from the Healthcare Cost and Utilization Project. We will test the impact of variations in PDMP characteristics on rates of hospitalizations due to POD and HOD across 18 U.S. states with available pre- and post-PDMP hospitalization data and heterogeneity in the year of PDMP operation, and among persons living in 13,512 zip code areas within those states across 1993-2014. PUBLIC HEALTH RELEVANCE:  The findings from this study will inform researchers and policymakers about the types of prescription drug monitoring program (PDMP) characteristics that would lead to the greatest reduction in prescription opioid (PO)-related harm, and identify potential unintended consequences of PDMP characteristics in terms of heroin- related harm and socioeconomic disparities in PO and heroin-related problems. This type of research can help policymakers decide how to better deploy scarce overdose-prevention resources: (1) invest funds in PDMP practices that produce the greatest reductions in PO-related harm; (2) modify PDMP features to decrease socioeconomic disparities in PO overdose and reduce rates of heroin-related overdose.",Prescription drug monitoring programs and opioid-related harm,9251805,R01DA039962,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' joint inflammation ', ' arthritic ', ' Arthritis ', ' Cocaine ', ' data representation ', ' Data Reporting ', ' Death ', ' Cessation of life ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Health ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Heterogeneity ', ' Hospitalization ', ' Hospitals ', ' Incidence ', ' Industry ', ' Inpatients ', ' Laws ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Manuals ', ' Persons ', ' Overdose ', ' Patients ', ' Pharmacy facility ', ' Pharmacies ', ' Population Characteristics ', ' Drug Prescriptions ', ' Drug Prescribing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Testing ', ' Time ', ' Typology ', ' Work ', ' Drug Monitoring ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' Schedule ', ' Caring ', ' Law Enforcement ', ' Injury ', ' improved ', ' Area ', ' Variation ', ' Variant ', ' Medical ', ' Training ', ' healthcare utilization ', ' healthcare service utilization ', ' healthcare service use ', ' health care service use ', ' Health Care Utilization ', ' health care service utilization ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Opioid ', ' drug use ', ' Drug usage ', ' Funding ', ' tool ', ' programs ', ' Investigation ', ' Frequencies ', ' Country ', ' Opiate Addiction ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' heroin overdose ', ' diamorphine overdose ', ' cancer pain ', ' experience ', ' Harm Reduction ', ' Harm Minimization ', ' Reporting ', ' Code ', ' Coding System ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Provider ', ' Population Group ', ' Address ', ' Data ', ' Cancer Patient ', ' Characteristics ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' socioeconomics ', ' Evidence based treatment ', ' care systems ', ' designing ', ' design ', ' Outcome ', ' Population ', ' public health relevance ', ' overdose prevention ', ' longitudinal database ', ' sharing data ', ' clinical decision-making ', ' prescription opioid abuse ', ' prescription opioid ', ' operation ', ' arthritic pain ', ' arthritis pain ', ' socioeconomic disparity ', ' opioid use ', ' data access ', ' health care availability ', ' healthcare service access ', ' healthcare access ', ' health care service availability ', ' health care service access ', ' accessibility to healthcare ', ' accessibility to health care ', ' accessibility of health care ', ' access to healthcare ', ' access to health care ', ' ']",NIDA,UNIVERSITY OF CALIFORNIA AT DAVIS,R01,2017,388811,0.08973357917820578
"Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM) PROJECT SUMMARY/ABSTRACT  This application is for a competing renewal of the Center for Prevention Implementation Methodology for HIV and Drug Abuse, a NIDA P30 Center of Excellence. The number of new HIV cases in the US remains stable at 56,000 per year and continues to disproportionately affect some groups, including young men who have sex with men (YMSM), especially from racial/ethnic minorities. The purpose of this methodology center is to develop new methodologies that can be used by federal and local agencies and communities to reduce HIV incidence. Biomedical interventions and strategies, including pre-exposure prophylaxis (PrEP), rapid testing for HIV and early and consistent treatment for persons who are HIV positive (Treatment as Prevention, TasP) have been shown to have high efficacy and effectiveness in reducing HIV transmission, but there remains a giant gap between what research knows and what services needed to reduce population level incidence of HIV. The major premise of this application is that the effective biomedical to reduce HIV incidence and disparities are in hand, but success will only be achieved when they are implemented in ways that meet individual, community, and health care delivery system needs. This methods proposal addresses this major gap between research and practice through implementation science and methodology, focusing on innovative ways to address the complex, mulitilevel interactions needed to implement HIV prevention programs effectively. Two Cores, an Administrative Core and an Innovative Implementation Methods Core for HIV and Drug Abuse will carry out this work.  Aim 1 is to develop innovative methods to maximize the impact of implementation research in HIV prevention. We do this through an extended set of systems science and engineering methods that focus on improving the measurement of implementation, the modeling of implementation strategies, and the testing of implementation strategies through rigorous trials. Five qualifying grants support this work.  Aim 2 is to apply these innovative methods to close the gap between existing research, policy, and practice for HIV prevention. In addition to working closely with our five qualifying grants, we work locally with municipal Departments of Public Health and the federal Substance Abuse and Mental Health Services Administration (SAMHSA) HIV programs to identify and prioritize gaps in knowledge, find optimal implementation strategies for reduction of HIV transmission, and design the next large implementation trials.  Aim 3 is to disseminate methods and train/mentor leaders at the intersection of HIV prevention, implementation science, and drug abuse fields to improve implementation of HIV prevention programs. This involves mentoring the early career researchers, publishing, and providing training to networks of HIV and drug abuse researchers. PROJECT NARRATIVE There are numerous rigorously evaluated prevention programs involving biomedical interventions for preventing HIV that have demonstrated impact in efficacy and effectiveness trials. Pre-exposure prophylaxis, HIV testing, and early and consistent antiretroviral treatment have high potential for preventing HIV infections, but these are yet to be implemented sufficiently in racial/ethnic minority communities. This Ce-PIM addresses the critical methods gaps that are holding back the movement of these programs from research to practice.",Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM),9335329,P30DA027828,"['Affect ', ' ages ', ' Age ', ' Dorsum ', ' Back ', ' Behavior ', ' Biomedical Research ', ' Communities ', ' Decision Making ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Cognitive Discrimination ', ' Discrimination ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Engineering ', ' ethnicity group ', ' Ethnic group ', ' Feedback ', ' Gender Identity ', ' Goals ', ' Grant ', ' Hand ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' Incidence ', ' Long-Term Care ', ' extended care ', ' Mentors ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Methods ', ' Methodology ', ' Biological Models ', ' Model System ', ' Biologic Models ', ' Movement ', ' body movement ', ' Persons ', ' Play ', ' Public Health ', ' Publishing ', ' Quality of life ', ' QOL ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Science ', ' Seeds ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Technology ', ' Testing ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' United States Substance Abuse and Mental Health Services Administration ', ' General Viruses ', ' Virus ', ' visual function ', ' Sight ', ' Vision ', ' Work ', ' P30 Protein ', ' P30 ', ' P-30 Protein ', ' ranpirnase ', ' Gender ', ' Generations ', ' Community Health Care ', ' Community Healthcare ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' ecstasy ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' base ', ' career ', ' improved ', ' Sexual Orientation ', ' Sex Orientation ', ' Training ', ' Individual ', ' Policies ', ' Measurement ', ' drug use ', ' Drug usage ', ' Ethnicity ', ' Ethnic Origin ', ' tool ', ' Knowledge ', ' programs ', ' Viral Load result ', ' Viral Load ', ' Viral Burden ', ' Complex ', ' Pattern ', ' System ', ' Services ', ' success ', ' care delivery ', ' Anti-Retroviral Agents ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' Municipalities ', ' novel ', ' Prevention program ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Early identification ', ' Modeling ', ' social stigma ', ' stigma ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' scientific organization ', ' Effectiveness ', ' prevent ', ' preventing ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Address ', ' High Prevalence ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Qualifying ', ' Transmission ', ' transmission process ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' socioeconomics ', ' developmental ', ' Development ', ' effectiveness trial ', ' implementation trial ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' implementation research ', ' designing ', ' design ', ' next generation ', ' efficacy trial ', ' Outcome ', ' Prevention approach ', ' Approaches to prevention ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' ethnic minority population ', ' ethnic minority ', ' Early treatment ', ' early therapy ', ' racial and ethnic ', ' implementation science ', ' research to practice ', ' research into practice ', ' cocaine use ', ' young men who have sex with men ', ' young MSM ', ' YMSM ', ' black men who have sex with men ', ' black MSM ', ' BMSM ', ' African-American men who have sex with men ', ' African American MSM ', ' AAMSM ', ' support tools ', ' minority communities ', ' pre-exposure prophylaxis ', ' PrEP ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,P30,2017,1344003,0.08917754346937293
"Age-Varying Effects in the Epidemiology of Drug Abuse     DESCRIPTION (provided by applicant): To improve the efficiency and efficacy of drug abuse interventions, an understanding of the age-related changes in behavior prevalences, comorbidities, and health disparities, and the evolving role of various risk factors from adolescence through middle adulthood, is crucial. Today there is an unprecedented amount of existing high-quality data that have enormous potential to shed new light on these issues. Many of these data sets are nationally representative, drawn from populations that span a wide range of ages. New methods now exist to tap those data in order to address important, new scientific questions about drug use, abuse, and dependence (drug UAD) from a developmental perspective. To this end, we propose the innovative application of the time-varying effect model (TVEM) to data from two complementary national studies of health risk behaviors: The National Longitudinal Study of Adolescent Health (N=20,745) and the 2012 National Survey on Drug Use and Health (N=63,809). TVEM flexibly estimates behavior prevalences and associations among variables as continuous, flexible functions of age. Specifically, the specific aims for this projec are as follows. (1) To model flexible, age-varying trends in drug UAD from adolescence into middle adulthood. We will estimate rates of alcohol, tobacco, marijuana, and other drug use, abuse and dependence as a complex function of continuous age from ages 12 to 50. Trends will be estimated across sex and race/ethnicity to document age-varying health disparities. (2) To elucidate the age-varying role of mental health problems in the course of drug UAD from adolescence into middle adulthood. We will examine how depressive symptoms and suicidal ideation are differentially associated with drug UAD as a continuous, complex function from ages 12 to 50. (3) To estimate age-varying effects of early and concurrent risk factors on drug UAD from adolescence into middle adulthood. We will examine how and when specific risk and protective factors are associated with drug UAD from ages 12 to 50. We will consider early risk factors at the individual, parent, peer, school, and community levels, as well as concurrent factors such as marriage and parenthood. (4) To examine contributors to health disparities in drug use. To advance understanding of the developmental course of health disparities, we will examine sex and race/ethnicity as moderators of (a) age-varying comorbidities of drug UAD and mental health problems and (b) age-varying associations between risk factors and drug UAD. This project will provide knowledge about the developmental course of drug UAD and related health disparities, allowing prevention scientists and clinicians to design interventions that matc the most promising mechanisms of change to the most appropriate age period within population subgroups. To maximize the project's overall impact, we will actively disseminate this promising new analytic approach to drug abuse researchers. PUBLIC HEALTH RELEVANCE: Existing national data have been used extensively to advance understanding of drug use, abuse, and dependence; comorbidities with mental health problems; the role of early and concurrent risk factors; and health disparities. However, empirical studies and behavioral theory have been largely silent on how these issues evolve continuously across age. This project will apply a new data analytic approach to existing cross- sectional and panel data to gain new insight into nuanced, age-related changes from adolescence through mid-adulthood, shedding light on ways to tailor interventions to individuals to increase intervention efficiency and efficacy to reduce drug abuse and its related consequences.",Age-Varying Effects in the Epidemiology of Drug Abuse,9276648,R01DA039854,"['adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' ages ', ' Age ', ' Alcohol Chemical Class ', ' Alcohols ', ' Behavior ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' co-morbidity ', ' Comorbidity ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Employment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Grant ', ' Health ', ' Light ', ' Photoradiation ', ' Marijuana ', ' marihuana ', ' Marital Status ', ' Marriage ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' Paper ', ' Parents ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Schools ', ' Surveys ', ' Survey Instrument ', ' Time ', ' Tobacco ', ' United States ', ' Work ', ' Gender ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' depressive symptoms ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Dataset ', ' Data Set ', ' improved ', ' Distal ', ' pharmacoepidemiological ', ' pharmacoepidemiologic ', ' drug epidemiology ', ' Pharmaceutical Epidemiology ', ' Pharmacoepidemiology ', ' insight ', ' Individual ', ' Workshop ', ' Educational workshop ', ' Data Quality ', ' drug use ', ' Drug usage ', ' Ethnicity ', ' Ethnic Origin ', ' Knowledge ', ' Scientist ', ' Feeling suicidal ', ' thoughts about suicide ', ' suicide ideation ', ' suicidal thinking ', ' suicidal ideation ', ' Suicidal thoughts ', ' Complex ', ' Dependence ', ' college ', ' collegiate ', ' drug efficacy ', ' Intercept ', ' peer ', ' Prevention ', ' psychological distress ', ' Modeling ', ' response ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' health disparity ', ' disparity in health ', ' Address ', ' Data ', ' Subgroup ', ' enroll ', ' Enrollment ', ' trend ', ' teenage ', ' teen years ', ' Teen ', ' Teenagers ', ' Process ', ' sex ', ' developmental ', ' Development ', ' Behavioral ', ' age dependent ', ' age related ', ' attributable death ', ' attributable mortality ', ' cost ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Treatment Efficacy ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' therapy design ', ' treatment design ', ' intervention design ', ' public health relevance ', ' effective intervention ', ' flexibility ', ' flexible ', ' Data Analytics ', ' Developmental Course ', ' adolescent health ', ' National Longitudinal Survey of Adolescent to Adult Health ', ' National Longitudinal Study of Adolescent Health ', ' Add Health ', ' ']",NIDA,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2017,226050,0.21078522912097405
"Contextualizing & responding to HIV risk behaviors among Black drug offenders DESCRIPTION (provided by applicant): Formerly incarcerated Black drug offenders are at an elevated risk for HIV infection. Despite substantial research expressing the need for HIV prevention services for ex-offenders post-release, this population has limited access to quality programming and services related to HIV risk reduction. This K01 application seeks to inform and adapt an HIV risk reduction intervention to address the needs of formerly incarcerated Black drug offenders who are being released from prisons in the New York City metropolitan area. This application supports the Principal Investigator's interest in becoming an independent behavioral scientist specializing in HIV prevention intervention development and adaptation. The proposed mentorship and training program will focus on the following key areas: mixed methods research; adaptation science; and intervention implementation. The proposed study will occur in three phases implemented over the course of five years. The formative phase will consist of survey administration on HIV literacy, needs and barriers to practicing protective behaviors, and HIV testing from 120 recently released Black drug offenders. Also during this phase, in-depth interviews with a subsample of 24 participants (12 male and 12 female participants) will also be conducted to gather more comprehensive information exploring needs and barriers to practicing HIV protective behaviors. The intervention development and adaptation phase, will consist of analyzing data from the survey research and in-depth interviews to tailor it for use with recently released Black drug offenders. In phase 3, the feasibility and acceptability of the adapted intervention will be pilot tested using a randomized clinical trial with 64 participants who are randomized to the adapted intervention or an Enhanced Referral Intervention arm. Building on the Information-Motivation and Behavioral Skills Model, this study will address the following specific aims: 1) To examine individual-level, environmental and contextual factors that affect HIV risk-related behaviors (i.e. illicit drug use and risky sexual behavior) among formerly incarcerated Black male and female drug offenders; 2) To adapt Project START, an HIV risk reduction intervention for formerly incarcerated men, using data gathered from Aim 1, to increase access to HIV testing and address drivers of HIV vulnerability among recently released Black male and female drug offenders; and 3) To pilot test the feasibility and acceptability of the adapted Project START using a randomized clinical trial with 64 participants (32 men, 32 women). The proposed study will utilize a mixed-methods approach to investigate drivers of HIV risk among recently released Black drug offenders. By providing more contextual information on risk behaviors, future evidence-based approaches can be developed and rapidly deployed, advancing HIV prevention science, and providing essential support for a vulnerable population that consistently experiences barriers in accessing HIV prevention services. PUBLIC HEALTH RELEVANCE: This K01 application seeks to inform and adapt an HIV risk reduction intervention to address the needs of formerly incarcerated Black drug offenders who are being released from prisons in the New York City metropolitan area. The proposed mentorship and training program will focus on the following key areas: mixed methods research; adaptation science; and intervention implementation. A mixed methods approach will be used to conceptualize HIV risk related behaviors among this population, resulting in the development of a novel approach to better understanding and ultimately addressing racial disparities in HIV prevalence.",Contextualizing & responding to HIV risk behaviors among Black drug offenders,9277232,K01DA036411,"['Affect ', ' Behavior ', ' Behavioral Research ', ' Communities ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Diagnosis ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Eyeball ', ' Eye ', ' Female ', ' Future ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Housing ', ' Interview ', ' literacy ', ' male ', ' men ', "" men's "", ' Mentors ', ' Mentorship ', ' Methods ', ' Motivation ', ' New York City ', ' Prisoner ', ' jail inmate ', ' correctional institution resident ', ' Prison Inmates ', ' Prisons ', ' Public Health ', ' Research ', ' Risk ', ' Science ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Supervision ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Training Programs ', ' United States ', ' Woman ', ' Gender ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' Research Methods ', ' Research Methodology ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' improved ', ' Area ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' Randomized Clinical Trials ', ' Training ', ' Individual ', ' Drug user ', ' Knowledge ', ' Scientist ', ' Home environment ', ' Home ', ' behavior change ', ' contextual factors ', ' Application Context ', ' interest ', ' Services ', ' experience ', ' metropolitan ', ' skills ', ' Participant ', ' prevention service ', ' research study ', ' behavior test ', ' behavioral test ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' offender ', ' criminal offender ', ' HIV risk ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Vulnerable Populations ', ' vulnerable group ', ' Risk Reduction ', ' health disparity ', ' disparity in health ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Institution ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Address ', ' Data ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Mentored Research Scientist Development Award ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Transmission ', ' transmission process ', ' Principal Investigator ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Behavioral ', ' Prevention education ', ' neglect ', ' protective behavior ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Guide prevention ', ' Population ', ' Prevalence ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' public health relevance ', ' evidence base ', ' arm ', ' drug offender ', ' racial disparity ', ' race disparity ', ' disparities in race ', ' illicit drug use ', ' ']",NIDA,COLUMBIA UNIVERSITY HEALTH SCIENCES,K01,2017,119012,0.0825246084870777
"Cohort Studies on HIV/AIDS and Substance Abuse in Miami     DESCRIPTION (provided by applicant): Liver disease is a major cause of death in HIV infected persons in the United States. While advances in antiretroviral therapy have significantly reduced HIV-related mortality, co-infection with hepatitis C virus (HCV), is widespread and accelerates progression of liver fibrosis to cirrhosis and liver carcinoma. In addition, substance abuse accelerates HIV disease, and may facilitate progression of liver fibrosis. The primary goal of this proposal is to continue to follow the existing Miami Adult Studies on HIV (MASH) cohort, its specimen repository and database, and expand it from the current 881 to 1,500 study participants. The purpose is to generate collaborative studies to investigate the impact of cocaine, by far the most prevalent drug of abuse in South Florida, on HIV infection, HIV/HCV co-infection, and on long-term morbidity with a focus on liver disease in this population with disparities in access to care. HIV and HCV un-infected cocaine users and non-users will also be recruited to allow determination of the impact of cocaine use alone, as well as the interaction of cocaine use with HIV, HCV, and HIV/HCV co-infection. As new and more effective treatments and access to care for HIV, HCV and drug abuse become available, maintaining a well- characterized cohort, specimen repository and database will create a strong resource platform for current and future collaborative research. Observing the uptake of new HCV treatments and potential new cocaine cessation programs in this at-risk population with health disparities will provide data on barriers and facilitators to effective treatments to prevent long-term morbidity and mortality. We have followed the MASH cohort of 881 participants for up to 12 years with excellent retention rates, and have created a specimen repository and a database. The MASH cohort in Miami is unique because it will be a mostly Hispanic cohort with a large number of African Americans, women, non-injector drug users, with predominantly heterosexual HIV- transmission etiology. We propose to (1) compare the progression of liver fibrosis over four years among cocaine users and non-users in HIV+/HCV-, HIV+/HCV+, HIV-/HCV+, and HIV-/HCV-, using a novel non- invasive diagnostic device, the Magnetic Resonance Elastography (MRE). We also propose to (2) compare the pattern over four years of biomarkers and identify genetic markers associated with the mechanisms of liver fibrosis among cocaine users and non-users. Understanding the role of cocaine use in the context of HIV and HIV/HCV co-infections and lack of lasting effects of treatments for cocaine use cessation are crucial in order to gain insights into the pathogenesis and disease outcomes, and to provide the basis for identifying antifibrotic therapies such as oxidative stress, which are amenable to intervention. These studies will be critical for program development, appropriate interventions, and for improving health in this population. PUBLIC HEALTH RELEVANCE: Understanding the role of cocaine use in the context of HIV, HCV and HIV/HCV co-infections with focus on progression of liver fibrosis, is crucial in gaining insights into the disease pathogenesis, outcomes, and the role of co-morbidities and health disparities of this population. This research will provide evidence-based information for program development and evaluation, appropriate and effective interventions, and for improving health in this population.",Cohort Studies on HIV/AIDS and Substance Abuse in Miami,9144756,U01DA040381,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Alcohol Chemical Class ', ' Alcohols ', ' Animals ', ' Cause of Death ', ' Cocaine ', ' Cocaine Abuse ', ' Concurrent Studies ', ' Cohort Studies ', ' co-morbidity ', ' Comorbidity ', ' Death ', ' Cessation of life ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Florida ', ' Future ', ' genetic biomarker ', ' Genetic Markers ', ' Goals ', ' Health ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' Hepatitis C virus ', ' HCV infection ', ' HCV ', ' Hepatitis C ', ' liver carcinoma ', ' Liver Cells Carcinoma ', ' Hepatoma ', ' Hepatocellular cancer ', ' Hepatocellular Carcinoma ', ' Hepatocarcinoma ', ' Primary carcinoma of the liver cells ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Modern Man ', ' Human ', ' Immunity ', ' Natural immunosuppression ', ' immunosuppression ', ' immune suppression ', ' Immunosuppressive Effect ', ' Immunosuppression Effect ', ' In Vitro ', ' Laboratories ', ' Liver diseases ', ' liver disorder ', ' hepatopathy ', ' hepatic disease ', ' Hepatic Disorder ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Persons ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Program Development ', ' Program Evaluation ', ' Quality of life ', ' QOL ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Resources ', ' Research Resources ', ' Risk Factors ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' United States ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Virus Diseases ', ' General Viruses ', ' Virus ', ' Woman ', ' cytokine ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' malnourished ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Malnutrition ', ' therapy failure ', ' Treatment Failure ', ' improved ', ' Area ', ' Clinical ', ' Animal Experiments ', ' insight ', ' Stimulus ', ' Cocaine Users ', ' hepatic fibrosis ', ' Liver Fibrosis ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Populations at Risk ', ' Oxidative Stress ', ' Funding ', ' uptake ', ' non-invasive diagnostic ', ' non-invasive diagnosis ', ' noninvasive diagnosis ', ' Metabolic ', ' chronic liver disease ', ' chronic liver disorder ', ' chronic hepatic disorder ', ' chronic hepatic disease ', ' Diagnostic ', ' Nature ', ' Specimen ', ' Research Specimen ', ' programs ', ' Pattern ', ' Mono-S ', ' MonoS ', ' interest ', ' fibrogenesis ', ' cohort ', ' Disease Outcome ', ' novel ', ' Participant ', ' Devices ', ' Pathogenesis ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' repository ', ' time interval ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' health disparity ', ' disparity in health ', ' prevent ', ' preventing ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Data ', ' Prognostic Factor ', ' Prognostic/Survival Factor ', ' General Prognostic Factor ', ' Magnetic Resonance Elastography ', ' Transmission ', ' transmission process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Heterosexuals ', ' Behavioral ', ' cirrhotic ', ' Cirrhosis ', ' antiretroviral therapy ', ' Outcome ', ' Population ', ' prospective ', ' treatment effect ', ' drug of abuse ', ' drugs of abuse ', ' drugs abused ', ' abused drugs ', ' public health relevance ', ' effective intervention ', ' evidence base ', ' FDA approved ', ' effective therapy ', ' effective treatment ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' cocaine use ', ' co-infection ', ' coinfection ', ' retention rate ', ' student retention ', ' retention strategy ', ' HIV/HCV ', ' HIV/Hepatitis C ', ' HCV/HIV ', ' Hepatitis C co-infection ', ' hepatitis C virus coinfection ', ' hepatitis C virus co-infection ', ' hepatitis C coinfection ', ' HCV coinfection ', ' HCV co-infection ', ' liver development ', ' disparities in morbidity ', ' morbidity disparities ', ' health care availability ', ' healthcare service access ', ' healthcare access ', ' health care service availability ', ' health care service access ', ' accessibility to healthcare ', ' accessibility to health care ', ' accessibility of health care ', ' access to healthcare ', ' access to health care ', ' ']",NIDA,FLORIDA INTERNATIONAL UNIVERSITY,U01,2017,1109960,0.03301287487101885
"Mentoring researchers on drug abuse and HIV DESCRIPTION (provided by applicant): Drug users with and at-risk for HIV continue to have poor access to health care and poor treatment outcomes. In addition, opioid addiction involving prescription opioids has skyrocketed. In this proposal for a mid-career investigator award, Dr. Chinazo Cunningham proposes to address the opioid epidemic and its intersection with HIV infection by: 1) becoming an internationally recognized leader in the field of drug abuse and HIV, expanding her research to include advanced research methods (comparative effectiveness research [CER] methods and complex clinical trials methods); 2) developing a standardized and structured mentorship approach to mentor junior investigators to conduct patient-oriented research related to drug abuse and/or HIV infection; and 3) becoming an effective leader in academic medicine, ensuring that the institutional infrastructure facilitates junior investigators obtaining skills necessary to become independent investigators. To achieve these goals, Dr. Cunningham will participate in courses and national conferences, have directed readings, and regularly meet with national leaders in related fields. Dr. Cunningham will particularly focus on mentoring women and racial/ethnic minorities-two groups who are under-represented in senior positions in academic medicine and NIH-funded research. Dr. Cunningham will utilize her existing research program as a foundation for which she will provide mentoring and expand her research skills to include CER and complex clinical trials methods. The aims of her research are to: 1) test the efficacy of a 16-week abstinence-reinforcing contingency management intervention on HIV viral load suppression among opioid-dependent HIV-infected individuals, using a randomized controlled trial design; and 2) examine mechanisms of achieving viral load suppression with the abstinence-reinforcing contingency management intervention. Dr. Cunningham's future research will include the establishment of a comprehensive ""live"" database of all opioid users within a large urban medical center. This database will be used to examine health outcomes associated with types of opioid use and to develop and test interventions focused on opioid use. Dr. Cunningham's long-term career objective is to improve access to care and health outcomes among drug-abusing populations with or at-risk for HIV infection by developing interventions that can reduce their disparities in health care and health. PUBLIC HEALTH RELEVANCE: This application for a K24 mid-career investigator award seeks to provide support to Dr. Chinazo Cunningham to provide excellent mentorship, effective leadership, and expand her current research to include advanced research methods (comparative effectiveness research methods and complex clinical trials methods). Dr. Cunningham will mentor junior investigators in the areas of drug abuse and HIV, with an emphasis on providing mentorship to racial/ethnic minorities and women. Dr. Cunningham will use her existing research project as a foundation to provide much of her mentorship. In addition, expanding her research to include comparative effectiveness research and complex clinical trials focused on opioid use will allow her to conduct new research and provide additional mentorship that can ultimately improve health outcomes of drug users with and at-risk for HIV.",Mentoring researchers on drug abuse and HIV,9240580,K24DA036955,"['Award ', ' Behavior ', ' Buprenorphine ', ' Clinical Trials ', ' Cocaine ', ' Color ', ' Communities ', ' Control Groups ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Feedback ', ' Foundations ', ' Goals ', ' Health ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Hematology Testing ', ' Hematological Tests ', ' Hematologic Tests ', ' Blood Tests ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incentives ', ' Leadership ', ' Medical Records ', ' Medicine ', ' Mentors ', ' Mentorship ', ' Methadone ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methods ', ' Motivation ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Oxycodone ', ' Roxicodone ', ' Oxycontin ', ' Oxycodone SR ', ' Oxycodeinon ', ' Dihydrohydroxycodeinone ', ' Patients ', ' Public Health ', ' Questionnaires ', ' Reading ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Research Support ', ' Risk ', ' Standardization ', ' Testing ', ' Toxicology ', ' Urine Urinary System ', ' Urine ', ' Woman ', ' Treatment outcome ', ' symposia ', ' summit ', ' convention ', ' conference ', ' symposium ', ' health care ', ' Healthcare ', ' Research Methods ', ' Research Methodology ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Caring ', ' base ', ' career ', ' improved ', ' Area ', ' Ensure ', ' Individual ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Opioid ', ' drug use ', ' Drug usage ', ' T4 Lymphocyte Count ', ' CD4+ Counts ', ' CD4+ Cell Counts ', ' CD4 Lymphocyte Count ', ' Funding ', ' Agonist ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Smoker ', ' Drug user ', ' Opiates ', ' programs ', ' Viral Load result ', ' Viral Load ', ' Viral Burden ', ' Complex ', ' Neurocognitive ', ' Opiate Addiction ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' Medical center ', ' Performance ', ' success ', ' Structure ', ' skills ', ' Participant ', ' contingency management ', ' Positioning Attribute ', ' Position ', ' HIV risk ', ' voucher ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Highly Active Antiretroviral Therapy ', ' highly active anti-retroviral therapy ', ' HAART ', ' patient oriented research ', ' patient oriented study ', ' pill ', ' health disparity ', ' disparity in health ', ' therapy adherence ', ' Smoking Cessation Intervention ', ' Smoking and Tobacco Use Cessation Interventions ', ' Address ', ' Adherence ', ' Data ', ' Improve Access ', ' International ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Research Infrastructure ', ' Infrastructure ', ' enroll ', ' Enrollment ', ' effectiveness research ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Outcome ', ' Population ', ' ethnic minority population ', ' ethnic minority ', ' Abstinence ', ' racial and ethnic ', ' comparative effectiveness ', ' public health relevance ', ' primary outcome ', ' secondary outcome ', ' efficacy testing ', ' cocaine use ', ' prescription opioid ', ' trial design ', ' improved outcome ', ' opioid use ', ' health care availability ', ' healthcare service access ', ' healthcare access ', ' health care service availability ', ' health care service access ', ' accessibility to healthcare ', ' accessibility to health care ', ' accessibility of health care ', ' access to healthcare ', ' access to health care ', ' ']",NIDA,"ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",K24,2017,48485,0.11979102193138146
"Cohort Studies on HIV/AIDS and Substance Abuse in Miami     DESCRIPTION (provided by applicant): Liver disease is a major cause of death in HIV infected persons in the United States. While advances in antiretroviral therapy have significantly reduced HIV-related mortality, co-infection with hepatitis C virus (HCV), is widespread and accelerates progression of liver fibrosis to cirrhosis and liver carcinoma. In addition, substance abuse accelerates HIV disease, and may facilitate progression of liver fibrosis. The primary goal of this proposal is to continue to follow the existing Miami Adult Studies on HIV (MASH) cohort, its specimen repository and database, and expand it from the current 881 to 1,500 study participants. The purpose is to generate collaborative studies to investigate the impact of cocaine, by far the most prevalent drug of abuse in South Florida, on HIV infection, HIV/HCV co-infection, and on long-term morbidity with a focus on liver disease in this population with disparities in access to care. HIV and HCV un-infected cocaine users and non-users will also be recruited to allow determination of the impact of cocaine use alone, as well as the interaction of cocaine use with HIV, HCV, and HIV/HCV co-infection. As new and more effective treatments and access to care for HIV, HCV and drug abuse become available, maintaining a well- characterized cohort, specimen repository and database will create a strong resource platform for current and future collaborative research. Observing the uptake of new HCV treatments and potential new cocaine cessation programs in this at-risk population with health disparities will provide data on barriers and facilitators to effective treatments to prevent long-term morbidity and mortality. We have followed the MASH cohort of 881 participants for up to 12 years with excellent retention rates, and have created a specimen repository and a database. The MASH cohort in Miami is unique because it will be a mostly Hispanic cohort with a large number of African Americans, women, non-injector drug users, with predominantly heterosexual HIV- transmission etiology. We propose to (1) compare the progression of liver fibrosis over four years among cocaine users and non-users in HIV+/HCV-, HIV+/HCV+, HIV-/HCV+, and HIV-/HCV-, using a novel non- invasive diagnostic device, the Magnetic Resonance Elastography (MRE). We also propose to (2) compare the pattern over four years of biomarkers and identify genetic markers associated with the mechanisms of liver fibrosis among cocaine users and non-users. Understanding the role of cocaine use in the context of HIV and HIV/HCV co-infections and lack of lasting effects of treatments for cocaine use cessation are crucial in order to gain insights into the pathogenesis and disease outcomes, and to provide the basis for identifying antifibrotic therapies such as oxidative stress, which are amenable to intervention. These studies will be critical for program development, appropriate interventions, and for improving health in this population. PUBLIC HEALTH RELEVANCE: Understanding the role of cocaine use in the context of HIV, HCV and HIV/HCV co-infections with focus on progression of liver fibrosis, is crucial in gaining insights into the disease pathogenesis, outcomes, and the role of co-morbidities and health disparities of this population. This research will provide evidence-based information for program development and evaluation, appropriate and effective interventions, and for improving health in this population.",Cohort Studies on HIV/AIDS and Substance Abuse in Miami,9491437,U01DA040381,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Alcohol Chemical Class ', ' Alcohols ', ' Animals ', ' Cause of Death ', ' Cocaine ', ' Cocaine Abuse ', ' Concurrent Studies ', ' Cohort Studies ', ' co-morbidity ', ' Comorbidity ', ' Death ', ' Cessation of life ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Florida ', ' Future ', ' genetic biomarker ', ' Genetic Markers ', ' Goals ', ' Health ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' Hepatitis C virus ', ' HCV infection ', ' HCV ', ' Hepatitis C ', ' liver carcinoma ', ' Liver Cells Carcinoma ', ' Hepatoma ', ' Hepatocellular cancer ', ' Hepatocellular Carcinoma ', ' Hepatocarcinoma ', ' Primary carcinoma of the liver cells ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Modern Man ', ' Human ', ' Immunity ', ' Natural immunosuppression ', ' immunosuppression ', ' immune suppression ', ' Immunosuppressive Effect ', ' Immunosuppression Effect ', ' In Vitro ', ' Laboratories ', ' Liver diseases ', ' liver disorder ', ' hepatopathy ', ' hepatic disease ', ' Hepatic Disorder ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Persons ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Program Development ', ' Program Evaluation ', ' Quality of life ', ' QOL ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Resources ', ' Research Resources ', ' Risk Factors ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' United States ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Virus Diseases ', ' General Viruses ', ' Virus ', ' Woman ', ' cytokine ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' malnourished ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Malnutrition ', ' therapy failure ', ' Treatment Failure ', ' improved ', ' Area ', ' Clinical ', ' Animal Experiments ', ' insight ', ' Stimulus ', ' Cocaine Users ', ' hepatic fibrosis ', ' Liver Fibrosis ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Populations at Risk ', ' Oxidative Stress ', ' Funding ', ' uptake ', ' non-invasive diagnostic ', ' non-invasive diagnosis ', ' noninvasive diagnosis ', ' Metabolic ', ' chronic liver disease ', ' chronic liver disorder ', ' chronic hepatic disorder ', ' chronic hepatic disease ', ' Diagnostic ', ' Nature ', ' Specimen ', ' Research Specimen ', ' programs ', ' Pattern ', ' Mono-S ', ' MonoS ', ' interest ', ' fibrogenesis ', ' cohort ', ' Disease Outcome ', ' novel ', ' Participant ', ' Devices ', ' Pathogenesis ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' repository ', ' time interval ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' health disparity ', ' disparity in health ', ' prevent ', ' preventing ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Data ', ' Prognostic Factor ', ' Prognostic/Survival Factor ', ' General Prognostic Factor ', ' Magnetic Resonance Elastography ', ' Transmission ', ' transmission process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Heterosexuals ', ' Behavioral ', ' cirrhotic ', ' Cirrhosis ', ' antiretroviral therapy ', ' Outcome ', ' Population ', ' prospective ', ' treatment effect ', ' drug of abuse ', ' drugs of abuse ', ' drugs abused ', ' abused drugs ', ' public health relevance ', ' effective intervention ', ' evidence base ', ' FDA approved ', ' effective therapy ', ' effective treatment ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' cocaine use ', ' co-infection ', ' coinfection ', ' retention rate ', ' student retention ', ' retention strategy ', ' HIV/HCV ', ' HIV/Hepatitis C ', ' HCV/HIV ', ' Hepatitis C co-infection ', ' hepatitis C virus coinfection ', ' hepatitis C virus co-infection ', ' hepatitis C coinfection ', ' HCV coinfection ', ' HCV co-infection ', ' liver development ', ' disparities in morbidity ', ' morbidity disparities ', ' health care availability ', ' healthcare service access ', ' healthcare access ', ' health care service availability ', ' health care service access ', ' accessibility to healthcare ', ' accessibility to health care ', ' accessibility of health care ', ' access to healthcare ', ' access to health care ', ' ']",NIDA,FLORIDA INTERNATIONAL UNIVERSITY,U01,2017,166800,0.03301287487101885
"Racial and ethnic disparities in alcohol and other drug use disorder recovery (F.220) 7. Project Summary Racial/ethnic health disparities have been well-documented in the onset, rate, course, and consequences of alcohol and other drug (AOD) use problems, often with substantially poorer outcomes in non-White racial/ethnic groups compared to non-Hispanic Whites. As a result, the NIAAA has made it a central strategic aim to investigate and eliminate health disparities. Despite 30 years of research documenting the presence of AOD-related racial/ethnic health disparities, the degree to which disparities negatively impact the emerging standard of assessing the effectiveness of AOD treatments (i.e.,  5 years AOD problem resolution),53 which is also when risk of problematic use is no higher than in the general population,84 is unknown. Publicly available datasets are very limited by their ability to directly measure AOD recovery-related constructs and national prevalence rates of non-White racial/ethnic groups who have achieved long-term problem resolution. In turn, this compromises our ability to assess the extent to which racial/ethnic health equality exists in terms of long- term AOD problem resolution and the recovery-related mechanisms associated with potential disparities. To begin to fill this knowledge gap, we propose to conduct secondary data analyses of the first recovery-focused nationally representative probability-based study to test if racial/ethnic health disparities exist. The National Recovery Study (PI: Kelly) consists of a web-based probability sampling frame of 39,809 adults who were screened to identify if they once had a problem with drugs or alcohol and no longer do. Complete data on 2,002 participants who answered yes is available. Participants were assessed with a battery of quantitative and qualitative survey items in 2016 which captured their AOD clinical history and recovery-related mechanisms associated racial/ethnic health equality in AOD problem resolution. This design will enable us to address the following aims: 1a. Test if racial/ethnic health disparities exist in (i) the duration between onset of alcohol and other drug problems and onset of problem resolution; and, (ii) the likelihood of achieving long-term problem resolution ( 5 years) 1b. If health disparities are observed, explore the mediating potential of psychosocial (accrued recovery capital, degree of treatment utilization, degree of recovery support-service utilization) and structural recovery-related factors (health insurance coverage, socioeconomic status, and recovery-related discrimination) in explaining observed disparities. 2. Conduct concurrent qualitative analysis to identify the top three strategies that participants report having used to resolve their alcohol or other drug problem (e.g., social support, secure accommodations, mental and physical health, financial management, employment, and recreation) and compare these strategies according to racial/ethnic characteristics. Mix the qualitative and quantitative data to determine if race/ethnicity is associated with themes identified in the recovery strategies. (F.220) 8. Project Narrative Despite 30 years of research documenting the disproportionate burden that alcohol and other drug (AOD)- related problems have on non-White racial/ethnic groups, the degree to which racial/ethnic health disparities negatively impact emerging standards for assessing the effectiveness of AOD treatments ( 5 years AOD problem resolution), which is when the risk of problematic use is no higher than in the general population, is unknown. This F32 postdoctoral training will aid the applicant in documenting US prevalence estimates of the number of non-White individuals who have resolved an AOD problem using data from the first nationally representative, probability-based, study of recovery. Specifically, the candidate will investigate the associations between race/ethnicity and stages of AOD problem resolution in the: 1. duration between onset of AOD problems and onset of problem resolution; and, 2. the likelihood of achieving stable long-term problem resolution. In doing so, we will establish the first line of nationally representative research on health equality in long-term AOD problem resolution and associated recovery-related mechanisms, ultimately translating findings into actionable targets for clinicians, policy, and public health proposals that can address the identified disparities.",Racial and ethnic disparities in alcohol and other drug use disorder recovery,9469824,F32AA025823,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Alcohol Chemical Class ', ' Alcohols ', ' Capital ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Cognitive Discrimination ', ' Discrimination ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' Drug Use Disorder ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economics ', ' Employment ', ' ethnicity group ', ' Ethnic group ', ' Financial Management ', ' Occupational activity of managing finances ', ' Health ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' History ', ' Recording of previous events ', ' Incidence ', ' indexing ', ' Health Insurance ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health Services ', ' Mental Hygiene Services ', ' Methods ', ' Methodology ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Probability ', ' Probability Samples ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recreation ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Science ', ' Social support ', ' social support network ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Translating ', ' Measures ', ' Mediating ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Clinical ', ' Phase ', ' Evaluation ', ' Training ', ' Individual ', ' Recovery ', ' Policies ', ' drug use ', ' Drug usage ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Knowledge ', ' Insurance Coverage ', ' Insurance Status ', ' programs ', ' Severities ', ' physical conditioning ', ' physical health ', ' psychosocial ', ' Services ', ' novel ', ' Participant ', ' General Population ', ' General Public ', ' Reporting ', ' Sampling ', ' behavioral health ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Qualitative Research ', ' health disparity ', ' disparity in health ', ' Effectiveness ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Data ', ' Resolution ', ' Strategic Planning ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Characteristics ', ' Process ', ' designing ', ' design ', ' Minority ', ' alcohol and other drug ', ' Outcome ', ' alcohol related problem ', ' Population ', ' Prevalence ', ' National Institute on Alcohol Abuse and Alcoholism ', ' NIAAA ', ' post-doctoral training ', ' postdoctoral training ', ' racial and ethnic ', ' demographics ', ' service utilization ', ' addiction ', ' addictive disorder ', ' racial and ethnic disparities ', ' alcohol consequences ', ' Secure ', ' screening ', ' ethnic health disparity ', ' ']",NIAAA,MASSACHUSETTS GENERAL HOSPITAL,F32,2017,63690,0.037463982941195906
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network     DESCRIPTION:  The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PUBLIC HEALTH RELEVANCE: This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9441344,UG1DA015815,"['Patients ', ' Peer Review ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Registries ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Rural Health ', ' Safety ', ' San Francisco ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Opioid ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' Services ', ' experience ', ' care delivery ', ' Participant ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' drug abuse prevention ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' disparity in health ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' designing ', ' design ', ' urban Indian ', ' urban American Indian ', ' urban Native American ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addiction ', ' addictive disorder ', ' public health relevance ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' health service use ', ' health service utilization ', ' data resource ', ' rural Americans ', ' therapeutic candidate ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' American Indian ', ' American Indians ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Educational aspects ', ' Education ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' Hepatitis C virus ', ' HCV infection ', ' HCV ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methadone ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methods ', ' Naloxone ', ' Narcanti ', ' Narcan ', ' Persons ', ' Oregon ', ' Overdose ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2017,830369,0.08695097140668363
"Social Networks and HIV Risk Behaviors of Special Populations of Drug Users DESCRIPTION (provided by applicant): The primary goal of this resubmitted K02 application is to further develop Dr. Carrie Oser's productive independent research career and to augment her research focus on HIV, substance abuse treatment, crime, and health disparities by gaining new training on social networks and HIV intervention development. The K02 builds upon her focus on special populations, including both rural drug users and African American drug users. The proposed training goals will provide new instruction in social networks, HIV intervention development, and the responsible conduct of research. The specific aims are: (1) to identify HIV and HCV risk and longitudinal changes in risk in the social networks of 503 rural out-of-treatment drug using women, as compared to men; and (2) to examine the effect of social networks, including structure (e.g., size, density), function (e.g., emotional and instrument support), and content (e.g., attitudes towards physicians), on HIV and HCV risk behaviors and health services utilization among African American drug using women, as compared to men, across criminal justice status. This significant and innovative study will have strong public healt impacts and will support NIDA's Health Disparities Initiative because of its potential to contribut to our understanding of the cultural and social network correlates of health disparities among both rural and African American drug users. In addition, this study improves upon the methodological limitations of previous research findings by examining various social networks (e.g., egocentric, dyadic, and sociocentric) and using longitudinal data in multilevel models. This proposed project will allow for a practical application of the substantive knowledge and analytical skills acquired from the K02 training activities and will ultimately culminate in the development of forthcoming investigator initiated NIDA grant applications. Specifically, these findings will be used as a foundation for future HIV social networks based intervention to increase special populations' use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism. PUBLIC HEALTH RELEVANCE: This study is significant to the public health field because of its potential to understand the individual, cultural, and social network factors associated with HI and HCV risk behaviors among two special populations - rural drug users and African American drug users. These findings will be used as a foundation for developing social network based HIV interventions to increase special populations' use of preventative health care and subsequently reduce the need for expensive medical services, as well as to decrease HIV risk behaviors including drug use, unprotected sex, and recidivism.",Social Networks and HIV Risk Behaviors of Special Populations of Drug Users,9276647,K02DA035116,"['Attitude ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Crime ', ' Data Collection ', ' data representation ', ' Data Reporting ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Female ', ' Foundations ', ' Future ', ' Goals ', ' Grant ', ' Health ', ' Health Services ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' Hepatitis C virus ', ' HCV infection ', ' HCV ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Kentucky ', ' male ', ' men ', "" men's "", ' Methodology ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Oxycodone ', ' Roxicodone ', ' Oxycontin ', ' Oxycodone SR ', ' Oxycodeinon ', ' Dihydrohydroxycodeinone ', ' Physicians ', ' Drug Prescriptions ', ' Drug Prescribing ', ' Prisons ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Rural Population ', ' training module ', ' Training Activity ', ' Woman ', ' Gender ', ' Measures ', ' falls ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Criminal Justice ', ' Injectable ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Social Network ', ' career ', ' density ', ' rural area ', ' urban area ', ' improved ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' Link ', ' Training ', ' Spiritualities ', ' Spirituality ', ' Individual ', ' Rural ', ' drug use ', ' Drug usage ', ' Drug user ', ' instrument ', ' Knowledge ', ' Life ', ' System ', ' S-nitro-N-acetylpenicillamine ', ' SNAP ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' Services ', ' experience ', ' named group ', ' Special Population ', ' Structure ', ' skills ', ' disorder prevention ', ' disease prevention ', ' recidivism ', ' Patient Self-Report ', ' Self-Report ', ' probation ', ' social ', ' HIV risk ', ' multilevel analysis ', ' multilevel modeling ', ' multilevel model ', ' methods to study multiple-level influences ', ' Emotional ', ' Pathway Analysis ', ' Network Analysis ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' HIV diagnosis ', ' health disparity ', ' disparity in health ', ' high risk sexual behavior ', ' risky sexual behavior ', ' high risk sexual activity ', ' high risk sex behavior ', ' high risk sex activity ', ' Data ', ' Applications Grants ', ' Grant Proposals ', ' Independent Scientist Award ', ' K02 Award ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Strategic Planning ', ' developmental ', ' Development ', ' substance abuse therapy ', ' substance abuse treatment ', ' Instruction ', ' willingness ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' practical application ', ' application in practice ', ' Network-based ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' public health relevance ', ' responsible research conduct ', ' injection drug use ', ' support network ', ' HIV/HCV ', ' HIV/Hepatitis C ', ' HCV/HIV ', ' Preventive healthcare ', ' Preventive health care ', ' Preventative healthcare ', ' Preventative health care ', ' health service use ', ' health service utilization ', ' high risk population ', ' high risk group ', ' rural African American ', ' ']",NIDA,UNIVERSITY OF KENTUCKY,K02,2017,115827,0.1196814521075345
"Health Consequences of Drug Use and IPV Trajectories for Young Latinas     DESCRIPTION (provided by applicant):  Few empirical studies have documented the life trajectories of gang-affiliated adolescent females and the long- term health consequences of adolescent drug use and partner violence victimization. The purpose of this study is to identify and determine how distinct drug use and intimate partner violence victimization trajectories that emerge in adolescence through young adulthood contribute to physical and mental health outcomes among Mexican American women within the context of a highly disadvantaged community. This group of women are particularly vulnerable given they have low rates of access and utilization of health care, are the most likely age group to be uninsured, and represent a nexus of risk, vulnerability and potentially high costs to communities given their reproductive and sexual health stage of life. This application proposes a 15 year follow up of a cohort of Mexican American adolescent females previously identified in a CDC funded study who were affiliated with male gang members during their adolescence and involved in high rates of drug use and victims of intimate partner violence. Building upon the research teams previous studies and using analytical tools from the theory of gender and power and social bonding theory, this application will implement a concurrent mixed methods nested design approach to provide a comprehensive understanding of the long-term consequences of drug use and IPV. The sample will consist of 300 young adult Mexican-American females. The specific aims for this study are: 1) determine the prevalence of physical (cardiovascular and metabolic risk markers and STI infection) and mental (depression, PTSD, anxiety/stress) health outcomes; 2) identify and characterize distinct drug use and IPV trajectories from adolescence through young adulthood; 3) determine whether sexual relationship power and family social bonds during distinct age-graded stages alter drug use and IPV trajectories and health outcomes; and 4) characterize qualitatively the culture and community context and their influence on drug use and IPV trajectories over the life course. This research will have an important positive impact by identifying women who are at the highest risk for developing harmful drug and IPV trajectories as they transition into young adulthood. In doing this, we will lay the foundation for identifying critical points of behavioral intervention during key age-graded periods as well as culturally and contextually appropriate values and strategies that will reduce health disparities among similar high-risk female populations that have gone underrepresented in existing research. PUBLIC HEALTH RELEVANCE:  This application seek a comprehensive understanding of the long term health consequences of drug use and intimate partner violence victimization physical and mental health outcomes among a vulnerable cohort of Mexican-American females recruited over 15 years ago who were affiliated with male gang members during their adolescence. The study will provide a unique opportunity to investigate detrimental life trajectories contributing t the prevalence of cardiovascular and metabolic risk markers, infection, depression, PTSD, anxiety and stress within a marginalized and underserved community context. Findings will contribute to policy discourse that can lead to the development of innovative public health programs and campaigns that will reduce health disparities among minority women. PHS 398/2590 (Rev. 11/07) Page Continuation Format Page",Health Consequences of Drug Use and IPV Trajectories for Young Latinas,9276638,R01DA039269,"['adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' adolescent girl ', ' Female Adolescents ', ' ages ', ' Age ', ' Anxiety ', ' Attention ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardio-vascular ', ' Cardiovascular system ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Complement Proteins ', ' Complement ', ' Decision Making ', ' depression ', ' Mental Depression ', ' Disadvantaged ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Family ', ' Female ', ' Foundations ', ' Health ', ' Heterogeneity ', ' Infection ', ' knowledge of results ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Long-Term Effects ', ' Longterm Effects ', ' male ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' Mexican Americans ', ' Chicanos ', ' Chicanas ', ' Neighborhoods ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Public Health ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Research ', ' Risk ', ' Stress ', ' Post-Traumatic Stress Disorders ', ' traumatic neurosis ', ' Posttraumatic Stress Disorders ', ' Posttraumatic Neuroses ', ' Post-Traumatic Neuroses ', ' PTSD ', ' violent behavior ', ' violent ', ' Violence ', ' Woman ', ' Friends ', ' Gender ', ' Female Health ', "" Women's Health "", ' Latino ', ' Uninsured ', ' Youth 10-21 ', ' Youth ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Gap Junctions ', ' mental ', ' Psyche structure ', ' healthcare utilization ', ' healthcare service utilization ', ' healthcare service use ', ' health care service use ', ' Health Care Utilization ', ' health care service utilization ', ' young adulthood ', ' adult youth ', ' young adult ', ' Policies ', ' drug use ', ' Drug usage ', ' Female Groups ', "" Women's Group "", ' Wife ', ' Reproductive Health ', ' Funding ', ' Metabolic ', ' Shapes ', ' Sister ', ' Prediabetes syndrome ', ' syndrome x ', ' pre-diabetes ', ' Prediabetic State ', ' Prediabetes ', ' Knowledge ', ' Life ', ' programs ', ' physical conditioning ', ' physical health ', ' age group ', ' cohort ', ' member ', ' gang ', ' social ', ' social attachment ', ' social bonding ', ' Sampling ', ' girls ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Latina ', ' Latinas ', ' health disparity ', ' disparity in health ', ' Low income ', ' Address ', ' Health system ', ' Sexual Health ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Risk Marker ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' violent partner ', ' partner violence ', ' sexual relationship ', ' cost ', ' youth drug use ', ' adolescent drug use ', ' intimate partner violence ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' analytical tool ', ' high risk ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' young man ', ' adolescent men ', ' adolescent man ', ' violence victimization ', ' drug use vulnerability ', ' vulnerability to drug use ', ' Affordable Care Act ', ' Obamacare ', ' health care service ', ' healthcare service ', ' high risk population ', ' high risk group ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2017,633944,0.11929657389475455
"Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS) DESCRIPTION (provided by applicant):  There is a critical need to develop a diverse pool of highly trained clinician scholars to foster the development of biomedical, behavioral and clinical research related to drug abuse, addiction, and HIV prevention and treatment in general medical settings. Patients who abuse substances are more likely to be seen in general medical settings such as emergency departments (ED), general medical primary care clinics and inpatient wards, HIV and adolescent health clinics, and women's health centers. These patients often present with a complex array of acute consequences and complications (e.g. intoxication, overdose, withdrawal, trauma and infectious diseases) of substance use as well as chronic conditions such as HIV disease, hepatitis, pulmonary and cardiovascular disease. Objectives: The Yale-Drug Abuse, Addiction, and HIV Research Scholars (DAHRS) program provides a comprehensive three year post-doctorate, interdisciplinary, Mentored Career Development Program to improve drug abuse, addiction, and HIV medical outcomes integrating prevention and treatment in general medical settings including ED, primary care, HIV, adolescent, and women's health clinics. Specifically, Yale-DAHRS will: [Aim 1] Develop clinician scientists with the knowledge, skills, and ability to become independent investigators, generating findings of practical value with significant impact to improve health outcomes of patients with and at risk for drug abuse, addiction, and HIV; [Aim 2] Develop future leaders by providing Scholars with leadership tools and skills and creating individualized programs to ensure success in leading multidisciplinary research teams in studying drug abuse, addiction and HIV, and implementation and integration of research findings into general medical settings; and [Aim 3] Enhance the diversity of drug abuse, addiction, and HIV researchers. Addressing women and minority faculty under representation will enhance the diversity of investigators and research topics, broaden perspectives in setting research priorities, increase clinical trial participation, and expand knowledge. Working synergistically with Yale's established training programs in drug abuse, HIV and clinical investigation, Yale- DAHRS will capitalize on existing academic infrastructure and expertise to ensure success. Unique, features include: (1) An interdisciplinary, diverse faculty of independent researchers in illicit and prescription drug abuse and addiction, tobacco, alcohol, HIV, and medical complexities such as pain and hepatitis C; (2) Synergy with well established, high quality post-doctoral training programs at Yale; (3) The use of clinical informatics for data collection, data management, diagnostic tool development, and information dissemination; and (4) The integration of such diverse fields as public health, informatics, clinical epidemiology, systems engineering and demography with the traditional clinical sciences of internal medicine, emergency medicine, HIV medicine, pediatrics, obstetrics and gynecology, psychiatry, and psychology; (5) Established clinical research laboratories, including the Yale-New Haven Hospital, a tertiary care center for southern New England and a community hospital for the Greater New Haven Area, serving an ethnically, racially, culturally, and economically diverse population, a Veterans Affairs Medical Center and community treatment centers such as the APT Foundation and Federally Qualified Health Centers; (6) Synergies with established research centers and institutes such as the Center for Interdisciplinary Research on AIDS and the Veterans Aging Cohort on HIV. Career Development Plan: Yale-DAHRS is a three year research training program that will prepare a total of six clinician investigators for careers focusing on drug abuse, addiction, and HIV in general medical settings during its first funding cycle. Scholars will earn the Master in Health Sciences degree, combining rigorous training in research methodology, statistics and design with seminars in topics related to drug abuse, addiction, and HIV content, leadership, grant writing and responsible conduct of research. Candidates will complete published mentored research project(s) and prepare an application for the next career step; i.e. NIH R21, R03, R15, R34 mechanism. The collaboration of the multidisciplinary faculty and the combined robust strengths of two principal investigators from Emergency and Internal Medicine, both with extensive experience mentoring and as independent funded investigators will drive the Yale-DAHRS program. Potential Research Projects: Multiple research projects are ""shovel ready"" for Scholar training and can be completed within our allotted time frame, such as secondary data analysis using national large datasets e.g. VA Aging Cohort (HIV); risk factors, prevention and treatment of prescription drug abuse, office-based treatment of opioid dependence with buprenorphine, systematic reviews and meta-analyses, creation of cost effective evaluation models for patients with drug abuse, addiction and HIV including prescription drug abuse; investigation of gender and racial/ethnic disparities in identification and treatment interventions and outcomes; evaluation of screening, and treatment initiation in special populations (i.e. adolescent-elderly, veterans, incarcerated, HIV); comparison of models of screening, brief intervention and referral to treatment (SBIRT) delivery by providers and other innovative technologies; effectiveness and implementation of SBIRT science in general medicine practice with acute and chronic medical complexities. PUBLIC HEALTH RELEVANCE:  Drug abuse, addiction, and HIV are significant public health issues, as they affect the health and well-being of a large portion of the population; have substantial negative health outcomes on individuals; and are extremely costly to the health care system. An investment in research to improve substance abuse and medical health outcomes is greatly needed. The proposed Yale-Drug Abuse, Addiction, and HIV Research Scholars (DAHRS) program focusing on general medical settings with patients throughout the life cycle will provide a three year post-doctoral, interdisciplinary, Mentored Career Development Program training six clinician-scientists for independent research careers in the field of drug abuse, addiction, and HIV through integration of prevention and treatment in general medical settings.","Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS)",9246468,K12DA033312,"['Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Acquired Immunodeficiency Syndrome ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Alcohol Chemical Class ', ' Alcohols ', ' Behavioral Research ', ' Biomedical Research ', ' Buprenorphine ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Clinical Informatics ', ' Clinical Study ', ' Clinical Research ', ' Clinical Trials ', ' Infectious Disorder ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communicable Diseases ', ' Communities ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' Demography ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Emergency Medicine ', ' Engineering ', ' Faculty ', ' Foundations ', ' Future ', ' Grant ', ' Gynecology ', ' Health ', ' Hepatitis ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' Hepatitis C virus ', ' HCV infection ', ' HCV ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Hospitals ', ' Community Hospitals ', ' Information Dissemination ', ' dissemination of results ', ' Inpatients ', ' Institutes ', ' Internal Medicine ', ' Laboratory Research ', ' Leadership ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Medicine ', ' Mentors ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' New England ', ' Northeastern United States ', ' Discipline of obstetrics ', ' Obstetrics ', ' Overdose ', ' Pain ', ' Painful ', ' Patients ', ' Pediatrics ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Program Development ', ' Psychiatry ', ' Psychology ', ' Publishing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Science ', ' statistics ', ' Time ', ' Tobacco ', ' Training Programs ', ' Veterans ', ' Woman ', ' Writing ', ' Gender ', ' Female Health ', "" Women's Health "", ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Research Methods ', ' Research Methodology ', ' Dataset ', ' Data Set ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' base ', ' career ', ' improved ', ' Area ', ' Acute ', ' Chronic ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Medical ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Ensure ', ' Evaluation ', ' Training ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Withdrawal ', ' Fostering ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Development Plans ', ' Funding ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' tool ', ' Diagnostic ', ' Research Priority ', ' Knowledge ', ' programs ', ' Scientist ', ' Investigation ', ' Complex ', ' Clinic ', ' System ', ' Opiate Addiction ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' Medical center ', ' innovative technologies ', ' data management ', ' experience ', ' named group ', ' Special Population ', ' success ', ' synergism ', ' cohort ', ' skills ', ' Prevention ', ' Intoxication ', ' HIV risk ', ' prescription drug abuse ', ' Modeling ', ' career development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Public Health Informatics ', ' consumer informatics ', ' Health Informatics ', ' Provider ', ' Effectiveness ', ' ward ', ' Address ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Health Sciences ', ' NCI Scholars Program ', ' Scholars Program ', ' Research Infrastructure ', ' Infrastructure ', ' Research Training ', ' Clinical Sciences ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Patient-Focused Outcomes ', ' Principal Investigator ', ' developmental ', ' Development ', ' Federally Qualified Health Center ', ' systematic review ', ' treatment center ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' cost effective ', ' cost-effective ', ' Trauma ', ' tertiary care ', ' post-doctoral training ', ' postdoctoral training ', ' clinical epidemiology ', ' addiction ', ' addictive disorder ', ' tool development ', ' racial and ethnic disparities ', ' screening, brief intervention, referral, and treatment ', ' screening, brief intervention, and referral to treatment ', ' SBIRT ', ' responsible research conduct ', ' young woman ', ' adolescent women ', ' adolescent woman ', ' screening ', ' clinical investigation ', ' adolescent health ', ' ']",NIDA,YALE UNIVERSITY,K12,2017,665902,0.10922386071168934
"Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border     DESCRIPTION (provided by applicant): The proposed project is a research collaboration between the University of Texas at El Paso, The Alliance for Border Collaborative and Program Comparers to adapt, implement, and evaluate a multi-level, community-based, HIV prevention intervention (Project Encuentro). The intervention will target active heroin and crack users and consists of increasing access to HIV testing via a social network HIV testing component and reducing sexual and drug use risk via a peer network brief behavioral Intervention. Encuentro also consists of conducting community awareness meeting to target structural factors affecting HIV risk. The intervention was developed in an area severely affected by violence and stigma towards drug users, El Salvador, which makes it particularly suitable for adaptation to meet the needs of drug users living in the proposed intervention site, the U.S.-Mexico border. The proposed intervention site also has been severely affected by violence which has curtailed any prior attempts to reduce the risk drug users' HIV risk. Violence has worsened structural factors which affect HIV risk such as, increasing police persecution and stigma and reducing access to resources. In our proposed project, we will engage in formative research to understand the context of HIV risk of drug users in the border region post violence and adapt the intervention accordingly. Findings will allow us to tailor intervention components to meet the needs of drug users in the region. Subsequently, we propose to test intervention effectiveness and evaluate implementation barriers and facilitators. To accomplish our project aims we will use a mixed qualitative, quantitative approach. We will begin with a formative phase by conducting in-depth interviews with drug users (n = 40) living in the region to understand how the context of drug use risk changed as a result of the violence and will administer a social network survey (n = 200) to characterize the configuration of risk networks. Findings will yield the necessary information to culturally adapt the intervention to meet the needs of drug users in the region and will help us focus our recruitment efforts where the riskiest networks are located. After the intervention is adapted with the help of our community advisory board and our community coalition, we will implement the intervention and will assess the effectiveness and reach via 6 cross-sectional surveys administered to drug users (n=1,200). We will assess the process of implementation by conducting ethnographic field notes of all intervention activities including community engagement and CAB and coalition meetings. We will assess the fidelity and quality of the intervention. Lastly, we will conduct key informant interviews with key stakeholders involved in the project and interviews and observations will be coded to reflect key systems factors related to successful implementation of intervention components in two intervention sites (El Paso, Texas and Ciudad Juarez, Mexico). Findings will be highly significant as we will be conducting parallel research on the effectiveness of interventions shown to be effective in Latino drug users in two very different contexts: El Salvador and the U.S-Mexico border. Findings will elucidate implementation challenges and barriers and such information can then be used to assess the effectiveness of diverse implementation strategies in organizations working to serve the needs of Latino drug users. PUBLIC HEALTH RELEVANCE: Findings will be highly significant as we will be conducting parallel research on the effectiveness of interventions shown to be effective in Latino drug users in two very different contexts: El Salvador and the U.S- Mexico border.",Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border,9254607,U01MD010657,"['Affect ', ' Awareness ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Cities ', ' Communities ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' El Salvador ', ' Epidemic ', ' Equipment ', ' Explosion ', ' facial ', ' faces ', ' Face ', ' Fear ', ' Fright ', ' Feedback ', ' Goals ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Immigration ', ' Injection of therapeutic agent ', ' Injections ', ' Interview ', ' Mexico ', ' Mission ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Social support ', ' social support network ', ' Surveys ', ' Survey Instrument ', ' Syringes ', ' Testing ', ' Texas ', ' Time ', ' Universities ', ' violent behavior ', ' violent ', ' Violence ', ' Police ', ' Latino ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' Social Network ', ' ethnographic ', ' Ethnography ', ' work setting ', ' Worksite ', ' Work-Site ', ' Work Place ', ' Work Location ', ' Job Site ', ' Job Setting ', ' Job Place ', ' Job Location ', ' Workplace ', ' base ', ' Site ', ' Area ', ' Phase ', ' Series ', ' Evaluation ', ' Border Crossings ', ' drug use ', ' Drug usage ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Needle-Exchange Programs ', ' Collaborations ', ' Liquid substance ', ' liquid ', ' fluid ', ' Drug user ', ' programs ', ' Event ', ' Side ', ' System ', ' Country ', ' meetings ', ' experience ', ' metropolitan ', ' Participant ', ' member ', ' Prevention ', ' social ', ' HIV risk ', ' Code ', ' Coding System ', ' response ', ' social stigma ', ' stigma ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Risk Reduction ', ' health disparity ', ' disparity in health ', ' Effectiveness ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Address ', ' Effectiveness of Interventions ', ' International ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Process ', ' sex ', ' informant ', ' substance abuse therapy ', ' substance abuse treatment ', ' designing ', ' design ', ' community organizations ', ' community based participatory research ', ' participatory action research ', ' community based research ', ' community based design ', ' implementation science ', ' combat ', ' public health relevance ', ' injection drug use ', ' peer networks ', ' violent crime ', ' ']",NIMHD,LEHIGH UNIVERSITY,U01,2017,462204,0.136020208412757
"Stress and Drug Use Vulnerability in the African American Community DESCRIPTION (provided by applicant): The impacts that drug addictions have on health disparities that adversely affect African Americans are grossly understudied. While there is strong evidence linking drug abuse to poor health and problem behaviors in the African American community, the progression of drug abuse is inconsistent (i.e., relatively late initiation and heavy use in the 30s) with national norms and remains unclear. Exposure to chronic stress and the subsequent activation of the hypothalamic-pituitary-adrenal (HPA) axis has been connected to drug addictions and poor health outcomes. This association is of particular importance since residents in these communities are exposed to many of the risk factors associated with the onset of drug abuse: familial risk, deprived social environment, unemployment, substandard education, low-to-no socioeconomic status, and enduring exposure to experiences of racism and discrimination. Repeated exposure to environmental stressors will lead to 'wear-and-tear' on the body's regulatory system and have profound implications on HPA functioning and the subsequent risk of developing an addiction. This study will pursue three primary aims: (1) Investigate HPA reactivity to acute stress as a predictor of current drug use severity. (2) Investigate trajectories of HPA regulation (level and circadian rhythm) as a predicto of drug use vulnerability across time. (3) Investigate delay discounting as a moderator between trajectories of HPA regulation and drug use vulnerability across time. This study will enroll 350 African American adults (ages 18-21) who reside in the southeastern U.S. and utilize a prospective longitudinal research design that consists of a laboratory assessment involving the Trier Social Stress Test, three in-home assessments that include clinical interviews and behavioral tasks, and six internet assessments that track drug use and related risk factors across a 2-year period. Primary independent variables include environmental stressors, stress-related biomarkers (i.e., salivary cortical, salivary DHEA, heart rate variability, and galvanic skn resistance), and delay discounting. Primary dependent variables include drug use, severity of drug use disorders, and drug use consequences. This study is highly innovative for three primary reasons: (1) A longitudinal research design will be used for the first time to investigate trajectories of HPA regulation as a predictor of drug use vulnerability; (2) The use of multiple indicators of the stress regulatory system, clinical interviews, and a novel behavioral task provides a more nuanced understanding of the research aims; and (3) This study focuses on an understudied population that suffers from drug-related health disparities, but are rarely included in cutting edge laboratory research. It is envisioned that this approach will uncover latent-curve trajectories of stress deregulation as a predictor of drug use vulnerability in this population. Findings from this study will identify causal mechanisms of drug addictions that will advance theory, research, prevention, and treatments aimed at addressing this growing public health problem. PUBLIC HEALTH RELEVANCE: The development of drug abuse in the African American community is often characterized by oversimplified models that are rooted in research studies that rarely include African Americans. This study will identify mechanisms that influence drug use vulnerability in at-risk African American adults who reside in the southeastern U.S. Such research is needed to develop socially and culturally informed prevention and treatment programs aimed at reducing drug-related health disparities that continue to plague African Americans.",Stress and Drug Use Vulnerability in the African American Community,9197280,R01DA034739,"['Cultural Assimilation ', ' Acculturation ', ' suprarenal gland ', ' Adrenals ', ' Adrenal Glands ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Affect ', ' ages ', ' Age ', ' Belief ', ' diurnal variation ', ' daily biorhythm ', ' circadian process ', ' circadian ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Diurnal Rhythm ', ' Circadian Rhythms ', ' Communities ', ' Crime ', ' Death ', ' Cessation of life ', ' Therapeutic Dehydroepiandrosterone ', ' Prasterone ', ' Dehydroisoandrosterone ', ' DHEA ', ' Androstenolone ', ' dehydroepiandrosterone ', ' Cognitive Discrimination ', ' Discrimination ', ' Downregulation ', ' Down-Regulation ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Educational aspects ', ' Education ', ' Gold ', ' Health ', ' Health behavior ', ' Proctocort ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Hydrocortisone ', ' Hypothalamic structure ', ' hypothalamic ', ' Hypothalamus ', ' Incidence ', ' Interview ', ' Laboratories ', ' Laboratory Research ', ' mortality ', ' Neighborhoods ', ' Pilot Projects ', ' pilot study ', ' Pituitary Gland ', ' Pituitary Nervous System ', ' Pituitary ', ' Hypophysis Cerebri ', ' Hypophysis ', ' Plague ', ' Yersinia pestis disease ', ' Psychotropic Drugs ', ' Psychopharmaceuticals ', ' Psychoactive Drugs ', ' Psychoactive Compound ', ' Psychoactive Agents ', ' Public Health ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Rewards ', ' Risk ', ' Risk Factors ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Stress ', ' Surveys ', ' Survey Instrument ', ' Time ', ' unemployed ', ' out of work ', ' joblessness ', ' jobless ', ' Unemployment ', ' violent behavior ', ' violent ', ' Violence ', ' Measures ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' improved ', ' Left ', ' Clinical ', ' racism ', ' Link ', ' mental ', ' Psyche structure ', ' Stimulus ', ' Spiritualities ', ' Spirituality ', ' Recovery ', ' Rural ', ' drug use ', ' Drug usage ', ' root ', ' Plant Roots ', ' Funding ', ' behavioral problem ', ' Problem behavior ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Exposure to ', ' Severities ', ' Salivary ', ' Home environment ', ' Home ', ' System ', ' environmental stressor ', ' experience ', ' hypothalamic-pituitary-adrenal axis ', ' hypothalmus-pituitary-adrenal axis ', ' hypothalamic-pituitary-adrenal (HPA) axis ', ' novel ', ' Prevention program ', ' treatment program ', ' research study ', ' Prevention ', ' social ', ' Impulsivity ', ' acute stress ', ' Regulation ', ' Modeling ', ' response ', ' theories ', ' drug development ', ' health disparity ', ' disparity in health ', ' Address ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Chronic stress ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' enroll ', ' Enrollment ', ' discount ', ' Behavioral ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' Clinical assessments ', ' Outcome ', ' discounting ', ' Population ', ' prospective ', ' Trier Social Stress Test ', ' innovation ', ' innovative ', ' innovate ', ' Resistance ', ' resistant ', ' disability burden ', ' addiction ', ' addictive disorder ', ' public health relevance ', ' multimodality ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' heart rate variability ', ' constriction ', ' longitudinal design ', ' injury burden ', ' behavioral economics ', ' drug use vulnerability ', ' vulnerability to drug use ', ' illicit drug use ', ' ']",NIDA,UNIVERSITY OF HOUSTON,R01,2017,389887,0.21249262221003148
"Health disparity in pharmacogenomics: African American SNPs and drug metabolism DESCRIPTION (provided by applicant): As pharmacogenomics moves from bench-top to bed-side, African Americans have been left out of the advances personalized medicine holds. To date, African Americans have been largely absent from the numerous pharmacogenetic studies that identify predictive single nucleotide polymorphisms (SNPs) that are being used clinically to improve care. As we move toward more comprehensive bioinformatics and high- throughput methods of evaluating the genome for functionally relevant SNPs that affect drug phenotypes, we are also producing a growing health disparity in the translation of these findings into the clinic for African Americans. Current genomic methods are trying to reach beyond genome-wide association in hopes of finding biological plausibility to genetic findings. This search has led to the use of expression quantitative trait loci (eQTLs) as a tool in pharmacogenetic association studies. SNPs labeled as eQTLs have intrinsic biological plausibility since they are significantly associated with changes in gene expression. However, no liver eQTL studies have been conducted in African Americans. By using liver-specific eQTLs, we will discover SNPs that affect drug metabolizing enzymes (DMEs), which will have wide-spread scientific and clinical impact; given that most drugs currently prescribed undergo some form of hepatic metabolism. Because of the increase genetic diversity found in African Americans, they may carry population specific SNPs can never be found by pharmacogenomics studies in populations of European-descent alone. Without African American focused pharmacogenomics studies we risk excluding African Americans from personalized medicine. We plan to use primary hepatocytes to conduct gene expression studies both before and after drug enzyme induction to identify genes that are differentially expressed. Drug enzyme induction is driven by increased gene transcription; therefore, by focusing on the genes that are differentially expressed after induction we can pin-point the drivers (i.e. genes) that regulate drug metabolizing enzymes. We will then look at SNPs within and in close proximity to these genes to determine if any are associated with differences in gene expression (dubbed DI-eQTLs). We will then look to see if these DI-eQTLs are associated with pharmacokinetic measures in the same set of cell cultures, affectedly preforming a pharmacokinetic and a pharmacogenetic study in the same individual. We hypothesize that drug enzyme induction will provide us with DI-eQTLs that are strongly associated to drug pharmacokinetics, a clinically relevant phenotype. To validate these findings we will query publically available data to look for an enrichment of our DI-eQTLs within the most strongly associated SNPs in pharmacogenomic GWAS data. The association between genotype, gene expression and drug pharmacokinetics in African Americans has never been conducted before and will provide an invaluable resource for pharmacogenomics and clinical pharmacology, as well as clinical translation in this understudied population. PUBLIC HEALTH RELEVANCE: The proposed studies will help identify genetic mutations that affect drug metabolism in African Americans, an under-studied population in pharmacogenomics. The discovery of these novel mutations will lead to better dosing of drugs that require the liver for metabolism and potentially less side-effects from these medications. By studying the genetic mutations that affect drug metabolism in African Americans we can more fully incorporate this population into personalized medicine.",Health disparity in pharmacogenomics: African American SNPs and drug metabolism,9264413,R01MD009217,"['Affect ', ' Africa ', ' ages ', ' Age ', ' Engineering / Architecture ', ' Architecture ', ' Biology ', ' cell culture ', ' Cell Culture Techniques ', ' Cell Body ', ' Cells ', ' Disorder ', ' Disease ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' Enzyme Induction ', ' Enzyme Gene ', ' Enzymes ', ' Gene Expression ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' Genotype ', ' In Vitro ', ' Learning ', ' Linkage Disequilibrium ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Medicine ', ' Methods ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Pharmacogenetics ', ' Drug Kinetics ', ' Pharmacokinetics ', ' Pharmacology ', ' Clinical Pharmacology ', ' Phenotype ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Translations ', ' Drug Side Effects ', ' Adverse drug effect ', ' Genetic Diversity ', ' Genetic Variation ', ' white race ', ' Occidental ', ' Caucasoid Race ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Caucasians ', ' Measures ', ' Treatment outcome ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Caring ', ' DNA Sequence ', ' Label ', ' improved ', ' Left ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Ensure ', ' Liver Cells ', ' Hepatic Parenchymal Cell ', ' Hepatic Cells ', ' Hepatocyte ', ' Individual ', ' African ', ' European ', ' drug use ', ' Drug usage ', ' Genetic ', ' tool ', ' Complex ', ' Clinic ', ' System ', ' American ', ' Quantitative Trait Loci ', ' QTL ', ' trait ', ' Structure ', ' novel ', ' drug metabolism ', ' drug clearance ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Code ', ' Coding System ', ' Regulation ', ' Sampling ', ' response ', ' Adverse event ', ' Adverse Experience ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Genomics ', ' Pharmacogenomics ', ' Bioinformatics ', ' Bio-Informatics ', ' health disparity ', ' disparity in health ', ' prevent ', ' preventing ', ' genetic association ', ' liver metabolism ', ' hepatic metabolism ', ' Dose ', ' DNA Sequence Alteration ', ' genomic alteration ', ' Sequence Alteration ', ' Genetic mutation ', ' DNA mutation ', ' DNA Alteration ', ' Data ', ' Prediction of Response to Therapy ', ' predictive of drug response ', ' prediction of response ', ' Regulatory Pathway ', ' Resolution ', ' in vivo ', ' Process ', ' protein function ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' Minority ', ' cost effective ', ' cost-effective ', ' Population ', ' clinically relevant ', ' clinical relevance ', ' public health relevance ', ' clinical care ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' Genetic study ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' study population ', ' clinical translation ', ' ']",NIMHD,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2017,393750,0.07890808701269215
"The Development and Evaluation of the Ho'ouna Pono Drug Prevention Curriculum     DESCRIPTION (provided by applicant): Research has indicated that Native Hawaiian youth have significantly higher rates of drug use than their non-Hawaiian counterparts (e.g., Wong, Klingle, & Price, 2004; Mayeda, Hishinuma, Nishimura, Garcia- Santiago, & Mark, 2006; Nishimura, Hishinuma, & Goebert, 2013), and that these differences are particularly pronounced in rural settings (Lai & Saka, 2005). Despite these findings, there have been very few drug prevention programs developed and evaluated specifically for these youth (Edwards, Giroux, & Okamoto, 2010; Rehuher, Hiramatsu, & Helm, 2008). Therefore, the purpose of this research proposal is to complete the development of a video-enhanced, culturally grounded, school-based drug prevention curriculum for rural Native Hawaiian youth (Ho'ouna Pono), and to evaluate the curriculum across all public middle/intermediate schools on Hawai'i Island. This will be accomplished through three specific aims. AIM 1 (Year 1) is to complete the Ho'ouna Pono drug prevention curriculum initially developed and validated in a NIDA-funded translational pilot/feasibility study (R34 DA031306). To date, five professionally filmed video vignettes depicting drug-related problem situations specific to rural Hawaiian youth and seven interactive classroom lessons have been created, implemented in randomly selected intervention schools, and preliminarily evaluated using a pre-test, post-test control group design. Aim 1 enhances and builds upon this work by producing two new video vignettes, re-editing a ""Behind the Scenes"" video, developing new classroom curricular components, and synthesizing the new content with the existing curriculum. AIM 2 (Years 2-3) is to evaluate the fully conceived curriculum across all middle/intermediate schools on Hawai'i Island (N = 15) using a dynamic wait- listed control group design (Brown, Wyman, Guo, & Pea, 2006). AIM 3 (Year 4) is to assess community, systemic, and curricular factors related to the implementation, adoption, and sustainability of the curriculum within public middle/intermediate schools on Hawaii Island. PUBLIC HEALTH RELEVANCE: Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have recently been shown to have significantly higher rates of drug use compared with other ethnic groups (Wu et al., 2013), research focused on drug prevention of these individuals is important to improve public health both in Hawai'i and on the Mainland U.S. This study actively engages rural communities in the full-scale development and evaluation of the Ho'ouna Pono drug prevention curriculum for Hawaiian youth, promoting the overall utility and effectiveness of the intervention. Further, the findings from this study will point to the core content of prevention interventions for Hawaiian youth in rural communities, which should be applicable to other ethnic youth populations in Hawaii and the Pacific Rim, as well as Native youth populations on the Mainland U.S.",The Development and Evaluation of the Ho'ouna Pono Drug Prevention Curriculum,9264517,R01DA037836,"['Adoption ', ' Communities ', ' Control Groups ', ' lesson plans ', ' Curriculum ', ' Educational Curriculum ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' ethnicity group ', ' Ethnic group ', ' Feasibility Studies ', ' Hawaii ', ' Island ', ' Public Health ', ' Research ', ' Research Proposals ', ' Rural Health ', ' Schools ', ' Science ', ' Testing ', ' Time ', ' Waiting Lists ', ' Work ', ' Measures ', ' pricing ', ' Price ', ' Film ', ' Rural Community ', ' Youth 10-21 ', ' Youth ', ' base ', ' improved ', ' Evaluation ', ' Individual ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' drug use ', ' Drug usage ', ' Funding ', ' Hawaiian population ', ' Hawaiian ', ' Outcome Study ', ' cohort ', ' Prevention Research ', ' Prevention ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' health disparity ', ' disparity in health ', ' Address ', ' Effectiveness of Interventions ', ' Indigenous ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' designing ', ' design ', ' Population ', ' Drug Prevention Program ', ' native youth ', ' community based participatory research ', ' participatory action research ', ' community based research ', ' community based design ', ' public health relevance ', ' intervention effect ', ' efficacy testing ', ' health equity ', ' rural setting ', ' Native Hawaiian ', ' ']",NIDA,HAWAII PACIFIC UNIVERSITY,R01,2017,404762,0.11304276041447972
"Institute for Translational Research Education (ITRE) in Adolescent Drug Abuse Abstract The applicant proposes the continued development and expansion of a successful research education program for graduate level students and professionals to acquire innovative research skills to address drug abuse and related behavioral health concerns of children and adolescents. Implementation Science continues to be at the forefront of innovative research education; the Institute for Translational Research and Education in Adolescent Drug Abuse (ITRE) will focus on training clinical researchers in implementation research methods, translation of research into community practice, and the practical skills of participatory research. A cross-disciplinary approach, involving multiple colleges at the University of South Florida and Northern Arizona University, as well as local community service agencies, has been developed with special attention to evidence-based practice, translational research, and children and adolescents as an at-risk population. Our new emphasis is on addressing research education with an expanded target of behavioral health researchers with interests in working with at-risk populations including children and families of AI descent and Hispanic populations who have drug abuse and other co-morbid behavioral health conditions, defined as the array of mental, emotional and behavioral disorders of childhood that, along with drug abuse, have devastating effects on adolescent development. Project Narrative This project proposes the continued development and expansion of an innovative model of research education that addresses best practices for translational research in the field of child and adolescent behavioral health, as it relates to substance abuse and co-occurring disorders with an emphasis on at-risk populations including children and families of AI descent and Hispanic populations.",Institute for Translational Research Education (ITRE) in Adolescent Drug Abuse,9314935,R25DA031103,"['Achievement Attainment ', ' Achievement ', ' Arizona ', ' Attention ', ' behavioral disorder ', ' Behavior Disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Clinical Study ', ' Clinical Research ', ' Communities ', ' Community Services ', ' lesson plans ', ' Curriculum ', ' Educational Curriculum ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Educational aspects ', ' Education ', ' Graduate Education ', ' Family ', ' Florida ', ' Foundations ', ' Goals ', ' services research ', ' Medical Care Research ', ' Health Services Evaluation ', ' Health Services Research ', ' Institutes ', ' Mentors ', ' Methods ', ' Nomads ', ' Migrant ', ' Newsletter ', ' Peer Review ', ' Publishing ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Students ', ' Translations ', ' Universities ', ' symposia ', ' summit ', ' convention ', ' conference ', ' symposium ', ' Family member ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Research Methods ', ' Research Methodology ', ' Magazine ', ' Journals ', ' career ', ' rural area ', ' urban area ', ' Clinical ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' co-occurring disorders ', ' Psychiatric Dual Diagnosis ', ' dual diagnosis ', ' Ensure ', ' Evaluation ', ' Training ', ' pediatric ', ' Childhood ', ' Emotional disorder ', ' Fostering ', ' Populations at Risk ', ' Funding ', ' Immigrant ', ' farm worker ', ' farmworker ', ' Knowledge ', ' programs ', ' interest ', ' college ', ' collegiate ', ' Services ', ' experience ', ' success ', ' Distance Learning ', ' skills ', ' Participant ', ' cultural competence ', ' member ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Modeling ', ' Adolescent Development ', ' behavioral health ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Provider ', ' health disparity ', ' disparity in health ', ' Address ', ' Evidence based practice ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Public Health Education ', ' Public Health Training ', ' Public Health Instruction ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Community Practice ', ' translation research ', ' Translational Science ', ' Translational Research ', ' developmental ', ' Development ', ' Clinical Services ', ' website ', ' web site ', ' youth drug abuse ', ' adolescent drug abuse ', ' implementation research ', ' underserved people ', ' under served population ', ' Underserved Population ', ' Minority ', ' Outcome ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Evidence based program ', ' implementation science ', ' community setting ', ' educational atmosphere ', ' university atmosphere ', ' training atmosphere ', ' school atmosphere ', ' learning environment ', ' learning atmosphere ', ' intellectual atmosphere ', ' educational environment ', ' education atmosphere ', ' collegiate atmosphere ', ' collegial atmosphere ', ' college atmosphere ', ' classroom environment ', ' certificate program ', ' Community of Practice ', ' curriculum enhancement ', ' curriculum expansion ', ' curricular enrichment ', ' learning outcome ', ' service learning ', ' service-based learning ', ' social media ', ' Minority Recruitment ', ' recruiting minorities ', ' education research ', ' ']",NIDA,UNIVERSITY OF SOUTH FLORIDA,R25,2017,326433,0.060157728196497215
"Strengthening Hispanic Families via NIDA Prevention Science DESCRIPTION (provided by applicant): These application requests 5 years of K01 support to accelerate the NIDA-focused interdisciplinary research career development of Dr. Ruben Parra-Cardona, a clinician-researcher who seeks to become an independent NIDA prevention researcher committed to underserved Hispanic adolescents and families. His current research evaluates a cultural adaptation of an evidence-based parenting intervention for at-risk Hispanic families with young children (ages 4-11), for which there is potential distal NIDA impact such as reduced risk of starting to smoke tobacco or to use other drugs. Complete evidence on distal benefits of early randomized trial interventions of this type cannot be seen unless the scale of research shifts upward, as in multi-site trials, and unless the measurements include bio-assays to confirm self-report drug use, with probes for potential gene- intervention interactions. Based on the proposed K01 career training objectives, the applicant will acquire the necessary skills to develop an interdisciplinary program of prevention research, informed by epidemiological and biomedical science. During 75% protected time for career development toward independent R01 project leadership, core learning objectives will be met (e.g., RCR, FCOI, grants management). In addition to its core, the training plan has 5 tracks: (1) enhanced mastery of small sample parenting intervention research; (2) enhanced mastery of research design and measurements for larger sample multi-site NIDA prevention research on youth developmental trajectories leading toward NIDA outcomes; (3) enhanced mastery of data analysis for interdependent observations from multiple sites; (4) new learning about integration of biological assays in NIDA family intervention and prevention research via collaborations with expert NIH toxicologists and genetics researchers; (5) mastery of electronic technology complements to current 'in person' intervention delivery and program impact assessment. The proposed award is crucial now that the applicant has become K01-eligible via permanent residency. His college has guaranteed protected time for this K01 career acceleration through structured mentoring program led by a NIDA K05 Senior Scientist, backed by a strong local team of federally funded co-mentors, as well as scientific advisors. Through the proposed K01 award, Dr. Parra-Cardona will gain mastery of the theory and research approaches now being refined by quantitative developmental scientists in new lines of NIDA prevention research. The training plan includes guided readings, coursework, among other activities leading to publications. A prevention pilot study will serve as a 'preliminary study' for a NIDA R01 grant proposal planned for Year 4 of the proposed award. This application is responsive to NIH and NIDA's strategic plans highlighting the need to implement interdisciplinary programs of research aimed at preventing young people from ever using drugs, as well as ensuring that at-risk and underserved minority populations benefit from these scientific efforts. PUBLIC HEALTH RELEVANCE: NIH and NIDA strategic goals stress (1) encouraging more minority scientists to pursue research careers bolstering their chances of R01 project success, and (2) interdisciplinary research programs on preventing young people from ever using drugs, and ensuring that at-risk and underserved minority populations benefit from these scientific efforts. The proposed K01 award is directly responsive to these strategic goals.",Strengthening Hispanic Families via NIDA Prevention Science,9459727,K01DA036747,"['collegiate ', ' American ', ' experience ', ' stressor ', ' success ', ' Cigarette ', ' Structure ', ' skills ', ' simulation ', ' Participant ', ' Prevention Research ', ' Prevention program ', ' research study ', ' Patient Self-Report ', ' Self-Report ', ' cultural values ', ' binge drinking ', ' episodic drinking ', ' binge alcohol consumption ', ' Heavy Drinking ', ' heavy alcohol use ', ' extreme drinking ', ' excessive ethanol ingestion ', ' excessive drinking ', ' excessive alcohol intake ', ' excessive alcohol ingestion ', ' excessive alcohol consumption ', ' excess ethanol ingestion ', ' excess alcohol ingestion ', ' excess alcohol consumption ', ' drink heavily ', ' Prevention ', ' Reporting ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Intervention Trial ', ' Interventional trial ', ' Modeling ', ' Sampling ', ' career development ', ' response ', ' theories ', ' junior high school ', ' middle school ', ' junior high ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' health disparity ', ' disparity in health ', ' prevent ', ' preventing ', ' Low income ', ' Address ', ' Data ', ' Applications Grants ', ' Grant Proposals ', ' High Prevalence ', ' Mentored Research Scientist Development Award ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Request for Applications ', ' NIH RFA ', ' Strategic Planning ', ' Senior Scientist ', ' Monitor ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' early onset ', ' cost ', ' early initiation drug use ', ' early onset drug use ', ' efficacy evaluation ', ' willingness ', ' externalizing behavior ', ' Outcome ', ' Population ', ' Prevalence ', ' therapy design ', ' treatment design ', ' intervention design ', ' high risk ', ' public health relevance ', ' evidence base ', ' multi-site trial ', ' intervention effect ', ' randomized trial ', ' Randomization trial ', ' reduced substance use ', ' substance use reduction ', ' reduction in substance use ', ' Prevention trial ', ' marijuana use ', ' cannabis use ', ' underserved minority ', ' minority scientist ', ' Acceleration ', ' ages ', ' Age ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Award ', ' Dorsum ', ' Back ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' childrearing ', ' Parenting behavior ', ' Parenting ', ' Child Rearing ', ' Complement Proteins ', ' Complement ', ' Cuban American ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' depression ', ' Mental Depression ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Protocol Screening ', ' Eligibility ', ' Eligibility Determination ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Family ', ' Foundations ', ' Future ', ' Genes ', ' Goals ', ' Grant ', ' Health ', ' Intervention Studies ', ' interventions research ', ' interventional study ', ' interventional research ', ' intervention research ', ' Leadership ', ' Learning ', ' Mentors ', ' Methodology ', ' Mexican Americans ', ' Chicanos ', ' Chicanas ', ' Michigan ', ' Persons ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Oregon ', ' Parents ', ' Pilot Projects ', ' pilot study ', ' Publications ', ' Scientific Publication ', ' Puerto Rican ', ' Reading ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Residencies ', ' Risk ', ' Science ', ' Smoke ', ' Stress ', ' Substance Addiction ', ' Substance Dependence ', ' Target Populations ', ' Technology ', ' Testing ', ' Time ', ' Tobacco ', ' United States ', ' Generations ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Youth 10-21 ', ' Youth ', ' base ', ' career ', ' Distal ', ' Site ', ' Biological ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Ensure ', ' Training ', ' Stimulus ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' school age ', ' School-Age Population ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' drug use ', ' Drug usage ', ' Sample Size ', ' Genetic Research ', ' Funding ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Genetic ', ' Specimen ', ' Research Specimen ', ' Empirical Research ', ' programs ', ' Scientist ', ' System ', ' college ', ' ']",NIDA,"UNIVERSITY OF TEXAS, AUSTIN",K01,2017,174935,0.06448522081204047
"Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM) PROJECT SUMMARY/ABSTRACT  This application is for a competing renewal of the Center for Prevention Implementation Methodology for HIV and Drug Abuse, a NIDA P30 Center of Excellence. The number of new HIV cases in the US remains stable at 56,000 per year and continues to disproportionately affect some groups, including young men who have sex with men (YMSM), especially from racial/ethnic minorities. The purpose of this methodology center is to develop new methodologies that can be used by federal and local agencies and communities to reduce HIV incidence. Biomedical interventions and strategies, including pre-exposure prophylaxis (PrEP), rapid testing for HIV and early and consistent treatment for persons who are HIV positive (Treatment as Prevention, TasP) have been shown to have high efficacy and effectiveness in reducing HIV transmission, but there remains a giant gap between what research knows and what services needed to reduce population level incidence of HIV. The major premise of this application is that the effective biomedical to reduce HIV incidence and disparities are in hand, but success will only be achieved when they are implemented in ways that meet individual, community, and health care delivery system needs. This methods proposal addresses this major gap between research and practice through implementation science and methodology, focusing on innovative ways to address the complex, mulitilevel interactions needed to implement HIV prevention programs effectively. Two Cores, an Administrative Core and an Innovative Implementation Methods Core for HIV and Drug Abuse will carry out this work.  Aim 1 is to develop innovative methods to maximize the impact of implementation research in HIV prevention. We do this through an extended set of systems science and engineering methods that focus on improving the measurement of implementation, the modeling of implementation strategies, and the testing of implementation strategies through rigorous trials. Five qualifying grants support this work.  Aim 2 is to apply these innovative methods to close the gap between existing research, policy, and practice for HIV prevention. In addition to working closely with our five qualifying grants, we work locally with municipal Departments of Public Health and the federal Substance Abuse and Mental Health Services Administration (SAMHSA) HIV programs to identify and prioritize gaps in knowledge, find optimal implementation strategies for reduction of HIV transmission, and design the next large implementation trials.  Aim 3 is to disseminate methods and train/mentor leaders at the intersection of HIV prevention, implementation science, and drug abuse fields to improve implementation of HIV prevention programs. This involves mentoring the early career researchers, publishing, and providing training to networks of HIV and drug abuse researchers. PROJECT NARRATIVE There are numerous rigorously evaluated prevention programs involving biomedical interventions for preventing HIV that have demonstrated impact in efficacy and effectiveness trials. Pre-exposure prophylaxis, HIV testing, and early and consistent antiretroviral treatment have high potential for preventing HIV infections, but these are yet to be implemented sufficiently in racial/ethnic minority communities. This Ce-PIM addresses the critical methods gaps that are holding back the movement of these programs from research to practice.",Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM),9454971,P30DA027828,"['Affect ', ' ages ', ' Age ', ' Dorsum ', ' Back ', ' Behavior ', ' Biomedical Research ', ' Communities ', ' Decision Making ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Cognitive Discrimination ', ' Discrimination ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Engineering ', ' ethnicity group ', ' Ethnic group ', ' Feedback ', ' Gender Identity ', ' Goals ', ' Grant ', ' Hand ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' HIV Antibody Positivity ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' HIV Seropositivity ', ' Incidence ', ' Long-Term Care ', ' extended care ', ' Mentors ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Methods ', ' Methodology ', ' Biological Models ', ' Model System ', ' Biologic Models ', ' Movement ', ' body movement ', ' Persons ', ' Play ', ' Public Health ', ' Publishing ', ' Quality of life ', ' QOL ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Science ', ' Seeds ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Technology ', ' Testing ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' United States Substance Abuse and Mental Health Services Administration ', ' General Viruses ', ' Virus ', ' visual function ', ' Sight ', ' Vision ', ' Work ', ' P30 Protein ', ' P30 ', ' P-30 Protein ', ' ranpirnase ', ' Gender ', ' Generations ', ' Community Health Care ', ' Community Healthcare ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' ecstasy ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' base ', ' career ', ' improved ', ' Sexual Orientation ', ' Sex Orientation ', ' Training ', ' Individual ', ' Policies ', ' Measurement ', ' drug use ', ' Drug usage ', ' Ethnicity ', ' Ethnic Origin ', ' tool ', ' Knowledge ', ' programs ', ' Viral Load result ', ' Viral Load ', ' Viral Burden ', ' Complex ', ' Pattern ', ' System ', ' Services ', ' success ', ' care delivery ', ' Anti-Retroviral Agents ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' Municipalities ', ' novel ', ' Prevention program ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Early identification ', ' Modeling ', ' social stigma ', ' stigma ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' scientific organization ', ' Effectiveness ', ' prevent ', ' preventing ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Address ', ' High Prevalence ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Qualifying ', ' Transmission ', ' transmission process ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' socioeconomics ', ' developmental ', ' Development ', ' effectiveness trial ', ' implementation trial ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' implementation research ', ' designing ', ' design ', ' next generation ', ' efficacy trial ', ' Outcome ', ' Prevention approach ', ' Approaches to prevention ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' ethnic minority population ', ' ethnic minority ', ' Early treatment ', ' early therapy ', ' racial and ethnic ', ' implementation science ', ' research to practice ', ' research into practice ', ' cocaine use ', ' young men who have sex with men ', ' young MSM ', ' YMSM ', ' black men who have sex with men ', ' black MSM ', ' BMSM ', ' African-American men who have sex with men ', ' African American MSM ', ' AAMSM ', ' support tools ', ' minority communities ', ' pre-exposure prophylaxis ', ' PrEP ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,P30,2017,39917,0.08917754346937293
"The Development and Evaluation of the Ho'ouna Pono Drug Prevention Curriculum     DESCRIPTION (provided by applicant): Research has indicated that Native Hawaiian youth have significantly higher rates of drug use than their non-Hawaiian counterparts (e.g., Wong, Klingle, & Price, 2004; Mayeda, Hishinuma, Nishimura, Garcia- Santiago, & Mark, 2006; Nishimura, Hishinuma, & Goebert, 2013), and that these differences are particularly pronounced in rural settings (Lai & Saka, 2005). Despite these findings, there have been very few drug prevention programs developed and evaluated specifically for these youth (Edwards, Giroux, & Okamoto, 2010; Rehuher, Hiramatsu, & Helm, 2008). Therefore, the purpose of this research proposal is to complete the development of a video-enhanced, culturally grounded, school-based drug prevention curriculum for rural Native Hawaiian youth (Ho'ouna Pono), and to evaluate the curriculum across all public middle/intermediate schools on Hawai'i Island. This will be accomplished through three specific aims. AIM 1 (Year 1) is to complete the Ho'ouna Pono drug prevention curriculum initially developed and validated in a NIDA-funded translational pilot/feasibility study (R34 DA031306). To date, five professionally filmed video vignettes depicting drug-related problem situations specific to rural Hawaiian youth and seven interactive classroom lessons have been created, implemented in randomly selected intervention schools, and preliminarily evaluated using a pre-test, post-test control group design. Aim 1 enhances and builds upon this work by producing two new video vignettes, re-editing a ""Behind the Scenes"" video, developing new classroom curricular components, and synthesizing the new content with the existing curriculum. AIM 2 (Years 2-3) is to evaluate the fully conceived curriculum across all middle/intermediate schools on Hawai'i Island (N = 15) using a dynamic wait- listed control group design (Brown, Wyman, Guo, & Pea, 2006). AIM 3 (Year 4) is to assess community, systemic, and curricular factors related to the implementation, adoption, and sustainability of the curriculum within public middle/intermediate schools on Hawaii Island. PUBLIC HEALTH RELEVANCE: Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have recently been shown to have significantly higher rates of drug use compared with other ethnic groups (Wu et al., 2013), research focused on drug prevention of these individuals is important to improve public health both in Hawai'i and on the Mainland U.S. This study actively engages rural communities in the full-scale development and evaluation of the Ho'ouna Pono drug prevention curriculum for Hawaiian youth, promoting the overall utility and effectiveness of the intervention. Further, the findings from this study will point to the core content of prevention interventions for Hawaiian youth in rural communities, which should be applicable to other ethnic youth populations in Hawaii and the Pacific Rim, as well as Native youth populations on the Mainland U.S.",The Development and Evaluation of the Ho'ouna Pono Drug Prevention Curriculum,9480129,R01DA037836,"['Adoption ', ' Communities ', ' Control Groups ', ' lesson plans ', ' Curriculum ', ' Educational Curriculum ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' ethnicity group ', ' Ethnic group ', ' Feasibility Studies ', ' Hawaii ', ' Island ', ' Public Health ', ' Research ', ' Research Proposals ', ' Rural Health ', ' Schools ', ' Science ', ' Testing ', ' Time ', ' Waiting Lists ', ' Work ', ' Measures ', ' pricing ', ' Price ', ' Film ', ' Rural Community ', ' Youth 10-21 ', ' Youth ', ' base ', ' improved ', ' Evaluation ', ' Individual ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' drug use ', ' Drug usage ', ' Funding ', ' Hawaiian population ', ' Hawaiian ', ' Outcome Study ', ' cohort ', ' Prevention Research ', ' Prevention ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' health disparity ', ' disparity in health ', ' Address ', ' Effectiveness of Interventions ', ' Indigenous ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' designing ', ' design ', ' Population ', ' Drug Prevention Program ', ' native youth ', ' community based participatory research ', ' participatory action research ', ' community based research ', ' community based design ', ' public health relevance ', ' intervention effect ', ' efficacy testing ', ' health equity ', ' rural setting ', ' Native Hawaiian ', ' ']",NIDA,HAWAII PACIFIC UNIVERSITY,R01,2017,6307,0.11304276041447972
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network     DESCRIPTION:  The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PUBLIC HEALTH RELEVANCE: This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9471536,UG1DA015815,"['etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' American Indian ', ' American Indians ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Educational aspects ', ' Education ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' Hepatitis C virus ', ' HCV infection ', ' HCV ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methadone ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methods ', ' Naloxone ', ' Narcanti ', ' Narcan ', ' Persons ', ' Oregon ', ' Overdose ', ' Patients ', ' Peer Review ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Registries ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Rural Health ', ' Safety ', ' San Francisco ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Opioid ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' Services ', ' experience ', ' care delivery ', ' Participant ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' drug abuse prevention ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' disparity in health ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' designing ', ' design ', ' urban Indian ', ' urban American Indian ', ' urban Native American ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addiction ', ' addictive disorder ', ' public health relevance ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' health service use ', ' health service utilization ', ' data resource ', ' rural Americans ', ' therapeutic candidate ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2017,901841,0.08695097140668363
"Couples-based intervention to reduce drug use and HIV transmission Project Summary YMSM in relationships with other men face unique and compounded risk factors for both drug use and HIV infection. Their vulnerability is unique from older MSM, unpartnered MSM and their heterosexual peers. This enhanced vulnerability emerges as exactly the developmental period when the establishment of romantic relationships emerges as salient. Despite their unique vulnerability for HIV infection and challenges related to drug use, there are very few couples- based intervention options for YMSM. There are presently no brief, couples-based interventions which integrate a focus on drug use and HIV prevention. The proposed study is geared toward the development of such an intervention. The only individually delivered intervention for YMSM to show significant reductions in both drug use and sexual HIV transmission risk behavior, the Young Mens Health Project (YMHP) was developed by members of this research team. YMHP focused on sexual risk in the context of casual partners. Beginning with this framework, our team has completed the initial stages of revising YMHP for use with couples, resulting in the creation of the Couples Health Project (CHP). Our formative work suggests that the prototype intervention is feasible and acceptable to participants. The next step is to develop components of the intervention which address pre- exposure prophylaxis (PrEP) uptake and to determine how best to integrate biological testing for STIs and drug use into the study. The new intervention will be informed by qualitative data gathered from intervention sessions delivered in our formative work and from qualitative interviews conducted with 20 HIV negative partnered YMSM. The final 28 months of the project are devoted to a randomized controlled trial (RCT) comparing CHP to an attention-matched educational control condition. The study team is led by Dr. Tyrel J. Starks (PI), a new investigator with substantial experience in the study of gay male couples. He has collaborated on numerous projects examining the nature of sexual agreements and their association with substance use and HIV transmission risk behavior. He is supported by a study team which includes Dr. Jeffrey Parsons, the PI of the original YMHP study. The team brings extensive experience in quantitative and qualitative data analysis, HIV prevention research, and specifically intervention development. Project Narrative  Public Health Significance HIV prevention strategies that address the specific needs of YMSM in stable relationships with other men are needed in response to accumulating evidence which points to the unique vulnerability of these men. The proposed project builds upon an effective individual intervention, the Young Mens Health Project, to develop a couples-based intervention which addresses drug use and sexual HIV transmission risk among partnered HIV negative YMSM (ages 18-29). Preliminary work by our research team has produced a prototype manual, and provided compelling evidence of feasibility and acceptability. The proposed project will revise this prototype manual to enhance the focus on pre-exposure prophylaxis (PrEP) and to incorporate biological testing for drug use and STIs into the study. During Phase II, a small randomized controlled trial (RCT) involving 50 couples will test the feasibility, acceptability, and preliminary efficacy of the new intervention relative to an attention-matched educational control.",Couples-based intervention to reduce drug use and HIV transmission,9346829,R34DA043422,"['Accounting ', ' ages ', ' Age ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Amphetamines ', ' Attention ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' Communication ', ' Counseling ', ' Couples ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' facial ', ' faces ', ' Face ', ' Feedback ', ' Goals ', ' Gonococcal Infection ', ' Gonorrhea ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incidence ', ' Infection ', ' Interview ', ' Joints ', ' Ketamine ', ' male ', ' Manuals ', ' Marijuana ', ' marihuana ', ' men ', "" men's "", ' Motivation ', ' Nitrates ', ' NO3- ', ' Public Health ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Rosa ', ' Rose ', ' Testing ', ' United States ', ' Work ', ' free base cocaine ', ' Crack Cocaine ', ' Latino ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' ecstasy ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' AIDS prevention ', ' base ', ' Phase ', ' Link ', ' Training ', ' Fingernail ', ' Finger Nail ', ' Structure of nail of finger ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' drug use ', ' Drug usage ', ' Gays ', ' uptake ', ' Anal Sex ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Couples Therapy ', ' Contracts ', ' Contracting Opportunities ', ' Nature ', ' Source ', ' experience ', ' 4-hydroxybutyric acid ', ' gamma-hydroxybutyric acid ', ' Structure ', ' skills ', ' Participant ', ' Prevention Research ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' prevention service ', ' peer ', ' member ', ' Agreement ', ' motivational enhancement therapy ', ' motivational interview ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Sampling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' health disparity ', ' disparity in health ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Address ', ' Adherence ', ' Biological Testing ', ' Data ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Update ', ' Transmission ', ' transmission process ', ' Preparation ', ' sex ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Heterosexuals ', ' Behavioral ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' male health ', "" men's health "", ' trial comparing ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' prototype ', ' standard of care ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' follow up assessment ', ' young man ', ' adolescent men ', ' adolescent man ', ' same-sex partnership ', ' same-sex couple ', ' same sex relationship ', ' same sex partner ', ' sexual HIV transmission ', ' young men who have sex with men ', ' young MSM ', ' YMSM ', ' efficacy study ', ' pre-exposure prophylaxis ', ' PrEP ', ' ']",NIDA,HUNTER COLLEGE,R34,2017,222300,0.0832515560440776
"Methamphetamine Research Program at Meharry Medical College DESCRIPTION (provided by applicant): The long-range goal of the proposed DIDARP program described in this application is to continue to increase the capacity of Meharry Medical College to conduct rigorous research in substance use disorders with an [ emphasis on health disparities and underserved populations. The research program will seek to understand the molecular underpinnings of acute and chronic methamphetamine (METH) exposure alone and in conjunction with human immunodeficiency virus (HIV) infection. We also plan to strengthen pur intellectual environment and enhance the interest levels of trainees and faculty in drug abuse research. New for this j application is the proposal to introduce training on screening and brief interventions for substance misuse to medical students, residents and faculty in the Family and Community Medicine clinics. The Specific Aims of the Meharry Medical College DIDARP Program during the next five years are: 1. To publish at least 20 or more peer-reviewed publications in high-impact journals in drug abuse research; 2. To submit 5 or more grant applications in drug abuse research by Year-03 of the award period; | 3. To acquire 3 or more investigator-initiated awards by the end of year-05; and 4. To stimulate additional faculty and trainee interest in drug abuse research by curricula enhancement, ' seminars and symposia. . Three projects are proposed, one primary proposal and two pilot projects. In the primary project, Dr. CV. ] Dash will seek to understand the link between METH abuse and HIV infection. In the first pilot project, Dr. J. Shawn Goodwin will study how METH abuse alters dopamine signaling by altering the dopamine transporter residency in lipid rafts. In second pilot project, Dr. Khilber and her collaborators which includes the PI and the Chair of Family and Community Medicine, Dr. Roger Zoorob, will test the effects of a tiered training program on screening, brief intervention and referral to treatment (SBIRT) for substance misuse fo ",Methamphetamine Research Program at Meharry Medical College,9193071,R24DA036420,"['HIV-related dementia ', ' HIV-Associated Cognitive Motor Complex ', ' HIV-1 dementia ', ' HIV-1 associated dementia ', ' HIV associated dementia ', ' HIV Dementia ', ' Dementia in human immunodeficiency virus (HIV) disease ', ' Dementia associated with AIDS ', ' Dementia Due to HIV Disease ', ' Acquired Immune Deficiency Syndrome related dementia ', ' Acquired Immune Deficiency Syndrome Dementia Complex ', ' AIDS-related dementia ', ' AIDS-Related Dementia Complex ', ' AIDS with dementia ', ' AIDS Dementia ', ' AIDS Dementia Complex ', ' Anxiety ', ' Award ', ' Awareness ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Community Medicine ', ' Disadvantaged ', ' Hydroxytyramine ', ' Dopamine ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Educational aspects ', ' Education ', ' Environment ', ' Faculty ', ' family medicine ', ' Family Practice ', ' Goals ', ' Grant ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Income ', ' Economical Income ', ' Economic Income ', ' Industry ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Mission ', ' Neurobiology ', ' neurobiological ', ' Peer Review ', ' Pilot Projects ', ' pilot study ', ' Poverty ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Program Development ', ' Publications ', ' Scientific Publication ', ' Publishing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Residencies ', ' Role ', ' social role ', ' medical schools ', ' school of medicine ', ' medical college ', ' Self Medication ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Medical Students ', ' Substance Use Disorder ', ' Educational process of instructing ', ' Teaching ', ' Tennessee ', ' Testing ', ' Training Programs ', ' Work ', ' symposia ', ' summit ', ' convention ', ' conference ', ' symposium ', ' DAT dopamine transporter ', ' dopamine transporter ', ' Magazine ', ' Journals ', ' base ', ' improved ', ' Acute ', ' Chronic ', ' Clinical ', ' Medical ', ' Series ', ' Link ', ' Training ', ' insight ', ' Individual ', ' Rural ', ' Life ', ' programs ', ' Scientist ', ' Investigation ', ' Clinic ', ' Country ', ' interest ', ' college ', ' collegiate ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' experience ', ' neuron loss ', ' neuronal loss ', ' neuronal death ', ' neuronal cell loss ', ' neuronal cell death ', ' neuron death ', ' neuron cell loss ', ' neuron cell death ', ' nerve cell loss ', ' nerve cell death ', ' skills ', ' novel ', ' Basic Science ', ' Basic Research ', ' Patient Self-Report ', ' Self-Report ', ' graduate student ', ' Admission activity ', ' Admission ', ' career development ', ' Membrane Microdomains ', ' lipid raft ', ' Sphingolipid-Cholesterol Rafts ', ' Sphingolipid Microdomains ', ' Cell Membrane Lipid Rafts ', ' health disparity ', ' disparity in health ', ' Metabolic Pathway ', ' Address ', ' methamphetamine abuse ', ' meth abuse ', ' Drug Rehabilitation Centers ', ' Drug Treatment Centers ', ' Drug Abuse Treatment Centers ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Applications Grants ', ' Grant Proposals ', ' Subgroup ', ' Neurosciences Research ', ' Pharmacological Treatment ', ' Molecular ', ' developmental ', ' Development ', ' methamphetamine addiction ', ' meth addiction ', ' addiction to methamphetamine ', ' METH dependence ', ' Methamphetamine dependence ', ' Behavioral ', ' Healthcare professional ', ' Health Care Professional ', ' Health Professional ', ' pathway ', ' Pathway interactions ', ' underserved people ', ' under served population ', ' Underserved Population ', ' methamphetamine exposure ', ' meth exposure ', ' ethnic minority population ', ' ethnic minority ', ' racial and ethnic ', ' therapeutic target ', ' addiction ', ' addictive disorder ', ' effective intervention ', ' primary care setting ', ' screening and brief intervention ', ' screening, brief intervention, referral, and treatment ', ' screening, brief intervention, and referral to treatment ', ' SBIRT ', ' methamphetamine use ', ' methamphetamine using ', ' METH using ', ' METH use ', ' curriculum enhancement ', ' curriculum expansion ', ' curricular enrichment ', ' methamphetamine effect ', ' METH effect ', ' minority student ', ' substance misuse ', ' ']",NIDA,MEHARRY MEDICAL COLLEGE,R24,2017,458326,0.04533793193897472
"Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African Americans     DESCRIPTION (provided by applicant): The Center for Translational and Prevention Science (CTAPS) was funded in 2009 to inform the development of prevention programs for rural African American youth through investigations of gene environment (G-E) interplay on drug use and HIV-related behavior. The proposed continuation augments CTAPS' scientific agenda to better address racial disparities in drug use and HIV-related behavior that affect rural African Americans. Emerging research suggests that exposure to chronic stress affects the functioning of inflammatory, neuroendocrine, and neurocognitive systems beginning in childhood and adolescence. The negative consequences of chronic stress affect health-related behaviors and forecast chronic diseases of aging. Emerging evidence suggests that these processes also may affect youth and young adults' development of drug misuse and HIV related behavior. The Center will sponsor a new generation of research on (a) the neuroendocrine, inflammatory, and neurocognitive pathways through which exposure to stress among rural African American youth and young adults creates vulnerabilities to drug use and HIV related behavior, (b), the malleable risk and protective processes that affect underlying vulnerability mechanisms , and (c) the translation of findings into new and refined preventive interventions for youth in general and rural African American youth in particular. The CTAPS will pursue these scientific goals via providing infrastructure for three support cores (Inflammation/Neuroendocrine, Neurocognitive, Biostatistics) that will enrich data from data from Core projects and pilot projects and a Pilot Core. CTAPS will facilitate communication among Center-affiliated investigators, support core directors, and core project PIs; oversee administration of Center-wide budgets and operations; provide infrastructure and administrative support for three support cores and a Pilot Core. CTAPS will spur progress via a transdisciplinary work group system designed to facilitate transdisciplinary collaboration and to organize the allocation of Center resources and disseminate research findings to multiple stakeholders including researchers, policy makers, educational organizations, and the public.             The proposed Center is designed to investigate how chronic stress that rural African American's experience in childhood and adolescence affects drug misuse and HIV-related behavior in young adulthood. The Center's work will contribute to the development of prevention programs that target vulnerabilities to drug use and HIV related behavior that may be developing ""under the skin"" in phsyiolobical and neurological systems.",Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African Americans,9304045,P30DA027827,"['adolescence (12-20) ', ' 12-20 years old ', ' Adolescence ', ' Affect ', ' Aging ', ' Behavior ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Budgets ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Communication ', ' Environment ', ' Genes ', ' Goals ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Inflammation ', ' Neurosecretory Systems ', ' Neuroendocrine System ', ' Neuroendocrine ', ' Pilot Projects ', ' pilot study ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Science ', ' Stress ', ' Translations ', ' Work ', ' Generations ', ' Youth 10-21 ', ' Youth ', ' Neurological ', ' Neurologic ', ' pediatric ', ' Childhood ', ' young adulthood ', ' adult youth ', ' young adult ', ' Policy Maker ', ' drug use ', ' Drug usage ', ' Funding ', ' Exposure to ', ' Inflammatory ', ' Investigation ', ' System ', ' Neurocognitive ', ' experience ', ' interdisciplinary collaboration ', ' transdisciplinary collaboration ', ' Prevention program ', ' Prevention ', ' drug development ', ' Skin ', ' Address ', ' Chronic stress ', ' Data ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Research Infrastructure ', ' Infrastructure ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' work group ', ' working group ', ' designing ', ' design ', ' malleable risk ', ' operation ', ' racial disparity ', ' race disparity ', ' disparities in race ', ' drug use vulnerability ', ' vulnerability to drug use ', ' drug misuse ', ' rural African American ', ' ']",NIDA,UNIVERSITY OF GEORGIA,P30,2017,965592,0.11631766570436483
"Interdisciplinary Research Training Institute on Hispanic Drug Abuse     DESCRIPTION (provided by applicant): This application requests continued support of the Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse (5 R25DA026401) that has developed and implemented a research education program aimed at promoting the career development of pre-doctoral and early career clinically focused scientists interested in conducting research that affects the Hispanic population. This comprehensive and coordinated effort focuses on providing research experience and increasing the skills required for the preparation and submission of competitive research applications for NIH extramural funding. This renewal application expands the scope of the IRTI program to include international clinically focused fellows from Mexico. Building upon the success and accomplishments of the existing IRTI, the specific aims of the IRTI are to (1) Continue to provide an improved educational training opportunity to enhance the skills for conducting interdisciplinary Hispanic drug research and developing applications for NIH funding among pre-doctoral, postdoctoral and early career faculty members (fellows) through the implementation of an 11-day intensive summer research training program; (2) Expand the scope of the IRTI program to include international, clinically focused fellows from Mexico that will serve to strengthen their capacity o conduct independent drug research and provide opportunities for U.S. and Mexico fellows to share knowledge that may develop into research activities aimed at enhancing bi-national public health efforts to address drug abuse and addiction; (3) Continue to execute an improved mentoring plan structured around a team of interdisciplinary senior faculty mentors who would be accessible and available to provide selected fellows with focused mentoring and continued support; (4) Continue to provide an improved networking structure and process that will assist fellows in building and maintaining relationships and communication with leading experts in the field of Hispanic drug research and fellow peers. Mentoring activities will focus on guiding and assisting the fellows in achieving benchmarks of progress including: a) Academic Career Progress; b) Scientific Publications; c) Scientific Presentations; and d) Research Funding. These outcomes will be facilitated through various types of support provided by the IRTI including: Mentor Commitment, Travel to Mentor Institution, E-Mentoring Technologies, Conferences/Workshops, and IRTI Mentoring Annual Meeting. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research in the interest of public health. Building upon the existing mentoring and networking success, the proposed IRTI renewal will continue to fill the gap in knowledge on how to develop effective research incubators that will increase the number of minority drug abuse researchers. PUBLIC HEALTH RELEVANCE: This application seeks funding to continue the Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse that seeks to promote the career development of underrepresented pre-doctoral, postdoctoral and early career clinically-focused scientists in the U.S. and Mexico interested in conducting research as it affects the Hispanic population. Hispanics face unique health challenges, and efforts to increase the number of well-qualified researchers prepared to conduct clinical research are vital to reducing health disparities among this underserved population. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive clinical research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitae the conduct of interdisciplinary drug abuse research.",Interdisciplinary Research Training Institute on Hispanic Drug Abuse,9265816,R25DA026401,"['Affect ', ' career transition ', ' career advancement ', ' Career Mobility ', ' Clinical Study ', ' Clinical Research ', ' Communication ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' facial ', ' faces ', ' Face ', ' Goals ', ' Health ', ' Incubators ', ' Institutes ', ' Leadership ', ' Mentors ', ' Mentorship ', ' Mexico ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Technology ', ' Training Programs ', ' Travel ', ' Work ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Competence ', ' symposia ', ' summit ', ' convention ', ' conference ', ' symposium ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' base ', ' career ', ' improved ', ' Clinical ', ' Training ', ' Discipline ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Workshop ', ' Educational workshop ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Research Activity ', ' drug use ', ' Drug usage ', ' Funding ', ' Nature ', ' Knowledge ', ' programs ', ' Scientist ', ' Complex ', ' Benchmarking ', ' Best Practice Analysis ', ' interest ', ' meetings ', ' experience ', ' success ', ' Self Efficacy ', ' Structure ', ' skills ', ' peer ', ' member ', ' Mediation ', ' Negotiation ', ' Negotiating ', ' career development ', ' psychosocial development ', ' theories ', ' health disparity ', ' disparity in health ', ' Institution ', ' Address ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' International ', ' Request for Applications ', ' NIH RFA ', ' Research Training ', ' Extramural ', ' EXTMR ', ' Extramural Activities ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' translation research ', ' Translational Science ', ' Translational Research ', ' Preparation ', ' Process ', ' developmental ', ' Development ', ' environmental enrichment ', ' environment enrichment for laboratory animals ', ' environment enrichment ', ' environmental enrichment for laboratory animals ', ' minority health ', ' underserved people ', ' under served population ', ' Underserved Population ', ' next generation ', ' Minority ', ' Outcome ', ' Population ', ' pre-doctoral ', ' predoctoral ', ' predoc ', ' pre-doc ', ' public health relevance ', ' early-career faculty ', ' faculty mentor ', ' senior faculty ', ' full professor ', ' summer research ', ' training opportunity ', ' education research ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R25,2017,340142,0.13783565054063016
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network     DESCRIPTION:  The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PUBLIC HEALTH RELEVANCE: This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9488698,UG1DA015815,"['etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' American Indian ', ' American Indians ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Educational aspects ', ' Education ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' Hepatitis C virus ', ' HCV infection ', ' HCV ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human T-Lymphotropic Virus Type III ', ' Human T-Cell Lymphotropic Virus Type III ', ' Human T-Cell Leukemia Virus Type III ', ' Human Immunodeficiency Viruses ', ' HTLV-III ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methadone ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methods ', ' Naloxone ', ' Narcanti ', ' Narcan ', ' Persons ', ' Oregon ', ' Overdose ', ' Patients ', ' Peer Review ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Registries ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Rural Health ', ' Safety ', ' San Francisco ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Opioid ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' Services ', ' experience ', ' care delivery ', ' Participant ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' drug abuse prevention ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' disparity in health ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' designing ', ' design ', ' urban Indian ', ' urban American Indian ', ' urban Native American ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addiction ', ' addictive disorder ', ' public health relevance ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' health service use ', ' health service utilization ', ' data resource ', ' rural Americans ', ' therapeutic candidate ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2017,342849,0.08695097140668363
"Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM) PROJECT SUMMARY/ABSTRACT  This application is for a competing renewal of the Center for Prevention Implementation Methodology for HIV and Drug Abuse, a NIDA P30 Center of Excellence. The number of new HIV cases in the US remains stable at 56,000 per year and continues to disproportionately affect some groups, including young men who have sex with men (YMSM), especially from racial/ethnic minorities. The purpose of this methodology center is to develop new methodologies that can be used by federal and local agencies and communities to reduce HIV incidence. Biomedical interventions and strategies, including pre-exposure prophylaxis (PrEP), rapid testing for HIV and early and consistent treatment for persons who are HIV positive (Treatment as Prevention, TasP) have been shown to have high efficacy and effectiveness in reducing HIV transmission, but there remains a giant gap between what research knows and what services needed to reduce population level incidence of HIV. The major premise of this application is that the effective biomedical to reduce HIV incidence and disparities are in hand, but success will only be achieved when they are implemented in ways that meet individual, community, and health care delivery system needs. This methods proposal addresses this major gap between research and practice through implementation science and methodology, focusing on innovative ways to address the complex, mulitilevel interactions needed to implement HIV prevention programs effectively. Two Cores, an Administrative Core and an Innovative Implementation Methods Core for HIV and Drug Abuse will carry out this work.  Aim 1 is to develop innovative methods to maximize the impact of implementation research in HIV prevention. We do this through an extended set of systems science and engineering methods that focus on improving the measurement of implementation, the modeling of implementation strategies, and the testing of implementation strategies through rigorous trials. Five qualifying grants support this work.  Aim 2 is to apply these innovative methods to close the gap between existing research, policy, and practice for HIV prevention. In addition to working closely with our five qualifying grants, we work locally with municipal Departments of Public Health and the federal Substance Abuse and Mental Health Services Administration (SAMHSA) HIV programs to identify and prioritize gaps in knowledge, find optimal implementation strategies for reduction of HIV transmission, and design the next large implementation trials.  Aim 3 is to disseminate methods and train/mentor leaders at the intersection of HIV prevention, implementation science, and drug abuse fields to improve implementation of HIV prevention programs. This involves mentoring the early career researchers, publishing, and providing training to networks of HIV and drug abuse researchers. PROJECT NARRATIVE There are numerous rigorously evaluated prevention programs involving biomedical interventions for preventing HIV that have demonstrated impact in efficacy and effectiveness trials. Pre-exposure prophylaxis, HIV testing, and early and consistent antiretroviral treatment have high potential for preventing HIV infections, but these are yet to be implemented sufficiently in racial/ethnic minority communities. This Ce-PIM addresses the critical methods gaps that are holding back the movement of these programs from research to practice.",Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM),9619855,P30DA027828,"['Affect ', ' Age ', ' ages ', ' Back ', ' Dorsum ', ' Behavior ', ' Biomedical Research ', ' Communities ', ' Decision Making ', ' health care delivery ', ' health services delivery ', ' Healthcare Delivery ', ' Heroin ', ' Diamorphine ', ' Diacetylmorphine ', ' Discrimination ', ' Cognitive Discrimination ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Engineering ', ' Ethnic group ', ' ethnicity group ', ' Feedback ', ' Gender Identity ', ' Goals ', ' Grant ', ' Hand ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Services Accessibility ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Seropositivity ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV antibody positive ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' Incidence ', ' Long-Term Care ', ' longterm care ', ' extended care ', ' Mentors ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Methods ', ' Methodology ', ' Biological Models ', ' Model System ', ' Biologic Models ', ' Movement ', ' body movement ', ' Persons ', ' Play ', ' Public Health ', ' Publishing ', ' Quality of life ', ' QOL ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Science ', ' Seeds ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Technology ', ' Testing ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Virus ', ' General Viruses ', ' Vision ', ' visual function ', ' Sight ', ' Work ', ' ranpirnase ', ' P30 Protein ', ' P30 ', ' P-30 Protein ', ' Gender ', ' Generations ', ' Community Healthcare ', ' Community Health Care ', ' ecstasy ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' base ', ' career ', ' improved ', ' Sexual Orientation ', ' Sex Orientation ', ' Training ', ' Individual ', ' Policies ', ' Measurement ', ' drug use ', ' Drug usage ', ' Ethnicity ', ' Ethnic Origin ', ' tool ', ' Knowledge ', ' programs ', ' Viral Load result ', ' Viral Load ', ' Viral Burden ', ' Complex ', ' Pattern ', ' System ', ' Services ', ' success ', ' Anti-Retroviral Agents ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' Municipalities ', ' novel ', ' Prevention program ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Early identification ', ' Modeling ', ' social stigma ', ' stigma ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' scientific organization ', ' Effectiveness ', ' prevent ', ' preventing ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Address ', ' High Prevalence ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Qualifying ', ' Transmission ', ' transmission process ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' socioeconomics ', ' developmental ', ' Development ', ' antiretroviral treatment ', ' anti-retroviral treatment ', ' anti-retroviral therapy ', ' antiretroviral therapy ', ' effectiveness trial ', ' implementation trial ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' implementation research ', ' designing ', ' design ', ' next generation ', ' efficacy trial ', ' Outcome ', ' Approaches to prevention ', ' Prevention approach ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' ethnic minority ', ' ethnic minority population ', ' early therapy ', ' Early treatment ', ' racial and ethnic ', ' implementation science ', ' research into practice ', ' research to practice ', ' cocaine use ', ' young MSM ', ' YMSM ', ' young men who have sex with men ', ' black MSM ', ' BMSM ', ' African-American men who have sex with men ', ' African American MSM ', ' AAMSM ', ' black men who have sex with men ', ' support tools ', ' minority communities ', ' PrEP ', ' pre-exposure prophylaxis ', ' implementation strategy ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,P30,2018,133780,0.08917754346937293
"Effects of State-Level Policy Implementation on Opiate Abuse and Mortality Project Summary States have responded to the current opiate crisis through implementing several different types of policies, such as prescription drug monitoring programs (PDMPs), expanded naloxone access, and Good Samaritan immunity. At present, the full efficacy of each of these policies is unknown beyond examinations of a limited set of policies, localities, or years. This research study will use causal statistical methods and a robust policy database to examine the impact of relevant policies on opiate use, dependence, and fatal overdose from 1999 to the present. For policy data, we will employ the new and as yet underutilized NIDA-funded Prescription Drug Abuse Policy System (PDAPS) to evaluate the effects of opiate relevant policies. We will accomplish this goal by coding this database by state and year and combining it with mortality data from the Center of Disease Control and data on use and dependence from the National Survey on Drug Use and Health, as well as time- varying control measures from the U.S. Census Bureau and FBI Uniform Crime Reports. We will analyze this dataset using fixed effects and difference-in-difference models, which are causal methods for observational data well-known for the elimination of unobserved heterogeneity, such that estimators are robust to any observable or unobservable time-invariant omitted variables. The fixed effects and difference-in-difference approaches respectively provide a causal interpretation of (a) whether a given state experiences a decrease in opiate outcomes after passing a particular policy, and (b) whether a state that passes a policy experiences a decrease in opiate outcomes relative to a state that does not have that policy. The PDAPS database contains detailed policy information (e.g. to whom practitioners can prescribe naloxone, who has access to PDMPs), such that we can determine which of the nuanced approaches to these policies are most efficacious. We will examine whether each policy component affects use, dependence, and fatal overdose for opiates generally as well as separately for prescription opiates and heroin. In addition, we will test for synergistic effects of policy; that is, whether the combination of any given policies is particularly effective. Finally, we will conduct these analyses by key demographics: gender, race/ethnicity, age, and urbanicity, which will permit the identification of related health disparities. Our proposed exploratory research provides an opportunity to test the impact of a rapidly evolving policy landscape on opiate outcomes and will contribute in additional ways. First, if certain policies or combinations of policies are identified as efficacious, the results would provide evidence for broader adoption to curb the current opiate crisis. Second, the identification of possible health disparities in the benefits of policy implementation may not only help public health professionals to work towards redressing these disparities, but also identify policies that may bypass social inequalities to provide comprehensive benefits to citizens. Finally, this exploratory study establishes a foundation for future research that will consider local policy variation, individual-level policy-driven changes, and non-fatal overdose. Project Narrative An unprecedented opiate crisis has emerged over the past decade in the U.S., and state governments have responded by implementing numerous policies to disrupt this trend. This study uses fixed effects modeling to determine which opiate-related policies have been effective in curbing opiate use, dependence, and fatal overdose by combining state-level data from the Center for Disease Control, the National Survey on Drug Use and Health, and the new NIDA-funded Prescription Drug Abuse Policy System, which identifies policies related to naloxone access, prescription drug monitoring programs, Good Samaritan immunity, and medical marijuana. By examining the independent and interactive effects of policies, along with analyses of their effects by key demographic characteristics, this project has the potential to improve morbidity and mortality related to the opiate crisis as well as address health disparities related to this issue.",Effects of State-Level Policy Implementation on Opiate Abuse and Mortality,9574542,R21DA046447,"['Adoption ', ' Affect ', ' Censuses ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Crime ', ' Demographic Factors ', ' Heroin ', ' Diamorphine ', ' Diacetylmorphine ', ' Foundations ', ' Goals ', ' Health ', ' Heterogeneity ', ' Immunity ', ' Methods ', ' Methodology ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Naloxone ', ' opioid abuse ', ' opioid drug abuse ', ' opiate drug abuse ', ' opiate abuse ', ' Overdose ', ' Drug Prescriptions ', ' Drug Prescribing ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Societies ', ' State Government ', ' Provincial Government ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Work ', ' Gender ', ' Measures ', ' Data Set ', ' Dataset ', ' Guidelines ', ' improved ', ' Variation ', ' Variant ', ' Link ', ' Evaluation ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' data base ', ' Data Bases ', ' Databases ', ' Opiates ', ' Opioid ', ' Policies ', ' drug use ', ' Drug usage ', ' Pain Relief Units ', ' Pain Centers ', ' Pain Clinics ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Dependence ', ' System ', ' misuse of prescription only drugs ', ' prescription misuse ', ' prescription drug misuse ', ' nonmedical prescription drug use ', ' non-medical prescription drug use ', ' Prescription medication misuse ', ' American ', ' experience ', ' social inequality ', ' research study ', ' Reporting ', ' Bypass ', ' prescription drug abuse ', ' prescription medication abuse ', ' Code ', ' Coding System ', ' Statistical Methods ', ' Regulation ', ' Modeling ', ' response ', ' mathematical model ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' health disparity ', ' disparity in health ', ' Address ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' trend ', ' Characteristics ', ' Healthcare professional ', ' Health Care Professional ', ' Health Professional ', ' Outcome ', ' demographics ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' prescription opioid ', ' medicinal cannabis ', ' medical cannabis ', ' Medicinal Marijuana ', ' Medical Marijuana ', ' improved outcome ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' opioid use ', ' Trends over time ', ' Temporal trend ', ' Time trend ', ' opioid crisis ', ' opiate crisis ', ' opioid epidemic ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid overdose ', ' opioid related death ', ' opioid overdose death ', ' opioid deaths ', ' opiate mortality ', ' opiate deaths ', ' opioid mortality ', ' heroin intake ', ' heroin use ', ' Prescription Drug Monitoring Program ', ' prescription monitoring program ', ' prescription opiate misuse ', ' opioid prescription medication misuse ', ' opioid medication misuse ', ' opioid analgesic misuse ', ' nonmedical use of prescription opioids ', ' nonmedical use of prescription opiates ', ' non-medical use of prescription opioids ', ' non-medical use of prescription opiates ', ' prescription opioid misuse ', ' ']",NIDA,OHIO STATE UNIVERSITY,R21,2018,243468,0.1321423894795368
"Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African Americans     DESCRIPTION (provided by applicant): The Center for Translational and Prevention Science (CTAPS) was funded in 2009 to inform the development of prevention programs for rural African American youth through investigations of gene environment (G-E) interplay on drug use and HIV-related behavior. The proposed continuation augments CTAPS' scientific agenda to better address racial disparities in drug use and HIV-related behavior that affect rural African Americans. Emerging research suggests that exposure to chronic stress affects the functioning of inflammatory, neuroendocrine, and neurocognitive systems beginning in childhood and adolescence. The negative consequences of chronic stress affect health-related behaviors and forecast chronic diseases of aging. Emerging evidence suggests that these processes also may affect youth and young adults' development of drug misuse and HIV related behavior. The Center will sponsor a new generation of research on (a) the neuroendocrine, inflammatory, and neurocognitive pathways through which exposure to stress among rural African American youth and young adults creates vulnerabilities to drug use and HIV related behavior, (b), the malleable risk and protective processes that affect underlying vulnerability mechanisms , and (c) the translation of findings into new and refined preventive interventions for youth in general and rural African American youth in particular. The CTAPS will pursue these scientific goals via providing infrastructure for three support cores (Inflammation/Neuroendocrine, Neurocognitive, Biostatistics) that will enrich data from data from Core projects and pilot projects and a Pilot Core. CTAPS will facilitate communication among Center-affiliated investigators, support core directors, and core project PIs; oversee administration of Center-wide budgets and operations; provide infrastructure and administrative support for three support cores and a Pilot Core. CTAPS will spur progress via a transdisciplinary work group system designed to facilitate transdisciplinary collaboration and to organize the allocation of Center resources and disseminate research findings to multiple stakeholders including researchers, policy makers, educational organizations, and the public.             The proposed Center is designed to investigate how chronic stress that rural African American's experience in childhood and adolescence affects drug misuse and HIV-related behavior in young adulthood. The Center's work will contribute to the development of prevention programs that target vulnerabilities to drug use and HIV related behavior that may be developing ""under the skin"" in phsyiolobical and neurological systems.",Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African Americans,9509390,P30DA027827,"['Adolescence ', ' adolescence (12-20) ', ' 12-20 years old ', ' Affect ', ' Aging ', ' Behavior ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Budgets ', ' Chronic Disease ', ' chronic disorder ', ' Chronic Illness ', ' Communication ', ' Environment ', ' Genes ', ' Goals ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Inflammation ', ' Neurosecretory Systems ', ' Neuroendocrine System ', ' Neuroendocrine ', ' Pilot Projects ', ' pilot study ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Science ', ' Stress ', ' Translations ', ' Work ', ' Generations ', ' Youth ', ' Youth 10-21 ', ' Neurological ', ' Neurologic ', ' pediatric ', ' Childhood ', ' young adulthood ', ' adult youth ', ' young adult ', ' Policy Maker ', ' drug use ', ' Drug usage ', ' Funding ', ' Exposure to ', ' Inflammatory ', ' Investigation ', ' System ', ' Neurocognitive ', ' experience ', ' interdisciplinary collaboration ', ' transdisciplinary collaboration ', ' Prevention program ', ' Prevention ', ' drug development ', ' Skin ', ' Address ', ' Chronic stress ', ' Data ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Research Infrastructure ', ' Infrastructure ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' work group ', ' working group ', ' designing ', ' design ', ' malleable risk ', ' operation ', ' race disparity ', ' disparities in race ', ' racial disparity ', ' vulnerability to drug use ', ' drug use vulnerability ', ' medication misuse ', ' drug misuse ', ' rural African American ', ' ']",NIDA,UNIVERSITY OF GEORGIA,P30,2018,982136,0.11631766570436483
"Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM) PROJECT SUMMARY/ABSTRACT  This application is for a competing renewal of the Center for Prevention Implementation Methodology for HIV and Drug Abuse, a NIDA P30 Center of Excellence. The number of new HIV cases in the US remains stable at 56,000 per year and continues to disproportionately affect some groups, including young men who have sex with men (YMSM), especially from racial/ethnic minorities. The purpose of this methodology center is to develop new methodologies that can be used by federal and local agencies and communities to reduce HIV incidence. Biomedical interventions and strategies, including pre-exposure prophylaxis (PrEP), rapid testing for HIV and early and consistent treatment for persons who are HIV positive (Treatment as Prevention, TasP) have been shown to have high efficacy and effectiveness in reducing HIV transmission, but there remains a giant gap between what research knows and what services needed to reduce population level incidence of HIV. The major premise of this application is that the effective biomedical to reduce HIV incidence and disparities are in hand, but success will only be achieved when they are implemented in ways that meet individual, community, and health care delivery system needs. This methods proposal addresses this major gap between research and practice through implementation science and methodology, focusing on innovative ways to address the complex, mulitilevel interactions needed to implement HIV prevention programs effectively. Two Cores, an Administrative Core and an Innovative Implementation Methods Core for HIV and Drug Abuse will carry out this work.  Aim 1 is to develop innovative methods to maximize the impact of implementation research in HIV prevention. We do this through an extended set of systems science and engineering methods that focus on improving the measurement of implementation, the modeling of implementation strategies, and the testing of implementation strategies through rigorous trials. Five qualifying grants support this work.  Aim 2 is to apply these innovative methods to close the gap between existing research, policy, and practice for HIV prevention. In addition to working closely with our five qualifying grants, we work locally with municipal Departments of Public Health and the federal Substance Abuse and Mental Health Services Administration (SAMHSA) HIV programs to identify and prioritize gaps in knowledge, find optimal implementation strategies for reduction of HIV transmission, and design the next large implementation trials.  Aim 3 is to disseminate methods and train/mentor leaders at the intersection of HIV prevention, implementation science, and drug abuse fields to improve implementation of HIV prevention programs. This involves mentoring the early career researchers, publishing, and providing training to networks of HIV and drug abuse researchers. PROJECT NARRATIVE There are numerous rigorously evaluated prevention programs involving biomedical interventions for preventing HIV that have demonstrated impact in efficacy and effectiveness trials. Pre-exposure prophylaxis, HIV testing, and early and consistent antiretroviral treatment have high potential for preventing HIV infections, but these are yet to be implemented sufficiently in racial/ethnic minority communities. This Ce-PIM addresses the critical methods gaps that are holding back the movement of these programs from research to practice.",Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM),9506715,P30DA027828,"['Affect ', ' Age ', ' ages ', ' Back ', ' Dorsum ', ' Behavior ', ' Biomedical Research ', ' Communities ', ' Decision Making ', ' health care delivery ', ' health services delivery ', ' Healthcare Delivery ', ' Heroin ', ' Diamorphine ', ' Diacetylmorphine ', ' Discrimination ', ' Cognitive Discrimination ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Engineering ', ' Ethnic group ', ' ethnicity group ', ' Feedback ', ' Gender Identity ', ' Goals ', ' Grant ', ' Hand ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Services Accessibility ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Seropositivity ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV antibody positive ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' Incidence ', ' Long-Term Care ', ' longterm care ', ' extended care ', ' Mentors ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Methods ', ' Methodology ', ' Biological Models ', ' Model System ', ' Biologic Models ', ' Movement ', ' body movement ', ' Persons ', ' Play ', ' Public Health ', ' Publishing ', ' Quality of life ', ' QOL ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Science ', ' Seeds ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Technology ', ' Testing ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Virus ', ' General Viruses ', ' Vision ', ' visual function ', ' Sight ', ' Work ', ' ranpirnase ', ' P30 Protein ', ' P30 ', ' P-30 Protein ', ' Gender ', ' Generations ', ' Community Healthcare ', ' Community Health Care ', ' ecstasy ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' base ', ' career ', ' improved ', ' Sexual Orientation ', ' Sex Orientation ', ' Training ', ' Individual ', ' Policies ', ' Measurement ', ' drug use ', ' Drug usage ', ' Ethnicity ', ' Ethnic Origin ', ' tool ', ' Knowledge ', ' programs ', ' Viral Load result ', ' Viral Load ', ' Viral Burden ', ' Complex ', ' Pattern ', ' System ', ' Services ', ' success ', ' Anti-Retroviral Agents ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' Municipalities ', ' novel ', ' Prevention program ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Early identification ', ' Modeling ', ' social stigma ', ' stigma ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' scientific organization ', ' Effectiveness ', ' prevent ', ' preventing ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Address ', ' High Prevalence ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Qualifying ', ' Transmission ', ' transmission process ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' socioeconomics ', ' developmental ', ' Development ', ' antiretroviral treatment ', ' anti-retroviral treatment ', ' anti-retroviral therapy ', ' antiretroviral therapy ', ' effectiveness trial ', ' implementation trial ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' implementation research ', ' designing ', ' design ', ' next generation ', ' efficacy trial ', ' Outcome ', ' Approaches to prevention ', ' Prevention approach ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' ethnic minority ', ' ethnic minority population ', ' early therapy ', ' Early treatment ', ' racial and ethnic ', ' implementation science ', ' research into practice ', ' research to practice ', ' cocaine use ', ' young MSM ', ' YMSM ', ' young men who have sex with men ', ' black MSM ', ' BMSM ', ' African-American men who have sex with men ', ' African American MSM ', ' AAMSM ', ' black men who have sex with men ', ' support tools ', ' minority communities ', ' PrEP ', ' pre-exposure prophylaxis ', ' implementation strategy ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,P30,2018,1018061,0.08917754346937293
"Optimizing Immunosuppression Drug Dosing via Phenotypic Precision Medicine PROJECT SUMMARY The authors have developed a computational platform to rapidly identify optimal drug and dose combinations from the innumerable possibilities. By testing this technique termed Phenotypic Personalized Medicine (PPM) in a diverse number of experimental systems representing different diseases, they have found that the response of biological systems to drugs can be described by a low order, smooth multidimensional surface. The main consequence of this is that optimal drug combinations can be found in a small number of tests. This inputoutput relationship is always based on experimental data, not modeling, and it would lead to a straightforward solution for handling human diversity in drug dosing needs, among other clinical problems. They will test the hypothesis that PPM can be developed and validated for clinical use by conducting a prospective clinical trial to compare the feasibility and efficacy of this approach to standard of care physician dosing. This group has previously used PPM-based optimization to find novel drug combinations in in vitro and in vivo models of cancer and infection. In a first-in-human study, they recently compared 4 PPM-dosed patients and 4 control (standard of care dosed) patients. They calculated the tacrolimus dosing regimen using the PPM process and showed significant improvement in variability and a trend toward improved efficacy. For this application, they aim to show in a clinical trial, that PPM is more effective than unaided physician dosing. This will allow the generation of data to justify a multi-center confirmatory study and to explore a wider array of clinical outcomes to optimize. PROJECT NARRATIVE This project uses a computational drug-dose optimization platform (Phenotypic Precision Medicine) to an important problem in transplant immunosuppression, the maintenance of patient tacrolimus blood levels within a clinically desired target range. Using empiric measurements of responses to previously administered doses, the Phenotypic Precision Medicine platform optimizes and suggests subsequent doses. A prospective clinical trial will compare the efficacy, feasibility, and safety of this approach to standard of care physician dosing.",Optimizing Immunosuppression Drug Dosing via Phenotypic Precision Medicine,9432394,R21DK116140,"['Combination Medication ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Patient-Focused Outcomes ', ' Monitor ', ' trend ', ' Process ', ' Calcineurin antagonist ', ' Calcineurin inhibitor ', ' Output ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' Outcome ', ' human study ', ' Population ', ' visual map ', ' prospective ', ' trial comparing ', ' standard of care ', ' compare efficacy ', ' comparative efficacy ', ' biological systems ', ' risk minimization ', ' Regimen ', ' arm ', ' precision-based medicine ', ' precision medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized medicine ', ' race disparity ', ' disparities in race ', ' racial disparity ', ' novel pharmacotherapy combination ', ' new pharmacotherapy combination ', ' new drug combination ', ' novel drug combination ', ' patient subtypes ', ' patient subpopulations ', ' patient subgroups ', ' patient subsets ', ' individual variability ', ' individual heterogeneity ', ' individual variation ', ' variation between patients ', ' variability between patients ', ' patient variation ', ' patient variability ', ' first in man ', ' first-in-human ', ' Affect ', ' Algorithms ', ' Blood ', ' Blood Reticuloendothelial System ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Clinical Trials ', ' Communicable Diseases ', ' Infectious Disorder ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Disease ', ' Disorder ', ' Drug Combinations ', ' Pharmacotherapy ', ' drug treatment ', ' Drug Therapy ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Goals ', ' Human ', ' Modern Man ', ' Immunosuppression ', ' immune suppression ', ' Immunosuppressive Effect ', ' Immunosuppression Effect ', ' In Vitro ', ' Incidence ', ' Infection ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' liver transplantation ', ' Liver Transplant ', ' Liver Grafting ', ' Hepatic Transplantation ', ' Maintenance ', ' Maps ', ' Methods ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Organ Transplantation ', ' organ xenograft ', ' organ graft ', ' organ allograft ', ' Transplantation Surgery ', ' Organ Transplants ', ' Grafting Procedure ', ' Patients ', ' Drug Kinetics ', ' Pharmacokinetics ', ' Phenotype ', ' Physicians ', ' Physiology ', ' Safety ', ' Testing ', ' Time ', ' Transplantation ', ' transplant ', ' Treatment Protocols ', ' Treatment Schedule ', ' Treatment Regimen ', ' Generations ', ' Measures ', ' Tacrolimus ', ' immunological markers ', ' immunological biomarkers ', ' immune-based biomarkers ', ' Immune Markers ', ' Immunologic Markers ', ' base ', ' Organ ', ' improved ', ' Procedures ', ' Surface ', ' Acute ', ' Solid ', ' Clinical ', ' Physiologic ', ' Physiological ', ' Randomized Clinical Trials ', ' Ensure ', ' liver function ', ' kidney function ', ' Renal function ', ' Individual ', ' Measurement ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Therapeutic ', ' Genetic ', ' Nature ', ' Transplant Recipients ', ' transplant patient ', ' Knowledge ', ' Area Under Curve ', ' Techniques ', ' System ', ' Toxic effect ', ' Toxicities ', ' response ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Dose ', ' Data ', ' in vivo Model ', ' CancerModel ', ' Cancer Model ', ' Clinical Data ', ' ']",NIDDK,UNIVERSITY OF FLORIDA,R21,2018,169781,0.08600311335193023
"The Development and Evaluation of the Ho'ouna Pono Drug Prevention Curriculum     DESCRIPTION (provided by applicant): Research has indicated that Native Hawaiian youth have significantly higher rates of drug use than their non-Hawaiian counterparts (e.g., Wong, Klingle, & Price, 2004; Mayeda, Hishinuma, Nishimura, Garcia- Santiago, & Mark, 2006; Nishimura, Hishinuma, & Goebert, 2013), and that these differences are particularly pronounced in rural settings (Lai & Saka, 2005). Despite these findings, there have been very few drug prevention programs developed and evaluated specifically for these youth (Edwards, Giroux, & Okamoto, 2010; Rehuher, Hiramatsu, & Helm, 2008). Therefore, the purpose of this research proposal is to complete the development of a video-enhanced, culturally grounded, school-based drug prevention curriculum for rural Native Hawaiian youth (Ho'ouna Pono), and to evaluate the curriculum across all public middle/intermediate schools on Hawai'i Island. This will be accomplished through three specific aims. AIM 1 (Year 1) is to complete the Ho'ouna Pono drug prevention curriculum initially developed and validated in a NIDA-funded translational pilot/feasibility study (R34 DA031306). To date, five professionally filmed video vignettes depicting drug-related problem situations specific to rural Hawaiian youth and seven interactive classroom lessons have been created, implemented in randomly selected intervention schools, and preliminarily evaluated using a pre-test, post-test control group design. Aim 1 enhances and builds upon this work by producing two new video vignettes, re-editing a ""Behind the Scenes"" video, developing new classroom curricular components, and synthesizing the new content with the existing curriculum. AIM 2 (Years 2-3) is to evaluate the fully conceived curriculum across all middle/intermediate schools on Hawai'i Island (N = 15) using a dynamic wait- listed control group design (Brown, Wyman, Guo, & Pea, 2006). AIM 3 (Year 4) is to assess community, systemic, and curricular factors related to the implementation, adoption, and sustainability of the curriculum within public middle/intermediate schools on Hawaii Island. PUBLIC HEALTH RELEVANCE: Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have recently been shown to have significantly higher rates of drug use compared with other ethnic groups (Wu et al., 2013), research focused on drug prevention of these individuals is important to improve public health both in Hawai'i and on the Mainland U.S. This study actively engages rural communities in the full-scale development and evaluation of the Ho'ouna Pono drug prevention curriculum for Hawaiian youth, promoting the overall utility and effectiveness of the intervention. Further, the findings from this study will point to the core content of prevention interventions for Hawaiian youth in rural communities, which should be applicable to other ethnic youth populations in Hawaii and the Pacific Rim, as well as Native youth populations on the Mainland U.S.",The Development and Evaluation of the Ho'ouna Pono Drug Prevention Curriculum,9473040,R01DA037836,"['Adoption ', ' Communities ', ' Control Groups ', ' Educational Curriculum ', ' lesson plans ', ' Curriculum ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Ethnic group ', ' ethnicity group ', ' Feasibility Studies ', ' Hawaii ', ' Island ', ' Public Health ', ' Research ', ' Research Proposals ', ' Rural Health ', ' Schools ', ' Science ', ' Testing ', ' Time ', ' Waiting Lists ', ' waitlist ', ' Work ', ' Measures ', ' Price ', ' pricing ', ' Film ', ' Rural Community ', ' Youth ', ' Youth 10-21 ', ' base ', ' improved ', ' Evaluation ', ' Individual ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' drug use ', ' Drug usage ', ' Funding ', ' Hawaiian population ', ' Hawaiian ', ' Outcome Study ', ' cohort ', ' Prevention Research ', ' Prevention ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' health disparity ', ' disparity in health ', ' Address ', ' Effectiveness of Interventions ', ' Indigenous ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' designing ', ' design ', ' Population ', ' Drug Prevention Program ', ' native youth ', ' participatory action research ', ' community based research ', ' community based design ', ' community based participatory research ', ' public health relevance ', ' intervention effect ', ' efficacy testing ', ' health equity ', ' rural setting ', ' Native Hawaiian ', ' ']",NIDA,HAWAII PACIFIC UNIVERSITY,R01,2018,335056,0.11304276041447972
"Institute for Translational Research Education (ITRE) in Adolescent Drug Abuse Abstract The applicant proposes the continued development and expansion of a successful research education program for graduate level students and professionals to acquire innovative research skills to address drug abuse and related behavioral health concerns of children and adolescents. Implementation Science continues to be at the forefront of innovative research education; the Institute for Translational Research and Education in Adolescent Drug Abuse (ITRE) will focus on training clinical researchers in implementation research methods, translation of research into community practice, and the practical skills of participatory research. A cross-disciplinary approach, involving multiple colleges at the University of South Florida and Northern Arizona University, as well as local community service agencies, has been developed with special attention to evidence-based practice, translational research, and children and adolescents as an at-risk population. Our new emphasis is on addressing research education with an expanded target of behavioral health researchers with interests in working with at-risk populations including children and families of AI descent and Hispanic populations who have drug abuse and other co-morbid behavioral health conditions, defined as the array of mental, emotional and behavioral disorders of childhood that, along with drug abuse, have devastating effects on adolescent development. Project Narrative This project proposes the continued development and expansion of an innovative model of research education that addresses best practices for translational research in the field of child and adolescent behavioral health, as it relates to substance abuse and co-occurring disorders with an emphasis on at-risk populations including children and families of AI descent and Hispanic populations.",Institute for Translational Research Education (ITRE) in Adolescent Drug Abuse,9456706,R25DA031103,"['Achievement ', ' Achievement Attainment ', ' Arizona ', ' Attention ', ' Behavior Disorders ', ' behavioral disorder ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Child ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Clinical Research ', ' Clinical Study ', ' Communities ', ' Community Services ', ' Educational Curriculum ', ' lesson plans ', ' Curriculum ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Education ', ' Educational aspects ', ' Graduate Education ', ' Family ', ' Florida ', ' Foundations ', ' Goals ', ' Health Services Research ', ' services research ', ' Medical Care Research ', ' Health Services Evaluation ', ' Institutes ', ' Mentors ', ' Methods ', ' Nomads ', ' Migrant ', ' Newsletter ', ' Peer Review ', ' Publishing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Students ', ' Translations ', ' Universities ', ' symposium ', ' symposia ', ' summit ', ' convention ', ' conference ', ' Family member ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Population Heterogeneity ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Research Methodology ', ' Research Methods ', ' Magazine ', ' Journals ', ' career ', ' rural area ', ' urban area ', ' Clinical ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' co-occurring disorders ', ' Psychiatric Dual Diagnosis ', ' dual diagnosis ', ' Ensure ', ' Evaluation ', ' Training ', ' pediatric ', ' Childhood ', ' Emotional disorder ', ' Fostering ', ' Populations at Risk ', ' Funding ', ' Immigrant ', ' farm worker ', ' farmworker ', ' Knowledge ', ' programs ', ' interest ', ' college ', ' collegiate ', ' Services ', ' experience ', ' success ', ' Distance Learning ', ' skills ', ' Participant ', ' cultural competence ', ' member ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Modeling ', ' Adolescent Development ', ' behavioral health ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Provider ', ' health disparity ', ' disparity in health ', ' Address ', ' Evidence based practice ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Public Health Education ', ' Public Health Training ', ' Public Health Instruction ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Community Practice ', ' translation research ', ' Translational Science ', ' Translational Research ', ' developmental ', ' Development ', ' Clinical Services ', ' website ', ' web site ', ' youth drug abuse ', ' adolescent drug abuse ', ' implementation research ', ' underserved people ', ' under served population ', ' Underserved Population ', ' Minority ', ' Outcome ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' Evidence based program ', ' implementation science ', ' community setting ', ' university atmosphere ', ' training atmosphere ', ' school atmosphere ', ' learning environment ', ' learning atmosphere ', ' intellectual atmosphere ', ' educational environment ', ' education atmosphere ', ' collegiate atmosphere ', ' collegial atmosphere ', ' college atmosphere ', ' classroom environment ', ' educational atmosphere ', ' certificate program ', ' curriculum expansion ', ' curricular enrichment ', ' curriculum enhancement ', ' learning outcome ', ' service-based learning ', ' service learning ', ' social media ', ' recruiting minorities ', ' Minority Recruitment ', ' education research ', ' recruit ', ' service delivery ', ' ']",NIDA,UNIVERSITY OF SOUTH FLORIDA,R25,2018,336761,0.060157728196497215
"Health disparity in pharmacogenomics: African American SNPs and drug metabolism DESCRIPTION (provided by applicant): As pharmacogenomics moves from bench-top to bed-side, African Americans have been left out of the advances personalized medicine holds. To date, African Americans have been largely absent from the numerous pharmacogenetic studies that identify predictive single nucleotide polymorphisms (SNPs) that are being used clinically to improve care. As we move toward more comprehensive bioinformatics and high- throughput methods of evaluating the genome for functionally relevant SNPs that affect drug phenotypes, we are also producing a growing health disparity in the translation of these findings into the clinic for African Americans. Current genomic methods are trying to reach beyond genome-wide association in hopes of finding biological plausibility to genetic findings. This search has led to the use of expression quantitative trait loci (eQTLs) as a tool in pharmacogenetic association studies. SNPs labeled as eQTLs have intrinsic biological plausibility since they are significantly associated with changes in gene expression. However, no liver eQTL studies have been conducted in African Americans. By using liver-specific eQTLs, we will discover SNPs that affect drug metabolizing enzymes (DMEs), which will have wide-spread scientific and clinical impact; given that most drugs currently prescribed undergo some form of hepatic metabolism. Because of the increase genetic diversity found in African Americans, they may carry population specific SNPs can never be found by pharmacogenomics studies in populations of European-descent alone. Without African American focused pharmacogenomics studies we risk excluding African Americans from personalized medicine. We plan to use primary hepatocytes to conduct gene expression studies both before and after drug enzyme induction to identify genes that are differentially expressed. Drug enzyme induction is driven by increased gene transcription; therefore, by focusing on the genes that are differentially expressed after induction we can pin-point the drivers (i.e. genes) that regulate drug metabolizing enzymes. We will then look at SNPs within and in close proximity to these genes to determine if any are associated with differences in gene expression (dubbed DI-eQTLs). We will then look to see if these DI-eQTLs are associated with pharmacokinetic measures in the same set of cell cultures, affectedly preforming a pharmacokinetic and a pharmacogenetic study in the same individual. We hypothesize that drug enzyme induction will provide us with DI-eQTLs that are strongly associated to drug pharmacokinetics, a clinically relevant phenotype. To validate these findings we will query publically available data to look for an enrichment of our DI-eQTLs within the most strongly associated SNPs in pharmacogenomic GWAS data. The association between genotype, gene expression and drug pharmacokinetics in African Americans has never been conducted before and will provide an invaluable resource for pharmacogenomics and clinical pharmacology, as well as clinical translation in this understudied population. PUBLIC HEALTH RELEVANCE: The proposed studies will help identify genetic mutations that affect drug metabolism in African Americans, an under-studied population in pharmacogenomics. The discovery of these novel mutations will lead to better dosing of drugs that require the liver for metabolism and potentially less side-effects from these medications. By studying the genetic mutations that affect drug metabolism in African Americans we can more fully incorporate this population into personalized medicine.",Health disparity in pharmacogenomics: African American SNPs and drug metabolism,9474053,R01MD009217,"['Affect ', ' Africa ', ' Age ', ' ages ', ' Architecture ', ' Engineering / Architecture ', ' Beds ', ' Biology ', ' Cell Culture Techniques ', ' cell culture ', ' Cells ', ' Cell Body ', ' Disease ', ' Disorder ', ' Pharmacotherapy ', ' drug treatment ', ' Drug Therapy ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Environment ', ' Enzyme Induction ', ' Enzymes ', ' Enzyme Gene ', ' Gene Expression ', ' Genes ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Genome ', ' Genotype ', ' In Vitro ', ' Learning ', ' Linkage Disequilibrium ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Medicine ', ' Methods ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Pharmacogenetics ', ' Drug Kinetics ', ' Pharmacokinetics ', ' Pharmacology ', ' Clinical Pharmacology ', ' Phenotype ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Translating ', ' Translations ', ' Adverse drug effect ', ' Drug Side Effects ', ' Genetic Variation ', ' Genetic Diversity ', ' Caucasians ', ' white race ', ' Occidental ', ' Caucasoid Race ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Measures ', ' Treatment outcome ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Caring ', ' DNA Sequence ', ' Label ', ' improved ', ' Left ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Ensure ', ' Liver Cells ', ' Hepatic Parenchymal Cell ', ' Hepatic Cells ', ' Hepatocyte ', ' Individual ', ' African ', ' European ', ' drug use ', ' Drug usage ', ' Genetic ', ' Exposure to ', ' tool ', ' Complex ', ' Side ', ' Clinic ', ' System ', ' American ', ' Quantitative Trait Loci ', ' QTL ', ' trait ', ' Structure ', ' novel ', ' drug metabolism ', ' drug clearance ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Code ', ' Coding System ', ' Regulation ', ' Sampling ', ' response ', ' Adverse event ', ' Adverse Experience ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Genomics ', ' Pharmacogenomics ', ' Bioinformatics ', ' Bio-Informatics ', ' health disparity ', ' disparity in health ', ' prevent ', ' preventing ', ' genetic association ', ' liver metabolism ', ' hepatic metabolism ', ' Dose ', ' DNA Sequence Alteration ', ' genomic alteration ', ' Sequence Alteration ', ' Genetic mutation ', ' DNA mutation ', ' DNA Alteration ', ' Data ', ' Regulatory Pathway ', ' Resolution ', ' in vivo ', ' Process ', ' protein function ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' Minority ', ' cost-effective ', ' cost effective ', ' Population ', ' clinical relevance ', ' clinically relevant ', ' public health relevance ', ' clinical care ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized medicine ', ' Genetic study ', ' transcriptional differences ', ' differentially expressed ', ' differential expression ', ' interindividual variation ', ' inter-individual variability ', ' inter-individual variation ', ' study population ', ' clinical translation ', ' Predict drug response ', ' drug response prediction ', ' ']",NIMHD,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2018,395000,0.07890808701269215
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network PROJECT SUMMARY / ABSTRACT The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PROJECT NARRATIVE This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9678685,UG1DA015815,"['Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' American Indians ', ' American Indian ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Health Service Area ', ' Service area ', ' Health Catchment Area ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disease ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Use Disorder ', ' Education ', ' Educational aspects ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' Naloxone ', ' Persons ', ' Oregon ', ' Patients ', ' Peer Review ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Registries ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Rural Health ', ' Safety ', ' San Francisco ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Health Care Costs ', ' Healthcare Costs ', ' Health Costs ', ' Healthcare ', ' health care ', ' HIV vaccine ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' Caring ', ' base ', ' improved ', ' Site ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' experience ', ' care delivery ', ' Participant ', ' prevention service ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' drug abuse prevention ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' disparity in health ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' designing ', ' design ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' Hepatitis C Therapy ', ' urban Indian ', ' urban American Indian ', ' urban Native American ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addictive disorder ', ' addiction ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' healthcare service ', ' health care service ', ' health service utilization ', ' health service use ', ' data resource ', ' rural Americans ', ' therapeutic candidate ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid overdose ', ' recruit ', ' primary care services ', ' healthcare settings ', ' health care settings ', ' treatment services ', ' methadone patient ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2018,1034412,0.08578632686993468
"Drug use disparities among Hispanics: elucidating the complex interactions between socio-cultural, neurocognitive and drug use-related factors Project Summary/Abstract: Hispanic adolescents are disproportionately affected by drug use and its consequences. This is reflected in high rates of school dropouts, arrest for drug possession, alcohol, drug use disorders, disability and drug related crash injuries and fatalities. Mounting evidence suggest that impaired neurocognitive functioning, exposure to early, severe, or chronic social disadvantage, and stress related to conflicting cultural practices, independently predict adverse drug use outcomes. Yet, studies employing an integrated approach to explore how these factors interact to increase or decrease the risk of experiencing adverse drug use consequences are limited. Therefore, the immediate and overarching goal of this K01 application is to receive intensive, supervised career-development training on the intersection between addiction neuroscience and social and cross-cultural research applied to drug use research that will enable me to pursue a line of independent research on drug use disparities. In this application, I propose to investigate how socio- cultural, neurocognitive and drug use related factors interact to explain the adverse outcomes seen in the Hispanic population. The specific aims of the proposed project include: 1) To determine whether neurocognitive factors (e.g., decision-making, episodic memory), mediate the associations between socio-cultural factors (e.g., early, severe, or chronic socio-economic disadvantage, ethnic discrimination, acculturative stress, Hispanic cultural values), and drug use outcomes (e.g. transition from use to drug use disorders, drug use trajectories, driving under the influence of drugs - DIU); 2) To examine whether socio-cultural factors moderate the associations between neurocognitive factors and drug use. These goals will be achieved by leveraging data, participants, and resources from an ongoing longitudinal study (parent study) that assesses decision-making and episodic memory in trajectories to cannabis addiction (R01DA031176), and interviewing a sub-sample of young Hispanics participating in the parent study and their parents or legal guardians (n=200 dyads). The proposed Mentored Research Scientist Development Award will build on my expertise in drug use epidemiology with advanced training in: addiction neuroscience, social and cross-cultural research on drug use disparities, interdisciplinary research on cognitive neuroscience and socio-cultural research, advanced statistical methods for analyzing longitudinal data, and responsible conduct of research. Overseeing this training is my primary mentor Dr. Raul Gonzalez, an expert in addiction neuroscience, and my co-mentor Dr. Mario De La Rosa, an expert in cross-cultural research and drug use disparities. The proposed K01, which is responsive to two of the two priority focus areas identified in the 2016-2020 NIDA Strategic Plan, will provide me with the resources, training, mentoring and knowledge needed to establish myself as a scientist with expertise on the intersection between addiction neuroscience and public health, and to develop a long-term independent transdisciplinary research program aimed at reducing and eliminating drug use disparities across and within minority populations. Project narrative: Socio-cultural and neurocognitive factors are important and potentially modifiable determinants of drug use, yet research examining the how these factors interact to explain drug use disparities is scarce. The proposed K01 training will support a Hispanic new and early stage investigator to become an independent researcher and a leader in interdisciplinary research on drug use disparities. Specifically, the outlined project will contribute to understand how social factors, Hispanic cultural values, neurocognitive processes and drug use related factors interact to explain the adverse drug use outcomes seen in the growing and heterogeneous Hispanic population, which is essential to design effective drug use preventive interventions.","Drug use disparities among Hispanics: elucidating the complex interactions between socio-cultural, neurocognitive and drug use-related factors",9583204,K01DA046715,"['Affect ', ' Alcohols ', ' Alcohol Chemical Class ', ' Clinical Research ', ' Clinical Study ', ' Conflict (Psychology) ', ' Conflict ', ' Decision Making ', ' Disadvantaged ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Future ', ' Goals ', ' Interview ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Legal Guardians ', ' Longitudinal Studies ', ' long-term study ', ' Mentors ', ' Mentorship ', ' Neurosciences ', ' Parents ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Stress ', ' Student Dropouts ', ' School Dropouts ', ' Supervision ', ' Testing ', ' Time ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Mediating ', ' Youth ', ' Youth 10-21 ', ' Injury ', ' career ', ' improved ', ' Area ', ' Chronic ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Ensure ', ' Training ', ' disability ', ' pediatric ', ' Childhood ', ' Individual ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' drug use ', ' Drug usage ', ' Exposure to ', ' Impaired cognition ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Knowledge ', ' programs ', ' cognitive function ', ' Scientist ', ' Complex ', ' Dependence ', ' Pattern ', ' Neurocognitive ', ' psychosocial ', ' Episodic memory ', ' experience ', ' knowledge base ', ' knowledgebase ', ' Structure ', ' skills ', ' Participant ', ' Mediation ', ' Negotiation ', ' Negotiating ', ' Applied Research ', ' Applied Science ', ' Economically Deprived Population ', ' underclass ', ' economically disadvantaged ', ' economic disadvantage ', ' Economically Deprived ', ' cultural values ', ' social ', ' multilevel analysis ', ' multilevel modeling ', ' multilevel model ', ' methods to study multiple-level influences ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' career development ', ' driving under influence ', ' ethnic discrimination ', ' theories ', ' Adverse event ', ' Adverse Experience ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cannabis ', ' drug abuse prevention ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' disparity in health ', ' Effectiveness ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Data ', ' High Prevalence ', ' Mentored Research Scientist Development Award ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Strategic Planning ', ' Clinical Data ', ' Cognitive ', ' Process ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' socioeconomics ', ' early onset ', ' early initiation drug use ', ' early onset drug use ', ' designing ', ' design ', ' Minority ', ' neurocognitive impairment ', ' neurocognitive decline ', ' IQ Deficit ', ' Neurocognitive Deficit ', ' Outcome ', ' Population ', ' cognitive neuroscience ', ' Cognitive remediation ', ' addictive disorder ', ' addiction ', ' treatment design ', ' intervention design ', ' therapy design ', ' multidisciplinary approach ', ' interdisciplinary approach ', ' longitudinal analysis ', ' responsible research conduct ', ' adverse consequence ', ' adverse outcome ', ' cognitive development ', ' cannabis use ', ' THC use ', ' THC co-use ', ' marijuana use ', ' protective factors ', ' ']",NIDA,UNIVERSITY OF FLORIDA,K01,2018,153098,0.22159522634227913
"Strengthening Hispanic Families via NIDA Prevention Science DESCRIPTION (provided by applicant): These application requests 5 years of K01 support to accelerate the NIDA-focused interdisciplinary research career development of Dr. Ruben Parra-Cardona, a clinician-researcher who seeks to become an independent NIDA prevention researcher committed to underserved Hispanic adolescents and families. His current research evaluates a cultural adaptation of an evidence-based parenting intervention for at-risk Hispanic families with young children (ages 4-11), for which there is potential distal NIDA impact such as reduced risk of starting to smoke tobacco or to use other drugs. Complete evidence on distal benefits of early randomized trial interventions of this type cannot be seen unless the scale of research shifts upward, as in multi-site trials, and unless the measurements include bio-assays to confirm self-report drug use, with probes for potential gene- intervention interactions. Based on the proposed K01 career training objectives, the applicant will acquire the necessary skills to develop an interdisciplinary program of prevention research, informed by epidemiological and biomedical science. During 75% protected time for career development toward independent R01 project leadership, core learning objectives will be met (e.g., RCR, FCOI, grants management). In addition to its core, the training plan has 5 tracks: (1) enhanced mastery of small sample parenting intervention research; (2) enhanced mastery of research design and measurements for larger sample multi-site NIDA prevention research on youth developmental trajectories leading toward NIDA outcomes; (3) enhanced mastery of data analysis for interdependent observations from multiple sites; (4) new learning about integration of biological assays in NIDA family intervention and prevention research via collaborations with expert NIH toxicologists and genetics researchers; (5) mastery of electronic technology complements to current 'in person' intervention delivery and program impact assessment. The proposed award is crucial now that the applicant has become K01-eligible via permanent residency. His college has guaranteed protected time for this K01 career acceleration through structured mentoring program led by a NIDA K05 Senior Scientist, backed by a strong local team of federally funded co-mentors, as well as scientific advisors. Through the proposed K01 award, Dr. Parra-Cardona will gain mastery of the theory and research approaches now being refined by quantitative developmental scientists in new lines of NIDA prevention research. The training plan includes guided readings, coursework, among other activities leading to publications. A prevention pilot study will serve as a 'preliminary study' for a NIDA R01 grant proposal planned for Year 4 of the proposed award. This application is responsive to NIH and NIDA's strategic plans highlighting the need to implement interdisciplinary programs of research aimed at preventing young people from ever using drugs, as well as ensuring that at-risk and underserved minority populations benefit from these scientific efforts. PUBLIC HEALTH RELEVANCE: NIH and NIDA strategic goals stress (1) encouraging more minority scientists to pursue research careers bolstering their chances of R01 project success, and (2) interdisciplinary research programs on preventing young people from ever using drugs, and ensuring that at-risk and underserved minority populations benefit from these scientific efforts. The proposed K01 award is directly responsive to these strategic goals.",Strengthening Hispanic Families via NIDA Prevention Science,9507793,K01DA036747,"['Acceleration ', ' Age ', ' ages ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Award ', ' Back ', ' Dorsum ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Child ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child Rearing ', ' childrearing ', ' Parenting behavior ', ' Parenting ', ' Complement ', ' Complement Proteins ', ' Cuban American ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Mental Depression ', ' depression ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Environment ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Family ', ' Foundations ', ' Future ', ' Genes ', ' Goals ', ' Grant ', ' Health ', ' Intervention Studies ', ' interventions research ', ' interventional study ', ' interventional research ', ' intervention research ', ' Leadership ', ' Learning ', ' Mentors ', ' Methodology ', ' Mexican Americans ', ' Chicanos ', ' Chicanas ', ' Michigan ', ' Persons ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Oregon ', ' Parents ', ' Pilot Projects ', ' pilot study ', ' Publications ', ' Scientific Publication ', ' Puerto Rican ', ' Reading ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Residencies ', ' Risk ', ' Science ', ' Stress ', ' Substance Addiction ', ' Substance Dependence ', ' Target Populations ', ' Technology ', ' Testing ', ' Time ', ' United States ', ' Generations ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Population Heterogeneity ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Youth ', ' Youth 10-21 ', ' base ', ' career ', ' Distal ', ' Site ', ' Biological ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Ensure ', ' Training ', ' Stimulus ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' cigarette use ', ' cigarette smoking ', ' school age ', ' School-Age Population ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' drug use ', ' Drug usage ', ' Sample Size ', ' Genetic Research ', ' Funding ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Genetic ', ' Exposure to ', ' Specimen ', ' Research Specimen ', ' Empirical Research ', ' programs ', ' Scientist ', ' Tobacco smoke ', ' System ', ' college ', ' collegiate ', ' American ', ' experience ', ' stressor ', ' success ', ' Structure ', ' skills ', ' simulation ', ' Participant ', ' Prevention Research ', ' Prevention program ', ' research study ', ' Patient Self-Report ', ' Self-Report ', ' cultural values ', ' binge drinking ', ' episodic drinking ', ' binge alcohol consumption ', ' Heavy Drinking ', ' heavy alcohol use ', ' extreme drinking ', ' excessive ethanol ingestion ', ' excessive drinking ', ' excessive alcohol intake ', ' excessive alcohol ingestion ', ' excessive alcohol consumption ', ' excess ethanol ingestion ', ' excess alcohol ingestion ', ' excess alcohol consumption ', ' drink heavily ', ' Prevention ', ' Reporting ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Intervention Trial ', ' Interventional trial ', ' Modeling ', ' Sampling ', ' career development ', ' response ', ' theories ', ' junior high school ', ' middle school ', ' junior high ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' health disparity ', ' disparity in health ', ' prevent ', ' preventing ', ' Low income ', ' Address ', ' Data ', ' Applications Grants ', ' Grant Proposals ', ' High Prevalence ', ' Mentored Research Scientist Development Award ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Request for Applications ', ' NIH RFA ', ' Strategic Planning ', ' Subgroup ', ' Senior Scientist ', ' Monitor ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' early onset ', ' cost ', ' early initiation drug use ', ' early onset drug use ', ' efficacy evaluation ', ' willingness ', ' externalizing behavior ', ' Outcome ', ' Population ', ' Prevalence ', ' treatment design ', ' intervention design ', ' therapy design ', ' high risk ', ' public health relevance ', ' evidence base ', ' multi-site trial ', ' intervention effect ', ' Randomization trial ', ' randomized trial ', ' substance use reduction ', ' reduction in substance use ', ' reduced substance use ', ' Prevention trial ', ' cannabis use ', ' THC use ', ' THC co-use ', ' marijuana use ', ' underserved minority ', ' minority scientist ', ' ']",NIDA,"UNIVERSITY OF TEXAS, AUSTIN",K01,2018,174214,0.06448522081204047
"Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges This is a proposal to renew funding of the Center for Drug Use and HIV Research (CDUHR) for years 21- 25. Recent advances in HIV biomedical and behavioral science have been shown to reduce HIV incidence and allow HIV-positive persons to reach near-normal lifespans. These achievements have led UNAIDS, the US and several local governments to propose strategies for Ending the HIV Epidemic. Notwithstanding these successes, attaining this goal among people who use drugs (PWUD) will require addressing a number of important existing barriers. The overall theme of this renewal is Ending HIV/AIDS among People who use Drugs: Overcoming Challenges. We define Ending HIV/AIDS as reducing new infections and increasing the proportion of PWUD who are virally suppressed. To accomplish this, we have identified these research priorities, which directly address the most significant challenges: (1) Devise new strategies to overcome emerging and persistent barriers to ending HIV/AIDS among PWUD. Barriers include recent increases in prescription opioid misuse, which have given rise to a new generation of heroin user and injectors, and lack of attention to the key role of substance use in new infections in men who have sex with men and heterosexuals. HIV-positive PWUD also experience disparities all along the continuum of HIV care, including delayed diagnosis, lower retention in care, delayed initiation of ART and poorer disease outcomes. (2) Conduct research on effective ways to broadly implement evidence-based interventions. HIV prevention and care programs for PWUD do not exist in many regions of the US and the rest of the world where they are needed most, and they are rarely implemented at public-health scale. (3) Develop new, innovative models of prevention and treatment interventions to address substance-use related disparities in HIV infection and treatment outcomes that take into account the complex, multilevel nature of HIV among PWUD.  We have made significant changes in our scope and structure for this renewal, and we will achieve our aims through five Cores, an Administrative Core and four Research Support Cores: (1) Infectious Disease Epidemiology and Theory, (2) Transdisciplinary Research Methods, (3) Dissemination and Implementation, and (4) Pilot Projects and Mentoring. These Cores support our research base and affiliated investigators to conduct cutting-edge science and enhance synergy across investigators from multiple disciplines, thereby leading to contributions to the field that are beyond what the individual projects could have achieved. In addition to the many successful initiatives that have been developed over CDUHR's history, new activities were added to respond to the evolving needs of our investigators. Also, in addition to our ongoing commitment to train new investigators to conduct high-impact research, we will collaborate with investigators in areas where HIV epidemics are occurring among PWUD (in rural and middle America, and in eastern Europe and Asia), building on our collective knowledge and expertise to advance toward Ending HIV/AIDS in those regions. Project Narrative A critical time has been reached in the course of the HIV epidemic, when the possibility to end HIVAIDS has been raised. Despite advances in biomedical treatments and behavioral interventions to reduce HIV incidence and its impact, people who use drugs (PWUD) have poorer outcomes. The Center provides a research infrastructure to enhance the productivity, synergy and impact of the research by affiliated investigators working to End HIV/AIDS among PWUD.",Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges,9197847,P30DA011041,"['Achievement ', ' Achievement Attainment ', ' Americas ', ' Attention ', ' Behavior ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavioral Sciences ', ' Biology ', ' Communities ', ' Heroin ', ' Diamorphine ', ' Diacetylmorphine ', ' Diagnosis ', ' Diagnostic Services ', ' diagnosis service ', ' Disease Outbreaks ', ' Outbreaks ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Emergency Situation ', ' Emergencies ', ' Epidemic ', ' Eastern Europe ', ' Evolution ', ' Face ', ' facial ', ' faces ', ' Far East ', ' Eastern Asia ', ' East Asia ', ' Future ', ' Goals ', ' Greece ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Seropositivity ', ' antigen positive AIDS test ', ' antibody positive AIDS test ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV antibody positive ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' Anti-HIV Positivity ', ' AIDS Seropositivity ', ' AIDS Seroconversion ', ' Incidence ', ' Income ', ' Economical Income ', ' Economic Income ', ' Indiana ', ' Infection ', ' Light ', ' Photoradiation ', ' Longevity ', ' lifespan ', ' life span ', ' Length of Life ', ' Mentors ', ' Methods ', ' Local Government ', ' Persons ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' New York ', ' Perception ', ' Pilot Projects ', ' pilot study ', ' Play ', ' Productivity ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Research Support ', ' Rest ', ' Risk ', ' Role ', ' social role ', ' Science ', ' Stigmatization ', ' Time ', ' ranpirnase ', ' P30 Protein ', ' P30 ', ' P-30 Protein ', ' Generations ', ' Treatment outcome ', ' Research Methodology ', ' Research Methods ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Caring ', ' base ', ' improved ', ' Left ', ' Area ', ' Medical ', ' Training ', ' Discipline ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' Rural ', ' Policies ', ' Inequality ', ' drug use ', ' Drug usage ', ' Funding ', ' Nature ', ' Research Priority ', ' Knowledge ', ' programs ', ' Complex ', ' Distant ', ' Route ', ' System ', ' Country ', ' Viral ', ' Injecting drug user ', ' persons who inject drugs ', ' people who inject illicit drugs ', ' people who inject drugs ', ' PWID ', ' Injection Drug User ', ' Services ', ' experience ', ' success ', ' synergism ', ' Heroin Users ', ' austin ', ' Structure ', ' Disease Outcome ', ' prevention service ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Modeling ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' HIV diagnosis ', ' health disparity ', ' disparity in health ', ' Address ', ' Health system ', ' Evidence based practice ', ' Infectious Disease Epidemiology ', ' Infectious Epidemiology ', ' International ', ' Interruption ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Infrastructure ', ' Infrastructure ', ' translation research ', ' Translational Science ', ' Translational Research ', ' Transmission ', ' transmission process ', ' Characteristics ', ' Heterosexuals ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' Outcome ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' Evidence based intervention ', ' public health research ', ' recruit ', ' treatment services ', ' Injections ', ' heroin intake ', ' heroin use ', ' prescription opiate misuse ', ' opioid prescription medication misuse ', ' opioid medication misuse ', ' opioid analgesic misuse ', ' nonmedical use of prescription opioids ', ' nonmedical use of prescription opiates ', ' non-medical use of prescription opioids ', ' non-medical use of prescription opiates ', ' prescription opioid misuse ', ' ']",NIDA,NEW YORK UNIVERSITY,P30,2018,1549182,0.059589963761982494
"Reducing Black Men's Drug Use and Co-Occurring Negative Mental and Physical Health Outcomes: Intersectionality, Social-Structural Stressors, and Protective Factors PROJECT SUMMARY/ABSTRACT Health inequities among Black men in the U.S. are stark. Drug use contributes to six of the top ten leading causes of death among Black men ages 18 to 54. Social-structural stressors such as discrimination, based on race or race and sexual identity, and drug use to cope with stress, are well-documented pathways to drug use among Black adults. Empirical evidence that drug use co-occurs with other negative health outcomes underscores an urgent public health need to examine drug use and other co-occurring negative health outcomes associated with social-structural stressors. Single-axis perspectiveseither race or sexual identity dominate drug use and health disparities research. Apart from HIV/AIDS research, research on the effects of social-structural stressors on Black mens drug use and co-occurring negative health outcomes at the intersection of sexual identity (i.e., heterosexual, sexual minority) and socioeconomic position (SEP) is virtually nonexistent. Critical gaps also exist about how protective factors (e.g., resilience, religiosity, positive racial/sexual identity) influence the effects of social-structural stressors on Black mens drug use and co- occurring negative health outcomes. To address these critical gaps, a longitudinal cross-lagged explanatory- sequential (QUANTqual) mixed methods study is proposed to test, via structural equation modeling, a conceptual model of social-structural stressors, protective factors, and drug use (alcohol, marijuana, nicotine, illicit drug use) and co-occurring negative mental (e.g., psychological distress) and physical (e.g., blood pressure) health outcomes among Black men at the intersection of sexual identity and SEP. Purposive quota sampling will be used to recruit 960 Black men, ages 18-54, stratified by sexual identity and SEP (240/group) in Washington, DC. Phase I includes the collection of self-reported social-structural stressors, protective factors, drug use, and mental health data, and objective drug use (i.e., urine toxicology) and physical health (e.g., blood pressure) data at Time 1, and 3 months later at Time 2 (Aims 1, 2). Blood samples will be collected at Time 2 only to assess cardiovascular disease biomarkers (e.g., total cholesterol). Phase II includes 4 focus groups with 6-8 Phase I participants (total n = 24 to 32) purposively sampled to explain Phase I results (Aim 3). Phase III involves a synthesis and validity assessment of the quantitative and qualitative results (Aim 3). The proposed research uses intersectionality, social-structural stress, and resilience theoretical frameworks to advance new and important knowledge about the extent to which social-structural stressors and protective factors influence drug use and co-occurring negative health outcomes among Black men at the intersection of sexual identity and SEP. This intersectional focus represents a paradigmatic shift from conventional single-axis and one-size-fits-all intervention approaches. The significance of the proposed research lies in the expected outcome of the future development of multi-level (i.e., individual and social-structural) interventions to reduce drug use and promote mental and physical health among Black men at different intersectional positions of risk. PROJECT NARRATIVE The proposed explanatory-sequential (QUANTqual) mixed-methods longitudinal cross-lagged study is relevant to public health because, in alignment with the NIDA Epidemiology Research Branchs mission, it advances new knowledge about the effects of social-structural stressors and protective factors on drug use and co-occurring negative mental and physical health outcomes for Black men at the intersection of sexual identity and socioeconomic position (SEP). A significant benefit of the proposed research is that it will have broad translational importance for future health disparities research and interventions designed to reduce drug use and health disparities among and between populations at multiple marginalized intersectional positions (e.g., race, gender, sexual identity, and SEP). The project advances new horizons about the effects of intersectional positions and related social-structural stressors and protective factors on drug use and co- occurring negative mental and physical health outcomes that conventional single-axis (e.g., either race or sexual identity) approaches obscure.","Reducing Black Men's Drug Use and Co-Occurring Negative Mental and Physical Health Outcomes: Intersectionality, Social-Structural Stressors, and Protective Factors",9496881,R01DA045773,"['21+ years old ', ' Affect ', ' Age ', ' ages ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohols ', ' Alcohol Chemical Class ', ' Blood Pressure ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cause of Death ', ' Cholesterol ', ' Discrimination ', ' Cognitive Discrimination ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Focus Groups ', ' Future ', ' Health ', ' Heart Diseases ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Homicide ', ' Marijuana ', ' marihuana ', ' men ', "" men's "", ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' Mission ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Nicotine ', ' Political Factor ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Support ', ' Risk ', ' Stress ', ' Suicide ', ' suicidality ', ' intent to die ', ' fatal suicide ', ' fatal attempt ', ' Testing ', ' Time ', ' Toxicology ', ' Urine ', ' Urine Urinary System ', ' Washington ', ' Gender ', ' Police ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Accidental Injury ', ' Unintentional Injury ', ' base ', ' Bi-sexual ', ' Bisexual ', ' Blood Sample ', ' Blood specimen ', ' Area ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' Economical Factors ', ' Economic Factors ', ' mental ', ' Psyche structure ', ' Individual ', ' Inequality ', ' drug use ', ' Drug usage ', ' Gays ', ' Knowledge ', ' Dependence ', ' Pattern ', ' physical conditioning ', ' physical health ', ' Equation ', ' experience ', ' stressor ', ' Participant ', ' Patient Self-Report ', ' Self-Report ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Social status ', ' social standing ', ' social position ', ' epidemiology study ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Studies ', ' Epidemiologic Research ', ' Reporting ', ' social ', ' Positioning Attribute ', ' Position ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' psychological distress ', ' Modeling ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' health disparity ', ' disparity in health ', ' low socioeconomic status ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' low SES ', ' Address ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Collection ', ' Process ', ' developmental ', ' Development ', ' Heterosexuals ', ' pathway ', ' Pathway interactions ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' virtual ', ' resilience ', ' Outcome ', ' stress resilience ', ' Population ', "" men's health "", ' male health ', ' multidisciplinary ', ' treatment design ', ' intervention design ', ' therapy design ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' sexual minority ', ' health data ', ' illicit drug use ', ' intersectionality ', ' recruit ', ' protective factors ', ' Adult ', ' adulthood ', ' Adult Human ', ' ']",NIDA,GEORGE WASHINGTON UNIVERSITY,R01,2018,727210,0.10473788718971687
"Cohort Studies on HIV/AIDS and Substance Abuse in Miami     DESCRIPTION (provided by applicant): Liver disease is a major cause of death in HIV infected persons in the United States. While advances in antiretroviral therapy have significantly reduced HIV-related mortality, co-infection with hepatitis C virus (HCV), is widespread and accelerates progression of liver fibrosis to cirrhosis and liver carcinoma. In addition, substance abuse accelerates HIV disease, and may facilitate progression of liver fibrosis. The primary goal of this proposal is to continue to follow the existing Miami Adult Studies on HIV (MASH) cohort, its specimen repository and database, and expand it from the current 881 to 1,500 study participants. The purpose is to generate collaborative studies to investigate the impact of cocaine, by far the most prevalent drug of abuse in South Florida, on HIV infection, HIV/HCV co-infection, and on long-term morbidity with a focus on liver disease in this population with disparities in access to care. HIV and HCV un-infected cocaine users and non-users will also be recruited to allow determination of the impact of cocaine use alone, as well as the interaction of cocaine use with HIV, HCV, and HIV/HCV co-infection. As new and more effective treatments and access to care for HIV, HCV and drug abuse become available, maintaining a well- characterized cohort, specimen repository and database will create a strong resource platform for current and future collaborative research. Observing the uptake of new HCV treatments and potential new cocaine cessation programs in this at-risk population with health disparities will provide data on barriers and facilitators to effective treatments to prevent long-term morbidity and mortality. We have followed the MASH cohort of 881 participants for up to 12 years with excellent retention rates, and have created a specimen repository and a database. The MASH cohort in Miami is unique because it will be a mostly Hispanic cohort with a large number of African Americans, women, non-injector drug users, with predominantly heterosexual HIV- transmission etiology. We propose to (1) compare the progression of liver fibrosis over four years among cocaine users and non-users in HIV+/HCV-, HIV+/HCV+, HIV-/HCV+, and HIV-/HCV-, using a novel non- invasive diagnostic device, the Magnetic Resonance Elastography (MRE). We also propose to (2) compare the pattern over four years of biomarkers and identify genetic markers associated with the mechanisms of liver fibrosis among cocaine users and non-users. Understanding the role of cocaine use in the context of HIV and HIV/HCV co-infections and lack of lasting effects of treatments for cocaine use cessation are crucial in order to gain insights into the pathogenesis and disease outcomes, and to provide the basis for identifying antifibrotic therapies such as oxidative stress, which are amenable to intervention. These studies will be critical for program development, appropriate interventions, and for improving health in this population. PUBLIC HEALTH RELEVANCE: Understanding the role of cocaine use in the context of HIV, HCV and HIV/HCV co-infections with focus on progression of liver fibrosis, is crucial in gaining insights into the disease pathogenesis, outcomes, and the role of co-morbidities and health disparities of this population. This research will provide evidence-based information for program development and evaluation, appropriate and effective interventions, and for improving health in this population.",Cohort Studies on HIV/AIDS and Substance Abuse in Miami,9494556,U01DA040381,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Alcohols ', ' Alcohol Chemical Class ', ' Animals ', ' Cause of Death ', ' Cocaine ', ' Cocaine Abuse ', ' Cohort Studies ', ' Concurrent Studies ', ' Comorbidity ', ' co-morbidity ', ' Cessation of life ', ' Death ', ' Disease ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmacotherapy ', ' drug treatment ', ' Drug Therapy ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Florida ', ' Future ', ' Genetic Markers ', ' genetic biomarker ', ' Goals ', ' Health ', ' Health Services Accessibility ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Primary carcinoma of the liver cells ', ' liver carcinoma ', ' Liver Cells Carcinoma ', ' Hepatoma ', ' Hepatocellular cancer ', ' Hepatocellular Carcinoma ', ' Hepatocarcinoma ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Human ', ' Modern Man ', ' Immunity ', ' Immunosuppression ', ' immune suppression ', ' Immunosuppressive Effect ', ' Immunosuppression Effect ', ' In Vitro ', ' Laboratories ', ' Liver diseases ', ' liver disorder ', ' hepatopathy ', ' hepatic disease ', ' Hepatic Disorder ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Persons ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Program Development ', ' Program Evaluation ', ' Quality of life ', ' QOL ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Resources ', ' Research Resources ', ' Risk Factors ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' United States ', ' Virus Diseases ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Woman ', ' cytokine ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' malnourished ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Malnutrition ', ' therapy failure ', ' Treatment Failure ', ' improved ', ' Area ', ' Clinical ', ' Animal Experiments ', ' insight ', ' Stimulus ', ' Cocaine Users ', ' hepatic fibrosis ', ' fibrotic liver ', ' Liver Fibrosis ', ' data base ', ' Data Bases ', ' Databases ', ' Populations at Risk ', ' Oxidative Stress ', ' Funding ', ' uptake ', ' non-invasive diagnostic ', ' non-invasive diagnosis ', ' noninvasive diagnosis ', ' Metabolic ', ' chronic liver disease ', ' chronic liver disorder ', ' chronic hepatic disorder ', ' chronic hepatic disease ', ' Diagnostic ', ' Nature ', ' Specimen ', ' Research Specimen ', ' programs ', ' Pattern ', ' Mono-S ', ' MonoS ', ' interest ', ' fibrogenesis ', ' cohort ', ' Disease Outcome ', ' novel ', ' Participant ', ' Devices ', ' Pathogenesis ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' repository ', ' time interval ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' health disparity ', ' disparity in health ', ' prevent ', ' preventing ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Data ', ' Prognostic Factor ', ' Prognostic/Survival Factor ', ' General Prognostic Factor ', ' Magnetic Resonance Elastography ', ' Transmission ', ' transmission process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Heterosexuals ', ' Behavioral ', ' cirrhotic ', ' Cirrhosis ', ' antiretroviral treatment ', ' anti-retroviral treatment ', ' anti-retroviral therapy ', ' antiretroviral therapy ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' Hepatitis C Therapy ', ' Outcome ', ' Population ', ' prospective ', ' treatment effect ', ' drugs of abuse ', ' drugs abused ', ' drug abused ', ' abused drugs ', ' abused drug ', ' drug of abuse ', ' public health relevance ', ' effective intervention ', ' evidence base ', ' FDA approved ', ' effective treatment ', ' effective therapy ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' cocaine use ', ' coinfection ', ' co-infection ', ' student retention ', ' retention strategy ', ' retention rate ', ' HIV/Hepatitis C ', ' HIV-HCV ', ' HIV and hepatitis C ', ' HIV and HCV ', ' HCV/HIV ', ' HIV/HCV ', ' hepatitis C virus coinfection ', ' hepatitis C virus co-infection ', ' hepatitis C coinfection ', ' HCV coinfection ', ' HCV co-infection ', ' Hepatitis C co-infection ', ' liver development ', ' healthcare service access ', ' healthcare access ', ' health care service availability ', ' health care service access ', ' accessibility to healthcare ', ' accessibility to health care ', ' accessibility of health care ', ' access to healthcare ', ' access to health care ', ' health care availability ', ' HCV ', ' Hepatitis C virus ', ' recruit ', ' ']",NIDA,FLORIDA INTERNATIONAL UNIVERSITY,U01,2018,1281233,0.03301287487101885
"Frailty, HIV Infection, Injection Drug Use and the Inflammatory-Microbiome PROJECT SUMMARY/ABSTRACT With effective antiretroviral therapy (ART), life expectancy for HIV-infected persons has markedly improved, yet marked deficits in survival remain for HIV-infected persons with a history of injecting drugs (PWID). Disparities among PWID have been attributed in part to a shifting spectrum of disease to aging-associated conditions driven by persistent inflammation even with ART. Frailty is an important aging-related state of vulnerability to stress, with an increased burden in HIV infection, strongly associated with heightened inflammation, and predictive of premature mortality and aging-related morbidity among PWID. Injecting drugs itself can increase the severity of inflammation in HIV. The human gut microbial ecosystem (gut microbiome) critically regulates inflammation and immunity. Alterations in the gut microbiome (gut dysbiosis) together with associated disruptions of gut structure and immune integrity constitute an inflammatory-microbiome signature (gut dysbiosis, increased gut permeability, translocation of microbial products, immune activation, heightened inflammation) linked to adverse aging-associated inflammatory conditions and disease. Proposed is a systematic investigation of the role of HIV infection and injection drug use (IDU) in defining the inflammatory- microbiome signature and determination of the relationship of this signature to frailty. Through assessments of the fecal and mucosal microbiome in the AIDS Linked to the IntraVenous Experience (ALIVE) cohort of HIV- infected and epidemiologically comparable HIV-uninfected PWID, we will determine how HIV infection and active IDU alter microbiome composition and function and the relationship of these changes to inflammation and frailty progression over time. Using a germ free murine model, we will further define the frail human microbial communities and gene products that precipitate inflammation. These studies will facilitate elucidation of gut microbial determinants of frailty among HIV-infected PWID and could significantly inform microbiota modulation strategies to reduce frailty-associated inflammation beyond ART. Understanding the role of the gut microbiome in relation to HIV, injection drug use, and frailty remains a critical next step to reducing the marked disparities in clinical outcomes among HIV-infected PWID. PROJECT NARRATIVE Persons co-impacted by HIV infection and drug use are living longer with effective antiretroviral therapy, but many still die much earlier and experience a heavy burden of frailty and age-related disease. We seek to understand how microbes in the gut may be linked to inflammation, how this process may be impacted by HIV and injection drug use, and how these factors may contribute to age-related diseases or frailty. Knowledge gained from these studies could inform development of effective strategies to improve survival and quality of life for persons aging with HIV infection and drug use.","Frailty, HIV Infection, Injection Drug Use and the Inflammatory-Microbiome",9623754,R01AG060825,"['Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Age ', ' ages ', ' Aging ', ' Alcohols ', ' Alcohol Chemical Class ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' cell motility ', ' Motility ', ' Cellular Motility ', ' Cellular Migration ', ' Cell Movement ', ' Cell Migration ', ' Cell Locomotion ', ' Chronic Disease ', ' chronic disorder ', ' Chronic Illness ', ' Cocaine ', ' Colon ', ' Communities ', ' Cessation of life ', ' Death ', ' Heroin ', ' Diamorphine ', ' Diacetylmorphine ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Gene Pool ', ' Recording of previous events ', ' History ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Homeostasis ', ' Physiological Homeostasis ', ' Autoregulation ', ' Hospitalization ', ' Human ', ' Modern Man ', ' Immunity ', ' Inflammation ', ' Institutionalization ', ' Life Expectancy ', ' Liver diseases ', ' liver disorder ', ' hepatopathy ', ' hepatic disease ', ' Hepatic Disorder ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Mucous Membrane ', ' Mucosal Tissue ', ' Mucosa ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Persons ', ' Phenotype ', ' Public Health ', ' Quality of life ', ' QOL ', ' Risk ', ' Ribosomal RNA ', ' rRNA ', ' Role ', ' social role ', ' Stress ', ' Syndrome ', ' Testing ', ' Time ', ' Tobacco ', ' Transplantation ', ' transplant ', ' virology ', ' Work ', ' Mediating ', ' Ecological Systems ', ' Ecologic Systems ', ' Ecosystem ', ' improved ', ' Clinical ', ' Physiologic ', ' Physiological ', ' Link ', ' Premature Aging ', ' Premature aging syndrome ', ' Recovery ', ' Premature Mortality ', ' drug use ', ' Drug usage ', ' Sample Size ', ' T4 Lymphocyte Count ', ' CD4+ Counts ', ' CD4+ Cell Counts ', ' CD4 Lymphocyte Count ', ' Inflammatory ', ' Intravenous ', ' Knowledge ', ' frailty ', ' Investigation ', ' Immune ', ' Immunes ', ' Severities ', ' Pattern ', ' Probiotics ', ' pro-biotic ', ' Mood Disorders ', ' Affective Disorders ', ' Injecting drug user ', ' persons who inject drugs ', ' people who inject illicit drugs ', ' people who inject drugs ', ' PWID ', ' Injection Drug User ', ' early experience ', ' experience ', ' Biological Neural Networks ', ' neural network ', ' cohort ', ' microbial ', ' Structure ', ' novel ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Metabolic Pathway ', ' prevent ', ' preventing ', ' Data ', ' Inflammation Process ', ' Multicellular Inflammation Process ', ' Germ-Free ', ' sex ', ' developmental ', ' Development ', ' microbiome ', ' metagenome ', ' antiretroviral treatment ', ' anti-retroviral treatment ', ' anti-retroviral therapy ', ' antiretroviral therapy ', ' age dependent ', ' age related ', ' Minority ', ' Outcome ', ' Population ', ' Microbe ', ' murine model ', ' mouse model ', ' healthy aging ', ' immune activation ', ' injection drug use ', ' intestinal microbiome ', ' intestinal biome ', ' gut-associated microbiome ', ' gastrointestinal microbiome ', ' enteric microbiome ', ' digestive tract microbiome ', ' GI microbiome ', ' gut microbiome ', ' fecal transplant ', ' fecal microbiota transplantation ', ' fecal microbiota transplant ', ' fecal microbiome transplantation ', ' fecal microbial transplantation ', ' fecal transplantation ', ' multispecies consortia ', ' microbial flora ', ' microbial consortia ', ' microbiota ', ' gene product ', ' reduce disparity ', ' disparity reduction ', ' Injections ', ' human-associated microbiota ', ' human-associated microbial communities ', ' human microflora ', ' human microbial communities ', ' human flora ', ' human microbiota ', ' microbiome studies ', ' microbiome science ', ' Microbiomics ', ' microbiome research ', ' Gut Mucosa ', ' microbial imbalance ', ' dysbiotic ', ' dysbacteriosis ', ' dysbiosis ', ' stool-associated microbiome ', ' stool microbiome ', ' fecal microbiome ', ' Intestinal Hyperpermeability ', ' Intestinal Epithelial Permeability ', ' Gut permeability ', ' Gut Hyperpermeability ', ' Gut Epithelial Permeability ', ' Intestinal permeability ', ' microbiome species composition ', ' microbiome community composition ', ' microbiome composition ', ' microbiome perturbation ', ' microbiome adaptation ', ' alter microbiome ', ' microbiome alteration ', ' ']",NIA,JOHNS HOPKINS UNIVERSITY,R01,2018,649179,0.09583144688895012
"Racial and ethnic disparities in alcohol and other drug use disorder recovery (F.220) 7. Project Summary Racial/ethnic health disparities have been well-documented in the onset, rate, course, and consequences of alcohol and other drug (AOD) use problems, often with substantially poorer outcomes in non-White racial/ethnic groups compared to non-Hispanic Whites. As a result, the NIAAA has made it a central strategic aim to investigate and eliminate health disparities. Despite 30 years of research documenting the presence of AOD-related racial/ethnic health disparities, the degree to which disparities negatively impact the emerging standard of assessing the effectiveness of AOD treatments (i.e.,  5 years AOD problem resolution),53 which is also when risk of problematic use is no higher than in the general population,84 is unknown. Publicly available datasets are very limited by their ability to directly measure AOD recovery-related constructs and national prevalence rates of non-White racial/ethnic groups who have achieved long-term problem resolution. In turn, this compromises our ability to assess the extent to which racial/ethnic health equality exists in terms of long- term AOD problem resolution and the recovery-related mechanisms associated with potential disparities. To begin to fill this knowledge gap, we propose to conduct secondary data analyses of the first recovery-focused nationally representative probability-based study to test if racial/ethnic health disparities exist. The National Recovery Study (PI: Kelly) consists of a web-based probability sampling frame of 39,809 adults who were screened to identify if they once had a problem with drugs or alcohol and no longer do. Complete data on 2,002 participants who answered yes is available. Participants were assessed with a battery of quantitative and qualitative survey items in 2016 which captured their AOD clinical history and recovery-related mechanisms associated racial/ethnic health equality in AOD problem resolution. This design will enable us to address the following aims: 1a. Test if racial/ethnic health disparities exist in (i) the duration between onset of alcohol and other drug problems and onset of problem resolution; and, (ii) the likelihood of achieving long-term problem resolution ( 5 years) 1b. If health disparities are observed, explore the mediating potential of psychosocial (accrued recovery capital, degree of treatment utilization, degree of recovery support-service utilization) and structural recovery-related factors (health insurance coverage, socioeconomic status, and recovery-related discrimination) in explaining observed disparities. 2. Conduct concurrent qualitative analysis to identify the top three strategies that participants report having used to resolve their alcohol or other drug problem (e.g., social support, secure accommodations, mental and physical health, financial management, employment, and recreation) and compare these strategies according to racial/ethnic characteristics. Mix the qualitative and quantitative data to determine if race/ethnicity is associated with themes identified in the recovery strategies. (F.220) 8. Project Narrative Despite 30 years of research documenting the disproportionate burden that alcohol and other drug (AOD)- related problems have on non-White racial/ethnic groups, the degree to which racial/ethnic health disparities negatively impact emerging standards for assessing the effectiveness of AOD treatments ( 5 years AOD problem resolution), which is when the risk of problematic use is no higher than in the general population, is unknown. This F32 postdoctoral training will aid the applicant in documenting US prevalence estimates of the number of non-White individuals who have resolved an AOD problem using data from the first nationally representative, probability-based, study of recovery. Specifically, the candidate will investigate the associations between race/ethnicity and stages of AOD problem resolution in the: 1. duration between onset of AOD problems and onset of problem resolution; and, 2. the likelihood of achieving stable long-term problem resolution. In doing so, we will establish the first line of nationally representative research on health equality in long-term AOD problem resolution and associated recovery-related mechanisms, ultimately translating findings into actionable targets for clinicians, policy, and public health proposals that can address the identified disparities.",Racial and ethnic disparities in alcohol and other drug use disorder recovery,9572386,F32AA025823,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Alcohols ', ' Alcohol Chemical Class ', ' Capital ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Discrimination ', ' Cognitive Discrimination ', ' Pharmacotherapy ', ' drug treatment ', ' Drug Therapy ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Economics ', ' Employment ', ' Ethnic group ', ' ethnicity group ', ' Occupational activity of managing finances ', ' Financial Management ', ' Health ', ' Health Policy ', ' healthcare policy ', ' health care policy ', ' Recording of previous events ', ' History ', ' Incidence ', ' indexing ', ' Health Insurance ', ' health insurance plan ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health Services ', ' Mental Hygiene Services ', ' Methods ', ' Methodology ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Probability ', ' Probability Samples ', ' Public Health ', ' Race ', ' Racial Stocks ', ' Racial Group ', ' Recreation ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Science ', ' Social support ', ' social support network ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Translating ', ' Measures ', ' Mediating ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' Clinical ', ' Phase ', ' Evaluation ', ' Training ', ' Individual ', ' Recovery ', ' Policies ', ' drug use ', ' Drug usage ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Knowledge ', ' Insurance Coverage ', ' Insurance Status ', ' Severities ', ' physical conditioning ', ' physical health ', ' psychosocial ', ' Services ', ' novel ', ' Participant ', ' General Population ', ' General Public ', ' Reporting ', ' Sampling ', ' behavioral health ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Qualitative Research ', ' health disparity ', ' disparity in health ', ' Effectiveness ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Data ', ' Resolution ', ' Strategic Planning ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Characteristics ', ' Process ', ' designing ', ' design ', ' Minority ', ' alcohol and other drug ', ' Outcome ', ' alcohol related problem ', ' Population ', ' Prevalence ', ' NIAAA ', ' National Institute on Alcohol Abuse and Alcoholism ', ' postdoctoral training ', ' post-doctoral training ', ' racial and ethnic ', ' demographics ', ' service utilization ', ' addictive disorder ', ' addiction ', ' racial and ethnic disparities ', ' alcohol consequences ', ' Secure ', ' screening ', ' ethnic health disparity ', ' service programs ', ' ']",NIAAA,MASSACHUSETTS GENERAL HOSPITAL,F32,2018,67858,0.037463982941195906
"Methamphetamine Research Program at Meharry Medical College DESCRIPTION (provided by applicant): The long-range goal of the proposed DIDARP program described in this application is to continue to increase the capacity of Meharry Medical College to conduct rigorous research in substance use disorders with an [ emphasis on health disparities and underserved populations. The research program will seek to understand the molecular underpinnings of acute and chronic methamphetamine (METH) exposure alone and in conjunction with human immunodeficiency virus (HIV) infection. We also plan to strengthen pur intellectual environment and enhance the interest levels of trainees and faculty in drug abuse research. New for this j application is the proposal to introduce training on screening and brief interventions for substance misuse to medical students, residents and faculty in the Family and Community Medicine clinics. The Specific Aims of the Meharry Medical College DIDARP Program during the next five years are: 1. To publish at least 20 or more peer-reviewed publications in high-impact journals in drug abuse research; 2. To submit 5 or more grant applications in drug abuse research by Year-03 of the award period; | 3. To acquire 3 or more investigator-initiated awards by the end of year-05; and 4. To stimulate additional faculty and trainee interest in drug abuse research by curricula enhancement, ' seminars and symposia. . Three projects are proposed, one primary proposal and two pilot projects. In the primary project, Dr. CV. ] Dash will seek to understand the link between METH abuse and HIV infection. In the first pilot project, Dr. J. Shawn Goodwin will study how METH abuse alters dopamine signaling by altering the dopamine transporter residency in lipid rafts. In second pilot project, Dr. Khilber and her collaborators which includes the PI and the Chair of Family and Community Medicine, Dr. Roger Zoorob, will test the effects of a tiered training program on screening, brief intervention and referral to treatment (SBIRT) for substance misuse fo ",Methamphetamine Research Program at Meharry Medical College,9390472,R24DA036420,"['AIDS Dementia Complex ', ' HIV-related dementia ', ' HIV-Associated Cognitive Motor Complex ', ' HIV-1 dementia ', ' HIV-1 associated dementia ', ' HIV associated dementia ', ' HIV Dementia ', ' Dementia in human immunodeficiency virus (HIV) disease ', ' Dementia associated with AIDS ', ' Dementia Due to HIV Disease ', ' Acquired Immune Deficiency Syndrome related dementia ', ' Acquired Immune Deficiency Syndrome Dementia Complex ', ' AIDS-related dementia ', ' AIDS-Related Dementia Complex ', ' AIDS with dementia ', ' AIDS Dementia ', ' Anxiety ', ' Award ', ' Awareness ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Community Medicine ', ' Disadvantaged ', ' Dopamine ', ' Hydroxytyramine ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Education ', ' Educational aspects ', ' Environment ', ' Faculty ', ' Family Practice ', ' family medicine ', ' Goals ', ' Grant ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Income ', ' Economical Income ', ' Economic Income ', ' Industry ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Methamphetamine ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Mission ', ' Neurobiology ', ' neurobiological ', ' Peer Review ', ' Pilot Projects ', ' pilot study ', ' Poverty ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Program Development ', ' Publications ', ' Scientific Publication ', ' Publishing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Residencies ', ' Role ', ' social role ', ' medical schools ', ' school of medicine ', ' medical college ', ' Self Medication ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Medical Students ', ' Substance Use Disorder ', ' Educational process of instructing ', ' Teaching ', ' Tennessee ', ' Testing ', ' Training Programs ', ' Virus Diseases ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Work ', ' symposium ', ' symposia ', ' summit ', ' convention ', ' conference ', ' dopamine transporter ', ' DAT dopamine transporter ', ' Magazine ', ' Journals ', ' base ', ' improved ', ' Acute ', ' Chronic ', ' Clinical ', ' Medical ', ' Series ', ' Link ', ' Training ', ' insight ', ' Individual ', ' Rural ', ' Life ', ' programs ', ' Scientist ', ' Investigation ', ' Clinic ', ' Country ', ' interest ', ' college ', ' collegiate ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' experience ', ' neuron loss ', ' neuronal loss ', ' neuronal death ', ' neuronal cell loss ', ' neuronal cell death ', ' neuron death ', ' neuron cell loss ', ' neuron cell death ', ' nerve cell loss ', ' nerve cell death ', ' skills ', ' novel ', ' Basic Science ', ' Basic Research ', ' Patient Self-Report ', ' Self-Report ', ' graduate student ', ' Admission activity ', ' Admission ', ' career development ', ' Membrane Microdomains ', ' lipid raft ', ' Sphingolipid-Cholesterol Rafts ', ' Sphingolipid Microdomains ', ' Cell Membrane Lipid Rafts ', ' health disparity ', ' disparity in health ', ' Metabolic Pathway ', ' Address ', ' methamphetamine abuse ', ' meth abuse ', ' Drug Rehabilitation Centers ', ' Drug Treatment Centers ', ' Drug Abuse Treatment Centers ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Applications Grants ', ' Grant Proposals ', ' Subgroup ', ' Neurosciences Research ', ' Pharmacological Treatment ', ' Molecular ', ' developmental ', ' Development ', ' methamphetamine addiction ', ' meth addiction ', ' addiction to methamphetamine ', ' METH dependence ', ' Methamphetamine dependence ', ' Behavioral ', ' Healthcare professional ', ' Health Care Professional ', ' Health Professional ', ' pathway ', ' Pathway interactions ', ' underserved people ', ' under served population ', ' Underserved Population ', ' meth exposure ', ' methamphetamine exposure ', ' ethnic minority ', ' ethnic minority population ', ' racial and ethnic ', ' therapeutic target ', ' addictive disorder ', ' addiction ', ' effective intervention ', ' primary care setting ', ' screening and brief intervention ', ' screening, brief intervention, and referral to treatment ', ' SBIRT ', ' screening, brief intervention, referral, and treatment ', ' methamphetamine using ', ' METH using ', ' METH use ', ' methamphetamine use ', ' curriculum expansion ', ' curricular enrichment ', ' curriculum enhancement ', ' METH effect ', ' methamphetamine effect ', ' minority student ', ' substance misuse ', ' ']",NIDA,MEHARRY MEDICAL COLLEGE,R24,2018,458326,0.04533793193897472
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network     DESCRIPTION:  The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PUBLIC HEALTH RELEVANCE: This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9502933,UG1DA015815,"['care delivery ', ' Participant ', ' prevention service ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' drug abuse prevention ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' disparity in health ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' designing ', ' design ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' Hepatitis C Therapy ', ' urban Indian ', ' urban American Indian ', ' urban Native American ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addictive disorder ', ' addiction ', ' public health relevance ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' healthcare service ', ' health care service ', ' health service utilization ', ' health service use ', ' data resource ', ' rural Americans ', ' therapeutic candidate ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid overdose ', ' recruit ', ' primary care services ', ' healthcare settings ', ' health care settings ', ' treatment services ', ' methadone patient ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' American Indians ', ' American Indian ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Health Service Area ', ' Service area ', ' Health Catchment Area ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disease ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Use Disorder ', ' Education ', ' Educational aspects ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' Naloxone ', ' Persons ', ' Oregon ', ' Patients ', ' Peer Review ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Registries ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Rural Health ', ' Safety ', ' San Francisco ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Health Care Costs ', ' Healthcare Costs ', ' Health Costs ', ' Healthcare ', ' health care ', ' HIV vaccine ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' Caring ', ' base ', ' improved ', ' Site ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' experience ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2018,909100,0.08695097140668363
"Couples-based intervention to reduce drug use and HIV transmission Project Summary YMSM in relationships with other men face unique and compounded risk factors for both drug use and HIV infection. Their vulnerability is unique from older MSM, unpartnered MSM and their heterosexual peers. This enhanced vulnerability emerges as exactly the developmental period when the establishment of romantic relationships emerges as salient. Despite their unique vulnerability for HIV infection and challenges related to drug use, there are very few couples- based intervention options for YMSM. There are presently no brief, couples-based interventions which integrate a focus on drug use and HIV prevention. The proposed study is geared toward the development of such an intervention. The only individually delivered intervention for YMSM to show significant reductions in both drug use and sexual HIV transmission risk behavior, the Young Mens Health Project (YMHP) was developed by members of this research team. YMHP focused on sexual risk in the context of casual partners. Beginning with this framework, our team has completed the initial stages of revising YMHP for use with couples, resulting in the creation of the Couples Health Project (CHP). Our formative work suggests that the prototype intervention is feasible and acceptable to participants. The next step is to develop components of the intervention which address pre- exposure prophylaxis (PrEP) uptake and to determine how best to integrate biological testing for STIs and drug use into the study. The new intervention will be informed by qualitative data gathered from intervention sessions delivered in our formative work and from qualitative interviews conducted with 20 HIV negative partnered YMSM. The final 28 months of the project are devoted to a randomized controlled trial (RCT) comparing CHP to an attention-matched educational control condition. The study team is led by Dr. Tyrel J. Starks (PI), a new investigator with substantial experience in the study of gay male couples. He has collaborated on numerous projects examining the nature of sexual agreements and their association with substance use and HIV transmission risk behavior. He is supported by a study team which includes Dr. Jeffrey Parsons, the PI of the original YMHP study. The team brings extensive experience in quantitative and qualitative data analysis, HIV prevention research, and specifically intervention development. Project Narrative  Public Health Significance HIV prevention strategies that address the specific needs of YMSM in stable relationships with other men are needed in response to accumulating evidence which points to the unique vulnerability of these men. The proposed project builds upon an effective individual intervention, the Young Mens Health Project, to develop a couples-based intervention which addresses drug use and sexual HIV transmission risk among partnered HIV negative YMSM (ages 18-29). Preliminary work by our research team has produced a prototype manual, and provided compelling evidence of feasibility and acceptability. The proposed project will revise this prototype manual to enhance the focus on pre-exposure prophylaxis (PrEP) and to incorporate biological testing for drug use and STIs into the study. During Phase II, a small randomized controlled trial (RCT) involving 50 couples will test the feasibility, acceptability, and preliminary efficacy of the new intervention relative to an attention-matched educational control.",Couples-based intervention to reduce drug use and HIV transmission,9458721,R34DA043422,"['Accounting ', ' Age ', ' ages ', ' Amphetamines ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Attention ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' Communication ', ' Counseling ', ' Couples ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Face ', ' facial ', ' faces ', ' Feedback ', ' Goals ', ' Gonorrhea ', ' Gonococcal Infection ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Incidence ', ' Infection ', ' Interview ', ' Joints ', ' Ketamine ', ' male ', ' Manuals ', ' Marijuana ', ' marihuana ', ' men ', "" men's "", ' Motivation ', ' Nitrates ', ' NO3- ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Testing ', ' United States ', ' Work ', ' Crack Cocaine ', ' free base cocaine ', ' Latino ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' ecstasy ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' base ', ' Phase ', ' Link ', ' Training ', ' Fingernail ', ' Finger Nail ', ' Structure of nail of finger ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' drug use ', ' Drug usage ', ' Gays ', ' uptake ', ' Anal Sex ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Couples Therapy ', ' Contracts ', ' Contracting Opportunities ', ' Nature ', ' Source ', ' experience ', ' 4-hydroxybutyric acid ', ' gamma-hydroxybutyric acid ', ' Structure ', ' skills ', ' Participant ', ' Prevention Research ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' prevention service ', ' peer ', ' member ', ' Agreement ', ' motivational enhancement therapy ', ' motivational interview ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Sampling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' health disparity ', ' disparity in health ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Address ', ' Adherence ', ' Biological Testing ', ' Data ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Update ', ' Transmission ', ' transmission process ', ' Preparation ', ' sex ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Heterosexuals ', ' Behavioral ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' Population ', ' innovative ', ' innovate ', ' innovation ', "" men's health "", ' male health ', ' trial comparing ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' prototype ', ' standard of care ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' follow up assessment ', ' adolescent men ', ' adolescent man ', ' young man ', ' same-sex couple ', ' same sex relationship ', ' same sex partner ', ' same-sex partnership ', ' sexual HIV transmission ', ' young MSM ', ' YMSM ', ' young men who have sex with men ', ' efficacy study ', ' PrEP ', ' pre-exposure prophylaxis ', ' recruit ', ' ']",NIDA,HUNTER COLLEGE,R34,2018,296400,0.0832515560440776
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network     DESCRIPTION:  The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PUBLIC HEALTH RELEVANCE: This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9697469,UG1DA015815,"['Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' American Indians ', ' American Indian ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Health Service Area ', ' Service area ', ' Health Catchment Area ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disease ', ' Disorder ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Drug Use Disorder ', ' Education ', ' Educational aspects ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Hepatitis C ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' Naloxone ', ' Persons ', ' Oregon ', ' Patients ', ' Peer Review ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Registries ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Rural Health ', ' Safety ', ' San Francisco ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Health Care Costs ', ' Healthcare Costs ', ' Health Costs ', ' Healthcare ', ' health care ', ' HIV vaccine ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' Caring ', ' base ', ' improved ', ' Site ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Islander American ', ' Pacific Islander ', ' Pacific Island Americans ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' experience ', ' care delivery ', ' Participant ', ' prevention service ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' drug abuse prevention ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' disparity in health ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' designing ', ' design ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' Hepatitis C Therapy ', ' urban Indian ', ' urban American Indian ', ' urban Native American ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addictive disorder ', ' addiction ', ' public health relevance ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' healthcare service ', ' health care service ', ' health service utilization ', ' health service use ', ' data resource ', ' rural Americans ', ' therapeutic candidate ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid overdose ', ' recruit ', ' primary care services ', ' healthcare settings ', ' health care settings ', ' treatment services ', ' methadone patient ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2018,37761,0.08695097140668363
"Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care Hispanic adolescents in the U.S. experience significant health disparities, particularly as it relates to drug use, unsafe sexual behaviors and sexually transmitted infections (STIs). In spite of these disparities, a paucity of effective preventive interventions exist for Hispanic adolescents, and even fewer have been disseminated widely (IOM/NRC, 2009). Given that primary care settings are increasingly becoming the entry-point through which parents bring youth with behavioral health concerns, adolescent primary care settings represent ideal, yet underutilized, settings in which to disseminate evidence-based preventive interventions. Preventive interventions which target risk and protective factors within the family, the most proximal and fundamental social system influencing human behavior, have been found to be among the most efficacious interventions in preventing and reducing drug use and sexual risk behaviors.  Familias Unidas is a Hispanic-specific, family-based intervention found to be efficacious and effective in preventing and reducing drug use, sexual risk behaviors, and self-reported STIs. Familias Unidas has been cited by the Institute of Medicine report on Preventing, Emotional, and Behavioral among Young People as ready for broad dissemination (IOM/NRC, 2009). To date, however, Familias Unidas has been only tested for efficacy and effectiveness in schools and has not been evaluated for efficacy/effectiveness in primary care. We have adapted and evaluated Familias Unidas for online delivery; successfully retaining 80% of Hispanic parents and their youth (recruited from schools) in the online, eHealth adaptation of Familias Unidas. We have also demonstrated the feasibility and acceptability of delivering eHealth Familas Unidas in primary care.  Evaluating innovative eHealth family-based interventions for Hispanic youth whose feasibility and acceptability is established in primary care settings is timely and of high public health significance. Therefore, the proposed study's overarching aim is to evaluate the relative effectiveness and cost effectiveness of eHealth Familias Unidas, compared to a referral to the National Institute Drug Abuses (NIDA) online information page for parents of Hispanic youth (referred hereafter as NIDA Online Information). To test the effectiveness of eHealth Familias Unidas Primary Care in preventing drug use, unprotected sexual behavior, and STIs in a universal sample of Hispanic youth, this study will randomize 456 Hispanic youth and their parents to eHealth Familias Unidas or to NIDA Online Information. Participants will be assessed at baseline, 6, 12, 24, and 36 months post baseline. Study hypotheses are that: 1) eHealth Familias Unidas will be effective, relative to NIDA Online Information, in preventing/reducing drug use, unprotected sexual behavior, and STI incidence in Hispanic adolescents over time and 2) Intervention effects will be partially mediated by family functioning for drug use and unprotected sexual behavior and by family functioning and unprotected sexual behavior for STI incidence. The cost effectiveness of eHealth Familias Unidas over a three year follow up will also be estimated. The proposed study will evaluate the effectiveness of an eHealth adaptation of an evidence-based face-to- face preventive intervention for Hispanic youth, in preventing drug use, sexual risk behaviors, and sexually transmitted diseases in primary care settings. The knowledge expected to be gained in this study will have strong implications for the delivery of prevention interventions in primary care, as well as contribute to the reduction of drug and sexual risk behavior related to disparities seen in Hispanic youth.",Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care,9473043,R01DA040756,"['Acculturation ', ' Cultural Assimilation ', ' Behavior ', ' Behavior Disorders ', ' behavioral disorder ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Chlamydia ', ' bedsonia ', ' Miyagawanella ', ' Climate ', ' climatic ', ' Meteorological Climate ', ' Conflict (Psychology) ', ' Conflict ', ' cost effectiveness ', ' Professional counselor ', ' Counselor ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Family ', ' Gonorrhea ', ' Gonococcal Infection ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Human ', ' Modern Man ', ' Incidence ', ' Institute of Medicine (U.S.) ', ' NAS/IOM ', ' Institute of Medicine ', ' Leadership ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Nurses ', ' nurse ', ' Parents ', ' Physicians ', ' Primary Health Care ', ' Primary Healthcare ', ' Primary Care ', ' Public Health ', ' Risk ', ' Risk Factors ', ' Schools ', ' Sex Behavior ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Staff Attitudes ', ' Testing ', ' Time ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Latino ', ' Mediating ', ' Youth ', ' Youth 10-21 ', ' Caring ', ' base ', ' improved ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' white American ', ' caucasian American ', ' pediatric ', ' Childhood ', ' Emotional disorder ', ' drug use ', ' Drug usage ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Knowledge ', ' Frequencies ', ' Clinic ', ' System ', ' Unsafe Sex ', ' Unprotected Sex ', ' High-Risk Sex ', ' experience ', ' Participant ', ' member ', ' Patient Self-Report ', ' Self-Report ', ' Reporting ', ' social ', ' Emotional ', ' Sampling ', ' behavioral health ', ' junior high school ', ' middle school ', ' junior high ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' drug abuse prevention ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' disparity in health ', ' Effectiveness ', ' prevent ', ' preventing ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Behavioral ', ' Healthcare professional ', ' Health Care Professional ', ' Health Professional ', ' sexual risk behavior ', ' sex risk ', ' care services ', ' care systems ', ' Outcome ', ' cost-effective ', ' cost effective ', ' innovative ', ' innovate ', ' innovation ', ' evidence base ', ' primary care setting ', ' intervention effect ', ' efficacy testing ', ' e-Health ', ' eHealth ', ' parent-adolescent communication ', ' relative effectiveness ', ' relative cost ', ' recruit ', ' protective factors ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2018,717999,0.07929300962446643
"Interdisciplinary Research Training Institute on Hispanic Drug Abuse     DESCRIPTION (provided by applicant): This application requests continued support of the Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse (5 R25DA026401) that has developed and implemented a research education program aimed at promoting the career development of pre-doctoral and early career clinically focused scientists interested in conducting research that affects the Hispanic population. This comprehensive and coordinated effort focuses on providing research experience and increasing the skills required for the preparation and submission of competitive research applications for NIH extramural funding. This renewal application expands the scope of the IRTI program to include international clinically focused fellows from Mexico. Building upon the success and accomplishments of the existing IRTI, the specific aims of the IRTI are to (1) Continue to provide an improved educational training opportunity to enhance the skills for conducting interdisciplinary Hispanic drug research and developing applications for NIH funding among pre-doctoral, postdoctoral and early career faculty members (fellows) through the implementation of an 11-day intensive summer research training program; (2) Expand the scope of the IRTI program to include international, clinically focused fellows from Mexico that will serve to strengthen their capacity o conduct independent drug research and provide opportunities for U.S. and Mexico fellows to share knowledge that may develop into research activities aimed at enhancing bi-national public health efforts to address drug abuse and addiction; (3) Continue to execute an improved mentoring plan structured around a team of interdisciplinary senior faculty mentors who would be accessible and available to provide selected fellows with focused mentoring and continued support; (4) Continue to provide an improved networking structure and process that will assist fellows in building and maintaining relationships and communication with leading experts in the field of Hispanic drug research and fellow peers. Mentoring activities will focus on guiding and assisting the fellows in achieving benchmarks of progress including: a) Academic Career Progress; b) Scientific Publications; c) Scientific Presentations; and d) Research Funding. These outcomes will be facilitated through various types of support provided by the IRTI including: Mentor Commitment, Travel to Mentor Institution, E-Mentoring Technologies, Conferences/Workshops, and IRTI Mentoring Annual Meeting. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research in the interest of public health. Building upon the existing mentoring and networking success, the proposed IRTI renewal will continue to fill the gap in knowledge on how to develop effective research incubators that will increase the number of minority drug abuse researchers. PUBLIC HEALTH RELEVANCE: This application seeks funding to continue the Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse that seeks to promote the career development of underrepresented pre-doctoral, postdoctoral and early career clinically-focused scientists in the U.S. and Mexico interested in conducting research as it affects the Hispanic population. Hispanics face unique health challenges, and efforts to increase the number of well-qualified researchers prepared to conduct clinical research are vital to reducing health disparities among this underserved population. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive clinical research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitae the conduct of interdisciplinary drug abuse research.",Interdisciplinary Research Training Institute on Hispanic Drug Abuse,9493447,R25DA026401,"['Affect ', ' Career Mobility ', ' career transition ', ' career advancement ', ' Clinical Research ', ' Clinical Study ', ' Communication ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Environment ', ' Face ', ' facial ', ' faces ', ' Goals ', ' Health ', ' Incubators ', ' Institutes ', ' Leadership ', ' Mentors ', ' Mentorship ', ' Mexico ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Technology ', ' Training Programs ', ' Travel ', ' Work ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Competence ', ' symposium ', ' symposia ', ' summit ', ' convention ', ' conference ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' base ', ' career ', ' improved ', ' Clinical ', ' Training ', ' Discipline ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Workshop ', ' Educational workshop ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Research Activity ', ' drug use ', ' Drug usage ', ' Funding ', ' Nature ', ' Knowledge ', ' programs ', ' Scientist ', ' Complex ', ' Benchmarking ', ' Best Practice Analysis ', ' interest ', ' meetings ', ' experience ', ' success ', ' Self Efficacy ', ' Structure ', ' skills ', ' peer ', ' member ', ' Mediation ', ' Negotiation ', ' Negotiating ', ' career development ', ' psychosocial development ', ' theories ', ' health disparity ', ' disparity in health ', ' Institution ', ' Address ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' International ', ' Request for Applications ', ' NIH RFA ', ' Research Training ', ' Extramural ', ' EXTMR ', ' Extramural Activities ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' translation research ', ' Translational Science ', ' Translational Research ', ' Preparation ', ' Process ', ' developmental ', ' Development ', ' environmental enrichment ', ' environment enrichment for laboratory animals ', ' environment enrichment ', ' environmental enrichment for laboratory animals ', ' minority health ', ' underserved people ', ' under served population ', ' Underserved Population ', ' next generation ', ' Minority ', ' Outcome ', ' Population ', ' predoctoral ', ' predoc ', ' pre-doc ', ' pre-doctoral ', ' public health relevance ', ' early-career faculty ', ' faculty mentor ', ' full professor ', ' senior faculty ', ' summer research ', ' training opportunity ', ' education research ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R25,2018,338651,0.13783565054063016
"Health Consequences of Drug Use and IPV Trajectories for Young Latinas     DESCRIPTION (provided by applicant):  Few empirical studies have documented the life trajectories of gang-affiliated adolescent females and the long- term health consequences of adolescent drug use and partner violence victimization. The purpose of this study is to identify and determine how distinct drug use and intimate partner violence victimization trajectories that emerge in adolescence through young adulthood contribute to physical and mental health outcomes among Mexican American women within the context of a highly disadvantaged community. This group of women are particularly vulnerable given they have low rates of access and utilization of health care, are the most likely age group to be uninsured, and represent a nexus of risk, vulnerability and potentially high costs to communities given their reproductive and sexual health stage of life. This application proposes a 15 year follow up of a cohort of Mexican American adolescent females previously identified in a CDC funded study who were affiliated with male gang members during their adolescence and involved in high rates of drug use and victims of intimate partner violence. Building upon the research teams previous studies and using analytical tools from the theory of gender and power and social bonding theory, this application will implement a concurrent mixed methods nested design approach to provide a comprehensive understanding of the long-term consequences of drug use and IPV. The sample will consist of 300 young adult Mexican-American females. The specific aims for this study are: 1) determine the prevalence of physical (cardiovascular and metabolic risk markers and STI infection) and mental (depression, PTSD, anxiety/stress) health outcomes; 2) identify and characterize distinct drug use and IPV trajectories from adolescence through young adulthood; 3) determine whether sexual relationship power and family social bonds during distinct age-graded stages alter drug use and IPV trajectories and health outcomes; and 4) characterize qualitatively the culture and community context and their influence on drug use and IPV trajectories over the life course. This research will have an important positive impact by identifying women who are at the highest risk for developing harmful drug and IPV trajectories as they transition into young adulthood. In doing this, we will lay the foundation for identifying critical points of behavioral intervention during key age-graded periods as well as culturally and contextually appropriate values and strategies that will reduce health disparities among similar high-risk female populations that have gone underrepresented in existing research. PUBLIC HEALTH RELEVANCE:  This application seek a comprehensive understanding of the long term health consequences of drug use and intimate partner violence victimization physical and mental health outcomes among a vulnerable cohort of Mexican-American females recruited over 15 years ago who were affiliated with male gang members during their adolescence. The study will provide a unique opportunity to investigate detrimental life trajectories contributing t the prevalence of cardiovascular and metabolic risk markers, infection, depression, PTSD, anxiety and stress within a marginalized and underserved community context. Findings will contribute to policy discourse that can lead to the development of innovative public health programs and campaigns that will reduce health disparities among minority women. PHS 398/2590 (Rev. 11/07) Page Continuation Format Page",Health Consequences of Drug Use and IPV Trajectories for Young Latinas,9491763,R01DA039269,"['Adolescence ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female Adolescents ', ' adolescent girl ', ' Age ', ' ages ', ' Anxiety ', ' Attention ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Communities ', ' Complement ', ' Complement Proteins ', ' Decision Making ', ' Mental Depression ', ' depression ', ' Disadvantaged ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Family ', ' Female ', ' Foundations ', ' Health ', ' Heterogeneity ', ' Infection ', ' knowledge of results ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Life Cycle Stages ', ' life course ', ' Life Cycle ', ' Long-Term Effects ', ' Longterm Effects ', ' male ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' Mexican Americans ', ' Chicanos ', ' Chicanas ', ' Neighborhoods ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Public Health ', ' Research ', ' Risk ', ' Stress ', ' Post-Traumatic Stress Disorders ', ' traumatic neurosis ', ' Posttraumatic Stress Disorders ', ' Posttraumatic Neuroses ', ' Post-Traumatic Neuroses ', ' PTSD ', ' Violence ', ' violent behavior ', ' violent ', ' Woman ', ' Friends ', ' Gender ', "" Women's Health "", ' Female Health ', ' Latino ', ' Uninsured ', ' Youth ', ' Youth 10-21 ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Gap Junctions ', ' mental ', ' Psyche structure ', ' healthcare utilization ', ' healthcare service utilization ', ' healthcare service use ', ' health care service use ', ' Health Care Utilization ', ' health care service utilization ', ' young adulthood ', ' adult youth ', ' young adult ', ' Policies ', ' drug use ', ' Drug usage ', ' Female Groups ', "" Women's Group "", ' Wife ', ' Reproductive Health ', ' Funding ', ' Metabolic ', ' Shapes ', ' Sister ', ' Prediabetes syndrome ', ' syndrome x ', ' prediabetic ', ' pre-diabetic ', ' pre-diabetes ', ' Prediabetic State ', ' Prediabetes ', ' Knowledge ', ' Life ', ' programs ', ' physical conditioning ', ' physical health ', ' age group ', ' cohort ', ' member ', ' gang ', ' social ', ' social attachment ', ' social bonding ', ' Sampling ', ' girls ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Latina ', ' Latinas ', ' health disparity ', ' disparity in health ', ' Low income ', ' Address ', ' Health system ', ' Sexual Health ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Risk Marker ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' violent partner ', ' partner violence ', ' sexual relationship ', ' cost ', ' youth drug use ', ' adolescent drug use ', ' intimate partner violence ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' analytical tool ', ' high risk ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' adolescent men ', ' adolescent man ', ' young man ', ' violence victimization ', ' vulnerability to drug use ', ' drug use vulnerability ', ' Obamacare ', ' Affordable Care Act ', ' healthcare service ', ' health care service ', ' high risk group ', ' high risk population ', ' recruit ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2018,616327,0.11929657389475455
"Y2Prevent: Preventing Drug Use and HIV through Empowerment, Social Support and Mentorship ABSTRACT African Americans represent only 14% of the population, but account for 44% of all new HIV infections reported yearly. The situation is particularly grave for Black/African American young men who have sex with men (AAYMSM), with seroprevalence rates of 19% for ages 15-22 and 26% for ages 23-29 among AAYMSM. These health outcomes are influenced by important social and structural factors, including violence and victimization, homophobia, discrimination, institutional racism, and economic and social marginalization. These experiences are significantly associated with illicit drug use, alcohol misuse, transactional sex work, and HIV risk behaviors. In response to this crisis, we are proposing to create a new theoretically driven, youth- centered intervention designed to build the capacity of AAYMSM to overcome these barriers to health. With this revised R34 application, we propose to further refine and pilot test an intervention, called Young Men's Adult Identity Mentoring (YM-AIM). Adapted from an existing CDC Diffusing Effective Behavioral Intervention, YM-AIM is a theory-driven, group-level intervention designed to help AAYMSM develop a healthy vision for their future (or possible future self) by defining a set of short- and long-term goals in the areas of education, health, family and intimate relationships. We propose to further strengthen and refine YM-AIM by adding a youth mentoring/support component, called Youth Initiated Mentoring (YIM). YIM uses a positive youth development framework to: a) build social capital to achieve immediate and long-term goals, b) build social support, c) identify and engage natural mentors in one's networks to address structural barriers, and d) develop relationships with supportive adults. We will integrate these two models into a single intervention called Y2Prevent. We will then work to further adapt, tailor, and evaluate Y2Prevent as an intervention to reduce illicit drug use and HIV/STI risk among AAYMSM. This intervention will emphasize: a) biomedical HIV prevention strategies for primary prevention, b) HIV/STI testing and treatment referral, c) drug screening and treatment referral, and d) positive youth development and future planning. We will conduct formative research to inform the adaptation/tailoring followed by a piloting of the new intervention to assess the feasibility, acceptability, and the preliminary efficacy. Our proposed positive youth development and resilience theory provide a strong, innovative framework for examining how AAYMSM with significant exposure to syndemic health and social disparities respond to engagement with prevention and treatment resources. The proposed intervention is intended to promote resilience, build social skills and assets among AAYMSM to help them recognize and overcome individual, social and structural barriers leading to risk, and adopt and maintain protective behaviors, such as safer sex, PrEP/PEP use, HIV/STI testing and healthcare utilization. The findings will inform the development of an R01 application that will propose a larger-scale, multi-city efficacy trail in a subsequent R01 application. PROJECT NARRATIVE Today there is a generation of African American/Black young men who have sex with men (AAYMSM) who are at exceedingly high risk for a wide range of adverse health outcomes, including tobacco, alcohol and illicit drug addiction, sexually transmitted infections (STIs), HIV/AIDS, and mental health disorders. Often, these young men experience multiple forms of discrimination (racism, homophobia) in multiple settings (home, school, neighborhood, workplace), with limited social support to buffer against these threats. In response, we propose to further refine and pilot test a theory-driven, evidence-based group-level intervention designed to help AAYMSM develop a healthy vision for their future (or possible future self) by defining a set of short- and long- term goals in the areas of education, health, family and intimate relationships using facilitated activities -- participants are asked to consider how their involvement in risky behaviors (e.g., illicit drug use, condomless sex, multiple sex partners) would interfere with achieving those goals.","Y2Prevent: Preventing Drug Use and HIV through Empowerment, Social Support and Mentorship",9621916,R34DA044106,"['Accounting ', ' Adolescence ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adoption ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Aggressive behavior ', ' Aggression ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohols ', ' Alcohol Chemical Class ', ' Behavior ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Buffers ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Cities ', ' Communities ', ' Mental Depression ', ' depression ', ' Diagnosis ', ' Discrimination ', ' Cognitive Discrimination ', ' Pharmacotherapy ', ' drug treatment ', ' Drug Therapy ', ' Economics ', ' Education ', ' Educational aspects ', ' Exercise ', ' Family ', ' Feedback ', ' Future ', ' Goals ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' Incidence ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Literature ', ' Maintenance ', ' Manuals ', ' men ', "" men's "", ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Mentors ', ' Mentorship ', ' Neighborhoods ', ' Primary Prevention ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Schools ', ' Sexual Partners ', ' sex partner ', ' Sexually Transmitted Diseases ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Social support ', ' social support network ', ' Stress ', ' Testing ', ' Tobacco ', ' Vision ', ' visual function ', ' Sight ', ' Caucasians ', ' white race ', ' Occidental ', ' Caucasoid Race ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Work ', ' Generations ', ' Measures ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Illicit Drugs ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Latino ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Youth ', ' Youth 10-21 ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' Caring ', ' Intention ', ' work setting ', ' Worksite ', ' Work-Site ', ' Work Place ', ' Work Location ', ' Job Site ', ' Job Setting ', ' Job Place ', ' Job Location ', ' Workplace ', ' base ', ' improved ', ' Area ', ' Diffuse ', ' racism ', ' Individual ', ' healthcare utilization ', ' healthcare service utilization ', ' healthcare service use ', ' health care service use ', ' Health Care Utilization ', ' health care service utilization ', ' young adulthood ', ' adult youth ', ' young adult ', ' satisfaction ', ' drug use ', ' Drug usage ', ' Early Intervention ', ' Funding ', ' Anal Sex ', ' Exposure to ', ' Knowledge ', ' Life ', ' programs ', ' Adopted ', ' Frequencies ', ' Home environment ', ' Home ', ' Protocols documentation ', ' Protocol ', ' inner city ', ' experience ', ' Performance ', ' success ', ' Safe Sex ', ' safer sexual behavior ', ' safer sex ', ' Responsible sexual behavior ', ' Responsible Sex ', ' Protected Sex ', ' Seroprevalences ', ' Self Efficacy ', ' condoms ', ' skills ', ' novel ', ' Participant ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' empowerment ', ' member ', ' NIH Program Announcements ', ' Program Announcement ', ' social skills ', ' social competency ', ' social competence ', ' interpersonal competency ', ' interpersonal competence ', ' Prevention ', ' Reporting ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' positive youth development ', ' Modeling ', ' response ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' drug abuse prevention ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' health disparity ', ' disparity in health ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Low income ', ' Address ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' social capital ', ' Consent ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' trend ', ' sex ', ' developmental ', ' Development ', ' sexual risk behavior ', ' sex risk ', ' Minority ', ' protective behavior ', ' resilience ', ' Outcome ', ' social disparities ', ' unhealthy alcohol use ', ' ethanol misuse ', ' alcohol misuse ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' racial and ethnic ', ' treatment design ', ' intervention design ', ' therapy design ', ' high risk ', ' evidence base ', ' operation ', ' adolescent men ', ' adolescent man ', ' young man ', ' sexual minority ', ' Homophobic ', ' Homophobia ', ' young MSM ', ' YMSM ', ' young men who have sex with men ', ' marginalization ', ' social exclusion ', ' violence victimization ', ' illicit drug use ', ' racial minority ', ' PrEP ', ' pre-exposure prophylaxis ', ' Drug Screening ', ' exposure to violence ', ' violence exposure ', ' ']",NIDA,CHILDREN'S HOSPITAL OF LOS ANGELES,R34,2018,267854,0.0535610043731097
"Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM) PROJECT SUMMARY/ABSTRACT  This application is for a competing renewal of the Center for Prevention Implementation Methodology for HIV and Drug Abuse, a NIDA P30 Center of Excellence. The number of new HIV cases in the US remains stable at 56,000 per year and continues to disproportionately affect some groups, including young men who have sex with men (YMSM), especially from racial/ethnic minorities. The purpose of this methodology center is to develop new methodologies that can be used by federal and local agencies and communities to reduce HIV incidence. Biomedical interventions and strategies, including pre-exposure prophylaxis (PrEP), rapid testing for HIV and early and consistent treatment for persons who are HIV positive (Treatment as Prevention, TasP) have been shown to have high efficacy and effectiveness in reducing HIV transmission, but there remains a giant gap between what research knows and what services needed to reduce population level incidence of HIV. The major premise of this application is that the effective biomedical to reduce HIV incidence and disparities are in hand, but success will only be achieved when they are implemented in ways that meet individual, community, and health care delivery system needs. This methods proposal addresses this major gap between research and practice through implementation science and methodology, focusing on innovative ways to address the complex, mulitilevel interactions needed to implement HIV prevention programs effectively. Two Cores, an Administrative Core and an Innovative Implementation Methods Core for HIV and Drug Abuse will carry out this work.  Aim 1 is to develop innovative methods to maximize the impact of implementation research in HIV prevention. We do this through an extended set of systems science and engineering methods that focus on improving the measurement of implementation, the modeling of implementation strategies, and the testing of implementation strategies through rigorous trials. Five qualifying grants support this work.  Aim 2 is to apply these innovative methods to close the gap between existing research, policy, and practice for HIV prevention. In addition to working closely with our five qualifying grants, we work locally with municipal Departments of Public Health and the federal Substance Abuse and Mental Health Services Administration (SAMHSA) HIV programs to identify and prioritize gaps in knowledge, find optimal implementation strategies for reduction of HIV transmission, and design the next large implementation trials.  Aim 3 is to disseminate methods and train/mentor leaders at the intersection of HIV prevention, implementation science, and drug abuse fields to improve implementation of HIV prevention programs. This involves mentoring the early career researchers, publishing, and providing training to networks of HIV and drug abuse researchers. PROJECT NARRATIVE There are numerous rigorously evaluated prevention programs involving biomedical interventions for preventing HIV that have demonstrated impact in efficacy and effectiveness trials. Pre-exposure prophylaxis, HIV testing, and early and consistent antiretroviral treatment have high potential for preventing HIV infections, but these are yet to be implemented sufficiently in racial/ethnic minority communities. This Ce-PIM addresses the critical methods gaps that are holding back the movement of these programs from research to practice.",Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM),9951869,P30DA027828,"['Affect ', ' Age ', ' ages ', ' Back ', ' Dorsum ', ' Behavior ', ' Biomedical Research ', ' Communities ', ' Decision Making ', ' health services delivery ', ' Healthcare Delivery ', ' health care delivery ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Cognitive Discrimination ', ' Discrimination ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Engineering ', ' ethnicity group ', ' Ethnic group ', ' Feedback ', ' Gender Identity ', ' Goals ', ' Grant ', ' Hand ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment access ', ' service availability ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV antibody positive ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' Anti-HIV Positivity ', ' HIV Seropositivity ', ' Incidence ', ' longterm care ', ' extended care ', ' Long-Term Care ', ' Mentors ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Methamphetamine ', ' Methods ', ' Methodology ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' body movement ', ' Movement ', ' Persons ', ' Play ', ' Public Health ', ' Publishing ', ' QOL ', ' Quality of life ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' Science ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Seeds ', ' Technology ', ' Testing ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' United States Substance Abuse and Mental Health Services Administration ', ' General Viruses ', ' Virus ', ' visual function ', ' Sight ', ' Vision ', ' Work ', ' P30 Protein ', ' P30 ', ' P-30 Protein ', ' ranpirnase ', ' Gender ', ' Generations ', ' Community Health Care ', ' Community Healthcare ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' ecstasy ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS prevention ', ' base ', ' career ', ' improved ', ' Sex Orientation ', ' Sexual Orientation ', ' Training ', ' Individual ', ' Policies ', ' Measurement ', ' Drug usage ', ' drug use ', ' Ethnic Origin ', ' Ethnicity ', ' tool ', ' Knowledge ', ' programs ', ' Viral Load result ', ' Viral Load ', ' Viral Burden ', ' Complex ', ' Pattern ', ' System ', ' Services ', ' success ', ' Anti-Retroviral Agents ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' Municipalities ', ' Structure ', ' novel ', ' Prevention program ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Early identification ', ' Modeling ', ' social stigma ', ' stigma ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' scientific organization ', ' Effectiveness ', ' preventing ', ' prevent ', ' HIV-2 test ', ' HIV-1 test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Address ', ' High Prevalence ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Qualifying ', ' transmission process ', ' Transmission ', ' socioeconomics ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' Development ', ' developmental ', ' antiretroviral therapy ', ' antiretroviral treatment ', ' anti-retroviral treatment ', ' anti-retroviral therapy ', ' effectiveness trial ', ' implementation trial ', ' men who have sex with men ', ' men who have sex with other men ', ' MSM ', ' implementation research ', ' design ', ' designing ', ' next generation ', ' efficacy trial ', ' Outcome ', ' Prevention approach ', ' Approaches to prevention ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' ethnic minority population ', ' ethnic minority ', ' Early treatment ', ' early therapy ', ' racial and ethnic ', ' implementation science ', ' research to practice ', ' research into practice ', ' cocaine use ', ' young men who have sex with men ', ' young MSM ', ' YMSM ', ' black men who have sex with men ', ' black MSM ', ' BMSM ', ' African-American men who have sex with men ', ' African American MSM ', ' AAMSM ', ' support tools ', ' minority communities ', ' pre-exposure prophylaxis ', ' PrEP ', ' implementation strategy ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,P30,2019,5767,0.08917754346937293
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network PROJECT SUMMARY / ABSTRACT The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PROJECT NARRATIVE This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9905147,UG1DA015815,"['Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' American Indians ', ' American Indian ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Service area ', ' Health Catchment Area ', ' Health Service Area ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Educational aspects ', ' Education ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Naloxone ', ' Persons ', ' Oregon ', ' Patients ', ' Peer Review ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' Scientific Publication ', ' Publications ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Safety ', ' San Francisco ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Island Americans ', ' Pacific Islander American ', ' Pacific Islander ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' experience ', ' care delivery ', ' Participant ', ' prevention service ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' Clinical Treatment ', ' trial treatment ', ' trial regimen ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' design ', ' designing ', ' Hepatitis C Therapy ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' urban Native American ', ' urban Indian ', ' urban American Indian ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addiction ', ' addictive disorder ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' health care service ', ' healthcare service ', ' health service use ', ' health service utilization ', ' data resource ', ' rural healthcare ', ' rural health care ', ' rural Americans ', ' therapeutic candidate ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' recruit ', ' primary care services ', ' health care settings ', ' healthcare settings ', ' treatment services ', ' methadone patient ', ' rural health disparities ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2019,286011,0.08578632686993468
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network PROJECT SUMMARY / ABSTRACT The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PROJECT NARRATIVE This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9905146,UG1DA015815,"['Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' American Indians ', ' American Indian ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Service area ', ' Health Catchment Area ', ' Health Service Area ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Educational aspects ', ' Education ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Naloxone ', ' Persons ', ' Oregon ', ' Patients ', ' Peer Review ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' Scientific Publication ', ' Publications ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Safety ', ' San Francisco ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Island Americans ', ' Pacific Islander American ', ' Pacific Islander ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' experience ', ' care delivery ', ' Participant ', ' prevention service ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' Clinical Treatment ', ' trial treatment ', ' trial regimen ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' design ', ' designing ', ' Hepatitis C Therapy ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' urban Native American ', ' urban Indian ', ' urban American Indian ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addiction ', ' addictive disorder ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' health care service ', ' healthcare service ', ' health service use ', ' health service utilization ', ' data resource ', ' rural healthcare ', ' rural health care ', ' rural Americans ', ' therapeutic candidate ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' recruit ', ' primary care services ', ' health care settings ', ' healthcare settings ', ' treatment services ', ' methadone patient ', ' rural health disparities ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2019,797698,0.08578632686993468
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network PROJECT SUMMARY / ABSTRACT The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PROJECT NARRATIVE This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9905141,UG1DA015815,"['Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' American Indians ', ' American Indian ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Service area ', ' Health Catchment Area ', ' Health Service Area ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Educational aspects ', ' Education ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Naloxone ', ' Persons ', ' Oregon ', ' Patients ', ' Peer Review ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' Scientific Publication ', ' Publications ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Safety ', ' San Francisco ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Island Americans ', ' Pacific Islander American ', ' Pacific Islander ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' experience ', ' care delivery ', ' Participant ', ' prevention service ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' Clinical Treatment ', ' trial treatment ', ' trial regimen ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' design ', ' designing ', ' Hepatitis C Therapy ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' urban Native American ', ' urban Indian ', ' urban American Indian ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addiction ', ' addictive disorder ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' health care service ', ' healthcare service ', ' health service use ', ' health service utilization ', ' data resource ', ' rural healthcare ', ' rural health care ', ' rural Americans ', ' therapeutic candidate ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' recruit ', ' primary care services ', ' health care settings ', ' healthcare settings ', ' treatment services ', ' methadone patient ', ' rural health disparities ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2019,142146,0.08578632686993468
"Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges This is a proposal to renew funding of the Center for Drug Use and HIV Research (CDUHR) for years 21- 25. Recent advances in HIV biomedical and behavioral science have been shown to reduce HIV incidence and allow HIV-positive persons to reach near-normal lifespans. These achievements have led UNAIDS, the US and several local governments to propose strategies for Ending the HIV Epidemic. Notwithstanding these successes, attaining this goal among people who use drugs (PWUD) will require addressing a number of important existing barriers. The overall theme of this renewal is Ending HIV/AIDS among People who use Drugs: Overcoming Challenges. We define Ending HIV/AIDS as reducing new infections and increasing the proportion of PWUD who are virally suppressed. To accomplish this, we have identified these research priorities, which directly address the most significant challenges: (1) Devise new strategies to overcome emerging and persistent barriers to ending HIV/AIDS among PWUD. Barriers include recent increases in prescription opioid misuse, which have given rise to a new generation of heroin user and injectors, and lack of attention to the key role of substance use in new infections in men who have sex with men and heterosexuals. HIV-positive PWUD also experience disparities all along the continuum of HIV care, including delayed diagnosis, lower retention in care, delayed initiation of ART and poorer disease outcomes. (2) Conduct research on effective ways to broadly implement evidence-based interventions. HIV prevention and care programs for PWUD do not exist in many regions of the US and the rest of the world where they are needed most, and they are rarely implemented at public-health scale. (3) Develop new, innovative models of prevention and treatment interventions to address substance-use related disparities in HIV infection and treatment outcomes that take into account the complex, multilevel nature of HIV among PWUD.  We have made significant changes in our scope and structure for this renewal, and we will achieve our aims through five Cores, an Administrative Core and four Research Support Cores: (1) Infectious Disease Epidemiology and Theory, (2) Transdisciplinary Research Methods, (3) Dissemination and Implementation, and (4) Pilot Projects and Mentoring. These Cores support our research base and affiliated investigators to conduct cutting-edge science and enhance synergy across investigators from multiple disciplines, thereby leading to contributions to the field that are beyond what the individual projects could have achieved. In addition to the many successful initiatives that have been developed over CDUHR's history, new activities were added to respond to the evolving needs of our investigators. Also, in addition to our ongoing commitment to train new investigators to conduct high-impact research, we will collaborate with investigators in areas where HIV epidemics are occurring among PWUD (in rural and middle America, and in eastern Europe and Asia), building on our collective knowledge and expertise to advance toward Ending HIV/AIDS in those regions. Project Narrative A critical time has been reached in the course of the HIV epidemic, when the possibility to end HIVAIDS has been raised. Despite advances in biomedical treatments and behavioral interventions to reduce HIV incidence and its impact, people who use drugs (PWUD) have poorer outcomes. The Center provides a research infrastructure to enhance the productivity, synergy and impact of the research by affiliated investigators working to End HIV/AIDS among PWUD.",Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges,9893141,P30DA011041,"['Achievement ', ' Achievement Attainment ', ' Americas ', ' Attention ', ' Behavior ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavioral Sciences ', ' Biology ', ' Communities ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Diagnosis ', ' diagnosis service ', ' Diagnostic Services ', ' Outbreaks ', ' Disease Outbreaks ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economics ', ' Emergencies ', ' Emergency Situation ', ' Epidemic ', ' Eastern Europe ', ' Evolution ', ' facial ', ' faces ', ' Face ', ' Eastern Asia ', ' East Asia ', ' Far East ', ' Future ', ' Goals ', ' Greece ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV antibody positive ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' Anti-HIV Positivity ', ' HIV Seropositivity ', ' Incidence ', ' Economical Income ', ' Economic Income ', ' Income ', ' Indiana ', ' Infection ', ' Photoradiation ', ' Light ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Mentors ', ' Methods ', ' Local Government ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' New York ', ' Perception ', ' pilot study ', ' Pilot Projects ', ' Play ', ' Productivity ', ' Public Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Support ', ' Rest ', ' Risk ', ' social role ', ' Role ', ' Science ', ' Stigmatization ', ' Time ', ' P30 Protein ', ' P30 ', ' P-30 Protein ', ' ranpirnase ', ' Generations ', ' Treatment outcome ', ' Research Methods ', ' Research Methodology ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS prevention ', ' Caring ', ' base ', ' improved ', ' Left ', ' Area ', ' Medical ', ' Training ', ' Discipline ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Individual ', ' Rural ', ' Policies ', ' Inequality ', ' Drug usage ', ' drug use ', ' Funding ', ' Drug user ', ' persons who use drugs ', ' people who use illicit drugs ', ' people who use drugs ', ' PWUD ', ' Nature ', ' Research Priority ', ' Knowledge ', ' programs ', ' Complex ', ' Distant ', ' Route ', ' System ', ' Country ', ' Viral ', ' Injecting drug user ', ' persons who inject drugs ', ' people who inject illicit drugs ', ' people who inject drugs ', ' PWID ', ' Injection Drug User ', ' Services ', ' experience ', ' success ', ' synergism ', ' Heroin Users ', ' austin ', ' Structure ', ' Disease Outcome ', ' prevention service ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Modeling ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' HIV diagnosis ', ' disparity in health ', ' health disparity ', ' Address ', ' Health system ', ' Evidence based practice ', ' Infectious Disease Epidemiology ', ' Infectious Epidemiology ', ' International ', ' Interruption ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Infrastructure ', ' Translational Research ', ' translation research ', ' Translational Science ', ' transmission process ', ' Transmission ', ' Characteristics ', ' Heterosexuals ', ' men who have sex with men ', ' men who have sex with other men ', ' MSM ', ' Outcome ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Evidence based intervention ', ' public health research ', ' recruit ', ' treatment services ', ' Injections ', ' heroin use ', ' heroin intake ', ' prescription opioid misuse ', ' prescription opiate misuse ', ' opioid prescription medication misuse ', ' opioid medication misuse ', ' opioid analgesic misuse ', ' nonmedical use of prescription opioids ', ' nonmedical use of prescription opiates ', ' non-medical use of prescription opioids ', ' non-medical use of prescription opiates ', ' Infrastructure ', ' ']",NIDA,NEW YORK UNIVERSITY,P30,2019,237750,0.059589963761982494
"Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care Hispanic adolescents in the U.S. experience significant health disparities, particularly as it relates to drug use, unsafe sexual behaviors and sexually transmitted infections (STIs). In spite of these disparities, a paucity of effective preventive interventions exist for Hispanic adolescents, and even fewer have been disseminated widely (IOM/NRC, 2009). Given that primary care settings are increasingly becoming the entry-point through which parents bring youth with behavioral health concerns, adolescent primary care settings represent ideal, yet underutilized, settings in which to disseminate evidence-based preventive interventions. Preventive interventions which target risk and protective factors within the family, the most proximal and fundamental social system influencing human behavior, have been found to be among the most efficacious interventions in preventing and reducing drug use and sexual risk behaviors.  Familias Unidas is a Hispanic-specific, family-based intervention found to be efficacious and effective in preventing and reducing drug use, sexual risk behaviors, and self-reported STIs. Familias Unidas has been cited by the Institute of Medicine report on Preventing, Emotional, and Behavioral among Young People as ready for broad dissemination (IOM/NRC, 2009). To date, however, Familias Unidas has been only tested for efficacy and effectiveness in schools and has not been evaluated for efficacy/effectiveness in primary care. We have adapted and evaluated Familias Unidas for online delivery; successfully retaining 80% of Hispanic parents and their youth (recruited from schools) in the online, eHealth adaptation of Familias Unidas. We have also demonstrated the feasibility and acceptability of delivering eHealth Familas Unidas in primary care.  Evaluating innovative eHealth family-based interventions for Hispanic youth whose feasibility and acceptability is established in primary care settings is timely and of high public health significance. Therefore, the proposed study's overarching aim is to evaluate the relative effectiveness and cost effectiveness of eHealth Familias Unidas, compared to a referral to the National Institute Drug Abuses (NIDA) online information page for parents of Hispanic youth (referred hereafter as NIDA Online Information). To test the effectiveness of eHealth Familias Unidas Primary Care in preventing drug use, unprotected sexual behavior, and STIs in a universal sample of Hispanic youth, this study will randomize 456 Hispanic youth and their parents to eHealth Familias Unidas or to NIDA Online Information. Participants will be assessed at baseline, 6, 12, 24, and 36 months post baseline. Study hypotheses are that: 1) eHealth Familias Unidas will be effective, relative to NIDA Online Information, in preventing/reducing drug use, unprotected sexual behavior, and STI incidence in Hispanic adolescents over time and 2) Intervention effects will be partially mediated by family functioning for drug use and unprotected sexual behavior and by family functioning and unprotected sexual behavior for STI incidence. The cost effectiveness of eHealth Familias Unidas over a three year follow up will also be estimated. The proposed study will evaluate the effectiveness of an eHealth adaptation of an evidence-based face-to- face preventive intervention for Hispanic youth, in preventing drug use, sexual risk behaviors, and sexually transmitted diseases in primary care settings. The knowledge expected to be gained in this study will have strong implications for the delivery of prevention interventions in primary care, as well as contribute to the reduction of drug and sexual risk behavior related to disparities seen in Hispanic youth.",Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care,9820025,R01DA040756,"['Behavior ', ' cost effectiveness ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Family ', ' Modern Man ', ' Human ', ' Incidence ', ' NAS/IOM ', ' Institute of Medicine ', ' Institute of Medicine (U.S.) ', ' Parents ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' Risk Factors ', ' Schools ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Testing ', ' Time ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Latino ', ' Mediating ', ' Youth 10-21 ', ' Youth ', ' base ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Drug usage ', ' drug use ', ' Knowledge ', ' System ', ' experience ', ' Participant ', ' Patient Self-Report ', ' Self-Report ', ' Reporting ', ' social ', ' Emotional ', ' Sampling ', ' behavioral health ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' disparity in health ', ' health disparity ', ' Effectiveness ', ' preventing ', ' prevent ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Behavioral ', ' innovation ', ' innovative ', ' innovate ', ' evidence base ', ' primary care setting ', ' intervention effect ', ' efficacy testing ', ' eHealth ', ' e-Health ', ' relative effectiveness ', ' relative cost ', ' recruit ', ' protective factors ', ' sexual risk behavior ', ' sex risk behavior ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2019,98895,0.07929300962446643
"2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership ABSTRACT Cancer drugs in the United States are almost exclusively developed by, tested in, and optimized for European- Americans. Disparities in U.S. drug development are the result of long-standing inequalities that occur throughout the entire drug discovery pipeline. Only a small number of basic, translational and clinical scientists are Latino/Hispanic or Black/African-American. Less than 2-5% of trial participants are Latino/Hispanic or Black/African-American. Yet, in spite of a lack of data, new drugs are approved by the U.S. Food and Drug Administration (FDA) and subsequently prescribed for Latino/Hispanic or Black/African-American patients, without sufficient testing. It is unacceptable, especially in this era of the Precision Medicine Initiative (PMI), that currently our drugs are developed by, and optimized for, only for an exclusive segment of our citizens. We seek to shift this paradigm by strengthening the existing partnership between University of California at Riverside (UCR) and City of Hope Comprehensive Cancer Center (CoH-CCC). In this proposed P20, UCR and CoH-CCC will partner to develop the resources, infrastructure, and training programs necessary to develop the next generation of therapeutics researchers that reflect the ethnic diversity of Inland Southern California. We anticipate that our P20 program will drive new collaborative R01 grants and K01 and T-type training grants. . Project Narrative (Overview) In this P20 University of California at Riverside (UCR) and City of Hope Comprehensive Cancer Center (CoH- CCC) will partner to develop the resources, infrastructure, and training programs necessary to develop the next generation of basic, translational, and clinical therapeutics researchers that reflect the diversity of the Inland Empire. Together, UCR and CoH-CCC aim to develop the collaborations, translational resources, and training programs to reduce disparities in drug development throughout the entire development pipeline.",2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership,9823800,P20CA242620,"['Acetylation ', ' Affect ', ' Antelopes ', ' Antelopines ', ' Antineoplastic Agents ', ' anticancer drug ', ' anticancer agent ', ' anti-cancer drug ', ' Tumor-Specific Treatment Agents ', ' Neoplastic Disease Chemotherapeutic Agents ', ' Cancer Drug ', ' Antineoplastics ', ' Antineoplastic Drugs ', ' Anti-Cancer Agents ', ' Award ', ' malignant breast neoplasm ', ' malignant breast tumor ', ' Breast Cancer ', ' California ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cities ', ' Clinical Trials ', ' Color ', ' Communities ', ' Drug Design ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Educational aspects ', ' Education ', ' Engineering ', ' Faculty ', ' Fellowship ', ' Goals ', ' Grant ', ' Spanish Americans ', ' Hispanic Americans ', ' Investments ', ' Joints ', ' Los Angeles ', "" men's "", ' men ', ' Mentors ', ' Mentorship ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Patients ', ' Physicians ', ' Prognosis ', ' outcome forecast ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' school of medicine ', ' medical college ', ' medical schools ', ' Societies ', ' Students ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Training Programs ', ' United States ', ' USFDA ', ' Food and Drug Administration ', ' United States Food and Drug Administration ', ' Universities ', ' Woman ', ' Work ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Latino ', ' Clinical ', ' Phase ', ' Ensure ', ' Training ', ' Individual ', ' European ', ' Fostering ', ' Inequality ', ' Funding ', ' Collaborations ', ' news ', ' Therapeutic ', ' Therapeutic Agents ', ' programs ', ' Scientist ', ' System ', ' Postdoctoral Fellow ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' American ', ' success ', ' Toxic effect ', ' Toxicities ', ' Participant ', ' Reporting ', ' drug development ', ' drug discovery ', ' Latina ', ' Latinas ', ' Mitochondrial Proteins ', ' Bioinformatics ', ' Bio-Informatics ', ' Institution ', ' Address ', ' Core Facility ', ' Data ', "" Master's Degree "", ' City of Hope Comprehensive Cancer Center ', ' Comprehensive Cancer Center ', ' Conduct Clinical Trials ', ' Not Hispanic or Latino ', ' Nonhispanic ', ' Non-Hispanic ', ' Development ', ' developmental ', ' triple-negative invasive breast carcinoma ', ' triple-negative breast cancer ', ' TNBC ', ' anticancer research ', ' cancer research ', ' anti-cancer research ', ' next generation ', ' Minority ', ' manufacturing facility ', ' Population ', ' cancer health disparity ', ' disparity in cancer ', ' cancer disparity ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' therapeutic development ', ' therapeutic agent development ', ' screening ', ' Drug Targeting ', ' precision medicine ', ' precision-based medicine ', ' Precision Medicine Initiative ', ' training opportunity ', ' ethnic diversity ', ' ethnically diverse ', ' disparity reduction ', ' reduce disparity ', ' minority communities ', ' clinical translation ', ' phase 1 testing ', ' phase I testing ', ' phase I evaluation ', ' phase 1 evaluation ', ' Infrastructure ', ' ']",NCI,UNIVERSITY OF CALIFORNIA RIVERSIDE,P20,2019,306700,0.08728368536255911
"Mentoring researchers on drug abuse and HIV DESCRIPTION (provided by applicant): Drug users with and at-risk for HIV continue to have poor access to health care and poor treatment outcomes. In addition, opioid addiction involving prescription opioids has skyrocketed. In this proposal for a mid-career investigator award, Dr. Chinazo Cunningham proposes to address the opioid epidemic and its intersection with HIV infection by: 1) becoming an internationally recognized leader in the field of drug abuse and HIV, expanding her research to include advanced research methods (comparative effectiveness research [CER] methods and complex clinical trials methods); 2) developing a standardized and structured mentorship approach to mentor junior investigators to conduct patient-oriented research related to drug abuse and/or HIV infection; and 3) becoming an effective leader in academic medicine, ensuring that the institutional infrastructure facilitates junior investigators obtaining skills necessary to become independent investigators. To achieve these goals, Dr. Cunningham will participate in courses and national conferences, have directed readings, and regularly meet with national leaders in related fields. Dr. Cunningham will particularly focus on mentoring women and racial/ethnic minorities-two groups who are under-represented in senior positions in academic medicine and NIH-funded research. Dr. Cunningham will utilize her existing research program as a foundation for which she will provide mentoring and expand her research skills to include CER and complex clinical trials methods. The aims of her research are to: 1) test the efficacy of a 16-week abstinence-reinforcing contingency management intervention on HIV viral load suppression among opioid-dependent HIV-infected individuals, using a randomized controlled trial design; and 2) examine mechanisms of achieving viral load suppression with the abstinence-reinforcing contingency management intervention. Dr. Cunningham's future research will include the establishment of a comprehensive ""live"" database of all opioid users within a large urban medical center. This database will be used to examine health outcomes associated with types of opioid use and to develop and test interventions focused on opioid use. Dr. Cunningham's long-term career objective is to improve access to care and health outcomes among drug-abusing populations with or at-risk for HIV infection by developing interventions that can reduce their disparities in health care and health. PUBLIC HEALTH RELEVANCE: This application for a K24 mid-career investigator award seeks to provide support to Dr. Chinazo Cunningham to provide excellent mentorship, effective leadership, and expand her current research to include advanced research methods (comparative effectiveness research methods and complex clinical trials methods). Dr. Cunningham will mentor junior investigators in the areas of drug abuse and HIV, with an emphasis on providing mentorship to racial/ethnic minorities and women. Dr. Cunningham will use her existing research project as a foundation to provide much of her mentorship. In addition, expanding her research to include comparative effectiveness research and complex clinical trials focused on opioid use will allow her to conduct new research and provide additional mentorship that can ultimately improve health outcomes of drug users with and at-risk for HIV.",Mentoring researchers on drug abuse and HIV,9449410,K24DA036955,"['Award ', ' Behavior ', ' Buprenorphine ', ' Clinical Trials ', ' Cocaine ', ' Color ', ' Communities ', ' Control Groups ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Feedback ', ' Foundations ', ' Goals ', ' Health ', ' treatment access ', ' service availability ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Hematology Testing ', ' Hematological Tests ', ' Hematologic Tests ', ' Blood Tests ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incentives ', ' Leadership ', ' Medical Records ', ' Medicine ', ' Mentors ', ' Mentorship ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methadone ', ' Methods ', ' Motivation ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Roxicodone ', ' Oxycontin ', ' Oxycodone SR ', ' Oxycodeinon ', ' Dihydrohydroxycodeinone ', ' Oxycodone ', ' Patients ', ' Public Health ', ' Questionnaires ', ' Reading ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Support ', ' Risk ', ' Standardization ', ' Testing ', ' Toxicology ', ' Urine Urinary System ', ' Urine ', ' Woman ', ' Treatment outcome ', ' symposia ', ' summit ', ' convention ', ' conference ', ' symposium ', ' health care ', ' Healthcare ', ' Research Methods ', ' Research Methodology ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Caring ', ' base ', ' career ', ' improved ', ' Area ', ' Ensure ', ' Individual ', ' Databases ', ' data base ', ' Data Bases ', ' Opioid ', ' Opiates ', ' Drug usage ', ' drug use ', ' CD4 Lymphocyte Count ', ' T4 Lymphocyte Count ', ' CD4+ Counts ', ' CD4+ Cell Counts ', ' Funding ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Smoker ', ' Drug user ', ' persons who use drugs ', ' people who use illicit drugs ', ' people who use drugs ', ' PWUD ', ' programs ', ' Viral Load result ', ' Viral Load ', ' Viral Burden ', ' Complex ', ' Neurocognitive ', ' Opiate Addiction ', ' opioid dependent ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' Medical center ', ' Performance ', ' success ', ' Structure ', ' skills ', ' Participant ', ' contingency management ', ' Positioning Attribute ', ' Position ', ' HIV risk ', ' voucher ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Highly Active Antiretroviral Therapy ', ' highly active anti-retroviral therapy ', ' HAART ', ' patient oriented research ', ' patient oriented study ', ' pill ', ' disparity in health ', ' health disparity ', ' therapy adherence ', ' smoking cessation treatment ', ' Smoking Cessation Intervention ', ' Address ', ' Adherence ', ' Data ', ' Improve Access ', ' International ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Enrollment ', ' enroll ', ' effectiveness research ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Outcome ', ' Population ', ' ethnic minority population ', ' ethnic minority ', ' Abstinence ', ' racial and ethnic ', ' comparative effectiveness ', ' public health relevance ', ' primary outcome ', ' secondary outcome ', ' efficacy testing ', ' cocaine use ', ' prescription opioid ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' trial design ', ' improved outcome ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' health care availability ', ' healthcare service availability ', ' healthcare service access ', ' healthcare availability ', ' healthcare accessibility ', ' healthcare access ', ' health care service availability ', ' health care service access ', ' health care access ', ' accessibility to healthcare ', ' accessibility to health care ', ' accessibility of health care ', ' access to healthcare ', ' access to health care ', ' opioid epidemic ', ' opioid crisis ', ' opiate crisis ', ' illicit opioid ', ' illicit opiate ', ' opioid agonist therapy ', ' opioid agonist treatment ', ' Opioid user ', ' Opioid drug user ', ' Opiate user ', ' buprenorphine treatment ', ' methadone treatment ', ' methadone maintenance treatment ', ' methadone maintenance therapy ', ' methadone maintenance program ', ' methadone maintenance ', ' Infrastructure ', ' ']",NIDA,ALBERT EINSTEIN COLLEGE OF MEDICINE,K24,2019,167241,0.11979102193138146
"Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM) PROJECT SUMMARY/ABSTRACT  This application is for a competing renewal of the Center for Prevention Implementation Methodology for HIV and Drug Abuse, a NIDA P30 Center of Excellence. The number of new HIV cases in the US remains stable at 56,000 per year and continues to disproportionately affect some groups, including young men who have sex with men (YMSM), especially from racial/ethnic minorities. The purpose of this methodology center is to develop new methodologies that can be used by federal and local agencies and communities to reduce HIV incidence. Biomedical interventions and strategies, including pre-exposure prophylaxis (PrEP), rapid testing for HIV and early and consistent treatment for persons who are HIV positive (Treatment as Prevention, TasP) have been shown to have high efficacy and effectiveness in reducing HIV transmission, but there remains a giant gap between what research knows and what services needed to reduce population level incidence of HIV. The major premise of this application is that the effective biomedical to reduce HIV incidence and disparities are in hand, but success will only be achieved when they are implemented in ways that meet individual, community, and health care delivery system needs. This methods proposal addresses this major gap between research and practice through implementation science and methodology, focusing on innovative ways to address the complex, mulitilevel interactions needed to implement HIV prevention programs effectively. Two Cores, an Administrative Core and an Innovative Implementation Methods Core for HIV and Drug Abuse will carry out this work.  Aim 1 is to develop innovative methods to maximize the impact of implementation research in HIV prevention. We do this through an extended set of systems science and engineering methods that focus on improving the measurement of implementation, the modeling of implementation strategies, and the testing of implementation strategies through rigorous trials. Five qualifying grants support this work.  Aim 2 is to apply these innovative methods to close the gap between existing research, policy, and practice for HIV prevention. In addition to working closely with our five qualifying grants, we work locally with municipal Departments of Public Health and the federal Substance Abuse and Mental Health Services Administration (SAMHSA) HIV programs to identify and prioritize gaps in knowledge, find optimal implementation strategies for reduction of HIV transmission, and design the next large implementation trials.  Aim 3 is to disseminate methods and train/mentor leaders at the intersection of HIV prevention, implementation science, and drug abuse fields to improve implementation of HIV prevention programs. This involves mentoring the early career researchers, publishing, and providing training to networks of HIV and drug abuse researchers. PROJECT NARRATIVE There are numerous rigorously evaluated prevention programs involving biomedical interventions for preventing HIV that have demonstrated impact in efficacy and effectiveness trials. Pre-exposure prophylaxis, HIV testing, and early and consistent antiretroviral treatment have high potential for preventing HIV infections, but these are yet to be implemented sufficiently in racial/ethnic minority communities. This Ce-PIM addresses the critical methods gaps that are holding back the movement of these programs from research to practice.",Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM),9729649,P30DA027828,"['Affect ', ' Age ', ' ages ', ' Back ', ' Dorsum ', ' Behavior ', ' Biomedical Research ', ' Communities ', ' Decision Making ', ' health services delivery ', ' Healthcare Delivery ', ' health care delivery ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Cognitive Discrimination ', ' Discrimination ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Engineering ', ' ethnicity group ', ' Ethnic group ', ' Feedback ', ' Gender Identity ', ' Goals ', ' Grant ', ' Hand ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment access ', ' service availability ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV antibody positive ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' Anti-HIV Positivity ', ' HIV Seropositivity ', ' Incidence ', ' longterm care ', ' extended care ', ' Long-Term Care ', ' Mentors ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Methamphetamine ', ' Methods ', ' Methodology ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' body movement ', ' Movement ', ' Persons ', ' Play ', ' Public Health ', ' Publishing ', ' QOL ', ' Quality of life ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' Science ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Seeds ', ' Technology ', ' Testing ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' United States Substance Abuse and Mental Health Services Administration ', ' General Viruses ', ' Virus ', ' visual function ', ' Sight ', ' Vision ', ' Work ', ' P30 Protein ', ' P30 ', ' P-30 Protein ', ' ranpirnase ', ' Gender ', ' Generations ', ' Community Health Care ', ' Community Healthcare ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' ecstasy ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS prevention ', ' base ', ' career ', ' improved ', ' Sex Orientation ', ' Sexual Orientation ', ' Training ', ' Individual ', ' Policies ', ' Measurement ', ' Drug usage ', ' drug use ', ' Ethnic Origin ', ' Ethnicity ', ' tool ', ' Knowledge ', ' programs ', ' Viral Load result ', ' Viral Load ', ' Viral Burden ', ' Complex ', ' Pattern ', ' System ', ' Services ', ' success ', ' Anti-Retroviral Agents ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' Municipalities ', ' Structure ', ' novel ', ' Prevention program ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Early identification ', ' Modeling ', ' social stigma ', ' stigma ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' scientific organization ', ' Effectiveness ', ' preventing ', ' prevent ', ' HIV-2 test ', ' HIV-1 test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Address ', ' High Prevalence ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Qualifying ', ' transmission process ', ' Transmission ', ' socioeconomics ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' Development ', ' developmental ', ' antiretroviral therapy ', ' antiretroviral treatment ', ' anti-retroviral treatment ', ' anti-retroviral therapy ', ' effectiveness trial ', ' implementation trial ', ' men who have sex with men ', ' men who have sex with other men ', ' MSM ', ' implementation research ', ' design ', ' designing ', ' next generation ', ' efficacy trial ', ' Outcome ', ' Prevention approach ', ' Approaches to prevention ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' ethnic minority population ', ' ethnic minority ', ' Early treatment ', ' early therapy ', ' racial and ethnic ', ' implementation science ', ' research to practice ', ' research into practice ', ' cocaine use ', ' young men who have sex with men ', ' young MSM ', ' YMSM ', ' black men who have sex with men ', ' black MSM ', ' BMSM ', ' African-American men who have sex with men ', ' African American MSM ', ' AAMSM ', ' support tools ', ' minority communities ', ' pre-exposure prophylaxis ', ' PrEP ', ' implementation strategy ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,P30,2019,1015767,0.08917754346937293
"Health Consequences of Drug Use and IPV Trajectories for Young Latinas     DESCRIPTION (provided by applicant):  Few empirical studies have documented the life trajectories of gang-affiliated adolescent females and the long- term health consequences of adolescent drug use and partner violence victimization. The purpose of this study is to identify and determine how distinct drug use and intimate partner violence victimization trajectories that emerge in adolescence through young adulthood contribute to physical and mental health outcomes among Mexican American women within the context of a highly disadvantaged community. This group of women are particularly vulnerable given they have low rates of access and utilization of health care, are the most likely age group to be uninsured, and represent a nexus of risk, vulnerability and potentially high costs to communities given their reproductive and sexual health stage of life. This application proposes a 15 year follow up of a cohort of Mexican American adolescent females previously identified in a CDC funded study who were affiliated with male gang members during their adolescence and involved in high rates of drug use and victims of intimate partner violence. Building upon the research teams previous studies and using analytical tools from the theory of gender and power and social bonding theory, this application will implement a concurrent mixed methods nested design approach to provide a comprehensive understanding of the long-term consequences of drug use and IPV. The sample will consist of 300 young adult Mexican-American females. The specific aims for this study are: 1) determine the prevalence of physical (cardiovascular and metabolic risk markers and STI infection) and mental (depression, PTSD, anxiety/stress) health outcomes; 2) identify and characterize distinct drug use and IPV trajectories from adolescence through young adulthood; 3) determine whether sexual relationship power and family social bonds during distinct age-graded stages alter drug use and IPV trajectories and health outcomes; and 4) characterize qualitatively the culture and community context and their influence on drug use and IPV trajectories over the life course. This research will have an important positive impact by identifying women who are at the highest risk for developing harmful drug and IPV trajectories as they transition into young adulthood. In doing this, we will lay the foundation for identifying critical points of behavioral intervention during key age-graded periods as well as culturally and contextually appropriate values and strategies that will reduce health disparities among similar high-risk female populations that have gone underrepresented in existing research. PUBLIC HEALTH RELEVANCE:  This application seek a comprehensive understanding of the long term health consequences of drug use and intimate partner violence victimization physical and mental health outcomes among a vulnerable cohort of Mexican-American females recruited over 15 years ago who were affiliated with male gang members during their adolescence. The study will provide a unique opportunity to investigate detrimental life trajectories contributing t the prevalence of cardiovascular and metabolic risk markers, infection, depression, PTSD, anxiety and stress within a marginalized and underserved community context. Findings will contribute to policy discourse that can lead to the development of innovative public health programs and campaigns that will reduce health disparities among minority women. PHS 398/2590 (Rev. 11/07) Page Continuation Format Page",Health Consequences of Drug Use and IPV Trajectories for Young Latinas,9692537,R01DA039269,"['Adolescence ', ' adolescence (12-20) ', ' 12-20 years old ', ' Female Adolescents ', ' adolescent girl ', ' Age ', ' ages ', ' Anxiety ', ' Attention ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Communities ', ' Complement Proteins ', ' Complement ', ' Decision Making ', ' depression ', ' Mental Depression ', ' Disadvantaged ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Family ', ' Female ', ' Foundations ', ' Health ', ' Heterogeneity ', ' Infection ', ' knowledge of results ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Longterm Effects ', ' Long-Term Effects ', ' male ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' Neighborhoods ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Public Health ', ' Research ', ' Risk ', ' Stress ', ' traumatic neurosis ', ' Posttraumatic Stress Disorders ', ' Posttraumatic Neuroses ', ' Post-Traumatic Neuroses ', ' PTSD ', ' Post-Traumatic Stress Disorders ', ' violent behavior ', ' violent ', ' Violence ', ' Woman ', ' Friends ', ' Gender ', ' Female Health ', "" Women's Health "", ' Latino ', ' Uninsured ', ' Youth 10-21 ', ' Youth ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Gap Junctions ', ' Nexus Junction ', ' Nexus ', ' Low-resistance Junction ', ' Communicating Junction ', ' Psyche structure ', ' mental ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' healthcare service use ', ' health care service use ', ' Health Care Utilization ', ' young adult ', ' young adulthood ', ' adult youth ', ' Policies ', ' Drug usage ', ' drug use ', "" Women's Group "", ' Female Groups ', ' Wife ', ' Reproductive Health ', ' Funding ', ' Metabolic ', ' Shapes ', ' Sister ', ' Prediabetes syndrome ', ' prediabetic ', ' pre-diabetic ', ' pre-diabetes ', ' Prediabetic State ', ' Prediabetes ', ' Knowledge ', ' Life ', ' programs ', ' physical conditioning ', ' physical health ', ' age group ', ' cohort ', ' member ', ' gang ', ' social ', ' social attachment ', ' social bonding ', ' Sampling ', ' girls ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Latina ', ' Latinas ', ' disparity in health ', ' health disparity ', ' Low income ', ' Address ', ' Health system ', ' Sexual Health ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Not Hispanic or Latino ', ' Nonhispanic ', ' Non-Hispanic ', ' Risk Marker ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' partner violence ', ' violent partner ', ' sexual relationship ', ' cost ', ' adolescent drug use ', ' youth drug use ', ' intimate partner violence ', ' design ', ' designing ', ' Minority ', ' Outcome ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' analytical tool ', ' high risk ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' young man ', ' adolescent men ', ' adolescent man ', ' violence victimization ', ' drug use vulnerability ', ' vulnerability to drug use ', ' Affordable Care Act ', ' Obamacare ', ' health care service ', ' healthcare service ', ' high risk population ', ' high risk group ', ' recruit ', ' infection risk ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2019,412076,0.11929657389475455
"Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care Hispanic adolescents in the U.S. experience significant health disparities, particularly as it relates to drug use, unsafe sexual behaviors and sexually transmitted infections (STIs). In spite of these disparities, a paucity of effective preventive interventions exist for Hispanic adolescents, and even fewer have been disseminated widely (IOM/NRC, 2009). Given that primary care settings are increasingly becoming the entry-point through which parents bring youth with behavioral health concerns, adolescent primary care settings represent ideal, yet underutilized, settings in which to disseminate evidence-based preventive interventions. Preventive interventions which target risk and protective factors within the family, the most proximal and fundamental social system influencing human behavior, have been found to be among the most efficacious interventions in preventing and reducing drug use and sexual risk behaviors.  Familias Unidas is a Hispanic-specific, family-based intervention found to be efficacious and effective in preventing and reducing drug use, sexual risk behaviors, and self-reported STIs. Familias Unidas has been cited by the Institute of Medicine report on Preventing, Emotional, and Behavioral among Young People as ready for broad dissemination (IOM/NRC, 2009). To date, however, Familias Unidas has been only tested for efficacy and effectiveness in schools and has not been evaluated for efficacy/effectiveness in primary care. We have adapted and evaluated Familias Unidas for online delivery; successfully retaining 80% of Hispanic parents and their youth (recruited from schools) in the online, eHealth adaptation of Familias Unidas. We have also demonstrated the feasibility and acceptability of delivering eHealth Familas Unidas in primary care.  Evaluating innovative eHealth family-based interventions for Hispanic youth whose feasibility and acceptability is established in primary care settings is timely and of high public health significance. Therefore, the proposed study's overarching aim is to evaluate the relative effectiveness and cost effectiveness of eHealth Familias Unidas, compared to a referral to the National Institute Drug Abuses (NIDA) online information page for parents of Hispanic youth (referred hereafter as NIDA Online Information). To test the effectiveness of eHealth Familias Unidas Primary Care in preventing drug use, unprotected sexual behavior, and STIs in a universal sample of Hispanic youth, this study will randomize 456 Hispanic youth and their parents to eHealth Familias Unidas or to NIDA Online Information. Participants will be assessed at baseline, 6, 12, 24, and 36 months post baseline. Study hypotheses are that: 1) eHealth Familias Unidas will be effective, relative to NIDA Online Information, in preventing/reducing drug use, unprotected sexual behavior, and STI incidence in Hispanic adolescents over time and 2) Intervention effects will be partially mediated by family functioning for drug use and unprotected sexual behavior and by family functioning and unprotected sexual behavior for STI incidence. The cost effectiveness of eHealth Familias Unidas over a three year follow up will also be estimated. The proposed study will evaluate the effectiveness of an eHealth adaptation of an evidence-based face-to- face preventive intervention for Hispanic youth, in preventing drug use, sexual risk behaviors, and sexually transmitted diseases in primary care settings. The knowledge expected to be gained in this study will have strong implications for the delivery of prevention interventions in primary care, as well as contribute to the reduction of drug and sexual risk behavior related to disparities seen in Hispanic youth.",Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care,9694685,R01DA040756,"['Acculturation ', ' Cultural Assimilation ', ' Behavior ', ' Behavior Disorders ', ' behavioral disorder ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' climatic ', ' Meteorological Climate ', ' Climate ', ' Conflict ', ' Conflict (Psychology) ', ' cost effectiveness ', ' Counselor ', ' Professional counselor ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Family ', ' Gonococcal Infection ', ' Gonorrhea ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Modern Man ', ' Human ', ' Incidence ', ' NAS/IOM ', ' Institute of Medicine ', ' Institute of Medicine (U.S.) ', ' Leadership ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' nurse ', ' Nurses ', ' Parents ', ' Physicians ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' Risk ', ' Risk Factors ', ' Schools ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' Staff Attitudes ', ' Testing ', ' Time ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Latino ', ' Mediating ', ' Youth 10-21 ', ' Youth ', ' Caring ', ' base ', ' improved ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' caucasian American ', ' white American ', ' Childhood ', ' pediatric ', ' Emotional disorder ', ' Drug usage ', ' drug use ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Knowledge ', ' Frequencies ', ' Clinic ', ' System ', ' Unsafe Sex ', ' unprotected intercourse ', ' condomless sex ', ' condomless intercourse ', ' Unprotected Sex ', ' High-Risk Sex ', ' experience ', ' Participant ', ' member ', ' Patient Self-Report ', ' Self-Report ', ' Reporting ', ' social ', ' Emotional ', ' Sampling ', ' behavioral health ', ' junior high school ', ' middle school ', ' junior high ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' disparity in health ', ' health disparity ', ' Effectiveness ', ' preventing ', ' prevent ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Not Hispanic or Latino ', ' Nonhispanic ', ' Non-Hispanic ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Behavioral ', ' Health Professional ', ' Healthcare professional ', ' Health Care Professional ', ' care systems ', ' care services ', ' Outcome ', ' cost effective ', ' innovation ', ' innovative ', ' innovate ', ' evidence base ', ' primary care setting ', ' intervention effect ', ' efficacy testing ', ' eHealth ', ' e-Health ', ' parent-adolescent communication ', ' relative effectiveness ', ' relative cost ', ' recruit ', ' protective factors ', ' sexual risk behavior ', ' sex risk behavior ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2019,659035,0.07929300962446643
"Drug use disparities among Hispanics: elucidating the complex interactions between socio-cultural, neurocognitive and drug use-related factors Project Summary/Abstract: Hispanic adolescents are disproportionately affected by drug use and its consequences. This is reflected in high rates of school dropouts, arrest for drug possession, alcohol, drug use disorders, disability and drug related crash injuries and fatalities. Mounting evidence suggest that impaired neurocognitive functioning, exposure to early, severe, or chronic social disadvantage, and stress related to conflicting cultural practices, independently predict adverse drug use outcomes. Yet, studies employing an integrated approach to explore how these factors interact to increase or decrease the risk of experiencing adverse drug use consequences are limited. Therefore, the immediate and overarching goal of this K01 application is to receive intensive, supervised career-development training on the intersection between addiction neuroscience and social and cross-cultural research applied to drug use research that will enable me to pursue a line of independent research on drug use disparities. In this application, I propose to investigate how socio- cultural, neurocognitive and drug use related factors interact to explain the adverse outcomes seen in the Hispanic population. The specific aims of the proposed project include: 1) To determine whether neurocognitive factors (e.g., decision-making, episodic memory), mediate the associations between socio-cultural factors (e.g., early, severe, or chronic socio-economic disadvantage, ethnic discrimination, acculturative stress, Hispanic cultural values), and drug use outcomes (e.g. transition from use to drug use disorders, drug use trajectories, driving under the influence of drugs - DIU); 2) To examine whether socio-cultural factors moderate the associations between neurocognitive factors and drug use. These goals will be achieved by leveraging data, participants, and resources from an ongoing longitudinal study (parent study) that assesses decision-making and episodic memory in trajectories to cannabis addiction (R01DA031176), and interviewing a sub-sample of young Hispanics participating in the parent study and their parents or legal guardians (n=200 dyads). The proposed Mentored Research Scientist Development Award will build on my expertise in drug use epidemiology with advanced training in: addiction neuroscience, social and cross-cultural research on drug use disparities, interdisciplinary research on cognitive neuroscience and socio-cultural research, advanced statistical methods for analyzing longitudinal data, and responsible conduct of research. Overseeing this training is my primary mentor Dr. Raul Gonzalez, an expert in addiction neuroscience, and my co-mentor Dr. Mario De La Rosa, an expert in cross-cultural research and drug use disparities. The proposed K01, which is responsive to two of the two priority focus areas identified in the 2016-2020 NIDA Strategic Plan, will provide me with the resources, training, mentoring and knowledge needed to establish myself as a scientist with expertise on the intersection between addiction neuroscience and public health, and to develop a long-term independent transdisciplinary research program aimed at reducing and eliminating drug use disparities across and within minority populations. Project narrative: Socio-cultural and neurocognitive factors are important and potentially modifiable determinants of drug use, yet research examining the how these factors interact to explain drug use disparities is scarce. The proposed K01 training will support a Hispanic new and early stage investigator to become an independent researcher and a leader in interdisciplinary research on drug use disparities. Specifically, the outlined project will contribute to understand how social factors, Hispanic cultural values, neurocognitive processes and drug use related factors interact to explain the adverse drug use outcomes seen in the growing and heterogeneous Hispanic population, which is essential to design effective drug use preventive interventions.","Drug use disparities among Hispanics: elucidating the complex interactions between socio-cultural, neurocognitive and drug use-related factors",9764333,K01DA046715,"['Affect ', ' Alcohols ', ' Alcohol Chemical Class ', ' Clinical Study ', ' Clinical Research ', ' Conflict ', ' Conflict (Psychology) ', ' Decision Making ', ' Disadvantaged ', ' Drug Use Disorder ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Future ', ' Goals ', ' Interview ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Legal Guardians ', ' longterm study ', ' long-term study ', ' Longitudinal Studies ', ' Mentors ', ' Mentorship ', ' Neurosciences ', ' Parents ', ' Public Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' Stress ', ' School Dropouts ', ' Student Dropouts ', ' Supervision ', ' Testing ', ' Time ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Mediating ', ' Youth 10-21 ', ' Youth ', ' Injury ', ' career ', ' improved ', ' Area ', ' Chronic ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Ensure ', ' Training ', ' disability ', ' Childhood ', ' pediatric ', ' Individual ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Drug usage ', ' drug use ', ' Exposure to ', ' Impaired cognition ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Knowledge ', ' programs ', ' cognitive function ', ' Scientist ', ' Complex ', ' Dependence ', ' Pattern ', ' Neurocognitive ', ' psychosocial ', ' Episodic memory ', ' experience ', ' knowledge base ', ' knowledgebase ', ' Structure ', ' skills ', ' Participant ', ' Mediation ', ' Negotiation ', ' Negotiating ', ' Applied Research ', ' Applied Science ', ' Economically Deprived Population ', ' underclass ', ' economically disadvantaged ', ' economic disadvantage ', ' Economically Deprived ', ' cultural values ', ' social ', ' multilevel analysis ', ' multilevel modeling ', ' multilevel model ', ' multi-level model ', ' multi-level analysis ', ' methods to study multiple-level influences ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' career development ', ' driving under influence ', ' ethnic discrimination ', ' theories ', ' Adverse event ', ' Adverse Experience ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cannabis ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' disparity in health ', ' health disparity ', ' Effectiveness ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Data ', ' High Prevalence ', ' Mentored Research Scientist Development Award ', ' Research Scientist Development Award ', ' Mentored Training Award ', ' K01 Program ', ' K01 Mechanism ', ' K01 Award ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Strategic Planning ', ' Clinical Data ', ' Cognitive ', ' Process ', ' socioeconomics ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' early onset ', ' early onset drug use ', ' early initiation drug use ', ' design ', ' designing ', ' Minority ', ' Neurocognitive Deficit ', ' neurocognitive impairment ', ' neurocognitive decline ', ' IQ Deficit ', ' Outcome ', ' Population ', ' cognitive neuroscience ', ' Cognitive remediation ', ' addiction ', ' addictive disorder ', ' therapy design ', ' treatment design ', ' intervention design ', ' interdisciplinary approach ', ' multidisciplinary approach ', ' longitudinal analysis ', ' responsible research conduct ', ' adverse outcome ', ' adverse consequence ', ' cognitive development ', ' marijuana use ', ' cannabis use ', ' THC use ', ' THC co-use ', ' protective factors ', ' ']",NIDA,UNIVERSITY OF FLORIDA,K01,2019,161387,0.22159522634227913
"Pilot Study of a Community-Pharmacy Model to Expand Access to Medications to Treat and Prevent Hepatitis C, Opioid Use Disorders, Overdose and HIV Among Persons Who Inject Drugs ABSTRACT/PROJECT SUMMARY The opioid epidemic is a major public health crisis in the United States, leading to substantial morbidity and mortality related to the consequences of opioid use disorders and injection drug use, namely hepatitis C virus (HCV), HIV, and overdose. Yet, we are at a unique historical moment, as we possess effective medications that can improve and sustain the lives of people who inject drugs (PWID). Currently there are medications that can be prescribed to 1) cure HCV (directly-acting antivirals or DAAs), 2) prevent HIV infection (Pre-exposure Prophylaxis [PrEP]), and 3) treat/prevent overdose (naloxone and medications to treat OUD). Furthermore, there is an unprecedented opportunity to eliminate HCV, a disease that is transmitted through injecting drugs. However, achieving the goals of elimination will require better systems for allowing PWID access to medications to cure hepatitis C, as well as medications to prevent overdose and HIV. Pharmacists and community-pharmacy programs may be an innovative solution for this problem. Collaborative Drug Therapy Agreements (CDTAs) allow pharmacists to have authority to autonomously perform testing and prescribing and dispensing medications. We propose to use this R34 mechanism to develop and pilot test a novel health service delivery model, namely a community-pharmacy program for providing DAAs and medications to prevent overdose and HIV among PWID with HCV. For Aim #1, we will conduct qualitative interviews with PWID with HCV and other key community stakeholders in order to inform the development of a community- pharmacy program to expand access to medications to treat HCV and prevent overdose and HIV. For Aim #2, we will pilot and evaluate the community-pharmacy program at a local pharmacy in Seattle. This application is submitted under the funding announcement PA-18-774 (Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse), which includes pilot testing of health service interventions that optimize access utilization of drug use disorder related services, as well as services for comorbid medical conditions. The proposed research leverages a number of existing community partnerships with local stakeholders and would lead to a future multi-site effectiveness study that would utilize existing community- based pharmacies in order to work toward improving drug users' health by expanding access to life-saving medications. PROJECT NARRATIVE Persons who inject drugs (PWID) face barriers to accessing efficacious and potentially life-saving medications. The purpose of the research is to develop and pilot a community-pharmacy based model of care for PWID that can offer treatment for hepatitis C virus (HCV), in addition to medications to prevent overdose and HIV. The proposed research would lead to a future multi-site effectiveness study that will utilize existing community- based pharmacies to expand access to relevant medications for PWID, in order to reduce health disparities in this group and reach the World Health Organization's goal to eliminate HCV by 2030.","Pilot Study of a Community-Pharmacy Model to Expand Access to Medications to Treat and Prevent Hepatitis C, Opioid Use Disorders, Overdose and HIV Among Persons Who Inject Drugs",9822934,R34DA047660,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Algorithms ', ' Antiviral Agents ', ' anti-virals ', ' anti-viral drugs ', ' anti-viral agents ', ' Antivirals ', ' Antiviral Drugs ', ' Awareness ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Communities ', ' Community Pharmacy ', ' co-morbidity ', ' Comorbidity ', ' health services delivery ', ' Healthcare Delivery ', ' health care delivery ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Disorder ', ' Disease ', ' Outbreaks ', ' Disease Outbreaks ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' Drug Use Disorder ', ' Drug Utilization ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' facial ', ' faces ', ' Face ', ' Focus Groups ', ' Future ', ' Goals ', ' Health ', ' Health Services ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incidence ', ' Indiana ', ' Interview ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Naloxone ', ' opioid drug abuse ', ' opiate drug abuse ', ' opiate abuse ', ' opioid abuse ', ' Organizational Goals ', ' Organizational Objectives ', ' Overdose ', ' Patients ', ' Pharmacies ', ' Pharmacy facility ', ' Pharmacists ', ' pilot study ', ' Pilot Projects ', ' Play ', ' Prospective Studies ', ' Public Health ', ' Research ', ' Risk ', ' social role ', ' Role ', ' Savings ', ' Testing ', ' Time ', ' United States ', ' Work ', ' World Health Organization ', ' problematic alcohol use ', ' problematic alcohol consumption ', ' problem drinking ', ' problem alcohol use ', ' hazardous alcohol use ', ' ethanol abuse ', ' alcohol problem ', ' alcohol co-abuse ', ' EtOH abuse ', ' Alcohol abuse ', ' Research Methods ', ' Research Methodology ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS prevention ', ' Caring ', ' base ', ' rural area ', ' rural region ', ' improved ', ' Site ', ' Medical ', ' Training ', ' young adult ', ' young adulthood ', ' adult youth ', ' Rural ', ' Populations at Risk ', ' Needle-Exchange Programs ', ' syringe service programs ', ' syringe exchange services ', ' syringe exchange ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Funding ', ' tobacco abuse ', ' Drug user ', ' persons who use drugs ', ' people who use illicit drugs ', ' people who use drugs ', ' PWUD ', ' Life ', ' programs ', ' Oral ', ' Protocols documentation ', ' Protocol ', ' System ', ' interest ', ' Injecting drug user ', ' persons who inject drugs ', ' people who inject illicit drugs ', ' people who inject drugs ', ' PWID ', ' Injection Drug User ', ' Services ', ' preference ', ' American ', ' experience ', ' authority ', ' Structure ', ' novel ', ' Agreement ', ' Prevention ', ' Modeling ', ' HIV diagnosis ', ' Provider ', ' disparity in health ', ' health disparity ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' Effectiveness ', ' preventing ', ' prevent ', ' HIV-2 test ', ' HIV-1 test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Address ', ' Funding Mechanisms ', ' Development ', ' developmental ', ' health economics ', ' treatment center ', ' Hepatitis C Therapy ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' Hepatitis C Transmission ', ' hepatitis C virus transmission ', ' HCV Transmission ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' treatment site ', ' service intervention ', ' addiction ', ' addictive disorder ', ' overdose prevention ', ' overdose death ', ' prescription opioid ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' injection drug use ', ' community partnership ', ' opioid use disorder ', ' opiate use disorder ', ' HIV/HCV ', ' HIV/Hepatitis C ', ' HIV-HCV ', ' HIV and hepatitis C ', ' HIV and HCV ', ' HCV/HIV ', ' clinical development ', ' pre-exposure prophylaxis ', ' PrEP ', ' Hepatitis C virus ', ' HCV ', ' opioid injection ', ' opioid injector ', ' opiate injection ', ' intravenous opioid ', ' intravenous opiate ', ' opioid epidemic ', ' opioid crisis ', ' opiate crisis ', ' recruit ', ' Service delivery model ', ' healthcare delivery model ', ' health care delivery model ', ' care delivery model ', ' Service model ', ' preservation ', ' side effect ', ' ']",NIDA,UNIVERSITY OF WASHINGTON,R34,2019,214590,0.10355772141199472
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network     DESCRIPTION:  The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PUBLIC HEALTH RELEVANCE: This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9686710,UG1DA015815,"['Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' American Indians ', ' American Indian ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Service area ', ' Health Catchment Area ', ' Health Service Area ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Educational aspects ', ' Education ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Naloxone ', ' Persons ', ' Oregon ', ' Patients ', ' Peer Review ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' Scientific Publication ', ' Publications ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Safety ', ' San Francisco ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Island Americans ', ' Pacific Islander American ', ' Pacific Islander ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' experience ', ' care delivery ', ' Participant ', ' prevention service ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' Clinical Treatment ', ' trial treatment ', ' trial regimen ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' design ', ' designing ', ' Hepatitis C Therapy ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' urban Native American ', ' urban Indian ', ' urban American Indian ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addiction ', ' addictive disorder ', ' public health relevance ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' health care service ', ' healthcare service ', ' health service use ', ' health service utilization ', ' data resource ', ' rural healthcare ', ' rural health care ', ' rural Americans ', ' therapeutic candidate ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' recruit ', ' primary care services ', ' health care settings ', ' healthcare settings ', ' treatment services ', ' methadone patient ', ' rural health disparities ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2019,691567,0.08695097140668363
"Optimizing Immunosuppression Drug Dosing via Phenotypic Precision Medicine PROJECT SUMMARY The authors have developed a computational platform to rapidly identify optimal drug and dose combinations from the innumerable possibilities. By testing this technique termed Phenotypic Personalized Medicine (PPM) in a diverse number of experimental systems representing different diseases, they have found that the response of biological systems to drugs can be described by a low order, smooth multidimensional surface. The main consequence of this is that optimal drug combinations can be found in a small number of tests. This inputoutput relationship is always based on experimental data, not modeling, and it would lead to a straightforward solution for handling human diversity in drug dosing needs, among other clinical problems. They will test the hypothesis that PPM can be developed and validated for clinical use by conducting a prospective clinical trial to compare the feasibility and efficacy of this approach to standard of care physician dosing. This group has previously used PPM-based optimization to find novel drug combinations in in vitro and in vivo models of cancer and infection. In a first-in-human study, they recently compared 4 PPM-dosed patients and 4 control (standard of care dosed) patients. They calculated the tacrolimus dosing regimen using the PPM process and showed significant improvement in variability and a trend toward improved efficacy. For this application, they aim to show in a clinical trial, that PPM is more effective than unaided physician dosing. This will allow the generation of data to justify a multi-center confirmatory study and to explore a wider array of clinical outcomes to optimize. PROJECT NARRATIVE This project uses a computational drug-dose optimization platform (Phenotypic Precision Medicine) to an important problem in transplant immunosuppression, the maintenance of patient tacrolimus blood levels within a clinically desired target range. Using empiric measurements of responses to previously administered doses, the Phenotypic Precision Medicine platform optimizes and suggests subsequent doses. A prospective clinical trial will compare the efficacy, feasibility, and safety of this approach to standard of care physician dosing.",Optimizing Immunosuppression Drug Dosing via Phenotypic Precision Medicine,9767781,R21DK116140,"['Affect ', ' Algorithms ', ' Blood ', ' Blood Reticuloendothelial System ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Clinical Trials ', ' Infectious Disorder ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communicable Diseases ', ' Disorder ', ' Disease ', ' Drug Combinations ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Goals ', ' Modern Man ', ' Human ', ' immune suppression ', ' Immunosuppressive Effect ', ' Immunosuppression Effect ', ' Immunosuppression ', ' In Vitro ', ' Incidence ', ' Infection ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Liver Transplant ', ' Liver Grafting ', ' Hepatic Transplantation ', ' liver transplantation ', ' Maintenance ', ' Maps ', ' Methods ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' organ xenograft ', ' organ graft ', ' organ allograft ', ' Organ Transplants ', ' Grafting Procedure ', ' Organ Transplantation ', ' Patients ', ' Pharmacokinetics ', ' Drug Kinetics ', ' Phenotype ', ' Physicians ', ' Physiology ', ' Safety ', ' Testing ', ' Time ', ' transplant ', ' Transplantation ', ' Treatment Schedule ', ' Treatment Regimen ', ' Treatment Protocols ', ' Generations ', ' Measures ', ' Tacrolimus ', ' Immunologic Markers ', ' immunological markers ', ' immunological biomarkers ', ' immune-based biomarkers ', ' Immune Markers ', ' base ', ' Organ ', ' improved ', ' Procedures ', ' Surface ', ' Acute ', ' Solid ', ' Clinical ', ' Physiological ', ' Physiologic ', ' Randomized Clinical Trials ', ' Ensure ', ' liver function ', ' Renal function ', ' kidney function ', ' Individual ', ' Measurement ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Therapeutic ', ' Genetic ', ' Nature ', ' Transplant Recipients ', ' transplant patient ', ' Knowledge ', ' Area Under Curve ', ' Techniques ', ' System ', ' Toxic effect ', ' Toxicities ', ' response ', ' Dose ', ' Data ', ' in vivo Model ', ' Cancer Model ', ' CancerModel ', ' Clinical Data ', ' Combination Medication ', ' Patient-Focused Outcomes ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Monitor ', ' trend ', ' Process ', ' Calcineurin inhibitor ', ' Calcineurin antagonist ', ' Output ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' Outcome ', ' human study ', ' Population ', ' visual map ', ' prospective ', ' trial comparing ', ' standard of care ', ' comparative efficacy ', ' compare efficacy ', ' biological systems ', ' risk minimization ', ' Regimen ', ' arm ', ' precision medicine ', ' precision-based medicine ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' racial disparity ', ' race disparity ', ' disparities in race ', ' novel drug combination ', ' novel pharmacotherapy combination ', ' new pharmacotherapy combination ', ' new drug combination ', ' patient subsets ', ' patient subtypes ', ' patient subpopulations ', ' patient subgroups ', ' individual variation ', ' individual variability ', ' individual heterogeneity ', ' patient variability ', ' variation between patients ', ' variability between patients ', ' patient variation ', ' first-in-human ', ' first in man ', ' computational platform ', ' computing platform ', ' side effect ', ' participant safety ', ' subject safety ', ' post-transplant ', ' posttransplantation ', ' posttransplant ', ' post-transplantation ', ' dose individualization ', ' appropriate dose ', ' optimal drug dose ', ' optimal drug dosage ', ' ']",NIDDK,UNIVERSITY OF FLORIDA,R21,2019,194156,0.08600311335193023
"Structural switching of the bifunctional Chlamydia trachomatis protein, Scc4 PROJECT SUMMARY The role of the bi-functional Chlamydia trachomatis protein, Scc4 (formerly Ct663), in regulating the type III secretion system (T3SS) and the essential, developmental cycle (between infectious elementary bod- ies and actively dividing, reticulate bodies) is not well-understood at the molecular level. Scc4 is a unique protein that functions (i) as a T3SS chaperone with Scc1 to regulate secretion of CopN (an essential viru- lence factor) and (ii) as a transcription factor regulating 66-RNA polymerase holoenzyme. Based on pro- gress made during the last funding period, the switching mechanism proposed for Scc4s dual functions involves a conformational change in its 3-dimensional structure. Because Scc4 has two essential func- tions and is unique to C. trachomatis, it is a novel target for developing anti-virulence drugs. In order to develop drugs targeting the T3SS and developmental cycle of C. trachomatis, the structural mechanisms controlling Scc4s chaperone function and its interaction with its protein partners must first be deter- mined. The long-term goal of the proposed research is to screen and design drugs targeting Scc4s func- tions, which would prevent the bacteria from spreading, likely curing C. trachomatis directly and certainly mitigating the development of antibiotic-resistant strains, when combined with current therapies. The overall objectives of this application are to understand the switching mechanism of Scc4 between its free and chaperone-complex forms. The central hypothesis is that a conformational switch in Scc4s structure regulates its dual activity. The rationale for the proposed research is that inhibitors to disrupt Scc4s chaperone functions can be designed, resulting in new approaches to treat C. trachomatis and new mo- lecular tools to study the T3SS and developmental cycle. The central hypothesis and objectives of this application will be tested and attained by pursuing two specific aims: determine the high-resolution 3D structure of (1) Scc4 and (2) Scc4 in complex with Scc1. It is anticipated that these aims will yield the ex- pected outcome of a structural model of Scc4s switching mechanism for rational drug design. This out- come is expected to have an important positive impact because structures of Scc4 will provide the infor- mation necessary to develop drugs targeting Scc4s conformational switch and/or binding interface with Scc1 fundamentally advancing the fields of structural biology and infectious disease biology. This contri- bution is significant because it is the first step in a continuum of research that is expected to lead to un- derstanding Scc4s dual functions at the atomic level and contribute to the treatment of the most com- mon, sexually transmitted bacterial disease. The proposed research is innovative because the NMR structural and biochemical characterization of a unique bi-functional protein from C. trachomatis to target bacterial virulence as a therapeutic strategy represents a new and substantive departure from the status quo. PROJECT NARRATIVE The proposed research is relevant to public health because Chlamydia trachomatis is the most common, sexually transmitted bacterial disease in the United States and can cause reproductive health complications and pneumonia in infants born to infected women. A novel enzyme of Chlamydia trachomatis, called Scc4, is an attractive drug target because it has two functions that contribute to the pathogenesis of this disease. Developing a structural model of Scc4 and its protein complexes is an essential step toward the rational design of drugs and to provide molecular tools to fundamentally advance the field of microbiology.","Structural switching of the bifunctional Chlamydia trachomatis protein, Scc4",9881133,R15GM109413,"['inhibitor/antagonist ', ' inhibitor ', ' Bacteria ', ' Biology ', ' Cellular Inclusions ', ' Inclusion Bodies ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' Rickettsia trachomae ', ' C. trachomatis ', ' C trachomatis ', ' Chlamydia trachomatis ', ' Infectious Disorder ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communicable Diseases ', ' Disorder ', ' Disease ', ' Drug Design ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Enzyme Gene ', ' Enzymes ', ' Female ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Goals ', ' In Vitro ', ' Infant ', ' Infection ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Microbiology ', ' Structural Models ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Molecular Conformation ', ' living system ', ' Organism ', ' Pneumonia ', ' Proteins ', ' Factor II ', ' Differentiation Reversal Factor ', ' Coagulation Factor II ', ' Blood Coagulation Factor II ', ' Prothrombin ', ' Public Health ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' RNA Polymerases ', ' DNA-Dependent RNA Polymerases ', ' DNA-Directed RNA Polymerase ', ' social role ', ' Role ', ' Bacterial Venereal Diseases ', ' Bacterial Sexually Transmitted Diseases ', ' Sigma Subunit ', ' Sigma Initiation Factor ', ' Sigma Element ', ' Sigma Factor ', ' backbone ', ' Spine ', ' Spinal Column ', ' Vertebral column ', ' Testing ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' United States ', ' Virulence ', ' Woman ', ' Work ', ' antibiotic resistant ', ' antibiotic drug resistance ', ' Resistant to antibiotics ', ' Resistance to antibiotics ', ' Antibiotic Resistance ', ' base ', ' Biological ', ' Biochemical ', ' Link ', ' Pelvic Inflammatory Disease ', ' pelvic inflammatory syndrome ', ' Reproductive Health ', ' Molecular Chaperones ', ' Chaperone ', ' Funding ', ' Holoenzymes ', ' Therapeutic ', ' tool ', ' Knowledge ', ' Adopted ', ' Complex ', ' cell type ', ' Blindness ', ' visual loss ', ' vision loss ', ' experience ', ' structural biology ', ' transcription factor S-II ', ' transcription factor IIS ', ' transcription elongation factor S-II ', ' transcription elongation factor A ', ' strand transfer protein alpha ', ' elongation factor SII ', ' TFIIS elongation factor ', ' TFIIS ', ' SII transcription elongation factor ', ' Structure ', ' novel ', ' Partner in relationship ', ' mate ', ' Pathogenesis ', ' Reporting ', ' Virulence Factors ', ' Pathogenicity Factors ', ' Molecular Interaction ', ' Binding ', ' disparity in health ', ' health disparity ', ' Ubiquinone-Cytochrome b-c2 Oxidoreductase ', ' Ubiquinol-ferricytochrome-c oxidoreductase ', ' Ubiquinol-Cytochrome-c Reductase ', ' Ubihydroquinone-Cytochrome-c Reductase ', ' QH(2)-Ferricytochrome-c Oxidoreductase ', ' QH(2)-Cytochrome-c Reductase ', ' Dihydroubiquinone-Cytochrome-c Reductase ', ' Cytochrome b-c2 Oxidoreductase ', ' Complex III ', ' Coenzyme QH2-Cytochrome-c Reductase ', ' Coenzyme Q-Cytochrome-c Reductase ', ' Electron Transport Complex III ', ' protein complex ', ' preventing ', ' prevent ', ' Data ', ' Global Change ', ' Resolution ', ' Not Hispanic or Latino ', ' Nonhispanic ', ' Non-Hispanic ', ' Type III Secretion System Pathway ', ' Type III Secretion System ', ' Molecular ', ' protein function ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' design ', ' designing ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Outcome ', ' three dimensional structure ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' pathogenic bacteria ', ' bacterial pathogen ', ' innovation ', ' innovative ', ' innovate ', ' resistant strain ', ' resistance strain ', ' young woman ', ' adolescent women ', ' adolescent woman ', ' Drug Targeting ', ' ']",NIGMS,LOUISIANA STATE UNIV A&M COL BATON ROUGE,R15,2019,434606,0.0586362304947264
"Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges This is a proposal to renew funding of the Center for Drug Use and HIV Research (CDUHR) for years 21- 25. Recent advances in HIV biomedical and behavioral science have been shown to reduce HIV incidence and allow HIV-positive persons to reach near-normal lifespans. These achievements have led UNAIDS, the US and several local governments to propose strategies for Ending the HIV Epidemic. Notwithstanding these successes, attaining this goal among people who use drugs (PWUD) will require addressing a number of important existing barriers. The overall theme of this renewal is Ending HIV/AIDS among People who use Drugs: Overcoming Challenges. We define Ending HIV/AIDS as reducing new infections and increasing the proportion of PWUD who are virally suppressed. To accomplish this, we have identified these research priorities, which directly address the most significant challenges: (1) Devise new strategies to overcome emerging and persistent barriers to ending HIV/AIDS among PWUD. Barriers include recent increases in prescription opioid misuse, which have given rise to a new generation of heroin user and injectors, and lack of attention to the key role of substance use in new infections in men who have sex with men and heterosexuals. HIV-positive PWUD also experience disparities all along the continuum of HIV care, including delayed diagnosis, lower retention in care, delayed initiation of ART and poorer disease outcomes. (2) Conduct research on effective ways to broadly implement evidence-based interventions. HIV prevention and care programs for PWUD do not exist in many regions of the US and the rest of the world where they are needed most, and they are rarely implemented at public-health scale. (3) Develop new, innovative models of prevention and treatment interventions to address substance-use related disparities in HIV infection and treatment outcomes that take into account the complex, multilevel nature of HIV among PWUD.  We have made significant changes in our scope and structure for this renewal, and we will achieve our aims through five Cores, an Administrative Core and four Research Support Cores: (1) Infectious Disease Epidemiology and Theory, (2) Transdisciplinary Research Methods, (3) Dissemination and Implementation, and (4) Pilot Projects and Mentoring. These Cores support our research base and affiliated investigators to conduct cutting-edge science and enhance synergy across investigators from multiple disciplines, thereby leading to contributions to the field that are beyond what the individual projects could have achieved. In addition to the many successful initiatives that have been developed over CDUHR's history, new activities were added to respond to the evolving needs of our investigators. Also, in addition to our ongoing commitment to train new investigators to conduct high-impact research, we will collaborate with investigators in areas where HIV epidemics are occurring among PWUD (in rural and middle America, and in eastern Europe and Asia), building on our collective knowledge and expertise to advance toward Ending HIV/AIDS in those regions. Project Narrative A critical time has been reached in the course of the HIV epidemic, when the possibility to end HIVAIDS has been raised. Despite advances in biomedical treatments and behavioral interventions to reduce HIV incidence and its impact, people who use drugs (PWUD) have poorer outcomes. The Center provides a research infrastructure to enhance the productivity, synergy and impact of the research by affiliated investigators working to End HIV/AIDS among PWUD.",Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges,9927869,P30DA011041,"['Achievement ', ' Achievement Attainment ', ' Americas ', ' Attention ', ' Behavior ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavioral Sciences ', ' Biology ', ' Communities ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Diagnosis ', ' diagnosis service ', ' Diagnostic Services ', ' Outbreaks ', ' Disease Outbreaks ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economics ', ' Emergencies ', ' Emergency Situation ', ' Epidemic ', ' Eastern Europe ', ' Evolution ', ' facial ', ' faces ', ' Face ', ' Eastern Asia ', ' East Asia ', ' Far East ', ' Future ', ' Goals ', ' Greece ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV antibody positive ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' Anti-HIV Positivity ', ' HIV Seropositivity ', ' Incidence ', ' Economical Income ', ' Economic Income ', ' Income ', ' Indiana ', ' Infection ', ' Photoradiation ', ' Light ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Mentors ', ' Methods ', ' Local Government ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' New York ', ' Perception ', ' pilot study ', ' Pilot Projects ', ' Play ', ' Productivity ', ' Public Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Support ', ' Rest ', ' Risk ', ' social role ', ' Role ', ' Science ', ' Stigmatization ', ' Time ', ' P30 Protein ', ' P30 ', ' P-30 Protein ', ' ranpirnase ', ' Generations ', ' Treatment outcome ', ' Research Methods ', ' Research Methodology ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS prevention ', ' Caring ', ' base ', ' improved ', ' Left ', ' Area ', ' Medical ', ' Training ', ' Discipline ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Individual ', ' Rural ', ' Policies ', ' Inequality ', ' Drug usage ', ' drug use ', ' Funding ', ' Drug user ', ' persons who use drugs ', ' people who use illicit drugs ', ' people who use drugs ', ' PWUD ', ' Nature ', ' Research Priority ', ' Knowledge ', ' programs ', ' Complex ', ' Distant ', ' Route ', ' System ', ' Country ', ' Viral ', ' Injecting drug user ', ' persons who inject drugs ', ' people who inject illicit drugs ', ' people who inject drugs ', ' PWID ', ' Injection Drug User ', ' Services ', ' experience ', ' success ', ' synergism ', ' Heroin Users ', ' austin ', ' Structure ', ' Disease Outcome ', ' prevention service ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Modeling ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' HIV diagnosis ', ' disparity in health ', ' health disparity ', ' Address ', ' Health system ', ' Evidence based practice ', ' Infectious Disease Epidemiology ', ' Infectious Epidemiology ', ' International ', ' Interruption ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Infrastructure ', ' Translational Research ', ' translation research ', ' Translational Science ', ' transmission process ', ' Transmission ', ' Characteristics ', ' Heterosexuals ', ' men who have sex with men ', ' men who have sex with other men ', ' MSM ', ' Outcome ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Evidence based intervention ', ' public health research ', ' recruit ', ' treatment services ', ' Injections ', ' heroin use ', ' heroin intake ', ' prescription opioid misuse ', ' prescription opiate misuse ', ' opioid prescription medication misuse ', ' opioid medication misuse ', ' opioid analgesic misuse ', ' nonmedical use of prescription opioids ', ' nonmedical use of prescription opiates ', ' non-medical use of prescription opioids ', ' non-medical use of prescription opiates ', ' Infrastructure ', ' ']",NIDA,NEW YORK UNIVERSITY,P30,2019,151965,0.059589963761982494
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network     DESCRIPTION:  The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PUBLIC HEALTH RELEVANCE: This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9928532,UG1DA015815,"['Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' American Indians ', ' American Indian ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Service area ', ' Health Catchment Area ', ' Health Service Area ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Educational aspects ', ' Education ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Naloxone ', ' Persons ', ' Oregon ', ' Patients ', ' Peer Review ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' Scientific Publication ', ' Publications ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Safety ', ' San Francisco ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Island Americans ', ' Pacific Islander American ', ' Pacific Islander ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' experience ', ' care delivery ', ' Participant ', ' prevention service ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' Clinical Treatment ', ' trial treatment ', ' trial regimen ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' design ', ' designing ', ' Hepatitis C Therapy ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' urban Native American ', ' urban Indian ', ' urban American Indian ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addiction ', ' addictive disorder ', ' public health relevance ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' health care service ', ' healthcare service ', ' health service use ', ' health service utilization ', ' data resource ', ' rural healthcare ', ' rural health care ', ' rural Americans ', ' therapeutic candidate ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' recruit ', ' primary care services ', ' health care settings ', ' healthcare settings ', ' treatment services ', ' methadone patient ', ' rural health disparities ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2019,18104,0.08695097140668363
"Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM) PROJECT SUMMARY/ABSTRACT  This application is for a competing renewal of the Center for Prevention Implementation Methodology for HIV and Drug Abuse, a NIDA P30 Center of Excellence. The number of new HIV cases in the US remains stable at 56,000 per year and continues to disproportionately affect some groups, including young men who have sex with men (YMSM), especially from racial/ethnic minorities. The purpose of this methodology center is to develop new methodologies that can be used by federal and local agencies and communities to reduce HIV incidence. Biomedical interventions and strategies, including pre-exposure prophylaxis (PrEP), rapid testing for HIV and early and consistent treatment for persons who are HIV positive (Treatment as Prevention, TasP) have been shown to have high efficacy and effectiveness in reducing HIV transmission, but there remains a giant gap between what research knows and what services needed to reduce population level incidence of HIV. The major premise of this application is that the effective biomedical to reduce HIV incidence and disparities are in hand, but success will only be achieved when they are implemented in ways that meet individual, community, and health care delivery system needs. This methods proposal addresses this major gap between research and practice through implementation science and methodology, focusing on innovative ways to address the complex, mulitilevel interactions needed to implement HIV prevention programs effectively. Two Cores, an Administrative Core and an Innovative Implementation Methods Core for HIV and Drug Abuse will carry out this work.  Aim 1 is to develop innovative methods to maximize the impact of implementation research in HIV prevention. We do this through an extended set of systems science and engineering methods that focus on improving the measurement of implementation, the modeling of implementation strategies, and the testing of implementation strategies through rigorous trials. Five qualifying grants support this work.  Aim 2 is to apply these innovative methods to close the gap between existing research, policy, and practice for HIV prevention. In addition to working closely with our five qualifying grants, we work locally with municipal Departments of Public Health and the federal Substance Abuse and Mental Health Services Administration (SAMHSA) HIV programs to identify and prioritize gaps in knowledge, find optimal implementation strategies for reduction of HIV transmission, and design the next large implementation trials.  Aim 3 is to disseminate methods and train/mentor leaders at the intersection of HIV prevention, implementation science, and drug abuse fields to improve implementation of HIV prevention programs. This involves mentoring the early career researchers, publishing, and providing training to networks of HIV and drug abuse researchers. PROJECT NARRATIVE There are numerous rigorously evaluated prevention programs involving biomedical interventions for preventing HIV that have demonstrated impact in efficacy and effectiveness trials. Pre-exposure prophylaxis, HIV testing, and early and consistent antiretroviral treatment have high potential for preventing HIV infections, but these are yet to be implemented sufficiently in racial/ethnic minority communities. This Ce-PIM addresses the critical methods gaps that are holding back the movement of these programs from research to practice.",Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM),9897352,P30DA027828,"['Affect ', ' Age ', ' ages ', ' Back ', ' Dorsum ', ' Behavior ', ' Biomedical Research ', ' Communities ', ' Decision Making ', ' health services delivery ', ' Healthcare Delivery ', ' health care delivery ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Cognitive Discrimination ', ' Discrimination ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Engineering ', ' ethnicity group ', ' Ethnic group ', ' Feedback ', ' Gender Identity ', ' Goals ', ' Grant ', ' Hand ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment access ', ' service availability ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV antibody positive ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' Anti-HIV Positivity ', ' HIV Seropositivity ', ' Incidence ', ' longterm care ', ' extended care ', ' Long-Term Care ', ' Mentors ', ' N-Methylamphetamine ', ' Methylamphetamine ', ' Desoxyephedrine ', ' Deoxyephedrine ', ' Crystal Meth ', ' Methamphetamine ', ' Methods ', ' Methodology ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' body movement ', ' Movement ', ' Persons ', ' Play ', ' Public Health ', ' Publishing ', ' QOL ', ' Quality of life ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' Science ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Seeds ', ' Technology ', ' Testing ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' United States Substance Abuse and Mental Health Services Administration ', ' General Viruses ', ' Virus ', ' visual function ', ' Sight ', ' Vision ', ' Work ', ' P30 Protein ', ' P30 ', ' P-30 Protein ', ' ranpirnase ', ' Gender ', ' Generations ', ' Community Health Care ', ' Community Healthcare ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' ecstasy ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS prevention ', ' base ', ' career ', ' improved ', ' Sex Orientation ', ' Sexual Orientation ', ' Training ', ' Individual ', ' Policies ', ' Measurement ', ' Drug usage ', ' drug use ', ' Ethnic Origin ', ' Ethnicity ', ' tool ', ' Knowledge ', ' programs ', ' Viral Load result ', ' Viral Load ', ' Viral Burden ', ' Complex ', ' Pattern ', ' System ', ' Services ', ' success ', ' Anti-Retroviral Agents ', ' antiretroviral ', ' anti-retroviral ', ' Antiretroviral Agents ', ' Municipalities ', ' Structure ', ' novel ', ' Prevention program ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Early identification ', ' Modeling ', ' social stigma ', ' stigma ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' scientific organization ', ' Effectiveness ', ' preventing ', ' prevent ', ' HIV-2 test ', ' HIV-1 test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Address ', ' High Prevalence ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Qualifying ', ' transmission process ', ' Transmission ', ' socioeconomics ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' Development ', ' developmental ', ' antiretroviral therapy ', ' antiretroviral treatment ', ' anti-retroviral treatment ', ' anti-retroviral therapy ', ' effectiveness trial ', ' implementation trial ', ' men who have sex with men ', ' men who have sex with other men ', ' MSM ', ' implementation research ', ' design ', ' designing ', ' next generation ', ' efficacy trial ', ' Outcome ', ' Prevention approach ', ' Approaches to prevention ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' ethnic minority population ', ' ethnic minority ', ' Early treatment ', ' early therapy ', ' racial and ethnic ', ' implementation science ', ' research to practice ', ' research into practice ', ' cocaine use ', ' young men who have sex with men ', ' young MSM ', ' YMSM ', ' black men who have sex with men ', ' black MSM ', ' BMSM ', ' African-American men who have sex with men ', ' African American MSM ', ' AAMSM ', ' support tools ', ' minority communities ', ' pre-exposure prophylaxis ', ' PrEP ', ' implementation strategy ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,P30,2019,169389,0.08917754346937293
"Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges This is a proposal to renew funding of the Center for Drug Use and HIV Research (CDUHR) for years 21- 25. Recent advances in HIV biomedical and behavioral science have been shown to reduce HIV incidence and allow HIV-positive persons to reach near-normal lifespans. These achievements have led UNAIDS, the US and several local governments to propose strategies for Ending the HIV Epidemic. Notwithstanding these successes, attaining this goal among people who use drugs (PWUD) will require addressing a number of important existing barriers. The overall theme of this renewal is Ending HIV/AIDS among People who use Drugs: Overcoming Challenges. We define Ending HIV/AIDS as reducing new infections and increasing the proportion of PWUD who are virally suppressed. To accomplish this, we have identified these research priorities, which directly address the most significant challenges: (1) Devise new strategies to overcome emerging and persistent barriers to ending HIV/AIDS among PWUD. Barriers include recent increases in prescription opioid misuse, which have given rise to a new generation of heroin user and injectors, and lack of attention to the key role of substance use in new infections in men who have sex with men and heterosexuals. HIV-positive PWUD also experience disparities all along the continuum of HIV care, including delayed diagnosis, lower retention in care, delayed initiation of ART and poorer disease outcomes. (2) Conduct research on effective ways to broadly implement evidence-based interventions. HIV prevention and care programs for PWUD do not exist in many regions of the US and the rest of the world where they are needed most, and they are rarely implemented at public-health scale. (3) Develop new, innovative models of prevention and treatment interventions to address substance-use related disparities in HIV infection and treatment outcomes that take into account the complex, multilevel nature of HIV among PWUD.  We have made significant changes in our scope and structure for this renewal, and we will achieve our aims through five Cores, an Administrative Core and four Research Support Cores: (1) Infectious Disease Epidemiology and Theory, (2) Transdisciplinary Research Methods, (3) Dissemination and Implementation, and (4) Pilot Projects and Mentoring. These Cores support our research base and affiliated investigators to conduct cutting-edge science and enhance synergy across investigators from multiple disciplines, thereby leading to contributions to the field that are beyond what the individual projects could have achieved. In addition to the many successful initiatives that have been developed over CDUHR's history, new activities were added to respond to the evolving needs of our investigators. Also, in addition to our ongoing commitment to train new investigators to conduct high-impact research, we will collaborate with investigators in areas where HIV epidemics are occurring among PWUD (in rural and middle America, and in eastern Europe and Asia), building on our collective knowledge and expertise to advance toward Ending HIV/AIDS in those regions. Project Narrative A critical time has been reached in the course of the HIV epidemic, when the possibility to end HIVAIDS has been raised. Despite advances in biomedical treatments and behavioral interventions to reduce HIV incidence and its impact, people who use drugs (PWUD) have poorer outcomes. The Center provides a research infrastructure to enhance the productivity, synergy and impact of the research by affiliated investigators working to End HIV/AIDS among PWUD.",Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges,9658468,P30DA011041,"['Achievement ', ' Achievement Attainment ', ' Americas ', ' Attention ', ' Behavior ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavioral Sciences ', ' Biology ', ' Communities ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Diagnosis ', ' diagnosis service ', ' Diagnostic Services ', ' Outbreaks ', ' Disease Outbreaks ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Economics ', ' Emergencies ', ' Emergency Situation ', ' Epidemic ', ' Eastern Europe ', ' Evolution ', ' facial ', ' faces ', ' Face ', ' Eastern Asia ', ' East Asia ', ' Far East ', ' Future ', ' Goals ', ' Greece ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' HTLV-III Seropositivity ', ' HTLV-III Seroconversion ', ' HIV antibody positive ', ' HIV Seroconversion ', ' HIV Positivity ', ' HIV Positive ', ' Anti-HIV Positivity ', ' HIV Seropositivity ', ' Incidence ', ' Economical Income ', ' Economic Income ', ' Income ', ' Indiana ', ' Infection ', ' Photoradiation ', ' Light ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Mentors ', ' Methods ', ' Local Government ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' New York ', ' Perception ', ' pilot study ', ' Pilot Projects ', ' Play ', ' Productivity ', ' Public Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Support ', ' Rest ', ' Risk ', ' social role ', ' Role ', ' Science ', ' Stigmatization ', ' Time ', ' P30 Protein ', ' P30 ', ' P-30 Protein ', ' ranpirnase ', ' Generations ', ' Treatment outcome ', ' Research Methods ', ' Research Methodology ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS prevention ', ' Caring ', ' base ', ' improved ', ' Left ', ' Area ', ' Medical ', ' Training ', ' Discipline ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Individual ', ' Rural ', ' Policies ', ' Inequality ', ' Drug usage ', ' drug use ', ' Funding ', ' Drug user ', ' persons who use drugs ', ' people who use illicit drugs ', ' people who use drugs ', ' PWUD ', ' Nature ', ' Research Priority ', ' Knowledge ', ' programs ', ' Complex ', ' Distant ', ' Route ', ' System ', ' Country ', ' Viral ', ' Injecting drug user ', ' persons who inject drugs ', ' people who inject illicit drugs ', ' people who inject drugs ', ' PWID ', ' Injection Drug User ', ' Services ', ' experience ', ' success ', ' synergism ', ' Heroin Users ', ' austin ', ' Structure ', ' Disease Outcome ', ' prevention service ', ' Prevention ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Modeling ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' HIV diagnosis ', ' disparity in health ', ' health disparity ', ' Address ', ' Health system ', ' Evidence based practice ', ' Infectious Disease Epidemiology ', ' Infectious Epidemiology ', ' International ', ' Interruption ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Infrastructure ', ' Translational Research ', ' translation research ', ' Translational Science ', ' transmission process ', ' Transmission ', ' Characteristics ', ' Heterosexuals ', ' men who have sex with men ', ' men who have sex with other men ', ' MSM ', ' Outcome ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Evidence based intervention ', ' public health research ', ' recruit ', ' treatment services ', ' Injections ', ' heroin use ', ' heroin intake ', ' prescription opioid misuse ', ' prescription opiate misuse ', ' opioid prescription medication misuse ', ' opioid medication misuse ', ' opioid analgesic misuse ', ' nonmedical use of prescription opioids ', ' nonmedical use of prescription opiates ', ' non-medical use of prescription opioids ', ' non-medical use of prescription opiates ', ' Infrastructure ', ' ']",NIDA,NEW YORK UNIVERSITY,P30,2019,2010478,0.059589963761982494
"Developing and Piloting a School Staff-Based Intervention to Reduce Alcohol and Drug Use Among Sexual Minority Youth PROJECT SUMMARY/ABSTRACT Alcohol and drug use (e.g., tobacco and marijuana use) are major public health problems affecting large proportions of youth. Alcohol and drug use also disproportionately burden certain youth populations, such as sexual minority youth (SMY; i.e., adolescents who identify as gay/lesbian or bisexual, or who have same- gender sexual behaviors or attractions). Compared with heterosexual youth, SMY have up to 600% higher odds of lifetime drug and alcohol use. Despite these substantial disparities, few evidence-based interventions exist for reducing alcohol and drug use among SMY. Nevertheless, SMY who report having supportive adults at school, greater school connectedness, and lower bullying victimization have lower drug and alcohol use. Therefore, an intervention that trains school staff (e.g., teachers, principals, nurses, counselors) to better understand SMY, support SMY, and engage in positive bystander behaviors that protect SMY from bullying victimization may reduce sexual-orientation disparities in drug and alcohol use. Furthermore, many school staff desire to support SMY, but they report a lack of training as their primary impediment. To address these gaps, I will execute two Specific Aims. In Aim #1, I will develop an online e-learning intervention aimed at improving school staffs knowledge, skills, and self-efficacy for supporting SMY. Using the intervention mapping approach, I will develop, user-test, and refine intervention materials by: conducting focus groups with a School Staff Advisory Board; performing usability tests via think aloud interviews with school staff; and collaborating with professional e-learning developers. In Aim #2, I will pilot test the feasibility and preliminary efficacy of this school staff-based intervention using a two-armed cluster-randomized controlled trial. I will enroll high schools participating in the fully-funded survey infrastructure of the MetroWest Adolescent Health Survey (MWAHS), located outside Boston, Massachusetts, where sexual-orientation disparities in drug and alcohol use still exist. Biennially, the MWAHS administers surveys to all students in each school, providing ample student-level data. In tandem, I will collect new longitudinal survey data (baseline and 6-month follow-up) from all school staff within each enrolled school. This e-learning intervention is easily modifiable and economically scalable, making it apt for wide dissemination with the potential for population-level impact in reducing drug and alcohol use disparities. To successfully complete my research, I will acquire training in: (1) the development of stakeholder- informed interventions, particularly e-learning programs; (2) implementation science research; and (3) the design and analysis of experimental studies. Guided by a strong interdisciplinary mentorship team, my planned training activities include mentorship meetings, formal coursework, training institutes, scientific seminars, and research conferences. Upon successful completion of my research and training plans, I will be propelled towards achieving my long-term goal, which is to become an independent scientific researcher specializing in stakeholder-informed intervention science aimed at reducing drug and alcohol use disparities for SMY. PROJECT NARRATIVE The Institute of Medicines 2011 report titled The Health of Lesbian, Gay, Bisexual, and Transgender (LGBT) People calls for the development of evidence-based interventions for reducing sexual minority youths large and persistent disparities in drug and alcohol use. The goals of the proposed research are to develop and pilot test an e-learning intervention that trains school staff to better understand, support, and protect sexual minority youth, and this novel intervention is hypothesized to increase adult support and school connectedness and simultaneously decrease bullying victimization, drug use, and alcohol use among sexual minority youth. Given the dearth of published research on alcohol and drug use interventions for sexual minority youth, this project will provide novel scientific contributions that can help foster health equity for sexual minority youth.",Developing and Piloting a School Staff-Based Intervention to Reduce Alcohol and Drug Use Among Sexual Minority Youth,9720056,K01AA027564,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohols ', ' Alcohol Chemical Class ', ' Behavior ', ' Boston ', ' Clinical Trials ', ' web-based training ', ' web-based instruction ', ' virtual learning ', ' virtual education ', ' technology-enhanced learning ', ' online learning ', ' online education ', ' on-line learning ', ' on-line education ', ' multimedia learning ', ' internet-based training ', ' internet-assisted education ', ' electronic learning ', ' eLearning ', ' digital learning ', ' digital education ', ' computer-based training ', ' computer-based learning ', ' computer-based instruction ', ' computer-based education ', ' computer-assisted instruction ', ' E-learning ', ' Confidence Intervals ', ' Counselor ', ' Professional counselor ', ' lesson plans ', ' Curriculum ', ' Educational Curriculum ', ' Dropout ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' Feedback ', ' Focus Groups ', ' Goals ', ' Health ', ' Health Surveys ', ' NAS/IOM ', ' Institute of Medicine ', ' Institute of Medicine (U.S.) ', ' Institutes ', ' interventions research ', ' interventional study ', ' interventional research ', ' intervention research ', ' Intervention Studies ', ' Interview ', ' marihuana ', ' Marijuana ', ' Massachusetts ', ' Mentorship ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' nurse ', ' Nurses ', ' Public Health ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Schools ', ' Science ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Students ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Tobacco ', ' training module ', ' Training Activity ', ' Gender ', ' Institutional Policy ', ' symposia ', ' summit ', ' convention ', ' conference ', ' symposium ', ' Longitudinal Surveys ', ' Youth 10-21 ', ' Youth ', ' base ', ' Bisexual ', ' Bi-sexual ', ' career ', ' improved ', ' Site ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Sex Orientation ', ' Sexual Orientation ', ' Ensure ', ' Training ', ' teacher ', ' Fostering ', ' satisfaction ', ' Policies ', ' Drug usage ', ' drug use ', ' Gays ', ' Lesbian ', ' Funding ', ' Educational Intervention ', ' instructional intervention ', ' Training Intervention ', ' Instruction Intervention ', ' Education for Intervention ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Knowledge ', ' programs ', ' Victimization ', ' bullying ', ' bully ', ' Protocols documentation ', ' Protocol ', ' Tobacco use ', ' Tobacco Consumption ', ' meetings ', ' preference ', ' experience ', ' high school ', ' Self Efficacy ', ' Structure ', ' skills ', ' novel ', ' peer ', ' Reporting ', ' Sampling ', ' social stigma ', ' stigma ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Qualitative Research ', ' Address ', ' Consent ', ' Data ', ' Applications Grants ', ' Grant Proposals ', ' Population Intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Research Training ', ' Enrollment ', ' enroll ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' Heterosexuals ', ' design ', ' designing ', ' Population ', ' Evidence based intervention ', ' experimental analysis ', ' multidisciplinary ', ' usability ', ' implementation science ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' high risk ', ' population based ', ' reduced alcohol use ', ' health equity ', ' Institutional Review Boards ', ' IRBs ', ' IRB ', ' sexual minority ', ' Lesbian Gay Bisexual Transgender ', ' LGBT ', ' marijuana use ', ' cannabis use ', ' THC use ', ' THC co-use ', ' adolescent health ', ' experimental study ', ' experimental research ', ' experiment ', ' Infrastructure ', ' ']",NIAAA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K01,2019,153369,0.05005006525774009
"Interdisciplinary Research Training Institute on Hispanic Drug Abuse     DESCRIPTION (provided by applicant): This application requests continued support of the Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse (5 R25DA026401) that has developed and implemented a research education program aimed at promoting the career development of pre-doctoral and early career clinically focused scientists interested in conducting research that affects the Hispanic population. This comprehensive and coordinated effort focuses on providing research experience and increasing the skills required for the preparation and submission of competitive research applications for NIH extramural funding. This renewal application expands the scope of the IRTI program to include international clinically focused fellows from Mexico. Building upon the success and accomplishments of the existing IRTI, the specific aims of the IRTI are to (1) Continue to provide an improved educational training opportunity to enhance the skills for conducting interdisciplinary Hispanic drug research and developing applications for NIH funding among pre-doctoral, postdoctoral and early career faculty members (fellows) through the implementation of an 11-day intensive summer research training program; (2) Expand the scope of the IRTI program to include international, clinically focused fellows from Mexico that will serve to strengthen their capacity o conduct independent drug research and provide opportunities for U.S. and Mexico fellows to share knowledge that may develop into research activities aimed at enhancing bi-national public health efforts to address drug abuse and addiction; (3) Continue to execute an improved mentoring plan structured around a team of interdisciplinary senior faculty mentors who would be accessible and available to provide selected fellows with focused mentoring and continued support; (4) Continue to provide an improved networking structure and process that will assist fellows in building and maintaining relationships and communication with leading experts in the field of Hispanic drug research and fellow peers. Mentoring activities will focus on guiding and assisting the fellows in achieving benchmarks of progress including: a) Academic Career Progress; b) Scientific Publications; c) Scientific Presentations; and d) Research Funding. These outcomes will be facilitated through various types of support provided by the IRTI including: Mentor Commitment, Travel to Mentor Institution, E-Mentoring Technologies, Conferences/Workshops, and IRTI Mentoring Annual Meeting. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitate the conduct of interdisciplinary drug abuse research in the interest of public health. Building upon the existing mentoring and networking success, the proposed IRTI renewal will continue to fill the gap in knowledge on how to develop effective research incubators that will increase the number of minority drug abuse researchers. PUBLIC HEALTH RELEVANCE: This application seeks funding to continue the Interdisciplinary Research Training Institute (IRTI) on Hispanic Drug Abuse that seeks to promote the career development of underrepresented pre-doctoral, postdoctoral and early career clinically-focused scientists in the U.S. and Mexico interested in conducting research as it affects the Hispanic population. Hispanics face unique health challenges, and efforts to increase the number of well-qualified researchers prepared to conduct clinical research are vital to reducing health disparities among this underserved population. The complex and technical nature of contemporary drug abuse research and the growing demands for drug-related knowledge across several disciplines requires that competitive clinical research investigators develop a broad-based set of scientific knowledge and scientific research skills that will facilitae the conduct of interdisciplinary drug abuse research.",Interdisciplinary Research Training Institute on Hispanic Drug Abuse,9700074,R25DA026401,"['Affect ', ' career transition ', ' career advancement ', ' Career Mobility ', ' Clinical Study ', ' Clinical Research ', ' Communication ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' facial ', ' faces ', ' Face ', ' Goals ', ' Health ', ' Incubators ', ' Institutes ', ' Leadership ', ' Mentors ', ' Mentorship ', ' Mexico ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Public Health ', ' Scientific Publication ', ' Publications ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Technology ', ' Training Programs ', ' Travel ', ' Work ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Competence ', ' symposia ', ' summit ', ' convention ', ' conference ', ' symposium ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' base ', ' career ', ' improved ', ' Clinical ', ' Training ', ' Discipline ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Educational workshop ', ' Workshop ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Research Activity ', ' Drug usage ', ' drug use ', ' Funding ', ' Nature ', ' Knowledge ', ' programs ', ' Scientist ', ' Complex ', ' Benchmarking ', ' Best Practice Analysis ', ' interest ', ' meetings ', ' experience ', ' success ', ' Self Efficacy ', ' Structure ', ' skills ', ' peer ', ' member ', ' Mediation ', ' Negotiation ', ' Negotiating ', ' career development ', ' psychosocial development ', ' theories ', ' disparity in health ', ' health disparity ', ' Institution ', ' Address ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' International ', ' Request for Applications ', ' NIH RFA ', ' Research Training ', ' Extramural Activities ', ' Extramural ', ' EXTMR ', ' Not Hispanic or Latino ', ' Nonhispanic ', ' Non-Hispanic ', ' Translational Research ', ' translation research ', ' Translational Science ', ' Preparation ', ' Process ', ' Development ', ' developmental ', ' environmental enrichment for laboratory animals ', ' environmental enrichment ', ' environment enrichment for laboratory animals ', ' environment enrichment ', ' minority health ', ' Underserved Population ', ' underserved people ', ' under served population ', ' next generation ', ' Minority ', ' Outcome ', ' Population ', ' pre-doctoral ', ' predoctoral ', ' predoc ', ' pre-doc ', ' public health relevance ', ' early-career faculty ', ' faculty mentor ', ' senior faculty ', ' full professor ', ' summer research ', ' training opportunity ', ' education research ', ' ']",NIDA,UNIVERSITY OF SOUTHERN CALIFORNIA,R25,2019,332859,0.13783565054063016
"Real-time prediction of emerging drug use epidemics in the United States Project summary The overdose epidemic in the United States has followed an exponential curve since 1979 with no sign of abating. On the contrary, a series of political, economic and technological factors are fueling drug use epidemics in the country. Technological advances have led to an explosion in the emergence of powerful synthetic substances which can be produced with minimal equipment. Inequalities, poor mental health services and other social issues contribute to an increased susceptibility to drug use disorders. Improved transport and communication infrastructure, including the internet, facilitates the emergence of drug markets. As a result, polysubstance use is diversifying presenting new health risks and new challenges for treatment. In 2017, over 70,000 people died of an overdose and HIV outbreaks were identified in two cities of Massachusetts. Curbing these alarming trends requires preemptive epidemic preparedness and the latter should be based on a rigorous and systematic assessment of the factors influencing drug use epidemics. These factors, however, are dynamic and interacting. We will use an emerging infectious disease framework and dynamic mathematical modeling methods to predict emerging drug use epidemics in the United States. Mathematical modeling has been used extensively to forecast emerging and re- emerging infectious disease epidemics because it allows to mechanistically represent the different factors determining disease transmission and their dynamics over time. We will develop a mathematical model of drug use in the United States which represents current patterns of drug use across the country and associated HIV, HCV and overdose incidence. It will explicitly represent heterogeneity in susceptibility to drug use disorders in the population, social networks and the influence of drug markets, law enforcement and healthcare services on drug use and associated health outcomes. This project will 1) systematically investigate the potential for emerging drug use epidemics; 2) identify the optimal allocation of resources towards combination of interventions to control them and limit associated harms and 3) pilot a targeted mass-media based intervention to increase access to appropriate prevention methods among a specific population at risk of an emerging drug use in real time as identified by the model. This project has the potential to significantly improve our public health response to emerging drug use epidemics and to reduce their toll on the health of the United States population. Project narrative Over the past two decades, three consecutive waves of emerging opioid epidemics and intersecting drug use epidemics have claimed more than 600,000 lives across the U.S. and caused drug use associated HIV outbreaks in previously unaffected rural populations. The harms are increasing exponentially with over 70,000 overdose deaths occurring in the past year only. This project proposes to use dynamic mathematical modeling to predict and effectively respond to emerging drug use epidemic threats and associated HIV, HCV and fatal overdose incidence.",Real-time prediction of emerging drug use epidemics in the United States,9822752,DP2DA049295,"['Cities ', ' Communication ', ' Outbreaks ', ' Disease Outbreaks ', ' Drug Use Disorder ', ' Economics ', ' Epidemic ', ' Equipment ', ' Explosion ', ' Health ', ' Heterogeneity ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Incidence ', ' mass information media ', ' Mass Media ', ' Massachusetts ', ' Mental Hygiene Services ', ' Mental Health Services ', ' Methods ', ' Overdose ', ' Politics ', ' Public Health ', ' Risk ', ' Rural Population ', ' Time ', ' United States ', ' Resource Allocation ', ' Social Network ', ' Law Enforcement ', ' base ', ' improved ', ' Series ', ' Predisposition ', ' Susceptibility ', ' Populations at Risk ', ' Inequality ', ' Drug usage ', ' drug use ', ' disease transmission ', ' infectious disease transmission ', ' communicable disease transmission ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Pattern ', ' Country ', ' drug market ', ' Prevention ', ' social ', ' Modeling ', ' response ', ' Emerging Communicable Diseases ', ' Emerging Infectious Diseases ', ' mathematical model ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' Abate ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Preparedness ', ' Readiness ', ' trend ', ' Outcome ', ' Population ', ' overdose death ', ' health care service ', ' healthcare service ', ' Hepatitis C virus ', ' HCV ', ' opioid epidemic ', ' opioid crisis ', ' opiate crisis ', ' Infrastructure ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",DP2,2019,2367000,0.17010969683654675
"Risk Factors for AIDS among Drug Users: Getting Close to Zero     DESCRIPTION: UNAIDS has announced a goal of Getting to Zero New HIV infections and Secretary Clinton has announced a goal of an AIDS free generation. Completely eliminating new HIV infections may not be possible in any large population of persons at high risk for HIV, but combined prevention, including treatment as prevention (TasP) may permit getting very close to zero new HIV infections. Psychoactive drug use generates many impediments getting close to zero. Drug use can lead to HIV infection through both sharing injection equipment and through drug use related unsafe sexual behavior. Drug use may also interfere with accessing and adhering to antiretroviral therapy (ART). Psychoactive drug use is also strongly associated with higher rates of HIV infection among racial/ethnic minorities. In this research, we will examine whether combined prevention can get close to zero new HIV infections among injecting and non-injecting drug users in New York City, including whether getting close to zero can minimize racial/ethnic disparities.  If combined prevention does lead to getting close to zero new infections drug users in NYC. This will require a) an analytic description of combined prevention, b) a clear conceptualization of getting close to zero, and c) new metrics and methods for assessing being close to zero.  We will study getting close to zero new HIV infections for drug users in NYC through four specific aims: 1. Determine the extent to which combined prevention  is getting close to zero for injecting related transmission of HIV in NYC. Develop new metrics for measuring a CtZ situation for injecting-related transmission and how racial/ethnic disparities might be minimized. 2. Conduct mathematical modeling, using biomarkers for high injecting risk (HCV infection) and high sexual risk (HSV-2 infection) and behavioral data to analyze HIV infection among PWID in terms of: 1) the PWID population as a whole, 2) disparities among major racial/ethnic groups, 3) sustainability for maintaining a CTZ situation with combined prevention, and 4) injecting related vs. sexual transmission of HIV among PWID. 3. Determine the extent to which ""combined prevention"" is reducing drug related sexual (DRS) transmission of HIV among non-injecting drug users (NIDUs) and PWID in NYC. Develop new metrics for measuring the potential for continuing sexual transmission and assess coverage of Treatment as Prevention (TasP) among NIDUs. Monitor trends in HSV-2 infection as a continuing driver of drug use sexual transmission. 4. Utilize geospatial analysis to characterize ""hotspots"" for continuing transmission of HIV among drug users in NYC, including potential geographic overlap between injecting related and sexual transmission of HIV, and racial/ethnic and HIV service characteristics of hotspots.  We will accomplish these aims through interviews and HIV, HCV, and HSV-2 testing of 600 subjects per year and continuation of our long-standing collaborations with the NY City and State Health Departments. PUBLIC HEALTH RELEVANCE: UNAIDS has announced a goal of ""getting to zero"" new HIV infections and the US government has announced a parallel goal of achieving ""an AIDS free generation. We will study whether combined prevention leads to ""getting close to zero"" new HIV infections for injecting and non-injecting drug users in New York City. This will include developing bio-behavioral metrics for use in getting close to zero, mathematical modeling, and identifying geographic ""hotspots"" of persistent probability of HIV transmission.",Risk Factors for AIDS among Drug Users: Getting Close to Zero,9625114,R01DA003574,"['Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Cities ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Equipment ', ' ethnicity group ', ' Ethnic group ', ' geographic site ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Geographic Locations ', ' Geography ', ' Goals ', ' Government ', ' Health ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' human alphaherpesvirus 2 ', ' herpes simplex ii ', ' Human herpes simplex virus type 2 ', ' Human (alpha) herpes virus 2 ', ' Herpesvirus progenitalis ', ' Herpesvirus 2 (alpha), Human ', ' Herpes Simplex Virus Type 2 ', ' Herpes Simplex Virus 2 ', ' HSV2 ', ' HSV-2 ', ' HHV-2 ', ' Human Herpesvirus 2 ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' HIV Seroprevalence ', ' Incidence ', ' Economical Income ', ' Economic Income ', ' Income ', ' Infection ', ' Institutes ', ' Interview ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Persons ', ' New York ', ' New York City ', ' Probability ', ' Psychopharmaceuticals ', ' Psychoactive Drugs ', ' Psychoactive Compound ', ' Psychoactive Agents ', ' Psychotropic Drugs ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' sex activity ', ' Sexual Behavior ', ' Sexual Activity ', ' Sex Behavior ', ' Social Marketing ', ' Testing ', ' Vaccines ', ' Generations ', ' Measures ', ' Syringe Sharing ', ' Needlesharing ', ' Needle Sharing ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS prevention ', ' improved ', ' Area ', ' Phase ', ' Predisposition ', ' Susceptibility ', ' Drug usage ', ' drug use ', ' Needle-Exchange Programs ', ' syringe service programs ', ' syringe exchange services ', ' syringe exchange ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Collaborations ', ' Drug user ', ' persons who use drugs ', ' people who use illicit drugs ', ' people who use drugs ', ' PWUD ', ' Injecting drug user ', ' persons who inject drugs ', ' people who inject illicit drugs ', ' people who inject drugs ', ' PWID ', ' Injection Drug User ', ' Unsafe Sex ', ' unprotected intercourse ', ' condomless sex ', ' condomless intercourse ', ' Unprotected Sex ', ' High-Risk Sex ', ' Services ', ' experience ', ' c new ', ' condoms ', ' Prevention program ', ' prevention service ', ' Shares syringes ', ' Prevention ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Modeling ', ' mathematical model ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' Data ', ' High Prevalence ', ' Sexual Transmission ', ' sexually transmitted ', ' Monitor ', ' transmission process ', ' Transmission ', ' trend ', ' Characteristics ', ' Process ', ' Behavioral ', ' antiretroviral therapy ', ' antiretroviral treatment ', ' anti-retroviral treatment ', ' anti-retroviral therapy ', ' biobehavior ', ' biobehavioral ', ' care systems ', ' care services ', ' Outcome ', ' Population ', ' Prevalence ', ' ethnic minority population ', ' ethnic minority ', ' racial and ethnic ', ' racial and ethnic disparities ', ' high risk ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' epidemiologic data ', ' Epidemiology data ', ' Epidemiological data ', ' sexual HIV transmission ', ' gender disparity ', ' high risk population ', ' high risk group ', ' Hepatitis C virus ', ' HCV ', ' Injections ', ' ']",NIDA,NEW YORK UNIVERSITY,R01,2019,639394,0.10540491543263228
"Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border     DESCRIPTION (provided by applicant): The proposed project is a research collaboration between the University of Texas at El Paso, The Alliance for Border Collaborative and Program Comparers to adapt, implement, and evaluate a multi-level, community-based, HIV prevention intervention (Project Encuentro). The intervention will target active heroin and crack users and consists of increasing access to HIV testing via a social network HIV testing component and reducing sexual and drug use risk via a peer network brief behavioral Intervention. Encuentro also consists of conducting community awareness meeting to target structural factors affecting HIV risk. The intervention was developed in an area severely affected by violence and stigma towards drug users, El Salvador, which makes it particularly suitable for adaptation to meet the needs of drug users living in the proposed intervention site, the U.S.-Mexico border. The proposed intervention site also has been severely affected by violence which has curtailed any prior attempts to reduce the risk drug users' HIV risk. Violence has worsened structural factors which affect HIV risk such as, increasing police persecution and stigma and reducing access to resources. In our proposed project, we will engage in formative research to understand the context of HIV risk of drug users in the border region post violence and adapt the intervention accordingly. Findings will allow us to tailor intervention components to meet the needs of drug users in the region. Subsequently, we propose to test intervention effectiveness and evaluate implementation barriers and facilitators. To accomplish our project aims we will use a mixed qualitative, quantitative approach. We will begin with a formative phase by conducting in-depth interviews with drug users (n = 40) living in the region to understand how the context of drug use risk changed as a result of the violence and will administer a social network survey (n = 200) to characterize the configuration of risk networks. Findings will yield the necessary information to culturally adapt the intervention to meet the needs of drug users in the region and will help us focus our recruitment efforts where the riskiest networks are located. After the intervention is adapted with the help of our community advisory board and our community coalition, we will implement the intervention and will assess the effectiveness and reach via 6 cross-sectional surveys administered to drug users (n=1,200). We will assess the process of implementation by conducting ethnographic field notes of all intervention activities including community engagement and CAB and coalition meetings. We will assess the fidelity and quality of the intervention. Lastly, we will conduct key informant interviews with key stakeholders involved in the project and interviews and observations will be coded to reflect key systems factors related to successful implementation of intervention components in two intervention sites (El Paso, Texas and Ciudad Juarez, Mexico). Findings will be highly significant as we will be conducting parallel research on the effectiveness of interventions shown to be effective in Latino drug users in two very different contexts: El Salvador and the U.S-Mexico border. Findings will elucidate implementation challenges and barriers and such information can then be used to assess the effectiveness of diverse implementation strategies in organizations working to serve the needs of Latino drug users. PUBLIC HEALTH RELEVANCE: Findings will be highly significant as we will be conducting parallel research on the effectiveness of interventions shown to be effective in Latino drug users in two very different contexts: El Salvador and the U.S- Mexico border.",Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border,9627718,U01MD010657,"['Affect ', ' Awareness ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Cities ', ' Communities ', ' Disease Frequency Surveys ', ' Cross-Sectional Survey ', ' Cross-Sectional Analyses ', ' Cross Sectional Analysis ', ' Cross-Sectional Studies ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' El Salvador ', ' Epidemic ', ' Equipment ', ' Explosion ', ' facial ', ' faces ', ' Face ', ' Fear ', ' Fright ', ' Feedback ', ' Goals ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Immigration ', ' Interview ', ' Mexico ', ' Mission ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' social support network ', ' Social support ', ' Survey Instrument ', ' Surveys ', ' Syringes ', ' Testing ', ' Texas ', ' Time ', ' Universities ', ' violent behavior ', ' violent ', ' Violence ', ' Police ', ' Latino ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS prevention ', ' Social Network ', ' Ethnography ', ' ethnographic ', ' Workplace ', ' work setting ', ' Worksite ', ' Work-Site ', ' Work Place ', ' Work Location ', ' Job Site ', ' Job Setting ', ' Job Place ', ' Job Location ', ' base ', ' Site ', ' Area ', ' Phase ', ' Series ', ' Evaluation ', ' Border Crossings ', ' Drug usage ', ' drug use ', ' Needle-Exchange Programs ', ' syringe service programs ', ' syringe exchange services ', ' syringe exchange ', ' needle exchange ', ' Syringe-Exchange Programs ', ' Collaborations ', ' Liquid substance ', ' liquid ', ' fluid ', ' Drug user ', ' persons who use drugs ', ' people who use illicit drugs ', ' people who use drugs ', ' PWUD ', ' programs ', ' Event ', ' Side ', ' System ', ' Country ', ' meetings ', ' experience ', ' metropolitan ', ' Structure ', ' Participant ', ' member ', ' Prevention ', ' social ', ' HIV risk ', ' Code ', ' Coding System ', ' response ', ' social stigma ', ' stigma ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Risk Reduction ', ' disparity in health ', ' health disparity ', ' Effectiveness ', ' HIV-2 test ', ' HIV-1 test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Address ', ' Effectiveness of Interventions ', ' International ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Process ', ' sex ', ' informant ', ' substance abuse treatment ', ' substance abuse therapy ', ' design ', ' designing ', ' community organizations ', ' community based participatory research ', ' participatory action research ', ' community based research ', ' community based design ', ' implementation science ', ' combat ', ' public health relevance ', ' injection drug use ', ' peer networks ', ' violent crime ', ' recruit ', ' Injections ', ' heroin use ', ' heroin intake ', ' implementation strategy ', ' ']",NIMHD,LEHIGH UNIVERSITY,U01,2019,550611,0.136020208412757
"Drug Benefit Design and Adherence Disparities in Older Adults Project Summary/Abstract Underuse of clinically effective medications among minority adults in midlife may contribute to racial and ethnic disparities in chronic disease related morbidity and mortality in late life. Medication affordability has been identified as an important driver of disparities in treatment adherence and recent trends in employer-sponsored prescription drug coverage toward increased patient cost sharing (e.g., copays) have the potential to exacerbate these disparities. Yet, there is a paucity of strong research evidence on the effects of out-of-pocket (OOP) drug costs on disparities in treatment adherence over the life course. In a prior study, we found evidence of a complex relationship between OOP drug costs and adherence which likely differs by race and ethnicity over time. For example, as patients age and OOP costs increase due to higher drug burden, patients may become more sensitive to cumulative drug costs regardless of race or ethnicity. In addition, potentially modifiable factors at the provider (e.g., prescribing habits) and health system level (e.g., refill complexity) may interact with OOP drug costs in ways that exacerbate adherence disparities in midlife. However, our prior study could not adequately explore these complex and interacting factors. The primary objective of this competing renewal is to estimate the effect of OOP drug costs on disparities in medication adherence among middle-aged adults (40-64) within a large integrated health care setting (>4 million members) offering a wide variety of drug benefits and consistent access to primary care. We hypothesize that the relationship between OOP drug costs and racial and ethnic differences in adherence will be modified by age. In addition, we will examine potential interactions between OOP drug costs and modifiable factors at the provider and health system level that may amplify disparities in adherence. Focusing on patients with cardiometabolic conditions (i.e., hypertension, diabetes) and select medication classes (e.g., lipid lowering, antihypertensives, antidiabetes), we will leverage a rich longitudinal electronic medical record and employ rigorous statistical methods to estimate the effect of OOP drug costs on medication adherence overall and by race and ethnicity, including examining age-specific effects and interactions between OOP drug costs and modifiable factors at the provider and health system level. In addition, we will identify aids and barriers to integrating health equity as a measurable criterion for evaluating drug benefit designs and relevant contextual factors from the perspective of decision makers (e.g., employers, health plans, pharmacy benefit managers). If successful the proposed study has the potential to inform the design of drug benefits that simultaneously promote clinical effectiveness and equitable health care outcomes. Narrative Underuse of clinically effective medications among minority adults in midlife may contribute to racial and ethnic disparities in chronic disease related morbidity and mortality in late life. The primary objective of this competing renewal is to enhance our understanding of the relationship between out-of-pocket drug costs and disparities in adherence to evidence-based treatments in midlife and to inform the design of drug benefits that simultaneously promote clinical effectiveness and equitable health care outcomes.",Drug Benefit Design and Adherence Disparities in Older Adults,9990921,R56AG032249,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Elderly ', ' senior citizen ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Antidepressive Agents ', ' anti-depressive agents ', ' anti-depressants ', ' anti-depressant drugs ', ' anti-depressant agent ', ' Antidepressants ', ' Antidepressant Drugs ', ' Antidepressant Agent ', ' Antihypertensive Agents ', ' Hypotensives ', ' Hypotensive Drugs ', ' Hypotensive Agent ', ' Antihypertensives ', ' Antihypertensive Drugs ', ' Anti-Hypertensives ', ' Anti-Hypertensive Drugs ', ' Anti-Hypertensive Agents ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Deductibles ', ' diabetes ', ' Diabetes Mellitus ', ' Drug Design ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Goals ', ' Habits ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Lipids ', ' Literature ', ' Mail Order ', ' Medicaid ', ' Methods ', ' midlife ', ' middle aged ', ' mid-life ', ' mid life ', ' middle age ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Patients ', ' Drug Prescribing ', ' Drug Prescriptions ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Time ', ' Electronic Medical Record ', ' Computerized Medical Record ', ' Drug Costs ', ' Treatment outcome ', ' Cost Sharing ', ' base ', ' Clinical ', ' Ethnic Origin ', ' Ethnicity ', ' uptake ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Complex ', ' Source ', ' System ', ' contextual factors ', ' Application Context ', ' experience ', ' member ', ' racial difference ', ' race differences ', ' ethnic difference ', ' ethnicity difference ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Statistical Methods ', ' Provider ', ' Address ', ' Health system ', ' Adherence ', ' Measurable ', ' Cancer Patient ', ' trend ', ' medication compliance ', ' medication adherence ', ' drug compliance ', ' drug adherence ', ' Evidence based treatment ', ' cost ', ' pharmacy benefit ', ' design ', ' designing ', ' Minority ', ' Clinical effectiveness ', ' Natural experiment ', ' racial and ethnic disparities ', ' treatment adherence ', ' health equity ', ' treatment disparity ', ' disparities in treatment ', ' health care settings ', ' healthcare settings ', ' health plan ', ' health plans ', ' care outcomes ', ' healthcare outcomes ', ' health care outcomes ', ' cardiometabolism ', ' cardiometabolic ', ' ']",NIA,KAISER FOUNDATION RESEARCH INSTITUTE,R56,2019,736746,0.14161740542440357
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network PROJECT SUMMARY / ABSTRACT The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PROJECT NARRATIVE This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9905155,UG1DA015815,"['opiate overdose ', ' recruit ', ' primary care services ', ' health care settings ', ' healthcare settings ', ' treatment services ', ' methadone patient ', ' rural health disparities ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' American Indians ', ' American Indian ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Service area ', ' Health Catchment Area ', ' Health Service Area ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Educational aspects ', ' Education ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Naloxone ', ' Persons ', ' Oregon ', ' Patients ', ' Peer Review ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' Scientific Publication ', ' Publications ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Safety ', ' San Francisco ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Island Americans ', ' Pacific Islander American ', ' Pacific Islander ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' experience ', ' care delivery ', ' Participant ', ' prevention service ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' Clinical Treatment ', ' trial treatment ', ' trial regimen ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' design ', ' designing ', ' Hepatitis C Therapy ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' urban Native American ', ' urban Indian ', ' urban American Indian ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addiction ', ' addictive disorder ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' health care service ', ' healthcare service ', ' health service use ', ' health service utilization ', ' data resource ', ' rural healthcare ', ' rural health care ', ' rural Americans ', ' therapeutic candidate ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2019,129831,0.08578632686993468
"Biomarkers for Dysbiosis-Related HIV-Associated Cognitive Disorders among Persons Who Inject Drugs in Puerto Rico ABSTRACT The current opioid injection incidence in the United States has risen to epidemic levels and is associated with increased risk of HIV-1 transmission and disease progression as well as with other infections in several US states. Given that most HIV+ people who inject drugs (PWID) are now likely to receive anti-retroviral therapy, traditional bio-markers such as HIV viral load and CD4 counts are unlikely to provide a comprehensive assessment of disease progression especially as it affects neurocognitive performance. New biomarkers are needed to track the effects of ongoing HIV infection as it impacts neurocognitive functions. Candidate biomarkers can be found in the interaction between HIV infection, dysbiosis, microbial translocation and systematic inflammation. HIV-1 infection is associated with lymphoid depletion in tissues underlying the gut epithelium, allowing microbial products to transduce into the parenchyma where they act as potent inducers of systemic inflammation. Even when HIV-1 viral load is suppressed by anti-retroviral treatment, chronic immune activation resulting from dysbiosis and translocation can persist. Opioid use also induces gut dysbiosis and supports bacterial translocation. The resulting inappropriate immune activation in PWID may enhance HIV-1 replication, lead to premature aging of T cells, and promote HIV disease progression, including exacerbated HIV-associated neurological disorders (HAND). A more comprehensive set of markers is therefore needed to better understand the course of HIV infection among people who inject drugs (PWID)biomarkers that reflect the combined physiologic impact of ongoing injection drug use and a range of biomic changes that can exaggerate and reinforce the cumulative impact of physiological effects on mental health. The overall objective of our proposed study is to advance the understanding of the effects of HIV infection and injection drug use on the microbiome, with the goal of discovering biomarkers for neurological disease progression among PWID that are related to chronic inflammation and dysbiosis coupled inflammation. Our highly experienced research team will make use of a well-established cohort of PWID in Puerto Ricoa region with historically high levels of injection drug use and an HIV incidence rate that is disproportionately associated with drug use. A prospective, multi-cohort longitudinal study will allow repeated measures from the study population and compare them with similar measures from control groups of HIV negative PWID and HIV-1 infected non-drug users from the same location. This longitudinal evaluation will allow our team to test the hypothesis that HIV-1 infection in PWID intensifies dysbiosis and inflammation which, in turn, exacerbates HIV replication, HAND and HIV treatment failures. We expect that this hypothesis, if true, will have important implications for the emerging drug epidemic in remainder of the United States. In addition to meeting the goals of RFA 18-023, this project will contribute to NIDA and OBSSR's strategic plans for research that bridges pre-clinical and socio-behavioral research, and is responsive to the NIH-wide mandate of improving minority health and reducing health disparities in the United States. NARRATIVE Given the high numbers of new injectors emerging from the rising opioid epidemic, a more comprehensive set of biomarkers is needed to fully understand neurocognitive impacts of HIV infection in people who inject drugs (PWID) in the United States today. This project advances the search for novel biomarkers by examining the links between HIV infection, dysbiosis, microbial translocation, and systemic inflammation among HIV-1 infected PWID in Puerto Rico as these factors predict the neurocognitive disorders known as HAND (HIV-associated neurocognitive disorders). A prospective, multi-cohort longitudinal study will allow repeated measures from the study population and compare them with similar measures from control groups of HIV negative PWID and HIV- 1 infected non-drug users from the same location.",Biomarkers for Dysbiosis-Related HIV-Associated Cognitive Disorders among Persons Who Inject Drugs in Puerto Rico,9687938,R01DA047823,"['Affect ', ' cognitive syndrome ', ' cognitive disorder ', ' cognitive disease ', ' Cognition Disorders ', ' Control Groups ', ' depression ', ' Mental Depression ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Future ', ' Goals ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' HTLV-III Seronegativity ', ' HTLV-III Seronegativities ', ' HIV negative ', ' HIV Seronegativities ', ' HIV Seronegativity ', ' Human immunodeficiency virus 1 ', ' Human Immunodeficiency Virus Type 1 ', ' HIV1 ', ' HIV-I ', ' HIV-1 ', ' Incidence ', ' Infection ', ' Inflammation ', ' Kentucky ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maine ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Midwest US ', ' Midwest U.S. ', ' Midwest ', ' Midwestern United States ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Natural Disasters ', ' neurological disease ', ' Neurological Disorders ', ' Neurologic Disorders ', ' Nervous System Diseases ', ' nervous system disorder ', ' Ohio ', ' Public Health ', ' Puerto Rico ', ' Recurrent ', ' Recurrence ', ' Research ', ' Risk ', ' Sampling Studies ', ' sociobehavioral ', ' sociobehavior ', ' Social Behavior ', ' Substance Use Disorder ', ' thymus derived lymphocyte ', ' T-Cells ', ' T-Lymphocyte ', ' Testing ', ' Body Tissues ', ' Tissues ', ' United States ', ' West Virginia ', ' immunophenotype ', ' Immunologic Subtyping ', ' Immunophenotyping ', ' Measures ', ' Treatment Failure ', ' therapy failure ', ' base ', ' Blood specimen ', ' Blood Sample ', ' improved ', ' Site ', ' Chronic ', ' Physiological ', ' Physiologic ', ' Link ', ' Evaluation ', ' Premature aging syndrome ', ' Premature Aging ', ' wasting ', ' Cocaine Users ', ' Drug usage ', ' drug use ', ' Disease Progression ', ' CD4 Lymphocyte Count ', ' T4 Lymphocyte Count ', ' CD4+ Counts ', ' CD4+ Cell Counts ', ' Inflammation Mediators ', ' inflammatory mediator ', ' Bacterial Translocation ', ' Viral Load result ', ' Viral Load ', ' Viral Burden ', ' In Situ ', ' Location ', ' Neurocognitive ', ' Mood Disorders ', ' Affective Disorders ', ' Injecting drug user ', ' persons who inject drugs ', ' people who inject illicit drugs ', ' people who inject drugs ', ' PWID ', ' Injection Drug User ', ' meetings ', ' experience ', ' Performance ', ' success ', ' cohort ', ' microbial ', ' Predictive Factor ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' gastrointestinal epithelium ', ' Gut Epithelium ', ' disparity in health ', ' health disparity ', ' therapy adherence ', ' US State ', ' Geographic state ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Strategic Planning ', ' Lymphoid ', ' transmission process ', ' Transmission ', ' pre-clinical ', ' preclinical ', ' minority health ', ' microbiome ', ' Human Microbiome ', ' human-associated microbiome ', ' metagenome ', ' antiretroviral therapy ', ' antiretroviral treatment ', ' anti-retroviral treatment ', ' anti-retroviral therapy ', ' prospective ', ' Coupled ', ' drug of abuse ', ' drugs of abuse ', ' drugs abused ', ' drug abused ', ' abused drugs ', ' abused drug ', ' high risk ', ' candidate marker ', ' candidate biomarker ', ' novel marker ', ' novel biomarker ', ' new marker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' non-drug ', ' nondrug ', ' gut microbiota ', ' intestinal tract microflora ', ' intestinal microflora ', ' intestinal microbiota ', ' intestinal microbes ', ' intestinal flora ', ' gut microflora ', ' gut microbiotic ', ' gut microbial consortia ', ' gut microbial composition ', ' gut microbial community ', ' gut microbe community ', ' gut flora ', ' gut community ', ' gut commensal ', ' gastrointestinal microbial flora ', ' enteric microbiota ', ' enteric microbial community ', ' Gastrointestinal microbiota ', ' GI microbiota ', ' immune activation ', ' injection drug use ', ' HIV-associated neurocognitive disorder ', ' HIV-1 associated neurocognitive disorder ', ' HIV 1 associated neurocognitive disorder ', ' neurocognitive disorder ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' study population ', ' Longitudinal cohort ', ' Longterm cohort ', ' Long-term cohort ', ' Longitudinal cohort study ', ' Longterm cohort study ', ' Long-term cohort study ', ' opioid injection ', ' opioid injector ', ' opiate injection ', ' intravenous opioid ', ' intravenous opiate ', ' opioid epidemic ', ' opioid crisis ', ' opiate crisis ', ' recruit ', ' Injections ', ' Opioid user ', ' Opioid drug user ', ' Opiate user ', ' dysbiosis ', ' microbial imbalance ', ' dysbiotic ', ' dysbacteriosis ', ' Infrastructure ', ' ']",NIDA,UNIVERSITY OF NEBRASKA LINCOLN,R01,2019,619730,0.10432994445562922
"Couples-based intervention to reduce drug use and HIV transmission Project Summary YMSM in relationships with other men face unique and compounded risk factors for both drug use and HIV infection. Their vulnerability is unique from older MSM, unpartnered MSM and their heterosexual peers. This enhanced vulnerability emerges as exactly the developmental period when the establishment of romantic relationships emerges as salient. Despite their unique vulnerability for HIV infection and challenges related to drug use, there are very few couples- based intervention options for YMSM. There are presently no brief, couples-based interventions which integrate a focus on drug use and HIV prevention. The proposed study is geared toward the development of such an intervention. The only individually delivered intervention for YMSM to show significant reductions in both drug use and sexual HIV transmission risk behavior, the Young Mens Health Project (YMHP) was developed by members of this research team. YMHP focused on sexual risk in the context of casual partners. Beginning with this framework, our team has completed the initial stages of revising YMHP for use with couples, resulting in the creation of the Couples Health Project (CHP). Our formative work suggests that the prototype intervention is feasible and acceptable to participants. The next step is to develop components of the intervention which address pre- exposure prophylaxis (PrEP) uptake and to determine how best to integrate biological testing for STIs and drug use into the study. The new intervention will be informed by qualitative data gathered from intervention sessions delivered in our formative work and from qualitative interviews conducted with 20 HIV negative partnered YMSM. The final 28 months of the project are devoted to a randomized controlled trial (RCT) comparing CHP to an attention-matched educational control condition. The study team is led by Dr. Tyrel J. Starks (PI), a new investigator with substantial experience in the study of gay male couples. He has collaborated on numerous projects examining the nature of sexual agreements and their association with substance use and HIV transmission risk behavior. He is supported by a study team which includes Dr. Jeffrey Parsons, the PI of the original YMHP study. The team brings extensive experience in quantitative and qualitative data analysis, HIV prevention research, and specifically intervention development. Project Narrative  Public Health Significance HIV prevention strategies that address the specific needs of YMSM in stable relationships with other men are needed in response to accumulating evidence which points to the unique vulnerability of these men. The proposed project builds upon an effective individual intervention, the Young Mens Health Project, to develop a couples-based intervention which addresses drug use and sexual HIV transmission risk among partnered HIV negative YMSM (ages 18-29). Preliminary work by our research team has produced a prototype manual, and provided compelling evidence of feasibility and acceptability. The proposed project will revise this prototype manual to enhance the focus on pre-exposure prophylaxis (PrEP) and to incorporate biological testing for drug use and STIs into the study. During Phase II, a small randomized controlled trial (RCT) involving 50 couples will test the feasibility, acceptability, and preliminary efficacy of the new intervention relative to an attention-matched educational control.",Couples-based intervention to reduce drug use and HIV transmission,9647452,R34DA043422,"['Accounting ', ' Age ', ' ages ', ' Amphetamines ', ' dl-Amphetamine ', ' Phenopromin ', ' Phenamine ', ' Desoxynorephedrin ', ' Attention ', ' bedsonia ', ' Miyagawanella ', ' Chlamydia ', ' Communication ', ' Counseling ', ' Couples ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' facial ', ' faces ', ' Face ', ' Feedback ', ' Goals ', ' Gonococcal Infection ', ' Gonorrhea ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' HTLV-III Seronegativity ', ' HTLV-III Seronegativities ', ' HIV negative ', ' HIV Seronegativities ', ' HIV Seronegativity ', ' Incidence ', ' Infection ', ' Interview ', ' Joints ', ' Ketamine ', ' male ', ' Manuals ', ' marihuana ', ' Marijuana ', "" men's "", ' men ', ' Motivation ', ' NO3- ', ' Nitrates ', ' Public Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' Testing ', ' United States ', ' Work ', ' free base cocaine ', ' Crack Cocaine ', ' Latino ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' Methylenedioxymethamphetamine ', ' MDMA ', ' 3,4 methylenedioxymethamphetamine ', ' ecstasy ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS prevention ', ' base ', ' Phase ', ' Link ', ' Training ', ' Structure of nail of finger ', ' Fingernail ', ' Finger Nail ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Individual ', ' Drug usage ', ' drug use ', ' Gays ', ' uptake ', ' Anal Sex ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Couples Therapy ', ' Contracts ', ' Contracting Opportunities ', ' Nature ', ' Source ', ' experience ', ' 4-hydroxybutyric acid ', ' gamma-hydroxybutyric acid ', ' Structure ', ' skills ', ' Participant ', ' Prevention Research ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' prevention service ', ' peer ', ' member ', ' Agreement ', ' motivational enhancement therapy ', ' motivational interview ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' Sampling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' disparity in health ', ' health disparity ', ' HIV-2 test ', ' HIV-1 test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Address ', ' Adherence ', ' Biological Testing ', ' Data ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Update ', ' transmission process ', ' Transmission ', ' Preparation ', ' sex ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' Heterosexuals ', ' Behavioral ', ' men who have sex with men ', ' men who have sex with other men ', ' MSM ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' male health ', "" men's health "", ' trial comparing ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' prototype ', ' standard of care ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' follow up assessment ', ' followup assessment ', ' young man ', ' adolescent men ', ' adolescent man ', ' same-sex partnership ', ' same-sex couple ', ' same sex relationship ', ' same sex partner ', ' sexual HIV transmission ', ' young men who have sex with men ', ' young MSM ', ' YMSM ', ' efficacy study ', ' pre-exposure prophylaxis ', ' PrEP ', ' recruit ', ' ']",NIDA,HUNTER COLLEGE,R34,2019,148200,0.0832515560440776
"Frailty, HIV Infection, Injection Drug Use and the Inflammatory-Microbiome PROJECT SUMMARY/ABSTRACT With effective antiretroviral therapy (ART), life expectancy for HIV-infected persons has markedly improved, yet marked deficits in survival remain for HIV-infected persons with a history of injecting drugs (PWID). Disparities among PWID have been attributed in part to a shifting spectrum of disease to aging-associated conditions driven by persistent inflammation even with ART. Frailty is an important aging-related state of vulnerability to stress, with an increased burden in HIV infection, strongly associated with heightened inflammation, and predictive of premature mortality and aging-related morbidity among PWID. Injecting drugs itself can increase the severity of inflammation in HIV. The human gut microbial ecosystem (gut microbiome) critically regulates inflammation and immunity. Alterations in the gut microbiome (gut dysbiosis) together with associated disruptions of gut structure and immune integrity constitute an inflammatory-microbiome signature (gut dysbiosis, increased gut permeability, translocation of microbial products, immune activation, heightened inflammation) linked to adverse aging-associated inflammatory conditions and disease. Proposed is a systematic investigation of the role of HIV infection and injection drug use (IDU) in defining the inflammatory- microbiome signature and determination of the relationship of this signature to frailty. Through assessments of the fecal and mucosal microbiome in the AIDS Linked to the IntraVenous Experience (ALIVE) cohort of HIV- infected and epidemiologically comparable HIV-uninfected PWID, we will determine how HIV infection and active IDU alter microbiome composition and function and the relationship of these changes to inflammation and frailty progression over time. Using a germ free murine model, we will further define the frail human microbial communities and gene products that precipitate inflammation. These studies will facilitate elucidation of gut microbial determinants of frailty among HIV-infected PWID and could significantly inform microbiota modulation strategies to reduce frailty-associated inflammation beyond ART. Understanding the role of the gut microbiome in relation to HIV, injection drug use, and frailty remains a critical next step to reducing the marked disparities in clinical outcomes among HIV-infected PWID. PROJECT NARRATIVE Persons co-impacted by HIV infection and drug use are living longer with effective antiretroviral therapy, but many still die much earlier and experience a heavy burden of frailty and age-related disease. We seek to understand how microbes in the gut may be linked to inflammation, how this process may be impacted by HIV and injection drug use, and how these factors may contribute to age-related diseases or frailty. Knowledge gained from these studies could inform development of effective strategies to improve survival and quality of life for persons aging with HIV infection and drug use.","Frailty, HIV Infection, Injection Drug Use and the Inflammatory-Microbiome",9789154,R01AG060825,"['Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Age ', ' ages ', ' Aging ', ' Alcohols ', ' Alcohol Chemical Class ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Motility ', ' Cellular Motility ', ' Cellular Migration ', ' Cell Movement ', ' Cell Migration ', ' Cell Locomotion ', ' cell motility ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Cocaine ', ' Colon ', ' Communities ', ' Death ', ' Cessation of life ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' dietary ', ' Diet ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Gene Pool ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Physiological Homeostasis ', ' Autoregulation ', ' Homeostasis ', ' Hospital Admission ', ' Hospitalization ', ' Modern Man ', ' Human ', ' Immunity ', ' Inflammation ', ' Institutionalization ', ' Life Expectancy ', ' liver disorder ', ' hepatopathy ', ' hepatic disease ', ' Hepatic Disorder ', ' Liver diseases ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Mucosal Tissue ', ' Mucosa ', ' Mucous Membrane ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Persons ', ' Phenotype ', ' Public Health ', ' QOL ', ' Quality of life ', ' Risk ', ' rRNA ', ' Ribosomal RNA ', ' social role ', ' Role ', ' Stress ', ' Syndrome ', ' Testing ', ' Time ', ' Tobacco ', ' transplant ', ' Transplantation ', ' virology ', ' Work ', ' Mediating ', ' Ecosystem ', ' Ecological Systems ', ' Ecologic Systems ', ' improved ', ' Clinical ', ' Physiological ', ' Physiologic ', ' Link ', ' Premature aging syndrome ', ' Premature Aging ', ' Recovery ', ' Premature Mortality ', ' Drug usage ', ' drug use ', ' Sample Size ', ' CD4 Lymphocyte Count ', ' T4 Lymphocyte Count ', ' CD4+ Counts ', ' CD4+ Cell Counts ', ' Inflammatory ', ' Intravenous ', ' Knowledge ', ' frailty ', ' Investigation ', ' Immune ', ' Immunes ', ' Severities ', ' Pattern ', ' Probiotics ', ' Mood Disorders ', ' Affective Disorders ', ' Injecting drug user ', ' persons who inject drugs ', ' people who inject illicit drugs ', ' people who inject drugs ', ' PWID ', ' Injection Drug User ', ' early experience ', ' experience ', ' cohort ', ' microbial ', ' Structure ', ' novel ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Metabolic Pathway ', ' preventing ', ' prevent ', ' Data ', ' Inflammation Process ', ' Multicellular Inflammation Process ', ' Germ-Free ', ' sex ', ' Development ', ' developmental ', ' microbiome ', ' metagenome ', ' antiretroviral therapy ', ' antiretroviral treatment ', ' anti-retroviral treatment ', ' anti-retroviral therapy ', ' age related ', ' age dependent ', ' Minority ', ' Outcome ', ' Population ', ' Microbe ', ' mouse model ', ' murine model ', ' healthy aging ', ' immune activation ', ' injection drug use ', ' gut microbiome ', ' intestinal microbiome ', ' intestinal biome ', ' gut-associated microbiome ', ' gastrointestinal microbiome ', ' enteric microbiome ', ' digestive tract microbiome ', ' GI microbiome ', ' fecal transplantation ', ' fecal transplant ', ' fecal microbiota transplantation ', ' fecal microbiota transplant ', ' fecal microbiome transplantation ', ' fecal microbial transplantation ', ' microbiota ', ' multispecies consortia ', ' microflora ', ' microbial flora ', ' microbial consortia ', ' gene product ', ' disparity reduction ', ' reduce disparity ', ' Injections ', ' human microbiota ', ' human-associated microbiota ', ' human-associated microbial communities ', ' human microflora ', ' human microbial communities ', ' human flora ', ' microbiome research ', ' microbiome studies ', ' microbiome science ', ' Microbiomics ', ' Gut Mucosa ', ' dysbiosis ', ' microbial imbalance ', ' dysbiotic ', ' dysbacteriosis ', ' fecal microbiome ', ' stool-associated microbiome ', ' stool microbiome ', ' Intestinal permeability ', ' Intestinal Hyperpermeability ', ' Intestinal Epithelial Permeability ', ' Gut permeability ', ' Gut Hyperpermeability ', ' Gut Epithelial Permeability ', ' microbiome composition ', ' microbiome species composition ', ' microbiome community composition ', ' microbiome alteration ', ' microbiome perturbation ', ' microbiome adaptation ', ' alter microbiome ', ' neural network ', ' ']",NIA,JOHNS HOPKINS UNIVERSITY,R01,2019,684522,0.09583144688895012
"Y2Prevent: Preventing Drug Use and HIV through Empowerment, Social Support and Mentorship ABSTRACT African Americans represent only 14% of the population, but account for 44% of all new HIV infections reported yearly. The situation is particularly grave for Black/African American young men who have sex with men (AAYMSM), with seroprevalence rates of 19% for ages 15-22 and 26% for ages 23-29 among AAYMSM. These health outcomes are influenced by important social and structural factors, including violence and victimization, homophobia, discrimination, institutional racism, and economic and social marginalization. These experiences are significantly associated with illicit drug use, alcohol misuse, transactional sex work, and HIV risk behaviors. In response to this crisis, we are proposing to create a new theoretically driven, youth- centered intervention designed to build the capacity of AAYMSM to overcome these barriers to health. With this revised R34 application, we propose to further refine and pilot test an intervention, called Young Men's Adult Identity Mentoring (YM-AIM). Adapted from an existing CDC Diffusing Effective Behavioral Intervention, YM-AIM is a theory-driven, group-level intervention designed to help AAYMSM develop a healthy vision for their future (or possible future self) by defining a set of short- and long-term goals in the areas of education, health, family and intimate relationships. We propose to further strengthen and refine YM-AIM by adding a youth mentoring/support component, called Youth Initiated Mentoring (YIM). YIM uses a positive youth development framework to: a) build social capital to achieve immediate and long-term goals, b) build social support, c) identify and engage natural mentors in one's networks to address structural barriers, and d) develop relationships with supportive adults. We will integrate these two models into a single intervention called Y2Prevent. We will then work to further adapt, tailor, and evaluate Y2Prevent as an intervention to reduce illicit drug use and HIV/STI risk among AAYMSM. This intervention will emphasize: a) biomedical HIV prevention strategies for primary prevention, b) HIV/STI testing and treatment referral, c) drug screening and treatment referral, and d) positive youth development and future planning. We will conduct formative research to inform the adaptation/tailoring followed by a piloting of the new intervention to assess the feasibility, acceptability, and the preliminary efficacy. Our proposed positive youth development and resilience theory provide a strong, innovative framework for examining how AAYMSM with significant exposure to syndemic health and social disparities respond to engagement with prevention and treatment resources. The proposed intervention is intended to promote resilience, build social skills and assets among AAYMSM to help them recognize and overcome individual, social and structural barriers leading to risk, and adopt and maintain protective behaviors, such as safer sex, PrEP/PEP use, HIV/STI testing and healthcare utilization. The findings will inform the development of an R01 application that will propose a larger-scale, multi-city efficacy trail in a subsequent R01 application. PROJECT NARRATIVE Today there is a generation of African American/Black young men who have sex with men (AAYMSM) who are at exceedingly high risk for a wide range of adverse health outcomes, including tobacco, alcohol and illicit drug addiction, sexually transmitted infections (STIs), HIV/AIDS, and mental health disorders. Often, these young men experience multiple forms of discrimination (racism, homophobia) in multiple settings (home, school, neighborhood, workplace), with limited social support to buffer against these threats. In response, we propose to further refine and pilot test a theory-driven, evidence-based group-level intervention designed to help AAYMSM develop a healthy vision for their future (or possible future self) by defining a set of short- and long- term goals in the areas of education, health, family and intimate relationships using facilitated activities -- participants are asked to consider how their involvement in risky behaviors (e.g., illicit drug use, condomless sex, multiple sex partners) would interfere with achieving those goals.","Y2Prevent: Preventing Drug Use and HIV through Empowerment, Social Support and Mentorship",9757740,R34DA044106,"['Accounting ', ' Adolescence ', ' adolescence (12-20) ', ' 12-20 years old ', ' Adoption ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Aggressive behavior ', ' Aggression ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohols ', ' Alcohol Chemical Class ', ' Behavior ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Buffers ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Cities ', ' Communities ', ' depression ', ' Mental Depression ', ' Diagnosis ', ' Cognitive Discrimination ', ' Discrimination ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' Economics ', ' Educational aspects ', ' Education ', ' Exercise ', ' Family ', ' Feedback ', ' Future ', ' Goals ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Incidence ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Literature ', ' Maintenance ', ' Manuals ', "" men's "", ' men ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Mentors ', ' Mentorship ', ' Neighborhoods ', ' Primary Prevention ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' Schools ', ' sex partner ', ' Sexual Partners ', ' Venereal Infections ', ' Venereal Disorders ', ' Venereal Diseases ', ' Sexually Transmitted Infection ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Diseases ', ' social support network ', ' Social support ', ' Stress ', ' Testing ', ' Tobacco ', ' visual function ', ' Sight ', ' Vision ', ' white race ', ' Occidental ', ' Caucasoid Race ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Caucasians ', ' Work ', ' Generations ', ' Measures ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Illicit Drugs ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Latino ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS prevention ', ' Caring ', ' Intention ', ' Workplace ', ' work setting ', ' Worksite ', ' Work-Site ', ' Work Place ', ' Work Location ', ' Job Site ', ' Job Setting ', ' Job Place ', ' Job Location ', ' base ', ' improved ', ' Area ', ' Diffuse ', ' racism ', ' Individual ', ' health care service utilization ', ' healthcare utilization ', ' healthcare service utilization ', ' healthcare service use ', ' health care service use ', ' Health Care Utilization ', ' young adult ', ' young adulthood ', ' adult youth ', ' satisfaction ', ' Drug usage ', ' drug use ', ' Early Intervention ', ' Funding ', ' Anal Sex ', ' Exposure to ', ' Knowledge ', ' Life ', ' programs ', ' Adopted ', ' Frequencies ', ' Home environment ', ' Home ', ' Protocols documentation ', ' Protocol ', ' Unsafe Sex ', ' unprotected intercourse ', ' condomless sex ', ' condomless intercourse ', ' Unprotected Sex ', ' High-Risk Sex ', ' inner city ', ' experience ', ' Performance ', ' success ', ' Safe Sex ', ' safer sexual behavior ', ' safer sex ', ' Responsible sexual behavior ', ' Responsible Sex ', ' Protected Sex ', ' Seroprevalences ', ' Self Efficacy ', ' condoms ', ' Structure ', ' skills ', ' novel ', ' Participant ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' empowerment ', ' member ', ' NIH Program Announcements ', ' Program Announcement ', ' social skills ', ' social competency ', ' social competence ', ' interpersonal competency ', ' interpersonal competence ', ' Prevention ', ' Reporting ', ' social ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' HIV risk ', ' positive youth development ', ' Modeling ', ' response ', ' theories ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' disparity in health ', ' health disparity ', ' HIV-2 test ', ' HIV-1 test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Low income ', ' Address ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' social capital ', ' Consent ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' trend ', ' sex ', ' Development ', ' developmental ', ' Minority ', ' protective behavior ', ' resilience ', ' Outcome ', ' social disparities ', ' alcohol misuse ', ' unhealthy alcohol use ', ' ethanol misuse ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' racial and ethnic ', ' therapy design ', ' treatment design ', ' intervention design ', ' high risk ', ' evidence base ', ' operation ', ' young man ', ' adolescent men ', ' adolescent man ', ' sexual minority ', ' Homophobia ', ' Homophobic ', ' young men who have sex with men ', ' young MSM ', ' YMSM ', ' social exclusion ', ' marginalization ', ' violence victimization ', ' illicit drug use ', ' racial minority ', ' pre-exposure prophylaxis ', ' PrEP ', ' Drug Screening ', ' violence exposure ', ' exposure to violence ', ' sexual risk behavior ', ' sex risk behavior ', ' infection risk ', ' ']",NIDA,CHILDREN'S HOSPITAL OF LOS ANGELES,R34,2019,256049,0.0535610043731097
"Effects of State-Level Policy Implementation on Opiate Abuse and Mortality Project Summary States have responded to the current opiate crisis through implementing several different types of policies, such as prescription drug monitoring programs (PDMPs), expanded naloxone access, and Good Samaritan immunity. At present, the full efficacy of each of these policies is unknown beyond examinations of a limited set of policies, localities, or years. This research study will use causal statistical methods and a robust policy database to examine the impact of relevant policies on opiate use, dependence, and fatal overdose from 1999 to the present. For policy data, we will employ the new and as yet underutilized NIDA-funded Prescription Drug Abuse Policy System (PDAPS) to evaluate the effects of opiate relevant policies. We will accomplish this goal by coding this database by state and year and combining it with mortality data from the Center of Disease Control and data on use and dependence from the National Survey on Drug Use and Health, as well as time- varying control measures from the U.S. Census Bureau and FBI Uniform Crime Reports. We will analyze this dataset using fixed effects and difference-in-difference models, which are causal methods for observational data well-known for the elimination of unobserved heterogeneity, such that estimators are robust to any observable or unobservable time-invariant omitted variables. The fixed effects and difference-in-difference approaches respectively provide a causal interpretation of (a) whether a given state experiences a decrease in opiate outcomes after passing a particular policy, and (b) whether a state that passes a policy experiences a decrease in opiate outcomes relative to a state that does not have that policy. The PDAPS database contains detailed policy information (e.g. to whom practitioners can prescribe naloxone, who has access to PDMPs), such that we can determine which of the nuanced approaches to these policies are most efficacious. We will examine whether each policy component affects use, dependence, and fatal overdose for opiates generally as well as separately for prescription opiates and heroin. In addition, we will test for synergistic effects of policy; that is, whether the combination of any given policies is particularly effective. Finally, we will conduct these analyses by key demographics: gender, race/ethnicity, age, and urbanicity, which will permit the identification of related health disparities. Our proposed exploratory research provides an opportunity to test the impact of a rapidly evolving policy landscape on opiate outcomes and will contribute in additional ways. First, if certain policies or combinations of policies are identified as efficacious, the results would provide evidence for broader adoption to curb the current opiate crisis. Second, the identification of possible health disparities in the benefits of policy implementation may not only help public health professionals to work towards redressing these disparities, but also identify policies that may bypass social inequalities to provide comprehensive benefits to citizens. Finally, this exploratory study establishes a foundation for future research that will consider local policy variation, individual-level policy-driven changes, and non-fatal overdose. Project Narrative An unprecedented opiate crisis has emerged over the past decade in the U.S., and state governments have responded by implementing numerous policies to disrupt this trend. This study uses fixed effects modeling to determine which opiate-related policies have been effective in curbing opiate use, dependence, and fatal overdose by combining state-level data from the Center for Disease Control, the National Survey on Drug Use and Health, and the new NIDA-funded Prescription Drug Abuse Policy System, which identifies policies related to naloxone access, prescription drug monitoring programs, Good Samaritan immunity, and medical marijuana. By examining the independent and interactive effects of policies, along with analyses of their effects by key demographic characteristics, this project has the potential to improve morbidity and mortality related to the opiate crisis as well as address health disparities related to this issue.",Effects of State-Level Policy Implementation on Opiate Abuse and Mortality,9701954,R21DA046447,"['Adoption ', ' Affect ', ' Censuses ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Crime ', ' relational database management systems ', ' database systems ', ' Data Base Management Systems ', ' Database Management Systems ', ' Demographic Factors ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Foundations ', ' Goals ', ' Health ', ' Heterogeneity ', ' Immunity ', ' Methods ', ' Methodology ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Naloxone ', ' opioid drug abuse ', ' opiate drug abuse ', ' opiate abuse ', ' opioid abuse ', ' Overdose ', ' Drug Prescribing ', ' Drug Prescriptions ', ' Public Health ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Societies ', ' Provincial Government ', ' State Government ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Work ', ' Gender ', ' Measures ', ' Dataset ', ' Data Set ', ' Guidelines ', ' improved ', ' Variant ', ' Variation ', ' Link ', ' Evaluation ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Individual ', ' Databases ', ' data base ', ' Data Bases ', ' Opioid ', ' Opiates ', ' Policies ', ' Drug usage ', ' drug use ', ' Pain Clinics ', ' Pain Relief Units ', ' Pain Centers ', ' Funding ', ' Ethnic Origin ', ' Ethnicity ', ' Dependence ', ' System ', ' misuse of prescription only drugs ', ' prescription misuse ', ' prescription drug misuse ', ' nonmedical prescription drug use ', ' non-medical prescription drug use ', ' Prescription medication misuse ', ' American ', ' experience ', ' social inequality ', ' research study ', ' Reporting ', ' Bypass ', ' prescription drug abuse ', ' prescription medication abuse ', ' Code ', ' Coding System ', ' Statistical Methods ', ' Regulation ', ' Modeling ', ' response ', ' mathematical model ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' disparity in health ', ' health disparity ', ' Address ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' trend ', ' Characteristics ', ' Health Professional ', ' Healthcare professional ', ' Health Care Professional ', ' Outcome ', ' demographics ', ' prescription opioid ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' Medical Marijuana ', ' medicinal cannabis ', ' medical cannabis ', ' Medicinal Marijuana ', ' improved outcome ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' Time trend ', ' Trends over time ', ' Temporal trend ', ' opioid epidemic ', ' opioid crisis ', ' opiate crisis ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid mortality ', ' opioid related death ', ' opioid overdose death ', ' opioid deaths ', ' opiate mortality ', ' opiate deaths ', ' heroin use ', ' heroin intake ', ' prescription monitoring program ', ' Prescription Drug Monitoring Program ', ' prescription opioid misuse ', ' prescription opiate misuse ', ' opioid prescription medication misuse ', ' opioid medication misuse ', ' opioid analgesic misuse ', ' nonmedical use of prescription opioids ', ' nonmedical use of prescription opiates ', ' non-medical use of prescription opioids ', ' non-medical use of prescription opiates ', ' ']",NIDA,OHIO STATE UNIVERSITY,R21,2019,190468,0.1321423894795368
"Cohort Studies on HIV/AIDS and Substance Abuse in Miami     DESCRIPTION (provided by applicant): Liver disease is a major cause of death in HIV infected persons in the United States. While advances in antiretroviral therapy have significantly reduced HIV-related mortality, co-infection with hepatitis C virus (HCV), is widespread and accelerates progression of liver fibrosis to cirrhosis and liver carcinoma. In addition, substance abuse accelerates HIV disease, and may facilitate progression of liver fibrosis. The primary goal of this proposal is to continue to follow the existing Miami Adult Studies on HIV (MASH) cohort, its specimen repository and database, and expand it from the current 881 to 1,500 study participants. The purpose is to generate collaborative studies to investigate the impact of cocaine, by far the most prevalent drug of abuse in South Florida, on HIV infection, HIV/HCV co-infection, and on long-term morbidity with a focus on liver disease in this population with disparities in access to care. HIV and HCV un-infected cocaine users and non-users will also be recruited to allow determination of the impact of cocaine use alone, as well as the interaction of cocaine use with HIV, HCV, and HIV/HCV co-infection. As new and more effective treatments and access to care for HIV, HCV and drug abuse become available, maintaining a well- characterized cohort, specimen repository and database will create a strong resource platform for current and future collaborative research. Observing the uptake of new HCV treatments and potential new cocaine cessation programs in this at-risk population with health disparities will provide data on barriers and facilitators to effective treatments to prevent long-term morbidity and mortality. We have followed the MASH cohort of 881 participants for up to 12 years with excellent retention rates, and have created a specimen repository and a database. The MASH cohort in Miami is unique because it will be a mostly Hispanic cohort with a large number of African Americans, women, non-injector drug users, with predominantly heterosexual HIV- transmission etiology. We propose to (1) compare the progression of liver fibrosis over four years among cocaine users and non-users in HIV+/HCV-, HIV+/HCV+, HIV-/HCV+, and HIV-/HCV-, using a novel non- invasive diagnostic device, the Magnetic Resonance Elastography (MRE). We also propose to (2) compare the pattern over four years of biomarkers and identify genetic markers associated with the mechanisms of liver fibrosis among cocaine users and non-users. Understanding the role of cocaine use in the context of HIV and HIV/HCV co-infections and lack of lasting effects of treatments for cocaine use cessation are crucial in order to gain insights into the pathogenesis and disease outcomes, and to provide the basis for identifying antifibrotic therapies such as oxidative stress, which are amenable to intervention. These studies will be critical for program development, appropriate interventions, and for improving health in this population. PUBLIC HEALTH RELEVANCE: Understanding the role of cocaine use in the context of HIV, HCV and HIV/HCV co-infections with focus on progression of liver fibrosis, is crucial in gaining insights into the disease pathogenesis, outcomes, and the role of co-morbidities and health disparities of this population. This research will provide evidence-based information for program development and evaluation, appropriate and effective interventions, and for improving health in this population.",Cohort Studies on HIV/AIDS and Substance Abuse in Miami,9698922,U01DA040381,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Alcohols ', ' Alcohol Chemical Class ', ' Animals ', ' Cause of Death ', ' Cocaine ', ' Cocaine Abuse ', ' Concurrent Studies ', ' Cohort Studies ', ' co-morbidity ', ' Comorbidity ', ' Death ', ' Cessation of life ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Florida ', ' Future ', ' genetic biomarker ', ' Genetic Markers ', ' Goals ', ' Health ', ' treatment access ', ' service availability ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' liver carcinoma ', ' Liver Cells Carcinoma ', ' Hepatoma ', ' Hepatocellular cancer ', ' Hepatocellular Carcinoma ', ' Hepatocarcinoma ', ' Primary carcinoma of the liver cells ', ' History ', ' Recording of previous events ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Human T-Lymphotropic Virus Type III Infections ', ' HTLV-III-LAV Infections ', ' HTLV-III Infections ', ' HIV Infections ', ' Modern Man ', ' Human ', ' Immunity ', ' immune suppression ', ' Immunosuppressive Effect ', ' Immunosuppression Effect ', ' Immunosuppression ', ' In Vitro ', ' Laboratories ', ' liver disorder ', ' hepatopathy ', ' hepatic disease ', ' Hepatic Disorder ', ' Liver diseases ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Program Development ', ' Program Evaluation ', ' QOL ', ' Quality of life ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Research Resources ', ' Resources ', ' Risk Factors ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' United States ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Virus Diseases ', ' Woman ', ' cytokine ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Malnutrition ', ' nutritional deficiency disorder ', ' nutrition deficiency disorder ', ' nutrition deficiency ', ' malnourished ', ' dietary deficiency ', ' Undernutrition ', ' Nutritional Deficiency ', ' Treatment Failure ', ' therapy failure ', ' improved ', ' Area ', ' Clinical ', ' Animal Experiments ', ' insight ', ' Stimulus ', ' Cocaine Users ', ' Liver Fibrosis ', ' hepatic fibrosis ', ' fibrotic liver ', ' Databases ', ' data base ', ' Data Bases ', ' Populations at Risk ', ' Oxidative Stress ', ' Funding ', ' uptake ', ' noninvasive diagnosis ', ' noninvasive diagnostic ', ' non-invasive diagnostic ', ' non-invasive diagnosis ', ' Metabolic ', ' chronic liver disease ', ' chronic liver disorder ', ' chronic hepatic disorder ', ' chronic hepatic disease ', ' Diagnostic ', ' Nature ', ' Specimen ', ' Research Specimen ', ' programs ', ' Pattern ', ' interest ', ' fibrogenesis ', ' cohort ', ' Disease Outcome ', ' novel ', ' Participant ', ' Devices ', ' Pathogenesis ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' repository ', ' time interval ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' disparity in health ', ' health disparity ', ' preventing ', ' prevent ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Data ', ' Prognostic Factor ', ' Prognostic/Survival Factor ', ' General Prognostic Factor ', ' Magnetic Resonance Elastography ', ' transmission process ', ' Transmission ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Heterosexuals ', ' Behavioral ', ' Cirrhosis ', ' cirrhotic ', ' antiretroviral therapy ', ' antiretroviral treatment ', ' anti-retroviral treatment ', ' anti-retroviral therapy ', ' Hepatitis C Therapy ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' Outcome ', ' Population ', ' prospective ', ' treatment effect ', ' drug of abuse ', ' drugs of abuse ', ' drugs abused ', ' drug abused ', ' abused drugs ', ' abused drug ', ' public health relevance ', ' effective intervention ', ' evidence base ', ' FDA approved ', ' effective therapy ', ' effective treatment ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' cocaine use ', ' co-infection ', ' coinfection ', ' retention rate ', ' student retention ', ' retention strategy ', ' HIV/HCV ', ' HIV/Hepatitis C ', ' HIV-HCV ', ' HIV and hepatitis C ', ' HIV and HCV ', ' HCV/HIV ', ' Hepatitis C co-infection ', ' hepatitis C virus coinfection ', ' hepatitis C virus co-infection ', ' hepatitis C coinfection ', ' HCV coinfection ', ' HCV co-infection ', ' liver development ', ' health care availability ', ' healthcare service availability ', ' healthcare service access ', ' healthcare availability ', ' healthcare accessibility ', ' healthcare access ', ' health care service availability ', ' health care service access ', ' health care access ', ' accessibility to healthcare ', ' accessibility to health care ', ' accessibility of health care ', ' access to healthcare ', ' access to health care ', ' Hepatitis C virus ', ' HCV ', ' recruit ', ' sociodemographics ', ' socio-demographics ', ' ']",NIDA,FLORIDA INTERNATIONAL UNIVERSITY,U01,2019,1116953,0.03301287487101885
"Reducing Black Men's Drug Use and Co-Occurring Negative Mental and Physical Health Outcomes: Intersectionality, Social-Structural Stressors, and Protective Factors PROJECT SUMMARY/ABSTRACT Health inequities among Black men in the U.S. are stark. Drug use contributes to six of the top ten leading causes of death among Black men ages 18 to 54. Social-structural stressors such as discrimination, based on race or race and sexual identity, and drug use to cope with stress, are well-documented pathways to drug use among Black adults. Empirical evidence that drug use co-occurs with other negative health outcomes underscores an urgent public health need to examine drug use and other co-occurring negative health outcomes associated with social-structural stressors. Single-axis perspectiveseither race or sexual identity dominate drug use and health disparities research. Apart from HIV/AIDS research, research on the effects of social-structural stressors on Black mens drug use and co-occurring negative health outcomes at the intersection of sexual identity (i.e., heterosexual, sexual minority) and socioeconomic position (SEP) is virtually nonexistent. Critical gaps also exist about how protective factors (e.g., resilience, religiosity, positive racial/sexual identity) influence the effects of social-structural stressors on Black mens drug use and co- occurring negative health outcomes. To address these critical gaps, a longitudinal cross-lagged explanatory- sequential (QUANTqual) mixed methods study is proposed to test, via structural equation modeling, a conceptual model of social-structural stressors, protective factors, and drug use (alcohol, marijuana, nicotine, illicit drug use) and co-occurring negative mental (e.g., psychological distress) and physical (e.g., blood pressure) health outcomes among Black men at the intersection of sexual identity and SEP. Purposive quota sampling will be used to recruit 960 Black men, ages 18-54, stratified by sexual identity and SEP (240/group) in Washington, DC. Phase I includes the collection of self-reported social-structural stressors, protective factors, drug use, and mental health data, and objective drug use (i.e., urine toxicology) and physical health (e.g., blood pressure) data at Time 1, and 3 months later at Time 2 (Aims 1, 2). Blood samples will be collected at Time 2 only to assess cardiovascular disease biomarkers (e.g., total cholesterol). Phase II includes 4 focus groups with 6-8 Phase I participants (total n = 24 to 32) purposively sampled to explain Phase I results (Aim 3). Phase III involves a synthesis and validity assessment of the quantitative and qualitative results (Aim 3). The proposed research uses intersectionality, social-structural stress, and resilience theoretical frameworks to advance new and important knowledge about the extent to which social-structural stressors and protective factors influence drug use and co-occurring negative health outcomes among Black men at the intersection of sexual identity and SEP. This intersectional focus represents a paradigmatic shift from conventional single-axis and one-size-fits-all intervention approaches. The significance of the proposed research lies in the expected outcome of the future development of multi-level (i.e., individual and social-structural) interventions to reduce drug use and promote mental and physical health among Black men at different intersectional positions of risk. PROJECT NARRATIVE The proposed explanatory-sequential (QUANTqual) mixed-methods longitudinal cross-lagged study is relevant to public health because, in alignment with the NIDA Epidemiology Research Branchs mission, it advances new knowledge about the effects of social-structural stressors and protective factors on drug use and co-occurring negative mental and physical health outcomes for Black men at the intersection of sexual identity and socioeconomic position (SEP). A significant benefit of the proposed research is that it will have broad translational importance for future health disparities research and interventions designed to reduce drug use and health disparities among and between populations at multiple marginalized intersectional positions (e.g., race, gender, sexual identity, and SEP). The project advances new horizons about the effects of intersectional positions and related social-structural stressors and protective factors on drug use and co- occurring negative mental and physical health outcomes that conventional single-axis (e.g., either race or sexual identity) approaches obscure.","Reducing Black Men's Drug Use and Co-Occurring Negative Mental and Physical Health Outcomes: Intersectionality, Social-Structural Stressors, and Protective Factors",9731450,R01DA045773,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Age ', ' ages ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohols ', ' Alcohol Chemical Class ', ' Blood Pressure ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cause of Death ', ' Cholesterol ', ' Cognitive Discrimination ', ' Discrimination ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Focus Groups ', ' Future ', ' Health ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heart Diseases ', ' Homicide ', ' marihuana ', ' Marijuana ', "" men's "", ' men ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Mission ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Nicotine ', ' Political Factor ', ' Public Health ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Research Support ', ' Risk ', ' Stress ', ' suicidality ', ' intent to die ', ' fatal suicide ', ' fatal attempt ', ' Suicide ', ' Testing ', ' Time ', ' Toxicology ', ' Urine Urinary System ', ' Urine ', ' Washington ', ' Gender ', ' Police ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' Unintentional Injury ', ' Accidental Injury ', ' base ', ' Bisexual ', ' Bi-sexual ', ' Blood specimen ', ' Blood Sample ', ' Area ', ' Imprisonment ', ' incarceration ', ' incarcerated ', ' Phase ', ' Economic Factors ', ' Economical Factors ', ' Psyche structure ', ' mental ', ' Individual ', ' Inequality ', ' Drug usage ', ' drug use ', ' Gays ', ' Knowledge ', ' Dependence ', ' Pattern ', ' physical conditioning ', ' physical health ', ' Equation ', ' experience ', ' stressor ', ' Structure ', ' Participant ', ' Patient Self-Report ', ' Self-Report ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Social status ', ' social standing ', ' social position ', ' epidemiology study ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Studies ', ' Epidemiologic Research ', ' Reporting ', ' social ', ' Positioning Attribute ', ' Position ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' psychological distress ', ' Modeling ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' disparity in health ', ' health disparity ', ' low socioeconomic position ', ' low socio-economic status ', ' low socio-economic position ', ' low SES ', ' low socioeconomic status ', ' Address ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Collection ', ' Process ', ' Development ', ' developmental ', ' Heterosexuals ', ' Pathway interactions ', ' pathway ', ' men who have sex with men ', ' men who have sex with other men ', ' MSM ', ' virtual ', ' resilience ', ' Outcome ', ' stress resilience ', ' Population ', ' male health ', "" men's health "", ' multidisciplinary ', ' therapy design ', ' treatment design ', ' intervention design ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' sexual minority ', ' health data ', ' illicit drug use ', ' racial identity ', ' intersectionality ', ' recruit ', ' protective factors ', ' sexual identity ', ' ']",NIDA,GEORGE WASHINGTON UNIVERSITY,R01,2019,638616,0.10473788718971687
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network     DESCRIPTION:  The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PUBLIC HEALTH RELEVANCE: This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9951612,UG1DA015815,"['Public Health ', ' Scientific Publication ', ' Publications ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Safety ', ' San Francisco ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Island Americans ', ' Pacific Islander American ', ' Pacific Islander ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' experience ', ' care delivery ', ' Participant ', ' prevention service ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' Clinical Treatment ', ' trial treatment ', ' trial regimen ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' design ', ' designing ', ' Hepatitis C Therapy ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' urban Native American ', ' urban Indian ', ' urban American Indian ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addiction ', ' addictive disorder ', ' public health relevance ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' health care service ', ' healthcare service ', ' health service use ', ' health service utilization ', ' data resource ', ' rural healthcare ', ' rural health care ', ' rural Americans ', ' therapeutic candidate ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' recruit ', ' primary care services ', ' health care settings ', ' healthcare settings ', ' treatment services ', ' methadone patient ', ' rural health disparities ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' American Indians ', ' American Indian ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Service area ', ' Health Catchment Area ', ' Health Service Area ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Educational aspects ', ' Education ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Naloxone ', ' Persons ', ' Oregon ', ' Patients ', ' Peer Review ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2019,36702,0.08695097140668363
"Western States Node of the National Drug Abuse Treatment Clinical Trials Network PROJECT SUMMARY / ABSTRACT The Western States (WS) Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) promotes evidence-based drug abuse prevention and treatment services through continued participation in the CTN. The Node 1) designs and implements clinical trials of evidence-based treatments of addiction through rapid recruitment of diverse study participants in partnership with NIDA and the CTN, 2) generates peer-reviewed publications in collaboration with treatment providers and other nodes, and 3) uses the CTN as a platform for training, dissemination, and research applications. The Regional Research and Training Center includes talented faculty and staff from Oregon Health & Science Center and University of California, San Francisco as well as leaders of affiliated healthcare partners providing integrated primary care and substance use disorder treatment. The Node was created in 2010 as an amalgam of two CTN Nodes--California-Arizona and Oregon/Hawaii (a charter member of the CTN). The Node was highly successful, during the current award, participating in 10 CTN trials, co-leading two of these and leading one; reporting results of CTN main studies, ancillary, and research using the CTN platform in 100+ publications, and actively disseminating evidence- based practices in 200 presentations. Node investigators also sought and received awards for 10 studies that used the CTN as a platform for research. Eight WS Node healthcare programs recruited over 1,300 participants into CTN studies. In the coming grant period the Node expands to include three national and regional primary care and HIV primary care research networks: OCHIN, the HIV Research Network, and the Oregon Rural Practice-Based Research Network (ORPRN). The Node retains core addiction treatment centers experienced in CTN protocols and exploits their links with primary care: Adapt (Roseburg, OR), CODA (Portland, OR) HealthRIGHT 360 (San Francisco, CA), La Frontera (Tucson, AZ), NARA (Portland, OR), and Signal Behavioral Health Network (Denver, CO). The Node's research agenda proposes study concepts that evaluate three strategies to integrate and enhance addiction treatment within healthcare settings. Study 1 builds a patient registry for HCV infection and tests a multi-contact brief intervention for alcohol use. Study 2 extends the registry testing a candidate therapeutic HIV vaccine. Study 3, a test of reverse integration (primary care clinicians in addiction treatment settings), assesses naloxone distribution and education to reduce fatal and nonfatal opioid overdoses and measures impact on return to use. Finally the WS Node continues to use the CTN as a platform for training, dissemination, and research applications. The Node has the potential to accelerate the advancement of integrated primary care and addiction in the coming years. PROJECT NARRATIVE This renewal application to conduct research in the NIDA Clinical Trials Network has broad public health implications focused on developing and testing ways to better treat medical problems and addiction through integrated care. The project will conduct clinical trials of treatments for drug use disorders in the context of primary care addressing hepatitis C, HIV, and opioid overdose--topics of urgent national importance. This research can accelerate the advancement of providing integrated treatments for medical problems and addiction in the coming years.",Western States Node of the National Drug Abuse Treatment Clinical Trials Network,9905154,UG1DA015815,"['Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' American Indians ', ' American Indian ', ' Arizona ', ' Asian Americans ', ' Award ', ' California ', ' Service area ', ' Health Catchment Area ', ' Health Service Area ', ' Cities ', ' Clinical Trials ', ' Colorado ', ' Communities ', ' Disorder ', ' Disease ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Drug Use Disorder ', ' Educational aspects ', ' Education ', ' Faculty ', ' Grant ', ' Hawaii ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Information Networks ', ' Leadership ', ' Los Angeles ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Naloxone ', ' Persons ', ' Oregon ', ' Patients ', ' Peer Review ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' Scientific Publication ', ' Publications ', ' Registries ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Safety ', ' San Francisco ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Social Workers ', ' Substance Use Disorder ', ' Talents ', ' Testing ', ' Time ', ' Translating ', ' Universities ', ' County ', ' Measures ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' health care ', ' Healthcare ', ' human immunodeficiency virus vaccine ', ' HIV/AIDS Vaccines ', ' HIV vaccine ', ' Caring ', ' base ', ' improved ', ' Site ', ' Clinical ', ' Medical ', ' Link ', ' Training ', ' Rural ', ' Pacific Island Americans ', ' Pacific Islander American ', ' Pacific Islander ', ' Progress Reports ', ' Collaborations ', ' Native Americans ', ' Rivers ', ' Knowledge ', ' programs ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Country ', ' experience ', ' care delivery ', ' Participant ', ' prevention service ', ' treatment program ', ' member ', ' Reporting ', ' AIDS/HIV problem ', ' HIV/AIDS problem ', ' HIV/AIDS ', ' AIDS/HIV ', ' behavioral health ', ' Quality of Care ', ' QOC ', ' behavioral pharmacology ', ' protocol development ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' patient registry ', ' Provider ', ' prevent drug use ', ' prevent drug addiction ', ' prevent drug abuse ', ' drug use prevention ', ' drug addiction prevention ', ' drug abuse prevention ', ' Address ', ' Evidence based practice ', ' Data ', ' Health Sciences ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' Clinical Data ', ' Clinical Treatment ', ' trial treatment ', ' trial regimen ', ' Conduct Clinical Trials ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' practice-based research network ', ' Evidence based treatment ', ' cost ', ' treatment center ', ' implementation research ', ' dissemination research ', ' Clinical Trials Network ', ' design ', ' designing ', ' Hepatitis C Therapy ', ' Hepatitis C treatment ', ' Hepatitis C Virus Treatment ', ' Hepatitis C Therapeutics ', ' HCV treatment ', ' HCV therapy ', ' urban Native American ', ' urban Indian ', ' urban American Indian ', ' safety net ', ' behavioral clinical trial ', ' implementation science ', ' addiction ', ' addictive disorder ', ' evidence base ', ' patient population ', ' brief alcohol intervention ', ' Amalgam ', ' leadership development ', ' health care service ', ' healthcare service ', ' health service use ', ' health service utilization ', ' data resource ', ' rural healthcare ', ' rural health care ', ' rural Americans ', ' therapeutic candidate ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' recruit ', ' primary care services ', ' health care settings ', ' healthcare settings ', ' treatment services ', ' methadone patient ', ' rural health disparities ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",UG1,2019,2200084,0.08578632686993468
"1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership ABSTRACT Cancer drugs in the United States are almost exclusively developed by, tested in, and optimized for European- Americans. Disparities in U.S. drug development are the result of long-standing inequalities that occur throughout the entire drug discovery pipeline. Only a small number of basic, translational and clinical scientists are Latino/Hispanic or Black/African-American. Less than 2-5% of trial participants are Latino/Hispanic or Black/African-American. Yet, in spite of a lack of data, new drugs are approved by the U.S. Food and Drug Administration (FDA) and subsequently prescribed for Latino/Hispanic or Black/African-American patients, without sufficient testing. It is unacceptable, especially in this era of the Precision Medicine Initiative (PMI), that currently our drugs are developed by, and optimized for, only for an exclusive segment of our citizens. We seek to shift this paradigm by strengthening the existing partnership between University of California at Riverside (UCR) and City of Hope Comprehensive Cancer Center (CoH-CCC). In this proposed P20, UCR and CoH-CCC will partner to develop the resources, infrastructure, and training programs necessary to develop the next generation of therapeutics researchers that reflect the ethnic diversity of Inland Southern California. We anticipate that our P20 program will drive new collaborative R01 grants and K01 and T-type training grants. . Project Narrative (Overview) In this P20 University of California at Riverside (UCR) and City of Hope Comprehensive Cancer Center (CoH- CCC) will partner to develop the resources, infrastructure, and training programs necessary to develop the next generation of basic, translational, and clinical therapeutics researchers that reflect the diversity of the Inland Empire. Together, UCR and CoH-CCC aim to develop the collaborations, translational resources, and training programs to reduce disparities in drug development throughout the entire development pipeline.",1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership,9823763,P20CA242619,"['Acetylation ', ' Affect ', ' Antelopes ', ' Antelopines ', ' Antineoplastic Agents ', ' anticancer drug ', ' anticancer agent ', ' anti-cancer drug ', ' Tumor-Specific Treatment Agents ', ' Neoplastic Disease Chemotherapeutic Agents ', ' Cancer Drug ', ' Antineoplastics ', ' Antineoplastic Drugs ', ' Anti-Cancer Agents ', ' Award ', ' malignant breast neoplasm ', ' malignant breast tumor ', ' Breast Cancer ', ' California ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cities ', ' Clinical Trials ', ' Color ', ' Communities ', ' Drug Design ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Educational aspects ', ' Education ', ' Engineering ', ' Faculty ', ' Fellowship ', ' Goals ', ' Grant ', ' Spanish Americans ', ' Hispanic Americans ', ' Investments ', ' Joints ', ' Los Angeles ', "" men's "", ' men ', ' Mentors ', ' Mentorship ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Patients ', ' Physicians ', ' Prognosis ', ' outcome forecast ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' school of medicine ', ' medical college ', ' medical schools ', ' Societies ', ' Students ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Training Programs ', ' United States ', ' USFDA ', ' Food and Drug Administration ', ' United States Food and Drug Administration ', ' Universities ', ' Woman ', ' Work ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Latino ', ' Clinical ', ' Phase ', ' Ensure ', ' Training ', ' Individual ', ' European ', ' Fostering ', ' Inequality ', ' Funding ', ' Collaborations ', ' news ', ' Therapeutic ', ' Therapeutic Agents ', ' programs ', ' Scientist ', ' System ', ' Postdoctoral Fellow ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' American ', ' success ', ' Toxic effect ', ' Toxicities ', ' Participant ', ' Reporting ', ' drug development ', ' drug discovery ', ' Latina ', ' Latinas ', ' Mitochondrial Proteins ', ' Bioinformatics ', ' Bio-Informatics ', ' Institution ', ' Address ', ' Core Facility ', ' Data ', "" Master's Degree "", ' City of Hope Comprehensive Cancer Center ', ' Comprehensive Cancer Center ', ' Conduct Clinical Trials ', ' Not Hispanic or Latino ', ' Nonhispanic ', ' Non-Hispanic ', ' Development ', ' developmental ', ' triple-negative invasive breast carcinoma ', ' triple-negative breast cancer ', ' TNBC ', ' anticancer research ', ' cancer research ', ' anti-cancer research ', ' next generation ', ' Minority ', ' manufacturing facility ', ' Population ', ' cancer health disparity ', ' disparity in cancer ', ' cancer disparity ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' therapeutic development ', ' therapeutic agent development ', ' screening ', ' Drug Targeting ', ' precision medicine ', ' precision-based medicine ', ' Precision Medicine Initiative ', ' training opportunity ', ' ethnic diversity ', ' ethnically diverse ', ' disparity reduction ', ' reduce disparity ', ' minority communities ', ' clinical translation ', ' phase 1 testing ', ' phase I testing ', ' phase I evaluation ', ' phase 1 evaluation ', ' Infrastructure ', ' ']",NCI,BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,P20,2019,241905,0.08728368536255911
"Pilot Study of a Community-Pharmacy Model to Expand Access to Medications to Treat and Prevent Hepatitis C, Opioid Use Disorders, Overdose and HIV Among Persons Who Inject Drugs ABSTRACT/PROJECT SUMMARY The opioid epidemic is a major public health crisis in the United States, leading to substantial morbidity and mortality related to the consequences of opioid use disorders and injection drug use, namely hepatitis C virus (HCV), HIV, and overdose. Yet, we are at a unique historical moment, as we possess effective medications that can improve and sustain the lives of people who inject drugs (PWID). Currently there are medications that can be prescribed to 1) cure HCV (directly-acting antivirals or DAAs), 2) prevent HIV infection (Pre-exposure Prophylaxis [PrEP]), and 3) treat/prevent overdose (naloxone and medications to treat OUD). Furthermore, there is an unprecedented opportunity to eliminate HCV, a disease that is transmitted through injecting drugs. However, achieving the goals of elimination will require better systems for allowing PWID access to medications to cure hepatitis C, as well as medications to prevent overdose and HIV. Pharmacists and community-pharmacy programs may be an innovative solution for this problem. Collaborative Drug Therapy Agreements (CDTAs) allow pharmacists to have authority to autonomously perform testing and prescribing and dispensing medications. We propose to use this R34 mechanism to develop and pilot test a novel health service delivery model, namely a community-pharmacy program for providing DAAs and medications to prevent overdose and HIV among PWID with HCV. For Aim #1, we will conduct qualitative interviews with PWID with HCV and other key community stakeholders in order to inform the development of a community- pharmacy program to expand access to medications to treat HCV and prevent overdose and HIV. For Aim #2, we will pilot and evaluate the community-pharmacy program at a local pharmacy in Seattle. This application is submitted under the funding announcement PA-18-774 (Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse), which includes pilot testing of health service interventions that optimize access utilization of drug use disorder related services, as well as services for comorbid medical conditions. The proposed research leverages a number of existing community partnerships with local stakeholders and would lead to a future multi-site effectiveness study that would utilize existing community- based pharmacies in order to work toward improving drug users' health by expanding access to life-saving medications. PROJECT NARRATIVE Persons who inject drugs (PWID) face barriers to accessing efficacious and potentially life-saving medications. The purpose of the research is to develop and pilot a community-pharmacy based model of care for PWID that can offer treatment for hepatitis C virus (HCV), in addition to medications to prevent overdose and HIV. The proposed research would lead to a future multi-site effectiveness study that will utilize existing community- based pharmacies to expand access to relevant medications for PWID, in order to reduce health disparities in this group and reach the World Health Organization's goal to eliminate HCV by 2030.","Pilot Study of a Community-Pharmacy Model to Expand Access to Medications to Treat and Prevent Hepatitis C, Opioid Use Disorders, Overdose and HIV Among Persons Who Inject Drugs",9978028,R34DA047660,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Algorithms ', ' Antiviral Agents ', ' Antiviral Drugs ', ' Antivirals ', ' anti-viral agents ', ' anti-viral drugs ', ' anti-virals ', ' Awareness ', ' Mental disorders ', ' Mental health disorders ', ' Psychiatric Disease ', ' Psychiatric Disorder ', ' mental illness ', ' psychiatric illness ', ' psychological disorder ', ' Communities ', ' Community Pharmacy ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' health care delivery ', ' Healthcare Delivery ', ' health services delivery ', ' Heroin ', ' Diacetylmorphine ', ' Diamorphine ', ' Disease ', ' Disorder ', ' Disease Outbreaks ', ' Outbreaks ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Pharmacotherapy ', ' Drug Therapy ', ' drug treatment ', ' Drug Use Disorder ', ' Drug Utilization ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Face ', ' faces ', ' facial ', ' Focus Groups ', ' Future ', ' Goals ', ' Health ', ' Health Services ', ' Hepatitis C ', ' HCV infection ', ' Hepatitis C virus infection ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitus C ', ' hep C ', ' hepatitis non A non B ', ' non A, non B hepatitis ', ' non-A, non-B hepatitis ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' HIV Infections ', ' HTLV-III Infections ', ' HTLV-III-LAV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' Incidence ', ' Indiana ', ' Interview ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Naloxone ', ' opioid abuse ', ' opiate abuse ', ' opiate drug abuse ', ' opioid drug abuse ', ' Organizational Objectives ', ' Organizational Goals ', ' Overdose ', ' Patients ', ' Pharmacy facility ', ' Pharmacies ', ' Pharmacists ', ' Pilot Projects ', ' pilot study ', ' Play ', ' Prospective Studies ', ' Public Health ', ' Research ', ' Risk ', ' Role ', ' social role ', ' Savings ', ' Testing ', ' Time ', ' United States ', ' Work ', ' World Health Organization ', ' EtOH abuse ', ' alcohol co-abuse ', ' alcohol problem ', ' ethanol abuse ', ' hazardous alcohol use ', ' problem alcohol use ', ' problem drinking ', ' problematic alcohol consumption ', ' problematic alcohol use ', ' Alcohol abuse ', ' Research Methods ', ' Research Methodology ', ' HIV Prevention ', ' HIV/AIDS prevention ', ' AIDS prevention ', ' Caring ', ' base ', ' rural region ', ' rural area ', ' improved ', ' Site ', ' Medical ', ' Training ', ' adult youth ', ' young adulthood ', ' young adult ', ' Rural ', ' Populations at Risk ', ' Syringe-Exchange Programs ', ' needle exchange ', ' syringe exchange ', ' syringe exchange services ', ' syringe service programs ', ' Needle-Exchange Programs ', ' Funding ', ' tobacco abuse ', ' PWUD ', ' people who use drugs ', ' people who use illicit drugs ', ' persons who use drugs ', ' Drug user ', ' Life ', ' programs ', ' Oral ', ' Protocol ', ' Protocols documentation ', ' System ', ' interest ', ' Injection Drug User ', ' PWID ', ' people who inject drugs ', ' people who inject illicit drugs ', ' persons who inject drugs ', ' Injecting drug user ', ' Services ', ' preference ', ' American ', ' experience ', ' authority ', ' Structure ', ' novel ', ' Agreement ', ' Prevention ', ' Modeling ', ' HIV diagnosis ', ' Provider ', ' disparity in health ', ' health disparity ', ' Pharmaceutical Agent ', ' Pharmaceuticals ', ' Pharmacological Substance ', ' Pharmacologic Substance ', ' Effectiveness ', ' preventing ', ' prevent ', ' AIDS test ', ' AIDS/HIV test ', ' HIV test ', ' HIV-1 test ', ' HIV-2 test ', ' Human immunodeficiency virus test ', ' Address ', ' Funding Mechanisms ', ' developmental ', ' Development ', ' health economics ', ' treatment center ', ' HCV therapy ', ' HCV treatment ', ' Hepatitis C Therapeutics ', ' Hepatitis C Virus Treatment ', ' Hepatitis C treatment ', ' Hepatitis C Therapy ', ' HCV Transmission ', ' hepatitis C virus transmission ', ' Hepatitis C Transmission ', ' Prevalence ', ' innovate ', ' innovative ', ' innovation ', ' treatment site ', ' service intervention ', ' addictive disorder ', ' addiction ', ' overdose prevention ', ' overdose death ', ' licit opioid ', ' opiate medication ', ' opioid medication ', ' prescribed opiate ', ' prescribed opioid ', ' prescription opiate ', ' prescription opioid ', ' injection drug use ', ' community partnership ', ' opiate use disorder ', ' opioid use disorder ', ' HCV/HIV ', ' HIV and HCV ', ' HIV and hepatitis C ', ' HIV-HCV ', ' HIV/Hepatitis C ', ' HIV/HCV ', ' clinical development ', ' PrEP ', ' pre-exposure prophylaxis ', ' HCV ', ' Hepatitis C virus ', ' intravenous opiate ', ' intravenous opioid ', ' opiate injection ', ' opioid injector ', ' opioid injection ', ' opiate crisis ', ' opioid crisis ', ' opioid epidemic ', ' recruit ', ' Service model ', ' care delivery model ', ' health care delivery model ', ' healthcare delivery model ', ' Service delivery model ', ' preservation ', ' side effect ', ' ']",NIDA,UNIVERSITY OF WASHINGTON,R34,2020,214590,0.10355772141199472
"Y2Prevent: Preventing Drug Use and HIV through Empowerment, Social Support and Mentorship ABSTRACT African Americans represent only 14% of the population, but account for 44% of all new HIV infections reported yearly. The situation is particularly grave for Black/African American young men who have sex with men (AAYMSM), with seroprevalence rates of 19% for ages 15-22 and 26% for ages 23-29 among AAYMSM. These health outcomes are influenced by important social and structural factors, including violence and victimization, homophobia, discrimination, institutional racism, and economic and social marginalization. These experiences are significantly associated with illicit drug use, alcohol misuse, transactional sex work, and HIV risk behaviors. In response to this crisis, we are proposing to create a new theoretically driven, youth- centered intervention designed to build the capacity of AAYMSM to overcome these barriers to health. With this revised R34 application, we propose to further refine and pilot test an intervention, called Young Men's Adult Identity Mentoring (YM-AIM). Adapted from an existing CDC Diffusing Effective Behavioral Intervention, YM-AIM is a theory-driven, group-level intervention designed to help AAYMSM develop a healthy vision for their future (or possible future self) by defining a set of short- and long-term goals in the areas of education, health, family and intimate relationships. We propose to further strengthen and refine YM-AIM by adding a youth mentoring/support component, called Youth Initiated Mentoring (YIM). YIM uses a positive youth development framework to: a) build social capital to achieve immediate and long-term goals, b) build social support, c) identify and engage natural mentors in one's networks to address structural barriers, and d) develop relationships with supportive adults. We will integrate these two models into a single intervention called Y2Prevent. We will then work to further adapt, tailor, and evaluate Y2Prevent as an intervention to reduce illicit drug use and HIV/STI risk among AAYMSM. This intervention will emphasize: a) biomedical HIV prevention strategies for primary prevention, b) HIV/STI testing and treatment referral, c) drug screening and treatment referral, and d) positive youth development and future planning. We will conduct formative research to inform the adaptation/tailoring followed by a piloting of the new intervention to assess the feasibility, acceptability, and the preliminary efficacy. Our proposed positive youth development and resilience theory provide a strong, innovative framework for examining how AAYMSM with significant exposure to syndemic health and social disparities respond to engagement with prevention and treatment resources. The proposed intervention is intended to promote resilience, build social skills and assets among AAYMSM to help them recognize and overcome individual, social and structural barriers leading to risk, and adopt and maintain protective behaviors, such as safer sex, PrEP/PEP use, HIV/STI testing and healthcare utilization. The findings will inform the development of an R01 application that will propose a larger-scale, multi-city efficacy trail in a subsequent R01 application. PROJECT NARRATIVE Today there is a generation of African American/Black young men who have sex with men (AAYMSM) who are at exceedingly high risk for a wide range of adverse health outcomes, including tobacco, alcohol and illicit drug addiction, sexually transmitted infections (STIs), HIV/AIDS, and mental health disorders. Often, these young men experience multiple forms of discrimination (racism, homophobia) in multiple settings (home, school, neighborhood, workplace), with limited social support to buffer against these threats. In response, we propose to further refine and pilot test a theory-driven, evidence-based group-level intervention designed to help AAYMSM develop a healthy vision for their future (or possible future self) by defining a set of short- and long- term goals in the areas of education, health, family and intimate relationships using facilitated activities -- participants are asked to consider how their involvement in risky behaviors (e.g., illicit drug use, condomless sex, multiple sex partners) would interfere with achieving those goals.","Y2Prevent: Preventing Drug Use and HIV through Empowerment, Social Support and Mentorship",9973159,R34DA044106,"['Accounting ', ' Adolescence ', ' 12-20 years old ', ' adolescence (12-20) ', ' Adoption ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Age ', ' ages ', ' Aggressive behavior ', ' Aggression ', ' Alcohol consumption ', ' Alcohol Drinking ', ' EtOH drinking ', ' EtOH use ', ' alcohol ingestion ', ' alcohol intake ', ' alcohol product use ', ' alcohol use ', ' alcoholic beverage consumption ', ' alcoholic drink intake ', ' ethanol consumption ', ' ethanol drinking ', ' ethanol ingestion ', ' ethanol intake ', ' ethanol product use ', ' ethanol use ', ' Alcohols ', ' Alcohol Chemical Class ', ' Behavior ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Mental disorders ', ' Mental health disorders ', ' Psychiatric Disease ', ' Psychiatric Disorder ', ' mental illness ', ' psychiatric illness ', ' psychological disorder ', ' Buffers ', ' Centers for Disease Control and Prevention (U.S.) ', ' CDC ', ' Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' United States Centers for Disease Control and Prevention ', ' Cities ', ' Communities ', ' Mental Depression ', ' depression ', ' Diagnosis ', ' Discrimination ', ' Cognitive Discrimination ', ' Pharmacotherapy ', ' Drug Therapy ', ' drug treatment ', ' Economics ', ' Education ', ' Educational aspects ', ' Exercise ', ' Family ', ' Feedback ', ' Future ', ' Goals ', ' Health ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' HIV Infections ', ' HTLV-III Infections ', ' HTLV-III-LAV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' Incidence ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Literature ', ' Maintenance ', ' Manuals ', ' men ', "" men's "", ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Mentors ', ' Mentorship ', ' Neighborhoods ', ' Primary Prevention ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Schools ', ' Sexual Partners ', ' sex partner ', ' Sexually Transmitted Diseases ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Infection ', ' Venereal Diseases ', ' Venereal Disorders ', ' Venereal Infections ', ' Social support ', ' social support network ', ' Stress ', ' Testing ', ' Tobacco ', ' Vision ', ' Sight ', ' visual function ', ' Caucasians ', ' Caucasian ', ' Caucasian Race ', ' Caucasoid ', ' Caucasoid Race ', ' Occidental ', ' white race ', ' Work ', ' Generations ', ' Measures ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' Illicit Drugs ', ' Hispanic Populations ', ' Latino Population ', ' Spanish Origin ', ' hispanic community ', ' Hispanics ', ' Latino ', ' Risky Behavior ', ' at risk behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' HIV Prevention ', ' HIV/AIDS prevention ', ' AIDS prevention ', ' Caring ', ' Intention ', ' Job Location ', ' Job Place ', ' Job Setting ', ' Job Site ', ' Work Location ', ' Work Place ', ' Work-Site ', ' Worksite ', ' work setting ', ' Workplace ', ' base ', ' improved ', ' Area ', ' Diffuse ', ' racism ', ' Individual ', ' Health Care Utilization ', ' health care service use ', ' healthcare service use ', ' healthcare service utilization ', ' healthcare utilization ', ' health care service utilization ', ' adult youth ', ' young adulthood ', ' young adult ', ' satisfaction ', ' drug use ', ' Drug usage ', ' Early Intervention ', ' Funding ', ' Exposure to ', ' Knowledge ', ' Life ', ' programs ', ' Adopted ', ' Frequencies ', ' Home ', ' Home environment ', ' Protocol ', ' Protocols documentation ', ' High-Risk Sex ', ' Unprotected Sex ', ' condomless intercourse ', ' condomless sex ', ' unprotected intercourse ', ' Unsafe Sex ', ' inner city ', ' experience ', ' Performance ', ' success ', ' Protected Sex ', ' Responsible Sex ', ' Responsible sexual behavior ', ' safer sex ', ' safer sexual behavior ', ' Safe Sex ', ' Seroprevalences ', ' Self Efficacy ', ' condoms ', ' Structure ', ' skills ', ' novel ', ' Participant ', ' Preventative strategy ', ' Preventive strategy ', ' Prevention strategy ', ' empowerment ', ' member ', ' Program Announcement ', ' NIH Program Announcements ', ' interpersonal competence ', ' interpersonal competency ', ' social competence ', ' social competency ', ' social skills ', ' Prevention ', ' Reporting ', ' social ', ' AIDS/HIV ', ' HIV/AIDS ', ' HIV/AIDS problem ', ' AIDS/HIV problem ', ' HIV risk ', ' positive youth development ', ' Modeling ', ' response ', ' theories ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' drug addiction prevention ', ' drug use prevention ', ' prevent drug abuse ', ' prevent drug addiction ', ' prevent drug use ', ' drug abuse prevention ', ' disparity in health ', ' health disparity ', ' AIDS test ', ' AIDS/HIV test ', ' HIV test ', ' HIV-1 test ', ' HIV-2 test ', ' Human immunodeficiency virus test ', ' Low income ', ' Address ', ' Chemical Dependence ', ' Drug Dependence ', ' Drug Dependency ', ' Drug Addiction ', ' social capital ', ' Consent ', ' Data ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Preventative intervention ', ' Prevention intervention ', ' preventional intervention strategy ', ' Preventive Intervention ', ' trend ', ' sex ', ' developmental ', ' Development ', ' Minority ', ' protective behavior ', ' resilience ', ' Outcome ', ' social disparities ', ' ethanol misuse ', ' unhealthy alcohol use ', ' alcohol misuse ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' racial and ethnic ', ' intervention design ', ' treatment design ', ' therapy design ', ' high risk ', ' evidence base ', ' operation ', ' adolescent man ', ' adolescent men ', ' young man ', ' sexual minority ', ' Homophobic ', ' Homophobia ', ' sexually transmitted HIV ', ' sexual HIV transmission ', ' YMSM ', ' young MSM ', ' young men who have sex with men ', ' marginalization ', ' social exclusion ', ' violence victimization ', ' illicit drug use ', ' racial minority ', ' PrEP ', ' pre-exposure prophylaxis ', ' Drug Screening ', ' exposure to violence ', ' violence exposure ', ' sex risk behavior ', ' sexual risk behavior ', ' infection risk ', ' social structural ', ' socio-structural ', ' sociostructural ', ' social structure ', ' anal intercourse without condom ', ' anal sex without condom ', ' condomless anal intercourse ', ' unprotected anal intercourse ', ' unprotected anal sex ', ' unsafe anal intercourse ', ' unsafe anal sex ', ' condomless anal sex ', ' ']",NIDA,CHILDREN'S HOSPITAL OF LOS ANGELES,R34,2020,253220,0.0535610043731097
"Cohort Studies on HIV/AIDS and Substance Abuse in Miami DESCRIPTION (provided by applicant): Liver disease is a major cause of death in HIV infected persons in the United States. While advances in antiretroviral therapy have significantly reduced HIV-related mortality, co-infection with hepatitis C virus (HCV), is widespread and accelerates progression of liver fibrosis to cirrhosis and liver carcinoma. In addition, substance abuse accelerates HIV disease, and may facilitate progression of liver fibrosis. The primary goal of this proposal is to continue to follow the existing Miami Adult Studies on HIV (MASH) cohort, its specimen repository and database, and expand it from the current 881 to 1,500 study participants. The purpose is to generate collaborative studies to investigate the impact of cocaine, by far the most prevalent drug of abuse in South Florida, on HIV infection, HIV/HCV co-infection, and on long-term morbidity with a focus on liver disease in this population with disparities in access to care. HIV and HCV un-infected cocaine users and non-users will also be recruited to allow determination of the impact of cocaine use alone, as well as the interaction of cocaine use with HIV, HCV, and HIV/HCV co-infection. As new and more effective treatments and access to care for HIV, HCV and drug abuse become available, maintaining a well- characterized cohort, specimen repository and database will create a strong resource platform for current and future collaborative research. Observing the uptake of new HCV treatments and potential new cocaine cessation programs in this at-risk population with health disparities will provide data on barriers and facilitators to effective treatments to prevent long-term morbidity and mortality. We have followed the MASH cohort of 881 participants for up to 12 years with excellent retention rates, and have created a specimen repository and a database. The MASH cohort in Miami is unique because it will be a mostly Hispanic cohort with a large number of African Americans, women, non-injector drug users, with predominantly heterosexual HIV- transmission etiology. We propose to (1) compare the progression of liver fibrosis over four years among cocaine users and non-users in HIV+/HCV-, HIV+/HCV+, HIV-/HCV+, and HIV-/HCV-, using a novel non- invasive diagnostic device, the Magnetic Resonance Elastography (MRE). We also propose to (2) compare the pattern over four years of biomarkers and identify genetic markers associated with the mechanisms of liver fibrosis among cocaine users and non-users. Understanding the role of cocaine use in the context of HIV and HIV/HCV co-infections and lack of lasting effects of treatments for cocaine use cessation are crucial in order to gain insights into the pathogenesis and disease outcomes, and to provide the basis for identifying antifibrotic therapies such as oxidative stress, which are amenable to intervention. These studies will be critical for program development, appropriate interventions, and for improving health in this population. PUBLIC HEALTH RELEVANCE: Understanding the role of cocaine use in the context of HIV, HCV and HIV/HCV co-infections with focus on progression of liver fibrosis, is crucial in gaining insights into the disease pathogenesis, outcomes, and the role of co-morbidities and health disparities of this population. This research will provide evidence-based information for program development and evaluation, appropriate and effective interventions, and for improving health in this population.",Cohort Studies on HIV/AIDS and Substance Abuse in Miami,9927614,U01DA040381,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Alcohols ', ' Alcohol Chemical Class ', ' Animals ', ' Cause of Death ', ' Cocaine ', ' Cocaine Abuse ', ' Cohort Studies ', ' Concurrent Studies ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Cessation of life ', ' Death ', ' Disease ', ' Disorder ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Pharmacotherapy ', ' Drug Therapy ', ' drug treatment ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Florida ', ' Future ', ' Genetic Markers ', ' genetic biomarker ', ' Goals ', ' Health ', ' Health Services Accessibility ', ' Access to Care ', ' access to health services ', ' access to services ', ' access to treatment ', ' accessibility to health services ', ' availability of services ', ' care access ', ' health service access ', ' health services availability ', ' service availability ', ' treatment access ', ' Hepatitis C ', ' HCV infection ', ' Hepatitis C virus infection ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitus C ', ' hep C ', ' hepatitis non A non B ', ' non A, non B hepatitis ', ' non-A, non-B hepatitis ', ' Primary carcinoma of the liver cells ', ' Hepatocarcinoma ', ' Hepatocellular Carcinoma ', ' Hepatocellular cancer ', ' Hepatoma ', ' Liver Cells Carcinoma ', ' liver carcinoma ', ' Recording of previous events ', ' History ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' HIV Infections ', ' HTLV-III Infections ', ' HTLV-III-LAV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' Human ', ' Modern Man ', ' Immunity ', ' Immunosuppression ', ' Immunosuppression Effect ', ' Immunosuppressive Effect ', ' immune suppression ', ' In Vitro ', ' Laboratories ', ' Liver diseases ', ' Hepatic Disorder ', ' hepatic disease ', ' hepatopathy ', ' liver disorder ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Persons ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Program Development ', ' Program Evaluation ', ' Quality of life ', ' QOL ', ' Research ', ' Research Design ', ' Study Type ', ' study design ', ' Resources ', ' Research Resources ', ' Risk Factors ', ' Role ', ' social role ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' United States ', ' Virus Diseases ', ' Viral Diseases ', ' viral infection ', ' virus infection ', ' virus-induced disease ', ' Woman ', ' cytokine ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' Hispanic Populations ', ' Latino Population ', ' Spanish Origin ', ' hispanic community ', ' Hispanics ', ' Nutritional Deficiency ', ' Undernutrition ', ' dietary deficiency ', ' malnourished ', ' nutrition deficiency ', ' nutrition deficiency disorder ', ' nutritional deficiency disorder ', ' Malnutrition ', ' Apoptosis Pathway ', ' Programmed Cell Death ', ' Apoptosis ', ' therapy failure ', ' Treatment Failure ', ' improved ', ' Area ', ' Clinical ', ' Animal Experiments ', ' Biological Substance Banks ', ' biological specimen repository ', ' biosample repository ', ' biospecimen repository ', ' specimen bank ', ' specimen repository ', ' Biological Specimen Banks ', ' insight ', ' Stimulus ', ' Cocaine Users ', ' fibrotic liver ', ' hepatic fibrosis ', ' Liver Fibrosis ', ' Data Bases ', ' data base ', ' Databases ', ' Populations at Risk ', ' Oxidative Stress ', ' Funding ', ' uptake ', ' non-invasive diagnosis ', ' non-invasive diagnostic ', ' noninvasive diagnostic ', ' noninvasive diagnosis ', ' Metabolic ', ' chronic hepatic disease ', ' chronic hepatic disorder ', ' chronic liver disorder ', ' chronic liver disease ', ' Diagnostic ', ' Nature ', ' programs ', ' Pattern ', ' interest ', ' fibrogenesis ', ' cohort ', ' Disease Outcome ', ' novel ', ' Participant ', ' Devices ', ' Pathogenesis ', ' AIDS/HIV ', ' HIV/AIDS ', ' HIV/AIDS problem ', ' AIDS/HIV problem ', ' abuse of substances ', ' substance abuse ', ' Substance abuse problem ', ' time interval ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' disparity in health ', ' health disparity ', ' preventing ', ' prevent ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Data ', ' General Prognostic Factor ', ' Prognostic/Survival Factor ', ' Prognostic Factor ', ' Apoptotic ', ' Magnetic Resonance Elastography ', ' Transmission ', ' transmission process ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' Heterosexuals ', ' Behavioral ', ' cirrhotic ', ' Cirrhosis ', ' anti-retroviral therapy ', ' anti-retroviral treatment ', ' antiretroviral treatment ', ' antiretroviral therapy ', ' HCV therapy ', ' HCV treatment ', ' Hepatitis C Therapeutics ', ' Hepatitis C Virus Treatment ', ' Hepatitis C treatment ', ' Hepatitis C Therapy ', ' Outcome ', ' Population ', ' prospective ', ' treatment effect ', ' abused drug ', ' abused drugs ', ' drug abused ', ' drugs abused ', ' drugs of abuse ', ' drug of abuse ', ' public health relevance ', ' effective intervention ', ' evidence base ', ' FDA approved ', ' effective treatment ', ' effective therapy ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' cocaine use ', ' coinfection ', ' co-infection ', ' retention strategy ', ' student retention ', ' retention rate ', ' HCV/HIV ', ' HIV and HCV ', ' HIV and hepatitis C ', ' HIV-HCV ', ' HIV/Hepatitis C ', ' HIV/HCV ', ' HCV co-infection ', ' HCV coinfection ', ' hepatitis C coinfection ', ' hepatitis C virus co-infection ', ' hepatitis C virus coinfection ', ' Hepatitis C co-infection ', ' liver development ', ' access to health care ', ' access to healthcare ', ' accessibility of health care ', ' accessibility to health care ', ' accessibility to healthcare ', ' health care access ', ' health care service access ', ' health care service availability ', ' healthcare access ', ' healthcare accessibility ', ' healthcare availability ', ' healthcare service access ', ' healthcare service availability ', ' health care availability ', ' HCV ', ' Hepatitis C virus ', ' recruit ', ' socio-demographics ', ' sociodemographics ', ' harmonized data ', ' data harmonization ', ' ']",NIDA,FLORIDA INTERNATIONAL UNIVERSITY,U01,2020,1097999,0.03301287487101885
"The Implementation, Adoption, and Sustainability of Ho'ouna Pono Project Summary/Abstract  Research has indicated that Native Hawaiian youth have significantly higher rates of drug use than their non-Hawaiian counterparts (e.g., Wong, Klingle, & Price, 2004; Mayeda, Hishinuma, Nishimura, Garcia- Santiago, & Mark, 2006; Nishimura, Hishinuma, & Goebert, 2013), and that these differences are particularly pronounced in rural settings (Saka, Takeuchi, Fagaragan, & Afaga, 2014). Despite these findings, there have been very few drug prevention programs developed and evaluated specifically for these youth (Edwards, Giroux, & Okamoto, 2010; Rehuher, Hiramatsu, & Helm, 2008). Further, efforts to address youth substance abuse have been poorly implemented and coordinated across the State of Hawaii (Waitzfelder, Engel, & Gilbert, 1998). Therefore, the purposes of this R34 proposal are to identify potential barriers or challenges to the implementation, adoption, and sustainability (IAS) of a culturally grounded, school-based drug prevention curriculum (Hoouna Pono) across all public middle, intermediate, or multi-level schools on Hawaii Island, and to create a comprehensive, community-based IAS action plan for the curriculum. This will be accomplished through three specific aims. AIM 1 (Assessing Environmental Demands, Year 1) is to develop and validate an implementation, adoption, and sustainability inventory related to Hoouna Pono, which will be theoretically informed by The Consolidated Framework for Implementation Research (CFIR; Damschroder & Hagedorn, 2011; Powell, Proctor, & Glass, 2014). The inventory will consist of items describing barriers or challenges to the successful adoption, implementation, and/or sustainability of Hoouna Pono on Hawaii Island. AIM 2 (Response Enumeration, Year 2) is to systematically elicit implementation strategies (or solutions) to the most problematic and/or difficult barriers to the IAS of the curriculum in public schools on Hawaii Island, and to rank-order these solutions based on their perceived ability to address or overcome each of the barriers to IAS. AIM 3 (Action Plan, Year 3) is to create a community based and validated action plan based on the findings from Aims 1 and 2, which will be evaluated in a future NIDA R01 grant proposal focused on dissemination and implementation research in health. Project Narrative  Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have been shown to have significantly higher rates of drug use compared with other ethnic groups (Wu et al., 2013), research focused on drug prevention of these individuals is important to improve public health both in Hawaii and on the Mainland U.S. This study actively engages rural public schools and communities in assessing the implementation, adoption, and sustainability of the Hoouna Pono drug prevention curriculum. The findings from this study will point to barriers and challenges to the successful implementation of evidence-based prevention curricula for rural, Pacific Islander, and indigenous communities, as well as to culturally grounded implementation strategies to promote the sustained public health impact of the curriculum.","The Implementation, Adoption, and Sustainability of Ho'ouna Pono",10123397,R34DA046735,"['Adoption ', ' Communities ', ' Educational Curriculum ', ' Curriculum ', ' lesson plans ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Ethnic group ', ' ethnicity group ', ' Faculty ', ' Future ', ' Glass ', ' Grant ', ' Health ', ' Hybrids ', ' Interview ', ' Equipment and supply inventories ', ' Inventory ', ' Island ', ' Literature ', ' Public Health ', ' Research ', ' Schools ', ' Testing ', ' Time ', ' Price ', ' pricing ', ' Administrator ', ' Youth 10-21 ', ' Youth ', ' base ', ' improved ', ' Area ', ' AOD use ', ' substance use ', ' substance using ', ' using substances ', ' Alcohol or Other Drugs use ', ' Individual ', ' Rural ', ' Pacific Islander ', ' Pacific Islander American ', ' Pacific Island Americans ', ' Policies ', ' drug use ', ' Drug usage ', ' Funding ', ' cooking ', ' Hawaiian ', ' Hawaiian population ', ' programs ', ' Pattern ', ' Structure ', ' Prevention ', ' Modeling ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' disparity in health ', ' health disparity ', ' Ground Substance Cytosol ', ' Ground Substance ', ' Effectiveness ', ' Address ', ' Grant Proposals ', ' Applications Grants ', ' Health Sciences ', ' Indigenous ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Population Sciences ', ' Preventative intervention ', ' Prevention intervention ', ' preventional intervention strategy ', ' Preventive Intervention ', ' implementation trial ', ' youth substance abuse ', ' adolescent substance abuse ', ' implementation research ', ' dissemination research ', ' rural disparities ', ' Population ', ' Drug Prevention Program ', ' Evidence based intervention ', ' 2-dimensional ', ' two-dimensional ', ' community based design ', ' community based research ', ' participatory action research ', ' community based participatory research ', ' implementation science ', ' effective intervention ', ' evidence base ', ' efficacy testing ', ' prevent substance use ', ' substance use prevention ', ' population health ', ' secondary analysis ', ' indigenous community ', ' rural locality ', ' rural place ', ' rural setting ', ' Native Hawaiian ', ' clinical implementation ', ' implementation strategy ', ' effectiveness testing ', ' ']",NIDA,HAWAII PACIFIC UNIVERSITY,R34,2020,95692,0.08250259884231641
"Racial and ethnic disparities in alcohol and other drug use disorder recovery (F.220) 7. Project Summary Racial/ethnic health disparities have been well-documented in the onset, rate, course, and consequences of alcohol and other drug (AOD) use problems, often with substantially poorer outcomes in non-White racial/ethnic groups compared to non-Hispanic Whites. As a result, the NIAAA has made it a central strategic aim to investigate and eliminate health disparities. Despite 30 years of research documenting the presence of AOD-related racial/ethnic health disparities, the degree to which disparities negatively impact the emerging standard of assessing the effectiveness of AOD treatments (i.e.,  5 years AOD problem resolution),53 which is also when risk of problematic use is no higher than in the general population,84 is unknown. Publicly available datasets are very limited by their ability to directly measure AOD recovery-related constructs and national prevalence rates of non-White racial/ethnic groups who have achieved long-term problem resolution. In turn, this compromises our ability to assess the extent to which racial/ethnic health equality exists in terms of long- term AOD problem resolution and the recovery-related mechanisms associated with potential disparities. To begin to fill this knowledge gap, we propose to conduct secondary data analyses of the first recovery-focused nationally representative probability-based study to test if racial/ethnic health disparities exist. The National Recovery Study (PI: Kelly) consists of a web-based probability sampling frame of 39,809 adults who were screened to identify if they once had a problem with drugs or alcohol and no longer do. Complete data on 2,002 participants who answered yes is available. Participants were assessed with a battery of quantitative and qualitative survey items in 2016 which captured their AOD clinical history and recovery-related mechanisms associated racial/ethnic health equality in AOD problem resolution. This design will enable us to address the following aims: 1a. Test if racial/ethnic health disparities exist in (i) the duration between onset of alcohol and other drug problems and onset of problem resolution; and, (ii) the likelihood of achieving long-term problem resolution ( 5 years) 1b. If health disparities are observed, explore the mediating potential of psychosocial (accrued recovery capital, degree of treatment utilization, degree of recovery support-service utilization) and structural recovery-related factors (health insurance coverage, socioeconomic status, and recovery-related discrimination) in explaining observed disparities. 2. Conduct concurrent qualitative analysis to identify the top three strategies that participants report having used to resolve their alcohol or other drug problem (e.g., social support, secure accommodations, mental and physical health, financial management, employment, and recreation) and compare these strategies according to racial/ethnic characteristics. Mix the qualitative and quantitative data to determine if race/ethnicity is associated with themes identified in the recovery strategies. (F.220) 8. Project Narrative Despite 30 years of research documenting the disproportionate burden that alcohol and other drug (AOD)- related problems have on non-White racial/ethnic groups, the degree to which racial/ethnic health disparities negatively impact emerging standards for assessing the effectiveness of AOD treatments ( 5 years AOD problem resolution), which is when the risk of problematic use is no higher than in the general population, is unknown. This F32 postdoctoral training will aid the applicant in documenting US prevalence estimates of the number of non-White individuals who have resolved an AOD problem using data from the first nationally representative, probability-based, study of recovery. Specifically, the candidate will investigate the associations between race/ethnicity and stages of AOD problem resolution in the: 1. duration between onset of AOD problems and onset of problem resolution; and, 2. the likelihood of achieving stable long-term problem resolution. In doing so, we will establish the first line of nationally representative research on health equality in long-term AOD problem resolution and associated recovery-related mechanisms, ultimately translating findings into actionable targets for clinicians, policy, and public health proposals that can address the identified disparities.",Racial and ethnic disparities in alcohol and other drug use disorder recovery,9765118,F32AA025823,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Alcohols ', ' Alcohol Chemical Class ', ' Capital ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Discrimination ', ' Cognitive Discrimination ', ' Pharmacotherapy ', ' Drug Therapy ', ' drug treatment ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Economics ', ' Employment ', ' Ethnic group ', ' ethnicity group ', ' Occupational activity of managing finances ', ' Financial Management ', ' Health ', ' Health Policy ', ' health care policy ', ' healthcare policy ', ' Recording of previous events ', ' History ', ' Incidence ', ' indexing ', ' Health Insurance ', ' health insurance plan ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Mental Health Services ', ' Mental Hygiene Services ', ' Methods ', ' Methodology ', ' Online Systems ', ' On-Line Systems ', ' online computer ', ' web based ', ' Probability ', ' Probability Samples ', ' Public Health ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Recreation ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Science ', ' Social support ', ' social support network ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Translating ', ' Measures ', ' Mediating ', ' Socio-economic status ', ' socio-economic position ', ' socioeconomic position ', ' Socioeconomic Status ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Clinical ', ' Phase ', ' Evaluation ', ' Training ', ' Individual ', ' Recovery ', ' Policies ', ' drug use ', ' Drug usage ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Knowledge ', ' Insurance Status ', ' Insurance Coverage ', ' Severities ', ' physical health ', ' physical conditioning ', ' psychosocial ', ' Services ', ' Structure ', ' novel ', ' Participant ', ' General Public ', ' General Population ', ' Reporting ', ' Sampling ', ' behavioral health ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Qualitative Research ', ' disparity in health ', ' health disparity ', ' Effectiveness ', ' Mediator ', ' Mediator of Activation ', ' Mediator of activation protein ', ' Address ', ' Data ', ' Resolution ', ' Strategic Planning ', ' Non-Hispanic ', ' Nonhispanic ', ' Not Hispanic or Latino ', ' Characteristics ', ' Process ', ' designing ', ' design ', ' Minority ', ' alcohol and other drug ', ' Outcome ', ' alcohol related problem ', ' Population ', ' Prevalence ', ' NIAAA ', ' National Institute on Alcohol Abuse and Alcoholism ', ' postdoctoral training ', ' post-doctoral training ', ' racial and ethnic ', ' demographics ', ' service utilization ', ' addictive disorder ', ' addiction ', ' racial and ethnic disparities ', ' alcohol consequences ', ' Secure ', ' screening ', ' ethnic health disparity ', ' service programs ', ' ']",NIAAA,MASSACHUSETTS GENERAL HOSPITAL,F32,2020,74130,0.037463982941195906
"Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border     DESCRIPTION (provided by applicant): The proposed project is a research collaboration between the University of Texas at El Paso, The Alliance for Border Collaborative and Program Comparers to adapt, implement, and evaluate a multi-level, community-based, HIV prevention intervention (Project Encuentro). The intervention will target active heroin and crack users and consists of increasing access to HIV testing via a social network HIV testing component and reducing sexual and drug use risk via a peer network brief behavioral Intervention. Encuentro also consists of conducting community awareness meeting to target structural factors affecting HIV risk. The intervention was developed in an area severely affected by violence and stigma towards drug users, El Salvador, which makes it particularly suitable for adaptation to meet the needs of drug users living in the proposed intervention site, the U.S.-Mexico border. The proposed intervention site also has been severely affected by violence which has curtailed any prior attempts to reduce the risk drug users' HIV risk. Violence has worsened structural factors which affect HIV risk such as, increasing police persecution and stigma and reducing access to resources. In our proposed project, we will engage in formative research to understand the context of HIV risk of drug users in the border region post violence and adapt the intervention accordingly. Findings will allow us to tailor intervention components to meet the needs of drug users in the region. Subsequently, we propose to test intervention effectiveness and evaluate implementation barriers and facilitators. To accomplish our project aims we will use a mixed qualitative, quantitative approach. We will begin with a formative phase by conducting in-depth interviews with drug users (n = 40) living in the region to understand how the context of drug use risk changed as a result of the violence and will administer a social network survey (n = 200) to characterize the configuration of risk networks. Findings will yield the necessary information to culturally adapt the intervention to meet the needs of drug users in the region and will help us focus our recruitment efforts where the riskiest networks are located. After the intervention is adapted with the help of our community advisory board and our community coalition, we will implement the intervention and will assess the effectiveness and reach via 6 cross-sectional surveys administered to drug users (n=1,200). We will assess the process of implementation by conducting ethnographic field notes of all intervention activities including community engagement and CAB and coalition meetings. We will assess the fidelity and quality of the intervention. Lastly, we will conduct key informant interviews with key stakeholders involved in the project and interviews and observations will be coded to reflect key systems factors related to successful implementation of intervention components in two intervention sites (El Paso, Texas and Ciudad Juarez, Mexico). Findings will be highly significant as we will be conducting parallel research on the effectiveness of interventions shown to be effective in Latino drug users in two very different contexts: El Salvador and the U.S-Mexico border. Findings will elucidate implementation challenges and barriers and such information can then be used to assess the effectiveness of diverse implementation strategies in organizations working to serve the needs of Latino drug users. PUBLIC HEALTH RELEVANCE: Findings will be highly significant as we will be conducting parallel research on the effectiveness of interventions shown to be effective in Latino drug users in two very different contexts: El Salvador and the U.S- Mexico border.",Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border,9844416,U01MD010657,"['Affect ', ' Awareness ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Cities ', ' Communities ', ' Cross-Sectional Studies ', ' Cross Sectional Analysis ', ' Cross-Sectional Analyses ', ' Cross-Sectional Survey ', ' Disease Frequency Surveys ', ' Heroin ', ' Diacetylmorphine ', ' Diamorphine ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' El Salvador ', ' Epidemic ', ' Equipment ', ' Explosion ', ' Face ', ' faces ', ' facial ', ' Fright ', ' Fear ', ' Feedback ', ' Goals ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' HIV Infections ', ' HTLV-III Infections ', ' HTLV-III-LAV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' Immigration ', ' Interview ', ' Mexico ', ' Mission ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk ', ' Social Environment ', ' social climate ', ' social context ', ' socioenvironment ', ' socioenvironmental ', ' Social support ', ' social support network ', ' Surveys ', ' Survey Instrument ', ' Syringes ', ' Testing ', ' Texas ', ' Time ', ' Universities ', ' Violence ', ' violent ', ' violent behavior ', ' Police ', ' Latino ', ' Risky Behavior ', ' at risk behavior ', ' Risk Behaviors ', ' HIV Prevention ', ' HIV/AIDS prevention ', ' AIDS prevention ', ' Social Network ', ' ethnographic ', ' Ethnography ', ' Job Location ', ' Job Place ', ' Job Setting ', ' Job Site ', ' Work Location ', ' Work Place ', ' Work-Site ', ' Worksite ', ' work setting ', ' Workplace ', ' base ', ' Site ', ' Area ', ' Phase ', ' Series ', ' Evaluation ', ' Border Crossings ', ' drug use ', ' Drug usage ', ' Syringe-Exchange Programs ', ' needle exchange ', ' syringe exchange ', ' syringe exchange services ', ' syringe service programs ', ' Needle-Exchange Programs ', ' Collaborations ', ' fluid ', ' liquid ', ' Liquid substance ', ' PWUD ', ' people who use drugs ', ' people who use illicit drugs ', ' persons who use drugs ', ' Drug user ', ' programs ', ' Event ', ' Side ', ' System ', ' Country ', ' meetings ', ' experience ', ' metropolitan ', ' Structure ', ' Participant ', ' member ', ' Prevention ', ' social ', ' HIV risk ', ' Coding System ', ' Code ', ' response ', ' stigma ', ' social stigma ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Risk Reduction ', ' disparity in health ', ' health disparity ', ' Effectiveness ', ' AIDS test ', ' AIDS/HIV test ', ' HIV test ', ' HIV-1 test ', ' HIV-2 test ', ' Human immunodeficiency virus test ', ' Address ', ' Effectiveness of Interventions ', ' International ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Preventative intervention ', ' Prevention intervention ', ' preventional intervention strategy ', ' Preventive Intervention ', ' Process ', ' sex ', ' informant ', ' substance abuse therapy ', ' substance abuse treatment ', ' designing ', ' design ', ' community organizations ', ' community based design ', ' community based research ', ' participatory action research ', ' community based participatory research ', ' implementation science ', ' combat ', ' public health relevance ', ' injection drug use ', ' peer networks ', ' violent crime ', ' recruit ', ' Injections ', ' heroin intake ', ' heroin use ', ' implementation strategy ', ' effectiveness testing ', ' ']",NIMHD,UNIVERSITY OF TEXAS EL PASO,U01,2020,412947,0.136020208412757
"Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care Hispanic adolescents in the U.S. experience significant health disparities, particularly as it relates to drug use, unsafe sexual behaviors and sexually transmitted infections (STIs). In spite of these disparities, a paucity of effective preventive interventions exist for Hispanic adolescents, and even fewer have been disseminated widely (IOM/NRC, 2009). Given that primary care settings are increasingly becoming the entry-point through which parents bring youth with behavioral health concerns, adolescent primary care settings represent ideal, yet underutilized, settings in which to disseminate evidence-based preventive interventions. Preventive interventions which target risk and protective factors within the family, the most proximal and fundamental social system influencing human behavior, have been found to be among the most efficacious interventions in preventing and reducing drug use and sexual risk behaviors.  Familias Unidas is a Hispanic-specific, family-based intervention found to be efficacious and effective in preventing and reducing drug use, sexual risk behaviors, and self-reported STIs. Familias Unidas has been cited by the Institute of Medicine report on Preventing, Emotional, and Behavioral among Young People as ready for broad dissemination (IOM/NRC, 2009). To date, however, Familias Unidas has been only tested for efficacy and effectiveness in schools and has not been evaluated for efficacy/effectiveness in primary care. We have adapted and evaluated Familias Unidas for online delivery; successfully retaining 80% of Hispanic parents and their youth (recruited from schools) in the online, eHealth adaptation of Familias Unidas. We have also demonstrated the feasibility and acceptability of delivering eHealth Familas Unidas in primary care.  Evaluating innovative eHealth family-based interventions for Hispanic youth whose feasibility and acceptability is established in primary care settings is timely and of high public health significance. Therefore, the proposed study's overarching aim is to evaluate the relative effectiveness and cost effectiveness of eHealth Familias Unidas, compared to a referral to the National Institute Drug Abuses (NIDA) online information page for parents of Hispanic youth (referred hereafter as NIDA Online Information). To test the effectiveness of eHealth Familias Unidas Primary Care in preventing drug use, unprotected sexual behavior, and STIs in a universal sample of Hispanic youth, this study will randomize 456 Hispanic youth and their parents to eHealth Familias Unidas or to NIDA Online Information. Participants will be assessed at baseline, 6, 12, 24, and 36 months post baseline. Study hypotheses are that: 1) eHealth Familias Unidas will be effective, relative to NIDA Online Information, in preventing/reducing drug use, unprotected sexual behavior, and STI incidence in Hispanic adolescents over time and 2) Intervention effects will be partially mediated by family functioning for drug use and unprotected sexual behavior and by family functioning and unprotected sexual behavior for STI incidence. The cost effectiveness of eHealth Familias Unidas over a three year follow up will also be estimated. The proposed study will evaluate the effectiveness of an eHealth adaptation of an evidence-based face-to- face preventive intervention for Hispanic youth, in preventing drug use, sexual risk behaviors, and sexually transmitted diseases in primary care settings. The knowledge expected to be gained in this study will have strong implications for the delivery of prevention interventions in primary care, as well as contribute to the reduction of drug and sexual risk behavior related to disparities seen in Hispanic youth.",Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care,9919521,R01DA040756,"['Acculturation ', ' Cultural Assimilation ', ' Behavior ', ' Behavior Disorders ', ' behavioral disorder ', ' Mental disorders ', ' Mental health disorders ', ' Psychiatric Disease ', ' Psychiatric Disorder ', ' mental illness ', ' psychiatric illness ', ' psychological disorder ', ' Chlamydia ', ' Miyagawanella ', ' bedsonia ', ' Climate ', ' Meteorological Climate ', ' climatic ', ' Conflict (Psychology) ', ' Conflict ', ' cost effectiveness ', ' Professional counselor ', ' Counselor ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Family ', ' Gonorrhea ', ' Gonococcal Infection ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' Human ', ' Modern Man ', ' Incidence ', ' Institute of Medicine (U.S.) ', ' Institute of Medicine ', ' NAS/IOM ', ' Leadership ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Nurses ', ' nurse ', ' Parents ', ' Physicians ', ' Primary Health Care ', ' Primary Care ', ' Primary Healthcare ', ' Public Health ', ' Risk ', ' Risk Factors ', ' Schools ', ' Sex Behavior ', ' Sexual Activity ', ' Sexual Behavior ', ' sex activity ', ' Sexually Transmitted Diseases ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Infection ', ' Venereal Diseases ', ' Venereal Disorders ', ' Venereal Infections ', ' Staff Attitudes ', ' Time ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' Hispanic Populations ', ' Latino Population ', ' Spanish Origin ', ' hispanic community ', ' Hispanics ', ' Latino ', ' Mediating ', ' Youth 10-21 ', ' Youth ', ' Caring ', ' base ', ' improved ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' white American ', ' caucasian American ', ' pediatric ', ' Childhood ', ' Emotional disorder ', ' drug use ', ' Drug usage ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' Knowledge ', ' Frequencies ', ' Clinic ', ' System ', ' High-Risk Sex ', ' Unprotected Sex ', ' condomless intercourse ', ' condomless sex ', ' unprotected intercourse ', ' Unsafe Sex ', ' experience ', ' Participant ', ' member ', ' Self-Report ', ' Patient Self-Report ', ' Reporting ', ' social ', ' Emotional ', ' Sampling ', ' behavioral health ', ' junior high ', ' middle school ', ' junior high school ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' drug addiction prevention ', ' drug use prevention ', ' prevent drug abuse ', ' prevent drug addiction ', ' prevent drug use ', ' drug abuse prevention ', ' disparity in health ', ' health disparity ', ' Effectiveness ', ' preventing ', ' prevent ', ' Mediator ', ' Mediator of Activation ', ' Mediator of activation protein ', ' Data ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Preventative intervention ', ' Prevention intervention ', ' preventional intervention strategy ', ' Preventive Intervention ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Non-Hispanic ', ' Nonhispanic ', ' Not Hispanic or Latino ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' Behavioral ', ' Health Care Professional ', ' Healthcare professional ', ' Health Professional ', ' care services ', ' care systems ', ' Outcome ', ' cost effective ', ' innovate ', ' innovative ', ' innovation ', ' evidence base ', ' primary care setting ', ' intervention effect ', ' efficacy testing ', ' e-Health ', ' eHealth ', ' parent-adolescent communication ', ' relative effectiveness ', ' relative cost ', ' recruit ', ' protective factors ', ' sex risk behavior ', ' sexual risk behavior ', ' cost estimation ', ' cost estimate ', ' effectiveness testing ', ' evaluate effectiveness ', ' effectiveness evaluation ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2020,755205,0.07929300962446643
"The Implementation, Adoption, and Sustainability of Ho'ouna Pono Project Summary/Abstract  Research has indicated that Native Hawaiian youth have significantly higher rates of drug use than their non-Hawaiian counterparts (e.g., Wong, Klingle, & Price, 2004; Mayeda, Hishinuma, Nishimura, Garcia- Santiago, & Mark, 2006; Nishimura, Hishinuma, & Goebert, 2013), and that these differences are particularly pronounced in rural settings (Saka, Takeuchi, Fagaragan, & Afaga, 2014). Despite these findings, there have been very few drug prevention programs developed and evaluated specifically for these youth (Edwards, Giroux, & Okamoto, 2010; Rehuher, Hiramatsu, & Helm, 2008). Further, efforts to address youth substance abuse have been poorly implemented and coordinated across the State of Hawaii (Waitzfelder, Engel, & Gilbert, 1998). Therefore, the purposes of this R34 proposal are to identify potential barriers or challenges to the implementation, adoption, and sustainability (IAS) of a culturally grounded, school-based drug prevention curriculum (Hoouna Pono) across all public middle, intermediate, or multi-level schools on Hawaii Island, and to create a comprehensive, community-based IAS action plan for the curriculum. This will be accomplished through three specific aims. AIM 1 (Assessing Environmental Demands, Year 1) is to develop and validate an implementation, adoption, and sustainability inventory related to Hoouna Pono, which will be theoretically informed by The Consolidated Framework for Implementation Research (CFIR; Damschroder & Hagedorn, 2011; Powell, Proctor, & Glass, 2014). The inventory will consist of items describing barriers or challenges to the successful adoption, implementation, and/or sustainability of Hoouna Pono on Hawaii Island. AIM 2 (Response Enumeration, Year 2) is to systematically elicit implementation strategies (or solutions) to the most problematic and/or difficult barriers to the IAS of the curriculum in public schools on Hawaii Island, and to rank-order these solutions based on their perceived ability to address or overcome each of the barriers to IAS. AIM 3 (Action Plan, Year 3) is to create a community based and validated action plan based on the findings from Aims 1 and 2, which will be evaluated in a future NIDA R01 grant proposal focused on dissemination and implementation research in health. Project Narrative  Because Hawaiians or part-Hawaiians represent the largest Pacific Islander population in the U.S. (Harris & Jones, 2005) and have been shown to have significantly higher rates of drug use compared with other ethnic groups (Wu et al., 2013), research focused on drug prevention of these individuals is important to improve public health both in Hawaii and on the Mainland U.S. This study actively engages rural public schools and communities in assessing the implementation, adoption, and sustainability of the Hoouna Pono drug prevention curriculum. The findings from this study will point to barriers and challenges to the successful implementation of evidence-based prevention curricula for rural, Pacific Islander, and indigenous communities, as well as to culturally grounded implementation strategies to promote the sustained public health impact of the curriculum.","The Implementation, Adoption, and Sustainability of Ho'ouna Pono",9912147,R34DA046735,"['Adoption ', ' Communities ', ' Educational Curriculum ', ' Curriculum ', ' lesson plans ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Ethnic group ', ' ethnicity group ', ' Faculty ', ' Future ', ' Glass ', ' Grant ', ' Health ', ' Hybrids ', ' Interview ', ' Equipment and supply inventories ', ' Inventory ', ' Island ', ' Literature ', ' Public Health ', ' Research ', ' Schools ', ' Testing ', ' Time ', ' Price ', ' pricing ', ' Administrator ', ' Youth 10-21 ', ' Youth ', ' base ', ' improved ', ' Area ', ' AOD use ', ' substance use ', ' substance using ', ' using substances ', ' Alcohol or Other Drugs use ', ' Individual ', ' Rural ', ' Pacific Islander ', ' Pacific Islander American ', ' Pacific Island Americans ', ' Policies ', ' drug use ', ' Drug usage ', ' Funding ', ' cooking ', ' Hawaiian ', ' Hawaiian population ', ' programs ', ' Pattern ', ' Structure ', ' Prevention ', ' Modeling ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' disparity in health ', ' health disparity ', ' Ground Substance Cytosol ', ' Ground Substance ', ' Effectiveness ', ' Address ', ' Grant Proposals ', ' Applications Grants ', ' Health Sciences ', ' Indigenous ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Population Sciences ', ' Preventative intervention ', ' Prevention intervention ', ' preventional intervention strategy ', ' Preventive Intervention ', ' implementation trial ', ' youth substance abuse ', ' adolescent substance abuse ', ' implementation research ', ' dissemination research ', ' rural disparities ', ' Population ', ' Drug Prevention Program ', ' Evidence based intervention ', ' 2-dimensional ', ' two-dimensional ', ' community based design ', ' community based research ', ' participatory action research ', ' community based participatory research ', ' implementation science ', ' effective intervention ', ' evidence base ', ' efficacy testing ', ' prevent substance use ', ' substance use prevention ', ' population health ', ' secondary analysis ', ' indigenous community ', ' rural locality ', ' rural place ', ' rural setting ', ' Native Hawaiian ', ' clinical implementation ', ' implementation strategy ', ' effectiveness testing ', ' ']",NIDA,HAWAII PACIFIC UNIVERSITY,R34,2020,207485,0.08250259884231641
"Developing and Piloting a School Staff-Based Intervention to Reduce Alcohol and Drug Use Among Sexual Minority Youth PROJECT SUMMARY/ABSTRACT Alcohol and drug use (e.g., tobacco and marijuana use) are major public health problems affecting large proportions of youth. Alcohol and drug use also disproportionately burden certain youth populations, such as sexual minority youth (SMY; i.e., adolescents who identify as gay/lesbian or bisexual, or who have same- gender sexual behaviors or attractions). Compared with heterosexual youth, SMY have up to 600% higher odds of lifetime drug and alcohol use. Despite these substantial disparities, few evidence-based interventions exist for reducing alcohol and drug use among SMY. Nevertheless, SMY who report having supportive adults at school, greater school connectedness, and lower bullying victimization have lower drug and alcohol use. Therefore, an intervention that trains school staff (e.g., teachers, principals, nurses, counselors) to better understand SMY, support SMY, and engage in positive bystander behaviors that protect SMY from bullying victimization may reduce sexual-orientation disparities in drug and alcohol use. Furthermore, many school staff desire to support SMY, but they report a lack of training as their primary impediment. To address these gaps, I will execute two Specific Aims. In Aim #1, I will develop an online e-learning intervention aimed at improving school staffs knowledge, skills, and self-efficacy for supporting SMY. Using the intervention mapping approach, I will develop, user-test, and refine intervention materials by: conducting focus groups with a School Staff Advisory Board; performing usability tests via think aloud interviews with school staff; and collaborating with professional e-learning developers. In Aim #2, I will pilot test the feasibility and preliminary efficacy of this school staff-based intervention using a two-armed cluster-randomized controlled trial. I will enroll high schools participating in the fully-funded survey infrastructure of the MetroWest Adolescent Health Survey (MWAHS), located outside Boston, Massachusetts, where sexual-orientation disparities in drug and alcohol use still exist. Biennially, the MWAHS administers surveys to all students in each school, providing ample student-level data. In tandem, I will collect new longitudinal survey data (baseline and 6-month follow-up) from all school staff within each enrolled school. This e-learning intervention is easily modifiable and economically scalable, making it apt for wide dissemination with the potential for population-level impact in reducing drug and alcohol use disparities. To successfully complete my research, I will acquire training in: (1) the development of stakeholder- informed interventions, particularly e-learning programs; (2) implementation science research; and (3) the design and analysis of experimental studies. Guided by a strong interdisciplinary mentorship team, my planned training activities include mentorship meetings, formal coursework, training institutes, scientific seminars, and research conferences. Upon successful completion of my research and training plans, I will be propelled towards achieving my long-term goal, which is to become an independent scientific researcher specializing in stakeholder-informed intervention science aimed at reducing drug and alcohol use disparities for SMY. PROJECT NARRATIVE The Institute of Medicines 2011 report titled The Health of Lesbian, Gay, Bisexual, and Transgender (LGBT) People calls for the development of evidence-based interventions for reducing sexual minority youths large and persistent disparities in drug and alcohol use. The goals of the proposed research are to develop and pilot test an e-learning intervention that trains school staff to better understand, support, and protect sexual minority youth, and this novel intervention is hypothesized to increase adult support and school connectedness and simultaneously decrease bullying victimization, drug use, and alcohol use among sexual minority youth. Given the dearth of published research on alcohol and drug use interventions for sexual minority youth, this project will provide novel scientific contributions that can help foster health equity for sexual minority youth.",Developing and Piloting a School Staff-Based Intervention to Reduce Alcohol and Drug Use Among Sexual Minority Youth,9928861,K01AA027564,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Alcohol consumption ', ' Alcohol Drinking ', ' EtOH drinking ', ' EtOH use ', ' alcohol ingestion ', ' alcohol intake ', ' alcohol product use ', ' alcohol use ', ' alcoholic beverage consumption ', ' alcoholic drink intake ', ' ethanol consumption ', ' ethanol drinking ', ' ethanol ingestion ', ' ethanol intake ', ' ethanol product use ', ' ethanol use ', ' Alcohols ', ' Alcohol Chemical Class ', ' Behavior ', ' Boston ', ' Clinical Trials ', ' E-learning ', ' computer-assisted instruction ', ' computer-based education ', ' computer-based instruction ', ' computer-based learning ', ' computer-based training ', ' digital education ', ' digital learning ', ' eLearning ', ' electronic learning ', ' internet-assisted education ', ' internet-based training ', ' multimedia learning ', ' on-line education ', ' on-line learning ', ' online education ', ' online learning ', ' technology-enhanced learning ', ' virtual learning ', ' web-based instruction ', ' web-based training ', ' Confidence Intervals ', ' Professional counselor ', ' Counselor ', ' Educational Curriculum ', ' Curriculum ', ' lesson plans ', ' Dropout ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Environment ', ' Feedback ', ' Focus Groups ', ' Goals ', ' Health ', ' Health Surveys ', ' Institute of Medicine (U.S.) ', ' Institute of Medicine ', ' NAS/IOM ', ' Institutes ', ' Intervention Studies ', ' intervention research ', ' interventional research ', ' interventional study ', ' interventions research ', ' Interview ', ' Marijuana ', ' marihuana ', ' Massachusetts ', ' Mentorship ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Nurses ', ' nurse ', ' Public Health ', ' Publishing ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Schools ', ' Science ', ' Sex Behavior ', ' Sexual Activity ', ' Sexual Behavior ', ' sex activity ', ' Students ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Tobacco ', ' Training Activity ', ' training module ', ' Gender ', ' Institutional Policy ', ' conference ', ' convention ', ' summit ', ' symposia ', ' symposium ', ' Longitudinal Surveys ', ' Youth 10-21 ', ' Youth ', ' base ', ' Bi-sexual ', ' Bisexual ', ' career ', ' improved ', ' Site ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' Sexual Orientation ', ' Sex Orientation ', ' Ensure ', ' Training ', ' teacher ', ' Fostering ', ' satisfaction ', ' Policies ', ' drug use ', ' Drug usage ', ' Gays ', ' Lesbian ', ' Funding ', ' Education for Intervention ', ' Instruction Intervention ', ' Training Intervention ', ' instructional intervention ', ' Educational Intervention ', ' Randomized Controlled Trials ', ' Knowledge ', ' programs ', ' Victimization ', ' bully ', ' bullying ', ' Protocol ', ' Protocols documentation ', ' Tobacco Consumption ', ' Tobacco use ', ' meetings ', ' preference ', ' experience ', ' high school ', ' Self Efficacy ', ' Structure ', ' skills ', ' novel ', ' peer ', ' Reporting ', ' Sampling ', ' stigma ', ' social stigma ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Qualitative Research ', ' Address ', ' Consent ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' Population Intervention ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Career Development Awards ', ' Career Development Awards and Programs ', ' Career Development Programs K-Series ', ' K-Awards ', ' Research Career Program ', ' K-Series Research Career Programs ', ' Research Training ', ' enroll ', ' Enrollment ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' Heterosexuals ', ' designing ', ' design ', ' Population ', ' Evidence based intervention ', ' experimental analysis ', ' multidisciplinary ', ' usability ', ' implementation science ', ' develop therapy ', ' intervention development ', ' treatment development ', ' therapy development ', ' high risk ', ' population based ', ' reduced alcohol use ', ' health equity ', ' IRB ', ' IRBs ', ' Institutional Review Boards ', ' sexual minority ', ' LGBT ', ' Lesbian Gay Bisexual Transgender ', ' THC co-use ', ' THC use ', ' Tetrahydrocannabinol co-use ', ' Tetrahydrocannabinol use ', ' cannabis use ', ' marijuana use ', ' adolescent health ', ' experiment ', ' experimental research ', ' experimental study ', ' Infrastructure ', ' ']",NIAAA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K01,2020,153930,0.05005006525774009
"Reducing Black Men's Drug Use and Co-Occurring Negative Mental and Physical Health Outcomes: Intersectionality, Social-Structural Stressors, and Protective Factors PROJECT SUMMARY/ABSTRACT Health inequities among Black men in the U.S. are stark. Drug use contributes to six of the top ten leading causes of death among Black men ages 18 to 54. Social-structural stressors such as discrimination, based on race or race and sexual identity, and drug use to cope with stress, are well-documented pathways to drug use among Black adults. Empirical evidence that drug use co-occurs with other negative health outcomes underscores an urgent public health need to examine drug use and other co-occurring negative health outcomes associated with social-structural stressors. Single-axis perspectiveseither race or sexual identity dominate drug use and health disparities research. Apart from HIV/AIDS research, research on the effects of social-structural stressors on Black mens drug use and co-occurring negative health outcomes at the intersection of sexual identity (i.e., heterosexual, sexual minority) and socioeconomic position (SEP) is virtually nonexistent. Critical gaps also exist about how protective factors (e.g., resilience, religiosity, positive racial/sexual identity) influence the effects of social-structural stressors on Black mens drug use and co- occurring negative health outcomes. To address these critical gaps, a longitudinal cross-lagged explanatory- sequential (QUANTqual) mixed methods study is proposed to test, via structural equation modeling, a conceptual model of social-structural stressors, protective factors, and drug use (alcohol, marijuana, nicotine, illicit drug use) and co-occurring negative mental (e.g., psychological distress) and physical (e.g., blood pressure) health outcomes among Black men at the intersection of sexual identity and SEP. Purposive quota sampling will be used to recruit 960 Black men, ages 18-54, stratified by sexual identity and SEP (240/group) in Washington, DC. Phase I includes the collection of self-reported social-structural stressors, protective factors, drug use, and mental health data, and objective drug use (i.e., urine toxicology) and physical health (e.g., blood pressure) data at Time 1, and 3 months later at Time 2 (Aims 1, 2). Blood samples will be collected at Time 2 only to assess cardiovascular disease biomarkers (e.g., total cholesterol). Phase II includes 4 focus groups with 6-8 Phase I participants (total n = 24 to 32) purposively sampled to explain Phase I results (Aim 3). Phase III involves a synthesis and validity assessment of the quantitative and qualitative results (Aim 3). The proposed research uses intersectionality, social-structural stress, and resilience theoretical frameworks to advance new and important knowledge about the extent to which social-structural stressors and protective factors influence drug use and co-occurring negative health outcomes among Black men at the intersection of sexual identity and SEP. This intersectional focus represents a paradigmatic shift from conventional single-axis and one-size-fits-all intervention approaches. The significance of the proposed research lies in the expected outcome of the future development of multi-level (i.e., individual and social-structural) interventions to reduce drug use and promote mental and physical health among Black men at different intersectional positions of risk. PROJECT NARRATIVE The proposed explanatory-sequential (QUANTqual) mixed-methods longitudinal cross-lagged study is relevant to public health because, in alignment with the NIDA Epidemiology Research Branchs mission, it advances new knowledge about the effects of social-structural stressors and protective factors on drug use and co-occurring negative mental and physical health outcomes for Black men at the intersection of sexual identity and socioeconomic position (SEP). A significant benefit of the proposed research is that it will have broad translational importance for future health disparities research and interventions designed to reduce drug use and health disparities among and between populations at multiple marginalized intersectional positions (e.g., race, gender, sexual identity, and SEP). The project advances new horizons about the effects of intersectional positions and related social-structural stressors and protective factors on drug use and co- occurring negative mental and physical health outcomes that conventional single-axis (e.g., either race or sexual identity) approaches obscure.","Reducing Black Men's Drug Use and Co-Occurring Negative Mental and Physical Health Outcomes: Intersectionality, Social-Structural Stressors, and Protective Factors",9906886,R01DA045773,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Age ', ' ages ', ' Alcohol consumption ', ' Alcohol Drinking ', ' EtOH drinking ', ' EtOH use ', ' alcohol ingestion ', ' alcohol intake ', ' alcohol product use ', ' alcohol use ', ' alcoholic beverage consumption ', ' alcoholic drink intake ', ' ethanol consumption ', ' ethanol drinking ', ' ethanol ingestion ', ' ethanol intake ', ' ethanol product use ', ' ethanol use ', ' Alcohols ', ' Alcohol Chemical Class ', ' Blood Pressure ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cause of Death ', ' Cholesterol ', ' Discrimination ', ' Cognitive Discrimination ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Focus Groups ', ' Future ', ' Health ', ' Heart Diseases ', ' Cardiac Diseases ', ' Cardiac Disorders ', ' heart disorder ', ' Homicide ', ' Marijuana ', ' marihuana ', ' men ', "" men's "", ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Methods ', ' Mission ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Nicotine ', ' Political Factor ', ' Public Health ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Research ', ' Research Design ', ' Study Type ', ' study design ', ' Research Support ', ' Risk ', ' Stress ', ' Suicide ', ' fatal attempt ', ' fatal suicide ', ' intent to die ', ' suicidality ', ' Testing ', ' Time ', ' Toxicology ', ' Urine ', ' Urine Urinary System ', ' Washington ', ' Gender ', ' Police ', ' Socio-economic status ', ' socio-economic position ', ' socioeconomic position ', ' Socioeconomic Status ', ' Unintentional Injury ', ' Accidental Injury ', ' base ', ' Bi-sexual ', ' Bisexual ', ' Blood Sample ', ' Blood specimen ', ' Area ', ' incarcerated ', ' incarceration ', ' Imprisonment ', ' Phase ', ' Economical Factors ', ' Economic Factors ', ' mental ', ' Psyche structure ', ' Individual ', ' Inequality ', ' drug use ', ' Drug usage ', ' Gays ', ' Knowledge ', ' Dependence ', ' Pattern ', ' physical health ', ' physical conditioning ', ' Equation ', ' experience ', ' stressor ', ' Structure ', ' Participant ', ' Self-Report ', ' Patient Self-Report ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' social position ', ' social standing ', ' Social status ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Epidemiological Studies ', ' Epidemiology Research ', ' epidemiologic investigation ', ' epidemiology study ', ' Reporting ', ' Position ', ' Positioning Attribute ', ' AIDS/HIV ', ' HIV/AIDS ', ' HIV/AIDS problem ', ' AIDS/HIV problem ', ' psychological distress ', ' Modeling ', ' Sampling ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' disparity in health ', ' health disparity ', ' low SES ', ' low socio-economic position ', ' low socio-economic status ', ' low socioeconomic position ', ' low socioeconomic status ', ' Address ', ' Data ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Collection ', ' Process ', ' developmental ', ' Development ', ' Heterosexuals ', ' pathway ', ' Pathway interactions ', ' MSM ', ' men who have sex with other men ', ' men who have sex with men ', ' virtual ', ' resilience ', ' Outcome ', ' stress resilience ', ' Population ', "" men's health "", ' male health ', ' multidisciplinary ', ' intervention design ', ' treatment design ', ' therapy design ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' sexual minority ', ' health data ', ' illicit drug use ', ' racial identity ', ' intersectionalities ', ' intersectionality ', ' recruit ', ' protective factors ', ' sexual identity ', ' social factors ', ' social structural ', ' socio-structural ', ' sociostructural ', ' social structure ', ' ']",NIDA,GEORGE WASHINGTON UNIVERSITY,R01,2020,634836,0.10473788718971687
"Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges This is a proposal to renew funding of the Center for Drug Use and HIV Research (CDUHR) for years 21- 25. Recent advances in HIV biomedical and behavioral science have been shown to reduce HIV incidence and allow HIV-positive persons to reach near-normal lifespans. These achievements have led UNAIDS, the US and several local governments to propose strategies for Ending the HIV Epidemic. Notwithstanding these successes, attaining this goal among people who use drugs (PWUD) will require addressing a number of important existing barriers. The overall theme of this renewal is Ending HIV/AIDS among People who use Drugs: Overcoming Challenges. We define Ending HIV/AIDS as reducing new infections and increasing the proportion of PWUD who are virally suppressed. To accomplish this, we have identified these research priorities, which directly address the most significant challenges: (1) Devise new strategies to overcome emerging and persistent barriers to ending HIV/AIDS among PWUD. Barriers include recent increases in prescription opioid misuse, which have given rise to a new generation of heroin user and injectors, and lack of attention to the key role of substance use in new infections in men who have sex with men and heterosexuals. HIV-positive PWUD also experience disparities all along the continuum of HIV care, including delayed diagnosis, lower retention in care, delayed initiation of ART and poorer disease outcomes. (2) Conduct research on effective ways to broadly implement evidence-based interventions. HIV prevention and care programs for PWUD do not exist in many regions of the US and the rest of the world where they are needed most, and they are rarely implemented at public-health scale. (3) Develop new, innovative models of prevention and treatment interventions to address substance-use related disparities in HIV infection and treatment outcomes that take into account the complex, multilevel nature of HIV among PWUD.  We have made significant changes in our scope and structure for this renewal, and we will achieve our aims through five Cores, an Administrative Core and four Research Support Cores: (1) Infectious Disease Epidemiology and Theory, (2) Transdisciplinary Research Methods, (3) Dissemination and Implementation, and (4) Pilot Projects and Mentoring. These Cores support our research base and affiliated investigators to conduct cutting-edge science and enhance synergy across investigators from multiple disciplines, thereby leading to contributions to the field that are beyond what the individual projects could have achieved. In addition to the many successful initiatives that have been developed over CDUHR's history, new activities were added to respond to the evolving needs of our investigators. Also, in addition to our ongoing commitment to train new investigators to conduct high-impact research, we will collaborate with investigators in areas where HIV epidemics are occurring among PWUD (in rural and middle America, and in eastern Europe and Asia), building on our collective knowledge and expertise to advance toward Ending HIV/AIDS in those regions. Project Narrative A critical time has been reached in the course of the HIV epidemic, when the possibility to end HIVAIDS has been raised. Despite advances in biomedical treatments and behavioral interventions to reduce HIV incidence and its impact, people who use drugs (PWUD) have poorer outcomes. The Center provides a research infrastructure to enhance the productivity, synergy and impact of the research by affiliated investigators working to End HIV/AIDS among PWUD.",Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges,9851851,P30DA011041,"['Achievement ', ' Achievement Attainment ', ' Americas ', ' Attention ', ' Behavior ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Behavioral Sciences ', ' Biology ', ' Communities ', ' Heroin ', ' Diacetylmorphine ', ' Diamorphine ', ' Diagnosis ', ' Diagnostic Services ', ' diagnosis service ', ' Disease Outbreaks ', ' Outbreaks ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Economics ', ' Emergency Situation ', ' Emergencies ', ' Epidemic ', ' Eastern Europe ', ' Evolution ', ' Face ', ' faces ', ' facial ', ' Far East ', ' East Asia ', ' Eastern Asia ', ' Future ', ' Goals ', ' Greece ', ' Recording of previous events ', ' History ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' HIV Infections ', ' HTLV-III Infections ', ' HTLV-III-LAV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HIV Seropositivity ', ' Anti-HIV Positivity ', ' HIV Positive ', ' HIV Positivity ', ' HIV Seroconversion ', ' HIV antibody positive ', ' HTLV-III Seroconversion ', ' HTLV-III Seropositivity ', ' Incidence ', ' Income ', ' Economic Income ', ' Economical Income ', ' Indiana ', ' Infection ', ' Light ', ' Photoradiation ', ' Longevity ', ' Length of Life ', ' life span ', ' lifespan ', ' Mentors ', ' Methods ', ' Local Government ', ' Persons ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' New York ', ' Perception ', ' Pilot Projects ', ' pilot study ', ' Play ', ' Productivity ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Research Support ', ' Rest ', ' Risk ', ' Role ', ' social role ', ' Science ', ' Stigmatization ', ' Time ', ' ranpirnase ', ' P-30 Protein ', ' P30 ', ' P30 Protein ', ' Generations ', ' Treatment outcome ', ' Research Methods ', ' Research Methodology ', ' HIV Prevention ', ' HIV/AIDS prevention ', ' AIDS prevention ', ' Caring ', ' base ', ' improved ', ' Left ', ' Area ', ' Medical ', ' Training ', ' Discipline ', ' AOD use ', ' substance use ', ' substance using ', ' using substances ', ' Alcohol or Other Drugs use ', ' Individual ', ' Rural ', ' Policies ', ' Inequality ', ' drug use ', ' Drug usage ', ' Funding ', ' PWUD ', ' people who use drugs ', ' people who use illicit drugs ', ' persons who use drugs ', ' Drug user ', ' Nature ', ' Research Priority ', ' Knowledge ', ' programs ', ' Complex ', ' Distant ', ' Route ', ' System ', ' Country ', ' Viral ', ' Injection Drug User ', ' PWID ', ' people who inject drugs ', ' people who inject illicit drugs ', ' persons who inject drugs ', ' Injecting drug user ', ' Services ', ' experience ', ' success ', ' synergism ', ' Heroin Users ', ' austin ', ' Structure ', ' Disease Outcome ', ' prevention service ', ' Prevention ', ' social ', ' AIDS/HIV ', ' HIV/AIDS ', ' HIV/AIDS problem ', ' AIDS/HIV problem ', ' HIV risk ', ' Modeling ', ' theories ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' HIV diagnosis ', ' disparity in health ', ' health disparity ', ' Address ', ' Health system ', ' Evidence based practice ', ' Infectious Epidemiology ', ' Infectious Disease Epidemiology ', ' International ', ' Interruption ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Research Infrastructure ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Transmission ', ' transmission process ', ' Characteristics ', ' Heterosexuals ', ' MSM ', ' men who have sex with other men ', ' men who have sex with men ', ' Outcome ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' Evidence based intervention ', ' public health research ', ' recruit ', ' treatment services ', ' Injections ', ' heroin intake ', ' heroin use ', ' non-medical use of prescription opiates ', ' non-medical use of prescription opioids ', ' nonmedical use of prescription opiates ', ' nonmedical use of prescription opioids ', ' opioid analgesic misuse ', ' opioid medication misuse ', ' opioid prescription medication misuse ', ' prescription opiate misuse ', ' prescription opioid misuse ', ' Infrastructure ', ' social structural ', ' socio-structural ', ' sociostructural ', ' social structure ', ' ']",NIDA,NEW YORK UNIVERSITY,P30,2020,2439803,0.059589963761982494
"Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM) PROJECT SUMMARY/ABSTRACT  This application is for a competing renewal of the Center for Prevention Implementation Methodology for HIV and Drug Abuse, a NIDA P30 Center of Excellence. The number of new HIV cases in the US remains stable at 56,000 per year and continues to disproportionately affect some groups, including young men who have sex with men (YMSM), especially from racial/ethnic minorities. The purpose of this methodology center is to develop new methodologies that can be used by federal and local agencies and communities to reduce HIV incidence. Biomedical interventions and strategies, including pre-exposure prophylaxis (PrEP), rapid testing for HIV and early and consistent treatment for persons who are HIV positive (Treatment as Prevention, TasP) have been shown to have high efficacy and effectiveness in reducing HIV transmission, but there remains a giant gap between what research knows and what services needed to reduce population level incidence of HIV. The major premise of this application is that the effective biomedical to reduce HIV incidence and disparities are in hand, but success will only be achieved when they are implemented in ways that meet individual, community, and health care delivery system needs. This methods proposal addresses this major gap between research and practice through implementation science and methodology, focusing on innovative ways to address the complex, mulitilevel interactions needed to implement HIV prevention programs effectively. Two Cores, an Administrative Core and an Innovative Implementation Methods Core for HIV and Drug Abuse will carry out this work.  Aim 1 is to develop innovative methods to maximize the impact of implementation research in HIV prevention. We do this through an extended set of systems science and engineering methods that focus on improving the measurement of implementation, the modeling of implementation strategies, and the testing of implementation strategies through rigorous trials. Five qualifying grants support this work.  Aim 2 is to apply these innovative methods to close the gap between existing research, policy, and practice for HIV prevention. In addition to working closely with our five qualifying grants, we work locally with municipal Departments of Public Health and the federal Substance Abuse and Mental Health Services Administration (SAMHSA) HIV programs to identify and prioritize gaps in knowledge, find optimal implementation strategies for reduction of HIV transmission, and design the next large implementation trials.  Aim 3 is to disseminate methods and train/mentor leaders at the intersection of HIV prevention, implementation science, and drug abuse fields to improve implementation of HIV prevention programs. This involves mentoring the early career researchers, publishing, and providing training to networks of HIV and drug abuse researchers. PROJECT NARRATIVE There are numerous rigorously evaluated prevention programs involving biomedical interventions for preventing HIV that have demonstrated impact in efficacy and effectiveness trials. Pre-exposure prophylaxis, HIV testing, and early and consistent antiretroviral treatment have high potential for preventing HIV infections, but these are yet to be implemented sufficiently in racial/ethnic minority communities. This Ce-PIM addresses the critical methods gaps that are holding back the movement of these programs from research to practice.",Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM),9975784,P30DA027828,"['Affect ', ' Age ', ' ages ', ' Back ', ' Dorsum ', ' Behavior ', ' Biomedical Research ', ' Communities ', ' Decision Making ', ' health care delivery ', ' Healthcare Delivery ', ' health services delivery ', ' Heroin ', ' Diacetylmorphine ', ' Diamorphine ', ' Discrimination ', ' Cognitive Discrimination ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Engineering ', ' Ethnic group ', ' ethnicity group ', ' Feedback ', ' Gender Identity ', ' Goals ', ' Grant ', ' Hand ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Services Accessibility ', ' Access to Care ', ' access to health services ', ' access to services ', ' access to treatment ', ' accessibility to health services ', ' availability of services ', ' care access ', ' health service access ', ' health services availability ', ' service availability ', ' treatment access ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' HIV Infections ', ' HTLV-III Infections ', ' HTLV-III-LAV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HIV Seropositivity ', ' Anti-HIV Positivity ', ' HIV Positive ', ' HIV Positivity ', ' HIV Seroconversion ', ' HIV antibody positive ', ' HTLV-III Seroconversion ', ' HTLV-III Seropositivity ', ' Incidence ', ' Long-Term Care ', ' extended care ', ' longterm care ', ' Mentors ', ' Methamphetamine ', ' Crystal Meth ', ' Deoxyephedrine ', ' Desoxyephedrine ', ' Methylamphetamine ', ' N-Methylamphetamine ', ' Methods ', ' Methodology ', ' Biological Models ', ' Biologic Models ', ' Model System ', ' Movement ', ' body movement ', ' Persons ', ' Play ', ' Public Health ', ' Publishing ', ' Quality of life ', ' QOL ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Research ', ' Research Design ', ' Study Type ', ' study design ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Science ', ' Seeds ', ' Plant Embryos ', ' Plant Zygotes ', ' seed ', ' Technology ', ' Testing ', ' United States Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Substance Abuse and Mental Health Services Administration ', ' Virus ', ' Vision ', ' Sight ', ' visual function ', ' Work ', ' ranpirnase ', ' P-30 Protein ', ' P30 ', ' P30 Protein ', ' Gender ', ' Generations ', ' Community Health Care ', ' Community Healthcare ', ' 3,4 methylenedioxymethamphetamine ', ' MDMA ', ' Methylenedioxymethamphetamine ', ' N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine ', ' N-Methyl-3,4-methylenedioxyamphetamine ', ' ecstasy ', ' HIV Prevention ', ' HIV/AIDS prevention ', ' AIDS prevention ', ' base ', ' career ', ' improved ', ' Sexual Orientation ', ' Sex Orientation ', ' Training ', ' Individual ', ' Policies ', ' Measurement ', ' drug use ', ' Drug usage ', ' Ethnicity ', ' Ethnic Origin ', ' tool ', ' Knowledge ', ' programs ', ' Viral Burden ', ' Viral Load ', ' Viral Load result ', ' Complex ', ' Pattern ', ' System ', ' Services ', ' success ', ' Antiretroviral Agents ', ' anti-retroviral ', ' antiretroviral ', ' Anti-Retroviral Agents ', ' Municipalities ', ' Structure ', ' novel ', ' Prevention program ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Prevention ', ' social ', ' AIDS/HIV ', ' HIV/AIDS ', ' HIV/AIDS problem ', ' AIDS/HIV problem ', ' HIV risk ', ' Early identification ', ' Modeling ', ' stigma ', ' social stigma ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' scientific organization ', ' Effectiveness ', ' preventing ', ' prevent ', ' AIDS test ', ' AIDS/HIV test ', ' HIV test ', ' HIV-1 test ', ' HIV-2 test ', ' Human immunodeficiency virus test ', ' Address ', ' High Prevalence ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Qualifying ', ' Transmission ', ' transmission process ', ' socio-economic ', ' socio-economically ', ' socioeconomically ', ' socioeconomics ', ' developmental ', ' Development ', ' anti-retroviral therapy ', ' anti-retroviral treatment ', ' antiretroviral treatment ', ' antiretroviral therapy ', ' effectiveness trial ', ' implementation trial ', ' MSM ', ' men who have sex with other men ', ' men who have sex with men ', ' implementation research ', ' designing ', ' design ', ' next generation ', ' efficacy trial ', ' Outcome ', ' Approaches to prevention ', ' Prevention approach ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' ethnic minority ', ' ethnic minority population ', ' early therapy ', ' Early treatment ', ' racial and ethnic ', ' implementation science ', ' research into practice ', ' research to practice ', ' cocaine use ', ' YMSM ', ' young MSM ', ' young men who have sex with men ', ' AAMSM ', ' African American MSM ', ' African-American men who have sex with men ', ' BMSM ', ' black MSM ', ' black men who have sex with men ', ' support tools ', ' minority communities ', ' PrEP ', ' pre-exposure prophylaxis ', ' implementation strategy ', ' ']",NIDA,NORTHWESTERN UNIVERSITY AT CHICAGO,P30,2020,1040945,0.08917754346937293
"Drug use disparities among Hispanics: elucidating the complex interactions between socio-cultural, neurocognitive and drug use-related factors Project Summary/Abstract: Hispanic adolescents are disproportionately affected by drug use and its consequences. This is reflected in high rates of school dropouts, arrest for drug possession, alcohol, drug use disorders, disability and drug related crash injuries and fatalities. Mounting evidence suggest that impaired neurocognitive functioning, exposure to early, severe, or chronic social disadvantage, and stress related to conflicting cultural practices, independently predict adverse drug use outcomes. Yet, studies employing an integrated approach to explore how these factors interact to increase or decrease the risk of experiencing adverse drug use consequences are limited. Therefore, the immediate and overarching goal of this K01 application is to receive intensive, supervised career-development training on the intersection between addiction neuroscience and social and cross-cultural research applied to drug use research that will enable me to pursue a line of independent research on drug use disparities. In this application, I propose to investigate how socio- cultural, neurocognitive and drug use related factors interact to explain the adverse outcomes seen in the Hispanic population. The specific aims of the proposed project include: 1) To determine whether neurocognitive factors (e.g., decision-making, episodic memory), mediate the associations between socio-cultural factors (e.g., early, severe, or chronic socio-economic disadvantage, ethnic discrimination, acculturative stress, Hispanic cultural values), and drug use outcomes (e.g. transition from use to drug use disorders, drug use trajectories, driving under the influence of drugs - DIU); 2) To examine whether socio-cultural factors moderate the associations between neurocognitive factors and drug use. These goals will be achieved by leveraging data, participants, and resources from an ongoing longitudinal study (parent study) that assesses decision-making and episodic memory in trajectories to cannabis addiction (R01DA031176), and interviewing a sub-sample of young Hispanics participating in the parent study and their parents or legal guardians (n=200 dyads). The proposed Mentored Research Scientist Development Award will build on my expertise in drug use epidemiology with advanced training in: addiction neuroscience, social and cross-cultural research on drug use disparities, interdisciplinary research on cognitive neuroscience and socio-cultural research, advanced statistical methods for analyzing longitudinal data, and responsible conduct of research. Overseeing this training is my primary mentor Dr. Raul Gonzalez, an expert in addiction neuroscience, and my co-mentor Dr. Mario De La Rosa, an expert in cross-cultural research and drug use disparities. The proposed K01, which is responsive to two of the two priority focus areas identified in the 2016-2020 NIDA Strategic Plan, will provide me with the resources, training, mentoring and knowledge needed to establish myself as a scientist with expertise on the intersection between addiction neuroscience and public health, and to develop a long-term independent transdisciplinary research program aimed at reducing and eliminating drug use disparities across and within minority populations. Project narrative: Socio-cultural and neurocognitive factors are important and potentially modifiable determinants of drug use, yet research examining the how these factors interact to explain drug use disparities is scarce. The proposed K01 training will support a Hispanic new and early stage investigator to become an independent researcher and a leader in interdisciplinary research on drug use disparities. Specifically, the outlined project will contribute to understand how social factors, Hispanic cultural values, neurocognitive processes and drug use related factors interact to explain the adverse drug use outcomes seen in the growing and heterogeneous Hispanic population, which is essential to design effective drug use preventive interventions.","Drug use disparities among Hispanics: elucidating the complex interactions between socio-cultural, neurocognitive and drug use-related factors",9997873,K01DA046715,"['Affect ', ' Alcohols ', ' Alcohol Chemical Class ', ' Clinical Research ', ' Clinical Study ', ' Conflict (Psychology) ', ' Conflict ', ' Decision Making ', ' Drug Use Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Future ', ' Goals ', ' Interview ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Legal Guardians ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Mentors ', ' Mentorship ', ' Neurosciences ', ' Parents ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Stress ', ' Student Dropouts ', ' School Dropouts ', ' Supervision ', ' Testing ', ' Time ', ' Hispanic Populations ', ' Latino Population ', ' Spanish Origin ', ' hispanic community ', ' Hispanics ', ' Mediating ', ' Youth 10-21 ', ' Youth ', ' injuries ', ' Injury ', ' career ', ' improved ', ' Area ', ' Chronic ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' Ensure ', ' Training ', ' disability ', ' pediatric ', ' Childhood ', ' Individual ', ' Interdisciplinary Research ', ' Multidisciplinary Collaboration ', ' Multidisciplinary Research ', ' Interdisciplinary Study ', ' drug use ', ' Drug usage ', ' Exposure to ', ' Cognitive Disturbance ', ' Cognitive Impairment ', ' Cognitive decline ', ' Cognitive function abnormal ', ' Disturbance in cognition ', ' cognitive dysfunction ', ' cognitive loss ', ' Impaired cognition ', ' Knowledge ', ' programs ', ' cognitive function ', ' Scientist ', ' Complex ', ' Dependence ', ' Pattern ', ' Neurocognitive ', ' psychosocial ', ' Episodic memory ', ' experience ', ' knowledgebase ', ' knowledge base ', ' Structure ', ' skills ', ' Participant ', ' Negotiating ', ' Negotiation ', ' Mediation ', ' Applied Science ', ' Applied Research ', ' cultural values ', ' social ', ' methods to study multiple-level influences ', ' multi-level analysis ', ' multi-level model ', ' multilevel model ', ' multilevel modeling ', ' multilevel analysis ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' career development ', ' driving under influence ', ' ethnic discrimination ', ' theories ', ' Adverse Experience ', ' Adverse event ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Cannabis ', ' drug addiction prevention ', ' drug use prevention ', ' prevent drug abuse ', ' prevent drug addiction ', ' prevent drug use ', ' drug abuse prevention ', ' disparity in health ', ' health disparity ', ' Effectiveness ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Mediator ', ' Mediator of Activation ', ' Mediator of activation protein ', ' Address ', ' Data ', ' High Prevalence ', ' K01 Award ', ' K01 Mechanism ', ' K01 Program ', ' Mentored Training Award ', ' Research Scientist Development Award ', ' Mentored Research Scientist Development Award ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Preventative intervention ', ' Prevention intervention ', ' preventional intervention strategy ', ' Preventive Intervention ', ' Strategic Planning ', ' Clinical Data ', ' Cognitive ', ' Process ', ' early onset ', ' early initiation drug use ', ' early onset drug use ', ' designing ', ' design ', ' Minority ', ' IQ Deficit ', ' intelligence quotient deficit ', ' neurocognitive decline ', ' neurocognitive impairment ', ' Neurocognitive Deficit ', ' Outcome ', ' Population ', ' cognitive neuroscience ', ' Cognitive remediation ', ' addictive disorder ', ' addiction ', ' intervention design ', ' treatment design ', ' therapy design ', ' multidisciplinary approach ', ' interdisciplinary approach ', ' longitudinal analysis ', ' responsible research conduct ', ' adverse consequence ', ' adverse outcome ', ' cognitive development ', ' Socioeconomically disadvantaged ', ' socio-economic disadvantage ', ' socio-economically disadvantaged ', ' socio-economically underprivileged ', ' socioeconomically underprivileged ', ' socioeconomic disadvantage ', ' THC co-use ', ' THC use ', ' Tetrahydrocannabinol co-use ', ' Tetrahydrocannabinol use ', ' cannabis use ', ' marijuana use ', ' protective factors ', ' social factors ', ' social disadvantage ', ' socio-cultural ', ' sociocultural ', ' social culture ', ' ']",NIDA,UNIVERSITY OF FLORIDA,K01,2020,157995,0.22159522634227913
"Predictors of hemorrhage among patients on direct acting oral anticoagulants ABSTRACT: Direct acting oral anticoagulants (DOAC), specifically rivaroxaban (RIVA) and apixaban (APX) have emerged as the most commonly used oral anticoagulants, replacing warfarin in patients with atrial fibrillation (AF) and venous thromboembolism (VTE). However, hemorrhage (HEM) is the most feared adverse effect and is a critical barrier to institution of these efficacious therapies. Anticoagulants have consistently ranked as the top offenders for adverse drug event related hospitalizations in the US, with HEM accounting for ~80% of adm is s ions . To predict HEM risk, investigators have developed clinical prediction rules (CPRs) focused mainly on warfarin- related HEM. However, the lack of CPRs for DOAC-related HEM, the variable inclusion of antiplatelets, the lack of assessment of gastro-protective therapies or interacting drugs (influencing APX and RIVA pharmacokinetics), the lack of assessment of risk across the spectrum of kidney function, and the scarce (to nil) representation of Blacks are critical knowledge gaps. Identifying factors contributing to the increased HEM risk among APX and RIVA users and elucidating their impact (effect size) is of critical importance In this application, we aim to identify predictors of HEM risk and define the impact (effect size) in a clinical cohort of medically complex, racially diverse patients on APX (n=1500) and RIVA (N=1500) and develop CPRs for APX-related-HEM and RIVA-related-HEM. Through Aim 1, we will identify and assess the influence of predictors (e.g. demographics, comorbidities) on risk of HEM. In Aim 2, we will elucidate the influence concomitant use of antiplatelet therapy, gastro-protective therapies (proton pump inhibitors and H2 Receptor Blockers) and interacting drugs (amiodarone, diltiazem and verapamil) on risk of HEM among RIVA and APX users. Aim 3 will focus on determining the influence of chronic kidney disease (CKD) spectrum on HEM risk and elucidate steady state pharmacokinetics (PK) and pharmacodynamics (PD) across the spectrum of kidney function among RIVA and APX users. Finally, Aim 4 will incorporate results from Aims 1-3 into building CPRs to personalize the prediction of HEM among APX and RIVA users. The prediction models will validated in an independent cohort (n=500 APX, n=500 RIVA). Our focus on complex patients seen in clinical practice with robust representation of understudied patients (Blacks, patients with moderate and severe-CKD) and assessment of common co-medications improves generalizability and applicability to real world patients. Public health Narrative: Identification of factors that predict risk of hemorrhage among patients taking direct acting oral anticoagulants is vital as it can help identify patients who stand to benefit or be harmed by anticoagulants drugs. The integration of these predictors into the current treatment approach can help provide personalized treatment, improving outcomes for the individual patient. The increasing burden of atrial fibrillation in the US and the world, highlight the immense potential of such research in facilitating the realization of tangible individual and population health benefits.",Predictors of hemorrhage among patients on direct acting oral anticoagulants,9863657,R01HL092173,"['Accounting ', ' Elderly ', ' advanced age ', ' elders ', ' geriatric ', ' late life ', ' later life ', ' older adult ', ' older person ', ' senior citizen ', ' American Heart Association ', ' Amiodarone ', ' Anticoagulants ', ' Anticoagulant Agents ', ' Anticoagulant Drugs ', ' blood thinner ', ' thrombopoiesis inhibitor ', ' Anticoagulation ', ' Atrial Fibrillation ', ' Auricular Fibrillation ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Dialysis procedure ', ' Dialysis ', ' dialysis therapy ', ' Diltiazem ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Fright ', ' Fear ', ' Genotype ', ' Glomerular Filtration Rate ', ' Hemorrhage ', ' Bleeding ', ' blood loss ', ' Hospitalization ', ' Hospital Admission ', ' Ions ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' men ', "" men's "", ' Patients ', ' Drug Kinetics ', ' Pharmacokinetics ', ' Phenotype ', ' Protective Agents ', ' Protective Drugs ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Verapamil ', ' Iproveratril ', ' Warfarin ', ' Health Benefit ', ' Risk Assessment ', ' Anticoagulant Chemotherapy ', ' Anticoagulant therapy ', ' Guidelines ', ' base ', ' improved ', ' Chronic ', ' Clinical ', ' Medical ', ' kidney function ', ' Renal function ', ' Individual ', ' participant recruitment ', ' Patient Recruitments ', ' Exposure to ', ' Proton Pump Inhibitors ', ' Knowledge ', ' Complex ', ' Oral ', ' Equation ', ' cohort ', ' H2 Receptors ', ' Histamine H2 Receptors ', ' H2 gene ', ' Predictive Factor ', ' Drug Interactions ', ' Prevention ', ' Benefits and Risks ', ' criminal offender ', ' offender ', ' Admission ', ' Admission activity ', ' Pharmacodynamics ', ' response ', ' Adverse effects ', ' Pharmacogenomics ', ' Institution ', ' Dose ', ' International ', ' Seminal ', ' Monitor ', ' trend ', ' Characteristics ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' elderly patient ', ' older patient ', ' Prevalence ', ' prospective ', ' Impairment ', ' demographics ', ' high risk ', ' clinical practice ', ' population health ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' clinical predictors ', ' genetic predictors ', ' Adverse drug event ', ' disparities in race ', ' race disparity ', ' racial disparity ', ' individual patient ', ' improved outcome ', ' racially diverse ', ' racial diversity ', ' recruit ', ' Individualized Predictors ', ' individualized predictions ', ' personalized predictors ', ' personalized predictions ', ' risk for stroke ', ' risk of stroke ', ' stroke risk ', ' PK/PD ', ' pharmacokinetics and pharmacodynamics ', ' venous thromboembolism ', ' ']",NHLBI,UNIVERSITY OF ALABAMA AT BIRMINGHAM,R01,2020,742075,-0.0026174372527379267
"Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care Hispanic adolescents in the U.S. experience significant health disparities, particularly as it relates to drug use, unsafe sexual behaviors and sexually transmitted infections (STIs). In spite of these disparities, a paucity of effective preventive interventions exist for Hispanic adolescents, and even fewer have been disseminated widely (IOM/NRC, 2009). Given that primary care settings are increasingly becoming the entry-point through which parents bring youth with behavioral health concerns, adolescent primary care settings represent ideal, yet underutilized, settings in which to disseminate evidence-based preventive interventions. Preventive interventions which target risk and protective factors within the family, the most proximal and fundamental social system influencing human behavior, have been found to be among the most efficacious interventions in preventing and reducing drug use and sexual risk behaviors.  Familias Unidas is a Hispanic-specific, family-based intervention found to be efficacious and effective in preventing and reducing drug use, sexual risk behaviors, and self-reported STIs. Familias Unidas has been cited by the Institute of Medicine report on Preventing, Emotional, and Behavioral among Young People as ready for broad dissemination (IOM/NRC, 2009). To date, however, Familias Unidas has been only tested for efficacy and effectiveness in schools and has not been evaluated for efficacy/effectiveness in primary care. We have adapted and evaluated Familias Unidas for online delivery; successfully retaining 80% of Hispanic parents and their youth (recruited from schools) in the online, eHealth adaptation of Familias Unidas. We have also demonstrated the feasibility and acceptability of delivering eHealth Familas Unidas in primary care.  Evaluating innovative eHealth family-based interventions for Hispanic youth whose feasibility and acceptability is established in primary care settings is timely and of high public health significance. Therefore, the proposed study's overarching aim is to evaluate the relative effectiveness and cost effectiveness of eHealth Familias Unidas, compared to a referral to the National Institute Drug Abuses (NIDA) online information page for parents of Hispanic youth (referred hereafter as NIDA Online Information). To test the effectiveness of eHealth Familias Unidas Primary Care in preventing drug use, unprotected sexual behavior, and STIs in a universal sample of Hispanic youth, this study will randomize 456 Hispanic youth and their parents to eHealth Familias Unidas or to NIDA Online Information. Participants will be assessed at baseline, 6, 12, 24, and 36 months post baseline. Study hypotheses are that: 1) eHealth Familias Unidas will be effective, relative to NIDA Online Information, in preventing/reducing drug use, unprotected sexual behavior, and STI incidence in Hispanic adolescents over time and 2) Intervention effects will be partially mediated by family functioning for drug use and unprotected sexual behavior and by family functioning and unprotected sexual behavior for STI incidence. The cost effectiveness of eHealth Familias Unidas over a three year follow up will also be estimated. The proposed study will evaluate the effectiveness of an eHealth adaptation of an evidence-based face-to- face preventive intervention for Hispanic youth, in preventing drug use, sexual risk behaviors, and sexually transmitted diseases in primary care settings. The knowledge expected to be gained in this study will have strong implications for the delivery of prevention interventions in primary care, as well as contribute to the reduction of drug and sexual risk behavior related to disparities seen in Hispanic youth.",Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care,10140857,R01DA040756,"['Acculturation ', ' Cultural Assimilation ', ' Behavior ', ' Behavior Disorders ', ' behavioral disorder ', ' Mental disorders ', ' Mental health disorders ', ' Psychiatric Disease ', ' Psychiatric Disorder ', ' mental illness ', ' psychiatric illness ', ' psychological disorder ', ' Chlamydia ', ' Miyagawanella ', ' bedsonia ', ' Climate ', ' Meteorological Climate ', ' climatic ', ' Conflict (Psychology) ', ' Conflict ', ' cost effectiveness ', ' Professional counselor ', ' Counselor ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Family ', ' Gonorrhea ', ' Gonococcal Infection ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' Human ', ' Modern Man ', ' Incidence ', ' Institute of Medicine (U.S.) ', ' Institute of Medicine ', ' NAS/IOM ', ' Leadership ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Nurses ', ' nurse ', ' Parents ', ' Physicians ', ' Primary Health Care ', ' Primary Care ', ' Primary Healthcare ', ' Public Health ', ' Risk ', ' Risk Factors ', ' Schools ', ' Sex Behavior ', ' Sexual Activity ', ' Sexual Behavior ', ' sex activity ', ' Sexually Transmitted Diseases ', ' Sexually Transmitted Disorder ', ' Sexually Transmitted Infection ', ' Venereal Diseases ', ' Venereal Disorders ', ' Venereal Infections ', ' Staff Attitudes ', ' Time ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' Hispanic Populations ', ' Latino Population ', ' Spanish Origin ', ' hispanic community ', ' Hispanics ', ' Latino ', ' Mediating ', ' Youth 10-21 ', ' Youth ', ' Caring ', ' base ', ' improved ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' white American ', ' caucasian American ', ' pediatric ', ' Childhood ', ' Emotional disorder ', ' drug use ', ' Drug usage ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' Knowledge ', ' Frequencies ', ' Clinic ', ' System ', ' High-Risk Sex ', ' Unprotected Sex ', ' condomless intercourse ', ' condomless sex ', ' unprotected intercourse ', ' Unsafe Sex ', ' experience ', ' Participant ', ' member ', ' Self-Report ', ' Patient Self-Report ', ' Reporting ', ' social ', ' Emotional ', ' Sampling ', ' behavioral health ', ' junior high ', ' middle school ', ' junior high school ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' drug addiction prevention ', ' drug use prevention ', ' prevent drug abuse ', ' prevent drug addiction ', ' prevent drug use ', ' drug abuse prevention ', ' disparity in health ', ' health disparity ', ' Effectiveness ', ' preventing ', ' prevent ', ' Mediator ', ' Mediator of Activation ', ' Mediator of activation protein ', ' Data ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Preventative intervention ', ' Prevention intervention ', ' preventional intervention strategy ', ' Preventive Intervention ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Non-Hispanic ', ' Nonhispanic ', ' Not Hispanic or Latino ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' Behavioral ', ' Health Care Professional ', ' Healthcare professional ', ' Health Professional ', ' care services ', ' care systems ', ' Outcome ', ' cost effective ', ' innovate ', ' innovative ', ' innovation ', ' evidence base ', ' primary care setting ', ' intervention effect ', ' efficacy testing ', ' e-Health ', ' eHealth ', ' parent-adolescent communication ', ' relative effectiveness ', ' relative cost ', ' recruit ', ' protective factors ', ' sex risk behavior ', ' sexual risk behavior ', ' cost estimation ', ' cost estimate ', ' effectiveness testing ', ' evaluate effectiveness ', ' effectiveness evaluation ', ' ']",NIDA,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2020,98895,0.07929300962446643
"Neuroscience, Immunology, Social Adversity and the Roots of Addictive Behaviors: Toward a New Framework for Drug Use Etiology and Prevention PROJECT SUMMARY: Overall Center The Center for Translational and Prevention Science (CTAPS; P20 MH068666, P30 DA027827) has been funded continuously since 2003 to advance next-generation basic and preventive investigations of risk, resilience, and drug use among African American young people living in resource poor communities in the southeastern US. CTAPS has pioneered research demonstrating how exposures to economic and social adversity promote drug use through their effects on neurobiological and peripheral systems. Of particular importance, research sponsored by CTAPS also has demonstrated the promise of family-centered drug use prevention programming in shielding young people from these neurobiological risks. At present, transformative progress in the prevention of addictive behavior among populations exposed to chronic stress has been hampered significantly by the lack of (a) integrative theoretical frameworks that generate hypotheses regarding the risk and resilience mechanisms that connect social adversity to addictive behavior and cardiometabolic risk, (b) infrastructures that can collect model driven data on multiple neurocognitive, peripheral biological, and behavioral systems associated with chronic stress, and (c) transdisciplinary teams that can integrate these data into the design and evaluation of prevention programs. The theoretical framework of the proposed P50 Research Center of Excellence is a next generation, neuroimmune network (NIN) model that CTAPS scientists developed to better describe the ways in which exposure to social adversity predispose young people to the onset and escalation of diverse forms of addictive behaviors. The NIN model specifies stress-induced alterations in the transactions between peripheral inflammation and neurocognitive systems that subserve emotion regulation in the development of addictive behavior vulnerability. As a P50 Center, we propose to build on and expand CTAPS pioneering work on (a) the biological and neurocognitive contributors to addictive behaviors that drive many drug use and health disparities African Americans experience and (b) the potential of family-centered prevention programming to ameliorate the influence of growing up in chronically stressful contexts. We will leverage an established team of investigators from diverse disciplines and an established infrastructure for testing transdisciplinary hypotheses. This infrastructure includes efficient, established pipelines connecting P50 research project (RP) and pilot study investigators to intellectual resources, wet labs, a state-of-the-science imaging facility, and a world class platform for processing imaging data. We will implement three innovative, thematically integrated RPs. RPs, innovative pilot projects, an expanded national resource system, and investigator development activities will be supported through our infrastructure system composed of a Research Support Core, an Administrative Core, and a Pilot Core. CTAPS activities will have wide-reaching implications for research, practice, and prevention concerning drug use and cardiometabolic risk in low-income and ethnic minority communities. 1 OVERALL CENTER: Project Narrative The proposed P50 application is designed to transform scientific understanding regarding the causes and prevention of addictive behaviors by investigating neuroimmune mechanisms that, in concert with family and contextual factors, affect risk for drug use and abuse. Findings will have far-reaching implications for research, practice, and prevention of drug use in communities across the nation.","Neuroscience, Immunology, Social Adversity and the Roots of Addictive Behaviors: Toward a New Framework for Drug Use Etiology and Prevention",10023720,P50DA051361,"['Adolescence ', ' 12-20 years old ', ' adolescence (12-20) ', ' Affect ', ' Behavior ', ' Buffers ', ' Communities ', ' Consultations ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Eating ', ' Food Intake ', ' Economics ', ' Emotions ', ' Family ', ' Fatty acid glycerol esters ', ' Fats ', ' Food ', ' Food or Food Product ', ' Inflammation ', ' Mentors ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Neurobiology ', ' neurobiological ', ' Neuroimmunomodulation ', ' Neuroimmune Mechanisms ', ' Neuroimmune Processes ', ' Neurosciences ', ' Pilot Projects ', ' pilot study ', ' Poverty ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Research Support ', ' Resources ', ' Research Resources ', ' Risk ', ' Science ', ' Stress ', ' Testing ', ' Work ', ' connective tissue-activating peptide ', ' CTAP ', ' ranpirnase ', ' P-30 Protein ', ' P30 ', ' P30 Protein ', ' Generations ', ' Addictive Behavior ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' Youth 10-21 ', ' Youth ', ' Immunology ', ' career ', ' image processing ', ' Peripheral ', ' Chronic ', ' Specified ', ' Specific qualifier value ', ' Biological ', ' Physiologic ', ' Physiological ', ' Training ', ' pediatric ', ' Childhood ', ' Discipline ', ' sugar ', ' Fostering ', ' drug use ', ' Drug usage ', ' root ', ' Plant Roots ', ' Funding ', ' R-Series Research Projects ', ' R01 Mechanism ', ' R01 Program ', ' Research Grants ', ' Research Projects ', ' Research Project Grants ', ' Exposure to ', ' tool ', ' programs ', ' Scientist ', ' Investigation ', ' Immunes ', ' Immune ', ' System ', ' Neurocognitive ', ' Application Context ', ' contextual factors ', ' experience ', ' Transact ', ' Participant ', ' Prevention program ', ' member ', ' Prevention ', ' social ', ' neural circuitry ', ' neurocircuitry ', ' synaptic circuit ', ' synaptic circuitry ', ' neural circuit ', ' methods to study multiple-level influences ', ' multi-level analysis ', ' multi-level model ', ' multilevel model ', ' multilevel modeling ', ' multilevel analysis ', ' Regulation ', ' Modeling ', ' theories ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' prevention evaluation ', ' Skin ', ' Provider ', ' drug addiction prevention ', ' drug use prevention ', ' prevent drug abuse ', ' prevent drug addiction ', ' prevent drug use ', ' drug abuse prevention ', ' disparity in health ', ' health disparity ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Low income ', ' Preventive ', ' Chronic stress ', ' Data ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' COBRE ', ' Center of Biomedical Research Excellence ', ' Centers of Research Excellence ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' care giving ', ' caregiving ', ' designing ', ' design ', ' next generation ', ' resilience ', ' Population ', ' Consumption ', ' innovate ', ' innovative ', ' innovation ', ' ethnic minority ', ' ethnic minority population ', ' emotional regulation ', ' emotion regulation ', ' network models ', ' evidence base ', ' cardiometabolic risk ', ' vulnerability to drug use ', ' drug use vulnerability ', ' Underrepresented Groups ', ' minority communities ', ' Neuroimmune ', ' imaging facilities ', ' Infrastructure ', ' enthusiastic atmosphere ', ' enthusiastic environment ', ' supportive atmosphere ', ' supportive environment ', ' ']",NIDA,UNIVERSITY OF GEORGIA,P50,2020,1781382,0.1636289773519223
"Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs PROJECT ABSTRACT The COVID-19 pandemic restrictions to reduce the spread of the SARS-CoV-2 have exacerbated global inequities. These restrictions may have particularly limited engagement in care of HIV-positive people who inject drugs (PWID). This longitudinal project aims to qualitatively assess evolving consequences of the COVID-19 pandemic on health risks and risk behaviors of HIV-positive PWID; and described the impact of stigma on HIV-positive PWID during the COVID-19 pandemic. We will leverage access to the SCRIPT (R00DA041245) study population (n=108); SCRIPT is a community-based RCT testing the feasibility of Acceptance and Commitment Therapy as a stigma intervention among PWID with HIV who are not connected to addiction or HIV care in St. Petersburg, Russia. The SCRIPT study population provides a unique opportunity to understand pandemic impacts on substance use and HIV risk behaviors, as well as health care utilization among community-based HIV-positive PWID. This project will inform rights-based, gender-inclusive preparedness strategies to mitigate adverse pandemic effects and prepare the key population of HIV-positive PWID for future pandemic situations. PROJECT NARRATIVE The COVID-19 lockdowns may have worsened engagement in care of HIV-positive people who injection drugs (PWID) and exacerbated existing stigma and discrimination, limiting this populations human rights. To prepare strategies that ensure equitable HIV and addiction services for HIV-positive PWID in times of emerging infectious disease threats, we are studying the consequences of the COVID-19 pandemic on their healthcare access, stigma, and human rights.","Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs",10199478,R00DA041245,"['Affect ', ' Behavior ', ' Belief ', ' Communities ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Discrimination ', ' Cognitive Discrimination ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Economics ', ' Environment ', ' Face ', ' faces ', ' facial ', ' Fright ', ' Fear ', ' Future ', ' Health ', ' Health Services Accessibility ', ' Access to Care ', ' access to health services ', ' access to services ', ' access to treatment ', ' accessibility to health services ', ' availability of services ', ' care access ', ' health service access ', ' health services availability ', ' service availability ', ' treatment access ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' HIV Seropositivity ', ' Anti-HIV Positivity ', ' HIV Positive ', ' HIV Positivity ', ' HIV Seroconversion ', ' HIV antibody positive ', ' HTLV-III Seroconversion ', ' HTLV-III Seropositivity ', ' Human Rights ', ' Infection ', ' Interview ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Personal Satisfaction ', ' well-being ', ' wellbeing ', ' Publishing ', ' Research ', ' Resources ', ' Research Resources ', ' Rights ', ' Risk ', ' Russia ', ' Social Distance ', ' Substance Use Disorder ', ' Testing ', ' Time ', ' Work ', ' Gender ', ' Generations ', ' Measures ', ' Misinformation ', ' Administrator ', ' Businesses ', ' health care ', ' Healthcare ', ' Risky Behavior ', ' at risk behavior ', ' Risk Behaviors ', ' Caring ', ' base ', ' Lifting ', ' Ensure ', ' AOD use ', ' substance use ', ' substance using ', ' using substances ', ' Alcohol or Other Drugs use ', ' Individual ', ' Health Care Utilization ', ' health care service use ', ' healthcare service use ', ' healthcare service utilization ', ' healthcare utilization ', ' health care service utilization ', ' gender discrimination ', ' Sex Discrimination ', ' drug use ', ' Drug usage ', ' Knowledge ', ' physical health ', ' physical conditioning ', ' Injection Drug User ', ' PWID ', ' people who inject drugs ', ' people who inject illicit drugs ', ' persons who inject drugs ', ' Injecting drug user ', ' Services ', ' Structure ', ' Participant ', ' Harm Minimization ', ' Harm Reduction ', ' drug market ', ' Reporting ', ' social ', ' HIV risk ', ' risk perception ', ' response ', ' stigma ', ' social stigma ', ' theories ', ' Emerging Infectious Diseases ', ' Emerging Communicable Diseases ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Qualitative Research ', ' Preparedness ', ' Readiness ', ' Data ', ' Therapeutic Effect ', ' pandemic ', ' pandemic disease ', ' anti-retroviral therapy ', ' anti-retroviral treatment ', ' antiretroviral treatment ', ' antiretroviral therapy ', ' Health protection ', ' Outcome ', ' Population ', ' community organizations ', ' addictive disorder ', ' addiction ', ' high risk ', ' study population ', ' access to health care ', ' access to healthcare ', ' accessibility of health care ', ' accessibility to health care ', ' accessibility to healthcare ', ' health care access ', ' health care service access ', ' health care service availability ', ' healthcare access ', ' healthcare accessibility ', ' healthcare availability ', ' healthcare service access ', ' healthcare service availability ', ' health care availability ', ' recruit ', ' primary care provider ', ' care providers ', ' Injections ', ' overdose risk ', ' COVID19 ', ' corona virus disease 2019 ', ' coronavirus disease 2019 ', ' COVID-19 ', ' 2019 novel coronavirus ', ' SARS-CoV-2 ', ' SARS-CoV2 ', ' SARS-associated coronavirus 2 ', ' SARS-coronavirus-2 ', ' SARS-related coronavirus 2 ', ' Severe acute respiratory syndrome coronavirus 2 ', ' Wuhan coronavirus ', ' 2019-nCoV ', ' COVID-19 epidemic ', ' COVID19 epidemic ', ' COVID19 pandemic ', ' corona virus disease 2019 epidemic ', ' corona virus disease 2019 pandemic ', ' coronavirus disease 2019 epidemic ', ' coronavirus disease 2019 pandemic ', ' COVID-19 pandemic ', ' ']",NIDA,BOSTON MEDICAL CENTER,R00,2020,160369,0.01819426589269301
"Institute for Translational Research Education (ITRE) in Adolescent Drug Abuse Abstract The applicant proposes the continued development and expansion of a successful research education program for graduate level students and professionals to acquire innovative research skills to address drug abuse and related behavioral health concerns of children and adolescents. Implementation Science continues to be at the forefront of innovative research education; the Institute for Translational Research and Education in Adolescent Drug Abuse (ITRE) will focus on training clinical researchers in implementation research methods, translation of research into community practice, and the practical skills of participatory research. A cross-disciplinary approach, involving multiple colleges at the University of South Florida and Northern Arizona University, as well as local community service agencies, has been developed with special attention to evidence-based practice, translational research, and children and adolescents as an at-risk population. Our new emphasis is on addressing research education with an expanded target of behavioral health researchers with interests in working with at-risk populations including children and families of AI descent and Hispanic populations who have drug abuse and other co-morbid behavioral health conditions, defined as the array of mental, emotional and behavioral disorders of childhood that, along with drug abuse, have devastating effects on adolescent development. Project Narrative This project proposes the continued development and expansion of an innovative model of research education that addresses best practices for translational research in the field of child and adolescent behavioral health, as it relates to substance abuse and co-occurring disorders with an emphasis on at-risk populations including children and families of AI descent and Hispanic populations.",Institute for Translational Research Education (ITRE) in Adolescent Drug Abuse,9683875,R25DA031103,"['Family ', ' Florida ', ' Foundations ', ' Goals ', ' Health Services Research ', ' Health Services Evaluation ', ' Medical Care Research ', ' services research ', ' Institutes ', ' Mentors ', ' Methods ', ' Newsletter ', ' Peer Review ', ' Publishing ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Students ', ' Translations ', ' Universities ', ' conference ', ' convention ', ' summit ', ' symposia ', ' symposium ', ' Family member ', ' Hispanic Populations ', ' Latino Population ', ' Spanish Origin ', ' hispanic community ', ' Hispanics ', ' diverse populations ', ' heterogeneous population ', ' population diversity ', ' Population Heterogeneity ', ' Research Methods ', ' Research Methodology ', ' Magazine ', ' Journals ', ' career ', ' rural region ', ' rural area ', ' urban area ', ' Clinical ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' co-occurring disorders ', ' dual diagnosis ', ' Ensure ', ' Evaluation ', ' Training ', ' pediatric ', ' Childhood ', ' Emotional disorder ', ' Fostering ', ' Populations at Risk ', ' Funding ', ' Immigrant ', ' farmworker ', ' farm worker ', ' Knowledge ', ' programs ', ' interest ', ' collegiate ', ' college ', ' Services ', ' experience ', ' success ', ' Distance Learning ', ' skills ', ' Participant ', ' cultural competence ', ' member ', ' abuse of substances ', ' substance abuse ', ' Substance abuse problem ', ' Modeling ', ' Adolescent Development ', ' behavioral health ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Provider ', ' disparity in health ', ' health disparity ', ' Address ', ' Evidence based practice ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Public Health Instruction ', ' Public Health Training ', ' Public Health Education ', ' trial regimen ', ' trial treatment ', ' Clinical Treatment ', ' Community Practice ', ' Translational Science ', ' translation research ', ' Translational Research ', ' developmental ', ' Development ', ' Clinical Services ', ' website ', ' web site ', ' youth drug abuse ', ' adolescent drug abuse ', ' implementation research ', ' under served population ', ' underserved people ', ' Underserved Population ', ' Minority ', ' Outcome ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' Evidence based program ', ' implementation science ', ' community setting ', ' classroom environment ', ' college atmosphere ', ' collegial atmosphere ', ' collegiate atmosphere ', ' education atmosphere ', ' educational environment ', ' intellectual atmosphere ', ' learning atmosphere ', ' learning environment ', ' school atmosphere ', ' training atmosphere ', ' university atmosphere ', ' educational atmosphere ', ' certificate program ', ' curricular enrichment ', ' curriculum expansion ', ' curriculum enhancement ', ' learning outcome ', ' service-based learning ', ' service learning ', ' social media ', ' recruiting minorities ', ' Minority Recruitment ', ' education research ', ' recruit ', ' service delivery ', ' Migrant ', ' treatment research ', ' Achievement ', ' Achievement Attainment ', ' Arizona ', ' Attention ', ' Behavior Disorders ', ' behavioral disorder ', ' Mental disorders ', ' Mental health disorders ', ' Psychiatric Disease ', ' Psychiatric Disorder ', ' mental illness ', ' psychiatric illness ', ' psychological disorder ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Clinical Research ', ' Clinical Study ', ' Communities ', ' Community Services ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Educational Curriculum ', ' Curriculum ', ' lesson plans ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Education ', ' Educational aspects ', ' Graduate Education ', ' ']",NIDA,UNIVERSITY OF SOUTH FLORIDA,R25,2020,331656,0.060157728196497215
"2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership ABSTRACT Cancer drugs in the United States are almost exclusively developed by, tested in, and optimized for European- Americans. Disparities in U.S. drug development are the result of long-standing inequalities that occur throughout the entire drug discovery pipeline. Only a small number of basic, translational and clinical scientists are Latino/Hispanic or Black/African-American. Less than 2-5% of trial participants are Latino/Hispanic or Black/African-American. Yet, in spite of a lack of data, new drugs are approved by the U.S. Food and Drug Administration (FDA) and subsequently prescribed for Latino/Hispanic or Black/African-American patients, without sufficient testing. It is unacceptable, especially in this era of the Precision Medicine Initiative (PMI), that currently our drugs are developed by, and optimized for, only for an exclusive segment of our citizens. We seek to shift this paradigm by strengthening the existing partnership between University of California at Riverside (UCR) and City of Hope Comprehensive Cancer Center (CoH-CCC). In this proposed P20, UCR and CoH-CCC will partner to develop the resources, infrastructure, and training programs necessary to develop the next generation of therapeutics researchers that reflect the ethnic diversity of Inland Southern California. We anticipate that our P20 program will drive new collaborative R01 grants and K01 and T-type training grants. . Project Narrative (Overview) In this P20 University of California at Riverside (UCR) and City of Hope Comprehensive Cancer Center (CoH- CCC) will partner to develop the resources, infrastructure, and training programs necessary to develop the next generation of basic, translational, and clinical therapeutics researchers that reflect the diversity of the Inland Empire. Together, UCR and CoH-CCC aim to develop the collaborations, translational resources, and training programs to reduce disparities in drug development throughout the entire development pipeline.",2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership,10006559,P20CA242620,"['Acetylation ', ' Affect ', ' Antelopes ', ' Antelopines ', ' Antineoplastic Agents ', ' Anti-Cancer Agents ', ' Antineoplastic Drugs ', ' Antineoplastics ', ' Cancer Drug ', ' Neoplastic Disease Chemotherapeutic Agents ', ' Tumor-Specific Treatment Agents ', ' anti-cancer drug ', ' anticancer agent ', ' anticancer drug ', ' Award ', ' malignant breast neoplasm ', ' Breast Cancer ', ' malignant breast tumor ', ' California ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cell Line ', ' CellLine ', ' Strains Cell Lines ', ' cultured cell line ', ' Cities ', ' Color ', ' Communities ', ' Drug Design ', ' Drug resistance ', ' drug resistant ', ' resistance to Drug ', ' resistant to Drug ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Education ', ' Educational aspects ', ' Engineering ', ' Faculty ', ' Fellowship ', ' Goals ', ' Grant ', ' Hispanic Americans ', ' Spanish Americans ', ' Investments ', ' Joints ', ' Los Angeles ', ' men ', "" men's "", ' Mentors ', ' Mentorship ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Patients ', ' Physicians ', ' outcome forecast ', ' Prognosis ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' medical schools ', ' medical college ', ' school of medicine ', ' Societies ', ' Students ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Training Programs ', ' United States ', ' United States Food and Drug Administration ', ' Food and Drug Administration ', ' USFDA ', ' Universities ', ' Woman ', ' Work ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' Hispanic Populations ', ' Latino Population ', ' Spanish Origin ', ' hispanic community ', ' Hispanics ', ' Latino ', ' Clinical ', ' Phase ', ' Ensure ', ' Training ', ' Individual ', ' European ', ' Fostering ', ' Inequality ', ' Funding ', ' Collaborations ', ' news ', ' Therapeutic ', ' Therapeutic Agents ', ' programs ', ' Scientist ', ' System ', ' Postdoc ', ' Research Associate ', ' post-doc ', ' post-doctoral ', ' Postdoctoral Fellow ', ' American ', ' success ', ' Toxicities ', ' Toxic effect ', ' Participant ', ' Reporting ', ' drug development ', ' drug discovery ', ' Latinas ', ' Latina ', ' Mitochondrial Proteins ', ' Bio-Informatics ', ' Bioinformatics ', ' Institution ', ' Address ', ' Core Facility ', ' Data ', "" Master's Degree "", ' City of Hope Comprehensive Cancer Center ', ' Comprehensive Cancer Center ', ' Conduct Clinical Trials ', ' Non-Hispanic ', ' Nonhispanic ', ' Not Hispanic or Latino ', ' developmental ', ' Development ', ' TNBC ', ' triple-negative breast cancer ', ' triple-negative invasive breast carcinoma ', ' anti-cancer research ', ' cancer research ', ' anticancer research ', ' next generation ', ' Minority ', ' manufacturing facility ', ' Population ', ' cancer disparity ', ' disparity in cancer ', ' cancer health disparity ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' therapeutic agent development ', ' therapeutic development ', ' screening ', ' Drug Targeting ', ' precision-based medicine ', ' precision medicine ', ' Precision Medicine Initiative ', ' training opportunity ', ' ethnically diverse ', ' ethnic diversity ', ' reduce disparity ', ' disparity reduction ', ' minority communities ', ' clinical translation ', ' phase 1 evaluation ', ' phase I evaluation ', ' phase I testing ', ' phase 1 testing ', ' Infrastructure ', ' clinical trial participant ', ' ']",NCI,UNIVERSITY OF CALIFORNIA RIVERSIDE,P20,2020,305324,0.08728368536255911
"AIDS Linked to the IntraVenous Experience (ALIVE) ABSTRACT In this competing renewal, we propose to continue a 30-year cohort of people who inject drugs (PWID). Since 1988, the AIDS Linked to the IntraVenous Experience (ALIVE) study has followed >5200 PWID in a community-based cohort in Baltimore, MD, providing critical insight into the natural and treated course of HIV among urban predominantly minority, disadvantaged PWID. Our team has been highly productive (107 publications in past cycle) and will continue cutting-edge investigations into high HIV/AIDS priority research questions, while serving as a foundation for an array of HIV-related epidemiological and pathogenesis studies. The opioid crisis across the US continues and has not abated in Baltimore. Baltimore has one of the highest US overdose rates and is experiencing demographic and behavioral transitions in the population most affected by opioid use -- from one that is primarily male, older and minority -- to one that affects more women, younger and white individuals. At the same time, there has also been a shift in the expression of HIV infection among PWID. Much of the population of PWID that the ALIVE study has traditionally followed is aging into the decade of life where HIV and its treatment are complicated by the onset of other chronic age-associated health conditions; in 2016, 40% of our cohort had >2 non-communicable diseases (NCD). At the same time <50% of our HIV-positive participants currently have suppressed HIV viral load highlighting a need for a more holistic approach to HIV care one that more broadly incorporates NCDs. Our proposed continuation will address the spectrum of the intersecting HIV and opioid epidemics with an eye towards understanding the impact of opioid use and HIV across the PWID life course. Our Specific Aims are: 1) To monitor temporal trends in the opioid epidemic comparing HIV infected and uninfected PWID across the lifespan, including characterization of shifting drug profiles and context over time and their impact on the incidence of fatal and non-fatal overdose, HIV and HCV infection and mortality. 2) To evaluate the dynamic associations between HIV care continuum outcomes and prevalence and control of NCDs (e.g., diabetes, hypertension, hyperlipidemia, chronic obstructive pulmonary disease [COPD]) and their joint impact on morbidity, mortality and quality of life; and 3) To continue to provide a platform for independently-funded investigations of HIV and drug use. To achieve these aims, we will 1) continue follow-up of HIV positive and negative PWID (~1500); 2) open recruitment once; and 3) evolve our data collection methods to include novel field-based, mHealth and drug testing assessments. The ALIVE cohort is unique in that it comprises a community-based PWID population of both genders with significant representation of African-Americans who are both in and out of medical care; these populations have been underrepresented in HIV and drug use research. Given the scientific rigor of the proposed methods, existing infrastructure, experienced investigators and multiple NIH-funded ancillary studies, we anticipate continued success and substantial scientific impact in the future. ! PROJECT NARRATIVE Many urban settings including Baltimore face dual opioid and HIV epidemics, one among older predominantly minority PWID who are disproportionately affected with HIV, and an emerging epidemic among younger white individuals living in suburban Baltimore who are at high risk for HIV. The findings from this study will inform both interventions targeting new PWID populations at risk for HIV as well as programs to optimize engagement of PWID in care and treatment for not only for HIV but for non-communicable diseases which will improve overall health and well-being.",AIDS Linked to the IntraVenous Experience (ALIVE),9905504,U01DA036297,"['Acquired Immunodeficiency Syndrome ', ' AIDS ', ' Acquired Immune Deficiency ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Affect ', ' Age ', ' ages ', ' Aging ', ' Baltimore ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cities ', ' Communities ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Continuity of Patient Care ', ' Continuity of Care ', ' Continuum of Care ', ' Data Collection ', ' Diabetes Mellitus ', ' diabetes ', ' Disadvantaged ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemic ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Eye ', ' Eyeball ', ' Face ', ' faces ', ' facial ', ' Foundations ', ' Future ', ' Geography ', ' Grant ', ' Health ', ' Hepatitis C ', ' HCV infection ', ' Hepatitis C virus infection ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitus C ', ' hep C ', ' hepatitis non A non B ', ' non A, non B hepatitis ', ' non-A, non-B hepatitis ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' HIV Infections ', ' HTLV-III Infections ', ' HTLV-III-LAV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HIV Seronegativity ', ' HIV Seronegativities ', ' HIV negative ', ' HTLV-III Seronegativities ', ' HTLV-III Seronegativity ', ' HIV Seropositivity ', ' Anti-HIV Positivity ', ' HIV Positive ', ' HIV Positivity ', ' HIV Seroconversion ', ' HIV antibody positive ', ' HTLV-III Seroconversion ', ' HTLV-III Seropositivity ', ' Hyperlipidemia ', ' Hyperlipemia ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Incidence ', ' Joints ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Learning ', ' Life Cycle Stages ', ' Life Cycle ', ' life course ', ' Liver diseases ', ' Hepatic Disorder ', ' hepatic disease ', ' hepatopathy ', ' liver disorder ', ' Longevity ', ' Length of Life ', ' life span ', ' lifespan ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Chronic Obstructive Airway Disease ', ' COPD ', ' Chronic Obstruction Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' Chronic Obstructive Pulmonary Disease ', ' male ', ' Medical Records ', ' Metabolic Diseases ', ' Metabolic Disorder ', ' Thesaurismosis ', ' metabolism disorder ', ' Methods ', ' Methodology ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Overdose ', ' Peer Review ', ' Personal Satisfaction ', ' well-being ', ' wellbeing ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Quality of life ', ' QOL ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Time ', ' Woman ', ' Work ', ' Gender ', ' Generations ', ' Measures ', ' smoking cessation ', ' cease smoking ', ' quit smoking ', ' stop smoking ', ' Treatment outcome ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' Risky Behavior ', ' at risk behavior ', ' Risk Behaviors ', ' Caring ', ' base ', ' suburban ', ' suburbia ', ' suburb ', ' improved ', ' Chronic ', ' Biological ', ' Medical ', ' Link ', ' Training ', ' insight ', ' residential building ', ' residential site ', ' residence ', ' AOD use ', ' substance use ', ' substance using ', ' using substances ', ' Alcohol or Other Drugs use ', ' Individual ', ' Opiates ', ' Opioid ', ' Populations at Risk ', ' drug use ', ' Drug usage ', ' Disease Progression ', ' Funding ', ' Collaborations ', ' Intravenous ', ' Research Priority ', ' Life ', ' AIDS drugs ', ' Anti-AIDS Agents ', ' Anti-AIDS Drugs ', ' Anti-HIV Drugs ', ' Anti-Human Immunodeficiency Virus Agents ', ' antiAIDS agent ', ' Anti-HIV Agents ', ' programs ', ' Viral Burden ', ' Viral Load ', ' Viral Load result ', ' frailty ', ' Investigation ', ' Pattern ', ' Injection Drug User ', ' PWID ', ' people who inject drugs ', ' people who inject illicit drugs ', ' persons who inject drugs ', ' Injecting drug user ', ' experience ', ' success ', ' cohort ', ' novel ', ' Participant ', ' holistic approach ', ' Pathogenesis ', ' Reporting ', ' AIDS/HIV ', ' HIV/AIDS ', ' HIV/AIDS problem ', ' AIDS/HIV problem ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Sentinel ', ' Address ', ' Data ', ' Research Training ', ' Ancillary Study ', ' Monitor ', ' trend ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' Behavioral ', ' Minority ', ' HCV Vaccine ', ' hepatitis C virus vaccine ', ' Hepatitis C Vaccine ', ' Outcome ', ' Population ', ' Prevalence ', ' drug detection ', ' drug testing ', ' platform-independent ', ' high risk ', ' alcohol risk ', ' licit opioid ', ' opiate medication ', ' opioid medication ', ' prescribed opiate ', ' prescribed opioid ', ' prescription opiate ', ' prescription opioid ', ' m-Health ', ' mobile health ', ' mHealth ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' reduce disparity ', ' disparity reduction ', ' Temporal trend ', ' Trends over time ', ' Time trend ', ' Wellbeing trends ', ' Wellness trends ', ' well being trends ', ' Health trends ', ' urban setting ', ' opiate crisis ', ' opioid crisis ', ' opioid epidemic ', ' recruit ', ' Infrastructure ', ' ']",NIDA,JOHNS HOPKINS UNIVERSITY,U01,2020,2760556,0.045326396776262164
"Biomarkers for Dysbiosis-Related HIV-Associated Cognitive Disorders among Persons Who Inject Drugs in Puerto Rico ABSTRACT The current opioid injection incidence in the United States has risen to epidemic levels and is associated with increased risk of HIV-1 transmission and disease progression as well as with other infections in several US states. Given that most HIV+ people who inject drugs (PWID) are now likely to receive anti-retroviral therapy, traditional bio-markers such as HIV viral load and CD4 counts are unlikely to provide a comprehensive assessment of disease progression especially as it affects neurocognitive performance. New biomarkers are needed to track the effects of ongoing HIV infection as it impacts neurocognitive functions. Candidate biomarkers can be found in the interaction between HIV infection, dysbiosis, microbial translocation and systematic inflammation. HIV-1 infection is associated with lymphoid depletion in tissues underlying the gut epithelium, allowing microbial products to transduce into the parenchyma where they act as potent inducers of systemic inflammation. Even when HIV-1 viral load is suppressed by anti-retroviral treatment, chronic immune activation resulting from dysbiosis and translocation can persist. Opioid use also induces gut dysbiosis and supports bacterial translocation. The resulting inappropriate immune activation in PWID may enhance HIV-1 replication, lead to premature aging of T cells, and promote HIV disease progression, including exacerbated HIV-associated neurological disorders (HAND). A more comprehensive set of markers is therefore needed to better understand the course of HIV infection among people who inject drugs (PWID)biomarkers that reflect the combined physiologic impact of ongoing injection drug use and a range of biomic changes that can exaggerate and reinforce the cumulative impact of physiological effects on mental health. The overall objective of our proposed study is to advance the understanding of the effects of HIV infection and injection drug use on the microbiome, with the goal of discovering biomarkers for neurological disease progression among PWID that are related to chronic inflammation and dysbiosis coupled inflammation. Our highly experienced research team will make use of a well-established cohort of PWID in Puerto Ricoa region with historically high levels of injection drug use and an HIV incidence rate that is disproportionately associated with drug use. A prospective, multi-cohort longitudinal study will allow repeated measures from the study population and compare them with similar measures from control groups of HIV negative PWID and HIV-1 infected non-drug users from the same location. This longitudinal evaluation will allow our team to test the hypothesis that HIV-1 infection in PWID intensifies dysbiosis and inflammation which, in turn, exacerbates HIV replication, HAND and HIV treatment failures. We expect that this hypothesis, if true, will have important implications for the emerging drug epidemic in remainder of the United States. In addition to meeting the goals of RFA 18-023, this project will contribute to NIDA and OBSSR's strategic plans for research that bridges pre-clinical and socio-behavioral research, and is responsive to the NIH-wide mandate of improving minority health and reducing health disparities in the United States. NARRATIVE Given the high numbers of new injectors emerging from the rising opioid epidemic, a more comprehensive set of biomarkers is needed to fully understand neurocognitive impacts of HIV infection in people who inject drugs (PWID) in the United States today. This project advances the search for novel biomarkers by examining the links between HIV infection, dysbiosis, microbial translocation, and systemic inflammation among HIV-1 infected PWID in Puerto Rico as these factors predict the neurocognitive disorders known as HAND (HIV-associated neurocognitive disorders). A prospective, multi-cohort longitudinal study will allow repeated measures from the study population and compare them with similar measures from control groups of HIV negative PWID and HIV- 1 infected non-drug users from the same location.",Biomarkers for Dysbiosis-Related HIV-Associated Cognitive Disorders among Persons Who Inject Drugs in Puerto Rico,9949662,R01DA047823,"['Affect ', ' Cognition Disorders ', ' cognitive disease ', ' cognitive disorder ', ' cognitive syndrome ', ' Control Groups ', ' Mental Depression ', ' depression ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemic ', ' Future ', ' Goals ', ' Health ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' HIV Infections ', ' HTLV-III Infections ', ' HTLV-III-LAV Infections ', ' Human T-Lymphotropic Virus Type III Infections ', ' HIV Seronegativity ', ' HIV Seronegativities ', ' HIV negative ', ' HTLV-III Seronegativities ', ' HTLV-III Seronegativity ', ' HIV-1 ', ' HIV-I ', ' HIV1 ', ' Human Immunodeficiency Virus Type 1 ', ' Human immunodeficiency virus 1 ', ' Incidence ', ' Infection ', ' Inflammation ', ' Kentucky ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Maine ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Midwestern United States ', ' Midwest ', ' Midwest U.S. ', ' Midwest US ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Natural Disasters ', ' nervous system disorder ', ' Nervous System Diseases ', ' Neurologic Disorders ', ' Neurological Disorders ', ' neurological disease ', ' Ohio ', ' Public Health ', ' Puerto Rico ', ' Recurrence ', ' Recurrent ', ' Research ', ' Risk ', ' Sampling Studies ', ' Social Behavior ', ' sociobehavior ', ' sociobehavioral ', ' Substance Use Disorder ', ' T-Lymphocyte ', ' T-Cells ', ' thymus derived lymphocyte ', ' Testing ', ' Tissues ', ' Body Tissues ', ' United States ', ' West Virginia ', ' Immunophenotyping ', ' Immunologic Subtyping ', ' immunophenotype ', ' Measures ', ' therapy failure ', ' Treatment Failure ', ' base ', ' Blood Sample ', ' Blood specimen ', ' improved ', ' Site ', ' Chronic ', ' Physiologic ', ' Physiological ', ' Link ', ' Evaluation ', ' Premature Aging ', ' Premature aging syndrome ', ' wasting ', ' Cocaine Users ', ' drug use ', ' Drug usage ', ' Disease Progression ', ' CD4+ Cell Counts ', ' CD4+ Counts ', ' T4 Lymphocyte Count ', ' CD4 Lymphocyte Count ', ' inflammatory mediator ', ' Inflammation Mediators ', ' Bacterial Translocation ', ' Viral Burden ', ' Viral Load ', ' Viral Load result ', ' In Situ ', ' Location ', ' Neurocognitive ', ' Affective Disorders ', ' Mood Disorders ', ' Injection Drug User ', ' PWID ', ' people who inject drugs ', ' people who inject illicit drugs ', ' persons who inject drugs ', ' Injecting drug user ', ' meetings ', ' experience ', ' Performance ', ' success ', ' cohort ', ' microbial ', ' Predictive Factor ', ' AIDS/HIV ', ' HIV/AIDS ', ' HIV/AIDS problem ', ' AIDS/HIV problem ', ' abuse of substances ', ' substance abuse ', ' Substance abuse problem ', ' Gut Epithelium ', ' gastrointestinal epithelium ', ' disparity in health ', ' health disparity ', ' therapy adherence ', ' US State ', ' Geographic state ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Strategic Planning ', ' Lymphoid ', ' Transmission ', ' transmission process ', ' preclinical ', ' pre-clinical ', ' minority health ', ' microbiome ', ' human-associated microbiome ', ' Human Microbiome ', ' metagenome ', ' anti-retroviral therapy ', ' anti-retroviral treatment ', ' antiretroviral treatment ', ' antiretroviral therapy ', ' prospective ', ' Coupled ', ' abused drug ', ' abused drugs ', ' drug abused ', ' drugs abused ', ' drugs of abuse ', ' drug of abuse ', ' high risk ', ' candidate biomarker ', ' candidate marker ', ' new marker ', ' novel biomarker ', ' novel marker ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' nondrug ', ' non-drug ', ' GI microbiota ', ' Gastrointestinal microbiota ', ' enteric microbial community ', ' enteric microbiota ', ' gastrointestinal microbial flora ', ' gut commensal ', ' gut community ', ' gut flora ', ' gut microbe community ', ' gut microbial community ', ' gut microbial composition ', ' gut microbial consortia ', ' gut microbiotic ', ' gut microflora ', ' intestinal flora ', ' intestinal microbes ', ' intestinal microbiota ', ' intestinal microflora ', ' intestinal tract microflora ', ' gut microbiota ', ' Immune Cell Activation ', ' immune activation ', ' injection drug use ', ' HIV 1 associated neurocognitive disorder ', ' HIV-1 associated neurocognitive disorder ', ' HIV-associated neurocognitive disorder ', ' neurocognitive disorder ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' study population ', ' Long-term cohort ', ' Longterm cohort ', ' Longitudinal cohort ', ' Long-term cohort study ', ' Longterm cohort study ', ' Longitudinal cohort study ', ' intravenous opiate ', ' intravenous opioid ', ' opiate injection ', ' opioid injector ', ' opioid injection ', ' opiate crisis ', ' opioid crisis ', ' opioid epidemic ', ' recruit ', ' Injections ', ' Opiate user ', ' Opioid drug user ', ' PWUO ', ' patients who use opioids ', ' people who use opioids ', ' persons who use opioids ', ' opioid user ', ' dysbacteriosis ', ' dysbiotic ', ' microbial imbalance ', ' dysbiosis ', ' Infrastructure ', ' ']",NIDA,UNIVERSITY OF NEBRASKA LINCOLN,R01,2020,605422,0.10432994445562922
